#version: 0.2
i n
t i
r e
t h
a n
e n
e r
e d</w>
o n
o f</w>
a t
r o
i n</w>
th e</w>
i t
a ti
a r
an d</w>
o n</w>
s i
a l
s t
a l</w>
o r
i c
a s
d i
e c
en t
a c
l o
in g</w>
d e
o r</w>
a s</w>
u r
t o</w>
e r</w>
w it
u l
wit h</w>
s e
o m
a m
o l
u c
e s
re s
o c
l y</w>
in e</w>
l e
en t</w>
p h
p ro
o u
p ati
c on
r i
w as</w>
d uc
ati on</w>
T h
er e</w>
v e</w>
i d
e s</w>
at ed</w>
a d
o s
v e
s .</w>
h e
p er
f f
a t</w>
i s</w>
a n</w>
i c</w>
m e
o t
a g
a p
i l
w ere</w>
ent s</w>
u s
c h
c e
i m
duc ed</w>
ti on</w>
i s
a b
t re
h y
t er
c om
t r
f or</w>
Th e</w>
p a
s u
n e
in e
o x
ec t
b y</w>
u n
pati ents</w>
e x
in duced</w>
b e
p l
re n
v er
e ff
ati on
in c
w e
e n</w>
r at
h i
a r</w>
it y</w>
m ent</w>
t er</w>
s ,</w>
p res
re as
a f
re d</w>
c ar
i f
m in
th at</w>
u t
h a
n o
c e</w>
s y
ti on
o p
g n
l i
t e
0 .
u d
l e</w>
r a
- induced</w>
m a
an t
ti c</w>
af ter</w>
tre at
m o
y .</w>
p re
v i
w h
g /
i st
at e</w>
ro u
p t
e m
th er
p or
con t
ti ve</w>
i z
u m
si on</w>
q u
ic al</w>
c l
) .</w>
e p
si gn
as e</w>
an t</w>
d o
ul ar</w>
c o
r u
m on
p o
th e
d a
b e</w>
e t
h o
u m</w>
on e</w>
g h
ur e</w>
ou s</w>
p ar
in f
d .</w>
os e</w>
re ce
i r
inc reas
no t</w>
if ic
car di
ther ap
s er
m g/
ect s</w>
an ti
treat ment</w>
g rou
res p
si s</w>
an g
sign ific
th er</w>
) ,</w>
or m
y ,</w>
e l
v ed</w>
g en
ent r
in g
i a</w>
b u
s e</w>
ar y</w>
lo w
m ic
d ru
u re
min ist
y l
hy per
ti v
c or
m or
as s
ad minist
e v
oc i
c a
ro m</w>
en ce</w>
I n</w>
t en
lo g
si on
d ur
f rom</w>
s p
o b
al ly</w>
e .</w>
re l
ti c
u ro
ass oci
lo p
u s</w>
S :</w>
pa th
eff ec
di s
th is</w>
t a
st ud
e ar
in d
eff ects</w>
re por
ar e</w>
es e</w>
tr a
b lo
us e</w>
de ve
p ot
tre ated</w>
ha d</w>
i d</w>
oc a
t ed</w>
ox ic
d ose</w>
O N
ve l
a z
t s</w>
d er
s ho
i o
deve lop
e st
ro m
th an</w>
associ ated</w>
e ,</w>
mg/ k
i th
se s</w>
su b
ti m
c ur
ac tiv
dur ing</w>
+ /
0. 0
f ol
f i
ou n
ation s</w>
cont ro
bu t</w>
m y
s c
o l</w>
resp on
ut e</w>
in j
id e</w>
ne uro
or y</w>
c y
o log
un c
l l
pot en
w ith
r an
administ r
rece i
ma y</w>
d ec
us ed</w>
v en
res ul
effec t</w>
pati ent
am ine</w>
i ti
rat s</w>
l l</w>
m ent
ren al</w>
stud y</w>
g h</w>
pati ent</w>
( 1
in ed</w>
p os
W e</w>
b o
o d</w>
ff e
en d
an c
in ter
i a
ati ve</w>
d ,</w>
be en</w>
tr an
v er</w>
+/ -</w>
therap y</w>
da y
t oxic
d y
ar di
grou p
n orm
si ve</w>
ag e</w>
es s</w>
ac t
signific ant
hi b
pres s
r on
c oca
d e</w>
fol low
es t</w>
we e
ha ve</w>
f unc
es .</w>
increas ed</w>
w he
com p
al l</w>
ation .</w>
be t
a il
al u
p i
f l
dec reas
sy n
significant ly</w>
0 0</w>
ot h</w>
ch ang
se iz
- 1
c entr
g g
u b
wh o</w>
cl in
me th
t w
l on
y ear
g i
mic ro
dru g
le vel
ac ute</w>
ic h</w>
en c
an ce</w>
administr ation</w>
n o</w>
wh ich</w>
v as
in tra
in v
at e
rece pt
ec h
su gg
am in
u di
( 2
ri s
in hib
or s</w>
grou p</w>
ag on
he m
ou t</w>
he ar
s t</w>
ffe ren
h as</w>
t ri
ab le</w>
re e</w>
f ail
id ence</w>
sho w
hi gh
di se
g l
signific ant</w>
gh t</w>
ob ser
s o</w>
p e
st udi
ve n</w>
cardi a
th ese</w>
S I
g r
d ro
g ra
dru g</w>
we en</w>
ec tion</w>
blo od</w>
develop ed</w>
bet ween</w>
re qu
ou r</w>
m pt
c ase</w>
oc ardi
an al
ul d</w>
v entr
di fferen
b oth</w>
ec tive</w>
pro te
Th is</w>
activ ity</w>
st r
me di
tran s
pa red</w>
al so</w>
s en
ine -induced</w>
sy st
wee k
de p
ventr ic
ine .</w>
f orm
f or
al l
si b
oc cur
1 .
b r
tion s</w>
i al</w>
re at
tw o</w>
ect ed</w>
rel ated</w>
o ther</w>
ure s</w>
c as
ine ,</w>
it s</w>
rat e</w>
clin ical</w>
i t</w>
m a</w>
ph en
de r</w>
d ic
com pared</w>
s ec
re c
tion .</w>
in u
ti al</w>
iz ed</w>
m an
lon g
m il
5 -
C L
mpt om
e th
es ,</w>
level s</w>
er g
tr ac
f ir
al s</w>
pl ic
n on
cardia c</w>
M E
mor e</w>
ventric ular</w>
cont inu
a st
i de
m g</w>
g e
mg/k g
t o
ol d</w>
v ing</w>
coca ine</w>
ver ,</w>
al o
p ri
SI ON
% )</w>
a in
u sion</w>
te st
lo w</w>
c lo
duc tion</w>
con centr
y p
hyper ten
R E
hear t</w>
ar i
ar ter
per i
S U
pl as
0 0
he pati
mo de
ev alu
c al
er al</w>
ec ti
d om
s ur
c ular</w>
increas e</w>
do ses</w>
si a</w>
resul ts</w>
contro l</w>
ris k</w>
C ON
se s
dep end
ep i
ou s
di d</w>
CL U
CON CLU
ti s</w>
CONCLU SION
sy mptom
m i
e -
si st
ne ph
Th ese</w>
b l
ver se</w>
se v
mon th
th i
A C
n it
re g
ch ol
an im
day s</w>
rat s.</w>
i .
y c
he mo
inc l
ch ron
com b
es the
show ed</w>
m al
recei ved</w>
treat ment
le p
ech an
blo c
do se
L T
a x
inhib it
ti g
toxic ity</w>
l ess</w>
si de</w>
my ocardi
m at
le v
u e</w>
l at
dy s
c i
il e</w>
norm al</w>
I n
su p
da y</w>
m echan
o ph
ation ,</w>
T H
it y.</w>
hy poten
follow ing</w>
path y</w>
press ure</w>
s ti
th rom
5 0</w>
ant agon
obser ved</w>
sev ere</w>
e i
2 .
func tion</w>
respon se</w>
is o
u se
T I
hi st
ac tion</w>
li ver</w>
mg/k g</w>
ven ous</w>
b as
an e
oun d</w>
ul ation</w>
o di
de ter
ar k
hy th
e d.</w>
v al
pa in</w>
incl ud
r hyth
oc y
v ul
we ver,</w>
SU LT
e d
at ing</w>
RE SULT
me as
or al</w>
de f
pl ac
an d
in al</w>
repor ted</w>
t ac
RESULT S:</w>
gra ph
ol y
po st
O D
chang es</w>
1 0</w>
il ity</w>
repor t</w>
tion ,</w>
s uc
chron ic</w>
f e
sib le</w>
recept or</w>
ri b
whe n</w>
se l
il l
us ing</w>
os t</w>
on ly</w>
d op
ind ic
k e</w>
ser um</w>
f act
m us
es tig
ic in</w>
ine -
e red</w>
t ro
comp le
' s</w>
l im
er s</w>
me an</w>
inv estig
m un
per id
myocardi al</w>
in .</w>
ME TH
pres sion</w>
l it
y m
olog ical</w>
ati c</w>
vas cular</w>
pres ent</w>
erg ic</w>
fail ure</w>
neph ro
in ,</w>
ar c
as ses
w e</w>
ous ly</w>
ad verse</w>
con vul
h or
hy dro
b ra
os ph
1 0
s ed</w>
5 %</w>
with out</w>
ce ll
t h</w>
th ree</w>
un der
bloc k
METH OD
decreas ed</w>
therap y.</w>
fi b
per io
- old</w>
y -
pro t
st er
c an</w>
th ou
in -
mechan is
p it
me t
fir st</w>
anal y
inc idence</w>
for e</w>
at ri
2 -
f requ
epi lep
E C
g lo
resp ecti
ex pos
ia .</w>
ph osph
v ari
gi ven</w>
cas es</w>
re duced</w>
w om
ab ol
tim e</w>
( P
i l</w>
a .</w>
inj ection</w>
b i
ver y</w>
d at
sugg est</w>
ad e</w>
u al</w>
sion .</w>
ar rhyth
recei ving</w>
d rom
i r</w>
m ost</w>
tion al</w>
si s.</w>
d ue</w>
u p
c at
3 .
patient s.</w>
administ ered</w>
s tim
al ph
de sc
si mil
hi gh</w>
ect ro
inf l
sen si
n er
t ing</w>
plas ma</w>
com plic
dise ase</w>
p at
in iti
ar g
im mun
comb in
as t</w>
re f
seiz ures</w>
plac e
en z
syn drom
f ound</w>
s y</w>
b le
im pro
ha vi
p r
em ia</w>
T o</w>
fl u
th ose</w>
pre vi
sion s</w>
respecti vel
hy po
ocy t
ac et
sec on
ia ,</w>
( A
an esthe
s )</w>
sho uld</w>
m it
t ot
H o
sp ec
f ind
o re
METHOD S:</w>
m ac
2 0</w>
sugg est
ent ed</w>
thou gh</w>
c ap
m er
s al
ma in
sy ch
( C
ca used</w>
sub j
h alo
year -old</w>
x im
il d
high er</w>
cardi o
we ll</w>
contro l
syst em
d ox
be havi
eff ect
com m
inf usion</w>
enc y</w>
ing s</w>
P A
intra venous</w>
duc e</w>
se qu
depend ent</w>
a ff
ei ther</w>
ent ly</w>
ad ren
per im
ce ll</w>
dise as
occur red</w>
t yp
c anc
sion ,</w>
gen er
mic e</w>
week s</w>
on ary</w>
a y
syndrom e</w>
symptom s</w>
studi es</w>
o gen
it e</w>
m ark
or ub
3 0</w>
ac id</w>
d am
simil ar</w>
the ir</w>
am p
p sych
gr am
de mon
be fore</w>
ve l</w>
re co
ou t
el ectro
ad di
d s</w>
( P</w>
h e</w>
d ra
re ac
group s</w>
pro g
si de
p er</w>
Ho wever,</w>
ran dom
norm al
no w
ce re
develop ment</w>
CONCLUSION S:</w>
bra in</w>
di ag
s om
com par
k g
C A
f t</w>
ve ly</w>
po si
en ti
e m</w>
r h
es s
in -induced</w>
at al</w>
ec t</w>
k now
A l
ne ur
lo s
drug s</w>
ic i
a ,</w>
vi e
V E
a v
k e
m ul
1 9
3 -
pro duced</w>
o ver</w>
k ine
dra w
4 -
cor onary</w>
dis continu
re ver
t ol
k ing</w>
dat a</w>
met abol
d ed</w>
en ce
m s</w>
5 0
ol e</w>
cur ren
ter m</w>
p ine</w>
ex perim
U N
m ia</w>
c hem
treatment .</w>
per form
mor ph
c ul
decreas e</w>
st at
combin ation</w>
ph y
inv ol
tot al</w>
c hemo
ure .</w>
o ver
month s</w>
in to</w>
am ide</w>
ch ild
R O
ox y
n ec
be ta
dis or
with in</w>
it y,</w>
t ox
se ver
m in</w>
ar ac
r ang
c le
low er</w>
ab ility</w>
e d,</w>
b ut
re t
um b
ti s
ro le</w>
dox orub
pre v
b ec
anim als</w>
with draw
ac h</w>
tol er
s ul
hypoten sion</w>
di st
L -
we i
suc h</w>
is t</w>
y o
4 .
i ly</w>
wh ile</w>
cardi a</w>
0.0 0
trans pl
non -
am ph
g reat
por t
r ine</w>
v alu
v al</w>
id ine</w>
ot or</w>
r at</w>
e lev
on e
( 3
u red</w>
mode l</w>
ca use</w>
1 2</w>
lo c
I t</w>
ol ic</w>
l or
ic ac
m is
ox id
mg/ m
e u
me dic
Th ere</w>
% ,</w>
br al</w>
u res
pi lo
s on
ic ally</w>
ho ur
find ings</w>
re gi
ra di
ane ous</w>
effec tive</w>
ex c
I I
v id
ar mac
f our</w>
c le</w>
th ere</w>
) -
A f
et y</w>
i p
le ft</w>
tac hy
z ed</w>
throm bo
h um
i es</w>
o per
M A
u r</w>
az ep
op en
sur g
at es</w>
uc le
t ub
dose -
o id
al e</w>
cy clo
1 -
e re
v ol
do g
t um
olog ic</w>
re as</w>
de s</w>
cat al
se t</w>
con cl
an y</w>
t e</w>
re ve
dy n
al ed</w>
ot oxic
i red</w>
5 .
eff icac
patient s,</w>
ur al</w>
d ing</w>
ent al</w>
pro long
- term</w>
a y</w>
u p</w>
d os
inf arc
re vie
m ents</w>
( S
K G
ant s</w>
halo perid
( 0.
le vel</w>
alph a
T w
concentr ations</w>
anc ed</w>
hepati c</w>
m ic</w>
1 5</w>
s af
ex peri
mode l
arter ial</w>
differen t</w>
is h
- dose</w>
v it
con di
B AC
s ing
a use</w>
RO UN
KG ROUN
BAC KGROUN
2 4</w>
da ily</w>
ap pro
meth yl
co uld</w>
c in
m ol
k in
A n
m ine</w>
prog res
pilo car
inj ur
at ory</w>
li thi
de t
arac ter
e tic</w>
y l</w>
poten tial</w>
s odi
ag ain
great er</w>
pe a
inj ec
micro gram
ing .</w>
p ac
an e</w>
O B
si s,</w>
re duction</w>
J EC
A N
ph eral</w>
d ul
Af ter</w>
im pa
ex am
pro p
bas el
again st</w>
c ol
u l</w>
in ary</w>
g en</w>
ar b
en s
0.0 5
hyperten sion</w>
ch aracter
stim ul
s a
ing ,</w>
l ab
. )</w>
l ine</w>
includ ing</w>
car b
f em
7 .
TI VE
bo d
OB JEC
o id</w>
al ter
l in
di ab
oca ine</w>
amph et
studi ed</w>
g o
OBJEC TIVE
at ten
is chem
glo mer
ad y
neur on
co ur
w ar
1 )</w>
p ul
6 -
hepati tis</w>
lo l</w>
dop amine</w>
ph armac
ur ther</w>
phy si
i ous</w>
2 0
mg/kg )</w>
6 .
( p</w>
ev idence</w>
on g</w>
i tion</w>
on ic</w>
am e</w>
o graph
p p
nit ro
reve aled</w>
pos sible</w>
n umb
BACKGROUN D
str uc
ro p
r ac
on set</w>
e ach</w>
ve ment</w>
year s</w>
prote in</w>
al ,</w>
meas ured</w>
ate ly</w>
am e
os pit
cell s</w>
beta -
prote in
pri m
en h
peri pheral</w>
centr al</w>
infl am
bod y</w>
l id
us ,</w>
N T
mon it
O n
br ady
1 ).</w>
follow ed</w>
dur ation</w>
yc in</w>
th al
iti es</w>
comm on</w>
S E
BACKGROUND :</w>
mal e</w>
th rou
l if
im port
ent an
A d
ac ti
p y
vi r
ch lor
catal ep
it ed</w>
v ac
tic s</w>
P ati
n a
o f
ll ed</w>
on t
perform ed</w>
G rou
ap p
seiz ure</w>
eu tic</w>
n ic
ad en
4 0</w>
antagon ist
A ll</w>
id enti
sodi um</w>
ri c</w>
( n</w>
poten ti
tic al</w>
s m
previ ously</w>
posi tive</w>
ad ul
c um
CONCLUSION :</w>
f low</w>
a in</w>
re ,</w>
po in
whe ther</w>
A D
Al though</w>
f ul
efficac y</w>
ge si
de x
evalu ated</w>
o d
ine ph
concentr ation</w>
chol est
wee k</w>
fl ur
t ly</w>
is m</w>
ta ined</w>
therap eutic</w>
1 ,</w>
N A</w>
y e
ma j
s ol
di vid
mg/kg ,</w>
mus cle</w>
he mor
b il
cere bral</w>
a d</w>
6 0</w>
he pat
re n</w>
l y
p oly
canc er</w>
curren t</w>
str ated</w>
c es</w>
pro po
ur ia</w>
hemor rh
enz ym
desc ri
A B
mic e.</w>
c is
stat us</w>
le u
secon d
n i
know n</w>
cardi om
cal ci
- treated</w>
ar ly</w>
an s</w>
pl e</w>
par tic
ce p
om a</w>
2 5</w>
perio d</w>
expos ure</w>
t .</w>
re duc
re cor
( N
ex pression</w>
an a
tiv ity</w>
st res
throm b
t est</w>
ear ly</w>
i. p
f en
ati n</w>
an ce
som e</w>
h ospit
ish ed</w>
child ren</w>
2 ,</w>
tox ic</w>
path y.</w>
s /
deter mine</w>
9 5%</w>
dyn am
typ e</w>
sing le</w>
r am
syst em</w>
id ne
Pati ents</w>
al .</w>
te m
k ed</w>
c oun
f ac
d ou
anti -
r ati
8 .
s hor
deter min
( D
basel ine</w>
s us
o st
S )</w>
( H
respon ses</w>
a ined</w>
demon strated</w>
az ol
hyper al
N o</w>
er .</w>
diag no
withdraw al</w>
enc ed</w>
los s</w>
con sist
N e
leu k
ac id
f urther</w>
1 00</w>
c ent
in ine</w>
numb er</w>
long -term</w>
whe reas</w>
al y
C h
z ap
oc amp
analy sis</w>
pri or</w>
ab normal
hi pp
en e
u tion</w>
mon ary</w>
l y,</w>
lit er
recept ors</w>
k idne
fi ed</w>
subj ects</w>
b o</w>
disor der
cardio vascular</w>
gl ut
m g
psych o
c ess
asses sed</w>
( 4
a th
si x</w>
i. v
c it
c er
P )</w>
seiz ures
I I</w>
re sist
P ro
pro duc
place bo</w>
hipp ocamp
de l
as si
di rec
chang e</w>
ation s.</w>
transpl ant
fi ve</w>
diseas e.</w>
bec ause</w>
convul s
al ity</w>
A c
system ic</w>
el l
includ ed</w>
A )</w>
ur inary</w>
nic ot
fact ors</w>
ep iso
ence ph
ac tive</w>
st ar
OBJECTIVE :</w>
r ap
oc h
c reat
in trac
i v
s hi
s :</w>
on e.</w>
in ten
( M
re le
mul ti
respectivel y.</w>
medi an</w>
pro b
A T
ad v
or ph
gl yc
exam ined</w>
0 %</w>
differen ces</w>
se en</w>
S T
surg er
sel ective</w>
rib ed</w>
olog y</w>
t ,</w>
stud y.</w>
ro s
he par
sur vi
e de
st ro
am ong</w>
R e
pro st
hour s</w>
hist ory</w>
hum an</w>
st ri
increas es</w>
mechanis m</w>
investig ated</w>
ti es</w>
prote ren
indic ate</w>
A M
tis su
in duc
f er
app ear
sub st
doxorub icin</w>
p ir
inf u
C om
u lo
ang io
ud e</w>
o -
min ut
bl ad
arter y</w>
w or
5 ,</w>
me n</w>
f entan
0 -
ge sia</w>
Grou p</w>
li ke</w>
- 1</w>
sensi tivity</w>
a u
sp inal</w>
cardiom yo
he ad
is ol
a w
oper ative</w>
prolong ed</w>
m m
he al
2 )</w>
resul ted</w>
sp ont
lithi um</w>
hyperten sive</w>
r it
ol -induced</w>
c ir
m en
experim ental</w>
su s</w>
ne w</w>
f ul</w>
atten u
ag e
A I
ren ce</w>
pres ented</w>
if ic</w>
- bl
otoxic ity</w>
chemo therapy</w>
l as
iz ation</w>
e l</w>
dys kine
ma xim
wom en</w>
liter at
medi ated</w>
gl uc
hydro x
f ol</w>
p le
ner v
f ic
8 -
second ary</w>
am ide
pres ent
re s</w>
pro f
contro lled</w>
e ti
E ff
% ),</w>
wei ght</w>
j u
mechanis ms</w>
sc op
ag ent</w>
maj or</w>
de press
ab s
ver sus</w>
cl on
G AB
iti s</w>
ev ents</w>
ag ent
the li
throu gh</w>
import ant</w>
calci um</w>
rat es</w>
spec ific</w>
n ucle
a ut
I C
dou ble
re st
bi op
in duction</w>
ro sis</w>
ate d.</w>
A t</w>
% ).</w>
dro me
cap sa
arrhyth mi
i ed</w>
dis c
ti co
pres su
le s</w>
am eth
frequ ency</w>
car cin
atri c</w>
ra z
syn drome
inhib ition</w>
m otor</w>
lo ro
associ ation</w>
en do
Tw o</w>
iso proteren
group s.</w>
v is
prim ary</w>
en g
dys function</w>
toxic ity.</w>
P re
ox ide</w>
N -
head ac
neuro pathy</w>
D E
s ame</w>
ster oid
p op
hem at
a k
1 4
inflam mat
cy t
pa m</w>
fem ale</w>
di ff
n ot
( E
tachy cardia</w>
ic e</w>
un der</w>
wom an</w>
ar d</w>
elev ated</w>
H B
a si
vac a
n ess</w>
er ,</w>
ati s
ab l
st and
o ro
infl u
m .</w>
alpha -
cyclo phosph
ab ly</w>
arb it
1 4</w>
ti s.</w>
pl us</w>
inflammat ory</w>
lid ocaine</w>
k al
tran si
pi vaca
comple te</w>
fib ri
con trac
con side
t al</w>
con f
res ol
experi enced</w>
ph ase</w>
or s.</w>
g u
P O
sup por
pul monary</w>
pre treatment</w>
differen ce</w>
ain ing</w>
l arg
m l
convuls ant</w>
ti l
impa ir
glo b
b ol
al one</w>
lit ax
i gn
o m</w>
k et
ag ents</w>
on i
neuro log
ta king</w>
s ;</w>
o lol</w>
1 3
u ally</w>
propo fol</w>
fibri ll
e qu
double -bl
ur ine</w>
tri al</w>
re ma
m m</w>
n ing</w>
rat s,</w>
d oc
antagon ist</w>
C on
on e,</w>
oc c
dam age</w>
9 .
repor ts</w>
o sis</w>
gr ade</w>
injur y</w>
random ized</w>
M D
place bo
in duce</w>
( -1
m b
( T
inj ected</w>
ho wever,</w>
u ses</w>
sub sequ
pres ence</w>
e pam</w>
agon ist
stim ulation</w>
S t
blad der</w>
at eral</w>
5- H
f o
u s.</w>
out com
1 2
v s</w>
c ut
x i
ac in</w>
O ur</w>
e ven</w>
diagno sis</w>
show n</w>
stud y,</w>
m ag
de g
administr ation.</w>
+/ -
res h
dynam ic</w>
dog s</w>
an emia</w>
sever al</w>
7 -
se d
ation shi
p ent
gen ic</w>
cour se</w>
amphet amine</w>
re tion</w>
hy p
C I
treatment ,</w>
ex amin
in d</w>
fail ure.</w>
n os
struc t
ot on
t y</w>
stres s</w>
ogen e
enceph alo
con tr
b ac
s in
re pe
p en
b enz
sal ine</w>
s ).</w>
D -
s o
py ri
pre dic
per f
tic ally</w>
secon d</w>
m id
infarc tion</w>
group .</w>
a re
A n</w>
follow -
1 1</w>
ye ar</w>
reac tions</w>
therap y,</w>
initi al</w>
On e</w>
pro l
ag e,</w>
rel ationshi
previ ous</w>
- related</w>
ana esthe
saf ety</w>
op io
su ff
sp ective</w>
fact or</w>
as pir
i g
effect s.</w>
ne g
s it
comb ined</w>
ab out</w>
t op
mo der
str ic
li ke
( 5
t y-
th resh
ro w
os ine</w>
ocyt open
discontinu ation</w>
is on</w>
ay ed</w>
le ast</w>
d ar
in divid
d -
conside red</w>
a ver
per sist
te d.</w>
m an</w>
li p
in tr
glomer ular</w>
cum ul
pos sib
oc ic
ob arbit
inter val</w>
ur ing</w>
func tion.</w>
pre gn
pac litax
mark ed</w>
behavi oral</w>
bas ed</w>
rang e</w>
l ym
c an
1 6</w>
par t
on d
the sis</w>
t en</w>
resul t</w>
al ine</w>
ure ,</w>
ro lim
ineph rine</w>
determin ed</w>
ag e.</w>
expos ed</w>
regi on
oc hem
mil d</w>
my o
c ent</w>
inhibit or</w>
f ree</w>
(2 )</w>
at h</w>
er y
adul t</w>
prot ective</w>
pilocar p
ell ular</w>
al s.</w>
sever ity</w>
p tion</w>
i di
g ast
evalu ate</w>
s co
high -dose</w>
cor rel
con fir
atri al</w>
in o
I V</w>
ner ve</w>
descri be</w>
demon st
v s.</w>
diab etic</w>
) ;</w>
pat ter
ap pea
ang i
activ ation</w>
P A</w>
the y</w>
impro ved</w>
epilep tic
cont rib
diag nos
b le</w>
mor t
AN D</w>
tim es</w>
rati o</w>
phen y
oph yl
haloperid ol</w>
az epam</w>
catalep sy</w>
a sis</w>
the tic</w>
pa ren
e very</w>
anal gesi
suggest s</w>
I S
en d</w>
b io
thromb ocytopen
ch loro
ex er
( L
( -
zap ine</w>
ri pt
or g
inter sti
heal th
b ro
am in</w>
d r
1 7
requ ired</w>
st e
sen s
C a
1 3</w>
revie w</w>
ol ,</w>
re tro
y n
ob tained</w>
con tra
1 5
re action</w>
im en
s h
re x
rat ory</w>
acet yl
disc us
ti zed</w>
me mb
ser oton
sul f
lym ph
ame ter
ic ill
de li
3 ,</w>
reas t</w>
i f</w>
f oc
complic ations</w>
um .</w>
2 00
t u
qu in
microgram s/
inc e</w>
0 ,</w>
ph yl
valu es</w>
lev o
1 8</w>
intersti tial</w>
M e
and /
D i
tre m
my e
m es
and/ or</w>
2 %</w>
y ro
ta k
de ath</w>
H y
obser v
invol ved</w>
ev ent
enzym e</w>
le sions</w>
io dar
rele ase</w>
ol .</w>
ment al</w>
all y,</w>
ate le
th en</w>
b reast</w>
suggest ed</w>
reco very</w>
n al</w>
fe at
1 %</w>
ri am
aly sis</w>
vi v
respon se
I V
monit or
com mon
y oun
tion s.</w>
it ing</w>
a m</w>
al ized</w>
se d.</w>
day s.</w>
al though</w>
t -
s k
e pt
E x
pl atin</w>
glyc er
b ind
ag es</w>
1 8
val pro
like ly</w>
oly tic</w>
hor mon
sign s</w>
l y.</w>
azep ine</w>
y st
l u
P ark
O n</w>
( 6
sy m
ma z
mo di
bu pivaca
nerv ous</w>
mis sion</w>
epilep tic</w>
complic ation</w>
activ ity.</w>
phen yl
mi ght</w>
i or</w>
per it
Ac ute</w>
ve ,</w>
rema ined</w>
ati vely</w>
alph a</w>
st ,</w>
ocic ep
rever sible</w>
go ing</w>
Park in
D O
n or
enh anced</w>
be ing</w>
use .</w>
sm all</w>
ro ph
( B
ri tis</w>
lo x
ic in-induced</w>
P h
A L
k g</w>
C O
wei gh
adv anced</w>
m ou
P -
1 6
tum or</w>
loc al</w>
H g
man if
en ing</w>
P T
C lin
D )</w>
tissu e</w>
p ur
e t</w>
brady cardia</w>
p ec
le .</w>
ex pl
ery th
3 %</w>
B oth</w>
ot ens
an ne
abnormal ities</w>
ve d.</w>
relationshi p</w>
ref le
pro per
pl atele
b ene
kidne y</w>
col l
as s</w>
prop ran
def ici
syst olic</w>
morph ine</w>
R )</w>
pro ce
. ,</w>
ven tion</w>
pilocar pine</w>
con duc
adren ergic</w>
seizures .</w>
hyperal gesia</w>
health y</w>
c op
W he
ser ious</w>
ac hi
ad ju
ex trac
vol um
te red</w>
i ratory</w>
or atory</w>
N S
v es</w>
mye lo
appea red</w>
st atis
par ameter
g row
do es</w>
me mor
creat inine</w>
addi tion,</w>
f -
di g
character is
tro ph
perit one
na use
desc ribed</w>
co ag
ation al</w>
r he
Th e
test ed</w>
ri l</w>
group ,</w>
re .</w>
min im
eth yl
a thi
tem por
re main
memb ran
me d
ca uses</w>
ox if
g ran
cumul ative</w>
ation s,</w>
( 7
A -
pot assi
resp iratory</w>
glut am
transi ent</w>
multi ple</w>
me ta
drug .</w>
ch anne
asses s
si a.</w>
vit amin</w>
o path
O f</w>
tub ular</w>
ri st
reco gn
minut es</w>
st ained</w>
investig ate</w>
week s.</w>
r ing</w>
graph ic</w>
con ver
coca ine-
m uc
de pres
ab dom
theli al</w>
occur rence</w>
hydrox y
um ,</w>
ev o
direc t</w>
19 9
( 8
cut aneous</w>
aff ected</w>
m ed</w>
cont aining</w>
re d.</w>
vari ous</w>
spont aneous</w>
ot yp
ex hib
n al
f r
ay s</w>
ab il
for m</w>
contr ast</w>
S E</w>
or s
par tial</w>
occ ur</w>
injec tions</w>
convul sions</w>
c y</w>
mg/m 2</w>
prev ented</w>
continu ous</w>
anesthe sia</w>
vas cul
rel ative</w>
med ical</w>
ap am
ag ed</w>
re p
manif est
bloc k</w>
0.05 ).</w>
ex ten
impro vement</w>
ri al</w>
pro v
pro duce</w>
de ath
chol in
ar th
a i
D uring</w>
( R
sho w</w>
in s</w>
identi fied</w>
H g</w>
r are</w>
l ,</w>
immun o
angi otens
C B
i.v .</w>
ei ght</w>
Parkin son
prev ent</w>
pres c
poin t
t ent</w>
anim al</w>
am iodar
se ven</w>
M T
( O
s ch
de pression</w>
a c</w>
s mo
re comm
(1 .
xim ately</w>
i tive</w>
ede ma</w>
asses s</w>
a ro
th ir
i ally</w>
( G
frequ ently</w>
dos age</w>
5-H T
ri ght</w>
l ac
survi val</w>
sign ed</w>
moder ate</w>
neuron s</w>
inhibit ed</w>
R NA</w>
4 %</w>
( +
Th ree</w>
ograph y</w>
form ation</w>
reg imen
ochem ical</w>
res t</w>
or ,</w>
meas ure
doc um
gl y
agon ist</w>
compar ison</w>
% .</w>
pot ent</w>
es tive</w>
E R
1 ),</w>
pharmac o
ameth as
ogen ic</w>
mal ign
comple te
appear s</w>
an xi
we ll
cor e</w>
ti me
suff ici
ischem ic</w>
est abl
ud ed</w>
d n
ca ffe
anc es</w>
H C
mit ted</w>
er o
abs ence</w>
2 1</w>
p an
im medi
co gn
ud ine</w>
s .
respectivel y
monitor ing</w>
com it
an d,</w>
lo com
ch est</w>
N a
pro c
im plic
w at
l ast
cle ar
proce d
flur ane</w>
increas ing</w>
halo th
h er</w>
s -
ri g
em ic</w>
ech ocardi
bind ing</w>
ane ously</w>
addi tion</w>
suggest ing</w>
neuro lep
influ ence</w>
diab et
cy sti
em ia.</w>
drug s.</w>
amin o
se x
in test
control s</w>
ot rop
medic ation</w>
k s</w>
w ide
under going</w>
syndrome .</w>
contra st,</w>
sy .</w>
l am
il tr
es s,</w>
nicot ine</w>
episo des</w>
6 %</w>
w ent</w>
s ity</w>
post -
le ad
dop a</w>
och ond
m al</w>
1 ,
of ten</w>
follow- up</w>
biop sy</w>
ti z
cep ti
th ec
protein uria</w>
di l
micro g/
m ar
amin ergic</w>
sin us</w>
hyper troph
adren oc
gener ation</w>
bo di
4 ,</w>
ogene sis</w>
ur ther
f ar
o red</w>
neg ative</w>
c ros
8 %</w>
lip id</w>
l ed</w>
um -
paclitax el</w>
def ic
volum e</w>
vi r</w>
ent am
disor der</w>
arrhythmi as</w>
P G
u sion,</w>
ox ic</w>
or s,</w>
T reat
. 0
consist ent</w>
(1 0</w>
f et
e di
inf ec
cor tico
in ic</w>
in de
func tional</w>
er s.</w>
ch all
ag l
Q T</w>
l un
t s.</w>
sensi tive</w>
appro ximately</w>
sus cepti
model s</w>
mag ne
resul ting</w>
evalu ation</w>
e p</w>
ur ac
ti l</w>
over all</w>
inc rist
hyperten sion.</w>
hospit al</w>
drug -induced</w>
cyclophosph amide</w>
at e,</w>
repe ated</w>
pa thetic</w>
om e</w>
mort ality</w>
literat ure</w>
wh om</w>
ur b
regi men</w>
recei ve</w>
re duce</w>
nephro tic</w>
ep ti
dex amethas
addi tional</w>
month s.</w>
man age
im ag
es pec
b or
anti psycho
al lo
a vir
ran ial</w>
pen icill
( I
impair ment</w>
espec ially</w>
mg/k g/
deg ree</w>
at e.</w>
ret ur
d g
S er
2 .</w>
ul arly</w>
aspir in</w>
S i
2 00</w>
ris perid
h al
av ail
vis ual</w>
subsequ ent</w>
hepar in</w>
coca ine-induced</w>
con sc
carb am
9 %</w>
us ers</w>
transpl ant</w>
press ed</w>
a de
r o</w>
dose- dependent</w>
b ri
C ardi
( 1</w>
under went</w>
potassi um</w>
post operative</w>
es tim
cy cl
ot rex
cardiomyo pathy</w>
achi e
3 )</w>
opio id</w>
m ut
arrhyth mic</w>
larg e</w>
C )</w>
A R
1 7</w>
ru s</w>
rolim us</w>
ic ul
concl ude</w>
antagonist s</w>
al co
Whe n</w>
8 0</w>
ver apam
thresh old</w>
m ,</w>
patient 's</w>
pa in.</w>
control s.</w>
a ke</w>
y cl
v om
c al</w>
alter ations</w>
acti vi
u tive</w>
s he</w>
or .</w>
mit ochond
progres sive</w>
pro phyl
platele t</w>
ore ,</w>
nec rosis</w>
do pa
4 8</w>
sk in</w>
p ected</w>
ocyt e</w>
clin ically</w>
U R
om orph
h ic
t om
stand ard</w>
memor y</w>
inhibit ors</w>
au th
I m
y ing</w>
micro scop
ex ist
attenu ated</w>
6 ,</w>
un d
suppor t</w>
he dul
chall eng
5 )</w>
D e
pl at
T R
ophyl line</w>
7 %</w>
d en
0. 5</w>
thrombo sis</w>
re current</w>
pre dn
ent .</w>
az ine</w>
( V
te en</w>
su stained</w>
he x
surger y</w>
par kin
comp oun
sp ite</w>
o z
flu oro
feat ures</w>
T )</w>
id al</w>
i.p .)</w>
b one</w>
Tw ent
H e
F urther
use ful</w>
the re
Treat ment</w>
st age</w>
sch iz
mol /
st ron
hippocamp al</w>
cy to
test s</w>
qu anti
con comit
9 0</w>
ta in</w>
initi ation</w>
ent ,</w>
d ine</w>
con sec
cogn itive</w>
am ine-induced</w>
aff ect</w>
Th us,</w>
t am
revie w
grow th</w>
an th
sc hedul
o v
er ing</w>
youn g</w>
anesthe tized</w>
p ic
manage ment</w>
g entam
frequ ent</w>
fibrill ation</w>
arc h</w>
adrenoc ept
o ff
lon g</w>
intra peritone
ut ed</w>
parkin son
nec ess
n ed</w>
intest inal</w>
complete ly</w>
R ec
neuro toxicity</w>
mon o
character ized</w>
F )</w>
rap id</w>
ment .</w>
indic ated</w>
S R
oc lon
ai m</w>
ag ic</w>
tak en</w>
path w
ad riam
ab normal</w>
suc cess
exc retion</w>
di ure
cholin ergic</w>
om e
i atric</w>
aden osine</w>
TI ON
L i
vi a</w>
sti t
perf usion</w>
isol ated</w>
anti depress
W ist
N A
ter min
statis tically</w>
pro ble
id ity</w>
hypoten sive</w>
hear ing</w>
az ole</w>
anti convulsant</w>
anal o
a or
s ),</w>
is ed</w>
cholest er
ac tions</w>
ne ut
f atal</w>
evo ked</w>
epileptic us</w>
clon idine</w>
agl and
- associated</w>
ve .</w>
s core</w>
respectivel y,</w>
pea k</w>
lab oratory</w>
h our</w>
are a</w>
SE :</w>
se g
on e-
7 5</w>
v incrist
man y</w>
as .</w>
Parkinson 's</w>
se m
meta st
immun e</w>
not ed</w>
le ,</w>
gra m</w>
N O
thrombocytopen ia</w>
thec al</w>
oxy gen</w>
neuron al</w>
inter val
f y</w>
common ly</w>
C N
ni qu
maxim um</w>
l .</w>
ho l</w>
det ected</w>
cor related</w>
repor ted.</w>
sp ecti
rever sed</w>
mi x
meth otrex
lat er</w>
er gen
p ap
ob j
ine d.</w>
conduc ted</w>
1 9</w>
ref r
n ine</w>
mon th</w>
inter action</w>
g am
consec utive</w>
viv o</w>
recor ded</w>
un til</w>
neuro path
ly ing</w>
em ergen
( 9
toler ated</w>
s li
oc on
gr ad
di ast
cardi otoxicity</w>
Ne uro
u pt
pilocarp ine-induced</w>
iz ed,</w>
i an</w>
electro cardio
el der
al -
refr act
prob ably</w>
capsa icin</w>
bet a</w>
as e,</w>
al le
I N
kg (-1
id om
ac comp
oph ren
develop ing</w>
C P
ve red</w>
resol ved</w>
headac he</w>
ch arg
ro w</w>
isoproteren ol</w>
inf ants</w>
anim als.</w>
s ing</w>
fentan yl</w>
est ro
canc er.</w>
bupivaca ine</w>
ap pe
th yro
pro m
dist urb
fail ed</w>
car e</w>
ar t
per cent</w>
i ve</w>
ect om
dose .</w>
c r
- like</w>
dop aminergic</w>
w o
subj ect
sel f-
parameter s</w>
on ucle
effect .</w>
ed ly</w>
di ed</w>
rit er
ri bu
re m
rat .</w>
mg/ d
double-bl ind</w>
diagnos ed</w>
UR PO
P URPO
-1 .
m l</w>
m RNA</w>
Clin ical</w>
sym pathetic</w>
con g
block ade</w>
aver age</w>
AI D
tion s,</w>
M )</w>
( mean</w>
seroton in</w>
mechan ical</w>
con si
K -
9 -
under lying</w>
prol act
metabol ic</w>
j ection</w>
b ility</w>
at s</w>
S e
vit ro</w>
PURPO SE:</w>
% ;</w>
nit ric</w>
ischem ia</w>
arrhyth mia</w>
schiz ophren
resist ant</w>
prost agland
mo re,</w>
GAB A
D NA</w>
perio d.</w>
individ u
war far
p ren
o lo
ble ed
sco res</w>
intra ven
di pyri
st op
propran olol</w>
dipyri dam
In tra
2 ).</w>
fe w</w>
ect ing</w>
cl u
alter n
( 5</w>
resist ance</w>
las tic</w>
accomp an
C H
level s.</w>
il l</w>
ide ,</w>
hemorrh age</w>
er b
enc es</w>
di azepam</w>
ac h
S ub
(2 .
pregn anc
ne w
li e
en al</w>
ch ed</w>
wo uld</w>
refle x</w>
no rep
tam oxif
se ,</w>
rec i
del ayed</w>
P R
refract ory</w>
le ar
ap omorph
ag g
1 00
surg ical</w>
t ech
se em
or der</w>
lun g</w>
com pl
E E
) -induced</w>
pop ul
confir med</w>
v es
pre val
per cent
conf idence</w>
chlor ide</w>
ap plic
ance .</w>
rel atively</w>
bil i
al tered</w>
L )</w>
C I</w>
lam iv
anti bodi
0.05 )</w>
y s</w>
ster oid</w>
gast ro
u ter
toler ance</w>
ti s,</w>
ref ore,</w>
nal ox
Wist ar</w>
C D
v ag
s por
Eff ects</w>
ocicep tive</w>
mark edly</w>
lo p</w>
deve lop</w>
(1 )</w>
random ly</w>
patter n</w>
effect s,</w>
diseas e,</w>
8 ,</w>
sup ple
mou se</w>
bil ateral</w>
A s</w>
2 8</w>
2 3
ve hic
stri atal</w>
ru b
h is</w>
diast olic</w>
c riter
b ile</w>
n .</w>
locom otor</w>
reg ul
om eth
be g
n g/
continu ed</w>
p raz
auth ors</w>
ac ce
7 ,</w>
2 5
tri als</w>
ol ar</w>
chol ine</w>
ar ge
0.0 00
side -
s le
partic ularly</w>
Th ir
I )</w>
z e</w>
tw ice</w>
os f
no vel</w>
gen eral</w>
correl ation</w>
8 0
vas odi
obser ved.</w>
n or</w>
hyperal gesi
eth an
diabet es</w>
de spite</w>
II I</w>
prot ection</w>
upt ake</w>
eryth ro
ind ometh
foc al</w>
am ine,</w>
C S
te x</w>
re ly</w>
activi ties</w>
2. 5</w>
valu e</w>
oxid ative</w>
behavi or</w>
Further more,</w>
trem or</w>
st ra
sion s.</w>
potenti ally</w>
ex ac
c ri
an ter
ad mitted</w>
( F
el ic
dyskine si
con sequ
am ine.</w>
activ ity,</w>
ac c
R es
P ,</w>
2 50</w>
pr us
mar row</w>
ful ly</w>
transplant ation</w>
st ate</w>
recomm end
ap paren
T E
requ ir
ne on
fol d</w>
analgesi c</w>
G F
D A</w>
inde x</w>
examin ation</w>
child ren
y r
prov ide</w>
intra thecal</w>
concomit ant</w>
us ually</w>
st re
pl ay</w>
high -
exc it
est er
dis charg
da il
t s,</w>
pheny to
otrop ic</w>
inten sity</w>
t le</w>
rap id
pre vention</w>
pre treated</w>
p as
ic ,</w>
at tri
50 %</w>
ster one</w>
glomer ul
cor tical</w>
cong estive</w>
2 4
subst anti
occur ring</w>
en e</w>
demonst rate</w>
de d.</w>
u it
physi ological</w>
ing es
in suffici
impa ired</w>
et ine</w>
benz odi
i um</w>
i es.</w>
wat er</w>
gener alized</w>
appro pri
A S
0 00</w>
su per
reci pi
phen obarbit
n =
hemo dynamic</w>
ffe red</w>
progres sion</w>
ineph r
ex tr
S he</w>
P er
se arch</w>
ne x
docum ented</w>
ap op
cor tex</w>
adren aline</w>
as th
5- F
metabol it
neurolog ical</w>
imag ing</w>
doxorub ic
adju st
S H
psych iatric</w>
ne ed</w>
exhib ited</w>
em ia,</w>
A m
tempor al</w>
outcom e</w>
oni um</w>
channe l</w>
caffe ine</w>
block ing</w>
thal am
mi gra
bas al</w>
st able</w>
neurolog ic</w>
iz e</w>
hypo kal
attri but
amiodar one</w>
Q T
vir al</w>
thir d</w>
su m
al s,</w>
SI G
r al</w>
prot oc
oc or
m as
. 00
p ub
mol ec
lif er
ide .</w>
hypo thesis</w>
E )</w>
o side</w>
m ade</w>
g est
ex cep
elev ation</w>
concl uded</w>
a -
per oxid
main tained</w>
2 2</w>
wide ly</w>
im pl
cas es.</w>
vol un
my oclon
metabol ism</w>
ep inephrine</w>
am ne
C Y
nitro prus
7 0</w>
reg ar
monit ored</w>
methyl -
ha em
a di
O R
In c
pro lifer
o ti
mid azol
wh ite</w>
symptom atic</w>
sti ll</w>
oly sis</w>
da y,</w>
at ro
R enal</w>
tech niqu
ol amine</w>
hem olytic</w>
rat e,</w>
pre -
p ose</w>
ocyt es</w>
nec ro
anti coag
F or</w>
E P
DE SIG
obj ective</w>
concl usion,</w>
Twent y-
urac il</w>
proper ties</w>
pro pi
n at
low -
co hor
am oun
1 .</w>
0.00 1).</w>
on ce</w>
am pl
in si
immun os
encephalo pathy</w>
elder ly</w>
tre at</w>
mat er
l ast</w>
decreas es</w>
car ri
vi rus</w>
stri at
rhe um
mus cular</w>
es s.</w>
disorder s</w>
di et
con duction</w>
cess ation</w>
sens ory</w>
se t
meth ad
hemorrh agic</w>
graph y</w>
an ,</w>
F our</w>
z ol
at tac
anti oxid
E n
ti ally</w>
ribu tion</w>
ne ed
id ate</w>
angiotens in</w>
y :</w>
le ad</w>
ind ,</w>
ate d,</w>
haloperid ol-induced</w>
fib ro
ep id
em bol
car bo
acti n</w>
te tra
stro ke</w>
s ince</w>
rop en
perform ance</w>
ot er
mitochond rial</w>
main ten
anti bio
B ec
5 00</w>
low ing</w>
st on
sensi tiz
s oci
reg ulation</w>
di z
bi ochemical</w>
accompan ied</w>
ab use</w>
y mptom
pharmaco kine
partic ip
in a</w>
cont ent</w>
5 %)</w>
t ure</w>
p epti
metast atic</w>
le y</w>
is h</w>
func tion,</w>
discontinu ed</w>
as es</w>
year s.</w>
ul e</w>
th reat
patient .</w>
p u
do but
H -
om a.</w>
oc ular</w>
epilep sy</w>
bol us</w>
H e</w>
mo dul
ine- treated</w>
defici ency</w>
z in
ket amine</w>
induc es</w>
hypoten sion.</w>
clo zapine</w>
verapam il</w>
se par
gen ous</w>
est radi
( p
rel ap
flu id</w>
fic ial</w>
em br
compar able</w>
E D
D 2</w>
ta ke</w>
repor t.</w>
random ized,</w>
gen e
b ic
6 )</w>
4 )</w>
j unc
high ly</w>
hyper activity</w>
discus sed.</w>
convul sive</w>
v ast
r ho
pr ag
org an
malign ant</w>
ill ary</w>
en al
def ined</w>
tachy cardia
pa in,</w>
maxim al</w>
fail ure,</w>
e y
clear ance</w>
apop to
C R
retur ned</w>
pub l
ou ab
S prag
D aw
3 5</w>
pressu re,</w>
p t</w>
symptom s.</w>
s. c
pro spective</w>
in te
dexamethas one</w>
d o</w>
Bec ause</w>
( 95%</w>
pre par
lim b
agonist s</w>
achie ved</w>
en .</w>
dog s.</w>
cle s</w>
ram idal</w>
prostagland in</w>
m ia.</w>
in dependent</w>
dep le
ca the
aut o
Daw ley</w>
DESIG N
3 0
u e-
toxic ity,</w>
star ting</w>
s ite</w>
persist ent</w>
or -
om en
gr af
coun t</w>
N MD
B P</w>
is tic</w>
hy dr
2 3</w>
) )</w>
prof ile</w>
infu sion.</w>
immunos up
hormon e</w>
di et</w>
contrib ute</w>
c h</w>
se .</w>
rapid ly</w>
preval ence</w>
pre ci
plas tic</w>
os in</w>
der iv
ab o
M R
n if
mo ve
membran e</w>
lim ited</w>
iltr ation</w>
divid ed</w>
Eff ect</w>
An ti
2 6</w>
vas o
syn ap
stre pt
injec tion.</w>
hepat oc
G )</w>
D ru
1. 5</w>
t ur
rib avir
ox i
model .</w>
b ar
ati c
appe ar</w>
tum ors</w>
si mul
remain s</w>
ph al
l ate</w>
in toxic
pharmac ological</w>
le ph
comp on
ax is</w>
w a
risperid one</w>
pro duction</w>
mainten ance</w>
inf used</w>
glutam ate</w>
aor tic</w>
star ted</w>
nitro glycer
inflam m
cis e</w>
ce f
cat ech
b rom
azep am
assess ment</w>
act ing</w>
comple x</w>
as c
DESIGN :</w>
the si
sed ation</w>
mon ke
intraven ously</w>
chang ed</w>
appropri ate</w>
A ,</w>
we ak
or ation</w>
nucle us</w>
o ver,</w>
idom ide</w>
gen e</w>
block ed</w>
M y
st ere
k .</w>
f rac
A T</w>
one -induced</w>
group s,</w>
pit uit
neut ropen
my c
cysti tis</w>
con sum
a un
4 5</w>
4 4</w>
ra m</w>
placebo -
or ally</w>
fem al
dom in
day s,</w>
cor ding</w>
P .</w>
s '</w>
meth amphetamine</w>
inf ection</w>
antagonist ,</w>
w er</w>
om as</w>
g al
di alysis</w>
cyclo spor
consc ious</w>
arc in
uro myc
the ophylline</w>
par t</w>
methotrex ate</w>
in sul
anti arrhythmic</w>
threat ening</w>
pe di
neur al</w>
in st
carcin oma</w>
0.0 1).</w>
surger y.</w>
mic e,</w>
long er</w>
inc id
dose ,</w>
bec ame</w>
F ol
si g
om et
kin ase</w>
if osf
S C
th io
struct ural</w>
p al
m u
inhibit ory</w>
S .</w>
E i
meth o
day )</w>
Hy per
volun te
p s</w>
lox acin</w>
anter ior</w>
reg res
qu ine</w>
pur pose</w>
os in
m ia,</w>
lif e-
g li
condi tions</w>
avail able</w>
Sprag ue-
us ual</w>
supple ment
phen omen
double-bl ind,</w>
cis platin</w>
b re
al one.</w>
M ore
E NT
tamoxif en</w>
rheum at
path ogenesis</w>
ma .</w>
it al</w>
immedi ately</w>
descri be
am ine-
U n
well -
seizures ,</w>
res er
pro por
indic ating</w>
experi ence</w>
cyclophosph amide
bet ter</w>
V )</w>
2 ,
carbam azepine</w>
b ul
antibodi es</w>
W h
PA TI
lo fen
de n</w>
ance ,</w>
Sprague- Dawley</w>
S cal
S -
7 )</w>
ro tox
ran s
point es</w>
B e
week ly</w>
st -
p ut
ol /
log ical</w>
is e</w>
emergen cy</w>
al b
GAB A</w>
3 2</w>
3 00</w>
suscepti bility</w>
otoxic ity.</w>
cor rec
C o
wor sen
saf e</w>
presc ribed</w>
ox in</w>
o ther
long -
lid oca
lat eral</w>
invol vement</w>
gastro intestinal</w>
consi der
compoun ds</w>
M P
2 /
possib ility</w>
amin onucle
PATI ENT
HB V</w>
sup pression</w>
literat ure.</w>
lead ing</w>
l act
haloth ane</w>
gam ma
characteris tics</w>
possib ly</w>
or th
or b
nephro pathy</w>
main ly</w>
li g
el ec
C A</w>
rati o
im b
fr action</w>
depend ently</w>
compar e</w>
as ,</w>
analy zed</w>
adrenocept or</w>
throu gh
stop p
ro x
respon sible</w>
n s</w>
levo dopa</w>
high est</w>
dyskine sia</w>
Ad minist
ic ardi
exac erb
es sen
r ation</w>
min ant</w>
le th
id s</w>
ex tent</w>
c ed</w>
The refore,</w>
test ing</w>
poin t</w>
min ,</w>
ex amine</w>
c he
aun dic
anxi ety</w>
S M
R ats</w>
More over,</w>
L ,</w>
H D
rec ent</w>
r as
prom ot
ph asi
pedi atric</w>
ocor tico
inf orm
hy pe
ere bral</w>
U /
C .</w>
4 00</w>
su d
rat e
p uromyc
lif e</w>
fi el
em b
av oid
appear ance</w>
ant in
a sia</w>
S ince</w>
up on</w>
th us</w>
reco vered</w>
pos ed</w>
norep inephrine</w>
nause a</w>
h ,</w>
fet al</w>
dys function.</w>
applic ation</w>
P las
sm all
le dg
P D
5 ).</w>
v an
ol ar
gener ally</w>
con ven
at or</w>
F ive</w>
(1 00</w>
y )</w>
sh oc
pop ulation</w>
oxy gen
op tic</w>
N G
0. 1</w>
t on
recommend ed</w>
pro vid
pr amine</w>
it ation</w>
vasodi lat
ur ic</w>
mat ure</w>
in ing</w>
en ro
be ll
administr ation,</w>
C -
reduc ing</w>
p ect
injur y.</w>
ic k
e ly</w>
I F
( 2</w>
system .</w>
rec ently</w>
pic rotox
ot en
magne si
ev id
di min
condi tion</w>
stron g
neuro pathy.</w>
e mo
an other</w>
L /
3 6</w>
3 .</w>
3 ,
- dependent</w>
t or
rang e,</w>
prolong ation</w>
neph ritis</w>
le g
f at
equ al</w>
bleed ing</w>
V PA</w>
on s</w>
nif edi
includ e</w>
fic ation</w>
endo genous</w>
amin oph
( n=
si m
sex ual</w>
ograph ic</w>
antagon ized</w>
A mon
0. 6
use ,</w>
spont aneously</w>
pro ca
occur s</w>
know ledg
dopa -induced</w>
condi tion
cl ero
ari ly</w>
anth rac
aminoph en</w>
C ocaine</w>
ser ies</w>
cl assi
P D</w>
transplant ation.</w>
ti le</w>
studi ed.</w>
sec retion</w>
phosph ate</w>
oc ript
lit tle</w>
level s,</w>
ic s</w>
alco hol</w>
2 7</w>
y si
steroid al</w>
seem s</w>
r ad
o ur
iti s.</w>
f ron
f low
er ior</w>
enal ap
thi az
rat e.</w>
pro specti
minim al</w>
intrac ranial</w>
il d</w>
excep t</w>
e jection</w>
apparen t</w>
ad ol
EC G</w>
Amon g</w>
uc in
ot oc
kg -1</w>
fac il
ear li
anti- inflammatory</w>
0 %)</w>
on al</w>
gly co
ence ,</w>
elec tr
contrac ep
cere bro
acet am
3 %)</w>
warfar in</w>
pro xim
ol an
ev ent</w>
cholester ol</w>
T -
NMD A</w>
2 9
v als</w>
rheumat oid</w>
oph ysi
month s,</w>
mo d
low -dose</w>
h all
g a
da y.</w>
ch o
ab ine</w>
0. 5
ven til
endo thelial</w>
cas es,</w>
cal cul
abo ve</w>
I ,</w>
1 /
year s,</w>
typ ical</w>
l ine
gran ulo
glut athi
epid ural</w>
EE G</w>
D es
wh ere</w>
ur g
sc ale</w>
phenyto in</w>
ot oxic</w>
hippocamp us</w>
S N
flu ox
d ent
c u
N O</w>
pu t</w>
oph il
mat ched</w>
ens ity</w>
I -
sc re
predn isol
men ing
medic ations</w>
lim iting</w>
fib rosis</w>
f am
drug s,</w>
deter i
coca ine.</w>
brady cardia
at yp
S im
simul t
sc al
ro ut
review ed</w>
puromyc in</w>
ob struc
min .</w>
l -
inter vals</w>
hyperten sion,</w>
hyper sensitivity</w>
e )</w>
deli ri
as ed</w>
w ill</w>
up per</w>
typ es</w>
s ac
prop yl
on ate</w>
ocardi al</w>
j aundic
ine mia</w>
in take</w>
identi fy</w>
ha ving</w>
g ang
dobut amine</w>
ap y
ad dic
abdom inal</w>
Plas ma</w>
8 )</w>
trans por
through out</w>
syn thesis</w>
ra ther</w>
adriam ycin</w>
ade qu
7 2</w>
tre mor
si d
re mia</w>
r ic
p .
k g/
indometh acin</w>
hypoten sion,</w>
fo ur
cor tis
A g
10 -
un i
s al</w>
r ab
quanti t
predic t
mus car
microgram s</w>
mg/kg ),</w>
mater nal</w>
li ght</w>
k ind
a reas</w>
ures .</w>
ur ia,</w>
sup pressed</w>
neurolep tic</w>
it h</w>
ful minant</w>
establ ished</w>
er s,</w>
to ge
parkinson ian</w>
is m.</w>
cohor t</w>
can n
antipsycho tic</w>
a emia</w>
OBJECTIVE S:</w>
produc es</w>
p lo
myo pathy</w>
meth od</w>
as signed</w>
H i
rat ing</w>
last ing</w>
i.v .)</w>
b asis</w>
as part
ac cording</w>
A .</w>
1 %)</w>
0. 9
rel ax
present ing</w>
om al</w>
drug ,</w>
de signed</w>
cir cul
arter i
anal gesia</w>
W ith</w>
U S
Administ ration</w>
tr ic
path y,</w>
impro ve</w>
ap pl
2 ),</w>
y g
ti vely</w>
retro spective</w>
requ i
individ ual</w>
ence .</w>
con cer
L .</w>
tac rolimus</w>
sit es</w>
re ten
lab el
individu als</w>
chem ical</w>
cell ular</w>
(A B
pituit ary</w>
oter icin</w>
ol der</w>
ne um
h om
as e.</w>
anesthe tic</w>
6 5</w>
to -
ret ino
re lev
o t</w>
life- threatening</w>
exist ing</w>
CA SE</w>
4 .</w>
un treated</w>
thrombo tic</w>
t a</w>
inf ected</w>
hum an
ca us
S ev
prol actin</w>
lamiv udine</w>
glob in</w>
dipyridam ole</w>
de oxy
ar rest</w>
' -
sup pres
nalox one</w>
h r</w>
go od</w>
describe d.</w>
cell s.</w>
pheny leph
percent age</w>
path ophysi
ma in</w>
impl ant
fer ase</w>
do w
chemo therapy.</w>
tic s.</w>
recept ors.</w>
proxim al</w>
on in</w>
gluc ose</w>
gast ric</w>
gamma -
ethan ol</w>
ate -
apy ramidal</w>
ame li
ac qu
AT P
t ex
se ly</w>
gentam icin</w>
es sive</w>
en ,</w>
af ter
ac tic</w>
L I
2 9</w>
0. 7
oc ca
m mol/
lo ad
invol ving</w>
hyper prolact
det ect
al ter</w>
agent s.</w>
Sev ere</w>
PG E
C T
( 3</w>
tri al.</w>
treat ments</w>
se ud
ri tis.</w>
requir ing</w>
necess ary</w>
infarc tion.</w>
in ation</w>
f ore
elic ited</w>
cy cle</w>
acet aminophen</w>
D S)</w>
1 50</w>
war d</w>
vascul itis</w>
respon ding</w>
mm Hg
ment ,</w>
le -
l eng
headac he
experim ents</w>
ce mia</w>
AC T</w>
week s,</w>
subsequ ently</w>
propo fol
posi tion</w>
per for
o .</w>
inges tion</w>
cir rho
atyp ical</w>
abdom y
Ser um</w>
0.00 1)</w>
valpro ic</w>
se ve
s os
re curren
muscar inic</w>
criter ia</w>
conven tional</w>
Me an</w>
region al</w>
preci pit
meas ures</w>
diff er</w>
com a</w>
co -
aw are</w>
anaesthe sia</w>
al op
Inc reas
4 %)</w>
2 4-
( group</w>
uro sem
sa des</w>
penicill amine</w>
ne o
me dul
m s.</w>
id ov
hall ucin
conver ting</w>
un it</w>
til ity</w>
patient ,</w>
midazol am</w>
kg )</w>
e me
abol ished</w>
(P <
y clo
sli gh
reduc es</w>
prev ent
oz otoc
gang li
cere bell
cardiomyo pathy.</w>
brom ocript
as al</w>
X -
3 9
stric tion</w>
s amp
region s</w>
or ity</w>
on .</w>
oc cl
anti body</w>
ti n</w>
there fore</w>
the m</w>
sus pected</w>
ri se</w>
qu es
fac e</w>
exer cise</w>
depress ed</w>
de s
ant s.</w>
7 %)</w>
19 8
0. 8
( 0.0
vaso press
osin ophil
i ved</w>
end -
contrib ut
cholest asis</w>
au g
allo dyn
2 %)</w>
rab b
nephro toxicity</w>
lac k</w>
episo de</w>
ent ly,</w>
re mo
on -
muc h</w>
migra ine</w>
cum ulation</w>
I NT
D op
Ad verse</w>
ti az
or i
mm Hg</w>
k ,</w>
cl ass</w>
children .</w>
art an</w>
ant ly</w>
ST R
On ly</w>
C M
3 ).</w>
0.0 1)</w>
ur ia.</w>
t as
spec ific
sp as
si a,</w>
response .</w>
ors ade</w>
o si
methad one</w>
iz ing</w>
depend ence</w>
deg re
ar m</w>
toxic ities</w>
pit e</w>
leuk emia</w>
hy d
hepatoc ellular</w>
comp ound</w>
anesthe sia.</w>
Des pite</w>
6 %)</w>
- -
sub cutaneous</w>
medul l
lat ency</w>
g ue</w>
H IV
H )</w>
Fol lowing</w>
0. 2</w>
vincrist ine</w>
sle ep</w>
s ar
rel ation</w>
om ycin</w>
ic -
he l
g re
fen flur
end ing</w>
1. 0</w>
( i.
p ron
n er</w>
magnesi um</w>
h und
cap top
b ir
R -
pressu re.</w>
ml /
lat er,</w>
glob ul
enzym es</w>
altern ative</w>
(2 0</w>
( 50</w>
top ical</w>
r in
pul se</w>
physi cal</w>
observ ation</w>
isoproteren ol-induced</w>
ine )</w>
diz zin
direc tly</w>
bu propi
9 9
os mol
m L</w>
fe rence</w>
estim ated</w>
ep inephr
cholest atic</w>
all y.</w>
A r
ma ,</w>
initi ated</w>
f av
dose s.</w>
diure tic</w>
desc rib
cor tex
al k
The y</w>
A s
1 2-
sud den</w>
steroid s</w>
sion s,</w>
mus t</w>
intraperitone al</w>
immun ore
b ur
aspart ate</w>
5- fluoro
vi ous</w>
ribavir in</w>
perio d,</w>
or e</w>
mix ed</w>
hist ological</w>
g ,</w>
dist ribution</w>
diff icul
arg inine</w>
Com par
(3 )</w>
need ed</w>
me tr
know n.</w>
inter fer
cy cles</w>
carbo platin</w>
ag e-
Cardi ac</w>
A P
2 6
tr as
suc cin
pre domin
hypertroph y</w>
doxorub icin-induced</w>
dos ing</w>
dam age.</w>
challeng e</w>
Pre treatment</w>
CY P
CI ,</w>
3 1</w>
( i
w all</w>
vom it
trans f
stro k
rig idity</w>
n oc
f ed</w>
antioxid ant</w>
al ol</w>
adren al
ac t</w>
ab le.</w>
w ay</w>
valpro ate</w>
si l
iso flurane</w>
is ch
investig ation</w>
il .</w>
i.p .
cros s-
cour ses</w>
carri ed</w>
L e
I g
st en
regres sion</w>
reac tive</w>
ot om
och rom
iti es.</w>
defic its</w>
cor d</w>
at a</w>
an o
amph otericin</w>
C ,</w>
trac t</w>
synap tic</w>
pro mis
f urosem
es )</w>
epilep sy.</w>
d ensity</w>
cul t
Si x</w>
2 7
vom iting</w>
ure a</w>
thresh ol
regimen s</w>
me ti
S P
ro n</w>
r y</w>
or ig
observ ations</w>
mg/ day</w>
ke le
inhib it</w>
implic ated</w>
hund red</w>
gen etic</w>
fi t</w>
d )</w>
ac cumulation</w>
U D
Q u
z idov
thi op
subject s.</w>
strept ozotoc
pro maz
physi ci
n a</w>
hyper cal
func tion
fron tal</w>
ent er
consist ed</w>
[ 3
s wit
hepati tis.</w>
find ing</w>
d ors
bene ficial</w>
ampl it
STR ACT</w>
C T</w>
5 7
ron ch
res c
recogn ized</w>
op i
on g
normal .</w>
n one</w>
kg(-1 )</w>
i b
el im
e -induced</w>
an .</w>
W OR
TE D</w>
PA N</w>
E l
D o
(+ )-
thal idomide</w>
strong ly</w>
resol ution</w>
regar ding</w>
prof en</w>
par tially</w>
norm oten
complic ated</w>
bor n</w>
block er</w>
WOR DS)</w>
UN CA
UNCA TED</w>
TR UNCATED</w>
F if
(AB STRACT</w>
un it
syn cop
subst ance</w>
publ ished</w>
ne i
ia sis</w>
glutathi one</w>
di sp
de part
MT X</w>
F -
vas ocon
ron ic</w>
pa rox
od ds</w>
molec ular</w>
gluc ocortico
extr apyramidal</w>
ev er</w>
2 8
sy ,</w>
spec tr
place ment</w>
dyskinesi as</w>
diagnos tic</w>
cl er
ad ine</w>
L V</w>
In ter
2 5-
radi o
ra rely</w>
om ic</w>
em at
di azepam
al bu
tiv en
test .</w>
shor t</w>
remain ing</w>
over dose</w>
nitroprus side</w>
micro g</w>
inform ation</w>
i.p .</w>
gra v
ca ref
W ith
Scal e</w>
H ist
sligh tly</w>
sel ected</w>
placebo- controlled</w>
olog ically</w>
intr am
clon id
aminonucle oside</w>
al g
TION :</w>
pro vi
pre ce
placebo .</w>
on ,</w>
e osinophil
Wh ile</w>
ve loc
tic ent
sp i
pres ents</w>
pregnanc y</w>
pent obarbit
nei ther</w>
min )</w>
infu sions</w>
f all</w>
activ ated</w>
0. 3</w>
( range</w>
v ant</w>
syn th
som n
re fl
metabolit es</w>
atro pine</w>
ar tic
success fully</w>
ici ans</w>
di an</w>
cer tain</w>
a ph
dil tiaz
cl onic</w>
ca using</w>
appl ied</w>
amoun t</w>
O ther</w>
C l
si ze</w>
par acetam
ot rans
neon atal</w>
l ic
il ateral</w>
hist opath
gu an
b ronch
adol es
L D
C or
4 0
4 ).</w>
y ;</w>
se s.</w>
oc arcin
manifest ations</w>
l er
g y
extrac t</w>
ex trem
ex pres
anticoag ul
amne sia</w>
al ong</w>
al most</w>
I T
-1 -
pro fi
potenti ated</w>
pl asia</w>
or rh
move ments</w>
fentan il</w>
estro gen</w>
ch ic
ameli or
MA P</w>
un usual</w>
sensitiz ation</w>
rh abdomy
it ory</w>
in ning</w>
deriv ati
3 3</w>
( 3.
samp les</w>
rever sal</w>
pron oun
par alle
o vari
lox ac
i dis
ch ar
O )</w>
- type</w>
vast atin</w>
um -induced</w>
re lie
prophyl axis</w>
pr acti
nause a,</w>
find ing
fi x
de generation</w>
d on
attribut ed</w>
T H</w>
M eth
B y</w>
ymptom atic</w>
respon ded</w>
protein s</w>
open -
lo cal
im i
G lu
Ch ronic</w>
3 7</w>
1 20</w>
ri f
p neum
n ociceptive</w>
follow- up
comple x
a )</w>
H ep
respectively ).</w>
injec tion,</w>
flu o
c .
bili ary</w>
ad ded</w>
symptom s,</w>
poly morph
mag nit
initi ally</w>
creat ine</w>
ap lastic</w>
S ign
M A</w>
I .</w>
CN S</w>
ul tras
ta il
studi es.</w>
pregn ant</w>
ost e
nifedi pine</w>
g er</w>
anti hypertensive</w>
S ,</w>
vari ety</w>
trans mission</w>
tem per
si vely</w>
inter mit
h .</w>
facil it
estradi ol</w>
essen tial</w>
dors al</w>
death .</w>
tri gg
t onic</w>
st o
phenobarbit al</w>
n ess,</w>
my el
mg )</w>
metabol ite</w>
maj ority</w>
f en</w>
b aro
IS C
A b
9 ,</w>
res on
ob ut
li po
le sion</w>
impro ve
import ance</w>
hydro chloride</w>
di ar
der ived</w>
comple ted</w>
a im
ISC US
I N</w>
F or
D ISCUS
5 5</w>
vie w</w>
vehic le</w>
treat ing</w>
stere otyp
rou s</w>
re verse</w>
pac t</w>
org an</w>
oni az
od -
is oniaz
extrac ellular</w>
exten sive</w>
di pine</w>
depres sive</w>
cathe ter
arac h
aden ocarcin
Y :</w>
1. 0
st rate
regi on</w>
prevent ing</w>
prednisol one</w>
pi ri
phosph at
per son
out put</w>
inhibit or,</w>
i bu
hemat ologic</w>
degre es</w>
cis plat
c -
bl ast
am mon
G -
F urther</w>
DISCUS SION
wh ose</w>
st in
shor t
path ological</w>
os pas
l up
ch rom
bene fit</w>
alb um
agent ,</w>
adju vant</w>
a vir</w>
M MA
ve -
test o
op tim
is ,</w>
equ i
det ection</w>
dent ate</w>
c ou
P ost
3 4</w>
thou ght</w>
reson ance</w>
plas mic</w>
pan ic</w>
op en</w>
on at
mg/kg ).</w>
he ad</w>
epi thelial</w>
drug -
capsa icin-induced</w>
b al
as e-
arrhythmi as.</w>
D is
B )</w>
t in
su ffered</w>
seg ment</w>
p id
open ia</w>
meas ure</w>
li ver
hepat otoxicity</w>
g em
enh ance
enceph al
dy ston
R A</w>
DISCUSSION :</w>
AD R</w>
0. 4
th at
sp ir
proc es
inten sive</w>
insuffici ency</w>
in es</w>
i onic</w>
fiel d</w>
experim ent
evalu able</w>
dist inc
St ud
Res ul
P C
AC E</w>
8 %)</w>
( 50
temper at
pronoun ced</w>
po or</w>
os cop
muc os
mg ,</w>
earli er</w>
a ir
U sing</w>
B lo
) /
tiven ess</w>
re mission</w>
nor adrenaline</w>
n -
mo vement</w>
induc ing</w>
g all
fac ial</w>
cl ar
catech ol
adequ ate</w>
T TI
SE TTI
F K
F .</w>
t y
reac h
o ventricular</w>
mpt om</w>
e ph
def ects</w>
at roph
anim als,</w>
a fferen
v ent
t orsade</w>
revie we
provid ed</w>
pre mature</w>
pi de
pepti de</w>
min or</w>
li th
l an
in tro
] ,</w>
S yst
3- year-old</w>
succin yl
mor b
hemo globin</w>
bar ri
b us
ation -
ab le
Thir ty-
SETTI NG
u ti
quin ol
prim arily</w>
enro lled</w>
electro n</w>
e :</w>
dig oxin</w>
curren tly</w>
consum ption</w>
M ost</w>
year s)</w>
ti d</w>
sol ution</w>
paclitax el
capsa ic
cap ac
apomorph ine</w>
anthrac ycl
ad mis
Sim il
SU RE
SU MMA
SUMMA R
R ,</w>
H ear
20 -
yl -
y pt
wa ve</w>
ru pt
pent yl
p on
log ic</w>
loc ated</w>
lo b
clin ic
cler osis</w>
beg inning</w>
anti epileptic</w>
acce ler
Resul ts</w>
AI M
ve in</w>
tic s,</w>
syndrome ,</w>
provi des</w>
mg .
differen tial</w>
ang ina</w>
alco h
adjust ed</w>
synth ase</w>
ros s</w>
q /
opath ic</w>
magne tic</w>
ex cl
enalap ril</w>
day s)</w>
benzodi azepine</w>
acetyl choline</w>
H ]
D ata</w>
5 .</w>
3 6
( AC
sulf ate</w>
rem if
pres sive</w>
pa inf
p olar</w>
mo ther
measure ments</w>
ifosf amide</w>
embr y
disorder .</w>
dic lofen
ce .</w>
c ulo
b en
amphet amine-induced</w>
adul ts</w>
R S</w>
ME A
Ad di
( range,</w>
toge ther</w>
side- effects</w>
rif amp
recipi ents</w>
re tic
quantit ative</w>
predn is
one ph
ch ild</w>
cann ab
T N
P <
MEA SURE
H .</w>
tub ul
re -
physi ologic</w>
p seud
occl usion</w>
man ner
magnit ude</w>
l )</w>
ic ular</w>
electr ical</w>
echocardi ography</w>
amin otrans
acce pt
3 8</w>
ul monary</w>
tac t</w>
t oc
sur face</w>
sion al</w>
reten tion</w>
mark er</w>
limb ic</w>
in ated</w>
human s.</w>
h and,</w>
es cal
differen ti
di ethyl
complic ations.</w>
atten tion</w>
athi op
angio edema</w>
Blo od</w>
5- year-old</w>
ve si
use d.</w>
relev ant</w>
pren atal</w>
mul ticent
le pt
interval ,</w>
im pact</w>
describ es</w>
ci meti
chloro quine</w>
c. v
be at
atri oventricular</w>
at er
N one</w>
5 4</w>
u nex
oc lop
embol ism</w>
de hydro
cal c
arth ritis</w>
anti gen</w>
an emia.</w>
20 %</w>
( N</w>
toler ability</w>
ter at
sul ph
pl ayed</w>
oti de</w>
kele tal</w>
con st
amin es</w>
-1 ,</w>
( MA
tig mine</w>
lo be</w>
lin ked</w>
ith rom
in tact</w>
gram s</w>
g s</w>
cri tical</w>
all ,</w>
ad mission</w>
a k</w>
SETTING :</w>
S D
9 %)</w>
4 2</w>
s pre
perio ds</w>
levo dopa-induced</w>
leth al</w>
le b
incl u
analy sis.</w>
agonist ,</w>
SUMMAR Y:</w>
P /
D ox
st abil
recor d
radi ation</w>
prob able</w>
ophyl l
o w
indic ates</w>
in tub
hospit al
hist amine</w>
cle ar</w>
bi polar</w>
be lie
ac tion.</w>
Si x
M P</w>
M I</w>
, 000</w>
ye t</w>
y s
tub er
ren in</w>
prog ester
pre disp
pentyl ene
olan zapine</w>
dr in
de gener
arge t</w>
antidepress ant</w>
. (ABSTRACT</w>
sup ra
press or</w>
immedi ate</w>
enc y.</w>
electro ly
di aly
de ,</w>
chang es.</w>
bupropi on</w>
van com
set t
rest ing</w>
reg ular</w>
proc ess</w>
pneum on
persist ed</w>
non steroidal</w>
medi ate</w>
fir st-
f il
et om
a ud
X )</w>
Sign ific
tor sades</w>
t arget</w>
refle x
recurren ce</w>
lear ning</w>
inflamm ation</w>
hist or
g ir
f asc
3 0-
10 %</w>
success ful</w>
m E
larg er</w>
idi opathic</w>
hour s.</w>
ectom y</w>
at ors</w>
ab les</w>
a qu
Intra venous</w>
ATP ase</w>
5 2</w>
withdraw al.</w>
studi es,</w>
per icardi
nitroglycer in</w>
hypokal emia</w>
hypo thesi
dose s,</w>
psycho tic</w>
produc ing</w>
painf ul</w>
op o
modi fied</w>
malign anc
li gi
l arge
cardi otoxicity.</w>
ap ne
C C
4 8
3 7
1 2.
0. 4</w>
w ide</w>
ul f
ther mia</w>
ri m
rhyth m</w>
protoc ol</w>
pentylene tetra
m ass</w>
intermit tent</w>
ine ster
in i
id o
hear ts</w>
fluox etine</w>
dimin ished</w>
co lo
chlor promaz
bili rub
ab stin
a sive</w>
Pre vious</w>
Ph ase</w>
P E
H IV</w>
Dru g</w>
0 )</w>
stimul ated</w>
propran olo
min ute</w>
l ing</w>
infu sion,</w>
electrocardio graphic</w>
deter m
agent .</w>
adriam yc
CS F</w>
= 0.0
wor k</w>
ul ar
ti es.</w>
shor ten
port al</w>
outcom es</w>
neutropen ia</w>
n ar
level .</w>
knowledg e,</w>
in ity</w>
identi fi
fat ty</w>
f el
er ous</w>
deliri um</w>
ane ur
R B
worsen ing</w>
su peri
schedul e</w>
reduc tions</w>
pres um
normoten sive</w>
mas sive</w>
lo fen</w>
il ,</w>
effec tiveness</w>
di hydro
Se ver
9 )</w>
1 1
( 30</w>
show s</w>
sev o
lo we
in- treated</w>
d ram
bromocript ine</w>
A p
4 50</w>
weigh t,</w>
sal t</w>
re sid
p -
normal ized</w>
amino phen
val v
super oxide</w>
ris ks</w>
meth yl</w>
globul in</w>
g ab
exc essive</w>
eti n</w>
estro gen
dist al</w>
d one</w>
biop si
benzodi azep
ac ut
L ong
A ),</w>
3 8
vac u
re stric
re li
orub icin</w>
intram us
i me
ha emo
control .</w>
at ax
ar d
apopto sis</w>
agg res
V T</w>
Ph en
O ver
C s
4- year-old</w>
(2 -
yl ate</w>
shoc k</w>
poin ts</w>
plac ed</w>
op ic</w>
li gh
enhance ment</w>
dis appeared</w>
det om
clo zap
channe l
blo od-
6- year-old</w>
5-F U</w>
time ,</w>
striat um</w>
stit ution</w>
peroxid ation</w>
ost atic</w>
n ,</w>
m um
kidne ys</w>
h r
et ax
catalep tic</w>
M ale</w>
M B
FK 50
u st
sens or
proca in
on omic</w>
o in
nephro sis</w>
mort al
me ans</w>
l ay
intrac erebral</w>
hal f</w>
e rec
dose- related</w>
de ep</w>
de .</w>
chloro thiaz
bri e
as ymptomatic</w>
S even</w>
L- arginine</w>
D H
7- year-old</w>
stand ing</w>
separ ate</w>
response ,</w>
ox idi
oc al</w>
neuropath ic</w>
lead s</w>
l is
hyp onat
heal th</w>
ex pressed</w>
ate -induced</w>
ast ro
ass ay</w>
a ther
E v
6 00</w>
5-H T</w>
- positive</w>
p um
o sis.</w>
me detom
ind in
in sti
ec oxi
disorder s.</w>
catalep sy.</w>
bra in.</w>
an ine</w>
Se iz
I L
G l
Con tro
A /
6 .</w>
ul ated</w>
tw o-
ref er
mono therapy</w>
log y</w>
jaundic e</w>
inter actions</w>
il i
gran ule</w>
form s</w>
electro encephalo
e ment</w>
aug ment
ath yro
3 9</w>
1 1.
tran sc
that ,</w>
thalam ic</w>
tachycardia .</w>
respon si
pro found</w>
ouab ain</w>
ol -
o k</w>
le d,</w>
g )</w>
fib ers</w>
fib er</w>
fi br
ere bro
epi rub
e .,</w>
chol inester
bac ter
PATIENT S</w>
El ectro
A Z
tri glycer
te d,</w>
t ob
stron g</w>
reviewe d.</w>
ren t</w>
reco ver
perfor me
pathw ay</w>
ill ed</w>
de m
cy tot
coll ected</w>
calcul ated</w>
be low</w>
an e-
album in</w>
a y.</w>
D ec
-1 0</w>
th re
subj ective</w>
propor tion</w>
o d.</w>
mg .</w>
mer ic
fl uc
dehydro gen
consc i
con current</w>
analgesi c
P V
P ),</w>
5-fluoro uracil</w>
yl ated</w>
w k</w>
sy mptom</w>
respecti vely</w>
neuro muscular</w>
is on
inv asive</w>
er v
coll ag
cit alop
ce phal
angio graphy</w>
K- 80
10 00</w>
un changed</w>
smo k
per me
ill in</w>
glomerul oneph
f oun
f iltration</w>
emb olic</w>
deple tion</w>
ar y,</w>
Ph armac
I D
A meric
A E
( W
s ot
re search</w>
prophyl actic</w>
mg/kg .</w>
ide -induced</w>
excit atory</w>
ex tra
erg y</w>
enc ing</w>
de si
cal cit
ca ud
ca ro
3 0%</w>
volunte ers</w>
ti mo
superi or</w>
stopp ed</w>
s ou
ol ig
o ,</w>
ha z
control s,</w>
ca ution</w>
block ers</w>
N- methyl-
M ul
Ei ght</w>
Ca 2
8- year-old</w>
4 7</w>
vari ables</w>
tuber culo
rang ed</w>
poten cy</w>
popul ation.</w>
hum ans</w>
hepar in-induced</w>
gen ital</w>
en s</w>
az athiop
T ,</w>
Com pared</w>
AD R
vomit ing,</w>
tic ,</w>
testo sterone</w>
ter ms</w>
ter but
spectr um</w>
ph leb
patter ns</w>
infec tion.</w>
di c</w>
cy te</w>
cur ve</w>
beta- adrenergic</w>
arg et
agg reg
S uc
R is
NS AID
Im mun
B ,</w>
met oclop
fentan yl
expos ure.</w>
abs or
P H
NO S</w>
yg d
spre ad</w>
remif entan
recept ors,</w>
microscop ic</w>
mic rom
maz en
leuk o
i ron</w>
g/ m
effect ,</w>
col chic
characteris tic</w>
analy ses</w>
am ygd
aff inity</w>
MA IN</w>
A V
ther mal</w>
s low</w>
respon sive</w>
mid d
lat ter</w>
kg ,</w>
intoxic ation</w>
hyperalgesi a.</w>
h ero
gen otyp
ful l</w>
event s.</w>
dynam ics</w>
[3 H]
4 3</w>
1 5-
weak ness</w>
tre n
th ym
sur ve
phosph or
insi pid
in h
ho od</w>
fe wer</w>
discontinu ed.</w>
der s</w>
dec line</w>
ant .</w>
al ing</w>
ad y</w>
acqu ired</w>
S O
2- year-old</w>
-1 )</w>
vas ospas
tri meth
se pt
s am
present ation</w>
pharmacokine tic</w>
ouab ain
myoclon us</w>
lim it
diff use</w>
d in
aud itory</w>
ant s,</w>
a e</w>
T en</w>
S T</w>
An im
y sm
ves sel
veloc ity</w>
s on</w>
m Glu
iz ation.</w>
ci prof
amin o</w>
U nit
T .</w>
N or
F o
D R
(1 0
tr ypt
techniqu e</w>
sli ght</w>
presc ri
post erior</w>
kin in</w>
iti s,</w>
is he
inf iltr
f le
dose- response</w>
disturb ances</w>
ant ,</w>
acid ,</w>
a sis.</w>
TION S:</w>
P L
Increas ed</w>
zidov udine</w>
uc ul
to pro
sol u
se em</w>
rever sib
resp ect</w>
re d,</w>
pro posed</w>
model ,</w>
me topro
mac roph
f ever</w>
enc ies</w>
deteri oration</w>
confir m</w>
bene f
b ound</w>
arach no
Li ver</w>
F ,</w>
C oca
3 /
3 ),</w>
2 5%</w>
ve d,</w>
th ,</w>
test ,</w>
t arget
se x</w>
se d,</w>
ques tion
prost ate</w>
po d
mg/m (2)</w>
mE q/
i on
gene sis</w>
func tions</w>
el ective</w>
demonst rates</w>
death s</w>
coca ine,</w>
cell s,</w>
asth en
al kal
ad renal</w>
acet aminophen
P P
IC H</w>
C G
5 5
0. 6</w>
( r</w>
un d</w>
th ick
qu ality</w>
micrograms/ kg</w>
lact ate</w>
h imb
dose- limiting</w>
clo se</w>
bl ind
avoid ance</w>
an tr
am ine
adv ant
administ ere
METHOD :</w>
7. 5</w>
uter ine</w>
ul tra
tro n</w>
ro se</w>
microscop y</w>
lup us</w>
ist ry</w>
hyper kal
ex clu
diar rhe
defici ent</w>
N either</w>
Ex perim
Ad riam
4 1</w>
0.0 5</w>
( e
( 4.
w ise</w>
w ild
t able
su mm
stimul i</w>
ser v
sequ el
rang ing</w>
par athyro
p. o
nephro pathy.</w>
lin es</w>
lat er.</w>
l ind
inte gr
i es,</w>
comp eti
ch ain</w>
ST UD
D F
D 1</w>
4 5
(0. 5</w>
the l
re present</w>
po i
pl ays</w>
leng th</w>
k -
he ter
grad ually</w>
epi lept
compon ent</w>
clo sely</w>
an dro
an -
acet ate</w>
P ain</w>
10 ,</w>
un known.</w>
s qu
progester one</w>
proble m</w>
patient s)</w>
oph thal
oc clu
neuro toxic</w>
iti es,</w>
intraperitone ally</w>
exc re
dose- dependently</w>
dis played</w>
cyclospor ine</w>
coun ts</w>
chron ically</w>
cerebell ar</w>
S ),</w>
HB e
B .</w>
- mediated</w>
z ole</w>
trans amin
tom ography</w>
to ok</w>
tiv ari
supplement ation</w>
short -term</w>
reg urg
phenyleph rine</w>
inhib its</w>
ine ff
expl ain</w>
er mal</w>
doc etax
cysti tis.</w>
concentr ations.</w>
ch ing</w>
behavi ors</w>
bac lofen</w>
angiotens in-
ame ter</w>
agent s,</w>
Unit ed</w>
Stud y</w>
P hy
My ocardial</w>
H R
DO X
Ch ang
A g</w>
ures ,</w>
suscepti ble</w>
side -induced</w>
se tron</w>
schizophren ia</w>
prob ability</w>
pe g
particip ants</w>
p anc
ol ip
immuno hist
f ati
end omet
em phasi
dipyridam ol
deli very</w>
cy ste
al azine</w>
U )</w>
Signific ant</w>
L- N
4 9</w>
ycl ic</w>
signific ance</w>
prolifer ation</w>
ox amine</w>
n ess.</w>
medic ation.</w>
ing ly</w>
evid ent</w>
aminotrans ferase</w>
ag grav
M M
M K-80
1 5.
(1 5</w>
val ent</w>
u me
star t</w>
se -
s w
occur red.</w>
o ural</w>
implic ations</w>
hyp ox
exc ess</w>
ec ain
condition ed</w>
INT ER
I T</w>
F rom</w>
B ased</w>
w ays</w>
tra um
tr am
sig n</w>
recogn ition</w>
quin idine</w>
proced ure</w>
partic ular</w>
ob lastic</w>
interfer on</w>
immunosup pressive</w>
enc y,</w>
do g</w>
depres sion.</w>
d s.</w>
cros s
anxi et
antin ociceptive</w>
aff ecting</w>
Sub j
P ar
ME NT
Hear t</w>
F lu
1- year-old</w>
st aining</w>
re uptake</w>
oxic ity</w>
opio id
ischem ia.</w>
is m,</w>
immuno deficiency</w>
depart ment</w>
captop ril</w>
bu lo
bec ome</w>
amplit ude</w>
amide ,</w>
ag ne
QT c</w>
ven ess</w>
vasopress in</w>
v ar
set ting</w>
sec re
pro min
par alysis</w>
investig ated.</w>
ing u
hyperprolact inemia</w>
hydro chlorothiaz
furosem ide</w>
el ect
cor responding</w>
conver sion</w>
can not</w>
barri er</w>
am id
al anine</w>
T ran
G en
F in
C P</w>
(1 -
unc lear
ul cer
th .</w>
sam ple</w>
ocy cl
ochrom e</w>
n asal</w>
is om
inf ant</w>
fenflur amine</w>
fe ren
el uc
bo y</w>
antagon ism</w>
all ergic</w>
al low
ag ain</w>
ER I
DO X</w>
Compar ison</w>
6 0
2. 0</w>
wild -type</w>
we l
tri ax
time .</w>
su mat
small er</w>
rel b
re placement</w>
phenomen on</w>
mod ulation</w>
it .</w>
intrac ellular</w>
ino relb
inf iltration</w>
id en
i .</w>
fl ut
evalu ated.</w>
determ ined.</w>
def ect
cholinester ase</w>
beg an</w>
bac k</w>
b yp
STUD Y</w>
E arly</w>
sumat ript
smo oth</w>
s.c .)</w>
ru ption</w>
p .</w>
orth ostatic</w>
mac ro
lim b</w>
l umb
in ser
ide s</w>
i ble</w>
fe ver,</w>
eph ed
enh ance</w>
dis ul
diet ary</w>
coun ter
cle arly</w>
carbam azep
ar ab
acid .</w>
L E
H ere
H ,</w>
9- year-old</w>
3 5
1 4.
yl ine</w>
vit ro
subj ected</w>
se p
sal ic
per man
paracetam ol</w>
ograph y.</w>
no w</w>
monke ys</w>
model s.</w>
le sion
hal f-
bic ucul
allodyn ia</w>
al one,</w>
stimul ating</w>
show ing</w>
sevo flurane</w>
respectively )</w>
qu e</w>
pressu res</w>
picrotox in</w>
par a
ous ly.</w>
hist ologic</w>
fact ors.</w>
appro ach</w>
aim ed</w>
T d
S D</w>
Dop pl
1 3.
us t</w>
struct ure</w>
sti l
som e
simil ar
seroton ergic</w>
prot ected</w>
mum ol/
ment s.</w>
m am
haem orrh
h ere</w>
fasc icul
ex pected</w>
embr yo
em plo
d ly</w>
alter ation</w>
a emic</w>
F e
D- penicillamine</w>
8 ).</w>
(N S
system s</w>
s low
ret inal</w>
prot ect</w>
proced ures</w>
present ed.</w>
perf used</w>
off sp
neuro trans
mo l</w>
mal form
infarc tion,</w>
ine ur
experim ent</w>
effec tively</w>
detect able</w>
bir th</w>
auto immune</w>
ar yn
S A
D 3</w>
( IC
under taken</w>
suff ering</w>
rec tal</w>
ratio s</w>
r in</w>
ph ot
oxid ase</w>
out patient</w>
ol ine</w>
lamiv ud
headache ,</w>
d d
d ;</w>
cannab in
attribut able</w>
abil ity.</w>
reach ed</w>
r e</w>
ocicep tion</w>
nicot ine-induced</w>
k ain
hospit alized</w>
gir l</w>
distinc t</w>
d an
consci ous
caro tid</w>
bu s</w>
arter ies</w>
I O
H er</w>
G r
50 ,</w>
ver sion</w>
ter al</w>
pl an
ovari an</w>
op yr
measure ment</w>
inter ven
infec tions</w>
exam ined.</w>
er -
contracep tiv
aut onomic</w>
am bul
Sever al</w>
H U
6 ).</w>
withdraw n</w>
us al</w>
tu be</w>
pro ved</w>
prev ents</w>
predic tive</w>
os ing</w>
ome tr
o vir</w>
manner .</w>
le ar</w>
is su
ig n</w>
ic ity</w>
electro physiological</w>
cycl ic</w>
capac ity</w>
b est</w>
atic ally</w>
ardi ve</w>
arachno id</w>
afferen t</w>
S ome</w>
IS O
E M
D X
( 4</w>
us ers.</w>
tic -induced</w>
retino ic</w>
phen otyp
manifest ed</w>
last ed</w>
in otropic</w>
eth in
ep e
en tial</w>
cardiom y
ax onal</w>
anti gen
R A
PR L</w>
Hy poten
H ospit
wh ole</w>
vancom ycin</w>
th or
stil be
sle ep
over dose.</w>
ma k
m s,</w>
insul in</w>
h )</w>
es oph
epileptic us.</w>
em erg
duc t</w>
cyt ochrome</w>
cross over</w>
const ant</w>
competi tive</w>
apomorph ine-induced</w>
anti tumor</w>
N )</w>
Chang es</w>
C 57
-1 0
-1 ,
+ )</w>
(2 )
ur ation</w>
tic lop
ta ining</w>
t one</w>
stilbe stro
st s</w>
si rolimus</w>
pharmacokine tics</w>
iso flur
hallucin ations</w>
group s:</w>
gem cit
g ain</w>
es :</w>
diltiaz em</w>
cas e-
anticoag ulation</w>
Ne ph
N it
C ase</w>
B M
0.05 ),</w>
( median</w>
yo himb
ti tr
ten ded</w>
t )</w>
substanti al</w>
sub cut
re presents</w>
prospecti vely</w>
pro x
op ril</w>
neuro toxicity.</w>
myocardi um</w>
morb idity</w>
mal ar
ju g
intra -
immunore activity</w>
if ied</w>
i. c.v
he at</w>
fix ed</w>
eti ology</w>
ent s.</w>
control led,</w>
CH F</w>
B P
us cit
thyro idis
thyro id</w>
tachycardia ,</w>
syn erg
sing le-
si x
o pa
nicot inic</w>
i on</w>
es ;</w>
den af
compar ing</w>
cas e,</w>
bradycardia .</w>
at es.</w>
anti cholinergic</w>
anthracycl ine</w>
ant o
ant ine
V PA
ST -
S A</w>
R ating</w>
I P
( Group</w>
vol ume
sym path
s or
rout ine</w>
po ison
os yn
optim al</w>
nephro genic</w>
medi a</w>
mark ers</w>
ine d,</w>
glob al</w>
ecti vely</w>
drin king</w>
def in
chemo therapeutic</w>
biopsi es</w>
attac ks</w>
Me dian</w>
H is</w>
C l</w>
valv ular</w>
rec tom
orph ine</w>
no de</w>
n ational</w>
mo od</w>
los s.</w>
docum ent
consequ ences</w>
cocaine- dependent</w>
cho ice</w>
cerebro spinal</w>
beat s/
ane -induced</w>
am ant
M -
A u
seiz ure
recor ds</w>
pharmac ologic</w>
perme ability</w>
o ve
ne ver</w>
m os
le thal
foun d.</w>
flu mazen
f ur
ex ce
dos ages</w>
defic it</w>
d ri
convul sions.</w>
control ,</w>
consequ ence</w>
c re
and s</w>
S event
O r
I so
Hi gh
AM E</w>
(2 00</w>
wel ve</w>
ventric le</w>
um erous</w>
ri a</w>
recor ded.</w>
pro fen
p ast</w>
ox ane</w>
metho ds</w>
medetom idine</w>
ir rit
in- associated</w>
hyper plasia</w>
headac h
glomerul i</w>
cur onium</w>
cr yst
compl ain
av oid</w>
U C
J ap
Gr ade</w>
Doppl er</w>
C57 B
4 ),</w>
stra in</w>
st em</w>
reac tion.</w>
pre lim
pap illary</w>
pa w</w>
p el
om otor</w>
morph ological</w>
m io
ine :</w>
in )</w>
ex ter
ede ma,</w>
dil ated</w>
chemo therap
amygd al
am il
am but
W e
U r
Phy si
For ty-
D .</w>
0.00 1),</w>
uti li
uni que</w>
spec ies</w>
s keletal</w>
s atis
resid ual</w>
promin ent</w>
predomin antly</w>
pivaca ine</w>
p in
ox yl
o vascular</w>
new ly</w>
n atal</w>
microm ol/
me perid
isoniaz id</w>
ing ly,</w>
hemo dialysis</w>
f ast
condi tions.</w>
behavi oural</w>
am it
al in</w>
T M
M R</w>
Long -term</w>
L o
H )
5 8</w>
5 7</w>
10 (-
( 4-
ure th
ure mic</w>
supra ventricular</w>
rema in</w>
performe d.</w>
o sis,</w>
nex t</w>
mening itis</w>
load ing</w>
l ess
ithrom ycin</w>
inf requ
fl ecain
ent ered</w>
dail y,</w>
caref ul</w>
ab le,</w>
L ith
Di fferen
D B
Com b
5 3</w>
thrombo embolic</w>
system ,</w>
sol ute</w>
prednis one</w>
phy sos
pathophysi ology</w>
olog y.</w>
me lat
le uc
k noc
intra vascular</w>
intr ad
haloperid ol.</w>
g/ d
dig it
at en
am ,</w>
M et
J an
I f</w>
Fin ally,</w>
E ach</w>
E T
2 ;</w>
to ward</w>
te mpt
sil denaf
se e
scre ening</w>
res uscit
ras h</w>
prelim inary</w>
om al
medi al</w>
lowe red</w>
lo ad</w>
l ation</w>
ir reversible</w>
inf or
hero in</w>
ed -
di p
cirrho sis</w>
chang es,</w>
can ine</w>
all -
ac ro
ac count</w>
SI AD
IV )</w>
GF -
. g
(H B
( K
y s.</w>
y ric</w>
x ameth
ver sity</w>
tu bulo
sub arachnoid</w>
stopp ing</w>
st om
sensi tiv
prospecti ve,</w>
proble ms</w>
phosph olip
mg/kg/ day</w>
me ll
man ag
intramus cular</w>
ine- associated</w>
imi pramine</w>
ill ust
femal es</w>
erythro poi
ede ma.</w>
dys function,</w>
develop mental</w>
amit ript
amide -induced</w>
V al
PA )</w>
MA T
Af ric
0. 8</w>
( 5.
valu es.</w>
temperat ure</w>
ri fic
pac ing</w>
ox antr
minut es.</w>
microgram /
mal es</w>
l ing
if ost
i el
end oc
duc t
decreas ing</w>
con sti
c lop
attenu ate</w>
ap ine</w>
antibio tic</w>
an emia,</w>
abnormal ities.</w>
S p
GABA ergic</w>
G ,</w>
( a</w>
( 40</w>
wom en.</w>
ventil ation</w>
vasocon stric
under g
ser ial</w>
sac rific
rhabdomy olysis</w>
res s</w>
requir e</w>
r amide</w>
op ulmonary</w>
olog ic
lithi um-induced</w>
ligi ble</w>
kind led</w>
id azol
h ar
f lo
eryth emat
dyston ia</w>
de v
ac ts</w>
ab use.</w>
O ral</w>
Neph ro
Grou ps</w>
youn ger</w>
vari able</w>
tivari ate</w>
schedul ed</w>
ra ised</w>
pl ast
per ox
mg/m 2/
mell it
low ering</w>
li pos
inc re
in s.</w>
in appropriate</w>
f as
docetax el</w>
diseas es</w>
discontinu ing</w>
dis mut
amide .</w>
alk alo
ac etic</w>
R et
Hep ar
G S
D N
7 ).</w>
50 -
4 6</w>
4 0%</w>
z om
transpor t</w>
ti car
threshol ds</w>
sol id</w>
soci al</w>
responsi veness</w>
respon d</w>
recept or-
pro mpt
plac e</w>
p up
on es</w>
olog y,</w>
midd le</w>
lim it</w>
inorelb ine</w>
hypothesi zed</w>
haem at
fo ot</w>
f inal</w>
discharg e</w>
dec l
cortis ol</w>
cle .</w>
bic arb
angio graph
acid osis</w>
U T
N P
L A</w>
AID S</w>
A D</w>
7 6</w>
ul c
tric yclic</w>
thor ac
shor tly</w>
s ha
prog no
produc t</w>
otom y</w>
opi ate</w>
hypercal cemia</w>
g ol
enc oun
cortico steroid</w>
continu ously</w>
blood- brain</w>
ather os
ap ar
analy sis,</w>
anaesthe tized</w>
ac u
Re ver
O -
MR I</w>
L- DO
Jan u
C ap
AM P</w>
6 7</w>
) :</w>
war r
un ilateral</w>
ty ros
suc c
sign aling</w>
re cur
press ing</w>
placebo ,</w>
it s.</w>
hyp oc
graf t</w>
follow-up .</w>
em ent.</w>
doxorubic in.</w>
creat in
cimeti dine</w>
ch i
VE N
T A
L ab
AT P</w>
0. 7</w>
0 /
(-1 )</w>
y ri
us h
ul ate</w>
tro p
timo lol</w>
th em
stimul ation.</w>
sp ac
se min
s clero
prov o
neut roph
neuropath y,</w>
mo tion</w>
medi um</w>
li gn
injur y,</w>
in hal
hyperalgesi c</w>
hemorrh age.</w>
fel l</w>
fam ily</w>
discus sed</w>
dep olar
def ect</w>
cir c
ation :</w>
R F
D ,</w>
8 7</w>
00 -
(4 )</w>
y iel
x y
st er</w>
simult aneously</w>
se l</w>
relap se</w>
re infor
praz osin</w>
plat in
ot al</w>
my asthen
mat ter</w>
ine /
id az
ia :</w>
i )</w>
hype remia</w>
ey e</w>
chlorpromaz ine</w>
S SR
S R</w>
P os
M ,</w>
INTER VEN
I L-
G .</w>
vul ner
un its</w>
tram ad
thiop ent
tetra hydro
syn thetic</w>
sp e
rest ored</w>
resp ective</w>
regimen .</w>
on azole</w>
numb ers</w>
ma x
investig ations</w>
in os
hel p</w>
establ ish</w>
elev ations</w>
diclofen ac</w>
dehydrogen ase</w>
cyto plasmic</w>
cir cum
cathe ter</w>
ati vel
antidepress ants</w>
an n
Rec ent</w>
Q RS</w>
MAT ERI
D P
CA 1</w>
C E
An g
5 6</w>
1 ;</w>
(0. 1</w>
ysm al</w>
un common</w>
stra ins</w>
shor ter</w>
rig id
rele as
refer red</w>
pre term</w>
potenti ation</w>
perman ent</w>
ocy tic</w>
ng/ ml
min oxidi
main tain</w>
inter vention</w>
inf erior</w>
increas ed.</w>
fibrill ation.</w>
elect rom
det ect</w>
cyste ine</w>
cer v
b ran
atroph y</w>
as h
arth ritis.</w>
ag it
a udi
P a
N-methyl- D-
C lo
C entr
AS A</w>
3. 0</w>
1 8.
theli um</w>
tempor ary</w>
t ardive</w>
subj ect</w>
statis tical</w>
simult aneous</w>
seve rely</w>
retro specti
pum p</w>
pa ir
omet ric</w>
mother s</w>
in somn
g on
fe ed
estim ate</w>
eff ici
d ap
correc ted</w>
consist ing</w>
ch ore
Subj ects</w>
N ine</w>
Janu ary</w>
II ,</w>
H D</w>
Anim als</w>
(O H)
vi sion</w>
un chang
ter s</w>
syn the
re mark
p H</w>
lo dipine</w>
lab et
ing est
ine ;</w>
h il
gluc o
epirub icin</w>
electrocardio gram</w>
depres sion,</w>
del ay</w>
byp ass</w>
brie f</w>
ar rest
U se</w>
S yn
N E</w>
MK-80 1</w>
M ed
L-N AME</w>
In trac
H alo
H R</w>
D el
C y
5 ),</w>
. ),</w>
( EC
yc in.</w>
ventr al</w>
v ec
un known</w>
sion -
self- administration</w>
seem ed</w>
remifentan il</w>
psycho sis</w>
pro ven</w>
pl asi
pas sive</w>
nephro sis.</w>
neg ati
methyl prednisolone</w>
low est</w>
los artan</w>
locom o
ll ing</w>
line ar</w>
indometh ac
frac tional</w>
fr ag
etom idate</w>
electroly te</w>
der ,</w>
cocaine- associated</w>
c ranial</w>
c ra
as yst
an e.</w>
] -
S ide</w>
M an
6 6</w>
5 9
. ).</w>
+/ -1
unclear .</w>
tissu es</w>
thromb in</w>
man ner</w>
lith iasis</w>
ic k</w>
hour s,</w>
fact ors,</w>
equi valent</w>
endomet rial</w>
emplo y
echocardi ographic</w>
cyclophosphamide -induced</w>
cortex ,</w>
comple tion</w>
cef triax
b )</w>
angiotensin- converting</w>
analo gue</w>
Re g
N- acetyl
F 1</w>
6 1</w>
3. 5</w>
(P T
(A D
tra ining</w>
thrombo embolism</w>
terbut aline</w>
suffici ent</w>
ser tr
se s,</w>
ri min
rad ical</w>
pro gram
praz ol
path ology</w>
on se
ol i
myoclon ic</w>
minim um</w>
level ,</w>
gli al</w>
fe a
ex tre
er 's</w>
compon ents</w>
ation )</w>
analo g</w>
al ways</w>
air way</w>
age al</w>
Sub sequ
M in
L V
I ts</w>
G T
G E
CB F</w>
1 6.
vi ron
val ve</w>
vacu ol
syncop e</w>
ser ved</w>
s well
rou gh</w>
ri tis,</w>
ret in
phleb itis</w>
pathw ays</w>
part um</w>
myo pathy.</w>
lumb ar</w>
ibu profen</w>
hydro chlor
gu ine
glomeruloneph ritis</w>
f un
f re
dog s,</w>
depend ence.</w>
de le
dat ab
chrom at
carcin oma.</w>
canc er,</w>
azathiop rine</w>
appro ach
alle vi
ac yclo
Th rom
M ic
Ei gh
( +/-
te trac
succinyl choline</w>
su xameth
sal ine,</w>
profi les</w>
op sy</w>
neo plastic</w>
mortal ity.</w>
mes na</w>
meas uring</w>
man nit
knoc k
is op
hospit al.</w>
ep tic</w>
ectom ized</w>
da un
d :</w>
cyt osine</w>
contrac tion</w>
com mun
at tempt
arrhyth mia.</w>
ap ri
amino glyco
abil ity,</w>
With in</w>
U -
SM -
L ).</w>
Hi gh</w>
He al
FK50 6</w>
Americ an</w>
(E D
vie w
sugg estive</w>
smo king</w>
pr ur
pilo t</w>
p ol
o il</w>
norep inephr
metopro lol</w>
lind ane</w>
iz ation,</w>
first- line</w>
dist ingu
diethyl stilbestro
dex tro
cerebro vascular</w>
ce ,</w>
cap illary</w>
behavi our</w>
an e,</w>
amin ophylline</w>
al located</w>
St udi
HIV -
C arb
(2. 5</w>
wide spread</w>
ut ure</w>
spec imen
sou ght</w>
pi per
panc re
obut yric</w>
n im
me gal
maz e</w>
inh aled</w>
in tak
h ap
fav or
f usion</w>
eth ambut
est er</w>
catech olamine</w>
attenu ation</w>
alg ia</w>
adenocarcin oma</w>
T ri
S ).</w>
He pati
B et
7 3</w>
7 .</w>
0. 0</w>
(2 5</w>
(+ )</w>
we l</w>
ut ing</w>
thrombo sis.</w>
ter ol</w>
subject s,</w>
so ur
shor t-
re activity</w>
prepar ations</w>
po or
physici ans</w>
peritone al</w>
mg/ d</w>
lab el</w>
hear t.</w>
expl ained</w>
correl ate</w>
con junc
circul ating</w>
bradycardia ,</w>
be ats</w>
ati tis</w>
Seiz ures</w>
P B</w>
L VE
viv o.</w>
sul piri
sc an</w>
retur n</w>
response s.</w>
protein uria.</w>
prot ects</w>
propyl thio
proces ses</w>
pres er
om a,</w>
nucle ar</w>
neuron s.</w>
necro sis.</w>
m L/
le sions.</w>
dys rhyth
dizzin ess</w>
di men
deteri or
dail y.</w>
channel s</w>
block .</w>
b is
atri ure
as p
ar ch
aff ective</w>
Pro po
Per i
P rop
Hypoten sion</w>
D ex
6 4</w>
yl )
vag inal</w>
u los
tas k</w>
sus p
relie f</w>
procain amide</w>
post natal</w>
phasi c</w>
ou s,</w>
opo i
nat ure</w>
men opa
mechanis ms.</w>
m im
leuko encephalopathy</w>
le ven</w>
f if
en viron
ect ed.</w>
derivati ves</w>
compl i
compar ative</w>
c m
aneur ys
anaesthe sia.</w>
an ol</w>
acc umb
absor ption</w>
MEASURE MENT
Cs A</w>
C M</w>
ur on
struct ures</w>
re sem
prom pt</w>
post ural</w>
obstruc tive</w>
mucos al</w>
min ocycl
kine tic</w>
in- related</w>
ifost ine</w>
iden tical</w>
hemat oma</w>
glucocortico id</w>
fi ram</w>
enh ances</w>
ecoxi b</w>
e ;</w>
der mal</w>
contracep tive</w>
concentr ation.</w>
con genital</w>
case- control</w>
at or
asi c</w>
amoun ts</w>
am b
Studi es</w>
M .</w>
7 8
4 0-
yl ation</w>
surger y,</w>
schizophren ic</w>
repor ting</w>
reg ard</w>
pos ses
poor ly</w>
paralle l</w>
oc tre
nitro -
neurotrans mit
me ly</w>
indin avir</w>
event s,</w>
ev ol
dou ble</w>
continu ation</w>
condi tions,</w>
chol ec
at tem
anti diuretic</w>
ant ed</w>
an con
al fentanil</w>
Dru g
B r
20 ,</w>
/ -
- to-
(- )-
under sto
tion ally,</w>
so ,</w>
ra ph
qu eti
predic t</w>
pap er</w>
p all
n atriure
multicent er</w>
metoclop ramide</w>
label ed</w>
intrac erebro
h er
gest ation</w>
erythemat os
em is
che mic
cat at
arter io
al do
al de
a uc
SN P</w>
PA N
Over all,</w>
N P</w>
BACKGROUN D</w>
A P</w>
8 5</w>
0. 3
vec ur
vari ed</w>
scop olamine</w>
re ference</w>
qu al
predict ors</w>
ox al
otoxic ity,</w>
om y
ocy to
occa sion
mg/ day)</w>
lithi um-
k illed</w>
iz ed.</w>
identifi ed.</w>
gentam ic
di phen
cyt es</w>
cont ribution</w>
colchic ine</w>
col on
citalop ram</w>
block ade
bilirub in</w>
ben ign</w>
arab ino
an at
Tran si
P B
G i
Dox orubicin</w>
B i
4 ,
( r
vag al</w>
v inorelbine</w>
the ophyll
significant .</w>
restric ted</w>
requi re
reac tions.</w>
of f</w>
modi fy</w>
it sel
in dependently</w>
id ine,</w>
gy rus</w>
gly ce
fol ic</w>
extre mely</w>
di ameter</w>
de mo
condi tion.</w>
comp uted</w>
clin icians</w>
calcit ri
aw a
attenu ates</w>
at el
amin obutyric</w>
alde hy
Twent y</w>
SH R</w>
PATIENT S:</w>
P sych
O 2</w>
METHOD S</w>
L ),</w>
F ancon
C F
10 )</w>
( from</w>
z ed.</w>
ur ticar
subst ances</w>
st ly</w>
s ph
res ,</w>
qu inine</w>
methyl phen
lay er</w>
hydrox y-
granulo mat
di lat
cortico steroid
comp ens
bo wel</w>
anti retro
am is
aggres sive</w>
ac cur
] .</w>
C at
C R</w>
A V</w>
5- hydroxy
0. 9</w>
( c
u sions</w>
tre x
sal ine.</w>
regul ated</w>
precipit ated</w>
prece ded</w>
perid ol</w>
paren teral</w>
myocardi tis</w>
mix ture</w>
melat onin</w>
lis in
li qu
isop ren
io hex
ific ation</w>
finding s,</w>
fas hi
en ergy</w>
embryo s</w>
e ous</w>
e ach
discus s</w>
disc rimin
collag en</w>
ciprof loxacin</w>
am .</w>
acid s</w>
O H-
C ol
7 7</w>
1. 2</w>
(p <
vis c
t ase</w>
sot alol</w>
sign al</w>
relax ation</w>
re produc
re ady</w>
potenti als</w>
ogen ous</w>
nerv es</w>
mos sy</w>
min al</w>
mGlu R
long- lasting</w>
l ide</w>
induc ible</w>
increas ingly</w>
implant ed</w>
il -induced</w>
g ad
four th</w>
excl uded</w>
del ta</w>
coag ulation</w>
cardi otoxic</w>
car nit
bio logical</w>
arrhythmi as,</w>
apne a</w>
an omal
al is</w>
Re por
Pro long
Pos sible</w>
N ar
ME TH</w>
Contro l</w>
C57B L/
6 3</w>
0.000 1).</w>
tyros ine</w>
tri als.</w>
the refore,</w>
strate gi
spas m</w>
rep olar
r al
pyri dox
neuro genic</w>
n es
mit oxantr
lipos omal</w>
it rate</w>
gre l</w>
fr act
form ul
en -
electrom yo
de sign
d s,</w>
ar ing</w>
ang ial</w>
acid -induced</w>
ac ross</w>
U ni
S ur
R .</w>
PA R
N on
E p
7 0
6 2</w>
5 9</w>
3 0,</w>
2 5,</w>
u sion.</w>
tum ors.</w>
test s.</w>
te zom
ta il</w>
substanti a</w>
stit uted</w>
sit u
sequ ence</w>
regurg itation</w>
rabb its</w>
ot otoxicity</w>
organ ic</w>
nephro toxic</w>
na prox
ishe d.</w>
inter pre
influ enced</w>
if y</w>
histopath ological</w>
exacerb ation</w>
eme tic</w>
dis semin
dem enti
de grad
cytot oxic</w>
contribut ing</w>
clo mi
baro reflex</w>
acc id
ab solute</w>
Z )</w>
Transi ent</w>
Ne w</w>
MATERI AL
M S</w>
E valu
3 4
tri al,</w>
t on</w>
t ary</w>
stop pe
sequ ential</w>
s at
ratio ,</w>
rad ic
promis ing</w>
pr inc
os ar
n umerous</w>
lesion ed</w>
hyp om
he av
he al</w>
glomer ulos
finding s.</w>
episo de
elim ination</w>
difficul t</w>
di hydroxy
contribut es</w>
combin ations</w>
but am
basel ine,</w>
ation ;</w>
ap l
ac cumul
Thir ty</w>
T welve</w>
P/ d
I s</w>
Ch in
CO 2</w>
0.0 1),</w>
(i. e.,</w>
y -induced</w>
ves sel</w>
termin ation</w>
tac rolim
streptozotoc in</w>
specific ally</w>
sc i
proper ties.</w>
produc ts</w>
phenyleph r
patient s'</w>
par as
oxygen ase</w>
out put
nit r
m atic</w>
lidoca ine.</w>
knock out</w>
i.p. ),</w>
h and
f in
en ox
en ed</w>
disorder s,</w>
determin ation</w>
d P/d
at rop
amin o-
albu min
ad junc
N ine
Here ,</w>
CO M
C yclo
C al
AIM S:</w>
6 9</w>
(P AN
trans ferase</w>
thorac ic</w>
ro d
retic ul
requi res</w>
outcom e.</w>
odi um</w>
ochem istry</w>
new born</w>
nec k</w>
menopa usal</w>
medull a</w>
inhib i
inc or
g y</w>
flow .</w>
equ ally</w>
ephed rine</w>
deriv ative</w>
consist ently</w>
compl ained</w>
bacter ial</w>
at rac
ast er
asses sed.</w>
P F
M o
In iti
C s</w>
C D</w>
(M T
war ds</w>
vast at
ton ic-
tin nit
st one</w>
sel ectively</w>
sel ec
s or</w>
pentobarbit al</w>
path ologic</w>
ond an
ne t</w>
nat ural</w>
n mol
me l
kine sia</w>
iso prost
inhibit or
ex t
encephalo pathy.</w>
electro physiologic</w>
cult ured</w>
con cent
cerv ical</w>
achie ve</w>
V -
Suc h</w>
N-methyl-D- aspartate</w>
Clin icians</w>
AR F</w>
(C B
y ).</w>
week ,</w>
ur in
ultra structural</w>
ten d
survi v
substanti ally</w>
subcut aneously</w>
su it
soci ation</w>
si ded</w>
record ings</w>
not ed.</w>
ne arly</w>
n mol/
ke y</w>
invol ve</w>
ine -</w>
i.p .,</w>
gluc uron
gemcit abine</w>
fo od</w>
fac t</w>
f ying</w>
f os
exce ed
disturb ance</w>
desc ending</w>
cortex .</w>
child hood</w>
ac idi
a :</w>
SC H</w>
O UT
E 2</w>
DE S</w>
D ep
Cardi ovascular</w>
Adriam ycin</w>
Addi tionally,</w>
5 %,</w>
00 ,</w>
(A )</w>
trans fer
tra z
termin al</w>
syndrom es</w>
survi val
second -
random ised</w>
question na
predic ted</w>
pre feren
per gol
ol s</w>
norm ally</w>
mg/m 2,</w>
ment s,</w>
local ized</w>
ling ual</w>
ine ural</w>
icac y</w>
hy bri
group )</w>
gl auc
emergen ce</w>
dismut ase</w>
der .</w>
dail y)</w>
d ate</w>
cortico steroids</w>
consi der</w>
be f
b .
attem pt</w>
antibio tics</w>
ambul atory</w>
al ready</w>
al az
administere d.</w>
ac hol</w>
Ris k</w>
Res pon
O R</w>
B -
9 6</w>
1. 3</w>
yohimb ine</w>
wh at</w>
ti es,</w>
stimul ant</w>
st a
s par
ren ess</w>
ren e</w>
progres sed</w>
po wer</w>
phosphat ase</w>
not .</w>
neuro protective</w>
neph ritis.</w>
mes angial</w>
medic ations.</w>
lor azepam</w>
inhibit ing</w>
ineff ective</w>
in ner</w>
hydrochlorothiaz ide</w>
hepati tis,</w>
fact ory</w>
exer t</w>
erec tile</w>
dissemin ated</w>
discharg ed</w>
den erv
decl ined</w>
cit rate</w>
caus al</w>
atrac ur
ate g
antipsycho tics</w>
anaesthe tic</w>
am yl
aff ects</w>
Simil ar</w>
IS O</w>
Fif ty-
Ca2 +</w>
B u
As ses
9 5</w>
9 0
6 8</w>
6 0%</w>
5-HT (1
3, 4-
1 5,</w>
( 7.
( 6.
y clin
vessel s</w>
vari ability</w>
ti ve,</w>
side s</w>
rat s:</w>
pre g
poly uria</w>
pati on</w>
path ic</w>
pac e
p <
om ime
measure d.</w>
intrad ermal</w>
inten se</w>
inhibit ors.</w>
ine 's</w>
he re
haloperid ol,</w>
gamma- aminobutyric</w>
foc i</w>
d u
contrib uted</w>
com for
bre ak
ameth ox
ad ver
T n
S af
E -
CYP 2
A ce
3 44</w>
(O R</w>
vasospas m</w>
vasocon striction</w>
trimeth op
transpor ter</w>
tonic- clonic</w>
ten sion</w>
t ment</w>
sumatript an</w>
sol ub
sec tions</w>
ro f
predisp osing</w>
poly mer
oz yg
ox y-
ni gr
mg/m (2
mal e
l af
laf ax
is ms</w>
il lo
haemo dynamic</w>
glyc ine</w>
glutam at
doxorubic in,</w>
dow n
character ize</w>
bre ath
amelior ated</w>
abnormal ity</w>
Ur inary</w>
Peri pheral</w>
P ac
N S</w>
Mic ro
M g
In hib
Centr al</w>
C lon
7 9</w>
4 /
(P R
(D E
we ak</w>
vesi cal</w>
vasodilat or</w>
var ying</w>
simil arly</w>
schizophren ia.</w>
s lic
review .</w>
prop an
pre existing</w>
pos ite</w>
other wise</w>
nephro toxicity.</w>
min -1</w>
mg/m 2.</w>
m ing</w>
in tran
in stitution</w>
in dex
ide -
hyponat remia</w>
flumazen il</w>
flow ,</w>
encoun tered</w>
ec it
disorder ,</w>
dam age,</w>
cy tic</w>
comp ris
co logy</w>
c im
analo gu
an ser
an ore
accept able</w>
V T
M on
M S
G F</w>
= 0.00
8 4</w>
6 ),</w>
5 1</w>
5 ,
1. 4</w>
(2 )-
us -
un related</w>
some times</w>
rec ru
protein uria,</w>
offsp ring</w>
obstruc tion</w>
no d
meth amphet
lymph oma</w>
lymph oblastic</w>
leuk emia.</w>
j ust</w>
insi c</w>
ill ness</w>
ho w</w>
gi ven
exhib it</w>
esoph ageal</w>
do m</w>
dex medetomidine</w>
con n
cholest asis.</w>
cas e.</w>
c ateg
anti convuls
an j
Nar anj
Ho dg
H IT</w>
Be havi
8 .</w>
2 %,</w>
(e .g
vascul itis.</w>
ther ,</w>
te tr
ste ad
ris k.</w>
retrospecti vely</w>
ran iti
r ul
pregnanc y.</w>
para dig
pace mak
ocyt es.</w>
occasion ally</w>
nucle i</w>
mechanis m.</w>
ly sos
liver .</w>
it y:</w>
insipid us</w>
inc ub
id ,</w>
i s.</w>
hippocamp us.</w>
h and</w>
g ro
et al</w>
dy st
di aph
cont in
cardi opulmonary</w>
bl ing</w>
benef its</w>
bar ic</w>
b und
an ese</w>
T ac
PA P</w>
P ri
Naranj o</w>
K et
IO P</w>
I /
Hg ,</w>
E D</w>
CB Z</w>
C e
8 0%</w>
6 %,</w>
x anth
tum our</w>
thiop ental</w>
tail -
sulf amethox
salic yl
respectively ;</w>
ra re.</w>
ot ec
osi tive</w>
os mo
o gen</w>
natriure tic</w>
mg/ day,</w>
l -induced</w>
intro duction</w>
incor por
id -
he mic
exter nal</w>
end oscop
en o
d end
calc ineur
benz o
az osin</w>
arteri os
appe ti
ana emia</w>
al er
V er
Syst emic</w>
R T
O c
NA ME
D D
B ra
An alysis</w>
7 4</w>
7 0%</w>
1 60</w>
vehic le
v in
ur rent</w>
trigg ered</w>
sildenaf il</w>
ren in-
recover y.</w>
re mis
prur it
pro st</w>
parameter s.</w>
on ol
myo si
mit ral</w>
me t</w>
mat ri
k s.</w>
im e</w>
gen es</w>
enter ic</w>
eluc idate</w>
deli ver
death ,</w>
de tail
cortico sterone</w>
con jug
chemo therapy,</w>
ana phyl
ain s</w>
M ore</w>
D L
AN CA
1 2,</w>
( 6</w>
vol t
un affected</w>
th o
suppor ts</w>
releas ing</w>
recomm end</w>
prolifer ative</w>
po w
pilocarp ine.</w>
par aly
p unc
osmol ality</w>
od rine</w>
myasthen ia</w>
man ia</w>
ir e</w>
ip )</w>
in :</w>
i ,</w>
hypercal ce
hydrox yl
hormon al</w>
glutamat ergic</w>
gest ational</w>
ge al</w>
et ing</w>
dizzin ess,</w>
cy st
cont ained</w>
compar is
clop ido
c old</w>
bal ance</w>
augment ed</w>
attac k</w>
am ycin</w>
acut ely</w>
T P
R an
R OD
Med ical</w>
HBe Ag</w>
Eff icacy</w>
9 0%</w>
9 ).</w>
8 2</w>
1. 6</w>
1 :
1 %,</w>
worsen ed</w>
w ash
ven tive</w>
tren d</w>
ti b
suit able</w>
stres s.</w>
st ep
so on</w>
scop ol
saf ely</w>
pi g
peroxid ase</w>
om yc
man ic</w>
li pide
i op
hyp no
hem olysis</w>
guine a</w>
fluox et
flecain ide</w>
fascicul ations</w>
ey es</w>
exer ci
es /
diseas es.</w>
de sign</w>
contrac tile</w>
conf oun
concentr ations,</w>
co de
caref ul
cannabin oid</w>
c och
az oc
ari pi
ar ly,</w>
am -
abstin ence</w>
ROD UC
P 450</w>
INT RODUC
HB s
CO X-
Am iodar
A L</w>
3 %,</w>
1 25</w>
(C H
year .</w>
y ch
su ic
resul ts.</w>
r af
pap aver
onol act
monit or</w>
min /
le t
label ing</w>
j oin
ing -
h n
fluo res
f uture</w>
expl an
ei gh
com pa
bil ater
bas ement</w>
antiretro viral</w>
alkal ine</w>
Saf ety</w>
S ymptom
N S)</w>
H em
F l
E leven</w>
CI :</w>
7 8</w>
5-F U
1. 8</w>
1 7.
0. 9%</w>
0. 5%</w>
um or</w>
tubulo interstitial</w>
swell ing</w>
suppor tive</w>
st ren
sim ple</w>
shorten ing</w>
sex ,</w>
s ca
repe ti
princ ip
prepar ation</w>
pre frontal</w>
patient s).</w>
parox etine</w>
opyr amide</w>
occlu sive</w>
nitr ite</w>
ml )</w>
mil li
log raf
liqu id</w>
levo dopa
in /
hyper ther
gener ated</w>
experi encing</w>
ex encephal
es ul
dyskine tic</w>
contro lling</w>
conscious ness</w>
carcin omas</w>
carb on</w>
beta- adrenoceptor</w>
antagonist s,</w>
anc es,</w>
amant adine</w>
am oxic
Th er
S G
R epe
MATERIAL S</w>
INTRODUC TION:</w>
Fif teen</w>
Dec emb
C erebral</w>
Asses s
AC TH</w>
3 ;</w>
2. 0
1 -1
(- /-
( 3-
u preg
tub ule</w>
tu mo
tri am
ti form</w>
sal butam
ra y</w>
psych ological</w>
practi ce</w>
p ine-induced</w>
om es</w>
mg/m 2)</w>
il ine</w>
id azole</w>
heav y</w>
gam ma</w>
fluo resc
exten ded</w>
erg ot
e asi
cy s
cent er</w>
az one</w>
adul ts.</w>
acet am</w>
Ther ap
Th us</w>
Rever sible</w>
O p
Heal th</w>
Drug -induced</w>
Ca (2
24- hour</w>
100 %</w>
trans -
thrombocytopen ia,</w>
striat um.</w>
sing le
secon ds</w>
sacrific ed</w>
ra re,</w>
ra -
propofol .</w>
pre pared</w>
pa fen
opio ids</w>
on going</w>
olan zap
oid s</w>
ogen icity</w>
ne ar</w>
mo bil
meperid ine</w>
medull ary</w>
lo o
large ly</w>
inf ants.</w>
id ine.</w>
gentam icin-induced</w>
fem oral</w>
exac t</w>
employ ed</w>
emis sion</w>
dis ruption</w>
der mat
cy pro
cur ves</w>
convul sion</w>
carb achol</w>
block s</w>
bicarb onate</w>
b er
at ally</w>
aryn geal</w>
anc ing</w>
al low</w>
al )</w>
adi ly</w>
ad d
Propo fol</w>
Prolong ed</w>
P K
L- NAME
AC h
( in</w>
use d,</w>
ta x
stat es</w>
sp ectro
si z
si c
see king</w>
scop ic</w>
reser ve</w>
point es.</w>
pent am
peg ylated</w>
parkinson ism</w>
knowledg e</w>
intrac or
in s,</w>
in o</w>
impair ment.</w>
i lo
i b</w>
hypo the
haz ard</w>
h ind</w>
exer ts</w>
ex cell
epinephr ine-induced</w>
e le
dram atically</w>
discontinu ed,</w>
diethylstilbestro l</w>
complic ation.</w>
circ ulation</w>
ce ph
catechol amines</w>
catal ase</w>
cardiomyo pathy,</w>
bu pren
bra ins</w>
bor tezom
au tis
at o
anticoagul ant</w>
al lograf
] )</w>
O b
Lab oratory</w>
F our
B /
7 %,</w>
5. 0</w>
year s;</w>
volunte ers.</w>
vascul ar
unchang ed.</w>
ul es</w>
tubul es</w>
tr act
tic .</w>
there by</w>
streptozotoc in-induced</w>
s.c .</w>
s ure</w>
reve al</w>
repor ted,</w>
re plic
rang e.</w>
post synaptic</w>
phosph o
ph er
pa w
p ly</w>
oph osph
oly sis.</w>
o plastic</w>
myelo ma</w>
mul tivariate</w>
los s,</w>
intr insic</w>
inter ac
fam il
ex plo
enti re</w>
enti n</w>
disul firam</w>
cor d
caus ative</w>
avoid ed</w>
anesthe sia,</w>
am ifostine</w>
alpha- methyl
ag ing</w>
ag es.</w>
SE .</w>
M I
M ),</w>
B as
Al so,</w>
A S</w>
1 A</w>
0 .</w>
( 8.
y me
under standing</w>
ud g
u ne
tumo ur
tramad ol</w>
tion )</w>
tig m
ti ve.</w>
seg ments</w>
ret ard
relap sed</w>
pati al</w>
p g/
ous ly,</w>
ogene sis.</w>
ob last
normal ,</w>
is ot
infu sion
i v</w>
form ation.</w>
fet uses</w>
ex ogenous</w>
entr y</w>
em a</w>
dur al</w>
drug -related</w>
carnit ine</w>
car r
canc er
bl un
belie ved</w>
belie ve</w>
b if
arg in
appro ved</w>
anto in</w>
ad ap
R NA
P N</w>
P -induced</w>
Mul ti
Immun o
Hospit al</w>
Evalu ation</w>
Decemb er</w>
Com ple
Chin ese</w>
C ).</w>
AM -
A A</w>
- cell</w>
(1 50</w>
( ></w>
z ing</w>
visc eral</w>
toler ated.</w>
ta st
stren g
strate gy</w>
sten osis</w>
sed ation,</w>
remo val</w>
polymer ase</w>
pentylenetetra z
patient s;</w>
on ly.</w>
nic ardi
ng/ ml</w>
na ive</w>
metr on
m ary</w>
great ly</w>
g er
evalu ating</w>
dro p</w>
deli vered</w>
degener ative</w>
contrac tility</w>
catalep sy,</w>
c rac
b red</w>
arb oxyl
apparen tly</w>
anti inflammatory</w>
adoles c
T or
S u
R el
Phen y
Na +
L- dopa</w>
Fancon i</w>
8 00</w>
0.0 1</w>
y lo
ver b
ven lafax
tra ined</w>
therap ies</w>
t ation</w>
synerg istic</w>
su fentanil</w>
si rolim
sca ven
pre fer
post partum</w>
pentam idine</w>
par ad
ou gh</w>
other s</w>
octre otide</w>
nor adrenergic</w>
neurolep tics</w>
mus cim
mitoxantr one</w>
manifest ation</w>
li um</w>
ist s</w>
impro ves</w>
hypo thermia</w>
hyper thermia</w>
headache .</w>
half- life</w>
ha ir</w>
go al</w>
gen it
epilep tiform</w>
enalap ri
em ul
diazepam ,</w>
di ffered</w>
brady kinin</w>
behavi or.</w>
allow ed</w>
W il
T oxicity</w>
T otal</w>
N ational</w>
N R
He mo
D SM-
Ch ild
AZ T</w>
9 7</w>
8 ),</w>
5-hydroxy trypt
(D O
( 60</w>
wom en,</w>
vitro .</w>
verb al</w>
tuberculo sis</w>
tri pt
st ages</w>
specimen s</w>
sim vastatin</w>
side- effect</w>
sensor ineural</w>
s ampl
r ag
progres sively</w>
proced ure.</w>
presum ably</w>
ph ases</w>
par tly</w>
p ure</w>
osmo tic</w>
oper ativel
monke ys.</w>
ml ,</w>
mannit ol</w>
labet alol</w>
ischem ia,</w>
intra operative</w>
inges tion.</w>
illust rates</w>
id .</w>
i si
hypo thalam
he i
gu ide
form ulation</w>
expres sion.</w>
examin ations</w>
ed ;</w>
deoxy chol
concer ning</w>
com pati
careful ly</w>
b arbit
analgesic s</w>
adriamyc in-induced</w>
acceler ated</w>
T B
Q -
Pro te
P e
Lith ium</w>
I U/
G P
B B
9 2</w>
3 90</w>
19 .
1. 1</w>
1 5%</w>
-1 00</w>
trans genic</w>
swit ched</w>
sub clinical</w>
st ed</w>
spec i
re combin
presc rib
potenti ate</w>
pl ant
par t,</w>
p.o .)</w>
or ing</w>
one- treated</w>
ograph y,</w>
obser ved,</w>
log istic</w>
le d.</w>
ket oro
iz es</w>
ish ing</w>
indic es</w>
id ation</w>
high- risk</w>
hemat uria</w>
group ).</w>
facilit ate</w>
f ind</w>
edi atric</w>
easi ly</w>
e a</w>
dy sp
dis comfor
del ta
colo rectal</w>
clin ic</w>
ce -
amil or
administ ering</w>
ad he
acro megal
ac coun
V as
Simil arly,</w>
O ut
H z</w>
GAB A-
C V
Bas el
AT RA</w>
A C</w>
5 8
3- 4</w>
(N MD
(MA P)</w>
( m
weigh t.</w>
week .</w>
ultras on
u tility</w>
typ ically</w>
transamin ase</w>
terat ogenic</w>
sub unit</w>
strok e.</w>
st ru
specific ity</w>
s l
r y
pro cess
placebo- controlled,</w>
pericardi al</w>
parox ysmal</w>
out .</w>
ouabain -induced</w>
on ia</w>
no dul
nitro s
necess it
mono amine</w>
mg/kg ;</w>
lign ocaine</w>
intra ventricular</w>
incid ences</w>
i.p. ).</w>
hippocamp us,</w>
experim ent,</w>
dialy sis.</w>
day ).</w>
contraceptiv es</w>
cap able</w>
c up
ax is.</w>
atheros clero
anti parkinsonian</w>
amitript yline</w>
aldehy de</w>
T T
S ec
Pati ent</w>
PGE 2</w>
Ig G</w>
ED 50</w>
D AT
A F</w>
3 %),</w>
18 0</w>
+/ -1.
( one</w>
( >
( 5-HT
zin c</w>
week s)</w>
war ran
test s,</w>
ston es</w>
stimul us</w>
sed ative</w>
s pro
r ated</w>
progno sis</w>
pre- existing</w>
per cutaneous</w>
pa re
ot opic</w>
modul ate</w>
microg/ kg</w>
metabol ism.</w>
mes enteric</w>
man .</w>
main taining</w>
locomo tion</w>
is ing</w>
inter view
inten si
id -induced</w>
hypertroph y.</w>
hemat ological</w>
he pt
function ing</w>
fati gu
ect opic</w>
ec tion.</w>
dyskine sia.</w>
don or</w>
develop ment.</w>
contr al
classi fied</w>
arrhyth mo
anti platelet</w>
anesthe tics</w>
aldo sterone</w>
ak athi
aggreg ation</w>
admis sion,</w>
abs ent</w>
S ch
Ret ro
RF -1
R ole</w>
PGE 1</w>
E uro
CY P</w>
Be fore</w>
B U
A spir
5 6
% );</w>
vent ro
ut ri
ultras ound</w>
succinyl chol
str ych
resul ts,</w>
res .</w>
refl ect</w>
opoi etic</w>
ocic ept
nit rous</w>
mut ation</w>
mo de</w>
micro M</w>
li ver,</w>
lev of
kg(-1 ),</w>
in direct</w>
ic ot
hydr amine</w>
hemorrh age,</w>
favor able</w>
fail ure
es tic
dep ri
con striction</w>
compati ble</w>
com e</w>
cl as
bra inst
ardi zed</w>
abnormal ities,</w>
S K
Rec ently,</w>
R R</w>
Pro t
OUT COM
OUTCOM E</w>
M us
H z
H ere</w>
Experim ental</w>
EP O</w>
tur no
there after
survi ved</w>
strategi es</w>
stit ute</w>
solub le</w>
si der
shi ft</w>
saf et
sac char
s one</w>
ro ute</w>
raz ole</w>
ran ulo
r un
put ative</w>
patient s),</w>
pall id
open- label</w>
month -old</w>
mode st</w>
microscop y.</w>
me tri
me flo
m ir
lisin opril</w>
initi ating</w>
ine- related</w>
immunosup pression</w>
ill ing</w>
h ind
h en
great est</w>
gen cy</w>
fun g
ep ide
endoc rine</w>
end- stage</w>
dyst onic</w>
diltiaz em
dig ox
d- release</w>
cor tic
condition ing</w>
complex es</w>
bra in,</w>
blind ed</w>
benzodiazep ines</w>
avail ability</w>
aten olol</w>
arabino side</w>
ar abine</w>
anc er</w>
adjust ment</w>
ab users</w>
[ CI
V entr
Symptom s</w>
St at
Pac litax
Nit ro
Jap anese</w>
F E
5 %),</w>
4 ;</w>
(OH) 2
( odds</w>
( U
wom en
toler ated,</w>
thyroidis m</w>
thal idom
termin ated</w>
su med</w>
stro ph
spir onolact
si s:</w>
sett ing.</w>
sept al</w>
seiz ure.</w>
ru pt</w>
ondan setron</w>
moder ately</w>
mo stly</w>
kg -1,</w>
intub ation</w>
in da
h ome
gly cemia</w>
expl ore</w>
es ).</w>
e ).</w>
dow n</w>
dis opyramide</w>
dis appearance</w>
demonst rating</w>
comp uter
comp ul
com a.</w>
centr ally</w>
ce l
calcineur in</w>
as eptic</w>
antin ociception</w>
anti viral</w>
anat om
al f
T D
ST- segment</w>
S D)</w>
P AC
Me as
M ice</w>
Le ft</w>
II I
HIV- infected</w>
H b</w>
Ev idence</w>
DX R</w>
CA 3</w>
B H
Ace t
3 %).</w>
0. 2
( i.v.)</w>
z il</w>
we ver</w>
vari ation</w>
vari abl
uter o</w>
tic -
significant ly.</w>
sertr aline</w>
proced ures.</w>
physos tigmine</w>
penicill in</w>
patient -
pa ired</w>
non- small</w>
micro angio
methylphen idate</w>
matri x</w>
mal on
ma x</w>
long- acting</w>
lidoca ine,</w>
lac tic</w>
l ac</w>
ful ness</w>
discontinu ation.</w>
diarrhe a</w>
dat a,</w>
consider ably</w>
clo sed</w>
challeng ed</w>
b ase</w>
artic le</w>
aro und</w>
ar ti
ar -
amplit u
acqu isi
Td P</w>
NSAID s</w>
LI D</w>
Hy po
De pression</w>
Assess ment</w>
AN CA</w>
14 ,</w>
1 %),</w>
0. 25</w>
( at</w>
% -
ven ti
understo od.</w>
unc er
treatment s.</w>
to wards</w>
ter .</w>
st radi
som at
sequel ae</w>
re :</w>
radio therapy</w>
prece ding</w>
praz ole</w>
pharmaco dynamic</w>
p tive</w>
ot rig
mmHg ,</w>
minut es,</w>
mam mary</w>
malform ations</w>
lo st</w>
kg ro
intoxic ation.</w>
inos it
implant ation</w>
ia )</w>
hypertroph ic</w>
hyper baric</w>
hemo dynamics</w>
haloth ane-
gon ad
g .</w>
f ar</w>
exclu ded.</w>
ester n</w>
es are
def ovir</w>
dec i
cyclophosphamide ,</w>
cul ture</w>
conf usion</w>
az ot
awa reness</w>
atax ia</w>
aspir in,</w>
ac ted</w>
a ur
M or
M any</w>
Gi ven</w>
GF R</w>
Cor onary</w>
C ent
A z
2. 4</w>
vecur onium</w>
ve di
transplant ed</w>
suppres s</w>
suppor ted</w>
s patial</w>
regimen s.</w>
recept or.</w>
reac tions,</w>
promot ing</w>
proca ine</w>
pr one</w>
p sor
oxid ation</w>
oc hemic
observ ational</w>
o tic</w>
nitro gen</w>
micro M)</w>
mic tur
mg/ day.</w>
man ip
line zol
kind ling</w>
isch aemic</w>
intr act
inter nal</w>
inter mediate</w>
ing s.</w>
imi pr
idi osyn
h loro
form alin</w>
fol low</w>
fib rate</w>
ethambut ol</w>
endo theli
en si
en anti
ecti n</w>
contro ver
contrac tions</w>
co administration</w>
cholester ol
behavi our
asp ects</w>
am ate</w>
addi tive</w>
a /
W estern</w>
Th al
T rans
Hep at
H IT
C 3
Basel ine</w>
9 1</w>
7 1</w>
5 %).</w>
4. 5</w>
2 6.
(C O
vi ro
tremor ,</w>
tion ed</w>
tion :</w>
time -
ticlop idine</w>
ter ,</w>
system atic</w>
syn thesi
si c</w>
s he
repolar ization</w>
remo ved</w>
re adily</w>
ph il
pel v
out patients</w>
otec an</w>
oc occ
normal ization</w>
neon ates</w>
meth oxy
meth amphetamine-induced</w>
man aged</w>
leng th
ibu profen
hyper ammon
hist ology</w>
hepat ocytes</w>
hemat oc
fol ate</w>
fi g
f loxacin</w>
event ually</w>
esare an</w>
erythropoi etin</w>
e /
dram atic</w>
dop amine-
de pos
contral ateral</w>
complic ations,</w>
com promis
colon y-
children ,</w>
cardio protective</w>
calcitri ol</w>
av es</w>
aqu eous</w>
aminonucle o
all ed</w>
adrenal ine-induced</w>
acyclo vir</w>
activ ation.</w>
Val pro
Uni versity</w>
Repe ated</w>
O ver</w>
N K
M agne
M ).</w>
HU S</w>
Bra in</w>
Al ter
A no
A (2
2. 3</w>
(-/- )</w>
z ine</w>
vincrist ine-induced</w>
traum atic</w>
tr ue</w>
tox in</w>
te m</w>
sib ility</w>
se c</w>
s ine</w>
ro pivacaine</w>
repeti tive</w>
recor ding</w>
qu ad
py r
psych omotor</w>
propylthio uracil</w>
prompt ly</w>
pro pafen
pilocarp ine,</w>
phen ic
on uc
omime tic</w>
olig uric</w>
n ocicept
my co
mus cles</w>
meta -
ment ation</w>
m -
lymph ocytic</w>
lo mer
lipo protein</w>
lethal ity</w>
le g</w>
j ac
intract able</w>
insti ll
in contin
fl ush
eryth ema</w>
efficac ious</w>
di phenyl
cys tic</w>
cyclospor in</w>
cou pl
concentr ation,</w>
compul sive</w>
cocaine- related</w>
coag ul
cisplat in,</w>
cis -
circul atory</w>
challeng e.</w>
cap ecit
c Tn
bupivaca ine.</w>
basel ine.</w>
az ol</w>
as alazine</w>
am phenic
am ous</w>
aden os
accumb ens</w>
R ),</w>
N ,</w>
Hodg kin
D ay</w>
Ar g
8 3</w>
1 1-
(N O)</w>
(N O
( the</w>
warran ted.</w>
ur ally</w>
thre e-
ter ious</w>
sulpiri de</w>
st as
seg mental</w>
ro ot</w>
rin one</w>
resc ue</w>
pro -
per cep
olog ous</w>
no v
mor ning</w>
micrograms/ kg/
m urine</w>
lat er
lamivud ine-
k ine</w>
insuffici ency.</w>
inhibit ors,</w>
in uria</w>
ic lo
hyperalgesi a,</w>
hydr ation</w>
gen der</w>
form ed</w>
fibr in
exer ted</w>
et op
enanti om
discharg es</w>
day s).</w>
day -old</w>
combin ation.</w>
com orb
can di
c li
block er,</w>
bicucul line</w>
antine oplastic</w>
anore x
am lodipine</w>
advant age</w>
ac k</w>
a vi
U l
Physi ci
LVE F</w>
K +
Iso proteren
Inc idence</w>
INTERVEN TIONS:</w>
Hg )</w>
H a
GS H</w>
E P</w>
D ).</w>
COX- 2</w>
A dul
ve lop
ul a</w>
tw or
ti r
t un
sup ine</w>
sulf on
slow ly</w>
shi f
s in</w>
repor t,</w>
renin- angiotensin</w>
regul atory</w>
pri de</w>
pre cur
pp m</w>
ph ent
pa ir</w>
or d
onuc lide</w>
on d</w>
ome g
nitroprus side-induced</w>
morph ology</w>
mitochond ria</w>
m M</w>
lig ation</w>
leuk openia</w>
less er</w>
know n,</w>
it s,</w>
it ,</w>
intra ocular</w>
ingest ed</w>
indic ative</w>
increas ed,</w>
ic .</w>
he im
h ab
follow-up ,</w>
fluoresc ence</w>
e ar</w>
dr y</w>
dipyridamol e-induced</w>
degrad ation</w>
de d,</w>
d ang
cult ures</w>
cra ving</w>
complain ts</w>
clonid ine.</w>
bran ch</w>
bo dy
bac kgro
b ru
ay s.</w>
as cit
ap aro
alcoh olic</w>
adoles cent</w>
Ventr icular</w>
T ak
S S</w>
S BP</w>
MD MA</w>
M T</w>
M PT
J un
In te
Grou p.</w>
G V
Fo od</w>
F atal</w>
F ).</w>
E 1</w>
7 ),</w>
5 /
2 3.
- based</w>
vac c
tiz ing</w>
t es</w>
sub -
s pl
s clerosis</w>
recipi ents.</w>
re jection</w>
prescrib ing</w>
pre operative</w>
pos t</w>
per ative</w>
pat ch
p tion.</w>
ove rex
om yo
om as.</w>
mg/d L</w>
ket ocon
iohex ol</w>
ing )</w>
inflamm ation.</w>
impair ments</w>
immunore active</w>
id ine-induced</w>
hospital ization</w>
hormon es</w>
gab ap
g an
fer ri
ex pan
epilept ogenic</w>
enh ancing</w>
dos age.</w>
dog .</w>
depress ant</w>
def ine</w>
conjunc tion</w>
classi cal</w>
cap sul
bri le</w>
b asic</w>
adrenocept ors</w>
adolesc ents</w>
abol ic</w>
W K
Rec o
R s</w>
N D
L ocal</w>
L P
In f
IC U</w>
IC RF-1
Hodgkin 's</w>
H emat
CA )</w>
C ancer</w>
AIM :</w>
6 ;</w>
6 0-
4 %,</w>
20 00</w>
2 4.
0 -1
( 8</w>
we an
vit al</w>
traum a</w>
tra di
tissu e.</w>
thrombocytopen ia.</w>
surviv ors</w>
str al</w>
stimul ation,</w>
stand ardized</w>
st ent</w>
st atic</w>
so ft</w>
side .</w>
sec tional</w>
ri gh
reli able</w>
rele ased</w>
recombin ant</w>
rat e-
rat ,</w>
provo ked</w>
prost atic</w>
prolact in
pect or
ob ses
neo plas
ne os
nar co
mut ations</w>
mor tem</w>
month s)</w>
m isoprost
lymph ocyte</w>
log raph
invol ves</w>
impro ving</w>
i -
hyper activity.</w>
high ligh
ga ve</w>
fl are</w>
exacerb ated</w>
es ),</w>
er )</w>
efficac y,</w>
e ligible</w>
di methyl
develop ed.</w>
decreas ed.</w>
de myel
cri tically</w>
cont ex
con sol
coll ap
clar ify</w>
captop ri
ca v
asth ma</w>
ass ay.</w>
analgesi a.</w>
ST Z
MT X
M orph
Inhib ition</w>
G ra
Ch ol
Al z
A ).</w>
1/ 2</w>
1 %).</w>
-1 7</w>
(i )</w>
treatment -
transf usion</w>
table ts</w>
system s.</w>
spi k
somn ol
rifamp icin</w>
regar d
regard less</w>
reduc tase</w>
ras h,</w>
radi onuclide</w>
propranolo l.</w>
pre clinical</w>
ph ere
p ine.</w>
p ine,</w>
oxy toc
osmol ar</w>
os ed</w>
om ep
o d,</w>
ne twor
n utri
my ocyte</w>
morph ine-induced</w>
ml .</w>
minoxidi l</w>
minocycl ine</w>
meth od
las er</w>
it y-
gall bladder</w>
excell ent</w>
ev ing</w>
etop oside</w>
en co
dyskinesi as.</w>
dele terious</w>
cor b
con stric
capsaic in-
ca u
c m</w>
bronch odi
atracur ium</w>
ap pa
aneurys m</w>
activ ating</w>
a er
Thir teen</w>
S pec
Re search</w>
O H
NS AI
N icot
N I
N .</w>
Hist opath
E pi
D M
CN U</w>
C ont
9 .</w>
2 A</w>
.00 1).</w>
- M
(S T
(S E)</w>
(1 9
(1 2</w>
ym pathetic</w>
vin blast
ve tir
ur able</w>
tremor s</w>
tim ul
thel ess,</w>
sup press
strok e,</w>
slic es</w>
sh am-
selec tivity</w>
rim -
re mic</w>
raz oxane</w>
presum ed</w>
post menopausal</w>
paren t</w>
o ple</w>
non selective</w>
negati ve.</w>
ne a</w>
n om
month s).</w>
meth ion
medi ating</w>
ist er
invol ve
intracerebro ventricular</w>
interval s.</w>
ic s,</w>
gre at</w>
gn os
genotyp e</w>
g ross</w>
extra vas
elim inated</w>
dy stroph
dur ation,</w>
diphen hydramine</w>
diclofen ac
capsaic in.</w>
c ran
b ar</w>
arter y.</w>
apopto tic</w>
anthrac yclin
antagon ize</w>
acetaminophen -induced</w>
S odium</w>
Pri or</w>
Pre vention</w>
Me dic
GABA (A)</w>
B ilateral</w>
An esthe
Alz heim
8 6</w>
5 ;</w>
3. 2</w>
23 390</w>
2 %),</w>
( 5-
zidov ud
weigh ted</w>
vulner ability</w>
un common
ter ti
stres s
ste ad</w>
squ amous</w>
reg ist
reas on
re al</w>
py ramidal</w>
prote in,</w>
process ing</w>
proc ess.</w>
patient s:</w>
p. o.</w>
of -
nigr a</w>
neuro n</w>
monit ore
micro som
m ec
m arg
kg -1.
ketoro lac</w>
is ation</w>
io di
insti tu
in- 1</w>
in verse</w>
ia /
hyperkal emia</w>
hyper cholesterol
home ost
hepat ocyte</w>
g ri
fact or-
experiment s,</w>
enz yme
e duc
diure tics</w>
dis co
depend ent.</w>
de struc
conside red.</w>
carbo plat
b ing
b ,</w>
appeti te</w>
a reas
Throm bo
ST Z</w>
SE ,</w>
M ethyl
K +</w>
I MP
I CA
En gl
Comple te</w>
Aspir in</w>
Ar ter
Ang io
AM I</w>
4. 0</w>
4 %),</w>
1. 9</w>
1. 7</w>
1, 25-
1 8-
0.0 2).</w>
(D A)</w>
(0. 3</w>
ta ined.</w>
suxameth onium</w>
stat e.</w>
sit u</w>
se en.</w>
s- -
s ection</w>
posi tively</w>
pl ate</w>
pl ant</w>
pathw ay.</w>
ozyg ous</w>
onucle ar</w>
ol )</w>
ogen etic</w>
nitro- L-arginine</w>
nim esul
neurotransmit ter</w>
neuro chemical</w>
metho d.</w>
manag ement.</w>
kine tics</w>
kidne y.</w>
kain ic</w>
infec tion,</w>
i m</w>
hepatoc arcin
gnos tic</w>
expos ure,</w>
escal ating</w>
dro w
diazepam .</w>
conver ted</w>
carb onate</w>
bus ulf
bef ore,</w>
aut opsy</w>
antagonist s.</w>
antagonist .</w>
ammon ia</w>
a j
With draw
V ari
SP EC
Physici ans</w>
O x
Hepar in-induced</w>
Fo s</w>
E th
De velop
Coca ine-induced</w>
8 %),</w>
6 9
-1 .</w>
- free</w>
(M D
(C Y
(3 00</w>
(0. 2</w>
y r</w>
vasodi lation</w>
unex pl
ulo x
ulc er</w>
transplant ation,</w>
transc ri
tinnit us</w>
susp ici
spec ial</w>
sour ce</w>
side ,</w>
ser a</w>
salbutam ol</w>
ro stral</w>
retro grade</w>
respon ders</w>
repe at</w>
recur red</w>
raz ol
rabb it</w>
psych os
prop ose</w>
present .</w>
phy loc
phenyl propan
ph e
person s</w>
per in
pe ople</w>
particip ated</w>
parathyro id</w>
ocyt es,</w>
ochrom ocyt
neuron s,</w>
me lan
lob al</w>
it amin</w>
infec tions.</w>
improve ments</w>
ic tal</w>
hypo thalamic</w>
g ain
fung al</w>
flut ter</w>
fibro sis.</w>
fati gue</w>
f osf
es us</w>
ep icardi
em ent,</w>
echocardi ography.</w>
desi pramine</w>
dec om
clinic al,</w>
clar ithromycin</w>
caud al</w>
bund le</w>
ate )</w>
ap ril</w>
acet azol
a sis,</w>
T o
S w
S up
R P
On cology</w>
M it
Jun e</w>
G lobal</w>
G ),</w>
Four teen</w>
E .</w>
DAT A</w>
D PA
Cat al
A M</w>
2 5.
.0 5).</w>
(1 0-
up -
traz od
tob ram
to ol</w>
tend ency</w>
techniqu es</w>
sub type</w>
stit ut
se n</w>
scal e.</w>
ro om</w>
ro les</w>
ro l
ro curonium</w>
reser pine</w>
raniti dine</w>
phosphor ylation</w>
perid one</w>
orig in</w>
onse t,</w>
necro sis,</w>
morph ine,</w>
micrograms/ kg)</w>
mel phal
literat ure,</w>
kg .</w>
k appa
it ary</w>
ir radiation</w>
individu als.</w>
in toler
identi fication</w>
hyperprolact ine
hyper lipide
heter ogene
headach es</w>
gangli a</w>
frequ encies</w>
for ced</w>
ex pect
evid enced</w>
establ ished.</w>
er ro
ei r</w>
dro xy
dilat ation</w>
de vi
dap sone</w>
cyt arabine</w>
cyclophosphamide .</w>
correl ates</w>
continu e</w>
concentr ation
compris ed</w>
colony- stimulating</w>
cep t</w>
bl ue</w>
an oid</w>
alb ino</w>
admis sion.</w>
aden omas</w>
Th eir</w>
NS CL
M echan
I P</w>
Ev ans</w>
E E</w>
Cont inu
C ),</w>
AM P
A Q
9 9</w>
8 %,</w>
5 -1
1 2)</w>
0.000 1)</w>
/ -</w>
- P
vi g
venti lat
v es.</w>
un able</w>
tr in
test ing.</w>
tachy cardi
supplement ed</w>
sub lingual</w>
stud ying</w>
stru al</w>
stat us.</w>
sig ma</w>
seve re,</w>
resuscit ation</w>
put am
predict or</w>
pre ventive</w>
pre treatment.</w>
ox ical</w>
orth otopic</w>
ol -treated</w>
ni gh
n ia</w>
mus cl
morph ologic</w>
micro injection</w>
medic ation,</w>
loc us</w>
lithi um
le f
itsel f</w>
inhibit or.</w>
influ ences</w>
im azole</w>
if or
hemo dynam
hear t,</w>
h am
grad ual</w>
glomerulos clerosis</w>
fe brile</w>
ex p
cyt os
concent rating</w>
coch lear</w>
aor ta</w>
anser in</w>
anc es.</w>
al prazol
Six ty-
Pharmac o
I S</w>
F re
Am ph
Afric an</w>
8 1</w>
3 5%</w>
2. 7</w>
2. 1</w>
.00 0
(AC E)</w>
( NT
xanth ine</w>
us ers,</w>
ul l</w>
ti d
surve y</w>
super ficial</w>
stoppe d.</w>
st ain
sist ent</w>
ri t</w>
pyri dine</w>
pod ocyte</w>
plas ma
pergol ide</w>
pa res
os por
naprox en</w>
interval .</w>
in stead</w>
im ages</w>
hepar in.</w>
g as</w>
four -
fluc tu
examin ation,</w>
ethin yl</w>
er up
endo thel
embry onic</w>
clo sure</w>
cimeti d
chrom os
cholec yst
ca use
bupren orphine</w>
arter ies.</w>
ap ical</w>
ang in
amygdal a</w>
acquisi tion</w>
a y,</w>
a defovir</w>
Six teen</w>
SR L</w>
Retro spective</w>
Parkin son</w>
N H
F em
Carb am
C ar
9 ),</w>
7 5%</w>
2 8.
1 4-
- onset</w>
(e.g .,</w>
(S E
yc in-induced</w>
y /
well- known</w>
we re:</w>
vi ol
triam te
tast e</w>
shorten ed</w>
sensitiv ity.</w>
s lop
rupt ed</w>
risperid one.</w>
rim- sulfamethox
pren atally</w>
post ulated</w>
plast y</w>
parathyro idis
multicent er,</w>
muc osi
morph ine.</w>
malon di
le ak
l ine,</w>
intra hepatic</w>
intak e.</w>
i. e.,</w>
hypertroph y,</w>
hyper calci
hepat otoxicity.</w>
g old</w>
g ated</w>
eth yl</w>
en flurane</w>
dys ph
di ed.</w>
cycl es.</w>
chron otropic</w>
ca in
bl ind</w>
antioxid ants</w>
analy zed.</w>
age- matched</w>
aff ected.</w>
addic tion</w>
V .</w>
Tor sades</w>
Prop ran
P res
I P)</w>
I ).</w>
HC V</w>
AL T</w>
A ut
A t
A U
5 '-
24- h</w>
(E E
y- state</w>
withdraw al,</w>
une vent
underg o</w>
u xim
tri azol
syn chron
sub acute</w>
si ve,</w>
rh esus</w>
reac h</w>
re striction</w>
re se
pro gnostic</w>
pneumon ia</w>
pent azoc
ot umor</w>
oper ated</w>
ome gal
oly sis,</w>
necro tizing</w>
na di
microg/ kg/
meas urable</w>
m RNA
lam otrig
ke phal
hypoc al
hypo ther
haemat ological</w>
etom id
en kephal
efficac y.</w>
e ),</w>
detail ed</w>
der m
dat a.</w>
continu ing</w>
consider able</w>
concomit antly</w>
clozap ine.</w>
cle ,</w>
cholin erg
ceftriax one</w>
carbamazep ine.</w>
cal cin
barbit ur
azol e.</w>
atro b
atel y,</w>
analy sed</w>
ab und
Ser ial</w>
L-DO PA</w>
Hg .</w>
D obut
C H</w>
= .0
7 ;</w>
7 %).</w>
3. 3</w>
2. 6</w>
- specific</w>
( <
year s).</w>
y le
v ox
unex pected</w>
un likely</w>
throm bus</w>
t ting</w>
sub mitted</w>
stereotyp y</w>
spi ke</w>
sci atic</w>
remark able</w>
ran k</w>
queti apine</w>
phyloc occ
ph ase.</w>
pacemak er</w>
or ic
op posite</w>
olo l,</w>
ol e-
ng/ m
mit omycin</w>
mictur ition</w>
loc ation</w>
lif e.</w>
k in</w>
is os
inser tion</w>
ine ).</w>
induc tion.</w>
hist ologically</w>
hap s</w>
gene tically</w>
fif th</w>
fact or.</w>
extrem e</w>
evol ution</w>
escal ation</w>
er ol</w>
eosinophil ia</w>
ent s,</w>
ec stas
diagno sis.</w>
dec arboxyl
correl ations</w>
coll ecting</w>
chlor amphenic
ceph alo
car vedi
c anal
aw ake</w>
assess ing</w>
arrhyth mia,</w>
appea red.</w>
an -induced</w>
ag es,</w>
acc ess</w>
Withdraw al</w>
Sevent y-
MEASUREMENT S</w>
I ),</w>
G R
G MP</w>
F os
F ),</w>
E ,</w>
D T
C K
B AL
Ano ther</w>
AV P</w>
A PAP</w>
5-HT(1 A)</w>
2. 2</w>
(NS AID
(NMD A)</w>
( s)</w>
( by</w>
xi let
w i
vetir acetam</w>
ver theless,</w>
ut roph
ur niqu
un responsive</w>
ular ,</w>
ul e
to urniqu
titr ated</w>
tion -
ten sive</w>
t ap
t al
t /
si ve-
ris k,</w>
relationshi ps</w>
rat ings</w>
promot e</w>
pro convulsant</w>
pre- treatment</w>
poly neuropathy</w>
peri pher
p tion,</w>
oper atively</w>
op tion</w>
oni um.</w>
on ce-
occur .</w>
non- steroidal</w>
ni ght</w>
my algia</w>
mus cle.</w>
modi fication</w>
microgram s.
medic ations,</w>
me xilet
local ization</w>
lidoca ine-induced</w>
k le</w>
it y;</w>
ino gen</w>
inhal ation</w>
ing :</w>
im oz
i. e.</w>
hyper parathyroidis
h erb
grad ed</w>
fact or
examin ation.</w>
epilep sy,</w>
end ot
dos ed</w>
dom eth
discomfor t</w>
creatin ine,</w>
concl usion</w>
concer ns</w>
con struc
compli ance</w>
code ine</w>
categ or
cardiomy ocytes</w>
ca re.</w>
c ost</w>
at ure</w>
as one</w>
arrhythmo genic</w>
aminoglyco side</w>
alter s</w>
Un der</w>
Further ,</w>
E mer
Clon idine</w>
An gi
Adul t</w>
9 %,</w>
7 /
6. 5</w>
3 7.
1 10</w>
0.0 3</w>
(E P
(A R
z o
vi gab
vigab at
un complicated</w>
ulo pathy</w>
ul tim
turno ver</w>
thyro x
thrombo sis,</w>
thrombo embol
test ed.</w>
t wit
sub stitution</w>
sub group</w>
spironolact one</w>
sig ma
sh ar
rit odrine</w>
re tri
prog est
preser ved</w>
prescri ption</w>
par ano
ophthal mo
nit rate</w>
neutroph il</w>
ne ede
n e</w>
lob ular</w>
lat encies</w>
isch aemia</w>
ir radi
inter action.</w>
inte rest</w>
im otor</w>
idiosyn cr
idaz ox
hypox ia</w>
hom ogen
hem is
gem fibro
func tions.</w>
form er</w>
fore arm</w>
erythro cyte</w>
eosinophil ic</w>
effici ent</w>
ed :</w>
document ed.</w>
di l</w>
bus pir
brainst em</w>
be y
associ ations</w>
anc y</w>
amin ophyll
V is
V O
Twenty- four</w>
S C</w>
P artic
NSAI D</w>
N C
L eu
Initi al</w>
In v
In dometh
Di ag
Comb ined</w>
Ca2 +
Ca ffe
Bet ween</w>
Amiodar one</w>
Addi tional</w>
9 4</w>
50 )</w>
3. 8</w>
2 %).</w>
13 5</w>
) ]</w>
(A N
z e
z ation</w>
w all
venlafax ine</w>
v on</w>
tw ic
trans formation</w>
ten of
t an
ser ve</w>
secre tion.</w>
sco red</w>
sc hem
rod ent</w>
recomm en
ral oxif
radic als</w>
pur pur
prote ase</w>
pro myelo
pos it
ple x
platele ts</w>
pic ture</w>
phen azine</w>
papaver ine</w>
over t</w>
orph in</w>
ometr y</w>
oid al</w>
off er</w>
neurolep tic-induced</w>
neuro transmission</w>
modi fic
mo ther</w>
mmHg )</w>
men strual</w>
lysos omal</w>
lomer ular</w>
li k
l ist</w>
immunohist ochemical</w>
ia sis.</w>
histor y,</w>
gl it
form ing</w>
echocardi o
duct us</w>
drow sin
determin ing</w>
depri v
demonst rat
cortis one</w>
compar tment</w>
breath ing</w>
beta- blocker</w>
aut ologous</w>
as corb
app ing</w>
app a</w>
ap preci
antagon istic</w>
angiograph y.</w>
al -induced</w>
acid -
a e.</w>
Sw is
S te
S /
Paclitax el</w>
PT U</w>
P ).</w>
O N</w>
L S</w>
II )</w>
I C</w>
HC l</w>
F S</w>
En do
C i
B D
A 1</w>
19 7
1 6-
, 00
(4 00</w>
ym al</w>
volum es</w>
vig il
tradi tional</w>
tion ;</w>
sha m</w>
rest ingly,</w>
resp ir
repe ate
rectom y</w>
reas on</w>
re inst
quanti fied</w>
pre medication</w>
phosph on
pathophysi ological</w>
over -
non ionic</w>
neuro psychiatric</w>
myelo id</w>
mg. kg-1</w>
metr y</w>
men .</w>
me an
l y-
isos orb
isoflur ane-induced</w>
intracor onary</w>
intra vesical</w>
intra renal</w>
inter f
interf ere</w>
ine ),</w>
indic ation</w>
in nerv
if en
i le
haemorrh age</w>
frac tions</w>
frac tion
fentanyl -induced</w>
feed ing</w>
f ing
f illing</w>
exten sion</w>
explan ation</w>
experiment ally</w>
ep o
enro l
electroencephalo graphic</w>
e x</w>
drom e</w>
diet .</w>
di ameter
develop s</w>
de af
d or
convul sions,</w>
colo r</w>
cis apri
cancer :</w>
c AMP</w>
bey ond</w>
are a.</w>
addic tion.</w>
a emia.</w>
P o
P 2
Meas ure
Hepati c</w>
He ad
B T
B NP</w>
3. 6</w>
20 )</w>
2 9.
2 7.
- opioid</w>
(A L
( two</w>
( a)</w>
z es</w>
ver te
unexpl ained</w>
underg one</w>
tremor .</w>
toge ther,</w>
terti ary</w>
ta uro
sens ation</w>
sc an
sar co
salicyl ic</w>
repor ts,</w>
re challenge</w>
protoc ol.</w>
pro arrhythmic</w>
pres yn
ph thal
or rhe
oc ur
nal trex
medic ated</w>
ly )</w>
loc ally</w>
intro duced</w>
insomn ia</w>
inosit ol</w>
inj ured</w>
infrequ ent</w>
indin avir
incid ent</w>
in ti
in t
impa ir</w>
ill ance</w>
icill in</w>
i.c.v .</w>
hybri diz
hic cup
given .</w>
ester ase</w>
direc ted</w>
detect ed.</w>
con serv
carb ox
blockade .</w>
biop sy.</w>
ar y.</w>
anti hist
anti emetic</w>
amis ul
al ve
aden o
V itamin</w>
R o</w>
PD .</w>
P G</w>
IN R</w>
Hemo dynamic</w>
E SR
Cyclo phosph
Br ady
B o
Ap pro
A ra-
2. 9</w>
(1 00
z one</w>
weigh t)</w>
throm ycin</w>
sub set</w>
stead y-state</w>
sen se</w>
ret te</w>
rem ia.</w>
re l</w>
re gener
propranolo l,</w>
promyelo cytic</w>
prob uc
princip al</w>
pri l</w>
predict able</w>
pre hen
popul ation,</w>
platin um</w>
pi g</w>
phenotyp e</w>
ol ate</w>
ob tain</w>
myosi tis</w>
multi focal</w>
mir ta
mim ic
mg/d l</w>
men ,</w>
membran es</w>
mec amyl
lamivudine- resistant</w>
lab or</w>
k i
invol un
ini b</w>
in ;</w>
id one</w>
hypokal emia.</w>
hil ar</w>
hem i
fast er</w>
f all
excit ability</w>
eff usion</w>
dur ation.</w>
di dan
dementi a</w>
dam aged</w>
d ual</w>
cyto sis</w>
cross- sectional</w>
clonid ine-induced</w>
cef ot
bac lofen
anter o
alk yl
TION AL
T op
T em
T c-
T am
RA TIONAL
Ne vertheless,</w>
Lo w</w>
Gl uc
Dis continuation</w>
DOX -induced</w>
CR F</w>
B 6
B 2</w>
AE s</w>
A min
5-fluoro urac
4 %).</w>
10 (9
- 2</w>
(5 00</w>
( b)</w>
( ME
( 9.
ucle ar</w>
swit ch</w>
sus pect
str um
str ati
stereotyp ed</w>
spro uting</w>
sh un
sec ret
rele ase.</w>
reduc ed.</w>
re perfusion</w>
qual it
per haps</w>
p imoz
osar coma</w>
neos tigmine</w>
n ox
min ).</w>
mg/kg/ day)</w>
lim its</w>
k ne
k appa</w>
instill ation</w>
incl usion</w>
hi p</w>
hemat opoietic</w>
granulomat ous</w>
glucuron ide</w>
gangli on</w>
feat ure</w>
f ast</w>
f .</w>
exam eth
ex change</w>
d ulox
d ot
d ).</w>
criter ia.</w>
controver si
citalop ram
ci ga
beta- D-
baro receptor</w>
b allo
arrest .</w>
amilor ide</w>
aler t</w>
acu ity</w>
V F</w>
TN F-
PO RT
P oly
Na Cl</w>
LI CA
L am
IMP LICA
II I,</w>
F K</w>
Di se
D (2)</w>
Com p
CD 4</w>
8- OH-
1 1,</w>
, 2
(P GE
(P D)</w>
y ),</w>
volume ,</w>
use fulness</w>
triglycer ide</w>
thick ness</w>
stere ot
sensor imotor</w>
sensi tized</w>
rul ed</w>
response s,</w>
reas ons</w>
re pair</w>
re bound</w>
rat es.</w>
provid ing</w>
previ ously.</w>
piper az
pepti des</w>
paras ympathetic</w>
p em
oxytoc in</w>
oxi b</w>
oper ation</w>
ocyto sis</w>
neutroph il
n g</w>
myel inated</w>
mix t
iz ine</w>
iz ations</w>
ist r
isoproteren ol.</w>
iop amid
involun tary</w>
injec tions.</w>
indic ations</w>
inclu des</w>
in adequate</w>
improve ment.</w>
imb al
hyper plasi
hematoc rit</w>
granulo cyte</w>
gabap entin</w>
fatigu e,</w>
facilit ated</w>
es cap
epide mio
elic it</w>
ectom y.</w>
dysrhyth mi
duc ts</w>
dis abl
crac k</w>
conf usion,</w>
concentr ation-
compoun ds.</w>
cell s/
bodi es</w>
bif id
behavi or,</w>
assess able</w>
aripi prazole</w>
anti cancer</w>
ang u
al ization</w>
age en
ab rupt</w>
Ver apam
SIAD H</w>
Qu in
P ath
P 2</w>
O C</w>
N MS</w>
L i</w>
Isoproteren ol</w>
Intra thecal</w>
IF N</w>
I fosf
HBe Ag
GT N</w>
E lev
8 9</w>
8 8</w>
4 8-
2 40</w>
1 3-
/ kg</w>
(1. 5</w>
yiel ded</w>
vi de
ul y</w>
tri als,</w>
tiv ation</w>
tib ular</w>
survi ving</w>
st and</w>
spl en
separ ated</w>
sc inti
s we
s per
ru gad
rigid ity.</w>
rest ra
resist ance.</w>
regimen ,</w>
pseud o
practi ce.</w>
phe ochromocyt
oxygen ation</w>
oro facial</w>
or in</w>
modul ating</w>
modi fi
model s,</w>
milli on</w>
meflo quine</w>
ma ke</w>
lab or
junc tional</w>
join t</w>
in ating</w>
fle xi
f al
exist s</w>
exist ence</w>
erythematos us</w>
electroencephalo gram</w>
dist rib
difficul ty</w>
diarrhe a,</w>
deple ted</w>
demo graphic</w>
cyt openia</w>
cyclo oxygenase</w>
cr amp
contex t</w>
con currently</w>
com a,</w>
chloro qu
cephal ospor
carr ageen
c alled</w>
c )</w>
bronchodi lat
ate ment</w>
anxiet y,</w>
anti thrombotic</w>
ant ly,</w>
andro gen</w>
alpha- adrenergic</w>
ag ranulo
ac tion,</w>
T G</w>
S ing
S hor
S P</w>
P seud
Multi ple</w>
Meth amphetamine</w>
Inter national</w>
F act
EM G</w>
E :</w>
Dep art
DL IN
Cap sa
C a</w>
Arter ial</w>
3 '-
2- adrenoceptor</w>
(1. 0</w>
(+/- )-
( up</w>
( n
( control
yle stradi
wor k
warr anted</w>
w ing</w>
ves '</w>
vehicle -treated</w>
valu es,</w>
utroph il</w>
uc asi
transc ript
therap y:</w>
the se,</w>
t or</w>
summ ary,</w>
ste at
st .</w>
sc ans</w>
res ection</w>
repor ts.</w>
recru ited</w>
recommen ded.</w>
recept or
re plac
pro gram</w>
pp ed</w>
potenti ates</w>
poison ing</w>
picrotox in-induced</w>
pi ratory</w>
physici an</w>
perio dic</w>
nov o</w>
neuro toxicity,</w>
monitor ing.</w>
methyl dopa</w>
meth orph
mellit us</w>
lymph ocytes</w>
lo l.</w>
lo l,</w>
lin k</w>
limb s</w>
lep tic</w>
k er
ir rig
ine ly</w>
in strum
ifor m</w>
id s,</w>
gene ic</w>
flur bi
fluoro quinol
exencephal y</w>
en large
e en</w>
dist ress</w>
differenti ated</w>
diaph rag
depend ing</w>
cyto kine</w>
cy cle.</w>
correc tion</w>
conjug ated</w>
concer n</w>
col itis</w>
chang e.</w>
carcin ogenesis</w>
c ot
assess ments</w>
ass ays</w>
asc ending</w>
angio graphic</w>
an d.</w>
amoxic illin</w>
amiodar one.</w>
alop ec
albumin uria</w>
advant ages</w>
adoles cent
Thal idomide</w>
T ol
T est
RO S</w>
P R</w>
MEASURE S:</w>
L evo
K )</w>
Inte restingly,</w>
In duction</w>
Im pro
IMPLICA TIONS:</w>
I R</w>
High -dose</w>
Gra ves'</w>
G u
C is
9 8</w>
8 6
6 /
2 -1
2 +/-
17 5</w>
100 ,</w>
(L V)</w>
(HB V)</w>
x .</w>
w aves</w>
ur k
ur idine</w>
um- dependent</w>
tur nal</w>
toxic ology</w>
thereafter .</w>
subst rate</w>
striat um,</w>
str al
solu tions</w>
so deoxychol
sion :</w>
ro t
ro dent
resem bling</w>
relev ance</w>
rel im
receptor- mediated</w>
propor tional</w>
propafen one</w>
ph ore
ne u
metri c</w>
meth oxy-
met ab
meas ures.</w>
me m
like li
lig ands</w>
le sions,</w>
l /
j er
j ec
investig ating</w>
in ver
in do
im mu
ill ic
gy nec
glyce mic</w>
g rel
for ce</w>
f at</w>
extrem ity</w>
ex pressing</w>
event .</w>
ept ogenic</w>
ent or
enox apar
diseas e:</w>
depos its</w>
day ),</w>
consider ation</w>
clon azepam</w>
char t</w>
block ,</w>
beats/ min</w>
be aring</w>
as ti
anti cataleptic</w>
analy ze</w>
amelior ate</w>
al gi
RE PORT
P ot
N on-
ME DLIN
MD D</w>
II .</w>
HC T
F 2</w>
Dec reas
D s</w>
Compar ative</w>
Ca(2 +)</w>
B rugad
B ac
Au stral
9 /
2 1-
1 40</w>
0. 15</w>
(C NS)</w>
(50 )</w>
zol pide
yr -old</w>
yl )-
yc in,</w>
viv o,</w>
ul t
tw ent
troph ic</w>
tro pine</w>
thiopent one</w>
th an
sus pen
su sta
ser ocon
rof ecoxib</w>
rit on
rigid ity,</w>
rec all</w>
r ine.</w>
pyridox ine</w>
prote in-
phenylephr ine-induced</w>
path y:</w>
os c
ophthal mic</w>
op ositive</w>
om at
methotrex ate.</w>
macroph age</w>
m on</w>
lithi um.</w>
le x
l s</w>
l aparo
isopren aline</w>
inter ference</w>
immu ne
ic in,</w>
ic es</w>
hypno tic</w>
hydroxyl ase</w>
h ome</w>
gluc os
gi ving</w>
fil am
epti de</w>
end- diastolic</w>
emul sion</w>
emerg ent</w>
eme sis</w>
e al</w>
dis per
coupl ed</w>
compens atory</w>
cholester ol,</w>
augment ation</w>
at ter
asyst ole</w>
ar ds</w>
anesthe si
allograf t</w>
ag itation</w>
Tak en</w>
Syn drome</w>
Subsequ ent</w>
St atis
S al
RATIONAL E:</w>
Prot ective</w>
L ;</w>
ICRF-1 87</w>
I M
H C</w>
GABA A</w>
E ch
C E</w>
C C</w>
Behavi oral</w>
B P)</w>
As sociation</w>
8-OH- DPA
3 8.
2, 3,
(P E
(8 0</w>
( grade</w>
us )</w>
tion ally</w>
thir d-
sy -
suspici on</w>
sub stituted</w>
stat us,</w>
smok ers</w>
sel y,</w>
seiz ure,</w>
scaven g
s lower</w>
rout inely</w>
ro ten
refl ected</w>
reach ing</w>
re placed</w>
rang e:</w>
posi tion.</w>
popul ations</w>
piri form</w>
ph enter
percep tion</w>
pen ile</w>
partic i
pan curonium</w>
on co
oc ci
n ociception</w>
mut ant</w>
mucos a</w>
model ing</w>
mg ),</w>
mal e,</w>
loxac in,</w>
kidne y,</w>
kg ),</w>
j udg
it ud
intra thec
infarc t</w>
indic ator</w>
incid ence,</w>
in patient</w>
ia ;</w>
hyd ram
hepar in,</w>
h ost</w>
grav is</w>
fo s</w>
fibrill ation,</w>
experi ences</w>
evalu ation.</w>
epi thelium</w>
enzym es,</w>
electromyo graphic</w>
e modi
dow n-
domin ant</w>
decarboxyl ase</w>
de position</w>
cr uc
cour se.</w>
complic ating</w>
clomi pramine</w>
chemotherap y-induced</w>
ch ec
bro ad</w>
bl ed</w>
aver aged</w>
asyst ol
ap tic</w>
anomal ies</w>
anc iclo
agonist s.</w>
agit ation,</w>
agg er
accid ental</w>
Vis ual</w>
U p
Swis s</w>
Ran dom
RB V</w>
Propran olol</w>
P ren
Mus cle</w>
L-DO PA
L id
Inv estig
Immuno hist
I r
Hyper tension</w>
HBs Ag</w>
G A
F 344</w>
D a
Con comit
Ch lor
9 ;</w>
7 %),</w>
6- hydroxy
5. 5</w>
3 3%</w>
1 30</w>
(2 50</w>
(- )</w>
( <</w>
' ,
year ,</w>
week -old</w>
vir t
ventil ated</w>
ut aneous</w>
ur ine.</w>
trop onin</w>
tim ing</w>
tic ity</w>
ti dine</w>
th ro
target ed</w>
sur ro
sub types</w>
sal ine-treated</w>
ra ise</w>
prophyl axis.</w>
profi le.</w>
proble m.</w>
present ation.</w>
predomin ant</w>
pre ference</w>
polymorph ism</w>
per t
pea ked</w>
parad oxical</w>
pa ediatric</w>
ox ide,</w>
oscop y</w>
ol ed</w>
ob vious</w>
o- occlusive</w>
nucle otide</w>
noc turnal</w>
metron idazole</w>
metoclop ram
man ,</w>
macroph ages</w>
likeli hood</w>
intran asal</w>
inhibi tion.</w>
inda c</w>
inclu ded.</w>
idiosyncr atic</w>
i az
hex ameth
guide lines</w>
gluco se,</w>
gangli onic</w>
g all</w>
fore brain</w>
fl un
feat ures,</w>
ex ist</w>
epicardi al</w>
enzym atic</w>
ene di
end ocardial</w>
emo tional</w>
dic hloro
demon str
datab ase</w>
cross- over</w>
clopido grel</w>
cirrho sis.</w>
cere br
carb on
ca uti
atri pt
at es,</w>
arg atrob
ar y-
antibodi es.</w>
am -induced</w>
allow s</w>
ag on</w>
activi ties.</w>
ab or
Whe reas</w>
W T</w>
V R
T GF-
St ates.</w>
Sp ont
S we
S ta
S ep
Qu anti
P rim
P ilo
P RE
NA C</w>
M arch</w>
LT )</w>
L Y
L A-
I A</w>
Halo peridol</w>
G B
Develop ment</w>
Clo zapine</w>
C r
9 3</w>
6 %).</w>
5-HT 1A</w>
5 +/-
3 A
3 9.
2 2.
0.00 1</w>
.0 1).</w>
(V PA)</w>
( IV)</w>
x yl
wash out</w>
val id
unit raz
u si
tw o
trigg er</w>
ter fen
survival .</w>
stimul atory</w>
st ay</w>
st av
sp ina</w>
small -cell</w>
sive- compulsive</w>
sion ;</w>
sed ation.</w>
sat uration</w>
ro d</w>
ri tic</w>
reduc ed,</w>
ran dom</w>
r ich</w>
qu ick
py raz
pup s</w>
promot ed</w>
pro thrombin</w>
pro genit
pre dis
pentylenetetraz ol</w>
par anoid</w>
p h</w>
ow ing</w>
one uro
ni gro
neutropen ia,</w>
muscim ol</w>
mitochond ri
mil dly</w>
microgram s)</w>
manif est</w>
malignanc ies</w>
ma king</w>
lymph oma.</w>
lat ent</w>
ip si
investig ation.</w>
gram .</w>
glauc oma</w>
fos car
fl unitraz
excep tion</w>
erythro id</w>
episode s.</w>
ens ory</w>
eff or
diabet es.</w>
defin ite</w>
decreas ed,</w>
dat e,</w>
d ental</w>
coun tri
classi c</w>
ch il
cephalo th
catal eptogenic</w>
c ,</w>
busulf an</w>
bilater ally</w>
as alaz
all- trans-
aden oma</w>
acid osis,</w>
accompan ying</w>
ac he</w>
ac e
Whe ther</w>
WK Y</w>
Th ere
St ates</w>
S tro
S ou
R T</w>
O A
Neuro toxicity</w>
N al
L ow
L M
In tr
H V
G er
Fem ale</w>
F ir
Emer gency</w>
Dop amine</w>
Depart ment</w>
D ys
D exameth
Ca ucasi
B CNU</w>
Alzheim er's</w>
AD V</w>
A N</w>
3. 7</w>
2 b</w>
1 2.5</w>
(S D)</w>
(1 )-
w al
under stand</w>
trac ted</w>
trac heal</w>
thym idine</w>
tempor ally</w>
techniqu e.</w>
sud den
sto p</w>
steroid s.</w>
star ted.</w>
sodi um,</w>
sit es.</w>
ser ies.</w>
rever ses</w>
rem ia,</w>
reinst atement</w>
region s.</w>
questionna i
punc t
produc tion.</w>
prehen sive</w>
pos ure</w>
ple ural</w>
phenyl but
phenyl )
ph ase,</w>
pector is</w>
p ill
output ,</w>
or =
one )</w>
ob es
non- selective</w>
new bor
nalox one.</w>
monitore d.</w>
micro g)</w>
memor y.</w>
male ate</w>
linezol id</w>
levof loxacin</w>
isosorb ide</w>
in ergic</w>
illic it</w>
ho wever</w>
hemo glob
hab it
foc us</w>
femal es.</w>
experiment s.</w>
epinephr ine.</w>
ecti ous</w>
differenti ation</w>
diagno sis,</w>
dev oid</w>
depend ent,</w>
ch ymal</w>
calcit onin</w>
c- fos</w>
b in
aut om
ang inal</w>
ad ic
accoun ted</w>
ab ec
Un like</w>
U .</w>
S tre
S ter
L E</w>
K (+)-
J uly</w>
H E
H A</w>
G- CSF</w>
ET -1</w>
EP S</w>
E Na
Con ver
Ce f
CYP -induced</w>
C ro
Anti -
Angi otens
Ad en
A H
8 /
6- week</w>
13 %</w>
1- adrenoceptor</w>
1- 2</w>
0.05 ,</w>
(7 5</w>
( all</w>
vitro ,</w>
ves tibular</w>
verapam il.</w>
ur i
um p
ul l
trimethop rim-sulfamethox
tourniqu et</w>
toc oph
ti vi
t rough</w>
sub sided</w>
su m</w>
spac e</w>
sot al
single -bl
sin us
s op
reversib le.</w>
rel ated.</w>
reinfor ce
reac tion,</w>
re a</w>
preval ent</w>
pre -</w>
praz os
polymorph isms</w>
persist ence</w>
ox carb
over load</w>
out flow</w>
or adi
one- associated</w>
odi pine</w>
ocur ar
occa sional</w>
nephro calcin
mon onuclear</w>
max )</w>
malondi aldehyde</w>
malar ial</w>
malar ia</w>
m t
m )</w>
leuc ov
l amin
l ),</w>
ketocon azole</w>
issu e</w>
isot retino
io do
indomethac in.</w>
in tolerance</w>
in adver
im mobil
glo bus</w>
fibro blast
facil itation</w>
ethyl ene</w>
estim ates</w>
ent ly.</w>
enlarge ment</w>
e f</w>
design .</w>
defect s.</w>
d- amphetamine</w>
cour se,</w>
corticosteroid s.</w>
consti tu
computer ized</w>
compa red.</w>
chang ing</w>
ca ine</w>
blun ted</w>
analo gs</w>
amiodar one,</w>
am ic</w>
altern ate</w>
alcoh ol
U S</w>
TR PV
T e
Syst olic</w>
Subsequ ently,</w>
Stre pt
Sec ond
Respon se</w>
Pren atal</w>
P ulmonary</w>
N-acetyl cysteine</w>
M B</w>
L os
IN D
Fol low-
F A</w>
E X
DB A/
D NA
BAL B/
B ri
Ab normal</w>
AC TH
6 0,</w>
6 ,
6 %),</w>
50 6</w>
3 50</w>
3 3
2 1%</w>
10 ).</w>
(S N
(L D
( medi
( i.p.)</w>
y s,</w>
well- tolerated</w>
vomit ing.</w>
ven ile</w>
upreg ulation</w>
under li
uncer ta
un like</w>
trin itrate</w>
trans mis
thromb oxane</w>
surve illance</w>
stat es.</w>
slop e</w>
significant ,</w>
sequel ae.</w>
salic ylate</w>
rest oration</w>
relax ant</w>
recipi ent</w>
ra i
r ant</w>
pur po
psor iasis</w>
pro ve</w>
pr ac
physos tigm
ol one</w>
ol e
oclon al</w>
no dos
nicot ine.</w>
n af
myelo suppres
my algi
methion ine</w>
metab otropic</w>
leth arg
ishe d,</w>
inter national</w>
inten s
initi ated.</w>
in sp
in bred</w>
in active</w>
impro ved.</w>
ili ary</w>
i x
he at
group ),</w>
frequ ency,</w>
follow s:</w>
fibro sis,</w>
fea sibility</w>
f f</w>
extravas ation</w>
expl oratory</w>
epileptic us,</w>
electro physi
dos ing.</w>
dis closed</w>
demonstrat ed.</w>
cyto kin
coun ter</w>
consol idation</w>
chore a</w>
bortezom ib</w>
ass ayed</w>
arth ro
ar ms</w>
administere d,</w>
activ ation,</w>
abl ation</w>
ab use,</w>
a emia,</w>
V en
Tam oxif
S )-
P =0.0
MB F</w>
L O
Hist ological</w>
H yp
H T
H 2
Follow- up</w>
Ex posure</w>
Comb ination</w>
CI PA
B 12</w>
Au g
2 5)</w>
17 %</w>
13 ,</w>
12 %</w>
0 ).</w>
(M R
(G SH
(C P
(C M
(A T
( including</w>
wor king</w>
well .</w>
ur sodeoxychol
unit .</w>
thick ening</w>
swit ching</w>
stimul ate</w>
sti ff
sign s,</w>
sev ent
ses sions</w>
sel ection</w>
sco res,</w>
repeate dly</w>
psych otropic</w>
precur sor</w>
por phy
plac ental</w>
phenobarbit al,</w>
perform ance.</w>
p ,</w>
oxid ant</w>
ou ter</w>
ot otoxic</w>
os uxim
organ ization</w>
op ri
od enal</w>
obses sive-compulsive</w>
nox ious</w>
nmol )</w>
nephro lithiasis</w>
neede d.</w>
necro tic</w>
misoprost ol</w>
mil d,</w>
mexilet ine</w>
membran ous</w>
lip ids</w>
lab ell
l angu
ing s,</w>
incontin ence</w>
hypom agne
hyd antoin</w>
g anciclo
fluores ce
fl ic
fav our
f illed</w>
expan sion</w>
ex agger
ethyl -
estic ular</w>
escap e</w>
ep sy</w>
endoscop ic</w>
double -
dopa .</w>
dist ribu
di ent</w>
demo graph
def er
confoun ding</w>
combin ing</w>
cerebell um</w>
cel ecoxib</w>
brady cardi
br achi
bal anced</w>
ati d
anim al
an x
amb uc
allo geneic</w>
aff or
adjunc t</w>
ac y</w>
T yp
Sp inal</w>
Sevent een</w>
R V
Prote inuria</w>
Pro spective</w>
M al
L T</w>
K I</w>
Indometh acin</w>
In flu
In de
IL -1
G lomerular</w>
Fre y</w>
For ty</w>
Del ta
D ue</w>
Cardi otoxicity</w>
C57BL/ 6
AU C</w>
AD )</w>
8. 5</w>
4 5%</w>
2 2%</w>
- 2
(i i)</w>
(C S
( or</w>
( 6-
year s),</w>
ye li
weigh ts</w>
vincrist ine.</w>
vari ations</w>
vari ant</w>
tumour s</w>
til t</w>
thi or
se mi
scal e,</w>
sar coma</w>
ri s</w>
region .</w>
re activation</w>
prostagland ins</w>
poison ing.</w>
phent olamine</w>
phenomen on.</w>
perox is
path ogenetic</w>
par ts</w>
par ti
paclitaxel .</w>
p ene
org ans</w>
op y
olo m
non invasive</w>
my osin</w>
mon oclonal</w>
modific ations</w>
m us</w>
leg s</w>
lamotrig ine</w>
isopren al
interven tions</w>
interpre ted</w>
inter medi
ing 's</w>
in ate</w>
im mature</w>
im idazol
ha emodi
gest ation.</w>
expres sion,</w>
en ough</w>
electro shock</w>
distrib uted</w>
dextro methorph
depress or</w>
de -induced</w>
consider ing</w>
con flic
compromis ed</w>
co- administration</w>
cardi otoxicity,</w>
c esarean</w>
b p
b er</w>
b and</w>
avail able.</w>
av age</w>
atrop ine,</w>
as ked</w>
as e)</w>
an ion</w>
amin ation</w>
alve olar</w>
akathi sia</w>
aim s</w>
ag re
acetyl cholinesterase</w>
ac etin</w>
a ;</w>
W ar
W H
SI S:</w>
S y
Reco very</w>
Rec urrent</w>
R P</w>
R N
Pro g
Pheny to
PO -
P- SM
P =
Or gan
O HD
Nicot ine</w>
High er</w>
Hepati tis</w>
Eigh teen</w>
Ech ocardi
Dobut amine</w>
Differen tial</w>
D- penicill
D ip
Continu ous</w>
Caffe ine</w>
CB 1</w>
B Z
AL F</w>
A 2</w>
7 ,
3. 4</w>
2. 8</w>
16 ,</w>
16 %</w>
(i. c.v
(P =0.0
(L VE
( greater</w>
yl line</w>
ventilat ory</w>
us age</w>
ur red</w>
tub ocurar
tobram ycin</w>
sympath omimetic</w>
suppor ting</w>
stres s,</w>
ste p</w>
sensitiz ation.</w>
sco re.</w>
satis factory</w>
safet y,</w>
respectively ),</w>
regurg it
recommend ations</w>
propofol ,</w>
pre cise</w>
plic ations</w>
phenomen a</w>
phen az
p s
oxygen ase-
ove mb
ovemb er</w>
oni um,</w>
ol ith
n ur
n ing,</w>
modul ates</w>
micro dialysis</w>
mg/kg/ day,</w>
mening itis.</w>
lac king</w>
ki log
kg(-1 ))</w>
impair ment,</w>
im ine</w>
idazox an</w>
hyper activity,</w>
hour s)</w>
highligh ts</w>
hel p
gal act
g ar
foc used</w>
exhib iting</w>
excre tion.</w>
estrogen s</w>
er a</w>
ep t</w>
end ed</w>
electro graphic</w>
electro convulsive</w>
elder ly.</w>
diar rho
di al</w>
de -
cyclo hex
cruc ial</w>
cri sis</w>
cor p
cont ents</w>
condi tion,</w>
bleed ing.</w>
blad der.</w>
bi osyn
attempt ed</w>
aspir in.</w>
as es.</w>
anxi olytic</w>
antidepress ants.</w>
andro gen
an s.</w>
an ic</w>
albu terol</w>
adrenoc or
] ).</w>
V ,</w>
Th ose</w>
S tr
R ap
Prim ary</w>
Pharmac ological</w>
P l
N orm
Meth ad
M es
IN G
Head ache</w>
Euro pe
CP P</w>
C ases</w>
Ad ren
Ac cording</w>
8 %).</w>
6 7
3. 9</w>
20 1</w>
10(9 )/
0.00 5).</w>
(-1 ))</w>
( with</w>
( 5-F
( +/-</w>
wor l
ver .</w>
vasodilat ation</w>
valu able</w>
urticar ia</w>
urk inj
tum ors,</w>
treat ed,</w>
transplant .</w>
transi tional</w>
transfer red</w>
succ ess</w>
stri king</w>
st rat
st atin</w>
sal v
s lowing</w>
ru s.</w>
retri ev
res um
recogn ize</w>
publ ic</w>
protoc ols</w>
pro long</w>
predic ting</w>
precipit ating</w>
pow er
posses s</w>
polymorph ic</w>
phospholip id</w>
phen olate</w>
phen acetin</w>
perio perative</w>
pentylenetetra zol
partic ular,</w>
pal sy</w>
pal pit
p tions</w>
oli go
occur red,</w>
o edema</w>
non specific</w>
nitro fur
neu tr
neph ritis,</w>
n ic</w>
mu g/
minim ize</w>
mi gr
mg/ 100</w>
membran e-
mark eting</w>
m ot
lithium- pilocarpine</w>
l ad
l ).</w>
ine mia,</w>
incub ation</w>
incorpor ation</w>
imag ing.</w>
ic al
i.c.v .)</w>
hydrochlor ide,</w>
human s,</w>
hn 's</w>
graph y.</w>
glycer yl</w>
g/m 2</w>
fle x</w>
fentanyl .</w>
exacerb ate</w>
environ mental</w>
eff e
ect able</w>
e sis</w>
dis soci
dexamethas one-induced</w>
denerv ation</w>
den se</w>
del ay
defic its.</w>
de red</w>
cran i
cent ers</w>
carvedi lol</w>
capecit abine</w>
but yl
bradycardi c</w>
blo t</w>
backgro und</w>
atax ia,</w>
arth r
ant -induced</w>
analogu es</w>
amne sic</w>
amin id
all y-
al lowing</w>
agonist s,</w>
W om
V incrist
TI CIPA
TICIPA NT
T er
Spont aneous</w>
Seiz ure</w>
REPORT :</w>
Pre -
PT Z</w>
PT H</w>
PAR TICIPANT
P N
N B
M ild</w>
M PA</w>
L ip
H S</w>
D ),</w>
Co operative</w>
9. 5</w>
8 ;</w>
6. 7</w>
4. 8</w>
3. 1</w>
3- week</w>
2- chloro
19 -
15 )</w>
0.0 2</w>
(H R)</w>
(1 2.
( both</w>
volt age</w>
vit amin
ventro lateral</w>
ven o-occlusive</w>
vacc ine</w>
us -induced</w>
ultim ately</w>
ulcer ative</w>
ty pe
tri phosphate</w>
trazod one</w>
trans dermal</w>
top otecan</w>
terbut al
t esticular</w>
surro un
struct urally</w>
speci men</w>
si st</w>
sh ap
schedul es</w>
re war
re presented</w>
re generation</w>
rap amycin</w>
raloxif ene</w>
ra sid
questionna ire</w>
proper ty</w>
program med</w>
proble ms.</w>
pro be</w>
present ation,</w>
pod ocytes</w>
plan ned</w>
pl aqu
pharmac ology</w>
pentylenetetra zole</w>
pene tr
pat ch</w>
p mol/
outcom es.</w>
os .</w>
offsp r
off ers</w>
nod ular</w>
new er</w>
myelo suppression</w>
mortal ity,</w>
morph ine-
month ly</w>
mmHg .</w>
min er
min ),</w>
melphal an</w>
manner ,</w>
mam mal
mal es,</w>
m (-
lograph y</w>
lit er</w>
le vetiracetam</w>
langu age</w>
k s,</w>
itud inal</w>
irrit ation</w>
ip rasid
intramus cul
ine d-release</w>
in ium</w>
ic in.</w>
ia -
i setron</w>
hybridiz ation</w>
histopath ologic</w>
h ol
fol inic</w>
flush ing</w>
fl ick</w>
fib ers.</w>
fen o
f ly</w>
explo red</w>
excre tion,</w>
epinephr ine,</w>
dro pped</w>
diagno ses</w>
des ferri
depend s</w>
deliver y.</w>
comorb id</w>
chromat ography</w>
chlor per
che lat
cer vi
cardiomy ocyte</w>
brachi al</w>
ax im
ation -induced</w>
as tic</w>
ari es</w>
arach id
apl asia</w>
amne sia.</w>
ame ly</w>
alter ing</w>
alpha- tocoph
aggrav ated</w>
adjust ing</w>
X ,</w>
Wom en</w>
We e
T a
SE )</w>
Psych iatric</w>
N ovember</w>
N T</w>
N F-
N AD
METH -induced</w>
LD L</w>
L- argin
IND ING
II I-
F INDING
E A</w>
Dise ase</w>
Di ab
D et
D Z
AC )</w>
A trial</w>
9 %).</w>
6. 0</w>
6- month</w>
5- year</w>
4- week</w>
2- 3</w>
2 9%</w>
2 4,</w>
10 .</w>
1 +/-
0. 5,</w>
-1 2</w>
(I F
(C R
(B P)</w>
week s).</w>
weak ness,</w>
vigil ance</w>
vari ants</w>
v oxamine</w>
u z
triglycer ides</w>
triglycer ide
tra u
titr ation</w>
thrombo phlebitis</w>
the -
t ing.</w>
studi ed,</w>
spar ing</w>
s ole</w>
ron eph
ri um</w>
reg ularly</w>
recept or,</w>
re th
rac heal</w>
r ine-induced</w>
pseud otumor</w>
progres s</w>
predisp ose</w>
phenyl )-
per sist</w>
parkinson ism.</w>
ot ri
or ic</w>
olog ies</w>
ochem istr
occa sions</w>
oc il
nephro pathy,</w>
nadi r</w>
n io
n ative</w>
mo ving</w>
mo bility</w>
microg/ kg)</w>
micro gram</w>
methyl- 4-
metabol ism,</w>
meta- analysis</w>
mes sen
mem ant
mechanis ms,</w>
mecamyl amine</w>
m ural</w>
kne e</w>
kg ).</w>
k age</w>
ju venile</w>
isoproteren ol,</w>
isom ers</w>
inf er
incre mental</w>
i.v .).</w>
hype remic</w>
ho t</w>
herb al</w>
g .
flurbi profen</w>
fashi on.</w>
ex tub
es mo
en larg
dulox etine</w>
dox azosin</w>
diff ers</w>
dex razoxane</w>
deterior ated</w>
defici ency.</w>
cyto plas
correc t</w>
cor ne
catheter ization</w>
cardio genic</w>
canal icular</w>
bifid a</w>
ax on
atri zo
ati tis,</w>
antine utrophil</w>
antigen s</w>
antero grade</w>
add ress</w>
ad ding</w>
activ ate</w>
accept ed</w>
a w</w>
X .</w>
War far
W or
Verapam il</w>
U rine</w>
S elective</w>
R h
O X
O F</w>
NP Y</w>
MEDLIN E</w>
MD MA
M aj
L D</w>
ICA L</w>
G M
Europe an</w>
Electro n</w>
Dexameth asone</w>
Del ayed</w>
Cro hn's</w>
C ]
C NS
Appro ximately</w>
4. 6</w>
3 +/-
18 ,</w>
18 %</w>
1, 000</w>
1 0.
1 -</w>
-1 7
(H C
(G F
(0. 25</w>
( total</w>
( t
( relative</w>
( day</w>
( 7</w>
x )</w>
vari ate</w>
us h</w>
urkinj e</w>
ulc ers</w>
tri me
tis :</w>
thromb olytic</w>
ter m,</w>
tas k.</w>
t os
streng th</w>
sin o
se mia</w>
scopol amine-induced</w>
reticul um</w>
retic ulo
reflex es</w>
rec re
overex pression</w>
ovari ectomized</w>
osmol al
nucle oside</w>
nitroglycer in-induced</w>
n amely</w>
myocardi um.</w>
mou se.</w>
molec ules</w>
mo tility</w>
mmol/ L</w>
men tioned</w>
medic ine</w>
m u</w>
li b
jaundic e.</w>
ipsi lateral</w>
ip en
involve ment.</w>
inter leuk
immunosup press
immun ological</w>
hear ts.</w>
gener al
fib res</w>
f a
exceed ed</w>
examin ing</w>
estradi ol
eluc id
effe rent</w>
ed ull
dose )</w>
dis play</w>
dihydroxy phenyl
dihydro -
digit alis</w>
di az
dex fenfluramine</w>
describ ing</w>
def en
cont act</w>
comparis ons</w>
clonid ine,</w>
clear ance,</w>
ch amb
caffe ine.</w>
ca strated</w>
bu ffered</w>
bl ack</w>
ast atin</w>
as sist
ap o
anti malarial</w>
amis ole</w>
aminonucleo side-induced</w>
achi eving</w>
a ine</w>
VT E</w>
V II
Throm b
TNF- alpha</w>
Re duction</w>
Pilo car
PG I
PARTICIPANT S:</w>
P neum
P E</w>
Neuro logical</w>
MEASUREMENT S:</w>
Influ ence</w>
Impro vement</w>
Hem orrh
FINDING S:</w>
F entan
E A
Do se-
Da ily</w>
D P</w>
D A
Conver sely,</w>
Catal epsy</w>
Brugad a</w>
B ar
7. 4</w>
3/ 4</w>
1. 25</w>
1 1%</w>
- negative</w>
) ).</w>
(R R</w>
(P =
(M M
(5-F U)</w>
ventil ation.</w>
ve red.</w>
variabl es.</w>
val s
v o
us p
unc lear</w>
ud ing</w>
u ment</w>
typ e.</w>
tum or.</w>
tot ally</w>
to o</w>
tic -like</w>
syndrom es.</w>
susta ined-release</w>
suppres ses</w>
success ful
si s;</w>
sever ity.</w>
sep tic</w>
sclero der
rifamp in</w>
rever sing</w>
require ments</w>
replic ation</w>
regul ating</w>
rec t</w>
queti ap
ques tion</w>
psychos timul
presyn aptic</w>
plasma phere
pilocarp ine-treated</w>
pi gs</w>
pericardi tis</w>
per oxide</w>
par ameter</w>
op yri
ont ine</w>
ologic ally,</w>
ol g
off ending</w>
oblast oma</w>
nodul es</w>
multi -
mic ro</w>
mer cap
lo be
le t</w>
le a
inter act</w>
inst ances</w>
ic ally,</w>
ic al,</w>
hr .</w>
histor ies</w>
hemorrh ages</w>
haloth ane.</w>
glutam ic</w>
glucocortico ids</w>
gener al,</w>
gen der,</w>
form in</w>
excit ation</w>
eth osuxim
essen tially</w>
erg oline</w>
end ocardi
enc es.</w>
en i
ecti ve.</w>
each .</w>
diseas es,</w>
dis ability</w>
diet ,</w>
diabet es,</w>
di atrizo
depriv ation</w>
concl u
co done</w>
cle ft</w>
cl a
chloramphenic ol</w>
caud ate</w>
carcin ogenic</w>
carbamazep ine,</w>
c ing
bro ad
be ag
b uc
b rou
b .</w>
ax ial</w>
atript an</w>
asth matic</w>
approach es</w>
anti- HB
am i
ac ous
abstin ent</w>
[ 4-
Therap y</w>
T r
T C</w>
Second ary</w>
SPEC T</w>
S el
R o
Post operative</w>
P en
P RO
P I
O .</w>
Nine teen</w>
NT G</w>
N a</w>
Maj or</w>
M M</w>
Lith i
Lam iv
K+ -
HCT Z</w>
F isch
F i
CL IN
C o-
Bi ochemical</w>
An t
AZ T
AN F
7 5
4. 4</w>
4. 2</w>
2 a</w>
2 1,</w>
19 %</w>
1. 4
1- year</w>
1 16</w>
0 ),</w>
/ d
-1 ),</w>
) -</w>
) ),</w>
(A M
(2 4</w>
(0. 1-
( three</w>
( control</w>
( but</w>
( SIAD
( 0-
z iprasid
volun tary</w>
ver tig
uro thelial</w>
trimeth aph
triamte rene</w>
tran s</w>
symptom at
summ ar
sul indac</w>
sham- operated</w>
sensitiv ity,</w>
scre ened</w>
risperid one,</w>
ri z
reduc tion.</w>
pyr ro
putam en</w>
prurit us</w>
proper ties,</w>
profi le,</w>
pro motion</w>
posit ron</w>
por al</w>
plant ar</w>
phosph odi
perf usion.</w>
parameter s,</w>
p ris
operativel y,</w>
open ia,</w>
omegal y</w>
olog ists</w>
ocyt oc
nor tript
non- Hodgkin's</w>
nimesul ide</w>
nigro striatal</w>
nicardi pine</w>
networ k</w>
neoplas ms</w>
narco tic</w>
n ocicep
mono therapy.</w>
mo fe
m ox
m c
loo p</w>
leuk ocyte</w>
kain ate</w>
k ept</w>
ir regular</w>
iopamid ol</w>
intra uterine</w>
integr ity</w>
insuffici ency,</w>
inf ectious</w>
in ess</w>
hyd roneph
hy pot
hallucin ations,</w>
h inal</w>
grow ing</w>
gl and</w>
gl and
gemfibro zil</w>
fraction ated</w>
fen ol
exten sively</w>
exclu sively</w>
exagger ated</w>
end omy
emphasi zes</w>
ecstas y</w>
ec h</w>
diure sis</w>
diseas e-
di pi
di oxide</w>
develop ed,</w>
destruc tion</w>
defect s,</w>
cryst all
cou gh</w>
conduc t
comple ment</w>
clas ses</w>
cerebr i</w>
brou ght</w>
bri dg
break through</w>
bo th.</w>
bleed ing,</w>
be at</w>
b. w
b. i.
ax on</w>
at r
as sum
ant rol
amitript yl
amin es,</w>
alprazol am</w>
alph a,</w>
adjunc tive</w>
adequ ately</w>
adenocarcin omas</w>
acut e,</w>
acetazol amide</w>
Y -
V e
Tamoxif en</w>
Stro ke</w>
Six ty</w>
Re gi
Partic ip
O P
Nephro toxicity</w>
L arg
I B
Di azepam</w>
Co x</w>
Ch loro
CLIN ICAL</w>
CA D</w>
C57BL/ 6</w>
Ara- C</w>
A(2 A)</w>
A R</w>
5. 3</w>
2 8%</w>
0.0 4
0.0 3).</w>
0 %,</w>
(i. e.</w>
(PAN )</w>
(C A
( approximately</w>
( L-NAME
yo to</w>
yl thio
ycl in</w>
vulner able</w>
vincrist ine,</w>
vigabat rin</w>
vari ance</w>
utili zation</w>
ur ide</w>
uc t
triazol am</w>
treat ed.</w>
th y
te l
t ative</w>
syndrome :</w>
sulph asalazine</w>
sub thalamic</w>
strych nine</w>
ste ady</w>
som atic</w>
significant ly,</w>
side- effects.</w>
separ ation</w>
scre en</w>
sch o
sal ine-
rodent s.</w>
rac emic</w>
psycho sis.</w>
protein s.</w>
propofol -induced</w>
pro s
pregn an
power ful</w>
popul ation-
phylococc us</w>
per ce
pe th
patter n
patient- controlled</w>
oter ol</w>
orig inal</w>
ord ination</w>
or y,</w>
onse t.</w>
on ly,</w>
ologic al,</w>
ol d,</w>
ocy s
ob tained.</w>
nod al</w>
nit ren
min (-1)</w>
microsom al</w>
microangio pathy</w>
micro vascular</w>
mg ).</w>
metho hex
le pro
label ,</w>
l enal
kg -1)</w>
ir respective</w>
insi ght</w>
injec tions,</w>
inflamm ation,</w>
in- releasing</w>
in um</w>
in put</w>
in complete</w>
hypothesi ze</w>
hormon e-
gen ce</w>
fluc onazole</w>
f action</w>
es tion</w>
draw n</w>
do ses
distingu ish
daun orubicin</w>
com position</w>
character ization</w>
chang e,</w>
catat onia</w>
carb ach
canc ers</w>
c GMP</w>
bupivaca ine,</w>
bor der
blad ders</w>
bing e</w>
behavi ors.</w>
azepam ,</w>
ation ).</w>
atid yl
ascorb ic</w>
as sumed</w>
as es,</w>
ar ub
ar ity</w>
anti ci
anatom ical</w>
amphet amine,</w>
activ ator</w>
acous tic</w>
acet yl</w>
acc o</w>
ac yclin</w>
V P
UN E
T orsade</w>
SK F</w>
Pe ak</w>
Particip ants</w>
M N
M /
Ket amine</w>
K yoto</w>
H T</w>
G s</w>
Eigh ty-
DE X</w>
D ose</w>
Concomit ant</w>
Cent er</w>
CD 4
C urrent</w>
C hemo
C S</w>
Brady cardia</w>
ADR -induced</w>
A ne
A k
8 5%</w>
2 -</w>
0 %).</w>
-to- treat</w>
(T ax
(EE G)</w>
(2 ))</w>
( RO
z ym
z olom
wor se</w>
withdraw n.</w>
we dg
virt ually</w>
viro logical</w>
verapam il,</w>
valid ated</w>
v es,</w>
uni ver
ul in</w>
thyrox ine</w>
thiaz ide</w>
ther n</w>
the sia</w>
test ing,</w>
tamoxif en.</w>
tachycardi as</w>
t y.</w>
suic ide</w>
succ essive</w>
solu tion.</w>
ses sion</w>
secret ory</w>
ron ate</w>
retard ation</w>
re absorption</w>
rat es,</w>
qu er
pro chlorper
pregnanc y,</w>
precipit ate</w>
potassi um,</w>
po real</w>
pi perid
perin atal</w>
percent )</w>
parox et
pares thesi
pare sis</w>
par i
p ass
ox ide.</w>
other .</w>
ot e</w>
or din
oph an</w>
once- daily</w>
om ing</w>
ocytoc lastic</w>
ocy te
nucle oti
ni acin</w>
necess ary.</w>
mit te
metabolit es.</w>
metabol ized</w>
man u
man ia.</w>
m sec</w>
lop urin
leuk aemia</w>
judg ed</w>
it er
isotretino in</w>
isol dipine</w>
induc tion,</w>
index ,</w>
immunosup pres
im ipen
ic s.</w>
i. t.</w>
i p</w>
hypokal emic</w>
homeost asis</w>
hei ght</w>
haz ards</w>
gluc agon</w>
erythro cytes</w>
end point</w>
emphasi ze</w>
effec tive,</w>
ed ar
ec hol</w>
dos age,</w>
dis sociation</w>
descri ption</w>
deliri um.</w>
defin itive</w>
dat es</w>
d ac
coun t,</w>
comm ence
combin ation,</w>
clu ster</w>
ciga rette</w>
calci um-
calc ification</w>
ca dian</w>
block ers.</w>
biop sy,</w>
bi om
ber ate</w>
benzodiazep in
ax ons</w>
artic les</w>
arteri ol
ap o</w>
anti thyroid</w>
angio edema.</w>
an al</w>
amisul pride</w>
amiodar one-induced</w>
adul tho
acetyl salicylic</w>
ab sc
[ 2-
Y MDD</w>
W B
V N
Ul tra
Ser oton
R V</w>
Pro st
PO )</w>
Nal ox
M axim
Leu k
K ap
Increas ing</w>
HB I
H um
G D</w>
Fact ors</w>
E stro
E R</w>
De li
DSM- IV</w>
Carbam azepine</w>
CYP2 C
BU N</w>
AN P</w>
99 m
6. 1</w>
4. 7</w>
3 2%</w>
2- receptor</w>
2 8-
2 4%</w>
14 )</w>
1 7-
(1 ,
( range:</w>
vac cin
uni versity</w>
un controlled</w>
um )</w>
ul ph
u g
trac he
toxic ity:</w>
toler ate</w>
tob acco</w>
them .</w>
termin als</w>
tenof ovir</w>
t ly,</w>
synthesi zed</w>
sup pressing</w>
sulph ate</w>
strept omycin</w>
stimul i.</w>
stat e,</w>
sp in
sp ent</w>
sion )</w>
scop y</w>
sco re,</w>
salv age</w>
s cor
s );</w>
review s</w>
reinfor c
regar ded</w>
rai ses</w>
radi ological</w>
r s</w>
r ine,</w>
qu ite</w>
qu ar
ps ori
pres erv
predisp osed</w>
possib le.</w>
po oled</w>
plex us</w>
pi rox
phenyto in.</w>
phenobarbit one</w>
pentazoc ine</w>
pent amid
pat ent</w>
pancre atitis</w>
oxygenase- 2</w>
ost atin</w>
orb ital</w>
ont al</w>
non fatal</w>
need s</w>
need le</w>
necessit ating</w>
micro liter
medi ates</w>
leucov orin</w>
l ic</w>
interfer on-
ing ;</w>
inde sine</w>
il st</w>
id ed</w>
i.v .,</w>
i ox
hypoc ap
hiccup s</w>
hemo dialysis.</w>
head -
guan ine</w>
glut amine</w>
gamma- glutam
g ic</w>
fluoresce in</w>
fea sible</w>
failure :</w>
exten d</w>
evalu ations</w>
dose :</w>
disturb ances,</w>
dep end</w>
def ined.</w>
cycl ine</w>
cour ses.</w>
conserv ative</w>
commun ity</w>
commun ic
co incid
cir cu
cTn T</w>
bu ff
bre ast
bra in-
blind ness</w>
ble .</w>
b ab
aw ak
apopto sis.</w>
antibodi es,</w>
amil ton</w>
alkyl ating</w>
addic ts</w>
a red</w>
Valpro ic</w>
T oxic</w>
Sur vi
Sing le</w>
Sim ult
ST N</w>
S urg
S oci
S m
S CH
Re duced</w>
R est
Per sistent</w>
P ent
O lan
Nine ty-
Neuro leptic</w>
Mon it
K(+)- ATPase</w>
IL- 6</w>
IF N-
H ol
H LA-
H AM-
H 2</w>
G astro
F unc
ENa C</w>
E ven</w>
E ry
Caucasi an</w>
Ca ref
CH F.</w>
C K</w>
Aug ust</w>
AT P-
7. 0</w>
7 50</w>
6 7%</w>
5-HT (2
2 3%</w>
2 %.</w>
10 4</w>
1. 5
1 );</w>
, "</w>
(c )</w>
(S H
(C s
zolpide m</w>
z er
w ast
volume .</w>
verte bral</w>
vel y.</w>
vehic le.</w>
vaso active</w>
v ocal</w>
ureth ral</w>
ur ine,</w>
underli e</w>
ultrason ography</w>
u ation</w>
tri ge
treatment ;</w>
treatment -related</w>
trans mural</w>
tob er</w>
to ,</w>
threshol d.</w>
thou gh
tauro chol
tachy arrhythmias</w>
ta m</w>
stra ins.</w>
stav udine</w>
squ are</w>
some what</w>
sever ity,</w>
se leg
respon der
relie ved</w>
relap se.</w>
recre ational</w>
re d-
protein uric</w>
proces ses.</w>
por tion</w>
phospho kinase</w>
pelv ic</w>
par ac
paclitaxel -induced</w>
paclitaxel ,</w>
p ra
oxal i
ow n</w>
out -
omep razole</w>
ol factory</w>
occur ren
naltrex one</w>
my ocytes</w>
my alg
muscl es.</w>
micro sph
meth y
memor y,</w>
ma de.</w>
low ,</w>
lo vastatin</w>
leak age</w>
larg est</w>
jac ent</w>
isom er</w>
inser ted</w>
inj ecting</w>
infrequ ently</w>
ill ness,</w>
i.v .),</w>
i NOS</w>
hypokal emia,</w>
hepat otoxicity,</w>
glyc opyr
form ation,</w>
flu voxamine</w>
fl av
fibr in</w>
fashi on</w>
expos ures</w>
exhib its</w>
endomy ocardial</w>
en su
en cour
echocardi ograph
dys plasia</w>
doc ument</w>
disper sion</w>
dis appeared.</w>
de sensitization</w>
day ;</w>
com prehensive</w>
collap se</w>
co ffe
co er
co ated</w>
cla vul
ciprof loxac
ci es</w>
chil d.</w>
c .</w>
beta- blocking</w>
b ed</w>
ay na
auto antibodies</w>
areas .</w>
an ionic</w>
an em
an abolic</w>
aminotrans fer
amin es.</w>
am ylo
alpha-tocoph erol</w>
alpha ,
acidi c</w>
a ure
a ,
Vari ous</w>
V i
U RE
Tac rolimus</w>
Sta phylococcus</w>
S V
Quanti tative</w>
Pre gn
Or th
O xy
Magne tic</w>
M 2</w>
In jection</w>
Histopath ological</w>
H amilton</w>
H F</w>
GAB A)</w>
Caref ul</w>
Cal ci
CC K-
An a
Alter ations</w>
AD R-
AD HD</w>
A pril</w>
A S)</w>
5. 6</w>
3 6.
3 3.
3 00
2. 5%</w>
2- adrenergic</w>
14 %</w>
0.0 2)</w>
0. 75</w>
0. 2%</w>
.00 1)</w>
- containing</w>
(P C
(O R
(3 )
(2 ),</w>
( serum</w>
( less</w>
yri dam
wh ole-
vis u
valu e.</w>
v ary</w>
un mas
ule us</w>
tr us
top ir
thi azol
testo ster
system ically</w>
similar .</w>
shoc k.</w>
seve re.</w>
se ts</w>
sat ur
sar com
ro pi
rheum atic</w>
rex cit
require ment</w>
refl ecting</w>
prop ensity</w>
progres sion.</w>
proce dural</w>
prepar ations.</w>
pl ain</w>
pin do
phenyto in,</w>
parano ia</w>
p inal</w>
ox etine</w>
ol ateral</w>
oc om
ob ia</w>
nor mo
nephro toxicity,</w>
n ull</w>
n mol</w>
n ess
myel in</w>
myco phenolate</w>
mut ants</w>
month .</w>
mirta zapine</w>
mg/m l</w>
metabolit e,</w>
met allo
messen ger</w>
mechan ically</w>
me an,</w>
m atic
m ast</w>
ly sis</w>
lign oca
is radi
interval s,</w>
insuffici ent</w>
in- based</w>
id s.</w>
hydro cortisone</w>
hepat otoxic</w>
glyc os
foscar net</w>
form al
flunitraz epam</w>
fact or,</w>
epi theli
enti ty</w>
encephalo pathy,</w>
ect ed,</w>
dur ations</w>
dro ps</w>
dro peridol</w>
dop amine,</w>
dobut amine-induced</w>
distingu ish</w>
disor i
disabl ing</w>
dipi vox
diltiazem ,</w>
describe d,</w>
de trus
d re
d ol
d enti
cycl ase</w>
cra v
clin ici
circul ation.</w>
chemotherap y-
characteris tics,</w>
cefot et
catheter s</w>
cat s</w>
cain ide</w>
buspir one</w>
bupivaca ine-induced</w>
block ers,</w>
benz yl
behavi or
be d
b ot
atro genic</w>
ati ve,</w>
atherosclero tic</w>
aster n</w>
ar a-
anxiet y.</w>
anx io
ant ec
ang le</w>
ameli oration</w>
age- related</w>
ad jacent</w>
] ),</w>
[ 95%</w>
Z )-induced</w>
VPA -induced</w>
V 1</w>
Twenty- six</w>
To ge
Therap eutic</w>
T ime</w>
T CD
Suc cess
Ser ious</w>
R ayna
Post -
Over all</w>
Oc tober</w>
O u
O ,</w>
Neuro logic</w>
Ne on
Meth otrex
K idne
IV ,</w>
I GF-
Gen eral</w>
Fisch er</w>
F etal</w>
Experim ent</w>
Dip yridam
Di rect</w>
DF O</w>
D il
Cyclophosph amide</w>
Com plications</w>
Child ren</w>
At ten
8. 0</w>
4. 1</w>
4 '-
20 /
2, 3-
2 %;</w>
18 )</w>
1, 25
(T d
(OH)2 D3</w>
(L V
(E M
(4 5</w>
(1 0%)</w>
( GABA
ycl ine</w>
x ,</w>
vastat in,</w>
vasoconstric tor</w>
v inc
u sional</w>
transf er</w>
the- counter</w>
target s</w>
surroun ding</w>
sup port
strong er</w>
ster ile</w>
ser um,</w>
ser i
satis faction</w>
sal iv
saf e,</w>
rupt ure</w>
rou gh
rest ore</w>
recor d</w>
prim ing</w>
pregnanc ies</w>
preferen tially</w>
pharmac ologically</w>
ph aryngeal</w>
pallid us</w>
open- label,</w>
om yeli
od y</w>
ocys tis</w>
occi pit
o grams</w>
nar row
mus cle,</w>
mou th</w>
monke y</w>
migra ine.</w>
memb ers</w>
mechanis m
mater ial</w>
manu fact
low .</w>
lig and</w>
li ving</w>
lef t-
lan sop
k D
jug ular</w>
invol ved.</w>
intub ation.</w>
intrathec ally</w>
in ability</w>
ill ness.</w>
il -
hypercalci uria</w>
hype rexcit
hil us</w>
hex iline</w>
here in</w>
hei gh
har m
haloth ane,</w>
gram ,</w>
glyco l</w>
fibrill ar</w>
femal es,</w>
f urther
f ish</w>
f ,</w>
examin es</w>
enkephal in</w>
en ium</w>
en flur
disul fir
disori ent
dis h</w>
depend ence,</w>
dam s</w>
d ens
cros s</w>
corne al</w>
con cept</w>
clo t</w>
cisapri de</w>
cing ulate</w>
cholecyst o
chlor ambuc
cap ill
ca th
c ad
bru ary</w>
azol e-induced</w>
aut oradi
aut op
attempt s</w>
attac ks.</w>
ati ve.</w>
arth ritis,</w>
arteri olar</w>
argatrob an</w>
arachid onic</w>
ar ri
ar m.</w>
applic ation.</w>
antibio tics.</w>
anti sense</w>
anti cholinerg
ane ously.</w>
ane ous
all-trans- retinoic</w>
all y)</w>
acid osis.</w>
Twenty- three</w>
Twenty- five</w>
Tol er
Success ful</w>
Sep tem
S L</w>
Regi onal</w>
Re view</w>
P s</w>
P K</w>
NS ).</w>
MT D</w>
MD A</w>
L IS
K O</w>
J o
Ifosf amide</w>
ISO -induced</w>
IF O</w>
H is
Gl ut
F requ
F ran
Differen ces</w>
D ou
CG P</w>
C an
B rom
AR S</w>
A G</w>
7 0-
6 +/-
5. 2</w>
4. 9</w>
30 )</w>
3- hour</w>
2- year</w>
2 25</w>
2 1.
100 -
1 st</w>
1 1)</w>
1 %.</w>
0.0 3
0 %),</w>
(MT X)</w>
(EC G)</w>
(3 ,
( L-
( 9</w>
yst ag
ye lo
wat er.</w>
vol vement</w>
vis its</w>
vascul itis,</w>
valpro ate.</w>
v ic
utili zed</w>
un stable</w>
ub ular</w>
ton gue</w>
th is,</w>
th -
te mo
table t</w>
synthe sis,</w>
sw im</w>
sur fac
succinylchol ine-induced</w>
stom ach</w>
spe ech</w>
sinus oidal</w>
sign als</w>
ser um.</w>
sept um</w>
second- line</w>
schedul e.</w>
s arc
rhyth m.</w>
reversib ility</w>
reten tion.</w>
ret ar
respir ation</w>
reli ably</w>
reac ted</w>
radi ographic</w>
quick ly</w>
quantit atively</w>
pyri d
prov oc
prolong ing</w>
progenit or</w>
pro tracted</w>
prefer red</w>
pre treatment,</w>
pre -treated</w>
performe d,</w>
pathw ays.</w>
pathophysi ologic</w>
ot otoxicity.</w>
ors '</w>
orig in.</w>
opy ram
ol ;</w>
ococc al</w>
obarbit al</w>
non- small-cell</w>
nitros amine</w>
neuro psychological</w>
neuro degenerative</w>
nalox one,</w>
myelo ma.</w>
mucosi tis</w>
mu -opioid</w>
move ments.</w>
mm 3</w>
ml/ min</w>
mil rinone</w>
metast ases</w>
medi ator</w>
manip ul
mammal ian</w>
malignanc y</w>
long itudinal</w>
kal emia</w>
insipid us.</w>
ingest ing</w>
indomethac in,</w>
inc i
immunohist ochemistry</w>
immuno globulin</w>
immune -mediated</w>
i ed.</w>
hydro gen</w>
hor iz
haloth ane-induced</w>
haem olytic</w>
gu n</w>
group ;</w>
g/d l</w>
fo ot
fluoro uracil</w>
flun ar
flu phenazine</w>
flu or
et ,</w>
er ic</w>
epti d
endot racheal</w>
enantiom ers</w>
doxorubic in-treated</w>
diz ocil
distinguish able</w>
diet s</w>
de ep
day s),</w>
dP/d t
d B</w>
cytot oxicity</w>
cou gh
cont ent,</w>
consti pation</w>
cocaine- exposed</w>
clopido grel
cisplat in.</w>
chemic ally</w>
c ure</w>
bur ning</w>
bo th,</w>
bi phasic</w>
beta- blockers</w>
atic ,</w>
as ymptom
aro tid</w>
antici p
anti convulsive</w>
ann ab
aneurys ms</w>
amphet amine-
aggrav ation</w>
af in
adren o
ab er
a b</w>
Y )</w>
Wist ar-
W -
W )</w>
U ,</w>
T ic
Survi val</w>
Stat us</w>
S A)</w>
R em
Prop ylthio
PT Z
P rin
P ositive</w>
Neon atal</w>
N- nitro
Mul tivariate</w>
Measure ments</w>
MM P-
M idazol
M em
Lid ocaine</w>
In volvement</w>
Hum an</w>
Hg ;</w>
H SP
D ays</w>
CYP2 D
C ur
Anim al</w>
Ac tivation</w>
5-hydroxytrypt amine</w>
4 4
3 8%</w>
2 -induced</w>
(p =0.0
(S SR
(O R,</w>
(AD R)</w>
(5 %)</w>
(2 ,
( IS
z on
wh ilst</w>
wh ic
vi si
visi t</w>
vesi cular</w>
uncommon .</w>
ud 's</w>
tri ple</w>
transi ently</w>
time -dependent</w>
til ide</w>
thi obarbit
temo zolom
te tan
te ach
synthe sis.</w>
survival ,</w>
sur al</w>
suc rose</w>
sub units</w>
strok es</w>
stres sed</w>
strati fied</w>
strat um</w>
st ability</w>
sph inc
sp le
sit es,</w>
si lon
si an</w>
sertr al
serocon version</w>
reversib le,</w>
rese arch
requi red.</w>
radio immuno
rabb its.</w>
quanti fy</w>
pyrro lid
pre medicated</w>
post ulate</w>
pol yp
phenyl -1,
perio ds.</w>
per oxy
path ogenic</w>
particip ate</w>
paralle l-
paradig m</w>
p ens
p =
oxcarb azepine</w>
over- the-counter</w>
out ,</w>
ot o
ophosph ate</w>
operativel y.</w>
on it
om as,</w>
oli po
ol ab
ogene sis,</w>
od ine</w>
ochemic ally</w>
neg atively</w>
n R
morph one</w>
miner al
mg/ 24</w>
mer open
medi ators</w>
malignanc ies.</w>
mRNA s</w>
m L
lithi um,</w>
levodopa .</w>
lev amisole</w>
le sion.</w>
kilog ram</w>
it rac
intracerebro ventric
inter ruption</w>
intak e,</w>
inh er
ine- containing</w>
induc ed,</w>
indic ators</w>
in- dependent</w>
in tim
in sen
hypo glycemia</w>
hyperprolact in
hydrochlor ide.</w>
gre en</w>
gran isetron</w>
gener 's</w>
ganciclo vir</w>
fract ure</w>
famil ial</w>
exer cis
ex amp
esoph ag
ery thromycin</w>
epilept ogenesis</w>
entr ant</w>
enrol led.</w>
enoxapar in</w>
eng e</w>
ed -dose</w>
ectom y,</w>
dist res
discontinu e</w>
dimen sional</w>
dig ital</w>
di deoxy
dextromethorph an</w>
devi ation</w>
delta -
decom pens
d antrol
concentration -dependent</w>
con ce
common ,</w>
com mer
co administered</w>
circum st
caus ality</w>
carcin oma,</w>
brie fly</w>
bir th.</w>
bac k
atheros clerosis</w>
aryn g
anti hyperalgesic</w>
anti bod
anthracyclin es</w>
amelior ates</w>
allodyn ia.</w>
al te
add res
acid s,</w>
[CI ],</w>
We gener's</w>
U .
TH E
R I
Out come</w>
OD )</w>
Nalox one</w>
N im
M ay</w>
Le w
Lamiv udine</w>
L H</w>
L AD</w>
J )</w>
In fusion</w>
INTERVEN TION:</w>
HC C</w>
H A
G Y
G T</w>
Fe bruary</w>
F L
F ANF
Ex tr
Ex amination</w>
Electro cardio
Con sider
CA -
C /
A 2A</w>
9 00</w>
9 +/-
7 +/-
19 ,</w>
13 )</w>
10 -1
1. 3
0. 1%</w>
-1 6</w>
(i.c.v .)</w>
(I N
(H D
(6 )</w>
(0. 5-
( "
wom an,</w>
weigh ing</w>
vinblast ine</w>
ventric les</w>
usp id</w>
tubocurar ine</w>
transi tion</w>
toxic ities.</w>
tic ed</w>
thrombocytopen ic</w>
terfen adine</w>
tacrolim us.</w>
sudden ly</w>
sub groups</w>
su be
strych n
stitut es</w>
sten osis.</w>
son 's</w>
sit e.</w>
shar p</w>
scor ing</w>
scal es</w>
sarco plasmic</w>
sal me
ro ta
ris k
reve als</w>
ret e</w>
resul t
resist ance,</w>
reser pine-induced</w>
recover y,</w>
re mor
re ad
prop ag
promot er</w>
practi tion
po ol</w>
plic ation</w>
pl us-
phenylpropan olamine</w>
peroxis ome</w>
peri vascular</w>
pe d
partici pation</w>
part uri
output .</w>
op a</w>
ob lo
nor adrenal
ni gra
neutropen ia.</w>
neuro blast
modi fying</w>
mg/d l,</w>
method s.</w>
meth imazole</w>
ment ed</w>
m 2</w>
lex y</w>
labor ator
l ;</w>
ket amine,</w>
inver sely</w>
inter neurons</w>
incre ment</w>
in- resistant</w>
in -</w>
in ).</w>
hypo thyroidism</w>
hypertroph ied</w>
hyper tonic</w>
hyper thyroidism</w>
hydr alazine</w>
hospital ization.</w>
h is
h abil
h ).</w>
group s;</w>
graf ts</w>
gen e-
gemcit ab
gain ,</w>
g adol
fre ely</w>
f ru
extrac ts</w>
experim ent.</w>
excre ted</w>
es tin</w>
ergot amine</w>
erg ol
er adic
epid ermal</w>
enalapri l.</w>
en tic</w>
el ing</w>
dox y
dil uted</w>
didan osine</w>
dev ice</w>
det ecting</w>
dem and</w>
deci sion</w>
de b
cytokin es</w>
cycl es,</w>
confir ms</w>
conf ined</w>
compoun ds,</w>
collag en
col on</w>
co st-
ch es</w>
catal y
bortezom ib
blockade ,</w>
beag le</w>
azot emia</w>
az ithromycin</w>
az ide</w>
asth ma.</w>
ar ,</w>
am en
all ergy</w>
al /
Typ e</w>
T ).</w>
T ),</w>
Statis tical</w>
Septem ber</w>
SO D</w>
S ex
Rh abdomy
Rap id</w>
R adi
Pneum ocystis</w>
P TH
P IL
M ark
L C
In stitute</w>
Gen er
G o
D (3)</w>
Con sequ
Com mon</w>
Ch aracter
Calci um</w>
B6 C3
Ane mia</w>
AT )</w>
AC E
> /
55 ,2
1. 5%</w>
0.000 1),</w>
- matched</w>
- 3</w>
(P B
(C D
(5 )</w>
(1 1.
(1 -1
(0. 4</w>
( an</w>
( GABA)</w>
we t</w>
w id
volt age-
vessel s.</w>
us :</w>
up- regulation</w>
un known,</w>
un detectable</w>
tuberculo sis.</w>
transcri ption</w>
ton ,</w>
tis m</w>
til ity.</w>
tac tile</w>
t ing
system atically</w>
suspen sion</w>
suspect ed.</w>
sup pl
stimul ates</w>
steroid -induced</w>
somat ostatin</w>
similar ities</w>
si as</w>
short- acting</w>
sep sis</w>
sed ated</w>
retriev al</w>
ret y
rest less
resc entic</w>
recogn ized.</w>
re d
quin pi
pseud olith
prote in.</w>
prost acyclin</w>
promot es</w>
population- based</w>
pharmaco dynamics</w>
persist ing</w>
patter n.</w>
paralle led</w>
par s</w>
over l
op tical</w>
on to</w>
om o
occipit al</w>
obser ve</w>
ob ese</w>
norepinephr ine,</w>
non- specific</w>
neuro physiological</w>
neph rin</w>
move ments,</w>
ml/ min/
mimic king</w>
midazol am,</w>
micro mol</w>
mic ron
memant ine</w>
mak es</w>
mEq/ L</w>
m O
load ed</w>
lif e
l ut
jaundic e,</w>
iodi x
intra- arterial</w>
imb ic</w>
ic ter
i sed,</w>
hyp oxic</w>
hor n</w>
histopath ology</w>
hepar an</w>
haemorrh agic</w>
gran ular</w>
glit azone</w>
g p</w>
g ative</w>
frequ ency.</w>
fluores cent</w>
fluctu ations</w>
femal e,</w>
favour able</w>
f it
exerci se.</w>
exam ic</w>
eu tical</w>
ep silon
en ing.</w>
en e,</w>
ell a</w>
duc tal</w>
droxy progesterone</w>
dox ep
differenti ate</w>
detrus or</w>
dend rit
de tri
cysti tis,</w>
con sumed</w>
con s
commence ment</w>
clear ance.</w>
chol ang
cannab is</w>
atroph y.</w>
atri a</w>
arterio venous</w>
arteri es,</w>
are a,</w>
appear ing</w>
aneur ysm
al lopurin
al is
agranulo cytosis</w>
agonist .</w>
adul ts,</w>
accur ate</w>
ac ne</w>
a ir</w>
U/ L</w>
Twenty- two</w>
TH C</w>
TA M</w>
Sever ity</w>
S ymptomatic</w>
S ]
S 1</w>
Repor ts</w>
Repor t</w>
Rayna ud's</w>
Pro phyl
P C</w>
N-acetyl -
M ater
L- dopa-induced</w>
Ig M</w>
I GF
HD L</w>
H ).</w>
GV HD</w>
Elev ated</w>
E m
Do ses</w>
Coca ine-
C s)</w>
C CR
Bu propi
Bo NT
BACKGROUND /
B6C3 F1</w>
B R
Angio edema</w>
8. 4</w>
55,2 12-
5. 8</w>
4 50
3A 4</w>
2. 5,</w>
10 1</w>
1 0.0</w>
-1 6
(R B
(P< 0.05).</w>
(P D).</w>
(NSAID s)</w>
(D F
( normal</w>
( Q
yl ]
wat er-
w anted</w>
vi sion,</w>
ventric le.</w>
urac il-induced</w>
unc ture</w>
un toward</w>
u ren
twic e-
transf u
transc ranial</w>
tra st
tid al</w>
thromboembol ism.</w>
thiobarbit uric</w>
the mo
thal lium</w>
terat ogen
teach ing</w>
suic idal</w>
su los
stress -induced</w>
sti tu
sion- free</w>
seizure -induced</w>
seizure -
se )</w>
schiz o
s. (ABSTRACT</w>
s ati
rest .</w>
reproduc ible</w>
recogn ised</w>
re ne
rat )</w>
radi al</w>
qu i
prurit us,</w>
prot ect
prog estin</w>
pri ap
pre neoplastic</w>
pot ently</w>
pi l</w>
phosph atidyl
phenobarbit al.</w>
ph ag
perox ides</w>
per m
per form</w>
p olar
out side</w>
otom y.</w>
ot roph
omyo si
omeg alo
oly sacchar
ol e,</w>
o ffered</w>
nephrocalcin osis</w>
neph rectom
n isoldipine</w>
mou se,</w>
modul atory</w>
mineral ocortico
min ;</w>
mim ic</w>
micrograms/ ml</w>
microgram s,</w>
mg/d )</w>
mercap to
m sec
los art
lo st
lo g</w>
liver s</w>
limit ed.</w>
lethal ity.</w>
l aryngeal</w>
l -treated</w>
k an
j aw</w>
it y
inter rupted</w>
infu sions.</w>
inform ed</w>
in activation</w>
in ),</w>
illust rate</w>
il ater
hyperprolactine mia.</w>
horiz ontal</w>
high- grade</w>
high- frequency</w>
hepatocarcin ogenesis</w>
help ful</w>
he avi
gra dient</w>
glucos aminid
glomerulos clero
fin ally</w>
extrem ities</w>
expres sions</w>
ethin ylestradi
et ric</w>
escal ated</w>
entor hinal</w>
elev ated.</w>
electro phore
el at
ed )</w>
dos ing,</w>
differen tially</w>
di ed,</w>
deli berate</w>
de s.</w>
dar k</w>
dan azol</w>
d itary</w>
cyt omegalo
cor d.</w>
consti pati
circum flex</w>
cir cadian</w>
ci par
ci lost
che wing</w>
cephaloth in</w>
cent er.</w>
cause s.</w>
catat on
carri er</w>
c il
bronch ial</w>
brom ide</w>
azol e,</w>
ation ),</w>
astro cytes</w>
ap olipo
antipsycho tics.</w>
anticonvuls ants</w>
and -
anaphyl actic</w>
amphet amine.</w>
alpha- 2</w>
al gesia</w>
al fentan
administr ations</w>
ad ine.</w>
ac r
abs orb
] ;</w>
Y M
Wistar- Kyoto</w>
WH O</w>
V AS</w>
Twenty- one</w>
T rial</w>
T oxic
S ensi
S ed
R S
Pre vi
Physi cal</w>
PA ,</w>
P S</w>
P I</w>
O H</w>
Na (+
NO -
My oclon
Mor ris</w>
Monit oring</w>
Li ght</w>
L at
Kidne y</w>
H ),</w>
Gen etic</w>
Gastro intestinal</w>
G I</w>
Fif ty</w>
F as</w>
F ail
F D
Engl ish</w>
ESR D</w>
E F</w>
DE S
D TI
Co gn
Chol est
CP -induced</w>
Afric an-
Aden osine</w>
8-OH-DPA T</w>
5 4
4 2%</w>
4 00
25 ).</w>
2 6%</w>
100 ,000</w>
1. 6
0.0 1,</w>
- evoked</w>
- a</w>
(P V
(NS CL
(6 %)</w>
(5-HT )</w>
(2 0%)</w>
(1 1</w>
(1 ,</w>
( as</w>
yn uren
ye 's</w>
whic h,</w>
ven a</w>
us -like</w>
ureth ane-
unevent ful</w>
twit ch</w>
trimethoprim-sulfamethox azole</w>
tric uspid</w>
treatment s,</w>
third- generation</w>
therap y;</w>
theophyll ine-induced</w>
them sel
sub cortical</w>
st ers</w>
spectr al</w>
sol v
sol ely</w>
six th</w>
single- agent</w>
sil ent</w>
secre ting</w>
se tr
se di
se ar
se -induced</w>
schizo affective</w>
sc at
ro bus
robus t</w>
ric h
regist ered</w>
re aring</w>
re al-
quad ri
provo ke</w>
prot ecting</w>
probuc ol</w>
point s.</w>
pirox ic
phosphodi esterase</w>
phenylbut azone</w>
peth idine</w>
person ality</w>
p ran
over dose,</w>
open- field</w>
occlu sion.</w>
o vir
neutropen ic</w>
neuro trophic</w>
n ystag
n on</w>
n am
myo pathy,</w>
molec ule</w>
min (-1
metabolit es,</w>
mellit us.</w>
mark et
m o</w>
lym ph</w>
loxac illin</w>
lithium -treated</w>
le de
irrig ation</w>
io d
intrac arotid</w>
intoxic ated</w>
inte resting</w>
insomn ia,</w>
injur ies</w>
indic ated.</w>
incub ated</w>
in patients</w>
impa i
il lede
ifosf amide-induced</w>
if edi
identi fying</w>
i ons</w>
i i)</w>
i an
hyperparathyroidis m</w>
here ditary</w>
glyco protein</w>
function ally</w>
flu x</w>
fal cipar
f ro
excl usion</w>
erup tion</w>
enco ding</w>
en cy
em iz
effec tive.</w>
eff lu
edi c</w>
dysrhythmi as</w>
dyskinesi a,</w>
diphenyl hydantoin</w>
differen c
develop ment,</w>
de tox
d ),</w>
cy clop
cord ance</w>
consequ ent</w>
concentration- time</w>
con sul
clozap ine,</w>
cl imb
chromos ome</w>
candi date</w>
c ally</w>
bur st</w>
blad der,</w>
beta- carb
b asi
aure us</w>
atrop ine.</w>
atri um</w>
assi st</w>
ascit es</w>
ar n
ap or
anti micro
anaesthe sia,</w>
an olic</w>
alle le</w>
al gesi
af il</w>
acyclo vir
acromegal ic</w>
accur acy</w>
a id</w>
[CI ]</w>
TM P-SM
T ou
T im
T UNE
Su stained</w>
Si rolimus</w>
SU B
SUB JEC
ST )</w>
S kin</w>
S W
S .
Respon ses</w>
PP I</w>
PA ),</w>
On ce</w>
Nephro tic</w>
Na use
NSCL C</w>
NSAID s.</w>
N ifedi
Mo der
Mater nal</w>
M otor</w>
M orphine</w>
M D</w>
Levo dopa-induced</w>
In divid
I tal
Halo th
H un
Glu R
Fail ure</w>
E ),</w>
Diag nos
Decreas ed</w>
De x</w>
D ig
Capsa icin</w>
Ca Cl
C d
BB B</w>
B one</w>
B cl
Anti convulsant</w>
Anesthe sia</w>
An xi
Ag )</w>
AN G</w>
A TION:</w>
7- N
50 %,</w>
4 3%</w>
2 8,</w>
199 5</w>
17 beta-
16 )</w>
12 5
0.00 1,</w>
-1 ).</w>
(S D</w>
(HB s
(E D)</w>
(A P
(A I
(1 7.
(1 6.
(1 5.
(0.0 5</w>
( d
( +/
yiel d</w>
wom an.</w>
w an
upt ak
ul atory</w>
uc h
toler able</w>
tol u
theophyll ine.</w>
test ed,</w>
t ).</w>
sw im
stereot y
stabil ized</w>
sk in.</w>
sit ting</w>
sino atrial</w>
signific ance.</w>
si um</w>
si s
shif ted</w>
sclero sis.</w>
scan ning</w>
ropi um</w>
rof ecoxi
rhabdomy olysis.</w>
respon d
regul ate</w>
re vascular
re b
random ised,</w>
r a</w>
progres sing</w>
pro ic</w>
pressu re
preferen tial</w>
posses ses</w>
po ses</w>
plas ticity</w>
picrotox in,</w>
phospholip ids</w>
phen el
per -
pea k
pari etal</w>
par at
or poreal</w>
oph asic</w>
open ing</w>
ol ec
nocicept ors</w>
nicot ine,</w>
neuro ten
ner ve.</w>
myoclon us,</w>
myelo genous</w>
monitor ing,</w>
modul ated</w>
min eral</w>
midd le-
micro g,</w>
mg/d L,</w>
me themo
me pivacaine</w>
maxim ally</w>
mac ular</w>
lor at
loc k
lif e,</w>
li pop
le n</w>
lamivud ine.</w>
labet al
l ate-
l amp
k es</w>
it em
ind ed</w>
inadver tent</w>
improve ment,</w>
im mobility</w>
ide )</w>
id azine</w>
i. m.</w>
hyd rate</w>
hexameth onium</w>
hem e</w>
gra des</w>
gr and</w>
ga it</w>
g/ kg</w>
g ained</w>
frag ments</w>
formul ations</w>
form e</w>
for tun
fluoxet ine.</w>
fentanyl ,</w>
feat ures.</w>
exp and
enzym es.</w>
embry o</w>
el l</w>
ear ly-
e ver
e ating</w>
dyston ia.</w>
dyn orphin</w>
drowsin ess</w>
don epe
do fe
dipivox il</w>
di lu
dexamethas one.</w>
detri mental</w>
derivati ve,</w>
del ine
deaf ness</w>
cypro hept
cryst als</w>
conn ective</w>
conduct ance</w>
coffe e</w>
ce tin</w>
cas es)</w>
bro mo
border line</w>
biop sy-
bicarb on
be gun</w>
b um
b im
az ine,</w>
ay s,</w>
auth ors'</w>
ation /
ati ves</w>
asth matic
asc ribed</w>
ari ju
anti muscarinic</w>
anti body
anaesthe ti
amplitu des</w>
allevi ate</w>
al ce
aggrav ate</w>
adv ised</w>
administ er</w>
adi c</w>
ac illin</w>
ac cent
abund ance</w>
[3 5
[ 1,
U K</w>
Top ical</w>
T MA</w>
St and
SUBJEC T
Rec om
Re ye's</w>
QT -
Pheny leph
P rom
P oin
Op io
Olan zapine</w>
O l
Nor th</w>
Na+ ,
N M
N 2
IC R</w>
Hol ter</w>
Hemorrh agic</w>
HBs Ag
G ).</w>
E astern</w>
Dox orub
Differen t</w>
DP H</w>
Com mitte
CD4 +</w>
Al tered</w>
A F
: 1</w>
9 %),</w>
8 +/-
5- day</w>
5 %
37 8
23 39
2 :</w>
199 8</w>
10 8</w>
10 ),</w>
1. 7
1. 0,</w>
1 15</w>
0.00 5)</w>
0.00 2).</w>
-- a</w>
(9 5</w>
(4 %)</w>
(3 3%)</w>
(1 4
( five</w>
( and</w>
( [
wi se,</w>
week s'</w>
warr ants</w>
w ound</w>
us ti
ur nal</w>
un predictable</w>
un ilater
u ous</w>
tri al
treatment :</w>
tissu es.</w>
ti ve
ti li
thir ds</w>
there after</w>
ter one</w>
ter azosin</w>
tail- flick</w>
t able</w>
system s,</w>
sub unit
sub dural</w>
su fentan
ston es.</w>
somnol ence</w>
sk in,</w>
siz e,</w>
sevo flur
ser ves</w>
sal t-
saf er</w>
s c</w>
ro le.</w>
result ant</w>
res cu
ren al,</w>
remark ably</w>
refer ral</w>
re habil
r ation
pur ified</w>
protoc ol
prolong ation.</w>
progres sion-free</w>
pri mat
pri lo
pr ick</w>
potenti al.</w>
post- operative</w>
post operatively</w>
platin um-
plas ma.</w>
phen e</w>
pap illede
oxy codone</w>
orrhe a</w>
on es.</w>
omyc in,</w>
om edi
olanzap ine,</w>
ol d)</w>
off -
ocytopen ia</w>
oca in
oc ellular</w>
o protective</w>
no ticed</w>
neuro surgical</w>
neuro genesis</w>
neuro degeneration</w>
ne vir
n- propyl
min us</w>
mg/ day).</w>
macro scopic</w>
m(- 2)</w>
m /
leg e</w>
las s</w>
kappa B</w>
it ect
ip p
ip ex
initi s</w>
in directly</w>
ill nes
if er
hyperther mia.</w>
hyper -
hemo dialy
guan idine</w>
gi ve</w>
fol lic
fil gr
fig ures</w>
fail ing</w>
f ist
extrac ted</w>
exercis ed</w>
ethin ylo
et ary</w>
estrogen -induced</w>
episo dic</w>
endothel in-1</w>
em pt
electrocardio grams</w>
ele ments</w>
el y,</w>
ec tion,</w>
ec lamp
dysp nea</w>
dys plastic</w>
dys arth
do pam</w>
dis ru
dimin ish</w>
determin ant</w>
der ang
depolar izing</w>
defic its,</w>
de s,</w>
cy an
complex .</w>
com pression</w>
cohor ts</w>
clo fib
cholest asis,</w>
channel s.</w>
c ne
bl ast</w>
bicucul line,</w>
b rety
b atter
aut oph
atel y.</w>
at ors.</w>
assess ment.</w>
arter itis</w>
arch itect
anti py
anthracycl ine-induced</w>
amoxic ill
alcoh ol,</w>
agre ement</w>
adrenocor tic
aden ylate</w>
act ually</w>
ach loro
acetyl chol
ac y
ab ly,</w>
[35 S]
Z .</w>
Tic lop
Thirty- five</w>
Th ough</w>
THE SIS:</w>
T ax
Simult aneous</w>
Scal e,</w>
SSR I</w>
S H</w>
Ris peridone</w>
R LS</w>
Qu es
Phenyto in</w>
PC R</w>
P rac
P DE
Nor plant</w>
NG -
Methad one</w>
MA P,</w>
M K
I schem
I M</w>
Hist ologic</w>
HB V-
H PL
H O
H 1</w>
Flu oro
Fentan yl</w>
E nal
Dru gs</w>
Deli rium</w>
Cogn itive</w>
Ca(2 +
C57BL/6 J</w>
Amph et
AS T</w>
AMP H</w>
A G
: 00</w>
8. 9</w>
6. 9</w>
5. 1</w>
5- fold</w>
5 alpha-
5 4-year-old</w>
4 8%</w>
3- year</w>
2- week</w>
2 n
2 7%</w>
199 0</w>
10 7</w>
1- methyl-4-
0.0 8</w>
0.0 4</w>
)- positive</w>
(S )-
(H Be
(A DR
(50 %)</w>
(2 5%)</w>
(1 4</w>
(1 3</w>
(1 20</w>
( TI
( QT
( 0,</w>
y sti
w k.</w>
ver tical</w>
vel y,</w>
vasodi l
vals artan</w>
val ence</w>
v ity</w>
urg ent</w>
un less</w>
un altered</w>
u ma
tum ori
trige minal</w>
tre ad
transmis sion.</w>
tr un
toler ance.</w>
tiv es</w>
tissu e,</w>
thre e
th ing</w>
test ).</w>
ten der
tem po
taurochol ate</w>
tas ks</w>
tam sulos
t ar
t :</w>
syncop al</w>
stereoty pi
sten o
stabil izing</w>
spec ies.</w>
sign s.</w>
ro om
relim inary</w>
rele ase,</w>
rel ate</w>
reinforc ing</w>
r ule</w>
ques tions</w>
punc ture</w>
propor tions</w>
prompt ed</w>
pro j
present ,</w>
pre mat
potenti ating</w>
poten cies</w>
port un
pin acidi
phot o
phenyl -
phen yl</w>
perce ived</w>
pelv is</w>
paraly sis.</w>
p ontine</w>
ou s.</w>
otrop in-releasing</w>
oten tial</w>
oper ating</w>
olo l.</w>
offspr ing.</w>
norepinephr ine.</w>
norepinephr ine-induced</w>
no ea</w>
neurotrans mis
neuro peptide</w>
necess arily</w>
nause a/
mod al
mod afin
microgram/ kg/
met formin</w>
medi a.</w>
mechanis m,</w>
me droxyprogesterone</w>
marg inal</w>
man age</w>
lu minal</w>
lith iasis.</w>
lipop olysacchar
ligh t-
life time</w>
leuko encephalopathy.</w>
leg ia</w>
l ing.</w>
kidne ys.</w>
ket o
k ing.</w>
isradi pine</w>
iso propyl
intro duc
inter fe
instrum ented</w>
in stituted</w>
impl ants</w>
impair s</w>
imbal ance</w>
im idaz
ic os
ic e.</w>
ic ally.</w>
i bility</w>
i atrogenic</w>
hyper glyce
hom ozygous</w>
histor ical</w>
gra vi
gentamic in.</w>
g/d L</w>
g insen
fibro tic</w>
extrac tion</w>
ext inc
ex ec
ethan ol.</w>
estradi ol-induced</w>
eosinophil ia,</w>
environ ment</w>
enti ally</w>
endo thelium</w>
electro des</w>
effici ency</w>
ec ho
e NOS</w>
dy e</w>
document ation</w>
distinc tive</w>
discharg e.</w>
dil ution</w>
degener ation.</w>
daun orub
counter acted</w>
cord ingly,</w>
conven i
contraceptiv es.</w>
consum ption,</w>
conduc ted.</w>
common .</w>
coll ection</w>
cne mi
classi fication</w>
chemic als</w>
char co
ch ill
calc ific
bu terol</w>
bronch ospas
ble s</w>
be d.</w>
ax is,</w>
auto regulation</w>
ate :</w>
arub icin</w>
anxio genic</w>
anti globulin</w>
antagonist )</w>
angio plasty</w>
angio genesis</w>
angin a.</w>
an ia</w>
amine -</w>
alkalo id</w>
age -</w>
after depolar
adver sely</w>
abil ities</w>
VII a</w>
T est</w>
S equ
S G</w>
Rel ative</w>
Pl atele
Parkinson ism</w>
Parkinson ian</w>
P reliminary</w>
P otential</w>
P or
P M</w>
O cular</w>
N /
M yo
M yelo
M PO-
Iso flurane</w>
IC H.</w>
HD .</w>
F ind
F R
Ex pression</w>
E G
D VT</w>
D R</w>
D M</w>
Consequ ently,</w>
Con vul
CE :</w>
CB (1)</w>
C reat
B 6</w>
B ).</w>
An g</w>
ACh E</w>
A ll
A -induced</w>
99m Tc-
78 8</w>
7. 1</w>
6- tetrahydro
6 5%</w>
6 -1
5. 4</w>
4 3-year-old</w>
4 +/-
3. 0
2- amino-
2 20</w>
2 10</w>
17 )</w>
15 ).</w>
12 ).</w>
1. 73</w>
0.0 2
.0 5)</w>
- ,</w>
) .(ABSTRACT</w>
(T M
(R A)</w>
(H R</w>
(A Z
(1 99
( to</w>
( s
( TH
( ISO
vehic le,</w>
vasodilat ory</w>
vag otomy</w>
v indesine</w>
typ e,</w>
twent y-
trigg ering</w>
transamin ases</w>
tim es,</w>
therap ies.</w>
the ore
th r
terat ogenicity</w>
techniqu es.</w>
tamoxif en
t ently</w>
synthe tase</w>
synap ses</w>
suscepti bil
stoppe d,</w>
steroid s,</w>
spe ed</w>
spas ms</w>
sodi um.</w>
shoc k,</w>
sho ul
seleg iline</w>
sc ra
roten one</w>
resol ved.</w>
requ est
rel ated,</w>
region ,</w>
rec t
re pair
re entrant</w>
radi ologic</w>
r p
r ,</w>
r )</w>
protoc ol,</w>
prost en
prolact inemia</w>
progno sis.</w>
pressu re-
post- treatment</w>
plast y.</w>
plasi a.</w>
plas min
piperaz in
pimoz ide</w>
picrotox in.</w>
phenyl-1, 2,3,
phenyl-1,2,3, 6-tetrahydro
phen o
phen acet
pharmaco therapy</w>
p.o .,</w>
p yl
p ith
ox ot
ot onic</w>
org est
omorph ic</w>
omeg a-
oly tic-
obstruc tion.</w>
o pathy</w>
nit rit
nim odipine</w>
ng/ml ,</w>
myo glob
min ip
micrograms/ kg,</w>
micrograms. kg-1.
microg/ m
metron idazol
metr y.</w>
me eting</w>
manip ulation</w>
ly sine</w>
lo dip
ligi ble.</w>
lat ano
lab or.</w>
k ynuren
j usti
iv )</w>
ister nal</w>
is m
investig ators</w>
intramuscul arly</w>
interview ed</w>
interven tion.</w>
inten tional</w>
infec tions,</w>
in ulin</w>
ia -induced</w>
hyper glycemia</w>
headach es.</w>
grow th.</w>
graph y,</w>
gra y</w>
gluco se-
ge l</w>
ga p</w>
fing er</w>
fi ve-
fel t</w>
falcipar um</w>
erythematos us.</w>
erg ic,</w>
en rich
el y.</w>
echocardi ography,</w>
dy scra
du odenal</w>
down regulation</w>
discrimin ation</w>
determin ations</w>
desferri oxamine</w>
des methyl
dermat omyosi
derm atitis</w>
demonstr ation</w>
del ays</w>
dec ano
dec ade
death s.</w>
dP/d t</w>
d p
cy nom
corp us</w>
controversi al.</w>
cont ain</w>
charg e</w>
cardio ver
carb oxy
caffe ine,</w>
ca use.</w>
biom ark
b ind</w>
arterios clero
aripi prazol
ap parat
alpha )</w>
allevi ated</w>
all- trans</w>
af en
adv oc
ad d</w>
ab users.</w>
a the
a kine
a ).</w>
Vas cular</w>
Up on</w>
TRPV 1</w>
Sy mptom</w>
STZ -induced</w>
S L
Rhabdomy olysis</w>
Q- T</w>
Pen icill
PG -
PA C</w>
P urkinje</w>
P H</w>
P )-induced</w>
Nit ric</w>
NO S)</w>
Midazol am</w>
M 1</w>
Lithi um-induced</w>
Larg e</w>
L ong</w>
L im
L ev
L F
L C</w>
Jo hn
Intra peritoneal</w>
I sol
I s)</w>
H or
H ence,</w>
G nR
Fe w</w>
Experim ents</w>
Diagnos tic</w>
D S</w>
Ca2+ ]
CO X</w>
C r</w>
C lass</w>
Bupropi on</w>
Brom ocript
As soci
AM PA</w>
8 0-
6-hydroxy dopamine</w>
5 8-year-old</w>
5 5%</w>
4. 3</w>
4. 0
3 6%</w>
3 5-year-old</w>
3 20</w>
2. 5
2 +</w>
199 3</w>
15 -1
12 3</w>
10 5</w>
10 2</w>
1 :</w>
1 -1.
0.0 7</w>
0.0 6</w>
0. 5-
) =
(medi an,</w>
(SIAD H)</w>
(GSH )</w>
(ED 50</w>
(C I)</w>
(A U
(1 4%)</w>
( Z
( CL
z en</w>
weigh t/
ver sus
ver age</w>
vasopress or</w>
vas omotor</w>
vag ina</w>
us cular</w>
ure a,</w>
uncommon ,</w>
ular -
tubul es.</w>
tren ds</w>
trans verse</w>
ti lit
thromb i</w>
thalam us</w>
ter rit
ta z
t .)</w>
supple ments</w>
supple mental</w>
sulfon yl
steat osis</w>
st ent
spik es</w>
somat os
smok ing,</w>
smo ked</w>
sil on</w>
sic kle</w>
si s)</w>
sal ts</w>
rod ents</w>
retar ded</w>
res or
region s,</w>
reco vered.</w>
reason able</w>
re modeling</w>
r able</w>
py rex
prot on</w>
prot ection.</w>
propor tion
prof es
proced ure,</w>
prednis one.</w>
pr amine.</w>
post mortem</w>
poly dip
point es,</w>
pig s.</w>
phenylpropan ol
ph or
path ies</w>
pair s</w>
p et
oxot remor
oste osarcoma</w>
os omal</w>
ore r</w>
op portun
one :</w>
olg us</w>
ogen s</w>
nitroglycer in,</w>
nifedi pine.</w>
new -onset</w>
neur itis</w>
nause a.</w>
myelo peroxidase</w>
multi forme</w>
mon grel</w>
molec ul
mofe til</w>
mit ript
min -1)</w>
mil l</w>
midazol am.</w>
micro glial</w>
metho d,</w>
methamphet amine-
meth icill
mellit us,</w>
mark et</w>
mal es.</w>
lu oro
laparo tom
ix is</w>
isoflur ane.</w>
intraven ously.</w>
infiltr ate</w>
increas e.</w>
in distinguishable</w>
immun ost
immun oblo
id opa</w>
hypothe sis,</w>
hyperammon emia</w>
headach es,</w>
hand ling</w>
graf t-
glut ar
gastro cnemi
fol lowe
fir ing</w>
fenflur amine,</w>
fast ing</w>
extr ap
expos ure
exam ple</w>
eti ologic</w>
ethosuxim ide</w>
et opo
episo de.</w>
endotheli um-dependent</w>
endo plasmic</w>
efflu x</w>
dystroph y</w>
down- regulation</w>
don ors</w>
dom peridone</w>
dis opyram
dipyridamol e-
defer oxamine</w>
dang erous</w>
cytoplas m</w>
cytomegalo virus</w>
cyclop ent
cyclo oxygenase-2</w>
curren ts</w>
criter ia,</w>
cramp s</w>
clo fibrate</w>
cli o
clavul anic</w>
chol e
chlor prop
characteris tics.</w>
cent ri
cardio respiratory</w>
calci um,</w>
c ro
c rescentic</w>
c id
biosyn thesis</w>
ballo on</w>
azepam .</w>
ast emiz
assist ed</w>
arterios us</w>
aro usal</w>
ar ray</w>
ar m,</w>
antibio tics,</w>
anorex ia</w>
anesthe tics.</w>
analo g
amine /
am ine)</w>
alopec ia</w>
alkal i</w>
al i
adap tive</w>
ad ine,</w>
acceler ation</w>
ab normally</w>
ab en
a -induced</w>
a ),</w>
Wh ite</w>
VO D</w>
V an
T- cell</w>
T 2-
T 1</w>
S ud
S qu
R if
Ques tion
P PA</w>
P =0.00
Ob j
O P</w>
Moder ate</w>
Magne sium</w>
MI B
M i
M CT</w>
Low -dose</w>
Long -
L ate</w>
K ,</w>
In vent
I mi
I denti
I U</w>
I R
I .
Hy dro
Hospit al,</w>
Hear ing</w>
H LA</w>
G entam
G O
Find ings</w>
Extr apyramidal</w>
DF P</w>
D ic
CI P</w>
C ir
C K-
Bri ef</w>
Aut opsy</w>
Ac cordingly,</w>
AQ P
ADR s</w>
A )
4 6
200 2</w>
199 9</w>
199 7</w>
17 ,</w>
0. 50</w>
. "</w>
) .
(S BP)</w>
(P G
(N M
(CH F)</w>
(C T)</w>
(7 )</w>
(1 5%)</w>
( no</w>
( max)</w>
( VE
" )</w>
zer o</w>
x en
warfar in.</w>
vi ability</w>
versus -
vasoconstric tion.</w>
v oid
uro thelium</w>
urb an</w>
un necessary</w>
u lop
u ate</w>
two- stage</w>
tw ard</w>
trimethop ri
top ically</w>
ti ter</w>
thyroidis m.</w>
thior idazine</w>
therap y-
tetr ap
t one.</w>
t ocain
suggest ed.</w>
stabil ization</w>
spor adic</w>
sit e,</w>
shun t</w>
sex es</w>
se e</w>
salme terol</w>
restra ined</w>
rem ote</w>
refl ects</w>
real- time</w>
ram i
ra emia</w>
r s
r d</w>
publ ic
pt s</w>
protein s,</w>
propi onic</w>
prolactin oma</w>
pro per</w>
pro lol</w>
prepar ation.</w>
phil ic</w>
pheny leth
peroxid ation,</w>
perform ing</w>
pentobarbit al-
paracetam ol-induced</w>
pap ill
pancre atic</w>
p mol
p e</w>
ot ep
oste o
ophthalmo logic</w>
op tions</w>
ometr y.</w>
ocy ste
occ u
o sides</w>
not able</w>
non- competitive</w>
nio tic</w>
nephro sis,</w>
ne ocor
ne bul
n M)</w>
multi ple
mu st
mod ality</w>
minim ally</w>
microg/ kg,</w>
mg/m2/ day</w>
mg/kg/ d</w>
methamphet amine.</w>
mes ylate</w>
ment ally</w>
maz epam</w>
mater i
m iti
m ariju
m M)</w>
lipo ic</w>
j un
it em</w>
ish es</w>
intr apl
interpre tation</w>
inter ictal</w>
influ enz
infiltr ation.</w>
increas e,</w>
implic ate</w>
immuno fluorescence</w>
immun opositive</w>
im at
if ens
ic ulation</w>
ibuprofen ,</w>
hypo phosphat
hypo album
hypercalce mic</w>
hospit als</w>
hospit al,</w>
heterogene ous</w>
heter ozygous</w>
heavi ly</w>
heal ing</w>
glycopyr ro
gad odi
g avage</w>
fle x
fib ron
fat al
fall s</w>
exceed ing</w>
evo ke</w>
event ,</w>
evalu ation,</w>
eti ologies</w>
eti l</w>
esmo lol</w>
erg ot</w>
enzyme -
eno ic</w>
eno graf
em .</w>
ecti ve,</w>
diphen hydram
differen t.</w>
dex tr
denerv ated</w>
demyel inating</w>
dehydrogen ase,</w>
de form
day s;</w>
cynom olgus</w>
cum in</w>
cu ff</w>
cop i
contr ary,</w>
cont ent.</w>
clinic .</w>
cle ared</w>
circ uit
cholec ysti
cervi x</w>
centri lobular</w>
cav ity</w>
cauti ously</w>
catat onic</w>
cat abol
carri ers</w>
cardi ac
cann ul
c ab
broad -
batter y</w>
b ular</w>
az os
ar te
ar ising</w>
apop lexy</w>
anxiet y-
antidepress ants,</w>
anticoagul ation.</w>
angiotens inogen</w>
analgesic s.</w>
amygdal a,</w>
amne sia,</w>
ammon ium</w>
alter ations.</w>
after ,</w>
affor ded</w>
afferen ts</w>
activ ates</w>
act in
act .</w>
acetyl -
[ 14
Z ),</w>
X ),</w>
Twenty- seven</w>
TI ON</w>
Sed ation</w>
SO UR
R ates</w>
Prost agland
Pregn ant</w>
PT U
P ub
P raz
O F
M CA</w>
L it
L QT
Isol ated</w>
Intrac erebro
Im port
Im medi
IN H</w>
F C</w>
E V
E LIS
DO CA-
Co A</w>
Ci prof
Ca ution</w>
BALB/ c</w>
BACKGROUND/ AIMS:</w>
Anxi ety</w>
An tin
Al so</w>
Al ph
A P-
A ED
9 6
6. 2</w>
5. 7</w>
4 9
4 5-year-old</w>
4 1%</w>
4 0,</w>
4 %;</w>
1. 8
1 4-year-old</w>
- derived</w>
(r =
(Td P)</w>
(T B
(H R
(H IV)</w>
(C V
(C G
(2 00
(2 0-
(1 9%)</w>
(1 /
( age</w>
women )</w>
weak ness.</w>
we en-
var ic
valpro ate,</w>
vacuol ization</w>
v oc
ut ropen
upreg ulated</w>
un desi
un acceptable</w>
u sion-
tr abec
tot al,</w>
tiz an
tion ).</w>
therap eu
tak en.</w>
ta urine</w>
t y,</w>
t welve</w>
t ors</w>
syncop e.</w>
super sensitivity</w>
sulph asalaz
suff er</w>
succin ate</w>
sub tle</w>
stom ach
ste ato
sphinc ter</w>
son iaz
slow ed</w>
sleep ing</w>
sevent h</w>
ser ies,</w>
sear ched</w>
schizophren ia,</w>
scaven ger</w>
s inu
rout es</w>
retin ol</w>
retic ular</w>
ren z
re organization</w>
prof il
prochlorper azine</w>
press in</w>
predic tion</w>
precipit ation</w>
posi tion,</w>
popul ations.</w>
po orer</w>
pneumon ia
pituit ary-
pic t
phosphor ylated</w>
person -
per hexiline</w>
pa per
pa in-
p 53</w>
os ensi
ori s.</w>
on orgest
omyc in-
oca proic</w>
oc cul
ob ic</w>
o gram</w>
no vel
no ti
nitroglycer in.</w>
nitro gen
neurolep tics.</w>
n ing.</w>
myoclon us.</w>
morb id</w>
mon ophasic</w>
migr ation</w>
mg ;</w>
metoclopram ide.</w>
methyl prednisol
methotrex ate-induced</w>
methotrex ate,</w>
metallo protein
melan oma</w>
medi ation</w>
meas ures,</w>
me .</w>
marg in</w>
manifest ations.</w>
man dat
mO sm
m idine</w>
low- density</w>
lop ri
lit ter
lis uride</w>
lenal idomide</w>
lad der</w>
labell ed</w>
k P
j ump
iso forms</w>
iodix anol</w>
intra hippocampal</w>
interac tions.</w>
infusion )</w>
inf ants,</w>
inde d,</w>
inclu de
in- converting</w>
immun ologic</w>
im age</w>
ifosf amide.</w>
hypercalce mia.</w>
hype remia.</w>
hydroxy chloroquine</w>
hydrox yl</w>
hy ste
ger iatric</w>
g ).</w>
fre e
frac tion,</w>
fibrin olytic</w>
feed back</w>
fav or</w>
extrac orporeal</w>
expl oration</w>
eti ological</w>
episode s,</w>
ens ure</w>
end- systolic</w>
em ph
electro de</w>
electro chemical</w>
edull ary</w>
dri ve</w>
doxorubic in-
dis rupted</w>
dil ation</w>
diagno sed.</w>
di verse</w>
di bular</w>
dendrit es</w>
cypro terone</w>
cre am</w>
conn ected</w>
comm encing</w>
com es</w>
clar ithrom
cholecysto kinin</w>
char ts</w>
catechol aminergic</w>
beta-D- glucuronide</w>
be than
be ating</w>
autis m</w>
ate d;</w>
ar y
apopto sis,</w>
antin uclear</w>
ann ual</w>
aneur ysmal</w>
an emic</w>
amygd alo
altern ating</w>
alter ations,</w>
alpha- methyl-
al ip
adrenocept or-
adrenal ectomized</w>
activi ties,</w>
acetaminophen .</w>
ac ral</w>
ac onit
ab using</w>
[3H] -
W IN</w>
Vincrist ine</w>
U ro
TR H</w>
T rem
T D</w>
Seroton in</w>
SD ,</w>
S Y
Pro b
Par tial</w>
PE T</w>
OH DA</w>
Nitro glycer
Ne utropen
N umerous</w>
N F
Mul ticent
MPT P</w>
M il
LD H</w>
L if
K ore
K (+)</w>
John son</w>
Immedi ately</w>
I soniaz
I s
Hepar in</w>
HBI G</w>
H g/
Gluc ocortico
G M-
F ish
Ex c
Ep inephrine</w>
En h
D ap
D 2
Committe e</w>
Col lege</w>
C erebro
Bet a-
B A
B 1</w>
AR T</w>
ADR .</w>
A PA
8- week</w>
7 00</w>
6- OHDA</w>
3 1,</w>
29 ,</w>
2/ 3</w>
15 6</w>
0. 1,</w>
(i ii)</w>
(e g,</w>
(LVE F)</w>
(I O
(B )</w>
(A E
(1. 0
(- )
( mean,</w>
( for</w>
( f
( IV
ziprasid one</w>
with in-
wh o,</w>
well- documented</w>
wedg e</w>
wall .</w>
volunte er</w>
viro logic</w>
v )</w>
ureth ane</w>
unclear ,</w>
ud in</w>
u ated</w>
trypt ophan</w>
trans l
tran examic</w>
toler ant</w>
toler ance,</w>
threshol d,</w>
thi on
th us,</w>
tetrac ycline</w>
target ing</w>
t es,</w>
t amp
tamp on
stat ins</w>
sodi um-
shoc k
sett ings</w>
self- reported</w>
second- generation</w>
schedul e,</w>
safet y.</w>
s oun
ru v
riton avir
ribavir in-induced</w>
rhabdomy olysis,</w>
retino pathy</w>
resol ve</w>
regener ative</w>
ral gi
quar tile</w>
pt h</w>
psycho sis,</w>
prosten ol</w>
prolifer ating</w>
proces sed</w>
prim idone</w>
pre cor
pneumon ia.</w>
ple as
plasmin ogen</w>
plac ent
pl ay
pith ed</w>
person al</w>
peripher ally</w>
per ind
pathw ay,</w>
p s.</w>
os al
orth op
orph anol</w>
ore s</w>
or i</w>
or ally,</w>
opyri dine</w>
olanzap ine.</w>
ol em
ochond rial</w>
oc e
nitren dipine</w>
ng/ml .</w>
ng/ml )</w>
neuro behavioral</w>
nes tic</w>
nephro n</w>
naf c
mt DNA</w>
modul ator</w>
ml .
mil d.</w>
middle- aged</w>
micro injections</w>
mg/ L</w>
methyl enedi
methoxy- 4-
meth amine</w>
membran e.</w>
memb er</w>
manufact ure
mal ai
m apping</w>
lipo proteins</w>
lin ing</w>
li um-
leuk emia,</w>
j e
it y)</w>
it es</w>
issu es</w>
iso form</w>
ir in
intr ap
intensi ties</w>
inf ant.</w>
ineff ective.</w>
immunohist ochemistr
im olar</w>
ide al</w>
id osis</w>
id ity.</w>
i tic</w>
hyperther mia,</w>
hyperammon emic</w>
hy dra
head- up</w>
haloperid ol
glauc oma.</w>
given ,</w>
g yr
frag mentation</w>
for ward</w>
flut amide</w>
fir st
f az
excl uding</w>
exam ined,</w>
eti d
emerg ed</w>
electroly tes</w>
earli est</w>
e .g
dy ses
dur ing,</w>
drug- free</w>
dom ain</w>
disturb ances.</w>
discus sed,</w>
disco vered</w>
disc rete</w>
di urnal</w>
de pth</w>
cryst al</w>
counter act</w>
cor d,</w>
contr act
continu es</w>
consum ption.</w>
complic ation,</w>
coer uleus</w>
co sts</w>
clozap ine-induced</w>
climb ing</w>
clear .</w>
cl am
chromat ography.</w>
chlor ide,</w>
children :</w>
ch y
cephal or
ce ased</w>
cat echol</w>
captopri l,</w>
ca emia</w>
c ame</w>
bilirub in,</w>
bicucul l
benz tropine</w>
bec oming</w>
baclofen .</w>
b ial</w>
b asis.</w>
az ine.</w>
atten ding</w>
atic .</w>
appro xim
apomorph ine.</w>
antec ed
antagon izes</w>
annab in
anesthe tiz
an kle</w>
amin ocaproic</w>
amethas one</w>
alpha-methyl dopa</w>
alkalo sis</w>
agl ate</w>
aer os
admis sions</w>
act ,</w>
accumb en
ac ne
a str
a p</w>
Y oun
VPA .</w>
U. S.</w>
U nex
Soci ety</w>
SE R
Rever sal</w>
Res piratory</w>
R A.</w>
Question na
Q X</w>
Prog res
Pre dic
PAN -induced</w>
PA .</w>
PA -
O ne
NG F</w>
ND I</w>
Morph ological</w>
Min ocycl
M as
Lit tle</w>
L oc
L ine
Intracerebro ventricular</w>
Increas es</w>
In formation</w>
Immunohist ochemical</w>
G ly
G em
Flu mazen
Ex er
E C</w>
Dis ul
D AT</w>
Con tr
Col chic
CD -1</w>
CA SE:</w>
C Y</w>
B W
B O
Amph otericin</w>
African- American</w>
Acet yl
A- I</w>
> or=
7. 8</w>
7- day</w>
6. 3</w>
6 5-year-old</w>
6 3%</w>
6 00
5 6-year-old</w>
5 %.</w>
38 39
3 -1
2 3-
2 1)</w>
2 ',
17 0</w>
14 5</w>
14 17
10 %,</w>
1. 5-
1-methyl-4- phenyl-1,2,3,6-tetrahydro
1 14</w>
0.0 4).</w>
/ A</w>
-1 4
- independent</w>
(e.g .</w>
(2 2</w>
(1 7</w>
(1 4.
ze tim
zetim i
xyl azine</w>
wor th
weak ly</w>
w ild</w>
vi sible</w>
versus- host</w>
ventil ation,</w>
val ves</w>
val idity</w>
ure -
uma b</w>
tur n</w>
trime ster</w>
tri fluoro
tread mill</w>
tran yl
trac er</w>
tom ographic</w>
to sis</w>
tion ing</w>
ti um</w>
thym ic</w>
that :</w>
thal as
temperat ure,</w>
ta per
t rou
t ality</w>
syncop e,</w>
swit ch
suppress ants</w>
succinylchol ine.</w>
struct ures.</w>
stimul ants</w>
six ty-
side )</w>
sed ent
se of
seof ul
sarc olem
sampl ing</w>
s low-
s "</w>
ron edar
righ ting</w>
rhyth m,</w>
rever ted</w>
reten tion,</w>
reproduc tive</w>
repor te
ren ch</w>
remis sions</w>
remis sion.</w>
rem oxi
re presenting</w>
rat :</w>
quer cetin</w>
purpur a</w>
promaz ine</w>
pro meth
precor dial</w>
peroxy nitrite</w>
perf usion,</w>
pect oris.</w>
patter n,</w>
pas e-
par val
par am
p ine
otrop in</w>
or ally.</w>
opioid s.</w>
op re
omep razol
om a:</w>
neg ligible</w>
mo re
mil der</w>
mil d-
migra ineur
methylphen id
methemo glob
methad one.</w>
mes n
mat ous</w>
manag ing</w>
lorat adine</w>
lin king</w>
lev onorgest
lay ers</w>
lamin a</w>
ket amine.</w>
kD a</w>
itrac onazole</w>
it uit
isot onic</w>
intraven ous
intens ity,</w>
inten ded</w>
infarc tions</w>
incre ments</w>
improve d,</w>
immunosuppres sion.</w>
imipr amine,</w>
imag ing,</w>
im ple
if ep
ifep rist
ic o
hypocal ce
hypo phy
hyper sensitivity.</w>
hyper kinesia</w>
hour .</w>
hospital ization,</w>
high .</w>
high ,</w>
hepar in-
harm ful</w>
ha m</w>
gli oblastoma</w>
gen icity</w>
g m</w>
g ating</w>
fro zen</w>
flunar izine</w>
fiel ds</w>
fibroblast s</w>
fibrill ary</w>
fenol dopam</w>
fat al.</w>
fasc iculation</w>
factor- alpha</w>
f oci
experi ence.</w>
ex piratory</w>
etomid ate.</w>
er y</w>
equ ili
end points</w>
en ing,</w>
emerg ing</w>
em pir
ed ing</w>
dyston ia,</w>
dis section</w>
din itrate</w>
dihydro pyridine</w>
diethyl nitrosamine</w>
diclofenac ,</w>
dialy s
di azep
deoxy corticosterone</w>
defen se</w>
dantrol ene</w>
cu los
cor n</w>
copi es/
convuls ing</w>
compris ing</w>
complete ly.</w>
compar t
clinici an</w>
cirrho sis,</w>
cho sen</w>
charco al</w>
challeng es</w>
cardio version</w>
cardi otoxic
carb idopa</w>
car ry</w>
capsaicin- evoked</w>
capecit ab
can des
cTn I</w>
bus ulph
be pri
be .</w>
avail able,</w>
aug ment</w>
at um</w>
asti m</w>
ant ar</w>
ant adine</w>
an is
am niotic</w>
am nestic</w>
age )</w>
adrenocept ors.</w>
adolescent s.</w>
ac tions.</w>
ac ill
abstin ence.</w>
[ Ca2+]
Z ,</w>
Y or
V P</w>
Twenty- nine</w>
The ophylline</w>
T2- weighted</w>
T ai
T X
Sup pression</w>
Sex ual</w>
SSR Is</w>
S ulf
S S)</w>
S OD
S -related</w>
Q D</w>
Prophyl actic</w>
Pro l
PRE TA
PR L-
P< 0.001).</w>
P2 X
Ox id
Ne gative</w>
Na +</w>
Mor tality</w>
K+- ATPase</w>
Inde x</w>
In din
Ig A</w>
INTER PRETA
Hypo kalemia</w>
Hyper sensitivity</w>
Hy droxy
H P</w>
H ER
H E</w>
G SH
G -induced</w>
E r
E N
Dou ble
Dop a</w>
Diag no
Diab etic</w>
DOX .</w>
DN F</w>
D- amphetamine</w>
D uration</w>
Com pan
Child ren
C l-
BM T</w>
B ody</w>
Acet aminophen</w>
A A
8 9
8 8%</w>
7. 3</w>
6 3-year-old</w>
4 9.
3 80</w>
3 1%</w>
2n d</w>
200 1</w>
200 ,</w>
20 .</w>
2 6,</w>
12 2</w>
12 00</w>
12 .</w>
10 9</w>
10 6</w>
1 -induced</w>
0. 3,</w>
- /-</w>
(p =
(ST Z)-induced</w>
(SH R)</w>
(S R
(N a
(MR I)</w>
(DE S)</w>
(9 %)</w>
(10 (-
(1 7%)</w>
( 0</w>
zym e</w>
worl d
whe re
ver s</w>
ven s-
vens- Johnson</w>
vacu olar</w>
ursodeoxychol ic</w>
uncer tain</w>
tw o,</w>
transcript ase</w>
tra it</w>
tolu ene</w>
to remif
tho rough</w>
thalidom ide.</w>
ta in
swim ming</w>
stabil iz
st ret
st ain</w>
specti ve,</w>
spec ulate</w>
somnol ence,</w>
solu tion,</w>
situ ation</w>
serv ice</w>
seg ments.</w>
ro cur
ris ing</w>
ribavir in.</w>
reviewe d,</w>
ret te
ren dered</w>
remain der</w>
relie ve</w>
rel in</w>
reinforce ment</w>
rehabil itation</w>
regul ates</w>
re mitted</w>
rac lopri
r ing
r -
quinol ones</w>
quanti ty</w>
qualit atively</w>
qualit ative</w>
py ruv
pseudolith iasis</w>
propofol -
prim ate</w>
pot ence</w>
posi tive,</w>
plan ch
phot on</w>
phenter mine</w>
phen oxy
ph ine</w>
perio dic
perform ance,</w>
pan cytopenia</w>
pal ate</w>
p g/m
p )</w>
ox o-
opioid -induced</w>
ophthal m
op posed</w>
one- third</w>
one ;</w>
on cology</w>
ol im
obj ect</w>
nortript yline</w>
nor -
nom ifens
nitrofur antoin</w>
nitro sou
neuroten sin</w>
n ous</w>
myo fibrillar</w>
minut es)</w>
mid -
micro gli
mic e:</w>
mg/m 2).</w>
mg/ d.</w>
mg. /
metho do
me fen
mas k</w>
lun gs</w>
lium- 201</w>
lin es.</w>
iso enzyme</w>
ip olar</w>
intra arterial</w>
integr ated</w>
insp ired</w>
innerv ation</w>
ing i
ine- evoked</w>
induc ed.</w>
individu als,</w>
in sensitive</w>
imidazol ine</w>
ifosf amide,</w>
hyperprolactin aemia</w>
hyper locomotion</w>
hydroneph rosis</w>
high- performance</w>
hemat uria.</w>
habit ual</w>
h lor
graft- versus-host</w>
gene- related</w>
g/ day</w>
g ),</w>
furosem ide.</w>
for ty-
fe ver.</w>
fam oti
fam ili
extra hepatic</w>
exten sor</w>
exce ed</w>
et oric
est rous</w>
epsilon -
en ic</w>
em ,</w>
earli er.</w>
dyskinesi as,</w>
dist en
digit alis
diff usion</w>
diarrho ea</w>
dexamethas one,</w>
derivati ves.</w>
dec re
cyt open
culos keletal</w>
cop per</w>
contra indicated</w>
consequ ences.</w>
confir ming</w>
con stitute</w>
compromis e</w>
compoun d,</w>
comparis on,</w>
chem istry</w>
che lation</w>
categor ies</w>
cas es),</w>
carri es</w>
capsul es</w>
capsaic in,</w>
ca re,</w>
bi di
beta 2-
bec omes</w>
b /
av o
ati tis.</w>
arth ralgi
arteriol es</w>
arrest ,</w>
aor ta
anticoagul ants</w>
anorex ia,</w>
analy ses.</w>
an te
alkal in
agon ism</w>
age ment</w>
adhe rence</w>
ab use
a per
a kinetic</w>
[ SD
Z n</w>
Warfar in</w>
Ven ous</w>
U F
Trem or</w>
Thrombo tic</w>
Tac hy
T A</w>
Sud den</w>
Ste vens-Johnson</w>
Stand ard</w>
SH R.</w>
S ul
S tri
Rif amp
Q )</w>
Prac ti
Per io
PT X</w>
PK C
PH T</w>
PA N-
P ediatric</w>
Ne ur
Nause a</w>
N ig
M ar
Li -
Intr alip
In duced</w>
IC P</w>
I- II</w>
Hepat ocellular</w>
Hemat ologic</w>
Halo perid
H S
H D-
G ram
G R</w>
Func tional</w>
E pid
DE S-
DBA/ 2</w>
D an
D S
Contro lled</w>
Consider ing</w>
C utaneous</w>
C um
C s.</w>
C oc
C 3</w>
ANCA -positive</w>
AD M</w>
A ra
9 0-
8. 3</w>
6. 4</w>
6 8-year-old</w>
6 7-year-old</w>
5-H I
5 3-year-old</w>
5 24
5 00
5 -10</w>
4 7-year-old</w>
3 60</w>
3 %.</w>
29 )</w>
20 ).</w>
14 2</w>
13 6</w>
13 3</w>
10 3</w>
10 /
1 12</w>
0.0 2),</w>
0. 12</w>
.0 1)</w>
(p =0.00
(P< 0.05)</w>
(NO S)</w>
(N E)</w>
(MT D)</w>
(M I)</w>
(CS F)</w>
(A OR</w>
(2 5-
(1 :
(1 6</w>
( hazard</w>
( days</w>
( average</w>
( adjusted</w>
( 8-
( 0.00
warr ant</w>
veloc ities</w>
variabl es,</w>
v ect
ust ine</w>
uni variate</w>
uncerta in.</w>
un recognized</w>
un if
un fractionated</w>
transpl ants</w>
transf usions</w>
tivi ties</w>
termin ating</w>
te leph
te -
taper ing</w>
ta ined,</w>
t ing-
sw ol
sur ge
suffici ently</w>
sub stitu
stre am</w>
stiff ness</w>
step wise</w>
step -
spac e.</w>
sp ray</w>
sirolim us.</w>
side- effects,</w>
ser ially</w>
seoful v
se ven
run ning</w>
riz atriptan</w>
rist ol-
ristol- My
ristol-My ers</w>
risperid one-induced</w>
ri vas
resul t,</w>
resem bled</w>
re started</w>
re distribution</w>
re challenged</w>
raniti d
random ization</w>
r hi
quinol one</w>
quin idine,</w>
pyraz in
psych i
prilo caine</w>
present ations</w>
pre eclamp
pr act
potassi um-
pop ular</w>
platele t-
planch nic</w>
pl ate
perind opril</w>
peri ventricular</w>
path ology.</w>
p- chloro
p il
p ass</w>
p =0.0
ox et
over use</w>
ost ri
osc ill
orb it
or =</w>
oph armac
om asti
olytic- uremic</w>
of ur
ococc us</w>
ochemic al,</w>
occl uded</w>
non- invasive</w>
non competitive</w>
nodos um</w>
nigr al</w>
ng/ mL</w>
neutr al</w>
neuropath ological</w>
n um
multi drug</w>
mou th,</w>
month s;</w>
mono therapy,</w>
mon omorphic</w>
modafin il</w>
mmol/ l</w>
mio sis</w>
min d</w>
micro L</w>
me trex
me q/
mb le</w>
manifest ing</w>
lup us-like</w>
los ses</w>
limit ing.</w>
limb s.</w>
leuk emic</w>
lepro sy</w>
le i
lei omy
jec tions</w>
is ox
irradi ation.</w>
intr at
ini i</w>
inhibi tion,</w>
influ x</w>
in struc
in put
in 's</w>
impai red.</w>
hyperlipide mia</w>
hyper nat
hyper bilirub
hy pop
hom ocyste
hist one</w>
glomeruloneph ritis.</w>
gener ate</w>
gall stones</w>
form ,</w>
flow s</w>
fl up
fix ed-dose</w>
filgr astim</w>
fe lodipine</w>
exist ed</w>
ev ening</w>
estradiol -17</w>
erro r</w>
equi potent</w>
equ imolar</w>
epidemio logical</w>
ep silon</w>
enti rely</w>
enox acin</w>
enc ies.</w>
emphasi zed.</w>
el uting</w>
ec gon
e jac
dp /d
doxy cycline</w>
dos ages.</w>
disturb ed</w>
discus sion</w>
diaphrag m</w>
dend ritic</w>
deliri um,</w>
d- tubocurarine</w>
cycl ing</w>
cont ains</w>
construc ted</w>
consist s</w>
concl usions</w>
con fig
col um
clo x
clio quin
clam p</w>
citalopram .</w>
cirrho tic</w>
ce ton,</w>
cath ep
carcin ogenicity</w>
carb oxyl
car inii</w>
calcul ated.</w>
cal bind
bum in</w>
bul bar</w>
brady kinesia</w>
bl urred</w>
bio log
beta- end
beta 1</w>
avo ide
autis m.</w>
attenu ating</w>
attac k.</w>
atracur i
atherosclero sis.</w>
at tained</w>
at or.</w>
ast ric</w>
as certain</w>
arti ficial</w>
anti dot
an a</w>
amygdalo id</w>
amide s</w>
am isol
alpha -</w>
allopurin ol</w>
alf a-
aldo ster
al ive</w>
act ual</w>
ac it
ac cordance</w>
ab str
[ OR
Z e
VPA ,</w>
Ultra structural</w>
Twenty- eight</w>
There fore</w>
T- wave</w>
T c</w>
T BP
Syst em</w>
Swe dish</w>
Sprag ue</w>
SOUR CE
S tim
S le
R i
R ,
Prol actin</w>
Prin ceton,</w>
Phen yl
Phen obarbital</w>
PR A</w>
NMD A-
N o
N J)</w>
Min oxidi
Met oclop
MT )</w>
M g</w>
M O</w>
LV F
LT G</w>
LD 50</w>
L-DOPA -induced</w>
K .</w>
Im pres
Im paired</w>
I/ II</w>
I bu
I D</w>
Hz )</w>
Ho wever</w>
H en
H /
Gl u</w>
GM- CSF</w>
GB M</w>
G L
F rench</w>
F as
F /
E S</w>
Do se
Dipyridam ole</w>
D RE
D G</w>
Cum ul
Compan y,</w>
Ci meti
Cef triax
CT /
CG RP</w>
C l,</w>
B ristol-Myers</w>
B lock
B enz
B F</w>
Az athiop
Anti arrhythmic</w>
An th
Ag e</w>
Ad ju
AT 2</w>
A UC
A P)</w>
A K
A E</w>
9 7
8 -1
7 6%</w>
7 3-year-old</w>
7 -1
6. 8</w>
6 6%</w>
5 9-year-old</w>
5 7%</w>
5 6%</w>
5 50</w>
30- year-old</w>
3 5.
3 2
200 -
2- 4</w>
19 )</w>
16 5</w>
15 ),</w>
13 2</w>
13 ).</w>
1 50
1 13</w>
1 1.5</w>
- controlled</w>
) -1-
(i e,</w>
(SE ).</w>
(OH)2 D
(OH) (2)
(3 0%)</w>
(2) 17
(+/ +)</w>
( Y
( 0
% /
y el
warfar in-associated</w>
vertig o</w>
ure ly</w>
unilater ally</w>
unchang ed,</w>
ulcer ation</w>
ul inum</w>
tuberculo us</w>
trigg ers</w>
treatment- emergent</w>
trans port
trans forming</w>
to genic</w>
tilit y,</w>
theophyll ine,</w>
tamsulos in</w>
ta p</w>
swol len</w>
support .</w>
supplement ation.</w>
sup ras
sup ply</w>
sulf adi
spi ro
somatos ensory</w>
sol ved</w>
sleep .</w>
sl udg
situ ations</w>
single -dose</w>
si s-
scinti graphy</w>
sacchar in</w>
s.c .
s of
row n</w>
riton avir</w>
relationshi p.</w>
recru it
record s.</w>
reat h</w>
re si
rat s;</w>
rat s)</w>
punct ate</w>
pu pil</w>
psori atic</w>
promis e</w>
prolong ation,</w>
profen ,</w>
pressu res,</w>
pren olol</w>
pre cl
post operatively.</w>
polymorph ous</w>
poly myositis</w>
poin t.</w>
plas tin</w>
pheochromocyt oma</w>
pert urb
particip ating</w>
panc reas</w>
pa uc
p al</w>
over activity</w>
ov an
outcom e,</w>
ous -
oste op
osmolal ity,</w>
orb ent</w>
omat ous</w>
om b
olog ic,</w>
ob sc
nucle us.</w>
non- ionic</w>
non oliguric</w>
nifedi pine,</w>
negati ve,</w>
ne l</w>
nar row</w>
myocardi tis.</w>
myo pathic</w>
my dri
mon ophosphate</w>
minut e,</w>
minim izing</w>
microg/ mL</w>
mes en
me ter</w>
man ual</w>
mal formation</w>
load ,</w>
lisin opri
le ak</w>
kin ase,</w>
it ari
intr ag
intoler ant</w>
influ encing</w>
individ ually</w>
in- like</w>
in otrop
in al,</w>
ico plan
ic )</w>
ibuprofen .</w>
ib b</w>
hypo vol
hyperten si
homogen ates</w>
hi r
hex achloro
hepat ocytes.</w>
hemoglob in,</w>
hemat uria,</w>
hem olysis.</w>
h ot
gri seofulv
gr al</w>
glomerul i.</w>
gland ular</w>
gentamic in,</w>
gain .</w>
fol i
flu id.</w>
fibr e</w>
fet us</w>
f usi
f resh
ey es.</w>
exerci se-induced</w>
examp le,</w>
exacerb ates</w>
erec tion</w>
epo prostenol</w>
enc es,</w>
emph asis</w>
electr ically</w>
doxep in</w>
double-bl inded</w>
dopa ,</w>
dizocil pine</w>
discrimin ate</w>
dis c</w>
dip lop
difficul ties</w>
diazepam -induced</w>
di ver
depart ment.</w>
defic it
daun omycin</w>
cyt es.</w>
cy cle,</w>
creatin ine.</w>
conscious ness.</w>
comple ting</w>
com posite</w>
col lateral</w>
cocaine- seeking</w>
cl ind
cimetid ine.</w>
chlorambuc il</w>
cel ecoxi
catheter .</w>
cas pase-
cap s
bur sts</w>
broad- spectrum</w>
beta- receptor</w>
bet ween-
be fore
bas olateral</w>
avoid ing</w>
aur a</w>
ator vastatin</w>
atax ia.</w>
aspir ation</w>
arter y,</w>
appropri ately</w>
apar t</w>
anteced ent</w>
antagon izing</w>
anat omic</w>
an )</w>
amp icillin</w>
ami k
am ox
alpha 2-
algesi c</w>
al end
agonist )</w>
ad ural</w>
acetaminophen ,</w>
ac alce
aber rant</w>
a em
We b
TH P</w>
T W
Stud y.</w>
Scal e.</w>
STZ -
SE M)</w>
S h
S B
R g
Oxid ative</w>
Organ ization</w>
Nifedi pine</w>
NSCL C.</w>
N E
Man agement</w>
M elat
M I.</w>
Li ke
L- Dopa</w>
L ack</w>
Jap an.</w>
Intrac ranial</w>
In dian</w>
I D)</w>
Haloth ane</w>
HV A</w>
H I
H CO
Flu oxetine</w>
Fl uc
F DA</w>
Ery thro
E O
Do gs</w>
DN A-
D oc
Cumul ative</w>
Cap top
CP Z</w>
CI -
C och
BH T</w>
Anth rac
AI N</w>
A qu
A gg
A :</w>
9. 2</w>
9 %;</w>
8. 7</w>
7 4-year-old</w>
6 4%</w>
6 %;</w>
5- az
4 9-year-old</w>
4 7.
4 7%</w>
3 7%</w>
3 5,</w>
3 2.
3 1.
3 %;</w>
2 B</w>
15- 45
12- lead</w>
1 1).</w>
1 %;</w>
0. 8%</w>
0. 13</w>
- in</w>
- exposed</w>
(R R
(EP S)</w>
(E R
(D H
(AR F)</w>
(A LT)</w>
(8 %)</w>
(1 ),</w>
( dd
zidovud ine.</w>
z af
xim e</w>
wor k-
wh en
ver ified</w>
vasospas m.</w>
vasodilat ing</w>
vascular ,</w>
van illo
vacuol es</w>
use s.</w>
ultras oun
two fold</w>
transi ent,</w>
tran sp
tib ial</w>
thrombo plastin</w>
thir ty-
test )</w>
tas k,</w>
tamoxif en,</w>
tac h
t ness</w>
t ent
symptomat ology</w>
sym metr
sulf ox
sulf hydr
sulf asalazine</w>
su perim
stric t</w>
star tle</w>
stain ing.</w>
st age,</w>
spre ad
splen ic</w>
sple en</w>
sp ine</w>
small ,</w>
sit y-
single-bl ind</w>
similar ity</w>
sign al
ser opositive</w>
sep sis.</w>
semi -
s.c .,</w>
s planchnic</w>
s car
ros s
ri es</w>
retard ation,</w>
resum ption</w>
restric tive</w>
replac ement.</w>
ren ovascular</w>
reli eving</w>
regul ation.</w>
reac he
re appeared</w>
ras h
rang es</w>
quinpi role</w>
quanti fication</w>
pup illary</w>
pul sati
provoc ation</w>
prot amine</w>
prolifer ation,</w>
progres sion,</w>
pro arrhythmia</w>
pris ingly,</w>
predis position</w>
prazos in,</w>
pr am
post transplant</w>
posi tive.</w>
plasmaphere sis</w>
perfor ant</w>
percent ,</w>
per c
peak -dose</w>
pal li
p ill</w>
p estic
ox ide-
oste omyeli
ost om
os ,</w>
oper ation.</w>
open- chest</w>
on es,</w>
of loxacin</w>
od ol
octre oti
oci al</w>
o plas
nor floxacin</w>
non hematologic</w>
non cardiac</w>
neuro endocrine</w>
neon ate</w>
nec rop
mumol/ kg</w>
mon ocyte</w>
moder ate-
moder ate,</w>
mg/m(2 ),</w>
mg/ d,</w>
methohex it
mes alazine</w>
membrane- bound</w>
mechanism (s)</w>
measure ments.</w>
mat uration</w>
malignanc y.</w>
malform ations.</w>
mal ine</w>
loxac in-induced</w>
long- standing</w>
lo z
l ution</w>
l li
l aryng
iodi de</w>
intraven ously,</w>
intracerebroventric ularly</w>
ing ),</w>
ine- based</w>
immunosuppress ant</w>
immun ocyt
imipr amine.</w>
im mer
identifi able</w>
ib i</w>
ian -like</w>
i. m
hypothalam us</w>
hypocal cemia</w>
hyperexcit ability</w>
hype remia,</w>
hybri d</w>
hom ovan
high light</w>
hepati tis
hel d</w>
hear t-
guan eth
gr ap
glucocortico id-induced</w>
glit az
gastrocnemi us</w>
gamma-glutam yl
g et
furosem ide,</w>
frac tion.</w>
fluoxet ine,</w>
extrem ities.</w>
expand ed</w>
excl ude</w>
eu than
eth oxy
es citalopram</w>
enlarg ed</w>
enc ap
en ge
em ptive</w>
el ,</w>
e a,</w>
dop amine.</w>
diatrizo ate</w>
di am
demyel ination</w>
de man
dd I</w>
d .)</w>
d -induced</w>
cyt arab
cor responded</w>
consum ing</w>
consci ous,</w>
compoun d.</w>
compl aining</w>
col lo
co ordination</w>
co ordin
chloro procaine</w>
chloro -
child ho
chamb er</w>
chall enge
centr e</w>
candi dates</w>
ca ver
c oc
c ity</w>
but ,</w>
bromocript ine.</w>
blo od.</w>
biopsy- proven</w>
bi v
beta x
ben cl
ballo on
azol ine</w>
at or,</w>
ascit es,</w>
as y</w>
as par
arb azine</w>
ar sen
ar ms.</w>
appreci able</w>
apolipo protein</w>
anticip ated</w>
anti histamine</w>
anti fungal</w>
angiograph y,</w>
ane ously,</w>
analgesi a,</w>
aminotransfer ase,</w>
am ibi</w>
albu min,</w>
aff initi
af loxacin</w>
adriamyc in-treated</w>
adreno receptor</w>
ad duct
accur ately</w>
ac up
ac erb
abnormal ity.</w>
ab rupt
a etiology</w>
[Ca2+] i</w>
Web ster</w>
W eight</w>
W R
VN B</w>
Un til</w>
Un fortun
Thirty- six</w>
Td P.</w>
T ra
T 3</w>
Sur ve
Squ ibb</w>
Sou th</w>
Signific antly</w>
Sequ ential</w>
SOURCE S:</w>
R enograf
R TI
Prostagland in</w>
Previ ously</w>
Pre- treatment</w>
Praz osin</w>
PGI 2</w>
P gp</w>
P 1</w>
Out comes</w>
Ou ab
Obj ective</w>
Nitro prus
Neutropen ia</w>
Na (+)</w>
NT S</w>
N '-
Multicent er</w>
Met abolic</w>
Mes na</w>
Mechan isms</w>
MR P2</w>
MIB G</w>
M od
M ental</w>
M c
Like wise,</w>
Li ke</w>
II I.</w>
Hg ).</w>
Ha emo
HIV -positive</w>
H ipp
H L</w>
GY KI</w>
Flumazen il</w>
F ul
Ex acerb
Epid ural</w>
E AC
Diagno sis</w>
DRE SS</w>
DNA ,</w>
D-penicill amine.</w>
D X</w>
D A-
Con sistent</w>
Cis platin</w>
Ch est</w>
CYP2D 6</w>
CA P</w>
C ho
C arcin
C PA</w>
Bar r</w>
B W</w>
B -induced</w>
Angiotens in</w>
Angiotens in-converting</w>
Ana esthe
Adriam ycin-induced</w>
Ab s
AB T-
A ER
>/ =
9. 4</w>
9. 3</w>
9 -1
80 1</w>
8 3%</w>
7 3%</w>
7 %;</w>
6. 6</w>
50- year-old</w>
5 8%</w>
5 4%</w>
3- PP
3 rd</w>
3 A</w>
2 2,</w>
16 ).</w>
15 00</w>
1. 0%</w>
1 20
0. 6%</w>
0. 16</w>
0. 10</w>
(V T)</w>
(T R
(PR L)</w>
(P D
(P B)</w>
(N =
(H AM-
(G P
(F K
(DO X
(C R)</w>
(A TR
(1 1%)</w>
( which</w>
( cumulative</w>
( SI
( METH
( 7.5</w>
( 7-
' .</w>
% ]</w>
yl ic</w>
year -
y ed</w>
y e</w>
x in</w>
weigh t-
weigh ed</w>
w ri
ver m
ventric le,</w>
ve ins</w>
vastat in.</w>
vascul ature</w>
vag otom
vag in
ur aemic</w>
up .</w>
unex pect
undesi rable</w>
trast uz
transpor ters</w>
tra in
thal lium-201</w>
tetrahydro cannabin
tetrac aine</w>
ter ans</w>
t .
supple ment</w>
sumatript an.</w>
sulf ate.</w>
studi ed:</w>
stro ke
stead ,</w>
stand ard
six -
si s).</w>
sett ing,</w>
sens ations</w>
self- administration.</w>
se st
s cler
rupt ured</w>
respon ds</w>
rel ating</w>
reg ained</w>
ratio .</w>
quin one</w>
question ed</w>
pul ses</w>
pub er
propag ation</w>
pro drug</w>
pri v
prescri ptions</w>
pregnan cy
post treatment</w>
porphy ria</w>
phosph oro
phenter m
per tin
per one</w>
pel le
peg interferon</w>
pe ti
path olog
paren chy
par ap
pap illo
or y.</w>
or aph
or an
opo rosis</w>
oni um-induced</w>
ol ing</w>
ol in</w>
ol ic,</w>
oin tment</w>
occ up
nur sing</w>
nicot ine-
newbor ns</w>
neuropath ies</w>
nerv es.</w>
neon ates.</w>
ne a,</w>
mumol/ L</w>
mul tic
micro l</w>
micro l)</w>
mg/m2/ d</w>
methylenedi oxy
ment ary</w>
me si
mar row
ma y,</w>
ma pro
m as</w>
m ang
ly ;</w>
leuk ocytoclastic</w>
leuk em
latano prost</w>
ker at
ish ment</w>
iox aglate</w>
intra striatal</w>
intoxic ation,</w>
inten tion
insi di
inhibitor -induced</w>
inflam ed</w>
infiltr ates</w>
ine- 3-
ine mia.</w>
implant ation.</w>
immun ocom
im poten
im ply</w>
ill ic</w>
ild en
i 's</w>
hypomagne semia</w>
hypo plasia</w>
hyperplasi a,</w>
hypercalce mia,</w>
hyper kine
hour ly</w>
hist ochemical</w>
high er,</w>
heterogene ity</w>
hepat omegaly</w>
har ve
guine a-
gravi s.</w>
go rous</w>
gi t</w>
gest ation,</w>
genotyp es</w>
gene sis.</w>
g ingi
foun d,</w>
formal in-induced</w>
flexi on</w>
fist ula</w>
fe eling</w>
f und
est ram
es -
enalapri l,</w>
embry os.</w>
embol ism.</w>
elim inate</w>
elev ated,</w>
el ast
ede ma
ect op
ec onomic</w>
e zetimi
e in</w>
dys function
drug 's</w>
dra w</w>
dimen sion</w>
diab e
dexamethas one-treated</w>
determ ined,</w>
design ,</w>
depend ency</w>
degener ation,</w>
def ective</w>
de smo
d 4
cy tidine</w>
criter ion</w>
countri es</w>
corticosteroid s,</w>
confir me
comp et
common est</w>
col onic</w>
coincid ed</w>
coch le
cilost azol</w>
characteris ed</w>
caud ate-
cat arac
cardio protection</w>
carboplat in,</w>
caffe ine-induced</w>
c ation</w>
bri um</w>
brety lium</w>
bir th
bind ing,</w>
barbitur ate</w>
bac te
aug ments</w>
ass ays.</w>
ass ay,</w>
arthr algia</w>
arteriosclero tic</w>
arterio graphy</w>
approach .</w>
app ed</w>
apomorph ine,</w>
ap ular</w>
ap s</w>
analogu e,</w>
anaestheti sed</w>
amp ut
amp icill
all .</w>
agon istic</w>
age ;</w>
age :</w>
aff ili
adhe sion</w>
adenocarcin oma.</w>
acid )</w>
absc ess</w>
a re,</w>
Z -
U L
Toge ther,</w>
Thirty- two</w>
Th iop
TN )</w>
TCD D</w>
T -induced</w>
Surg ical</w>
Str uct
St age</w>
S ilden
S c
S C)</w>
Reco gn
Random ized</w>
PF C</w>
P SA</w>
P O</w>
O V
Nig er
NS ),</w>
NO AR
NF- kappaB</w>
N ec
Mg (2
MPO- ANCA</w>
MA )</w>
M MP
Lip id</w>
J ,</w>
Import antly,</w>
HBeAg -positive</w>
H P
GP i</w>
G TN
G F)</w>
Fos -
F ocal</w>
F ab
Exacerb ation</w>
Ex cept</w>
Enal april</w>
EE G.</w>
Double -bl
Dic lofen
DR G</w>
DO PAC</w>
DESIG N</w>
D BP</w>
Cyclo spor
Con centr
Comp uted</w>
Cardi omyo
Can ad
CA .</w>
B us
Amin o
A(2 A)
A pop
A ff
A )-
9. 7</w>
8. 8</w>
8. 6</w>
7-N I</w>
7 9%</w>
60- year-old</w>
55,212- 2</w>
5. 9</w>
5-F luoro
5 th</w>
5 5-year-old</w>
40- year-old</w>
4 7
4 6-year-old</w>
4 4%</w>
30- min</w>
3- h</w>
3- fold</w>
3 7-year-old</w>
3 6-year-old</w>
24 )</w>
200 4</w>
200 3</w>
2 3-year-old</w>
2 2-year-old</w>
2 2)</w>
1: 1</w>
199 4</w>
19 6
18 ).</w>
15 4</w>
14 .</w>
12 9</w>
1- receptor</w>
1 19</w>
1 11</w>
) ].</w>
(Tax ol;</w>
(S P
(S HR
(P L
(M B
(D X
(Cs A)</w>
(4 0%)</w>
(3) H]
(2 2%)</w>
(2 0
(1 000</w>
( six</w>
( chi
( 5-FU
" .</w>
when ever</w>
well- recognized</w>
wean ing</w>
wat er)</w>
warfar in,</w>
wan n</w>
ventro medial</w>
valpro ate-induced</w>
v oric
v ice</w>
utili zing</w>
ure ter
un wanted</w>
un iform</w>
un affected.</w>
ulo pathy.</w>
twice- daily</w>
twent y</w>
triam cin
trem ulo
trans mit
tract us</w>
tr amine</w>
thr ice</w>
thio guanine</w>
them ,</w>
tend on</w>
temozolom ide</w>
te g
tac rine</w>
t ris
t ing,</w>
synerg is
sulf ate,</w>
subcut aneous
sub endocardial</w>
sp on
sol itari
siz e.</w>
sign al-
sic k
sh are</w>
sed ati
secre tion,</w>
sco res.</w>
scat tered</w>
sar coma.</w>
ronedar one</w>
ron tal</w>
ric ket
ri ses</w>
rewar ding</w>
rese mble</w>
res h</w>
renz ep
remo val
relim b</w>
reflex .</w>
re present
re challenge.</w>
quinol ine</w>
psychos ocial</w>
prolifer ation.</w>
profes sion
pro thrombotic</w>
practition ers</w>
potenti al,</w>
possib il
poly drug</w>
play ing</w>
placebo -treated</w>
pil si
physostigm ine.</w>
phleb itis.</w>
phenyl alanine</w>
phent ol
pharmac eutical</w>
percent ),</w>
pe op
patch es</w>
pa ins</w>
pa in-related</w>
p amid
over come</w>
other s.</w>
ot an</w>
orig in
opi ates</w>
one ).</w>
olig uria</w>
ob taining</w>
o estrogen</w>
neuroblast oma</w>
nal bu
n ose</w>
myelo pathy</w>
myalgi as</w>
muscl es,</w>
mou th
morph ologically</w>
month ,</w>
mo tiv
mmol/ kg</w>
mixt ures</w>
mineralocortico id</w>
micrograms/kg/ min</w>
micro cephal
mg/m(2 ))</w>
mg/d l)</w>
mg/d L.</w>
mg. kg-1.
melat on
mal a
mac ulop
ma st
lun g,</w>
load .</w>
lit ers</w>
levo bupivacaine</w>
lat e,</w>
las go
lasgo w</w>
large -
lac tam</w>
l ar</w>
kind ling.</w>
iter pen
investig ation,</w>
inj ectable</w>
initi ation.</w>
ini um-
ing re
inc o
in- mediated</w>
in in</w>
impl ant</w>
ifosf amide
ic /
hypocap nia</w>
hyperkal aemia</w>
hypercholesterol emia</w>
hyper triglyceride
hydroxy- 3-
hydroxy but
high- density</w>
hemodynam ically</w>
hemo dilution</w>
hear ts,</w>
hap lo
hallucin ations.</w>
gli bencl
gl um
general ised</w>
gen es.</w>
gall stone</w>
fol d)</w>
flu ids</w>
fl an
fibron ectin</w>
extinc tion</w>
examin ations,</w>
ex ci
ever olim
eu phor
eth ane</w>
erro rs</w>
eptid ase</w>
enti ty.</w>
endomet ri
enco ded</w>
en e.</w>
en e-
eme togenic</w>
electr on-
dro ph
dose- effect</w>
donepe zil</w>
docum ents</w>
disturb ance,</w>
dis s
diaz oxide</w>
diaph ore
dex medetom
der s,</w>
depart ments</w>
dementi a.</w>
defect .</w>
de d-release</w>
cytot oxic
cypro mine</w>
cre ated</w>
cop e</w>
confir m
compa res</w>
comm enced</w>
co enzyme</w>
clear ances</w>
cisplat in-induced</w>
cin acalce
catalep sy
cardio selective</w>
carb im
bo th
ble omycin</w>
bio availability</w>
beta ,</w>
backgro un
bab ies</w>
b reath</w>
b am
ax illary</w>
ax etil</w>
avir in</w>
ativel y,</w>
aster ixis</w>
aspir in-
asp ect</w>
as :</w>
areas ,</w>
antin ocicep
antibod y,</w>
anti anginal</w>
angiograph ically</w>
anesthetiz ed,</w>
an odine</w>
an ide</w>
an and
aminophyll ine.</w>
aminophyll ine,</w>
allodyn ic</w>
ain -
ain ,</w>
aggreg ates</w>
ag glut
ag al</w>
affiniti es</w>
af f</w>
accumul ated</w>
acceler ate</w>
ac ar
a e,</w>
[SD ]</w>
Ze al
Wee k</w>
Thirty- three</w>
TN F</w>
TH )</w>
TB ARS</w>
T umor</w>
T ime
T en
T S</w>
T 4</w>
Sch wann</w>
SUBJECT S:</w>
S ot
Ran iti
RB C</w>
R ib
Propo fol
Pot assi
Pa CO2</w>
PP H</w>
PB N</w>
PAN -treated</w>
P 450
O LT
Nitroglycer in</w>
N-nitro sodi
N- methyl
MM F</w>
LE V</w>
L- type</w>
J aundic
In di
IV .</w>
ISO -treated</w>
II -
IGF- I</w>
ID 50</w>
I T)</w>
Hipp ocamp
HC V-
H M
Ex peri
Estro gen</w>
Electro physiological</w>
E PO
E F
E (2)17
Disul firam</w>
Dis or
Dex razoxane</w>
DES- exposed</w>
D ist
D PD</w>
Con current</w>
Co- administration</w>
Car bo
CP K</w>
CB D
C riter
C X
C G</w>
Austral ian</w>
Americ ans</w>
Am ifostine</w>
Am B</w>
99 m</w>
9. 8</w>
9. 0</w>
8. 1</w>
7, 8-
6 8%</w>
6 1-year-old</w>
5 2%</w>
4- fold</w>
4 2.
4 2-year-old</w>
25- year-old</w>
2. 8
2. 5-
1- 3</w>
1 6-year-old</w>
1 5-year-old</w>
1 17</w>
00- mg</w>
0.0 5%</w>
0. 17</w>
(SN P)</w>
(N -
(I L
(H IT
(6 00</w>
(4 4%)</w>
(3 5</w>
(1 3.
(1 2.5</w>
(1 2%)</w>
(0. 5
( v
( aged</w>
ym panic</w>
yl ]-
x -
wor sen</w>
wh y</w>
week )</w>
wean ling</w>
wast ing</w>
war m</w>
void ing</w>
vinblast ine,</w>
vascul at
vacu ous</w>
us age.</w>
ure teral</w>
unif orm
uc h</w>
toxic ities,</w>
ting- enzyme</w>
tim es.</w>
ti t
thi x
thalam us,</w>
ter s.</w>
te icoplan
tap ered</w>
tail- tremor</w>
sympath o
suppres sion.</w>
superim posed</w>
successful .</w>
sub o</w>
sub chronic</w>
stom atitis</w>
stand ar
st aff</w>
spik e-
sp ot
sotal ol,</w>
sor afen
so gest
sirolim us,</w>
si al
short -</w>
shap e</w>
sh rin
sett ings.</w>
sest amibi</w>
sequ in
separ ately</w>
sel enium</w>
sc ot
s me
rp 2</w>
rhi z
rest ,</w>
res tim
remis sion,</w>
regimen s,</w>
recurren ce.</w>
re in
radi olab
r one</w>
pro tr
pro mi
prescri p
pre gab
practi ce,</w>
prac tic
plus- maze</w>
pleas ant</w>
pinacidi l</w>
phosphon o
persist s</w>
persist ently</w>
per phenaz
pentobarbital- anesthetized</w>
parkinson ian-like</w>
paren ts</w>
paren chymal</w>
paras it
parallel- group</w>
p ane
pane l</w>
ox on</w>
ox az
orthop edic</w>
orth o
or bidi
oph il</w>
on 's</w>
ol imbic</w>
nutri tional</w>
nucle us,</w>
not e</w>
nitroprus side.</w>
nic oran
neuro active</w>
necessit ated</w>
ne omycin</w>
ne l
ne ar-
nausea/ vomiting</w>
n g)</w>
n as
myelosuppres sion,</w>
myelo dysplastic</w>
mus culoskeletal</w>
monke ys,</w>
mo id</w>
micro M,</w>
mg/m(2 )/
mg/m(2 ).</w>
mg/ day),</w>
mg/ K
methyl ene</w>
met for
meropen em</w>
meflo qu
measure d,</w>
manag ement,</w>
man ic-
maculop apular</w>
macro lide</w>
m oc
long- term,</w>
lip id-
lik re
letharg y,</w>
larg e,</w>
lact ation</w>
l d</w>
l at</w>
kind s</w>
it alop
isoprenal ine-induced</w>
isoniaz id.</w>
isoniaz id-induced</w>
irradi ated</w>
intrapl antar</w>
intim al</w>
interfe res</w>
intens ity.</w>
inher ited</w>
indinavir .</w>
in yl)
in sec
immunost aining</w>
imat inib</w>
ide n</w>
hypothe ses</w>
hyponat remia.</w>
hyperther mic</w>
hyperglyce mia,</w>
hyper reflex
hydr ation,</w>
hr ,</w>
hormon e.</w>
homovan illic</w>
hepar in
haz ard
h /
gy rus.</w>
graf ting</w>
gonad al</w>
glycopyrro late</w>
glutam ate,</w>
glucosaminid ase</w>
genotyp ed</w>
g um</w>
g el
fiel d,</w>
fib rous</w>
fail s</w>
fac ility</w>
extrap ol
ex pen
etoric oxib</w>
eti ology.</w>
estim ation</w>
essen ti
ere bell
erebell ar</w>
enro ll
enrich ed</w>
end- tidal</w>
en abl
electroly tes,</w>
elect ric</w>
effor t</w>
ed ly,</w>
echocardio gram</w>
e f
dysph ag
drug s:</w>
document ed,</w>
dizzin ess.</w>
disorder :</w>
discontinu ation,</w>
discontinu ance</w>
dis solved</w>
dipyridamol e.</w>
didan os
di one</w>
dextr an</w>
determin ants</w>
den si
defin it
defici ency,</w>
decano ate</w>
de sogest
de bil
dd C</w>
day time</w>
d one.</w>
d /
cy ano
cr ypt
cou mar
conver ting-enzyme</w>
control ;</w>
continu ed.</w>
conscious ness,</w>
com orbidi
colchic ine-induced</w>
cogn ition</w>
clioquin ol</w>
chron ic,</w>
channel s,</w>
categ ory</w>
carr ying</w>
cann ula</w>
canc ers.</w>
but yl-
busulph an</w>
bur n</w>
bronchodilat or</w>
bol uses</w>
blo tting</w>
blo od,</w>
betax olol</w>
behaviour .</w>
be it</w>
b un
b a
azol e-
audi ogenic</w>
ato prost</w>
ation -related</w>
aten olol,</w>
ass ay
arthr alg
antipsycho tics,</w>
anti serum</w>
antagon ised</w>
angin a,</w>
anaphyl axis</w>
an uric</w>
alpha (2)-
albu ter
al beit</w>
adriamyc in.</w>
adrenal ine.</w>
adeno virus</w>
activ ity;</w>
acetyl cysteine</w>
[35S] TBP
[ (3)H]
Yor k</w>
With out</w>
Wil son's</w>
Thirty- eight</w>
T x
T MP
T J
Sub st
St ate</w>
SA H</w>
S S
S F
Rel ationshi
RB Cs</w>
Prom pt</w>
Pre clinical</w>
Ph osph
Per icardi
PTU -induced</w>
PIL O</w>
PG- 9</w>
P lac
P i
One -
O I
Nor thern</w>
N P)</w>
N C</w>
Mit ochondrial</w>
Methotrex ate</w>
Melat onin</w>
Measure ment</w>
M- mode</w>
Los s</w>
Li Cl</w>
L ess</w>
L M</w>
K A</w>
Invent ory</w>
Intrac erebral</w>
Inter action</w>
IS P</w>
II I)</w>
IC V</w>
HBV- DNA</w>
G ranulo
G M</w>
FE V1</w>
F uture</w>
F at
Exer cise</w>
Ex tensive</w>
EX P
EC G,</w>
E po
E B</w>
Do x</w>
Do es</w>
Di ff
D (1)</w>
Contro ls</w>
Clo zap
Cl )</w>
Chloro quine</w>
Carbam azep
Captop ril</w>
CYP 3A4</w>
CH D</w>
C oun
Bromocript ine</w>
Block ade</w>
Bac lofen</w>
B or
B IS</w>
Ak t</w>
AQ P2</w>
AID S-related</w>
A plastic</w>
7. 7</w>
7- nitro
7 2-year-old</w>
6 9%</w>
5 2-year-old</w>
5 1%</w>
4 -1
3839 3</w>
3- day</w>
3 H-
3 9-year-old</w>
3 70</w>
3 4-year-old</w>
3 4%</w>
3 2)</w>
3 -</w>
2, 000</w>
2 2-
14 4</w>
13 9</w>
1,25- dihydroxy
0.0 3)</w>
- interstitial</w>
,00 0/
(W K
(T D
(N S)</w>
(IC H)</w>
(AC h
(2. 0</w>
(2 7.
(2 6</w>
(2 3</w>
(1 8</w>
( non-
( mean
( di
( defined</w>
( d)</w>
( alpha-
zidovud ine,</w>
yr )</w>
youn g,</w>
yn thetic</w>
yl )</w>
wor ds</w>
wor d</w>
wid ening</w>
week s),</w>
wa ve
w rit
w k
vinc a</w>
vi sion.</w>
vi able</w>
vanillo id</w>
van ishing</w>
us er</w>
unit s/
unex posed</w>
unevent ful
un myelinated</w>
un de
umb il
ular ly,</w>
ug inos
u ter</w>
typ es.</w>
tum or-
trimethaph an</w>
triamte rene
tri c</w>
tocain ide</w>
ticlop idine-induced</w>
ti ters</w>
ther l
themsel ves</w>
the ory</w>
thalidom ide-induced</w>
temperat ure.</w>
taz idi
suxameth onium.</w>
susceptibil ity.</w>
suppress ant</w>
suppres sive</w>
suppl ied</w>
sugg estion</w>
sub threshold</w>
stimul i,</w>
stereotyp ic</w>
steno ses</w>
sour ces</w>
si es</w>
shif ts</w>
self- report</w>
seizure -like</w>
sed ating</w>
sec tion.</w>
se mis
semis ynthetic</w>
s.c .),</w>
ro ot
righ t-
review ,</w>
resem bles</w>
re min
re jec
radio therapy.</w>
radio active</w>
r ings</w>
r .</w>
questionnai res</w>
provid ers</w>
priap ism</w>
pre ven
poin t,</w>
po t</w>
piper azine</w>
phyl axis</w>
phenylephr ine.</w>
pheno thiaz
persist ed.</w>
periodic ally</w>
peri portal</w>
pent oxif
particip ants.</w>
pan cur
p es</w>
ox yp
ous ness</w>
otep a</w>
osteop oro
oste oporosis</w>
osal ic
organ ophosph
one ),</w>
om ycin.</w>
of ,</w>
ocy an
obj ec
objec tives</w>
nucle i.</w>
noti ce
non sustained</w>
non significant</w>
no tion</w>
neutrophil s</w>
neurotransmit ters</w>
neuro cognitive</w>
ne sted</w>
ne ostri
mye lography</w>
multic entr
mol ar</w>
modifi es</w>
mmHg ;</w>
ml ).</w>
mit ting</w>
min i
min -1,</w>
mimic ked</w>
mid odrine</w>
micrograms/ ml,</w>
micrograms/ ml)</w>
mg/d l.</w>
mg/ l</w>
metast asis</w>
membran es.</w>
me glum
m er</w>
ly s
lu men</w>
low ers</w>
long est</w>
log -
lipopolysacchar ide</w>
limb s,</w>
lim itation</w>
lik ely.</w>
li ve</w>
lev amisol
laparotom y</w>
kin ase-
kal likre
k- alkali</w>
is ons</w>
intrac isternal</w>
interleuk in-
insti lled</w>
insi gh
insec tic
inhibitor )</w>
infu sions,</w>
infarc ted</w>
individu al
ind ole</w>
in- of-
in oc
ill u
ill ain-
il s</w>
hypother mic</w>
hypothalam ic-
hypomagne sem
hydrochlorothiaz ide,</w>
hr s</w>
his ti
hemodynam ics,</w>
hemis phere
hear t
h u
gynec ologic</w>
gly bur
glomerulosclero sis.</w>
gest od
ger m</w>
g k
g aug
form .</w>
follow ing:</w>
fo relimb</w>
flex or</w>
fl ud
fix ed-
fibr inogen</w>
fib ers,</w>
ferri tin</w>
f resh</w>
extra -
extr adural</w>
exten ded-release</w>
expres s</w>
ethan ol-induced</w>
eth yn
et .</w>
estram ustine</w>
establ ished,</w>
es cent</w>
es c
equi val
epsilon- aminocaproic</w>
epilep sy
ep omedi
ens or
encephal itis</w>
encap sul
emb ran
elder ly,</w>
el ed</w>
dys functions</w>
drug- drug</w>
drowsin ess,</w>
dou b
dofe tilide</w>
digox in.</w>
dextro se</w>
detox ification</w>
depres sion
depolar ization</w>
deple tion.</w>
dele tion</w>
de fl
cytos kele
cur cumin</w>
cu t</w>
conce pt
con stitutes</w>
comp uter</w>
commer ci
com posed</w>
coca ine's</w>
coag ulopathy</w>
cholecysti tis</w>
ch ick
cephalor idine</w>
carb imazole</w>
calcul i</w>
but ylated</w>
bis ulf
bind s</w>
bic al
bical ut
beta-carb ol
basel ine)</w>
azathiop rine.</w>
attac ks,</w>
asystol e.</w>
as ym
arri val</w>
arrhyth m
ardi ac</w>
anti bacterial</w>
analo g,</w>
amylo id</w>
amino )
am lodip
am bi
alte red.</w>
all ing</w>
alf a</w>
ag oraph
afterdepolar izations</w>
affili ated</w>
aer uginos
adultho od.</w>
acro le
achie ved.</w>
abund ant</w>
ab used</w>
a -like</w>
X -induced</w>
VE GF</w>
V /
V ).</w>
Un ilateral</w>
Tri meth
Tri als</w>
Tou rette
Tai w
T P</w>
T :</w>
Sur prisingly,</w>
Spec ific
SH R
S- transferase</w>
S ensory</w>
S CL
S B-
S -induced</w>
Re actions</w>
Random ized,</w>
R -induced</w>
Questionna ire</w>
Poin tes</w>
Pharmaco kinetic</w>
Pati ent
PGE (2)</w>
PA ).</w>
Orth ostatic</w>
On set</w>
Ob serv
O -induced</w>
N-nitrosodi ethyl
N K</w>
My co
Mem ory</w>
Maxim al</w>
MTX ,</w>
MP EP</w>
MENT AL</w>
MA ,</w>
M eni
Lo g
L ang
L Y</w>
L EC
K ing
K D</w>
K Cl</w>
Jaundic e</w>
Investig ation</w>
INTERPRETA TION:</w>
I F</w>
Hun ting
Hem olytic</w>
HIV -1</w>
HD L-
HD ,</w>
HC H</w>
H al
H V</w>
H AL
GnR H</w>
Gem cit
Ful minant</w>
Forty- six</w>
F SG
Epi lep
EXP ERI
EXPERI MENTAL</w>
E MB
Doxorub icin-induced</w>
DSM- III-
DBA/ 2
Cur ren
Cor tical</w>
Clin ically</w>
Cholest atic</w>
Cardiomyo pathy</w>
Ca +
CM V</w>
CM F</w>
C ell</w>
C O</w>
C N</w>
B ladder</w>
B K</w>
Am antadine</w>
Addi tion</w>
ANCA -associated</w>
AM PH
A verage</w>
A tropine</w>
A O
A ;</w>
8. 2</w>
8 4%</w>
70- year-old</w>
7 7
7 6-year-old</w>
6 9-year-old</w>
6 7.
6 2%</w>
50 %.</w>
5-fluorourac il.</w>
5-az acy
5-HT 1
5-FU .</w>
5-FU -induced</w>
5- amin
5, 7-
5 3%</w>
40 )</w>
4 th</w>
4 80</w>
4 5,</w>
4 1-year-old</w>
4 %.</w>
3 :</w>
3 2-year-old</w>
2', 3'-
2 );</w>
199 6</w>
199 2</w>
16 4</w>
13 8</w>
12- week</w>
10(- 5)</w>
1. 9
1. 3%</w>
1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine</w>
1- week</w>
1- hour</w>
1- h</w>
1, 0
1 8-year-old</w>
1 7-year-old</w>
1 24</w>
0. 20</w>
0. 14</w>
- fed</w>
- activated</w>
, 0
(NM S)</w>
(H U
(H R),</w>
(H IV
(GF R)</w>
(F D
(D M
(AZ T)</w>
(AU C)</w>
(A d
(3, 4-
(2 7%)</w>
(2 6.
( seven</w>
( four</w>
w t</w>
w indo
windo w</w>
vari es</w>
valpro ex</w>
v .</w>
uro logical</w>
uptak e.</w>
under took</w>
un usually</w>
un bound</w>
umbil ical</w>
typ es,</w>
tro pon
trimethopri m</w>
tric ho
tri phasic</w>
tri mox
tranyl cypromine</w>
transcript s</w>
toxic osis</w>
toxic ological</w>
thyroidis m,</w>
three fold</w>
thio per
tempor arily</w>
te mazepam</w>
tachy arrhythmia</w>
surg ically</w>
struct ur
steroid -
stereotypi es</w>
stere o
step s</w>
st or
st ing</w>
spectro phot
solv ent</w>
sol e
si zed</w>
sha red</w>
ses sions.</w>
ser ologic</w>
sequ ences</w>
sensitiz ation,</w>
self- administered</w>
selec tiv
sedent ary</w>
second s.</w>
scho ol</w>
sc rat
sc )</w>
rout e.</w>
ro su
rivas tigmine</w>
ris k-
retro bulbar</w>
request ed</w>
repair .</w>
relax ants</w>
rel y,</w>
regres sed</w>
reflex ,</w>
re ple
re ar
ration ale</w>
radi ograph
pu er
prot otyp
propranolo l-induced</w>
propi onate</w>
prolong s</w>
prol ide</w>
profession als</w>
prof oun
procain amide,</w>
pra vastatin</w>
poly uria.</w>
poly neuropathy.</w>
poly amine</w>
pindo lol</w>
pill s</w>
pi renzep
phosph ate.</w>
phen ir
pertin ent</w>
perit on
percent ages</w>
per son</w>
per ic
pentylenetetrazol e-induced</w>
pentobarbit al.</w>
pentobarbit al-induced</w>
pentamid ine.</w>
pe floxacin</w>
pattern s.</w>
path ies.</w>
paraly zed</w>
papillede ma</w>
pall idal</w>
pa in:</w>
p =0.00
p 38</w>
over dosage</w>
or ies</w>
oph ageal</w>
oper able</w>
oneuro pathy</w>
one al</w>
ondan setr
om on
olog ist</w>
olec ular</w>
olar yn
off "</w>
ocon vul
oc ap
observ ation.</w>
o proliferative</w>
nystag mus</w>
nucle i,</w>
no reth
nitroprus side,</w>
nif ied</w>
neuropath y:</w>
neph ron
nat ur
narrow ing</w>
na ec
myocardi um,</w>
mul tivari
morph ometric</w>
month s),</w>
mo re.</w>
minip um
mid line</w>
micromol/ L</w>
microangio pathic</w>
micro M).</w>
micro M),</w>
mic ,</w>
mg/m l)</w>
metopro lol,</w>
metabol izing</w>
mes yl
medi ast
me tic</w>
maz e.</w>
mat ur
mark ers,</w>
manic- depressive</w>
m ifeprist
m e</w>
lumb os
loo ked</w>
li sted</w>
li osis</w>
leuk ocytes</w>
leg al</w>
le ver</w>
late- onset</w>
lansop razole</w>
l ess.</w>
l es.</w>
kg ;</w>
k Hz</w>
junc tion</w>
jer ks</w>
ituit ary</w>
ipex ole</w>
investig ational</w>
interview s</w>
insul t</w>
ino si
inges tion,</w>
ine- like</w>
incorpor ated</w>
in one</w>
im pulse</w>
il /
ic v</w>
ia sis,</w>
hyper insul
hydroxy- 2-
hydroxy urea</w>
histor y.</w>
halothane- anesthetized</w>
h ous
h ard</w>
h ),</w>
glutathi one-
gingi val</w>
gentamic in-treated</w>
gangli a,</w>
gadol inium</w>
g estive</w>
g ar</w>
fusi dic</w>
ful filled</w>
fle st
fea sib
fact ,</w>
facilit ates</w>
expect ed,</w>
et odol
erythropoi esis</w>
er s:</w>
er ase</w>
epilept ogenesis.</w>
epi di
epidi dy
ent ec
emphasi zed</w>
elucid ated.</w>
elev ation,</w>
electrocardio gram.</w>
ecgon ine</w>
ec lo
e g
e droph
dyscra sias</w>
drug- resistant</w>
drin k
dra in
disturb ance.</w>
dist or
dist ance</w>
diltiazem .</w>
digit oxin</w>
diff ering</w>
diclofenac .</w>
dialys ate</w>
de ta
d otal</w>
coun ts,</w>
cortis ol-induced</w>
control s)</w>
cont ribu
cont ext
constipati on,</w>
conn ection</w>
conflic t</w>
conf er</w>
com promi
coll icul
co w
co efficient</w>
circu it</w>
chloroqu ine-induced</w>
chloro ethyl
chlor diazep
challeng e,</w>
ch oro
ch arge
cerebell um.</w>
cef azol
cau tion.</w>
carboplat in.</w>
capsaicin- sensitive</w>
byp as
but orphanol</w>
bupren orph
brady kin
br ush</w>
bo ys</w>
beta-end orphin</w>
bet amethasone</w>
benzodiazepin es,</w>
bef radi
beats/ min.</w>
basi lar</w>
b.i. d.</w>
b os
atten tion-
ation s;</w>
ate d:</w>
aspir in-induced</w>
aro x
antihist amines</w>
antidepress ant
anti le</w>
anore xi
angio grams</w>
angi ect
analog ous</w>
an in</w>
alpha- 2b</w>
alpha (1)-
allodyn ia,</w>
agranulo cyto
agit ation.</w>
aff ected,</w>
adv is
ad al
acu ity,</w>
acti vely</w>
absorb ed</w>
absor ption.</w>
abec arn
a pro
] o</w>
Zeal and</w>
Z idov
Z D
V SD</w>
V CR</w>
Un it</w>
URE S:</w>
U/ L,</w>
Toler ance</w>
Ticlop idine</w>
Thromb ocytopenia</w>
There after,</w>
Th at</w>
Tem poral</w>
Tachy cardia</w>
TM S</w>
T re
T issue</w>
T CA</w>
Subj ective</w>
Sub cutaneous</w>
Ster oid</w>
SY N
SYN THESIS:</w>
S pir
S o
S in
S ,
Prote in</w>
Prot ection</w>
Potassi um</w>
Platele t</w>
Pilocar pine</w>
Phenyleph rine</w>
Par t</w>
PAN .</w>
PAN ,</w>
P ic
P PAR
P CR
Oc tre
Ne therl
NK 1</w>
N er
N CT
Mg SO
ME L</w>
Los artan</w>
Lo wer</w>
Lew is</w>
LE .</w>
L is
L P</w>
L N
L AM</w>
K ing's</w>
Inde ed,</w>
Im pression</w>
I K
Hyper prolactinemia</w>
Here in,</w>
HU S.</w>
HC .</w>
H2 O</w>
Gu illain-
G H</w>
Fir st,</w>
Enh anced</w>
En d-
ER K</w>
E stradi
E GF</w>
Dil tiaz
Det ail
De ath</w>
D SE</w>
D MT
D L-
Cy t
Convul sions</w>
C PT
C -induced</w>
Bu t</w>
Bu pivacaine</w>
Ap plication</w>
Anesthe si
Ab out</w>
AM P-
AID S.</w>
A/ J</w>
A x
A typical</w>
A sian</w>
A AP</w>
8 6%</w>
7-nitro inda
6 4-year-old</w>
5-HT 3</w>
5-Fluoro uracil</w>
5 8.
5 7-year-old</w>
4- amin
4 8,</w>
4 6.
3-PP P</w>
3- 5</w>
3,4- dihydroxyphenyl
26 ).</w>
2. 0%</w>
17 ).</w>
14 9</w>
12 6</w>
1. 5,</w>
1. 4%</w>
0.05 ;</w>
0.00 1;</w>
0.0 9</w>
0. 30</w>
0 ;</w>
.00 1),</w>
-M ei
-1 /
)- associated</w>
) ],</w>
(RO S)</w>
(P< 0.01).</w>
(P F
(M PT
(H IT)</w>
(FK 50
(D SM-
(D R
(CY P)-induced</w>
(AT P)</w>
(8 0%)</w>
(7 %)</w>
(4 1%)</w>
(3 6%)</w>
(3 )/
(3 %)</w>
(2 9%)</w>
(2 4%)</w>
(2 1%)</w>
(2 ).</w>
(2 %)</w>
(1 6%)</w>
(0.0 1-
(0. 7
( about</w>
( X
( 5,</w>
( '
ym ph
yiel ding</w>
y ocardial</w>
with dre
well ,</w>
week ly.</w>
warfar in-related</w>
vol emic</w>
vi rus.</w>
ver ing</w>
vel s</w>
vasodilat ors</w>
urin alysis</w>
urethane- anesthetized</w>
univer sity-
un reported</w>
un diagnosed</w>
ultra structure</w>
ub i
u es</w>
tubulo -interstitial</w>
trou bl
trau ma.</w>
topir amate</w>
tom ography,</w>
to- moderate</w>
to id</w>
tion ),</w>
thi otepa</w>
tenof ovir
teleph one</w>
tel angiect
techniqu e,</w>
tax ol</w>
syndrom es,</w>
swe ating</w>
suspect ed,</w>
sulfox imine</w>
sulfhydr yl</w>
sub scale</w>
sub cellular</w>
streng th
stra in,</w>
st ell
st asis</w>
spectro scopy</w>
side s.</w>
si ve.</w>
short ness</w>
seroton in,</w>
ser ine</w>
sequin an</w>
se ter</w>
scleroder ma</w>
scaveng ing</w>
sampl ed</w>
rest less</w>
respon der</w>
res ectable</w>
represent ative</w>
reduc tion,</w>
reco ver</w>
rec ur</w>
reac t</w>
re tained</w>
rate -induced</w>
rat ropium</w>
rac e,</w>
quin oxal
quin ine-induced</w>
quanti ties</w>
propo sed.</w>
program .</w>
prof ylline</w>
produc tion,</w>
procain amide.</w>
proc ou
proc ess,</w>
pro pri
preserv ation</w>
prednis one,</w>
predis poses</w>
post ure</w>
poly uria,</w>
plas ma,</w>
pituitary- adrenal</w>
pide mic</w>
phylococc al</w>
ph ed
paw -
pauc ity</w>
parturi ents</w>
parkinson ism,</w>
pares thesia</w>
par g
pa in
pa id</w>
oxali platin</w>
oxali plat
other ,</w>
os a</w>
op e</w>
omo dul
ologic ally.</w>
oligo dend
oligodend ro
olaryn g
observ ation,</w>
obes ity</w>
ob vi
o edema,</w>
not ably</w>
not ,</w>
neuro toxic
neuro protection</w>
n M</w>
multicentr e</w>
morph ic</w>
mo i
ml -1</w>
mil l
migraineur s</w>
microscop y,</w>
micrograms/ ml.</w>
microg/ rat)</w>
micro -
mg/m 2),</w>
methy ser
methad one-
megal oblastic</w>
mat ching</w>
market ed</w>
m oun
lysos omes</w>
ly so
lut e
lumbos acral</w>
line arly</w>
limit s.</w>
letharg y</w>
lear ning,</w>
lan -Mei
kin d</w>
kidne ys,</w>
ket o-
ke t</w>
k er</w>
k Hz
jump ing</w>
j o
itsel f.</w>
it ance</w>
isoniaz id,</w>
isoflur ane,</w>
iso -
isch aemia.</w>
irin otecan</w>
ir t
ip ratropium</w>
invol ved,</w>
investig ator</w>
intoler able</w>
inter view</w>
inter acts</w>
inter -
intention -to-treat</w>
int ent
insigh ts</w>
inosi ti
ind ap
inclu sions</w>
in izing</w>
in ess,</w>
immunos orbent</w>
im potence</w>
im ide</w>
ifen pro
if entan
ide s,</w>
id )</w>
ia -like</w>
hypot on
hyperkal emia,</w>
hyper cap
hydro morphone</w>
hum oral</w>
hr )</w>
hot -
hept ano
hemi paresis</w>
hemat oma.</w>
hem olytic-uremic</w>
gyr us,</w>
gynec omasti
grow th,</w>
grap h</w>
granulo cytopenia</w>
gram s.</w>
gl ands</w>
g ross
func tions,</w>
follow s</w>
fol d,</w>
fluoroquinol ones</w>
flu vox
ff -
fet us.</w>
ezetimi be</w>
ey e.</w>
ess ation</w>
ere 's</w>
eradic ation</w>
epo etin</w>
enantiom er</w>
en erg
emplo ying</w>
em ents</w>
elic its</w>
eff usion.</w>
e leven</w>
e icos
dys regulation</w>
drug -dependent</w>
dri ven</w>
dose -</w>
diure tics.</w>
dist ant</w>
dissoci ated</w>
din it
diameter ,</w>
den ied</w>
del usions</w>
debil it
de tach
de hydration</w>
de fibrill
datab ase.</w>
da zole</w>
cy r
coun sel
conver sion.</w>
context ual</w>
con nec
compens ated</w>
compar ison
col later
co vari
clon us</w>
clo tting</w>
cli pp
citalopram ,</w>
circu its</w>
cir cl
ciprofloxac in.</w>
chem oconvul
cent ,</w>
cauti ous</w>
cau tions</w>
catheter ization.</w>
cataton ia.</w>
cat s.</w>
cas es).</w>
captopri l.</w>
calci um.</w>
cal f</w>
ca sts</w>
c- Fos</w>
brady arrhythmia</w>
bio assay</w>
beta- blockade</w>
benzo yl
benef it.</w>
az ine-induced</w>
az ana
ate d-
at azana
associ ation.</w>
ar ise</w>
ar is
ar ial</w>
ar ate</w>
appea red,</w>
app ly</w>
antipsycho tic-induced</w>
antimicro bial</w>
anti- arrhythmic</w>
anti thrombin</w>
angio gram</w>
angio genic</w>
amplitu de,</w>
amphet amines</w>
am rinone</w>
alpha- adrenoceptor</w>
all erg
all enge</w>
al cit
al as
ag in
adjust ments</w>
acti ve,</w>
ac .</w>
abol ish</w>
a x</w>
a rom
[14 C]
Youn g</w>
X ).</w>
W A
Valpro ate</w>
Unfortun ately,</w>
Thirty- one</w>
Test o
Tax ol</w>
TT P-
T F
T 2</w>
Silden afil</w>
SC s</w>
S tra
S ar
S AM
Reg ular</w>
Recogn ition</w>
Pro spective,</w>
Par ad
Par acetam
PD ,</w>
PA /
P< 0.05).</w>
P r
P he
Op tic</w>
O tot
Na +/
NP C</w>
NG- nitro-L-arginine</w>
NCT 00
N ot
Meni ere's</w>
Maxim um</w>
Mark ed</w>
Le vels</w>
L HR
L CT</w>
Ischem ic</w>
Intralip id</w>
Inf ants</w>
In tensive</w>
Immunohist ochemistry</w>
IC )</w>
Hyper tensive</w>
Hyper cal
Hg ),</w>
Hepat otoxicity</w>
HIT .</w>
H u
H ET
H )-
Gl yc
GABA ,</w>
G lasgow</w>
G AD
Frequ ency</w>
Fi bro
Fe wer</w>
Fancon i's</w>
Exc essive</w>
Ep o</w>
ED (50)</w>
EC Gs</w>
E tom
Doc etax
De ep</w>
DZ R</w>
DOCA- salt</w>
DO PA</w>
DO CA</w>
D on
D IC</w>
D I
D C
Cap ecit
C u
C essation</w>
C :</w>
BT X</w>
B asal</w>
Ap omorph
Al co
Abs ence</w>
AP L</w>
AD AM
AC h</w>
AC S</w>
A ge
9 3
86 44</w>
8 7
7 7%</w>
7 5-year-old</w>
6- OHD
6 2-year-old</w>
50 00</w>
5-HT 2</w>
5 HT
4 9%</w>
4 6%</w>
3- month</w>
3 4.
3 3-year-old</w>
3 1-year-old</w>
25 %,</w>
24 h</w>
200 6</w>
2. 9
2. 6
2- fold</w>
2 C</w>
2 7-year-old</w>
2 7,</w>
2 6-
2 3)</w>
17beta- estradiol</w>
15-45 13</w>
1417 16
14 ),</w>
12 8</w>
12 1</w>
10- year</w>
1 A
1 0.5</w>
)- treated</w>
(PAN )-induced</w>
(P< 0.001).</w>
(P P
(HC V)</w>
(EM G)</w>
(CY P)</w>
(C I
(B B
(7 5%)</w>
(2 1</w>
(1 8.
(1 ).</w>
(1 )
(0. 3
(-1 ),</w>
(+ )
z ine,</w>
yl- L-
withdre w</w>
week s;</w>
wal king</w>
w t)</w>
vul gar
vis ed</w>
ve /
ve )</w>
vaccin ation</w>
uter o.</w>
usion- weighted</w>
us sis</w>
us ate</w>
us -associated</w>
uromyc in</w>
ur ic
un successful</w>
un restrained</w>
un anesthetized</w>
u lography</w>
troubl es
triamcin olone</w>
tri ple
tri phosphatase</w>
tri az
tremor s,</w>
treatment )</w>
tre t
tret ino
transi t</w>
transcri p
trans mitted</w>
tract .</w>
trac tion</w>
topir am
tizan idine</w>
tion /
ti p</w>
thereafter ,</w>
therap y-induced</w>
ther .</w>
testoster one,</w>
ter s,</w>
ter med</w>
ter -
ten d</w>
tech ne
te d
tax an
tampon ade</w>
ta ins</w>
t ly.</w>
synap tos
symmetr ical</w>
susp ect</w>
supras pinal</w>
supplement s.</w>
subst rates</w>
subst ance
sub sets</w>
ston es,</w>
stit uting</w>
ster nal</w>
stell ate</w>
spro ut
spec ulated</w>
spec ies,</w>
spe ech
sol itary</w>
smok ers.</w>
sludg e</w>
significant ).</w>
side s,</w>
shap ed</w>
seroton in-
sec )</w>
se arch
sarcom as</w>
s.c .).</w>
s. go
rota rod</w>
ri a,</w>
restra in
reser p
relap sing</w>
regurgit ation.</w>
regul ar
refract or
recur ring</w>
recogn i
recipi ents,</w>
reas ,</w>
re ward</w>
re model
re flux</w>
raph e</w>
rap am
raclopri de</w>
r in,</w>
r ar
quetiap ine.</w>
propi on
progest ogen</w>
princip ally</w>
prescri bed.</w>
pre- test</w>
prazos in.</w>
poly ethylene</w>
pi v
physi ology</w>
phy to
phospho inositi
phosphat ase,</w>
phenotyp es</w>
phenel zine</w>
phen id
phen ad
ph as
pg/ ml</w>
peroxid ation.</w>
pentylenetetraz ol-induced</w>
penetr ation</w>
pem ph
pathw ays,</w>
paroxet ine.</w>
palli ative</w>
oxidi zed</w>
oxal ate</w>
over flow</w>
out patients.</w>
ot subo</w>
ot ox
osalic ylic</w>
os ity</w>
ori es,</w>
organ s.</w>
ophthalm op
op ini
op ac
onco log
on om
on itrate</w>
on -induced</w>
ol e.</w>
of ovir</w>
occur ,</w>
oc ol
o- called</w>
o himb
normal ized.</w>
non- diabetic</w>
non- NMDA</w>
nitrogen ,</w>
ni ff
nephro toxic
nat urally</w>
n ine
myoglob in
my ocytes.</w>
must ine</w>
mu g</w>
mon onitrate</w>
mode stly</w>
mitochondri a.</w>
mit otic</w>
mirta zap
mg/kg/ day.</w>
mg/ day;</w>
meth oxamine</w>
medull a.</w>
medi um-
mc g/
manipul ations</w>
malar ia.</w>
m ad
lute inizing</w>
loxac in.</w>
loxac ill
locomo tion,</w>
litter mat
lic king</w>
lib it
li ves</w>
levodopa ,</w>
leu prolide</w>
length ening</w>
leg ic</w>
lea f</w>
le aves</w>
lac ked</w>
it y).</w>
ir rel</w>
investig ates</w>
intest ine</w>
intent -to-treat</w>
intensi fied</w>
inst ability</w>
injec tion)</w>
initi ate</w>
infu sional</w>
in-of- four</w>
in- hospital</w>
in es.</w>
import ant.</w>
implic ations.</w>
il ity,</w>
ic l
hypother mia,</w>
hyponat raemia</w>
hypom ania</w>
hyperten sion:</w>
hyperlipide mia,</w>
hype re
hydrox y</w>
hydro lysis</w>
hydro cephal
hydr alaz
hyd anto
hy pos
hy al
hind limb</w>
high er.</w>
haemo dynamics</w>
haem olysis</w>
group :</w>
gross ly</w>
gri p</w>
granulomat osis.</w>
grad u
gk 1
gen der
g -
function ing.</w>
fru sem
follic ular</w>
flan k</w>
fin aster
fif ty-
faz od
factor ial</w>
f ai
exec utive</w>
excit otoxic</w>
ex foli
estro genic</w>
ere s</w>
equili brium</w>
enzyme- linked</w>
endothel in</w>
endoc annabin
ence :</w>
encapsul ated</w>
en cainide</w>
elim in
elev ation.</w>
eigh t-
effec tiven
echocardio grams</w>
ech o</w>
e min
e "</w>
drug -associated</w>
dou bled</w>
dose- dependent,</w>
distribu tion,</w>
distingu ished</w>
dismut ase,</w>
discus ses</w>
discharg e,</w>
dis proportion
dis position</w>
differenc es.</w>
di git</w>
des flurane</w>
derivati ves,</w>
der gic</w>
deple tion,</w>
demograph ics,</w>
decreas e.</w>
decompens ated</w>
dec ided</w>
dec ade</w>
de mic</w>
dang er</w>
crani otomy</w>
countri es.</w>
cortico ster
contraceptiv es,</w>
contrac tility.</w>
continu ous-
cont amin
conjunc tiv
conf used</w>
comparis on.</w>
commerci ally</w>
comm is
com ycin</w>
col itis.</w>
cohor t.</w>
coca ine-</w>
co- administered</w>
clo b
clob az
clinic ally.</w>
cl usion</w>
cimetid ine,</w>
chole lithiasis</w>
chlorprop amide</w>
chlor thal
ch i</w>
cere bri
cell -
cefot ax
cef tazidi
carcin ogen
carbox ylate</w>
capill aries</w>
c ations</w>
c at</w>
c am
bupropi on.</w>
bu met
bronch opulmonary</w>
bridg ing</w>
break down</w>
bor der</w>
block er.</w>
biv olol</w>
beta 2</w>
benzodiazepin es.</w>
behavi orally</w>
bacter io
b oun
avoide d.</w>
atroph y,</w>
ate /
at ab
asymptom atic.</w>
asthen ia</w>
assum ption</w>
applic ation,</w>
ap noea</w>
ap ir
anxi oly
anti- epileptic</w>
an op
am ine-treated</w>
allograf ts</w>
all yl
al :</w>
aggrav ates</w>
ag astr
aeros ol</w>
adduct or</w>
ad ducts</w>
ad d-
acet ate.</w>
accumul ation.</w>
accoun ting</w>
acc ru
[35S]TBP S</w>
Z n
Y ohimb
V T,</w>
V T)</w>
V L
Un der
U G
Treat ment
Thirty- four</w>
TUNE L</w>
Strept ozotoc
Stim ulation</w>
Sign s</w>
Sensi tivity</w>
SE NT
R- 27
R it
R ac
R 1</w>
Pot enti
Per fusion</w>
PTH r
PC B</w>
P- 450</w>
P ituitary</w>
P S
P M
P CA</w>
Opio id</w>
NS .</w>
Myoclon us</w>
Minoxidi l</w>
Mas sive</w>
MTX .</w>
M id
M ain
M CA
Log istic</w>
L-NAME ,</w>
L ov
L 2</w>
L );</w>
K ),</w>
Ital ian</w>
Intra -
Initi ally,</w>
Inf arc
Im mediate</w>
III B</w>
Hodg kin</w>
Haloperid ol-induced</w>
H US
G E</w>
G AD</w>
G 2</w>
Forty- eight</w>
Fl ecain
F V
Eigh ty</w>
ED .</w>
EC G.</w>
EAC A</w>
E B
Dex medetomidine</w>
DB S</w>
D atab
D :</w>
Colchic ine</w>
Children 's</w>
Chemo therapy</w>
Ca(2+ )-
CT .</w>
COM T</w>
CN U
CI )</w>
C oma</w>
C hem
C TR
C D)</w>
C 1</w>
Br d
BD 10
B re
B DNF</w>
Associ ated</w>
Antin ociceptive</w>
An aly
Alter n
ATP ase,</w>
AR F.</w>
AL L</w>
AC .</w>
A I</w>
A A)</w>
A -treated</w>
9 8
9 2%</w>
7. 2</w>
7 8%</w>
7 6
7 2%</w>
7 1%</w>
6, 7-
6 8
6 1%</w>
58 26
5. 0
5 9%</w>
5 2
48 6</w>
4 8.
4 30</w>
4 3.
4 3-
3 9%</w>
3 8-year-old</w>
3 5-
200 7</w>
20 %,</w>
2. 7
2 9-year-old</w>
2 70</w>
2 3,</w>
2 2
2 1-year-old</w>
19 ).</w>
16 7</w>
16 .</w>
13. 5</w>
11. 8</w>
10 %.</w>
1. 7%</w>
1. 6%</w>
1,25- (OH)2D3</w>
0.00 3).</w>
0. 19</w>
.000 1).</w>
-1, 3-
-1 3
- J
- 0.
, 8
(p H</w>
(P E)</w>
(P A
(ISO )-induced</w>
(IS O)</w>
(IO P)</w>
(E T
(C a
(C K)</w>
(C F
(B UN
(ATR A)</w>
(A ED
(7 0</w>
(2 3%)</w>
(1 5-
(1 3%)</w>
(0.0 1</w>
(0. 15</w>
( max
( groups</w>
( especially</w>
( LT
zaf ib
yclin es</w>
work- up</w>
wor k,</w>
wi der</w>
well- established</w>
well ing</w>
w /
ven tional</w>
vasospas m,</w>
vas culo
val id</w>
un remark
un pleasant</w>
ultrason ography.</w>
ular- weight</w>
ul tr
ud itory</w>
u sions,</w>
tum or
tubul es,</w>
trun k</w>
troubles ome</w>
tro glitazone</w>
trau ma,</w>
transplant ation:</w>
trabec ular</w>
ton gu
to phore
time ly</w>
ti gh
thior idaz
thiopent al,</w>
theore tical</w>
ter ing</w>
tender ness</w>
te tro
te ,</w>
t ari
t adal
synergis tically</w>
susp ended</w>
struct ured</w>
stri ps</w>
stilbestro l</w>
stereotyp y,</w>
sten osis,</w>
st u
st ores</w>
st ated</w>
squ irrel</w>
sole us</w>
sleep -
simult aneously.</w>
sim ply</w>
seve re
ses ophageal</w>
sensi tivities</w>
seizures ;</w>
seizures :</w>
scal p</w>
s o-called</w>
s a</w>
ry anodine</w>
ro si
ro pivaca
ri l
retro peritoneal</w>
ren sic</w>
remo ph
relax ation.</w>
reache d.</w>
reac tion
re- exposure</w>
re produced</w>
rate- pressure</w>
rate /
rate )</w>
ram ad
rac e</w>
quantit ated</w>
pyri midine</w>
pyrex ia</w>
pyl ori</w>
pros thetic</w>
propylthio urac
prop oxy
proble ms,</w>
pro enkephalin</w>
prepar ations,</w>
pract olol</w>
poly uric</w>
pneumonia e</w>
plaqu e</w>
pic ardi
phosphor us</w>
phosphon ates</w>
phenylpropanol amine.</w>
phenylephr ine,</w>
phenomen on,</w>
phen olic</w>
pharmac y</w>
peroxid ase,</w>
perio ds,</w>
per mitted</w>
patient ),</w>
path ologically</w>
path ogenesis.</w>
pare sis,</w>
pal sy.</w>
pa i
p H,</w>
oxygen .</w>
oxygen ,</w>
over doses</w>
outcom es,</w>
ouabain .</w>
osin ophil</w>
osar com
optim um</w>
oper ations</w>
oper ation,</w>
om e-
olog ist
ocyto sis.</w>
ob st
ob iliary</w>
nor mother
non- treated</w>
non- fatal</w>
non toxic</w>
non pregnant</w>
nigh t
ng/m L.</w>
nevir apine</w>
nalox one-
na ph
n ings</w>
n ar</w>
n ACh
mul tiv
muc ous</w>
mox on
morph ology,</w>
mono aminergic</w>
molec ular-weight</w>
mobil ization</w>
mo tivation</w>
ml/ kg</w>
mir ro
min ority</w>
mild- to-moderate</w>
mil rin
microg/kg/ min</w>
mg/kg );</w>
methamphet amine,</w>
meth icillin</w>
mes olimbic</w>
mes artan</w>
mer its</w>
medi um.</w>
me ,</w>
mas s,</w>
malai se,</w>
los ing</w>
loc i</w>
lobe m
limit ations</w>
li ability</w>
leuk open
lat ency,</w>
lamivud ine,</w>
lac king.</w>
l um
kg(-1 ).</w>
kg -1.</w>
ket anserin</w>
k a
je jun
inv ari
intraperitone ally)</w>
interven tion,</w>
interac tions,</w>
inst ance</w>
insipid us,</w>
infiltr ation,</w>
inf antile</w>
indo l</w>
ind u
in ib
impair ing</w>
im p
if ied.</w>
identifi ed,</w>
id ine
ici ally</w>
hyperkal emia.</w>
hyper thyroidism.</w>
hyper plastic</w>
hyper kinetic</w>
hydro ly
hot- plate</w>
hom ogene
hind paw</w>
hemat opoi
heat -
health y,</w>
he rent</w>
he re.</w>
hazard ous</w>
haemodi alysis</w>
h arm</w>
gy naec
guan osine</w>
group ed</w>
griseofulv in</w>
glucose- 6-
gi ant</w>
gemfibro z
furosem ide-induced</w>
ful l-
frequ ently,</w>
frequ ent,</w>
four ,</w>
form ulated</w>
fluoroquinol one</w>
flav on
fl at</w>
fir st,</w>
feno fibrate</w>
f ex
f ear
f air
exist ent</w>
exencephal ic</w>
evalu ates</w>
et es</w>
establ ishment</w>
ery throm
erv ical</w>
er m
epidemio logic</w>
encoun te
en sis</w>
en il</w>
elic iting</w>
electrophysi ology</w>
electromyo graphy</w>
effor ts</w>
eff ac
ed ed</w>
ec tiveness</w>
e tra
drug- seeking</w>
dro perid
dor sol
disease- free</w>
diseas ed</w>
disc rep
dis par
diazepam -
diameter s</w>
detail s</w>
derm atitis,</w>
dem eclo
deliver y,</w>
death s,</w>
de son
dan azol
d ronedarone</w>
cyprohept adine</w>
cy sts</w>
cros ses</w>
cran io
cr ude</w>
cough ,</w>
cortic otropin-releasing</w>
convul sion.</w>
contribu tions</w>
consol id
consec u
conjunc tivi
concentr ated</w>
compli ance.</w>
complex ity</w>
complex es.</w>
complex ,</w>
complain t</w>
com pres
cocaine- kindled</w>
coca ethylene</w>
coagul ation.</w>
co st
co existing</w>
clopidogrel .</w>
cl amp
circum feren
cinacalce t</w>
chol angi
chlorpromaz ine-induced</w>
chemotherapy- naive</w>
challeng ing</w>
cep tion</w>
celecoxi b,</w>
cause s,</w>
cat ar
carrageen an</w>
carcin ogen</w>
car til
capsul e</w>
cannabin oids</w>
canc ers,</w>
cab ergoline</w>
c ue</w>
c rest</w>
bromocript ine,</w>
bre ak</w>
brady kine
bod y.</w>
bis phosph
bind ing.</w>
bim atoprost</w>
bepri dil</w>
behaviour s</w>
behavior al,</w>
be ,</w>
balloon ing</w>
autis tic</w>
atten tion.</w>
atten tion,</w>
at ing,</w>
asi a.</w>
asc icul
are sis</w>
architect ure</w>
ar s</w>
appro val</w>
applic able</w>
apne a.</w>
aper ta</w>
antioxid ant,</w>
antibio tic,</w>
anti tumour</w>
anti tuberculous</w>
anti eme
anthracyclin es.</w>
analgesic ,</w>
anaesthe tics</w>
an s,</w>
alpha 7</w>
alpha 1-
allevi ating</w>
albumin uria,</w>
akathi sia,</w>
agit ated</w>
adrenoceptor- mediated</w>
administr ation;</w>
adi pose</w>
aden ine</w>
addic tive</w>
acup uncture</w>
acromegal y</w>
accumul ate</w>
accomp any</w>
ac in.</w>
ac counts</w>
abdom en</w>
a kinesia</w>
Z P</w>
Wor ld</w>
Wh it
WB C</w>
W est</w>
V T.</w>
V AN
V ),</w>
URE :</w>
U PD
U L-
Th yro
Th i
T ardive</w>
T S
T AS
Sm all</w>
Sle ep</w>
Sec on
SC r</w>
Repor ted</w>
R T-
Pro found</w>
Post operatively,</w>
PTZ -induced</w>
PRO C
PROC ED
PRE SENT
PAC AP</w>
P D)</w>
OUT CO
OUTCO ME
O phthal
O S</w>
O CD</w>
O ),</w>
Ner ve</w>
NS F</w>
N ).</w>
N (G
N(G )-
Mo vement</w>
Mechan ical</w>
MEASURE :</w>
MA .</w>
M ac
M E</w>
Li -treated</w>
L or
Kap lan-Mei
K d</w>
K 1</w>
IT S</w>
II IN
Heal th
HPL C</w>
H :</w>
H (2)
Ger man</w>
Gentam icin</w>
G ol
Forty- five</w>
Fir st</w>
Fifty- two</w>
F urosem
F r
F ab</w>
Echocardi ography</w>
EP I</w>
ELIS A</w>
Diltiaz em</w>
Di ethyl
Det ection</w>
D yst
D os
Con gestive</w>
Cerebro spinal</w>
Cal c
CP .</w>
CG I-
CCK- 8-
C u</w>
C italop
C erebellar</w>
C D-
C CNU</w>
Behavi oural</w>
B ene
Azathiop rine</w>
Atten uation</w>
AT 1</w>
AL A-
AD .</w>
AC ,</w>
A(2A) R</w>
A uditory</w>
A ri
A part</w>
A b</w>
A F-
9. 1</w>
9 4%</w>
8 8
8 2%</w>
8 0,</w>
7 9
6 -induced</w>
524 66</w>
50 ),</w>
5-HI AA</w>
5 H-
5 6.
5 6,</w>
5 3
5 1-year-old</w>
30 ).</w>
30 ),</w>
3. 3%</w>
28 ).</w>
24 7</w>
23 2</w>
2, 4-
2 8)</w>
2 50
2 +
198 8</w>
13 1</w>
12 5,</w>
12 ),</w>
10- 20</w>
1 1),</w>
0.00 2)</w>
0.0 3),</w>
0. 25,</w>
0 2</w>
-1 00
(i. t.)</w>
(V AS)</w>
(PGE 1)</w>
(N A
(DO X)</w>
(CB F)</w>
(AN CA
(A ra-
(8 6%)</w>
(8 5</w>
(2 2.
(14 )
(1 8%)</w>
(1 7
( non
( maximum</w>
( mGluR
( inter
( after</w>
" ,</w>
yri dox
yohimb ine.</w>
yl ,</w>
wh it
we ster
wester n</w>
water- soluble</w>
war d.</w>
wall s</w>
wa reness</w>
w est</w>
w as,</w>
w ake</w>
volunte ers,</w>
vitamin osis</w>
viol ent</w>
vide o-
vi anolic</w>
ver atro
vast ating</w>
valv ulopathy</w>
us ;</w>
ursodeoxychol ate</w>
uro lithiasis</w>
up- regulated</w>
up ,</w>
unit ,</w>
under taken.</w>
unde restim
unc ular</w>
um /
u odenal</w>
two- dimensional</w>
tri ed</w>
tra in-of-four</w>
toremif ene</w>
top o
toler ability.</w>
tissu es,</w>
timo lol.</w>
timo lo
til mic
tico ag
ther mo
tetrac hlor
t -term</w>
synerg ism</w>
survi ved.</w>
sugg es
stereotyp y.</w>
sten osed</w>
steato hepatitis</w>
stain ing,</w>
sta phylococcal</w>
st able.</w>
small -
simul ated</w>
sider oblastic</w>
si veness</w>
sen sus</w>
secon d,</w>
se en,</w>
samp le.</w>
saf e.</w>
s niff
s ?</w>
rhyth ms</w>
rhyth mic</w>
reve aling</w>
resuscit ated</w>
resum ed</w>
restless ness,</w>
remoxi pride</w>
relationshi p,</w>
recurren ces</w>
re feren
re construc
qu il
qu arter
psor iasis.</w>
protein ur
prophyl ac
prop yl</w>
produc ts.</w>
proble m,</w>
prob able.</w>
previ ously,</w>
pregab alin</w>
predomin ance</w>
pre operatively</w>
pow der</w>
post- transplant</w>
pneumon ia,</w>
placebo )</w>
pilsi cainide</w>
pide mio
pi al</w>
phleb itis,</w>
phenotyp ic</w>
pert ussis</w>
per phenazine</w>
per ia
pentoxif ylline</w>
penicill amine.</w>
pemph ig
partic les</w>
parad oxic
paracetam ol.</w>
para ventricular</w>
pamid ronate</w>
pal mit
pai red-
p eptic</w>
oxantr one</w>
ox ine</w>
oto acoustic</w>
oscop ic</w>
os up
org as
or )</w>
open- angle</w>
one- half</w>
olig onucle
oli pidemic</w>
ol us</w>
off ic
ocyto sis,</w>
occul t</w>
occu pati
occl usion,</w>
obes ity,</w>
o esophageal</w>
o athe
o )</w>
numb ness</w>
nomifens ine</w>
neuro -
ner ve,</w>
nephro lithiasis.</w>
neph rectomy</w>
nafc illin</w>
n ally</w>
myosi tis.</w>
myasthen ic</w>
mus cle
morb idity.</w>
mor ic
mono amine-
mmHg ).</w>
ml/ 100</w>
mitochondri a,</w>
minoxidi l.</w>
midazol am
micrograms/ m
mi anserin</w>
mg/kg )-induced</w>
mg/d L).</w>
metrex ol</w>
methohex ital</w>
methemoglob inemia</w>
met al</w>
mesen chymal</w>
mening eal</w>
medic ally</w>
me pivaca
maxim um-
manifest ations,</w>
mandat ory</w>
magnit u
macroph ages.</w>
lo metrexol</w>
lithium /
lig and
lidoca ine-
li ved</w>
leuk openia,</w>
leu kin
leg .</w>
left- sided</w>
lansop razol
kan amycin</w>
k now</w>
iz otan</w>
itsel f,</w>
item s</w>
intub ation,</w>
interfer ing</w>
insomn ia.</w>
inform ation.</w>
infarc tion:</w>
in version</w>
in completely</w>
import ant,</w>
import ance.</w>
imipen em
il it
il -based</w>
icter ic</w>
ia ).</w>
hypox emia</w>
hypo physi
hyperplasi a.</w>
hyper phosphat
homocyste ine</w>
hist ology.</w>
hist ology,</w>
hepar in-associated</w>
hemat omas</w>
heigh ten
h id
h ence</w>
glut eth
gluco se.</w>
gluc onate</w>
gen otoxic</w>
gadodi amide</w>
ful l
fre e-
fract ures</w>
fol d.</w>
fluc loxacillin</w>
flo sequinan</w>
flecain ide.</w>
first -dose</w>
filam ents</w>
fenflur amine-
fascicul ations.</w>
facilit ating</w>
f rank</w>
f osin
f lox
f issu
ext ent,</w>
expect ancy</w>
estradi ol,</w>
essenti al.</w>
epomedi ol</w>
epide mic</w>
eosinophil s</w>
entec avir</w>
ent an</w>
endotheli um-
endocardi tis</w>
ell s</w>
electroencephalo graphy</w>
educ tal</w>
educ ation</w>
ec tions</w>
e osinophil</w>
e asy</w>
duc ts.</w>
dorsol ateral</w>
diseas e;</w>
discrimin ative</w>
dis playing</w>
diplop ia</w>
dimen sions</w>
digox in,</w>
differen ce.</w>
di l,</w>
det ection.</w>
der ly</w>
depend ed</w>
deoxychol ic</w>
deoxy glucose</w>
densi ties</w>
demograph ic,</w>
delta 9-
deline ate</w>
decreas e,</w>
de vastating</w>
datab ases</w>
dac arbazine</w>
d "</w>
cytos keletal</w>
cur ative</w>
cu e-induced</w>
cortis ol,</w>
convuls ants</w>
contrac tions.</w>
contrac ted</w>
contrac epti
consecu tively</w>
conflic ting</w>
com promising</w>
cohor t,</w>
cocaine- treated</w>
co- trimox
co- infected</w>
co vered</w>
clinic opath
cisplat in-based</w>
chromat ograph
cholester ol.</w>
children 's</w>
chec ked</w>
cess ation.</w>
cef uro
cathep sin</w>
categor ized</w>
catechol amine-induced</w>
catabol ism</w>
cas c
casc ade</w>
carb en
capac ity.</w>
candes artan</w>
c ister
but yn
bu deson
br ation</w>
bl astic</w>
bio logic</w>
beta-carbol ine-3-
beta- 1</w>
beats/ min,</w>
be hind</w>
barri er.</w>
barbitur ates</w>
b y-
b li
b end
aver age,</w>
aten olol.</w>
ate ),</w>
at om
aripiprazol e.</w>
ari s.</w>
ar ms,</w>
appl ying</w>
antipy re
antigen ,</w>
anticoagul ated</w>
angio edema,</w>
anesthe tic.</w>
anesthe tic-induced</w>
anesthe tic,</w>
an ec
an ast
amisul pri
amik acin</w>
am s</w>
alu min
alpha 2</w>
all- cause</w>
all er
alend ronate</w>
alcoh ol.</w>
al an
al .,</w>
agonist -induced</w>
age- dependent</w>
adriamyc in,</w>
adrenal ectomy</w>
administr ated</w>
aden osis</w>
ad op
act oid</w>
acet ate,</w>
accumben s.</w>
ac ri
ac in,</w>
abor tion</w>
ab ated</w>
Y ,</w>
Vas o
V ol
Ul tras
T um
T ramad
T OF</w>
Stri atal</w>
St ar
Specific ally,</w>
Spec ific</w>
Shor t-term</w>
Sevent y</w>
SER CA
S- adenos
S (+)-
Rest ing</w>
Relationshi p</w>
R ing
R I</w>
Qu inine</w>
Progres sive</w>
Plac e
PP E</w>
PN D</w>
PG s</w>
PC P</w>
PA NS
PA F</w>
P uromycin</w>
P -treated</w>
Ouab ain</w>
O LT</w>
O D</w>
O CT</w>
Norm al</w>
NT E</w>
My ocardi
Mod ulation</w>
Minocycl ine</w>
Micro scopic</w>
Mechan ism</w>
Man ia</w>
MR I.</w>
M rp2</w>
M odi
M ex
M en
M N</w>
M IT
M C</w>
M C
Lov astatin</w>
LT ,</w>
LP S</w>
LD L-
L ind
L E)</w>
K 2</w>
J .</w>
Investig ations</w>
Intra operative</w>
Individ ual</w>
In j
In dependent</w>
Identi fication</w>
IV -
IL- 1</w>
I P),</w>
I :</w>
Hypoten sive</w>
Hyp onat
HIV /
HC Q</w>
HA ART</w>
H ex
H R,</w>
H A)</w>
GR 13
GR13 89
GABA- ergic</w>
G GT</w>
Forty- two</w>
F B
Experi ence</w>
Eth anol</w>
Eth ambut
Estro gen
Engl ish
Electro encephalo
EM LA</w>
E pidemio
E ligible</w>
E .
Double-bl ind</w>
Dig oxin</w>
Diab etes</w>
Di etary</w>
DTI C</w>
DNA .</w>
DE N</w>
Cor relation</w>
CON TE
CH F,</w>
CF R</w>
C er
C elec
C are</w>
C B</w>
BP C</w>
B ro
B raz
B ic
B en
Ari pi
An ticoag
Amphet amine</w>
Amiodar one-induced</w>
AM L</w>
A wareness</w>
9. 6</w>
9 3%</w>
7. 9</w>
7 5,</w>
7 4%</w>
6- keto-
6 6-year-old</w>
6 6-
6 4
6 -</w>
5-amin osalicylic</w>
4 8-year-old</w>
4 5-
30 %,</w>
3 00,</w>
200 5</w>
200 4.</w>
200 3,</w>
200 2.</w>
20- year-old</w>
20 ),</w>
2- h</w>
2 1),</w>
198 7</w>
17 2</w>
15 1</w>
15 /
14 ).</w>
13 ),</w>
12- month</w>
12 /
11 %,</w>
10- fold</w>
10(- 9)</w>
10(- 6)</w>
10 ;</w>
1 1/
1 -10</w>
00 0
0. 3%</w>
0. 11</w>
. ;</w>
-to- beat</w>
-1 5</w>
-1 1</w>
(control )</w>
(WK Y)</w>
(S OD)</w>
(P O
(P =</w>
(NSCL C).</w>
(N D
(M C
(L-NAME )</w>
(L DH
(IN R)</w>
(C T
(C )</w>
(A V)</w>
(7 0%)</w>
(6- OHD
(6 0%)</w>
(5 8%)</w>
(3 8.
(2 9</w>
(1 9.
(1 5
(0. 3-
' ,</w>
zol e,</w>
yel low</w>
x am
wri thing</w>
withdraw n,</w>
weigh t).</w>
we re,</w>
war ning</w>
war m
w all,</w>
vulgar is</w>
vul g
viol ence</w>
vincrist ine-treated</w>
vic tim
verm ectin</w>
ver ify</w>
vect or</w>
ve in.</w>
vasoconstric tive</w>
vancom ycin.</w>
val er
vag us</w>
uro th
uro logic</w>
up ward</w>
up or</w>
unexpect edly</w>
understo od,</w>
um :</w>
ultr af
trop ane</w>
tremulo us</w>
transf usion.</w>
trans duction</w>
ti schem
ti line</w>
ti ght</w>
thromboembol ism,</w>
thromb olysis</w>
therap ies,</w>
th in
tetrahydrocannabin ol</w>
tetrac a
terbutal ine.</w>
tacrolim us,</w>
tachy arrhythmias.</w>
t ations</w>
summar ize</w>
summ ation</w>
subcutaneous ly)</w>
sub convulsant</w>
stric tly</w>
strept oz
strategi es.</w>
ster ic</w>
star ted,</w>
standard -dose</w>
st rom
st em
st age.</w>
spin al-
sph ing
spec ified</w>
spas ticity</w>
spas m.</w>
sp ind
somn ambul
sleep ,</w>
sion ).</w>
single-bl ind,</w>
similar ,</w>
si ll
sex -matched</w>
ses sion.</w>
serocon ver
sequ entially</w>
self- limited</w>
sc ol
scol io
sar alas
s ent</w>
ro flu
rifamp icin.</w>
reversib ly</w>
reticul ata</w>
responder s.</w>
resol u
res sion</w>
regurgit ation,</w>
rect us</w>
record ings.</w>
pyruv ate</w>
pyri mid
pul sed</w>
pul se
psychostimul ant</w>
propyl ene</w>
prim ed</w>
premat urely</w>
precur s
pre pulse</w>
post marketing</w>
posi tive
pl au
phosphoinositi de</w>
phosph ate-
phenylbut az
phen cycl
ph ere</w>
perfor ation</w>
per oneal</w>
pepti dergic</w>
pem oline</w>
patient ).</w>
parval bumin</w>
parathyro id
param etric</w>
paraly sis,</w>
palpit ations</w>
pac ing.</w>
p. m.</w>
p ame
ox o
ox ide
ox amine.</w>
oti tis</w>
ot olaryng
orig in,</w>
organ isms</w>
or n
opioid s,</w>
one /
on azole.</w>
om es.</w>
ol l
ol d.</w>
off set</w>
od ular</w>
occur s.</w>
occup ancy</w>
occa sions,</w>
ob ac
o s</w>
num er
not ed,</w>
nit rates</w>
nigra .</w>
nigra ,</w>
neuron es</w>
ner 's</w>
necess ity</w>
ne fazod
nat ure.</w>
naprox en,</w>
n ad
myocardi tis,</w>
myel in
mus ,</w>
mucos a.</w>
monitore d,</w>
modi um</w>
mod al</w>
moc lobem
mm ,</w>
mm )</w>
ml/ min,</w>
micro vesicular</w>
mg/d L)</w>
methyl ation</w>
met am
mer captop
mechan o-
measure ments,</w>
mar k</w>
man n</w>
main tained.</w>
mac aqu
mGlu R</w>
mEq/ L.</w>
m s)</w>
m ist
m Glu</w>
m ;</w>
low- osmolar</w>
low- molecular-weight</w>
low- grade</w>
lor acar
lo op
ll ect
levo thyroxine</w>
lep ir
labell ing</w>
lab our
l a
j ud
iti n</w>
isom erase</w>
irrit ability,</w>
ion ized</w>
involve ment,</w>
intub ated</w>
intran e
intermit tently</w>
interleuk in</w>
ine mic</w>
index .</w>
ind ole
incontin ence.</w>
include d:</w>
in- 2-
in s
in osine</w>
implic ating</w>
immun omodul
ime l
imag es.</w>
ile um</w>
ide a</w>
ide -treated</w>
hyperparathyroidis m.</w>
hyper ton
hyper polar
hyper glycemic</w>
hyper coagul
hormon es.</w>
hi m</w>
hex y
hex idine</w>
hemo static</w>
hand -
ha ir
h in
h and.</w>
h ;</w>
great er.</w>
glutathi one,</w>
glomerul us</w>
gener ation,</w>
gall -
g/m 2/
g az
g ate</w>
fur azol
four .</w>
fo rensic</w>
flu id,</w>
fiel d.</w>
fi ed.</w>
fe ar</w>
favor ably</w>
fav our</w>
far ,</w>
famili ar</w>
famil ies</w>
fair ly</w>
ey es,</w>
exc ret
examin ations.</w>
ex ud
ex pon
ethyl ]-
ethinylo estradiol</w>
ethinylestradi ol</w>
estim ating</w>
ery the
epirub ic
ep tive</w>
ep s</w>
end or
encephal y</w>
en ec
empt ying</w>
electrophore sis</w>
electrocardio graphy</w>
effect s;</w>
effect s:</w>
ec tr
each ).</w>
dyses thesia</w>
dy l</w>
drug ;</w>
dro ple
drain age</w>
doxorubic in/
double-bl inded,</w>
dop amin
dom ains</w>
diure tics,</w>
disorient ation</w>
discharg es.</w>
dis charge
dis cer
differen ce,</w>
di um</w>
detect ed,</w>
des at
dermatomyosi tis</w>
degener ating</w>
defic it.</w>
deep -
dec lining</w>
dec ay</w>
de pot</w>
de ad</w>
dam ental</w>
dam ages</w>
d ine,</w>
d ated</w>
cyclospor ine.</w>
cyclo -
cut ane
cross- reactivity</w>
cros sed</w>
coun ted</w>
cor respond</w>
conveni ent</w>
consider ations</w>
consi st</w>
conjunctiv al</w>
conf usional</w>
conduc t</w>
concer ned</w>
complain ts.</w>
compens ate</w>
commun ity-
combin ations.</w>
com at
clo su
clin ics</w>
cl es.</w>
cis- RA</w>
chlor phenir
chlor ide.</w>
childho od.</w>
chem opre
character ized.</w>
ch ing,</w>
ch ance</w>
cent ro
cent ers.</w>
cef am
cefam and
cataly tic</w>
cardio vascular,</w>
car mo
ca val</w>
c ages</w>
bromocript ine-induced</w>
bo x</w>
ble ph
bl ac
bin ant</w>
bi us</w>
beta- CC
benzo [
bend roflu
beg in</w>
be zafib
be long
be l
bal ance,</w>
autoph ag
auth or</w>
ate ;</w>
atax ic</w>
astemiz ole</w>
ari um</w>
ara- C</w>
ar in</w>
apparat us</w>
ano rec
ane )</w>
analy ses,</w>
an k
alpha-methyl dopa.</w>
allevi ation</w>
al oxif
al c
aggres sion</w>
after load</w>
after discharge</w>
adv ance
addres sed</w>
addic ts.</w>
ad duct</w>
acti ve.</w>
acromegal y.</w>
ac compl
ac cess
abrupt ly</w>
a prot
a PT
[ CI,</w>
Z R</w>
Y .</w>
Wil c
W R-27
V ir
V inorelbine</w>
V CM
U nified</w>
Trimeth op
Toxic ities</w>
Tourette 's</w>
TE )</w>
TD P</w>
Stat es,</w>
St ress</w>
Shor tly</w>
SSR I
SCH 23390</w>
S um
Rem ifentan
Reg ist
Recom binant</w>
Rec ently</w>
R at</w>
R )-
Q R
Q ,</w>
Propylthio uracil</w>
Pro cain
Pre dn
Post mortem</w>
Phenyl propan
Path ological</w>
PRESENT ATION:</w>
PO 2</w>
PE G-
P- glycoprotein</w>
P T</w>
P -1
Ol der</w>
O (2)</w>
Nim esul
Na+, K(+)-ATPase</w>
N is
Min im
MATERI AL</w>
M er
Line zol
LVF X</w>
LM W
L-argin ine,</w>
L DA</w>
Kaplan-Mei er</w>
K CC
Isoniaz id</w>
Indin avir</w>
Increas e</w>
Im pair
IN )</w>
IL-1 beta</w>
IGF -1</w>
Hist ologically,</w>
Hippocamp al</w>
Haemo dynamic</w>
H T)</w>
H 3</w>
GABA (B)</w>
G c-
Flecain ide</w>
FK50 6.</w>
FANF T</w>
Euro pe</w>
En dom
El ectr
EC )</w>
E S
Diclofen ac</w>
Detail ed</w>
Delta 9-
De mo
D- 2</w>
Criter ia</w>
Col l
Coca ine-associated</w>
Coc E</w>
Co omb
Character ization</w>
Cat ech
Carbo platin</w>
Carbamazep ine-induced</w>
CS F)</w>
CONTE X
CN I</w>
CA D.</w>
C ;</w>
B y
B up
B le
B art
Analy ses</w>
An algesic</w>
Ag e,</w>
AZT -treated</w>
AS ).</w>
AR B</w>
AN OV
AL A</w>
AD P</w>
A v
9 2
8 th</w>
8 %;</w>
7 7-year-old</w>
7 3
6- di
6 6
6 5-
59 4</w>
50 %)</w>
5-HT (2)</w>
5- di
5 4.
5 %;</w>
4- 6</w>
4 7,</w>
4 5.
4 4-year-old</w>
3. 3%)</w>
3- mercapto
3 ',
25 6</w>
200 7,</w>
200 6.</w>
200 5.</w>
2- 5</w>
2 8-year-old</w>
2 7-
2 15</w>
19 1</w>
19 0</w>
17 1</w>
15 9</w>
14 th</w>
14 3</w>
13 .</w>
12 7</w>
11 ;</w>
1. 3-
1. 2-
1. 2%</w>
1 50,</w>
1 3-year-old</w>
1 0.0
0.05 );</w>
0.00 1);</w>
0. 45</w>
-1. 5</w>
-1 H-
-1 ;</w>
-1 8</w>
- 2-
(W H
(T T
(T P
(R )-
(PGE 2)</w>
(P< 0.001)</w>
(METH )</w>
(MD A)</w>
(L ID)</w>
(L ID
(IC 50</w>
(I P)</w>
(HU S)</w>
(HBs Ag)</w>
(HBe Ag
(G B
(G -
(D B
(CB Z)</w>
(A V
(50 ,</w>
(5. 0</w>
(5- 20</w>
(4 5%)</w>
(3 6</w>
(2 /
(1 25</w>
(1 0,</w>
(1 %)</w>
(0.0 3</w>
(0. 75</w>
( within</w>
% ])</w>
z ones</w>
ylestradi ol</w>
y rate</w>
weak er</w>
wal k</w>
w ol
w k,</w>
w av
voric onazole</w>
vis it.</w>
vehic le-
ve ;</w>
vasopress in.</w>
vasodilat or,</w>
v ine</w>
us -related</w>
urticar ia/
uro theli
ur ium</w>
uniform ly</w>
un ipolar</w>
ultras onic</w>
uc to
tu be.</w>
tro methamine</w>
tric ycl
tre tin
transi ent.</w>
tran quil
tox ins</w>
tor r</w>
ton 's</w>
to- severe</w>
time- course</w>
tigm ine,</w>
ticlop idine.</w>
ti ag
thio l</w>
the ade
th en,</w>
th emia</w>
ter t-
ter g
ten ance</w>
tel mis
te le
te ar</w>
tax ane</w>
tar tr
tachycardi c</w>
t es
t ;</w>
syst ole</w>
sulf oxide</w>
sugges tions</w>
streptoz oc
step- through</w>
spon dy
spi perone</w>
speech ,</w>
speci al
sp ect
sli t</w>
six teen</w>
situ ation.</w>
sirolim us-
sign alling</w>
sic k</w>
shrin kage</w>
shoul der</w>
shar ply</w>
ser ving</w>
ser ological</w>
sed -
scop y.</w>
sclero sis,</w>
scler osing</w>
sc an.</w>
satur ated</w>
satis fac
s kele
s gk1
rot ational</w>
ris o
ribavir in,</w>
rib onucle
reticulo cyte</w>
rest oring</w>
responsi ven
relie f.</w>
rel ations</w>
reci pit
rec ently,</w>
ras h.</w>
rar a</w>
radiolab eled</w>
radioimmuno assay</w>
rac em
rabb its,</w>
quetiap ine,</w>
quadri ple
pyridox al</w>
py el
pyel oneph
py e
pur inergic</w>
pul mon
pseudo ephedrine</w>
promis ed</w>
prolact in-
prolact in,</w>
produc ts,</w>
proces ses,</w>
proced ures,</w>
priv an</w>
pres ently</w>
prece de</w>
pre therapy</w>
prac tical</w>
pr o</w>
possib le,</w>
poly cy
plate a
piroxic am</w>
pin prick</w>
pic a</w>
perio d
perc enti
per iden</w>
peop le.</w>
pent agastr
pe liosis</w>
paralle l,</w>
par tum
paper ,</w>
paired- pulse</w>
pacemak er.</w>
p.o .).</w>
p 24</w>
oxy butyn
ox azepam</w>
over active</w>
oton ia</w>
osi 's</w>
orrh ag
or phenad
ong st</w>
oneuro tic</w>
omyc in-induced</w>
omon as</w>
obser ve
o sid
o pathy.</w>
nutri tion</w>
numb er,</w>
nucleoti des</w>
nortript yl
non convulsive</w>
nocicept or</w>
nocicep tion.</w>
nmol ),</w>
nitrofur anto
ng/m L,</w>
neurotransmis sion.</w>
neurolep tics,</w>
neuro developmental</w>
nel fin
necess ary,</w>
nec k,</w>
ne y</w>
nalbu phine</w>
n- 3</w>
n ation
myelosuppres sion.</w>
minut e)</w>
mini ature</w>
min i-
mill ilit
mil k</w>
mil k-alkali</w>
midazol am-induced</w>
microgram/ ml</w>
micro injected</w>
micro g.</w>
micro circulation</w>
mi befradi
mg/ min</w>
mg/ m</w>
method s,</w>
methad one,</w>
meth im
mes o
meperid ine,</w>
men orrhag
mediast inal</w>
medi um
me g
me dox
medox om
maximum- tolerated</w>
mariju ana</w>
main stay</w>
mac rom
mGluR 5</w>
mEq/ L)</w>
lymph oid</w>
lu k
lox y
lip id
lin es,</w>
ligh theade
lib id
leuc ocytoclastic</w>
lear ned</w>
le x</w>
le sion,</w>
l ings</w>
l essen
l es,</w>
l and</w>
kg(-1 ).
k ly</w>
iz er</w>
isoproteren ol-treated</w>
isoproteren ol-
ip ),</w>
intraperitone ally,</w>
intrad uodenal</w>
intrac ardiac</w>
interval :</w>
interac tion,</w>
inter ventricular</w>
inter leukin
inte lli
inte llect
insul in,</w>
institu tion.</w>
ing "</w>
infusion ;</w>
in noc
import antly,</w>
implic ated.</w>
implant able</w>
impl ying</w>
impair ment
immobil ization</w>
imipen em</w>
il )</w>
ifen sive</w>
id arubicin</w>
ic ity.</w>
ic a</w>
i. d.</w>
i gral</w>
hyponat remia,</w>
hypercholesterol emia,</w>
hyp olipidemic</w>
hydroneph ro
hour s).</w>
her ni
hemis phere</w>
he re,</w>
ham ster
haemorrh age.</w>
h aled</w>
gu ide</w>
glomeruloneph ritis,</w>
glomerul i,</w>
gli osis</w>
gener ic</w>
gener ating</w>
gen e.</w>
gaug e</w>
gar lic</w>
g odi
g ide</w>
frag ment
for sk
flu phenaz
fl atten
filam ent</w>
fic ation.</w>
fibrin olysis</w>
fenflur amine.</w>
fen bu
fatigu e.</w>
fall ing</w>
f loxacin,</w>
f ine</w>
exten ding</w>
expos ures.</w>
expl ains</w>
experi ence,</w>
exfoli ative</w>
exerci se,</w>
excret ory</w>
exc ised</w>
ex po
everolim us</w>
etomid ate,</w>
eti ology,</w>
ergot amine/
erec tions</w>
enzyme ,</w>
encephal ic</w>
ell ar</w>
eff usion,</w>
ect o
e.g .</w>
e gal
e NO
dyn es/
dro p
dose- dependent.</w>
diss ected</w>
direc tion</w>
differenti ating</w>
diagno sed,</w>
di valproex</w>
di e</w>
desmo pressin</w>
des loratadine</w>
der s.</w>
deple ting</w>
demonstr able</w>
defin ition</w>
de tail</w>
de position.</w>
de m</w>
de )</w>
dat e.</w>
dap tom
d- aspartate</w>
d- amphetamine-induced</w>
d a</w>
cyr rhiz
cu es</w>
crystall uria</w>
crav ing,</w>
coupl ing</w>
control )</w>
contra st-
contr ary</w>
continuous- infusion</w>
cong es
config uration</w>
comb ined,</w>
comat ose</w>
cogn iti
clinic ally,</w>
clind amycin</w>
cisplat in-
cis atracurium</w>
circul ation,</w>
chromos omal</w>
chore oathe
cholin omimetic</w>
cholang itis</w>
chol ine-
chlorothiaz ide</w>
chelat ing</w>
chang ed.</w>
ch on
cephalospor ins</w>
cells/ micro
cell s)</w>
ce fac
ce as
caspase- 3</w>
cardiotoxic ity:</w>
cardiom egal
carcin omas.</w>
ca ve
ca str
c ure
c ial</w>
c all</w>
bupropi on,</w>
buff er</w>
bu min
bot ulinum</w>
block age</w>
biolog ically</w>
beta- lactam</w>
beta 4</w>
benzo ate</w>
before .</w>
b es
az ithrom
az ido
autom atic</w>
atroph ic</w>
astro glial</w>
asthmatic s</w>
as )</w>
arboxyl ic</w>
aqu apor
apri de</w>
approxim ate</w>
applic ations</w>
appl ied.</w>
apar t.</w>
antigen -positive</w>
anticonvuls ants.</w>
analy z
ana emia.</w>
ana emia,</w>
an uria</w>
an hydr
an :</w>
an -treated</w>
aminoglyco sides</w>
amide )</w>
am ongst</w>
al istic</w>
agne tic</w>
agit tal</w>
advoc ated</w>
administr ation:</w>
adap tation</w>
acut e-
acne .</w>
acid :</w>
acetam ,</w>
access ory</w>
accent uated</w>
absor ption,</w>
a i</w>
W ol
Unex pect
Tre ated</w>
Thrombo sis</w>
Thirty- seven</w>
Testo sterone</w>
Test s</w>
Tem por
Td p</w>
TB I</w>
T NS
Seventy- five</w>
Se x</w>
ST S</w>
SN P-induced</w>
SIAD H.</w>
SH R,</w>
SE LEC
S wit
S NA
Reg istry</w>
Recom m
RV LM</w>
R ech
R apam
R aloxif
R U
R AMP
Pseud otumor</w>
Propylthio uracil-induced</w>
Plas modium</w>
Pilocar pine-induced</w>
Pent azoc
PTHr P</w>
PG F2</w>
PE .</w>
P an
P MS
P DA</w>
P B,</w>
P 400</w>
Otot oxicity</w>
Or g</w>
O T
Non steroidal</w>
Nitroprus side</w>
Neuro pathy</w>
Neur onal</w>
Na+ ,</w>
NT 69
NSAID s,</w>
NR H</w>
Myelo suppression</w>
Min or</w>
Micro injection</w>
Metoclop ramide</w>
Medic ines</w>
Man nit
Main tenance</w>
MA MP</w>
M en</w>
Long- Evans</w>
Lif e-
Le vetiracetam</w>
LI D
L- NOAR
L s</w>
L R
Kap osi's</w>
Inter view</w>
Individ u
In stead,</w>
Immun osup
IC 50</w>
Hor mon
High -
Here in</w>
He modi
HIT T</w>
HD ).</w>
Guillain- Barr</w>
Gc- globulin</w>
G d-
G al
Fran ce</w>
Fluoro -J
F orm
F ib
F K-
F F
English -
English- language</w>
Electrocardio graphic</w>
El derly</w>
Echocardi ographic</w>
EC T</w>
EC S</w>
E 2-induced</w>
Dose- response</w>
Disor ders</w>
DOX ,</w>
DMT U</w>
DE NA</w>
D MI</w>
Cy A</w>
Con ventional</w>
Coch ran
Co administration</w>
CONTEX T:</w>
CK- MB</w>
C- fiber</w>
C MR
C Cl
Bup ren
B reast</w>
B F
B ),</w>
Alzheim er</w>
Al most</w>
Al fentanil</w>
AM CA</w>
ADR -treated</w>
AD E</w>
AC E-
AC -
AB R</w>
= .
9. 9</w>
8 7%</w>
7. 6</w>
7. 5,</w>
7. 5%</w>
7-nitroinda zole</w>
7- OH-
7 1-year-old</w>
6- TG</w>
6 J</w>
6 3
5-azacy tidine</w>
40 %,</w>
4- year</w>
4- 5</w>
3 ]</w>
3 2-
29 ).</w>
28- day</w>
21- day</w>
200 7.</w>
200 2,</w>
2 60</w>
2 16</w>
16 8</w>
15 .</w>
15 %,</w>
14- day</w>
14 8</w>
14 1</w>
10 ,000</w>
10 (6)</w>
10 (3)/
1. 0-
1, 3-
0.000 1</w>
0.000 0
0. 24</w>
0. 2,</w>
.0 5),</w>
-1 3</w>
- square</w>
, 11-
(control ),</w>
(TB AR
(T GF-
(PT U)</w>
(P )</w>
(O R)</w>
(NSCL C)</w>
(NS AI
(M K-80
(E SR
(CO X)</w>
(B M
(A DH
(9 0%)</w>
(9 /
(5 3%)</w>
(5 ,
(4 8</w>
(4 /
(3 8%)</w>
(3 5.
(3 5%)</w>
(3 3</w>
(3 1%)</w>
(3 0-
(1. 2</w>
(1 0)</w>
(0.1- 1</w>
( peak</w>
( measured</w>
( h
( J
( 90</w>
zol mitript
z otoc
yr ,</w>
youn g
yn ic</w>
yl)- 2-
y "</w>
women ;</w>
war nings</w>
w iden
voltage- dependent</w>
viv o
veratro l</w>
ver -
vasculat ure.</w>
v il
university- affiliated</w>
un premedicated</w>
un g</w>
ultra -
ulcer ogenic</w>
ul i
u gh
trimeth adi
tr y</w>
tob ac
tinnit us.</w>
thy ron
the less</w>
thalidom ide,</w>
thalas semia</w>
ten ds</w>
teg mental</w>
te li
tail- cuff</w>
surger y:</w>
sulphasalaz ine.</w>
struct ure.</w>
strong est</w>
stri k
strik ingly</w>
st ents</w>
spir al</w>
sorafen ib</w>
sor ption</w>
sl ice</w>
single- photon</w>
sing le,</w>
sensitiz ing</w>
see k</w>
second- degree</w>
schedul es.</w>
sal ine)</w>
s.go v</w>
rul line</w>
rosu vastatin</w>
ro und</w>
ro lip
rolip ram</w>
ril men
rifamp icin-induced</w>
ri bo
revascular ization</w>
ret initis</w>
ret ard</w>
reser ve.</w>
reser pine.</w>
res our
res ected</w>
reproduc ibility</w>
repor t:</w>
removal .</w>
rejec tion,</w>
regul ation,</w>
ref rac
recover ing</w>
recogn izing</w>
rec ent
reat er</w>
reas ses
raz ox
ran spor
rami pri
r t
r d
quin ine.</w>
quin idine.</w>
qu ater
putam en,</w>
pup ils</w>
pt osis</w>
psori atic
procain amide-induced</w>
proble matic</w>
pro line</w>
pro jection</w>
pro grams</w>
preser ve</w>
pres cho
prefer able</w>
predic ts</w>
pr amine-induced</w>
poten c
potassi um.</w>
post ul
polyp eptide</w>
point s,</w>
pod ocytes.</w>
po )</w>
platele ts.</w>
platea u</w>
placebo ;</w>
piv otal</w>
pimoz ide,</w>
picardi al</w>
pi thelial</w>
physici ans.</w>
phosphor yl
phospholip ase</w>
phenomen a.</w>
phen procou
phen idate</w>
pharmacokine tics.</w>
pharmacokine tics,</w>
peria qu
pentobarbit al,</w>
patient s);</w>
paresthesi as</w>
pancre atitis,</w>
paclitaxel -
pa rous</w>
oxy acetic</w>
ox ime</w>
out- patients</w>
oun ds</w>
ouabain -treated</w>
ou pl
ot op
oste ogenic</w>
oscop y.</w>
osar coma.</w>
os ulf
opath ology</w>
one 's</w>
on ov
on )</w>
om er
ol mesartan</w>
od en
ocy anine</w>
ocor tical</w>
occa sions.</w>
oc arb
obstruc tion,</w>
obst etric</w>
observ ations.</w>
ob io
ob enz
o urinary</w>
o therapy</w>
non human</w>
non diabetic</w>
non depolarizing</w>
noc ifensive</w>
no ise</w>
nit rate/
nicardi pine-induced</w>
neuro imaging</w>
ne tilmic
n g.
multivari able</w>
more over,</w>
modul ators</w>
mo ti
mit omycin-
mis sed</w>
mid brain</w>
microsph eres</w>
micrograms/ kg),</w>
microgli a</w>
micro tubule</w>
micro g.
mic rom</w>
mg/kg/ min</w>
mg/d L),</w>
methylenedioxy methamphetamine</w>
methad one-induced</w>
meth oc
meth iodide</w>
meth ach
metabolit e.</w>
mesn a,</w>
men )</w>
membran e,</w>
mefen amic</w>
max ,</w>
mas seter</w>
manifest s</w>
manage able</w>
mal ari
magnesi um,</w>
macroph ages,</w>
m s).</w>
m mol</w>
lymph aden
lun g
loz enge</w>
lor azepam.</w>
liter )</w>
lin kage</w>
lignoca ine.</w>
li p</w>
levonorgest rel</w>
le )</w>
lac ks</w>
l ine.</w>
l ick
ke ep</w>
ke d,</w>
ka olin</w>
ist os
isol ation</w>
is th
is let</w>
intrac aver
insectic ide</w>
injur ious</w>
inf ant
ind ocyanine</w>
in yl</w>
in operable</w>
in herent</w>
implic ation</w>
immun ity</w>
illnes ses</w>
idi l</w>
id ity,</w>
ia c</w>
hyste rectomy</w>
hypothe sis.</w>
hypothalamic- pituitary-adrenal</w>
hypo plastic</w>
hypo kine
hous ed</w>
hour ,</w>
homeost asis.</w>
her pes</w>
hepat obiliary</w>
hem olysis,</w>
hem ip
he rence</w>
harve sted</w>
haemo globin</w>
h app
h ands</w>
gynaec ological</w>
guinea- pig</w>
gu t</w>
granulo cy
glyco gen</w>
gam bling</w>
gall- bladder</w>
gal ant
g ases</w>
further ,</w>
fun damental</w>
fore ign</w>
flumazen il.</w>
fibro blast</w>
fib rom
ff- Parkinson
ff-Parkinson -
ff-Parkinson- White</w>
fet uses.</w>
fenol dop
failure ;</w>
extub ation</w>
exist .</w>
exacerb ations</w>
ex chang
evol ved</w>
ev ul
ethan ol,</w>
estrogen ,</w>
es sively</w>
es '</w>
epitheli um.</w>
episo de,</w>
ep ing</w>
enzyme .</w>
entor ial</w>
ent ering</w>
en graf
en comp
employ ed.</w>
eme sis.</w>
embryo pathy</w>
elev ate</w>
electrocardio gram,</w>
el se
each ,</w>
e- like</w>
e ye
e y</w>
e tretin
e ther</w>
e ligible.</w>
e h
e b
dysrhyth mic</w>
dysp ep
dysarth ria,</w>
dys plasia.</w>
dys lipide
doxorubic in-related</w>
down ward</w>
dom perid
dom inal</w>
disorient ation,</w>
dis col
dis ability.</w>
dimin ishing</w>
differen tly</w>
dideoxy cytidine</w>
detect able.</w>
destruc tive</w>
day s'</w>
dap son
dail y).</w>
cyto static</w>
cyt es,</w>
cutane a</w>
cot ranspor
cortico striatal</w>
correc tly</w>
correc ted
corp uscular</w>
cor on
control le
con vol
commer cial</w>
cogn i
co infected</w>
co incident</w>
clox acillin</w>
chlorpromaz ine,</w>
chlor al
chi ef</w>
chemoconvul s
cerebell um,</w>
cer amide</w>
cent res</w>
cell ular
ceftriax one.</w>
cefazol in</w>
cardiomyo path
carboxyl ic</w>
carbon ate.</w>
carbamazep ine-induced</w>
carb onic</w>
bru ising</w>
bodi es,</w>
block er
bleed s</w>
ble omycin,</w>
bio logy</w>
bicucull ine-induced</w>
bi guan
bi ge
ber g</w>
barri er,</w>
baclofen ,</w>
ba ical
autoph agic</w>
aut osomal</w>
ate -dose</w>
ate -dependent</w>
at ors,</w>
as /
arthralgi as</w>
arthralg ia,</w>
arth ri
arterios us.</w>
ar is</w>
apne a,</w>
antiretro vir
anti- emetic</w>
anti malari
anti arrhyth
antagon ism.</w>
ant op
anne xin</w>
anim al.</w>
androgen s</w>
andro genic</w>
amygdal a-
ampl ified</w>
amelior ating</w>
altern atives</w>
alpha, beta-
alpha 2
aller gi
adv ise</w>
adi pon
aden oma.</w>
acr ynic</w>
acid- base</w>
acid s.</w>
abs ent.</w>
[ n</w>
[ corrected
Wil m
U ),</w>
Toge ther</w>
TT P</w>
TI MI</w>
T MP</w>
Sin us</w>
ST- T</w>
SN C
SD ).</w>
S ide-
S ci
S 9
Ris perid
Rec ur
RE M</w>
RB F</w>
R s)</w>
R ep
R S)</w>
Quin idine</w>
Qu eti
QT- prolonging</w>
Pseud omonas</w>
Pre ventive</w>
Potenti ation</w>
Pic rotox
PT )</w>
PL D</w>
P ap
P W
P P</w>
P IIIN
P CO2</w>
Op tim
Octre otide</w>
O m
Nine ty</w>
Nim odipine</w>
Ne w
Na+ -
Na -
NT -
NS ,</w>
NO S
NM S.</w>
NA G</w>
N2 O</w>
N-acetyl- beta-D-
N Y
N ,
MR S</w>
MA O</w>
MA O-
MA C</w>
M n
M K</w>
M 5</w>
M -1</w>
Lim ited</w>
Lew y</w>
LI D.</w>
L- carnitine</w>
L H-
L 6</w>
L 1</w>
K now
In voluntary</w>
Impair ment</w>
Im pact</w>
Ig E</w>
IT B</w>
I ]
I E
Hypercal cemia</w>
Hyper algesia</w>
Ha emat
HR T</w>
HLA- DR
HET E</w>
HAM- D</w>
H U</w>
H B</w>
H 2-
Gener alized</w>
GABA B</w>
G reater</w>
G re
Fish er</w>
FK50 6-
F olic</w>
Etom idate</w>
E(2)17 G</w>
E K
E (2)</w>
Dose- limiting</w>
Di privan</w>
De si
De f
DSM-III- R</w>
D s)</w>
D Y
D -1</w>
Creat inine</w>
Con version</w>
Con cer
Compar isons</w>
Ch E</w>
CT A</w>
CM .</w>
CI =
CA ,</w>
C57B l/
C ros
C hi
C ana
C CB
Bor tezom
BoNT /A</w>
Bcl -
B io
B ay</w>
B aro
B :</w>
Ar rhyth
Ant agonism</w>
Anesthesi ologists</w>
Am p
Alco hol</w>
Ab dominal</w>
ATP- sensitive</w>
AN F</w>
AB P</w>
A udi
A ten
A TIONS:</w>
A PD
A AF</w>
A (1)</w>
9 5
8 97</w>
6- fold</w>
6 6.
6 5
5 5.
5 5-
48- hour</w>
4 4.
4 20</w>
39 ,</w>
3. 9
3. 8%</w>
3. 0,</w>
3 5)</w>
3 40</w>
3 000</w>
2339 0,</w>
23 %,</w>
200 6,</w>
2. 4
2 7)</w>
2 6)</w>
2 28</w>
2 1.</w>
199 1</w>
18 3</w>
16 2</w>
15-1 788</w>
15 55</w>
14 7</w>
14 6</w>
13 7</w>
13 4</w>
125 I-
12- year-old</w>
10- year-old</w>
10- day</w>
10(9)/ L</w>
1. 1-
1 13
1 1-year-old</w>
1 0.9</w>
1 0.6</w>
1 0.2</w>
0.00 8).</w>
0. 22</w>
0. 18</w>
0. 12
-1. 0</w>
-1, 2-
-1 4</w>
- A</w>
- 4-
- -</w>
(W T)</w>
(V i
(ST Z)</w>
(S M
(S ):</w>
(P N
(M P
(L AD)</w>
(HBs Ag
(H V
(D N
(D D
(CH F).</w>
(C y
(Ad riam
(A RF
(8 5%)</w>
(6 3%)</w>
(5 2.
(3 9%)</w>
(3 7%)</w>
(2 0%</w>
(100 %</w>
(1-1 3)</w>
(1 9</w>
( increased</w>
( incidence</w>
y ol
xam oterol</w>
writ ten</w>
where by</w>
week ly,</w>
wat er,</w>
w in
volume tric</w>
vol ar</w>
vir us-
vesi cles</w>
ver s
vasodil ation.</w>
vac iz
v afloxacin</w>
ush ing's</w>
us ),</w>
uro dynamic</w>
ur gency</w>
unmas ked</w>
uncerta in,</w>
un resectable</w>
un ineph
um ;</w>
ul nar</w>
ul ic</w>
ucin do
u wol
u ve
u pri
tw o.</w>
trin it
tri meta
trastuz umab</w>
transplant ,</w>
trans thoracic</w>
trans itory</w>
tramad ol,</w>
trache a</w>
tol ter
tobac co
tic s:</w>
thym us</w>
thre e,</w>
thre at</w>
though ,</w>
thir st</w>
thioper amide</w>
the ta</w>
tetra zol
territ ory</w>
terbutal ine,</w>
ter m.</w>
tacrolim us-induced</w>
ta zol
t -induced</w>
t 's</w>
symptom atic,</w>
sur pris
suppres sion,</w>
super vision</w>
sulpiri de,</w>
sulfamethox azole</w>
sulfadi azine</w>
sulf asalaz
sul ind
subst ances.</w>
sub mucosal</w>
su t
ster ior</w>
sten otic</w>
st ran
spread ing</w>
spont aneously.</w>
specimen s.</w>
spas tic</w>
spar floxacin</w>
sp ra
sp ong
sotal ol.</w>
soci o
smo ke</w>
small -dose</w>
sion -induced</w>
simul ating</w>
sh am
sep ti
self- administration,</w>
self- administer</w>
seizure -related</w>
sedi ment</w>
scopol amine,</w>
sampl es.</w>
sal vianolic</w>
s one-induced</w>
s l</w>
s av
s agittal</w>
rough ly</w>
rifamp ic
ri lu
retur ning</w>
reth ral</w>
restrain t</w>
resol ved,</w>
requ is
remoph or</w>
relap se,</w>
reinfor ced</w>
regres sion.</w>
rectom y.</w>
recipi ent.</w>
recipi ent
re produce</w>
re entry</w>
re acting</w>
rat s).</w>
ra uwol
ra c</w>
r t-
r in.</w>
r CBF</w>
quad rant</w>
pulsati le</w>
publ ished.</w>
pu st
protocol s.</w>
prophyl axis,</w>
promot ers</w>
prometh azine</w>
prog ab
proc al</w>
pro inflammatory</w>
pri ma
presum ptive</w>
present ed,</w>
pregnan olone</w>
pot ent,</w>
posses sing</w>
por t</w>
poly cystic</w>
pneumon itis</w>
plat form</w>
plant ation</w>
pl an</w>
piri de</w>
pine al
person- years</w>
periaqu eductal</w>
per oxidative</w>
pepti de,</w>
pemphig us</w>
pec uli
paw .</w>
patch y</w>
pass ed</w>
partici pat
paradig m.</w>
p.o .),</w>
p mol</w>
oxotremor ine</w>
oxi b
ox prenolol</w>
over night</w>
out bred</w>
ouabain -
organophosph or
or ally)</w>
opioid ergic</w>
on yl</w>
ometr y,</w>
omal ac
om edull
ol e-induced</w>
off '</w>
of en
oce le</w>
occur s,</w>
oc eptive</w>
ob tained,</w>
normoten sion</w>
non- pregnant</w>
non ischemic</w>
nitrosou rea</w>
ng/m L)</w>
neuropath ies.</w>
neurolog ically</w>
networ ks</w>
nerv es,</w>
nephrectom ized</w>
nalox one-induced</w>
n ical</w>
n ary</w>
myo globin</w>
myalg ia,</w>
mu tism</w>
mu mol</w>
mou se)</w>
moti f</w>
mother s.</w>
month s'</w>
mono amines</w>
moderate- to-severe</w>
mo ro
ml ),</w>
mifeprist one</w>
microgram .
mi as</w>
mg/kg/ day).</w>
mg/ 70</w>
metr y,</w>
metopro lol.</w>
methoc tramine</w>
meth i
meth azol
metast ases.</w>
meta- analysis.</w>
mes angi
mening itis,</w>
me et</w>
me -
maz indol</w>
maz e,</w>
mat ine</w>
macro li
mOsm /
m ur
lymph oma,</w>
lymph adeno
ly ).</w>
losart an.</w>
lo fex
lip ids,</w>
life- threat
li tis</w>
level s;</w>
lea ving</w>
lat ency.</w>
laparo scopic</w>
lact ate,</w>
laborator y,</w>
l- N
l es
l av
kin ase.</w>
ith m</w>
ip ).</w>
ion tophore
iod inated</w>
intra ventric
intermedi ate-
interferon- alpha</w>
inter cellular</w>
integr ation</w>
insul ts</w>
instruc ted</w>
initi ated,</w>
inhal ation.</w>
ing ).</w>
inf ective</w>
ine a</w>
induc er</w>
index es</w>
indap amide</w>
ind welling</w>
inci sion</w>
in significant</w>
immunomodul atory</w>
immunohistochemistr y.</w>
immunocom promised</w>
immunoblo tting</w>
immuno globul
im idazole</w>
il -treated</w>
if ying</w>
ide :</w>
id ine-
ic y</w>
ic ity,</w>
ic h
i as</w>
hypother mia.</w>
hypoten sion:</w>
hypo perfusion</w>
hypo glyce
hypercholesterol emia.</w>
hyperbilirub inemia</w>
hydrochlorothiaz ide.</w>
hydr ation.</w>
hist ochemistry</w>
hepati tis:</w>
hepat ocytes,</w>
hematoc rit
heighten ed</w>
health care</w>
haemorrh age,</w>
h -1</w>
gu ided</w>
granulomat osis</w>
granulo ma</w>
gran ules</w>
graf ting.</w>
gluteth imide</w>
gestod ene</w>
genit ourinary</w>
gen e,</w>
gabap ent
g/ min</w>
g/ kg)</w>
g av
g ;</w>
fund us</w>
fresh ly</w>
frag ment</w>
four- point</w>
four teen</w>
followe d.</w>
foci .</w>
foc using</w>
flut ter.</w>
flur ane-induced</w>
flu -like</w>
fatal ities</w>
fat ality</w>
fat al,</w>
famoti dine</w>
facilit atory</w>
fac e,</w>
f ut
f iltr
exter na</w>
explo red.</w>
explan ations</w>
exceed s</w>
event ual</w>
eu gen
ethan ol
et h</w>
estrogen -
erg onov
ere d.</w>
er obic</w>
epi rac</w>
epi gastric</w>
ephed rine.</w>
enter ocol
ent ally</w>
enrol led,</w>
enc ies,</w>
en sed</w>
en profylline</w>
en demic</w>
em poral</w>
electro -
eigh th</w>
effac ement</w>
ectop y</w>
ecti vely,</w>
e pl
e ase</w>
dysrhyth mia</w>
dy sur
down stream</w>
dog s)</w>
docetax el
dis plays</w>
dis odium</w>
dis cour
direc tional</w>
diphenhydram ine,</w>
dimin ution</w>
digox in-induced</w>
diaphrag matic</w>
diagnos ing</w>
dex fenfluramine,</w>
develop .</w>
deterior ation.</w>
depri ved</w>
depres s</w>
dementi a,</w>
def ined,</w>
de x</w>
day -
d ,
cytoskele ton</w>
cytos olic</w>
crav ing.</w>
cranio facial</w>
coun ting</w>
cost- effective</w>
cortic es</w>
convul sion
contra sted</w>
cons ent</w>
confirm ation</w>
conduc tion,</w>
con stituted</w>
con sensus</w>
compon ents.</w>
compli ance,</w>
complete .</w>
comple ted.</w>
colum n</w>
co- treatment</w>
co ding</w>
co d
cm ;</w>
clomi pramine.</w>
clomi phene</w>
clarithrom ycin.</w>
cis- retinoic</w>
circl ing</w>
chon dro
cho ose</w>
chlorpromaz ine.</w>
chloral ose</w>
cerv ic
cent er,</w>
catechol amines.</w>
catechol amines,</w>
catal ase,</w>
cas t</w>
carcin oid</w>
capac ity,</w>
cad aver
cadaver ic</w>
ca use,</w>
c res
c iclo
c age</w>
bri mon
body -
blun t</w>
bl ind,</w>
bicarbon ate.</w>
bic yclo
beta- hydroxylase</w>
beta- adrenoceptors</w>
ben ser
behavi ors,</w>
beat -to-beat</w>
be vaciz
bal ance.</w>
b asis,</w>
azot emia,</w>
azos in,</w>
avi an</w>
atracuri um.</w>
ation s:</w>
ate -treated</w>
asth ma,</w>
ast at
aro se</w>
argin ine-
arc ot
arachno idi
anxiety- like</w>
antidepress ant,</w>
anti phospholipid</w>
anti migraine</w>
anser in,</w>
anorec tic</w>
angi oneurotic</w>
angi itis</w>
anast om
analy sed.</w>
an y,</w>
aminoglyco side-induced</w>
am ifost
alpha 1</w>
alpha -1</w>
alopec ia,</w>
allo steric</w>
all y-induced</w>
al "</w>
again .</w>
ag ra
aeruginos a</w>
adultho od</w>
adrenal ine,</w>
addic tion,</w>
ad ec
ad ds</w>
achie vement</w>
acetyl transferase</w>
accompl ished</w>
ac ade
able ;</w>
a e)</w>
Zidov udine</w>
Z O
Z ).</w>
Yohimb ine</w>
X- A</w>
Wol ff-Parkinson-White</w>
Wilm s'</w>
W al
Ve terans</w>
Unexpect edly,</w>
U A</w>
Tw o-
Toler ability</w>
Th en</w>
Tempor ary</w>
TN S</w>
T u
T LP
T LE</w>
Syn cope</w>
Strept ococcus</w>
Statis tically</w>
Sot alol</w>
Side- effects</w>
ST AT
SR S</w>
SH Rs</w>
SH ,</w>
SC -
S mo
S ensor
S em
S e</w>
S core</w>
S P)</w>
Rib avirin</w>
Res er
Rech allenge</w>
Rec or
Re duc
Rapam ycin</w>
RA 0
R- R</w>
R y
Pseud o
Predic tors</w>
Phy sos
Pharmaco kinetics</w>
PR S</w>
PF 4</w>
P ul
P ergol
P arox
P ON
OUTCOME :</w>
O Cs</w>
Ne ural</w>
Na(+ )/
N- methyl</w>
N eu
N RA0
Myocardi tis</w>
Myo pathy</w>
Methyl phenidate</w>
MT .</w>
MP O</w>
MENT :</w>
M ZR</w>
M I,</w>
M G</w>
Leuk openia</w>
Lab et
LHR H</w>
L-NAME .</w>
Kore an</w>
Ket ocon
Imi pramine</w>
Im proved</w>
IV ).</w>
II ),</w>
I T-
HI P/
H 2-receptor</w>
Go od</w>
GS K
GABA .</w>
GA P-
G ran
G rad
Furosem ide</w>
Forty- one</w>
Fluc onazole</w>
F s</w>
F O</w>
Ev ent</w>
Epi leptic</w>
Endo thelial</w>
El ect
ER K
EE Gs</w>
ED TA</w>
EC 50</w>
E osinophil
E ar
Docetax el</w>
DP CP
DF P-induced</w>
D yn
D y
Curren tly,</w>
Concentr ations</w>
Cochran e</w>
Clin ically,</w>
Centr e</w>
Calc ineur
CS F.</w>
CO (2)</w>
CF U-
CD 8
CBD CA</w>
CB D</w>
C- reactive</w>
C lop
C .
Ble eding</w>
Bcl -2</w>
BT X-A</w>
B ut
B is
Aut o
Apop tosis</w>
Anti oxidant</w>
Ant ine
Am ne
Am lodipine</w>
Ad v
AZT -induced</w>
AT P,</w>
AR CH</w>
AO AA</w>
AM ,</w>
A symptomatic</w>
A cyclo
A K</w>
A F.</w>
= .00
9 0,</w>
8 1%</w>
7- fold</w>
7 %.</w>
6. 0
50 /
5- methyl
5 9.
4- day</w>
4, 5-
36 ).</w>
30- day</w>
30 %.</w>
3, 5-
3 3)</w>
24 3</w>
200 0.</w>
2. 3
2 1).</w>
2 '-
199 4,</w>
19 80</w>
19 4</w>
10(- 3)</w>
1- 4</w>
1 h</w>
1 20,</w>
1 0.4</w>
0.5 2</w>
0.000 5).</w>
0.000 1,</w>
0.00 4).</w>
0.0 1
0. 28</w>
0. 1-
.0 1),</w>
-10 ,11-
-1 8
- n-propyl
- drug</w>
- 7</w>
- 0.4
, S)-
+/ +</w>
)- related</w>
(p< 0.05).</w>
(S V
(S OD
(S A
(R P
(R ,S)-
(P =0.00
(NSAI D)</w>
(MA )</w>
(I D
(HBe Ag)</w>
(H b)</w>
(FK50 6)</w>
(D P
(C PK
(Adriam yc
(A SA</w>
(A F)</w>
(8 1%)</w>
(7 3%)</w>
(7 /
(50 -
(50 )=
(5 7%)</w>
(5 2%)</w>
(4- fluoro
(3 0
(3 ),</w>
(2 8%)</w>
(2 5
(1- 7)</w>
(1 6
(1 0.
(+/- )</w>
( without</w>
( gamma-
zon is
zon a</w>
zol e.</w>
y t
y 's</w>
xim al</w>
x ia</w>
world wide</w>
wor k.</w>
with ,</w>
wei gh</w>
wa y.</w>
w hi
vis it,</w>
vi gorous</w>
vi d</w>
vessel s,</w>
vecur onium.</w>
vastat in-induced</w>
vasodilat ation.</w>
vasoconstric tion,</w>
vari able.</w>
v inorelb
us ).</w>
ure ter</w>
ur ished</w>
ur ap
ur aemia</w>
under -
um ab
u y
tun nel</w>
tro glitaz
triglyceride s,</w>
tri hexy
trihexy phenid
treatment ).</w>
traz ol</w>
transp eptidase</w>
transmis sion,</w>
trans duc
toxic ity;</w>
toc olytic</w>
to uch</w>
to ols</w>
time ;</w>
ti um-
ti ous</w>
thyron ine</w>
therap y)</w>
ther to</w>
tempo l</w>
t s:</w>
t s)</w>
synchron ous</w>
sy ring
surviv ors.</w>
subst ances,</w>
str ab
stitut ed.</w>
stimul us.</w>
stat in-
st able,</w>
spinal- epidural</w>
spi king</w>
sper mat
spar te
so .</w>
smok ing.</w>
sl urred</w>
sertral ine,</w>
sel dom</w>
scrat ching</w>
scopol amine.</w>
scolio sis</w>
sci enti
scal es.</w>
sar izotan</w>
sar coma,</w>
s.c. )-induced</w>
s ound</w>
s er</w>
ru n</w>
rop ini
room .</w>
rom yo
rofecoxi b.</w>
ro le,</w>
rit od
risk- benefit</w>
rilu zole</w>
rh initis</w>
ret ina</w>
resol ving</w>
resist ance
requis ite</w>
ren oprotective</w>
recommend ation</w>
recent -onset</w>
rec ti
re tin</w>
re perfusion.</w>
rat entorial</w>
rat 's</w>
rami pril</w>
radioimmuno assay.</w>
radio activity</w>
r f
r TMS</w>
questionnai re.</w>
quater nary</w>
qu it
purpo se,</w>
pum p.</w>
pulse less</w>
psycho pathology</w>
psycho active</w>
psych opharmac
pseud o-
prob es</w>
prob enec
pri ate</w>
preser ved.</w>
prescri be</w>
prepar ation,</w>
prefer ring</w>
prednisol one.</w>
pre mixed</w>
pre conditioning</w>
pr amine,</w>
post- training</w>
posi tivity</w>
pos tischem
polymorph onuclear</w>
polycy themia</w>
pol lic
po ison</w>
physostigm ine,</w>
phot oph
phosph ate,</w>
pheochromocyt oma.</w>
phenotyp e.</w>
ph an</w>
pg/ mL</w>
pentobarbit one</w>
pent ol
penicill in-
pea ks</w>
pea king</w>
patient :</w>
path ology,</w>
pare sis.</w>
pac ked</w>
pa the
pa st
p o</w>
p ad
ouabain ,</w>
otroph ic</w>
oti fen</w>
ot e
osteomyeli tis</w>
orn ith
orig inating</w>
orbit of
or tic</w>
opportun ity</w>
ophil ic</w>
oper ant</w>
opath y,</w>
op ent
on ec
on "</w>
omeprazol e.</w>
omedull in</w>
ome ga
omat osis</w>
olo l-induced</w>
ol ution</w>
ograph ically</w>
ocyt uria</w>
och ol
occupati onal</w>
obses sive</w>
obser ver</w>
o glyc
nucle ol
noradrenal ine,</w>
no urished</w>
no otropic</w>
no des</w>
nitro tyrosine</w>
nitren dip
nicoran dil</w>
nevir ap
ne bivolol</w>
natur alistic</w>
nat ure,</w>
naprox en.</w>
n- Whit
n s.</w>
n ia,</w>
my o-
mut ation.</w>
mucosi tis,</w>
moxon idine</w>
morphine- dependent</w>
mon om
mo genic</w>
mmol/ L)</w>
mm /
ml/min/ 100</w>
mit tent</w>
minocycl ine-induced</w>
minipum ps</w>
minim al-
min(-1 ),</w>
mim ics</w>
mil lis
millis ec
migra ine,</w>
microcephal y</w>
mg/m L</w>
methyser gide</w>
methyl dopa.</w>
methicill in-resistant</w>
methamphetamine- dependent</w>
metam iz
melan oma.</w>
medic ine.</w>
medi ated.</w>
materi al.</w>
mat ch</w>
mark ers.</w>
man ia,</w>
man 's</w>
malform ations,</w>
m argin
ly tic</w>
low- risk</w>
low- protein</w>
low er,</w>
long term</w>
log- rank</w>
lo us</w>
lo r</w>
lo bul
limit ed,</w>
lig ation-induced</w>
libid o</w>
li ve
levamisol e.</w>
leuk otri
l ing,</w>
iz ations.</w>
iv ocal</w>
iti s:</w>
is ometric</w>
is ob
is ms.</w>
inv asi
intracor tical</w>
interval )</w>
integr al</w>
insidi ous</w>
inser tion.</w>
injur ies.</w>
injec tion
ingre dient</w>
ing eal</w>
ing -induced</w>
inde ed</w>
inadver tently</w>
in- sensitive</w>
in ase</w>
in appropriately</w>
im pul
il legal</w>
il ing</w>
il ic</w>
ia ),</w>
i ome
hypo glycemic</w>
hypo activity</w>
hyperprolactine mic</w>
hydroxy ure
hormon e,</w>
high -</w>
hi therto</w>
hex a
heter ozyg
he aled</w>
haloth ane
gynecomasti a</w>
guaneth idine</w>
gram s,</w>
go t</w>
gn ath
gir ls</w>
gi ves</w>
ge u
ge fit
gaz e</w>
g/ d</w>
g o</w>
furazol idone</w>
function ing,</w>
frequ ently.</w>
frequ ency
frequ encies.</w>
form oterol</w>
form al</w>
fo od-
fo etal</w>
fluoxet ine-induced</w>
flexi ble</w>
fl uroth
first- time</w>
find ing.</w>
finaster ide</w>
femal e.</w>
fe et</w>
fa il</w>
f ain
ey e,</w>
extrapol ated</w>
expl or
evul inic</w>
evol ving</w>
etopo side,</w>
etodol ac</w>
ethambut ol-induced</w>
eth al</w>
estradi ol.</w>
establ ishing</w>
ept or</w>
epilep tics</w>
epi andro
enzym ic</w>
endot ox
end arte
end ,</w>
en thix
empir ical</w>
emin ence</w>
electro cortico
ed- onset</w>
ec hi
e sis.</w>
e at
dystroph y.</w>
dysarth ria</w>
dynes/ cm
du oden
dose- dense</w>
dos ages,</w>
dog ,</w>
disopyram ide.</w>
dis ulf
dis placement</w>
dipyridamol e,</w>
dimin ishes</w>
digox in-
differenti ation.</w>
diff usion-weighted</w>
diag nose</w>
dextro amphetamine</w>
dex amphetamine</w>
dex am
dexam fet
develop s.</w>
deterior ating</w>
desi re</w>
dermat ologic</w>
deg ran
deficit /
deficit/ hyperactivity</w>
decre ment</w>
dec a
debilit ating</w>
de qu
de acetyl
day (-1)</w>
d ine-induced</w>
cyst oscopy</w>
cyclospor ine,</w>
cyclopent yl
crac k
counter acts</w>
coun ts.</w>
coun t.</w>
cor responds</w>
controversi al</w>
control s;</w>
contrac tility,</w>
constric ted</w>
confirme d.</w>
conduc tion.</w>
con curren
commis sural</w>
coll ected.</w>
co herence</w>
cm /
clozap ine-treated</w>
clon al</w>
clo sed-
clipp ing</w>
clas s.</w>
clas s,</w>
circumst ances</w>
cho w</w>
ch ori
cephal ic</w>
cefotet an</w>
caudate- putamen</w>
catarac t</w>
carbach ol-induced</w>
carbach ol,</w>
ca st
c olic</w>
c .)</w>
but yr
bur den</w>
bupivaca ine-
bul im
bu b
bronchospas m</w>
breast ,</w>
br ush
bo vine</w>
bleph aro
ble ,</w>
bis phosphonates</w>
bir th,</w>
bicalut amide</w>
bi ventricular</w>
bi periden</w>
bi ochemical,</w>
bi as</w>
beta- blockers.</w>
beta- adrenoreceptor</w>
beta- 2</w>
beta ine</w>
beta (2)-
benzoyl ecgonine</w>
benzodiazep ine,</w>
bam buterol</w>
b -
aver sive</w>
audi ometry</w>
audi ograms</w>
atr an</w>
ation s)</w>
ati pame
atherosclero sis,</w>
ather ogenic</w>
at re
assess ment,</w>
aspar tic</w>
ase- positive</w>
ascorb ate</w>
asc icular</w>
as pect
as e
art an,</w>
ari e-
arcot -M
arb ox
arabino side.</w>
ar ia</w>
aquapor in-
ap rine</w>
ap r
antipsycho tic-like</w>
antipsycho tic,</w>
antidepress ant-induced</w>
anticoagul ation,</w>
antibod y.</w>
anti- parkinsonian</w>
anti oxidative</w>
antagonist ),</w>
ant en
ant )</w>
anhydr ase</w>
aneurysm s.</w>
anaphyl actoid</w>
an oids</w>
amitriptyl ine.</w>
amine ;</w>
amine :</w>
amin ol
amant adine.</w>
alpha-methyl- p-
alpha 3</w>
all idal</w>
alg or
alfentan il.</w>
aldehy de,</w>
al t
ag en</w>
advant age
adrenocept ors,</w>
adren erg
adju v
adipon ectin</w>
addi tionally</w>
add- on</w>
adap tations</w>
acade mic</w>
ab users,</w>
a ul
[ 3-
YM 430</w>
X- ray</w>
Wee kly</w>
WR-27 21</w>
VT A</w>
V ig
V F.</w>
V CM</w>
V 2</w>
U I</w>
Trimethop rim-sulfamethox
To oth</w>
Time -
TT P/
TH E</w>
T O
T E</w>
T C
Syst em
Suc cin
Subst ance</w>
Struct ural</w>
Sch iz
ST ),</w>
SE ARCH</w>
SE ).</w>
SAM e</w>
S cre
S cop
S CN
S ;</w>
S 14
Ring er's</w>
Ri ght</w>
Recur rence</w>
Re action</w>
R at
R AL
Prolong ation</w>
Pro ximal</w>
Perio perative</w>
Pa O2</w>
PA -induced</w>
P y
P ir
P al
P ER
Ou t</w>
OA B</w>
Neuro psychiatric</w>
NSAID -induced</w>
NO ,</w>
NB QX</w>
NA S</w>
N-nitrosodiethyl amine</w>
N-methyl- d-aspartate</w>
N ov
N G</w>
N CE:</w>
Met o
MPT P-
MM C</w>
MA O
M olecular</w>
M SA</w>
Lind ane</w>
Li pos
Levo dopa</w>
Lang endor
LT ),</w>
L- dopa.</w>
L ymph
L A
K E
Intra ocular</w>
Inter mittent</w>
Inhib itory</w>
Individu als</w>
In tram
In dic
Impres sions</w>
II I/
I mat
I HD</w>
Hyper baric</w>
Hy dr
Hunting ton's</w>
Hospit al.</w>
HUS ,</w>
HBsAg -positive</w>
HBeAg -negative</w>
H Y
GA G</w>
G ab
Forty- three</w>
Fifty- four</w>
FE AT
F ast
F ascicul
F U</w>
F G</w>
Ex trac
Epi rub
Ep inephr
Endo thel
Elect romyo
EC M</w>
EC G
E rec
E phed
E N</w>
E -17
Dose -related</w>
Don epe
Do pa
DBA/2 J</w>
D2 R</w>
D er
D G
D CE</w>
D 1/
Cs A.</w>
Creat ine</w>
Cor tis
Contr ary</w>
Con di
Clop ido
Clin ical,</w>
Cl assi
Cl ar
Cl -</w>
Ch ec
Ch arcot-M
Celec oxib</w>
Ceftriax one</w>
Ce bus</w>
Cd A</w>
Cana dian</w>
CT ,</w>
CR H</w>
C ushing's</w>
C 57</w>
BoNT -A</w>
Bi opsy</w>
Benz odi
BZ D</w>
B P.</w>
B P,</w>
B MI</w>
B C</w>
B ;</w>
Appro priate</w>
An y</w>
Al b
Ace tazol
Ac tivity</w>
Ac cumulation</w>
AR F,</w>
AL )</w>
AF- DX</w>
AE D</w>
ADR +
AD R,</w>
A dequ
> =</w>
8 9.
8 ,
7 9-year-old</w>
6- thioguanine</w>
6 50</w>
6 0)</w>
50- mg</w>
5- M
5 7.
5 3,</w>
4-amin opyridine</w>
4 5)</w>
39 ).</w>
3. 6
3. 5%</w>
3-mercapto propionic</w>
3,4- D
3 6-
3 00-
3 )
23 4</w>
2- hour</w>
2- adrenoceptors</w>
2 9-
2 2).</w>
2 17
2 1
2 )
199 3,</w>
198 9</w>
198 6</w>
19 8</w>
19 80
19 5</w>
16 ),</w>
141716 A</w>
100 %,</w>
1, 6
1 20-
1 1.0</w>
1 0.3</w>
00 /
0.7 5%</w>
0.0 6
0.0 4)</w>
0.0 %</w>
0 +/-
/ P
-1 20</w>
-- -
- I</w>
) ]
(S R)</w>
(S )</w>
(R R)</w>
(P a
(P R)</w>
(N R
(N P
(N H
(N A)</w>
(MA P),</w>
(H A
(F S)</w>
(E AC
(8 00</w>
(5 6%)</w>
(5 5</w>
(3 2</w>
(3 2%)</w>
(3 /
(3 ,</w>
(2 4%</w>
(2 .0
(1 1)</w>
(0. 7</w>
(0. 5,</w>
(0. 25-
( s.c.)</w>
( patient</w>
( more</w>
( left</w>
( high</w>
( heart</w>
( difference</w>
( 50%</w>
( 0-1
z imel
yridox ine</w>
yr amine</w>
yol k</w>
ym path
year )</w>
yc in-
y aw
y al</w>
worl d</w>
work up</w>
work ers</w>
whole- body</w>
wat er
vis ited</w>
verapam il
ver theless</w>
ventric ulography</w>
ve ter
ve ins.</w>
valu e,</w>
v ular</w>
v im
uter us</w>
use ful
urticar ia,</w>
uro toxicity</w>
urg e</w>
ur ate</w>
upri ght</w>
understo od</w>
unc oupl
un treated,</w>
un predict
ulo pathy,</w>
udi l</w>
ub ital</w>
u )</w>
trypt amine</w>
tretino in</w>
treatment- resistant</w>
transfer ase,</w>
tran su
transu rethral</w>
trac ts</w>
trac tive</w>
tra vel
toler ability,</w>
to gen
tissu e-
tis h</w>
ticlop idine,</w>
ticar c
tic /
tic )</w>
thy smo
throm bi
threshol ds.</w>
th s</w>
th in</w>
th ick</w>
ten sion
ten -
teicoplan in</w>
tauro ursodeoxycholate</w>
tan dem</w>
tachy cardiac</w>
ta u</w>
t one,</w>
t apping</w>
syndrome )</w>
sympath o-
swell ing,</w>
sup rac
summ ary</w>
sumatript an,</w>
sulph on
suc h,</w>
subsequ ently,</w>
sub optimal</w>
stud y;</w>
stra ins,</w>
stra i
sti tial</w>
ster on
st y
st upor</w>
st -induced</w>
spectro metry</w>
spectro metry.</w>
specific ,</w>
sol ut
slic es.</w>
sigma (1)</w>
shock -induced</w>
sex u
sequ encing</w>
sensor y-
seizure- inducing</w>
second arily</w>
se as
scre ens</w>
scot omas</w>
sco re
scaveng er,</w>
scal ene</w>
sc en
satis factor
saline- injected</w>
s -induced</w>
run -in</w>
rt- PA</w>
rit uxim
ricket s</w>
retrospecti vely.</w>
retard ation.</w>
resp ect
resid ents</w>
rescu e.</w>
requi red,</w>
reporte dly</w>
replic ation.</w>
replac ement,</w>
relax ations</w>
reinforce ment.</w>
reg im
refrac tive</w>
recogn ized,</w>
radi ocon
rad icular</w>
quin april</w>
quarter s</w>
pur su
public ations</w>
prote oglyc
prot ective.</w>
propylthio uracil-induced</w>
prophylac tically</w>
prolong ed.</w>
program ,</w>
profoun dly</w>
prob able
pro of</w>
pro l</w>
pro convulsive</w>
preven tion.</w>
precl uded</w>
prece des</w>
pre hospital</w>
pos ing</w>
por tions</w>
poison ing,</w>
ple thysmo
plasi a,</w>
plac ing</w>
phot osensi
perman ently</w>
perm it</w>
pericardi tis.</w>
pericardi tis,</w>
perf usate</w>
pe dic
paradig ms</w>
papaver ine.</w>
pal ate,</w>
pal atal</w>
pac ing,</w>
pa in)</w>
pa di
pa d</w>
p assi
p 75
oxcarb azep
over drive</w>
ov agal</w>
ou se</w>
ot oxin</w>
ost er</w>
osmolal ity.</w>
os pinal</w>
origin ally</w>
ore x</w>
or um</w>
or al,</w>
opportun istic</w>
oplas mo
om edullary</w>
olg i</w>
ol in
occurren ces</w>
oc ent
oc al
obj ectively</w>
o estradiol</w>
o edema.</w>
non- significant</w>
nocicep tion,</w>
ng/ kg/
neurolep tic,</w>
neuro vascular</w>
neuro peptides</w>
neuro biological</w>
nephro lith
neoplas ms.</w>
necessit ate</w>
ne fir
n ac
n NOS</w>
n ;</w>
mydri asis</w>
myalg ia.</w>
multi organ</w>
mucos a,</w>
mono hydrate</w>
moi ety</w>
mode s</w>
modal ities</w>
minocycl ine.</w>
micrograms.kg-1. min-1</w>
mibefradi l</w>
mi um</w>
metoclopram ide,</w>
methylprednisol one.</w>
methylphenid ate.</w>
methyl transferase</w>
methyl glutar
mesi al</w>
mes alaz
mefloqu ine.</w>
medic ine,</w>
medi ated,</w>
mean ing
mas ked</w>
mar mo
mapro tiline</w>
male ate,</w>
mala ise</w>
mRNA .</w>
mL/ min/
mE q</w>
m mol
m ia;</w>
m ass
m Ab</w>
m ),</w>
luk ast</w>
lograph y.</w>
locomo tion.</w>
lobe .</w>
lo t
ligi bility</w>
lig ation.</w>
leth an
length ened</w>
leng th,</w>
lenal idom
le ish
leish man
l en
kallikre in</w>
k ling</w>
iz ers</w>
iterpen e</w>
isol ated,</w>
io -
intrag astric</w>
intest inal,</w>
intersti tium</w>
inter scalene</w>
inter im</w>
inter acting</w>
integr in</w>
insul in-like</w>
institu tions</w>
institu tional</w>
insp iratory</w>
inflammat ory,</w>
infiltr ating</w>
infer i
inf using</w>
inf ra
in ous</w>
in determin
in amide</w>
implic it</w>
imipr amine-induced</w>
imidaz enil</w>
ido pa
ic- tonic</w>
ic hi
i vermectin</w>
hypox ia.</w>
hypox ia,</w>
hypomagnesem ia,</w>
hypocalce mia,</w>
hypo gly
hyper sensitivity,</w>
hydroxy toluene</w>
hy ster
hour s;</w>
hol ding</w>
hexachloro cyclohex
her nia</w>
hepat omegal
hemo therapy</w>
heigh t,</w>
haloperid ol-treated</w>
haemodi lution</w>
haemat oma</w>
habit uation</w>
h os
h old</w>
guan fac
grav ity</w>
granulocy te-
go es</w>
glycos uria</w>
glybur ide</w>
glucose-6- phosphate</w>
gluc agon
gl and.</w>
gangli a.</w>
gadol inium-
g inning</w>
g ent</w>
fron t
flur azepam</w>
flest olol</w>
fl us
first- episode</w>
fibrill atory</w>
fashi on,</w>
far .</w>
fai led.</w>
extub ated</w>
extrem ities,</w>
ext ent.</w>
expect ed.</w>
ex per
evid ence
event s:</w>
eti olog
eth acrynic</w>
est er,</w>
es un
es in</w>
erythro cytes.</w>
epirub icin.</w>
epilep sy-
epididy mal</w>
environ ment.</w>
entr y.</w>
enthix ol</w>
ent ation</w>
ent )</w>
ent 's</w>
encounte red.</w>
encephal on</w>
en op
en able</w>
emis sions</w>
embry onal</w>
electro retino
electr onic</w>
edar av
dysph or
dys functions.</w>
drom ic</w>
dou bling</w>
dose- depend
dobut amine.</w>
distribu tion.</w>
disten sion</w>
disru ptive</w>
dis rupt
dis appeared,</w>
diethylstilbestro l.</w>
diaph or
di ents</w>
dex verapamil</w>
desogest rel</w>
dens ity,</w>
demyel in
del usional</w>
degre e.</w>
def ining</w>
dec lines</w>
deb riso
de :</w>
da z
cyclohex yl
cyclo- oxygenase</w>
cur ve.</w>
cult ures.</w>
cri sis.</w>
cre ate</w>
cr yo
cour ses,</w>
convol uted</w>
controver sy</w>
control s).</w>
control ).</w>
contracep tion</w>
contra st-induced</w>
contra indication</w>
conjug ate</w>
cong estion</w>
conf ocal</w>
condi tional</w>
conclu sive</w>
concent ric</w>
concent rate</w>
con i
con flu
comorbidi ties</w>
comorb idity</w>
communic ation</w>
colon y</w>
colchic ine.</w>
clobaz am</w>
clinicopath ologic</w>
clar ified.</w>
cil astatin</w>
cid ofovir</w>
choro idal</w>
chlordiazep oxide</w>
chlor alo
chill s,</w>
chemotherap y:</w>
cer tain
cell ul
cefuro xime</w>
cav a</w>
catechol amine-
carrageen an-induced</w>
cardiomyo pathic</w>
carbox amide</w>
car mustine</w>
calcium- channel</w>
c ine</w>
bypas s.</w>
but olol</w>
bumet anide</w>
bp m</w>
bos entan</w>
bol us.</w>
biomark ers</w>
bin alt
binalt orph
between- group</w>
bas ed,</w>
bacter ium</w>
b one-
b amate</w>
b abo
azot emic</w>
azathiop rine,</w>
auto antibody</w>
auth or
audi ometric</w>
ati ve-
atazana vir</w>
at ric
at or-
ascit es.</w>
artic ular</w>
arth ritic</w>
art esun
arie- Tooth</w>
ar yl</w>
ar yl
ap se</w>
antr one</w>
antipyre tic</w>
antioxid ants,</w>
anti-HB s</w>
anti tuberculosis</w>
anti fibrinolytic</w>
anten atal</w>
ant -
anem ia:</w>
anatom y</w>
anand amide</w>
ana erobic</w>
an other.</w>
an il
amygdal a.</w>
aminonucleo side.</w>
amino guanidine</w>
amide /
ameth yl
alph a.</w>
aggreg ation.</w>
ag o
ag inal</w>
ag al
adul t.</w>
adenos ine,</w>
addic ted</w>
ad ded.</w>
actin omycin</w>
act u
act s,</w>
aconit ine</w>
acetyl ated</w>
accumul ating</w>
accid ents</w>
ac tions,</w>
ac com
abecarn il</w>
ab ut
ab ri
ab ic
a prost</w>
] :</w>
X- 2)</w>
W IN
V A</w>
UPD RS</w>
Treatment -related</w>
Tramad ol</w>
Thiop ental</w>
Th rough</w>
Tac rolim
Ta q
TUNE L-
TR AC
TRAC TION:</w>
TP M</w>
TMP-SM X</w>
T ur
T l</w>
T T</w>
T M</w>
T /
Syn thesis</w>
Surg ery</w>
Secon d,</w>
SV R</w>
ST ,</w>
SN S</w>
SN HL</w>
SC T</w>
SA H.</w>
S us
S o</w>
S NA</w>
S LE</w>
S A),</w>
S 100
Res olution</w>
Repor ting</w>
Recomm end
Raniti dine</w>
Raloxif ene</w>
RE LE
RELE VAN
R ot
R R
R L
R K
R H</w>
R G
Q 10</w>
Propofol -
Prog ester
Pres ent</w>
Practi tion
Post ural</w>
Penicill amine</w>
Pe g
Path ologic</w>
Parad oxical</w>
Paracetam ol</w>
Pa ren
PT ,</w>
PIIIN P</w>
PG )</w>
PATIENT :</w>
PANS S</w>
P ;</w>
O vari
Not ably,</w>
Nephro genic</w>
Na+, K+-ATPase</w>
NT69 L</w>
NT D</w>
NO .</w>
NMDA- receptor</w>
N icardi
N et
N N
Myoclon ic</w>
MTX -induced</w>
MT X)</w>
MDMA /
M er</w>
M H
M F</w>
M F
Loc omotor</w>
Li /
Li -induced</w>
LI Ds</w>
LE ,</w>
L R</w>
L H
KE Y</w>
K- ATPase</w>
K- 3
Jap an</w>
J NK</w>
Inter stitial</w>
In jections</w>
IP ).</w>
II ).</w>
ICRF-1 8
I mag
I MA
I H
Hyponat remia</w>
His -P
Hal f</w>
HO E</w>
HIV -1-
HIT ,</w>
H all
Glut amate</w>
Ger man
Gab ap
GL EP
GLEP P1</w>
G olgi</w>
G ST-
G SP
G 6
Fos car
Flu oxet
Fascicul ations</w>
FEAT URES:</w>
F ree</w>
F am
Ep iso
Electro physiologic</w>
EX TRACTION:</w>
EMB A
EC o
E stim
E AD
E 2,</w>
E ).</w>
Di ure
Di hydro
DX R-induced</w>
DOX -treated</w>
D-penicill amine-induced</w>
D en
D PO
D I</w>
Cs A-
Cros s-
Con sec
Con genital</w>
Comp uter
Clin ic</w>
Cholest asis</w>
Chem ical</w>
Charcot-M arie-Tooth</w>
Cer tain</w>
Capecit abine</w>
Cal cit
Ca ro
CO PD</w>
CNS ,</w>
CM L</w>
CG S</w>
CG RP
CB F
CA T</w>
CA S</w>
CA ),</w>
C ou
C l.</w>
C ase-
C PAP</w>
C L</w>
C F</w>
Be ginning</w>
BZ D
B rown</w>
B iliary</w>
B ile</w>
B ay
Ap parent</w>
An alo
Amino glyco
Am mon
Altern atively,</w>
Alph a-
Adju vant</w>
AS P
AR I</w>
AP PRO
AM )</w>
AH -10
ADR- 5
AD HD.</w>
A mitript
A KI</w>
A -1</w>
A (2)</w>
> or=</w>
< 0.001).</w>
< /
8 9%</w>
7 8-year-old</w>
6- mercaptop
5-fluorourac il,</w>
5-HT(2 B)</w>
5-HT 2A</w>
5-FU ,</w>
5-1 5</w>
5 00,</w>
4. 3%</w>
4 2)</w>
39 )</w>
37 ).</w>
36 ),</w>
3. 6%</w>
3 7)</w>
3 3-
26 8</w>
25 ),</w>
25 %.</w>
24- year-old</w>
24- (OH)(2)
24 ),</w>
200 4,</w>
20 2</w>
20 1
2, 4
2 6-year-old</w>
2 50,</w>
199 9,</w>
16 %,</w>
15. 5</w>
15 7</w>
14 C-
10- min</w>
10(- 7)</w>
10 th</w>
1. 8%</w>
1. 00
1- selective</w>
1,25-dihydroxy vitamin</w>
1 0.8</w>
00 0/
0.6 9</w>
0. 40</w>
0. 27</w>
0 3</w>
-1 50</w>
-- ></w>
- G
- 0.7
+ ,</w>
(v )
(p -
(V TE)</w>
(V PA).</w>
(TM P-SM
(SP EC
(S p
(P I)</w>
(L M
(HC C)</w>
(E E)</w>
(D L
(CO X-2)</w>
(AL L)</w>
(A m
(8 4%)</w>
(6 7%)</w>
(6 4%)</w>
(5 /
(4 3%)</w>
(4 2%)</w>
(4 00
(2. 5,</w>
(2 7</w>
(2 6%)</w>
(100 %)</w>
(10 %),</w>
(1. 25</w>
(1 -10</w>
(0.0 3-
(0. 8</w>
(0. 8
( un
( two
( systolic</w>
( such</w>
( score</w>
( plasma</w>
( mainly</w>
( acute</w>
' )</w>
zom epirac</w>
zol amide/
yr .</w>
yl yl</w>
year- old,</w>
y- -
y ros
worth y</w>
whole- cell</w>
whe reas,</w>
well- described</w>
wean ed</w>
warm th</w>
warfar in-induced</w>
vulg aris.</w>
volum ic</w>
vol ati
visc osity</w>
vir us,</w>
vi b
verapam il-induced</w>
ven ular</w>
vasopress in,</w>
vascul itic</w>
vacuol ation</w>
vacc ine.</w>
urticar ial</w>
urin aly
unmas king</w>
univer sal</w>
un selected</w>
un intentional</w>
uc hen
uc cin
tur ning</w>
tumori genesis</w>
tum or,</w>
tuberculo sis,</w>
transmit ter</w>
transfu sions,</w>
transamin ase,</w>
tran sesophageal</w>
tract ,</w>
topo isomerase</w>
tis ation</w>
tinnit us,</w>
tim ed</w>
thyro trop
threshol ds,</w>
thi one
thi onate</w>
thi azine</w>
th ous
th enium</w>
tetrahydro -
tetrachlor ide</w>
test ;</w>
termin als.</w>
ter 's</w>
tension -type</w>
te .</w>
t ),</w>
syn ergy</w>
symptom s;</w>
sympath ectomy</w>
sym pathe
supplement ary</w>
sup ratentorial</w>
substanti ate</w>
sube pithelial</w>
strom al</w>
streptozotoc in.</w>
stra in.</w>
stereot ax
stat es,</w>
st ut
sper mine</w>
spec ially</w>
son -
slow- release</w>
sk in-
simul ate</w>
sim vastatin.</w>
sim pl
sildenaf il.</w>
short- lasting</w>
sevoflur ane,</w>
sett ings,</w>
ses ;</w>
sertral ine.</w>
sequ ence.</w>
separ ately,</w>
selectiv ity.</w>
seg reg
secre ted</w>
se man
seman tic</w>
se m</w>
sclero tic</w>
scinti graphic</w>
sarcolem mal</w>
sal ine;</w>
run s</w>
rot ations</w>
rilmen idine</w>
rig id</w>
retri e
retic ular
resul t.</w>
rest en
resp i
respi rat
resol ves</w>
reser pin
research .</w>
res veratrol</w>
reproduc i
remodel ing.</w>
relap se-
regul ator</w>
regener ation.</w>
red ness</w>
recur red.</w>
rectom ized</w>
recor ded,</w>
rec alled</w>
reb oun
re medi
re j
re introduction</w>
re al
re admitted</w>
rauwol sc
rapid ,</w>
rang es.</w>
ra rely,</w>
r ut
qu ired</w>
q .
pyrrolid inyl)
pyri dos
pyr one</w>
py ram
puber tal</w>
psoriatic s</w>
protocol s,</w>
prot ection,</w>
proper ty,</w>
pronoun ce
prolong ed,</w>
progres sive,</w>
progest ins</w>
profil es,</w>
produc t,</w>
princ i
prim id
pri mi
pressure- volume</w>
pre emptive</w>
pre cautions</w>
pran dial</w>
pr ud
post traumatic</w>
posi tions</w>
poly godi
poly arteritis</w>
pollic is</w>
pol icy</w>
pmol )</w>
plast y,</w>
plaqu es</w>
piperid ine</w>
pilocarp ine-
phenyleth yl
phentol amine,</w>
ph obia</w>
ph ases.</w>
perf u
per mitting</w>
per g
penicill amine-induced</w>
pelle ts</w>
peculi ar</w>
pector is,</w>
pat h</w>
participat es</w>
partic le</w>
parti ally,</w>
para esthe
par ame
pair -fed</w>
paclitaxel /
pac ed</w>
p antop
oxybutyn in</w>
oxy morphone</w>
ox amine,</w>
ot ap
osi s:</w>
orphenad rine</w>
ori e</w>
organ el
orbitof rontal</w>
or ide</w>
or chi
opioid -
ophyl line
ophthalmop legia</w>
ophthalmo log
on /
ol der,</w>
ol ).</w>
oin t
od al</w>
ocap nia</w>
oc u
oc tap
observ ations,</w>
ob t
ob liter
o k
o be
numer ical</w>
noreth ind
nor- binaltorph
nitrate/ nitrite</w>
nigh t.</w>
nigh t,</w>
nicardi pine.</w>
nic ergoline</w>
ng/ d
newbor n.</w>
neo plasia</w>
natriure sis</w>
n-Whit ney</w>
n ul
muscim ol,</w>
mum ol
multi factorial</w>
mu -
moric izine</w>
mofe til
mmol/ l)</w>
mmol/ L.</w>
ml ;</w>
mit ogen
mist ak
min (-1))</w>
mictur i
microsph ere</w>
microsom es</w>
microscop e</w>
micrograms/ mL</w>
microgram/kg/ min</w>
microgram/ kg</w>
microgram )</w>
micro liters</w>
micro globulin</w>
micro emulsion</w>
micro bub
mic e)</w>
mg/kg/ h</w>
mg/K g</w>
mg /</w>
mg %</w>
membran es,</w>
medull a,</w>
medi um,</w>
mat ter.</w>
mat ter,</w>
mat ory</w>
margin ally</w>
manage able.</w>
man son
mL/ kg</w>
m id</w>
m A</w>
m 2.</w>
m ).</w>
lymph omas</w>
low- frequency</w>
lor azepam,</w>
lob ar</w>
lipo philic</w>
lig ation,</w>
li er</w>
lev ome
lef tward</w>
le ast
labour .</w>
labetal ol.</w>
lab our</w>
kynuren ine</w>
kynuren ic</w>
knoc k-
kg .
ketoro lac
keto profen</w>
ket amine-
kappa -opioid</w>
kP a</w>
k ing,</w>
it ching</w>
iso volumic</w>
iso quinol
is ation.</w>
irt ine</w>
irrit ability</w>
ir regular
ir on-
ip ,</w>
iome prol</w>
invari ably</w>
introduc ed.</w>
intravenous ly)</w>
intram yocardial</w>
intr al
inte rest.</w>
insul t.</w>
inst ances,</w>
innoc uous</w>
influenz a</w>
infer red</w>
induc ibility</w>
individu alized</w>
indic ations,</w>
indetermin ate</w>
inco ordination</w>
incl ined</w>
in- clavulanic</w>
in- 4-
in g/
in ess.</w>
if i
id ze
ic ro
i.m .,</w>
i se
hypothalam us,</w>
hypos padi
hypop ar
hypopar athyro
hypokal aemia</w>
hypo prote
hypertensi ves</w>
hyperten sive,</w>
hyperten sion
hyperprolactine mia,</w>
hyper active</w>
hydrox ylation</w>
hydrocephal us</w>
hydr ated</w>
hippocamp i</w>
highligh ted</w>
hepat oblast
hepat o
hepat ectomy</w>
he xim
he ating</w>
haplo type</w>
haloperid ol-
half- lives</w>
group s)</w>
gro oming</w>
gra de
glomer ulopathy</w>
ginsen osides</w>
gang rene</w>
galact osid
galact os
gal lium</w>
ga str
g/ kg,</w>
g/ 24</w>
g ap
ful min
frusem ide</w>
frequ ent.</w>
four- hour</w>
foscar ne
for ce
flunitraz ep
fluc loxacill
flox uridine</w>
fl am
fif teen</w>
fibrin ogen
fentan yl-
feno profen</w>
famil y.</w>
f its</w>
extrem ity.</w>
extr asystol
extr act.</w>
expl oring</w>
excit ability.</w>
exci sion</w>
ex plic
evo kes</w>
evalu ated,</w>
euphor ia</w>
etid oca
ethyn ylestradiol</w>
estrogen s.</w>
esc ence</w>
es --
erythro dysesthesia</w>
erythematos us,</w>
erythemat ous</w>
erm ally</w>
erg ometr
epid er
epiandro sterone</w>
ent ac
enroll ment</w>
enox im
endocannabin oid</w>
encour aging</w>
encephalo pathy:</w>
en in</w>
em ed</w>
ell ation</w>
electrophysi ologically</w>
ejac ulatory</w>
edroph onium</w>
ear .</w>
dysrhythmi as,</w>
dysph oric</w>
dy ing</w>
dulox et
duct openia</w>
drug- eluting</w>
dri ving</w>
dose- limiting.</w>
dose ).</w>
dn ess,</w>
distres sing</w>
distres s,</w>
disp ens
disor gan
diseas e)</w>
disabl ed</w>
dis ci
disci pl
direc t-
dimin ished.</w>
dilat ation,</w>
dig estive</w>
diarrho ea,</w>
diaphore sis,</w>
dialy sis,</w>
di pyrone</w>
di isopropyl
dev ic
deta il.</w>
design ated</w>
der ing</w>
deliri ous</w>
definit ely</w>
defici encies</w>
de stro
de emed</w>
datab ase,</w>
dan aparo
d ness</w>
d ine.</w>
d .
cyclo hexim
cult ure,</w>
cul ating</w>
crystall ine</w>
counter part
contrac tion,</w>
continu ously.</w>
constitu ent</w>
const ellation</w>
conside red,</w>
consequ ently</w>
consequ ence,</w>
condition ing.</w>
con fer
complic ate</w>
complain ts,</w>
coca ine:</w>
clu sters</w>
cit rulline</w>
chrom atin</w>
cholecyst ectomy</w>
cholec alc
cho ice.</w>
chloro zotoc
chloramphenic ol.</w>
chlor hexidine</w>
chill s</w>
chem osensi
ch or
ch .</w>
cent .</w>
cefotax ime</w>
cef ox
ce li
carmo fur
cardiover sion.</w>
cardi otonic</w>
car pal</w>
car ing</w>
capill ari
capac itance</w>
canal icul
calcul ate</w>
c es.</w>
bu tion</w>
bu il
br and</w>
br ac
bortezomib -induced</w>
bo ard</w>
block er)</w>
blo od
blast s</w>
bl u
bl in
biopsi es,</w>
bi ochemically</w>
beta- H
benz ofur
ben ign
behaviour ,</w>
be ha
be f</w>
basel ine).</w>
bas e-
b ucindo
b ox
b cl
azido thymidine</w>
axon s.</w>
awak e,</w>
aw ay</w>
autophag y</w>
audi ologic</w>
attention- deficit/hyperactivity</w>
ate d)</w>
ate -associated</w>
ate -</w>
at o</w>
at ase</w>
arc uate</w>
ar ic</w>
apr ind
approach ed</w>
appear ance.</w>
apne ic</w>
aph asia</w>
ap it
ap ath
anxiety- related</w>
antihist amin
antidot e</w>
anticonvuls ant,</w>
antibio tic.</w>
anti- oxidant</w>
anti dysrhythmic</w>
anti dyskinetic</w>
anorexi gen
angi ocardi
analy se</w>
an s
an ol,</w>
an of
an /
an 's</w>
amygdala- kindled</w>
amphet amine-</w>
amitriptyl ine,</w>
aminophyll ine-induced</w>
amant adine,</w>
alu minal</w>
alpha, 5alpha-
albu min.</w>
al ),</w>
aj maline</w>
agoraph obia</w>
agal us</w>
advantage ous</w>
adrenocor tical</w>
adenos ine-
acyclovir .</w>
acrole in</w>
acetylchol ine,</w>
acet one</w>
ac in-induced</w>
ac a</w>
abnormal iti
abnormal .</w>
ab ro
a ren
a .
[OR ]</w>
ZO -1</w>
X- 4</w>
W ell
Ver y</w>
V TE
UL- FS</w>
Thyro id</w>
Thrombo embolic</w>
Te trac
Tak otsubo</w>
TM Z</w>
TM X</w>
TLP R</w>
TGF- beta</w>
TGF- beta
TA C</w>
T ric
T c
T G
Swe den
Succin yl
Su xameth
Sou th
Seventy- two</w>
Sel f-
Schiz ophren
SU N
SUN -13
SUN-13 34
SR L-
SI ,</w>
SD BP</w>
SC 1</w>
SA P</w>
S pas
S il
S TI
S J
Rifamp icin</w>
Renograf in-
Remifentan il</w>
Recommend ations</w>
RA S</w>
R ati
Quin ine-induced</w>
Pul se</w>
Pub M
Pro pafen
Pre valence</w>
Practi ce</w>
Place bo</w>
Pergol ide</w>
Penicill amine-induced</w>
Paclitax el
PV N</w>
PT U.</w>
PR L,</w>
PR ,</w>
PH ,</w>
PE ,</w>
PA G</w>
P U
P PA
P NS</w>
Oxy toc
Out patient</w>
O d
Neuro lep
Na Cl
NH L</w>
N- [4-
N MR</w>
Mo od</w>
MgSO 4</w>
Mal ign
MT X-
MT ,</w>
MMP- 9</w>
MK-80 1,</w>
M isoprost
M CP
Life- threatening</w>
Lid oca
Le sions</w>
Lam otrig
Labet alol</w>
L-NOAR G</w>
L- 1</w>
L ethal</w>
L act
L CT/
L 5</w>
KCC 2</w>
K v
Intram uscular</w>
Intra vesical</w>
Intra ventricular</w>
In ten
In flam
IFN- alpha</w>
IF N/
ID V</w>
IC D</w>
I DA</w>
Histopath ology</w>
Histopath ologic</w>
Hist ology</w>
His-P urkinje</w>
Hepar in-associated</w>
Hemat ological</w>
HIP/ PAP</w>
HC C.</w>
HC ,</w>
H om
H ar
H F)</w>
H 1-
Gener ally,</w>
Gemcit abine</w>
Gabap entin</w>
GV HD.</w>
GS K-3
GR1389 50</w>
GR P)</w>
GM -induced</w>
GF ,</w>
G y</w>
G y
G li
G astric</w>
G all
Fluoro-J ade</w>
Fish er's</w>
Fifty- three</w>
Fact or</w>
FK- 506</w>
FANF T-
F ull</w>
F allo
F H
Ethambut ol</w>
Estradi ol</w>
Epirub icin</w>
Epilep sy</w>
Engl and</w>
Endo genous</w>
En ox
Electr ical</w>
EE -treated</w>
ECo G</w>
E-17 G</w>
E van
E c
E L</w>
E 1-induced</w>
Dop aminergic</w>
DE HP</w>
D uchen
D IC
D D</w>
D 6</w>
Cortis ol</w>
Cor tico
Consec utive</w>
Con tri
Citalop ram</w>
Cimeti dine</w>
Chemo therapy-induced</w>
Ch ar
Ce phal
Car vedi
Capsa icin-induced</w>
CT GF</w>
CR P</w>
CR F
CO X
CM RO
CI S</w>
CA 1,</w>
C3 H/
C ranial</w>
C an</w>
By J</w>
Bic ucul
Be sides</w>
BM D</w>
B D</w>
Atten tion</w>
Aqu eous</w>
An ter
Amne sia</w>
Al lo
Ac ut
AP AC
APAC HE</w>
AE s.</w>
AD H</w>
AD ).</w>
AC I</w>
A str
A ortic</w>
A mil
A II</w>
A H</w>
99 )</w>
80- year-old</w>
8- week,</w>
8- hydroxy-2-
8- fold</w>
8 1)</w>
7 0,</w>
6-keto- PG
6 35</w>
6 2.
6 1-
5826 1</w>
5-hydroxytrypt ophan</w>
5-HT(1 B/
5-HT TLPR</w>
5-HT P</w>
5-HT (3)</w>
5- 6</w>
5 7,</w>
5 -</w>
5 );</w>
4. 2%</w>
4- mg</w>
4- hydroxy
30 .</w>
3. 7
3- methyl
3, 000</w>
3', 5'-
3 :
3 1)</w>
3 1
3 );</w>
3 '
28 ),</w>
28 %,</w>
25 3</w>
24 ,
23 7</w>
200 3.</w>
200 1.</w>
20 4</w>
2-chloro procaine</w>
2 80</w>
2 30</w>
199 6.</w>
198 5</w>
17 4</w>
17 %,</w>
15. 0</w>
15- minute</w>
13 /
13 %,</w>
1.0 5</w>
1. 75</w>
1. 4%)</w>
1,25 (OH)2D3</w>
1 18</w>
1 1,
0.6 2</w>
0.5 6</w>
0. 8,</w>
0. 4%</w>
0. 3-
0. 125</w>
/- )</w>
/ c</w>
-1 45
- plantar</w>
)- based</w>
(r 2</w>
(c Tn
(TGF- beta
(SSR Is)</w>
(SE M)</w>
(S NP
(S ER
(PT Z)</w>
(PT Z),</w>
(PR A)</w>
(P< 0.01)</w>
(P N)</w>
(O P
(LD H)</w>
(L )</w>
(I B
(DOX )-induced</w>
(DO PAC
(D el
(C D)</w>
(B rd
(Ara- C)</w>
(ADH D)</w>
(ACh E)</w>
(A ST)</w>
(A IN)</w>
(8 8%)</w>
(8 3%)</w>
(8 2%)</w>
(8 %),</w>
(7 6%)</w>
(6-OHD A)</w>
(6 2.
(5 5%)</w>
(4 8%)</w>
(4 6.
(4 3.
(3 80</w>
(3 4%)</w>
(2. 3</w>
(2- chloroethyl
(2 8</w>
(2 3.
(2 00-
(10 /
(1 80</w>
(1 60</w>
(1 00-
(1 0.0</w>
(0.0 4</w>
(0.0 2</w>
(-1 ).</w>
( week</w>
( on</w>
( nine</w>
( ip)</w>
( except</w>
( blood</w>
( beta-
( anti-
" off"</w>
xen obio
win dow
wa ve,</w>
w t,</w>
voltage- gated</w>
vide otap
verapam il-
ve -induced</w>
vasospas tic</w>
vasodil ation,</w>
vasoconstric t
vaso depressor</w>
v oid</w>
v ill
v ap
utili z
us u
us er
uro protective</w>
ur o</w>
ur ines</w>
un differentiated</w>
um- deficient</w>
two- thirds</w>
twic e,</w>
tw in</w>
tur n,</w>
tubul in</w>
tro vafloxacin</w>
tro pi
tric hloro
tri iodo
tremor s.</w>
transl ational</w>
transcrip tional</w>
trans- retinoic</w>
tr yp
tr unc
tr on
tr al</w>
toxic ologic</w>
tol azoline</w>
tim es)</w>
tic tal</w>
tic "</w>
ti bi
tibi alis</w>
thym ocyte</w>
thym ia</w>
thrombo ses</w>
thir ty</w>
thiopent al.</w>
thick ness,</w>
thiaz ide-induced</w>
thi ou
therap y).</w>
tetr aben
tetan ic</w>
termin ate</w>
terbutal ine-induced</w>
te am</w>
te a</w>
tadal afil</w>
tachy p
t yramine</w>
t le
t ard
tard a</w>
system ic,</w>
symptomat ology.</w>
symptom -free</w>
suxameth onium-induced</w>
surve y.</w>
subst ance.</w>
subject s)</w>
subject ,</w>
sub- Ten
sub population</w>
sub icul
strychn ine-induced</w>
stre et</w>
strati fication</w>
stimul ator</w>
stav ud
st ay.</w>
st ains</w>
sprout ing.</w>
splen omegaly</w>
spi ren
spectr a</w>
spas m,</w>
som no
so ver,</w>
so a
sleep- wake</w>
sl er</w>
sin o-
signal- regulated</w>
sigma 1</w>
sib lings</w>
sib ling</w>
show n.</w>
she ep</w>
sex ually</w>
sex es.</w>
ses )</w>
seroton inergic</w>
seri ous,</w>
separ ately.</w>
semi quantitative</w>
second s,</w>
sec ,</w>
se mic
scienti f
sc an,</w>
saralas in</w>
saliv ary</w>
s ap
ru p
ru bell
rota -
rofecoxi b,</w>
ro ll
rit anserin</w>
ris ks.</w>
ri se,</w>
ri ol</w>
resuscit ation.</w>
restless ness</w>
response )</w>
repolar ization.</w>
remo ve</w>
relapse- free</w>
rej ection.</w>
reflex es.</w>
reflex es,</w>
recurren t,</w>
recogn iz
rec essive</w>
reason ably</w>
re new
re dox
re d;</w>
rat s'</w>
ras ag
rapid -
radio therapy,</w>
radic als.</w>
ra ising</w>
qu ick</w>
prurit us.</w>
proper ly</w>
program me</w>
proce eded</w>
proce ed</w>
pro collagen</w>
primat es</w>
primat es.</w>
pri min
prevent able</w>
pressure ;</w>
pressu res.</w>
prednisol one,</w>
pre requisite</w>
pre pon
prepon der
pre optic</w>
pre morbid</w>
pre medication.</w>
pre load</w>
pram ipexole</w>
potenti als.</w>
post- SE</w>
post injection</w>
post er
post anesthesia</w>
possibil ities</w>
popul arity</w>
polygodi al</w>
pituit aries</w>
pir arubicin</w>
phospholip ids,</w>
phenyl acetic</w>
ph otoc
peroxis omal</w>
perme ability.</w>
perm its</w>
periton itis</w>
peri -
per is
pent adec
paw ,</w>
pattern s,</w>
patch -
pass age</w>
paroxet ine,</w>
parenchy ma</w>
paren tal</w>
parano ia.</w>
parac ellular</w>
papill a</w>
pan ic
painf ul
pac kage</w>
pa uses</w>
pa use</w>
oxid ation,</w>
ox ac
out weigh</w>
out growth</w>
other s,</w>
otec an,</w>
ost at</w>
os al</w>
orth opa
oro pharyngeal</w>
ornith ine</w>
ore p
optim ize</w>
open ,</w>
on y</w>
ol iv
ol ine-induced</w>
ol d-
ol :</w>
occurren ce.</w>
o val
o ds</w>
novel ,</w>
non- alcoholic</w>
non treated</w>
nit raz
neuro toxicity:</w>
neuro psych
nerv ous
neon atally</w>
neg ligible.</w>
nec k.</w>
ne d.</w>
nam ely,</w>
n ia.</w>
myo pathy:</w>
mus cul
mon o-
mode lling</w>
mmol/ kg)</w>
mmol/ L,</w>
mm 3)</w>
mix ed-
minut e.</w>
minoxidi l-induced</w>
minim ized</w>
min -1),</w>
mil nac
mil i
micrograms/kg/ min)</w>
micrograms/ kg.</w>
micro l,</w>
micro globul
mg/ l,</w>
mg. kg-1)</w>
methylglutar yl</w>
methyl- 6-
methodo logy</w>
methi azole</w>
meth asone</w>
meperid ine.</w>
meglum ine</w>
mar -plantar</w>
man eu
malignanc y,</w>
mal e.</w>
main tains</w>
mac h
ma y
ma -like</w>
mL/ min</w>
m U/
m L.</w>
lyso zyme</w>
ly :</w>
lob es</w>
lit ter</w>
libit um</w>
li st
li ber
levonorgest rel
levof loxacin,</w>
leuk aemia.</w>
left- ventricular</w>
leak y</w>
lay er.</w>
lat ter,</w>
labetal ol,</w>
l s,</w>
l :</w>
kg(-1 )
ke eping</w>
kain ate-induced</w>
kP a)</w>
k y</w>
k ed.</w>
k ary
isoflur ane-
iso propyl</w>
ism :</w>
is sure</w>
ir on,</w>
ip uncture</w>
iohex ol.</w>
iohex ol,</w>
intrat ubular</w>
intrane ural</w>
intram ural</w>
interven tions.</w>
insul in-dependent</w>
input s</w>
innerv ated</w>
inj ected.</w>
initi ation,</w>
ing in</w>
ing ham</w>
ing ent</w>
ine- dependent</w>
indole acetic</w>
indic ation.</w>
ind ing</w>
in organic</w>
in es,</w>
in -1-
impoten ce.</w>
impl ies</w>
immunohistochemistr y,</w>
immunohist ochemically</w>
immun olab
immun o-
im pression</w>
im pac
illnes ses.</w>
ific ation.</w>
ifenpro dil</w>
idiosyn c
idiosync rati
idi lol</w>
identifi es</w>
ide ),</w>
ic v)</w>
ic idal</w>
ic -induced</w>
ia- reperfusion</w>
i pr
i let
hypoparathyro idis
hypom an
hypoalbum inemia,</w>
hypo algesia</w>
hypertriglyceride mia</w>
hyperten sion;</w>
hyperreflex ia</w>
hypernat remia</w>
hyperlipide mia.</w>
hydroxy zine</w>
hormon es,</w>
hom o
hom e.</w>
hist amine,</w>
hiccup s.</w>
hepatocarcin ogenesis.</w>
hepati c,</w>
health ,</w>
he d,</w>
har ms</w>
hand- foot</w>
haemo dynam
haemat uria</w>
h ope</w>
h im
h an
guide lines.</w>
gu id
grad ing</w>
gonad otrop
go als</w>
glycos amino
glycer ol</w>
glucocortico id-
gli omas</w>
gl icl
gl ab
geu sia</w>
gen u
gen omic</w>
ganciclo vir
gamma-glutam yl</w>
gamma- hydroxybut
gall amine</w>
galant amine</w>
gal anin</w>
g/m 2,</w>
g/m 2)</w>
g over
g e</w>
g aro
garo toxin</w>
g -1</w>
further .</w>
fre e,</w>
formul ation.</w>
formul ation,</w>
form ance</w>
fore brain.</w>
follow up</w>
foc uses</w>
flut ter,</w>
fluo rop
fl at
fl are
five- year</w>
fil ter</w>
fibroblast s.</w>
fi er</w>
fen oterol</w>
fa ec
f icially</w>
exclu ded,</w>
exacerb ating</w>
ex change,</w>
ev acu
etid ocaine</w>
ethan olic</w>
ethambut ol.</w>
et uses</w>
est rus</w>
es sel</w>
erro r
ergotamine/ caffeine</w>
epirub icin,</w>
epilepsy- prone</w>
ep it
ent ries</w>
ent eral</w>
enflur ane.</w>
endoscop y</w>
end s</w>
end ings</w>
en s,</w>
en em</w>
en anth
empir ically</w>
embry otoxic</w>
embol ization</w>
elucid ating</w>
electro diagnostic</w>
el ess</w>
effect or</w>
ecti ve
e.g .,</w>
dyst oni
dysp nea,</w>
duc ts,</w>
du e,</w>
drug- specific</w>
dose ;</w>
dose ),</w>
dofe tili
diure tic,</w>
disulfir am-induced</w>
disul fi
disopyram ide,</w>
dis k</w>
diphenyl hydanto
dimen hydr
dihydro- 5H-
diarrhe a.</w>
diabe tics</w>
di propyl
di lev
di acetyl
dex razox
desi pramine.</w>
desferri oxamine.</w>
desat uration</w>
derang ements</w>
depart ment,</w>
denerv ation.</w>
demeclo cycline</w>
del ay,</w>
degener ated</w>
deep- vein</w>
de serves</w>
de hydration,</w>
de afferen
dd i</w>
day s/
dam aging</w>
da idze
d4 T</w>
d ]
cyto protective</w>
cyt openia,</w>
crypt ococcal</w>
cross- tolerance</w>
cros sover,</w>
cow s</w>
counsel ing</w>
coumar in</w>
cot inine</w>
contro ll
contrac tion.</w>
contr adic
constric tion,</w>
constitu ents</w>
confoun ders,</w>
conduc ting</w>
computer -
compon ent.</w>
complex es,</w>
complete ly,</w>
compl ain</w>
collo idal</w>
collagen ase</w>
coca ine/
clon ic-tonic</w>
cle f
cle avage</w>
ciprof loxacin,</w>
cin nar
chore iform</w>
chore a.</w>
chlor dec
child 's</w>
character izes</w>
channe l.</w>
ch ose</w>
cephalospor in</w>
cent )</w>
cells/ mm3</w>
caver nous</w>
caver nos
cau tion,</w>
catheter s.</w>
cardiomyo pathy:</w>
cardio -
cardiac ,</w>
carcin ogenesis.</w>
carbo prost</w>
carb idopa
carb ap
calbind in-
caffe ic</w>
c ine
but yl</w>
bronchodi lation</w>
bran ches</w>
br af
blo t
bisphosph onate</w>
birth weight</w>
biomark er</w>
bio avail
bi otrans
bi le.</w>
beta (1)-
benz trop
be red</w>
basel ine),</w>
b.i. d.)</w>
b it
b h</w>
b are</w>
awa iting</w>
avir ,</w>
autoradi ographic</w>
auto regulatory</w>
aut onom
attempt .</w>
atri um.</w>
ate br
at oxin</w>
astro cytic</w>
astro cyt
ast roph
as sign
arti ficially</w>
arterio graphy.</w>
arrhythmi as
arac ter</w>
ar ization</w>
ar ding</w>
ar )</w>
aprot inin</w>
appropri ate.</w>
ap ram</w>
ap point
ap eptide</w>
aorta .</w>
antimicro bi
anticonvuls ants,</w>
antibody -positive</w>
anti- platelet</w>
anti social</w>
anter i
anomal ies.</w>
an z
an osine</w>
an astro
amplitu de.</w>
amin al</w>
am o
am niqu
alpha 2-adrenergic</w>
alkalin ization</w>
alfa- 2a</w>
agon al</w>
aggres siveness</w>
age ).</w>
ag o,</w>
after war
advis able</w>
adrenocortic otropic</w>
aden omas.</w>
ad sorption</w>
actu arial</w>
activ ity:</w>
activ ations</w>
acti ve-
acr yl
achi ev
accumul ation,</w>
accom mod
accid ent</w>
acc es
abuse :</w>
abo ve-
abl ative</w>
aber r
a rec
[3H] spiperone</w>
[ 11
[ 1-
ZD V</w>
Z ol
Z TP</w>
Wilc oxon</w>
W at
Vincrist ine-induced</w>
Ven lafax
Vas cul
V III</w>
Un usual</w>
Top ir
Th io
Ter at
TTP- HUS</w>
TR (-)</w>
TN F
T- positive</w>
T yr
T i
T Q</w>
Sul piride</w>
South west</w>
Ser vice</w>
Scre ening</w>
SE M</w>
SA C</w>
S P-
Reg arding</w>
Re ye</w>
RELEVAN CE:</w>
RE G
R- (+)-
R emission</w>
R a
R M</w>
R CT
R A,</w>
R ).</w>
Qu ality</w>
Propofol- Lip
Progester one</w>
Prob able</w>
Prin z
Phenylpropan olamine</w>
Per formance</w>
Per cutaneous</w>
PO THESIS:</w>
PL C</w>
PF S</w>
PF 4/
PB -treated</w>
PAR P</w>
PA H</w>
P< 0.001),</w>
P- 2</w>
P u
P entam
P em
P S)</w>
P CI</w>
P B.</w>
P :</w>
Ophthal mo
OX C</w>
O me
O ddi</w>
O at
Non hematologic</w>
Netherl ands</w>
Na(+ ),</w>
NS -
NRA0 160</w>
NC r</w>
N- desmethyl
N ot</w>
N orep
N -induced</w>
N (
Mo de
Mg(2 +)</w>
Mg(2 +
Mex ilet
Methyl dopa</w>
Me perid
Man ual</w>
Malign ant</w>
MT EP</w>
MP H</w>
MMP- 2</w>
MI D</w>
Low -
LQT S</w>
LMW H</w>
LCT/ MCT</w>
L- Dopa
L ear
L d
K ir
K O
Ir reversible</w>
Indi a.</w>
Inc id
Imat inib</w>
IL- 6,</w>
IL -17</w>
III/ IV</w>
IF S</w>
I s-
I ll
I Q</w>
I -induced</w>
I (K
Hz ,</w>
Hor ner's</w>
His panic</w>
Hex abri
Haemat ological</w>
HY POTHESIS:</w>
HR P</w>
HCO 3</w>
H er
H ]</w>
H D)</w>
H +</w>
Grou p-
Gol d
GTN -induced</w>
Further more</w>
Fifty- five</w>
F enflur
F UD
F HF</w>
Erec tile</w>
Elev ation</w>
Ei ther</w>
Eff ectiveness</w>
EP S.</w>
ED ,</w>
E w
E ti
E NT</w>
E H
Dyst onia</w>
Diethyl stilbestrol</w>
Dap sone</w>
DR D2</w>
DH T</w>
DH P</w>
DE )</w>
D aun
D CE
D C</w>
D A,</w>
D (2
Cyclospor in</w>
Coca ine-related</w>
Chec k
Character is
Cardi oprotective</w>
Can di
CaCl (2)-
Ca esarean</w>
CYP2C 19</w>
CS F,</w>
CS .</w>
CONCLUSION S</w>
CNS .</w>
CL O
CD 50</w>
CB F)</w>
C- fibers</w>
C yc
C remophor</w>
C am
C V</w>
Bupren orphine</w>
Behavi or</w>
Be zol
Bac lofen
BO O</w>
BH A</w>
B- cell</w>
B S
B R</w>
B CN
B B</w>
Aripi prazole</w>
Ap nea</w>
Anti bodies</w>
Angio graphy</w>
Anaesthe sia</w>
Amil oride</w>
All -
Ak athi
Adequ ate</w>
Acet aminophen
Ac quired</w>
Ac ce
AED s</w>
ACTH -induced</w>
ACTH -
ACE i</w>
A me
A B</w>
>/ =</w>
9 9%</w>
9 5.
9 4
9 1%</w>
80 )</w>
8 8.
8 7)</w>
7- year</w>
7 H
7 79</w>
7 61</w>
7 6,</w>
7 5)</w>
60 %,</w>
6- h</w>
6 th</w>
6 5.
59 3</w>
55 %,</w>
5. 0,</w>
5-hydroxy indoleacetic</w>
5- min</w>
5- mg</w>
5 ]</w>
5 7)</w>
5 5)</w>
5 48</w>
5 40</w>
48 ).</w>
40 /
4. 6%</w>
4- point</w>
4 2-
4 2,</w>
35 %,</w>
3- hydroxy-
3- hydroxy
3- O-
3 K
3 7,</w>
3 2,</w>
28 .</w>
25 00</w>
24 ).</w>
23 5</w>
200 1,</w>
200 0,</w>
20 9</w>
20 %.</w>
2. 0,</w>
2-amino- 7-
2- mercapto
2- deoxyglucose</w>
2 h</w>
2 C
2 13</w>
2 12</w>
198 4</w>
19- year-old</w>
18 7</w>
18 5</w>
18 0
17 3</w>
16 3</w>
15 ;</w>
15 8</w>
15 2</w>
14. 5</w>
11. 2</w>
10-1 5</w>
1. 1%</w>
1- adrenergic</w>
1- 5</w>
1, 500</w>
1, 4-
1 7.5</w>
0.6 6</w>
0.6 5</w>
0.6 3</w>
0.5 7</w>
0.4 6</w>
0.05 .</w>
0.00 6).</w>
0.00 3)</w>
0.0 25</w>
0.0 25).</w>
0. 7,</w>
0. 4,</w>
0. 36</w>
0. 35</w>
0. 31</w>
0. 29</w>
0. 25%</w>
0. 21</w>
0. 2-
/ SM
-1, 4-
-1 2
-1 000</w>
- 2.
)- ATPase</w>
(p< 0.05)</w>
(W B
(Vi agra
(R V)</w>
(R R,</w>
(R -
(QT c)</w>
(PG I
(P K
(P I
(P A)</w>
(P =.0
(N AC)</w>
(M MP
(LDH ),</w>
(IC U)</w>
(HB I
(H M
(H C)</w>
(DX R)</w>
(D VT)</w>
(CR F)</w>
(CM V)</w>
(C GRP)</w>
(BUN )</w>
(AI DS)</w>
(AE s)</w>
(A Q
(8 /
(6 1%)</w>
(6 /
(5- nitro-
(4 7%)</w>
(4 %),</w>
(3 7.
(3 50</w>
(3 2.
(3 1.
(2. 5-
(2. 4</w>
(2 ,</w>
(19 66-
(1. 9</w>
(1. 8</w>
(1 25
(0. 25,</w>
(0. 2-
(0. 1,</w>
( using</w>
( rh
( protocol</w>
( pre
( phase</w>
( not</w>
( level</w>
( alpha</w>
( R</w>
( A</w>
' off'</w>
" on"</w>
zolamide/ timolol</w>
z ero
y ing,</w>
y -</w>
world wide
withdraw ing</w>
w .</w>
w )</w>
vo ice</w>
vis its.</w>
vis it
vis ,</w>
vide o</w>
vi bration</w>
ves ti
vertig o,</w>
ver a</w>
ve rex
verex pression</w>
ve red,</w>
vasodilat ation,</w>
vancom ycin,</w>
valer ate</w>
val idation</w>
val idate</w>
vagotom ized</w>
vacuol ated</w>
use :</w>
urticaria/ angioedema</w>
ure )</w>
urap idil</w>
urac il,</w>
une qu
under score</w>
un suspected</w>
un described</w>
un aware</w>
u d</w>
u -
twice- weekly</w>
tro pic
trimethoprim-sulfamethox azole.</w>
trimethop rim
trimethadi one</w>
trime ster
tricho sis</w>
treatment -induced</w>
treat ed)</w>
treat able</w>
tre s</w>
tre moro
transl ated</w>
transfer rin</w>
transf used</w>
tramad ol.</w>
trac e</w>
tr ast</w>
toxic o
tox oplasmo
tom ography.</w>
tolter odine</w>
tobram ycin.</w>
thromb ocy
thro at</w>
thir teen</w>
thione in</w>
thio guan
thick ened</w>
thi gh</w>
thi amyl
thalam us.</w>
th yl
tetrazol ium</w>
tetr alin</w>
test ),</w>
temperat ures</w>
telmis artan</w>
tech nical</w>
taxan es</w>
tartr ate</w>
tac rine-induced</w>
syst olic,</w>
synth ase,</w>
synchron ized</w>
synaptos omal</w>
synap se</w>
swe at</w>
sw allowing</w>
surfac e.</w>
supra threshold</w>
suppres sed.</w>
support ,</w>
super nat
sup pressor</w>
sup posed</w>
sulfon amide</w>
successful ly.</w>
sub types,</w>
sub side
sub convulsive</w>
su stain</w>
su nit
strate g
stor age</w>
stimul us,</w>
stent ing</w>
st oc
spike- wave</w>
soun d-induced</w>
solitari us</w>
so y
sleep iness</w>
sk ill
six ,</w>
sis -induced</w>
sim vastatin,</w>
sildenaf il,</w>
signal ing.</w>
short- ter
shor test</w>
she ath</w>
ses sions,</w>
ses sion,</w>
seroton in.</w>
seri ously</w>
ser a
sera dish</w>
sep sis,</w>
sem ati
sel f</w>
sel eni
sel ected.</w>
sel ect</w>
sco red.</w>
scaveng ers</w>
scan s.</w>
scal es,</w>
scal e)</w>
samp le,</w>
saliv ation,</w>
salicyl ates</w>
sac ro
sa c</w>
rubell a</w>
rout es.</w>
rota- rod</w>
ropini role</w>
rol idine</w>
rocur onium.</w>
rocur onium,</w>
ro se
ro cortisone</w>
ris t</w>
rib os
rh in
rever sal
revascular ization.</w>
retro viral</w>
responder s,</w>
respon sib
reserp ine-treated</w>
research ers</w>
renin- angiotensin-
remifentan il-based</w>
regener ating</w>
record s,</w>
record ings,</w>
reci procal</w>
rec umb
reat ment</w>
read ings</w>
re appearance</w>
rapid ly.</w>
rap idity</w>
ran ular</w>
ran ol
rac lon
r ural</w>
quar ter</w>
qual ity-
pyrid ine-
pyri methamine</w>
pyri din
pyrazin amide</w>
purpo ses</w>
prud ent</w>
provoc ative</w>
provi ded.</w>
protein )</w>
prote as
prost one</w>
propofol :</w>
prop eptide</w>
proj ect</w>
progester one.</w>
progenit ors</w>
produc t.</w>
pro cycl
pre menopausal</w>
pre junctional</w>
pre ganglionic</w>
post- mortem</w>
post partum
post operatively,</w>
posses sed</w>
por e</w>
polydip sia,</w>
poin ting</w>
po grel
platinum- based</w>
pl u
pl it
pl ates</w>
piperazin -1-
pill s.</w>
pig ment</w>
pi ed</w>
phosphatidyl serine</w>
phosph oc
phosphoc reat
pher ic</w>
phenyto in-induced</w>
phenoxy benz
phenacet in,</w>
phen ol</w>
ph ob
ph ase-
pestic ides</w>
pergol ide.</w>
percent ).</w>
penicill ins</w>
pen is</w>
peg filgrastim</w>
pea k-
particip ant</w>
parallel- group,</w>
pancre atitis.</w>
pancre ati
palpit ations,</w>
pallid otomy</w>
p un
p end
p en</w>
oxaliplat in,</w>
ox ia</w>
overl apping</w>
overex pressing</w>
over sho
ov ary</w>
out ine</w>
ou ts</w>
oter minal</w>
ot es</w>
osteoporo sis.</w>
oscill ation</w>
organ s,</w>
or der.</w>
op es</w>
one- way</w>
on- off</w>
on gest
omime tics</w>
omega )-
oly mer
oligonucle otide</w>
olig uria.</w>
ol der.</w>
ol amine-induced</w>
oid ,</w>
ograph ical</w>
offspr ing,</w>
odi lat
ocyte -
och lear</w>
occu pied</w>
oc utaneous</w>
obes ity.</w>
obac ter</w>
ob long
o protein</w>
o il.</w>
o .)</w>
notice able</w>
normother mic</w>
normal ised</w>
normal -
norethind rone</w>
noradrenal ine.</w>
nor cocaine</w>
non- Hodgkin</w>
nmol/ kg</w>
nio s</w>
nicot ine's</w>
ng/ml ).</w>
new ,</w>
neurotransmis sion,</w>
neurolep tic
neuro sensory</w>
neuro pharmacological</w>
neur al-
nephrocalcin osis.</w>
neon ate.</w>
neocor tical</w>
neocor tex</w>
nefazod one</w>
ne d,</w>
nar ingin</w>
na il</w>
n ame</w>
n M),</w>
n )</w>
myocardi opathy</w>
myo- inositol</w>
my otonia</w>
my ocytes,</w>
mu tis
mu star
msec .</w>
msec ,</w>
morph ology.</w>
mo tion.</w>
mmHg ),</w>
mixt ure.</w>
mis ul
minim al.</w>
microliter )</w>
micrograms. kg-1</w>
microgram/ ml,</w>
microgram s.</w>
microgram s),</w>
micro l/
micro biological</w>
mi pramine</w>
mi metic</w>
mg/m2/ week</w>
mg/m (2)
mg/kg/ d)</w>
mg./ kg.</w>
mg./ kg
methadone- maintained</w>
meth anolic</w>
metalloprotein ases</w>
medi an,</w>
mechan o
mechan ics</w>
mat che
mas ses</w>
mannit ol-induced</w>
malignanc ies,</w>
macro cytic</w>
mOsm /kg</w>
mL/ min,</w>
mGluR s</w>
m ia-induced</w>
m ated</w>
m aps</w>
m V</w>
m L)</w>
lymph oproliferative</w>
lop in
long standing</w>
local ize</w>
loc ations</w>
loc ation,</w>
lo l-induced</w>
liver -
live do</w>
liter ,</w>
lit re
lisinopri l.</w>
ligh tly</w>
lig ated</w>
leukotri ene</w>
leukopen ia.</w>
leu pro
lethal ity,</w>
leg s.</w>
leg s,</w>
lear ning.</w>
le st
lat ter.</w>
lat est</w>
las er-
lact one</w>
l one</w>
l ity</w>
l ingu
l ess,</w>
l ens</w>
l ase</w>
l ability</w>
kg/ min</w>
kg/ day</w>
ket amine-induced</w>
ker ato
ke ys</w>
iso enzymes</w>
ip ec
investig ated,</w>
inver ted</w>
intr aluminal</w>
intest ine,</w>
interleukin -1
inter cal
inter active</w>
inten tion</w>
insul in.</w>
instrum ental</w>
ino ic</w>
influenz ae</w>
ine x
indinavir -associated</w>
indic ations.</w>
inde s
increas es.</w>
incid ents</w>
incid ental</w>
incid ence.</w>
inc h</w>
in consistent</w>
impoten ce,</w>
implic ates</w>
imp ending</w>
immunocyt ochemistry</w>
immuno prophylaxis</w>
immuno assay</w>
ime tic</w>
imag es,</w>
ifen acin</w>
idine di
id- stimulating</w>
ia sis:</w>
i.v .
i ro
hypoten sion
hypokal em
hypo thyroidism.</w>
hypercalci uria.</w>
hyper vitaminosis</w>
hyper uric
hydro lase</w>
hydro las
hydro cortis
hydram nios</w>
hospit als.</w>
hor seradish</w>
homogene ous</w>
homogen ate</w>
ho c</w>
her al
hemo phil
hemi parkinsonian</w>
hematocrit ,</w>
he d
hallucin ation</w>
half- life,</w>
grow th
graph ically</w>
graph ic,</w>
grade ly</w>
gonad otropin</w>
gn aw
glycosamino glyc
gh relin</w>
genu ine</w>
gener ation.</w>
gene sis,</w>
gen der.</w>
gastro enter
gall stones,</w>
g/d l,</w>
g/ day)</w>
full -term</w>
fre e.</w>
fr ucto
fore arm.</w>
foc ally</w>
fo pam</w>
flush ing,</w>
fluor idate</w>
flumazen il,</w>
fl ash
fl a
find ing,</w>
fe el</w>
fast ed</w>
fal se</w>
fail ures</w>
f um
f ra
f issure</w>
extr as
expan sion,</w>
excit ability,</w>
exchang er</w>
ex -
evidence -based</w>
evid ent.</w>
evalu able.</w>
eu tic
eu glycemic</w>
ethyl- beta-carboline-3-
eth nic
estim ated.</w>
erythro der
ergonov ine</w>
ergol ine,</w>
er t</w>
er ine</w>
er :</w>
er -dose</w>
equ ina</w>
epitheli um,</w>
ep ime</w>
ent ine</w>
ent ;</w>
ent -
enlarg ement,</w>
encour age</w>
enabl ed</w>
en ure
en n
en ly</w>
embry otoxicity</w>
embry ol
embran ous</w>
elev ating</w>
electromyo gram</w>
electroencephalo grams</w>
electro shock-induced</w>
ele mental</w>
ele ment</w>
el in</w>
el astic</w>
eigh teen</w>
eh n</w>
ede matous</w>
ed ronic</w>
ear ly,</w>
e dic
e .
dysphag ia</w>
dys functional</w>
dur ation)</w>
drug -treated</w>
drin k</w>
dre am
down regulated</w>
doses )</w>
dose "</w>
dors i</w>
dor sum</w>
don ors.</w>
do x</w>
distor tion</w>
distinc tly</w>
distinc tion</w>
discharge d.</w>
difficul t.</w>
differen t,</w>
differen ce
diff use
diagno ses.</w>
di phosphate</w>
di methyl</w>
di le
di hydrochloride</w>
desi red</w>
derivati ve.</w>
der -
depres ses</w>
deple tions</w>
dep ren
dep olymer
deoxy uridine</w>
delay ed.</w>
defect ,</w>
def ini
decompens ation</w>
decom pression</w>
deci sion-
deaf ness.</w>
de liver</w>
dang ers</w>
dail y),</w>
da ugh
d l-
cys tic
cyclo hept
cycl es;</w>
cy stin
cup s</w>
counterpart s.</w>
control led.</w>
contribut ory</w>
contribut or</w>
contrast- enhanced</w>
contra indications</w>
consul tation</w>
constitu tive</w>
conf ers</w>
concer n.</w>
con temporary</w>
collater als</w>
col i</w>
cochle a</w>
cocaine- ethanol</w>
coca ine;</w>
co-trimox azole</w>
closu re.</w>
clon azepam,</w>
clear -
clear- cut</w>
clear ,</w>
cl aims</w>
circuit ry</w>
ciga ret
cholest asi
chol ed
chi -square</w>
chec k</w>
ch aracter</w>
cer uleus</w>
cer ti
cer iv
cefac lor</w>
ce iling</w>
cav ity.</w>
cas ca
caro ten
cardiomy ocytes.</w>
carcin oma:</w>
carbim azole.</w>
caps ular</w>
cann ulated</w>
can al</w>
calcin osis</w>
calci uria</w>
cal lo
c ation
c DNA</w>
bun garotoxin</w>
bul lous</w>
brush -evoked</w>
brimon idine</w>
bridg e</w>
br y
both ).</w>
bodi es.</w>
blun ting</w>
biosyn the
biopsi es.</w>
bilater ally.</w>
bige min
bicarbon ate,</w>
bethan idine</w>
bethan echol</w>
beta- oxidation</w>
beta- hydroxy
beg un
bec lo
be sides</w>
be am</w>
baro receptors</w>
avir /
aver sion</w>
autoradi ography</w>
autop sy.</w>
autom atic
aur anof
atten tional</w>
attac h
atri a.</w>
ate ).</w>
at tractive</w>
at ing.</w>
at -
asymptom atic,</w>
associ ation,</w>
as cer
as ak
as -
artic le,</w>
arti caine</w>
aris ch</w>
apy ri
appreci ated</w>
appear ance,</w>
app end
aph ere
ap raclon
aor t
antinocicep tion,</w>
antigen .</w>
anticholinerg ics</w>
antiarrhyth mic
anti- tumor</w>
anti- hyperalgesic</w>
anti diabetic</w>
anti cholinesterase</w>
anti amnesic</w>
anthracyclin es,</w>
ano ic</w>
ang er</w>
androgen -independent</w>
analgesic s,</w>
an y
an uria,</w>
an do
ampl ification</w>
amine- associated</w>
am ostat</w>
alpha (2)</w>
all s</w>
alkalo ids</w>
alfentan il,</w>
alf uz
aler tness</w>
aler ted</w>
alcohol ism</w>
alb en
al ;</w>
akine sia.</w>
air ways</w>
air s</w>
agre ed</w>
agranulocyto sis,</w>
after no
aff in
aff ect
adv ances</w>
adriamyc in-
acit retin</w>
acetyl amino
accompan ies</w>
acceler ates</w>
ac in
ac ,</w>
abol ishing</w>
abo ve.</w>
abnormal ity,</w>
abl ation.</w>
ab ine-induced</w>
a uro
a phosphor
a hr</w>
a dis
[ 4,
Y et,</w>
Y ahr</w>
W M</w>
W I</w>
Vascul itis</w>
Valpro ate-induced</w>
V max</w>
V E</w>
V CR
Uni variate</w>
Unex pected</w>
Treat ments</w>
Trans genic</w>
Tr x
Toxic ology</w>
Tim m</w>
Thirty- nine</w>
Th en,</w>
Th ail
Ter but
TUNEL- positive</w>
TR I</w>
TP O</w>
TP MT</w>
T ubular</w>
T ro
T X</w>
T DH
T CP</w>
Sub stitution</w>
Sub acute</w>
Streptozotoc in</w>
Ster oids</w>
Spir onolact
Sixty- seven</w>
Ser ologic</w>
Sc hedul
SW V</w>
SN Ps</w>
SI )</w>
SH )</w>
SG O
SA L</w>
S9 788</w>
S, 3
S ham
S ha
S aline</w>
S a
S Z</w>
S M</w>
Ret inoic</w>
Repe at</w>
Reg ression</w>
Re active</w>
RO C</w>
RN A-
RN 23
RAL H</w>
R outine</w>
R oc
Queti apine</w>
QT L</w>
Q .</w>
Pro j
Pro gram</w>
Por tal</w>
Phenyleph rine-induced</w>
Ph il
Pericardi tis</w>
Per son
Per man
PROCED URE:</w>
PR 3-
PPAR alpha</w>
PON V</w>
PO D</w>
PK C</w>
PG ,</w>
PF4/ heparin</w>
PD TC</w>
PB O</w>
P< 0.05</w>
P reg
P NP</w>
P IP
P 2-
Ox carb
On dan
Oc ca
OP ID
OLT .</w>
OD E</w>
O verexpression</w>
O AT
O A</w>
Nimesul ide</w>
Niger ian</w>
Na prox
NT G-induced</w>
NO- deficient</w>
NI K-
N-acetyl-beta-D- glucosaminidase</w>
N- terminal</w>
N- acetyl</w>
N rf
N P,</w>
N DE
N ),</w>
More over</w>
Modi fication</w>
Mil rinone</w>
Me tron
Mc N-
Mannit ol</w>
Man n-Whitney</w>
MPTP- lesioned</w>
ME S</w>
MB C</w>
MA PK</w>
MA P.</w>
M ain</w>
M H</w>
M ;</w>
Line ar</w>
Lif e</w>
Lear ning</w>
Lamotrig ine</w>
LE ),</w>
L ung</w>
L F</w>
L AM-
L A)</w>
King dom</w>
KG F</w>
K- 2</w>
K ine
K W-
K RN23
K (ATP)</w>
In tran
In sul
In s
In haled</w>
Immuno fluorescence</w>
Immun e</w>
Ibu profen
II :</w>
I S)</w>
I PR
Ho ehn</w>
Hist amine</w>
Hemodi alysis</w>
Hall ucin
HM G-
HMG- CoA</w>
HC )</w>
HAL -induced</w>
H sp
H AL</w>
Gram -positive</w>
Gluc agon</w>
GF R,</w>
GF .</w>
G ly</w>
G HB</w>
Frequ ent</w>
Fl ut
FK50 6-induced</w>
F O
F G
Erythro poi
ER G</w>
EM B</w>
E ye</w>
E b
Dys kinesia</w>
Dose -dependent</w>
Dex tro
Demo graphic</w>
De termin
De pressive</w>
Datab ase</w>
DX R.</w>
DT PA</w>
DH A</w>
DES CR
DESCR IP
D1/ D2</w>
D ac
Cyclospor ine</w>
Cyclophosph amide-induced</w>
Cy to
Con serv
Cl 2</w>
Cis plat
Ciprof loxacin</w>
Ciprof loxacin-induced</w>
Characteris tics</w>
Carvedi lol</w>
Cardi o
Ca+ +</w>
CYP 1A
CYP -treated</w>
CT P</w>
CS F-
CS F
CS A</w>
CPT -11</w>
CP -treated</w>
CO RT</w>
CO 2,</w>
CMRO 2</w>
CM ),</w>
CI s</w>
CH B</w>
CB Z,</w>
CB F,</w>
CA A</w>
C x
C V-
C P)</w>
Bus ulf
Brd U</w>
Bezol d-
BU P</w>
BB N</w>
B olus</w>
B Q
B ID</w>
B AE
B 3</w>
Austral ia.</w>
Aten olol</w>
Arg atrob
Apomorph ine</w>
Amin ophylline</w>
Ame li
Agg res
Adv anced</w>
Adren al
AV -
ATP ases</w>
ASP 58
AS ,</w>
AN IMA
AH-10 58</w>
ADR-5 29</w>
A- 3
A misul
A defovir</w>
> 0.05).</w>
< 10</w>
9- fold</w>
9 6.
9 5%
8 %.</w>
7. 0
7 6.
7 5.
7 4
6 5,</w>
5-hydroxytrypt amine
5 HT</w>
5 54</w>
5 4,</w>
5 3.
5 3)</w>
5 2)</w>
5 %);</w>
45 %,</w>
4. 7
4. 5%</w>
4 25</w>
4 10</w>
4 00,</w>
4 -1.
3. 8
3,4- methylenedioxymethamphetamine</w>
3 alpha,5alpha-
3 75</w>
3 6)</w>
3 48</w>
3 3).</w>
29 ),</w>
27 70
25 ;</w>
24- week</w>
24, 25-
200 5,</w>
20 3</w>
20 ,000</w>
2- fur
2 ]</w>
2 75</w>
2 24</w>
2 0.8</w>
199 9.</w>
199 8.</w>
199 5.</w>
198 2</w>
19 .</w>
18 6</w>
18 2</w>
18 1</w>
18 %,</w>
17 6</w>
17 ),</w>
16 6</w>
15 S)-
14 %,</w>
12- hour</w>
11. 3</w>
100 ,00
10 38
1,25 (OH)2D
1 ]</w>
0.8 5</w>
0.5 9</w>
0.00 5),</w>
0.0 3%</w>
0.0 2,</w>
0. 90</w>
0. 70</w>
0. 7%</w>
0. 39</w>
0. 33</w>
0. 1
0 %;</w>
.000 1),</w>
.0 4).</w>
-1 23</w>
- 3
, 6
(p< 0.001).</w>
(mean +/-
(inter quartile</w>
(di -n-propyl
(V F)</w>
(T NF-
(T E
(SSR I
(S -
(PT U
(PE T)</w>
(O C)</w>
(NSAID s).</w>
(M R)</w>
(M P)</w>
(M I).</w>
(L i
(I T)</w>
(I T
(H PL
(H CT
(G TN)</w>
(G T
(G D)</w>
(F F
(F EV
(E PO)</w>
(E )-
(D ox
(D A),</w>
(CH F),</w>
(CG I-
(C lin
(C h
(C P)</w>
(C M)</w>
(C AB
(B P),</w>
(ARF ).</w>
(AM I)</w>
(AC TH)</w>
(A UC
(A PA
(A A)</w>
(9 5%
(50 )
(4- chloro
(4 5.
(4 2.
(3. 5</w>
(3. 0</w>
(2 %</w>
(10 %).</w>
(1- 3</w>
(1 0%</w>
(0. 6</w>
(+/- )
( t</w>
( low</w>
( iv)</w>
( eight</w>
( case</w>
( F</w>
( .
zolmitript an</w>
zidovud ine-induced</w>
ze braf
z op
z inc
yohimb ine,</w>
yl)-2- thiazol
year s'</w>
y ou
y ness</w>
y b
x er
with held</w>
with hel
with draw</w>
well- tolerated,</w>
wedg ed</w>
we d.</w>
we ar
volati le</w>
voc al
vitamin s</w>
visu alized</w>
visu al
vis ory</w>
vin yl</w>
vi sed.</w>
vi ru
veter inary</w>
venlafax ine.</w>
vehicle )</w>
vaso relaxation</w>
vas omo
var ices</w>
van idilol</w>
v ation</w>
uy ak
use s,</w>
uro kinase</w>
uro genital</w>
ur y</w>
ur ve
up dated</w>
unremark able.</w>
unmas k</w>
under goes</w>
uncoupl ing</w>
unc t
un saturated</w>
un dibular</w>
un commonly</w>
un altered.</w>
umb ar</w>
um p</w>
um ),</w>
ulo se</w>
ulcer s,</w>
u sions.</w>
twit ches</w>
twic e/
tumour s.</w>
tropi setron</w>
triiodo thyronine</w>
tri ad</w>
tre e</w>
transport .</w>
tradi tionally</w>
trabec ul
tox in,</w>
tor tic
tor ic
toler ated;</w>
tol but
toge ther.</w>
tle bor
tlebor o</w>
tiz ation</w>
tis ing</w>
tic ally,</w>
ti ll</w>
thyro toxicosis</w>
thi ocyan
them a</w>
the lin
tetro dot
tetr alo
tetan us</w>
termin ation.</w>
terat ogen</w>
tender ness,</w>
tempo ro
te t
tak es</w>
tachy phylaxis</w>
table ts.</w>
t- tissue</w>
t es.</w>
t ag
t AMCA</w>
syst ol
surge on</w>
sulpiri de-induced</w>
sulph adi
sulfonyl urea</w>
substanti ated</w>
subst rate,</w>
subject s:</w>
sube picardial</w>
sub divided</w>
struct ures,</w>
struct ure-
strok es.</w>
strok es,</w>
stret ching</w>
streng th,</w>
strai ght</w>
strab is
stomach ,</w>
stiff ness,</w>
steat osis.</w>
steat osis,</w>
ste al</w>
ste adily</w>
stabil ity,</w>
st un
st ac
sph er
sp ic
sotal ol-induced</w>
soa ked</w>
so as</w>
smok ers,</w>
small est</w>
sim ple
signal ing,</w>
sid ual</w>
sial ic</w>
si ed</w>
si bu
si a:</w>
sho we
she ll</w>
she ep
sha res</w>
sevent y-
setr on,</w>
serv ices</w>
sept o
sensitiz e</w>
sensi tive.</w>
sensi tisation</w>
self- limiting</w>
sel ective,</w>
sedi mentation</w>
se mic</w>
se al</w>
schizophren ia:</w>
sacrific e</w>
sa phen
saphen ous</w>
s/ R
s-- a</w>
s orbit
s cl
rupt ure.</w>
rodent s,</w>
ro tation</w>
ro le
right- sided</w>
righ tward</w>
ribo se)</w>
rheumat ological</w>
retro gradely</w>
reticul um,</w>
reticul at
responsiven ess.</w>
responsi vity</w>
respir ation,</w>
reser vo
replic ated</w>
reple te</w>
renin-angiotensin- aldosterone</w>
ren ally</w>
remo ved.</w>
relie f,</w>
reli ability</w>
relax ed</w>
relap ses</w>
regres sion,</w>
regar ds</w>
receptor s)</w>
recei ved,</w>
reason s,</w>
read ing</w>
re perfu
re mit
re dox</w>
re ;</w>
ratio )</w>
rat tleboro</w>
rash es,</w>
ranitid ine.</w>
rang e)</w>
radiocon trast</w>
radi ating</w>
rabb it.</w>
r us
quin id
quad r
put resc
purpur ic</w>
pum ps</w>
prototyp e</w>
protein ;</w>
protein /
protect or</w>
proteas ome</w>
prospecti vely.</w>
propafen one.</w>
prometh azine,</w>
produc ed.</w>
proca ine.</w>
pro- inflammatory</w>
pro- arrhythmic</w>
pro jections</w>
princi ple</w>
prima quine</w>
preval ence,</w>
prepar ative</w>
preeclamp sia</w>
pre medic
pre clu
preclu des</w>
pp m,</w>
potassium- sparing</w>
postul ated.</w>
post- transplantation</w>
post- synaptic</w>
post surgical</w>
posi tioned</w>
pos tictal</w>
por tive</w>
polydip sia</w>
poly clonal</w>
poly amines</w>
pol yc
poin ted</w>
pogrel ate</w>
po or.</w>
po l</w>
po doc
plau sible</w>
plasmaphere sis.</w>
placebo -</w>
piri l
pir one</w>
piper onyl</w>
pine al</w>
pig mented</w>
physostigm ine-induced</w>
physici an.</w>
phosphoro fluoridate</w>
phosph ati
phenyl)- 4-
phenel z
pg/ ml,</w>
person s.</w>
perox isom
perox ides,</w>
perio d;</w>
perio d)</w>
pergol ide,</w>
paw s</w>
pathophysi ology.</w>
pathophysi ology,</w>
path ogens</w>
pat ency</w>
particip ants,</w>
parkin son</w>
parg yline</w>
paresthesi as,</w>
paradoxic ally</w>
par aph
pancur onium.</w>
pa que</w>
p< 0.05).</w>
p-chloro phenylalanine</w>
p s,</w>
p ole</w>
p ase</w>
p able</w>
p H
p ,
oxaz aphosphor
over weight</w>
over all,</w>
ovari an,</w>
ov ulation</w>
ot ub
ot ropium</w>
osteo arthritis</w>
oscill ations</w>
os pec
orthopa edic</w>
ors al</w>
orrhe a.</w>
orrhe a,</w>
orph ine,</w>
or rho
opioid -dependent</w>
oper ations.</w>
opent et
op recipit
op or
op ed
oped uncular</w>
ont g
one- related</w>
one ur
ondansetr on.</w>
on ide</w>
on azole,</w>
ol one,</w>
oid -induced</w>
od orsal</w>
occurren ce,</w>
occlu sions</w>
occa sion</w>
obser ving</w>
obsc ure.</w>
o il,</w>
o hex
now ,</w>
normal isation</w>
nor adrenaline-induced</w>
non sedating</w>
nocicep tin</w>
nitroprus side
nim odi
night ma
neuropath ologic</w>
neuro troph
neuro physiologic</w>
neuro hypophy
nephron s</w>
nephrectom y.</w>
nelfin avir</w>
necro tising</w>
nebul ized</w>
ne vertheless</w>
ne o-
nat ally</w>
nafc ill
naf amostat</w>
n s,</w>
n g,</w>
n anop
n M,</w>
my ocyt
mut ations.</w>
multicent re,</w>
multi system</w>
mucosi tis.</w>
mou th.</w>
mot oric</w>
monke y.</w>
mon onucle
modifi ed.</w>
moclobem ide</w>
mis diagnosed</w>
mirro red</w>
minoxidi l,</w>
minip ump
min/ 100</w>
min -1.
mid od
microsph e
micromol/ kg,</w>
micromol/ kg)</w>
micrograms/ g</w>
microg/ 0.5</w>
micro perfusion</w>
micro liter</w>
micro l),</w>
micro g
micro circulatory</w>
micro bleeds</w>
mi vac
mg/ g</w>
mg/ (
metronidazol e,</w>
methyl- 2-
methach oline</w>
meth om
meth anol</w>
metalloprotein ase</w>
meta zol
mesn a.</w>
mening o
membrane- stabilizing</w>
medic inal</w>
meaning ful</w>
me stran
maz ep
mark s</w>
mapro til
manufacture r</w>
man dibular</w>
mainten ance.</w>
macrom olec
macroli des</w>
mac y
mGluR 1</w>
mEq/ L,</w>
m :</w>
m 2,</w>
lymphadeno pathy</w>
lymphaden opathy,</w>
low er-
losart an,</w>
lofex idine</w>
lob a</w>
lo ok</w>
littermat es</w>
lipid- lowering</w>
limb ,</w>
lidoca ine)</w>
li sts</w>
levof loxacin.</w>
leuc openia</w>
lept omen
length s</w>
leishman iasis</w>
lead s.</w>
lay er,</w>
lat e.</w>
lab ile</w>
l uc
l ined</w>
l a</w>
kilog ram
kappa -
k uyak
junc tion.</w>
j it
iz ine,</w>
iz ar
it us</w>
isoprenal ine.</w>
isol ated-
isch aemia,</w>
ir CR
io dine</w>
investig ations.</w>
intraperitone all
intran igral</w>
intrad ermally</w>
intracaver nous</w>
intra vesi
intoler ance.</w>
interven tional</w>
inter n
intellect ual</w>
insul in-
institu tion,</w>
inst ance,</w>
ins ular</w>
injec tion:</w>
initi ates</w>
inhibitor s:</w>
inf undibular</w>
indic es.</w>
indic ated,</w>
increas es,</w>
inclu ded,</w>
inc rimin
inc ess
incess ant</w>
inc er
in ward</w>
in suff
in side</w>
in ner
in activated</w>
imple mentation</w>
impl ied</w>
immuno allergic</w>
immun ization</w>
immer sion</w>
immedi ate-
im pregn
illu strated</w>
il :</w>
id o-
icter us</w>
ical Tri
ic um</w>
ic ally-
ic -like</w>
ibu tilide</w>
i um,</w>
i led.</w>
i al,</w>
hypoten sion;</w>
hypocalce mia.</w>
hypo thyroidism,</w>
hypo thyroid</w>
hypo gon
hypogon adis
hyper sensitiv
hyper lipid
homeost asis,</w>
histopath ologically</w>
hist ologically.</w>
hir udin</w>
hir su
her b</w>
hemorrh ages.</w>
hemorrh ages,</w>
hemodynam ics.</w>
hemodialy sis,</w>
hemo dilu
hematopoi esis</w>
hap to
ham pe
halothane- associated</w>
hall mark</w>
hab en
h o</w>
h (-1)</w>
gynec ological</w>
guan ylate</w>
group s).</w>
granulo cytes</w>
graf ted</w>
glutathione- S-transferase</w>
gli oma</w>
ger bil
gen er</w>
gen ated</w>
gefit inib</w>
gastro -
gad opentet
g out</w>
fut ure.</w>
fosin opril</w>
forsk ol
formul a</w>
for ,</w>
flup enthixol</w>
flu ids,</w>
flu id-
flow metry</w>
flatten ing</w>
fixed- ratio</w>
fil tered</w>
fel bamate</w>
fas ci
f ram
f ox
ext ingu
exc ited</w>
examp les</w>
ex ha
ex change.</w>
ethyl ]
et rial</w>
et in-
estrogen s,</w>
erythe ma,</w>
ere d,</w>
epilept ogenesis,</w>
ep oxide</w>
enti ties</w>
ent opeduncular</w>
ent ing</w>
ensu ing</w>
ensu ed</w>
enhance d.</w>
endotheli um.</w>
endomet rium</w>
end ocytosis</w>
enabl ing</w>
en dur
eme sis,</w>
embol ism,</w>
el as
ect al</w>
echocardiograph ically</w>
earli er,</w>
ear s</w>
each )</w>
eNO S-
e z
e osin</w>
dysrhythmi as.</w>
du plication</w>
drople ts</w>
dro spiren
dro p-
dp/d t</w>
dose- finding</w>
dopamine- mediated</w>
donepe z
dom ain
disturb ing</w>
discrep ancy</w>
discontinu ations</w>
disco vered.</w>
dinit ro
dimethyl amino
dihydroxyphenyl acetic</w>
dihydro-5H- di
digitalis -</w>
differenc es,</w>
diet )</w>
didanos ine.</w>
diclofenac -induced</w>
dic loxacillin</w>
diabet es
di agonal</w>
dexmedetom idine,</w>
dexamfet amine</w>
dev ices</w>
detach ment</w>
det ection,</w>
derm atitis.</w>
derang ement</w>
defen sive</w>
deci sions</w>
dec ongest
de s-
de aling</w>
daz ox
daptom ycin</w>
dang er
d le</w>
d inal</w>
cytarab ine.</w>
cyclospor in.</w>
cu ff
cor ro
cor por
coni ine</w>
con spic
compon ent,</w>
compar ator</w>
compar able.</w>
comp eting</w>
coll ections</w>
colchic ine,</w>
cogni tion.</w>
code ine.</w>
co oling</w>
co existence</w>
clozap ine-related</w>
clox acill
clopidogrel ,</w>
clonid ine's</w>
clon ed</w>
clon azepam.</w>
cl es,</w>
cit rate,</w>
circumferen tial</w>
chori onic</w>
chemo kine</w>
charg ed</w>
ch ains</w>
ch ain
cerebri .</w>
cere bel
cepti bility</w>
ceph apir
cellular ity</w>
ce bus</w>
cation ic</w>
catheter ized</w>
cas es;</w>
cardiomy ocytes,</w>
carcin om
carben icillin</w>
carbam o
captopri l-treated</w>
calci um-dependent</w>
cad mium</w>
c t</w>
c AMP-
bur st-
bu ter
bu ild
bradykine sia,</w>
bp m.</w>
bol us,</w>
bo y,</w>
bisulf ite</w>
bisulf it
bi weekly</w>
bi perid
bevaciz umab</w>
beta- estradiol</w>
beta 4-
bas e,</w>
bacter ia</w>
baclofen -induced</w>
bac k-
b izar
b ing</w>
b id</w>
b arium</w>
auto receptor</w>
aur a.</w>
attem p
ativel y.</w>
ate -related</w>
at ures</w>
ass ays,</w>
aspart ate,</w>
aspar agin
as pi
as phy
arthro plasty.</w>
artesun ate</w>
arteri al,</w>
arrhythmo genicity</w>
aripiprazol e,</w>
are ly</w>
approach ,</w>
apo A-
ap ex</w>
ap atri
aorta ,</w>
antigen s,</w>
anti- inflammatory,</w>
anti- allodynic</w>
anti thymocyte</w>
anti proliferative</w>
anti n</w>
anomal ous</w>
animal s;</w>
animal s'</w>
animal 's</w>
angio plasty.</w>
ance )</w>
an- 2-
an um</w>
an aplastic</w>
an abol
amitriptyl ine-induced</w>
amino oxyacetic</w>
amino acid
amin oterminal</w>
amilor ide.</w>
amide -
ambi ent</w>
am sac
am odi
am il</w>
alumin um</w>
alprazol am,</w>
alpha- lipoic</w>
alpha- amino-
alpha 2b</w>
alpha (1
alopec ia.</w>
alle les</w>
al ity,</w>
age- adjusted</w>
ag o.</w>
ag ed.</w>
ag atran</w>
after wards</w>
advance d,</w>
adul t,</w>
adolescent s,</w>
ad mixture</w>
ad amant
acu ity.</w>
act omy
act ing,</w>
acetyl ator</w>
acetazol amide,</w>
acet amide</w>
accept ance</w>
abstr acted</w>
abs ent,</w>
abl y.</w>
ab ine,</w>
a ined.</w>
a etiological</w>
[corrected ]</w>
[OR ],</w>
[ HR
[ Ca
[ 125
W S</w>
Vaso pressin</w>
Van comycin</w>
Val s
VR L</w>
V G
V F,</w>
Ur d</w>
Up per</w>
UD CA</w>
U/ kg</w>
Twenty- four-hour</w>
Tran sc
Tou rette</w>
The ophyll
Thal idom
Ta king</w>
TM CD</w>
TIVE :</w>
TI N</w>
TI A</w>
TE E</w>
T ex
T ac</w>
T MA.</w>
T G,</w>
T AM
Sup portive</w>
Sum atriptan</w>
Ste re
Soci al</w>
Si rolim
Sha kuyak
Schizophren ia</w>
SU N</w>
SSR 18
SSR18 150
SSR 1038
SPEC TIVE:</w>
SO CS
SNA P</w>
SN D</w>
SG K1</w>
S om
S keletal</w>
S evo
S co
S PAR
S CO
S AR
S 2</w>
Renograf in</w>
Re sidual</w>
Re flex</w>
Rati o</w>
RE SEARCH</w>
RB Cs.</w>
R he
R elev
R AN
R 2</w>
QT- interval</w>
Psych osis</w>
Pro buc
Prinz met
Previ ously,</w>
Post natal</w>
Po sterior</w>
Picrotox in</w>
Physos tigmine</w>
Phen obarbit
Pharmaco vigilance</w>
Patient s'</w>
PV Cs</w>
PR IS</w>
PMS F</w>
PGE 2-induced</w>
PER SPECTIVE:</w>
PE P</w>
P< 0.05),</w>
P< 0.01)</w>
P< 0.001)</w>
P- glyco
P od
P g
P atter
P R)</w>
P Q</w>
P ICU</w>
P H-
P =.0
Oxytoc in</w>
Oxy gen</w>
Optim al</w>
Od ds</w>
Oc curren
Observ ations</w>
OR G</w>
O pen
O ff
O G</w>
O /
Nitro fur
Neuro protective</w>
NT Ds</w>
NIK- 247</w>
NC 92
NC92 H2</w>
NA ,</w>
N-methyl-D- aspartic</w>
N-acetyl cyste
N-[4- (5-nitro-
N-[4-(5-nitro- 2-fur
N-[4-(5-nitro-2-fur yl)-2-thiazol
N- nitro-L-arginine</w>
N(G)- nitro-L-arginine</w>
N ucle
N early</w>
N MRI</w>
N 6-
Mit oxantrone</w>
Mi pa
Mg 2+</w>
Mg +
Methotrex ate-induced</w>
Medic ations</w>
MPT P-induced</w>
METH .</w>
ME K</w>
MD )</w>
MA -induced</w>
M un
M t
M os
M ontg
M ini
M ec
M V
M S.</w>
M P)</w>
M O
M MA</w>
M CF
M 3</w>
Lor azepam</w>
Lo s</w>
Linezol id</w>
Langendor ff</w>
LAM- resistant</w>
L-N MMA</w>
L S:</w>
L S)</w>
L CBF</w>
L 6-
Ketocon azole</w>
Ket oro
K reb
J arisch</w>
Is- 5-M
Ir b</w>
Inter fer
Ins 1
Infarc tion</w>
In stitutes</w>
In dex
Impro ve
Imag ing</w>
Ig G,</w>
Ibu profen</w>
IV H</w>
IS T</w>
IP P</w>
IL- 3</w>
IF O-induced</w>
IF -1</w>
IC ),</w>
I le
I dazox
I X</w>
I P,</w>
I 2</w>
Hormon al</w>
Hear ts</w>
He ter
Ha em
HLA- DR</w>
HB V.</w>
HAM- D
H W
H I-
H F
H AT
Gy nec
GluR 2</w>
Ger many</w>
GF AP-
GE M</w>
G lomer
G T)</w>
G NC92H2</w>
Foscar net</w>
Fifty- six</w>
Fat ty</w>
FE N</w>
FANFT- ---
F rac
F Z-
F R</w>
F ;</w>
Ex clusion</w>
Ew ing's</w>
Euro p
Episo des</w>
Eosinophil ic</w>
Endom etrial</w>
En ter
En cephalo
Emer gence</w>
Eff ective</w>
Ec stas
Ear lier</w>
ERK 1/2</w>
EG b</w>
E toric
E smo
E s
E O</w>
E 2.</w>
E /A</w>
Duchen ne</w>
Dobut amine-induced</w>
Dis opyramide</w>
Di phenyl
Di phen
Di ar
D ia
D LT
D E</w>
D 4</w>
D -induced</w>
D (1
Cr )</w>
Cou mad
Contri bution</w>
Computer ized</w>
Compar ing</w>
Comp ounds</w>
Cocaine- Induced</w>
Clozap ine-induced</w>
Clopido grel</w>
Cir culating</w>
Chol inergic</w>
Chlor ambuc
Cat at
Cardi opulmonary</w>
Carb on</w>
Carb achol</w>
CYP 3A
CM ,</w>
CK ,</w>
CI N</w>
CI -1
CD .</w>
CA s</w>
C3 H</w>
C max</w>
C S)</w>
C M)</w>
Bicucul line</w>
Bezold- Jarisch</w>
Be sides,</w>
BP H</w>
BB B.</w>
BAE P</w>
BA Y</w>
B ot
B inding</w>
B SA</w>
B PD</w>
B H</w>
B E</w>
B 4</w>
B 1
At tempt
Astr agalus</w>
As berg</w>
Ar g</w>
Anticoag ul
Anthrac yclines</w>
Alb ino</w>
Al do
Akathi sia</w>
Administ r
Ad visory</w>
Ad ding</w>
Ad dic
Ab use</w>
ANIMA LS:</w>
ANCA .</w>
ANCA )</w>
AN )</w>
AC Ei
AC ),</w>
ABT- 594</w>
A mi
A 5</w>
A 10</w>
A -</w>
= 1.
99 ,</w>
9. 5%</w>
9 7.
9 3,</w>
80 %,</w>
7 th</w>
7 142</w>
7 -</w>
6-mercaptop urine</w>
6 25</w>
6 -1.
5-HT1 B</w>
5-HT (4)</w>
5- bromo
5 FU</w>
5 80</w>
5 5,</w>
40 ).</w>
4. 1%</w>
4- hour</w>
4- D
4 3)</w>
4 18</w>
378 49</w>
378 4
34 4/
30 %)</w>
3- hydroxy-3-
3- 6</w>
3 8,</w>
3 8)</w>
3 4).</w>
3 30</w>
3 30
3 24</w>
28 2</w>
27 9</w>
27 8</w>
26 .</w>
24 5</w>
24 25
24 %,</w>
23 ),</w>
2. 8,</w>
2. 4%</w>
2. 1%</w>
2- CdA</w>
2 90</w>
2 72</w>
2 27</w>
2 26</w>
199 8,</w>
19 7</w>
19 75</w>
19 6</w>
19 /
19 ),</w>
19 %,</w>
18- month</w>
18 ;</w>
18 0-
18 .</w>
16. 3</w>
16 %.</w>
15- min</w>
15 3</w>
12. 8</w>
12. 6</w>
12. 3</w>
12. 2</w>
12. 1</w>
12- week,</w>
12 ;</w>
10(- 4)</w>
1.0 4</w>
1. 9%</w>
1. 6-
1- month</w>
1- 6</w>
1, 200</w>
1 0.1</w>
1 +</w>
00 )</w>
0.9 8</w>
0.8 %)</w>
0.7 8</w>
0.6 %)</w>
0.5 5</w>
0.5 3</w>
0.5 1</w>
0.0 3,</w>
0. 48</w>
0. 44</w>
0. 4-
/ day</w>
/ capsaicin</w>
.0 3).</w>
-2 '-
-1- piperazin
- frozen</w>
- 4
, 48
+/- 0.0
+/ -1</w>
)- receptor</w>
)- mediated</w>
(p .
(U PD
(T N
(SR L)</w>
(S P)</w>
(S O
(S D
(PP I)</w>
(PAN ).</w>
(P= 0.
(P TH)</w>
(P <</w>
(P -
(O X
(MB F)</w>
(L i)</w>
(L D)</w>
(L A)</w>
(I g
(I R)</w>
(HV A)</w>
(HA AR
(GB M)</w>
(G I)</w>
(EAC A)</w>
(E F
(E )</w>
(D ex
(D LT)</w>
(D -
(CPK )</w>
(C O)</w>
(C K-
(C E
(C AT)</w>
(C AD)</w>
(Brd U)</w>
(AV P)</w>
(AN CA)</w>
(AD P-
(A l
(A SA)</w>
(A LT),</w>
(A ID
(A F
(8 )</w>
(7 1%)</w>
(6 %),</w>
(5 6.
(4. 0</w>
(4 ),</w>
(3 8</w>
(3 6.
(3 4</w>
(2. 5%)</w>
(2 5.
(2 5,</w>
(2 +)</w>
(10- 20</w>
(10 -100</w>
(1 2%</w>
(1 1/
(1 ))</w>
(0.5- 2</w>
(0.0 5-
(0. 25
(+/-)- PG-9</w>
(+ ),</w>
( twice</w>
( rate</w>
( number</w>
( grades</w>
( given</w>
( dose</w>
( delta</w>
( before</w>
( age,</w>
( T</w>
( RE
( OD
( MAP</w>
( C</w>
zol edronic</w>
z ofen
z atebr
yl ine,</w>
yl -1-
yeli d</w>
ycl ine-induced</w>
y et.</w>
xi mel
x- ray</w>
x ),</w>
worldwide .</w>
wor th</w>
wk )</w>
weigh ts,</w>
week ).</w>
wear ing-
wav es.</w>
warfar in-
war ming</w>
wa y,</w>
voc alization</w>
vis ually</w>
vis cer
virus- infected</w>
virt ue</w>
vir us
vid a</w>
vi vid</w>
veloc ity.</w>
veloc ity,</w>
vas ovagal</w>
vari able,</w>
vari ability,</w>
val eric</w>
vag otomy.</w>
v illo
villo us</w>
use d:</w>
urotheli um.</w>
ure mia</w>
underli es</w>
ultrasoun d,</w>
ultrason ographic</w>
ultim ate</w>
ulo spinal</w>
ulc er.</w>
tumor- bearing</w>
tub ero
tryp sin</w>
triple -
treatment ),</w>
treat .</w>
transplant ations</w>
transfu sions.</w>
train ing.</w>
train ing,</w>
trac king</w>
tra it.</w>
tra ff
toxic .</w>
topiram ate.</w>
top ic</w>
tobacco ,</w>
to- body</w>
tit ude</w>
tis ;</w>
tis -like</w>
til t-
tic ity.</w>
tic ally.</w>
tiag abine</w>
ti redness</w>
ti lled</w>
thyro id-stimulating</w>
thrombocy th
thrombo phlebitis,</w>
three- year</w>
thiopent one,</w>
thio redox
thi ocarb
thi amine</w>
themsel ves.</w>
the red</w>
th en
tetrap legic</w>
tetralo gy</w>
tetraca ine,</w>
tet any</w>
teratogen icity.</w>
ter odi
ter i
ten sion,</w>
ten der</w>
teli thromycin</w>
techniqu es,</w>
techne tium-
tech no
te eth</w>
tas ks.</w>
tas k
tari o</w>
tacrolim us-associated</w>
ta .</w>
ta ,</w>
t ation.</w>
t "</w>
synthesi ze</w>
syndrome ;</w>
symptom -
sym metric</w>
survi ve</w>
supra -
supplement ation,</w>
sup rag
sulfonyl ure
sulfon amides</w>
sulf onate</w>
sulf ad
succ umb
subunit s,</w>
subject s).</w>
sub type
sub total</w>
sub therapeutic</w>
sub stituting</w>
sub groups.</w>
su n
stud y:</w>
strychn ine.</w>
strychn ine,</w>
strept ococcal</w>
stop -
stomach .</w>
stimul ant-induced</w>
stereot actic</w>
statis tics</w>
stat ins.</w>
stac hy
stabil ize</w>
sta y,</w>
st ate-dependent</w>
st ag
spont aneous
sper midine</w>
sp an
som an</w>
sof t-tissue</w>
smok eless</w>
siz es</w>
situ .</w>
sit e-
sist ance</w>
sinu si
sino aortic</w>
shif ting</w>
shi vering</w>
sequel ae,</w>
sequ est
sept um.</w>
self- injection</w>
sedati ve-
sec tion,</w>
se ed</w>
scleroder ma-like</w>
scinti graphy.</w>
scientif ic</w>
sc ar</w>
sav ings</w>
sampl es,</w>
sal ine-</w>
sa ving</w>
sa id</w>
s- like</w>
s nor
s -old</w>
s -1</w>
ru thenium</w>
rou re
rosi glitazone</w>
ro li
ritonavir .</w>
risk :</w>
rifamp icin,</w>
rif abut
rib osomal</w>
rh EPO</w>
review ing</w>
rever sion</w>
retrie ved</w>
respond ing.</w>
resor ption</w>
resolu tion.</w>
resid ues</w>
reserpin ized</w>
reser pine,</w>
res in</w>
res in
resin ifer
replac ing</w>
renew ed</w>
remoxi pri
remo ving</w>
rele ases</w>
reg ime</w>
refractor iness</w>
recti fier</w>
record ing.</w>
rec anal
reason s.</w>
re starting</w>
re organ
re med
re institution</w>
re d:</w>
rauwolsc ine</w>
radi ation.</w>
r arity</w>
qui et</w>
pyrrolid in-2-
pyrrolidin-2- one</w>
pyridox ine.</w>
py uria</w>
putresc ine</w>
punct ure.</w>
pulsati lity</w>
public ation</w>
publ ished,</w>
pt s,</w>
pt osis,</w>
psychostimul ants</w>
psychi atri
protect ant</w>
propylthiourac il.</w>
propyl -
prolact in.</w>
progab ide</w>
proca ine,</w>
pro state.</w>
pro be.</w>
pro arrhythmia.</w>
primi tive</w>
prescrip tions,</w>
pres s</w>
preponder ance</w>
pregn an-
preferen ce.</w>
pre transplant</w>
pre chemotherapy</w>
pran olol</w>
potenc y,</w>
post transplantation</w>
poly somno
poly cyst
pneumon itis,</w>
ple mentation</w>
plan ning</w>
placebo ).</w>
placebo ),</w>
pl en
pirenzep ine</w>
piper acillin</w>
pide m</w>
pict ure.</w>
pi ric</w>
phosphono heptano
phenterm ine.</w>
phenterm ine,</w>
phenomen a,</w>
pheno thiazine</w>
phencycl idine</w>
phen oidal</w>
ph on
ph aryn
ph ac
pg/m L,</w>
perturb ation</w>
person nel</w>
persist ent,</w>
peripher y</w>
perin uclear</w>
perfor med
percent .</w>
perce pt
per s</w>
pentylenetetraz ol,</w>
pentamid ine-induced</w>
ped unc
path ogenesis,</w>
parap aresis</w>
parame dic
paradig m,</w>
par a-
pal mar-plantar</w>
p urine</w>
p ter
oz o
oxy bu
oxif loxacin</w>
ox amniqu
ox acin</w>
overl ap</w>
over looked</w>
otom y,</w>
oto x</w>
ot otoxicity,</w>
ot otoxic
ot ing</w>
ot et
osmol al</w>
osc ine</w>
osc il
ori ens</w>
ore x
ord inary</w>
or y-
or der,</w>
opini on</w>
opi ates.</w>
oph ore</w>
oper oxidase</w>
open h
op anc
opanc reat
on ym
on ly)</w>
omega- nitro-L-arginine</w>
olig uria,</w>
ol ive</w>
ol ine,</w>
ol ),</w>
oid s.</w>
ogen s.</w>
of -dose</w>
ocyan id
obvi ously</w>
obe se,</w>
ob ste
ob ia,</w>
o x</w>
o res
numb er.</w>
novel ty</w>
normoten sive,</w>
normo volemic</w>
normal ities</w>
non- users</w>
non- drug</w>
non small</w>
non linear</w>
nodul es,</w>
no vi
nitros o-
nitroglycer in-
neutrophil ia</w>
neuroblast oma.</w>
neuro toxin</w>
netilmic in</w>
nephro pathy:</w>
neph ri
nefir acetam</w>
nad olol</w>
na phthal
na i
nACh R</w>
myo fibri
my x
my oneuropathy</w>
muscim ol.</w>
mul tin
mou se
mother 's</w>
mot ript
morph ogenesis</w>
mono valent</w>
monke y
mon ophosph
moder n</w>
mo od,</w>
mmol/ l,</w>
mmol/ kg,</w>
mm/ sec</w>
mm ;</w>
mm 3.</w>
mm 3,</w>
mm .</w>
ml -1)</w>
ml (-1)</w>
mix ing</w>
mivac urium</w>
mio sis.</w>
minut es).</w>
min s</w>
min g,</w>
min -1.</w>
min -1).</w>
microbub bles</w>
micro tubules</w>
micro M.</w>
micro L,</w>
mg/kg/ min)</w>
mg/d l;</w>
mg/( kg.
mg/ L,</w>
mg. kg-1,</w>
metronidazol e-induced</w>
metri z
methyl dopa,</w>
meth ox
meta proteren
meso theli
ment ation,</w>
mening i
men ;</w>
medic ines</w>
medi a-induced</w>
me -induced</w>
mas s.</w>
malondi aldehyde,</w>
mal nutrition</w>
mal ine-induced</w>
mal es)</w>
main tained,</w>
ma kal
m IU/
m AMPH</w>
lymph ocytes.</w>
lymph ocytes,</w>
low- osmolality</w>
loracar bef</w>
loc ation.</w>
lo vastatin,</w>
ll ation</w>
lithium- pilocarpine-induced</w>
like wise</w>
lig and,</w>
leucov or
lepir udin</w>
le brand</w>
le af
lamin in</w>
lact ating</w>
lac un
laborator y.</w>
labor ative</w>
lab or,</w>
l .
kg -1),</w>
ketocon azole.</w>
ket one</w>
kal emic</w>
kHz .</w>
k ill
jit ter
jer king</w>
iz ed-
ix ed</w>
ist .</w>
issu e.</w>
isoprost ane</w>
iso- osmolar</w>
ischem ia-reperfusion</w>
ir ta
iox ag
iodo -
inv a
inva sion</w>
intub ating</w>
intrat ympanic</w>
intra- aortic</w>
intermit t
interfe red</w>
inter individual</w>
int act,</w>
inst ability.</w>
injec tion).</w>
inhal ational</w>
infusion ).</w>
infra red</w>
infiltr ate.</w>
infarc ts</w>
inf in
inf ant,</w>
ine al</w>
indinavir ,</w>
increas e)</w>
incorpor ating</w>
inci sional</w>
in- A</w>
in th</w>
in tent</w>
in stituted.</w>
in ol</w>
in n
impair ments.</w>
immune -
immun ologically</w>
immun ized</w>
immedi ately.</w>
imbal ance.</w>
im ped
ile al</w>
il iac</w>
il am
il -associated</w>
ig o</w>
idazox an,</w>
id -associated</w>
icalTri al
ibuprofen -induced</w>
ia -related</w>
i.p. ;</w>
hypovol emia</w>
hypot onic</w>
hypospadi as</w>
hyperton ia</w>
hypere osinophil
hypercoagul able</w>
hypercap nia</w>
hyper ventilation</w>
hyper thyroidism,</w>
hyper intense</w>
hydro peroxides</w>
hydro alcoholic</w>
hydram ni
hydra z
hum or</w>
hor ses</w>
hippocamp al-
high- resolution</w>
high- energy</w>
hepato renal</w>
hepati s</w>
hepar an
hemo stasis</w>
hemis pheric</w>
hemis phe
hemat ology</w>
hem opoietic</w>
help ed</w>
hel ps</w>
hed onic</w>
heart- lung</w>
h ard
gri d</w>
graf ts.</w>
graf t.</w>
glyco gen
glyc ine,</w>
glucuron ide-induced</w>
glomerulosclero sis,</w>
glo s
gli otic</w>
genotyp ic</w>
ge t</w>
gamma- HCH</w>
gam bl
gadopentet ate</w>
ga ine</w>
g/d l)</w>
g in</w>
g ains</w>
g (-1)</w>
fron t-
fresh -frozen</w>
free zing</w>
fr ame
fore stomach</w>
followe d-
followed- up</w>
fo rel
fo od.</w>
fluvox amine.</w>
flus piril
fluoro phosphate</w>
fluo rene</w>
flu idity</w>
flecain ide,</w>
flavon oid</w>
fl acc
fil ter
fibrill ation:</w>
fib rate,</w>
fi ve,</w>
fer ulic</w>
fenflur amine-induced</w>
femal es)</w>
feed ing.</w>
fe ver
fe et,</w>
fe el
fav ored</w>
fast -
famil y,</w>
f u
f ec
ey di
eydi g</w>
extravas ation.</w>
extras timul
extr a</w>
expl anted</w>
exencephal y,</w>
excre tions</w>
exc essively</w>
ex pi
event -free</w>
euthan ized</w>
euthan ati
ethyl hex
estrogen .</w>
estradiol -17
esophag itis</w>
erup tion,</w>
erb al</w>
er ation</w>
equi valence</w>
epti des</w>
epinephr ine-
ep ri
eosinophil ia.</w>
endur ance</w>
endot oxin</w>
endoscop y.</w>
endocardi tis.</w>
endoc rin
endo thelin
end- point</w>
encephalo path
en ol
en es</w>
embryol eth
embol i</w>
electron- dense</w>
electrom agnetic</w>
eigh ty-
effectiven ess.</w>
effect )</w>
eff usions</w>
edarav one</w>
ed ),</w>
echocardiograph y:</w>
ech im
early- onset</w>
e yelid</w>
e w
e ren
e a.</w>
e 's</w>
dyspep sia</w>
dyses thesi
du al-
drug s;</w>
dr yness</w>
dp/d t
dox azosin,</w>
dose- related,</w>
dose- intensity</w>
dos cop
dopamine- related</w>
don or,</w>
docetax el,</w>
divid ing</w>
diure tic-induced</w>
diure sis.</w>
diure sis,</w>
distribu tions</w>
distingu ishing</w>
discontinu ous</w>
discol oration</w>
discipl inary</w>
dis tilled</w>
dis place</w>
dis appear</w>
dis advantages</w>
direct- acting</w>
direc t,</w>
diphenhydram ine.</w>
diltiazem -induced</w>
dihydroxy tryptamine</w>
dig iti
diffuse ly</w>
diff er.</w>
dichloro phenyl)
diast olic,</w>
diast ole</w>
diaphor ase</w>
diameter .</w>
diam orphine</w>
diacetyl morphine</w>
determin es</w>
determin ation.</w>
deterior ation,</w>
descri ptive</w>
des min</w>
depression -like</w>
depolar izations</w>
deoxy nucleoti
deoxy adenosine</w>
demonstrat ed,</w>
delta9- THC</w>
deliver ies</w>
dehydro epiandrosterone</w>
degre e,</w>
deform ity</w>
defl ection</w>
defibrill ator</w>
decreas ed;</w>
decl ine.</w>
de oxy-
daunorub icin-induced</w>
daunorub icin,</w>
dar be
danazol .</w>
danaparo id</w>
daidze in</w>
d, l-
d l
d ark
cytopen ia.</w>
cyt ometry</w>
cyt ologic</w>
cyst ectomy</w>
cyclohept en-
cult ures,</w>
cu ed</w>
criter ia:</w>
cri sis,</w>
cramp s,</w>
counter balanced</w>
cot reatment</w>
cortis ol.</w>
corticosteroid -induced</w>
corb ic</w>
cor onal</w>
conveni ence</w>
contracep tion.</w>
contra st.</w>
continu ous,</w>
contamin ated</w>
cont acts</w>
cont acted</w>
constric tion.</w>
constipati on.</w>
consequ ently,</w>
consequ ences,</w>
conjug ates</w>
confoun ded</w>
conflu ent</w>
confirme d,</w>
config ur
confer red</w>
conf usion.</w>
condition s:</w>
con vinc
con genit
compli ant</w>
compet ent</w>
compart ment.</w>
community- acquired</w>
com ing</w>
collicul us</w>
co valent</w>
co operative</w>
co effici
co ar
clonid ine-evoked</w>
clo c
clinic al
clinical trial
clin ic,</w>
cle a
clavul an
clarithrom ycin,</w>
cl or
ci pro
ci es.</w>
chromos omes</w>
choline- devoid</w>
cholangi opancreat
cholang itis.</w>
chol ere
chlorthal idone</w>
chlorthal id
chloroqu ine.</w>
chloroqu ine,</w>
chic ks</w>
chi sis</w>
chi as
chelat or</w>
chec k-
cell aneous</w>
cell -mediated</w>
cell ,</w>
ceftriax one,</w>
cef oper
cav ity,</w>
catarac ts</w>
cas pase</w>
carri ers.</w>
carrageen in</w>
cardiomyo plasty</w>
cardiomegal y</w>
carboplat in-induced</w>
carbo hydrate</w>
carbach ol.</w>
car dinal</w>
capsaic in-treated</w>
calcific ation,</w>
calc ified</w>
calbind in</w>
caffe ine-
c- fos
c ured</w>
c ue-
c t
c iliary</w>
c a</w>
c ]
c /
buprenorph ine.</w>
bund le-
bul k</w>
broad ly</w>
bod y,</w>
bo ost
bo gaine</w>
blo ody</w>
blind ness.</w>
ble ed</w>
bilater ally,</w>
bicucull ine.</w>
bi phasi
bi ochemistry</w>
bezafib rate</w>
beta-carb oline</w>
beta .</w>
benz yl</w>
benz ene</w>
benz amide</w>
benser azide</w>
bed time</w>
beclo methasone</w>
beats/ min)</w>
be n</w>
be ds</w>
be d,</w>
be an</w>
be agl
bcl -2</w>
base- line</w>
bacte remia</w>
bab y</w>
b all
b F
az ido-
az ed
awak ening</w>
aw asak
aver aging</w>
autop sy,</w>
autom ated</w>
auto immun
aut o-
audi o
atri a,</w>
ation al,</w>
ate d
ate "</w>
asym metric</w>
astroph ic</w>
astro cytes.</w>
assum e</w>
asses sed,</w>
assay )</w>
ascer tained</w>
arthri tis:</w>
arom atic</w>
arg ue</w>
apro z
appro x.</w>
appreci ably</w>
apparat us.</w>
apo A-I</w>
apl asia.</w>
apar t,</w>
ap ella</w>
anx ious</w>
anticonvuls ant.</w>
anti- cancer</w>
anti seizure</w>
anti anxiety</w>
anth ocyanid
ant acid</w>
anomal ies,</w>
angiotensin- converting-enzyme</w>
anec dotal</w>
and- wave</w>
anastro zole</w>
anaphyl axis.</w>
an os
an ions</w>
an i
amput ation</w>
amphet amines.</w>
amphet amines,</w>
amiodar one-associated</w>
aminol evulinic</w>
amin ol</w>
alu es</w>
alpha- fet
alpha- bungarotoxin</w>
alpha 5</w>
alkalo sis,</w>
algor ithm</w>
al- based</w>
al one;</w>
al motript
akathi sia.</w>
aggres sion.</w>
age- specific</w>
affor d</w>
aer obic</w>
adop ted</w>
adequ acy</w>
aden omatous</w>
ad ing</w>
activ ity-
activ ity)</w>
acin ar</w>
acidi fication</w>
acetylchol ine-induced</w>
acetyl ators</w>
acetyl ation</w>
accumben s,</w>
abstin ence,</w>
a reflex
[2- (3,4-
Y- maze</w>
Y 56
X +
Wil lebrand</w>
WA Y</w>
WA Y
W F</w>
Ve hic
Val vular</w>
VR 1</w>
VE P</w>
V indesine</w>
V alues</w>
V LDL</w>
Ultras on
U rin
U K.</w>
Tx B2</w>
Tu bulo
Topir amate</w>
Th re
Th iaz
Th ai</w>
TR I
TI C)</w>
TGF- alpha</w>
TE M
TB M</w>
T in
T an
T RE
TRE AT
T LE.</w>
T GF
T D.</w>
Suxameth onium</w>
Sus ceptibility</w>
Sup ra
Sul indac</w>
Subsequ ently</w>
Sub lingual</w>
Sub arachnoid</w>
Strept omycin</w>
Stra in</w>
Star ting</w>
So on</w>
Sm ad
Sim p
Seroton ergic</w>
Ser tr
Sensor ineural</w>
SUBJECT S</w>
STAT 3</w>
SR ,</w>
SM F</w>
SE X</w>
SA D</w>
S- T</w>
S ulph
S timul
S CI
S ARS</w>
Ris ks</w>
Reser pine</w>
Renografin- 76</w>
Rem ark
Regist er</w>
Recor ds</w>
Re as
RO P</w>
RN F
R s.</w>
R os
R om
R en
R ed</w>
R U</w>
R F</w>
R AST</w>
QT .</w>
Q- wave</w>
Q- Tc</w>
Q S/
Q ),</w>
Propofol-Lip uro</w>
Pro toc
Pro echim
Predn is
Practition ers</w>
Pharmac ologic</w>
Per hexiline</w>
Path ophysi
Parkinson ism.</w>
PU FA</w>
PT CA</w>
PH E</w>
PGE 2.</w>
PD -1
PCR .</w>
PC E</w>
PAC AP
P< 0.05)</w>
P< 0.01).</w>
P2 X</w>
P- gp</w>
P- 4</w>
P ur
P s)</w>
P MN
P L</w>
P IC
P D-
P CT</w>
P +
On tario</w>
O- de
O wing</w>
O G)</w>
O 2,</w>
O 2)</w>
Norm alization</w>
No vel</w>
Nis sl</w>
Nicot ine-induced</w>
Nicardi pine</w>
Neuro muscular</w>
Nec ro
N- [
N( omega)-
N i
N ex
N asal</w>
N P.</w>
N A)</w>
N )-
Myco bacterium</w>
Mit omycin</w>
Misoprost ol</w>
Minim al</w>
Mg 2+
Metoclop ram
Methyl -
Med line</w>
MR I,</w>
MI F</w>
MB C.</w>
M u
M is
M irta
M el
M ass
M all
M acro
M S-
M MP</w>
M K-
M CI-1
Lipos omal</w>
Le vel</w>
Lat ency</w>
Lab or
LI MIT
LI D,</w>
L-argin ine.</w>
L eydig</w>
L H,</w>
L EP
King dom
K awasak
Jap an,</w>
Ischem ia</w>
Inj ury</w>
IT C-
IB D</w>
I di
I STR
I 1</w>
Hyper icum</w>
Hu EPO</w>
Hexabri x</w>
Hemo globin</w>
Hallucin ations</w>
HR V</w>
HR .</w>
HD AC</w>
HC P</w>
HC G</w>
HB s</w>
H N</w>
Go od
Gly cyrrhiz
Glucocortico id-induced</w>
GO T,</w>
GF R.</w>
GE C</w>
GABA- mediated</w>
GABA- A</w>
GABA (B
G ene</w>
G O</w>
G G
G C</w>
Fos- IR</w>
Forty- nine</w>
Fl ur
Fat 1</w>
Fab '</w>
FSG S</w>
FK50 6,</w>
F ac
F T</w>
F 344/
F -induced</w>
Ex cit
Esmo lol</w>
Ery thema</w>
Epinephr ine-induced</w>
Em bry
Electro ly
EMBA SE</w>
EH X
EC E
EC A</w>
E MP</w>
E 217
Dyn amic</w>
Dis ruption</w>
Dex fenfluramine</w>
Decreas es</w>
DS P-4</w>
DPCP X</w>
DOX /
DL T</w>
DH S</w>
DESCRIP TION:</w>
DB A</w>
DA ergic</w>
D- Tr
D ulox
D o</w>
D N</w>
D H</w>
D 3,</w>
Coomb s'</w>
Continu ed</w>
Conserv ative</w>
Con fusion</w>
Comb ining</w>
Com prehensive</w>
Coll ectively,</w>
Co Q10</w>
Clon azepam</w>
Chlor promazine</w>
Chang e</w>
Ch rom
Cerebro vascular</w>
Case- control</w>
Candi da</w>
Cal ifor
CY P.</w>
CY A</w>
CR -
CR ,</w>
CP OB
CP H</w>
CP ,</w>
CM -induced</w>
CL D</w>
CD8 +</w>
CA ).</w>
C y</w>
C olo
C au
C annab
C T)</w>
C -treated</w>
Bri tish</w>
Bortezom ib</w>
BD L</w>
BALB/ c
B ipolar</w>
B er
B epri
B alb
B al
B a
B Z</w>
B W)</w>
B PA
B CH
As corbic</w>
Arg inine</w>
Ara- C.</w>
Ap gar</w>
Anti depress
Ang el
Amitript yline</w>
All ergic</w>
Adren aline</w>
Ac id</w>
Ab solute</w>
Ab normalities</w>
AT RA.</w>
ASP58 54</w>
AMPH -induced</w>
AM B</w>
AL C</w>
AIM S</w>
AB .</w>
A si
A mb
A SEX</w>
A P,</w>
A LT,</w>
< 0.05).</w>
90 7</w>
9 6%</w>
9 00
80 ).</w>
8. 4%</w>
8 9-
8 6.
8 2.0
82.0 7
8 12
8 -10</w>
78 10
60 2</w>
60 .</w>
6- year</w>
6- hour</w>
6,7- di
6 40</w>
6 3.
59 2</w>
5. 0%</w>
5-HT(2 C)</w>
5-HT 4</w>
5-HT 2B</w>
5-F U/
5- ASA</w>
5- 8</w>
5, 10-
5 9,</w>
5 8,</w>
5 6)</w>
5 2,</w>
5 %-
48- 67
48 6
40 %.</w>
4. 6
4 7)</w>
4 4)</w>
4 1).</w>
4 0%)</w>
36 6</w>
36 2</w>
30 th</w>
3- (
3,4-dihydroxyphenyl acetic</w>
3 52</w>
3 25</w>
27 .</w>
27 ).</w>
24 /
20- mg</w>
20 4
2-amino-7- phosphonoheptano
2- month</w>
2- day</w>
2- agonist</w>
2- 6</w>
2, 3,4-
2',3'- dideoxycytidine</w>
2 :1</w>
2 48</w>
2 2.5</w>
2 17</w>
2 16
2 0.0</w>
2 -1.
199 7.</w>
199 4.</w>
199 2.</w>
199 0,</w>
17 1555</w>
17 .</w>
17 ,
16 9</w>
16 1</w>
16 /
15. 8</w>
14. 4</w>
14. 2</w>
14 /
13. 9</w>
12. 7</w>
12 th</w>
100 %.</w>
10(9 )</w>
10 7
1. 35</w>
1- like</w>
1- 1</w>
1,25- (OH)2D
1 alpha-
1 a</w>
1 50-
1 1.</w>
1 (-/-)</w>
0.4 2</w>
0.0 %,</w>
0.0 %)</w>
0. 9-
0. 80</w>
0. 23</w>
0. 2%)</w>
0-1 20</w>
/ ml.</w>
/ HCTZ</w>
.00 4).</w>
.00 1</w>
.0 2)</w>
.0 2).</w>
. 7
-bl ue</w>
- up</w>
- out</w>
- of-
- labeled</w>
- H
- B
- >
- 6
- 0.6
,2 3-
, 9
)- containing</w>
)- -
) +
(n= 6)</w>
(i NOS)</w>
(e NOS)</w>
(c )
(TBAR S)</w>
(T MA)</w>
(T D)</w>
(SOD ),</w>
(SIAD H).</w>
(S E</w>
(S CL
(S C)</w>
(PR A),</w>
(P CA)</w>
(P C)</w>
(NS ).</w>
(ND I)</w>
(N a)</w>
(ME S)</w>
(M PA)</w>
(L-NAME ,</w>
(L O
(L E
(IC P)</w>
(HD L)</w>
(HBI G)</w>
(GABA )
(ED 50
(E R)</w>
(E F)</w>
(DR G)</w>
(CP )-induced</w>
(C CK-
(C CB
(C AP
(BB B)</w>
(B PR
(AP L)</w>
(AC h)</w>
(A n
(A MP
(7 9%)</w>
(6 5</w>
(6 5%)</w>
(6 1</w>
(5 5.
(5 4%)</w>
(400 mg/kg,</w>
(4 2</w>
(4 0-
(4 0%</w>
(4 %</w>
(3) H-
(3 1</w>
(2 8.
(14) C-
(10- 50</w>
(1 75</w>
(1 5,</w>
(1 5%),</w>
(1 1
(0. 9</w>
(0. 4
( stage</w>
( risk</w>
( overall</w>
( first</w>
( either</w>
( doxorubic
( baseline)</w>
( ara-
( ages</w>
( a
% :</w>
zonis amide</w>
yros ine</w>
yl- CoA</w>
yl urea</w>
yl cholinesterase</w>
yl -induced</w>
yc ill
y- based</w>
y- Asberg</w>
y ne
y loxy
y ?</w>
xyl az
worsen s</w>
wor st</w>
women :</w>
women ).</w>
wit nes
well- defined</w>
well- characterized</w>
week ),</w>
we t-
wet- dog</w>
wash ed</w>
wa ke
w w
w rist</w>
w ished</w>
w ays.</w>
vitamin -
viol et</w>
view ed</w>
vide o
victim s</w>
vic inity</w>
ventric les.</w>
ventilat or</w>
ve terans</w>
ve get
vasopress ors</w>
vas t</w>
varic ose</w>
vancom ycin-induced</w>
valu es)</w>
val ve.</w>
vacuol ization,</w>
vaccin ated</w>
v ist</w>
v apor
v a</w>
uter o,</w>
usi ve.</w>
us oidal</w>
urticar ia.</w>
ureter ic</w>
ures :</w>
ure ;</w>
ur ide,</w>
uptak e,</w>
unit s.</w>
uneventful .</w>
underestim ated</w>
un identified</w>
un favorable</w>
un consciousness</w>
un affected,</w>
ulcer s.</w>
ulcer ation,</w>
ul ation.</w>
ub ic</w>
u t</w>
two- fold</w>
twit ching</w>
turno ver,</w>
trypt oph
tropon in-
tript ans</w>
trimethoprim /
trimethaph an-induced</w>
trihexyphenid yl</w>
triglycer ide,</w>
triamterene .</w>
tremoro genic</w>
treat ed;</w>
trastuz umab
transplant s.</w>
transfu sion
trans placental</w>
tran d
tract s.</w>
toxic ,</w>
tox in.</w>
tortic oll
tor r,</w>
top ography</w>
tom ato</w>
tol me
tolme tin</w>
tol az
titr e</w>
tit ution</w>
tion ary</w>
tion al,</w>
time )</w>
til ting</w>
ti ve-
ti tres</w>
ti s)</w>
ti otropium</w>
thyro toxic
thiou rea</w>
thioridaz ine.</w>
thin k</w>
thiazol idinedi
thiaz ides</w>
therapeu tically</w>
theore tically</w>
thalam otomy</w>
th en-
tetr amethyl
test es</w>
tes tis</w>
termin als,</w>
tent h</w>
temozolom ide.</w>
te en
tampon ade
ta urine,</w>
ta ke
t. i.d.</w>
t z
t t
t ness,</w>
t le,</w>
t ab
syndrome "</w>
synchron ization</w>
sympatho adrenal</w>
superi ority</w>
summ ed</w>
sulph ate,</w>
sufentan il.</w>
suc kling</w>
subunit s.</w>
sub-Ten on's</w>
sub- effective</w>
sub normal</w>
sub maximal</w>
sub cl
su gar</w>
stu por
stu po
structur ally,</w>
stroke :</w>
strok e-
stric t
streptozotoc in-
strateg y.</w>
strabis mus</w>
stom y</w>
ster ol</w>
stent ing.</w>
stat ory</w>
st ent.</w>
st en</w>
spike- and-wave</w>
spectrophot ometric</w>
specific ally,</w>
spec ul
som nif
sof tw
sleep iness,</w>
sk y</w>
sk ull</w>
sk illed</w>
situ ations.</w>
sing .</w>
sim us</w>
sim end
sig moid</w>
si vity</w>
si s),</w>
shun ting</w>
shi ver
sham- lesioned</w>
sgk1 (+/+)</w>
sex .</w>
ses :</w>
serv ic
ser um-
sequel a</w>
sequ ence,</w>
sept um,</w>
sens ori
seleg il
sel ecting</w>
seizure -free</w>
sed )</w>
sec tions.</w>
seas onal</w>
se ated</w>
sch er
scher ichi
scherichi a</w>
sc rut
scrut in
sc otom
sc ious</w>
sarco idosis</w>
sar pogrelate</w>
salt- sensitive</w>
salbutam ol,</w>
sal ts.</w>
sac ral</w>
s/R Ds</w>
s way</w>
rough out</w>
ros ace
rop ic</w>
root s</w>
roli pr
ro ent
risperid one-treated</w>
rifamp in.</w>
ri zine</w>
ri pen
ri gorous</w>
rhabdomy osarcoma.</w>
retrospecti ve,</w>
retino pathy,</w>
retin oids</w>
retin oblastoma</w>
resuscit ation,</w>
resten osis</w>
rest ore
resist ances</w>
resinifer atoxin</w>
rescu ed</w>
res ume
res titution</w>
repolar ization,</w>
remifentan il.</w>
relax ing</w>
rel y.</w>
rel ates</w>
reflex -mediated</w>
ref used</w>
reduc t
recruit ment</w>
rec le
reas on,</w>
re perfusion,</w>
re move
re i-
re exposure</w>
re challenge
re absorption,</w>
raz od
ration 's</w>
rati os.</w>
rat ings.</w>
raph ic</w>
ranitid ine,</w>
radi atum</w>
radi ant</w>
ra ,</w>
r ational</w>
quinoxal ine-
quin idine-induced</w>
quadriple g
quadri paresis</w>
py ro
pust ular</w>
purpo ses.</w>
pur ity</w>
puer peri
psycho ses</w>
proteoglyc an</w>
prot ec
propoxy phene</w>
proper ti
prop acetam
prolactin omas</w>
proj ecting</w>
progno sis,</w>
pro- convulsant</w>
pro pa
pro anthocyanid
preserv ative</w>
prefer ably</w>
pre proenkephalin</w>
pre menstrual</w>
pre anesthetic</w>
pr e</w>
potenti als,</w>
post seizure</w>
post pon
post dose</w>
poly unsaturated</w>
poly substance</w>
ple ur
platele ts,</w>
plasmaphere sis,</w>
placent a</w>
plac ement.</w>
pir acetam</w>
pindo lol,</w>
pict ure,</w>
physici an-
physi ologically</w>
photoc ell</w>
phosph ate-induced</w>
phenyl )</w>
phenprocou mon</w>
phenothiaz ines</w>
phen ethyl
pharmac ogenetic</w>
phag ia</w>
pet echi
perphenaz ine-induced</w>
peroxid ase-
perme ability,</w>
peri oral</w>
peri ocular</w>
per ineal</w>
pentol inium</w>
pentazoc ine-induced</w>
pentagastr in</w>
penicillin- G</w>
penicill in.</w>
pel let</w>
peg -
pea k,</w>
patient- reported</w>
past ure
partic ulate</w>
partic ularly,</w>
paren ter
parad oxic</w>
parac ervical</w>
palmit ate</w>
pal pable</w>
pain less</w>
p. p.m.</w>
p ure-
p si
p ing</w>
oxyl in</w>
oxide- deficient</w>
ox azol
over growth</w>
over dose:</w>
out- patient</w>
out- of-
osar coma,</w>
orig inate</w>
ori ented</w>
organophosphor us</w>
organ ophosphate</w>
or ial</w>
or al)</w>
opor phy
opioid .</w>
opi per
op allidal</w>
onec rosis</w>
one- year</w>
one -</w>
ondansetr on,</w>
on ce
omet ro
omer y-Asberg</w>
ome ter</w>
om in
ologist .</w>
olanzap ine-induced</w>
ol ine.</w>
ol es</w>
ogen ously</w>
offic in
of ovir
ocyte .</w>
octreoti de,</w>
ocon stric
ochemistr y,</w>
oc t
oc r
obt und
observe d;</w>
obj ect
ob it
o ily</w>
o encephalopathy</w>
normal izes</w>
nor-binaltorph imine</w>
non- stressed</w>
non- opioid</w>
non- human</w>
non- hematologic</w>
non- dyskinetic</w>
non traumatic</w>
non responders</w>
non compliance</w>
non alcoholic</w>
nodul e</w>
nocicept ors.</w>
no de.</w>
nitros ative</w>
nitroglycer ine</w>
nitrofuranto in.</w>
nitrit e-
nine ty-
nifedi p
ni ble</w>
ni acin.</w>
ng/ml ;</w>
ng/ml ),</w>
neuropath ology</w>
neurolep tic.</w>
neuro epithelium</w>
neuro anatomical</w>
neural- tube</w>
neur aminid
ner ve-
necrop sy</w>
nam ed</w>
nal mefen
n ine-
n M).</w>
myelo toxicity</w>
myelo pathy.</w>
myalgi as/
myalgi as.</w>
myalgi as,</w>
my otub
mut ag
mumol/ l</w>
multiv essel</w>
multi plic
move ment.</w>
move ment
mouth rin
mother s,</w>
mos mol/
month )</w>
mon os
mol ind
mol )</w>
mode oxy
mo ,</w>
ml/ kg/
miti gated</w>
miti gate</w>
mit ogenic</w>
misoprost ol.</w>
misoprost ol,</w>
mis match</w>
mis cellaneous</w>
minimal- change</w>
min g
min ent</w>
min -induced</w>
microgram/ ml.</w>
microgram/ kg)</w>
microg/m L)</w>
microg/ side)</w>
microg/ paw
microg/ ml</w>
micro puncture</w>
micro L)</w>
mi g
mg/m2/ day,</w>
mg/m2/ d.</w>
mg/m(2)/ day</w>
mg/m 2;</w>
mg/kg/ day),</w>
mg/ l.</w>
mg/ L.</w>
mg/ 5</w>
mg I/
methyl- 5-
methyl dopa-induced</w>
methy lethan
methoxy phenyl)
methohexit one</w>
metast asi
mesyl ate.</w>
melphal an-
meg ak
megak ary
medoxom il</w>
medic ation-
meas ure.</w>
me ter
me sis</w>
maxim ize</w>
max illary</w>
max ),</w>
mark ed,</w>
mannit ol.</w>
mandat ory.</w>
malform ation.</w>
macro scop
ma p</w>
ma :</w>
mGluR 8</w>
mGluR 2/3</w>
m om
m L,</w>
m 2)</w>
lymph openia</w>
low- flow</w>
lon af
lonaf ar
lonafar ni
log y,</w>
lob es.</w>
lo pathy</w>
lo ose</w>
lisinopri l,</w>
lipos omes</w>
lip s</w>
linezol id,</w>
lind ane.</w>
lind ane,</w>
limb .</w>
lib ido
li d</w>
level s:</w>
leuc ine</w>
leptomen ingeal</w>
leg ia.</w>
le ural</w>
le tion</w>
later alis</w>
laryng oscopy</w>
l-N AME</w>
l atis
latis simus</w>
l ar
l ady</w>
l -associated</w>
know n;</w>
kidne y-
ket otifen</w>
k n
ju x
j aw
iz ine.</w>
it ch</w>
ischem ia:</w>
isch aem
is obut
irrit ant</w>
ipr an</w>
ip in</w>
ion ophore</w>
intran as
intrac ell
intra vaginal</w>
intra -</w>
interview .</w>
intermedi ate-dose</w>
interleukin- 6</w>
interac ted</w>
inter stimulus</w>
inter lobular</w>
intensi fication</w>
intelli gen
integr ity.</w>
intak es</w>
inst ant
inst ances.</w>
initi ally,</w>
inhibitor ),</w>
ingu inal</w>
infusion :</w>
infusion -related</w>
inferi ority</w>
inester ase</w>
ine ar</w>
induc ed-
indu stri
individual 's</w>
individu al.</w>
ind ol
inco ordin
in qu
in olol</w>
in atal</w>
immunolab eling</w>
ilo st
il ian</w>
il ed</w>
if erol</w>
idi pine</w>
ide -associated</w>
ici ous</w>
ic on
ic ol
i.p. )-induced</w>
i.m .)</w>
i.c.v .),</w>
i. t
i. c.</w>
i ris</w>
i pation</w>
i e,</w>
hypophysi al-
hypophy s
hyponat remic</w>
hypocap nic</w>
hypoc ellular</w>
hypo kinesia</w>
hyperpolar ization</w>
hyperparathyroidis m,</w>
hydroxy vitamin</w>
hydroxy proline</w>
hour )</w>
hom ozyg
ho arsen
hist ories,</w>
hist aminergic</w>
hist amine-induced</w>
hist amine-
high- osmolar</w>
high- affinity</w>
hexameth onium,</w>
hex ac
hexac os
hero in.</w>
hepatomegal y,</w>
heparin- platelet</w>
hemor adi
hemoglob in.</w>
hemo sider
heat /capsaicin</w>
hear ing,</w>
har maline</w>
haplo types</w>
han dic
halothane- epinephrine</w>
hall marks</w>
haemodi aly
h ence,</w>
guanfac ine</w>
guan id
growth -associated</w>
granulocyte- macrophage</w>
glyc ol-
glucocortico ids.</w>
gli omas.</w>
general ized,</w>
gen es,</w>
gastro intestinal,</w>
gastro esophageal</w>
gamma-glutamyl transpeptidase</w>
gam mag
gall stones.</w>
galact orrhea</w>
ga thered</w>
g out.</w>
g an</w>
function ;</w>
ful filling</w>
frag ility</w>
fract alk
four fold</w>
fos sa</w>
formul ations.</w>
forel imb
foot .</w>
fol ds</w>
fluroth yl</w>
fl ap
fix ation</w>
fist ul
fic ation,</w>
ffe re
fenbu fen
femal e)</w>
fe lodip
fatal ities.</w>
facil ities</w>
fac ed</w>
fac e-
f ill
extingu ished</w>
expo sed,</w>
explic it</w>
expen sive</w>
expen se</w>
exceed ingly</w>
exc ess.</w>
ex em
exem pl
evid ences</w>
evid ence,</w>
evacu ation</w>
euthanati zed</w>
etomid ate-induced</w>
ethyl-beta-carboline-3- carboxylate</w>
et s</w>
estradi ol-treated</w>
erythropoi etic</w>
erup tions</w>
ergometr ine</w>
er ron
epileptic us-induced</w>
ephed rine,</w>
ep ir
ep in</w>
entr al</w>
entan o
ent :</w>
enrich ment</w>
enoxim one</w>
endoscop ically</w>
endo vascular</w>
endarte rectomy</w>
end point.</w>
en ucle
en em
em ide</w>
em bed
em b</w>
elic obacter</w>
electrocardio graphy,</w>
electro shock,</w>
electro des.</w>
electr on
elas tin</w>
eigh t.</w>
efficac i
effectiven ess,</w>
eff usions,</w>
educ ation,</w>
ecto dermal</w>
ec ith
early- stage</w>
e vi
dysphor ia</w>
dysp noea</w>
dyslipide mia</w>
dyn orph
dram atic
dr as
dras tically</w>
dox apram</w>
down- regulated</w>
dose- related.</w>
dor sal
domin ated</w>
dog s:</w>
document ing</w>
dobut amine-
dn /P
dizzin ess
distres s.</w>
dist ur
discomfor t,</w>
disco very</w>
disco id</w>
discer nible</w>
dis si
dis rupt</w>
dilev alol</w>
dile m
dihydro ergotamine</w>
diet s.</w>
dic arboxylic</w>
diazepam- withdrawn</w>
diam m
dialy tic</w>
di thiocarb
di ethyl</w>
di d.</w>
di amine</w>
dexmedetom idine.</w>
dex tran
desogest rel
des- Arg
des oxy
depren yl</w>
deliver ing</w>
delay ing</w>
delay ed-onset</w>
degran ulation</w>
degrad ed</w>
def initi
deep ly</w>
decre ments</w>
deca des</w>
de oxyp
dapson e.</w>
dP/d t,</w>
d or</w>
d ino
d Tc</w>
cytotoxic ity.</w>
cyclophosphamide -treated</w>
cyclohexim ide</w>
cy st</w>
cy ge
cut -
cul min
cu es.</w>
cro makal
cre am,</w>
cramp s.</w>
cr y
cotranspor ter</w>
corticosteroid .</w>
corro bor
coordin ation,</w>
conver t</w>
control ),</w>
contract ure</w>
contracepti ve-induced</w>
consum ers</w>
consum e</w>
constric tive</w>
const ants</w>
conspic uous</w>
connec tions</w>
conges tion,</w>
con ve
compa red,</w>
comorb idity.</w>
comfor t</w>
colo ur</w>
coincid ing</w>
code ine,</w>
coar se</w>
coagul ative</w>
coagul ation,</w>
coag ulopathy.</w>
clon us,</w>
clinicaltrial s.gov</w>
clind am
cli p</w>
clamp ing</w>
cis DD
ciprofloxac in-induced</w>
cil ni
cigaret tes</w>
ci benz
chromatograph y-
choled och
cholecysto kin
cho osing</w>
cho ices</w>
chlor methiazole</w>
chlor inated</w>
chi e
chi (2)</w>
chemo reflex</w>
chelat ors</w>
character izing</w>
centr al-
cell s;</w>
cefox itin</w>
cef azed
ceas ed.</w>
ce ti
ce tam
caus ation</w>
caus ally</w>
carvedi lol.</w>
carcin ogens</w>
carbox amide
carboplat in-
carbo platin
caps azepine</w>
calcul us</w>
calcific ations</w>
cal orie</w>
cal ib
cad her
ca esarean</w>
c y.</w>
c rist
c occi
c es,</w>
c RA</w>
but toc
but oxide</w>
bur st
bucindo lol</w>
buc cal</w>
bre vi
bran ch
brainst em.</w>
br uc
bp m)</w>
boost ed</w>
bizar re</w>
bilirub in.</w>
bilater al,</w>
bi loba</w>
beta- glucuronide</w>
beta- galactosid
beta- caroten
beta- blockers,</w>
benzodiazep ine-
benef its.</w>
bendroflu azide</w>
be ver
bas ket</w>
bac k.</w>
b.w .,</w>
b ands</w>
b and
b ),</w>
azot emia.</w>
auranof in</w>
aul t</w>
augment ing</w>
atten d
atre sia</w>
atr icians</w>
ation "</w>
ati dine</w>
ather ,</w>
at rin</w>
assess ments.</w>
aspect s.</w>
asp inal</w>
as u
as h</w>
arte me
aro us
ari ses</w>
ar one</w>
ar io
ar i</w>
appeti te-
apparen t.</w>
aphere sis</w>
apatri lat</w>
antimalari als</w>
antidepress ant.</w>
anti- PF4/heparin</w>
anti epileptogenic</w>
anti dromic</w>
anti angiogenic</w>
anti adrenergic</w>
antec ubital</w>
antagon ism,</w>
anorex ic</w>
ann u
angiocardi ography</w>
angio pathy</w>
anesthe tics,</w>
ane di
and all-
andall- Sel
andall-Sel it
analyz ed,</w>
analy zing</w>
analgesic .</w>
anaesthe tics.</w>
an s'</w>
amylo idosis</w>
amsac rine</w>
amoxicill in/
amino hipp
amine- initiated</w>
amine ).</w>
amine ),</w>
amin ase</w>
amen orrhea</w>
amen able</w>
am yr
am en</w>
altern ation</w>
alpha-methyl dopa-induced</w>
alpha-amino- 3-hydroxy-
alpha- smooth</w>
alpha- adrenoceptors</w>
alpha- 2
alpha 1-adrenoceptor</w>
allo pregnanolone</w>
allevi ates</w>
all er</w>
alkalo idal</w>
alkalin ized</w>
aldoster one,</w>
albuter ol.</w>
alben dazole</w>
al is,</w>
al in
al epl
al dol
air flow</w>
again ,</w>
ag matine</w>
affor ds</w>
afferen ts.</w>
af osf
af ine</w>
adren omedullin</w>
adenos ine.</w>
adenocarcin oma,</w>
ad rib
ad just</w>
activ ators</w>
acqu ire</w>
acit ret
acid -associated</w>
acetylamino fluorene</w>
acet onide</w>
accept ability</w>
accent u
ac cord</w>
above- mentioned</w>
abl ated</w>
ab user</w>
ab duc
ab atrin</w>
a, K
a quine</w>
a der</w>
a del
[Ca ]o</w>
[125 I]
[1, 5-
[ P</w>
[ Na
[ 7
[ 10
YM -16
YM-16 15
X- linked</w>
WR 2425
W e,</w>
W SR</w>
W SP</w>
W G</w>
Vir al</w>
Vig abatrin</w>
Vals artan</w>
VE STI
VESTI GA
V ar
V P-
V I</w>
UD C</w>
U tili
U p</w>
U 378
U378 8
Tum ors</w>
Trimethoprim-sulfamethox azole</w>
Ticlop idine-induced</w>
Th ym
Th roughout</w>
Tem pol</w>
Tc- 99m</w>
TP R</w>
TMP /SM
TDH L</w>
TD R</w>
TD M</w>
T x</w>
T razod
T RO
T CPOB
T -treated</w>
System atic</w>
Swit zer
Surve illance</w>
Su per
Spec ial</w>
Shor t</w>
Shakuyak u-
Ser a</w>
Se leg
SUN-1334 H</w>
SN P.</w>
SM emb</w>
SM V</w>
SIG N
SIGN IF
SIGNIF ICA
SIGNIFICA NCE:</w>
SG C</w>
SELEC TION:</w>
SE RT</w>
SE P</w>
SE -induced</w>
SD .</w>
SC s)</w>
SB- 2770
SA R</w>
S. E.
S-adenos yl-L-
S-adenos yl
S ympathetic</w>
S r
S pi
S he
S W</w>
S VR
S 3</w>
S 3
Ro 15-1788</w>
Rhe um
Reg ulation</w>
Reduc tions</w>
RP E</w>
RESULT S</w>
RCT s</w>
R, 4
R AS
R (-)-
Qu er
QT Ls</w>
QT (F
QR S,</w>
PubM ed</w>
Proechim ys</w>
Prob ability</w>
Pre operative</w>
Pr ur
Post partum</w>
Phosph or
Phenyto in-induced</w>
Pharmaco kine
Pharmac ology</w>
Pharmac eutic
Per inatal</w>
PV /
PO P
POP UL
PE A</w>
PDE 3A</w>
PA T</w>
P- S
P- P</w>
P t
P lat
P anc
P Z</w>
P SC</w>
P EP
P -10
P )-
Occurren ce</w>
ON )</w>
OD C</w>
O S
Non- steroidal</w>
Neuro psychological</w>
Netherl and
Nephro calcinosis</w>
Na (+)-
NT S1</w>
NI C</w>
NH E
NH 4
ND I.</w>
NAD PH-
N at
N E-
N A-
N .
N +
My asthenia</w>
Mus cim
Morph ometric</w>
Montg omery-Asberg</w>
Minocycl ine-induced</w>
Mi gra
Meto prolol</w>
Meperid ine</w>
Medic ation</w>
Meas ures</w>
Mac roph
MS O</w>
ME M</w>
MATERIAL S:</w>
MAO I</w>
MA BP</w>
M s</w>
M ay
M ad
M UG
M SDBP</w>
M MI</w>
M CP</w>
M (2)</w>
Li Cl
Larg er</w>
LM W-
LIMIT ATIONS:</w>
LH- RH</w>
LD H,</w>
L-DOPA .</w>
L imbic</w>
L en
L I</w>
L AS</w>
L A,</w>
L .
K ar
Isoproteren ol-induced</w>
Is-5-M n</w>
Intrac or
Inter actions</w>
In cl
Immunosup pressive</w>
Ig G-
Ifosf amide-induced</w>
IN VESTIGA
II b/
II E
ICA M-1</w>
IC I</w>
IC H,</w>
I sot
I s.</w>
I U
I MID</w>
Hz .</w>
Ho w</w>
Health care</w>
He at</w>
HIV-1- infected</w>
HIV- seropositive</w>
HIV -related</w>
HD- MTX</w>
HD T</w>
H elicobacter</w>
H dac
H SCT</w>
H R-
H A.</w>
H -induced</w>
Gran isetron</w>
Good pasture
Glucocortico ids</w>
GSK 3
GO T</w>
GF AP</w>
G row
G e
G adol
G EC
G 35
Func tion</w>
Frac tional</w>
Forty- four</w>
Flur bi
Flu id</w>
Fifty- seven</w>
Fifty- one</w>
Fe ver,</w>
Fab ry</w>
FO LF
FK BP
F oc
F lun
F inal</w>
F icol
F etuses</w>
F er
F N</w>
F J
F CE</w>
Extrac ellular</w>
Excit atory</w>
Ex ogenous</w>
Etoric oxib</w>
Erythropoi etin</w>
Endo theli
Encephalo pathy</w>
Enal apri
En d
Elev ations</w>
Electroencephalo graphic</w>
ER -
EP SCs</w>
EP 1</w>
ENa C,</w>
EK G</w>
EE G,</w>
EE -induced</w>
E scherichia</w>
E qu
E L
Dulox etine</w>
Dos age</w>
Do w
Do fe
Diff use</w>
Develop mental</w>
Desi pramine</w>
Der mat
Dep end
Decreas e</w>
DY RK
DSM- III</w>
DP SGC</w>
DO PAC
DE N-
DD S</w>
D- 00
D ar
D MB
D 3-
D 28
D 2/
D 2-
Cyt ochrome</w>
Cs A,</w>
Contr ast</w>
Concomit antly,</w>
Con trast
Con scious</w>
Com mun
Clar ithromycin</w>
Cho re
Chlor amphenic
Chi ari</w>
Ch ron
Carcin ogenicity</w>
Ca2+ -activated</w>
CR ),</w>
CM I</w>
CG R
CC D</w>
CA R</w>
C- fibres</w>
C s,</w>
C ox
C openh
C op
C ilost
Bot ulinum</w>
Bi op
Bet a</w>
Bepri dil</w>
Ben ign</w>
Bec k</w>
Bcl- x
Bart ter's</w>
BZD s/RDs</w>
BH A,</w>
BALB/ C</w>
B- HT</w>
B ax</w>
B ax
B PRS</w>
B L
B ID
B 19</w>
Av y/
Au th
Associ ations</w>
Assess ments</w>
Ara C</w>
Anti tumor</w>
Anti psychotic</w>
Anti epileptic</w>
Anti depressant</w>
Ang -
An tim
An d</w>
Amb ulatory</w>
Alph a</w>
Aggres sive</w>
Adriam ycin.</w>
Adriam yc
Administ ration's</w>
Acce ler
AZ T,</w>
AZ A</w>
AV M</w>
ATP ase.</w>
AT G</w>
AR B
APPRO AC
AP C</w>
AM P.</w>
AL Y
AL L.</w>
AE s,</w>
AE G35
ACh R</w>
AC C</w>
AC ).</w>
AB T</w>
AB C-
AB -
A- V</w>
A to</w>
A rab
A X</w>
A SI
> 50</w>
> 2</w>
9 ]</w>
9 8%</w>
9 10</w>
9 0/
80 .</w>
8. 5%</w>
8-hydroxy-2- (di-n-propyl
8 3-year-old</w>
8 %);</w>
7H 6</w>
7- CK
7 -10</w>
6. 25</w>
6-keto-PG F1</w>
6- month-old</w>
6,7-di methoxy-4-
6 36</w>
6 3,</w>
6 -12</w>
500 /
50 s</w>
50 6-
50 4</w>
50 ,48
50 ).</w>
5-fluorourac il-induced</w>
5-HT(1B/ D)</w>
5'- phosphate</w>
5 00-
48- h</w>
4- methyl
4- 7</w>
4- 4
4, 5
4 :
4 1,</w>
4 1)</w>
4 -</w>
39 8</w>
38 4</w>
37 7</w>
30 ;</w>
3. 75</w>
3- -
3 TC</w>
3 9-
3 3%,</w>
3 -induced</w>
29 ;</w>
29 9</w>
29 2</w>
29 %,</w>
25 /
24- 48</w>
24 .</w>
2339 0
23 ;</w>
201 Tl</w>
20 th</w>
20 ;</w>
20 %)</w>
2. 6%,</w>
2. 2%</w>
2- oxo
2- ,</w>
2, 2,
2 E1</w>
2 50-
2 23</w>
2 +/-1
2 *
199 7,</w>
198 8,</w>
19. 5</w>
19 66</w>
18. 9</w>
18 4</w>
18 /
18 ),</w>
17 ;</w>
17 7</w>
17 36
16 ;</w>
15. 3</w>
15. 2</w>
15-1 78
15 5</w>
14 0/
13. 6</w>
13. 2</w>
13 1
12. 0</w>
12- 24</w>
11. 1</w>
11 18</w>
10- point</w>
10(- 8)</w>
10 (-1
1. 86</w>
1. 8-
1. 31</w>
1. 27</w>
1. 26</w>
1. 2,</w>
1-1. 0</w>
1, 8-
1 0.7</w>
0.9 3</w>
0.8 4</w>
0.8 2</w>
0.7 4</w>
0.7 %,</w>
0.6 25</w>
0.6 1</w>
0.5 8</w>
0.5 %,</w>
0.00 5</w>
0.0 75</w>
0. 5).</w>
0. 38</w>
0. 32</w>
0. 26</w>
0- fold</w>
0 9</w>
0 8
.00 1,</w>
-10,11- dihydro-5H-di
- striatal</w>
- pretreated</w>
- 0.5
(p< 0.01)</w>
(n ACh
(max ))</w>
(m t
(V AS).</w>
(T MP
(T G)</w>
(T )</w>
(S t
(S TN)</w>
(S K
(PB ),</w>
(P< 0.01),</w>
(P H
(OR :</w>
(NP Y)</w>
(N a,K
(N E),</w>
(MM C)</w>
(M ac
(M F
(I L-
(H R,</w>
(GF AP)</w>
(G- CSF)</w>
(FD A)</w>
(F K</w>
(F E
(ED ).</w>
(E C</w>
(DE X)</w>
(D RE
(D IC)</w>
(D )</w>
(C o
(C NI
(C AD).</w>
(AN P)</w>
(ADP- ribose)</w>
(AC E
(A ST),</w>
(A OA
(> or=
(9 %),</w>
(8 3</w>
(8 %</w>
(7 2%)</w>
(7 %</w>
(6. 7</w>
(6 8%</w>
(5 9%)</w>
(5 4.
(5 2</w>
(5 ),</w>
(4- methyl
(4 6</w>
(4 4.
(4 3</w>
(4 '-
(3. 9</w>
(3. 3</w>
(3. 2</w>
(3 9</w>
(3 4.
(3 3.
(2) =
(2 40</w>
(10- 30</w>
(1. 5%)</w>
(1. 1</w>
(1- 5</w>
(1 3/
(1 2/
(1 00,</w>
(0. 9
( torsade</w>
( ten</w>
( secondary</w>
( s),</w>
( q
( primary</w>
( period</w>
( paracetam
( k
( i.p.,</w>
( hemoglobin</w>
( experiment</w>
( cocaine</w>
( baseline</w>
( area</w>
( L-N
' s.</w>
% -1
" ).</w>
zimel dine</w>
zebraf ish</w>
z otep
yt osine</w>
yn chron
yl] form
yiel ds</w>
yaw ning</w>
y -old</w>
ximel agatran</w>
xer ostom
xen on</w>
witnes sed</w>
within- session</w>
with out.</w>
whi le,</w>
wh at
well- being</w>
weight/ day)</w>
week -
wal a</w>
wa iting</w>
w ,</w>
vinblast ine.</w>
vigil ant</w>
vigabat rin.</w>
video- EEG</w>
vi z
vi remia</w>
ver t</w>
ven ous,</w>
ven ,</w>
vecur onium,</w>
vari ability.</w>
val acyclovir</w>
vacc ine,</w>
v ity,</w>
v ing,</w>
uve itis</w>
ut um</w>
use ;</w>
us ers:</w>
us ality</w>
uro toxic</w>
uro protection</w>
uro graphy</w>
urethane- anaesthetized</w>
ur na</w>
up per-
unineph rectomized</w>
und 's</w>
un remarkable</w>
un published</w>
un likely.</w>
un detectable.</w>
um m
ultrasoun d.</w>
ular .</w>
ul ina</w>
ul ation,</w>
ubi quinone</w>
u til
u gh</w>
ty ram
two- week</w>
tur ned</w>
tubero infundibular</w>
tub al</w>
tro phy
trimethaph an.</w>
trimeta phan</w>
trige min
triaz olo
tri pel
tripel enn
trem e</w>
transplant s,</w>
transp eptid
transcri pt</w>
trans venous</w>
trand rine</w>
trac ing</w>
tot emporal</w>
tongu e,</w>
ton sill
tol met
to oth</w>
to :</w>
tis /
tion ?</w>
time -related</w>
time -</w>
tigm ine.</w>
tid ine.</w>
tic ity,</w>
ti ated</w>
thyro idi
thrombo sis:</w>
thrombi .</w>
thromb ocytosis</w>
three -</w>
thous and</w>
though t.</w>
third- degree</w>
thioredox in</w>
thi aben
therapy- related</w>
ther mal
thalam ocortical</w>
tetra ethyl
tert- butyl
termin ated.</w>
ter in</w>
ten id
tele metry</w>
techne tium</w>
target s.</w>
tak en,</w>
tail- withdrawal</w>
tail ed</w>
t ted</w>
t s
t ol</w>
t i</w>
t ate</w>
syring e</w>
synchron y</w>
synap ses.</w>
sy novi
suxameth onium,</w>
surve yed</w>
surve ill
surpris ingly</w>
sur ance</w>
supra therapeutic</w>
sup ram
summar ized</w>
sulind ac.</w>
sufentan il/
succumb ed</w>
successful ,</w>
subst rate.</w>
subst ance,</w>
subcl avian</w>
sub types.</w>
sub stitute</w>
sub sternal</w>
sub massive</w>
sub capsular</w>
su perf
su bu
struct ure,</w>
stro king</w>
stric ture</w>
stress ful</w>
stres ses</w>
stres s-
streptozoc in-induced</w>
sto ol</w>
stereotypi es.</w>
stereotax ic</w>
stere ospec
ster ing</w>
standar d-
st olic</w>
st arch</w>
st ages.</w>
sple en,</w>
spironolact one,</w>
spermat ozo
sper m
specific ity,</w>
speci alized</w>
spac e,</w>
sp utum</w>
sp ines</w>
sour ce.</w>
soun d-
sorbit ol</w>
son ography</w>
socio economic</w>
so on
small .</w>
sit es)</w>
sino- aortic</w>
sim ulation</w>
sigma -
si es.</w>
si ella</w>
shorten ing,</w>
short- term,</w>
short- lived</w>
shor t,</w>
sha kes</w>
sha k
sh ed</w>
ses ).</w>
serv ice.</w>
ser one
ser ology</w>
sen ing</w>
sen ile</w>
self- injurious</w>
selectiv ity,</w>
sel en
secret ago
scre en
scleroder ma.</w>
sci ence</w>
scho ol-
sch istos
scen ari
satisfac tion.</w>
saliv ation</w>
sal es</w>
sacrific ed.</w>
sac ca
s q</w>
s phenoidal</w>
s ect
s -blue</w>
rub ber</w>
rox ithromycin</w>
roten one-induced</w>
ron ium</w>
roent gen
rim idine</w>
ri le</w>
rex ate</w>
rever t</w>
reve al
retur ns</w>
retin oid</w>
reticular is</w>
resuscit ative</w>
restric tion.</w>
rest ores</w>
responsi ve,</w>
response ;</w>
respond ents</w>
resid ent</w>
require ment,</w>
reporte d;</w>
remin is
reminis cent</w>
rem n
releas ers</w>
relax ation,</w>
rein state</w>
rein stat
regist ered.</w>
reg istry</w>
refl ection</w>
recruit ed.</w>
reco vered,</w>
receptor /
recept ors
reas .</w>
re traction</w>
re tain</w>
re place</w>
re ad</w>
re activation,</w>
re act
rash es</w>
ranol azine</w>
radi ot
radi olig
radi o-
r ing.</w>
r ine-
qual ified</w>
qu is
qu ine-induced</w>
qu ine,</w>
pyridos tigmine</w>
pyrazin amide.</w>
pyraz olo
pyram id
pyr rolidine</w>
py uria,</w>
purpo se.</w>
psychopharmac ological</w>
psych ogenic</w>
prur itic</w>
prostagland ins.</w>
prostagland ins,</w>
prost anoid</w>
prost adi
prost .</w>
proper ty.</w>
progester one,</w>
probenec id</w>
priap ism.</w>
pri t</w>
pri ori</w>
pri migra
prevent ed.</w>
preser ving</w>
prescho ol</w>
pren alter
premat ur
preeclamp sia.</w>
precl ude</w>
pre- operative</w>
pre- ejection</w>
pre- clinical</w>
pre renal</w>
pre pro
pre core</w>
pram ipex
practic es</w>
pra vastatin,</w>
postpartum .</w>
post- liver</w>
post infarction</w>
post ganglionic</w>
possibil ity.</w>
posi tional</w>
por cine</w>
polycyst um</w>
poly therapy</w>
poly sacchar
poly -
po plit
po etin</w>
platinum- resistant</w>
plate au
plasma -
plac ement,</w>
pi x
pi ret
physi ological,</w>
photosensi tivity</w>
phosphodi ester
phosphatidyl choline</w>
phenyl alan
phentol amine.</w>
phen e.</w>
perio per
pericardi um</w>
perg illo
perc us
per zine</w>
pepti de.</w>
pepti de-
pent e
penetr ating</w>
path ologies</w>
patch- clamp</w>
passi ve-
parti al,</w>
pari et
paraly tic</w>
paracetam ol,</w>
papillo mas</w>
pancreati tis
pal sy,</w>
pa ro
pa in;</w>
p urely</w>
p g</w>
oxi b,</w>
oxazaphosphor ine</w>
ox a
overex pressed</w>
over loo
over load
out i</w>
otroph in</w>
otri me
otrime praz
oten ic</w>
ote pa
ot ed</w>
ospas m</w>
os an</w>
ortho gnath
orthognath ic</w>
oro lingual</w>
orgas mic</w>
organ ogenesis</w>
or ci
orci pren
or al-
or /
op posing</w>
op it
oni um-
onco logic</w>
on ly;</w>
on line</w>
on ic
on go
on ed</w>
on ad
ometr ically</w>
omeprazol e,</w>
om ot
om icro
om echan
olith iasis</w>
olanzap ine-treated</w>
ol s.</w>
ol s,</w>
ogen ,</w>
officin alis</w>
off ice</w>
of loxacin,</w>
of ilam
ocu log
octap eptide</w>
ococc i</w>
ochemic ally,</w>
oc rit</w>
obstruc ted</w>
o ked</w>
o gn
nystag mus,</w>
nutri tion.</w>
nutri ents</w>
nucleoti de-
nucle o
nox -G
nox-G ast
nox-Gast au
nox-Gastau t</w>
not es</w>
nortriptyl ine.</w>
normal ;</w>
norm ocapnia</w>
noreth ister
norethister one</w>
nor thern</w>
nor ZTP</w>
non- oliguric</w>
non- epileptic</w>
non- convulsive</w>
non users</w>
non randomized</w>
non prescription</w>
non malignant</w>
non epileptic</w>
nmol/ min/
nit rate-
nicardi pine,</w>
neutrophil s.</w>
neuropath y;</w>
neurolep t</w>
neuro surgery</w>
neuro excitatory</w>
neuro degeneration.</w>
neuro biology</w>
neur ulation</w>
neur axial</w>
neos tigmine,</w>
neo plasia.</w>
negati vity</w>
ne st
ne fopam</w>
narco tics</w>
naf enop
nadi rs</w>
n-propyl -
myelosuppres sive</w>
mye lography.</w>
myco bacterial</w>
my otoxicity</w>
mut ual</w>
mut ations,</w>
mustar d</w>
mumol/ kg)</w>
multiple ,</w>
multi- organ</w>
multi drug-resistant</w>
muc ocutaneous</w>
mt DNA-
motiv ational</w>
mor ning.</w>
mor ning,</w>
monoamine- depleted</w>
mon oc
molind one</w>
modifi able</w>
moder ate.</w>
mo val</w>
mm ed</w>
mitoxantr one.</w>
mitogen -activated</w>
mirtazap ine.</w>
minim izes</w>
milnac ipran</w>
millisec ond
milli grams</w>
micromol/ l</w>
micromol/ l)</w>
micrograms/kg/ min.</w>
microgram. kg-1.
microg/ ml)</w>
micro g),</w>
micro fil
micro bial</w>
mi me
mg/ h</w>
metronidazol e.</w>
metri zo
methylphenid ate,</w>
methyl )-
methyl )
methom yl</w>
methim azole-induced</w>
meth otrimepraz
meth an
metfor min.</w>
metazol ine</w>
metallo thionein</w>
metabol ic,</w>
met ar
mestran ol</w>
mes enter
mepivaca ine.</w>
melaton in.</w>
medul lo
medium- sized</w>
mecamyl amine,</w>
measure ment.</w>
me tric
me rely</w>
materi als</w>
mast ectomy</w>
mas ked,</w>
marrow .</w>
marrow ,</w>
market .</w>
manufacture r
man ually</w>
malai se.</w>
macro globul
mac ula</w>
ma de,</w>
mL .
mEq/ kg</w>
m s;</w>
m oxifloxacin</w>
m ole</w>
m itis</w>
m afosf
m RNA-
m M).</w>
lung s,</w>
low -</w>
los por
long- chain</w>
long er.</w>
lo recle
lipo protein-
lipo prote
lin ks</w>
limit s,</w>
light- dark</w>
ligh ter</w>
lidoca ine;</w>
lic ensed</w>
li z
lev o-
leukem ia:</w>
leuk ocyturia</w>
leiomy osarcoma</w>
ledg e</w>
leb itis</w>
le an
le ;</w>
le :</w>
lav icular</w>
lat ing</w>
lat encies.</w>
large- scale</w>
lansoprazol e,</w>
lam ellar</w>
l- arginine</w>
l us
l ished</w>
l and
l -1</w>
kine tics.</w>
kin ases</w>
kg(-1 )),</w>
ket otic</w>
ket ogenic</w>
kan am
k il
k h
k en</w>
k 5</w>
justi fy</w>
jaundic ed</w>
j at
ity ?</w>
iter ature</w>
isth oton
isosorb ide-
isoflur ane
iso thiocyan
is chemic
is al</w>
irradi ation,</w>
iontophore sis</w>
iodo benzyl
investig ations,</w>
intraventric ularly</w>
intrap aren
intraparen chymal</w>
intr as
interval s)</w>
interfer on.</w>
inter rupt</w>
inter group</w>
inter course</w>
inte rest
inte g
int act.</w>
inner -
inner- city</w>
injur y;</w>
initi ator</w>
inhibitor -related</w>
inhibit or-
ing -related</w>
inform ation,</w>
infarc tions,</w>
infarc t.</w>
inex pen
ine/ kg</w>
ine- ,</w>
indu str
incrimin ated</w>
incid ent.</w>
in- vivo</w>
in- inhibitor</w>
in pyraz
in ert</w>
in -1
improve ment
implant s.</w>
impai red,</w>
immunosup pressed</w>
immunore activity.</w>
immunoblo t</w>
immuno fluoresc
imipenem -
im id
ido sis.</w>
iden tic
id ol</w>
ici pal</w>
ic lospor
i.c.v .).</w>
i. t.)</w>
hypothe tical</w>
hypothalam us.</w>
hypothalam o-
hypoten sion-
hypophysial- portal</w>
hypophosphat emia</w>
hypoglyce mia.</w>
hypoalbum inemia</w>
hypertriglyceride mia,</w>
hyperkal emic</w>
hypercal caemia</w>
hyper- responsiveness</w>
hyper trophy
hyper osmolality</w>
hydroxy ethyl</w>
hydro philic</w>
hydro morph
hydra zine</w>
hybridiz ation.</w>
hyal in
hu perzine</w>
hospital izations</w>
hoarsen ess</w>
hirsu tism</w>
hind quarters</w>
hil us.</w>
high- intensity</w>
hexacos anol</w>
hexachlorocyclohex ane</w>
hero in,</w>
hepatocarcin ogenicity</w>
hepatoc ell
hepatoblast omas</w>
hemodialy zed</w>
hemisphere .</w>
hemip legia</w>
health .</w>
head ,</w>
hamster s,</w>
ham sters</w>
halo genated</w>
h arb
gu statory</w>
grow th-
gre y</w>
graph ical</w>
granulomat osis,</w>
granulo cytosis</w>
graf ts,</w>
gradu ally.</w>
go od,</w>
glutam ate-
glucuron id
glucosaminid ase,</w>
glucocortico id
glob ally</w>
glo ve</w>
glibencl amide,</w>
gli a</w>
gland s.</w>
gland s,</w>
gl ass</w>
gl and,</w>
ginsen g</w>
gemfibroz il.</w>
gemcitab ine.</w>
gemcitab ine-induced</w>
ge ment</w>
galactos amine</w>
g/m 2.</w>
g m/
g elat
g ed</w>
g d</w>
g ati
g as
frame work</w>
fract ures.</w>
frac tions.</w>
form s.</w>
force d-
for amen</w>
foci ,</w>
foc al,</w>
flurbi profen,</w>
flur ane,</w>
flup irtine</w>
fluoro -
fluo ren
flud rocortisone</w>
flu id
flo uro
flacc id</w>
fl ush</w>
first- degree</w>
fing ers</w>
filter ability</w>
fif ty</w>
fibroblast s,</w>
fib er
fi ve
fi les</w>
fenfluramine- phentermine</w>
feel ings</w>
fe et.</w>
fact ori
f uc
f low-
f er</w>
f ate</w>
f =
extrasystol es</w>
extrac ranial</w>
extra vascular</w>
extra renal</w>
extr am
extr act,</w>
expi red</w>
exha us
exer ting</w>
exclu sive</w>
excit ement</w>
excep tional</w>
exacerb ation.</w>
ex am</w>
evid ence.</w>
evalu ations,</w>
eugen olol</w>
etretin ate</w>
etopo side.</w>
etiolog ies.</w>
eth ical</w>
et y,</w>
et ron</w>
estro l</w>
establ ishes</w>
est ers</w>
est ed</w>
esophag us</w>
es ulf
es orubicin</w>
erythropoi et
erythrom ycin.</w>
erythro cytes,</w>
ero sive</w>
erec t</w>
equ ivocal</w>
episode s),</w>
epidemio logy</w>
epid ur
ent rop
engraf tment</w>
energ e
endothelium- derived</w>
end point,</w>
end orph
encephal omyeli
encephal itis.</w>
enanth ate</w>
en tion</w>
en buterol</w>
em piric</w>
eluc idation</w>
else where</w>
elim inating</w>
electroretino gram</w>
electroly tic</w>
electrocardio graph</w>
ejac ulation</w>
ef avi
ect in,</w>
ect ed
echocardio gram.</w>
e- based</w>
e -</w>
e '</w>
dystroph y,</w>
dur able</w>
drug- naive</w>
droperid ol.</w>
drink ers</w>
dr in</w>
doxorubic in:</w>
doses :</w>
dose- escalation</w>
dopa -
dop pl
domperid one,</w>
dog s;</w>
dithiocarb amate</w>
disulfir am.</w>
disulf ide</w>
dissoci ative</w>
disproportion ately</w>
dispens ing</w>
discomfor t.</w>
direc tly,</w>
dipyridamole- thallium</w>
dimenhydr inate</w>
dimen sion
dil .</w>
digiti zed</w>
difficul ties,</w>
difficul t,</w>
diamm ine
di version</w>
di hydroxy-
di el
di ary</w>
dextro r
desi pramine,</w>
der ma</w>
der i
depriv ation.</w>
depend ence:</w>
del usions,</w>
del ay.</w>
defl ation</w>
defic it,</w>
decision- making</w>
decade .</w>
decade ,</w>
dec apit
de sensitization.</w>
de ma</w>
de ine</w>
de fibrillation</w>
day -1</w>
day (-1))</w>
d umm
d n</w>
d f=
d B)</w>
d -1</w>
cyto genetic</w>
cytarab ine,</w>
cyt ometry.</w>
cyt ology</w>
cyge us</w>
cyclophosphamide /
cycl ine.</w>
cycl es)</w>
cy sto
cult ure.</w>
cul prit</w>
criter ia)</w>
creatin ine;</w>
countri es,</w>
cost- effectiveness</w>
cor tin</w>
convul sed</w>
conver sion,</w>
controlle d-release</w>
control :</w>
contra indicated.</w>
continu um</w>
cont ents,</w>
consul ted</w>
const ant.</w>
conjunctivi tis</w>
conjunctivi tis,</w>
confoun ders.</w>
concomit ant
concentr ation)</w>
compon ents,</w>
comple mentary</w>
compar atively</w>
comp an
comb ined.</w>
collap se.</w>
col on.</w>
coagul ant</w>
coag ulopathy,</w>
co sis</w>
co operation</w>
co ded</w>
co d</w>
cm 2</w>
clor azep
clofib rate,</w>
clinic o-
classi cally</w>
cister na
circumst ances,</w>
circum ference</w>
cibenz oline</w>
ci lex
chromat ographic</w>
chore a,</w>
chole lithiasis.</w>
chloroqu ine-
chlorambuc il.</w>
chloralo se-
chic k</w>
chemopre ventive</w>
chemo -
chem ist
che st-
characteris tically</w>
ch urna</w>
ch ro
cetam olol</w>
cervi x.</w>
certain ly</w>
cerebro protective</w>
cephalospor in,</w>
centro temporal</w>
cefamand ole</w>
cave ol
cau tionary</w>
catheter ization,</w>
catechol -
cat s,</w>
cat enin</w>
cat .</w>
carmofur -induced</w>
cardi olip
carbap enem</w>
capsul es.</w>
capecitab ine.</w>
capac ities</w>
calcul i.</w>
calcitri ol.</w>
cal retin
cal modul
c u</w>
c row
c is</w>
c hemoradi
c alls</w>
c ).</w>
buspir one,</w>
bundle- branch</w>
budeson ide</w>
bromo -
brety li
break through
bre e
brain- derived</w>
br ing</w>
br ad
bp m,</w>
bor ne</w>
bor e</w>
body weight</w>
blot ting.</w>
ble omycin.</w>
bl inde
bir ds</w>
bio genic</w>
bicyclo phosphoro
bic eps</w>
bi g</w>
bi bli
beta- thalassemia</w>
beta /
bes artan</w>
behaviour al,</w>
begun .</w>
bed side</w>
beat s.
beat s,</w>
be st-
bas es</w>
barbit uric</w>
backgroun d.</w>
backgroun d,</w>
bac k,</w>
b.w .</w>
b.w .)</w>
b y,</w>
b rown</w>
b erb
b avirin</w>
b ath
azol ,</w>
axon s,</w>
av y</w>
aur a,</w>
atten ded</w>
attac k
atis m</w>
ation ?</w>
ation .(ABSTRACT</w>
ati gue</w>
ate- evoked</w>
at opic</w>
asystol e,</w>
ast ly,</w>
aspirin- sensitive</w>
asi a,</w>
as ses</w>
as k</w>
as etron</w>
as e;</w>
arthro pathy</w>
arteri tic</w>
arsen ic</w>
arri ved</w>
arrhythm ia:</w>
arom atase</w>
ar ities</w>
apro cl
approach es.</w>
appreci ated.</w>
appeti te,</w>
apolipo proteins</w>
ap sed</w>
ap ra
ap one</w>
ap illary</w>
anxioly tic-like</w>
antinocicep tion.</w>
antigen -
antidot es</w>
anticoagul ants.</w>
antibio tic-induced</w>
anti- tuberculosis</w>
anti- HCV</w>
anti parkinsonian-like</w>
anti apoptotic</w>
aneurysm .</w>
anesthesi a
ane- based</w>
ance ment</w>
anc ies</w>
analy tical</w>
analy sis).</w>
analogu es.</w>
an oxic</w>
amyl amine</w>
amph oter
amoxicill in-clavulanic</w>
amox ycill
amox apine</w>
amisulpri de.</w>
amin orex</w>
amin op
amilor ide,</w>
amifost ine.</w>
amb ulation</w>
am rin
altern ative.</w>
alprazol am.</w>
alpha-methyl-p- tyrosine</w>
alpha-methyl dopa,</w>
alpha-fet oprotein</w>
alpha- blocking</w>
alpha- H</w>
alpha /
alpha -1-
alkalo ids,</w>
alg ia.</w>
alfa- 2b</w>
aldol ase</w>
alcohol ics</w>
alcoh ol-
albuter ol,</w>
al ity.</w>
al in,</w>
al e-
al ).</w>
al 's</w>
agranulocyto sis.</w>
agonist ),</w>
aggres sion,</w>
age ing</w>
age ),</w>
ag outi</w>
ag o</w>
ag ene
aff lic
advoc ate</w>
adul ter
adrenocortic otropin</w>
adi pos
adhe sive</w>
adenos ine-induced</w>
adenocarcin omas.</w>
aden ylyl</w>
aden oma,</w>
adel ph
ad mixed</w>
ad mit
acyclovir -induced</w>
actomy osin</w>
acri lex</w>
acquisi tion,</w>
aconit ine-induced</w>
acne ,</w>
acet ate-
ace butolol</w>
accru ed</w>
acceler ating</w>
ac yl</w>
ac yl
abro gated</w>
abor tion.</w>
abol ished,</w>
abil ities.</w>
abduc ens</w>
ab it
ab and
ab alin</w>
aPT T</w>
a ]
[4- (2-
[2-(3,4- dichlorophenyl)
[ 8
Z -induced</w>
Z )-
Y ale-
Wor sening</w>
With ania</w>
Wil ms</w>
Warfar in-induced</w>
WK Y.</w>
WK Y,</w>
W er
W ash
Venlafax ine</w>
VT s</w>
VPA -associated</w>
VP T</w>
V es
V IP
V H</w>
V -induced</w>
Uro logical</w>
Up jo
Ultra structurally,</w>
U/ L),</w>
U preg
Typ ical</w>
Thre e-
Thiop ent
Ta urine</w>
TMP-SM Z</w>
TI DA</w>
T rop
T riam
T et
T ER
T CR</w>
T A-
Sy d
Succinyl choline</w>
St res
Sou thern</w>
Smo king</w>
Sixty- two</w>
Sixty- three</w>
Sixty- four</w>
Sing le-
Sim vastatin</w>
Shor t-
Sevo flurane</w>
Seventy- eight</w>
Sep arate</w>
Sensi tization</w>
Scop olamine</w>
Sal butam
STZ- diabetic</w>
STUD Y:</w>
ST- elevation</w>
SSR18150 7</w>
SPEC T.</w>
SP N</w>
SOD ,</w>
SNC 80</w>
SE RV
SC T.</w>
SC ).</w>
SC ),</w>
SB-2770 11
SB P,</w>
S-adenosyl-L- methionine</w>
S t.</w>
S or
S low</w>
S ig
S ham</w>
S an</w>
S R)</w>
S HB
S F</w>
S );</w>
Roc he
Ro yal</w>
Ret inal</w>
Rep eti
Remark ably,</w>
Relev ant</w>
Rel atively</w>
Reas ons</w>
Re moval</w>
Re fract
RU 486</w>
RT- PCR</w>
RESULT :</w>
REPORT S:</w>
REG ISTR
R e-
R ather,</w>
R ab
R X</w>
R VO
R N-
R CC</w>
R A)</w>
Qu al
Pub lished</w>
Prur itus</w>
Procain amide</w>
Procain amide-induced</w>
Pro gram
Pro -
Prinzmet al's</w>
Preg abalin</w>
Po oled</w>
Po ison</w>
Physi ological</w>
Phil adelph
Perman ent</w>
Pericardi al</w>
Pentazoc ine</w>
Partic ipation</w>
PT X-induced</w>
PT T</w>
PR IS
POPUL ATION:</w>
PL P</w>
PKC epsilon</w>
PI 3K
PH EN</w>
PH ).</w>
PGI 2,</w>
PGE 1.</w>
PC PA</w>
PB C</w>
PAN- injected</w>
P< 0.00
P ure</w>
P op
P in
P dn/P
P ast</w>
P N.</w>
P L-
P F</w>
P C-
Oxcarb azepine</w>
Orth o</w>
Organ ic</w>
OF F</w>
OD .</w>
OB SERV
OAT -
O s
O PC
O H,</w>
O CS</w>
Nrf 2</w>
Niger i
Neurolep tic-induced</w>
Neuro toxic</w>
Neuro sc
Net work</w>
Nephro lithiasis</w>
Na ,
NT S
NO SIS:</w>
NDE A</w>
NB Q
NAD PH</w>
NA GE
NAGE MENT:</w>
N-acetyl- beta-
N-[4-(5-nitro-2-furyl)-2-thiazol yl]form
N- hexacosanol</w>
N- 2-
N ur
N d
N Z
N N</w>
Mos sy</w>
Mini -M
Mini-M ental</w>
Mexilet ine</w>
Met formin</w>
Mem ant
Mar row</w>
MS- 8
MS M</w>
MR -
MPT P-treated</w>
MM T</w>
MK-80 1.</w>
MK 801</w>
MK 80
ME T</w>
ME LD</w>
MB s</w>
MA NAGEMENT:</w>
M ut
M uc
M ill
M U</w>
M P-
M P,</w>
M 1,</w>
Long itudinal</w>
Lidoca ine-induced</w>
Li gh
Li ,</w>
Leuk emia</w>
Len nox-Gastaut</w>
Le uc
LN C-
LNC- 8
L-argin ine-
L iterature</w>
L enal
L astly,</w>
Know ledge</w>
Ketoro lac</w>
Kawasak i</w>
KW- 39
K m</w>
K (+)
Ir respective</w>
Inv asive</w>
Intracor onary</w>
Intra- arterial</w>
Intra hippocampal</w>
Intr ad
Inter vention</w>
Inhib it
Inf ectious</w>
Indic ations</w>
Im plications</w>
IV ),</w>
IU/ l,</w>
INVESTIGA TIONS:</w>
IM PA
IIb/ III
III- IV</w>
III ).</w>
II -induced</w>
IGF B
IFN- gamma</w>
IF X</w>
ID C</w>
I(K r)</w>
I sop
I den
I H</w>
I A)</w>
Hemorrh age</w>
Hemat uria</w>
Hem olysis</w>
He in
HR -12
HLA- B
HIV .</w>
HER G</w>
HD P</w>
HD MTX</w>
HB O2</w>
HB F</w>
HB )</w>
HAM-D -17</w>
H2 O
H ic
H ess</w>
H PA</w>
Granulo matous</w>
Granulo cyte</w>
Gra des</w>
GnR H-
Gl y-
GSK-3 beta</w>
GR K2</w>
GAP- 43</w>
GAD 65</w>
G- protein</w>
G- Co
G-Co A)</w>
G s)</w>
G ross</w>
G as
G am
G P</w>
G DNF</w>
G /
Fre und's</w>
Fran ce.</w>
Fe atures</w>
Fas udil</w>
FR 1736
FOLF O
FL AP</w>
FE V
FD C</w>
FB M</w>
F- 41</w>
F low</w>
F lest
F ever</w>
F eno
F atigue</w>
F P-
F ITC-
F AC</w>
Ex treme</w>
Ex tra
Evan s-blue</w>
Estrogen s</w>
Epidemio logical</w>
Epi lept
Ep ste
Enox apar
Enh ancement</w>
En dot
En doc
Em erg
Electroly te</w>
Eb ste
ET V</w>
EO G</w>
EG CG</w>
EE -
ED 7</w>
E T</w>
E MT
Dys kine
Dou ble</w>
Dos ages</w>
Donepe zil</w>
Dis order</w>
Diphen hydramine</w>
Dil ated</w>
Dig it
Dia stolic</w>
Di azepam,</w>
Di az
Di alysis</w>
De termination</w>
De pres
De fic
Dap sone-induced</w>
Dan azol</w>
DT P</w>
DN A)</w>
DM CM</w>
DI AG
DIAG NOSIS:</w>
DE S.</w>
DE C</w>
DD E</w>
D x</w>
D u
D ro
D iz
D em
D bh</w>
D WI</w>
D AR
D 3.</w>
D -treated</w>
D (3
D (2)-
Cy sti
Cy pro
Cur cumin</w>
Cross- sectional</w>
Cor rec
Cor dar
Con sci
Com peti
Coch lear</w>
Clo se</w>
Cl (-)</w>
Child -P
Cent er,</w>
Cef otet
Carcin oma</w>
Car nit
Calcineur in</w>
CaCl 2</w>
CaCl (2)</w>
Ca usality</w>
Ca ud
CV D</w>
CT/ LCT</w>
CT C</w>
CR s</w>
CP u</w>
CP T</w>
CP E-
CP ),</w>
CO L
CNS -
CN U)</w>
CM P</w>
CLO Z</w>
CI PN</w>
CH F
CH )</w>
CCK-8- SE</w>
CCB s</w>
CC PA</w>
CB 2</w>
C- 96
C yst
C Z</w>
C C.</w>
C 2</w>
Braz ilian</w>
Br -
BM C</w>
BCH E</w>
B ur
B rattleboro</w>
B otox</w>
B ir
B U</w>
B RS</w>
B M</w>
B L</w>
Auth ors</w>
Austral ia,</w>
Attempt s</w>
At tac
Argatrob an</w>
Antine utrophil</w>
Anti hypertensive</w>
Anti cholinergic</w>
Anthrac ycline</w>
Ang us</w>
Ang ina</w>
Ana phylaxis</w>
An wala</w>
Amisul pride</w>
Am oxic
Am io-
Age -related</w>
Afric a.</w>
Af ter
Adriam ycin,</w>
Adren ergic</w>
Ad C</w>
Acetyl cysteine</w>
Acetazol amide</w>
AV A</w>
AV 3
ATP ase)</w>
AT ),</w>
AS P</w>
AS L-
AS A-
AS -
AP O</w>
ANOV A</w>
AN ALY
AM P)</w>
AL R</w>
AER s</w>
ADAM TS
AD ,</w>
AC Z</w>
AC PT
AC P-10
AC C-96
AB )</w>
A- IV</w>
A tri
A tor
A septic</w>
A s)</w>
A granulocytosis</w>
A PO
A L-
A HR-12
A 2
< or=</w>
< .05).</w>
90 %.</w>
90 %,</w>
9 7%</w>
9 66</w>
9 50</w>
9 20</w>
9 1,</w>
9 ,
8 A</w>
8 8)</w>
8 65</w>
8 5)</w>
8 4-year-old</w>
8 4
8 33</w>
8 20</w>
7-OH- AAF</w>
7 5-
7 5%,</w>
7 40</w>
7 4.
7 );</w>
60- min</w>
6- 8</w>
6 55
6 5)</w>
6 3)</w>
6 000</w>
6 )
6 %.</w>
57 .</w>
524 6
5. 8
5-HT(1 A)-
5-HT 6</w>
5-HT ,</w>
5- 7</w>
5,10- imine</w>
5 6-
5 -1-
48- 72</w>
48 /
4-D AMP</w>
4 67</w>
4 6-
4 000</w>
3alpha,5alpha- THP</w>
39 7</w>
39 %,</w>
38 1</w>
37 %,</w>
35 ),</w>
32 P-
30- mg</w>
30- day-old</w>
30- 60</w>
3. 7%</w>
3. 5%,</w>
3- benz
3- 7</w>
3, 7-
3 8-
3 6,</w>
3 4)</w>
3 0.0</w>
3 %);</w>
29 3</w>
28. 5</w>
28 4</w>
27 ),</w>
25 1</w>
21- day-old</w>
200 8.</w>
20- HETE</w>
2. 3%</w>
2. 25</w>
2. 1-
2-mercapto ethane</w>
2-chloro adenosine</w>
2-amino- 5-
2- antagonist</w>
2 :
2 29</w>
2 2),</w>
2 2%.</w>
2 11</w>
2 1.5</w>
2 1.3</w>
2 +/-1.
199 6,</w>
199 5,</w>
198 3</w>
19. 2</w>
18. 5</w>
18 9</w>
18 8
17. 3</w>
17 8</w>
16 00</w>
16 ,23-
16 ,
15S)- di
15 4,5
14 5
131 I-
13. 1</w>
13- cis-retinoic</w>
13 ;</w>
12. 5,</w>
12. 4</w>
12 79
113 89-
11. 9</w>
11. 4</w>
11 th</w>
100 %)</w>
10 -12</w>
10 %;</w>
1.0 8</w>
1.0 7</w>
1.0 2</w>
1. 6,</w>
1. 4,</w>
1. 17</w>
1. 10</w>
1. 00</w>
1,8- cine
1 ]
1 20/
1 18
1 165</w>
1 12
1 100</w>
00 2</w>
0.8 %,</w>
0.6 8</w>
0.6 4</w>
0.6 %,</w>
0.000 5)</w>
0.00 6)</w>
0.0 25)</w>
0. 4%)</w>
0. 37</w>
0. 34</w>
/ LVE
.00 8).</w>
.00 5).</w>
-1. 7
- B</w>
- 5-
- 0.8
+ ).</w>
(f MR
(dd I)</w>
(control s)</w>
(WH O)</w>
(V OD)</w>
(V N
(TR PV
(T UNE
(T O
(SPEC T)</w>
(SHR ).</w>
(S LE)</w>
(RR =
(R V
(R T)</w>
(P< 0.001),</w>
(N Y
(Mac aca</w>
(MA O
(M S
(M PO
(M M)</w>
(LD 50)</w>
(L QT
(IN H)</w>
(IC RF-1
(I M
(I )</w>
(HM G-CoA)</w>
(HAAR T)</w>
(H PA)</w>
(ED 50)</w>
(E P)</w>
(E Na
(E N
(Del ta
(DSM- IV)</w>
(D AT)</w>
(C K),</w>
(B U
(B T
(B R
(B MT)</w>
(B A
(AR B)</w>
(APA P)</w>
(AL F)</w>
(AED s)</w>
(ADR s)</w>
(AC TH
(AC )</w>
(A D)</w>
(9 1%)</w>
(7 8</w>
(7 4.
(7 2</w>
(7 %),</w>
(6 9%)</w>
(6 8%)</w>
(6 6%)</w>
(6 2%)</w>
(6 )-
(6 ),</w>
(6 %).</w>
(50 %),</w>
(5. 5</w>
(5 4</w>
(5 %).</w>
(4 1</w>
(3 9.
(3 6%),</w>
(3 0%</w>
(3 %).</w>
(2. 7%)</w>
(2. 6%)</w>
(2-chloroethyl )-1-
(10- 40</w>
(1. 3</w>
(1. 3%)</w>
(1 8
(1 3%),</w>
(1 2)</w>
(0. 3,</w>
(0. 125</w>
(0. 1-10</w>
(-1 )
(-/- ))</w>
( standard</w>
( primarily</w>
( paclitaxel</w>
( maximal</w>
( lower</w>
( l-
( i.v.).</w>
( i.p.
( four
( dopamine</w>
( con
( adriamyc
( [3H]
( UD
( QTc</w>
( 8-OH-DPA
( 5%</w>
% ],</w>
% ]).</w>
zofen opril</w>
z oster</w>
z onal</w>
z alcit
yl- 4-
yl line,</w>
year ly</w>
ye icos
y- chain</w>
y rimidine</w>
y rap
y losing</w>
xi s.</w>
xenobio tic</w>
xanth ines</w>
x ic</w>
withdraw al-induced</w>
widen ed</w>
wat ch</w>
war ned</w>
w t/
w t
w er's</w>
w ax
w alk
w -
vol %</w>
vit re
visual ize</w>
visu al-
vis its,</w>
vim entin</w>
vil inear</w>
vesti bulo
venlafax ine,</w>
ven om</w>
vel b
ve "</w>
vasomo tion</w>
vas ogenic</w>
vari ance.</w>
vancom yc
van inolol</w>
val ,</w>
vagotom y,</w>
vag ue</w>
vacu ole</w>
vaca ine</w>
v indes
utili ze</w>
us s</w>
uro genic</w>
urg ical</w>
urg -
urg- Stra
urg-Stra uss</w>
ureth ra</w>
unremark able,</w>
unit s,</w>
unevent fully</w>
under scores</w>
under line</w>
uncerta in
un usu
un treated.</w>
un successful.</w>
un restricted</w>
un n</w>
un medicated</w>
um ).</w>
ular ly.</w>
ul es.</w>
uch s</w>
ubi quit
u min
u an
tz man</w>
tyros ine,</w>
typ ing</w>
twenty- four</w>
turno ver.</w>
tumour .</w>
tumori genic</w>
tum oral</w>
tubul e.</w>
tuber cul
trun k,</w>
tro pan
tro meth
tript yline</w>
triazol am.</w>
triazol am,</w>
tri gu
tremor i
tremori genic</w>
trazod one,</w>
transf usion,</w>
transamin ases,</w>
trans luminal</w>
tran dol
tra ins</w>
tr ab
tox ins,</w>
tos ylate</w>
top ographic</w>
tongu e-
tolbut amide</w>
to uch
to tic</w>
to p</w>
to e</w>
to .</w>
tion s)</w>
tim es/
tilt- table</w>
ticarc illin</w>
tic ulo
ti sed</w>
ti gi
ti ary</w>
thym oxamine</w>
thrombocytopen ia/
thromb oly
three- month</w>
thre e.</w>
thiopent one.</w>
thi otepa
therapy- na</w>
therapeu tic"</w>
the ories</w>
the ophylline
th ol</w>
tetrac yclic</w>
testoster one.</w>
terti ary-
terg uride</w>
terfen adine.</w>
terat ogenesis.</w>
ter bin
tem oc
te olol</w>
te mazep
te j
te ar
tari bavirin</w>
tamoxifen -induced</w>
tachyp nea,</w>
tachy arrhythmias,</w>
table ts,</w>
t s/
t c
synap to
sym metric
sy mb
symb ol</w>
switch ,</w>
swe ating,</w>
susta ined,</w>
surroun ded</w>
surge ons</w>
suprag ranular</w>
super vised</w>
sup posit
sunit inib</w>
summar izes</w>
sulpiri de.</w>
sulfonylure as</w>
sulf ated</w>
sufentan il,</w>
succinylchol ine,</w>
succ ess.</w>
subu ro
substitu tions</w>
subst ra
subj ectively</w>
subcut aneously,</w>
sub type.</w>
sub traction</w>
sub sensitivity</w>
sub lingu
sub dermal</w>
su staining</w>
su ffere
stut tering</w>
stud y)</w>
striat oni
striatoni gral</w>
stres s/
strept o
strat a</w>
stra in
stom atitis,</w>
stimul ants.</w>
stere ological</w>
ster ixis</w>
stem -cell</w>
ste ep
spot s</w>
spong e</w>
spondy lo
spind le</w>
sphing omy
specific .</w>
spas ms.</w>
sparte ine</w>
span ning</w>
spac es</w>
sp illo
sp an</w>
soy bean</w>
soon er</w>
son- Angus</w>
son ographic</w>
somnif era</w>
somnambul ism</w>
som edi
som ato
solub ility</w>
solu tion)</w>
so y</w>
smo o
sme ar</w>
sligh t,</w>
sirolimus- based</w>
sing ly</w>
sing ,</w>
sin ess</w>
simend an</w>
signal- averaged</w>
sign al.</w>
sign .</w>
sign ,</w>
sig mo
sick ness</w>
si lym
silym arin</w>
sheep .</w>
sh ad
sgk1 (-/-)</w>
sex -</w>
sex -
seven ,</w>
sensory- motor</w>
sensitiz es</w>
sens ing</w>
semati lide</w>
self- terminating</w>
self- reports</w>
sel ectin</w>
seiz urogenic</w>
seg ment.</w>
seg ment
sedative- hypnotic</w>
second- order</w>
second s).</w>
secon d.</w>
sec .</w>
se t,</w>
se a</w>
scot oma</w>
scat ter</w>
sc ann
satur ation,</w>
satisfac tion,</w>
satis fied</w>
sarcolem ma</w>
saline- pretreated</w>
salbutam ol.</w>
sal ts,</w>
sal sal
sa i
s. ).</w>
s pati
s in,</w>
ry th
rul ing</w>
ru tin</w>
rom an
roman dibular</w>
ro stro
ro bu
ris tin</w>
ri mmed</w>
ri a.</w>
rewar d.</w>
review ers</w>
rever sed,</w>
retino pathy.</w>
retino in</w>
reticulo cytes</w>
respirat ory,</w>
resp ects</w>
resi due</w>
reproduc ib
reproducib ly</w>
repeate d
ren omedullary</w>
ren in,</w>
ren al-
remifentan il-
relax ant,</w>
reinst ated</w>
regimen )</w>
ref ined</w>
reduc tion)</w>
recur .</w>
record ing,</w>
reconstruc tion</w>
recogni tion,</w>
rece ptive</w>
re- uptake</w>
re vision</w>
re taining</w>
re started.</w>
re produces</w>
re mac
re introduced</w>
re administration</w>
re activation.</w>
re absorption.</w>
rate- limiting</w>
rate- corrected</w>
rate :</w>
rat ed.</w>
rat ).</w>
radic als,</w>
rad icul
rac hi
rab ep
r ite</w>
r ing,</w>
quis qual
quinol inic</w>
qui escent</w>
question able</w>
quanti fied.</w>
quadriple gic</w>
quad ric
qu asi
quasi -
qu ant
qu am
pyri meth
pyrex ia,</w>
py razol
puromyc in.</w>
puromyc in-induced</w>
pup s.</w>
pt osis.</w>
psychi at
psych ic</w>
prur igo</w>
proxim ity</w>
protr usions</w>
protr usion</w>
prost anoids</w>
pros the
propri etary</w>
promaz ine,</w>
prolactin oma.</w>
prolactin aemia</w>
proj ected</w>
progres s.</w>
prog uan
profil es.</w>
profen .</w>
probuc ol-treated</w>
pro stat
pro pos
pro hib
pro gen
pro drugs</w>
pro cysteine</w>
prim ary,</w>
pressure )</w>
preser ves</w>
pren olol,</w>
pregnancy -induced</w>
pregnan- 20-
preci sely</w>
pre medication,</w>
pre contracted</w>
prac tically</w>
pr ic
post- treatment.</w>
post ures</w>
post menstrual</w>
possib ly,</w>
pos th
porphy rin</w>
poplit eal</w>
poly neuropathy,</w>
poly mer</w>
pol acrilex</w>
point es
ple ocytosis</w>
plas matic</w>
piroxic am.</w>
pilocarp ine-</w>
pig mentation</w>
pi perox
photoph obia</w>
phosphocreat ine</w>
phosphatidyl inositol</w>
phosphat ases</w>
phosphat ase.</w>
phosph ot
phosph onic</w>
phil us</w>
phenotyp e,</w>
phenobarbit al-
phenacet in.</w>
phenacet in-
pharmaco therapies</w>
phag ocytosis</w>
ph le
perme able</w>
perm selectivity</w>
perin atally</w>
peri partum</w>
peri orbital</w>
percept ual</w>
percep tion.</w>
per- indomethacin</w>
per oz
per ir
per ,</w>
pent etra
ped uncular</w>
pe tic</w>
patient- years</w>
patient )</w>
patholog ies.</w>
particip ant
parenter ally</w>
parathyroid ectomized</w>
parameter .</w>
papaver ine-induced</w>
pantop razol
pan cytopenia,</w>
palpit ation</w>
pain- free</w>
pac ing-induced</w>
pa ins,</w>
pH i</w>
p< 0.001)</w>
p75 (NT
p, p-
p ing
p ct
p 53,</w>
oxygen ation.</w>
oxy phen
oxy pert
ox opiper
ox ide-induced</w>
ox aproz
ow n.</w>
over view</w>
over dosage.</w>
over .</w>
out line</w>
out let</w>
out flow.</w>
otom imetic</w>
ot ere
ostom y</w>
osteoporo sis,</w>
oste openia</w>
oste omalac
ost asis</w>
os ul
origin ates</w>
orgas m</w>
organel les</w>
organ ell
or on
optim ized</w>
optim ization</w>
optim ally</w>
opioid ,</w>
opi ates,</w>
opi ate-
ophthalmo logical</w>
opac ification</w>
op tions.</w>
op isthoton
op amid
onym ous</w>
onic id</w>
oncolog ists</w>
once- weekly</w>
omet rial</w>
ome- wide</w>
om is
oly l</w>
oligo deoxy
ol- 3-
ol amine-
of ten
ochemistr y.</w>
och ro
oc ulo
oc oc
oc in</w>
oc am
oblast oma.</w>
o v</w>
o propa
o profen</w>
o plast
o ocytes</w>
nucle olar</w>
nucle ic</w>
not e
nos al</w>
normoten sion,</w>
normal ize</w>
normal )</w>
non- use</w>
non- pegylated</w>
non- ischemic</w>
non lymphocytic</w>
non inflammatory</w>
non e,</w>
no tic</w>
no i
no -
nitrosou re
nitros amine.</w>
nitrit e/
nitraz epam</w>
nit us</w>
nigh tly</w>
nicotine- N'-
nicot ine-treated</w>
ng/ ml/
neuropsych ologic</w>
neurolog y</w>
neuro filament</w>
neuro ectodermal</w>
neur ite</w>
neu mo
ness :</w>
ness /
nes ot
nervous ness,</w>
nerv ousness</w>
nerv osa</w>
nephro toxicity:</w>
neostri atum</w>
neostri atal</w>
neocor tex
neo antigens</w>
neo adjuvant</w>
necro ses</w>
nebul ization</w>
nation wide</w>
nalmefen e</w>
n- acetylcysteine</w>
n l)</w>
myoglobin uric</w>
myoglobin uria,</w>
myoglob inuria</w>
myelo dysplasia</w>
myelo blastic</w>
myelo ablative</w>
mye litis</w>
my otoxic</w>
my oc
mut ational</w>
mut ants.</w>
mumol/ L,</w>
mumol e/
multiple -
multi modal</w>
multi factori
mtDNA- encoded</w>
motiv ated</w>
morb idity,</w>
mol/ l)</w>
modeoxy uridine</w>
model s:</w>
mode st,</w>
modal ities.</w>
mmol/ l.</w>
mmol/ L).</w>
mmol/ L
mm Hg/
ml/ kg)</w>
mis use</w>
mirtazap ine,</w>
mirro r</w>
mio sis,</w>
microsphe res.</w>
micromol/ l,</w>
micromol/ L)</w>
microm ,</w>
microliter s)</w>
micrograms/ rat</w>
micrograms.kg-1. min-1)</w>
microg/m L.</w>
microg/ kg),</w>
micro vessels</w>
micro l;</w>
micro dialysis.</w>
mg/m l).</w>
mg/kg/ h)</w>
mg/d L
mg/ L)</w>
mg./kg .,</w>
metriz amide</w>
meti pranolol</w>
methylprednisol one,</w>
methion ine-
metabol izer</w>
metabol ised</w>
metabol ically</w>
met aplasia</w>
mes h
mes encephalic</w>
mes al
menorrhag ia</w>
meningo encephalitis</w>
medi odorsal</w>
medi a,</w>
mechanis tic</w>
measure ment,</w>
me val
me traz
me tered</w>
me ter.</w>
me te
maxim um,</w>
mark er,</w>
mariju an
mannit ol,</w>
man o
man n
mammal s.</w>
mal nourished</w>
mal e)</w>
mainten ance,</w>
magnesi um.</w>
macromolec ules</w>
macaqu e</w>
ma -
mRNA ,</w>
m(- 2).</w>
m ia:</w>
m as.</w>
m M/
m M,</w>
lysos omes.</w>
lymph om
lu min
lox apine</w>
low- level</w>
low er.</w>
loracar bef
long- QT</w>
lon anserin</w>
lograph y,</w>
log ar
loc ations.</w>
lobe line</w>
lo th
lo s</w>
liver -associated</w>
lithium/ pilocarpine</w>
lit er.</w>
lip oxygenase</w>
lin ole
lightheade dness</w>
ligand s,</w>
libido ,</w>
li zation</w>
li a</w>
levome promazine</w>
levodopa -
levo thyrox
lessen ed</w>
lesion -induced</w>
lepir ud
leg ia,</w>
leb siella</w>
lear n</w>
lear n
le in</w>
le 's</w>
last ing,</w>
large -dose</w>
lan d.</w>
lamotrig ine,</w>
lad os
lact at
la g</w>
l end</w>
l ation.</w>
kg(-1 );</w>
kg -1).</w>
ke b
keb ach</w>
ke 's</w>
k ilo
k illing</w>
junc tions</w>
je op
iz ations,</w>
ity- -
ity .(ABSTRACT</w>
it ting</w>
it ch
ist s.</w>
issu e,</w>
isosorbide- 5-
isolated- HIT</w>
isol one</w>
isob aric</w>
iso zyme</w>
irrit ation,</w>
irrit ating</w>
irregular ities</w>
irCR F-41</w>
ir y</w>
ir lukast</w>
ipp ed</w>
iopamid ol,</w>
ion ic,</w>
invasi vely</w>
intraven ous,</w>
intraperitone ally.</w>
intracor poreal</w>
intr aspinal</w>
interview ,</w>
interven tions,</w>
intersti ti
interpre t</w>
intermitt ent,</w>
inter peduncular</w>
inter cros
inten sely</w>
intelli gence</w>
insuffici ency
inst ability,</w>
insp ection</w>
inotrop y</w>
inn ate</w>
injur y:</w>
initi ators</w>
inib .</w>
inher it
inhal ation,</w>
infrequ ent.</w>
infrequ ent,</w>
infl ation</w>
infiltr ates,</w>
infer tility</w>
inf anc
ine ligible</w>
industri al</w>
indomethac in-treated</w>
ind or
incorpor ate</w>
include :</w>
inc ap
in- Barr</w>
in usoidal</w>
in take
in stead,</w>
in opril</w>
in one,</w>
in conclusive</w>
in active.</w>
impro ve.</w>
imple mented</w>
implant ation,</w>
immunocom pet
immuno therapy</w>
immun oprecipit
immediate- release</w>
immedi ately,</w>
imipenem /
im pulses</w>
im perative</w>
im il
ili ac
ig no
ifosfamide /
ifer in</w>
if ies</w>
if erous</w>
if era</w>
idi xic</w>
ide ;</w>
icot inic</w>
icl one</w>
ical "</w>
i um.</w>
i quantitative</w>
i er</w>
i ent</w>
i PTH</w>
i =
hyste rectomy.</w>
hypox ia-induced</w>
hypoten sion)</w>
hypophosphat emic</w>
hyperinsul inemia</w>
hyperglyce mia.</w>
hypercholesterol aemia</w>
hyperammon emia.</w>
hyperalgesi a:</w>
hyper sensitive</w>
hyper secretion</w>
hyper oxal
hyper lipoprote
hyper dynamic</w>
hydrox yeicos
hydro codone</w>
hydralaz ine.</w>
hydralaz ine,</w>
hyd roure
hour s),</w>
hospital ised</w>
hormone- refractory</w>
homogen ates.</w>
hol id
hol ds</w>
ho o
high- salt</w>
high- pressure</w>
high- dose,</w>
heter otop
herb s</w>
heral d</w>
hepat otoxic
heparan ase</w>
hemoglob inuria</w>
hemodynam ic,</w>
hemisphere s</w>
hemic hol
hemi paresis,</w>
hem op
heav y-chain</w>
hear ing.</w>
hampe red</w>
ham ster</w>
half- time</w>
haemodialy sis.</w>
haemodi lu
haben ula</w>
h AI
hAI ]
gro om
gre ml
gr as</w>
gonad otropin-releasing</w>
go ro
go od.</w>
go od-
gnaw ing</w>
glyco side</w>
glyc ation</w>
glucos uria,</w>
glomer ulopathy.</w>
glomer ulo
glicl azide</w>
glibencl amide</w>
gir l.</w>
gir l
get ting</w>
gentamic in-mediated</w>
genotyp e.</w>
gener al.</w>
gangli oside</w>
gabapent in.</w>
gab a
g/m (2)</w>
g/ kg/
g out
g aining</w>
g R
gR [
gR[ hAI]
fron totemporal</w>
fron t</w>
fragment ation.</w>
fract ure.</w>
fore paw</w>
fore arms</w>
for d</w>
foot -
food- maintained</w>
fluvox amine,</w>
fluspiril ene</w>
flush es</w>
fluor inated</w>
fluid- attenuated</w>
flud arabine</w>
fluctu ations.</w>
fluctu ating</w>
fluc ytosine</w>
fluc onazole.</w>
flu vastatin</w>
flecain ide-induced</w>
fl or
fl in
fl ick
fl er
fl are,</w>
fin ished</w>
filam ent
fibrom y
fib ros
fib res.</w>
fib rate-induced</w>
fi gh
fer tility</w>
fenbu fen</w>
fen oter
femal e;</w>
feed ing,</w>
feasib le.</w>
fascicul ations,</w>
factor- beta1</w>
f oxine</w>
f loxac
ey es)</w>
ey e-
extub ation.</w>
exter nally</w>
exten sion.</w>
exposure :</w>
expon entially</w>
explor ation.</w>
exper t</w>
exist s.</w>
exist ,</w>
excit otoxicity</w>
excit ation,</w>
ex tran
ex pose</w>
ev enly</w>
etidoca ine,</w>
eti foxine</w>
ethan ol-
eth opropa
esthe sia</w>
es .
ero sion</w>
eradic ate</w>
er ule
er s'</w>
er ;</w>
er /
er ),</w>
equ ip
epit opes</w>
epirubic in/
epirub icin-induced</w>
epicardi um</w>
epi genetic</w>
epi b
ep oxygenase</w>
eosinophil s.</w>
eosinophil s,</w>
enti az
ent in,</w>
ent h</w>
ent ero
eng aged</w>
enflur ane,</w>
endo gen
end- organ</w>
end points.</w>
encephalomyeli tis</w>
encephalo pathic</w>
enc kebach</w>
en ess</w>
en ables</w>
employ ed,</w>
emerg e</w>
embry os,</w>
elev ates</w>
electrophore tic</w>
el uate</w>
el an
effici ently</w>
ed s</w>
ec um</w>
ear s,</w>
ear ly.</w>
ear ,</w>
e ligibility</w>
e ?</w>
dystroph in</w>
dysrhyth mia.</w>
dysph onia</w>
dysfunction :</w>
dys morphic</w>
dys men
dys geusia</w>
duc t.</w>
drug- taking</w>
drug )</w>
drospiren one</w>
dro x
dro ps.</w>
doxorubicin- containing</w>
double- dumm
doses ;</w>
dor somedi
dopamin erg
dol asetron</w>
do steron
diure tic.</w>
disulfir am-
disulfir am,</w>
disrupt s</w>
disproportion ate</w>
disp osing</w>
diseas e).</w>
discharg es,</w>
dis placed</w>
dis inhibition</w>
dis appears</w>
dimin ished,</w>
dimethyl thiourea</w>
digoxin- specific</w>
digitalis -induced</w>
dideoxy inosine</w>
diatrizo ate.</w>
diatrizo ate,</w>
diabetes -induced</w>
di ri
di plo
di phasic</w>
di isopropyl</w>
di fluoro
di flun
di a</w>
develop ment
dev ice.</w>
deta iled.</w>
design ing</w>
descri ptions</w>
des quam
dermat ological</w>
der m</w>
der ive</w>
depos its.</w>
depos its,</w>
depend ently.</w>
deoxyp yridoxine</w>
deoxynucleoti dyl</w>
deline ated</w>
delay ed,</w>
degre es,</w>
definiti vely</w>
deep er</w>
decade s,</w>
dec ed
deb ate</w>
de vised</w>
de hyd
de bri
daunorub icin.</w>
daun omycin-induced</w>
darbe poetin</w>
dantrol ene.</w>
da m</w>
dP/d tej
d- amphetamine.</w>
d- amphetamine,</w>
d t</w>
d res
d ine-associated</w>
d actinomycin</w>
d F
d (-1))</w>
cytotoxic ity,</w>
cyto sis.</w>
cyto k
cystic er
cyst oscopic</w>
cyst ometro
cyan ide</w>
cure d.</w>
cumul ated</w>
cu stom
cu ne
cryst als.</w>
cri tic
cortic otropin</w>
corpor a</w>
cor ds</w>
copies/ mL</w>
cop ulatory</w>
cop al</w>
convuls ant,</w>
controll able</w>
contract ures</w>
contrac tions,</w>
contra sting</w>
continu ed,</w>
contin gency</w>
cont amination</w>
constric tor</w>
consolid ation.</w>
consider ations.</w>
conn ecting</w>
conges tion.</w>
concurren tly.</w>
concomitant ly.</w>
concl usive.</w>
concentration- response</w>
con su
con form
con dy
con du
con c
compromi se.</w>
compoun d
complete d,</w>
complete ,</w>
compet e</w>
compar ably</w>
com ycin-induced</w>
com man
collo id</w>
collap sed</w>
collag en-
coll ected,</w>
coll ect</w>
col d-
col a</w>
cogniti ve-
cocaine- positive</w>
cocaine- abusing</w>
coca ine)</w>
co- occurring</w>
co vering</w>
co verage</w>
co sis.</w>
co localized</w>
co existed</w>
co bal
cm )</w>
clu es</w>
closed- chest</w>
clofib rate.</w>
clo ser</w>
cl um
cl org
cl adrib
cisapri de,</w>
cinnar izine</w>
choreoathe toid</w>
chor io
cholere tic</w>
choledoch olithiasis</w>
cholecyst ectomy.</w>
cholecalc iferol</w>
cholang itis,</w>
chol ic</w>
chlordec one</w>
chie fly</w>
chick s.</w>
chemoconvuls ants</w>
che st,</w>
channe l-
chamb er.</w>
ch l
ch )</w>
cere bru
cerebru m</w>
cephapir in</w>
cephaloth in.</w>
cephal ex
cent ric</w>
cent ers,</w>
cell .</w>
ceftriax one-associated</w>
cefotet an.</w>
cef tiz
cef onicid</w>
caud a</w>
catheter ,</w>
catechol- O-
catalepsy :</w>
cas opit
cas e).</w>
cartil age</w>
cardiolip in</w>
cardio depressant</w>
cardio active</w>
car inic</w>
car dic
cannul ae</w>
cann ulation</w>
cal i
cal '</w>
cab ergoline,</w>
ca emia,</w>
c us</w>
c os
c in</w>
c c</w>
but azone</w>
but az
bronchospas m,</w>
bronchodilat ing</w>
breath ing,</w>
bradykin in,</w>
brady arrhythmias</w>
both )</w>
bo y.</w>
block ed.</w>
blin k</w>
blepharo spasm</w>
bl ur
bif ur
bi phenylacetic</w>
bi le-
bi ased</w>
bi -
beta-hydroxy steroid</w>
beta- blocker,</w>
beta- HS
beta-HS D2</w>
beta -</w>
beta )</w>
bet ter,</w>
ber aprost</w>
benzodiazep ine-induced</w>
benzo[ a,
benef it,</w>
benef ici
belong ing</w>
beg ins</w>
be ers</w>
barbitur ate-induced</w>
baical ein</w>
b.w .
b.i. d
b ute</w>
b ones</w>
b erg
b ath</w>
b at
b arely</w>
b ]
b ).</w>
azole- associated</w>
ax is
avir .</w>
aur icular</w>
au x
attenu ated.</w>
attac k,</w>
athi one</w>
ather o
ath s</w>
ate- day</w>
at taining</w>
at op
at a.</w>
asyst olic</w>
asthen ia,</w>
assess ments,</w>
ass ing</w>
as pergillo
as ing</w>
arthro plasty</w>
arterios us,</w>
arteriol es.</w>
arteri ole</w>
arter ially</w>
arrest ed</w>
arn s
ar yl-
ar van
ar izine</w>
aquaporin- 2</w>
apyri dine</w>
apra xia</w>
appropri ately.</w>
apopto sis-
apne as</w>
apath y</w>
ap ism</w>
ap ine,</w>
antihist amines.</w>
anticholinerg ics.</w>
anti- neutrophil</w>
anti- muscarinic</w>
anti- hypertensive</w>
anti- cataleptic</w>
anti- androgen</w>
anti trypsin</w>
anti parkinson</w>
anti manic</w>
anti estrogen</w>
anti cocaine</w>
anti bacter
anti androgen</w>
anti allodynic</w>
anti akinetic</w>
anthrac enedi
anth us</w>
antagonist ;</w>
ant "</w>
anser in.</w>
anomal y,</w>
ann ually</w>
ank ylosing</w>
anis ocor
angio edema
anesthesi ologist</w>
anesthesi a-induced</w>
andro lone</w>
ance :</w>
anastom osis</w>
anal icular</w>
anaesthe tic.</w>
an om
an icteric</w>
an eth
an ;</w>
an -</w>
ampicill in.</w>
amoxicill in.</w>
amoun ted</w>
amodi aquine</w>
amne si
aminotransfer ases</w>
aminonucleo side,</w>
aminonucleo side
amino- 8-
amino-8- D-
amino ind
amino )-
amine 's</w>
am ent</w>
alu s.</w>
alte red,</w>
alpha2 ABC-
alpha- naph
alpha- hydroxy-
alpha(2)- adrenoceptor</w>
alpha 7-
almotript an</w>
allyl glycine</w>
allograf t.</w>
allergi es</w>
all-trans- RA</w>
alf op
alend ron
albu min)</w>
al lox
al izing</w>
al ide</w>
al aprocl
akine sia,</w>
agonist -
agglut inin</w>
ag u
ag le</w>
af t</w>
adver tent</w>
adv ice</w>
adv ancing</w>
adhe ren
aden osin
addres sed.</w>
addic tion
adap ted</w>
ad vised.</w>
ad venti
ad ine-induced</w>
acyclovir ,</w>
acut ely,</w>
act s.</w>
acryl amide</w>
acromegal y,</w>
acid ophilic</w>
achiev es</w>
achie ved,</w>
acetazol amide.</w>
ace ae)</w>
accur ac
accid entally</w>
acceler ator</w>
ac -induced</w>
absorb able</w>
absc es
abo ve,</w>
aberr ations</w>
ab solut
ab le-
a us
a ifen
a ids</w>
_ F</w>
[Na ]o</w>
[4, 3-
[3 H]</w>
[ mean</w>
[ 5-
[ 3.
[ 2.
[ 199
[ (2-
Zn (2+)</w>
Z Rs</w>
Z ;</w>
Z -treated</w>
YM-1615 1-1</w>
X R</w>
Wor k
Well -
Wee ks</w>
Wat er</w>
Wash ing
W omen
W enckebach</w>
W all
W /
Vari ations</w>
VN R</w>
VIP (-/-)</w>
VCR -induced</w>
V erbal</w>
V aginal</w>
V R</w>
V IP</w>
V I
V EC
Urin alysis</w>
Upreg ulation</w>
Ultras ound</w>
Ul tim
U/ L.</w>
U/ L);</w>
U K-
U K
U -1
U-1 59
Tric yclic</w>
Tran examic</w>
Tra um
Tin nitus</w>
Thail and.</w>
Th resh
Th or
Test ing</w>
Terbut aline</w>
Ter tiary</w>
Te tra
TW EA
TRI AL</w>
TR s</w>
TP P</w>
TJ -
TI s</w>
TH F</w>
TGF-beta (1)</w>
TGF- beta1</w>
TE T</w>
TE PA</w>
TE P</w>
TCPOB OP</w>
TCD D-induced</w>
TAS K-2</w>
TAM -induced</w>
TA F
T ob
T g</w>
T URE:</w>
T SH</w>
T LC</w>
T L
T AT
T 1-
Sur face</w>
Supra ventricular</w>
Sub group</w>
Sub -
Su peroxide</w>
Ster oid-induced</w>
Star D6</w>
Sta v
Som n
Sixty- one</w>
Simult aneously,</w>
Simp son-Angus</w>
Seventy- seven</w>
Ser ological</w>
Sem iquantitative</w>
Sel ected</w>
Sch istos
Salbutam ol</w>
Sal ic
SVR I</w>
SR 250
SR 141716A</w>
SN R.</w>
SN P,</w>
SELEC TION</w>
SD S</w>
SCN 5
SC T)</w>
SC S</w>
SB-277011 A</w>
SA ).</w>
S. D
S(+)- ketamine</w>
S ympath
S patial</w>
S atis
S ando
S VT</w>
S PA
S N</w>
S K</w>
S B</w>
Risperid one-induced</w>
Rest less</w>
Res cue</w>
Repeti tive</w>
Rel ation</w>
Refract ory</w>
Rec eptor</w>
RNA ,</w>
RAMP 2</w>
R ut
R opi
R are</w>
R PN</w>
R D</w>
R AM
R -treated</w>
Quin idine-induced</w>
QT c
QS/ QT.</w>
Q o
Q O
Q Kd</w>
Q ).</w>
Pub lic</w>
Pt O2</w>
Proj ect</w>
Pri apism</w>
Pres ented</w>
Pres ence</w>
Post marketing</w>
Pharmac eutical</w>
Ph ent
Perio dic</w>
Per me
Pentam idine</w>
Pem oline</w>
Peg ylated</w>
Pdn/P dn</w>
Patter ns</w>
Parox etine</w>
Par alle
Panc re
PT CR</w>
PT ),</w>
PROCED URES:</w>
PR C</w>
PO G</w>
PN U-159
PL G</w>
PL ).</w>
PK A</w>
PIC TURE:</w>
PGI (2)</w>
PGE 2,</w>
PGE 1-induced</w>
PG .</w>
PD-1 28
PD-128 ,
PAN- perfused</w>
PA -treated</w>
P ram
P at
P ED
P C,</w>
P =</w>
P <</w>
P :
P 50</w>
P 4
P 120
Open -
Op en</w>
Ome prazole</w>
Observ ational</w>
Ob ses
OR :</w>
OR ,</w>
OI H</w>
O ther
O ste
O S)</w>
O PN</w>
O EA</w>
O AC</w>
Norep inephrine</w>
Nor adrenergic</w>
Nitroprus side-induced</w>
Ninety- three</w>
Neuro pathic</w>
Neuro genic</w>
Neur ons</w>
Ne os
Na(+ )
Na PB</w>
Na HCO3</w>
Na Cl,</w>
Na /
Na (v)
NT- pro</w>
NSAID ,</w>
NR 2B</w>
NO S,</w>
NG ,</w>
NAD H</w>
NA c</w>
N- butyl-
N- (2-
N(omega)- nitro-L-arginine</w>
N MB
Myco phenolate</w>
Multi focal</w>
Mon keys</w>
Mirta zapine</w>
Min nesot
Migra ine</w>
Methyl prednisolone</w>
Mem orial</w>
Mec amylamine</w>
Me an
May o</w>
Mar yl
MV O2</w>
MUG A</w>
MT ),</w>
MS NA</w>
MR Z</w>
MM .</w>
MDMA/ METH</w>
MD A,</w>
MA PD</w>
MA ),</w>
M- 0
M ouse</w>
M IF-1</w>
M Hb</w>
M CE</w>
M .
M -1
Lymph ocyte</w>
Lis inopril</w>
Ld T</w>
Lang er
LY 37
LY37 9
LY 27
LY27 46
LV .</w>
LT ).</w>
LP O</w>
LP -1</w>
LM W</w>
LE ).</w>
LC V</w>
L- Arginine</w>
L y
L g
L L
L BNP</w>
L -</w>
L )-
Kreb s</w>
KO P-
K+ ,</w>
K it
K I-
K 1
J u
J er
J 2</w>
Isop ren
Intrac isternal</w>
Intrac ellular</w>
Intra hepatic</w>
Inter nal</w>
Insul in</w>
Inflam matory</w>
In stitut
In appropriate</w>
In advertent</w>
Improve ments</w>
Iden tical</w>
Idazox an</w>
IU/ L,</w>
IM /
IL K</w>
IIb/III a</w>
II B</w>
IF N)</w>
IF N
IC G</w>
IC ).</w>
I- converting</w>
I- III</w>
I so</w>
I c</w>
I atrogenic</w>
I -123</w>
Hz ).</w>
Hypoten sion,</w>
Hyper kalemia</w>
Hydro chlorothiazide</w>
Hun t</w>
Hic cups</w>
Hg Cl2</w>
He y
He avy</w>
HIV -associated</w>
HCV- coinfected</w>
HC N</w>
HC H,</w>
HAM- A</w>
HA AR
H(2) O
H R)</w>
H L
H AM
Gre at</w>
Glycyrrhiz a</w>
Gly bur
Gen otyp
Gen der</w>
GY KI-
GV HD,</w>
GT P
GSP E</w>
GR 1279
GP T</w>
GM 1</w>
GABA (A
G- 6-
G unn</w>
G LP-1</w>
G ITS</w>
G HB
G BM
Fos- ir</w>
Fir st-
Fentan yl-induced</w>
Fenflur amine</w>
Fast ing</w>
FF P</w>
F344/ NCr</w>
F uchs</w>
F ore
F lup
F c
F arns
F Z</w>
F X
F VIIa</w>
F M
F IO
F AN</w>
F 2-
Ex amin
Er k</w>
Epste in-Barr</w>
Endothel in</w>
En doscop
Electrocardio gram</w>
Ebste in's</w>
ET (A)</w>
ESR D.</w>
EP S,</w>
EP 3</w>
ED T
E vent
E u
E pac
Drug -related</w>
Dis opyram
Dipyridam ole-induced</w>
Di azepam
Dextro methorph
Des cri
Dep letion</w>
Del ta</w>
De teri
Daun orubicin</w>
Dan ish</w>
DR 3</w>
DPA T</w>
DN F)</w>
DH E</w>
DES -treated</w>
DES -induced</w>
DEN- initiated</w>
DE X
DE S,</w>
DD T</w>
DD P</w>
D-00 4</w>
D- pen</w>
D osing</w>
D am
D DP
D ;</w>
D (2)
Cysti tis</w>
Con trac
Comp ound</w>
Colo r</w>
Classi fication</w>
Cl- BZ
Chol ester
Cho rea</w>
Chloramphenic ol</w>
Chin a.</w>
Child-P ugh</w>
Ch urg-Strauss</w>
Ch -7</w>
Cent ers</w>
Catal ase</w>
Caro lin
Carnit ine</w>
Canad a</w>
Canad a.</w>
Ca+ 2</w>
CT X</w>
CT S</w>
CS s</w>
CS S</w>
CR L
CPE- C</w>
CP Z.</w>
CP U
CP G</w>
CO 2)</w>
CO -
CN QX</w>
CM R</w>
CI .</w>
CH O-
CH ,</w>
CCR 2</w>
CCK-8- NS</w>
CB V</w>
CA S:</w>
CA PE</w>
CA MI</w>
CA F</w>
C ath
C annabin
C ZP</w>
C Q</w>
C PA/
C PA,</w>
C P-
C C)</w>
C >
C -related</w>
C (max)</w>
Bio logical</w>
Benzodi azep
Bene ficial</w>
Be agle</w>
Baro reflex</w>
BR L</w>
BAL B</w>
B ud
B ronch
B im
B S</w>
B N
B LA</w>
B ChE</w>
B AL</w>
Az ot
Auto immune</w>
Aut onomic</w>
Au tism</w>
Asses sing</w>
Arrhyth mias</w>
Arg -
Aqu af
Anticoag ulation</w>
An tic
Amio- Aqueous</w>
Ameli oration</w>
Alter native</w>
Alter ation</w>
Alph a
All- trans-retinoic</w>
Al f
Aff ective</w>
Aff airs</w>
Administ ered</w>
Acyclo vir</w>
Acyclo vir
Acetaminophen -induced</w>
Ac cid
AV P-
AT P.</w>
AT P)</w>
AT N</w>
AS ),</w>
AR ,</w>
AQP 6</w>
AP- 2</w>
AP s</w>
AP L.</w>
AP B</w>
AP -1</w>
ANCA ,</w>
ANALY SIS:</w>
AN T</w>
AN H</w>
AM I.</w>
AHR-12 234</w>
AH ).</w>
AE ,</w>
AD P/
AD P-
ACTH ,</w>
ACC-96 53</w>
AC EA
ABT- 7
AB- 47</w>
A- lesioned</w>
A- (1-1
A y
A sterixis</w>
A sac
A ro
A reas</w>
A c</w>
A OA
A K-
</ =
< 0.01).</w>
< .001)</w>
< .001).</w>
99 m-
95 191</w>
9 cRA</w>
9 27</w>
9 0)</w>
9 '
9 %.</w>
80 ),</w>
8. 7%</w>
8. 3%</w>
8- OHD
8 7.
8 5-year-old</w>
8 2-year-old</w>
7 9)</w>
7 6.</w>
7 11389-
600 2</w>
6. 7%</w>
6. 5%</w>
6. 4
6 ]</w>
6 8.
6 4.
6 00-
55 2
506- treated</w>
50 3</w>
50 .</w>
50 %).</w>
5. 4
5. 2%</w>
5-methyl -10,11-dihydro-5H-di
5-HT -
5- minute</w>
5- flouro
5,7- dihydroxytryptamine</w>
5 ]
5 7-
5 62</w>
5 3-
5 )
48-67 91</w>
48 %,</w>
4- h</w>
4- OH-
4- 8</w>
4, 4'-
4 :</w>
4 91</w>
4 47</w>
4 2%,</w>
4 00-
39 ),</w>
37 8</w>
35 ;</w>
32P- post
30- minute</w>
30 5</w>
30 /
30 %).</w>
3. 4%</w>
3. 2,</w>
3. 0-
3,4-dihydroxyphenyl alanine</w>
3,4-D AP</w>
3 h</w>
3 B</w>
3 7-
3 4-
3 4,</w>
3 33</w>
3 2),</w>
3 12</w>
3 10</w>
3 1).</w>
27 3</w>
27 %,</w>
26 ),</w>
24 6</w>
24 4</w>
24 1</w>
24 00</w>
20- 40</w>
20 ,
2.0 %,</w>
2. 6%</w>
2. 4)</w>
2. 2,</w>
2-amino- 4-
2- wk</w>
2- methyl
2- adrenoceptor-mediated</w>
2- DG</w>
2 19</w>
2 18</w>
2 1/
2 1%)</w>
2 0.1</w>
2 0.0
1: 200
1: 100,000</w>
199 2,</w>
199 0.</w>
198 6,</w>
198 4,</w>
19 74</w>
19 3</w>
19 2</w>
19 28
17- item</w>
16. 6</w>
16. 4</w>
15. 7</w>
15- 30</w>
15 th</w>
15 %)</w>
14. 8</w>
14 ;</w>
13 93
12. 5%</w>
12 8
10- 30</w>
10(9)/ l</w>
10 20</w>
10 %)</w>
1, 8
1 H-
0.9 6</w>
0.9 4</w>
0.9 2</w>
0.8 6</w>
0.8 3</w>
0.7 6</w>
0.7 0,</w>
0.5 %.</w>
0.4 7</w>
0.4 1</w>
0.4 %,</w>
0.3 %,</w>
0.000 )</w>
0.00 7).</w>
0.00 4)</w>
0.0 25%</w>
0. 6,</w>
0 7</w>
0 1</w>
0 -10
.00 2).</w>
.0 5</w>
. s.).</w>
. 4.</w>
-1. 6
-1. 2</w>
-1,3- dipropyl
-1 7.
-1 65</w>
- shaped</w>
- abusing</w>
- S
- DXR</w>
+/-1 2</w>
+/- 4</w>
* 3</w>
)- dependent</w>
(r =</w>
(p= 0.
(p. o.)</w>
(n= 10)</w>
(n NOS)</w>
(medi an:</w>
(mean :</w>
(V PA),</w>
(UPD RS)</w>
(Tax ol)</w>
(T x
(T LE)</w>
(T LE),</w>
(Sp ear
(SSRI s).</w>
(SE ),</w>
(S B
(RB V)</w>
(R AS)</w>
(PT Z)-induced</w>
(PC P)</w>
(P T)</w>
(P S
(P PA)</w>
(P IL
(P HT)</w>
(P DE
(P AR
(Na,K )-ATPase</w>
(NO ),</w>
(NH L)</w>
(N GF)</w>
(M g
(M T)</w>
(M N
(M M).</w>
(M CA)</w>
(M CA
(LD L)</w>
(L F
(L C
(K (i)</w>
(IC V)</w>
(HR :</w>
(HBeAg )-positive</w>
(H O
(G V
(G E
(G 6
(F HF)</w>
(F A)</w>
(ESR D)</w>
(ED (50)</w>
(EC S)</w>
(E X
(E B
(DRE SS)</w>
(DF O)</w>
(D i
(D BP)</w>
(CY P2
(CP P)</w>
(CM L)</w>
(CG I)</w>
(C NS),</w>
(C N
(C IP
(C I</w>
(C I,</w>
(C I),</w>
(C C
(C A)</w>
(C 3
(C ),</w>
(BM I)</w>
(B NP)</w>
(B F
(B D
(Adriamyc in)</w>
(AQ P
(ANCA )-positive</w>
(AB R)</w>
(A ng</w>
(A P)</w>
(9 6%)</w>
(9 4%)</w>
(9 2%)</w>
(9 )</w>
(8 R,
(7 8%)</w>
(7 ),</w>
(6 0%</w>
(6 %</w>
(5-FU ),</w>
(5, 7-
(5 7</w>
(5 5%).</w>
(5 1%)</w>
(5 %),</w>
(4 8.
(4 6%)</w>
(4 ,</w>
(3. 7%)</w>
(3. 3%)</w>
(3 %),</w>
(25 -100</w>
(2 9.
(2 6%</w>
(2 5%</w>
(2 4.
(2 4
(2 2%),</w>
(2 0,</w>
(2 0%).</w>
(2 %).</w>
(12. 5%)</w>
(1. 6</w>
(1. 4</w>
(1 9-
(1 7%</w>
(1 5/
(1 4%</w>
(1 4%),</w>
(1 30</w>
(1 3-
(1 3%).</w>
(1 )-induced</w>
(0.3- 3</w>
(0.3 -10</w>
(0. 9%</w>
(-)- nicotine</w>
(- 4
(- 3
(+)- PD-128,
(+)- CP
( vitamin</w>
( sem</w>
( selective</w>
( s.
( s).</w>
( recombin
( ratio</w>
( positive</w>
( plus</w>
( placebo</w>
( of</w>
( intravenous</w>
( icv)</w>
( e)</w>
( decreased</w>
( creatinine</w>
( between</w>
( beta</w>
( M</w>
( January</w>
( In
( 0)</w>
% ]),</w>
" ),</w>
} -
zolpide m.</w>
zol e-induced</w>
z icon
z alepl
yst emic</w>
yri mid
yme tac
ym pan
ym b
yl- 6-
yl- 2-
year ;</w>
y .(ABSTRACT</w>
xy lo
x ip
with out,</w>
wild -
wide -
where in</w>
whe l
weight/ day</w>
wei g
wean ing,</w>
weak ,</w>
warran ted,</w>
wall s.</w>
w/ w)</w>
w t).</w>
w ks</w>
w as:</w>
w all-
w .
vom ited</w>
volun t
volum es.</w>
viru ses</w>
vill us</w>
view .</w>
ver y-
ven ules</w>
ven ipuncture</w>
ven ess,</w>
ve ins,</w>
vastat in-
vascul arly</w>
vari ants,</w>
vari ably</w>
vals art
val ir
val dec
ut ch</w>
use d;</w>
use -dependent</w>
us ly</w>
us er.</w>
urve dic</w>
ures ;</w>
up ff
upff er</w>
uncertain ty</w>
un responsiveness</w>
un paired</w>
un opposed</w>
un loading</w>
un infected</w>
un d-
un conjugated</w>
un conditioned</w>
un adjusted</w>
um -</w>
ultraf iltration</w>
ultraf iltr
ulcer ation.</w>
uc lid
uc ent</w>
u sion
u f
twice/ day</w>
tun g
tung sten</w>
tumour s,</w>
tumour ,</w>
tumor s:</w>
tubul e,</w>
tu f
trypt ase</w>
troglitaz one-induced</w>
tript an</w>
trimester .</w>
tric h
triamterene ,</w>
tri tiated</w>
tri phenyl
tri flu
triflu oper
treatment- naive</w>
tre on
tranyl cy
tranylcy prom
transport ,</w>
transpl an
transfer ase.</w>
transf er.</w>
transc utaneous</w>
trans location</w>
trans formed</w>
trans form</w>
tract able</w>
tra in</w>
toxoplasmo sis</w>
toxico kinetics</w>
tot al)</w>
tor sa
togen y</w>
toc olysis</w>
to fore</w>
ting ling</w>
time -to-
tigi l</w>
tigh tness</w>
tic- range</w>
tic '</w>
thyrotrop in</w>
thyro id
thyl isothiocyan
through out.</w>
thrombo phlebitis.</w>
thrombo -
thromb ectomy</w>
three- week</w>
three- fold</w>
threat ening.</w>
thix ene</w>
thirty- six</w>
thiopent al-
thiop urine</w>
thio -
thiamyl al</w>
thi s.</w>
therap y),</w>
thalas semic</w>
tetro fos
tetrac ycl
terfen adine,</w>
terbin afine</w>
terat ogenesis</w>
ten sions</w>
ten on</w>
teen ag
technetium- 99m</w>
tast arch</w>
tamoxifen -treated</w>
tak otsubo</w>
tadal af
tacrolim us-related</w>
tacrolim us)</w>
tachy kin
tachy arrhythmia.</w>
table t.</w>
ta ilo
t ympanic</w>
t wel
t inea</w>
t RA</w>
t -</w>
system :</w>
synchron isation</w>
syn geneic</w>
symptom s)</w>
sympath olytic</w>
sw allow
sut ured</w>
suspici ous</w>
surviv ors,</w>
surveill ance.</w>
suprac lavicular</w>
suppress ants.</w>
supernat ant</w>
super sensitivity.</w>
sup ran
sulphasalaz ine-induced</w>
sulphadi azine</w>
sulph ated</w>
sulfad ox
sulf inpyraz
sudden ,</w>
suc ce
subunit ,</w>
substance -induced</w>
subject -
subicul um</w>
sub lethal</w>
su m.</w>
su m,</w>
su ited</w>
stupo rous</w>
structure- activity</w>
stri pe</w>
stress ors</w>
stress -related</w>
stres sor</w>
streptozotoc in-treated</w>
strength ened</w>
sto ols</w>
sti ll
ste ine</w>
stand ing,</w>
stand ardi
stabiliz ers</w>
stabiliz er</w>
stabil ized,</w>
stabil ity.</w>
st ored</w>
st ents.</w>
st asis.</w>
spot ting</w>
spind les</w>
spik es.</w>
sphing osine</w>
specul ative.</w>
special ist</w>
spe ed,</w>
spas ms,</w>
sp ring</w>
sp in</w>
sp ells</w>
sou gh
sorafen ib
son ograms</w>
som uc
solu tion
sol ifenacin</w>
sniff ing</w>
sme ll</w>
slow ing.</w>
slop es</w>
six- month</w>
site- specific</w>
sirolim us-induced</w>
sinu ses</w>
sinu s.</w>
single- drug</w>
single- center</w>
significant )</w>
signific ance,</w>
sigmo id
side- effect.</w>
sick ness
sickness -like</w>
sibu tramine</w>
si vely.</w>
si vely,</w>
si s/
si alo
shor ten</w>
shiver ing,</w>
sham -treated</w>
sh allow</w>
sexu ality</w>
sex es,</w>
sevoflur ane.</w>
severe )</w>
seven -
ses ame</w>
serone gative</w>
seroconver sion,</w>
ser osi
sequest ration</w>
sens or</w>
sens ation.</w>
semin al</w>
semi- synthetic</w>
sel ective
seizures )</w>
seg ments,</w>
sed atives</w>
search es</w>
se ous</w>
se -1,
scre ening.</w>
scre en,</w>
score )</w>
sco res
schem e</w>
scar ce.</w>
scal e:</w>
sap onin</w>
salme ter
sal ine
sai rei-
sacro coc
s plic
s pa
s ):</w>
ru ment</w>
rosi glitaz
room ,</w>
rofecoxi b
ro se,</w>
ro l</w>
rituxim ab</w>
rituxim ab
ripen ing</w>
ric -
ribonucle ic</w>
rheumat ology</w>
rh IL-1
rh G-CSF</w>
rever se-
ret ching,</w>
resume d.</w>
responsib le.</w>
respond ence</w>
respon ded.</w>
respir ation.</w>
respectively );</w>
resor uf
reser ved</w>
reser ve,</w>
res ection.</w>
repor ter</w>
repe ated.</w>
ren dering</w>
ren der</w>
remove d,</w>
remn ant</w>
remin der</w>
remedi es</w>
reli ance</w>
reinfor ces</w>
regul ators</w>
regres sions</w>
regist r
regim ens
regi me.</w>
reflex -
refer r
ref ine</w>
reduc tions.</w>
reduc ed-
recumb ent</w>
recommend s</w>
recipient s:</w>
receptor- blocking</w>
recei ves</w>
reb oxet
rear rang
re treated</w>
re modelling</w>
re challenge,</w>
rati os,</w>
rate- dependent</w>
rat s),</w>
rasag iline</w>
rapid ly,</w>
rapam yc
random ization,</w>
random -
ramipri l.</w>
radiot ele
radiograph s</w>
radi ol
radiol ucent</w>
radi ation-induced</w>
rachi al</w>
r in-
r SO
r ),</w>
question ing</w>
qu inu
quinu pri
pyri form</w>
pyri do
pyeloneph ritis</w>
put aminal</w>
purpur a-
purpura- hemolytic</w>
pure- tone</w>
pur ple</w>
punct ate-evoked</w>
pum p,</w>
pulmon ary,</w>
pul sive</w>
psycho pathological</w>
psych otomimetic</w>
prox ymetac
propranolo l-
promin ently</w>
prolifer ators</w>
progres sed.</w>
produc ed,</w>
probuc ol,</w>
pro lin
pro kinetic</w>
pro coagulant</w>
pro cat
procat erol</w>
pro carb
princip les</w>
prilo ca
prevent ed,</w>
preven tion,</w>
presyn cope</w>
pregnancy :</w>
preferen ce,</w>
precurs or,</w>
pre treating</w>
pre pubertal</w>
pre operatively,</w>
pre malignant</w>
pre determined</w>
pre defined</w>
pr asu
pp m)</w>
pow er.</w>
post- traumatic</w>
post ure.</w>
positive )</w>
popul ations,</w>
polydip sia.</w>
poly myositis.</w>
poly myosi
poly b
polyb rene</w>
pol l
point es)</w>
pod ocytes,</w>
po or-
plu g</w>
pl anne
piroxic am,</w>
piret anide</w>
pirenzep ine,</w>
pilocarp ine-evoked</w>
pig s,</w>
pig mentary</w>
pict ures</w>
physici an,</w>
physi opathology</w>
physi cally</w>
phthal ate</w>
phot ograph
phospho protein</w>
phle bo
phil ia</w>
pheochromocyt omas</w>
phenyleth yn
phenyl glycine</w>
phenyl biguan
phenprocou mon
pharmaco vigilance</w>
pharmac ore
pharmac ists</w>
ph aryng
pg/ ml)</w>
peroxisom es</w>
peroxid ase.</w>
peris inusoidal</w>
perir hinal</w>
perio d).</w>
peri renal</w>
perfor atum</w>
perf usion-
percenti le</w>
per mis
per ist
perist al
per al</w>
pepti de
pentyl ent
pentylent etra
penicill in-induced</w>
pec tral</w>
pe ol</w>
pe metrex
pe er-
paw- pressure</w>
path omechan
path ogn
path ogens.</w>
pass ing</w>
parval bumin
parturi ent</w>
parano ia,</w>
paramedic s</w>
paradig ms.</w>
papaver ine,</w>
pancreatitis -associated</w>
palpit ations.</w>
pal sy
pal mo
pa st,</w>
pa rom
pa qu
p< 0.001).</w>
p- coumar
p x
p ine-treated</w>
p i</w>
p and
pand ed</w>
p H.</w>
oxygen ation,</w>
oxybu procaine</w>
oxid ase-
oxamniqu ine</w>
oversho ot</w>
overloo ked.</w>
overl apped</w>
over load.</w>
over activity.</w>
ou tward</w>
ou red</w>
ou ght</w>
otyp al</w>
otom ies</w>
ot um
ot emporal</w>
oste osarcom
osal ping
os m
os i</w>
os co
osco rea</w>
os a
ortho g
orthog onal</w>
orrh agic</w>
orph an
oro somuc
organ isms.</w>
or ies.</w>
or ice</w>
or der
or all
opi pam</w>
ophthalmolog ists</w>
oph aryngeal</w>
oper icardi
open ed</w>
opa r</w>
oneuro pathy.</w>
one ],</w>
on- off"</w>
on- chronic</w>
on war
on ;</w>
on ).</w>
omis sion</w>
omedi ast
om y</w>
oly sis:</w>
oly m
olom e</w>
olog raphic</w>
oligonucle oti
oligodendro cytes</w>
ol ide</w>
ol id</w>
ol ay
ol amine,</w>
oid s,</w>
ofur in</w>
off ,</w>
ocy n
ocor tic
ocom ial</w>
ochrom es</w>
och lor
ocent esis</w>
oc hor
obste tr
observ able</w>
obsc ure</w>
oblong ata</w>
obit z</w>
obarbit al,</w>
ob entine</w>
o B</w>
nul li
nucleol i</w>
not ochor
nos ocomial</w>
nor th</w>
non- responders</w>
non- painful</w>
non- acetaminophen-induced</w>
non transgenic</w>
non responders.</w>
non protein</w>
non hematological</w>
non cardiovascular</w>
nodul es.</w>
no f
nof sky</w>
nmol ).</w>
nitr one</w>
nit ration</w>
nit rates,</w>
nit rate,</w>
nimesul ide-
nimesulide- beta-
nimesulide-beta- cyclo
nimesulide-beta-cyclo dextr
nigh ts</w>
nifedi pine-induced</w>
nex in</w>
new -
neutrophil s,</w>
neuro surgery.</w>
neuro radiological</w>
neuro adaptations</w>
neur one</w>
neur algia</w>
neostri at
neo plasi
neede d,</w>
necro sis;</w>
ne y,</w>
ne ar
ne a.</w>
naltrex one.</w>
nalbu ph
nadi r,</w>
nACh Rs</w>
n- hex
n- 3
n is
n ail
n NOS
myocardi tis:</w>
myelo ma,</w>
myalgias/ arthralgias</w>
my otonic</w>
my opericardi
mut h</w>
mut ants,</w>
muscim ol-
muscar in
mun icipal</w>
mug/ kg</w>
move ment,</w>
mot or-
morph olin
morph ism</w>
mon olay
mon ni
molecul e.</w>
mol/ L</w>
mofetil ,</w>
model ed</w>
model :</w>
mo tility,</w>
mo .</w>
mmol/ liter</w>
mm ).</w>
ml/ 24</w>
mixt ures.</w>
mixt ure,</w>
mitomycin- C</w>
mit ot
mit ogen</w>
mistak en</w>
mis sing</w>
miner alization</w>
min g.</w>
min aprine</w>
min );</w>
mili e
milie u</w>
midod rine.</w>
microscop ically.</w>
microscop ical</w>
micrograms/kg/ min,</w>
micrograms/kg/ d</w>
micrograms/ kg).</w>
micrograms/ day</w>
micrograms/ d
microgram s).</w>
microg/paw ),</w>
microg/kg/ min,</w>
microg/kg/ day</w>
microg/ kg).</w>
microg. kg(-1).
microangio pathy.</w>
micro phthal
micro infusion</w>
micro dissected</w>
micro L/
mg/m l,</w>
mg/kg/ week</w>
mg/d L;</w>
mg/d ;</w>
mg. kg(-1).
mexilet ine.</w>
mexilet ine,</w>
methyl-6- (
methyl ]-
methodo log
meth cath
metfor min,</w>
metar aminol</w>
metaproteren ol</w>
metamiz ol</w>
metabol izers</w>
meta z
mesh work</w>
mesen ch
meropen em.</w>
men tion</w>
medullo blast
me d.</w>
me d,</w>
mc g</w>
may be</w>
matur ation.</w>
mat ric
mas king</w>
mark edly,</w>
mark ed
manson i</w>
manifest ation.</w>
manag ed.</w>
man ometry</w>
man dates</w>
mam ent
malform ed</w>
male ate.</w>
malar ia,</w>
magnitu des</w>
magnesi um-deficient</w>
macroph age-
mac ron
mRNA- containing</w>
mL (-1)</w>
mGluR s,</w>
mEq/ L).</w>
m- 2</w>
m s:</w>
m osph
m ess
m M
m .)</w>
m (2)</w>
m (2)
lymph atic</w>
lut eal</w>
lus it
lox ic
lorecle zole</w>
lor azepam
lopin avir/
lop ec
long itud
lonafarni b</w>
log ram</w>
local ised</w>
loc illin</w>
load s</w>
load ing.</w>
lo tin
lo t</w>
lli gence</w>
liver :</w>
littermat es.</w>
lithium/ pilocarpine-induced</w>
lithium- associated</w>
lit ters</w>
lis dexamfetamine</w>
lipo id</w>
lip ase</w>
linezol id.</w>
lignoca ine,</w>
ligh t.</w>
ligand s.</w>
lig and.</w>
lig and-
life-threat ening.</w>
life-threat ening,</w>
life- time</w>
lick ing,</w>
li xim
levodopa /
level ;</w>
leukem ia)</w>
leuk ocytosis</w>
les sen</w>
least ,</w>
lear ance</w>
le vetir
le flun
le d;</w>
le an</w>
le /
later ;</w>
lados tigil</w>
lacun os
lact ate.</w>
lac rim
labetal ol-induced</w>
l ich</w>
l ect
l ecith
l aud
l acti
knowledg e.</w>
knock down</w>
kg o</w>
justi fied.</w>
jump ing,</w>
jud ic
join ts,</w>
join t.</w>
jer ks.</w>
jejun um</w>
j our
j el
iz ation-
it ol</w>
it an</w>
ist s,</w>
isoproteren ol
isoprenal ine,</w>
isom er,</w>
isol ate</w>
iso prolol</w>
iso eugenolol</w>
iso electric</w>
ish ,</w>
ischem ia/
is tic-like</w>
irrit ation.</w>
irrig ation.</w>
ir reversible,</w>
ir CRF</w>
ipec ac</w>
ioxag late,</w>
iopamid ol.</w>
ion otropic</w>
invol ution</w>
investig ator
intrag lomerular</w>
intrac ister
intra patient</w>
intoler ance,</w>
intim a</w>
intest ine.</w>
inter rup
inter neurons.</w>
inter neurons,</w>
inter current</w>
inte rest,</w>
int act
institu tion
inst rument</w>
inosit ol
inos uccin
inoc ulation</w>
innerv ating</w>
injec tion;</w>
inj ect
initi s.</w>
inhibit ed.</w>
inhibit ed,</w>
inhibi tions</w>
inher itance</w>
inhal ing</w>
inhal er</w>
ingre dients</w>
ing ing</w>
infec tion:</w>
ineff icacy</w>
ineff ectiveness</w>
ineff ective,</w>
ine- pretreated</w>
ine ]</w>
induc ed)</w>
ind atr
indatr aline</w>
increas ing,</w>
in- secreting</w>
in uria,</w>
in stitute</w>
in kgo</w>
in ism.</w>
in dependent,</w>
in complete.</w>
import antly</w>
import ance,</w>
imped ance</w>
immunosuppres sion,</w>
immuno fluorescent</w>
immobil ized</w>
imipenem- cilastatin</w>
im pressive</w>
im in
im azole-induced</w>
ill ingham</w>
ill in-induced</w>
ile us</w>
il y,</w>
il ity.</w>
ifi ed,</w>
if est
idi oventricular</w>
idi ol</w>
ide ation</w>
id ly</w>
icalTrial s.gov</w>
ic ted</w>
ic king</w>
ib otenic</w>
ia ?</w>
i xis.</w>
i sed.</w>
i i</w>
hypot onia</w>
hypoprote inemia,</w>
hypom anic</w>
hypo plasia.</w>
hypo plasia,</w>
hypo locomotion</w>
hyperreflex ia,</w>
hyperphosphat emia</w>
hypernat raemia</w>
hypercalci uric</w>
hyperal dosteron
hyper intensity</w>
hyper intensities</w>
hyp olip
hydroxybut yl)
hydroxy ethyl
hydrolas es</w>
hydrochlor ide)</w>
hydro ceph
hydroceph alus.</w>
hydro carbon</w>
hydramni os.</w>
hy oscine</w>
hr s.</w>
hospit al-based</w>
hor t</w>
hor n.</w>
hom ologous</w>
ho st
histor ic</w>
histopath ology.</w>
histopath ology,</w>
histi ocytes</w>
hist amine.</w>
his tidine</w>
hipp ocam
high- potency</w>
high- dosage</w>
high er-dose</w>
here tofore</w>
her petic</w>
hepatocarcin ogenic</w>
hepatitis -like</w>
hepati s.</w>
hepat oprotective</w>
hepat opathy</w>
hepat ocytic</w>
heparin ized</w>
hemorrh age:</w>
hemop ty
hemodilu tion,</w>
hemichol inium-
hem in</w>
hem angi
heat ,</w>
he tastarch</w>
he n</w>
he ated</w>
he ade
haz ar
harve st
hard ly</w>
hapto globin</w>
hap ten</w>
hand s.</w>
hand ling.</w>
hallucin ogenic</w>
half- maximal</w>
haemorrh ages</w>
h l</w>
h ens</w>
h ad
h :</w>
guid ance</w>
guan aben
guanaben z</w>
gu es</w>
gu ar
group -
granulo mas</w>
gran ul
gram -negative</w>
gradu ally,</w>
gra dients</w>
gout y</w>
go se
glycos uria,</w>
glycopyr ronium</w>
glycol- conjugated</w>
glyco sides</w>
glycer yl
gly cyrrhiz
globul in,</w>
glab ra</w>
gi um</w>
gentamic in-
gender -matched</w>
gen ome-wide</w>
gemcitab ine,</w>
gel atin</w>
ge me
gastro- intestinal</w>
gastro scopy</w>
gamma R
g/m 2),</w>
g/d L)</w>
g/ kg),</w>
g um.</w>
g p
g ot
g m.</w>
g m
g ing</w>
g ases,</w>
g al</w>
function )</w>
fulmin ans</w>
ful .</w>
front- line</w>
frequ encies,</w>
fract ures,</w>
fra il</w>
fosin opri
fos phenytoin</w>
forskol in,</w>
form s,</w>
form er.</w>
forelimb s</w>
fore arm,</w>
for ce-
fo sel
fo od
fluorop yrimidine</w>
fluoro uracil,</w>
fluor ide</w>
flu ids.</w>
flow metry.</w>
fla res</w>
fl ap</w>
first- pass</w>
filtr ation.</w>
filgr as
filgras tim
figh ting</w>
fi xime</w>
fi er:</w>
fet us,</w>
feasib ility,</w>
fav oured</w>
fav ors</w>
fasc icular</w>
factor- beta</w>
fac ts</w>
f us
f uro
f rom
f ost
f mol/
f loxacin-induced</w>
f ile</w>
f all,</w>
extre mit
extram edullary</w>
extr usion</w>
exten ds</w>
expon ential</w>
experi ences.</w>
expand ing</w>
exerci se
exer tional</w>
excit ation.</w>
excep tionally</w>
ex ogenously</w>
evol u
ev ening.</w>
eti l,</w>
ethyl enedi
ethosuxim ide,</w>
ethinylo estradiol-induced</w>
ethinylestradi ol-induced</w>
ethan olamine</w>
eth nic</w>
et -
es .(ABSTRACT</w>
erythropoi esis.</w>
erythro blast
ergot amine,</w>
erec tions.</w>
ere br
er ing,</w>
er -induced</w>
equ ipped</w>
equ ations</w>
equ ation</w>
epinephr ine-containing</w>
epileptic us:</w>
epilepsy :</w>
environ ment,</w>
enterocol itis</w>
ent ered,</w>
ensu ed,</w>
enkephal ins</w>
enhance d,</w>
endothelium- independent</w>
endometri osis</w>
end ritic</w>
end osulf
end ings.</w>
encour aged</w>
ence ;</w>
ence )</w>
enalapri l-treated</w>
en ig
en apine</w>
en -induced</w>
emergen cies</w>
emergen cies.</w>
embryo pathy.</w>
embol ization.</w>
elic a</w>
elev ations,</w>
el y
el u
effect ;</w>
eff ected</w>
educ ated</w>
ed ge</w>
ecstas y
ec tic</w>
ec opipam</w>
ec lofen
eat ers</w>
e zing</w>
e ther
e sis,</w>
e ochromocyt
e k</w>
duoden um</w>
droperid ol,</w>
drop- out</w>
draw back</w>
dr astic</w>
doxorubic in-based</w>
dow n.</w>
doub t
dose- ranging</w>
dorsomedi al</w>
doppl er</w>
dog s),</w>
dofetili de-induced</w>
do ing</w>
diure tic
disul ph
disru ptions</w>
dispar ity</w>
disp ensed</w>
disor dered</w>
dis appear
dis advantage</w>
diri thromycin</w>
dino prostone</w>
dinit rate.</w>
dimethyl benz
dilu ent</w>
dihydroxyphenyl alanine</w>
difficul ties.</w>
diff usion,</w>
diel drin</w>
di versity</w>
di str
di phosph
di morphic</w>
di methylethan
di mer</w>
di meglum
di a
di (2-
df= 1,</w>
devi ation,</w>
devi ation)</w>
develop mentally</w>
determin ations.</w>
desi re,</w>
dermatomyosi tis-like</w>
depriv ation,</w>
depres sion)</w>
depres sed.</w>
deple te</w>
dens it
deman ds</w>
del toid</w>
dehyd rat
decreas e)</w>
deafferen tation</w>
de signs</w>
de sig
de serve</w>
de position,</w>
de methyl
de aminase</w>
dd C,</w>
day -1)</w>
day );</w>
dap sone-induced</w>
da .</w>
d- -
d it
d ing.</w>
d ge
d UT
d );</w>
d '</w>
cytos ol</w>
cytokin es.</w>
cyt ochromes</w>
cyt ochro
cyt ochemical</w>
cyst s.</w>
cyprohept adine,</w>
cyclospor ine-treated</w>
cyclospor ine-induced</w>
cyclohepten- 5,10-imine</w>
cycl es).</w>
cyan osis</w>
cy cli
cut off</w>
curren ts.</w>
curren t,</w>
cres yl</w>
creatin ine
cre am.</w>
crac k-
cr ush
counter action</w>
coun try</w>
cou ple
cost al</w>
correl ation.</w>
correc ts</w>
correc ting</w>
correc ted.</w>
cord ant</w>
cor respondence</w>
cor n
cop y</w>
cop per-indomethacin</w>
convul se</w>
convinc ing</w>
controversi al,</w>
cont ingent</w>
cont ents.</w>
consum p
consolid ation,</w>
conserv atively</w>
conjug ation</w>
conduc ted,</w>
concer n,</w>
concentration -related</w>
conce iv
computer -controlled</w>
competi tively</w>
competi tion</w>
compar ative,</w>
comp rise</w>
comp act
compact a</w>
comm issu
combin ation:</w>
com pressive</w>
com pressed</w>
com position.</w>
colon oscopy</w>
colo cysto
collag en.</w>
col itis,</w>
cohor ts.</w>
co inc
clonid ine;</w>
clo sing</w>
clo fil
clindam ycin.</w>
cl ump
cl entiaz
cisplat in
circumst ances.</w>
cimetid ine-induced</w>
cil astat
ciclo prolol</w>
chore ic</w>
chol ine-induced</w>
chlorprop amide.</w>
chlorphenir amine</w>
chlorphenir amine,</w>
chlorozotoc in</w>
chemopre vention</w>
chemo prophylaxis</w>
chem ot
channe l,</w>
ch lo
ch in
ceti rizine</w>
ceriv astatin</w>
cephalospor ins,</w>
cent ur
cellul itis</w>
cells/ microL</w>
ceftriax one-induced</w>
cefotax ime
ce mia.</w>
ce ment</w>
cause -
caudate- putamen,</w>
cataton ia,</w>
cat astrophic</w>
cast s.</w>
cas es/
cas e
carvedi lol,</w>
caro ti
cardiover ter-
cardiac -
cardi tis</w>
carcin omas,</w>
carboxy piperaz
carbon yl</w>
carben icill
carb ons</w>
carb aryl</w>
capecitab ine-induced</w>
capecitab ine,</w>
cap re
canalicul i</w>
calib er</w>
calcium- binding</w>
calcitri ol,</w>
calcific ation.</w>
calci um-induced</w>
cal pain</w>
ca zole</w>
ca .</w>
c m,</w>
c GM
butyr ylcholinesterase</w>
butyl bicyclophosphoro
but yro
bur n
bupivaca ine/
bun azosin</w>
bul b
budeson ide.</w>
bronch ogenic</w>
bronch oconstric
bronch i
bro ader</w>
brevi ated</w>
bre ed</w>
br in
br ary</w>
box .</w>
bo ther
bo ar
bl ue-
bl inded,</w>
bisphosph onat
bis muth</w>
bir th-
biotrans formation</w>
bif era</w>
bif ascicular</w>
bi ot
bi oc
bever ages</w>
beta- methyl-
beta- lact
beta 1-
bet amethas
berb erine</w>
benztrop ine,</w>
benzodiazep ine.</w>
benign ,</w>
benef ited</w>
belong s</w>
behaviour s.</w>
be ings</w>
be ar</w>
barbit al</w>
bam buter
bacterio logic</w>
back- diffusion,</w>
babo ons</w>
b p</w>
b ony</w>
b an
b ag
azithrom ycin.</w>
az in
az ide-induced</w>
az ide,</w>
aux iliary</w>
auto receptors</w>
autis m,</w>
attri bute</w>
atri um,</w>
atri o-
atom oxetine</w>
ative- free</w>
ation- ,</w>
ation -associated</w>
ate- 3-O-
atazana vir
at tained.</w>
at onic</w>
at ology</w>
at mosph
at able</w>
at .</w>
at ,</w>
asym metr
astro gliosis</w>
aster ixis.</w>
assist ance</w>
aspart ate.</w>
as sem
as se
as enapine</w>
as e/
arub icin,</w>
arti cles.</w>
arter itis.</w>
arrhythmias ;</w>
are .</w>
ard less</w>
arachnoidi tis</w>
arabino side,</w>
ar ryth
ar mament
apri l,</w>
apraclon idine</w>
ap ine-induced</w>
ap art
antipsycho tic
antibacter i
anti-HB e</w>
anti- seizure</w>
anti- anxiety</w>
anti rheumatic</w>
anti proteinuric</w>
anti myosin</w>
anti genic</w>
anti fibrillatory</w>
anti epileptics</w>
anti dotal</w>
anti dopaminergic</w>
anti depressive</w>
anti al</w>
anthracycl ine-based</w>
anth anum</w>
antero ventral</w>
antagonist -induced</w>
ant olol</w>
anim al,</w>
anil ide</w>
ang rad
aneurysm ,</w>
ane ph
ane :</w>
ana x</w>
ana -dependent</w>
an uria.</w>
an hedonic</w>
amyr in</w>
amp les</w>
amlodip ine,</w>
amisulpri de,</w>
aminoglyco sides.</w>
amino) tetralin</w>
amino glutethimide</w>
amin ,</w>
ambi gu
am peroz
altern ati
altern ate-day</w>
altern ans</w>
alpha1- adrenergic</w>
alpha- mang
alpha- ENaC</w>
alpha,beta- me
alpha ),</w>
allopurin ol,</w>
alle y</w>
alkalo ids.</w>
ali ve,</w>
albumin uria.</w>
al um</w>
al titude</w>
al though,</w>
al so,</w>
al prostadi
al one)</w>
al one
al dose</w>
air .</w>
aim ing</w>
ail able</w>
aifen esin</w>
aggreg ating</w>
agglut ination</w>
agglut in
agent ;</w>
ag ing.</w>
afterwar ds.</w>
after load,</w>
af luoro
adul t-
adreno receptors</w>
adolescent .</w>
administr ation)</w>
adjust ment,</w>
addic ts,</w>
act in,</w>
acitret in.</w>
acidi fied</w>
acetylchol ine.</w>
acetam .</w>
acet oxy-
accumul ations</w>
accoun t,</w>
accept ably</w>
ac tam</w>
ac knowledg
ac k
ac ide
ac he
ac eclofen
absor p
abic yclo
abdom in
ab ac
aPT T
a king</w>
a ided</w>
a ]</w>
[HR ]</w>
[CI ]:</w>
[1, 2,4
[(3)H] -
[ odds</w>
[ RR
[ 1</w>
Z in
Y MRS</w>
X- ra
X O</w>
Women 's</w>
Wer nic
Warfar in-associated</w>
Wall is</w>
WIN 55,212-
W AI
Vi usi
Vari ables</w>
VTE ,</w>
VPA -
V inorelb
V Y)</w>
V OD.</w>
V DS</w>
Uni ver
Under standing</w>
Ultim ately,</w>
UF P-1
U3788 3A</w>
U- exposed</w>
U sed</w>
U p-
U R</w>
U M-
U H</w>
Trx R1</w>
Trans plantation</w>
Trans plant</w>
Top otecan</w>
Thresh old</w>
Thio guanine</w>
Tetra hydro
Td P,</w>
Tan g</w>
Taiw anese</w>
Taiw an.</w>
TW A</w>
TTP/ HUS</w>
TREAT MENT:</w>
TR H,</w>
TNS r</w>
TMP/SM X</w>
TI CH</w>
TI )</w>
TA S</w>
T ren
T arget
T K</w>
T G)</w>
T 2
T -1</w>
Syst em.</w>
Syn erg
Syn drome
Swe den</w>
Surve y</w>
Super ficial</w>
Suc c
Stud y,</w>
Stud ent's</w>
Struct ured</w>
St op
Spironolact one</w>
Sm aller</w>
Sixty- six</w>
Sixty- five</w>
Simil arly</w>
Sertr aline</w>
Seleg iline</w>
Sec ond</w>
Schistos oma</w>
Schedul e</w>
ST .</w>
SSRI s.</w>
SR250 8</w>
SR .</w>
SP s</w>
SN r</w>
SM S</w>
SM P</w>
SM ON</w>
SJ L</w>
SETTING ,</w>
SE ),</w>
SCI D</w>
SCH 000
S14 G-
S14 0
S100 B</w>
S.E. M
S,3 R-
S,3R- AC
S taining</w>
S pe
S lit
S amples</w>
S P,</w>
S 1)</w>
S )-1-
S (+)</w>
Rib avir
Reg ardless</w>
Rec i
Re fer
Re bound</w>
Re N
ReN 18
Rap idly</w>
Rac 1</w>
RVO T-
RP N.</w>
RNF L</w>
RNA .</w>
RL S.</w>
REGISTR ATION:</w>
RE )</w>
RAS SF
RAN K
RA L</w>
R- T
R oles</w>
R k
R ectal</w>
R ate</w>
R andall-Selit
R ami
R S-
R E</w>
R AE
R 56
Questionna i
Prost acyclin</w>
Prophyl axis</w>
Probuc ol</w>
Pro vid
Pro ble
Pres cri
Pregn ancy</w>
Predn isolone</w>
Pre disposing</w>
Pram ipexole</w>
Post- mortem</w>
Por sol
Poly uria</w>
Poin tes.</w>
Platele ts</w>
Ph lebitis</w>
Per it
Partic ular</w>
Pancre atitis</w>
Paclitaxel -induced</w>
Pac ific</w>
PTU -associated</w>
PT s</w>
PT A</w>
PRL- R</w>
PR A,</w>
PP H.</w>
PKC gamma</w>
PH ),</w>
PG S</w>
PG F
PE NK</w>
PD E</w>
PD ).</w>
PD ),</w>
PA/ kainate</w>
P= 0.
P< .001).</w>
P450 sc
P s
P il
P ear
P b</w>
P Y
P P-
P NE</w>
P Is</w>
P C.</w>
P (2
One- year</w>
Ondan setron</w>
Olan zap
Ob served</w>
OT FC</w>
ON .</w>
OLT X</w>
OD N</w>
OBSERV ATIONS:</w>
O v
O ROS</w>
O LO
O (2))</w>
Nor adrenaline</w>
Non invasive</w>
Non convulsive</w>
Ninety- six</w>
Neuro pharmacological</w>
Neuro logy</w>
Neuro imaging</w>
Neuro chemical</w>
Neos tigmine</w>
Ne vir
NaCl -treated</w>
Na, K-ATPase</w>
Na v</w>
NY HA</w>
NSCL C,</w>
NSAI D-
NO x</w>
NO -induced</w>
NO (
NMD A/
NK 3</w>
NAD PH
N-[4-(5-nitro-2-furyl)-2-thiazolyl]form amide</w>
N- ethyl-
N- Acetylcysteine</w>
N, N-
N utri
N one.</w>
N ociceptive</w>
N isoldipine</w>
N el
N a,</w>
N ECA</w>
N 3-
N 0
Mus cular</w>
Mt TW
Mon o
Mode l</w>
Mic hi
Metron idazole</w>
Meth od</w>
Meth amphetamine-induced</w>
Met ab
Met a-
McN- 56
Mark ov</w>
Man ifest
Mall ory</w>
Mad opar</w>
MT 42</w>
MS-8 57</w>
MP I</w>
MP E
METH ,</w>
ME D</w>
MDMA ,</w>
MD S</w>
MD .</w>
MD ,</w>
MCI-1 54</w>
MA P-induced</w>
MA OI
M uch</w>
M ass</w>
M VO
M P.</w>
M I-
M G
MG MT</w>
M CR</w>
M B)</w>
M 3
Lithi um-
Li Cl.</w>
Lg A</w>
Leuk oencephalopathy</w>
Lamiv ud
LY379 268</w>
LY 14
LY14 18
LVE F.</w>
LV M</w>
LO U/
LNC-8 34</w>
LEP s</w>
L6- S1</w>
L- lysine</w>
L- dopa,</w>
L- W</w>
L- AP
L- 70
L-70 1,
L s)</w>
L 6,</w>
L 4</w>
L 4-
Know n</w>
Kap osi</w>
K upffer</w>
K rus
K lebsiella</w>
K i</w>
K R
K CN</w>
Jer se
Isopren aline</w>
Isoniaz id-induced</w>
Is radi
Is ra
Intran asal</w>
Intrac aver
Intra vascular</w>
Inte lligence</w>
Incid ences</w>
In stitu
In patient</w>
In direct</w>
In clusion</w>
Immunosup pression</w>
Immun ological</w>
Im potence</w>
Ill ness</w>
Ig G
Ig E
Identi fier:</w>
Ibuprofen -induced</w>
IV M</w>
ISO .</w>
ISO -
ISO ,</w>
IP SCs</w>
IN Rs</w>
IL- 2</w>
III :</w>
III ),</w>
II A</w>
II /
IGFB P-
IF O,</w>
ICRF-18 7.</w>
IC U.</w>
IC ER</w>
I. V.</w>
I ohex
I mid
I b
I DE
I )
Hypo glycemia</w>
Hyper trophic</w>
Ho e</w>
Hist ory</w>
High ly</w>
Hepat ocyte</w>
Hen och
Hemat opoietic</w>
Hemat oma</w>
Hein z</w>
HW -165</w>
HU S)</w>
HU 210</w>
HU -2
HT ),</w>
HSP 70</w>
HPL C.</w>
HIV +</w>
HIT TS</w>
HI- I</w>
HDL- cholesterol</w>
HCV- infected</w>
HC l.</w>
HC l,</w>
HBI g</w>
HB O</w>
H oxa
H ct</w>
H b,</w>
H b
H NP</w>
H HI-I</w>
H (3
Gram -negative</w>
Glyc er
Glut athione</w>
Glucocortico id</w>
Glomer ul
Gl n</w>
Gem fibro
GSH -P
GP x</w>
GABA(B (1
G6 PD</w>
G- CSF.</w>
G ar
G AP
G 145
G145 R</w>
G (
Four ier</w>
Fos -like</w>
Flurbi profen</w>
Flu t</w>
Flest olol</w>
Fi bri
Fem oral</w>
Fem al
FG IN
FD G</w>
F/ Y56
F ast</w>
F S.</w>
F (2)-
F(2)- isoprostane</w>
Ex panded</w>
Eth in
Estradi ol
Epilept ogenic</w>
Ephed rine</w>
Ephed ra</w>
Endom yocardial</w>
End- stage</w>
En zyme</w>
Emerg ent</w>
Electromyo graphy</w>
Electromyo graphic</w>
Eighty- seven</w>
Echocardi ograms</w>
EV IDE
ESR D,</w>
EPO .</w>
EP R</w>
EP 3
ELIS A.</w>
EL B</w>
EE G-
EC T.</w>
EAD s</w>
EA AC
E mesis</w>
E PO-
E FS</w>
E DA</w>
Dyskine sias</w>
Dys function</w>
Dox -induced</w>
Dise ases</w>
Di oscorea</w>
Di et</w>
Dexameth as
Deteri oration</w>
Depend ence</w>
Dep ending</w>
Delta9- THC</w>
Defic its</w>
De aths</w>
Dam age</w>
Dac arbazine</w>
Da hl</w>
DZ P</w>
DPO AEs</w>
DP I</w>
DO X-
DO C</w>
DO B</w>
DM SA</w>
DH PG</w>
DF MO</w>
DESIGN ,</w>
DCE -
DAT A:</w>
DA P,</w>
D- like</w>
D ual</w>
D ROP</w>
D PD
D P.</w>
Cyclo oxygenase-2</w>
Cor tic
Cor responding</w>
Copenh agen</w>
Cop per</w>
Consider able</w>
Con focal</w>
Comple x</w>
Colchic ine-induced</w>
Col laborative</w>
Co ur
Clon idine-induced</w>
Clo stri
Cir rho
Cir cadian</w>
Cilost azol</w>
Chrom os
Cholester ol</w>
Chlorambuc il</w>
Ch ic
Ch AT</w>
Cephal ospor
Catech olamine-induced</w>
Catat onia</w>
Catal eptic</w>
Cardi omy
Cap gras</w>
Calcit riol</w>
Caffe ine-induced</w>
Ca p</w>
Ca MK
CYP2C 8
CX CR
CX 7
CV R</w>
CV AD</w>
CSF- AK</w>
CS ,</w>
CR .</w>
CP DD</w>
CP 94
CO P</w>
CO C</w>
CNS B
CN I-
CL S</w>
CL )</w>
CK 8</w>
CI- 9
CH .</w>
CG I</w>
CD DP</w>
CC B</w>
CB F.</w>
CB (2)</w>
CA RT</w>
CA I</w>
CA D
CA B
CA 3,</w>
CA -induced</w>
C3H/ He</w>
C ult
C ri
C p</w>
C lear</w>
C ity</w>
C ellular</w>
C ells</w>
C c
C ]</w>
C X-
C 4</w>
Busulf an</w>
Brugad a-
Brd U-
Brady kinin</w>
Br n-3
Bo th,</w>
Bir th</w>
Biop sies</w>
Benzodi azepine</w>
Balb /c</w>
BU d
BU P,</w>
BS O</w>
BP 897</w>
BM IPP</w>
BF U-
BD Z</w>
B ow
B ost
B el
B ab
B SE
B )
B (t
Ax is</w>
Av ailable</w>
Austral ia</w>
Attac k</w>
Arter io
Arab ic</w>
Ar e</w>
Aquaf ol</w>
Apop totic</w>
Anti platelet</w>
Anti bio
Anter ior</w>
Ant agonists</w>
Ang- (1-7)</w>
Ang elica</w>
Anesthe tized</w>
Ana phyl
An algesia</w>
Ammon 's</w>
Am B.</w>
Al prazol
Al pers</w>
Administr ation.</w>
Addic tion</w>
Acyclovir -induced</w>
Accid ental</w>
Ac ross</w>
Ab str
Ab er
AZ T.</w>
AZ T-
AV3 V</w>
AT 3/
AT3/ EAAC
AT ,</w>
AS A,</w>
APPROAC H:</w>
AM PA/kainate</w>
AM L.</w>
AM I,</w>
AM .</w>
ALA- D</w>
AID S,</w>
AI M</w>
AG N</w>
AEG35 156</w>
AD A</w>
AC F</w>
ABT-7 69</w>
AB D</w>
AB C</w>
A ther
A systole</w>
A sc
A pp
A lopec
A ir
A ca
A beta-
A J</w>
A 3</w>
A )-induced</w>
> 50%</w>
> 12</w>
= 65</w>
= 50</w>
= 1</w>
= .000
< 90</w>
99mTc- DMSA</w>
9. 8%</w>
9. 0
9- tetrahydrocannabinol</w>
9 5)</w>
9 0%)</w>
80 8</w>
80 2</w>
8 5/
8 5.
8 4.
8 1-year-old</w>
78 ),</w>
711389- S</w>
70 %,</w>
7 8.
7 2)</w>
7 )
61- 80
60 %.</w>
6- 7</w>
6 ByJ</w>
6 9.
6 0%)</w>
6 '-
55 8</w>
55 562</w>
52 22</w>
50 6-induced</w>
50 %;</w>
5-HT(2 A)</w>
5-HT 7</w>
5-HT 2C</w>
5-HT .</w>
5-1- 6</w>
5- methoxy
5- Az
5, 6,
5, 5-
5 9)</w>
5 8)</w>
5 60</w>
5 6%,</w>
5 4)</w>
5 4),</w>
5 4%,</w>
5 30</w>
5 25</w>
5 2%,</w>
5 00-mg</w>
5 +/-1
48 ;</w>
45 8</w>
45 1</w>
40- 50</w>
40 ;</w>
40 8</w>
4. 6,</w>
4- deoxypyridoxine</w>
4- Cl-BZ
4 ]</w>
4 9).</w>
4 77</w>
4 4,</w>
4 29</w>
4 1%,</w>
38 9</w>
38 ).</w>
35 47
300 164</w>
30- second</w>
30- fold</w>
30- 40</w>
30 6</w>
30 2</w>
3. 5,</w>
3-hydroxy-3- methylglutaryl</w>
3- NT</w>
3- /-</w>
3,4-D CPG</w>
3, 4
3, 3-
3, 0
3'- deoxy
3 T3</w>
3 55</w>
3 3,</w>
3 2%,</w>
3 18</w>
3 1),</w>
29 4</w>
29 .</w>
28 ;</w>
28 9</w>
27 6</w>
26 7</w>
26 4</w>
26 3</w>
25- mg</w>
25 4</w>
25 %)</w>
24,25- (OH)2D3</w>
23 8</w>
23 1</w>
23 ).</w>
200 9,</w>
200 8</w>
200 8,</w>
200 0-
20- minute</w>
20 5</w>
20 24</w>
2. 7-
2. 5)</w>
2. 1;</w>
2- min</w>
2- a]
2- OH
2- -
2,3, 4,5-
2 B
2 =
2 5.0</w>
2 21</w>
2 2.</w>
2 2,
199 3.</w>
198 5.</w>
198 5,</w>
1928 370</w>
19 77</w>
19 73</w>
19 60
19 2024</w>
18. 7</w>
18. 4</w>
17 /
16 +/-
15. 6</w>
15- day</w>
15- 20</w>
140/ 90</w>
14. 3</w>
14. 3%</w>
14. 1</w>
14 29
14 2
13. 7</w>
12. 9</w>
12- h</w>
12 ,000</w>
12 ,
11. 6</w>
100 .</w>
100 ,000/
100 )</w>
10- mg</w>
10(- 2)</w>
10 ,00
1.0 1</w>
1. 55</w>
1. 49</w>
1. 44</w>
1. 4-
1,25- (OH)2
1, 24-(OH)(2)
1, 00
1 mg/kg</w>
1 A2</w>
1 A-
1 14
1 +/-1.
1 +/-1
1 )
0.9 )</w>
0.9 %,</w>
0.8 7</w>
0.8 1</w>
0.7 7</w>
0.7 6,</w>
0.02 2).</w>
0.000 3).</w>
0.000 2).</w>
0.00 7)</w>
0.00 2</w>
0.0 8
0.0 6).</w>
0.0 2%</w>
0.0 18).</w>
0.0 15).</w>
0. 8)</w>
0. 72</w>
0. 17
0. 15%</w>
0. 12,</w>
0. 1).</w>
0 -10</w>
.00 3).</w>
.0 5,</w>
-P C</w>
-1- phosphate</w>
-1, 2,4-
-1 60</w>
-1 6-
-1 0,</w>
- motor</w>
- inducing</w>
- deficient</w>
- R
- ATPase</w>
- 9.
- 3,</w>
, 7
+/ -10
)- infected</w>
)- 2-
(paracetam ol)</w>
(mt DNA)</w>
(mGluR s)</w>
(m )</w>
(d 4
(chi 2</w>
(chi (2)</w>
(WB C)</w>
(Viagra )</w>
(VE GF)</w>
(V CM
(Tax otere
(SV R)</w>
(SE M</w>
(SA H)</w>
(RP P)</w>
(RB Cs)</w>
(P< 0.05),</w>
(P ro
(P h
(P W
(P G)</w>
(OP ID
(OH) 2-
(O V
(O P)</w>
(O LT)</w>
(NT S)</w>
(NT G)</w>
(NT Ds)</w>
(NS C</w>
(NA G)</w>
(N RTI
(N E
(N C
(N Ac
(MT X
(MD D)</w>
(M n
(M UG
(M PO)</w>
(M H
(LV D
(LM W
(LID ).</w>
(L-NAME ;</w>
(L i-
(H ol
(H US
(H D-
(H CF
(H )</w>
(GSH ),</w>
(GP i)</w>
(G lu
(F L
(ED50 =
(ED (50)=
(EC T)</w>
(E LIS
(D Z
(D M)</w>
(CI ):</w>
(CAB G)</w>
(CA S:</w>
(BUN ),</w>
(B Z
(B HT)</w>
(ANCA )-associated</w>
(AE D)</w>
(AD V)</w>
(AD M)</w>
(AD HD).</w>
(A TP
(9 3%)</w>
(8. 0</w>
(8 9.
(8 7%)</w>
(8 %).</w>
(7 7.
(7 7%)</w>
(7 6.
(7 0%</w>
(62. 5%)</w>
(6 6</w>
(6 6.
(6 5%</w>
(6 4</w>
(50 %).</w>
(5 8.
(5 1.
(5 00
(4. 3</w>
(4. 2</w>
(4. 1%)</w>
(4-fluoro phenyl)
(4- hydroxybutyl)
(4 9%)</w>
(4 4</w>
(3- 30</w>
(3 3%).</w>
(3 20</w>
(3 %</w>
(200 0)</w>
(2. 9</w>
(2. 7</w>
(2. 2</w>
(2. 1</w>
(2)- receptor</w>
(2 7%),</w>
(2 50-
(2 5%).</w>
(2 5%),</w>
(2 2-
(2 1/
(2 0%),</w>
(2 +
(19 8
(1. 25-
(1 8%</w>
(1 8%).</w>
(1 7%).</w>
(1 6%),</w>
(1 5%).</w>
(1 4/
(1 4%).</w>
(1 2%).</w>
(1 2%),</w>
(1 10</w>
(1 -100</w>
(1 )/
(1 %</w>
(0.00 1-
(-)- 3-PPP</w>
(+)- amphetamine</w>
(+)- UH</w>
(+)- AJ</w>
( ventricular</w>
( usually</w>
( type</w>
( thre
( therapeutic</w>
( stat
( single</w>
( severe</w>
( saline)</w>
( range)</w>
( pre-
( placebo)</w>
( negative</w>
( mGlu
( induced</w>
( estimated</w>
( each</w>
( diabetic</w>
( determined</w>
( control,</w>
( acetaminophen
( II)</w>
( 9%</w>
( 5-HI
" on-off"</w>
zop iclone</w>
zatebr adine</w>
zaf irlukast</w>
z yme
z ed,</w>
z )</w>
ym ic</w>
ym e</w>
yl] -1-
yl) prop
yl transferase</w>
year- old-
ye ast</w>
ye ast
y- related</w>
y pe
y osin</w>
y no
x perim
xperim ent</w>
x eno
x /
x ).</w>
wom an-
withdraw al:</w>
wid th</w>
what ever</w>
weight/ body</w>
weight- based</w>
weigh t;</w>
wave form</w>
wav es,</w>
wast ing.</w>
wash -out</w>
wa ve.</w>
wa king</w>
w inter
vomit ing)</w>
volunt arily</w>
volume )</w>
vir gin</w>
vinorelb ine.</w>
vim entin,</w>
vib ratory</w>
vesi cles.</w>
ves :</w>
verapamil- sensitive</w>
ver tic
ver atri
ventilat ing</w>
ventil ated.</w>
ventil ated,</w>
ven o
vehicle ;</w>
vehicle -</w>
vasodilat or.</w>
vasculo pathy</w>
vasculat ure,</w>
vas ore
vari ations.</w>
valv es,</w>
valpro ate:</w>
val ently</w>
val .</w>
vagin a.</w>
vag ally</w>
v ices</w>
v ent</w>
v as</w>
user s;</w>
us age,</w>
us '</w>
uro toxicity.</w>
urinaly sis,</w>
ure mia.</w>
ure a.</w>
ure -induced</w>
ure ).</w>
urac il.</w>
ur ine-
ur ic.</w>
ur ge
ur a</w>
ur .</w>
univer s
uni qu
uneventful ly.</w>
uneventful ,</w>
unequ ivocal</w>
under recognized</w>
und s.</w>
un translated</w>
un te
un stressed</w>
un satisfactory</w>
un interrupted</w>
un fortun
un determined</w>
un covered</w>
un buffered</w>
un biased</w>
um -treated</w>
ultrason ography,</w>
ultim ately,</w>
ulop ontine</w>
ulo phine</w>
ule us,</w>
ule g
ul us</w>
ul d,</w>
ud y</w>
uct ose</w>
ucle otide</w>
uch al</w>
u mo
u ed</w>
u ating</w>
u ally,</w>
two- compartment</w>
twit ch
tumori genesis.</w>
tubocurar ine,</w>
tropon ins</w>
tro lean
trolean dom
trinit rate.</w>
trimethoprim/ sulfamethoxazole</w>
trifluoro acetylated</w>
trifluoro acetyl</w>
trial :</w>
tri phosphate-induced</w>
tri oxide</w>
tri mipramine</w>
tri heptano
tri -
tremulo us
treatment- seeking</w>
tre prost
treprost in
treprostin il</w>
travel ed</w>
transplant able</w>
transi ents</w>
transfusion -dependent</w>
transf ected</w>
transduc er</w>
trans ection</w>
tran st
trac er.</w>
trab ected
tra its</w>
tr u
tr iterpen
touch -evoked</w>
tot oxic</w>
torticoll is</w>
tor r.</w>
ton ically</w>
to rod</w>
tizan idine.</w>
tiv es.</w>
tiv ated</w>
tion s;</w>
tion ed.</w>
timolo l-induced</w>
tid ine,</w>
ticlop id
tic/ pharmacodynamic</w>
tic ular</w>
tic oline</w>
tic k</w>
tic ally-
thyrotrop in-releasing</w>
thyro id,</w>
thromb olysis.</w>
thromb ocyte</w>
thre o-
though ts</w>
thorac otomy</w>
thor ax</w>
tho roughly</w>
thir st,</w>
thion amide-induced</w>
thio glucose</w>
th ous</w>
th )</w>
tetrap aresis</w>
tetraben azine</w>
testoster one-
ten- year</w>
ten ing</w>
tem sirolimus</w>
tem pl
teli throm
telangiect asia</w>
telangiect asia.</w>
te trandrine</w>
te lukast</w>
target ,</w>
tain ment</w>
tachycardia :</w>
tachycardi as.</w>
ta u
t- to-
t- day</w>
t s;</w>
t rough
t olyl</w>
t PA</w>
synthesi s/
synth ase.</w>
symptomat ology,</w>
symptom atic.</w>
symptom .</w>
symptom ,</w>
sympathe tically</w>
sympath omimetics</w>
sy phil
swit ches</w>
swell ing.</w>
sw ings</w>
susceptibil ity,</w>
survi ved,</w>
surve ys</w>
surger ies</w>
surfac e,</w>
sur ing</w>
supra optic</w>
suppress ants,</w>
sulph onate</w>
sulfasalaz ine.</w>
sulf ation</w>
suggest ed,</w>
subside d.</w>
subject s'</w>
sube pend
subepend ymal</w>
sub- chronic</w>
sub icular</w>
sub groups,</w>
sub fiel
sub endothelial</w>
su k
su gamma
stun ning</w>
stud ents</w>
struct ure
struc tion</w>
stroke /
stro gen
stric ta</w>
stri dor</w>
stri a</w>
stret ch</w>
stres sed.</w>
streptozotoc in,</w>
stin /d
stin/d alfop
stimul ant,</w>
stereo isomers</w>
ster ols</w>
step- down</w>
sten osi
stavud ine.</w>
stat ins,</w>
stabil ized.</w>
stabil ization,</w>
st yr
st ayed</w>
st atic
st ages,</w>
st aff
squ a
spra y.</w>
spl it</w>
spironolact one.</w>
spir april</w>
spillo ver</w>
spi per
spermatozo a</w>
specimen s,</w>
spas m
sp an.</w>
somnol ent</w>
somn ia</w>
solu tions.</w>
smoo th-
small- vessel</w>
slow ly.</w>
sligh tly.</w>
sligh tly,</w>
slic es,</w>
sleep iness.</w>
sle e
skele ton</w>
six ty</w>
sion s-
single ton</w>
sin s</w>
similar ities,</w>
sildenaf il-induced</w>
sigma 2</w>
sigma (2)</w>
side ),</w>
showe d:</w>
short age</w>
she ath
severe ).</w>
seven .</w>
ses qu
seroton ergic,</w>
seri ous.</w>
ser s</w>
ser a.</w>
ser a,</w>
sensi tive,</w>
sensi tised</w>
sens ation,</w>
sen escent</w>
semic arb
semi- quantitative</w>
self- limiting.</w>
sel ected,</w>
seiz ed</w>
seg ment,</w>
sed :</w>
second )</w>
sec tioned</w>
se t.</w>
se men</w>
se ll</w>
se ll
se al
scre ening,</w>
scl eral</w>
schiz otypal</w>
scenari o</w>
scal e).</w>
sc abic
sc ab
sarcom as,</w>
sarc open
sampl ing.</w>
sam e.</w>
sal t,</w>
sacrococ cygeus</w>
sacrific ed,</w>
sacrific e,</w>
s- Webster</w>
s pared</w>
s orb
s na
s kin
s in-
s hel
s a.</w>
s P120
rout e,</w>
ropivaca ine.</w>
ro torod</w>
ro sis.</w>
ro sis,</w>
ro d,</w>
ris ks,</w>
rin sing</w>
rim antadine</w>
rifamp in,</w>
rif ug
ric e-
ribavir in-related</w>
rib ose</w>
ri sen</w>
ri mal</w>
rhyth ms.</w>
rhin orrhea</w>
rh IGF-1</w>
reveal ed.</w>
retin yl</w>
reticulat a,</w>
reticul um.</w>
restric t</w>
responsiven ess,</w>
respect s.</w>
resolu tion,</w>
resi ding</w>
reservo ir</w>
research ,</w>
require ments.</w>
reproduci ble,</w>
repor ting.</w>
reple tion</w>
ren ic</w>
removal ,</w>
remed y</w>
remac emide</w>
rema ind
relev ant.</w>
relax ant.</w>
relationshi p
rel in,</w>
rel ide</w>
rel ati
rehabil it
regul arity</w>
refle xi
reduct ase,</w>
reconstruc tive</w>
recommend ing</w>
recommend ations.</w>
recogniz able</w>
receptor s;</w>
reboun ded</w>
reasses s
rear ing,</w>
reaction s;</w>
reaction s:</w>
re- entry</w>
re teral</w>
re tains</w>
re member</w>
re mem
re induction</w>
re flu
re cycling</w>
re breathing</w>
re bleeding</w>
rati os
rate- treated</w>
rat es:</w>
rapam ycin,</w>
rang e
ram ycin</w>
radiolig and</w>
radic al-
radi ation,</w>
racem ate</w>
ra rely.</w>
r- HuEPO</w>
r CMR
quinupri stin/dalfop
quinoxaline- 2,3-
quin uclid
quin ine-dependent</w>
quin ine-associated</w>
quick er</w>
questionnai re,</w>
ques tion.</w>
quer ied</w>
quality- adjusted</w>
quadripleg ia</w>
qu arti
pyridox al-
pyri da
pyraz ine</w>
pyl ori
putam en.</w>
purpur a,</w>
pup pi
pum ps.</w>
puerperi um</w>
puer peral</w>
pt s)</w>
psych ometric</w>
provo kes</w>
protein- coupled</w>
prot oporphy
prot amine-
protamine- heparin</w>
prost at</w>
propranolo l)</w>
propor tionally</w>
propofol- fentanyl</w>
propo sed,</w>
pronounce d,</w>
pron ociceptive</w>
prolifer ator-
proliferator- activated</w>
prolactin- secreting</w>
prol apse</w>
proguan il</w>
progres sor</w>
progres sive.</w>
progres ses</w>
program m
profes sional</w>
procycl idine</w>
prochlorper azine.</w>
probable "</w>
pro ven,</w>
pro parg
pro mo
pro dynorphin</w>
pro drug,</w>
pro arrhythmia,</w>
priv ate</w>
primigra vida</w>
primat es,</w>
pri van
pri or
previ ous
prevent ative</w>
prev ail
preserv ative-free</w>
prescrip tions.</w>
prescri ption.</w>
pres sion.</w>
prenalter ol</w>
premat ure
predomin ate</w>
pre- emptive</w>
pre treatments</w>
pre infusion</w>
pre existent</w>
pre em
pre -term</w>
praz osin
prasu grel</w>
potenc y.</w>
postpon ed</w>
postischem ic</w>
post- pacing</w>
post- marketing</w>
post- ingestion</w>
post- infusion</w>
post- CA
post ur
post prandial</w>
post infusion</w>
post exposure</w>
posi tive-
posi tions.</w>
posi tioning</w>
pos itory</w>
pos ac
port os
portos ystemic</w>
poly (ADP-ribose)</w>
poison ed</w>
poin ter</w>
po oling</w>
pneumon itis.</w>
platin um.</w>
platelet- derived</w>
plas macy
plan ar</w>
pl enic</w>
pl ant.</w>
pix antrone</w>
pir acetam,</w>
piper acill
pineal ectomy</w>
pineal ectomized</w>
pindo lol.</w>
pi ent</w>
pi ec
physician- diagnosed</w>
physici ans,</w>
phy se
photo dynamic</w>
phospholip idosis</w>
phospho kinase,</w>
phil icity</w>
pher d</w>
phenylbutaz one.</w>
phenylbutaz one,</w>
phenyl piperaz
pharmac ology,</w>
pharmac ologic
phag ocytic</w>
ph renic</w>
ph a
pha eochromocyt
pg/m L)</w>
pg/ mg</w>
peti t</w>
pestic ide</w>
perit ubular</w>
percep tions</w>
percent ;</w>
per spec
per mit
pepti des,</w>
pentylenetetrazol e.</w>
penicill ins.</w>
penicill in,</w>
pedunc ulopontine</w>
paw )</w>
pati on.</w>
pathw ay
pat as</w>
paresthesi a,</w>
paras ympath
param agnetic</w>
parac rine</w>
par ane
parane oplastic</w>
par amethasone</w>
par aff
papillede ma.</w>
pancur onium,</w>
palmo plantar</w>
palmit o
pallid us.</w>
pal ate.</w>
pac k
pa y</w>
pa c</w>
p< 0.01).</w>
p< 0.001),</w>
p< 0.0001)</w>
p75 NT
p-chloro amphetamine</w>
p- 6-
p,p- DDE</w>
p ush</w>
p up</w>
p ons</w>
p neumo
p ep
p entano
p ed</w>
p allo
pallo r</w>
p ale</w>
oxy meth
oxy metazoline</w>
oxy cod
oxib s</w>
oxi metry,</w>
oxal actam</w>
ox alo
ox adi
ox acillin</w>
ox -
over whel
oval e</w>
ov aginal</w>
out-of- hospital</w>
out lined</w>
out break</w>
ous )</w>
otrop ia</w>
otolaryng ologic</w>
ot ype
osteomyeli tis.</w>
oste osarcoma.</w>
osmol arity</w>
osmol ar
osc illo
os seous</w>
os in.</w>
os in-
os clerosis</w>
ors ing</w>
orosomuc oid</w>
ori es:</w>
organ ism</w>
organ .</w>
orex in-A</w>
ore mentioned</w>
ord inated</w>
orcipren aline</w>
or ative</w>
or able</w>
opy ran
opi ate-induced</w>
ophysi cal</w>
oph obia</w>
opath ogenesis</w>
op pose</w>
one- trial</w>
one- dependent</w>
one theless,</w>
on ych
on togeny</w>
on set
on s.</w>
on ine</w>
on in,</w>
on ia.</w>
on ds</w>
on ate,</w>
on :</w>
omeg a</w>
om ni
om it
om ide</w>
om embranous</w>
olo [
oliv ary</w>
ol/ drospirenone</w>
ol is</w>
off en
odi lation</w>
od or</w>
ocyte -specific</w>
oculog yric</w>
ocardi um</w>
oc ard</w>
obj ects</w>
ob tun
o th
o p</w>
o h
o gastric</w>
o edema
nulli parous</w>
now .</w>
nov o
notice d.</w>
note worthy</w>
normoten sion.</w>
normal izing</w>
norepinephr ine-
non- hematological</w>
non- depolarizing</w>
non- convulsing</w>
non- convulsant</w>
non- cardiac</w>
non- binge</w>
non- ICU</w>
non users,</w>
non smokers</w>
non responsive</w>
non immune</w>
non enzymatic</w>
non arteritic</w>
nodos um.</w>
nodos a</w>
nodos a.</w>
no ea,</w>
nitro arginine</w>
nitrite/ nitrate</w>
nitrendip ine-treated</w>
nitrate- free</w>
nimesul ide.</w>
nimesul ide,</w>
nigro -striatal</w>
nigh t-
nic k-
ng/kg/ min)</w>
neurotroph in</w>
neurolep tic-
neurohypophy sis</w>
neuro plastic</w>
neuro pharmacologic</w>
neuro genesis,</w>
neuraminid ase</w>
networ ks.</w>
nes tin</w>
nephrotoxic .</w>
nephro path
neon ates,</w>
neo vascular
need le.</w>
need le-
necro lysis</w>
ne gl
ne dap
naloxone- precipitated</w>
nal idixic</w>
nal -
na )</w>
n uchal</w>
n s).</w>
n inth</w>
n g),</w>
n arc
n ap
n abil
myotub es</w>
myocardi opathy.</w>
myocardi a</w>
myo pathies</w>
myelo -
myco phenolic</w>
my ometrial</w>
muscar ine</w>
mumol/ l)</w>
multiv itamin</w>
multiplic ity</w>
multiple -dose</w>
multi- center</w>
multi disciplinary</w>
mug/ ml</w>
mu k
more )</w>
month -
monitor .</w>
mon ocytes</w>
mon etary</w>
mom ent</w>
molecul es.</w>
modul ation.</w>
model )</w>
mo ved</w>
mo glyc
mo )</w>
mmol/ l).</w>
mmol .
ml/min/ 1.73</w>
miti gating</w>
mis e</w>
minut e/
minipump s.</w>
minipum p</w>
ming ly</w>
min(-1 ).</w>
millisec onds</w>
millilit er</w>
mild- type</w>
migr ation,</w>
mid face</w>
microsom es,</w>
micron s</w>
micron odular</w>
microm ol
micrograms/m L)</w>
microgram/kg/ min,</w>
microgram/kg/ min)</w>
microgram.kg-1. min-1</w>
microg/m L,</w>
microg/ rat</w>
microg/ mouse,</w>
micro surgical</w>
micro graph
micro M/
micro A</w>
mic e;</w>
mic e).</w>
mg/kg/ min,</w>
mg/kg/ injection)</w>
mg/d l),</w>
mg/d ).</w>
mg/ sq</w>
mg. kg(-1)</w>
meval onate</w>
methyser gi
methyl-6-( phenylethyn
methyl xanthine</w>
methyl atropine</w>
methoxy flurane</w>
methotrimepraz ine</w>
methion ine.</w>
methemo globin</w>
metamiz ole</w>
metalloprotein ase-
met /
mesi late</w>
meropen em
mer bar
ment ing</w>
ment -
mening iti
men :</w>
memant ine.</w>
melaton in,</w>
melan in</w>
medium -term</w>
medium -</w>
medi ators.</w>
medetom idine,</w>
mechan ical,</w>
measure d:</w>
mean )</w>
me z
me tac
me obentine</w>
me loxic
mb ran
materi al,</w>
matche d,</w>
marmo sets</w>
marked ly.</w>
marijuan a,</w>
manufacturer 's</w>
mann 's</w>
mal e-
mal athi
mal adaptive</w>
mafosf amide</w>
macrom olecular</w>
ma ;</w>
mGluR 4</w>
mGlu 5</w>
mE q
m us.</w>
m omet
m ia)</w>
m ation</w>
m apped</w>
m T
m M.</w>
m M),</w>
m L;</w>
m K</w>
m 2).</w>
m (O
lys ophosph
lys ine-
lymph omas.</w>
ly "</w>
lup us,</w>
lu peol</w>
lowe red.</w>
low- dose,</w>
low- affinity</w>
los s)</w>
los al</w>
lopurin ol</w>
loop s</w>
long er-
log (10)</w>
locom ot
local iz
localiz ation-related</w>
load ing,</w>
lo ud</w>
lo ts</w>
lo se</w>
liver -related</w>
liter s)</w>
line age</w>
lind ane-induced</w>
limit ations.</w>
like )</w>
lightheade dness,</w>
light- heade
lif t</w>
lif es
li ability.</w>
level s)</w>
leuko encephalopathy:</w>
leuko encephalopathy,</w>
leuk ocytosis.</w>
leuk ocytes,</w>
leuk ocyt
leuc ine-
let es</w>
lepro matous</w>
length y</w>
length -of-
leg ,</w>
leflun omide</w>
le y,</w>
le ts</w>
le sional</w>
le ).</w>
latano prost
laser- Doppler</w>
laryng ospasm</w>
lansoprazol e.</w>
lam y
lact ated</w>
lac rimal</w>
lac eration</w>
laborator ies</w>
lab ility,</w>
l yc
l in</w>
l avage</w>
l ars</w>
l anthanum</w>
l and,</w>
l agg
l -related</w>
knock- out</w>
kind ling
kin s</w>
kin in
kg(-1 )).</w>
ketocon azole-induced</w>
keto profen,</w>
ker atitis</w>
kal -
kal- Wallis</w>
k wise</w>
k 's</w>
join tly</w>
jitter iness</w>
jer ks,</w>
jel ly</w>
jat am
jatam ans
jatamans i</w>
j iro
jiro vec
iv oc
it osan</w>
it ochondrial</w>
it ed.</w>
isth mus</w>
isox sup
isox azole</w>
isox azol
isosorbide-5- mononitrate</w>
isol dip
iso quinoline</w>
iso enzymes.</w>
ise thionate</w>
ir on.</w>
io prom
investig ators,</w>
introduc tion.</w>
intravesi cally</w>
intraperitoneall y).</w>
intrap ulmonary</w>
intrap leural</w>
intramuscul arly,</w>
intramuscul ar
intra striat
intra hippocamp
intrahippocamp ally</w>
intra dialytic</w>
intra aortic</w>
intoxic ations</w>
interven ing</w>
interpre ting</w>
interleuk in-1</w>
interferon- gamma</w>
intercal ated</w>
inter rupt
inter quartile</w>
inter neuron</w>
inter connected</w>
intensi fy</w>
instant aneous</w>
insidi ously</w>
inqu ire</w>
inositol -1-phosphate</w>
inges tions</w>
infrequ ently.</w>
infor m</w>
influ ence.</w>
inflamm ation-related</w>
infl ated</w>
infiltr ates.</w>
infarc t-
infant s:</w>
inf used.</w>
inf usate</w>
inf ancy</w>
ine- -
ine vit
ine .
indomethac in-induced</w>
ind omet
incoordin ation.</w>
incontin ence,</w>
includ ing:</w>
inc iting</w>
in- stent</w>
in uria.</w>
in di
in ations</w>
in ase-
in aemia</w>
in adequately</w>
impregn ated</w>
impac ted</w>
immunost ain
immunore activities</w>
immunoglobul ins</w>
immunocompet ent</w>
immuno assay.</w>
imipen em,</w>
imidazol e-
imbal ance,</w>
im pres
im posed</w>
im migr
im ino
illust rating</w>
ill ness
il ;</w>
ig a
iga rette</w>
if ol
if f</w>
idiosyncrati c,</w>
idiosyncr asy</w>
ide s.</w>
id ine-associated</w>
id -related</w>
icul ate</w>
ici ency</w>
ical cit
ic lon
ic in-associated</w>
ic ide</w>
i.p. c.</w>
i ri
i qu
i o</w>
i ed,</w>
i bogaine</w>
i as.</w>
hypoton ia,</w>
hypoparathyroidis m</w>
hypop ituit
hypokine sia.</w>
hypogonadis m</w>
hypoglyce mia,</w>
hypo ventilation</w>
hypno tics</w>
hypertensi ves.</w>
hyperplasi as</w>
hyperlipide mic</w>
hyperkine sia.</w>
hyperexcit ability.</w>
hypercalci uria,</w>
hyper vol
hyper ventilation,</w>
hyper ren
hyper reactivity</w>
hyper pyrexia</w>
hyper lactat
hyper hid
hyper gly
hydroxyure a.</w>
hydroxyl ase,</w>
hydroxyl amine</w>
hydroxy quinol
hydroxy fas
hydroxy anis
hydroxyanis ole</w>
hydronephro sis.</w>
hydronephro sis,</w>
hydrocortis one.</w>
hydrochlor ic</w>
hybri ds</w>
hund red-
human .</w>
hu PB
hos tility</w>
hoo ded</w>
homozyg otes</w>
homogen ized</w>
ho uld</w>
histi ocytic</w>
hist ochemically</w>
hist amine
highligh ted.</w>
high er-
hid den</w>
heter otopic</w>
herni ation</w>
here in.</w>
hepat oxicity</w>
hemi anop
hemat otoxicity</w>
hemat ologic
heat- shock</w>
health -
head .</w>
he me-
he don
harb oring</w>
hand s,</w>
hamster s.</w>
halothane- altered</w>
halothane /
haloperidol :</w>
hair y</w>
haemo glob
haem olysis.</w>
ha ve,</w>
h ans</w>
h ERG</w>
guide lines,</w>
guanid inosuccin
gran i
gra vis,</w>
gra de,</w>
goro usly</w>
gonad ectomized</w>
go -
glyco proteins</w>
glucuron idation</w>
gluco sid
globul in.</w>
glauc omatous</w>
glauc oma,</w>
gi es</w>
gest ation)</w>
gerbil s</w>
ger m
genotyp ing</w>
genotyp es.</w>
gener ates</w>
gener ated.</w>
gen ist
gen iculate</w>
gast rectomy</w>
gap ,</w>
gammag lobul
gamma-hydroxybut yrate</w>
galact orrhea.</w>
gal an
g/ mouse,</w>
g/ ml)</w>
g/ cm
g ut
g ell
further more</w>
fum arate</w>
full- field</w>
fructo se-1,
free z
free dom</w>
fractalk ine</w>
fract ure,</w>
fr ame</w>
four- fold</w>
fost ered</w>
forsk olin</w>
form er
former ly</w>
for ces</w>
foot- shock</w>
followe d,</w>
fo x</w>
flut amide.</w>
flut amide,</w>
fluphenaz ine.</w>
fluoren yl
flucloxacill in.</w>
flest olol,</w>
five fold</w>
first- trimester</w>
fing er-
fin ally,</w>
filam ents.</w>
fil m</w>
fibrill ations</w>
fib ric</w>
fet uses,</w>
fenoldop am-induced</w>
fenbufen .</w>
femal es;</w>
feat ure.</w>
feasib le,</w>
fe vers</w>
fe ed</w>
favor ing</w>
fascicul aris
factor s:</w>
fac e.</w>
fa ther</w>
f ri
f light</w>
f ell
exud ative</w>
exter oceptive</w>
expres sive</w>
expos ures,</w>
explo res</w>
expl aining</w>
expan sion.</w>
exp end
expend it
excell ent.</w>
exameth onium</w>
ex it</w>
evi prostat</w>
event -related</w>
euphor ia,</w>
etin- beta</w>
ethosuxim ide.</w>
ethambut ol,</w>
et an
et )</w>
esophag us,</w>
esophag itis.</w>
escal ations</w>
es oxime</w>
es citalopram,</w>
es ac
es ?</w>
es );</w>
erythro mel
erule in</w>
erec tion,</w>
er lotin
er do
epilep sies.</w>
epididy mitis</w>
epider mi
ephed r
ep tion</w>
eosinophil uria</w>
enti ty,</w>
entac apone</w>
ent ra
ent a
eni i</w>
enhance ment,</w>
eng th</w>
ene -induced</w>
ene )</w>
endoscop y,</w>
endocannabin oids</w>
endoc ochlear</w>
end- of-dose</w>
end point
end orsing</w>
encephal on,</w>
enceph aly
en- VPA</w>
emul si
empt ying,</w>
empt y</w>
embryoleth ality</w>
embed ded</w>
elucid ated</w>
else whe
elic itation</w>
electrophore sis.</w>
electron- microscopic</w>
electro shock.</w>
electro cortical</w>
elast ine</w>
eigh t,</w>
effect :</w>
ef arox
educ ation.</w>
ed at
ed -type</w>
ed "</w>
echo graphic</w>
echo genic</w>
ec z
ec ur
ec centric</w>
ec arbox
eNOS- deficient</w>
e- dependent</w>
e- associated</w>
e lo
e lithiasis</w>
e ]
dystoni as</w>
dysphag ia,</w>
dysp nea.</w>
dyscra si
dynes/cm 5</w>
dynam ics,</w>
dur ations.</w>
dur a</w>
duct ular</w>
duc t,</w>
drug ).</w>
drom otropic</w>
drink ing,</w>
dri p</w>
dri ed</w>
doxep in.</w>
dox o-
down regulating</w>
double-dumm y,</w>
double- masked,</w>
doub t</w>
dose-depend ently.</w>
dose /
dop amine/
dop amine
don or
dol lars</w>
doc tors</w>
dn ess.</w>
diver gence</w>
distrib ut
dissi p
disper sed</w>
disorgan ized</w>
discrep ancies</w>
discol or
dis similar</w>
dis section,</w>
dis location</w>
dis ap
dis ability,</w>
diplo id</w>
dip s
din ucleotide</w>
dilem ma</w>
diisopropyl fluorophosphate</w>
dihydro pyrimidine</w>
dihydro pyridine-
diethyl carbam
diethyl -
dichloro diammine
dic hlor
diaz oxide,</w>
dialy zed</w>
diagno ses,</w>
diabet es;</w>
dia thesis</w>
di(2- ethylhex
di ed;</w>
di buc
di benz
dextromethorph an,</w>
dexamethas one-
devic es.</w>
devi ations</w>
determin ations,</w>
detect able,</w>
det ects</w>
destruc tion.</w>
desoxy corticosterone</w>
dermatomyosi tis.</w>
depress ing</w>
depres sion:</w>
deple tes</w>
dep lo
deoxy corticoster
den sely</w>
demograph ics</w>
dem arc
dele ted</w>
dehydrogen ase.</w>
degrad ation.</w>
degrad able</w>
def eren
decano ate.</w>
decade s.</w>
dec id
debriso quine</w>
deb ated.</w>
de st</w>
de hydration.</w>
de fibrillation.</w>
de bul
de als</w>
de al</w>
de ad
day (-1),</w>
daugh ters</w>
dam s.</w>
dUT P</w>
dP/dtej c</w>
dP/d t)</w>
d iterpene</w>
d f</w>
d ase</w>
cytopen ic</w>
cytokin es,</w>
cytochro me-
cyto sis,</w>
cyt ometric</w>
cyprohept adine.</w>
cycl ical</w>
cy tox
cy cle
curren t.</w>
cur vilinear</w>
cur ves.</w>
cur ve,</w>
cur ar
cryst al
crypt ogenic</w>
cross- sensitization</w>
cross- resistance</w>
cros sing</w>
cro moglyc
crist ae</w>
crani os
cr yp
covari ates</w>
covari ates,</w>
counter parts</w>
counter acting</w>
coun ty</w>
coun tr
coun tered</w>
cough ing</w>
cou mad
cortic es.</w>
cortic al,</w>
correl ating</w>
convulsion s;</w>
conver gence</w>
contrac t</w>
continu ance</w>
contin ent</w>
construc tion</w>
const ant,</w>
consist ent.</w>
consider ably.</w>
cons enting</w>
condy lo
conclu sively</w>
concept uses</w>
concept us</w>
concentration s:</w>
concentr ation;</w>
con templ
con gener</w>
con cordance</w>
compres sion.</w>
compart mental</w>
comit ant</w>
comb ine
comb at</w>
com mitted</w>
com mitte
com ato
colony- forming</w>
colo red</w>
colo rect
coll ection.</w>
coer ulospinal</w>
cochle a.</w>
cocaine- using</w>
cocaine- maintained</w>
co- morbidity</w>
co valently</w>
co uld,</w>
co ol
co il</w>
co factors</w>
cm/ s</w>
clozap ine-associated</w>
cloc kwise</w>
clo ts</w>
clo faz
cl im
cl ick</w>
cl aim</w>
cit rate.</w>
cis- platin</w>
circum ci
circuit s.</w>
ciprofloxac in-associated</w>
cimetid ine-associated</w>
cilni dipine</w>
ci l</w>
chromatography- mass</w>
chromatograph y/
choro id</w>
cholestasi s:</w>
cholest atic
cholangiopancreat ography</w>
chol ine,</w>
cho ol</w>
chloro form</w>
chloro fluoro
chlor pro
chil d,</w>
chemosensi tiz
chemic al,</w>
challeng es.</w>
ch eno
ch ain,</w>
cess ation,</w>
cervic ovaginal</w>
certi fic
cephalospor ins.</w>
cell s:</w>
celecoxi b.</w>
cefotet an-induced</w>
cef epime</w>
ce t
ce mbran
ce fosel
catar acts,</w>
catalepsy -associated</w>
catal yst
castr ation</w>
cartil agin
caro ta</w>
carnit ine,</w>
cardiomyo pathies</w>
cardiac -specific</w>
cardi ology</w>
cardi ologic</w>
carboxypiperaz in-4-
carbox am
carboxam ido
carbamazep ine
carbam ate</w>
car teolol</w>
car must
captopri l-induced</w>
capsul e.</w>
capillari es.</w>
cap t
candi di
candes art
cancer -related</w>
can ,</w>
cam era</w>
callo sum</w>
cali br
calcul ations</w>
calc ulation</w>
cal oric</w>
caffe ine-treated</w>
ca red</w>
ca re
ca ecum</w>
ca ,</w>
c. ),</w>
c yl
c up</w>
c k</w>
c iclospor
butylbicyclophosphoro thionate</w>
buspir one.</w>
bupropi on-induced</w>
bumet an
bulim ia</w>
bul bifera</w>
buff ering</w>
buc umo
buc olome</w>
bru x
bronchospas m.</w>
brom ide,</w>
bro basilar</w>
brin zolamide/timolol</w>
breath ,</w>
breast .</w>
bran ched</w>
brain- stem</w>
brady cardiac</w>
brady arrhythmias.</w>
br a</w>
bortezomib .</w>
bortezomib -associated</w>
bol us-
bol us),</w>
bo ys.</w>
blood- retinal</w>
blood- pressure</w>
block s.</w>
blo t.</w>
blind ness,</w>
biosynthe sis,</w>
biop sy
bioavail ability.</w>
bio tin</w>
bigemin y</w>
bi valir
bi us'</w>
beta-caroten e</w>
beta- catenin</w>
beta- agonists</w>
beta ENaC</w>
bet le</w>
benzofur an-
benzo[a, d]
benzo ic</w>
benz il
benef it
beha ves</w>
beha ved</w>
beagl es.</w>
beag les</w>
be er</w>
basel ine:</w>
bas ophilic</w>
bar k</w>
bal ancing</w>
bacte remia,</w>
backgroun ds</w>
b. d.</w>
b ud
b ones.</w>
b one,</w>
b lonanserin</w>
b iting</w>
b )
azos in.</w>
azoc ine</w>
azido- 3'-deoxy
az treon
az o
az ide.</w>
axon opathy</w>
awak en
aver ages</w>
av itary</w>
av id
automatic ity</w>
auto antibodies.</w>
auto antibodies,</w>
augment ation.</w>
audi t</w>
audi ological</w>
audi ogram</w>
aud it
auc us</w>
attenu ation,</w>
attenu ated,</w>
attend ant</w>
attempt ing</w>
attemp ted.</w>
atrio- ventricular</w>
ati cal</w>
ath le
at- risk</w>
asymptom atic
astro cyte</w>
astemiz ole,</w>
associ ative</w>
associ ated.</w>
associ ated,</w>
associ ate</w>
assign ment</w>
asses ses</w>
asphy xia</w>
ase- mediated</w>
as le
as e),</w>
as arone</w>
arthralg ia.</w>
arterios clerosis</w>
arter itis,</w>
arrhythmi as:</w>
arrest s</w>
arg ues</w>
arachnoidi tis.</w>
ar ming</w>
ar ia
ar c</w>
aprind ine,</w>
approach -
approach- avoidance</w>
appetite- suppressant</w>
apop lex
aph thous</w>
anxioly tics</w>
anxi olysis</w>
anto in-induced</w>
antieme tics</w>
antidepressant -associated</w>
anticonvuls ant
anticholinerg ic,</w>
antiarrhythmic s</w>
anti- Parkinson</w>
anti- Gi
anti sera</w>
antagon ise</w>
ant ing</w>
angiograph y:</w>
angio plasty,</w>
anesthesi ologists</w>
anesthe ti
ane /
and os
ance ).</w>
anatom ically</w>
anand amide,</w>
analy tic</w>
analogu es,</w>
analgesic -induced</w>
ana em
an swe
an other,</w>
an es</w>
an ),</w>
amyl ase</w>
ampicill in-
ammon emia</w>
aminonucleoside -treated</w>
amino ]-
amin om
amide ]</w>
amide -related</w>
am y
am pros
am mary</w>
am a</w>
altern ations</w>
alpha2- adrenoceptors</w>
alpha-tocoph er
alpha-naph thylisothiocyan
alpha- asarone</w>
alpha- 2a</w>
alpha ENaC,</w>
alpha 4
alpha (7)</w>
alpha (1)</w>
allerg y.</w>
alle les.</w>
alle ged</w>
alkalo sis.</w>
alkalo id,</w>
alk yl</w>
alfentan il-induced</w>
aldoster on
al curonium</w>
al -treated</w>
al '</w>
aggreg ation,</w>
aggrav ating</w>
ag relide</w>
afterdepolar izations.</w>
after discharges</w>
after -
afen ib</w>
af orementioned</w>
adv ent</w>
adul ts:</w>
adrenocept or
adrenerg ic-
administr ative</w>
adjunc ts</w>
adequ ate.</w>
adenosin ergic</w>
adeno viral</w>
addres ses</w>
addic tion:</w>
addic t</w>
ad judic
acute- on-chronic</w>
acup unct
acknowledg ed</w>
acetyl methad
acetaminophen -
acet aldehyde</w>
ace promazine</w>
acceler ome
ac yl-CoA</w>
ac yclin
ac ic</w>
ac eous</w>
ac en
ac cord
absolut ely</w>
abs ences</w>
abol ition</w>
abnormal ,</w>
abdom en,</w>
ab enz
a- -
a phasi
a .)</w>
a 's</w>
] );</w>
[ S
[ N-
[ 7-
[ 4.
[ 2,
[ 2
[ 15
[ (3
Zidov ud
Z angrad
Youn ger</w>
Y M-0
Y 1</w>
Y ),</w>
X- C</w>
X a</w>
X L</w>
WR2425 11</w>
WR -10
W ech
W a
W EB</w>
Vol um
Vis c
Vi ro
Ven o-occlusive</w>
Ve h</w>
Van ishing</w>
Van comycin-induced</w>
VTE .</w>
VT /
VP U</w>
VP -16</w>
VE Ps</w>
VE GF
VCM s</w>
VCM s.</w>
V oric
V ecur
V ag
V S</w>
V M-
V IT</w>
V II</w>
V D</w>
V B</w>
V AL
VAL /HCTZ</w>
V -related</w>
Utili zing</w>
Ur sodeoxychol
Up- regulation</w>
Un treated</w>
US P
U/ ml</w>
U. S.
U- shaped</w>
U- II</w>
U se
U Q</w>
U ;</w>
U ).</w>
Two- thirds</w>
Tubulo interstitial</w>
Triam te
Tri azol
Tri al.</w>
Trazod one</w>
Tran sesophageal</w>
Tr p</w>
Thrombo phlebitis</w>
Thromb olytic</w>
Thir d</w>
Thiopent one</w>
Thi or
Th r
Th om
Th ermal</w>
Terat ogenic</w>
Tem per
TWEA K</w>
TNF alpha</w>
TN G</w>
TI VE</w>
TI MP
TH P,</w>
TH L</w>
TH C.</w>
TEM PO
TEMPO L</w>
TD P.</w>
TA A</w>
T ub
T radi
T onic</w>
T it
T ech
T R</w>
T PV/
T PA</w>
T OC</w>
T O</w>
T LE,</w>
T KI</w>
T C)</w>
T +
Syd ney,</w>
Sy n</w>
Swit ching</w>
Swis s-Webster</w>
Sweden .</w>
Stop ping</w>
Ster ile</w>
Stav udine</w>
St AR</w>
Spir ulina</w>
Sp ina</w>
Sor afenib</w>
Six -
Seventy- one</w>
Ser vices</w>
Se ve
Se g
Se Cr</w>
Scal es</w>
Sar coma</w>
Salic ylate</w>
Sal mon
STZ- icv</w>
STZ .</w>
ST EP</w>
ST -1</w>
SSR1038 00</w>
SSR 14
SSR14 97
SSR1497 44
SR -14
SR-14 17
SR-1417 16
SPAR C-
SPARC- null</w>
SM- 58
SK _F</w>
SK F
SH P</w>
SGO T</w>
SG As</w>
SERCA 2</w>
SCL C</w>
SCL -
SCH000 13</w>
SC F</w>
SC D</w>
SA E</w>
S usp
S ural</w>
S to
S hould</w>
S est
S PA</w>
S LS</w>
S LE
S I</w>
S CD
S AP
S A.</w>
S -</w>
S (c)
Rit alin</w>
Rg 5/
Rg5/ Rk
Rg 3
Rg 1</w>
Rest oration</w>
Rep ub
Rem oxi
ReN18 69</w>
Radi ation</w>
RV M</w>
RS V</w>
RP P</w>
RO S-
RO M-1
RAM H</w>
RA -induced</w>
R56 865</w>
R- AN
R- 467</w>
R- 3</w>
R ous
R oten
R of
R ho
R b
R SR</w>
R SA</w>
R S.</w>
R Rs</w>
R IS</w>
R IS
R CA</w>
R ATG</w>
R (+)-
Quer cetin</w>
QT ,</w>
QT (
Q- AMI</w>
Q ST</w>
Psych opharmac
Propran olol,</w>
Propafen one</w>
Prom oting</w>
Progres sion</w>
Pro state</w>
Pres sor</w>
Prednis one</w>
Pre -</w>
Porsol t</w>
Pod ocyte</w>
Phosphor ylation</w>
Phenyto in,</w>
Per sist
Parox ysmal</w>
PV -
PT R</w>
PR3- ANCA</w>
PR s</w>
PR M</w>
PPAR beta/
PP ).</w>
PO MC</w>
PMN Ls</w>
PL- DOX</w>
PL A</w>
PIL O-induced</w>
PG ),</w>
PEG- IFN</w>
PDE 3B</w>
PD T</w>
PC R)</w>
PC NA</w>
PC D</w>
PC C</w>
PAN /
PA S</w>
P450sc c</w>
P yridoxine</w>
P recipit
P ost</w>
P it
P epti
P anic</w>
P H.</w>
P -</w>
Over t</w>
Ovari ectomy</w>
Or ally</w>
Ophthal mic</w>
Occa sional</w>
Oat p
OT Z</w>
OPC -145
OP P</w>
OA AS</w>
O smo
O per
O SA</w>
O K
O Cs.</w>
O ATP-
O AB.</w>
O 2/
O 2-
O .
Norm oten
Nitro -
Nex t,</w>
New born</w>
Neurosc i.</w>
Neuro physiological</w>
Neuro peptide</w>
Neuro n</w>
Neu N</w>
Ne omycin</w>
Nause a,</w>
Nal trex
Na- K-
Na S</w>
NY T</w>
NT G.</w>
NT )</w>
NSAID .</w>
NP S</w>
NO S-
NO P</w>
NMDA/ glycine</w>
NK 2</w>
NK (1)</w>
NI H</w>
NI ),</w>
NG .</w>
NF- kappa</w>
NE -induced</w>
ND I,</w>
NB U</w>
NAD H-
N2 O-
N-desmethyl diazepam</w>
N-acetylcyste ine,</w>
N-acetyl-beta- glucosaminidase</w>
N-2- fluorenyl
N onetheless,</w>
N ic
N VP</w>
N SU
N R</w>
N R-AN
N E,</w>
N Ac
N AT2</w>
N AC
N 1</w>
My ocyte</w>
My HC</w>
Morph ologic</w>
Mod afin
Minim um</w>
Micro injections</w>
Mg C
Methad one-induced</w>
Meth imazole-induced</w>
Meta- analysis</w>
Met for
Mer open
Memant ine</w>
McN-56 52</w>
MT D.</w>
MT ).</w>
MS X-
MP C</w>
MN NG</w>
MI- ARI</w>
MI ).</w>
MH PG</w>
MEDLIN E,</w>
ME P</w>
MD R-T
MD D.</w>
MCF P</w>
MB .</w>
MAO- B</w>
MA L</w>
MA F
MAF b
M- TMCD</w>
M at
M ammary</w>
M ag
M a
M _
M Z</w>
M 204
M 16
M -induced</w>
Low ering</w>
Lim it
Li po
Lev ofloxacin</w>
Lev amisole</w>
Le iden</w>
Lat er</w>
Langer hans</w>
LY 29
LY29 3
LY293 558</w>
LT P</w>
LR 132</w>
LH ON</w>
LE V.</w>
L-DOPA ,</w>
L- 5-HTP</w>
L up
L u</w>
L ond
L ate-
L A.</w>
L :</w>
L 9'
L9' A</w>
L 78
Krus kal-Wallis</w>
Kingdom .</w>
Kar nofsky</w>
KW-39 02</w>
KRN23 91</w>
K- 35
K+ -induced</w>
K loth
K i-
K T-
K Cl,</w>
K CN
K 18</w>
K (v)
J ack
Isradi pine</w>
Isot retinoin</w>
Iso flurane-induced</w>
Intrad ermal</w>
Inter leuk
Inter ictal</w>
Inten se</w>
Initi ation</w>
Initi ally</w>
In dap
In -
Impres sions-
Immun ocyt
IgE -mediated</w>
Idi opathic</w>
IV R</w>
IV :</w>
IU/ L</w>
IS E</w>
IR C</w>
IP C</w>
IO P,</w>
IL-1 0,</w>
IL 6</w>
IL -10</w>
IK r</w>
III b</w>
II EF</w>
IGF- IL-3</w>
IFN/ RBV</w>
IF S-induced</w>
IC S</w>
IB O</w>
I- 00
I s,</w>
I UD
I HA</w>
I EN
IEN F</w>
I 1-
Hypo thermia</w>
Hyp ox
Hydroxy chloroquine</w>
Hydro x
Hy pe
Hy d
Hunting ton</w>
Hey mann</w>
Hen le</w>
Hem olytic-uremic</w>
Health y</w>
Haloperid ol,</w>
Haemo philus</w>
HSP 90</w>
HR- 592</w>
HM G</w>
HIV/ AIDS</w>
HIV ,</w>
HER 2</w>
HCV- RNA</w>
HC a</w>
HC Cs</w>
HBeAg -
HBV- HIV</w>
H- reflex</w>
H- F
H examethonium</w>
H T.</w>
H S-
H F.</w>
H A,</w>
Gu inea</w>
Gu ide
Grad ual</w>
Goodpasture 's</w>
Glycer yl</w>
Gluc ose</w>
Gluc ar
Gen ital</w>
Gemcit abine-induced</w>
Gar lic</w>
Gadol inium</w>
GV G</w>
GTP gamma
GTN .</w>
GT D</w>
GST- P</w>
GSK3 34
GSK 20
GSK20 70
GSK2070 40</w>
GSH ,</w>
GR1279 35</w>
GEC s</w>
GBM .</w>
GAP- 43-
G c</w>
G ang
G H,</w>
G D3</w>
G A</w>
G ;</w>
Fran ce
Fol ey</w>
Fluoxet ine-induced</w>
Flu ores
First- line</w>
Fifty- nine</w>
Fibro test</w>
Fibri llation</w>
Fc gammaR
Farns worth
Fam oti
FUD R</w>
FOLFO X-4</w>
FL X</w>
FK506- related</w>
FK 3
F n
F dd
F SL</w>
F SH</w>
F LA-
F I
F AA</w>
F 1-
Europ e,</w>
Ep i</w>
Endoscop ic</w>
Eighty- one</w>
Eighty- eight</w>
Ecstas y</w>
EX PG</w>
ER P</w>
ER .</w>
EP 4</w>
EE )</w>
ED 95</w>
ED -1-
EC 145</w>
E x</w>
E wing</w>
E q/
E max</w>
E ll
E ligibility</w>
E X-4</w>
E 18.
Drug -
Doxorub icin,</w>
Dox azosin</w>
Double-bl ind,</w>
Donepe z
Diz zin
Del ay
De b
DSM- IV-
DR G.</w>
DNA- positive</w>
DLT s</w>
DIC .</w>
DIC ,</w>
DH EA</w>
DF O.</w>
DES -associated</w>
DE X-induced</w>
DE NS
DE NA-
DD AVP</w>
DD ).</w>
D2/ D3</w>
D2 B6
D2B6 F1</w>
D-penicill amine,</w>
D-Tr p-6-
D- 99</w>
D utch</w>
D s.</w>
D om
D aucus</w>
D antrol
D T-
D MSO</w>
D ID</w>
D AB
D 5
D 3-induced</w>
D 2-receptor</w>
D 2-induced</w>
D 1-like</w>
Cyclo oxygenase</w>
Cx 43</w>
Curren tly</w>
Coumad in</w>
Cortico steroids</w>
Cordar one</w>
Concer ns</w>
Con f
Commun ity</w>
Com pl
Co- treatment</w>
Co deine</w>
Clostri dium</w>
Clon ic</w>
Clo mi
Citalop ram
Cis apride</w>
Cirrho sis</w>
Chol elithiasis</w>
Chlor prop
Check li
Character istic</w>
Ch ild</w>
Ch -induced</w>
Cent er.</w>
Cau ses</w>
Caro tid</w>
Carb imazole</w>
Canad a,</w>
Cam bodi
Cal vert</w>
CaCl(2)- treated</w>
Ca2+ .</w>
Ca(2+ )]
Ca the
Ca )</w>
CYP3A 4,</w>
CYP2C 9</w>
CXCR 4</w>
CV -1
CT R</w>
CT -induced</w>
CR F1</w>
CR ).</w>
CPA/ EE</w>
CP94 253</w>
CP K,</w>
CON TRO
CM T</w>
CK DH</w>
CK D</w>
CI P.</w>
CH A</w>
CGRP -</w>
CG S
CF M-
CD- 8
CD C</w>
CCl 4</w>
CC G
CB Z.</w>
CA F
CA D,</w>
C57Bl/ 6J</w>
C yclic</w>
C s).</w>
C ost
C learance</w>
C in
C igarette</w>
C i</w>
C he
C esarean</w>
C ab
C a,</w>
C _
C ]-
C SE</w>
C F)</w>
C CNU
C CA</w>
C C,</w>
Bus pirone</w>
Bromocript ine-induced</w>
Bra ins</w>
Bow man's</w>
Bortezom ib
Benzodiazep ines</w>
Be ing</w>
Bac opa</w>
BW ),</w>
BT S</w>
BT F</w>
BPA A</w>
BFU- E</w>
BD 100
BA U</w>
B u</w>
B max</w>
B mK</w>
B illingham</w>
B T</w>
B RR</w>
B MT.</w>
B L-
B IP
B CKDH</w>
B AC</w>
B 6,</w>
B -type</w>
Azot emia</w>
Az ithromycin</w>
As th
Arrhyth mia</w>
Aripi prazol
Ap peti
Ap o</w>
Anti convulsive</w>
Anter o
Analo g</w>
Ami k
Americ ans.</w>
Americ a</w>
Am sler</w>
Alprazol am</w>
All ergy</w>
Al together,</w>
Al lopurinol</w>
Al buterol</w>
Al bumin
Ag ing</w>
Ag ain,</w>
Adul ts</w>
Adren oc
Adju sted</w>
Ad mission</w>
Acut e,</w>
Acetyl cholinesterase</w>
Ac tivities</w>
Ac tive</w>
Ac tion</w>
AV P,</w>
ATP /
ATP/ ADP</w>
ASL- 8
ASL-8 123</w>
AS A
AS 1928370</w>
AR .</w>
AQP 8</w>
APA P.</w>
APA P-induced</w>
APA P-
AN T1</w>
AN ,</w>
AM LE
AM 12
AL S</w>
AL S.</w>
AL N+
AI N.</w>
AI )</w>
AG E</w>
AF P</w>
AF L</w>
AER S</w>
AED s.</w>
AE .</w>
ADR s.</w>
AD HD,</w>
AD C</w>
AD ),</w>
ACP-10 3</w>
ACE I</w>
AC 927</w>
AB I-00
AA P,</w>
A-(1-1 7)</w>
A- associated</w>
A- 7
A-7 400
A-7400 03</w>
A trac
A rac
A TI
A LT
A AN</w>
A A.</w>
A 2a</w>
A 1
A )/
A (1)
= 50%</w>
< 3</w>
< 0.05)</w>
< .01).</w>
: 1.</w>
90 ).</w>
9. 5,</w>
9- year</w>
9- month</w>
9 th</w>
9 47</w>
9 4)</w>
9 26</w>
9 2)</w>
9 19</w>
812 97</w>
8- hour</w>
8- day</w>
8 H</w>
8 9%,</w>
8 50</w>
8 5-
8 4,</w>
8 38
8 29
8 -12</w>
8 ,000</w>
73 15
70 %.</w>
7/ 7</w>
7. 7
7-N I,</w>
7-CK A</w>
7- 9</w>
7 9.
7 0)</w>
69 593</w>
60- 90</w>
60 6</w>
6-OHD A.</w>
6-OHD A-lesioned</w>
6- thioguan
6- nitro-
6- n-propyl-
6- glucuronide</w>
6- day</w>
6 :</w>
6 80</w>
6 7-
6 7,</w>
6 30</w>
6 2.5%</w>
6 2%,</w>
6 1,</w>
6 +/-1
58 %,</w>
54 18</w>
50 ,000</w>
50 %),</w>
5/ 6</w>
5. 7
5. 5%</w>
5. 1%</w>
5-hydroxytrypt oph
5-F C</w>
5- week</w>
5, 6-
5 70</w>
5 4).</w>
5 3.</w>
5 20
5 ,000</w>
45 ;</w>
40- 7
40 th</w>
40 .</w>
40 ),</w>
4- -
4 9)</w>
4 6,</w>
4 6)</w>
4 4.</w>
4 1.
4 -12</w>
4 -10</w>
4 );</w>
39 2</w>
39 1</w>
37. 5%</w>
36 7</w>
35 /
33. 3%</w>
3. 3,</w>
3. 2%</w>
3. 1;</w>
3. 1%</w>
3. 0)</w>
3- weekly</w>
3- methoxy-4-
3- (3-
3,4- di
3',5'- monophosphate</w>
3 7.5</w>
3 5%)</w>
3 3),</w>
3 27</w>
3 2.5</w>
3 -10</w>
3 +/-1
3 '</w>
29 8</w>
28 6</w>
28 3</w>
27 ;</w>
26. 5</w>
26 ;</w>
26 1</w>
25 9</w>
25 5</w>
25 .</w>
23 9</w>
23 6</w>
200- 400</w>
200 9.</w>
200 -1
20- fold</w>
20 6</w>
2. 8%</w>
2. 7)</w>
2. 6-
2. 5-fold</w>
2. 4,</w>
2. 20</w>
2. 2).</w>
2. 0-
2-chloro proca
2-OH E</w>
2-1 7
2- mediated</w>
2- agonists</w>
2- (
2,3, 7,8-
2, 500</w>
2 ]
2 A/
2 7.5</w>
2 65</w>
2 22</w>
2 18
2 1.9</w>
2 1.2</w>
2 0.3</w>
2 "</w>
198 8.</w>
19. 3</w>
19- 00
19 78</w>
19 4
188 84</w>
18. 8</w>
18- 24</w>
17. 8</w>
17 8
17 5,</w>
16. 8</w>
16. 7%</w>
16. 5</w>
16. 2</w>
16- week</w>
16 377</w>
16 0
15S)-di HETE</w>
154,5 26</w>
15. 4</w>
15 -</w>
15 ,
14. 9</w>
13. 4</w>
13. 3</w>
13- week</w>
13 3
12 50</w>
12 %,</w>
11. 7</w>
11 195</w>
100 635</w>
10- week</w>
10 -100</w>
10 ,
10 (6
1/ 2)</w>
1.0 4-1.
1.0 -1.
1. 9,</w>
1. 83</w>
1. 8,</w>
1. 7%)</w>
1. 65</w>
1. 59</w>
1. 48</w>
1. 34</w>
1. 29</w>
1. 19</w>
1. 18</w>
1-methyl-4-phenyl-1,2,3,6-tetrahydro pyrid
1- treated</w>
1- min</w>
1- des
1- M
1- 7</w>
1- -
1,25 (OH)2
1,25 (OH)(2)
1, 2-
1, 1-
1 =
0.9 ;</w>
0.9 9</w>
0.9 7</w>
0.9 ,</w>
0.9 %)</w>
0.7 5,</w>
0.7 3</w>
0.5 4</w>
0.4 9</w>
0.3 8,</w>
0.12 5%</w>
0.000 3)</w>
0.000 ).</w>
0.00 3</w>
0.00 1
0.0 8,</w>
0.0 7).</w>
0.0 5-
0.0 14-
0.0 12).</w>
0.0 1%</w>
0. 60</w>
0. 50,</w>
0. 1%,</w>
0 6</w>
/ N
/ B
.00 2</w>
.0 1</w>
. mmHg
-1H- 3-benz
-16 ene
-1 9
-1 4.
-1 0-
-1 );</w>
- selective</w>
- only</w>
- assisted</w>
- 6</w>
- 3-
,00 0,</w>
+/-1. 5</w>
)- deficient</w>
) -1
(two ),</w>
(recombin ant)</w>
(r CBF)</w>
(p< 0.01).</w>
(p< 0.0001).</w>
(n= 8)</w>
(n= 12)</w>
(n .s.).</w>
(medi an
(i ox
(cTn T)</w>
(VN B)</w>
(V T).</w>
(V P)</w>
(V L
(TMP-SM X)</w>
(TI A)</w>
(T ac
(St udy</w>
(SSR I)</w>
(S)- 4
(S W
(S S
(S NR
(S G
(RP N)</w>
(R LS)</w>
(R F
(PT X)</w>
(PR ).</w>
(PGI 2)</w>
(P< .001).</w>
(P ar
(P TH
(P M
(OR s)</w>
(OR =
(N- methyl-
(N or
(N I
(N F
(N B
(MUG A)</w>
(MR SA)</w>
(MPT P)-
(MK-80 1),</w>
(MD A),</w>
(MA O)</w>
(M e
(M S)</w>
(M PO-
(M PA),</w>
(M O
(M DR
(L Y
(L S)</w>
(L H
(L C)</w>
(K )</w>
(IV -
(IL )-
(IF O)</w>
(IF N-
(IF N)</w>
(IF N)-
(ICRF-1 87)</w>
(I R
(I Q
(I M)</w>
(I .
(HR V)</w>
(HPL C)</w>
(HIV ).</w>
(HIT T)</w>
(HCT Z)</w>
(H SP
(H F
(H E
(H D)</w>
(H AL)</w>
(G nR
(G ST-
(G D
(F ish
(F V
(F S
(F ANF
(F (1,
(ET -1)</w>
(EC o
(EC OG)</w>
(EC M)</w>
(EC )</w>
(E xperiment</w>
(E S
(E 2),</w>
(DP H)</w>
(DOPAC )</w>
(DF P)</w>
(DE S).</w>
(D I
(D HE
(D A
(CO ),</w>
(CCK- 8-
(CB Z).</w>
(CB Z),</w>
(CB D
(C r)</w>
(C a,
(C TR
(C R),</w>
(C PA)</w>
(C NS).</w>
(C Is)</w>
(C Cl
(C AS</w>
(C AR
(B o
(B SI
(B CNU)</w>
(AM L)</w>
(ADR )-induced</w>
(A S
(A PL).</w>
(A N)</w>
(A G)</w>
(A ER
(A E)</w>
(A DE)</w>
(A ,</w>
(> /
(< or=
(9 6</w>
(8 8.
(8 6.
(8 1</w>
(7 9</w>
(7 6</w>
(6 8.
(6 2</w>
(50 -100</w>
(50 ))</w>
(5-FU ).</w>
(5 F
(5 9</w>
(5 1</w>
(5 -10</w>
(4. 5</w>
(4. 1</w>
(4- 6</w>
(4 8%</w>
(4 7</w>
(4 2%</w>
(4 )
(3. 7</w>
(3. 6</w>
(3. 1</w>
(3 7</w>
(3 6%</w>
(3 3%</w>
(3 0%),</w>
(3 -10</w>
(25- 50</w>
(2. 8</w>
(2. 1%)</w>
(2- 3</w>
(2 A)</w>
(2 6/
(2 4%).</w>
(2 1.
(19 %),</w>
(15- 30</w>
(13. 6%)</w>
(100 %),</w>
(10(- 5)</w>
(1. 8
(1. 7</w>
(1. 7%)</w>
(1. 5-
(1- pyrrolidinyl)
(1, 3-
(1 8%),</w>
(1 50-
(1 40</w>
(1 3%</w>
(1 2-
(1 15</w>
(1 1%).</w>
(1 1%),</w>
(0.5- 5</w>
(0.1- 0.3</w>
(0.03- 0.3</w>
(0. 9%)</w>
(0. 7%)</w>
(0. 56</w>
(0. 5%)</w>
(0. 1-1.0</w>
(0. 1-1
(0. 1%)</w>
(+/-)- SM</w>
(+/-)- 2-
(+)-PD-128, 907</w>
(+)-CP CA</w>
(+)- 5-methyl-10,11-dihydro-5H-di
(+)- 3-PPP</w>
( weeks</w>
( t-
( study</w>
( starting</w>
( reference</w>
( reduction</w>
( pro
( placebo,</w>
( patients</w>
( over</w>
( once</w>
( occurring</w>
( means</w>
( male</w>
( l
( diastolic</w>
( dex
( containing</w>
( confidence</w>
( compared</w>
( cohort</w>
( chronic</w>
( chi</w>
( central</w>
( cardiac</w>
( calcium</w>
( bolus</w>
( baseline),</w>
( based</w>
( 0/
' s)</w>
" high
" crack
" atyp
zolpide m,</w>
ziprasid one.</w>
z os
z o-
yr one</w>
yr in-
yr ).</w>
young er,</w>
yohimb ine-induced</w>
year s-old</w>
yc le</w>
yc in-treated</w>
yb dot
y- proven</w>
y- evoked</w>
y thro
ythro poi
y mo
y ment</w>
y go
ygo tic</w>
y gium</w>
y a</w>
y .
xerostom ia,</w>
x es</w>
women ),</w>
women 's</w>
within- subject,</w>
withhel d.</w>
with holding</w>
whit e-
whe el</w>
wh ole.</w>
well- tolerated.</w>
well- differentiated</w>
weak ened</w>
we l.</w>
water ),</w>
wast ing,</w>
warr anting</w>
war n</w>
war m-
wall s,</w>
wake fulness</w>
w ish</w>
w illing</w>
w ay
vulner ability.</w>
vo uc
vo gli
visu alization</w>
vir al-
vigabat rin,</w>
vib ris
vi sions</w>
vi an</w>
vi ability.</w>
vesi cle</w>
vertig o.</w>
verte brobasilar</w>
veratri dine</w>
ver ine</w>
ver at
ventro -
ventric ulo
ventric les,</w>
ven ography</w>
ve in-
ve in,</w>
vasore activity</w>
vasopress ors.</w>
vascul iti
varic ocele</w>
vari ed,</w>
vari ation.</w>
vari able-
vap t
valv es.</w>
vag olytic</w>
vacuol isation</w>
v orum</w>
v antolol</w>
v ,</w>
utiliz ation.</w>
ust a
useful .</w>
uscit ation</w>
us -treated</w>
us -dependent</w>
uro log
uro lithiasis.</w>
uro cortin</w>
urg ently</w>
ureth ra
urethra .</w>
ures ).</w>
ure ter.</w>
ur s</w>
ur ized</w>
ur gen
ur an
ur ,</w>
upt a
upta ke
upreg ul
unte ers</w>
units/ min</w>
unexpl ained.</w>
und us</w>
un successful,</w>
un sell</w>
un recognised</w>
un protected</w>
un known;</w>
un doub
un determined.</w>
un controllable</w>
un associated</w>
un acceptably</w>
um -related</w>
ulos a</w>
ulo plas
ul eti
uleti de</w>
ul erg
ug ment
ud in,</w>
ucle ar-
u tility.</w>
tyros ine-
type -1</w>
type )</w>
two- year</w>
two- step</w>
two -</w>
twenty- eight</w>
tw ins</w>
tuf ts</w>
tubercul in</w>
tub es</w>
tu be,</w>
trunc al</w>
tropic amide</w>
tro duction</w>
tris omy</w>
trimethopri m.</w>
trichloro ethane</w>
tren d.</w>
treatment- limiting</w>
treatment -associated</w>
treat ,</w>
trazod one.</w>
transpor ters.</w>
transcrip tion-
transcription- polymerase</w>
trans- nicotine-N'-
trans sphenoidal</w>
trans lation</w>
tranquil iz
tran se
tram id</w>
traff icking</w>
tract s,</w>
tract ant</w>
tra vel</w>
tr uly</w>
tourniqu et,</w>
tongue- task</w>
toler able.</w>
togen ari
to sis.</w>
to dd
todd l
to )</w>
tiv ity,</w>
tion -induced</w>
timo lol,</w>
tim ide</w>
til lo
tic- pharmacodynamic</w>
tic ated</w>
tib ia</w>
thyro toxic</w>
thyro parathyroidectomized</w>
thym idine,</w>
through put</w>
thrombo genic</w>
thrombi ,</w>
thromb in-induced</w>
thromb in-
thir d,</w>
thioper amide,</w>
thion ine</w>
thio ph
thiazolidinedi ones</w>
thiazol idine-
thiaben dazole</w>
thi ols</w>
thi epin</w>
thi en
theophyll ine-
the se.</w>
the ast</w>
thalidom ide-
thal ass
th yo
th ia
th an-
tetrodot oxin</w>
tetrodot ox
tetrac hloro
test s:</w>
test s)</w>
test ing;</w>
test inal</w>
tertiary- care</w>
terat ological</w>
ter )</w>
tent ing</w>
tenofovir ,</w>
tenid ap</w>
ten si
ten fold</w>
ten ding</w>
temoc april</w>
temazep am,</w>
teg af
techno logy</w>
techniqu e)</w>
tear fulness</w>
te dly</w>
te d)</w>
tax ol,</w>
target -
tamponade .</w>
tail- tremor.</w>
tachycardia ;</w>
tachycardia /
tachy kinin</w>
ta urine.</w>
ta hydro
ta -
t. i.
t- AMCA</w>
t ympan
t us</w>
t us
t urb
t s),</w>
t led</w>
t andos
synthesi zing</w>
synthesi zed.</w>
syndrome ).</w>
syn ucle
syn onymous</w>
sy ru
suspen sion.</w>
surro gate</w>
surg e</w>
surfac es</w>
sur moun
supran uclear</w>
super precipitation</w>
sup pository</w>
summar ized.</w>
sulfon amide
sulfadox ine-
sulf ate
sulf amo
suk ub
suggest ,</w>
sugamma dex</w>
suburo thelial</w>
subside d,</w>
subject- rated</w>
sub unit.</w>
sub side</w>
sub di
subdi visions</w>
sub anesthetic</w>
sty rene</w>
stut ter
structur al,</w>
stroke ;</w>
striat a</w>
stri opallidal</w>
stri ated</w>
streptozoc in</w>
strepto kinase</w>
strength s</w>
stre am.</w>
strategi es,</w>
stra in-dependent</w>
str ation</w>
stimul ations</w>
sti bo
steroid .</w>
steroid -treated</w>
steroid ,</w>
ster il
stat in-induced</w>
stachy s</w>
st one.</w>
st ered</w>
st ents,</w>
st em.</w>
st aging</w>
splic ing</w>
spiro peridol</w>
spiro metry</w>
spin y</w>
specti vely,</w>
spect ac
specimen .</w>
specific ity.</w>
spec t</w>
spar floxacin,</w>
sp ell
sour ces.</w>
sos omal</w>
son ography,</w>
somnambul istic-like</w>
somatos ensor
som ite</w>
solu tion;</w>
solitari i</w>
sol vent
sol ic
sol ar</w>
sodi um/
socio demographic</w>
snor ing</w>
sniff ing,</w>
small er,</w>
slow- wave</w>
skill s</w>
skele ton
six .</w>
sit e
sis- like</w>
sis ?</w>
sion- inducing</w>
sion s:</w>
sinusi tis.</w>
single-bl inded</w>
single- cell</w>
simple x</w>
sil ver</w>
sign als,</w>
sigma (2)-receptor</w>
sider osis</w>
sic ca</w>
sib ly</w>
si tis</w>
si s--
si res</w>
si lastic</w>
shoc ks</w>
she ll
sha ke</w>
sh run
sevent een</w>
sett led</w>
ses amin</w>
sertral ine-treated</w>
seroton in
ser ythropoi
ser t
ser ous</w>
ser ologically</w>
sequ enti
sequ enced</w>
sequ enc
septi caemia</w>
sensor ium</w>
sensitiz ation;</w>
self- medication</w>
see mingly</w>
see king.</w>
sed ative,</w>
sed ated,</w>
sect ors</w>
secret e</w>
sec tions,</w>
sec tioning</w>
search .</w>
sear ching</w>
se len</w>
se en
se ).</w>
scho ol
scan s,</w>
scab ies</w>
sc rot
scrot um</w>
sc ram
satur ation.</w>
satisfactor ily</w>
sat ran
satran idazole</w>
sar in</w>
salicyl ate,</w>
sal t)</w>
sal ine).</w>
s- old)</w>
s ore</w>
s lowe
s lim
slim ming</w>
s ay</w>
s ]</w>
s ],</w>
s ,
rout es,</w>
room -
room- temperature</w>
ron aut
rom e</w>
rolipr am,</w>
ro yal</w>
ro vorum</w>
ro mo
ritonavir ,</w>
risk "</w>
ring ed</w>
rim cazole</w>
righ t.</w>
ricket s.</w>
ric- oxide</w>
ri d
ri be
rheumat ologic</w>
reversal .</w>
rever ting</w>
rever sed.</w>
retur n.</w>
retro sternal</w>
retin oblastoma.</w>
reticulo endothelial</w>
reticul in</w>
restric tions</w>
restric ted.</w>
restore d.</w>
responsi ve.</w>
response ).</w>
respon ded,</w>
resour ce</w>
resem bl
resembl ance</w>
resc ents</w>
requ est</w>
reproduci bil
replic ate</w>
reperfu sion-induced</w>
rep ut
ren dipine</w>
remifentan il,</w>
remifentan il
remem bered</w>
remaind er,</w>
reli ed</w>
reinforce ment,</w>
reinforc er</w>
reinfor ce</w>
region ally</w>
regimen :</w>
regim es</w>
refractor iness.</w>
ref rontal</w>
red- cell</w>
recurren ces,</w>
recruit ed,</w>
recru iting</w>
recogni tion.</w>
recogni sed.</w>
recipi ent,</w>
receptor- dependent</w>
receptor- alpha</w>
recanal ization</w>
rec ently.</w>
rec all,</w>
rearrang ement</w>
re- entrant</w>
re visit
re uptake.</w>
re treat</w>
re transplantation</w>
re loc
reloc ation/
re ds</w>
re d)</w>
rat s.(ABSTRACT</w>
rat ings,</w>
rat a
rasag il
rapid- sequence</w>
rapam ycin.</w>
rap e</w>
ranitid ine-induced</w>
random ized.</w>
random ization.</w>
ran ked</w>
rai sed.</w>
rag ge
ragge d-
radic ulopathy</w>
racem osa</w>
rac ial</w>
rabep razole</w>
rSO (2)</w>
r- pro
r- hu
r unc
r ump</w>
r alazine</w>
r ade</w>
quinol ones,</w>
quin ine,</w>
qui pa
question ed.</w>
quant al</w>
quality- of-
qual ity,</w>
quadric eps</w>
quadri paresis,</w>
qu ine.</w>
pyrrolidinyl) methyl]-
pyrrolid in
pyrida zin
pyramid ale</w>
pyeloneph ritis,</w>
py ran
purpur a/
pup il
pun ished</w>
pul se,</w>
pul s
puber ty</w>
psychostimul ant-induced</w>
psycho sis:</w>
psycho ses,</w>
psycho geriatric</w>
psychiatri sts</w>
psychiat ry</w>
psychi atr
psych omot
psor iasis,</w>
pseudolith iasis.</w>
pseud omembranous</w>
proxymetac aine</w>
prostagland in-induced</w>
prost acyclin
pros thesis</w>
propylthiourac il,</w>
propyl -1-
propyl )
propos al</w>
propofol -M
propafen one,</w>
pronounce d.</w>
prompt ing</w>
prolifer ate</w>
prolact inemia.</w>
progres sive-
program ming</w>
progester one-induced</w>
progest ag
progen y</w>
profil ing</w>
pro li
pro be,</w>
pri or,</w>
prescri bed,</w>
preferen ces</w>
preeclamp sia,</w>
precipit ous</w>
pre- training</w>
pre treatments.</w>
pre treatment)</w>
pre load,</w>
pre fer</w>
pre dil
predil ection</w>
pre ablation</w>
pramipex ole,</w>
pract olol,</w>
pr in
posth yp
post renal</w>
pos tis
popul nea</w>
polyp s</w>
polymorph isms.</w>
polyc hemotherapy</w>
poly ur
poly trauma</w>
poly ribos
poly herbal</w>
poly graphic</w>
poly acrylamide</w>
pol ice</w>
pointes "</w>
point es:</w>
podoc aly
po sed.</w>
po ols</w>
po ol.</w>
po fung
pofung in</w>
po di
pneum ococcal</w>
pmol ),</w>
plo t</w>
platinum- containing</w>
platin um,</w>
plat in,</w>
plas ticity.</w>
plac e.</w>
pl ying</w>
pl ane</w>
pir one,</w>
piperox an</w>
piperid in-1-
pimoz ide.</w>
pilsi cain
pilo -
pill s,</w>
pig mentation,</w>
phyto sterols</w>
phyto estrogen</w>
physi c
phy ria</w>
phthal ein</w>
photoph obia,</w>
phosph ates</w>
phenylethyl ene</w>
phenyleth an
phenyl) -1-
phenyl piperazine</w>
phenoxybenz amine</w>
phenobarbit al-induced</w>
phenacetin- containing</w>
pharyn x</w>
pharmac y,</w>
pharmac ology.</w>
phac o
phaco emulsi
ph iliac
ph ases,</w>
ph an,</w>
petechi ae</w>
person ne
persist ed,</w>
perphenaz ine.</w>
permis sive</w>
peritone um</w>
period ical</w>
perin uclear-
peri kary
pergol ide-induced</w>
performed :</w>
perform ances</w>
perfor ated</w>
percus sion</w>
per taining</w>
per pet
per il
pepti dom
pepti des.</w>
pentylenetetrazol e-
pentol ini
pente trazol</w>
pentazoc ine,</w>
pentadec apeptide</w>
pentadec anoic</w>
pent osi
pentosi dine</w>
pent ose</w>
penicill amine,</w>
penetr ate</w>
pemetrex ed</w>
pel vis,</w>
peer- reviewed</w>
paw- withdrawal</w>
patient ;</w>
pathogn om
pathognom onic</w>
patch es,</w>
parti tion</w>
part ly,</w>
parenchy ma.</w>
parasit osis</w>
parameter s:</w>
parac entral</w>
par t.</w>
par af
par ab
parab rachial</w>
papillede ma,</w>
papill a.</w>
pap ular</w>
pantop razole</w>
pan ic,</w>
pan -
pamid ron
pallid us,</w>
pal met
pal m
pair s.</w>
painful ,</w>
paclitaxel/ cisplatin</w>
paclitaxel- eluting</w>
pacemak er,</w>
pac king</w>
pa ins.</w>
pa edi
p< 0.0001).</w>
p- di
p-di oxin</w>
p- aminohipp
p wise</w>
p ush
p tively</w>
p inch</w>
p idine</w>
p ic</w>
p enc
p ).</w>
oxypert ine</w>
oxotremor ine-induced</w>
oxide /
oxid ants</w>
oxcarbazep ine.</w>
ox ,</w>
over using</w>
over production</w>
over lying</w>
over doses,</w>
over dosed</w>
ovari es</w>
ov ary,</w>
otyp ic</w>
otrop h</w>
otri p
ototoxic ity:</w>
oton sill
ote tr
ost aining</w>
osm oly
oscop y,</w>
oscil lat
osa hexa
osahexa enoic</w>
os tin</w>
os plen
orub ic
oron asal</w>
organophosphor us-induced</w>
organell es.</w>
organ ochlor
organ ized</w>
orchi ectomy</w>
orb idity</w>
oral- contraceptive</w>
or li
orli stat
or ized</w>
or ch
opini on,</w>
oper ator</w>
opath ological</w>
op tion.</w>
op soas</w>
op positional</w>
op posit
op am,</w>
oni um)</w>
one- week</w>
one- hour</w>
ond amine</w>
onco genic</w>
on ly).</w>
on fer
on azole-induced</w>
on a</w>
omega- oxidation</w>
omediast inum</w>
ome- encapsulated</w>
omat osis.</w>
om apatrilat</w>
om a-
ole ifera</w>
ol l</w>
ol itis</w>
ol der
ol -associated</w>
off- drug</w>
off ering</w>
ocyn in</w>
ocycl ic</w>
octreoti de.</w>
ocr ypt
och lo
occul ta</w>
occ ured</w>
oc togenari
oc alce
observe d:</w>
observ ational,</w>
obser vers</w>
obser ver
obliter ation</w>
oblast s</w>
ob acill
obacill us</w>
o- t
o- p-dioxin</w>
o vul
o uring</w>
o steron
o rough</w>
o des</w>
o -</w>
nutri tion,</w>
nur ses</w>
nur se</w>
numb ers,</w>
nucleotide- binding</w>
nucle osides</w>
normal- appearing</w>
norm oxic</w>
nor meperidine</w>
non- toxic</w>
non- sustained</w>
non- randomized</w>
non- problematic</w>
non- dopaminergic</w>
non users.</w>
non neoplastic</w>
non ketotic</w>
nomifens ine,</w>
no thing</w>
no se,</w>
nmol/ mg</w>
nmol/ g</w>
nmol/ 0.5</w>
nmol .
nmol ,</w>
nitroprus side-
nitrite- nitrate</w>
nitrit e,</w>
nit ro</w>
nit ric-oxide</w>
nit rates.</w>
nit rate.</w>
nine ty</w>
night- time</w>
nicot inamide</w>
nick- end</w>
nic k</w>
ni p</w>
ng. /ml.</w>
newbor ns.</w>
neutrophil ic</w>
neutr alized</w>
neutr alization</w>
neurotransmit ters,</w>
neurotoxic ,</w>
neuro toxins</w>
neuro steroids</w>
neuro steroid</w>
neuro po
neuro pil</w>
neuro humoral</w>
neuro effector</w>
neuro cardiogenic</w>
neur ally</w>
nephrotoxic ,</w>
nephro tic-range</w>
nephro sclerosis</w>
nephro genous</w>
neoplas m</w>
necrop sied</w>
ne sic</w>
nausea/ vomiting,</w>
narco sis</w>
narc ol
nanop articles</w>
naloxone- reversible</w>
nad olol,</w>
n= 8)</w>
n m</w>
n iz
n a.</w>
n M/
myosi tis,</w>
myopericardi tis</w>
myoclon ic,</w>
myelo mening
myelo ma:</w>
myel ination</w>
mydri atic</w>
mydri asis,</w>
myasthen ia-like</w>
my op
my ogenesis</w>
my ofilam
mutis m,</w>
muscimol- stimulated</w>
mun o</w>
mumol/ L)</w>
multi for
multi f
multi agent</w>
mul tis
muk ul</w>
muc inous</w>
mu g)</w>
msec )</w>
mother ,</w>
mot or,</w>
mos enii</w>
morb ill
morbill iform</w>
monoamine- depleting</w>
monkey s:</w>
mon oneuropathy</w>
mon ocytic</w>
mon ocyte
mon ab
momet asone</w>
molecul e,</w>
modul ator,</w>
moder ate-dose</w>
mode ,</w>
modal ities,</w>
moc k</w>
mo od.</w>
mo -
mmol/ kg).</w>
mm (3)</w>
ml/ min)</w>
ml/ g/
ml -1,</w>
mitoxantr one,</w>
mis use.</w>
mis sed.</w>
minocycl ine,</w>
minim al,</w>
min ation</w>
min :</w>
milrin one-induced</w>
milrin one,</w>
milli ons</w>
mili eu
migra ine-like</w>
midazolam /
microscop e.</w>
micromol/ l.</w>
microliter s/
microliter /
micrograms/d l.</w>
microg/ rat,</w>
microg/ g</w>
micro tubul
micro some</w>
micro g).</w>
micro electrode</w>
micro circulation.</w>
mic ar</w>
mic .</w>
mi anserin,</w>
mg/m2/ day.</w>
mg/kg .
mg/d l).</w>
mg/ min)</w>
mg.kg-1. min-1</w>
mg.kg-1. d-1</w>
mg. ml-1</w>
metrizo ate</w>
metopro lo
methyl- 6,7-dimethoxy-4-
methyl cell
methicill in.</w>
methazol amide</w>
methamphet amine-</w>
meth iodi
meth ane</w>
metaz epam</w>
metast ases,</w>
meta- analyses</w>
mesyl ate,</w>
mesangi um</w>
mesalaz ine.</w>
mes ulerg
mer it</w>
mer cur
meningi oma</w>
men thol</w>
men stru
men s</w>
membran oproliferative</w>
melan oma,</w>
medication- free</w>
medic ines,</w>
medi um-induced</w>
mean ing</w>
me qu
me phenytoin</w>
me phed
maz ind
matur ation,</w>
matri x.</w>
mat ings</w>
mat ch
mat a</w>
marrow -
mar ri
maprotil ine.</w>
manufact ured</w>
mano alide</w>
manipul ation.</w>
manip ulated</w>
manifest ation,</w>
mang iferin</w>
mang anese</w>
man e
mam m
mamm als</w>
male /
mala ox
mal tolyl</w>
maj or
mag na</w>
mag n
macroscop ically</w>
macron odular</w>
macro cytosis</w>
mach ine</w>
macaqu es</w>
ma iled</w>
ma i-
mOsm/ kg,</w>
mL/ 100</w>
mL (-1))</w>
mGluR 5,</w>
mGlu 3</w>
mGlu 2</w>
mEq/ L),</w>
m y</w>
m ide</w>
m ere</w>
m ate</w>
m assi
m AChR</w>
m 2;</w>
lymph oplas
lymph o
lusit ropic</w>
lung s.</w>
lun g.</w>
lum en.</w>
loz eng
lox oprofen</w>
low- potency</w>
lot ec
los ses.</w>
los oxantrone</w>
lor metazepam</w>
lopinavir/ ritonavir</w>
loo king</w>
long- interval</w>
logar ithm</w>
log ram
log 10</w>
loc ate</w>
lo vian</w>
lo cy
liver ;</w>
lith otrip
liter ),</w>
lit re</w>
liqu orice</w>
lipos ome-encapsulated</w>
lipopolysacchar ide-induced</w>
lipid- soluble</w>
lip omatosis</w>
lip ids.</w>
lip -DXR</w>
line -</w>
line )</w>
lin k
limit ,</w>
limb -
like '</w>
like "</w>
lik ely,</w>
lig ation-,</w>
life- year</w>
lif est
lifest y
lidocaine- kindling</w>
li go
li able</w>
level )</w>
leuk ocytosis,</w>
leuc ocyte</w>
leuc o
leu ke
lesion s;</w>
les s)</w>
length -dependent</w>
leiomy osarcom
lef t,</w>
leaf let</w>
lead -induced</w>
lea ve</w>
le xi
laud anosine</w>
later ally</w>
last ing.</w>
lan dic</w>
lamy dial</w>
lamivud ine-treated</w>
lact ulose</w>
lact otroph</w>
lacrim ation</w>
lab ele
l- ephedrine</w>
l ends</w>
l ectin</w>
l b</w>
l ay</w>
l aryn
l (-1)</w>
l 's</w>
kinase- MB</w>
kin ins</w>
kidne y
ket amine-treated</w>
kan zo-
kal a-
kala- az
k ra
k r
k e-
k Pa
justi fied</w>
justi fi
junc tive</w>
junc tions.</w>
judg ment</w>
ju n</w>
jejun um,</w>
j et</w>
iz ation;</w>
iz ation).</w>
iv .</w>
iv ,</w>
itrac onazole,</w>
iti s).</w>
item poral</w>
it y),</w>
it ly</w>
it ation,</w>
it amin
isox azole-
isoxazole- 4-
isopropyl -
isop uleg
isom er.</w>
isol ates</w>
isol ated.</w>
iso volumetric</w>
ism ;</w>
ise thion
is ondamine</w>
is er</w>
irin otecan,</w>
ir besartan</w>
iqu ante
iquante l</w>
iop ent
iod ine
investig ator.</w>
investig ated:</w>
invari able</w>
inv ent
introduc ed,</w>
intrathec ally.</w>
intrastriat ally</w>
intram itochondrial</w>
intrag astr
intragastr ically</w>
intracerebroventric ularly,</w>
intracaver nosal</w>
intrac utaneous</w>
intra- hepatic</w>
intra- CA1</w>
intra operatively</w>
interleukin-1 beta</w>
interest ed</w>
inter oceptive</w>
inter contraction</w>
intensi vi
inten tionally</w>
intelligen ce.</w>
instruc tions</w>
institu tions.</w>
instill ations</w>
instill ation.</w>
instill ation,</w>
inst em</w>
input .</w>
inoc ulated</w>
inoc ula</w>
innerv ation.</w>
innerv ate</w>
initi ally.</w>
inhibit ors
ing er</w>
ing -dose</w>
influ x.</w>
infant 's</w>
inf ul</w>
inf ra-
inexpen sive</w>
ine- sensitive</w>
ine ?</w>
indor amin</w>
ind ine</w>
increas ing.</w>
increas e).</w>
incid ence:</w>
inci pient</w>
incer ta</w>
incap acit
inc urred</w>
in- vitro</w>
in- stimulated</w>
in- patients</w>
in- 3</w>
in yl
in trigu
in stituting</w>
in spir
in spi
in ol,</w>
in dependent.</w>
in apparent</w>
in activating</w>
imple ment
impac ts</w>
immunosuppress ants</w>
immunosuppress ant.</w>
immunore activity,</w>
immunohist ochemical,</w>
immunocyt ochemical</w>
immuno electron</w>
immun operoxidase</w>
immun ogenic</w>
immobil ity.</w>
immobil ity,</w>
immer sions,</w>
imipenem/ cilastatin</w>
imen s</w>
imbal ances</w>
imat inib
imag ery</w>
im possible</w>
im pe
im er</w>
ilo prost</w>
ill in,</w>
ill -
ili rub
ili opsoas</w>
ile ut
il umin
igno red</w>
ifenpro dil,</w>
idi um</w>
idi opath
identifi ed;</w>
identifi ed:</w>
iden tically</w>
ide oxy
ide ally</w>
id y</w>
id um</w>
id aemic</w>
id -treated</w>
ich thyo
ic in-
ic al-
ic -</w>
ic ),</w>
ic "</w>
ib er
ia --
i.v .;</w>
i. c.)</w>
i prone</w>
i on-
i g</w>
i es:</w>
hyster osalping
hypox ia-
hypox anth
hypot est
hypotest osteron
hypophysi al</w>
hypophosphat emia,</w>
hyponat ra
hypomagnesem ia.</w>
hypolip idaemic</w>
hypokal aemia.</w>
hypokal aemia,</w>
hypogly caemia</w>
hypoalbum inemia.</w>
hypo insul
hypo aldosteron
hyperten sion)</w>
hyperphosphat emia.</w>
hyperlipoprote inemia</w>
hypere strogen
hyperbilirub inemia,</w>
hyperalgesi a)</w>
hyper trichosis</w>
hyper tricho
hyper susceptibility</w>
hyper phagia</w>
hyper osmolar</w>
hyper metabolism</w>
hyper locomotion,</w>
hyper gammaglobul
hyper filtration</w>
hyper cellularity</w>
hype rem
hyp ochol
hydroxyl ase-
hydroxy phenyl)-
hydroxy chloroquine-
hydroxychloroquine- plus-
hydrochlorothiaz ide-
hydrochlor ide
hydrocephal us,</w>
hydro bromide</w>
hy aline</w>
hr s,</w>
hr lich</w>
hospital ized.</w>
hospit als,</w>
hormone- releasing</w>
hor ses.</w>
home ostatic</w>
ho we
histor ically</w>
hist amin
high- level</w>
high- amplitude</w>
heterotop ia</w>
heter o
her it
hepat oma</w>
hepar ins</w>
hemorrh ag
hemopty sis</w>
hemo stasis.</w>
hemo philiac
hemo di
hemodi af
hemisphe res.</w>
heat .</w>
health- care</w>
hazar dou
hazardou s.</w>
happ ens</w>
handic apped</w>
hand ling
halothane- adrenaline</w>
haloperidol -</w>
hallucin atory</w>
habit uated</w>
h olic</w>
h MBF</w>
guaneth idine,</w>
gu aifenesin</w>
group s),</w>
gra vis
gra di
gover ning</w>
gol d-induced</w>
glycyrrhiz in</w>
glyceryl trinitrate</w>
glycer in</w>
glyc olysis</w>
glutathi one.</w>
glutam ate-induced</w>
glucuron ide.</w>
glucocorticoid- inducible</w>
gluc arate</w>
glo t
gli oma.</w>
gli oblast
gg ed</w>
genotyp es,</w>
genist ein</w>
gener ations</w>
gener alization</w>
gene- targeted</w>
gender -related</w>
gen ipin</w>
gen dered</w>
geme prost</w>
gell an</w>
ge ometric</w>
gastr in</w>
gast ritis,</w>
ganciclovir ,</w>
gan ax
gamma-glutamyl transferase</w>
gamma- vinyl</w>
gamma- ENaC</w>
gamma ,</w>
gamma )</w>
gall ic</w>
gall bladders</w>
gabapent in,</w>
gaba ergic</w>
ga it,</w>
g/d L.</w>
g out,</w>
g m)</w>
g f
gf 8</w>
g ating.</w>
fund us
function al,</w>
function :</w>
fructose-1, 6-di
front al,</w>
from ,</w>
frequency -dependent</w>
foscarne t.</w>
forty- two</w>
formul a.</w>
follic ulo
fol ia</w>
fol ate-induced</w>
fluphenaz ine,</w>
fluoxet ine-treated</w>
fluoxet ine-
fluorop yrimid
flunitrazep am.</w>
flunitrazep am
flunar izine,</w>
flumazen il-treated</w>
fluctu ation</w>
flo or</w>
flexi on,</w>
flav one</w>
flat ul
flare .</w>
fit ting</w>
fissu re.</w>
first- order</w>
finger- tapping</w>
fing ers.</w>
filament ous</w>
fibron ectin,</w>
fibromy algia</w>
fibro sis;</w>
fibro sis:</w>
fibrin oid</w>
fibrill ation;</w>
fib rates</w>
fi ed,</w>
fi ant</w>
fer rit
fenfluramine- associated</w>
fe w.</w>
favor able.</w>
fai led,</w>
factor- kappaB</w>
fac i
f usion.</w>
f ur</w>
f ine-
f ill</w>
f ed
f acti
f )</w>
exud ate</w>
extub ation,</w>
extravas ation,</w>
extrastimul i</w>
extrapol ation</w>
extran e
extra striatal</w>
exposure )</w>
explo ited</w>
expendit ure</w>
exp ands</w>
exp and</w>
exist s,</w>
exec ution</w>
excit ement,</w>
exci pi
excell ent,</w>
ex port</w>
ex pir
ex on</w>
ex encephaly
evo king</w>
evid ent,</w>
everolim us.</w>
ever y-
eugen ol</w>
eu k
etopo side
ethyl ket
ethyl )</w>
ethoxy qu
ethinylestradi ol/drospirenone</w>
eth idium</w>
estrogen -treated</w>
estradi ol-3-
est rone</w>
esmo lol-induced</w>
escal ation.</w>
es citalopram.</w>
erythrom ycin,</w>
erythe ma.</w>
error s.</w>
ergot oxine</w>
ergot -derived</w>
erg oc
erec tion.</w>
er arch
er a.</w>
equival ents</w>
equival ent.</w>
equip ment</w>
equili bration</w>
equ ine</w>
epinephr ine's</w>
epilep sies</w>
epib atidine</w>
ephed rine-induced</w>
ep s,</w>
ep oxy
ep if
entrop y</w>
enterocol itis.</w>
enter ococcal</w>
enter itis</w>
enta enoic</w>
ent er</w>
ent ate</w>
ent ).</w>
ensu ed.</w>
enroll ment.</w>
enrol led;</w>
enop us</w>
enlarg ement.</w>
enh ar</w>
energe tics</w>
energ etic</w>
endotheli al-
endometri oid</w>
endocardi um</w>
end- of-
end- expiratory</w>
end plate</w>
encephalo pathies.</w>
encephal y.</w>
en il,</w>
en ia</w>
en gendered</w>
en during</w>
en ded.</w>
emphasi zing</w>
emergen cy.</w>
embryo pathy:</w>
em physe
ely x</w>
electrophysi ology,</w>
electrocortico graphic</w>
el uted</w>
el ong
el lo
el apsed</w>
el abor
el ab
elab oration</w>
eight- year-old</w>
eigh ty</w>
eicos ap
eicosap entaenoic</w>
eicos anoids</w>
ei ther.</w>
efficac ies</w>
effect s--
educ ational</w>
edat rexate</w>
ed- release</w>
ed- forward</w>
ed ical</w>
ed ).</w>
ectom ized,</w>
ectom ies,</w>
echocardio gram,</w>
echan ical</w>
early- phase</w>
ear ance</w>
e ties</w>
e ased</w>
e an</w>
e IF
e GFR</w>
dysur ia.</w>
dysur ia,</w>
dysrhyth mia,</w>
dyskinesi a:</w>
dysfunction ;</w>
dys plasia,</w>
dys plasi
dynam ics.</w>
dynam ically</w>
dy serythropoi
dur ation;</w>
duoden um,</w>
du plic
drin ks</w>
dri ve.</w>
dri man
doxo- HF</w>
dow n,</w>
doses ).</w>
dose- rel
dor zolamide/timolol</w>
dopamin ergic,</w>
dop examine</w>
donepez il,</w>
domperid one.</w>
dobutamine- atropine</w>
dobut amine,</w>
do stachys</w>
dizziness /
disulph ide</w>
distor ted</w>
diss ecting</w>
disrupt ing</w>
disru ption.</w>
dispar ities</w>
disp ut
disorient ation.</w>
disorder s:</w>
disease- modifying</w>
discrimin ation.</w>
discour age</w>
discontinu ed;</w>
disap pointing</w>
dis solution</w>
dis satisfaction</w>
dis position.</w>
dis ed</w>
dis close</w>
dis appoint
dis abilities</w>
diphenylhydanto in.</w>
diphenylhydanto in,</w>
dimethyl -1-
dilat or</w>
dilat ing</w>
dil ute</w>
dil ate</w>
dihydroxy vitamin</w>
dihydro folate</w>
dihydro benzofuran-
dihydrobenzofuran- 7-
digit orum</w>
digit alis,</w>
diflun isal</w>
diff use,</w>
diethyl nitros
diet -fed</w>
dic h
dibenz o-p-dioxin</w>
diaz oxide.</w>
diarrho ea.</w>
diaphrag m.</w>
di vision</w>
di oxo-
di ffe
dex fenfluramine.</w>
develop ,</w>
detox ifying</w>
deterior ations</w>
destro yed</w>
desmethyl imipramine</w>
desi rable</w>
desat ur
des-Arg 9-
des methyl</w>
dermat ome</w>
dermat ology</w>
depres sions</w>
depos ited</w>
depolymer ization</w>
depolar ization,</w>
deoxychol ate</w>
deoxy guanosine</w>
denti str
dens ity.</w>
dend rite</w>
denaf il</w>
demyelin ation.</w>
demyelin ation,</w>
deman d.</w>
delta ,</w>
dele tions</w>
del en
degener ate</w>
defici ency
deferen s</w>
defer oxamine,</w>
defer iprone</w>
def ovir
def ec
decom position</w>
decl ined.</w>
decarboxyl ase,</w>
dec or
dec entr
dec el
debul king</w>
death )</w>
death ),</w>
de pot
de mented</w>
de fiant</w>
de al
deal t</w>
de activation</w>
daunorub ic
dapson e-
dac arb
dP/dt max</w>
d- to-
d- PG
d rank</w>
d one,</w>
d al
cytoplas m.</w>
cyto protection</w>
cyclospor ine-
cyclopentyl adenosine</w>
cyclopent olate</w>
cyclohexyl adenosine</w>
cycl ine-induced</w>
cycl ase,</w>
cyano sis,</w>
cyan o-
cut- off</w>
cure tt
cup s/
cul ated</w>
crystall uria.</w>
cryp t</w>
crow ded</w>
cross- over,</w>
cross- linking</w>
cross- fo
cromakal im</w>
cro cin</w>
cri ses</w>
cres cent</w>
creat es</w>
crack- cocaine</w>
cr ush</w>
cr )</w>
covari ates.</w>
countr y.</w>
cou reteral</w>
cortic otrop
cortic ospinal</w>
cortic es,</w>
coron ary,</w>
cor tag
copies/ ml)</w>
coordin ation.</w>
convulsion s)</w>
convuls ants.</w>
conver sely,</w>
controlle d-
contribut ors</w>
contral ater
contempl ating</w>
consul t
construc t</w>
constric tions,</w>
constitu tively</w>
constitu tional</w>
const antly</w>
consider ation.</w>
cons ent,</w>
cong ru
confoun ders</w>
conform ational</w>
confirm ation.</w>
conclu de,</w>
concentration- effect</w>
concentr ation:</w>
con val
con tig
con ference</w>
computer- assisted</w>
compromi se,</w>
complic ates</w>
complex ing</w>
complex -mediated</w>
compens ation</w>
compart ments</w>
comp as
compas sion
comorbidi ties,</w>
comorb idity,</w>
community- based</w>
common ly,</w>
comb ine</w>
com prehen
com position,</w>
com edic
colorect al,</w>
collap sing</w>
collagen -</w>
collag en,</w>
cogniti ve,</w>
cod on</w>
cocci di
cocaine- like</w>
coag ulo
co- transporter</w>
co- infection</w>
co ver</w>
co stly</w>
co st.</w>
co re,</w>
co ordinated</w>
co de</w>
clu b</w>
clofib rate-induced</w>
clo sel
clo r</w>
clinico- pathological</w>
clinic s.</w>
clentiaz em</w>
clear ing</w>
clear -cell</w>
clea ved</w>
classi fication,</w>
cl ue</w>
cl enbuterol</w>
cl au
cl aimed</w>
cit rovorum</w>
cit rat
cister na</w>
cisplatin- containing</w>
cis- platinum</w>
cir cular</w>
cipro fibrate</w>
cilex etil</w>
ciga rette
cid ofovir
ciclo vir</w>
ci ticoline</w>
chron ic-
choreoathe tosis</w>
cholinester ases</w>
cholinester ase,</w>
cholinerg ically</w>
cholinerg ic,</w>
cholester yl</w>
cholecysti tis.</w>
cholecalc ifer
chol era</w>
chol angiography</w>
cho ic
cho anal</w>
chloro form
chlordiazep oxide,</w>
chloralose- anesthetized</w>
chlor isondamine</w>
chlor ide-induced</w>
chl oral</w>
chil les</w>
chemotherap y;</w>
chemot actic</w>
chemo at
chemoat tractant</w>
chemist ries</w>
chemic als.</w>
chemic ally-induced</w>
chem ilumin
chelat or,</w>
chec k
characteris e</w>
char ybdot
ch os
ch im
ch asing</w>
cervic ogenic</w>
cervi x,</w>
certi fied</w>
cerebr al,</w>
cer uloplas
centr ally-
centr al)</w>
cent ).</w>
ceftazidi me</w>
cefoper azone</w>
cefazed one</w>
cefac lor
ce- daily</w>
ce mic</w>
catheter s,</w>
catheter isation</w>
cathep sins</w>
categor ies.</w>
categor ical</w>
categ ories:</w>
catal ase.</w>
catal ase)</w>
catabol ism.</w>
cat ap
cat abolic</w>
castr ation.</w>
casopit ant</w>
case- crossover</w>
cardio- respiratory</w>
cardio pathy</w>
cardio graphy</w>
cardio accelerator</w>
cardic ,</w>
cardia ,</w>
carcinogen ,</w>
carcin ogenesis,</w>
carboplatin- paclitaxel</w>
carboplatin /
carbam yl
car ami
capillari es,</w>
capill ar
cap ture</w>
cannab is,</w>
canc erous</w>
cam pt
calci um/
cal ab
cadher in</w>
ca erulein</w>
ca emia.</w>
c ubic</w>
c rescents</w>
c o</w>
c ing</w>
c GVHD</w>
butam ben</w>
bur sting</w>
bulim ic</w>
build ing</w>
buff er,</w>
bu fur
bu d</w>
bronchodilat ors</w>
brom ide.</w>
bro modeoxyuridine</w>
bro mazepam</w>
brie fl
bree der</w>
breath ing.</w>
breast -
bran ded</w>
brainst em,</w>
brad yp
bot ul
bortezomib -
bone- marrow</w>
blun ts</w>
blu e,</w>
block ;</w>
blind ly</w>
blac k,</w>
bl at
blat t</w>
birth- weight</w>
biphasi c,</w>
bio available</w>
bing e.</w>
bing e-
bim odal</w>
bil at.</w>
bifid a.</w>
bicucul line-</w>
bi polar
bi le,</w>
beta-lact am
beta-galactosid ase</w>
beta-end orph
beta-H SD</w>
beta- amyloid</w>
beta- agonist</w>
beta- adrenoceptor-mediated</w>
beta ,
bet agal</w>
benzyl penicillin</w>
benztrop ine.</w>
benz opyran
benz aprine</w>
ben flu
ben azep
belie f</w>
beg an,</w>
beats/ min
beat /
be vantolol</w>
be statin</w>
be lotec
be ds.</w>
barri ers</w>
baro reflex-mediated</w>
barbitur ates.</w>
bar rel</w>
bambuter ol,</w>
baical ensis</w>
bacter icidal</w>
bacter ia.</w>
bacte remia.</w>
back scatter</w>
bF GF</w>
b t
b out
b ob
b ites</w>
b id.</w>
b arb
b all</w>
b ad</w>
azos ulf
azep ine,</w>
azathiop rine-induced</w>
azathiop r
az imil
az elastine</w>
axon opathy.</w>
ax etil,</w>
awak ened</w>
awa ren
avoide d,</w>
avoid ance.</w>
avi d</w>
av lovian</w>
autop sies</w>
autop sied</w>
autonom ous</w>
auto antibody-positive</w>
auth ors.</w>
aut otrans
au gh
attention- deficit</w>
attempt s,</w>
attach ment</w>
attach ed</w>
atro phy
atro gen
atri enoic</w>
atracuri um,</w>
atipame zole</w>
ation ally</w>
ati ve/
ath ymic</w>
aten olo
ate- specific</w>
ate- adjusted</w>
at us</w>
at tain</w>
at ories,</w>
at omic</w>
asthmatic us</w>
asthmatic s.</w>
ast ronaut
ast e</w>
assay ed.</w>
ass ur
ass antin</w>
asparagin ase</w>
as e-induced</w>
as e).</w>
arvan il</w>
arti fact</w>
arthro scopic</w>
arthralgi as,</w>
arteriol es,</w>
arterio graphy,</w>
arteri al-
arteme ther
arous al.</w>
armament arium</w>
arg ued</w>
areflex ia,</w>
are ol</w>
arbit r
ar rang
ar ra
aqu ap
aquap orin</w>
approxim ated</w>
appropri ate,</w>
appl ied,</w>
apparen t,</w>
app ra
apoplex y.</w>
ap no
aort as</w>
aor to-
anxio gen
antiretrovir als</w>
antipy rine</w>
antipy rene</w>
antioxid ants.</w>
antioxid ant.</w>
antigen s.</w>
anticoagul ants,</w>
anticip ated.</w>
antibody -mediated</w>
anti- nuclear</w>
anti- nociceptive</w>
anti- myeloperoxidase</w>
anti- ischemic</w>
anti- eme
anti- diuretic</w>
anti- convulsant</w>
anti- cocaine</w>
anti- apoptotic</w>
anti- amnesic</w>
anti- TNF-alpha</w>
anti- MPO</w>
anti- L
anti- HIV</w>
anti tus
anti hypercalcemic</w>
anti hyperalgesia</w>
anti dystonic</w>
anti catatonic</w>
anti acetylcholine</w>
antagonist s:</w>
antagonist ).</w>
ant acids</w>
ant -like</w>
ans wer</w>
angiotens in
angio pathic</w>
ang les</w>
ang e</w>
anesthe tic
aneph ric</w>
anem ia;</w>
andro st
anatom y.</w>
anaphyl axis,</w>
analy zes</w>
analy sing</w>
analo g.</w>
an us</w>
an oxia</w>
an encephaly</w>
amyl ase,</w>
amphetamine- like</w>
amphetamine- group</w>
amperoz ide</w>
amp ren
amoxicillin/ clavulan
amoun ting</w>
amino- acid</w>
amino )</w>
amin ophylline
amin obut
amik acin.</w>
amide ),</w>
am ple</w>
am ex
am es
alumin ium</w>
altern ately</w>
alter ation,</w>
alpha- synucle
alpha- subunit</w>
alpha- actin
alpha- EMT
alpha- ,</w>
alpha(2)- adrenergic</w>
alpha 4</w>
allodyn ia/
allo wed.</w>
allergi es.</w>
all y;</w>
alin idine</w>
alfuz osin</w>
alfa- 2
aldehy de-
alcohol ism.</w>
al- prone</w>
al ol-induced</w>
al ol,</w>
al arming</w>
al -related</w>
ail -
agonist ;</w>
aggres sively</w>
aggres si
aggreg ated</w>
aggreg ate</w>
agene sis</w>
ag ulation</w>
ag ing,</w>
ag am
after load.</w>
afflic ted</w>
affin ity.</w>
affin ity,</w>
afferen ts,</w>
aff ir
advis able.</w>
adventi tial</w>
adv ance</w>
adultho od,</w>
adrenocortic otrophic</w>
adrenoceptor- blocking</w>
adren omedullary</w>
adren ergic,</w>
administr ation).</w>
adjust ed-dose</w>
adheren ce.</w>
adhe sion,</w>
adequ ate,</w>
aden otonsill
aden omyo
ade n</w>
addres sing</w>
addi tive.</w>
addi tive,</w>
ad y-state</w>
acut e/
acid- reactive</w>
acid A</w>
acid /
acid -treated</w>
acetyl enic</w>
acetyl codeine</w>
acetyl ators.</w>
accumb al</w>
accru al</w>
acc ess.</w>
ac rine</w>
ac hal
ac char
ac ampros
absc ess.</w>
abol ishes</w>
abol ished.</w>
abil ities,</w>
abdom en.</w>
ab ul
ab sten
a/ Tr
a/Tr an</w>
a ving</w>
a o
a ine-
a f</w>
a etiology,</w>
a defovir
a SAH</w>
a -associated</w>
[corrected ].</w>
[3H] flunitrazepam</w>
[2-(3,4-dichlorophenyl) ethyl]-
[11 C]
[ Mg2+
[ 2,3-
[ 1-1
Zol pidem</w>
Zin c</w>
Zangrad o</w>
Y 2</w>
X enopus</w>
Wilc ox
Wh ole-
Wh at</w>
Wech sler</w>
WR-10 65</w>
WIN 55,212-2</w>
WAY -100
W alk
W MH</w>
W ICH</w>
W D</w>
Vol unteers</w>
Vig il
Ver a/Tran</w>
Ventr ic
Vehic le
Vecur onium</w>
Vas odilat
Vari ation</w>
Val ve</w>
VT ).</w>
VR ).</w>
VPA -treated</w>
VL BW</w>
VG B</w>
V- t
V ic
V c
V O</w>
V M</w>
V IE
VIE W
V 1
Use fulness</w>
Uro lithiasis</w>
Ultrason ographic</w>
UL N</w>
UFP-1 12</w>
UF H</w>
UD S</w>
U/ L)</w>
U- 4
U su
U MB
Trop onin</w>
Triamte rene</w>
Tren delen
Trans mission</w>
Trans forming</w>
Tra it</w>
Thym us</w>
Thromb olysis</w>
Thor acic</w>
Thiaz ide</w>
Thalidom ide-induced</w>
Th orough</w>
Tex as</w>
Te li
Taiw an</w>
Tai pe
Tac rine</w>
TX A</w>
TT S</w>
TR K-
TP E</w>
TN P-
TMP-SM X.</w>
TM J</w>
TJ Ms</w>
TI s.</w>
TI MP</w>
TH A</w>
TGF beta1</w>
TF A-
TE O
TD F</w>
TD 50</w>
TC PO2</w>
TB V</w>
TAS K
TASK -1</w>
TA U</w>
T2 *</w>
T1- weighted</w>
T remor
T ras
T ot
T on
T gR[hAI]
T each
T aste</w>
T ail-
T V
T MTX</w>
T MA,</w>
T D,</w>
T AMI</w>
T )-induced</w>
Symptom s,</w>
Sup plementation</w>
Sulf on
Sulf asalaz
Subj ect
Sub clinical</w>
Streptozotoc in-induced</w>
Ste pwise</w>
Ste ady-state</w>
Spec tr
Spec i
Sp O2</w>
Smad 4</w>
Sle ep
Sixty- eight</w>
Simil arities</w>
Sil ent</w>
Si ri
Shakuyaku- kanzo-
Sh am-
Sem i-
Secon d-
Sci ence</w>
Sch u
Sch iff</w>
Scal e-
SUMMAR Y</w>
ST /
ST ).</w>
SSR I.</w>
SR-141716 A</w>
SR S
SR L,</w>
SR I</w>
SR 1417
SP -induced</w>
SN R</w>
SN A)</w>
SM-58 87</w>
SM IT</w>
SM 1</w>
SL M</w>
SI RM</w>
SI B</w>
SHB G</w>
SGO T,</w>
SERCA 2a</w>
SE VO</w>
SE RT
SERT (+)</w>
SE M
SD Z</w>
SD ),</w>
SC ,</w>
S- 3
S- (-)-
S t</w>
S hi
S ear
S cat
S aw</w>
S SS</w>
S LE.</w>
S LE,</w>
S CBF</w>
S -100</w>
Ry R
Rot aro
Ropi vacaine</w>
Rof ecoxib</w>
Ro enig
Ro 15-4513</w>
Rever sibility</w>
Ret t</w>
Res uscitation</w>
Remoxi pride</w>
Rel apse</w>
Reduc ing</w>
Re y
Re view
Re sistance</w>
Re produc
ROS- mediated</w>
RNA s</w>
RG 13
RE VIEW
RB V-induced</w>
RASSF 1A</w>
RA PA</w>
R- wave</w>
R- mediated</w>
R od
R iz
R ig
R h</w>
R W
R T.</w>
R SD</w>
R P,</w>
R M-
R ;</w>
R /
R (-/-)</w>
Quanti fication</w>
Qo L</w>
QT(F ram
QO L</w>
Q- NO
Q L</w>
Q B</w>
Q /
Pu er
Psych otic</w>
Protoc ol</w>
Prostagland ins</w>
Propofol ,</w>
Pro voc
Pro minent</w>
Pro lifer
Pro gest
Pro arrhythmic</w>
Predic tive</w>
Pot entially</w>
Pop ulation</w>
Po is
Place bo
Pilo t</w>
Pi ribe
Phent olamine</w>
Pharmaceutic als,</w>
Ph ot
Perme ability</w>
Per haps</w>
Pen ile</w>
Patient -controlled</w>
Pati ents,</w>
Pathophysi ology</w>
Parkinson ism,</w>
Par ap
Pap aver
Paclitax el,</w>
Pac ker</w>
Pa inful</w>
PV- immunopositive</w>
PT U,</w>
PT FC</w>
PT D</w>
PRL- secreting</w>
PRL- producing</w>
PNU-159 548</w>
PGE (1)</w>
PF T-
PF (11)</w>
PEP /LVE
PEP/LVE T</w>
PDE 4</w>
PDE 3</w>
PD- deficient</w>
PD N</w>
PD A.</w>
PCR ,</w>
PC r</w>
PB S</w>
PAN- nephrotic</w>
P=0.0 2).</w>
P= 0.01).</w>
P2X (7)</w>
P- 450
P(2 y
P v
P t</w>
P ol
P m(O
P i</w>
P c</w>
P avlovian</w>
P ase</w>
P W</w>
P PA.</w>
P OD
P M/
P ISE</w>
P CO
P 25</w>
P .
Ox ali
Out patients</w>
Ouab ain
Osmo tic</w>
Opio id-induced</w>
Ophthalmo logic</w>
On going</w>
On co
On ce-daily</w>
On -
Octre oti
Occa sion
OBJEC TIVE</w>
OAT- ICH</w>
OA c</w>
O- (2-
O ligo
O ZRs</w>
O PG</w>
O H.</w>
O B</w>
Normoten sive</w>
Nor way</w>
Nor plant
Nitrofur antoin</w>
Nit ro</w>
Nit rendipine</w>
Ninety- one</w>
Nigeri ans</w>
Neph rin</w>
Necro tizing</w>
Nec rosis</w>
Nec rop
Ne bivolol</w>
Nat ural</w>
Nar dostachys</w>
Naprox en</w>
Naltrex one</w>
Na+/ H+</w>
Na+- K+-ATPase</w>
Na(+)/ K(+)-ATPase</w>
Na(+)/ K(+)
Na(+)/K(+) ATPase</w>
NS- CAP</w>
NS VT,</w>
NS F.</w>
NR-AN X-C</w>
NO- synthase</w>
NO- cGMP</w>
NO( x)</w>
NO V
NMD A,</w>
NM S,</w>
NG Cp</w>
ND ST-1</w>
NC SE</w>
NC Q
NA SH
NA .</w>
NA ),</w>
N2 O/
N. OAc</w>
N-nitro sou
N-butyl- N-
N- nitroso-
N- ethyl
N- desmethyl</w>
N- S
N umb
N uclear</w>
N or-
N esac
N ac.</w>
N GF,</w>
N E.</w>
N CPH</w>
Muscim ol</w>
Mus carinic</w>
Mul tivari
MtTW 15</w>
Morph ine-induced</w>
Modafin il</w>
Mit o-
Mipa fox</w>
Mipa fox
Minnesot a</w>
Mill er</w>
Mil k-alkali</w>
Mid odrine</w>
Micro dialysis</w>
Meth ion
Metab otropic</w>
Mes angial</w>
Men ing
Medic ine</w>
Mean while,</w>
Me flo
Man ic</w>
Mal a
MTX- N
MT -
MSX- 3</w>
MR I-
MR -18
MP PA</w>
MMP- 9,</w>
MMP s</w>
MM SE</w>
MM F,</w>
MM ,</w>
MK- 9
MIT O</w>
MI ),</w>
METHOD OLO
MDMA/ THC</w>
MD S-
MD B</w>
MCP -1</w>
MB ),</w>
MA P
MA HA</w>
MA -treated</w>
M/ W
M obitz</w>
M ixed</w>
M ei
M az
M al</w>
M SO
M S)</w>
M PA,</w>
M ODE</w>
M LT</w>
Long- lasting</w>
Loc alized</w>
Limit ations</w>
Li -PC</w>
Lact obacillus</w>
Lact ate</w>
LY2746 14</w>
LY 23
LY23 59
LV -
LT E</w>
LOU/ M/W
LO X</w>
LO CM</w>
LN NA</w>
LMW- GAG</w>
LM s</w>
LID O</w>
LI TE</w>
LF P</w>
LEC TION</w>
LDL- C</w>
LC x</w>
L78 10</w>
L/ min</w>
L-NAME -induced</w>
L-AP 4</w>
L-701, 324</w>
L- tryptophan</w>
L- dopa
L- OH
L- NG-
L- Arg</w>
L- 5418</w>
L- 36
L ou
L PBN</w>
L P-S
L HL</w>
L H.</w>
L D)</w>
L CR
L As</w>
L AD.</w>
L 2,</w>
Kv 3.4</w>
Kine tics</w>
Ket amine,</w>
KR H-
KG )</w>
K er
K en
K anz
K ain
K a
K W</w>
K S</w>
K P
K OP
K O)</w>
K MgC
K F
KF 178
K A,</w>
K (i)</w>
Jerse y</w>
J oin
J T</w>
Ital y</w>
Ital y.</w>
Investig ators</w>
Intra ven
Interfer on-
Initi ative</w>
Inf usions</w>
Indometh acin-induced</w>
Indin avir
Inc ub
In troduction</w>
In testinal</w>
In hal
Immun ostaining</w>
Immun oblo
Imi pen
IT P</w>
IS DN</w>
INTERVEN TION</w>
IN R,</w>
IN H
IN ).</w>
IMP ase</w>
IMP PA</w>
IM L</w>
IL- 2,</w>
II a</w>
IFN- alpha2b</w>
ID .</w>
ICRF-18 7,</w>
IC V-
IC SS</w>
IC RF</w>
IC Ds</w>
I t
I sl
I ron</w>
I on
I lo
I c
I a</w>
I MI</w>
I HC</w>
Hyper tension,</w>
Hyper calciuria</w>
Hyper activity</w>
Hyp om
Hydroxy urea</w>
Hydr alaz
Hoxa 2</w>
Hormon e</w>
Hom er</w>
Histopath ologically,</w>
Hi sian</w>
Hep G2</w>
Hemodi lution</w>
Head -up</w>
He ad</w>
Ha emodi
HV PG</w>
HSP 47</w>
HLA-DR 3</w>
HIV/ HCV-coinfected</w>
HIT T
HE 6
HE6 E
HE6E 7
HD L2</w>
HC V,</w>
HC M</w>
HB V,</w>
HB .</w>
HAT T</w>
H-F ABP</w>
H- graft</w>
H- P</w>
H(3 )-receptor</w>
H(2) O(2)</w>
H s</w>
H TN
H MR-18
H A),</w>
H 76,</w>
H 3-
H 1-receptor</w>
H (3)</w>
H (2)-
Guide lines</w>
Grow th</w>
Grou p,</w>
Gold enhar</w>
Gold blatt</w>
Gol gi
Glybur ide</w>
Glut amic</w>
Glut am
German y,</w>
Gentam icin-induced</w>
Gener ally</w>
Gang li
Gall stones</w>
Gal -1</w>
GYKI- 23</w>
GY /
GTPgamma S</w>
GSK334 429</w>
GS SG</w>
GG T-positive</w>
GFAP- IL6</w>
GF P</w>
GF ),</w>
GA L-
G insen
G inkgo</w>
G est
G entac
G d</w>
G as</w>
G W
G S</w>
G C-
G AM
G )-
Fos -positive</w>
Fore arm</w>
Fluoxet ine,</w>
Fl ud
Fir st
Fin aster
Fibro scan</w>
Fi br
Femal es</w>
Fe der
Fas L</w>
Fas -
Farnsworth -M
Farnsworth-M unsell</w>
FSG HS</w>
FIO 2</w>
FH F,</w>
FE SS</w>
FD A-
FB AL</w>
F- actin</w>
F ur
F rontal</w>
F ri
F ram
F il
F gf8</w>
F el
F av
F OS</w>
F CR</w>
F BF</w>
F =
F 1,6
Exc ess</w>
Ex encephaly</w>
Evalu ations</w>
Eth osuxim
Estim ates</w>
Estim ated</w>
Erythro cyte</w>
Epo R-
Endotheli um-dependent</w>
Endot racheal</w>
Endoc rine</w>
En profylline</w>
Electrocardio graphy</w>
Electro physiology</w>
Eighty- six</w>
Eighty- five</w>
EVIDE NCE:</w>
ER ,</w>
EPO CH</w>
EPO ,</w>
EP s)</w>
EP C</w>
EP (4)</w>
EO s</w>
EMB -induced</w>
EM s</w>
EHX A</w>
EE .</w>
ED (50)
ECE -1</w>
EA E</w>
EA AT3/EAAC
EAAT3/EAAC 1</w>
E217 G</w>
E specially</w>
E sc
E s</w>
E picardial</w>
E jection</w>
E hrlich</w>
E ho</w>
E a
E PA</w>
E M</w>
E I
E BF</w>
E 2-17
Dox il</w>
Dofe tili
Disul fir
Dis soci
Dis semin
Dip yrone</w>
Diff usion-weighted</w>
Diff icul
Diar rho
Diar rhe
Di hydroxy
Dex -induced</w>
Determin ants</w>
Depres sion,</w>
Dep o-
Delta9- TH
Deli berate</w>
Delay ed-onset</w>
Def ects</w>
De pressed</w>
De fin
Datab ase.</w>
Dap tom
DYRK 3</w>
DX R-treated</w>
DTI C.</w>
DP -induced</w>
DO TAT
DO I</w>
DN QX</w>
DM N.OAc</w>
DM CM-induced</w>
DL B</w>
DG Cs</w>
DF X</w>
DF O-
DEX -treated</w>
DE K</w>
DE H
DB U</w>
DB H</w>
DAR PP-
D(2 )/
D ideoxy
D ental</w>
D SE,</w>
D PH,</w>
D M-
D K-35
D GF</w>
D G2</w>
D AIDS</w>
D A)</w>
D 2)</w>
D (1)-
D(1)- like</w>
Cr Cl</w>
Coun ty</w>
Coun cil</w>
Cortic otropin-releasing</w>
Correc tion</w>
Cor ti</w>
Cor ne
Contro l,</w>
Contrast -induced</w>
Concer n</w>
Con tramid</w>
Compar able</w>
Comb inations</w>
Com pulsive</w>
Com mon
Cocaine- exposed</w>
Coca ine,</w>
Co .,</w>
Cl ind
Cis -
Chin a,</w>
Chic ago,</w>
Ch allenge</w>
Centr ally</w>
Ceftriax one-associated</w>
Cef epime</w>
Cd k5</w>
Catech olamine</w>
Cardio respiratory</w>
Cardi oxane</w>
Cannab is</w>
Calcit onin</w>
Ca elyx</w>
Ca CO
Ca /
CYP2D 6.</w>
CYP2D 6
CX7 17</w>
CV PP</w>
CV P</w>
CV ,</w>
CV ),</w>
CS SA</w>
CS F).</w>
CS C</w>
CR F.</w>
CPU 228</w>
CP P,</w>
CP DG2</w>
CP -10
CP-10 1,
COX- 2-
COX -1</w>
COL LECTION</w>
CO RM-
CO ER</w>
CN A)</w>
CM F
CL Z</w>
CL L</w>
CL E</w>
CL 2</w>
CFM- 2</w>
CF SL</w>
CF R.</w>
CE F</w>
CD ZP</w>
CD P-induced</w>
CD 44</w>
CD 1</w>
CC K
CC 1</w>
CA s)</w>
CA T,</w>
CA ST</w>
CA PD</w>
CA B-induced</w>
CA 1.</w>
C57BL/6 J,</w>
C3 H
C- units</w>
C- terminal</w>
C tr
C s/
C rescentic</w>
C re
C old</w>
C il
C ervical</w>
C as
C anc
C T-
C R)</w>
C PA.</w>
C G)</w>
C CL2</w>
C 3.</w>
C 2,</w>
C 1
Bre wer's</w>
BrdU- labeled</w>
Braz il.</w>
Bra instem</w>
BoNT /
Bo wel</w>
Bet ter</w>
Bene fits</w>
Bay K-
Bart ter</w>
Bar re</w>
Bal ti
Baclofen ,</w>
Bac ter
BP H.</w>
BD100 8</w>
BD10 47</w>
BD K</w>
BCN U-exposed</w>
B ul
B rit
B onfer
B ilirub
B X
B UN
B SI
B E-
B E
B CVPP</w>
B CNU
B AM
BAM -1
B 8</w>
B -treated</w>
Azathiop rine-induced</w>
Az U
Atrac urium</w>
Ather osclerosis</w>
Asac ol</w>
App earance</w>
Antin uclear</w>
Anti thrombotic</w>
Antero grade</w>
Ano rex
Angio vist</w>
Anesthe tic</w>
An n
An algesi
Amphet amine-
Amiodar one-associated</w>
Aminoglyco side</w>
Amin o</w>
Alopec ia</w>
Aldo sterone</w>
Al though,</w>
Al a
Air way</w>
Agg ression</w>
Agg ra
Ag on
Ag matine</w>
Afric a,</w>
Adren omedullin</w>
Aden ocard</w>
Addi tive</w>
Ad junctive</w>
Aber rant</w>
Ab bot
ATP- dependent</w>
AT D-treated</w>
AT (1)</w>
AS A)</w>
AS /
AR C</w>
AQP 4</w>
AP I
AP H,</w>
AP 5</w>
AP ),</w>
AOA A.</w>
ANOV A,</w>
AN .</w>
AL F,</w>
AK AP
AID A</w>
AI T</w>
AH F</w>
ADR AC</w>
ADAMTS 13</w>
AD M.</w>
AD M-induced</w>
AD 00
ACTH -</w>
ACEi .</w>
AC (-
AB ,</w>
A/ Org</w>
A- H</w>
A(1) R</w>
A z</w>
A trop
A stro
A muno</w>
A micar</w>
A l</w>
A chilles</w>
A ST
A PD</w>
A O-
A H)</w>
A F,</w>
A AV
A A,</w>
A 5
A 2,</w>
A .
A -related</w>
> 10</w>
= 4</w>
= 3</w>
= 2</w>
</ =</w>
< 70</w>
< 0.0
99 9
93 129</w>
90- min</w>
90 107
90107 A/Org</w>
90 .</w>
9- month-old</w>
9 9.
9 8)</w>
9 7%,</w>
9 5,</w>
9 4.
9 2,</w>
9 +/-1
82.07 15</w>
80 %)</w>
8. 5,</w>
8-hydroxy-2-(di-n-propyl amino)tetralin</w>
8-OHD PAT</w>
8- wk</w>
8- phenyl
8- hydroxy-
8- cyclopentyl
8- amino
8- OH
8 8,</w>
8 77</w>
8 72</w>
8 7-year-old</w>
8 40</w>
8 );</w>
7810 94</w>
78 .</w>
78 %,</w>
75 %.</w>
70 5</w>
7. 8
7. 5-
7- oxo-
7- chloro
7 9%,</w>
7 8)</w>
7 62</w>
7 6)</w>
7 5).</w>
7 4)</w>
7 4%,</w>
7 27
7 26
7 2-
7 1)</w>
66. 7%</w>
61-80 48</w>
60 ;</w>
60 ).</w>
60 ),</w>
6. 4%</w>
6. 1%</w>
6- oxo-
6- /-</w>
6 9,</w>
6 8,</w>
6 8)</w>
6 8%)</w>
6 7),</w>
6 7%,</w>
6 6)</w>
6 44</w>
6 4-
6 3-
6 1,
5alpha- pregnan-20-
5HT 1A</w>
59 +/-
57 9</w>
57 ).</w>
56 999
55 9
55 1</w>
50,48 8H</w>
50 6)</w>
50 5</w>
50 +/-
5. 6%</w>
5-flouro uracil</w>
5-HT1 B/
5,7- DHT</w>
5 75</w>
5 1).</w>
5 0.0</w>
5 -1.
48- week</w>
48 ),</w>
45 ),</w>
40 116</w>
4. 8
4. 5;</w>
4-OH- CB
4- wk</w>
4- month</w>
4- hydroxy-
4- (3-
4, 5,
4 H
4 9,</w>
4 7-
4 7%,</w>
4 5%)</w>
4 40</w>
4 4).</w>
4 39</w>
4 36
4 34</w>
4 31</w>
4 3%,</w>
4 14</w>
4 1),</w>
4 -induced</w>
39. 5</w>
39. 3</w>
36 9</w>
36 %.</w>
36 %,</w>
35 7</w>
35 %.</w>
34 %,</w>
32P-post labeling</w>
30 min</w>
30 366</w>
3. 9%</w>
3. 8).</w>
3. 5)</w>
3. 5%)</w>
3. 4;</w>
3-methoxy-4- hydroxy
3- phenyl
3- nitrotyrosine</w>
3- month-old</w>
3 CR
3 500</w>
3 5.5</w>
3 41</w>
3 4),</w>
3 38</w>
3 34</w>
3 31</w>
3 3.3</w>
3 3%)</w>
3 26</w>
3 23</w>
3 22</w>
3 20/
3 2.6</w>
3 2.3</w>
3 15
3 1.</w>
3 1%.</w>
29 7</w>
29 6</w>
29 5</w>
29 1</w>
29 +/-
28. 7</w>
28. 6</w>
28. 4</w>
28 +/-
26. 6%</w>
26 9</w>
26 2</w>
26 %,</w>
25. 6</w>
25. 1</w>
25 +/-
25 (OH)
24 2</w>
2339 0.</w>
23. 7</w>
23 3</w>
21- item</w>
200 2-
20- 30</w>
20 mg</w>
2.0 5</w>
2. 8;</w>
2. 7;</w>
2. 7).</w>
2. 7%</w>
2. 58</w>
2. 4;</w>
2. 48</w>
2. 32</w>
2. 30</w>
2. 13</w>
2. 1,</w>
2-oxo thiazolidine-
2-chloro deoxyadenosine</w>
2-amino-7-phosphonoheptano ic</w>
2-amino-5- phosphono
2- month-old</w>
2- methyl-6-(phenylethyn
2- hydroxy
2- EE</w>
2- AAF</w>
2,3,4- tetrahydro
2, 6-di
2, 6
2 ],</w>
2 D</w>
2 D6</w>
2 C)</w>
2 2/
2 1st</w>
2 1.7</w>
2 1%,</w>
199 7-
198 9,</w>
198 7.</w>
19. 9</w>
19-00 5</w>
19 ;</w>
19 79</w>
19 70</w>
19 70
17. 7</w>
17 9</w>
17 53
16. 7</w>
16 %).</w>
15 55
15 +/-
15 %),</w>
14. 0</w>
14 C</w>
14 0
1393 17</w>
13. 8</w>
13. 0</w>
13- fold</w>
13- cis-RA</w>
13 5,</w>
12 9/
12 9)</w>
12 5-
12 -1
11. 4%</w>
11- dehydro
10. 3%</w>
10 mg/kg</w>
10 :1</w>
10 9/
10 1)</w>
10 (7)</w>
1/ 2-
1.0 9</w>
1.0 6</w>
1.0 3,</w>
1.0 1-1.
1. 9)</w>
1. 8%,</w>
1. 7-
1. 7,</w>
1. 67</w>
1. 4;</w>
1. 43</w>
1. 3;</w>
1. 23</w>
1. 20</w>
1. 15</w>
1. 14
1. 1.
1- wk</w>
1- day</w>
1- [2-
1- 8</w>
1- (2-
1,8-cine ole</w>
1,25-dihydroxy cholecalciferol</w>
1,25- (OH)(2)
1, 9
1, 600</w>
1 alpha</w>
1 S,3R-AC
1 R</w>
1 A.</w>
1 A)</w>
1 17)</w>
1 (
1 %);</w>
00 1).</w>
0.9 5</w>
0.9 1</w>
0.8 8</w>
0.8 %;</w>
0.8 %.</w>
0.7 ;</w>
0.7 0
0.6 0,</w>
0.4 3</w>
0.2 5)</w>
0.02 );</w>
0.0000 1).</w>
0.00 9).</w>
0.00 3),</w>
0.00 2),</w>
0.0 9
0.0 4),</w>
0.0 27).</w>
0.0 1;</w>
0.0 11</w>
0.0 1-
0. 4).</w>
0. 37
0. 18
0. 12).</w>
0. 10).</w>
0. 1)</w>
0-10 .</w>
0- 2</w>
0 5</w>
/ macrophage</w>
/ benefit</w>
.00 5)</w>
.0 7).</w>
.0 2),</w>
. 8
. 5.</w>
-16 ene-
-10 /
-1 9-
-1 6.
-- an</w>
- D</w>
,000/ cu</w>
, N-
+/-1. 3</w>
+/ -10</w>
+ ),</w>
)- 3-
)- 2</w>
)- 1</w>
(p< 0.001)</w>
(p >
(nACh Rs)</w>
(n= 7)</w>
(n= 15)</w>
(n= 10
(n= 1).</w>
(m ca
(i.c.v .),</w>
(i. c.)</w>
(i NO
(fMR I)</w>
(ara- C)</w>
(acetaminophen )</w>
(Y 56
(V R
(V )</w>
(U K
(TRPV 1)</w>
(TO F)</w>
(TD P)</w>
(T X
(T NF
(T G),</w>
(T F
(T CA)</w>
(T C)</w>
(SPEC T).</w>
(SCL C).</w>
(S NH
(S L
(S CO
(S CH</w>
(S CH
(S AM
(R- R</w>
(R T-
(R S)</w>
(R R),</w>
(R P)</w>
(Par lo
(PV N)</w>
(PR ),</w>
(PG s)</w>
(PE F
(PC R)</w>
(PAN SS)</w>
(PAN S
(P< 0.05</w>
(P< 0.0001)</w>
(P K)</w>
(P CP
(P CO
(P CNA)</w>
(P CI
(P AC)</w>
(P AC
(O CT
(O CD)</w>
(NY HA)</w>
(N e
(N S),</w>
(N P)</w>
(N N
(N K
(N C)</w>
(N AS
(N ,N-
(MT X).</w>
(MT D),</w>
(MM P-
(MM G)</w>
(METH )-induced</w>
(MD MA
(MA P).</w>
(MA DR
(M I),</w>
(M D)</w>
(LMW H)</w>
(LD L-
(L-NAME ),</w>
(L- NOAR
(IT B)</w>
(IQ R</w>
(IC H).</w>
(I (K
(HUS ).</w>
(HIV )-infected</w>
(HIT T
(HIT ),</w>
(HAM- D),</w>
(H b</w>
(H F)</w>
(H CC
(H 2
(GSH -P
(GF R),</w>
(GABA) A</w>
(GABA )-
(GABA (A
(G rade</w>
(G TN
(G GT
(G AD)</w>
(F SG
(ENa C)</w>
(EE G).</w>
(EE G),</w>
(ECo G)</w>
(EC G),</w>
(E m
(E ho</w>
(E T)</w>
(E G
(E 2)</w>
(DM CM),</w>
(DE S)-
(DE NA)</w>
(DE N)</w>
(D ose</w>
(D SE)</w>
(D P)</w>
(D MP
(D G)</w>
(Cy A)</w>
(CY )</w>
(CP Z)</w>
(CK- MB)</w>
(CF R)</w>
(CB F
(C3 H</w>
(C r
(C l
(C a)</w>
(C X
(C DD
(B u
(B W
(B P
(B DNF)</w>
(B CNU
(Am B)</w>
(AT P),</w>
(AT 1)</w>
(AL L).</w>
(A ugment
(A r
(A RB
(A NOV
(A K
(A IM
(A H
(9 9
(9 7.
(9 5)</w>
(9 1</w>
(8. 6</w>
(8 9%)</w>
(7. 6%)</w>
(7 9.
(7 5,</w>
(7 4%)</w>
(7 3</w>
(6 9.
(6 8</w>
(6 7</w>
(6 5.
(6 3%</w>
(6 3%),</w>
(6 0%).</w>
(5F U)</w>
(5-HT ),</w>
(5-HI AA)</w>
(5,7- DH
(5 9.
(5 8</w>
(5 7%</w>
(5 6</w>
(5 1%</w>
(4. 7%)</w>
(4. 0-
(4- amino
(4- D
(4- (2-
(4 9</w>
(4 7.
(4 5%),</w>
(4 4%</w>
(4 1%</w>
(4 %).</w>
(3. 1%)</w>
(3- chloro
(3 9%</w>
(3 4%),</w>
(3 3%),</w>
(3 1%).</w>
(3 1%),</w>
(200- 250</w>
(2. 0-
(2- 8</w>
(2 H)-
(2 A)
(2 8%),</w>
(2 7%).</w>
(2 5/
(2 4-
(2 3/
(2 1.4%)</w>
(2 1%</w>
(2 1%).</w>
(2 0/
(199 5)</w>
(14) C]
(125 )
(10- 300</w>
(1. 4%)</w>
(1. 2%)</w>
(1. 0-
(1- 4</w>
(1 H)-
(1 8/
(1 3
(1 28</w>
(1 23</w>
(1 2
(1 1.3</w>
(1 1%</w>
(0.1- 3</w>
(0.00 3-
(0.0 75</w>
(0. 2
(-1) );</w>
(- -
(- ))</w>
(+)- S</w>
( vehicle)</w>
( urinary</w>
( transient</w>
( tacrolimus)</w>
( superoxide</w>
( saline</w>
( respiratory</w>
( previously</w>
( percentage</w>
( particularly</w>
( nausea,</w>
( most</w>
( modified</w>
( moderate</w>
( lidocaine)</w>
( late</w>
( i.v.),</w>
( early</w>
( drug</w>
( d</w>
( class</w>
( both,</w>
( although</w>
( alpha
( absolute</w>
( above</w>
( L</w>
( F)</w>
( 0.05,</w>
( 0%)</w>
( %</w>
( %
' s,</w>
"high "</w>
"crack "</w>
"atyp ical"</w>
" 2</w>
{ 3-
zop iclon
zonis amide.</w>
zom epir
ziprasid one,</w>
zidovud ine-treated</w>
zicon otide</w>
zero .</w>
zero ,</w>
zalepl on</w>
zalcit abine</w>
z el</w>
ys ms</w>
yrin- G</w>
yr s</w>
yp e</w>
you ths</w>
ym ph</w>
yl-6- AzU
yl-6-AzU d</w>
yl- coenzyme</w>
yl ate.</w>
year s);</w>
yc in-associated</w>
y- like</w>
y rate,</w>
y po
y er</w>
xylaz ine-
x ia,</w>
ww w.
wri th
worth while</w>
work ers.</w>
wor ks</w>
wo od</w>
withdraw als</w>
withdraw al;</w>
wide ,</w>
wh or
wh ol
weight/ day,</w>
weig hed,</w>
week s:</w>
wean lings</w>
weak ening</w>
weak .</w>
we d,</w>
we aring</w>
we an</w>
wave forms</w>
wash es</w>
war tzman</w>
war med</w>
war d,</w>
wall- motion</w>
wal k.</w>
w rist
w ounds</w>
w ire</w>
w ing,</w>
w if
vouc her</w>
voric onazole.</w>
volum es,</w>
viv o-
vitre ous</w>
vit real</w>
viscer a</w>
visc ous</w>
vill i</w>
vigabat r
videotap ed</w>
victim ization</w>
vi sed,</w>
vi al</w>
vi ability,</w>
vesi coureteral</w>
verte bra
ventric ular,</w>
ventric ul
ventric u
ven tions</w>
veloc ity-
veloc ities,</w>
vehicle- controlled,</w>
vehicle /
vehic les</w>
ve- mask</w>
ve dac
ve -like</w>
vasodilat ors.</w>
vasodilat ors,</w>
vasoconstrict or.</w>
vasoconstric tors</w>
vaso relaxant</w>
vasculo genic</w>
variabl es:</w>
vari ance,</w>
valu es),</w>
valpro ate)</w>
valdec oxib</w>
val ve-mask</w>
vagin a,</w>
vacuol es.</w>
v l
v ing.</w>
v asive</w>
v a
v WF</w>
uter i</w>
ut ory</w>
ust at</w>
useful ,</w>
uro logy</w>
urk it
ure mia,</w>
ur onal</w>
ur idine.</w>
ur ide.</w>
ur gence</w>
ur aemia.</w>
ur aemia,</w>
up stream</w>
unusu al.</w>
unpredict ably</w>
univers ally</w>
unit s-
unit ary</w>
unit -
unilater al,</w>
unex plo
under scoring</w>
un treated;</w>
un suitable</w>
un stead
un selective</w>
un resolved</w>
un ds</w>
un diluted</w>
un conscious</w>
un competitive</w>
un coated</w>
un blinded</w>
umab .</w>
um s</w>
ultra- short-acting</w>
ul ty</w>
ul in
uct ured</w>
ub in
ubin ac</w>
u al
u LI
uLI F</w>
tyram ine,</w>
type -
two- way</w>
two- side
two-side d.</w>
two ;</w>
twenty- two</w>
tur t
tur ning,</w>
tun ately,</w>
tumori genicity</w>
tumor- promoting</w>
tubulo pathy</w>
tubulo pathy.</w>
tub es.</w>
tu ate</w>
trypt oline</w>
trough -
trough- concentrations</w>
trop ical</w>
troleandom ycin-induced</w>
troglitaz one.</w>
tris odium</w>
tris mus</w>
tris mus,</w>
tript yl
triple- binge</w>
trifluoper azine</w>
tricycl ics</w>
tricycl ic-induced</w>
tricho tillo
trich rome</w>
tric hom
tric arboxylic</w>
triazolo [1,5-
tri maz
trex ed</w>
trem end
tremend ous</w>
treatment s:</w>
treat s</w>
trazod one-induced</w>
traz ol-induced</w>
transpor ter
transpor ted</w>
transplant ation),</w>
transfer ase-mediated</w>
trans gene</w>
trans for
transfor aminal</w>
trandol april</w>
tramad ol/
trache ostom
trabecul ectomy</w>
trabected in</w>
tra enoic</w>
tr ying</w>
tr ade</w>
tox in-induced</w>
tor r)</w>
top otecan,</w>
top oside</w>
tom e
tome tr
tom a.</w>
tolu ene.</w>
tol azol
to x</w>
to o.</w>
to es</w>
to es.</w>
tive ;</w>
tissue- type</w>
tissu e)</w>
tion "</w>
time- of-
time- intensity</w>
tim ulation</w>
tim plantation</w>
tim es),</w>
til t.</w>
til t-induced</w>
tico -
tic les</w>
tic -associated</w>
ti vely.</w>
ti tu
ti tis</w>
ti tious</w>
ti prenolol</w>
thyrotoxic osis.</w>
thym id
thy mo
thrombocytopenia/ thrombosis</w>
thrombocytopen ia:</w>
thrombocytopen ia)</w>
thromb openia</w>
though ts,</w>
tho se,</w>
thirty- nine</w>
thioph ate</w>
thiop urines</w>
thion amide</w>
thio semicarb
thick ness.</w>
thick ening,</w>
thiazol -4-
thi osulf
thi omal
thi gh
thi am
thermo regulatory</w>
therapy- -a</w>
ther mic</w>
them orrhagic</w>
thalidom ide
thalass aemia</w>
thalam otomies</w>
thalam ic,</w>
th rice-
th ly</w>
th inning</w>
tetrofos min</w>
tetrap are
tetrahydro pyran
tetrahydropyran yl
tetraethyl ammon
tetan y.</w>
tetan us,</w>
test s).</w>
test :</w>
test -positive</w>
test -negative</w>
tert- butyl-
territ ories.</w>
termin ation,</w>
termin ates</w>
terg oline</w>
teratogen ic.</w>
ter pen
terpen oid</w>
tensi le</w>
tenofovir .</w>
tempor ary,</w>
tempo romandibular</w>
tem plate</w>
tem afloxacin</w>
telithrom ycin.</w>
teicoplan in.</w>
te zos
te l-
tel- Ha
te eth
te enth</w>
te a,</w>
taxan es.</w>
tast e,</w>
task ;</w>
target -controlled</w>
tap er</w>
tan g</w>
tailo red</w>
tail ,</w>
tachy phyl
ta il.</w>
t- [35S]
t ude</w>
t s).</w>
t ory</w>
t old</w>
t ann
t all</w>
t al,</w>
system ;</w>
system )</w>
syphil is</w>
synth ase-
syndrome ?</w>
syndrom es:</w>
syncop es</w>
syncop e:</w>
syn echi
symptom atically</w>
sympatho- inhibitory</w>
sympath omime
sympath ectomized</w>
swe et
swallow ing.</w>
sw ine.</w>
suspen sions</w>
suscepti ble.</w>
sur fact
supram axim
supramaxim al</w>
supra physiological</w>
supposit ories</w>
super saturated</w>
sup ine,</w>
sun burn</w>
sumatript an-induced</w>
sulind ac,</w>
sulfox im
sulfinpyraz one</w>
sulfate -17</w>
sulfasalaz ine-induced</w>
sulfasalaz ine,</w>
sulfadoxine- pyrimethamine</w>
sulf oxide,</w>
sulf one</w>
sul prostone</w>
suit ability</w>
suic ide.</w>
suffere rs</w>
suff ers</w>
sufentan il-
succ es
suc tion</w>
substra ins</w>
substitu ents</w>
substanti al,</w>
subst rates.</w>
subst rates,</w>
subject s;</w>
subject s),</w>
subject .</w>
subfiel ds.</w>
subcut aneously.</w>
sub thalamotomy</w>
sub tenon</w>
sub stitutes</w>
sub sides</w>
sub si
sub scales</w>
sub populations</w>
sub conjunctival</w>
su gar
sty rene
stud y).</w>
stud ent</w>
strict ures</w>
stri ps.</w>
streptozotocin- diabetic</w>
strength ens</w>
streng then</w>
streng th.</w>
str ative</w>
str and</w>
stomach s</w>
stoc k</w>
stimul i
stimul ation-
stimulation- evoked</w>
stimul ants,</w>
stiff ness.</w>
stereotax ically</w>
stereospec ific
stent ing,</w>
stent -assisted</w>
stem s</w>
stat in,</w>
star ch
standar d.</w>
stain .</w>
stachy a</w>
st ation
st al
stal k</w>
st age-specific</w>
st age-
sprout ing,</w>
spread ,</w>
spor ts</w>
spondy litis</w>
splen ectomy</w>
spiro cer
spik es,</w>
sphingomy el
sphinc ter
spher oids</w>
spectrophot ometry.</w>
speci es-
speci es
spec tra
spe ed.</w>
spas ticity.</w>
spas ticity,</w>
spas modi
spasmodi c</w>
spar se.</w>
sp ur
sp lot
sough t.</w>
son ogram</w>
somatosensor y-evoked</w>
som e,</w>
solub il
sol id-
sol di
sodium- depleted</w>
sniff ing.</w>
smooth- muscle</w>
smok ing-related</w>
sme ars</w>
slow s</w>
slow ing,</w>
sleep walking</w>
slee ve</w>
skill s,</w>
six fold</w>
sist er</w>
sis "</w>
sirolimus- eluting</w>
sirolim us-treated</w>
single- vessel</w>
single- fiber</w>
sin us,</w>
simple ,</w>
similar ly,</w>
sign als.</w>
sigma- receptors</w>
side- effect,</w>
sib ling
si es,</w>
si a/
shun ting.</w>
shrin k
showe d,</w>
shoul der-
shoulder- hand</w>
shorten s</w>
shorten ing.</w>
short-ter m/
shi p</w>
shi har
shak es,</w>
shad ow
sevent y</w>
ses sion)</w>
seroton erg
ser osal</w>
sequel a.</w>
septi cemia</w>
septi cemia.</w>
separ ating</w>
sep sis-induced</w>
sensori -motor</w>
sensor y,</w>
sensi tive
sens ations.</w>
sem ide</w>
self- report.</w>
self- rating</w>
self- limited,</w>
seleni um-deficient</w>
seizures ).</w>
seiz ing</w>
see king,</w>
see k
sedati ve/
sed ;</w>
sed /
sed/ refractory</w>
secretago gues</w>
second -</w>
se ts.</w>
scre w</w>
scrat ching,</w>
scopol amine),</w>
sclero therapy</w>
sclero sis:</w>
scl areol</w>
scar ring</w>
scann ing.</w>
scan ned</w>
scal e;</w>
scal e),</w>
sc ro
sc he
sc ,</w>
sati va</w>
sati v
sarcom as.</w>
sarcolem ma,</w>
salt- independent</w>
salsal ate</w>
sal ine),</w>
sa ve</w>
sa u
sP120 T</w>
s/ BW</w>
s- rubella</w>
s st
s pot</w>
s in.</w>
s apir
s ant</w>
s ad
s ]),</w>
s G145R</w>
rub idaz
rub bing</w>
rs 6
rs 16
rs16 947</w>
rs 112
rs112 73
rs11273 54</w>
rox ithrom
rot ation.</w>
ross over</w>
rose us</w>
rosace iform</w>
ros ophil
rosophil a</w>
ropivaca ine-induced</w>
ropivaca ine,</w>
romo phthalein</w>
ro se.</w>
riz ona</w>
riz atript
ritonavir -
ritod rine.</w>
ritod rine-induced</w>
risk ),</w>
ript ans</w>
rin ast</w>
rifug ation</w>
rifampic in-associated</w>
rifabut in-induced</w>
ribonucle ase</w>
ri monab
ri es,</w>
ri b</w>
rhabdomy osarcoma,</w>
rh uLIF</w>
rh H
reversib ility.</w>
retur ned.</w>
retro spect
ret ards</w>
resuscit ated.</w>
resul ted.</w>
restric ts</w>
restric tion,</w>
response :</w>
respon dent
respon d.</w>
respectively ].</w>
resp ired</w>
resour ces</w>
resor p
resistance ;</w>
resi sti
reservo ir
rescu e"</w>
res urgence</w>
res thesia</w>
repeti tion</w>
repeated ly.</w>
repair ,</w>
rep titious</w>
reorgan ization.</w>
ren z</w>
ren perone</w>
ren o
remoxipri de,</w>
remodel ing,</w>
remo ves</w>
remifentan il-induced</w>
rema ined.</w>
releas er</w>
relap sed/refractory</w>
relap sed,</w>
rel ent
reinstat ement.</w>
regul ated,</w>
regist ration</w>
region -specific</w>
reflexi ve</w>
refer ring</w>
reduced- function</w>
reduc tion;</w>
reduc tion/
reduc tas
reduc ed-dose</w>
red -dose</w>
recurren ce,</w>
recti fying</w>
recover .</w>
recor de
recor d.</w>
recommend ations,</w>
recommen ded,</w>
recogn ise</w>
receptor- positive</w>
receptor- binding</w>
receptor s:</w>
receptor -like</w>
receptor )</w>
recei ved.</w>
recei pt</w>
rec ted</w>
rec oll
rec apit
rec alcit
recalcit rant</w>
reassess ment</w>
reache d,</w>
re- treatment</w>
re vised</w>
re otide</w>
re mitting</w>
re instituted</w>
re initiated</w>
re infection</w>
re infarction</w>
re formulated</w>
re evaluated</w>
re considered.</w>
re appear</w>
re alized</w>
re activity.</w>
re )</w>
re 's</w>
ratio =
ratio :</w>
rate ;</w>
rata eg
rataeg us</w>
rapid- cycling</w>
rapid -onset</w>
rap idil</w>
raloxif ene,</w>
radio frequency</w>
radical- scavenging</w>
radi us</w>
radi opharmac
raclopri de,</w>
rabb it,</w>
ra ys</w>
ra re
ra j</w>
r-hu EPO</w>
r icul
r as</w>
r amp
r IFN
r FVIIa</w>
r =
quinupristin/dalfop ristin</w>
quinuclid inyl</w>
quinpi role,</w>
quinoxaline-2,3- dione</w>
quin one
quick ly.</w>
questionnai res.</w>
question able.</w>
quarti les</w>
quantit ate</w>
quanti fying</w>
quality-of- life</w>
qual ities</w>
qu oti
qu ili
quili brium</w>
qu at</w>
q d</w>
pyruv ate,</w>
pyram ids</w>
pyr amine</w>
pyeloneph ritis.</w>
py re
py k
pyk notic</w>
pursu it</w>
pur ification</w>
pur ch
punc tuate</w>
pul se-
pul p</w>
pter ygium</w>
psycho therapy</w>
psycho sexual</w>
psycho pathy</w>
psych otri
pseudo ephedrine.</w>
pseud ochol
pseudochol inesterase</w>
prur i
proxim al,</w>
prox il</w>
provo king</w>
provi sion</w>
prototyp ical</w>
proteinur ia:</w>
protein- bound</w>
protein- I</w>
protein ase</w>
prote olytic</w>
prote in-1</w>
prote ases</w>
prot on-
prot ective,</w>
prost ate-specific</w>
prost ,</w>
propyl ]-
propofol-M CT/LCT</w>
propofol- lidocaine</w>
propofol /
propag ation.</w>
propag ated</w>
pron eness</w>
promis ing.</w>
proli gest
progressive- ratio</w>
profoun d,</w>
process ing.</w>
probuc ol.</w>
prob es)</w>
pro- cataleptic</w>
pro viral</w>
pro ves</w>
pro lol,</w>
pro jec
primin g.</w>
primid one.</w>
press urized</w>
present ations,</w>
present ;</w>
prescho ol-
pres ses</w>
pres pec
prespec ified</w>
pregnanc ies.</w>
prednisol one-induced</w>
precurs ors</w>
pre- synaptic</w>
pre- natally</w>
pre- existent</w>
pre pa
pre loaded</w>
pre injection</w>
pre exposure</w>
pre drug</w>
pre dose</w>
pre cautionary</w>
pre admission</w>
praz iquantel</w>
pra vastatin.</w>
pow er,</w>
pow dered</w>
potenti ation.</w>
poster i
post- partum</w>
post- operatively.</w>
post- natal</w>
post- drug</w>
post- SE,</w>
post transfusion</w>
post pacing</w>
post nat
post induction</w>
post dosing</w>
post anesthetic</w>
post -</w>
possib le
posac onazole</w>
pos themorrhagic</w>
porphy r
population- based,</w>
popul ation:</w>
pon s,</w>
polyp epti
polymorph ism,</w>
poly po
poly pharmacy</w>
poly microbial</w>
poly angiitis</w>
poi kilo
podoc in</w>
pneumonia e.</w>
pmol/ mg</w>
pmol/ l</w>
pmol/ l)</w>
pmol/ 100</w>
pmol ,</w>
plo ts</w>
plex us,</w>
plethysmo graphy</w>
ple uro
ple kh
plekh h
plau sib
platelet- rich</w>
platelet- activating</w>
plaqu es.</w>
planne d.</w>
place b
pl ant,</w>
pituit ary.</w>
pit ting</w>
pit falls</w>
pinacidi l-induced</w>
pic ro
physici ans'</w>
physici an's</w>
physi cal
physical ,</w>
photo refractive</w>
photo damaged</w>
phosphor us,</w>
phosphon o-
phospho kinase.</w>
phosphati dyl</w>
phosph o-
phenylethan olamine-
phenylalan ine,</w>
phenyl- N-
phenyl)-4- methyl-
phenyl)- piperazin-1-
phenyl ]-
phenyl ]
phen e-induced</w>
phen e,</w>
phen di
phendi metraz
phen ,</w>
phase- II</w>
pharyng itis</w>
pharmacore sistance</w>
pharmac y.</w>
pharmac ist</w>
ph onic</w>
ph ase)</w>
pg/m L).</w>
pg/ g,</w>
person s,</w>
perphenaz ine,</w>
peris one</w>
peripher al,</w>
perioper atively</w>
perim es
perimes encephalic</w>
pericardi um.</w>
peri adolescent</w>
perg ill
pergill us</w>
perfor ation.</w>
perf usions</w>
perf us
per vasive</w>
per sever
per oral</w>
per ma</w>
peptide- (25-
pentylentetra zole</w>
pentylenetetrazol e,</w>
pentazoc ine.</w>
pentamid ine,</w>
pent enoic</w>
pent a
pem oline-induced</w>
pel let
peg- IFN</w>
peg yl
pedic el</w>
pedic el
pedi atricians</w>
pea k.</w>
pe tr
paw s.</w>
patholog ies,</w>
path ogene
path ogen</w>
patch es.</w>
patch .</w>
patch ,</w>
passive- active</w>
pas ses</w>
parturi ents.</w>
partic ular.</w>
paroxet ine-treated</w>
parkinson i
pariet o-
parieto- occipital</w>
parenchy ma,</w>
parathyroid ectomy</w>
paras ite</w>
parameter ,</w>
paralle ls</w>
paraesthe sia</w>
para dis
paradis cal'</w>
par kin</w>
par asi
parasi tic</w>
par an
par agu
paragu ari
paraguari ensis</w>
papillo ma</w>
papill ae</w>
paper s</w>
paper .</w>
panic ked</w>
panc reas
pan nic
pan ic.</w>
pan ames
pallid um</w>
pall or,</w>
pad .</w>
paclitaxel -associated</w>
paclitaxel -</w>
pa kine</w>
p< 0.05</w>
p< 0.01)</w>
p-coumar ate</w>
p- tyrosine</w>
p- p38</w>
p soas</w>
p s-rubella</w>
p l</w>
p kr
p 35</w>
p 11.
p /
oxygenase- 1</w>
oxy morph
oxy l</w>
oxy ]-
oxotremor ine.</w>
oxotremor ine,</w>
oxopiper azin
oxide- oxygen</w>
oxid ation.</w>
oxid ant
oxalo acetic</w>
oxac tam</w>
ox orubicin</w>
ox it
ow a</w>
overl ap
over load,</w>
over doses.</w>
ov orin</w>
output s</w>
our niqu
oun t</w>
oun is</w>
ou se
ou ma
oter idol</w>
ot rol
ot ax
osteo arthritis.</w>
oste olytic</w>
oste oc
osmolal ities</w>
osi s-like</w>
oscillo metric</w>
oscillat ory</w>
os timul
os m</w>
os in-induced</w>
os in,</w>
os cy
orrho ea,</w>
orph anol,</w>
orig inated</w>
organ ogenesis.</w>
orall y),</w>
or idine</w>
or gement</w>
opyri dine.</w>
optim izing</w>
opre valence</w>
opoi esis</w>
opo sterior</w>
opi om
opiom elan
ophthalmop legia.</w>
oper ate</w>
open ia.</w>
open er</w>
opamid ol</w>
opac ities</w>
op amine</w>
onych omy
ont 's</w>
ongo ing.</w>
oneur ial</w>
one- like</w>
onco logical</w>
onco gene</w>
once- per-
once- daily,</w>
on- line</w>
on ectomy</w>
on ce.</w>
omyeli a</w>
omycin- C</w>
olytic- uraemic</w>
ologist s.</w>
olog y:</w>
olip id</w>
olin -1
oligodeoxy nucleotide</w>
oligo hydramnios</w>
ole- board</w>
ole anolic</w>
ol- mediated</w>
ol ized</w>
ol itan</w>
ol dest</w>
ol d).</w>
ol d),</w>
ol amines</w>
oint ment.</w>
ograph ies</w>
ogen .</w>
ofur anos
offic e-based</w>
of :</w>
ocyto tic</w>
ocur onium</w>
oculo motor</w>
ocom pati
oclon ic</w>
ocil in</w>
ochromocyt oma</w>
ochond ria</w>
ochlo remic</w>
oce les</w>
occur red;</w>
occasion ally,</w>
ocal oric</w>
ocal ci
oc tahydro
oc rom
oc orm
oc ob
oc lo
oc lav
oc er
ob tain
ob romophthalein</w>
ob ia.</w>
ob er
o rous</w>
o proxil</w>
o plasmic</w>
numb er-
number- neede
number-neede d-to-
num eric</w>
novo "</w>
nortriptyl ine,</w>
normother mia</w>
normo kalemic</w>
normal ized,</w>
normal ization.</w>
norm als</w>
noradrenal ine-
nor floxacin,</w>
non- significantly</w>
non- protein</w>
non- nephrotoxic</w>
non- leprosy</w>
non- inferiority</w>
non- inducible</w>
non- enzymic</w>
non- dependent</w>
non- comparative</w>
non- cocaine</w>
non- Q-wave</w>
non surgical</w>
non smoking</w>
non responder</w>
non randomized,</w>
non peptide</w>
non parametric</w>
non irradiated</w>
non aspirin</w>
nom ogram</w>
nodul aris</w>
nocicept ors,</w>
noc ist
no se-
no de,</w>
nmol/min/ gm</w>
nmol/ l</w>
nitros obut
nitroglycer ine.</w>
nitrofuranto in,</w>
nitro- N-nitro
nitro-N-nitro so
nitrit e.</w>
nitraz ep
nimodi pine,</w>
nimesulide-beta-cyclodextr in</w>
nimesul ide-induced</w>
nicot in
nicoran dil,</w>
ng/m L;</w>
ng/m L).</w>
ng/m L),</w>
ng/ mg</w>
ng/ kg</w>
ng/ L;</w>
ng/ 5</w>
new- born</w>
nevirap ine-containing</w>
neutr alizing</w>
neurotransmit ter,</w>
neuron s;</w>
neuron s)</w>
neuro trop
neuro lept
neuro kinin</w>
neuro degeneration,</w>
neur itis.</w>
neur itis,</w>
neur alg
networ k.</w>
nest cage</w>
nes s)</w>
ner stone</w>
ner amex
nephron .</w>
nephrolith iasis:</w>
nephrolith iasis,</w>
neph ritic</w>
neph rin,</w>
neoplas m.</w>
neon ate,</w>
neocortex .</w>
nei gh
nedap l
nedapl atin</w>
necrop sy,</w>
necessit ates</w>
nebul ised</w>
near- normal</w>
ne t
ne doc
nedoc rom
ne ,</w>
narco sis.</w>
nar inone</w>
naph th
naltrex one,</w>
nalox on
nalbuph ine.</w>
nai ve,</w>
nafenop in</w>
n= 8),</w>
n- c
n-c b
n- 6</w>
n ude</w>
n s)</w>
n isoldip
n ine,</w>
n es</w>
n anom
nanom olar</w>
n androlone</w>
n amic</w>
n M.</w>
myoc ells</w>
myo fibroblasts,</w>
myelin olysis.</w>
mye los
myalg ia/
my onec
my ogenic</w>
mutis m.</w>
mut ation,</w>
muscle )</w>
mumol/ mg</w>
mumol/ L.</w>
mum ps-rubella</w>
multivari ate-adjusted</w>
multif ari
multifari ous</w>
multi plex
muc us</w>
moun t</w>
mother -
mosmol/ kg)</w>
mort alized</w>
morphine- 6-glucuronide</w>
morph ometry.</w>
mor ph</w>
month s:</w>
monos perma</w>
mononucle osis</w>
monom ethyl-
monolay er</w>
monocyte /macrophage</w>
mono- infected</w>
mono therapies</w>
monni era</w>
mon telukast</w>
mon ey</w>
molecul are</w>
mol es/
mol ar
mofetil .</w>
modific ations.</w>
mobil ization.</w>
mo tility.</w>
mo st,</w>
mo od-
mmol/ L;</w>
mm 3).</w>
mm 2)</w>
mm ),</w>
mm (3
ml/ min.</w>
ml/ min).</w>
ml. min-1</w>
mix ed,</w>
mitochondri al-
mis sense</w>
mis s</w>
mis leading</w>
mini- pump</w>
min(-1 )).</w>
min or
min -associated</w>
milrin one.</w>
mil itary</w>
mil d;</w>
migraineur s.</w>
migra inous</w>
middle- ear</w>
microscop ically</w>
micromol/ kg</w>
micromol/ L.</w>
micromol/ L,</w>
micrograms/m L.</w>
micrograms/ side)</w>
micrograms/ mouse)</w>
micrograms/ ml).</w>
micrograms/ min</w>
micrograms/ kg;</w>
microgram/ ml)</w>
microg/kg/ day)</w>
microg/ kg.</w>
microg/ 5</w>
microangio pathy,</w>
micro vasculature.</w>
micro stachya</w>
micro gnath
micro V)</w>
micro Eq/
mic onazole</w>
mg/m(2) ).</w>
mg/m l.</w>
mg/kg/ hr</w>
mg/kg )+
mg/d L);</w>
mg/(kg. d)</w>
mg/ week</w>
mg/ l)</w>
mg/ L).</w>
mg. kg/day</w>
mez locillin</w>
methylprednisol one-treated</w>
methylenedi oxy-
methyl atropine,</w>
methy lox
methohexit one.</w>
methodo logical</w>
methemoglob inemia,</w>
methcath inone</w>
methazol amide.</w>
methad one-treated</w>
methad one's</w>
meth iaz
metfor min-induced</w>
mete red-dose</w>
metabol ism:</w>
meta iodobenzyl
met all
metall ic</w>
met -
messen g
mesotheli oma</w>
mesal amine</w>
mes or</w>
merbar one,</w>
ment :</w>
men tions</w>
men tioned.</w>
melphal an.</w>
melaton in-
medic ations;</w>
medic ally.</w>
medetom idine.</w>
mechano- insensitive</w>
mechano- allodynia</w>
mec onium</w>
measure ment
meas l
measl es-
measles- mumps-rubella</w>
me x
me th</w>
me ters</w>
me ter,</w>
me pyramine</w>
me f
mef antr
mefantr ine</w>
me al</w>
matur ity</w>
matric es</w>
mater nally</w>
mas quer
mariju ana-dependent</w>
manson i.</w>
mane b</w>
man ic-like</w>
malathi on</w>
mala oxon</w>
mal function</w>
mal e;</w>
magnitu de.</w>
magnitu de,</w>
macroglobul inemia</w>
mach ines</w>
mac ul
mac hin
mac /
ma )</w>
mL/min/ 1.73</w>
mL/ minute/
mGlu 7</w>
mEq/ liter</w>
mEq/ l</w>
mEq/ l,</w>
mEq/ kg)</w>
m- chloro
m rp2</w>
m oxalactam</w>
m it</w>
m ap
m To
mTo R</w>
m L).</w>
m CPP</w>
m .,</w>
m 's</w>
lyso zym
lymphoplas macy
lymphadeno pathy.</w>
ly sin
ly ),</w>
lu mefantrine</w>
low- birth-weight</w>
low n</w>
loracarbef -treated</w>
lop ent
lop amil</w>
longitud inal,</w>
longer- lasting</w>
long- ter
long us</w>
long er
longer -term</w>
log ists</w>
log ically</w>
log ic,</w>
locy tic'</w>
locomot or-
local ,</w>
loc us.</w>
loc king</w>
loc ations,</w>
lob es,</w>
lo must
lo co
lixim ab</w>
liver s.</w>
liver -cell</w>
lithium 's</w>
lith iasis,</w>
liter ).</w>
lis uride,</w>
linezol id-induced</w>
line arity</w>
lind ers</w>
lin comycin</w>
limit ing,</w>
limb ic,</w>
lim on
ligi ble,</w>
ligh ts</w>
ligh t,</w>
lifesty le</w>
life- saving</w>
lie f</w>
lidoca ine/
libit um.</w>
li tis,</w>
li gam
levonorgestrel .</w>
levodopa/ carbidopa</w>
levodopa -treated</w>
levo simendan</w>
levo bupivacaine.</w>
level and</w>
leupro relin</w>
leuk ostasis</w>
leuk ocytopenia</w>
leuk ocytes.</w>
leuk aemia,</w>
leucovor in,</w>
letharg ic</w>
lethal .</w>
less -
lesion ed,</w>
ler can
lercan idipine</w>
length-of- stay</w>
leng th.</w>
lead -in</w>
latanoprost -
latanoprost- timolol</w>
lat ency
las er-induced</w>
laparo scopy.</w>
lan reotide</w>
lamotrig ine.</w>
lamivud ine-induced</w>
lamin ae</w>
lam b
lagg ed</w>
lad ders</w>
lact ation.</w>
label ing,</w>
l-N NA</w>
l in,</w>
l ax
l aur
l aden</w>
l -</w>
kra in</w>
knock- in</w>
kne es</w>
kn ech
kine tics,</w>
kind ling,</w>
kinase- MM</w>
kilogram ,</w>
kil led.</w>
kidney- transplant</w>
ki ren</w>
kg/ min)</w>
ketorolac .</w>
ketorolac ,</w>
ketocon azole,</w>
ket amine/
kerato pathy</w>
ker t</w>
ke y
ke ph
kallikre in-
kain ate,</w>
kHz ,</w>
kD a,</w>
kD a)</w>
k D,</w>
junc tion,</w>
jun -B</w>
ju ice</w>
jer ky</w>
jeop ardized</w>
jaw -
ization- activated</w>
ix is,</w>
ivoc al.</w>
ity- related</w>
iti s)</w>
it u
it ro
istr y,</w>
istr uctured</w>
ist ing</w>
issu es,</w>
issu ed</w>
isoxsup rine</w>
isob olographic</w>
is ocaloric</w>
is oc
is m)</w>
is ke</w>
is axon
is )</w>
irrit ability.</w>
ir reversible.</w>
ir regularity</w>
ir ing</w>
ir ac
ip sapir
ip ran
iox il
ion s.</w>
investig ators.</w>
invent ory</w>
inv ited</w>
inv alu
invalu able</w>
intub ated,</w>
intro duce</w>
intrapl ant
intraperitone al)</w>
intrac avitary</w>
intra- articular</w>
intra- accumbens</w>
intra- abdominal</w>
intra vitreal</w>
intra renally</w>
intra individual</w>
intoxic ation:</w>
intim ately</w>
interview ing</w>
interval ;</w>
interval -
interval ),</w>
interstiti um.</w>
intermedi olateral</w>
interfer on/
interfer on-induced</w>
intercros s.</w>
inter- individual</w>
inter vie
inter vertebral</w>
inter ru
inter patient</w>
inter nal
inter face</w>
inter cross</w>
intensivi sts</w>
inten sit
integr in-
inte restingly,</w>
insul a,</w>
insuff lation</w>
institution alized</w>
inser ts</w>
input s.</w>
inosit ol,</w>
injur y-induced</w>
injec tion-
inj ure</w>
initi s,</w>
inh abit
ing ,"</w>
infu sion-
influenz a-like</w>
infl icted</w>
infin ity).</w>
infec tion
infarc tion)</w>
infarc tion
infanc y,</w>
inf ran
inf inity</w>
ine- 2-
ine th
ine mia-induced</w>
ine d:</w>
ine ],</w>
ine -1-
induc i
indo bu
indic es,</w>
inclu sions.</w>
inci sion,</w>
in- utero</w>
in- patients.</w>
in- derived</w>
in stitut
in significant.</w>
in sensitivity</w>
in s)</w>
in patients.</w>
in patients,</w>
in ofuranos
in ocyte</w>
in i</w>
in es
in consistently</w>
in conclusive.</w>
in ception</w>
in avian</w>
in attention</w>
in )-induced</w>
in (1-13)</w>
impl an
immunosuppress ant,</w>
immunoprecipit ation</w>
immuno histological</w>
immune- complex</w>
immigr ants</w>
immer sed</w>
imin odi
imidazole- 4-
imid april</w>
ime tics</w>
im purity</w>
im mortalized</w>
illu strative</w>
ili itis</w>
ile um.</w>
il itation</w>
il ),</w>
ifol ia</w>
ific ation,</w>
ifeprist one</w>
ido sis,</w>
idiopath ic,</w>
idine dione</w>
ide- sensitive</w>
id ose</w>
id ine-treated</w>
id anosine</w>
id -</w>
ich -
icalcit ol</w>
ic o</w>
ic aine</w>
ic -related</w>
ic '</w>
iber i
ia -associated</w>
i.t .).</w>
i.p. );</w>
i otrol
i es;</w>
hypox emia.</w>
hypox emia,</w>
hypoton y</w>
hypoten sive,</w>
hypoten sion).</w>
hypopituit ar
hypophys ectomized</w>
hypophy seal</w>
hypop nea</w>
hypoman ia/
hypom ag
hypomag nes
hypocal ci
hypocal caemia</w>
hypo kinetic</w>
hypo function</w>
hypo algesic</w>
hypno sis,</w>
hyperpolar ization-activated</w>
hyperkine sia,</w>
hypercholesterol emic</w>
hypercap nia,</w>
hyperammon aemia</w>
hyper somnolence</w>
hyper responsiveness</w>
hyper responsive</w>
hyper magne
hyper hydration</w>
hyper glyc
hyper acute</w>
hyper activation</w>
hydroxyure a-associated</w>
hydroxyfas udil</w>
hydroxyeicos ate
hydroxyeicosate traenoic</w>
hydroly zed</w>
hydraz ide</w>
hydra ulic</w>
hyd ant
hydant oin
hybridiz ation,</w>
hyalin osis</w>
hyal uron
hr -1</w>
hr ).</w>
howe ver.</w>
hous ing</w>
hospital ized,</w>
hormone- binding</w>
hor se</w>
hor n,</w>
homo sexual</w>
hom olog
hom ogenous</w>
ho locytic'</w>
ho dg
hodg kin
histor ies.</w>
hist ological,</w>
hist olog
hist ochemistry.</w>
hist o
his tid
hippocam pi
hind paw.</w>
hind limbs</w>
hil us,</w>
highligh ting</w>
hid onic</w>
hexa hydro
hex o
heterozyg ote</w>
heterozyg osity</w>
heter ogenous</w>
hepatocell ular-
hepatitis ;</w>
hepat otox
hepat osplen
heparin- coated</w>
hepar in-dependent</w>
hemisphe res,</w>
hemianop ia</w>
hematopoi esis.</w>
hemat oxylin</w>
hemat omas,</w>
hem i-
hel per</w>
heart- to-body</w>
heart- rate</w>
heart beat</w>
heal ing.</w>
headache :</w>
headache )</w>
har maline-induced</w>
hand ling,</w>
halothane/ epinephrine</w>
haloperidol +
half- life.</w>
half- li
haemat uria.</w>
haemat ocrit</w>
ha sten
h op
h ole-board</w>
h CG</w>
h BNP</w>
h .
h -1)</w>
h -
guinea- pigs</w>
guide d,</w>
guan ylyl</w>
guan idine,</w>
group s.(ABSTRACT</w>
group );</w>
gro und</w>
greml in</w>
great er,</w>
gre w</w>
gravis :</w>
grap e</w>
granulo mas.</w>
granulo ma.</w>
grani setron,</w>
gran ulosa</w>
gram -positive</w>
gradu al,</w>
gra ve</w>
gose relin</w>
gonad otroph
gol d-
go it
glycosaminoglyc ans</w>
glyc yl
glyc ol,</w>
glutar ate</w>
glutam yl</w>
glucuron ide,</w>
glucos uria</w>
glucagon .</w>
glomerul us,</w>
glomerul ar,</w>
gli osis,</w>
gl y,</w>
gl ustat</w>
gl ue</w>
gl u
gl c</w>
gir l,</w>
ginsen o
ginsen g,</w>
genotyp e,</w>
gene tics</w>
ge ometry</w>
gati floxacin</w>
gangli osides</w>
gang ren
gamma-glutamyl transpeptid
gamma-glutam yl-
gamma- aminobut
gamma- HCH,</w>
gamma ENaC</w>
gambl ing.</w>
gambl ing,</w>
gall bladder,</w>
galact orrhea,</w>
gadodi amide.</w>
gad oteridol</w>
ga it.</w>
g/d L,</w>
g/d L).</w>
g/ liter</w>
g p)</w>
g ates</w>
g allo
g -1).</w>
fut ure,</w>
fur a-
function ed</w>
full -dose</w>
fu gu
fraction ation</w>
frac tions,</w>
frac tion)</w>
fr uctose</w>
four- month</w>
four th-
fosf amide</w>
foscarne t,</w>
formal in-
form ations</w>
forced- swim</w>
for ti
for ce.</w>
for ce,</w>
follow s.</w>
fol ded</w>
fol d).</w>
fo am</w>
fo am
foam y</w>
flup irt
fluoro meth
fluc onazole,</w>
flu -
flow s,</w>
flow ers</w>
flow )</w>
flick er</w>
flex ure</w>
flash es</w>
fl ash</w>
fl aps</w>
fit ted</w>
first- generation</w>
first -</w>
fir m
fing er
filtr ation,</w>
fill ing.</w>
fig uring</w>
fig ure</w>
fiel ds,</w>
fic ations</w>
fibros ing</w>
fibro blastic</w>
fib rate.</w>
fet u
ferri oxamine</w>
fer oxamine</w>
fenoldop am,</w>
fen amic</w>
fen -
felodip ine.</w>
fel ine</w>
fec al</w>
fe w,</w>
famoti dine.</w>
fal lop
fail ures.</w>
f used</w>
f ]
f VIII</w>
ez ing,</w>
extremit y,</w>
extrap ulmonary</w>
extra- adrenal</w>
extra ocular</w>
exten s
expos ing</w>
explan ation.</w>
exercis ing</w>
exencephal y.</w>
exempl ified</w>
excit otoxicity.</w>
exc rete</w>
exc ess,</w>
exam s</w>
ex o</w>
ex ic</w>
ex haled</w>
ex changes</w>
ex anth
ex act
exact ly</w>
ex .</w>
evid ently</w>
ever y
evalu ations.</w>
evalu ated:</w>
evalu able,</w>
eu volemic</w>
eu ph
etomid ate-
etiolog ies,</w>
ethyl- 5-
ethyl ene,</w>
ethyl )
ethopropa zine,</w>
ethanol -</w>
eth mo
etan idazole</w>
et c.</w>
et c.
et 's</w>
estrogen -dependent</w>
estim ations</w>
est r
est er.</w>
est .</w>
ess ness</w>
esmo lol,</w>
es tic</w>
es otropia</w>
es erine</w>
es citalopram
erythroder ma,</w>
erythro cytic</w>
erythro blasts</w>
erup tions,</w>
erron eous</w>
erron e
errone ously</w>
ergot amine.</w>
erdo steine</w>
eradic ated</w>
er- 344</w>
er tap
er s)</w>
er ian</w>
er a,</w>
equ ation.</w>
ept ors</w>
epoxy eicos
epoxyeicos atrienoic</w>
epinephr ine-treated</w>
epinephr ine)</w>
epileptic ,</w>
epilepsy -related</w>
epidermi di
epider moid</w>
epid urally</w>
epi -
ep och
ep ist
enure sis.</w>
enucle ated</w>
entra in
entr y,</w>
ent ers</w>
ent ail
ent "</w>
eng orgement</w>
ene -1-
endothelin -1,</w>
endothel in-converting</w>
endosulf an</w>
endogen ously</w>
endocrin ological</w>
end otoxic</w>
end oneurial</w>
end olym
end ar</w>
encounte red,</w>
encomp asses</w>
encomp ass</w>
ence -
enantiom ers.</w>
en- 3-
en yl</w>
en velop
en th
en sis,</w>
en qu
en -associated</w>
en )</w>
emo zolom
emerg ed.</w>
embryo .</w>
em ic,</w>
em -
ell ing</w>
ell ed</w>
elimin ated.</w>
electrophysi ological,</w>
electrophore sis,</w>
electromyo graphy.</w>
electrom echanical</w>
electrocortico gram</w>
electrocardio graphy.</w>
electro retin
electro grams</w>
electro des,</w>
electro clinical</w>
ele ments.</w>
el .</w>
el -
eg g</w>
efficaci ous,</w>
effect ing</w>
effect ).</w>
efavi renz
ed- in</w>
ed ?</w>
ect in.</w>
echocardiograph ic,</w>
echocardio grams.</w>
eb selen</w>
ear -
each ;</w>
eIF 2
e- N
e- 1</w>
e uc
e li
dysrhyth mogenic</w>
dysph asia</w>
dysp noea,</w>
dyskine tic,</w>
dysfunction )</w>
dys chromat
dyschromat op
dynorph in(1-13)</w>
dynes/cm 5,</w>
duloxet ine,</w>
drowsin ess.</w>
drow sy</w>
drop s,</w>
drin king.</w>
driman ial</w>
dres sing</w>
dre ams</w>
draw ing</w>
draw bac
dr icaine</w>
dp/dt max</w>
doxorubic in;</w>
doxorubic in-associated</w>
doses ),</w>
dose- escalating</w>
dos age-
dorsal is</w>
dopamine- dependent</w>
dopamine- beta-hydroxylase</w>
dop amine-induced</w>
donepez il.</w>
don ors,</w>
don or.</w>
don or)</w>
dog s).</w>
dofetili de,</w>
do -
dl- propranolol</w>
diver gent</w>
dit e
disten tion</w>
dist ances</w>
disru p
dispar ate</w>
disorgan ization</w>
disorder s;</w>
disease- related</w>
diseas e
dise quilibrium</w>
discus sion.</w>
discrimin ating</w>
discour aged</w>
disc retion</w>
dis section.</w>
dis placing</w>
dis plac
dis oproxil</w>
dis odi
dis figuring</w>
dis appearing</w>
dis advant
dipyridamole- echocardiography</w>
dipyridamol e/
diplop ia,</w>
diphenyl acetoxy-
diphen yl</w>
dimen sions,</w>
dil uting</w>
dil ation.</w>
diisopropyl phosphorofluoridate</w>
dihydro tachy
digitalis -
digit ox
dig estion</w>
difluoro methyl
difficul t-to-
difference ).</w>
diethylcarbam azine</w>
diet s,</w>
dideoxy inos
dichlorodiammine platinum</w>
dichloro diphenyl
dichloro -
dic arbox
dic arb
diast ol
diaphrag m,</w>
diaphore sis</w>
diameter s/BW</w>
di valent</w>
di v
di tion</w>
di thio
di quat</w>
di propionate</w>
di oxide.</w>
di olol</w>
di morphism</w>
di meth
di enes</w>
di encephalon</w>
di acetate</w>
di -
dextror phan</w>
dexamethas one)</w>
develop ed;</w>
dev oted</w>
determin ants.</w>
deterior ate</w>
detail ing</w>
destro ys</w>
desc ent</w>
des pair</w>
des flurane-induced</w>
des butyl
derang ed</w>
depression -related</w>
depress ants</w>
depres si
deple ted,</w>
depend ent)</w>
deoxycorticoster one-
deoxy ribonucleic</w>
dens a</w>
denerv ation,</w>
den ud
den omin
demeclo cycline.</w>
deman d,</w>
delta- aminolevulinic</w>
delta- ALA-D</w>
delta -opioid</w>
deli an</w>
del usions.</w>
defini tion.</w>
def ascicul
decongest ant</w>
decom pression.</w>
decid ing</w>
deci sive</w>
decentr alized</w>
dec line
dec ide</w>
deaf ness,</w>
de st
de sensitized</w>
de l</w>
de ionized</w>
dd Y</w>
dd I.</w>
dd I)</w>
days/ week</w>
daptom ycin.</w>
danger ous.</w>
dam ,</w>
dail y;</w>
da ,</w>
dP/dt max,</w>
dP/dt (max)</w>
dP/dt (max))</w>
dP/d T</w>
dF Urd</w>
d4 T-
d- positive</w>
d- chain</w>
d ronedar
d b</w>
d G</w>
d B.</w>
d .(ABSTRACT</w>
cytox an</w>
cytoplas m,</w>
cytopen ias</w>
cyto static
cyt ometry,</w>
cystometro grams</w>
cystin uria.</w>
cyclo oxygen
cyclo benzaprine</w>
cycl ing.</w>
cycl ic-
cycl ase-
cyan ocob
cur cu
culmin ating</w>
cue- elicited</w>
crystal lization</w>
cryst als,</w>
cryst allo
cry os
criter i
creat ing</w>
cre ation</w>
cre a)</w>
cranios chisis</w>
crani ospinal</w>
cramp ing</w>
cour ses)</w>
couple ts</w>
cough .</w>
cot ton</w>
cost s,</w>
cortis one,</w>
cortis ol
corticoster one,</w>
cortico -
cortex )</w>
correl ates.</w>
correl ated.</w>
cor nerstone</w>
copies/ ml</w>
cop ing</w>
convul sion,</w>
conver ts</w>
controversi es</w>
control s),</w>
contracepti ve,</w>
contra -
contig uous</w>
cont ention</w>
cont act.</w>
constric tions</w>
configur ations</w>
conf ron
condu it</w>
conclu sions.</w>
conclu des</w>
conclu ded,</w>
concept ual</w>
concentration s;</w>
conce pts</w>
con formed</w>
con e</w>
con ception</w>
con cep
compromi sed.</w>
complic ations;</w>
complic ation
comple ment.</w>
compens ates</w>
comparison s,</w>
compar able,</w>
compa red:</w>
comp ut
communic ation.</w>
communic ation,</w>
commun ity.</w>
commun ities</w>
colo ured</w>
collap se,</w>
collag ens</w>
coll ectively</w>
col or
col ic,</w>
col d,</w>
cocaine/ crack</w>
cocaine- primed</w>
co-trimox azole.</w>
co- ordination</w>
co- morbid</w>
co ved</w>
co localization</w>
co b
co al
cm 2)</w>
cm -
clum siness</w>
clu stered</w>
clu ster
closu re,</w>
clorg yline</w>
clon es</w>
clofib rate-treated</w>
clo trimaz
clo sed.</w>
clio quinol
clinicopath ological</w>
clef ts,</w>
clear ances,</w>
cle are
classi fication.</w>
clas ses,</w>
clar ification</w>
clar ification.</w>
clamp ed</w>
cl ub
cl aud
claud ic
cit ric</w>
cisplat inum</w>
cisplat in-</w>
cirrho tics</w>
circuit .</w>
cir cle</w>
cilost azol,</w>
chromat ography,</w>
chro ma
chondro itin</w>
cholinester ase.</w>
cholin omime
cholester ol/
chlorthalid one,</w>
chlorozotoc in.</w>
chlorofluoro carbons</w>
chloro procaine.</w>
chloro procaine,</w>
children )</w>
child bearing</w>
chick en
chemotherapy- related</w>
chemoradi ation</w>
chemic als,</w>
che mon
che d-chain</w>
chang es;</w>
chang es:</w>
chang e:</w>
chamb ers</w>
chamb er,</w>
challenge d.</w>
ch itosan</w>
ch atter
ceruloplas min</w>
ceriv astat
cerebel lo
cephaloth in,</w>
cephalex in</w>
centr al,</w>
cent res.</w>
cellul itis.</w>
cell /
celi ac</w>
cefuro xi
ceftriax one-treated</w>
ceftriax one-dependent</w>
ceftazidi me,</w>
cefotet an,</w>
cefoper az
ceas ed,</w>
ce in</w>
catechol-O- methyltransferase</w>
catap lexy</w>
case- patients</w>
casca de.</w>
cas pofungin</w>
cas ein</w>
cas eating</w>
cartilagin ous</w>
carrageen in-induced</w>
carmo fur</w>
careful ly.</w>
cardiover sion,</w>
cardiomyopath y;</w>
cardiomyo plasty.</w>
cardiomegal y,</w>
cardio selectivity,</w>
carboxyl ate)</w>
carboxamido adenosine</w>
carbox yp
carbim azole,</w>
carbamazepine -10,11-
carb oxy-
carb ocrom
car pi</w>
capt ured</w>
capsaic in-</w>
cap ability</w>
cannul as</w>
cannab idiol</w>
cancer )</w>
calmodul in</w>
calcul ating</w>
calcitri ol-induced</w>
calcific ations.</w>
calab ura</w>
cal losal</w>
cal endar</w>
caffe ine's</w>
ca regi
ca emic</w>
cGM P-
c y,</w>
c ubital</w>
c p
c ),</w>
butyl ]-
but orphanol,</w>
but ano
busulf an,</w>
burn t</w>
bur ns</w>
bur gh</w>
bur g</w>
bur den
buprenorph ine,</w>
bund les</w>
bul l
bul bos
bulbos pinal</w>
buff er.</w>
bucumo lol</w>
bu tr
bu s.</w>
bruc ello
bronchodilat ation</w>
bronch oscopy</w>
bronch o-
brom peridol</w>
bro aden
brie f,</w>
bretyli um,</w>
breath .</w>
breast fed</w>
break fast</w>
brain- barrier</w>
bradykine sia.</w>
bradykin in.</w>
bradycardia ;</w>
brady arrhythmias,</w>
bra ins.</w>
bra in)</w>
boun d
bother some</w>
bone- labeling</w>
bol us)</w>
bol ab
bolab rin</w>
body weight,</w>
bo wel.</w>
bo ur
bo o
blur ring</w>
blood- nerve</w>
blood- flow</w>
blood- brain-barrier</w>
blocker -induced</w>
blockade -induced</w>
block )</w>
bli sters</w>
ble b
blad ders.</w>
blad der
blac k
bl ica</w>
bl an
bivalir udin</w>
bis -
bis (2-chloroethyl)-1-
biperid en.</w>
biperid en,</w>
biosynthe sis.</w>
biosyn thetic</w>
biopsi ed</w>
bioavail ability,</w>
bio active</w>
bin ucle
bili ary,</w>
biguan ides</w>
bige minal</w>
bifid a,</w>
bic ycle</w>
bi as.</w>
beta-H SD
beta-D- glucuronide-induced</w>
beta- glucuronide-induced</w>
beta- blocker.</w>
beta- blockade,</w>
beta- AR</w>
beta- ,</w>
beta(1)- adrenergic</w>
beta ine,</w>
beta 2-receptor</w>
beta 2-adrenoceptor</w>
beta 2
beta 1-adrenoceptor</w>
beta 1,</w>
benzoyl ecgon
benzofur an</w>
benz ene
benign .</w>
benefici al.</w>
ben dazole</w>
belotec an</w>
bed time.</w>
bec lin</w>
bec arn
beat s.</w>
be fun
be ad
bas e/
bas e.</w>
bal ance
bag -
bag- valve-mask</w>
bacterio logical</w>
bacter ia,</w>
back cross</w>
bac illary</w>
bac ill
b.w t.</w>
b w</w>
b out</w>
b on
b lown</w>
b itemporal</w>
b isoprolol</w>
b er's</w>
b ari
aztreon am</w>
azol -induced</w>
azithrom ycin,</w>
ax it
avoid s</w>
autoradi ograph
autoimmun ity.</w>
auto regulation.</w>
autis tic-like</w>
author ities</w>
auth ors,</w>
aus cult
auro thioglucose</w>
atten d</w>
atrogen ically</w>
atri al,</w>
ator vastatin,</w>
ator vastat
atmosph eric</w>
atic a</w>
ati sm
athero thrombotic</w>
athe tosis</w>
ath letes</w>
ate :
at ure.</w>
at tracted</w>
at tainment</w>
aster ixis,</w>
astemiz ole.</w>
associ ations.</w>
asse mb
ass ure</w>
ass ed</w>
ass a
aspir in)</w>
aspir ated</w>
aspi ro
as comycin</w>
arthro gr
arth ria</w>
arterio grams</w>
arterio gram</w>
arteri al
arrest s.</w>
ark in
aria e</w>
ari es,</w>
argatrob an-treated</w>
are :</w>
architect ure.</w>
arabino side
arab inofuranos
ara- C.</w>
ar y;</w>
ar ranged</w>
ar r
ar anthus</w>
aprot in
aprind ine</w>
apri l.</w>
approach ing</w>
approach es,</w>
appro val,</w>
applic ability</w>
appear ances</w>
apparat us,</w>
apomorph ine)</w>
apo E</w>
apne a-
aph rag
ap terin</w>
ap ine.</w>
ao ren
anz aoren
anxiet y/
anxiet y-</w>
antipsycho tic.</w>
antine oplast
antihistamin ics</w>
antihist amines,</w>
antieme tic,</w>
antidepressant -like</w>
anticip ate</w>
anticholinerg ics,</w>
antibacteri als</w>
antiarrhyth mic,</w>
anti-HB c</w>
anti- tumour</w>
anti- nicotinic</w>
anti- neoplastic</w>
anti- human</w>
anti- glomerular</w>
anti- anginal</w>
anti- TCA</w>
anti- Go
anti tumoral</w>
anti myoclonic</w>
anti cardiolipin</w>
anth rene</w>
antero septal</w>
ante mortem</w>
ante grade</w>
antagonist /
answe red</w>
anorex ia.</w>
anomal y</w>
annu ally.</w>
anisocor ia</w>
animal s),</w>
anim al)</w>
angio gram.</w>
angi itis.</w>
anesthesi ologist.</w>
anec dot
ane- treated</w>
and inavian</w>
ance ),</w>
anc y.</w>
anc es)</w>
analy sis:</w>
analgesi c-
anaestheti st</w>
anabol izing</w>
an- 3-
an ia.</w>
an ia,</w>
an hedon
an encephaly.</w>
an amycin</w>
an -associated</w>
an -1,
amrin one,</w>
amplitu des,</w>
amphetamine- evoked</w>
amlodip ine/
amlodip ine.</w>
amiodar one:</w>
amiodar one-treated</w>
aminoind an-1,
aminoglyco side-
aminoacid uria,</w>
amino ]
amin oc
amil ial</w>
amide -associated</w>
am obarbital</w>
am ni
am er
alve us</w>
alve ol
alternati ves.</w>
altern atively</w>
altern ated</w>
alprostadi l</w>
alpha2- isoform</w>
alpha-mang ostin</w>
alpha-amino-3-hydroxy- 5-methyl
alpha-amino-3-hydroxy-5-methyl isoxazole-4-
alpha-amino-3-hydroxy- 5-
alpha-EMT BL</w>
alpha- receptor</w>
alpha- r
alpha- hydroxylase</w>
alpha- chloralose</w>
alpha,beta- amyrin</w>
alpha(1)- adrenergic</w>
alpha (3)</w>
allox an</w>
allodyn ia)</w>
allerg y,</w>
alle lic</w>
all ergen
alk ylated</w>
ali ve.</w>
algor ith
alg ia-like</w>
aler tness,</w>
alendron ate.</w>
alcohol ism,</w>
alcohol -related</w>
alcoh ol-induced</w>
al- body</w>
al so.</w>
al one).</w>
al e,</w>
ak er</w>
aj maline-induced</w>
ai ve</w>
agre es</w>
ago gic</w>
aggres sive,</w>
aggreg ability</w>
agent s;</w>
agent -induced</w>
ag ricul
ag reli
ag mat
ag li
ag eu
af ness</w>
af e
adreno receptors.</w>
adrenal ine-
adrenal ectomy,</w>
adren olytic</w>
adolesc ence</w>
adol ine</w>
admis sions,</w>
administr ations.</w>
adjudic ated</w>
adipos ity</w>
adi one</w>
addi tion.</w>
ad ed</w>
activ ator.</w>
act s;</w>
act in-
acr ylate</w>
acide mia</w>
acid- sensitive</w>
acid otic</w>
achiev able</w>
ache ,</w>
achal ol</w>
acetylmethad ol</w>
acetyl- L-carnitine</w>
acetazol amide-induced</w>
acetate- salt</w>
aceclofen ac</w>
accommod ation</w>
accommod ation.</w>
accid ents.</w>
accent uation</w>
acceler ation.</w>
ac yclic</w>
ac ial</w>
ac her</w>
ac ea</w>
ac cep
abstr acts</w>
abstr act</w>
abrupt ly.</w>
abl act
aband oned</w>
ab u
ab ruption</w>
ab breviated</w>
a- mediated</w>
a- day</w>
a- actin
a use
a ined,</w>
a ic</w>
a emo
a V
a -related</w>
a )
a '</w>
a "</w>
[RR ]</w>
[3H] dopamine</w>
[(2- methyl
[ P
[ NS
[ N
[ K+
[ 9
[ (-)-
Z PI</w>
Yale- New</w>
YM 872</w>
Y- 23
Y-23 ,0
Y et</w>
Y NA</w>
Y AG</w>
X E
Wil li
Wh ole</w>
We gener</w>
Wat ch</w>
Wal den
WH I</w>
WB H</w>
W P</w>
W I)</w>
W AR
W .</w>
Voric onazole</w>
Viusi d</w>
Visc eral</w>
Vigil ance</w>
Vi ol
Vi gi
Ve ter
Vas odilation</w>
Val idation</w>
VT ;</w>
VT ),</w>
VPA -exposed</w>
VPA )</w>
VN B,</w>
VE L</w>
V s</w>
V ital</w>
V inc
V e</w>
V al</w>
V agal</w>
V acu
V P)</w>
V MAT
VMAT 2</w>
V HD</w>
V HD
V FT</w>
V D
V AN</w>
V AL</w>
V AD</w>
V AC
V 2-receptor</w>
Ur ticar
Upjo hn
Uni vers
Unfortun ately</w>
Under lying</w>
Ultrason ography</w>
USP IO
US A</w>
UM- 272</w>
UL- morphine-induced</w>
UL DA</w>
UK- 61,
UD P-
U/ m2</w>
U/ kg)</w>
U- B</w>
U- 900
U- 69593</w>
U- 50,488H</w>
U sers</w>
U reth
U rapidil</w>
U max</w>
U krain</w>
U T</w>
U P</w>
U B</w>
Tur ner's</w>
Tur ke
Tum our</w>
Tro glitazone</w>
Trendelen burg</w>
Trans plant
Tradi tional</w>
Tourette -like</w>
Tor onto</w>
Tob ramycin</w>
Tn T</w>
Time- course</w>
Tim olol</w>
Thom son
Theophyll ine-induced</w>
Tetrac yclines</w>
Tetrac ycline-induced</w>
Test .</w>
Tech ne
Teach ing</w>
Tc- TBI</w>
Taq IA</w>
Ta il</w>
TX A2</w>
TX 14
TX14 (A)</w>
TTP- HUS.</w>
TT X</w>
TRPV 5</w>
TRPV 1
TRK- 820</w>
TR -</w>
TO R)</w>
TO F-
TNF- alpha,</w>
TM T</w>
TJ- 80
TJ s</w>
TH IS</w>
TE s</w>
TE R</w>
TE M</w>
TE M-
TEM- untreated</w>
TD I</w>
TB Z</w>
TAF I</w>
T+ A</w>
T yrosine</w>
T yro
T ween</w>
T sukub
T s</w>
T riptans</w>
T rac
T ourniqu
T et</w>
T emozolom
T el
T UR
T PTD</w>
T OR
T L</w>
T C,</w>
T A)</w>
T ;</w>
T 10</w>
Syn thetic</w>
Sweden ,</w>
Swe et's</w>
Susp ici
Sulf adi
Su anzaoren
Str ong</w>
Str ati
Stere ological</w>
St om
Sr l</w>
Spont aneously</w>
Spectr um</w>
So -1
Slit 2</w>
Sixty- nine</w>
Sing ap
Sil astic</w>
She pherd</w>
Sham- operated</w>
Sh wartzman</w>
Sex ,</w>
Seve rely</w>
Sep ar
Sensor imotor</w>
Sel ection</w>
Seg mental</w>
Schu knech
Sc andinavian</w>
Satis factory</w>
Salmon ella</w>
STZ -treated</w>
ST AT</w>
ST A</w>
SSRI -induced</w>
SSR149744 C</w>
SSR1038 00,</w>
SSR I,</w>
SR BT</w>
SPAR C</w>
SPA D</w>
SP- IR</w>
SP S</w>
SP ),</w>
SO (4)</w>
SN Z
SN FP-
SNFP- VS</w>
SM emb
SL F</w>
SK P</w>
SK -1</w>
SIAD H,</w>
SI S</w>
SI P</w>
SHR SP</w>
SG PT</w>
SE Ps</w>
SE M;</w>
SE M,</w>
SE M).</w>
SCO P-induced</w>
SCN 8A</w>
SCL- 90-
SC- 36
SC T).</w>
SB- 26
SB-26 99
SA H,</w>
S14G- HN</w>
S140 80</w>
S/ HYPOTHESIS:</w>
S tren
S pan
S on
S mac/
S m</w>
S ites</w>
S ine
S hen
S et
S en
S cot
S clero
S chool</w>
S ]</w>
S S-
S ASP</w>
S ACS</w>
S -1</w>
S -145
S (+
Rut land</w>
Roten one</w>
Rotaro d</w>
Roenig k</w>
Ro 436
Ro436 8
Ro4368 554</w>
Risperid one,</w>
Ribavir in-induced</w>
Rest ric
Respon ding</w>
Relationshi ps</w>
Refer ral</w>
Rec re
Rec over
Rec ord
Rec ei
Re ticulo
Re lief</w>
Rat s,</w>
Raniti dine-induced</w>
Rami pril</w>
Rab b
Ra rely,</w>
RVOT- VT</w>
RTI -1
RS NA</w>
RS I</w>
RS B</w>
RO L</w>
RO 15-4513</w>
RN- x</w>
RN A)</w>
RI HA</w>
RI A.</w>
RF S</w>
RB C.</w>
RB C)</w>
RATIONAL E</w>
RAMP 3</w>
RAMP 1,</w>
RA M</w>
RA D</w>
R s,</w>
R ocuronium</w>
R es.</w>
R as</w>
R as
R S,</w>
R RSB</w>
R PL
R PD</w>
R O</w>
R IA</w>
R (-)</w>
Qual it
QT d</w>
QT c-
QT c,</w>
QR :</w>
Q-NO H</w>
Q S
Q N
Q -treated</w>
Pu pil</w>
Psych omotor</w>
Psych i
Pseud o-
Provoc ation</w>
Propran olol-induced</w>
Pro vera</w>
Pro motion</w>
Pro gnostic</w>
Pro convulsant</w>
Pro chlorper
Pro ce
Pri mid
Pri ma
Pres um
Pre medication</w>
Pre emptive</w>
Por t
Poly morphic</w>
Poly morph
Pois son</w>
Pneum on
Platele t-
Picrotox in-induced</w>
Physi ology</w>
Phen procou
Phe ochromocytoma</w>
Pg I2</w>
Person ality</w>
Persist ence</w>
Per ox
Per ception</w>
Per ce
Pent obarbital</w>
Pe liosis</w>
Path ogenesis</w>
Paren teral</w>
Paralle l</w>
Parad oxic
Paracetam ol-induced</w>
Par as
Par ameter
Pa rent</w>
Pa ired</w>
Pa O2/
PV A</w>
PTZ ,</w>
PTH /
PTH/ PTHrP</w>
PT P
PT A-
PRIS .</w>
PR L:</w>
PR L.</w>
PR .</w>
PO M</w>
PO B</w>
PL A/
PIP IDA</w>
PI3K gamma</w>
PI SE.</w>
PH T.</w>
PGE (1)-induced</w>
PG- 9.</w>
PG P
PFT- alpha</w>
PF ),</w>
PE FR</w>
PE ).</w>
PD s</w>
PD GF-
PD G,</w>
PC- SOD</w>
PC ).</w>
PB -
PATI ENT</w>
PA- injected</w>
PA O</w>
PA M</w>
PA )-induced</w>
P=0.0 4).</w>
P< 0.001;</w>
P< .001),</w>
P2X 7</w>
P2X 3</w>
P2- component</w>
P- selectin</w>
P- like</w>
P up
P ro</w>
P reser
P ra
P p
P lo
P imoz
P anax</w>
P amid
P VT</w>
P SV
P S.</w>
P N,</w>
P CP.</w>
P '</w>
Over -
Ovari an</w>
Ov x</w>
Other wise,</w>
Orth otopic</w>
Opio ids</w>
Op tical</w>
Ome prazol
Off spring</w>
Occasion ally,</w>
Obj ect</w>
Ob ser
OR X
OR .</w>
OPID N</w>
OH- H
OH- D(2)</w>
OD N
OD ,</w>
OA E</w>
O- acetyl</w>
O T</w>
O LDA</w>
O 2-</w>
O ).</w>
Nutri tion</w>
Nov a</w>
Norm alized</w>
Norep inephr
Nor inyl</w>
Non- invasive</w>
Non- hematologic</w>
Nit rous</w>
Ninety- two</w>
Ninety- nine</w>
Ninety- eight</w>
Nimesul ide-induced</w>
Nim odi
Nicot inic</w>
Ni acin</w>
Netherland s.</w>
Nephro toxic</w>
Nephro pathy</w>
Neph rosis</w>
Necrop sy</w>
Ne ed
Nd 1-
Na+/ K+</w>
Na+/ K+-ATPase</w>
Na(+) ,
NT D.</w>
NT -3</w>
NS Cs</w>
NR T</w>
NP Y-
NP Y
NO LA</w>
NO C
NMB As</w>
NK H
NK 1,</w>
NK )</w>
NI MO</w>
NI ;</w>
NHE 3</w>
NHE 3,</w>
NF s</w>
NE- ARF</w>
ND PD</w>
NC r
NB IA</w>
NADH- oxidase</w>
NA SH</w>
NA F</w>
N-methyl- N'-
N-methyl-N'- nitro-N-nitroso
N-butyl-N- (4-hydroxybutyl)
N-acetylcyste ine.</w>
N-acetyl procainamide</w>
N-[ (1-
N- type</w>
N- Methyl-
N-Methyl- D-
N- 76
N(G)- nitro-
N ag
N ac</w>
N X</w>
N M</w>
N J
N IC
N HB
N D</w>
N CA
N -</w>
N -13</w>
N (6)-
Myo glob
My algia</w>
Mut ations</w>
Mus culoskeletal</w>
Multivari able</w>
Multi -
Morph ine-
Mor ic
Mon th</w>
Mon ophasic</w>
Mo (t
Mit omycin-C</w>
Midazol am-induced</w>
Micro scop
Micro angiopathic</w>
Mi befradi
MgSO (4)</w>
Mg(2+ )-ATPase</w>
Mg Al</w>
Mg ATPase</w>
Metron idazol
Methion ine</w>
Meth ods</w>
Met -
Mes enteric</w>
Mening itis</w>
Men strual</w>
Medic ation-induced</w>
Me fenamic</w>
Mas seter</w>
Mannit ol-induced</w>
Manifest ations</w>
Man tel-Ha
Mal e,</w>
MTX /
MS SBP</w>
MS A.</w>
MR- 33</w>
MR SA</w>
MR ,</w>
MPT P.</w>
MPO- ANCA,</w>
MN U</w>
MMP- 2,</w>
MMA ,</w>
MIB I</w>
METHOD S/
METH -
ME G</w>
ME .</w>
MDMA -induced</w>
MD P</w>
MD ),</w>
MCP -1
MC L</w>
MAFb x</w>
MA Q-NOH</w>
MA P)</w>
MA 40-
MA /
M. S.</w>
M- 6-
M ifepristone</w>
M e-
M ang
M X
M LM
M J</w>
M I)</w>
M HT</w>
M HC</w>
M FS</w>
M CNS</w>
M 40
M 30</w>
M 2,</w>
M 1-selective</w>
M 1-
Long- acting</w>
LiCl /
Li/ D
Li kert</w>
Li Cl,</w>
Lenal idom
Le u</w>
Le ber's</w>
Lat encies</w>
Lat ano
Labor atories,</w>
Labor ator
LY1418 65</w>
LY 3547
LY 1753
LVE F,</w>
LV O</w>
LT CPP</w>
LT B4</w>
LID s.</w>
LID /
LI TA</w>
LI S</w>
LH- Z
LE VEL</w>
LDL- c</w>
LD .</w>
LA AM</w>
L4- L5</w>
L-NG- nitroarginine</w>
L-Dopa .</w>
L-Dopa -induced</w>
L- thyroxine</w>
L- glutamic</w>
L- dihydroxyphenylalanine</w>
L- ascorbate</w>
L ys
L u
L t
L of
L ign
L as
L RTI
L O</w>
L Na</w>
L Na+
L I-
LI- PILO</w>
L G
L En
L Ca</w>
L AR</w>
L 3-
L 180
L 13
L13 08
L1308 F</w>
L (-1)</w>
Kloth o</w>
Kine tic</w>
Ket anserin</w>
KP 14
KOP- R</w>
KOP r
KF178 37</w>
K1 C-
K- dependent</w>
K ounis</w>
K anamycin</w>
K YNA</w>
K T</w>
K IT
K CD-
K 8/
K8/ K18</w>
K /
K (Na)</w>
Ju venile</w>
Join t</w>
Janu ary,</w>
J cl
Iso v
Iohex ol</w>
Intraven ously</w>
Intracaver nous</w>
Intra thec
Intr insic</w>
Interfer on</w>
Inter ruption</w>
Inter group</w>
Ins1 P</w>
Inhibit ors</w>
Inhal ation</w>
Inflam mation</w>
Inf ection</w>
Indometh acin,</w>
Indin avir,</w>
Indi a</w>
Indap amide</w>
Incub ation</w>
Incl uded</w>
Inc .,</w>
In tub
In os
In do
In bred</w>
Impres sion-
Import ant</w>
Immunocyt ochemistry</w>
Immunoblo tting</w>
Immun operoxidase</w>
Imid az
Ilo prost</w>
Ig M,</w>
Ig A-
Ig A,</w>
Ifosf amide,</w>
IV A</w>
IU/ L.</w>
IU D</w>
IT PA</w>
IS V</w>
IS MN</w>
IS F-induced</w>
IS -
INTERPRETA TION</w>
IN H.</w>
IL -10/
II/ III</w>
II- IV</w>
II b</w>
IGF BP
IE G</w>
ID V
ICV- STZ</w>
IC H)</w>
IC A</w>
I. v.</w>
I- ex
I to</w>
I sch
I rel
I ran
I ox
I lex</w>
I R)</w>
I M,</w>
I E</w>
I B</w>
I AD</w>
I ;</w>
I (f
Hypo the
Hypo kal
Hyper trichosis</w>
Hyper lipide
Hyp oxia</w>
Hyp ocapnia</w>
Hydro cortisone</w>
Hydralaz ine-induced</w>
Hydr alazine</w>
Hg );</w>
Heter ozygous</w>
Hepar in,</w>
Hen le's</w>
Hemo dynamics</w>
Heal th,</w>
Hdac 3</w>
Har ris</w>
Haloth ane-induced</w>
Ha ven</w>
HSP 72</w>
HS- PG</w>
HS V-t
HR CB
HM PAO</w>
HLA-DR 4</w>
HE6E7 T-1</w>
HE S</w>
HE C</w>
HDL- c</w>
HD Cy</w>
HD C.</w>
HD ),</w>
HC T</w>
HC N1</w>
HC A</w>
HC 1</w>
HC ).</w>
HBsAg (+)</w>
HBeAg ,</w>
HB e</w>
HB ).</w>
HA I</w>
H2- blocker</w>
H2 O,</w>
H os
H ong</w>
H ero
H az
H and</w>
H an
H T,</w>
H S.</w>
H PS</w>
H PD</w>
H HE6E7T-1</w>
H A-
H 3
H3 R</w>
H 2,</w>
H (1)</w>
Gynec ologic</w>
Guillain- Barre</w>
Gran ule</w>
Gram ont's</w>
Grad ed</w>
Glyc ine</w>
Glut amine</w>
GluR 2+</w>
Glomerul i</w>
German y)</w>
Gentac oll</w>
Genotyp ing</w>
Gas 6</w>
GW 29
GTN ,</w>
GT P</w>
GSP E
GSH-P x</w>
GS ).</w>
GP I</w>
GHB A</w>
GF R)</w>
GB S</w>
GAP-43- IR</w>
GAD 67</w>
GABA A/
G-6- PD</w>
G- protein-coupled</w>
G s-
G onad
G all</w>
G _
G PT
G Cs</w>
G CV</w>
G CS</w>
G B)</w>
G 1</w>
Fram ingham</w>
Fos- immunoreactive</w>
Form ation</w>
For tunately,</w>
Fol ate</w>
Fn 14</w>
Flut amide</w>
Flup irtine</w>
Fluores cein</w>
Flun arizine</w>
Fisch er-344</w>
Finaster ide</w>
Fifty- eight</w>
Fib rosis</w>
Fi ve-
Fdd A</w>
Fav orable</w>
Fam ily</w>
Fallo t</w>
Fac ilitation</w>
FV B/
FR1736 57</w>
FL U
FL I</w>
FK506- associated</w>
FH F.</w>
FGIN -1-
FGIN-1- 27</w>
FEV 1,</w>
F1,6 BP</w>
F/Y56 7
F undus</w>
F ru
F lo
F linders</w>
F ish</w>
F en-
F e</w>
F c</w>
F amilial</w>
F al
F ZP</w>
F Z,</w>
F VII
F SRS</w>
F SH,</w>
F S
F PZ</w>
F MF</w>
F M</w>
F HR</w>
F DP</w>
F CH
F -1</w>
Exer ci
Ex tended</w>
Ex cl
Evalu ating</w>
Ev oked</w>
Europ e.</w>
Euro s</w>
Etom id
Eti ology</w>
Eti ologic</w>
Ethosuxim ide</w>
Estrogen -induced</w>
Estradiol -17</w>
Er b
Equ al</w>
Epidemio logic</w>
Enter ococcus</w>
Enoxapar in</w>
Endothel in-1</w>
End- systolic</w>
En viron
Em pir
Electroencephalo graphy</w>
Eighty- two</w>
Eighty- four</w>
Echocardi ogram</w>
EV L</w>
ET (B
ESR S</w>
ES O</w>
ES M</w>
EP SC</w>
EP M</w>
EP .</w>
EM E</w>
EM ,</w>
EE ,</w>
ED L</w>
ED 50s</w>
ECG s.</w>
ECG s,</w>
EC TS</w>
EC S.</w>
EC S-induced</w>
EC OG</w>
EC D</w>
EB +
E2-17 G</w>
E18. 5.</w>
E- /-</w>
E vol
E very</w>
E toposide</w>
E topo
E to</w>
E qui
E pac</w>
E dition</w>
E dema</w>
E X</w>
E S:</w>
E S)</w>
E PO)</w>
E LITE</w>
E AA</w>
E ;</w>
E 40
E (GABA)</w>
Dyst onic</w>
Dys k</w>
Drug -associated</w>
Doppl er-
Diure tic</w>
Dissemin ated</w>
Disopyram ide-induced</w>
Dis cri
Dis charge</w>
Dipyridam ole-
Diphenyl hydantoin</w>
Diphenyl hydanto
Digit alis</w>
Dig ox
Differen ti
Diaz emul
Diarrho ea</w>
Di valproex</w>
Di urnal</w>
Di rected</w>
Dex verapamil</w>
Dex -
Determin ing</w>
Des ferrioxamine</w>
De le
De anol</w>
De afness</w>
Dar k</w>
Daptom ycin</w>
Dantrol ene</w>
DZ R,</w>
DY N</w>
DX NP</w>
DT PA-
DT I</w>
DT C</w>
DS M</w>
DP ).</w>
DOX Y</w>
DOPAC ,</w>
DO TA</w>
DO PS</w>
DN G</w>
DN .</w>
DM 235</w>
DL PFC</w>
DH A-
DENS PM</w>
DC X-
DARPP- 32</w>
DA- 8
DA B</w>
DA -1</w>
D2- like</w>
D-Trp-6- LHRH</w>
D- glutam
D- MED</w>
D- AMPH</w>
D(2)- like</w>
D x
D ur
D up
D uct
D ry</w>
D rosophila</w>
D im
D idanosine</w>
D ams</w>
D SE.</w>
D S,</w>
D L</w>
D KA</w>
D IA</w>
D CA</w>
D BP
D -1
D (3)
D (2),</w>
Cyclophosph amide,</w>
Cyc les</w>
Cy A/
Cy A.</w>
Cult ured</w>
Cs A-</w>
Convul sive</w>
Consci ousness</w>
Conf idence</w>
Concer ning</w>
Con clu
Competi tion</w>
Col umb
Cocaine- dependent</w>
Coca ine's</w>
Coc k
Co hort</w>
Co agulation</w>
Co A-
Clo mipramine</w>
Clo fibrate-induced</w>
Clind amycin</w>
Clin ic,</w>
Citalopram -induced</w>
Ciprof loxac
Cimeti dine-induced</w>
Chol inesterase</w>
Chlorprop amide-induced</w>
Chloro quine-induced</w>
Chlor promaz
Chlor hexidine</w>
Check list</w>
Ch ina</w>
Ch .</w>
Cephal oridine</w>
Cent res</w>
Cefotet an-induced</w>
Caucasi ans</w>
Cath aranthus</w>
Carb oxyp
Car mo
Capsa icin,</w>
Califor nia</w>
Calcineur in-inhibitor</w>
Ca2+ -
Ca(2+)- dependent</w>
Ca(2+)- ATPase</w>
CYP2D6 *
CYP2C 9
CYP1A 2*
CYP1A2* 1
CYP 3A</w>
CYP 1A2</w>
CY P-
CY P,</w>
CX- 397</w>
CTR -treated</w>
CSF Q</w>
CS D</w>
CRL R,</w>
CRF (1)</w>
CP EC</w>
CO PD.</w>
CO 2.</w>
CO ,</w>
CNSB 002</w>
CN )</w>
CM V-
CL P</w>
CL 218
CI- AKI</w>
CI- 779</w>
CI MD</w>
CI :
CI (95)</w>
CHF 3
CH P</w>
CH C</w>
CGS 216
CGI- SF</w>
CGI- S</w>
CFU- GM</w>
CF M-1</w>
CF B</w>
CE S-
CE Q</w>
CE ,</w>
CD8 32</w>
CD-8 32</w>
CD 34
CD 154</w>
CD 11
CD ,</w>
CD ).</w>
CD ),</w>
CCR 9</w>
CCR 3</w>
CCK- 8</w>
CC O</w>
CC K</w>
CB A</w>
CB (1)
CAD O</w>
CA VB</w>
CA RV</w>
CA P+
CA N</w>
CA 1-3</w>
CA )-
C57BL/ 10
C3H/ He
C ys</w>
C rossover</w>
C rac
C ra
C oxibs</w>
C ost</w>
C n</w>
C leveland</w>
C inc
C Z
C RE
C PA-induced</w>
C MT
C IC
C E)</w>
C CN
C CI</w>
C CI-779</w>
C 3,</w>
Bu pivaca
Bu erg
Bre ak
Bost on</w>
Bonfer ron
Bis phosphonates</w>
Beta- blockers</w>
Benz tropine</w>
Be h</w>
Bcl-x (L)</w>
Bax ter</w>
Bar nes</w>
Baclofen -induced</w>
BZD /
BZD/ RD</w>
BW ,</w>
BUd R</w>
BR L
BP N</w>
BP ).</w>
BM Cs</w>
BL- 3
BL-3 45
BID ,</w>
B- 6</w>
B v
B ran
B os
B lu
B lack</w>
B end
B atter
B asi
B NP)</w>
B N</w>
B K
B HR</w>
B ER</w>
B EP</w>
B Ch
B CAA</w>
B 2)</w>
B 2
B -related</w>
B (2)</w>
Avy/ A</w>
Audi ometric</w>
Ator vastatin</w>
Aspir in-induced</w>
As pergillus</w>
As p</w>
Aro clor</w>
Arg entine</w>
Arac hidonic</w>
Ara U</w>
Ara G</w>
Ar ticles</w>
Appeti te</w>
Apomorph ine,</w>
Ap paren
Antim al
Antidepress ants</w>
Anti emetic</w>
Ann ual</w>
Angi osarcoma</w>
Angel man</w>
Anaesthe ti
An der
Amphet amine-induced</w>
Amph oB</w>
Ammon ia</w>
Americ a,</w>
Am rinone</w>
Am B,</w>
Alpha- lipoic</w>
Allo pregnanolone</w>
Allo P</w>
Albumin uria</w>
Al er
Al anine</w>
Ak t,</w>
Aggra vation</w>
Age -matched</w>
Ag itation,</w>
Ag ents</w>
African- Americans</w>
Adrenoc eptor</w>
Adrenal ectomy</w>
Administ ering</w>
Ad ol
Ad .
Acetazol amide-induced</w>
Acceler ation</w>
Aca demic</w>
Ac tu
Ac tivated</w>
Ac cur
Ab s</w>
Ab )</w>
AV P)</w>
AUC -1/
AT T-
AS 2-
AS2- 1</w>
AS +
AR N-
AQ P-2</w>
API SE,</w>
ANCA ).</w>
AN P.</w>
AN A</w>
AMPH /
AMP H-
AMLE t</w>
AM PA-
AM P,</w>
AM /
ALN+ D28
AL F.</w>
AKAP 150</w>
AI S</w>
AI R</w>
AED s,</w>
AE s)</w>
AD OR
ACTH .</w>
ACEA -10
ACE Is</w>
ABI-00 7</w>
A-3 17
A-317 491</w>
A- 8
A- ->
A wake</w>
A tax
A st
A sp
A sia.</w>
A rizona</w>
A pr
A po
A my
A long</w>
A j
A becarn
A TION</w>
A O</w>
A G)</w>
A ECM</w>
A E)</w>
> 300</w>
> 1</w>
= 60</w>
= 20</w>
= 10</w>
= "
< or=
< 50%</w>
< 40</w>
< 2</w>
< 0.001)</w>
< .05)</w>
: YAG</w>
: ICR</w>
: 1)</w>
: 00,</w>
99mTc- glucarate</w>
99mTc- PIPIDA</w>
99m Tc</w>
99 ;</w>
95% CI</w>
90 ,
9 33</w>
9 11</w>
9 -1.
86 44.</w>
838 36
83836 E</w>
829 58</w>
80 /
80 %.</w>
8. 5+/-
8. 4
8. 25</w>
8. 0%</w>
8-cyclopentyl -1,3-dipropyl
8-OH-DPA T,</w>
8- year</w>
8- week-old</w>
8- 243</w>
8 9,</w>
8 8%,</w>
8 6.7</w>
8 6%,</w>
8 5%,</w>
8 4),</w>
8 3%,</w>
8 2,</w>
8 1%,</w>
8 %-
7315 a</w>
70 ),</w>
7. 7%</w>
7. 6%</w>
7- hydroxy-
7 F/Y567
7 7.
7 44</w>
7 3.
7 14</w>
7 14
7 1.4%</w>
7 0/
7 0%)</w>
67 %.</w>
6. 6,</w>
6. 2%</w>
6-keto- prostaglandin</w>
6- wk</w>
6- dimethyl
6 9).</w>
6 8).</w>
6 7;</w>
6 7)</w>
6 64</w>
6 5%,</w>
6 2)</w>
6 1)</w>
6 0.5</w>
6 %);</w>
5HT 3</w>
5826 1,</w>
57 ;</w>
57 %,</w>
56 %).</w>
55 ,9
50 6,</w>
50 48
50 1</w>
5. 6,</w>
5. 6%,</w>
5. 5%,</w>
5. 4%</w>
5-bromo uracil</w>
5-bromo -2'-
5-HT(2 A/
5-F U-
5- point</w>
5- microm</w>
5- lipoxygenase</w>
5- ISMN</w>
5- CHO-
5- 9
5- 25</w>
5- 20</w>
5'- dFUrd</w>
5 mg</w>
5 Y</w>
5 :
5 4-
5 1,</w>
5 1
486 92</w>
48 1</w>
45 -1
400 %</w>
40- minute</w>
40 4</w>
40 30
4030 W
40 %).</w>
4. 9
4. 4%</w>
4. 4%)</w>
4. 0-
4-OH-CB 107</w>
4-Cl-BZ T</w>
4-4 602</w>
4- dichloro
4, 6-
4'- iodo-
4 9.</w>
4 8)</w>
4 7.5</w>
4 60</w>
4 5.9</w>
4 4-
4 4),</w>
4 4%,</w>
4 3,</w>
4 3),</w>
4 2.</w>
4 2.7</w>
4 2.5</w>
4 2).</w>
4 2
4 1%.</w>
4 1%).</w>
4 0.3</w>
4 0.0%</w>
4 +</w>
39. 2</w>
39 9</w>
3839 3,</w>
38. 9</w>
38. 8</w>
38. 5</w>
38. 5%</w>
38 8</w>
38 %,</w>
38 %).</w>
3784 9.</w>
36. 4%</w>
36 00</w>
35 9</w>
35 +/-
34 4)</w>
31 P</w>
300 ,000</w>
30 8</w>
30 36
30 1</w>
30 ,000</w>
3. 5-
3. 4-
3. 4
3. 36</w>
3. 32</w>
3. 25</w>
3. 0).</w>
3. 0%</w>
3- methoxy-
3- hydroxylase</w>
3- OH
3,4- dihydro
3, 7
3',5'- T2</w>
3' U
3 x
3 alpha-
3 MA</w>
3 H]
3 65</w>
3 5).</w>
3 43</w>
3 4.6</w>
3 3%),</w>
3 29</w>
3 1;</w>
3 11</w>
3 1.6</w>
3 00-mg</w>
3 0.6</w>
3 -1.
29. 6</w>
29 6
29 %);</w>
28 th</w>
28 8</w>
27 80</w>
27 7</w>
27 %),</w>
26. 8</w>
26 %.</w>
25- hydroxyvitamin</w>
25- 75</w>
25 7</w>
24. 3</w>
24 ;</w>
24 9</w>
24 0-
23390 -induced</w>
23. 6</w>
23. 4</w>
23. 3</w>
23 3
23 2
23 /
23 ,8
23,8 84</w>
23 ,
21. 4%</w>
200-1 10</w>
200 7)</w>
20- year</w>
20 :1</w>
20 8</w>
20 8-243</w>
20 7</w>
20 -</w>
20 +</w>
20 +/-
2.0 2</w>
2. 96</w>
2. 94</w>
2. 75</w>
2. 7,</w>
2. 6;</w>
2. 5;</w>
2. 52</w>
2. 5).</w>
2. 4%)</w>
2. 35</w>
2. 3%,</w>
2. 15</w>
2. 00</w>
2-oxothiazolidine- 4-
2-chloroproca ine-
2-chloro -
2-amino-4- phosphon
2- selective</w>
2- minute</w>
2- mg/kg</w>
2- en-VPA</w>
2- acetylaminofluorene</w>
2- [
2- CADO</w>
2,3, 4,
2,2, 2-
2, 5-di
2',3'- dideoxyinosine</w>
2 B)</w>
2 6-week</w>
2 25-
2 20
2 2.7</w>
2 2.0</w>
2 2%).</w>
2 14</w>
2 1.6</w>
2 1-</w>
2 0.7</w>
2 '
2 %);</w>
1alpha- OH-D(2)</w>
1S,3R-AC PD</w>
199 9-
199 1,</w>
199 0
198 9.</w>
198 7,</w>
198 3,</w>
198 0,</w>
196 6-
19. 8</w>
19 9</w>
19 76</w>
19 71</w>
19 68</w>
19 *
19 %.</w>
19 %),</w>
18. 3</w>
18. 0</w>
18- month-old</w>
18 8</w>
17. 2</w>
16. 9</w>
16. 6%</w>
16. 0</w>
16 0)</w>
150 ;</w>
15. 4%</w>
15. 2%</w>
15 d-PG
142 801</w>
14- fold</w>
14 :00</w>
13 th</w>
13 640</w>
13 00</w>
13 0/
13 ,
13 %.</w>
13 %)</w>
125I- labeled</w>
120- min</w>
12 h</w>
12 S</w>
12 54</w>
12 -</w>
12 %.</w>
12 %),</w>
11. 8%</w>
11. 1%</w>
11 %),</w>
100- mm</w>
100- fold</w>
100,00 0).</w>
100 ),</w>
10-1 4</w>
10- month</w>
10(9)/ L,</w>
10 5
10 (3)</w>
1/ 3</w>
1/ 35</w>
1/ 2-year-old</w>
1/ 2,</w>
1.5- 3</w>
1.3 2,</w>
1.0 ;</w>
1. 9-
1. 9%,</w>
1. 77</w>
1. 72</w>
1. 70</w>
1. 7%,</w>
1. 61</w>
1. 5-1
1. 5%,</w>
1. 5%)</w>
1. 45</w>
1. 41</w>
1. 38</w>
1. 36</w>
1. 25-
1. 24</w>
1. 14</w>
1. 11</w>
1. 1,</w>
1-des amino-8-D-
1-1 4</w>
1- month-old</w>
1- 4,</w>
1- ,</w>
1, 5
1, 4
1, 000/
1 h.</w>
1 a
1 B
000 ,000</w>
0.9 2).</w>
0.9 1,</w>
0.9 0
0.9 ).</w>
0.8 ;</w>
0.8 9</w>
0.8 +/-
0.7 9</w>
0.7 3,</w>
0.6 5,</w>
0.6 1,</w>
0.6 -1.
0.5 ;</w>
0.5 ),</w>
0.4 8,</w>
0.4 5,</w>
0.2 1).</w>
0.01 ).(ABSTRACT</w>
0.000 1;</w>
0.00 9),</w>
0.00 7</w>
0.00 5,</w>
0.00 5%</w>
0.00 2,</w>
0.00 ).</w>
0.0 9).</w>
0.0 8).</w>
0.0 4,</w>
0.0 2;</w>
0.0 11).</w>
0.0 1.</w>
0.0 0</w>
0.0 ,</w>
0. 7-
0. 6-
0. 6)</w>
0. 39
0. 25-
0. 24
0. 2)</w>
0. 19,</w>
0. 17,</w>
0. 12)</w>
0. 10
0- 4</w>
0 :
0 ,
0 %.</w>
/ low</w>
/ cm2</w>
/ O
/ METHODS:</w>
/ HC
/ 24</w>
.000 1)</w>
.00 00
.0 4)</w>
.0 25)</w>
. 9
. 5</w>
. 3.</w>
-1-piperazin yl]
-1- phenyl-
-1 9</w>
-1 99
-1 7-
-1 500</w>
-1 5.
-1 25
-1 200</w>
-- in</w>
-- case</w>
- log</w>
- F
- C</w>
- 50</w>
- 0.4</w>
,8 72</w>
+/-1. 9</w>
+/-1. 7</w>
+/-1 4</w>
+ BZ</w>
). m(2)
)- resistant</w>
)- ,</w>
(v /
(p Hi
(n= 2),</w>
(n =</w>
(max ).</w>
(m -
(gamma- hexachlorocyclohex
(dd C)</w>
(chi 2=
(Z D
(Y56 7F/Y567
(Y MR
(X 2</w>
(WH O</w>
(W or
(W R
(W I)
(W A
(V P-1
(V P
(V F).</w>
(UD CA)</w>
(Taxotere )</w>
(TR I)</w>
(TNF- alpha)</w>
(TMP-SM Z)</w>
(TI N)</w>
(T ype</w>
(T W
(T SH)</w>
(T NS
(T J
(T AS
(T -
(SSR I),</w>
(SNP s)</w>
(SNP )-induced</w>
(SHR ),</w>
(SB P),</w>
(S)-4 C3H
(S TR
(S NA
(S LE).</w>
(S D:</w>
(S BP</w>
(S AP)</w>
(S AL
(S .</w>
(RO S),</w>
(RB F)</w>
(R I)</w>
(Q o
(Parlo del
(Pa CO2</w>
(PTU )-induced</w>
(PR C)</w>
(PGE (2))</w>
(PF C)</w>
(PE P)</w>
(PAR P)</w>
(PAN ),</w>
(P= 0.4
(P= .00
(P< 0.001</w>
(P< 0.0001).</w>
(P v
(P f
(P S)</w>
(P ON
(P MS
(P H)</w>
(P D),</w>
(P >0.05).</w>
(OPID N)</w>
(O TC)</w>
(O S)</w>
(O Cs)</w>
(NT -
(NT )</w>
(NSAID s),</w>
(NR H)</w>
(NO x)</w>
(NO S),</w>
(NO ).</w>
(NMD A),</w>
(N .</w>
(MPTP)- lesioned</w>
(MPT P)</w>
(MM I)</w>
(MK-80 1,</w>
(ME S),</w>
(MD MA,</w>
(MD MA)</w>
(MB C)</w>
(MA BP</w>
(MA BP)</w>
(M VO
(M PE
(M M),</w>
(M I
(M DD).</w>
(M CA),</w>
(LVE F),</w>
(LID s)</w>
(LID ),</w>
(L- dopa
(L- AP
(L PS)</w>
(L HR
(L H)</w>
(L 1-
(K i=
(K O)</w>
(K D)</w>
(IL -1
(IFN- alpha)</w>
(IC H),</w>
(IC )</w>
(I GF
(HD MTX)</w>
(HC Q)</w>
(HBsAg )-positive</w>
(H T)</w>
(H T
(H S)</w>
(H P
(H E)</w>
(H C).</w>
(H AT
(H AL
(GSH-P x)</w>
(GP x)</w>
(GABA A)</w>
(G CS)</w>
(G BM
(G AD
(Fish er's</w>
(FANF T)</w>
(F R
(F G
(F =
(ER P)</w>
(ED (50)
(EC T).</w>
(E n
(E RP
(E O
(E M)</w>
(Dox )</w>
(Del ta</w>
(DX R
(DSM- III-
(DO CA)-
(DM I)</w>
(DL B)</w>
(DF P).</w>
(DB S)</w>
(D TIC)</w>
(D PO
(D MT
(D M</w>
(Clin or
(Clin icalTrials.gov</w>
(CY P).</w>
(CR s)</w>
(CO 2)</w>
(CF U-
(CD 50)</w>
(CB 1)</w>
(C al
(C R</w>
(C PT)</w>
(C IP)</w>
(C HC).</w>
(C CK
(C AM
(C 57
(BPR S)</w>
(B ZD
(B P</w>
(B O
(B K)</w>
(B Ch
(AMP H)</w>
(AD C)</w>
(AD ).</w>
(ACTH )-induced</w>
(A ra
(A c
(A b
(A R)</w>
(A PT
(A PO
(A AP
(A -
(A (2A)
(99 m
(9 7%)</w>
(9 3.3%)</w>
(9 -
(9 ),</w>
(9 %).</w>
(8. 2</w>
(8 9</w>
(8 7.
(8 4%</w>
(8 0%</w>
(8 ),</w>
(7 9%</w>
(7 50</w>
(7 5-
(7 4</w>
(7 4%</w>
(7 3%</w>
(7 1%),</w>
(7 0-
(6. 5%</w>
(6. 0</w>
(6 9%),</w>
(6 7.
(6 7%</w>
(6 4%</w>
(6 4%),</w>
(5. 0%)</w>
(5-HT )
(5 8%</w>
(5 8%),</w>
(5 6%).</w>
(5 5%),</w>
(5 3</w>
(5 3.
(5 0.0</w>
(4. 6</w>
(4. 4</w>
(4 9.
(4 7%</w>
(4 5%</w>
(4 3%</w>
(4 3%).</w>
(4 3%),</w>
(4 1.
(4 ))</w>
(3. 8</w>
(3- 4</w>
(3 7%</w>
(3 6%).</w>
(3 5%</w>
(3 5%),</w>
(3 3.3%)</w>
(3 2%</w>
(3 2%),</w>
(3 0-1
(3 '-
(2. 6</w>
(2. 4%)</w>
(2- Cd
(2- 4</w>
(2 9/
(2 80</w>
(2 8
(2 60</w>
(2 6%).</w>
(2 6%),</w>
(2 6
(2 3%</w>
(2 2%).</w>
(2 1)</w>
(2 1%),</w>
(2 00,</w>
(2 0.8%)</w>
(2 -10</w>
(2 );</w>
(2 )/
(1: 1)</w>
(16. 7%)</w>
(125) I]
(10 mg/kg,</w>
(1/ 2)</w>
(1. 25
(1. 00
(1. 0,</w>
(1- 30</w>
(1- 2</w>
(1 6/
(1 45</w>
(1 35</w>
(1 29</w>
(1 22</w>
(1 1.5</w>
(1 %).</w>
(0.001- 0.1</w>
(0.0 8</w>
(0.0 6</w>
(0. 63</w>
(0. 48</w>
(0. 12</w>
(0. 125,</w>
(0-1 0)</w>
(0 ;</w>
(-1 );</w>
(-1 )).</w>
(-- )-
(-)- sulpiride</w>
(+/- SD)</w>
(+)- propranolol</w>
(+ 5
(' M
( weight</w>
( versus</w>
( vehicle
( time</w>
( t)</w>
( spontaneous</w>
( sham
( s.c.</w>
( renal</w>
( reduced</w>
( myocardial</w>
( mostly</w>
( mono
( minimum</w>
( log-rank</w>
( isoproterenol</w>
( initiated</w>
( initial</w>
( infusion</w>
( increase</w>
( if</w>
( i.p.),</w>
( hot</w>
( formerly</w>
( expressed</w>
( elevated</w>
( during</w>
( doxorubicin</w>
( dox
( d-
( cyclophosphamide,</w>
( complex</w>
( cisplatin,</w>
( beta-CC
( apo
( ap
( anti-HB
( also</w>
( according</w>
( UN
( R)</w>
( LT)</w>
( L-DOPA
( CON
( =</w>
( 0.001</w>
( 0%</w>
( 0%),</w>
( *
' paradiscal'</w>
' holocytic'</w>
% .mmHg
" white</w>
" therapeutic"</w>
" rescue"</w>
" in</w>
" ecstasy
zotep ine</w>
zolmitript an.</w>
zimel idine</w>
ze ma,</w>
z ileut
ystag mo
yst olic</w>
ysi al</w>
yri an</w>
yr s)</w>
young est</w>
yo derma</w>
yne -
ynchron ization</w>
ymb ol</w>
yle ster</w>
yl] pyridine</w>
yl) phthalate</w>
yl) ethyn
yl)ethyn yl]pyridine</w>
yl y
yl cytosine</w>
yl ase</w>
yl ]</w>
yeast -induced</w>
year ).</w>
year 's</w>
yc lopent
y/ learning</w>
y- o</w>
y tos
y to
yto plasmic</w>
y ser
y raz
y n</w>
y '</w>
xyl in</w>
xip amide</w>
xanth one</w>
wrist .</w>
worsen ing.</w>
worsen ed,</w>
worl d.</w>
work up,</w>
wor se.</w>
wor ked</w>
wor ds,</w>
wo ke</w>
within- subjects</w>
withhel d,</w>
withdraw al-
with standing</w>
with :</w>
window .</w>
widen ing,</w>
wide spread,</w>
wide ly.</w>
whole- brain</w>
whol ly</w>
white- matter</w>
whit e,</w>
whe ezing</w>
wh ole,</w>
weight- to-body</w>
weight- adjusted</w>
weigh t
week ly)</w>
wearing- off</w>
we aving</w>
we ar</w>
war ds,</w>
wan ed</w>
w/ v)</w>
w- nitro-L-arginine</w>
w ron
w rin
w ra
wra p</w>
w is
w ed</w>
vulg are</w>
vomit ing;</w>
vol tam
vo uch
vo s</w>
viz .</w>
vivo :</w>
vivo "</w>
visual- spatial</w>
virus -positive</w>
vir us-related</w>
vinorelb ine,</w>
vindes ine.</w>
vincrist ine-associated</w>
vin yl-
vil li
view ,</w>
videotap e</w>
vic on</w>
vi tis</w>
vi st-
vessel .</w>
vertic il
verticil lat
vers a.</w>
verm is</w>
verat rine</w>
ver tex</w>
ver sion.</w>
ver s,</w>
ver olim
ver ifying</w>
ver 's</w>
ventric ular-
ven .</w>
veloc ities.</w>
veget ative</w>
vecur onium-induced</w>
vect ors</w>
ve d:</w>
ve 's</w>
vastat in-associated</w>
vasopress in-resistant</w>
vasoconstric ting</w>
vasculo pathy.</w>
vas op
vapor ized</w>
valv ulopathy,</w>
valu es;</w>
valu e)</w>
valpro mide</w>
valer ate,</w>
val ium</w>
vacuol ation,</w>
vaccin ation.</w>
vacc ine-
v ity.</w>
v is</w>
v icious</w>
v ic</w>
v alo
valo yl</w>
v ae</w>
utroph ilic</w>
utili zed.</w>
util isation</w>
ut tering</w>
ut om
utom erase</w>
usi dic</w>
use -
us er,</w>
us ?</w>
us +
urotheli um,</w>
uro pathy</w>
urinaly sis.</w>
urin es,</w>
urin aria</w>
ureter itis,</w>
ur s
ur onic</w>
ur ia)</w>
ur i</w>
up set,</w>
uniqu ely</w>
unineph rectomy</w>
unexplo red.</w>
unequ al</w>
undoub tedly</w>
underestim ate</w>
under nourished</w>
under lines</w>
un washed</w>
un steady</w>
un pro
un necessary.</w>
un modified</w>
un intended</w>
un injured</w>
un favourable</w>
un familiar</w>
un detected</w>
un blocked</w>
un anticipated</w>
un anesthetized,</w>
un anaesthetized</w>
uma rol</w>
um ents</w>
um 's</w>
ultra- short</w>
ultra structur
ultrastructur ally.</w>
ulo se,</w>
ull ary</w>
ulcer ations</w>
ulcer ,</w>
ul in,</w>
ul ation-
ul ate,</w>
ul a,</w>
ug e</w>
ucle ated</w>
uccin ic</w>
ucasi an</w>
uc osal</w>
uc i
u tr
u a</w>
ty ph
two- vessel</w>
two- choice</w>
twenty- one</w>
tur ns</w>
tur ke
tun ing</w>
tumor- free</w>
tumor s;</w>
tubul in,</w>
tuber cular</w>
tu ft</w>
tt p
ttp :
ttp: /
ttp:/ /
trun k.</w>
troph oblastic</w>
trop olitan</w>
trometh amine.</w>
triple -drug</w>
triphenyl tetrazolium</w>
trinit ro
trimethoprim-sulfamethox azole,</w>
trimethopri m,</w>
trimethop rim-
trimethaph an,</w>
triheptano in</w>
triglyceride s.</w>
triglycer id
trifluoro methyl
trichom on
triazolo[1,5- c]
trial s:</w>
trial ;</w>
tri methyl
tri azine</w>
tri ad
tri acyl
trex ol</w>
tren e</w>
tren ded</w>
tren d);</w>
tren d).</w>
treatment s;</w>
treat ed),</w>
tre e,</w>
travel l
trastuzumab ,</w>
tranylcyprom ine,</w>
transplant ation;</w>
transplan ted,</w>
transmit ters</w>
transmit ters.</w>
transi tioning</w>
transi tion
transition al-
transitional- cell</w>
transf ers</w>
transduc ers</w>
transamin ases.</w>
trans mucosal</w>
trans membrane</w>
trans lo
trans lating</w>
trans lat
trans jugular</w>
trans formation.</w>
trans femoral</w>
trans duced</w>
trans -1,2-
tranquil izers</w>
tramad ol-induced</w>
tram adol
trache a,</w>
trac ings</w>
trac ed</w>
trabecul ae</w>
tra y</w>
tra it,</w>
tr iterpene</w>
tr apping</w>
toxic ity).</w>
tot aling</w>
tos ylate.</w>
tos uccinic</w>
toremif ene,</w>
tonsill ectomy.</w>
tonic- clon
tometr ine</w>
tom eg
tomeg alo
tomegalo virus</w>
tolter od
tolaz amide.</w>
tocain ide.</w>
toc otri
tocotri en
toc olysis.</w>
to- female</w>
to- G</w>
to day</w>
to -treated</w>
tizan idine,</w>
tiv ity.</w>
titr ating</w>
tissu e;</w>
tis -
tion al.</w>
time- activity</w>
til t,</w>
tigm ine-
tig en</w>
tig ated</w>
tic- dynamic</w>
tic a</w>
tiaz ofurin</w>
tiag abine,</w>
ti trexed</w>
ti ters.</w>
ti ter.</w>
ti o
ti ming,</w>
ti es;</w>
ti en
tien ilic</w>
ti apride</w>
ti apri
thyrox ine.</w>
thymo quinone</w>
thym oma</w>
thym idine.</w>
thrombocyth emia.</w>
thrombo- embolic</w>
thrombo sis;</w>
thrombo sis)</w>
thrombo philia</w>
thromb us,</w>
thromb ot
thromb osed</w>
throm bus.</w>
thro at,</w>
three- year-old</w>
three- vessel</w>
thous ands</w>
though t,</w>
thorac ic,</w>
tho rough
thir d.</w>
thiotepa ,</w>
thiosulf ate</w>
thiosemicarb azide</w>
thioridaz ine,</w>
thiopent one-
thiomal ate</w>
thio thixene</w>
thio diphosph
thiazol-4- yl)ethynyl]pyridine</w>
thi ocol
thiocol chic
thi obut
thi apine</w>
thermal g
therapy- resistant</w>
ther modi
theore tic</w>
then- pct
then- cisDD
the ta
the pt
thept ene</w>
the modi
themodi alysis</w>
th- west</w>
th inner</w>
th in-
th ana
tetrahydro isoquinol
tetrahydro folate</w>
tetrahydro -1H-3-benz
tetrachloro dibenzo-p-dioxin</w>
tetraca ine.</w>
tetrac yclines</w>
tetra enoic</w>
tetr ameth
territ ories</w>
terodi line</w>
terodi line,</w>
termin ally</w>
teratogen s.</w>
teratogen icity,</w>
ter oneph
ter n
tern atin</w>
ter ine</w>
ter ic</w>
ter azosin,</w>
ter /
ten u
ten sor</w>
ten sion.</w>
ten sion-
ten atal</w>
temporo ammon
temporoammon ic</w>
temper ament</w>
tem .</w>
telmis artan,</w>
tele metric</w>
teenag ers</w>
tech nic
te lo
te en-
te bo
tebo ro
teboro xime</w>
te aring</w>
tc p</w>
taz ana
taurochol ic</w>
tap e</w>
tann in</w>
tamoxifen :</w>
tal c</w>
tail s</w>
tachyp nea</w>
table t,</w>
tab ul
ta- lateral</w>
ta utomerase</w>
t. d.
t-[35S] butylbicyclophosphorothionate</w>
t- test).</w>
t- positive</w>
t- G
t ural</w>
t or,</w>
t ocic
t ness.</w>
t fold</w>
t ectal</w>
t ec
t al-
t PA,</w>
t )-
systol ic-
system ically.</w>
system ically,</w>
system atic
syst ole,</w>
syru p</w>
synthesis/ release</w>
syndrome ),</w>
synaptos omes</w>
synap ses,</w>
syn tometrine</w>
syn cy
syncy tial</w>
symptom- limited</w>
symptom s:</w>
sympatho inhibitory</w>
sympathe tically-
symmetric al,</w>
switch ers</w>
swell ings</w>
survi vals</w>
surve y,</w>
surve y
surpris ing</w>
surmoun table</w>
surg e.</w>
surfact ant</w>
surfac es.</w>
surfac e)</w>
sur reptitious</w>
sur passed</w>
supplement s,</w>
suppl y.</w>
supernat ants</w>
super ven
super spinal</w>
super sensitive</w>
super oxide.</w>
sulph ate.</w>
sulph ate-associated</w>
sulfon yl</w>
sulfamo yl-
sulfamethox azole-
sulfadi azine.</w>
sulf hyd
sul b
sulb act
sufentanil- propofol</w>
succinylchol ine;</w>
succin ate,</w>
succe eded</w>
succ essively</w>
succ ess,</w>
subtype -selective</w>
substance -abusing</w>
subsi ding</w>
subsequ ently.</w>
subj ective,</w>
sub- )</w>
sub type,</w>
sub tracted</w>
sub tended</w>
sub regions</w>
sub protective</w>
sub plantar</w>
sub lines</w>
sub group,</w>
sub granular</w>
sub fraction</w>
sub field</w>
sub family</w>
su profen</w>
su perfused</w>
stupor .</w>
studi ed;</w>
stud y--
stud y
stru m</w>
stroke- prone</w>
stri ped</w>
stres s)</w>
strept omycin.</w>
strept omycin-induced</w>
strept omycin,</w>
strength ening</w>
strab ism
strabism us.</w>
stor age.</w>
stimul us-induced</w>
stimul ator.</w>
stimul ator,</w>
stimul ation:</w>
stimul ation-induced</w>
stimul ated,</w>
stimul ant
stil bo
stibo gluconate</w>
steroid- sensitive</w>
steroid -free</w>
steroid -dependent</w>
stereotyp ical</w>
stereotyp es</w>
stereotyp e</w>
stereospec ific</w>
stereo selective</w>
stereo isomer</w>
ster ,</w>
step .</w>
steno ses.</w>
sten osis:</w>
steep er</w>
steato hepatitis.</w>
steato hepatitis,</w>
ste ep</w>
ste al.</w>
ste al-prone</w>
star v
standar d)</w>
stand still</w>
stand -
stabiliz er.</w>
stabil ization.</w>
st s,</w>
st inging</w>
st em,</w>
st ays</w>
st ay
st ation</w>
st ant</w>
sst (1)</w>
squa res</w>
spra ys</w>
spor t</w>
spor ad
spont aneously,</w>
spont ane
spirocer cosis</w>
sper mid
sper m</w>
spectro scopic</w>
spectro metric</w>
spectro meter</w>
spectr um,</w>
specti ve.</w>
species -specific</w>
spe eds</w>
spe ak
spati ally</w>
spar se</w>
spac es.</w>
spac es,</w>
spac ed</w>
spa red.</w>
soun ds</w>
sos orb
sorb ate</w>
sor al
somat otop
som it
solv ents</w>
solv ent.</w>
solitari us,</w>
sol ve</w>
softw are</w>
softw are.</w>
sodi um)</w>
smok er</w>
sm ural</w>
slow ,</w>
sleep- inducing</w>
sle epl
skeleton s</w>
siz es,</w>
sixty- two</w>
sixty- nine</w>
sixty- five</w>
six- week</w>
situ ation,</w>
sit afloxacin</w>
sist ant</w>
sis -related</w>
sion s;</w>
sion s)</w>
sinus oids</w>
single- pass</w>
single- nucleotide</w>
single- center,</w>
simult aneously,</w>
simult aneous
similar :</w>
sim vastatin-induced</w>
sil ver-
significant ),</w>
sigma -1</w>
sibu tr
sibling s.</w>
sial ylation</w>
si tis.</w>
si gh
si e
si dom
shun t.</w>
shun t,</w>
shrink age.</w>
short-term/ working</w>
short- sleep</w>
short- course</w>
short- axis</w>
short- acting,</w>
shor ter-
shor t.</w>
shif t.</w>
she n</w>
she ar</w>
sha king</w>
sh aft</w>
sex /
sex -specific</w>
sex -related</w>
sex -,</w>
sevoflur ane-based</w>
sevoflur ane-
sett ing:</w>
sesqu iterpene</w>
servic es.</w>
serv o-
servo- controlled</w>
sert indole</w>
serotonin- selective</w>
serotonin- reuptake</w>
serosi tis</w>
seri ous
ser o-
ser o
ser ine,</w>
septo plasty.</w>
sen cephal
semin iferous</w>
semati li
self- stimulation</w>
self- selection</w>
self- rated</w>
self- administering</w>
selegil ine.</w>
selegil ine,</w>
selec tion.</w>
selec tion,</w>
seizure- prone</w>
seizure -associated</w>
segreg ation</w>
segreg ated</w>
seen :</w>
seem s,</w>
sedati ves,</w>
sed ation;</w>
secre tions</w>
search ,</w>
seal ants</w>
se- pretreated</w>
se ;</w>
se :</w>
scrutin y.</w>
scopol amine-</w>
scop e</w>
sco p</w>
schistos om
schedul es,</w>
sc .</w>
sc ),</w>
satur ations</w>
sarcopen ic</w>
sarco plas
sarco idosis,</w>
sap orin</w>
salv a</w>
salt- loaded</w>
salmeter ol,</w>
saline- exposed</w>
salicyl azosulf
salicyl ate-induced</w>
sal ure
sal ient</w>
sairei- to</w>
saf ely.</w>
saf ely,</w>
sacrific e.</w>
sacchar in,</w>
sacca dic</w>
sa w</w>
sa quin
sa k
s.go v,</w>
s.c. ;</w>
s- of-
s port
s ne
s n
s l-
s i</w>
s hipp
s d</w>
s atel
satel lit
s aff
saff lower</w>
s .)</w>
s (-1)</w>
runc ulin</w>
run ning,</w>
run down</w>
rul es</w>
ru bral</w>
rt PA</w>
rox yl
roten one.</w>
rostro caudal</w>
rose um</w>
ros acea</w>
root s,</w>
ron e,</w>
ron cho
rofecoxib :</w>
ro megal
ro lling</w>
ro landic</w>
rivas tigmine,</w>
rituximab .</w>
ritonavir- boosted</w>
risk /benefit</w>
rimonab ant</w>
rim ox
rifampic in-dependent</w>
ricket s,</w>
ric etin</w>
ribos ylation</w>
ribonucle otide</w>
ri se.</w>
ri de</w>
rhabdomy oly
rhIL-1 R
rhIL-1R a</w>
rhH GF</w>
rh inos
rhinos inu
reverse- transcriptase</w>
retrospect ,</w>
retriev al.</w>
ret est</w>
resuscit ate</w>
restore d,</w>
respectively :</w>
respect ,</w>
resour ce-
resoruf in-
resorufin- O-de
resor ption.</w>
resol ve,</w>
resistance -associated</w>
resist ant.</w>
resid ence</w>
resid ence.</w>
reserp ine-
rese ar
res ynchronization</w>
res sin</w>
res ;</w>
res )</w>
require ments,</w>
require ment.</w>
request s</w>
request ed.</w>
repolar isation</w>
replac em
repeti tively</w>
repeate d-
repe ated,</w>
repair ing</w>
rep uted</w>
rene .</w>
remoxipri de.</w>
remis sions.</w>
remin ds</w>
remifentanil- propofol</w>
remif ent
remifent nail</w>
remed y.</w>
rema in.</w>
relocation/ separation</w>
relev ance.</w>
relax ants.</w>
relationshi ps.</w>
relap ses,</w>
rel uct
rel ation.</w>
regular ly.</w>
regul ations</w>
regres sed.</w>
regimens :</w>
reg ain</w>
refract ory,</w>
refr action</w>
reflu x.</w>
reflex ogenic</w>
referr als</w>
referen ces</w>
referen ce,</w>
ref ers</w>
ref er</w>
reduction/ discontinuation</w>
red und
red "</w>
recumb ency</w>
recru desc
recrudesc ence</w>
recover ies</w>
recommend ation).</w>
recoll ection</w>
recipient :</w>
reb oxetine</w>
reasses s</w>
reason s:</w>
real ized.</w>
real ize</w>
reach es</w>
re- in-
re- exposed</w>
re- examined</w>
re- evaluated</w>
re- administration</w>
re visited</w>
re trac
re sides</w>
re presentation</w>
re per
reper to
re operation</w>
re myelination</w>
re mind</w>
re ma</w>
re location</w>
re introduced.</w>
re emergence</w>
re elin</w>
re con
re ared</w>
re ally</w>
raz oline</w>
raz epam</w>
rate ),</w>
rat s--
rat ing,</w>
rat er</w>
rat ed,</w>
rat ),</w>
random- effects</w>
ran ean</w>
ramipri l,</w>
raloxif ene
rai sed,</w>
ragged- red</w>
radio graph</w>
radi ography</w>
radi alis</w>
rac e/
race/ ethnic
ra rest</w>
ra re;</w>
ra emic</w>
r-pro UK</w>
r yn
r y,</w>
r r
r ha
rha ph
r an</w>
r HuEPO</w>
r HV
r CBV</w>
quinol one,</w>
quin azoline</w>
quin acrine</w>
ques tion,</w>
quasi- morphine</w>
quantit ation</w>
q ,</w>
pyrro lo
pyro phosphate</w>
pyrimeth amine-
pyridox ine,</w>
pyridin ium</w>
pyrid ine,</w>
pursu ed</w>
pursu e</w>
purpura/ hemolytic</w>
puppi es</w>
pup s,</w>
punct ure,</w>
pum ps,</w>
pum p
pulmon ary-
pul ses.</w>
pul se.</w>
pul l</w>
puer arin</w>
pter idine</w>
pt l
pt ed</w>
psychostimul ant.</w>
psychopharmac ologic</w>
psychi atric
pseud oc
provid er.</w>
prototyp ic</w>
protoc ol-
protein ).</w>
protein ),</w>
prot ective
prostat ectomy</w>
prostagland in-
prost an
propyl-1- phosphonic</w>
propyl }-
propranolo l),</w>
proportion ate</w>
propofol- remifentanil</w>
propofol -related</w>
propion ate.</w>
propi on</w>
prophyl axis
proparg yl
propacetam ol</w>
prop ane</w>
prompt ly.</w>
promot ers.</w>
promin ent.</w>
promaz ine.</w>
prolifer ator</w>
prolactin omas.</w>
prolactin omas,</w>
progres sively.</w>
program s.</w>
progest in-
progab ide,</w>
prof ylline,</w>
prof use</w>
procycl idine,</w>
prochlorper azine,</w>
process ing,</w>
proce eding</w>
proce dur
procarb azine,</w>
proble matic
prob ing</w>
prob es.</w>
prob able,</w>
prob abilities</w>
proanthocyanid in</w>
pro- thrombotic</w>
pro ving</w>
pro trac
pro state,</w>
pro position</w>
pro platin</w>
pro kine
pro estrus</w>
pro drome</w>
pro drom
prodrom al</w>
pro conflict</w>
primid one,</w>
priap ism,</w>
prevent able.</w>
preval ent.</w>
preval ences</w>
presyn copal</w>
pressu re:</w>
pres urgical</w>
prepar e</w>
pren at
premature ly.</w>
prematur ity,</w>
pregnancy -related</w>
pregnan olone,</w>
pregab alin,</w>
preem ptively</w>
predomin ately</w>
predomin ance,</w>
prednis one-treated</w>
predict ably</w>
predic tions</w>
precurs ors.</w>
precl uding</w>
precipit ates</w>
pre- treatment.</w>
pre- transplant</w>
pre- chemotherapy</w>
pre weaning</w>
pre training</w>
pre trained</w>
pre test</w>
pre piriform</w>
pre operatively.</w>
pre loading</w>
pre ischemic</w>
pre exist
pre conditioning.</w>
pre administration</w>
prazos in-
pram ine-treated</w>
practition er</w>
prac ticed</w>
pr ick
pr ice</w>
pp m.</w>
pp ing</w>
potenti ated.</w>
pot ent.</w>
postur ing,</w>
postischem ia</w>
posthyp oxic</w>
poster olateral</w>
post- succinylcholine</w>
post- ischemic</w>
post- infusion.</w>
post- glomerular</w>
post- exposure</w>
post- acute</w>
post- LT
post- BMT</w>
post treatment.</w>
post synap
post stenotic</w>
post rema</w>
post junctional</w>
post ero
post dose.</w>
positive- pressure</w>
pos timplantation</w>
pos themodialysis</w>
port able</w>
porphy rin
porphy ria.</w>
por ted</w>
por adic</w>
popul ation).</w>
popul ar
poor- risk</w>
polysomno graphic</w>
polyribos omes</w>
polymer ization</w>
poly sorbate</w>
poly radicul
poly hydramnios</w>
poly hydramnios.</w>
poly ene</w>
poly arthritis,</w>
poll ici
pollici s.</w>
polar ization</w>
polar ity</w>
point es).</w>
poin t-
pod ocyte
pod ate</w>
po ver
po sed
po or,</w>
po ),</w>
pneumonia e,</w>
pneum omediastinum</w>
pmol/ l,</w>
plo tted</w>
plo idy</w>
plateau ed</w>
plat form
plasma ;</w>
plan ime
placent as</w>
placent a-mediated</w>
placebo :</w>
placeb os.</w>
plac es</w>
plac e,</w>
pl ied</w>
pl ase</w>
pl anted</w>
pituit ary,</w>
piroxic am
pirox antrone</w>
piri be
piperid ine-
piperid in
pimoz ide-induced</w>
pilsicain ide,</w>
pilocarpine- PVA</w>
pilocarp ine:</w>
pill .</w>
pid ase</w>
picrotox in-</w>
picrotox in-
pic loz
pi ate</w>
pi )</w>
physi otherapy</w>
physi ologic,</w>
phyloc occi
phy tate</w>
phosphot yrosine</w>
phosphoryl ation.</w>
phosphoro thio
phosphor amide</w>
phosphor amid
phospholip ids.</w>
phosphodiester ase,</w>
phere sis</w>
pheochromocyt oma,</w>
phenylpropanol amine,</w>
phenyl-1, 3-
phenyl)-piperazin-1- yl]-
phenyl)-4-methyl- 7,8-
phenyl)- 2-
phenyl methyl
phenyl isopropyl
phenyl amino
phenprocoumon -induced</w>
phenotyp ing</w>
phenotyp ed</w>
phenobarbit one,</w>
phenelz ine.</w>
phenel zine,</w>
phen ol-induced</w>
phas ed-
phas e;</w>
pharyn x,</w>
pharmaco therapeutic</w>
phag ia,</w>
phaeochromocyt oma.</w>
ph otic</w>
ph obic</w>
pg/m L;</w>
pg/ ml;</w>
pg/ ml.</w>
peth idine.</w>
petechi al</w>
pestic ide,</w>
perturb ations</w>
perspec tives.</w>
personne l.</w>
person- years)</w>
permit ted.</w>
perman ent,</w>
peripher y.</w>
peripher al-
period ontal</w>
peril ymph</w>
peric on
peri- operative</w>
performed ;</w>
percep tion,</w>
per spective.</w>
per petr
per operative</w>
per one,</w>
per if
per amide</w>
peptide-(25- 35
peptide-(25-35 )-induced</w>
pepti dic</w>
peop le,</w>
pentylenetetrazol e-</w>
pentobarbit al-treated</w>
pent oxy
pen ic
penic illo
pem pidine</w>
pedi atric
pe d,</w>
paw s,</w>
pauc i-
patient s?</w>
patient /
pathomechan ism</w>
path .</w>
pat .</w>
past e</w>
passive- avoidance</w>
passi vely</w>
parval bu
parvalbu min,</w>
participant s'</w>
particip ated.</w>
parti al)</w>
part ner</w>
part ner
part ate</w>
parom omycin</w>
paro tid</w>
paresthesi as.</w>
pares the
parasympath omimetic</w>
paraph il
parap legia,</w>
paralle ling</w>
paraesthe si
paradig ms,</w>
para- tyrosine</w>
para hippocampal</w>
par ity,</w>
par ative</w>
par amount</w>
par amen
paramen ingeal</w>
par a</w>
pantoprazol e.</w>
pannic ul
panc reas.</w>
pan uveitis</w>
pan ick
palmet to</w>
pal pation</w>
pal pation.</w>
pal ms</w>
painful ness</w>
paclitaxel/ carboplatin</w>
paclitaxel :</w>
paclitaxel -treated</w>
paclitaxel -evoked</w>
paclitaxel -based</w>
pacemak ers</w>
pa st.</w>
pa rec
pa fox
pa enia</w>
p< 0.01</w>
p75(NT R)-
p.o .;</w>
p yoderma</w>
p tive,</w>
p ine-,</w>
p ine)</w>
p in</w>
p O2</w>
p ERK1/2</w>
p 65</w>
p 300</w>
p .)</w>
p '-
oz one-
oxyphen butazone</w>
oxyl in-
oxylin- eosin</w>
oxygen -
oxycod one,</w>
oxy tocic
oxy benz
oxopiperazin yl-1-
oxif ylline</w>
oxid ore
oxidore duct
oxid ative/
oxid ase,</w>
oxic -
oxi gen
oxazol id
oxaproz in</w>
oxac alcit
oxacalcit riol</w>
ox y</w>
ox acill
overwhel ming</w>
over- expression</w>
over- all</w>
over all.</w>
ove al</w>
out lines</w>
ouse hold</w>
our ce</w>
oun d
ouabain- hypertensive</w>
ouabain -dependent</w>
ou ret
ou gh
otyp e</w>
otolaryng ologists</w>
oti fen
ot ological</w>
ot ologic</w>
ot ere</w>
osyn cr
osyn aptic</w>
osteomalac ia</w>
osteo arthritic</w>
osmolar ity,</w>
osi s-
oscop ically</w>
os timulation</w>
os per
os om
os ensory</w>
os clero
ors fall</w>
orrho ea</w>
oro xylin</w>
oro -
orig ins</w>
orig ins.</w>
ori metric</w>
ori entation</w>
organel le</w>
ore active</w>
ordin arily</w>
order :</w>
orchi ectomy.</w>
orb it,</w>
oradi ometric</w>
or ders</w>
opri l,</w>
opri de</w>
opre dn
opposit e.</w>
opiomelan ocor
opiomelanocor tin</w>
opioid -like</w>
opi ate.</w>
ophthalmo pathy</w>
ophthalmo logy</w>
oper ative,</w>
op tico-
op odium</w>
op eptides</w>
op eptide</w>
onwar ds.</w>
ongo ing,</w>
ong er</w>
one- fifth</w>
one- -
ond apar
ondapar inu
onco statin-
once- a-day</w>
on- treatment</w>
on- going</w>
on- demand</w>
on to
on tin</w>
on thly</w>
on s,</w>
on lein</w>
on is
onis amide</w>
on in-
on if
onif lor
on es:</w>
on ce,</w>
on azole-associated</w>
on ate.</w>
omyo graphy</w>
omyc in/
omorph ological</w>
ometr y)</w>
omegal y,</w>
ome trexol</w>
ome theptene</w>
omasti a</w>
om iting</w>
om ers</w>
om a)</w>
om ,</w>
olog y-
olo[ 3,
olo[3, 2-a]
olo mic</w>
olo -
oliv oc
olin-1 alpha</w>
oligonucleoti des</w>
ole gal</w>
ol- exposed</w>
ol- 20-
ok ad
okad aic</w>
oint ments</w>
oid /
ogene ity</w>
often .</w>
often ,</w>
off- pump</w>
off- period</w>
off- line</w>
ofen adine</w>
of r
odi azepine</w>
od endritic</w>
ocytopen ia,</w>
ocys tic</w>
octreoti de)</w>
octap eptides</w>
ocon striction</w>
ocon centr
oclav ine</w>
ochrom ic</w>
ochol ate-3-O-
ochemic ally.</w>
och olic</w>
occur ;</w>
occlu ded.</w>
occl ud
occasion s:</w>
ocarcin oma</w>
ocarb oxaz
oc o
oc et</w>
oc ad
obvi ated</w>
obtund ation</w>
obtund ation,</w>
obtain able</w>
obstetr ical</w>
obser ver.</w>
obsc ure,</w>
ober man</w>
obenz o
obac tam</w>
ob ul
ob lig
ob ladder</w>
o thec
o il
o ides</w>
o fibrate</w>
o estrous</w>
o Cy
oCy te</w>
nystag mus.</w>
numb ness,</w>
nucle i)</w>
notochor d</w>
normoten sion;</w>
norm ocalce
norepinephr ine)</w>
nor- B
nor pethidine</w>
non- traumatic</w>
non- surgical</w>
non- randomised</w>
non- pigmented</w>
non- neoplastic</w>
non- insulin-dependent</w>
non- injured</w>
non- injected</w>
non- imidazole</w>
non- haematological</w>
non- enzymatic</w>
non- cirrhotic</w>
non- case</w>
non- arteriosclerotic</w>
non- anesthetized</w>
non- Q</w>
non transmural</w>
non susceptible</w>
non survival</w>
non squamous</w>
non spatial</w>
non significantly</w>
non progressive</w>
non operative</w>
non narcotic</w>
non kindled</w>
non ionic,</w>
non invasively</w>
non inferiority</w>
non genotoxic</w>
non exposed</w>
non e
non convulsing</w>
non compliant</w>
non cirrhotic</w>
non castrated</w>
non cardiogenic</w>
non calcified</w>
non anticoagulated</w>
nocist atin</w>
no se.</w>
no otrop
no des,</w>
nmol/ L</w>
nitroglycerin- ,</w>
nitrogen .</w>
nitrendip ine.</w>
nitrendip ine,</w>
nitr ative</w>
nis can
nimodi pine.</w>
nightma res.</w>
night time</w>
nif e
nife kal
nicot ine)</w>
ni ger</w>
nex t-day</w>
newbor ns,</w>
newbor n,</w>
neut ered</w>
neurotransmit ters.</w>
neurolog ist</w>
neurolog ic,</w>
neuro- ophthalmologic</w>
neuro radi
neuro pore</w>
neuro modulator</w>
neuro genesis.</w>
neuro chemical,</w>
netilmic in-treated</w>
nerve- conduction</w>
nerv os
neramex ane</w>
nephron ,</w>
nephrocalcin osis,</w>
nephro pathies.</w>
nephrectom ized-
neph rin.</w>
neostriat um,</w>
neos tigmine.</w>
neoplas ms,</w>
neo- Timm</w>
neigh bor
necrop sy.</w>
nec ros
nec dotal</w>
near- complete</w>
ne vertheless,</w>
nation al,</w>
nas opharyngeal</w>
nas ogastric</w>
narrow ed</w>
narcol epsy</w>
naltrex one-
nal orphine</w>
nafcill in.</w>
na vig
na prolol</w>
nNOS (-/-)</w>
n- regulation</w>
n t
n ir
nir uri</w>
n id
n ically</w>
n g).</w>
n ers</w>
n agogic</w>
myx edema</w>
myofibri ls,</w>
myocyt olysis</w>
myoclon ia</w>
myo path
myo fibers</w>
myelo toxicity,</w>
myelo proliferative</w>
myelo peroxidase-
myelo pathy,</w>
myelo monocytic</w>
myco logic</w>
myalgia/ arthralgia</w>
my ricetin</w>
my ri
my otoxicity.</w>
my onecrosis</w>
my ocilin</w>
mutag enic</w>
mut ated</w>
mut ant,</w>
muscarin ic,</w>
mur mur
mumol/ liter)</w>
mumol/ kg/
mumol/ L).</w>
mum ole</w>
mum ol)</w>
multiple x</w>
multin ucleated</w>
multifactori al.</w>
multicent ric</w>
multi- centre</w>
multi stage</w>
multi parous</w>
multi form</w>
mul tigated</w>
mul ler
muller ian</w>
mu- opiate</w>
msec ).</w>
mox is
moxis yly
mouse :</w>
mother- infant</w>
mother .</w>
morphine- tolerant</w>
morph ometr
morph ol
morph o
morph ine-treated</w>
morph in
month ly.</w>
month 's</w>
monomethyl- L-arginine</w>
monom eric</w>
mono amines.</w>
mon oxide</w>
mon osynaptic</w>
mon onit
mon oneur
mon ocyte-
mon ic</w>
mol/ l</w>
mol/ l),</w>
mol sidom
moi ety,</w>
modul ators,</w>
modifi ers</w>
modifi er</w>
modifi ed,</w>
model ing.</w>
mode ll
modal ity.</w>
modafin il,</w>
mo ve</w>
mo st.</w>
mo st-
mo pathy</w>
mo genicity</w>
mmol/L ]</w>
mm 2</w>
ml/ kg,</w>
ml/ g</w>
ml -1.</w>
ml -1),</w>
ml );</w>
mixed- breed</w>
mix ed-type</w>
mit r
mit o
mistak enly</w>
mis ,</w>
minut es;</w>
minut es),</w>
minoxidi l-treated</w>
minim ization</w>
minim ised</w>
minim ise</w>
min ing</w>
min -1;</w>
mime tics</w>
milnac ipran
millilit ers</w>
milli on,</w>
milieu .</w>
mil d
migra ine:</w>
mig ratory</w>
mifeprist one.</w>
midod rine,</w>
midazolam/ meperidine</w>
mid facial</w>
mid brain,</w>
micturi tions</w>
microtubul e-
microsom es.</w>
microscop ically,</w>
micromol/ l).</w>
micromol/ g</w>
micrograph s</w>
micrograms/m L).</w>
micrograms/ l</w>
micrograms/ 0.5</w>
micrograms/ 0.2</w>
microgram/ kg,</w>
microg/kg/ min)</w>
microg/ ml;</w>
microg/ mL
microg/ hour</w>
microg/ g,</w>
microg/ day</w>
microg/ L</w>
microg.kg(-1). h(-1)</w>
microfil are
micro- dystrophin</w>
micro vasculature</w>
micro tubules.</w>
micro tubular</w>
micro structural</w>
micro regional</w>
micro prolactinoma</w>
micro phonic</w>
micro n</w>
micro dialysate</w>
micro cystic</w>
micro circulation,</w>
micro biologic</w>
micro V/
mic ally</w>
mi x</w>
mi glustat</w>
mgI/ ml)</w>
mg/m(2)/ week</w>
mg/m l/
mg/m L,</w>
mg/m L)</w>
mg/kg/ infusion)</w>
mg/kg/ day;</w>
mg/ 100
mg. ml-1)</w>
mg :</w>
mex ic
mexic anum</w>
metr y)</w>
metoclopram ide-treated</w>
metoclopram ide-induced</w>
methylenedioxy amphetamine</w>
methyl-6,7-dimethoxy-4- ethyl-beta-carboline-3-carboxylate</w>
methyl- 8-
methyl xanthines</w>
methyl ergonovine</w>
methy leth
methoxy flurane,</w>
methoxy )
methotrex ate-treated</w>
methohexit al.</w>
methohexit al,</w>
method ).</w>
methion ine,</w>
methim azole.</w>
methicill in-sensitive</w>
methicill in-induced</w>
methad one-associated</w>
meth oxyp
meth aemo
metastasi zing</w>
metast asis.</w>
metaiodobenzyl guanidine</w>
metabol ism
met/ dex</w>
met yrap
mesyl ate-induced</w>
messeng ers</w>
mesench yme</w>
mesalaz ine,</w>
mes ocortic
mes encephalon</w>
mercap to-
mer s.</w>
mer ic</w>
mequ iv
mequiv /
meq/ kg)</w>
mepivaca ine,</w>
menorrhag ia,</w>
mening itis:</w>
men ol</w>
men ),</w>
memor y/learning</w>
memor y-
melphal an,</w>
meloxic am</w>
melan chol
mel amine</w>
medoxom il-based</w>
medium- chain</w>
medic olegal</w>
medic al,</w>
mechanis tically</w>
mec li
meas ures:</w>
meas ur
me tropolitan</w>
me trazol</w>
me tra
me tergoline</w>
me los</w>
mcg/ kg/min</w>
mc g/kg</w>
maxim izing</w>
max illo
maxillo facial</w>
matri x,</w>
mat ing</w>
mass age</w>
mas cul
marri ed</w>
marmo set</w>
mar melos</w>
mar ital</w>
manufacture r.</w>
manner ;</w>
maneu ver</w>
man ometric</w>
man ic.</w>
man di
malon ate/
malonate/ MDMA</w>
malform ation,</w>
male- to-female</w>
male ),</w>
mal es;</w>
mal ate</w>
maj or.</w>
mai- y
magnesi um-
macro prolactinoma</w>
mac ulopathy.</w>
ma them
mRNA s.</w>
mL/ s</w>
mL/ min.</w>
mL. min-1</w>
mEq/ liter,</w>
mEq/ L;</w>
m- H
m-H orsfall</w>
m(- 2),</w>
m s),</w>
m erg
m dr
m ca
m /kg</w>
m .
lysos om
lysophosph atidyl
lys ine.</w>
lymph osarcoma</w>
lymph omas,</w>
lymph oceles</w>
ly sis.</w>
ly ser
lut ea</w>
lup us.</w>
lum irac
luc idum</w>
loxacill in-induced</w>
low- molecular</w>
low er-dose</w>
los s;</w>
long- acting,</w>
lon ium</w>
lograph ic</w>
log y.</w>
log dose</w>
locomotor- activating</w>
local ization.</w>
lobul e.</w>
lobe ,</w>
lo x</w>
lo st,</w>
lo sed</w>
lo reth
lo id</w>
lo der
lo ci
ll erian</w>
liver -/-</w>
liver )</w>
litter mate</w>
litre -1</w>
lithium- neuroleptic</w>
lithium- methomyl</w>
lith otomy</w>
lith ogenic</w>
lith ocholate-3-O-
literat ure;</w>
lit tle,</w>
lit az
lis uride.</w>
liqu id-
lipo proteins,</w>
lipo fus
lip s,</w>
lip id,</w>
linole ic</w>
ling er-
linger- Ell
linger-Ell ison</w>
limit s)</w>
lik e,</w>
lignoca ine/
lignoca ine-induced</w>
light-heade dness,</w>
lidoca ine-</w>
lid onine</w>
lick ing.</w>
lic k</w>
li tis.</w>
levothyrox ine,</w>
levonorgestrel ,</w>
levo bupivacaine,</w>
levetir acetam.</w>
level s),</w>
levamisol e-induced</w>
lev osul
lev orphanol</w>
leupro li
leuke moid</w>
leuk omalac
leuco agglutinin</w>
lessen s</w>
less ons</w>
lesion s:</w>
lesion ing</w>
lept om
lenalidom ide.</w>
lenalidom ide-
lenalidom ide,</w>
leiomy oma</w>
lect ins</w>
lecith in</w>
leak age.</w>
lead s,</w>
le ver-
le gged</w>
le ag
leag ues</w>
lay ers.</w>
lay ers,</w>
later alized</w>
later al/
lateral/ basolateral</w>
lat runculin</w>
last s</w>
last -
larg er,</w>
lar vae</w>
lan diolol</w>
lamivudine- untreated</w>
lamivudine- na</w>
lam oxactam</w>
lam ell
lacunos um-
lacti tol</w>
lact otroph
lact ate:
lactate: pyruvate</w>
labor ating</w>
labor :</w>
label s</w>
lab oring</w>
l/ min,</w>
l/ m</w>
l- -
l idine</w>
l ation,</w>
l ate
kne e.</w>
kindling ).</w>
kin ins,</w>
kin es</w>
kg/ m2</w>
kg/ m
key words</w>
ket otifen
ket ol
ket anserin,</w>
kerato plasty</w>
ker atin</w>
kain ate.</w>
k y
k ot
k o
k ingly,</w>
k )</w>
jux tam
jud gement</w>
jour n
join t,</w>
jirovec i</w>
j ect
iz ot
iz ole</w>
iz ed;</w>
iz ation:</w>
iz an
izan idine</w>
iv ),</w>
iti dine</w>
ithrom ycin-induced</w>
iter ranean</w>
item ,</w>
itamin s</w>
it y/
it in.</w>
it e,</w>
ist ,</w>
isradi pine,</w>
isot ope</w>
ison icotinic</w>
isom yosin</w>
isom ers.</w>
isom ers,</w>
isol ectin</w>
isoflurane- anesthetized</w>
iso zym
iso volemic</w>
ish .</w>
isethion ate.</w>
ischemic ,</w>
ischemia/ reperfusion</w>
ischem ia;</w>
ischem ia-induced</w>
isaxon ine</w>
is ometheptene</w>
is al.</w>
is :</w>
irrit able</w>
irrig ations</w>
irrig ation,</w>
ir reversibly</w>
ir )</w>
ipsi later
ip .</w>
iohex ol)</w>
iodix an
io ther
io glos
ioglos sus</w>
investigator -bl
invasi ve,</w>
intub ations</w>
intub ated.</w>
intro n</w>
intrigu ing</w>
intrathec ally,</w>
intran i
intrani gr
intral e
intrale sional</w>
intracister nally</w>
intracerebroventric ularly.</w>
intracell ularly</w>
intrac ytoplasmic</w>
intrac erebr
intra- operative</w>
intra vital</w>
intr a</w>
intoxic ations.</w>
interview s.</w>
interval- prolonging</w>
interrupt ing</w>
intermediate- caudal</w>
interleukin- 6,</w>
interleukin- 2</w>
interfer on,</w>
inter subject</w>
inter related</w>
inter play</w>
inter peak</w>
inter nuclear</w>
inter feren
intellect ually</w>
integ rate</w>
intact -
int ent.</w>
insufficiency :</w>
inspir ation</w>
insipid us:</w>
insipid us-like</w>
inser ted.</w>
inotrop ism</w>
inotrop ic,</w>
injur ies,</w>
injection- site</w>
injec tion),</w>
initi ation-
inhibitor- based</w>
inhibitor -associated</w>
inhibi tion-induced</w>
inherit ance.</w>
inhal er.</w>
inges tion;</w>
ing- treatment</w>
ing ly.</w>
infusion ),</w>
infrequ ently,</w>
infran odal</w>
influ ence,</w>
inflamm ation)</w>
infiltr ations</w>
infiltr ated</w>
infiltr ate,</w>
infer tility.</w>
infarc tion;</w>
infarc t,</w>
inevit able</w>
ine- rich</w>
ine ligible.</w>
ine ered</w>
ine );</w>
ine )-induced</w>
ine "</w>
induc ted</w>
induc ers</w>
indomethac in-
indobu fen</w>
individu ally,</w>
individu al,</w>
indinavir -treated</w>
indinavir -induced</w>
indic ators.</w>
index ed</w>
index ).</w>
inde ed,</w>
inda zole</w>
ind ole,</w>
incub ation,</w>
incre mentally</w>
incor rect</w>
incor rec
inclu sion.</w>
incid entally</w>
incer ta-lateral</w>
incapacit ating</w>
inc ed</w>
in- positive</w>
in- patient</w>
in- labeled</w>
in- immunoreactive</w>
in- 3-
in to:</w>
in k
in ess
in duration</w>
in dispens
indispens able</w>
in discriminate</w>
in dione</w>
in definitely</w>
in definit
in consistent.</w>
in compatible</w>
in come</w>
in born</w>
in ally</w>
in aemic</w>
impul sivity</w>
improvement )</w>
impro ve,</w>
impro per</w>
implic ated,</w>
implant .</w>
impairment /
immunofluoresc ence,</w>
immunoblo t
immuno prophylaxis.</w>
immun oradiometric</w>
immobil ization.</w>
immobil ization,</w>
iminodi acetic</w>
imi metic</w>
im y
im .</w>
illnes ses,</w>
ill .</w>
ill ,</w>
ili as</w>
il les</w>
ig atran</w>
ifosfamide/ mesna</w>
ifer ine</w>
if oli
if l
iel d</w>
idi pine,</w>
idi c</w>
identic al,</w>
identi ty</w>
ide spread</w>
id in</w>
id ene
id arubicin,</w>
id -like</w>
ick 's</w>
ich- Wistar</w>
ic- coated</w>
ic- androgenic</w>
ic us</w>
ic s;</w>
ic ks</w>
ic ile</w>
ic e-
ic an</w>
ic ;</w>
ic ).</w>
iaz emul
ia '</w>
i.v. )-induced</w>
i.p )</w>
i.c.v .,</w>
i. pl
i. a.</w>
i ses</w>
i proplatin</w>
i as,</w>
i K
i ).</w>
hypoxanth ine</w>
hypox aemia</w>
hypovol emic</w>
hypovol emia,</w>
hypotestosteron emia</w>
hypoprote inemia</w>
hyponatra emia.</w>
hypomagnes aemia</w>
hypokine sia,</w>
hypoaldosteron ism</w>
hypo prolactinemia</w>
hypo perfused</w>
hypo esthe
hypo density</w>
hypo active</w>
hypno tic,</w>
hypertrophy :</w>
hyperten sin
hypersensitiv ity-
hyperreflex ia.</w>
hyperprolactin aemia,</w>
hyperphosphat emia,</w>
hyperoxal uria</w>
hyperlipid aemia.</w>
hyperkine sis.</w>
hyperkal aemia.</w>
hyperalgesi a).</w>
hyperaldosteron ism</w>
hyperal bum
hyperalbum inemia-induced</w>
hyper triglycerid
hyper thyrox
hyper thymia</w>
hyper sexuality</w>
hyper sensi
hyper permeability</w>
hyper motility</w>
hyper cortisol
hyper coagulation</w>
hyper activ
hyp ochloremic</w>
hyp esthesia</w>
hydroxy zine,</w>
hydrox ide</w>
hydroure teroneph
hydronephro tic</w>
hydromorph one.</w>
hydroly sis,</w>
hydrocortis one,</w>
hydro ps</w>
hydro alcohol</w>
hyd rate.</w>
hy stere
hy gi
hund reds</w>
human s:</w>
huPB L-
hr ),</w>
hour s);</w>
hospital isation</w>
hormone- dependent</w>
hormon e-induced</w>
homogen ate.</w>
homocyste ine,</w>
homo iother
ho b
hippocampal- striatal</w>
hind brain</w>
high- throughput</w>
high- flow</w>
high- degree</w>
hi g
hig he
hi erarch
hexameth yl
hexachloro phene</w>
hex os
heterogene ous,</w>
heterogene ity,</w>
hero in-dependent</w>
hero in-
here in,</w>
herb s,</w>
heral ded</w>
hept adine</w>
hepatomegal y.</w>
hepat oproliferative</w>
hepat omas</w>
hepat ocyt
heparin- protamine</w>
hemor he
hemophiliac s</w>
hemophil iac</w>
hemophil ia</w>
hemodiaf iltration</w>
hemo perfusion,</w>
hemisphere ,</w>
hemip legic</w>
hemicholinium- 3</w>
hemi- parkinsonian</w>
hemi paresis.</w>
hemat omas.</w>
hemat ologically</w>
hemat ological,</w>
hemat ologic,</w>
hemangi omatosis</w>
hem otoxicity</w>
hem if
hel pl
hear t/
health y.</w>
headache ;</w>
head -to-
haz ya</w>
har m.</w>
hapto glob
handling -induced</w>
hand grip</w>
ham art
hamart oma</w>
ham ar
haloperidol- elicited</w>
haloperidol -associated</w>
haloperid ol;</w>
haloperid ol)</w>
hal ving</w>
hal f
haemoglob in,</w>
haemodynam ics,</w>
haemodilu tion,</w>
haemo static</w>
haemo phagocytic</w>
haemat opoietic</w>
haem olytic-uraemic</w>
had ,</w>
ha im</w>
h/ rat</w>
h. p.
h ur
h uge</w>
h ue</w>
h ouse</w>
h ole</w>
h mt
h as,</w>
h PF4</w>
h (-1))</w>
gynecomasti a.</w>
gy non-
guide line</w>
guid ing</w>
guanidinosuccin ate</w>
guan idine.</w>
guan abenz
gu y
growth- promoting</w>
group- housed</w>
gro unds</w>
grel ,</w>
granul es,</w>
gran in-derived</w>
gran di
gra vida</w>
gra vid
gra de.</w>
gover n
good- risk</w>
gonadotrop h</w>
glycosaminoglyc an</w>
glycopyrro late.</w>
glycopyrro late,</w>
glybur ide,</w>
glutathione- S-
glutar yl-coenzyme</w>
glutar aldehyde</w>
glutam ine,</w>
glutam ate.</w>
glucosid ase,</w>
glucos amine</w>
glucocortico steroids.</w>
gluco se
glucagon ,</w>
gluc onate,</w>
glomeruloneph ri
gli osis.</w>
glauc ine</w>
girl s)</w>
gh t,</w>
gh t
get s</w>
ger an
gentamic in)</w>
gener ative</w>
gener ational</w>
gener ally,</w>
gene tic,</w>
gen ome</w>
gen icity,</w>
gen ic,</w>
gen ers</w>
gemfibroz il-induced</w>
gemfibroz il,</w>
ge ographical</w>
gav age.</w>
gaug e,</w>
gastro scopy.</w>
gast ritis</w>
gast rectomy.</w>
gang rene.</w>
ganciclovir .</w>
ganax olone</w>
gamma-glutamyl cysteine</w>
gamma- deficient</w>
gamma- D-glutam
gall ate</w>
gal as
galas ap
gadolinium- DTPA</w>
g/m2/ day</w>
g/m (2))</w>
g/d l).</w>
g/ ml</w>
g/ l,</w>
g/ day.</w>
g/ L)</w>
g um,</w>
g row</w>
g ren
g odipine</w>
g au
g ation</w>
g -1.</w>
g -1.
g -1)</w>
furo ate</w>
fur an</w>
fur an-2-
full- blown</w>
ful fill</w>
ful fil
fugu e-like</w>
fructose-1,6-di phosphate</w>
fru it</w>
fron top
fron to-
fro g</w>
freez e-
fram e,</w>
fragment ation,</w>
frag mented</w>
four- year-old</w>
four ;</w>
four -</w>
foun d:</w>
fosinopri l-induced</w>
fosf ob
fos sa.</w>
forty- one</w>
forty- five</w>
formal in,</w>
fore -</w>
for ty</w>
for t
foot ball</w>
foot ,</w>
folliculo stellate</w>
fol d;</w>
fol ates</w>
foc us.</w>
fo ti
fluoroquinol ones.</w>
fluoropyrimid ine-based</w>
fluorometh olone</w>
fluoro scopic</w>
fluoro phenyl)
flunar izine.</w>
fluid ;</w>
fluc ytos
flu ency</w>
flexi ble
fler oxacin</w>
flavon oid,</w>
flap s.</w>
fixed- effect</w>
fix ed,</w>
fissu res</w>
firm ly</w>
fil ters</w>
fig ures.</w>
fifty- one</w>
fifty- five</w>
fibro genic</w>
fibro genesis</w>
fibrinogen ,</w>
fibrill ation)</w>
fibrill ated</w>
fibr in-
fib res,</w>
fib ati
ff in</w>
fet al,</w>
feren ces</w>
fer ubinac</w>
fer tili
fer rous</w>
fentanyl -treated</w>
fenoter ol.</w>
feno fibrate,</w>
fenflur amines</w>
fen ob
feed back,</w>
fec es</w>
feat uring</w>
fe moro
favour ably</w>
fat ,</w>
fast- acting</w>
fast ing,</w>
fascicularis )</w>
fascicul ation.</w>
fallop ian</w>
fall .</w>
fain t</w>
factor- I</w>
facti tious</w>
face- rubbing</w>
fac ial,</w>
f u</w>
f ondaparinu
f loxacin.</w>
f lowing</w>
f i</w>
f ade</w>
f MRI</w>
f EP
ey el
extrem es</w>
extravas ated</w>
extrac tion.</w>
extrac ardiac</w>
extra- pyramidal</w>
extr insic</w>
extinc tion,</w>
exposure ;</w>
explor ation,</w>
expl ants</w>
expl ant</w>
expl ain,</w>
expir ation</w>
experi ences,</w>
exp 2</w>
exerci se-
exer tion</w>
excit ation-
exce ede
examin er</w>
ex- vivo</w>
ex pul
ex pedi
ex ped
ex pector
ex ons</w>
ex il
ew ish</w>
every day</w>
event ually,</w>
event s;</w>
evalu ated;</w>
evalu ate,</w>
euk ario
eukario tic</w>
eu thymic</w>
eu thymia</w>
eu s.</w>
eti ologically</w>
ethyl- 2-
ethyl ene
ethyl adenine</w>
ethyl )-
ethoxy )
eth oxy-
eth idine</w>
etc. ).</w>
et y.</w>
et te</w>
et in.</w>
et exil
esulf onate</w>
estradiol-3- sulfate-17</w>
estr us,</w>
est -
esmo lol.</w>
escal ation,</w>
escal at
escalat ing-dose</w>
es olid</w>
erythropoiet in.</w>
erythro dysesthesi
erythro cy
erythematos us:</w>
erup tion.</w>
ero tic</w>
ero sions</w>
ergot rile</w>
ergol ine.</w>
ergoc rist
er s;</w>
er ations</w>
er );</w>
er ).</w>
equi hypotensive</w>
equi effective</w>
equi analgesic</w>
equ ivocal.</w>
eptid ase-
eptidase- G2</w>
ept al</w>
epo etin-beta</w>
episode s)</w>
epinephr ine/
epileptic s.</w>
epidur al,</w>
epidermidi s</w>
epid oxorubicin</w>
epi- doxorubicin</w>
epi si
epi phy
ep s.</w>
ep ic
enzym atically</w>
environ ments.</w>
envelop e</w>
enure sis</w>
entrain ment</w>
enth usi
entero hepatic</w>
enter opath
enter ic-coated</w>
entan ,</w>
ent e</w>
ent ary</w>
ens zel</w>
enroll ment,</w>
enqu iry</w>
enoxapar in.</w>
enoxapar in,</w>
enkephal inergic</w>
enkephal in.</w>
eni platin</w>
enh ancer</w>
enh anc
engraf t
eng org
eng mai-y
eng ineered</w>
endotheli um,</w>
endometri osis.</w>
endo phthal
end s.</w>
end om
end ocytic</w>
encoun tering</w>
encoun ter</w>
encomp assed</w>
enco des</w>
enco de</w>
ence ).</w>
ence ),</w>
enantiom er.</w>
enalapri lat</w>
enalapri l-induced</w>
en- 2-
en icillin</w>
en gender</w>
en d.</w>
en ;</w>
emo tion
emo den
emergen cy
emerg es</w>
embran e</w>
embol us</w>
emat ous</w>
elsewhe re,</w>
ell ular
elimin ates</w>
eli ac</w>
elev ations.</w>
electrophysi ologic,</w>
electromyo gram.</w>
electroencephalo gram.</w>
electroencephalo gram,</w>
electrocardio grams,</w>
electrocardio gram
elder ly:</w>
el godipine</w>
el ectively</w>
el ected</w>
el berg
eigh tfold</w>
eicos anoid</w>
eg le</w>
effect s)</w>
efavi renz</w>
edic ,</w>
edema ;</w>
ectop y.</w>
ecto derm</w>
ect asia</w>
ecstas y)</w>
echo thiophate</w>
ech loreth
ec zema,</w>
ec utive</w>
earli er)</w>
each ):</w>
each ),</w>
eNOS- Tg</w>
eNO S,</w>
e-N e</w>
e- mediated</w>
e sian</w>
e sia</w>
e oniflor
e at</w>
e ae)</w>
e able</w>
e +
dysur ia</w>
dysphag ia.</w>
dysmen orrhea</w>
dysfunction ).</w>
dysesthesi as</w>
dys r
dy e,</w>
dur ing-treatment</w>
dur ation:</w>
duloxet ine-treated</w>
drug- related.</w>
drug- coated</w>
drug :</w>
drox y-
dro p,</w>
dri ve,</w>
dream s,</w>
dramatic ally.</w>
dramatic ally,</w>
dra ined</w>
dra in</w>
doxy cycline.</w>
doxorubicin/ docetaxel</w>
doubt ful</w>
double- stained</w>
dou bl
dose- intensive</w>
dose =
dopamine- receptor</w>
don or-
don ation.</w>
domin ance</w>
domain s.</w>
dom estic</w>
dog :</w>
dog 's</w>
docetaxel /
docetaxel .</w>
doc osahexaenoic</w>
do dec
dizocil pine,</w>
diver tic
disulfiram- ethanol</w>
distur bed.</w>
distur b</w>
dist ended</w>
dist ance.</w>
dist ance,</w>
dissoci ation.</w>
dissoci ate</w>
dissip ated</w>
disorder ing</w>
discus sing</w>
discrimin ation,</w>
discolor ation,</w>
disco ver</w>
discer n</w>
disappear .</w>
disabl ing.</w>
dis on's</w>
dis integration</w>
dis array</w>
dis appea
dipi valoyl</w>
diphenylacetoxy- N-methyl
din ir</w>
dimethyl-1- propargyl
dimension ally</w>
dimenhydr in
dilu tions</w>
dilu ent.</w>
diltiazem -treated</w>
dilat es</w>
dilat ation.</w>
dihydrotachy sterol</w>
dihydro ergocrist
digit ally</w>
digit alized</w>
dig oxigen
difficul ty.</w>
diff icile</w>
diethylstilbestro l-
diethylnitros amine-initiated</w>
diethyl propion</w>
diet ;</w>
diet ),</w>
dichlorodiphenyl trichloroethane</w>
dichlor vos</w>
dicarbox ylate</w>
dic yclo
dibuc aine</w>
diazepam -treated</w>
diaz abicyclo
diast ere
diaphore sis.</w>
diagno sis;</w>
diabet es-
diabe tics.</w>
di py
di pren
di ph
di ol</w>
di methoxy
di mesylate</w>
di meglumine</w>
di d,</w>
di butyr
di aldehyde</w>
dextror phan,</w>
dextran .</w>
dextran ,</w>
dexrazox ane.</w>
devic e,</w>
development ;</w>
develop s,</w>
determ ine:</w>
deterior ated,</w>
desmo press
desig ned,</w>
des Arg
dermat osis</w>
derivati ves:</w>
depres sed,</w>
depolar ization.</w>
deplo yment</w>
depend ency.</w>
depart ments.</w>
depart ments,</w>
dep ic
denud ation</w>
den uded</w>
den sed</w>
demyel inated</w>
demograph ically</w>
demarc ated</w>
deman ding</w>
delta- amino
deline ated.</w>
del usion</w>
dehydrogen ase-
dehydrat ase</w>
deform ities</w>
deform ability</w>
definit e,</w>
defini tions</w>
deficit -
deficit- hyperactivity</w>
defici encies.</w>
defer oxamine.</w>
defect s:</w>
defect ),</w>
defascicul ation.</w>
deep- brain</w>
decreas es.</w>
decor ticated</w>
decongest ants,</w>
decom pressed</w>
decl ar
dec ur
dec tin</w>
dec ont
dec eased</w>
debilit ated</w>
death ;</w>
death :</w>
deaf ened</w>
deacetyl ase</w>
de sensitize</w>
de re
de met
de af</w>
de ;</w>
de /
dd C-induced</w>
day s
datab ases,</w>
danazol -induced</w>
danazol ,</w>
dam pen
dam aged.</w>
dam age;</w>
dail y-
da zole.</w>
dP/dt max),</w>
dP/dt (max).</w>
d4 T
d- modality</w>
d- methadone</w>
d- certified</w>
d- alpha-tocopherol</w>
d- Chiari</w>
d,l- propranolol</w>
d ures</w>
d t/
d t
d s)</w>
d act
d ab
d PAG</w>
d (CH
d(CH 2)
d(CH2) 5
d (-1)</w>
cytoskele ton
cyt olytic</w>
cystin uria</w>
cystic a</w>
cysti tic</w>
cyste ine.</w>
cyl ind
cyclospor ine-based</w>
cyclospor in,</w>
cyclohex anedi
cyclo- oxygenase-2</w>
cyanocob al
cyano tic</w>
cy tidine.</w>
custom ary</w>
curren tly,</w>
curren t-
curett age</w>
cur arization</w>
cumul ative.</w>
cu tis</w>
cu es,</w>
cu .
crystallo id</w>
crystall uria,</w>
crypt ococ
crush ing</w>
cruc i
cross-fo stering</w>
cross- legged</w>
cros ses,</w>
cromoglyc ate</w>
cri minal</w>
cran ium</w>
crack /
crack/ cocaine</w>
cow 's</w>
counter part</w>
coun ting,</w>
coun sel</w>
coumad in</w>
cost- utility</w>
cos metic</w>
corticosteroid ,</w>
corticoster one.</w>
cortag ine</w>
corrobor ate</w>
correl ative</w>
correc ted,</w>
coron ary-
cor tically</w>
cor nea</w>
cop ies</w>
convuls ant-induced</w>
conve yed</w>
controver sy.</w>
contradic tory</w>
contract ures,</w>
contract ure.</w>
contraceptiv es:</w>
contra sts</w>
contr acting</w>
continu ity</w>
continu al</w>
contex t.</w>
contex t,</w>
consul tation.</w>
construc ts</w>
consist ency</w>
conserv ation</w>
consequ ence.</w>
cons ented</w>
congru ent</w>
confoun ding.</w>
confir matory</w>
conf u
conf id
conduct ances</w>
condition ed-
concer ns.</w>
concer ned,</w>
concent rates</w>
conceiv able</w>
con geners</w>
con found</w>
con formation</w>
con densed</w>
con dens
con cordant</w>
computer ised</w>
compres sions</w>
compon ent
complic ations:</w>
complex ed</w>
comple tion.</w>
comple mented</w>
compet ence</w>
comparison s.</w>
comparison s).</w>
comp ute</w>
comp elling</w>
comp act</w>
comp ac
common er</w>
combin es</w>
combin ation-
comato se.</w>
colocysto plasty</w>
collicul us.</w>
collagen ase-induced</w>
collagen ase,</w>
coll ection,</w>
colchic ines</w>
col lege</w>
col leagues</w>
col d-induced</w>
coinc ides</w>
cognitive- enhancing</w>
cogn ate</w>
cochle a,</w>
cocaine- use</w>
cocaine- reinforced</w>
cocaine- free</w>
cocaine- exposed,</w>
cocaine- evoked</w>
cocaine- addicted</w>
coca ine
coca ethylene,</w>
co- morbidity,</w>
co- localized</w>
co st,</w>
co oled</w>
co ol</w>
co factor</w>
co des</w>
co axial</w>
co arsen
co arc
coarc tation</w>
co -treated</w>
cm ),</w>
clump ing</w>
clozap ine's</w>
closel y.</w>
clorazep ate</w>
clonid ine-
clon azepam
clomi pramine-treated</w>
clomi pramine-induced</w>
clobaz am.</w>
clo ti
clipp ing.</w>
clioquin ol.</w>
clinici ans,</w>
climb ing,</w>
classi fy</w>
clas ses.</w>
cladrib ine</w>
cladrib ine.</w>
cla f</w>
cl one</w>
cl it
cl ing</w>
cl icks</w>
cl aw
cl ass
citrat us</w>
citalopram -induced</w>
cisplatin um,</w>
cisplat in/
cisapri de.</w>
cisapri de-induced</w>
cisDD P-
cisDDP- then-pct
cis- RA)</w>
circumst antial</w>
circul ations.</w>
circ us</w>
cing ulate,</w>
cigarette ,</w>
ci razoline</w>
ci es,</w>
chron ologic</w>
chroma ffin</w>
chos en.</w>
cholinester ase-positive</w>
cholinerg ics</w>
choline- supplemented</w>
cholin oc
cholecystokin in.</w>
cholecyst ectomy,</w>
cholecalcifer ol.</w>
chol ate</w>
chol angiography,</w>
chol angio
cho w
chlorprop amide,</w>
chlorothiaz ide.</w>
chlordec one-induced</w>
chlorambuc il-induced</w>
chloralo se.</w>
chlor imipramine</w>
chlor ide)</w>
childho od,</w>
child :</w>
chias mal</w>
chias m</w>
chi p</w>
chest- pain-related</w>
cheno deoxycholic</w>
chemotherapy- na</w>
chemotherap ies</w>
chemotherap eu
chemosensitiz ers</w>
chemosensi tive</w>
chemoradi otherapy</w>
chemo- na</w>
check- up.</w>
chec ks</w>
che wing,</w>
characteris tics:</w>
character ized,</w>
character ization.</w>
channel- blocking</w>
chang ed,</w>
chain s,</w>
chain .</w>
ch ylo
ch ocer
ch lamydial</w>
ch ances</w>
ch -
cerebri ,</w>
cer ulospinal</w>
cer uletide</w>
cer ta
cephaloth in-
cephalospor in-induced</w>
cephal ad</w>
centr ally.</w>
cent re.</w>
cent age</w>
cembran oids</w>
cell ulose</w>
cell s),</w>
celi prolol</w>
ceftiz oxime</w>
ceftiz oxi
cefotet an-
cefosel is</w>
cefazol in,</w>
cef dinir</w>
ce fixime</w>
ce ;</w>
cavernos al</w>
caveol in-1</w>
cav a.</w>
cause- and-
cause-and- effect</w>
caus ality.</w>
cau tioned</w>
catheter izations</w>
catech in</w>
cataly zes</w>
cataly ze</w>
castr ation,</w>
cas es);</w>
cas e)</w>
cartil age,</w>
caroti d,</w>
carnit ine.</w>
cardioverter- defibrill
cardiom otor</w>
cardio thoracic</w>
cardio embolic</w>
cardiac- valve</w>
carcin omatosis</w>
carbon yl
carbon ate-induced</w>
carbon ate,</w>
carbocrom ene</w>
carbo hyd
carami phen,</w>
car min
car bet
capsul e,</w>
capsaicin- stimulated</w>
cannul a.</w>
cannul a,</w>
candidi asis</w>
candes artan,</w>
can cell
calretin in</w>
calibr ated</w>
calcul ated:</w>
calcitri ol-treated</w>
calcineur in.</w>
calcineur in-inhibitor</w>
calbindin- D(2
calbindin-D(2 8
calbind in,</w>
cal di
cal cemic</w>
caffeine- free</w>
caffe inism.</w>
caffe inated</w>
ca vit
ca ulophine</w>
ca ucasian</w>
ca proic</w>
c-fos ,</w>
c- jun</w>
c us
c oxib
c ox
c ited</w>
c id</w>
c d
c c/
c ar</w>
c AUC-1/
cAUC-1/ 2</w>
byp assing</w>
by- pass</w>
butyro phen
butyl bromide</w>
but yric</w>
busulf an.</w>
buspir one-treated</w>
burst- suppression</w>
burst- forming</w>
bur row
bupivacaine- fentanyl</w>
bufur alol</w>
bud ralazine</w>
bu thionine</w>
bronchodilat or,</w>
bronchoconstric tion,</w>
bronch itis</w>
bronch itis.</w>
bro ther</w>
bro ken</w>
brimon idine.</w>
bridg ed</w>
bridg e,</w>
bretyli um.</w>
breakthrough s</w>
break s</w>
break down.</w>
branch ial</w>
bran ch.</w>
bradycardia )</w>
brady cardic,</w>
brac ket</w>
br ings</w>
bout ons</w>
botul ism</w>
bot tle</w>
bor der,</w>
body- surface</w>
bodi ly</w>
boar d-certified</w>
bo y
block ers:</w>
blind ing</w>
ble ed,</w>
blast oma</w>
blast ocy
blac ks.</w>
bit ter</w>
bisulfit e.</w>
bisphosphonat es.</w>
bis(2-chloroethyl)-1- nitrosourea</w>
bis an
bisan trene</w>
bis (3,
bis (1-
biot in
biopsy- confirmed</w>
biomark ers,</w>
biolog ical,</w>
bioc hemotherapy</w>
bio physical</w>
bio distribution</w>
bio assays</w>
bio assay,</w>
bing ing</w>
bing e'</w>
bim onthly</w>
bilater al.</w>
bigemin y,</w>
bicalut amide-
bibli ographies</w>
bi directional</w>
bezafib rate,</w>
bevaciz umab.</w>
bethan ech
beta-galactosid ase,</w>
beta-CC t</w>
beta-CC E</w>
beta- receptors</w>
beta- blocker
beta- blockade.</w>
beta- antagonist</w>
beta- E</w>
beta- (4-
beta(1)- adrenoceptor</w>
beta =
bet agam
best- known</w>
bepri dil
benzodiazep ine/
benzo[a,d] cyclohepten-5,10-imine</w>
benef icially</w>
bendroflu azide.</w>
benazep ril</w>
ben ch
belie ved.</w>
behavior :</w>
beats/ min),</w>
beats. min-1,</w>
be me
be have</w>
be ef</w>
bat an
basi chondro
baro reflexes</w>
baro receptor-
baro denervated</w>
barbitur ates,</w>
bar .</w>
ball s,</w>
bacterio static</w>
bac osides</w>
b w)</w>
b uni
b rate</w>
b outs</w>
b ly</w>
b id)</w>
b ending</w>
b ark
azol .</w>
azimil ide,</w>
az april</w>
ay urvedic</w>
axon al,</w>
ax ill
awa it</w>
aver t</w>
aver m
av ocad
autop sy
automatic ity,</w>
autom atis
automatis ms</w>
autom atically</w>
autoimmun ity,</w>
audi ometry.</w>
atyp ia</w>
atr ici
atom oxet
ato sib
atipame zole.</w>
ation --
ati z
athle tic</w>
ather omatous</w>
ather ogenesis</w>
ath esin</w>
atele t</w>
ate gies</w>
ate d"</w>
ate 's</w>
at ran
at on</w>
at on
at ing-
at es),</w>
at ergic</w>
asymptomatic ;</w>
asymmetr ical</w>
astronaut s</w>
astrocyt oma</w>
astro cytosis.</w>
astro cytes,</w>
asth ma;</w>
assum ptions</w>
assum ing</w>
assum es</w>
assemb ly</w>
assem bled</w>
aspir in/
aspart ate-
asparagin ase.</w>
asle ep
asi atica</w>
as su
as on</w>
arti cles,</w>
arthralgi as/
arteriosclero tic,</w>
arteriosclero sis.</w>
arterio pathy</w>
arterial ized-
arteri es:</w>
artemether /
artemether/ lumefantrine</w>
arte mis
arrhythmi as)</w>
arrhythm ia;</w>
arrest )</w>
aro used</w>
armac ia</w>
arkin son's</w>
ari se.</w>
ari an</w>
arginine- vasopressin</w>
argatrob an,</w>
arg ument</w>
arec oline,</w>
areas :</w>
arch ,</w>
arbitr ary</w>
arb azepine</w>
ar ily,</w>
ar /
apri lat</w>
applic ations.</w>
appeti te.</w>
append ic
apoptosis- associated</w>
apoA- I,</w>
apno e
apnea- hypopnea</w>
apne ic,</w>
apath y,</w>
ap posed</w>
ap er</w>
any where</w>
anxioly tic,</w>
anxiet y)</w>
antitus sive</w>
antiretrovir als,</w>
antin icotinic</w>
antimicrobi als</w>
antihistamin ic</w>
antihist amine.</w>
antigen- presenting</w>
antieme tics,</w>
anticoagul ation-related</w>
anticoagul ant.</w>
anticholinerg icity</w>
antiarrhythmic s,</w>
anti- cholinergic</w>
anti serum.</w>
anti myeloperoxidase</w>
anti mitotic</w>
anti heparin-platelet</w>
anti glutamatergic</w>
anti estrogens</w>
anti estrogenic</w>
anti biom
anti amphetamine</w>
anti -</w>
anthracycl ine-
anthracenedi ones</w>
anthrac ene</w>
anth ra
anteri or,</w>
antagon ization</w>
ant i</w>
ant azoline</w>
ant ),</w>
anorexigen -associated</w>
anomal y.</w>
ano dermal</w>
ank yrin-G</w>
ani on,</w>
angiotensin- receptor</w>
angiograph ic,</w>
angio pathy.</w>
angio -
aneurysm s,</w>
anesthetiz e</w>
anesthesia -related</w>
anesthesi a;</w>
anesthesi a:</w>
anem ias</w>
anem ia)</w>
ane/ nitrous</w>
ane- associated</w>
ane ).</w>
ane ),</w>
androgen ,</w>
and y</w>
ance ;</w>
ance -
anc rod</w>
anc illary</w>
anatom y,</w>
anastom osis.</w>
analy sis;</w>
analog s.</w>
analo gy</w>
anal eptic</w>
anal bum
anaesthe tics,</w>
anaesthe tic-induced</w>
anaesthe tic,</w>
anaesthe sia:</w>
anaesthe si
an- niacin</w>
an- G
an-G an
an-Gan z</w>
an- American</w>
an hepatic</w>
an as
an agrelide</w>
an ).</w>
amylo idosis.</w>
amy otrophic</w>
ampren avir</w>
amplitu des.</w>
ampl ifi
ampicillin- cefotaxime</w>
ampicill in,</w>
amphetamine- dependent</w>
amphetamine- class</w>
amph o</w>
amoxicillin/ clavulanic</w>
amoxicill in,</w>
aminotransfer ase.</w>
aminop eptidase</w>
aminoindan-1, 5-
aminoindan-1,5- dicarboxylic</w>
amino propyl
amino acids</w>
amine- containing</w>
amine- atropine</w>
amelior ated.</w>
ambul ate</w>
ambul ance</w>
am id</w>
am end
am ),</w>
aly :</w>
alter ation.</w>
alte plase</w>
alpha-r ANP</w>
alpha-methyl histamine</w>
alpha-amino-3-hydroxy-5- methyl-4-
alpha- keto
alpha- blockers</w>
alpha- blocker</w>
alpha- adrenoceptors.</w>
alpha- TC</w>
alpha- Methyl-
alpha-Methyl- p-tyrosine</w>
alpha- HCH</w>
alpha,beta-me ATP</w>
alpha(1)- adrenoceptor</w>
alpha 2a</w>
alpha 2-</w>
alpha -induced</w>
allyl cysteine</w>
allograf ts.</w>
all yl-
alkyl ase</w>
aldoster one-
alcohol ics,</w>
alcoh ol)</w>
albumin /
albumin -
album inemic</w>
alaprocl ate</w>
al- specific</w>
al w
al th</w>
al prenolol</w>
al prenolol,</w>
al pidem</w>
al is.</w>
al ine-induced</w>
al ine,</w>
al imbic</w>
al ign
al bolabrin</w>
al /kg</w>
aj mal
agricul tural</w>
agoraph obia,</w>
agonist s:</w>
agonist /
agonist -like</w>
agmat ine.</w>
agl ate)</w>
agit ated,</w>
aggressi veness,</w>
ageu sia</w>
agent s),</w>
agent )</w>
age- ,</w>
ag ranular</w>
ag litaz
ag ency</w>
ag en
ag ed-
ag arose</w>
afterno on</w>
afterno on.</w>
after .</w>
af un
af ascicular</w>
aeruginos a.</w>
aeros olized</w>
ady namic</w>
advoc ated.</w>
adulter ated</w>
adul ts;</w>
adrenocept or.</w>
adrenerg ically</w>
adren al-
adolesc ence.</w>
admis sions.</w>
administere d;</w>
adi p
adhe sions</w>
adhe rent</w>
aden osis.</w>
addi tives</w>
addi tionally,</w>
adap t</w>
ad sor
ad nex
ad ded,</w>
acy tidine</w>
acute- phase</w>
acute- onset</w>
acupunct ural</w>
acu point</w>
acu min
active- controlled,</w>
activ ated,</w>
act in.</w>
acromegal ics</w>
acro meg
acquisi tion.</w>
acid- rich</w>
acid -related</w>
acid +
acid ),</w>
ach es</w>
acetyl- L-
acetaminophen -related</w>
acet olol</w>
acet amide-induced</w>
ace promazine,</w>
ace but
ace a
accurac y,</w>
accord ingly.</w>
accid ent.</w>
acces sed</w>
accept ance.</w>
accept able.</w>
accep ted.</w>
accentu ates</w>
accent uate</w>
ac ul
ac itidine</w>
ac ept</w>
ac epif
abuse /
absten tion</w>
absorb ance</w>
absces ses</w>
absc ess,</w>
abor tions,</w>
abnormaliti es;</w>
abnormaliti es:</w>
abl o</w>
abdom inal,</w>
ab user.</w>
ab ine.</w>
ab ine-associated</w>
ab duction</w>
a. m.</w>
a. m.,</w>
a- Pacific</w>
a vascular</w>
a kin
a id.</w>
a etiology.</w>
a VF,</w>
a F
a ?</w>
] =
[K+ ]</w>
[8 ]</w>
[5- amino-
[3H] thymidine</w>
[2, 1-
[14 C]-
[10 ]</w>
[1-1 1
[1-11 C]
[1- (14)C]
[(2-methyl -1,3-
[(2-methyl-1,3- thiazol-4-yl)ethynyl]pyridine</w>
[ median</w>
[ bis
[ T
[ Li
[Li (+
[Li(+ )]</w>
[ G
[ Ca(2+)]
[Ca(2+)] (i)</w>
[ AUC
[ A
[ 7.
[ 19
[ 18
[ 13
[ 0.6
[ (125)I]
[ (+/-)-
Zol linger-Ellison</w>
Zn SO(4)</w>
Zidovud ine-induced</w>
Z yb
Z onisamide</w>
Z T
Z Rs.</w>
Z P)</w>
Yor k,</w>
Yale- Brown</w>
Y KP14
XE LOX</w>
X LH</w>
X I
X ;</w>
X 2</w>
X /
Willi ams</w>
Wil son</w>
Wh ilst</w>
Wernic ke's</w>
Washing ton</w>
Washing ton,</w>
Walk er</w>
WR 27
WR27 21</w>
W/ F
W/F u</w>
W- ICH.</w>
W is
W idespread</w>
W eigh
W ard</w>
W T
W PW</w>
W LP-S
WLP-S -10</w>
W I
W F-
W A</w>
W A-3
WA-3 35</w>
W ,</w>
Volum e</w>
Vol ume
Vincrist ine,</w>
Ves tibular</w>
Verapam il-induced</w>
Verapam il,</w>
Vehicle +
Vehicle+ Isoflurane</w>
Ve si
Val salva</w>
Vag otomy</w>
VM- 26</w>
VE R</w>
V on</w>
V m</w>
V indes
V PD</w>
V MR
V II.</w>
V I,</w>
V CD</w>
V AS-
V AS,</w>
V :</w>
V 3</w>
V 232
V 1-
V (1)</w>
Ursodeoxychol ic</w>
Ur gent</w>
Upjo h
Univers ity,</w>
Un controlled</w>
Ultra structure</w>
UT R</w>
US PI
US A.</w>
UMB 24</w>
UK-61, 26
UF T</w>
UF A)</w>
UD R)</w>
U/ ml,</w>
U.S. A.</w>
U-900 42</w>
U terine</w>
U claf</w>
U V</w>
U TIs.</w>
U RO
U N</w>
U MD
U K,</w>
U I.</w>
U GI</w>
Trimethoprim-sulfamethox azole-induced</w>
Tri phasi
Traum atic</w>
Tras ina</w>
Transc ranial</w>
Trans placental</w>
Trans dermal</w>
Tran smural</w>
Tran sit
Tourniqu et</w>
Tor r</w>
Tor on
Tn I</w>
Time -dependent</w>
Tim entin</w>
Ti e
Thrombo embolism</w>
Thir d,</w>
Thior idazine</w>
Theophyll ine-associated</w>
The ore
Th is,</w>
Th 1</w>
Tetrahydro cortisol</w>
Testo ster
Test ,</w>
Ten ofovir
Teli thromycin</w>
Techne tium-
Td R</w>
Tc ES</w>
Tax ol,</w>
Target ed</w>
Tamoxif en-induced</w>
Tam m-Horsfall</w>
Tacrolim us,</w>
TX B2</w>
TT X-
TT P.</w>
TP ).</w>
TMP y
TMP -induced</w>
TM S)</w>
TIMP -1</w>
TI -
THE O</w>
TGF-beta II
TGF-betaII R</w>
TG B</w>
TF MP
TCD D,</w>
TB OB</w>
T izanidine</w>
T ig
T iaz
T c)</w>
T UDC</w>
T SH,</w>
T SC
T LS</w>
T I</w>
T GR</w>
T GR
TGR (A
TGR(A 1-
TGR(A1- 7)
TGR(A1-7) 3
T FA</w>
T CC</w>
T CAs</w>
T C.</w>
T 9-
T 5</w>
T 4)</w>
T 1
Synerg istic</w>
Syndrome .</w>
Syn aptic</w>
Sw an-Ganz</w>
Sur viv
Sup port</w>
Sup ine</w>
Sulph asalazine</w>
Sulf asalazine</w>
Succinyl choline-induced</w>
Succ essive</w>
Subst anti
Suanzaoren tang</w>
Stri kingly,</w>
Strati fication</w>
Str ategies</w>
Stat ins</w>
Stand ardized</w>
St uttering</w>
St upor</w>
St ate-
St an
Squ amous</w>
Spironolact one-induced</w>
Spi ro
Specific ity</w>
Speci al
Spec tral</w>
Spe ech</w>
Sou theast</w>
Son ographic</w>
Somn ol
Somn ambul
So ft</w>
Smad 3</w>
Smac/ Di
Smac/Di ablo</w>
Sirolim us-induced</w>
Siri raj</w>
Single- agent</w>
Silden af
Signific antly,</w>
Shen fu</w>
Shakuyaku-kanzo- to</w>
Shakuyaku- Kanz
Shakuyaku-Kanz o-
Seventy- nine</w>
Sev en-
Sel enium</w>
Seiz ures,</w>
Sco res</w>
Schuknech t</w>
Sch war
Sch onlein</w>
Sar izotan</w>
Sal v
Sal ine,</w>
SY 5Y</w>
SUMMAR IE
SUMMARIE S:</w>
SULT 1
SU F</w>
STR AT
STRAT EG
STRATEG Y:</w>
ST- depression</w>
ST P1</w>
ST N.</w>
ST N-
SRL- based</w>
SR1417 16</w>
SR T</w>
SP- PI</w>
SOD 1</w>
SO N</w>
SN H
SM Vs</w>
SL P</w>
SL 327</w>
SK EO</w>
SI LE
SILE NT</w>
SI CH</w>
SI ).</w>
SHR SR</w>
SH x</w>
SH AM</w>
SG PT,</w>
SG ).</w>
SF O</w>
SERCA 2b</w>
SE M),</w>
SE Fs</w>
SD s</w>
SD S-
SD RR</w>
SD H</w>
SD :</w>
SCN5 A</w>
SCL S</w>
SCH 23390,</w>
SCH -
SC O</w>
SC .</w>
SB- 2
SB P.</w>
SB 33
SB33 48
SB3348 67</w>
SAR s</w>
SA A</w>
S.E.M .)</w>
S-3 12-
S- methyl
S- allylcysteine</w>
S- 3,4-DCPG</w>
S- 2-
S yrian</w>
S v
S tric
S ti
S poradic</w>
S p</w>
S ol
S light</w>
S can</w>
S can
S S.</w>
S S,</w>
S Q
S LV
S HC.</w>
S AD)</w>
S -treated</w>
S -associated</w>
S -18
S-18 1
Ry anodine</w>
Ros u
Riz atriptan</w>
Rit on
Rifamp in</w>
Rifamp icin-induced</w>
Rheum atology</w>
Rh esus</w>
Rg5/Rk 1</w>
Rg3 (S)</w>
Retro spectively,</w>
Retro spective,</w>
Retro grade</w>
Ret inol</w>
Ret ention</w>
Respon ders</w>
Repub lic</w>
Rel ax
Reg 2</w>
Recre ational</w>
Record ings</w>
Reci procal</w>
Rec on
Re liable</w>
Re al-
Rb +</w>
Rayna ud</w>
Random ised</w>
Randall-Selit to</w>
Ran kin</w>
Ran dom</w>
Radi otherapy</w>
Radi ological</w>
Radi al</w>
Rac emic</w>
RTI -3
RTI-3 36</w>
RT- PCR.</w>
RT X</w>
RT ).</w>
RPL S</w>
RP ).</w>
RN ase</w>
RL S,</w>
RG13 9
RG139 65</w>
RE M)</w>
RAE B-
RA C</w>
RA -treated</w>
R,4 R-
R, 3
R(+)- BAC</w>
R u
R osi
R hazya</w>
R ev
R ash
R as-
R PTP
RPTP beta</w>
R NS</w>
R HA</w>
R CM</w>
R :
R .
R -1
R (-
Quin pi
QT(F ri
QN B</w>
Q- A</w>
Q OD</w>
Q -induced</w>
Py raz
Psychopharmac ological</w>
Psych ophysical</w>
Pseudo ephedrine</w>
Prom pted</w>
Prolifer ating</w>
Proj ect
Proce dures</w>
Proble matic</w>
Prob ands</w>
Pro ver
Pro ducts</w>
Preser vation</w>
Prescri ption</w>
Pres sure</w>
Pres ently,</w>
Predic ting</w>
Precipit ation</w>
Pre- existing</w>
Pre mature</w>
Pre incubation</w>
Pre existing</w>
Por phyria</w>
Poly myositis</w>
Poly amines</w>
Po wer</w>
Po or</w>
Pm(O (2))</w>
Plat inum</w>
Pl us</w>
Pl aqu
Pit ts
Pir arubicin</w>
Pin sch
Pin acidi
Pimoz ide</w>
Pilocar pine-treated</w>
Pilocar pine,</w>
Pil o</w>
Physos tigmine,</w>
Phosph odi
Phosph atidyl
Philadelph ia</w>
Phenyl butazone</w>
Phenobarbit al-induced</w>
Pharmaco dynamic</w>
Person s</w>
Perox is
Perit oneal</w>
Peri -
Per centage</w>
Pentazoc ine-induced</w>
Pent oxifylline</w>
Pent obarbit
Park ,</w>
Parameter s</w>
Paradoxic ally,</w>
Par a
Pamid ronate</w>
Pal li
Pa w</w>
Pa CO</w>
Pa CO2,</w>
PW V</w>
PV R</w>
PV M</w>
PV L</w>
PV G
PVG /c</w>
PURPO SE</w>
PTH ,</w>
PT X.</w>
PT SD</w>
PT CA.</w>
PR O</w>
PR IN
PR I</w>
PR BC</w>
PR -
PPA DS</w>
PP Is</w>
PP I.</w>
PO SURE
PO RP</w>
PO 2,</w>
PIL O,</w>
PH AR
PGI 2.</w>
PG I-
PF C.</w>
PED F</w>
PE T.</w>
PE T,</w>
PE S</w>
PE MA</w>
PE AK</w>
PDGF- B</w>
PD C</w>
PC x</w>
PB SC</w>
PACAP +/-</w>
PAC PP</w>
PA LA</w>
PA K</w>
PA H.</w>
PA H,</w>
PA G)</w>
PA ;</w>
P< 0.0001).</w>
P4 50,</w>
P2 1,</w>
P/ 3/4</w>
P-glyco protein,</w>
P- positive</w>
P- immunoreactive</w>
P- BM
P- 3.0</w>
P yridox
P yr
P si
P s.</w>
P edi
P as
P arg
P ab
P S,</w>
P PVL</w>
P PCx</w>
P MM</w>
P M,</w>
P J
P I/
P I,</w>
P >0.05).</w>
P -1</w>
P );</w>
Oxy morphone</w>
Over dose</w>
Ouabain -induced</w>
Organ ophosph
Open- label</w>
One- hundred-
One ,</w>
Om ni
Om apatrilat</w>
Olanzap ine-treated</w>
Observ ation</w>
Ob struction</w>
OX R1</w>
OX O
OS U</w>
OR TC</w>
OR R</w>
OR L-1</w>
OR E</w>
OR /O
OR/O S-
OPC-145 97</w>
ON O-
OH D2</w>
O-(2- thiodiphosph
O t
O piate</w>
O perative</w>
O ]
O X</w>
O PD</w>
O P-induced</w>
O MD</w>
O M</w>
O CS.</w>
O C,</w>
O AD</w>
O A.</w>
O 2.</w>
O 2),</w>
O (2).</w>
Norepinephr ine-induced</w>
Nor triptyline</w>
Nor dic</w>
Non cardiac</w>
Nitrofur antoin-induced</w>
Nitro- L-arginine</w>
Nitro bid</w>
Nis sl-
Ninety- four</w>
Ninety- five</w>
Nic ergoline</w>
New ly</w>
Neurolep tics</w>
Neuro behavioral</w>
Nel son's</w>
Nec k</w>
Na- K-ATPase</w>
Na(v) 1.8</w>
Na(+)- K(+)-ATPase</w>
Na(+), K(+)-ATPase</w>
Na HCO
Na BB</w>
NZ W</w>
NT R)</w>
NT P</w>
NT G-
NT F</w>
NT /
NS- 398</w>
NS S</w>
NS E</w>
NS -3</w>
NP ).</w>
NO T</w>
NM U</w>
NH4 Ac</w>
NE T</w>
NE O</w>
NADPH- diaphorase</w>
NAD (P
NAD(P )
NAC -treated</w>
NA SH,</w>
NA PA</w>
NA F
NA -treated</w>
NA ).</w>
N6- cyclohexyladenosine</w>
N0 82</w>
N-nitrosodiethyl amine-initiated</w>
N-methyl-N'-nitro-N-nitroso guanidine</w>
N-methyl-D- aspartate,</w>
N-methyl- 2-
N-Methyl-D- aspartate</w>
N-76 A</w>
N- nitrosobut
N- n-propyl
N- methylox
N- lesioned</w>
N- ammonia</w>
N- [2-
N- (1-
N- (
N x</w>
N w-nitro-L-arginine</w>
N tcp</w>
N omega-nitro-L-arginine</w>
N odular</w>
N oc
N albu
N af
N W</w>
N PRS</w>
N L</w>
N IN
N ID
N E)</w>
N C.</w>
N 36
N36 3
N 1-
N (2)
Myo -
Myelo toxicity</w>
My otonia</w>
My ocet</w>
My algi
Muscim ol,</w>
Mun ich-Wistar</w>
Mu MT
Morph ologically,</w>
Mono amine</w>
Monit or
Mo(t )/
Mo dul
Mn PO</w>
Mito- Q</w>
Minoxidi l,</w>
Min i</w>
Mil der</w>
Micro gynon-
Michi gan</w>
Mg+ +</w>
Meto /HCTZ</w>
Methyl phenid
Methyl ene</w>
Metfor min-induced</w>
Met yrap
Met am
Mes alazine</w>
Meropen em</w>
Mer ck</w>
Medic ine,</w>
Med ullary</w>
Med Watch</w>
Mechan istic</w>
Meas ured</w>
Meas ure</w>
Me t</w>
Me droxyprogesterone</w>
Me dro
Me di
Mantel-Ha enszel</w>
Mala oxon</w>
Macroph ages</w>
Macro scopic</w>
Mac aca</w>
Ma haim</w>
MVO 2,</w>
MS SA</w>
MR C</w>
MR 1</w>
MR .</w>
MPE P,</w>
MP P
MP E</w>
MP ),</w>
MN PA</w>
MM F.</w>
MK-80 1-induced</w>
MK-80 1)</w>
MF S.</w>
MEDLIN E.</w>
ME NT</w>
ME ,</w>
MDR-T B</w>
MDMA (+)</w>
MD S/
MD K</w>
MD D)</w>
MCA v</w>
MCA O</w>
MCA -induced</w>
MATERIAL /METHODS:</w>
MAO- A</w>
MA G
MA D
MAD RS</w>
MA -exposed</w>
MA -abusing</w>
M3 G</w>
M- PGF2</w>
M orbidity</w>
M atri
M as</w>
M PA.</w>
M ORE</w>
M OR</w>
M OP</w>
M NPC</w>
M Hz</w>
M G.</w>
M CT/LCT</w>
M CL
M CA.</w>
M BP</w>
M AC)</w>
Lup us</w>
Lor acar
Lof ex
Loc alization</w>
Lis uride</w>
Lis dexamfetamine</w>
Lipo ic</w>
Lign ocaine</w>
Lidoca ine,</w>
LiCl -treated</w>
Li vers</w>
Li ver
Lev amisol
Leuc ovorin</w>
Leu -
Lenal idomide</w>
Le sion</w>
Late- onset</w>
Lat er,</w>
Las er</w>
LY1753 26</w>
LV S</w>
LV H</w>
LRTI s</w>
LP S-induced</w>
LP C</w>
LO S</w>
LHR H,</w>
LH-Z I</w>
LE C</w>
LDL- cholesterol</w>
LD F</w>
LD (50)</w>
LCR /HC
LCR/HC R</w>
LC 6
L-arginine- nitric</w>
L-N MMA,</w>
L-N I
L-DO PA)</w>
L-36 5,
L-365, 260</w>
L- lysin
L- glutamate</w>
L- NO
L- 655
L-655 ,
L-655, 70
L- 3,4-dihydroxyphenylalanine</w>
L umbar</w>
L ox
L ometrexol</w>
L in
L ength</w>
L e</w>
L amb
L actic</w>
L ])</w>
L W</w>
L V)</w>
L SD</w>
L R)</w>
L P)</w>
L OC</w>
L N)</w>
L CB
L CA
L AC,</w>
L 1-
L 1,</w>
Kore a.</w>
Kir 6.2</w>
Kir 2.3</w>
Kingdom ,</w>
Kidne ys</w>
Ken y
Kain ic</w>
KT- 362</w>
KRH- 594</w>
KOPr -1</w>
KMgC it</w>
KCD- 232</w>
K+- channel</w>
K ey</w>
K et</w>
K appa
K RAS</w>
K IT</w>
K Cl
K A.</w>
K 8</w>
K (m)</w>
K (i
J ust</w>
J udg
J o-
J NK
J ).</w>
Isoproteren ol-treated</w>
Ir -
Ir- CP
Ion tophore
Investig ators.</w>
Invent ory,</w>
Intrathec ally</w>
Intrac arotid</w>
Intra striatal</w>
Intra renal</w>
Intr apl
Inter ventions</w>
Inter active</w>
Inten si
Inte gr
Institut e,</w>
Inj ectable</w>
Inhibit or</w>
Index .</w>
Incl uding</w>
In ulin</w>
In tractable</w>
In toxic
In stead</w>
In somnia</w>
In otropic</w>
In ner</w>
In g
In duc
Impressions- Severity</w>
Immuno fluorescent</w>
Immuno electron</w>
Immuno deficiency</w>
Immun ologic</w>
Imipen em</w>
Ig G.</w>
Ifosf amide
Idi osyncr
Ib g</w>
IV th</w>
IV U</w>
IV I
IVI G</w>
IV B</w>
IU/ kg</w>
IU/ L;</w>
IT S)</w>
IT Pase</w>
IT ERI
ITERI A:</w>
ISO P</w>
IS /
IS ).</w>
IP SC</w>
IP R</w>
IP H</w>
IO CM</w>
INTERVEN TION
IMPA 1</w>
IM/ P/3/4</w>
IL-1 beta,</w>
IL- 6-/-</w>
III A</w>
II B
IIB 7
II -</w>
IGF- I,</w>
IFN- alpha-2b</w>
IF S-</w>
IC P.</w>
IC (50)</w>
I- IV</w>
I- II)</w>
I sosorb
I shihar
I ra
I owa</w>
I le</w>
I bogaine</w>
I b/
I X,</w>
I R,</w>
I MT</w>
I M.</w>
I M)</w>
I HD,</w>
I GE</w>
I B-
IB- ME
I AN</w>
I (Na
I (2)</w>
Hyper prolactinaemia</w>
Hyper ammonemia</w>
Hydroxy zine</w>
Hydr ation</w>
Hy paque</w>
Hsp 27</w>
Hospit als</w>
Hist ochemical</w>
His -
Hg/ min</w>
Hg ]</w>
Hero in</w>
Hepat ocytes</w>
Hepar an</w>
Henoch -
Henoch- Schonlein</w>
Hemat ocrit</w>
Head ache,</w>
Haemodi lution</w>
HV A/
HV A,</w>
HU-2 10</w>
HU TT</w>
HU ,</w>
HT N-
HSP G</w>
HSP 73</w>
HS P-
HRCB P</w>
HPL C-
HP +
HO CM</w>
HO -1</w>
HMR-18 26</w>
HL 60</w>
HIV- negative</w>
HI T-positive</w>
HET 00
HET00 16</w>
HD- CTX</w>
HD AR
HCT Z.</w>
HC B</w>
HBsAg ,</w>
HBeAg .</w>
HB c
HB MP</w>
HB D
HB ,</w>
HAT T.</w>
HAM D</w>
HAL ,</w>
HAAR T.</w>
HA- 966</w>
H2 O2</w>
H2 O.</w>
H/ M</w>
H- benz
H- PILO</w>
H u</w>
H ir
H ence</w>
H el
H e-Ne</w>
H cy</w>
H abit
H S)</w>
H N,</w>
H MM</w>
H LR</w>
H H</w>
H FS</w>
H E)</w>
H Ch
H CBD</w>
H AT</w>
H AS</w>
H 9
Gu an
Gs- coupled</w>
Grou pe</w>
Gre en
Gram -
Golgi -
Glu R-3</w>
Gl a</w>
Gi ant</w>
Gemfibro z
Ge fit
Gam ma-
Gall amine</w>
Gal lium</w>
GV IA</w>
GT S</w>
GT CSs</w>
GST- P-positive</w>
GSH P
GR1389 50,</w>
GP i,</w>
GP IIb/IIIa</w>
GL UT
GF R-
GF -induced</w>
GE N</w>
GB R</w>
GAP 43-
GAP43- ir</w>
GABA- peptides</w>
GABA- B</w>
GABA(A )-
GA ER
G( o)</w>
G y,</w>
G ri
G px
G illes</w>
G ene
G al</w>
G U</w>
G STP1</w>
G P)</w>
G L-
G CF</w>
G AE
GAE E</w>
Fre e
Fran cis
Four -
Fos B</w>
Forty- seven</w>
Form alin</w>
Fluoro-J ade
Fluoro J
Flun it
Fluc loxacillin</w>
Flu voxamine</w>
Flu o
Fin ally</w>
Fibro Scan</w>
Fentan yl,</w>
Feder al</w>
Fe brile</w>
FcgammaR II
Fallo t.</w>
Fallo t,</w>
FZ- enanthate</w>
FZ- decanoate</w>
FVB/ n</w>
FV B</w>
FSG S.</w>
FL AIR</w>
FK3 17</w>
FJ +</w>
FI GO</w>
FE F
FCH L</w>
FANFT---- 5%</w>
FANF T-induced</w>
F- PAN</w>
F z</w>
F usidic</w>
F ixed</w>
F ent</w>
F enol
F emoden
F UR</w>
F T)</w>
F S,</w>
F N,</w>
F LA</w>
F IVB</w>
F F</w>
F Cs</w>
F AD</w>
F AB</w>
F (
Extrac orporeal</w>
Extr adural</w>
Experi ences</w>
Exerci se-induced</w>
Ex agger
Ethin ylestradiol</w>
Eth inyl</w>
Esc italop
Es sen
Er got</w>
Epo etin</w>
Epilep tiform</w>
Eosinophil ia</w>
Environ mental</w>
Endo MT</w>
En zym
En tec
En flurane</w>
En d</w>
Empir ical</w>
Embry onic</w>
Electrocardio grams</w>
Eigh t-
Eff icac
Eff ect
EX POSURE
ET -1,</w>
ET (A
EPO- resistant</w>
EP3 (-/-)</w>
EP I-ex
EP ),</w>
EM ).</w>
EK C,</w>
EG C</w>
EF AD</w>
ED-1- positive</w>
ECE -1
EC ,</w>
EB RT</w>
E- 9,
E verolim
E st
E le
E duc
E ast</w>
E ar</w>
E V</w>
E SAE</w>
E Q</w>
E ORTC</w>
E OP
E HDP</w>
E GT
E GFP</w>
E GF-
E 17</w>
Dys arthria</w>
Dyn orphin</w>
Dy sp
Dro p</w>
Dox .</w>
Dow n-regulation</w>
Dom peridone</w>
Dofe tilide</w>
Docetax el,</w>
Dobut amine-atropine</w>
Do b</w>
Dizzin ess</w>
Disulfir am-induced</w>
Dist inc
Dis continuance</w>
Dil antin</w>
Diethyl stilbestro
Diclofen ac-induced</w>
Diarrhe a</w>
Di privan
Di git</w>
Di aly
Dextromethorph an</w>
Dexamethas one-induced</w>
Dex medetomidine,</w>
Dex -treated</w>
Dex )</w>
Detail s</w>
Des c
Dermat omyosi
Dep oCyte</w>
Den /
Demo graphic,</w>
Def ective</w>
Decemb er,</w>
Dec .</w>
De sign,</w>
Dan azol-induced</w>
DX ,</w>
DTI C,</w>
DT- diaphorase</w>
DT G</w>
DT FC</w>
DR R</w>
DPO AE</w>
DPD PE</w>
DOTAT OC</w>
DN P</w>
DN P-
DMB A-induced</w>
DM O</w>
DM H</w>
DL B.</w>
DK-35 C</w>
DF P.</w>
DE ,</w>
DD T-induced</w>
DCX- labeled</w>
DC G-
DB P,</w>
DA-8 159</w>
D-Tr p
D- rich</w>
D- glucose</w>
D- arginine</w>
D- amphetamine.</w>
D- amphetamine-induced</w>
D- Phe
D(1 A)</w>
D ronedarone</w>
D r
D oberman</w>
D en</w>
D e</w>
D andy</w>
D VT,</w>
D P)</w>
D MP</w>
D MP
D MI
D M,</w>
D IP</w>
D II
D HC
D GF.</w>
D G.</w>
D G)</w>
D CP</w>
D CM</w>
D CK
D A.</w>
D 1,</w>
D (4)</w>
D (3),</w>
Cypro terone</w>
Cypro heptadine</w>
Cyc le</w>
Cy totoxic</w>
Cy tomegalovirus</w>
CsA- based</w>
Cs/ HP
Cs A-treated</w>
Cro ton</w>
Cra ving</w>
Cr yst
Cr ypt
Cour ses</w>
Corne al</w>
Cor relates</w>
Contrast ing</w>
Contrac eption</w>
Continu ation</w>
Consci ous,</w>
Condi tioned</w>
Concentr ation</w>
Concentr ation-
Con tra
Con ner
Con duction</w>
Competi tive</w>
Common ly</w>
Com posite</w>
Com plic
Coca ethylene</w>
Co ffe
Clozap ine-associated</w>
Clo fibrate</w>
Clin opodium</w>
Classi cal</w>
Cisplat in-induced</w>
Cis apri
Cimeti dine,</w>
Cimeti d
Chromos omes</w>
Chloro procaine</w>
Chlorambuc il-induced</w>
Child hood</w>
Child 's</w>
Char ts</w>
Ch ,</w>
Cent re,</w>
Cd kn
Caud a</w>
Catal ep
Carmo fur
Cardiomy ocyte</w>
Cardi otoxic</w>
Cardi ogenic</w>
Carbo platin,</w>
Carb onic</w>
Carb enicillin</w>
Capecit abine-induced</w>
Cambodi an</w>
Cab ergoline</w>
CaMK II
Ca/ Cr</w>
Ca(2+ )
Ca M</w>
Ca Cl</w>
Ca -
Ca (V
Ca(V )
Ca(V) 3.2</w>
CYP2C8 *3</w>
CYP2C 8</w>
CYP2 B1</w>
CYP1A2*1 F</w>
CYP- injected</w>
CYP s</w>
CY -induced</w>
CX 3CR
CX3CR 1</w>
CV- L</w>
CV O</w>
CTR -
CT Z</w>
CT L</w>
CT D</w>
CS P</w>
CS -
CR T</w>
CR T.</w>
CR ITERIA:</w>
CR F,</w>
CPT -P
CPT -1
CP X</w>
CP P)</w>
CP F
CP B</w>
COX- inhibitors</w>
CONCLUSION S/
CO N</w>
CO .</w>
CNI- free</w>
CN Is</w>
CN Is.</w>
CN I-induced</w>
CMR g</w>
CM G</w>
CL218 ,872</w>
CL O</w>
CL ,</w>
CK D.</w>
CI M</w>
CI C</w>
CHF3 381</w>
CH D,</w>
CH AR
CHAR GE</w>
CGRP 8-
CGRP8- 37</w>
CGRP (8-
CGI- I</w>
CG A,</w>
CG ,</w>
CD A</w>
CD 7
CD 40</w>
CD 40-
CD 36</w>
CD 34</w>
CCl 4-induced</w>
CCR 7,</w>
CCR 10</w>
CCK- B</w>
CCK- A</w>
CC U</w>
CB IR</w>
CB D-rich</w>
CAF F-PAN</w>
CAB G</w>
CA P.</w>
CA M
CA 2</w>
C57Bl/ 6</w>
C57B L</w>
C1 q</w>
C/ 2</w>
C. I.</w>
C- type</w>
C- nociceptor</w>
C- fibre</w>
C- dams</w>
C ot
C lu
C eph
C ell
C HB.</w>
C F1</w>
C EEG</w>
C CO
C 4,</w>
C +
But orphanol</w>
Busulf an-induced</w>
Buerg er</w>
Bud d-Chiari</w>
Brugada- type</w>
Brugad a-like</w>
Bre vicon</w>
Braz il,</w>
Brady kinesia</w>
Brady cardia,</w>
Bonferron i</w>
Bo ard</w>
Bis pectral</w>
Bim oclo
Bim atoprost</w>
Bilirub in</w>
Bi phasic</w>
Bi ochemically,</w>
Beta- blocker</w>
Beta- adrenergic</w>
Bel gi
Behavi oral,</w>
Basel ,</w>
Baro receptor</w>
Bac kgro
BUN ,</w>
BQ 123</w>
BP O</w>
BO LD</w>
BM S-181
BH ),</w>
BH (4)</w>
BD10 63</w>
BB PRI</w>
BAM-1 120</w>
B6 NCr
B- precursor</w>
B- 24
B urkit
B t
B locking</w>
B ladders</w>
B in
B c
B arbit
B ang
B allo
B ack</w>
B V</w>
B SP</w>
B S-
B RAC</w>
B IIB7
B IH</w>
B EAC
B CA
B B-
B A</w>
B .
B -associated</w>
B (t)</w>
Ax onal</w>
Avy/ a</w>
Auto antibodies</w>
Aut oradi
Aug ment
Atten tional</w>
Atri um</w>
Atax ia</w>
Ast emiz
Aspir in,</w>
Asi a-Pacific</w>
As say</w>
As partate</w>
Arg 296
Arg296 Cys</w>
Ar ti
Ar th
Ar te
Ar rest</w>
Ar n
Apomorph ine-induced</w>
Antin ociception</w>
Anti- inflammatory</w>
Anti viral</w>
Anti thyroid</w>
Anti sense</w>
Anti psycho
Angio vist-
Angio graphic</w>
Ang (1-7)</w>
Ander son</w>
Anaphyl actic</w>
Analgesi c
Anaestheti sts</w>
An x
An tigen</w>
An tenatal</w>
An atom
An aemia</w>
Amp icill
Amp B</w>
Aminoglyco side-induced</w>
Amino oxyacetic</w>
Amin ophyll
Amin o-
Americ an,</w>
Am p</w>
Altern ating</w>
Al end
Al bumin</w>
Al a-
Ak t/
Age -dependent</w>
Adriam ycin-
Adju st
Ad. N
Ad dison's</w>
Ad -
Acceler ated</w>
Ac -
Abecarn il</w>
Ab stin
Ab rupt</w>
Ab n-cb
AVP- stimulated</w>
AV NRT</w>
AUC s</w>
AU C.</w>
AU C,</w>
ATT- ALF</w>
ATI N.</w>
AT T</w>
AT RA-induced</w>
AT .</w>
AT ).</w>
ASA- dipyridamole</w>
AS L</w>
AS H</w>
AS A.</w>
AS 18
AS18 92
AS .</w>
ARN- x</w>
ARB s</w>
AR T.</w>
AR A-
APPRO Ve</w>
APD C</w>
AO- 8</w>
AN R</w>
AN ES</w>
AM N082</w>
ALA- synthetase</w>
AL ,</w>
AK- FLU
AK T1</w>
AI d</w>
AI c</w>
AI U</w>
AI N-76A</w>
AI N,</w>
AI ),</w>
AER D</w>
ADR- E
ADP- ribosylation</w>
AD X-
AD T</w>
AD NF
AD HD-
ACTH -independent</w>
ACE- inhibitor</w>
AC(- O
AC S)</w>
AC R</w>
AC E,</w>
AC A</w>
AB CD</w>
AB CB1</w>
AA F)</w>
A/ LPS</w>
A/ B</w>
A- to-G</w>
A- mediated</w>
A- delta</w>
A- I,</w>
A voiding</w>
A tazana
A o</w>
A necdotal</w>
A m</w>
A im</w>
A egle</w>
A delta-
A cit
A ci
A beta</w>
A X
A TIN</w>
A ST,</w>
A R)</w>
A Q-A</w>
A HR</w>
A GE
A G,</w>
A ALF</w>
A 2)</w>
A 1,</w>
> 500</w>
> 5.0</w>
> 40</w>
> 25%</w>
> 15</w>
= 250</w>
= 12</w>
< 60</w>
< 50</w>
< 300</w>
< 0.01)</w>
< 0.0001),</w>
< .01),</w>
< .001),</w>
< .0
: 00
99 8</w>
99 4</w>
99 ),</w>
90- day</w>
90 9</w>
9. 1%</w>
9- week</w>
9- ethyladenine</w>
9- cis-retinoic</w>
9 :00</w>
9 90</w>
9 8%,</w>
9 7)</w>
9 62</w>
9 6-hour</w>
9 6,</w>
9 6)</w>
9 54</w>
9 5),</w>
9 45</w>
9 4),</w>
9 3%,</w>
9 1-
9 1%,</w>
9 1
85/ 340</w>
80 00</w>
80 +/-
8/ 10</w>
8. 8%</w>
8. 6%</w>
8. 5%)</w>
8. 2%</w>
8-phenyl theophylline</w>
8-amino quinoline</w>
8- MOP</w>
8 ].</w>
8 ]
8 9-year-old</w>
8 7).</w>
8 6)</w>
8 6%)</w>
8 5).</w>
8 1.
8 -</w>
77 434</w>
75 th</w>
726 64</w>
7/ 10</w>
7. 4%;</w>
7. 3%</w>
7. 2%</w>
7. 1%</w>
7. 1%)</w>
7-oxo- PgI2</w>
7- week</w>
7- F
7 9,</w>
7 7)</w>
7 6-
7 6),</w>
7 53</w>
7 3-
7 3)</w>
7 3).</w>
7 2%.</w>
7 2
7 1,</w>
7 1%,</w>
7 0.5%</w>
7 0.0</w>
67 -1
65- 65
65-65 70</w>
64 139</w>
600 1</w>
60- 80</w>
60 1</w>
60 -120</w>
6. 3,</w>
6. 1,</w>
6-oxo- prostaglandin</w>
6-keto-PG F
6-hydroxy melatonin</w>
6-hydroxy dopamine.</w>
6-hydroxy dopamine-
6-OHD A/LPS</w>
6- week,</w>
6- tetramethyl
6- methoxy-
6 9)</w>
6 9%)</w>
6 8-
6 8%,</w>
6 7).</w>
6 5.</w>
6 5.3</w>
6 5%)</w>
6 48</w>
6 43</w>
6 2,</w>
6 17</w>
6 162</w>
6 13</w>
6 1%,</w>
6 );</w>
5alpha- reductase</w>
5HT 2</w>
59 2,</w>
59 ),</w>
58 6</w>
56999 A</w>
56 ;</w>
56 %.</w>
559 40</w>
552 12-
55,9 40</w>
55 ;</w>
55 9</w>
55 %.</w>
500 -1000</w>
50- 60</w>
50 ;</w>
50 8</w>
50 6.</w>
5. 7%</w>
5. 3,</w>
5. 3)</w>
5-hydroxytryptamine (1
5-hydroxytryptamine(1 A)</w>
5-hydroxytrypt amine,</w>
5-di methyl-
5-bromo-2'- deoxyuridine</w>
5-HT1B/ D</w>
5-HT(1B/ 1
5-HT(1B/1 D)</w>
5-HT(1A)- receptor</w>
5-HT(1 B)</w>
5-HT 1-like</w>
5-HT -1
5-FU/ LCV</w>
5-FU -related</w>
5-F (2
5-F(2 t)-
5-1 50</w>
5- ethyl-5-
5'- triphosphate</w>
5'- O-(2-thiodiphosph
5'- N-ethyl
5 99
5 9-
5 82</w>
5 8-
5 8).</w>
5 6).</w>
5 43</w>
5 37</w>
5 3.9</w>
5 3.7</w>
5 13</w>
5 1)</w>
48/ 80</w>
48 9</w>
48 5</w>
48 0-
45 Ca2+</w>
45 3</w>
45 +/-
44. 4%</w>
44 408</w>
40- min</w>
40- 59
40 s</w>
40 3</w>
40 ,000</w>
4/ 10</w>
4. 9%</w>
4. 8%</w>
4. 7%</w>
4. 3,</w>
4. 2,</w>
4. 1)</w>
4. 0,</w>
4- week-old</w>
4- month-old</w>
4- iPTH</w>
4- HC</w>
4, 0
4'- epi-doxorubicin</w>
4 ],</w>
4 H-
4 90</w>
4 9+/-
4 8.5</w>
4 8.4</w>
4 79</w>
4 7.</w>
4 7).</w>
4 62</w>
4 50,</w>
4 5).</w>
4 4;</w>
4 36</w>
4 3).</w>
4 3%.</w>
4 28</w>
4 23</w>
4 1-
4 0.8</w>
4 0.1</w>
4 0.0</w>
4 ,000</w>
4 +
4 %
3H- TBOB</w>
3: 1)</w>
39. 9</w>
39 4</w>
39 3</w>
38 ;</w>
38 9
38 5</w>
38 227</w>
38 +</w>
3784 9,</w>
37. 6</w>
37 ;</w>
37 6</w>
37 4</w>
37 ),</w>
36. 3</w>
36 ;</w>
35 S-
34 ;</w>
33 %.</w>
320/ 25</w>
30- year</w>
30- month-old</w>
30- 35</w>
30 9</w>
30 -</w>
30 ,
30 );</w>
3/ 8</w>
3.0 ;</w>
3. 95</w>
3. 7,</w>
3. 7)</w>
3. 63</w>
3. 52</w>
3. 4-fold</w>
3. 4,</w>
3. 2;</w>
3. 1-
3. 1,</w>
3. 0.</w>
3-methyl chol
3-1 99
3-(3- hydroxyphenyl)-
3- minute</w>
3- mg/kg</w>
3- methyl-5-
3- methoxy
3- fold)</w>
3- OH-H
3- 8</w>
3- 4)</w>
3,7- disulf
3,4- DC
3,4- DAP,</w>
3'- azido-3'-deoxy
3' UTR</w>
3 =
3 5.6</w>
3 5.4</w>
3 42</w>
3 4.5</w>
3 37</w>
3 36</w>
3 32</w>
3 2).</w>
3 2%).</w>
3 14</w>
3 1/
3 1.1</w>
3 1-
3 1%,</w>
3 0.8</w>
3 0.8%</w>
3 +</w>
3 )-
3 (2H)-
2A/ 2C</w>
29. 4</w>
29. 4%</w>
28 5</w>
28 00</w>
27. 8</w>
27. 7</w>
27. 6</w>
27. 6%</w>
27. 4</w>
26. 7</w>
26. 3</w>
26 /
25. 9</w>
25. 5</w>
25- OHD2</w>
25 8</w>
25 %;</w>
24. 9</w>
24. 5%</w>
24. 1</w>
24- month-old</w>
24 th</w>
24 -</w>
24 %)</w>
23. 1</w>
23 762</w>
23 0
23 .</w>
23 +/-
22. 9%</w>
22- oxacalcitriol</w>
200- 300</w>
200 5).</w>
200 2),</w>
200 1).</w>
200 0).</w>
200 0),</w>
200 0
20- min</w>
20- day-old</w>
20- 24</w>
20 655
20 1-
201- 99
20 );</w>
2/ day</w>
2.0 ;</w>
2.0 6</w>
2. 9-
2. 9,</w>
2. 8-
2. 8).</w>
2. 8%,</w>
2. 6,</w>
2. 54</w>
2. 46</w>
2. 45</w>
2. 3,</w>
2. 21</w>
2. 2-
2. 10</w>
2-1 99
2-1 2</w>
2-1 .0
2- propion
2- methoxy-4-
2- methoxy
2- ethylhex
2- dimensional</w>
2- deoxy-
2- adrenoreceptor</w>
2- adrenoceptors.</w>
2- 8</w>
2- 2</w>
2,3- dihydroxy
2,3- dihydrobenzofuran-7-
2,3,7,8- tetrachlorodibenzo-p-dioxin</w>
2,3,4- tetrahydro-
2, 8
2 beta-
2 R)</w>
2 D
2 2.6</w>
2 2.3</w>
2 2%,</w>
2 2%)</w>
2 1;</w>
2 14
2 13)</w>
2 10
2 1.8</w>
2 0.2</w>
2 +)</w>
2 ))</w>
1H- NMR</w>
1A 2,</w>
1:200 ,000</w>
199 3-199
199 1-1
198 1).</w>
197 6,</w>
197 55</w>
197 1,</w>
1960 s,</w>
19. 6</w>
19. 4</w>
19 72</w>
19 67</w>
19 65</w>
19 64</w>
18. 6%</w>
18. 2</w>
18- hydroxy
18 00</w>
18 0,</w>
18 %)</w>
17. 3%</w>
17 %.</w>
16,23- D(3)</w>
16 th</w>
16 0-
16 -1
16 %;</w>
15d-PG J2</w>
15. 9</w>
15-178 8.</w>
15-178 8,</w>
15- 21-day-old</w>
15 A10</w>
15 00-mg</w>
14C- IMPPA</w>
14. 8%</w>
14. 2%</w>
14 00</w>
14 ,
14 %.</w>
13. 5%</w>
13 9.</w>
13 5)</w>
13 0
12. 3+/-
12- wk</w>
12- dimethylbenz
12 5)</w>
12 10</w>
12 -18</w>
12 -14</w>
12 %).</w>
11/ 15</w>
11. 5%</w>
11 beta-hydroxysteroid</w>
100- 200</w>
100 ).</w>
100 %).</w>
10/ 11</w>
10.0 ,</w>
10- unit</w>
10- mg/kg</w>
10- day-old</w>
10- cm</w>
10(9)/ l,</w>
10(9)/ L)</w>
10(6 )/
10(3)/ microliter
10 7.
10 172</w>
10 -</w>
1.5 8-
1.0 3</w>
1. 95</w>
1. 85</w>
1. 84</w>
1. 56</w>
1. 54</w>
1. 50</w>
1. 5-fold</w>
1. 5)</w>
1. 5%),</w>
1. 47</w>
1. 42</w>
1. 28</w>
1. 27,</w>
1. 22</w>
1. 21</w>
1. 2-1
1. 2).</w>
1. 13</w>
1. 12</w>
1. 11,</w>
1. 10-
1. 1-1.
1. 1-1
1. 1).</w>
1. 00-
1-1 2</w>
1-1 00</w>
1- {3-
1- null</w>
1- methyl
1- infected</w>
1- antitrypsin</w>
1- adrenoceptors.</w>
1- 5)</w>
1- 4)</w>
1,8 4-iPTH</w>
1,4- dihydropyridine</w>
1,3- bis(2-chloroethyl)-1-nitrosourea</w>
1,25-(OH)2D 3.</w>
1,25-(OH)2 D2</w>
1,25- (OH)2-
1,25(OH)2D 3.</w>
1, 700</w>
1, 57
1, 5-
1 st,</w>
1 ]).</w>
1 0.6
1 -10
0/ Eho</w>
0.9 7,</w>
0.9 6).</w>
0.8 5,</w>
0.8 1;</w>
0.8 -1.
0.7 8,</w>
0.7 2).</w>
0.7 %)</w>
0.6 7,</w>
0.6 4,</w>
0.6 3,</w>
0.6 2,</w>
0.5 9,</w>
0.5 1,</w>
0.5 -1.0</w>
0.4 9,</w>
0.4 %;</w>
0.4 %).</w>
0.3 ;</w>
0.3 7,</w>
0.2 2,</w>
0.2 %.</w>
0.04 5).</w>
0.04 2).</w>
0.04 );</w>
0.03 1).</w>
0.02 6)</w>
0.000 4).</w>
0.00 8</w>
0.00 6</w>
0.00 6),</w>
0.00 3-
0.00 1.</w>
0.0 8%</w>
0.0 7)</w>
0.0 6,</w>
0.0 34</w>
0.0 32</w>
0.0 3-
0.0 29).</w>
0.0 25,</w>
0.0 17).</w>
0.0 16).</w>
0.0 15</w>
0.0 13).</w>
0.0 12)</w>
0.0 12
0.0 1);</w>
0.0 ).</w>
0.0 %),</w>
0. 8-
0. 7)</w>
0. 5%)</w>
0. 28
0. 25).</w>
0. 2).</w>
0. 16).</w>
0. 16
0. 15,</w>
0. 11,</w>
0. 10,</w>
0. 1%)</w>
0-1 99
0- 3.</w>
0 8</w>
0 ,000</w>
0 );</w>
/ year.</w>
/ 8
.g -1.
.000 1</w>
.00 5</w>
.00 3)</w>
.0 3)</w>
. 14).</w>
. /
. -
-16ene- 23
-14 C]
-100 %</w>
-10 (-
-1. 25</w>
-1,2- bis(3,
-1, 2,3,4-tetrahydro
-1 8.
-1 5-
-1 4,
-1 25</w>
-- the</w>
- the</w>
- squ
- pull</w>
- active</w>
- a-
- We
- 5
- 4</w>
- 48</w>
- 3.
- /-)</w>
,00 0
+/-1. 6</w>
+/-1. 2</w>
+/-1. 0</w>
+/-1 7</w>
+/-1 6</w>
+/- 5</w>
+/- 2</w>
+ MR-
+ +</w>
)- selective</w>
)- like</w>
) dt/
) and</w>
) >
) (-/-)</w>
) %</w>
(v/ v)</w>
(thre e),</w>
(stat ins)</w>
(s d</w>
(s d)</w>
(r= 0.9
(r TMS)</w>
(pHi )</w>
(p< 0.001),</w>
(p seud
(n= 8),</w>
(n= 6),</w>
(n= 50),</w>
(n= 5);</w>
(n= 3)</w>
(n= 20)</w>
(n= 19)</w>
(n= 16)</w>
(n= 14
(n= 10</w>
(mGluR 5)</w>
(m RNA)</w>
(i.p. ))</w>
(four ),</w>
(e NO
(dd C),</w>
(control s).</w>
(cTn I)</w>
([ Ca2+]
(YMR S),</w>
(Wor ld</w>
(W MD</w>
(V T),</w>
(V SD)</w>
(V OD
(V M
(V D
(V AS</w>
(Td P).</w>
(TT P/
(TR H)</w>
(TP R)</w>
(TM P)</w>
(TH )</w>
(TD F)</w>
(TD 50)</w>
(T or
(T T)</w>
(T S)</w>
(T S
(T NS)</w>
(T GF
(T CD
(T C),</w>
(T AM)</w>
(Spear man's</w>
(SR S)</w>
(SA P,</w>
(S)- 4-
(S er
(S e
(S S)</w>
(S R</w>
(S NS)</w>
(S GO
(S F
(S D,</w>
(S D),</w>
(S Cr)</w>
(S AP
(S A)</w>
(RT- PCR)</w>
(RR s)</w>
(RB C)</w>
(R,S)- AM12
(R W
(R VL
(R T
(R NS)</w>
(R CT
(R A).</w>
(R A),</w>
(R =
(R )
(QT Ls)</w>
(Q O
(Ph armacia</w>
(PV C)</w>
(PT U),</w>
(PT ),</w>
(PR L)-
(PIL O)</w>
(PGI 2),</w>
(PE G-
(PCI ).</w>
(PC T)</w>
(PANS S),</w>
(P< 0.001);</w>
(P< .05).</w>
(P< .01).</w>
(P SA)</w>
(P R</w>
(P NP)</w>
(P DT
(P CI)</w>
(P ),</w>
(P '</w>
(O r
(Na Cl)</w>
(NSAID ).</w>
(NO )-
(N SC-
(N SC
(N EC
(N DE
(N BQ
(N AD
(N A),</w>
(N /
(MP H)</w>
(MMP s)</w>
(MM P)</w>
(MM F)</w>
(MK-80 1)</w>
(MI F)</w>
(MH PG)</w>
(ME )</w>
(MD S).</w>
(MB C).</w>
(MAO Is)</w>
(M rp
(M g)</w>
(M RP
(M C)</w>
(M BP)</w>
(M AC)</w>
(LT P)</w>
(L I
(L E)</w>
(L CBF)</w>
(L A</w>
(Ig G)</w>
(IN R</w>
(IL- 6)</w>
(IC (50)</w>
(IB D).</w>
(I(K r
(I S)</w>
(I P
(I NH
(I K
(I F)</w>
(I A)</w>
(I /
(I -
(HD- MTX)</w>
(HBsAg ),</w>
(HBeAg ),</w>
(HB V).</w>
(HAT T)</w>
(H SCT)</w>
(H P)</w>
(H A)</w>
(Glu R
(GST- P)</w>
(GP x),</w>
(GGT ),</w>
(GE M)</w>
(G ST)</w>
(G R)</w>
(G P)</w>
(G M-
(G GT)</w>
(G )</w>
(FEV 1,</w>
(FEV 1)</w>
(FE SS)</w>
(FD P)</w>
(F os
(F lu
(F M
(F 344)</w>
(F -
(EP S),</w>
(EP M)</w>
(ELIS A)</w>
(EC E
(E str
(E KG)</w>
(E AD
(E AA)</w>
(E ),</w>
(DXR )-induced</w>
(DSM-III- R)</w>
(DSM- IV</w>
(DOCA)- salt</w>
(DO X),</w>
(DH P)</w>
(DES)- exposed</w>
(DE X
(DD AVP)</w>
(D iazemul
(D bh</w>
(D ay</w>
(D WI)</w>
(D TI
(D T
(D R)</w>
(D P</w>
(D IC).</w>
(D I)</w>
(D G
(Cy tox
(Ca, L)</w>
(Ca (2+
(CYP2 C
(CY P
(CS P)</w>
(CS F),</w>
(CS A)</w>
(CR P)</w>
(CR ).</w>
(CP M)</w>
(CO X
(CN I)</w>
(CM R)</w>
(CM F)</w>
(CH D)</w>
(CDD P)</w>
(CCB s)</w>
(CA R)</w>
(C57 B
(C ap
(C SE)</w>
(C RF
(C Q)</w>
(C PP).</w>
(C OR
(C K
(C HB)</w>
(C HB).</w>
(C C)</w>
(C AT),</w>
(C AT
(C .
(C -
(C ,</w>
(Bo NT/
(BU P)</w>
(B IC),</w>
(B E)</w>
(B D)</w>
(B BB
(B 6)</w>
(AZ A)</w>
(AU C</w>
(AR C)</w>
(AN F)</w>
(AM PA)</w>
(AL A)</w>
(AER S)</w>
(AED s).</w>
(AED s),</w>
(ADR ),</w>
(AD R-
(AD H)</w>
(AC Ei
(AC C)</w>
(A SE
(A O
(A LT,</w>
(A HF)</w>
(A EC
(A AL
(A A),</w>
(> 15</w>
(< 10</w>
(95% CI:</w>
(9. 8</w>
(9. 2%)</w>
(9 9</w>
(9 5%)</w>
(9 2</w>
(9 0
(87. 5%)</w>
(8. 7</w>
(8. 3</w>
(8-OH-DPA T)</w>
(8 S,
(8 9%</w>
(8 7%</w>
(8 2%</w>
(8 1%),</w>
(8 0-120</w>
(8 0%).</w>
(8 0
(7. 7</w>
(7. 1%)</w>
(7- OH-
(7 8%</w>
(7 7</w>
(7 7%</w>
(7 3.
(7 0/
(7 0%),</w>
(6. 7%)</w>
(6. 2</w>
(6- TG)</w>
(6 3</w>
(6 0-120</w>
(6 0-1
(6 0-
(6 %;</w>
(50- 200</w>
(5. 8</w>
(5. 7%)</w>
(5. 6</w>
(5. 2%)</w>
(5. 1</w>
(5-HT 3)</w>
(5- ASA)</w>
(5,7-DH T)</w>
(5 3%</w>
(45. 5%)</w>
(4. 9%)</w>
(4. 8</w>
(4. 5%)</w>
(4. 3%)</w>
(4. 2%)</w>
(4-chloro phenyl)-
(4-amino phenyl)-4-methyl-7,8-
(4- hydroxy
(4 9%</w>
(4 7%).</w>
(4 7%),</w>
(4 ,
(31. 3%)</w>
(30- 300</w>
(3. 75</w>
(3. 6%)</w>
(3. 5-
(3. 4%)</w>
(3 alpha-hydroxy-
(3 9%).</w>
(3 75</w>
(3 70</w>
(3 7
(3 000</w>
(3 0.0</w>
(3 0,</w>
(3 0%).</w>
(26. 7%)</w>
(22. 2%)</w>
(2/ 3)</w>
(2. 5
(2. 3%)</w>
(2. 2%)</w>
(2- mercapto
(2, 6-di
(2) ),</w>
(2 9%).</w>
(2 8/
(2 75</w>
(2 7-
(2 4/
(2 3%).</w>
(2 25</w>
(2 2%</w>
(2 1-
(2 000</w>
(2 0.0%)</w>
(2 0),</w>
(2 %;</w>
(2 %),</w>
(19 66</w>
(19 %).</w>
(15- 20</w>
(11. 1%)</w>
(100- 200</w>
(10. 1%)</w>
(10(- 6)</w>
(10(- 6)
(10 4</w>
(10 -15</w>
(10 ),</w>
(1. 75</w>
(1. 6%)</w>
(1. 1%)</w>
(1 90</w>
(1 8-
(1 77</w>
(1 7/
(1 7-
(1 7%,</w>
(1 7%),</w>
(1 67</w>
(1 6-
(1 6%).</w>
(1 4),</w>
(1 39</w>
(1 37</w>
(1 3)</w>
(1 3)
(1 2.4</w>
(1 1),</w>
(1 0.5</w>
(1 ,000</w>
(0.5- 1</w>
(0.25- 0.5</w>
(0.01- 0.1</w>
(0.0 25</w>
(0.0 ,</w>
(0. 83</w>
(0. 8%)</w>
(0. 6%).</w>
(0. 55</w>
(0. 45</w>
(0. 32</w>
(0. 3%</w>
(0. 16</w>
(0. 10</w>
(0- 30</w>
(-1 0
(-1 .
(-)- adrenaline</w>
(-)- OSU</w>
(+/-)-2- carboxypiperazin-4-
(+)- cis</w>
(+)- PH
( when</w>
( values</w>
( ultrasonic</w>
( u
( treatment</w>
( toxic</w>
( torsades</w>
( through</w>
( those</w>
( tested</w>
( systemic</w>
( sub-)</w>
( sodium</w>
( short</w>
( sensitivity</w>
( see</w>
( schedule</w>
( saline-
( saline,</w>
( response</w>
( responder
( regimen</w>
( prostaglandin</w>
( prostacyclin
( principally</w>
( platelet</w>
( per</w>
( part</w>
( pain,</w>
( other</w>
( oral</w>
( one).</w>
( nor-B
( nausea</w>
( mixed</w>
( midazolam
( micro
( mice)</w>
( mes
( maximum,</w>
( last</w>
( laser</w>
( ischemia</w>
( injected</w>
( i.v.</w>
( i.p.</w>
( i.p.).</w>
( hyperglycemic</w>
( human</w>
( hippocampus,</w>
( haloperidol</w>
( glomerular</w>
( gestational</w>
( genotype</w>
( final</w>
( excluding</w>
( every</w>
( equivalent</w>
( electromagnetic</w>
( diphenyl
( didanos
( diazepam</w>
( decrease</w>
( corrected</w>
( coronary</w>
( complete</w>
( central)</w>
( c-
( baseline,</w>
( basal</w>
( average,</w>
( around</w>
( allodynia)</w>
( albumin,</w>
( X</w>
( QT</w>
( QRS</w>
( L-DOPA)</w>
( IV</w>
( IIE
( GABA(A)</w>
( B</w>
( 0.05
( 0%).</w>
( %)</w>
' binge'</w>
' ;</w>
% ):</w>
"ecstasy ")</w>
" torsade</w>
" sub
" spontaneous
" sinus
" probable"</w>
" normal
" non
" de</w>
" clozapine</w>
zon ula</w>
zon es.</w>
zomepir ac.</w>
zol amide</w>
zileut on</w>
zetimi be</w>
zap rinast</w>
z z
z one.</w>
z ol</w>
z ine.</w>
z in</w>
z ia</w>
z ,</w>
ys ine</w>
yp ne
ypne a-
ypnea- ortho
ypnea-ortho de
ypnea-orthode ox
yo e
yoe it
ymph atic</w>
ymb opo
ymbopo g
ymbopog on</w>
ym ents</w>
yl-L- carnitine</w>
yl-2- phenoxy
yl- 3-
yl)- pyridine</w>
yl)- N-
yl)- 5-
yl) urea</w>
yl) butyl]-
yl) amino]
yl methyl
yl idene
yl carbamo
yl ate,</w>
yl amine</w>
yl -</w>
yel low
yel inic</w>
yclopent ane
y/ radiotherapy</w>
y lox
ylox y-
y ing.</w>
y et,</w>
y );</w>
xylazine- ketamine</w>
xi par
xerostom ia</w>
xeno graft</w>
xanth ine,</w>
x/ day;</w>
x- then-cisDD
x ine</w>
x enograf
x ene,</w>
x edema</w>
x L</w>
wt .,</w>
wron g</w>
writ ing</w>
writ ing,</w>
wrin kling</w>
worsen ing,</w>
worsen ed.</w>
work load</w>
work er</w>
work day</w>
wor ds.</w>
wom an)</w>
wk ).</w>
within- subject</w>
withdraw al)</w>
wit z</w>
winter ian
winter i</w>
wif e</w>
wide- complex</w>
whole- blood</w>
where upon</w>
whe el
whe al</w>
whe al,</w>
wh ites</w>
well- controlled</w>
well- be
weigh t),</w>
weigh s</w>
week- old)</w>
week s-old</w>
week ly).</w>
week ends</w>
wee t</w>
wearing- off,</w>
weak ness:</w>
we ed</w>
we av
wax /
wax/ polymer</w>
water- replete</w>
water- maze</w>
wash out,</w>
wash ing</w>
warm th,</w>
warfarin- drug</w>
war ning.</w>
war dly</w>
walk ing,</w>
wake ful
wa ve-
wa it</w>
w t),</w>
w orm
vul us</w>
vom it</w>
volunte ers:</w>
volume -
voltage- sensitive</w>
voltage- clamp</w>
volt age.</w>
vol vulus</w>
vogli bo
voglibo se.</w>
vocal izations</w>
vivo- in</w>
vitamin- D2</w>
vitamin s.</w>
vitamin s,</w>
vis iting</w>
virus -mediated</w>
viol ence,</w>
viol aceous</w>
vinorelb ine/
vindes ine,</w>
vincrist ine-evoked</w>
vincrist ine-
vie 's</w>
vic ti
victi m</w>
vi t</w>
vi s.</w>
vi ri
vi gorously</w>
vi br
vestibulo -
vessel ,</w>
vesi co
vesi cles,</w>
ves )</w>
verticillat us</w>
vers ol</w>
verapamil ]o</w>
verapam il/
ver sy</w>
ver sa</w>
ver ified.</w>
ventric le-
ventric le)</w>
ventil ation).</w>
vent ing</w>
veno venous</w>
veno occlusive</w>
ven tion.</w>
ven om
ven odilat
ven -
velocity- encoded</w>
velb ine</w>
vein- stenosed</w>
vehicle- pretreated</w>
vehicle- injected</w>
vehicle- infused</w>
vehicle ).</w>
vedac lidine</w>
vecur oni
ve g
ve ).</w>
vasospas ms</w>
vasopress ors,</w>
vasoconstrict ors,</w>
vascular ity</w>
vascul itis:</w>
vas ation</w>
varic osi
varicosi ties</w>
varic ella</w>
varic eal</w>
vari ant.</w>
vari ant
var denafil</w>
vapt an</w>
vapor iz
vanillo id
vancomyc in-resistant</w>
valv ulopathy.</w>
valv ulo
valvulo pathies</w>
valu e:</w>
vals artan,</w>
valpro ate-treated</w>
val ganciclovir</w>
val g</w>
vagin ally</w>
vag i.</w>
vacuol ization.</w>
vaccine- escape</w>
vaccin ation,</w>
va 2]
v s-
v i</w>
v ).</w>
uy tren
uytren 's</w>
utiliz ation,</w>
uter us.</w>
uter us,</w>
uter otonic</w>
uter o
use t
uset ts</w>
use /
use )</w>
us pid
us hed,</w>
us h,</w>
us artan</w>
us --
urticaria/ angioedema.</w>
urs olic</w>
uroth yl</w>
uro xene,</w>
uro toxicity,</w>
uro spor
uro protect
uro porphyr
uroporphyr inogen</w>
uro kinase,</w>
uro graphy.</w>
urin iferous</w>
uric holic</w>
uri tic</w>
urge -We
urge-We ber</w>
urethane- anaesthetised</w>
ureth ra,</w>
ureth ane.</w>
ures --
ures )</w>
ure ters</w>
ure less</w>
ure d.</w>
urap idi
urapidi l,</w>
uran yl</w>
ur n</w>
ur ine"</w>
ur ination</w>
ur idine-induced</w>
ur idine-
ur icos
ur ic,</w>
upreg ulate</w>
upper- extremity</w>
up swings</w>
up s</w>
up lo
up lex</w>
unusu al,</w>
unstead iness</w>
unpredict able,</w>
university- based</w>
unit ro
unit ;</w>
uniform ity</w>
uni directional</w>
uni -</w>
unfortun ate</w>
undesi rab
under- reported</w>
under- recognized</w>
under way.</w>
under taken,</w>
un successfully</w>
un stained</w>
un relieved</w>
un reliable</w>
un recognized.</w>
un purified</w>
un ning</w>
un net
un necessary,</w>
un matched</w>
un loaded</w>
un important</w>
un impaired</w>
un impaired.</w>
un healthy</w>
un encapsulated</w>
un ding</w>
un defined</w>
un corrected</w>
un burnt</w>
un available.</w>
um- exposed</w>
ultrasoun d-
ultraf ast</w>
ultra- low</w>
ultra structure.</w>
ulos clerosis</w>
ulo se.</w>
ulin astatin</w>
ul y,</w>
ul ent</w>
ul ations</w>
ul ating</w>
uci ating</w>
uc iferine</w>
ubiquit ously</w>
ubi qu
ubiqu itin</w>
u sid
u reas.</w>
u per
u ge
u g.
u er</w>
u ates</w>
u al,</w>
u ),</w>
tyrosine- methionine-
tyrosine-methionine- aspartate-
type :</w>
type ).</w>
typ ed</w>
two- year-old</w>
two- week-old</w>
two- sided</w>
two- kidney</w>
two- drug</w>
twice/ day,</w>
twenty- five</w>
twel ve-
tw isting</w>
tw in,</w>
turt les</w>
turke ys.</w>
tur keys</w>
tumor :</w>
tum ,</w>
tubocurar ine.</w>
tuber osa</w>
tuber cle.</w>
tu bu
tubu log
tubulog lomerular</w>
tryptoph an-niacin</w>
tryptoph an,</w>
trypt amine,</w>
trunc ated</w>
trou bling</w>
troponin- T</w>
tropic amide.</w>
trop yl</w>
trometh amine,</w>
tro x
tro r
tror rh
trorrh ag
triterpen oid</w>
tript ans,</w>
tripelenn amine</w>
tripelenn amine,</w>
trinit rate,</w>
trimeta ph
trime sters</w>
trihexyphenid yl,</w>
trifluoro ethane</w>
trichloro ethan
tric uspid
triazolo[1,5-c] pyrimid
triacyl glycer
tri phenylethylene</w>
tri phenyl</w>
tri ed,</w>
tren d,</w>
tremor genic</w>
tremor )</w>
treatment- refractory</w>
treatment 's</w>
tre e.</w>
trau b</w>
transt ympanic</w>
transporter -1</w>
transpor ter,</w>
transplant -free</w>
translat es</w>
transl uc
transi tioned</w>
transi tion,</w>
transi ently,</w>
transfer rin,</w>
transfer ases</w>
transe pid
transepid ermal</w>
transcript ase-
transamin itis,</w>
trans-1,2- cyclohexanedi
trans vaginal</w>
trans rectal</w>
trans position</w>
trans parent</w>
trans mitral</w>
trans late</w>
trans ketol
trans formation,</w>
trans activators</w>
tranquiliz er,</w>
tramadol/ APAP</w>
tract -
trache otomy</w>
trache a.</w>
trac ers</w>
trac ers.</w>
tra ined,</w>
toxoplasmo sis.</w>
toxic osis.</w>
toxic ology.</w>
toxic ity?</w>
toxic ity--
toxic -
toxic )</w>
tox oplasmic</w>
tox ins.</w>
tox in-sensitive</w>
tourniqu et
tot al-body</w>
torticoll is,</w>
tor af
topiram ate-induced</w>
topiram ate-
topiram ate,</w>
tongu e.</w>
ton ic/
tonic/ clonic</w>
tom y.</w>
tom ograph
tolmet in.</w>
tolmet in,</w>
toler ating</w>
tolaz amide</w>
tol cap
tolcap one</w>
tol aryng
tocoph erol</w>
to- systemic</w>
to- side</w>
to- right</w>
to- left</w>
to uc
to dol
todol ac</w>
to day,</w>
titr ation.</w>
titr ation,</w>
titr ate</w>
tis/ dermatomyositis</w>
tion- event</w>
tion al
tional -dose</w>
tion -associated</w>
timolo l-
times/ week</w>
time :</w>
time ).</w>
tili de-induced</w>
tigm ine-induced</w>
tigh tly</w>
tic- rigid</w>
tic ryn
tiag abine.</w>
ti pran
ti pped</w>
ti or
tior rhiz
ti o</w>
ti le,</w>
ti flu
tiflu ad
ti d)</w>
ti a</w>
ti .</w>
thyrox ine,</w>
thyrotoxic osis,</w>
thyroidi tis</w>
thromboly tics.</w>
thrombocyth aemia</w>
thrombo genesis</w>
thromb ocytosis,</w>
thromb ocyto
thromb ectomy.</w>
thrice- weekly</w>
three- quarters</w>
three- dimensional</w>
threat ened</w>
thre e;</w>
thorac otomy.</w>
thorac ol
thoracol umbar</w>
thirty- three</w>
thirty- four</w>
third- line</w>
thiou re
thioridaz ine-induced</w>
thion amides</w>
thiocolchic o
thiobut yro
thio- TEPA</w>
thio acetamide-induced</w>
thio TEPA</w>
thick nes
thick en
thiaz ide-sensitive</w>
thiaz ide
thiamyl al-
thia di
thi xen
thi ethyl
thiethyl per
thi er</w>
thermo graphy</w>
there of</w>
therap eutical</w>
ther mist
ther g
ther :</w>
then uria</w>
themsel ves,</w>
thana sia.</w>
thalas sem
thalassem ia.</w>
thalam o-
th umb
th in,</w>
th esin</w>
tex t
tetrap legia</w>
tetrameth yl-
tetrahydrocannabin ol-
tetrahydro- 7,8-
tetrahydro deoxycorticosterone</w>
tetrahydro cortisol</w>
tetraethyl ammonium</w>
tetracycl ine.</w>
tetracycl ine-
tetraben azine-induced</w>
tetra acetic</w>
tetr amine</w>
tetr alin,</w>
tetr afluoro
tetr ab
tetan us.</w>
testoster one-treated</w>
test s;</w>
test ing:</w>
test ed;</w>
territ ory.</w>
terg uride,</w>
teratogen s</w>
ter odine</w>
ter azosin.</w>
ter :</w>
tent ative</w>
tenofovir -induced</w>
tenid ap
ten s</w>
tempor al-
temperat ure)</w>
temper am
telangiect asia,</w>
tegaf ur</w>
tech nically</w>
te lomer
telomer ase</w>
te d;</w>
te bral</w>
taxan es,</w>
tax otere</w>
tax ol.</w>
taurochol ate,</w>
tast e.</w>
task -related</w>
tartr ate,</w>
target s,</w>
target .</w>
tar io
tario ,</w>
tar g</w>
tar da.</w>
tap ered.</w>
tandos pirone</w>
tamsulos in,</w>
tamponade ,</w>
tamoxifen )</w>
tamoxifen 's</w>
tal ipex
tal ine-induced</w>
tag lu
tadalaf il.</w>
tacrolim us:</w>
tacrolim us-
tachyphyl axis.</w>
tachycardia )</w>
tac rine-
tac rine,</w>
tac alcit
tabul ated.</w>
ta ur
ta BO
taBO M</w>
t.d. s.</w>
t-G ault</w>
t- type</w>
t- test.</w>
t- PA)</w>
t- MDS/
t- E
t-E aton</w>
t- A-
t-A- C
t-A-C ath</w>
t ouret
touret tism</w>
t ors
tors ad
torsad ogenic</w>
t or.</w>
t ness/
tness/ Sedation</w>
t max</w>
t ing)</w>
t ases</w>
t ance</w>
t amide</w>
t alk
t 1/2</w>
t .,</w>
t -related</w>
systolic- diastolic</w>
systol ic/
synthesi sed</w>
synovi tis,</w>
synovi al</w>
syndrome --a</w>
syndrome '</w>
syndrome ",</w>
synchron ously</w>
synchron ized,</w>
synaptos omes.</w>
synapto genesis</w>
sympatho- adrenal</w>
sympath ovagal</w>
sympath ectomy.</w>
symmetr ic,</w>
sy- proven</w>
switch ing-
swe ating.</w>
sw ine</w>
sut ureless</w>
susta ined.</w>
susceptibil ities</w>
survey ed.</w>
surger y)</w>
surge on.</w>
surg ical,</w>
surfac e-
sur prisingly,</w>
sur ate</w>
supras pin
supram am
supra physiologic</w>
supra orbital</w>
supra hy
suprahy oid</w>
suppress ant.</w>
suppres sibility</w>
supplement ,</w>
supple ment.</w>
suppl ying</w>
super vision.</w>
super vision,</w>
super sensitivity,</w>
super infections</w>
super -
sup posed
supposed ly</w>
sup ination</w>
summ er</w>
summ aries</w>
summ ari
sulpiri de
sulphon amide</w>
sulphasalaz ine,</w>
sulph oxidation</w>
sulfonyl urea,</w>
sulfonyl naphthal
sulfonylnaphthal ene-1-
sulfonylnaphthalene-1- sulfon
sulfonylnaphthalene-1-sulfon amide,</w>
sulfadi azine-induced</w>
sulfad oxine</w>
sulf oxide.</w>
sulf obromophthalein</w>
sulf apyridine</w>
sulf am
sul fo
sufentanil/ midazolam</w>
sudden -onset</w>
succ imer</w>
suc ral
sucral f
subst ances)</w>
sublingu ally.</w>
subject 's</w>
sube picardi
sube p
sub-Ten on</w>
sub- groups</w>
sub toxic</w>
sub serving</w>
sub scales,</w>
sub o-
sub ling
subling ually</w>
sub diaphragmatic</w>
sub continent</w>
sub average</w>
sub analysis</w>
sub acute,</w>
su ture</w>
su b</w>
stutter ing.</w>
stupor ,</w>
studi es)</w>
studi es).</w>
stru gg
strom 's</w>
strok ing,</w>
strok e-like</w>
stric ,</w>
striat al-
stri ps,</w>
stri p</w>
stret ched</w>
stret ch
stress ors.</w>
stress or,</w>
stren uous</w>
stre am,</w>
strati fied,</w>
stran ded</w>
stra p</w>
stra in).</w>
str ang
stor hin
stom at
stoc king</w>
sto res,</w>
sto ols.</w>
stimul i)</w>
stimul ators.</w>
stimul ations,</w>
stimul ation)</w>
sti p
stip pl
sti ff</w>
steroid- sparing</w>
steroid- only</w>
steroid -based</w>
steril ization</w>
stereotypi es,</w>
stereotyp y;</w>
ster one,</w>
ster i
step p
step ,</w>
steno ses,</w>
steat ogenic</w>
stead .</w>
ste al"</w>
station ary</w>
statin- gemfibrozil</w>
statin- fibrate</w>
stat ure.</w>
stat in.</w>
stat ,</w>
star ing</w>
star ing,</w>
standard- risk</w>
standar dised</w>
standar d,</w>
stand ards</w>
stain able</w>
stag ge
stabiliz ers.</w>
sta urospor
sta sis,</w>
sta phylococci
st orm
st oring</w>
st one-like</w>
st ob
st ening</w>
st ear
st ating</w>
st at</w>
st ;</w>
squ am
squam ous
squamous -cell</w>
squ al
squal ene</w>
spro uted</w>
spot s,</w>
spontane ous,</w>
spong io
spong iform</w>
spondy litis.</w>
spon so
sponso red</w>
splot ch</w>
sple en.</w>
spl itting</w>
spl in
spiro metric</w>
spir adoline</w>
spin ally</w>
spin al-induced</w>
spin al,</w>
sphingomy elin</w>
sphing os
spermat ogenesis</w>
sper sed</w>
spell s,</w>
speech .</w>
spectrophot ometrically</w>
spectra .</w>
spectr um.</w>
specimen ,</w>
specific ities</w>
species- typical</w>
spec ify</w>
spe ed
speed ball
spati otemporal</w>
spasm olytic</w>
spas mogenic</w>
sparte ine,</w>
spar floxacin-induced</w>
spac er</w>
spac ef
sp aper</w>
sp an,</w>
sou thern</w>
sou th</w>
soral en</w>
sorafenib ,</w>
son- Re
son-Re es</w>
son omicro
somnol ence.</w>
somato statin-
somat odendritic</w>
som ites</w>
som ata</w>
solv ent,</w>
solub ility,</w>
solid- organ</w>
solic ited</w>
soldi ers</w>
sof tening</w>
sodium- potassium</w>
sodium- independent</w>
sodi um-induced</w>
sodi um-dependent</w>
soci o-
snor ting</w>
smok ed.</w>
smok e,</w>
sme ar
small- molecule</w>
small -</w>
sludg e,</w>
slop e,</w>
sli des</w>
sleep -dependent</w>
skin- test</w>
siz es.</w>
siz able</w>
sixty- one</w>
situ ,</w>
site (s)</w>
sis- associated</w>
sirolim us)</w>
sion ed</w>
sion ),</w>
sinusi tis</w>
sino- atrial</w>
single- nephron</w>
single- dose,</w>
single- centre</w>
sin ap
sinap ic</w>
simul ations</w>
simpl ified</w>
simpl er</w>
similar ly.</w>
sim vastatin-
sim vastat
sim plic
sill ar</w>
sil ence</w>
sign ifying</w>
sign alled</w>
side- to-side</w>
side- effects:</w>
side- chain</w>
side -related</w>
sick ness.</w>
sick ness,</w>
sic um</w>
sibutr amine.</w>
sib le,</w>
si ve/
si res.</w>
shrun ken</w>
show n,</w>
shorter- acting</w>
short-ter m
short- duration</w>
shock ;</w>
shipp ed</w>
shell ,</w>
shel f</w>
sheep ,</w>
she d
shed ding</w>
shar p-
shar p
sharp ness</w>
sh ut
sh aring</w>
sevoflur ane-induced</w>
sever al-
several- fold</w>
ses '</w>
seroconver sion.</w>
sero status</w>
seri ousness</w>
ser ia</w>
sequenc ing.</w>
sequ ell
septo plasty</w>
sensitiv ity:</w>
semin oma</w>
sem istructured</w>
sell ar</w>
self- perceived</w>
self- limited.</w>
self- described</w>
self- controlled</w>
selen ite</w>
selective ')</w>
sel f
sel ecti
seizures =
seizures .(ABSTRACT</w>
seizure- prolonging</w>
seizure- free,</w>
seg mented</w>
see ing</w>
sedent ary;</w>
sedati ves.</w>
sed ation/
sect or</w>
second s),</w>
sec ured</w>
sec ure</w>
sec tion
sec (-1
sec(-1 ).m(2)
sec(-1).m(2) .
sec(-1).m(2). cm
se st</w>
se pi
se eds</w>
se "</w>
scrutin y</w>
scro tal</w>
scre ens,</w>
scram bling</w>
scotom as,</w>
scor ing.</w>
sco re:</w>
scleroder moid</w>
scinti graphy,</w>
school- age</w>
school children</w>
scho ol.</w>
schizophren ia-like</w>
schedul ing</w>
schedul es:</w>
schedul e:</w>
schedul e-dependent</w>
sch ist
scen ario
scar city</w>
scar ce</w>
scann ing,</w>
sc ribed</w>
sc rape</w>
sc oline</w>
sc ene</w>
sc ant</w>
sc ant
sc ).</w>
sc )-induced</w>
satisfactor y.</w>
satisfactor y,</w>
sarco glyc
sarc openia</w>
saralas in-treated</w>
sar izot
saquin avir</w>
salt- depleted</w>
salt- dependent</w>
salmeter ol.</w>
saliv a</w>
salicyl ate.</w>
sal t
sal ine:</w>
saf er,</w>
sacro iliitis</w>
sacca des</w>
s/ min,</w>
s. e.
s. "</w>
s-of- function</w>
s- S
s-S ay
s-Say re</w>
s ulation</w>
s tig
s s
s orbent</w>
s old</w>
s ke
s ings</w>
s ine
s h</w>
s angu
s and
s ].</w>
s -related</w>
s ")</w>
ry ocy
ryocy storhin
rupt ure,</w>
run -
run- in,</w>
rubidaz one</w>
ru m</w>
ru g
ru di
rt L180
rr ALR</w>
roxithrom ycin.</w>
rox indole</w>
row siness</w>
roten one-treated</w>
roten one,</w>
rot ation,</w>
rosiglitaz one.</w>
roph ag
rop yri
rop ometric</w>
ron oun
ronoun ced</w>
rom is
roll ment</w>
role um</w>
role -induced</w>
rof t-Gault</w>
roentgen ogram</w>
ro taline-induced</w>
ro ta</w>
ro lingual</w>
ro lid
ro l)</w>
ro ci
roci verine</w>
rizatript an,</w>
ritonavir -treated</w>
rit anserin,</w>
risperid one-
risk ;</w>
rin one,</w>
rin )</w>
rim ifentan
rimifentan il</w>
right- to-left</w>
ribo flav
ribavir in-associated</w>
rib s</w>
ri mental</w>
ri m</w>
ri gorously</w>
ri fication</w>
ri es.</w>
ri er</w>
rhyth mias</w>
rho ids</w>
rho dam
rhodam ine
rho d
rhod amine</w>
rhinosinu sitis.</w>
rhi zom
rheum atism</w>
rhe ological</w>
rhaph y.</w>
rhabdomy osarcoma</w>
rhIL-1 1</w>
rh initis.</w>
rf onad
rewar d)</w>
revisit ed.</w>
reversal ,</w>
rever se,</w>
rever s
rety lium</w>
retro vir</w>
retro placental</w>
retriev al,</w>
retin ol-
retinol- binding</w>
reticulo cytes,</w>
reticulat a.</w>
ret initis.</w>
ret ching</w>
restless ness.</w>
resten osis.</w>
rest orative</w>
rest ing,</w>
rest ;</w>
responsib le,</w>
response ),</w>
responder s"</w>
respond ing,</w>
respon sibility</w>
respon ses;</w>
respon ses)</w>
respir ations</w>
respect .</w>
resource- limited</w>
resoruf in</w>
resorp tions,</w>
resor ption,</w>
resisti n</w>
resistance )</w>
reserp ine-</w>
research er</w>
resc ence</w>
res ect
reput ation</w>
reproducibil ity,</w>
reporte d:</w>
replic ative</w>
replic ating</w>
repeti tions</w>
reorgan ization,</w>
renin- -
renin-- angiotensin</w>
ren al/
remit ters</w>
rema ster</w>
rema ined,</w>
reluct ant</w>
reli able,</w>
relax ants,</w>
relationshi ps,</w>
relap se
rel ational</w>
rel ation,</w>
reinstat ement,</w>
regurgit ations</w>
regul ated.</w>
regul ar,</w>
regres s</w>
registr y.</w>
regist ers</w>
regist ered,</w>
regist er</w>
region s:</w>
regimen ).</w>
regar d.</w>
reg aining</w>
reflex )</w>
referen ce.</w>
refer red.</w>
ref ine
recurren ces.</w>
recur red,</w>
recur arization</w>
rectom y,</w>
recover s</w>
rechallenge d.</w>
receptor- stimulating</w>
receptor- selective</w>
receptor- medi
receptor- independent</w>
receptor :</w>
receptor -related</w>
rec uper
rec all.</w>
reboxet ine.</w>
reboun d.</w>
reasses sed</w>
reas suring</w>
reas signed</w>
reas on.</w>
read iness</w>
reac ts</w>
reac tive.</w>
reac tion;</w>
re-in- an
re- uptake.</w>
re- evaluation</w>
re- emergence</w>
re uptake,</w>
re treats</w>
re tested</w>
re positioning</w>
re parative</w>
re paralysis</w>
re oxygenation</w>
re infusion</w>
re hospitalization</w>
re exposed</w>
re evaluation</w>
re entry.</w>
re duplication</w>
re consider</w>
re ated</w>
re agents</w>
re agents.</w>
re activity,</w>
re activated</w>
rate- blood</w>
rate ).</w>
rat ers</w>
rat ax
rat ;</w>
rans plant</w>
rang e;</w>
ran ks</w>
ran k
ramp ant</w>
ramipri lat</w>
ram p</w>
ram o
ramo setron</w>
raloxif ene.</w>
raloxif ene-
ral titrexed</w>
radiolab elled</w>
radioimmuno assays.</w>
radio- labeled</w>
radio receptor</w>
radic ulography</w>
radi osensi
radi ological,</w>
radi o</w>
rad ine</w>
rad )</w>
rac he
rac h
rac e;</w>
rac e-
ra d</w>
ra Ver
rHV -1</w>
rCMR Glu</w>
r y.</w>
r uciating</w>
r ings.</w>
r ine:</w>
r ine-related</w>
r Hu</w>
r BLA</w>
r 1</w>
r 1(
r1( neo-
r1(neo- /-)</w>
r ).</w>
quoti ent</w>
quisqual ic</w>
quisqual ate</w>
quinpi role.</w>
quinoxaline- 7-
quinoxal ine
quinoxal in-1-
quinone imine</w>
quinid ine-like</w>
quin april,</w>
quick ly,</w>
question ed,</w>
qual ity.</w>
quadri paresis.</w>
quadr ants</w>
qu ineth
q. i.d.</w>
q 12
pyruv ic</w>
pyrrolid one</w>
pyrimid inyl)
pyrimid in
pyrimidin yl-2-phenoxy
pyridoxal- phosphate</w>
pyridox ine-
pyridos tigmine.</w>
pyrido [1,
pyrid ines</w>
pyri lam
pyrazolo [4,3-
pyrazol e-
pyrazole- 3-
pyrazole-3- carboxamide
pyl oric</w>
pyl or
pye lography</w>
pye litis,</w>
py lo
push -pull</w>
puromyc in-
puromycin- aminonucleoside</w>
purch ase</w>
pur ities</w>
pupil s,</w>
pun ding</w>
pulmon ic</w>
public ations.</w>
puber ty.</w>
pub ic</w>
pu zz
pt s.</w>
pt s),</w>
psychostimul ants.</w>
psychostimul ants,</w>
psycho ses.</w>
psycho pathology.</w>
psychiatric -like</w>
psych ot
psychot ogenic</w>
pseudolith iasis,</w>
pseudo- obstruction</w>
pseudo- Bartter's</w>
pseudo aneurysms</w>
pseudo aneurysm</w>
pseudo acromegaly</w>
pseud otum
pseud op
ps apir
pruri ens</w>
proxim ate</w>
prox if
provi der</w>
provi ded,</w>
prov ince</w>
proteinur ia;</w>
protein- mixed</w>
protein- binding</w>
protein ase-
protein aceous</w>
protec tion)</w>
prosthe ses.</w>
pros tigmine-
propylthio -</w>
propyl pentano
propylpentano yl)urea</w>
propyl -2
propyl )-
propranolo l:</w>
propranolo l-treated</w>
propofol- LCT/MCT</w>
propofol +
propofol )</w>
propo ses</w>
prophylaxis ;</w>
properti es:</w>
proper .</w>
propan olol</w>
propacetam ol,</w>
prop olis</w>
prop en
prop anoic</w>
prompt ly,</w>
promis ing,</w>
prom oter
prom nesic</w>
prolong ed-release</w>
prolin ic</w>
proligest one</w>
prol ine,</w>
prokine tic
proj ect
prohib ited</w>
progres sions</w>
progestin- only</w>
proced ure).</w>
procain amide
problematic .</w>
pro- drug</w>
pro- ANP</w>
pro to-
pro to
pro sencephal
pro parac
pro motion.</w>
pro hypertensive</w>
pro be
pro apoptotic</w>
pro -</w>
priloca ine,</w>
prick ,</w>
pric ks</w>
pri or.</w>
pri mor
previous ly-
preval ent,</w>
presyn ap
pressure- lowering</w>
pressure- diameter</w>
press ors</w>
preserv ative.</w>
preser ved,</w>
prescrip tion-event</w>
prescrib ing.</w>
prescho ol
preschool ers</w>
pren olol.</w>
premedic ant.</w>
prelim in
pregnancy ;</w>
pregnanc ies,</w>
pregn ant,</w>
preexist ing,</w>
predomin ance.</w>
predis position.</w>
predict ability</w>
predic ted,</w>
precur arization</w>
precipit ant</w>
prece d
pre- induction</w>
pre- drug</w>
pre treated,</w>
pre test)</w>
pre tectal</w>
pre mise</w>
pre marketing</w>
pre injury</w>
pre induction</w>
pre index</w>
pre hypotension</w>
pre excitation</w>
pre constricted</w>
pre cancerous</w>
pre c
prec oci
precoci ous</w>
pre adolescent</w>
prazosin )</w>
praz ocin</w>
practition ers,</w>
practic ing</w>
pr un
pr ices</w>
pr amine)</w>
pr al
pral id
pp sal
pp (N
pp(N H)
potenti ation,</w>
potenti ated,</w>
poten cy
poten cies.</w>
postul ated,</w>
postis o
postiso proteren
post-CA B,</w>
post- translational</w>
post- therapy</w>
post- receptor</w>
post- prandial</w>
post- nat
post- herpetic</w>
post- arvanil</w>
post- acquisition</w>
post- MI</w>
post- LT</w>
post ures.</w>
post treatment,</w>
post switch</w>
post natally</w>
post myocardial</w>
post index</w>
post drug</w>
post baseline</w>
post ablation</w>
positive /
posi tion
pos ited</w>
porphy ria,</w>
por ter</w>
popul ation)</w>
polysacchar ides</w>
polysacchar ide</w>
poly vinyl</w>
poly synaptic</w>
poly neuropathies</w>
poly my
polymy xin</w>
poly modal</w>
poly estradiol</w>
poly anion</w>
poly amines,</w>
poll ak
point s:</w>
point s),</w>
point es;</w>
point )</w>
podocaly x
pod ocytic</w>
po res</w>
po isons</w>
pneum ococci</w>
pneum atic</w>
plu gs</w>
plekhh 2</w>
ple uritic</w>
ple ocytosis.</w>
ple i
plausib le.</w>
plat ypnea-orthodeox
plast y:</w>
plas mid</w>
plas m
plant aris</w>
planime tric</w>
plan i
plan es</w>
placent ally</w>
placent a,</w>
pl ug
pl es.</w>
pl es,</w>
pl ate,</w>
pl ants</w>
pl akin
pkr 1-null</w>
piv ampicillin</w>
pituitary- adrenocortical</w>
pirox antr
piri de-induced</w>
pirenzep ine.</w>
pir profen</w>
pir menol</w>
piperid in-4-
piper ine</w>
pilo t,</w>
pilo erection</w>
pill ,</w>
pig ment
pig .</w>
piec eme
pieceme al</w>
picrotox inin</w>
picloz otan</w>
pic a.</w>
physic ochemical</w>
physi opath
phy tom
photosensi tive</w>
photograph s</w>
photo aging</w>
phosphorothio ic</w>
phosphono- 3-
phosphon op
phosphonop entano
phosphonopentano ic</w>
phosphon acetyl-L-
phospholip id-
phosphocreat ine,</w>
phosphati dy
phosphatidy lethan
phosphate- depleted</w>
phosphate- dehydrogenase</w>
phosphate- buffered</w>
phosphat uria</w>
phosphat ase)</w>
phosph ofr
phosphofr ucto
phosph ite</w>
phosph ate/
phosphate/ creatine</w>
phor bol
phon ophobia</w>
phob ics,</w>
phob ia.</w>
pher om
pheochromocyt omas.</w>
phenyto in-
phenylpropanol amine-containing</w>
phenylbutaz one-associated</w>
phenyl- 2-
phenyl)- 8-
phenyl propyl)
phenyl hydantoin</w>
phenyl glycol</w>
phenyl acetate</w>
phenter amine</w>
phenoxybenz amine.</w>
phenoxybenz amine,</w>
phenotyp es.</w>
phenotyp es,</w>
phenothiaz ine-induced</w>
phenomen ology</w>
phenobarbit one-
phenobarbit al:</w>
phenobarbit al)</w>
phenir amine</w>
phenaz opyridine</w>
phenad rine</w>
phen formin</w>
phen ethyl</w>
pharmacokine tic/pharmacodynamic</w>
pharmacokine tic-pharmacodynamic</w>
pharmaco therapy.</w>
pharmaco therapy,</w>
phacoemulsi fication</w>
phac lofen
ph ores
phores ed</w>
pg/ ml).</w>
pg/ 10</w>
peti form
peth idine,</w>
pet roleum</w>
person- year)</w>
person al
persist s.</w>
persist .</w>
persist ,</w>
perox ide.</w>
perox ide,</w>
peritone ally</w>
periton itis.</w>
peristal tic</w>
peripher ally,</w>
perinuclear- staining</w>
perif ascicular</w>
perid ol,</w>
pericardi ocentesis</w>
peric analicular</w>
peri venular</w>
peri metry</w>
pergol ide-treated</w>
perfusion- fixed</w>
perform s</w>
perfor ation,</w>
perf ect
perfect ly</w>
per spective</w>
per spective,</w>
per sec
per s,</w>
per orally</w>
per nio
per min
per ineural</w>
per ineur
per hap
perhap s,</w>
peptidom imetics</w>
pepti dase</w>
pentylenetetrazol -
pentylenetetraz ol.</w>
pentolini um,</w>
pentobarbit one,</w>
pentetra zole-induced</w>
pentamid ine-associated</w>
pentam eric</w>
pentagastr in.</w>
pent oth
penicill amine-associated</w>
penicill amine)</w>
pen e</w>
pen butolol</w>
pem pid
pem oline.</w>
pem iro
pelle ts.</w>
pelle t,</w>
pel vis.</w>
pegyl ated-
peg- IFN-alpha2b</w>
peg IFN</w>
peg IFN)</w>
ped al</w>
peak )</w>
pe floxac
paw :</w>
pauci- immune</w>
patient- specific</w>
patient s--
pati onal</w>
pati on,</w>
pat ency.</w>
pass ant</w>
pass ages</w>
parvalbumin -containing</w>
partum ,</w>
parti cles.</w>
parti cles,</w>
part ners</w>
parox ysms</w>
parg yline,</w>
paresthesi ae</w>
paren ts,</w>
pare un
parathyroid ectomy,</w>
parasit es.</w>
parasit aemia</w>
paraph ilias</w>
parap legia</w>
paramedic s.</w>
parame dic</w>
paraly zing</w>
paraly sed</w>
paraff in-
paradoxic ally,</w>
paradoxic al,</w>
par icalcitol</w>
paqu e.</w>
papillo macular</w>
papill a,</w>
pap ules</w>
panic ogenic</w>
pan cytopenia.</w>
pan cerebellar</w>
palsy :</w>
palpit ation,</w>
palmito yl</w>
palm ar</w>
pallid otomy.</w>
palli ation</w>
pal sies</w>
pal m</w>
pair wise</w>
pad s</w>
pad ,</w>
paclitaxel- resistant</w>
pack aging</w>
pacemak ers.</w>
pa in/
pa in-induced</w>
pa in).</w>
pa in),</w>
pa eoniflor
p= 0.5
p= 0.
p< 0.01,</w>
p< 0.01),</w>
p< 0.001</w>
p75NT R-
p75(NTR)- IR</w>
p75(NT R)</w>
p-chloro phenylalanine,</w>
p- value</w>
p- benzo
p, p'-
p ud
p ine-
p in-
p ice</w>
p ess
p ending</w>
p T
p >
p 50</w>
p ),</w>
oz ygotic</w>
oz ol
ozol inone</w>
oz antrone</w>
oxytocic s</w>
oxytoc in,</w>
oxymorph one,</w>
oxybenz amine</w>
oxy tetracycline</w>
oxy methamphetamine</w>
oxy hemoglobin</w>
oxy co
oxyco done.</w>
oxopiperazinyl-1- yl)prop
oxopiper azine</w>
oxo- 5-
oxidi zing</w>
oxide -mediated</w>
oxide -dependent</w>
oxidative/ nitrosative</w>
oxic- ischemic</w>
oxic am</w>
oxi metry</w>
oxi b.</w>
oxcarbazep ine,</w>
oxaliplat in.</w>
oxaliplat in-induced</w>
oxadi az
ox ol
oxol inic</w>
ox ides</w>
ox azine</w>
ox androlone</w>
ox andro
oxandro lon
ovul atory</w>
oversho ot
overload -induced</w>
overl aps</w>
over stimulation</w>
over dose
ove restim
ovari ectomy</w>
oval bumin</w>
ov ine</w>
ov es
ov ary.</w>
ov aqu
out weighs</w>
out weighed</w>
out flow,</w>
ous ness,</w>
ous ?</w>
our s</w>
our s,</w>
ou rea</w>
ou mar
otrop y</w>
otrans ferase</w>
otoxic ,</w>
otox ins</w>
otox in,</w>
otolaryng ologist</w>
oto protectant</w>
oti lonium</w>
other "</w>
othec in</w>
otetr alin</w>
ot strap</w>
ostom y.</w>
osteosarcom as</w>
osteomyeli tis,</w>
osteo dystrophy</w>
oste otomy</w>
oste onecrosis</w>
oste oblastic</w>
osmoly tes</w>
osmo receptor</w>
oscy amine</w>
oscil lop
os uria</w>
os ome</w>
os ine-
os )</w>
orth ost
orphan '</w>
orph ine.</w>
orph anin</w>
orph an</w>
ori ent
ori b
orib ine</w>
organophosph orous</w>
organochlor ine</w>
ore t
ord on</w>
ord an</w>
orb ed</w>
or ts</w>
or tion</w>
or tin</w>
or sak
or s).</w>
or rhaphy.</w>
or is</w>
or ally-
or -induced</w>
opyri dine,</w>
opyri d
opy rine</w>
opri m</w>
opportun ities</w>
opoi etin</w>
opo etic</w>
opioid -treated</w>
opioid -related</w>
ophthal mia</w>
ophosph amide</w>
oper ations,</w>
open- arm</w>
open s</w>
op osi
op olysacchar
op neum
op indo
op ex
op e
op amil</w>
onto genetic</w>
oni onic</w>
oni an</w>
oni -
oni- Deb
oni-Deb r</w>
ong -B
ong-B aker</w>
one- vessel</w>
one- sided</w>
one- quarter</w>
one- methyl</w>
one ]</w>
oncolog y,</w>
onco tic</w>
once-per- cycle</w>
on- time</w>
on- only</w>
on idine</w>
on ad</w>
on -associated</w>
on ),</w>
on '</w>
omyc es</w>
omit ted</w>
omicro scopy</w>
omeprazol e-induced</w>
omegal y.</w>
omega- 3</w>
omedi ol</w>
ome prol
om yelo
om ifens
om eric</w>
om ata</w>
olog y;</w>
olog ies,</w>
olo l:</w>
olivoc ochlear</w>
oligodeoxy nucleotides</w>
oligodendro cyte</w>
oligo hydramnios.</w>
oligo -
olig uric.</w>
olamine- pretreated</w>
ol-20- one</w>
ol ong</w>
ol esoxime</w>
ol az
ol -</w>
ol 's</w>
oint ment,</w>
oid .</w>
oid -
offen ders</w>
off .</w>
of loxacin.</w>
of loxacin-induced</w>
of er
of .</w>
odol pas
odi amide</w>
ocyte- integr
ocyte-integr ins
ocyte ,</w>
ocyt es)</w>
ocurar ine</w>
octreoti de:</w>
octogenari ans.</w>
ocrypt ine</w>
ocorm ia</w>
ocompati bility</w>
ocom o
ocomo tion</w>
ochem ist
ocent ric</w>
oce le.</w>
occup ying</w>
occup ancy.</w>
occul ta,</w>
occlud ens
occludens -1</w>
occlu der</w>
oc ket</w>
oc ine</w>
oc in
oc erebellar</w>
obvi ate</w>
obste tric
obst ac
obses sional</w>
observer s.</w>
observ ation-
observation- carri
observation-carri ed-forward</w>
obsc ured</w>
oblong ata.</w>
object s,</w>
object -
obio logy</w>
obenz odiazepine</w>
obenz amide</w>
ob last</w>
ob ic
o-t subo</w>
o- urinary</w>
o- lateral</w>
o yl-
o tility</w>
o sterol</w>
o romandibular</w>
o phen
o il/
o estradiol,</w>
o est
o X
nutri ent</w>
nur ser
nur se,</w>
numer ically</w>
numb ness.</w>
num bered</w>
nul l)</w>
nucleotide- gated</w>
nucleoti dase</w>
nucleol on
nucleo sides.</w>
nucle ation</w>
nov o.</w>
noti ce</w>
not es.</w>
normal s.</w>
normal s,</w>
normal ity</w>
normal ised.</w>
normal cy</w>
normal ),</w>
norm s</w>
norm ocap
nor-binaltorph im
nor veg
nor meperidine,</w>
nor ketamine</w>
nor fenfluramine</w>
nor fenfluramine,</w>
nor cocaine,</w>
non- voiding</w>
non- steroid</w>
non- sedating</w>
non- schizophrenic</w>
non- reactive</w>
non- pharmacological</w>
non- obstructive</w>
non- noxious</w>
non- lithium</w>
non- insulin</w>
non- inferior</w>
non- infectious</w>
non- hormonal</w>
non- failing</w>
non- ergot</w>
non- cocaine-exposed</w>
non- clear-cell</w>
non- castrated</w>
non- cancer</w>
non- TDM</w>
non- Q-AMI</w>
non- FA</w>
non- B</w>
non valvular</w>
non survivors</w>
non suffering</w>
non smokers.</w>
non significant,</w>
non responding</w>
non relapse</w>
non psychiatric</w>
non prednisone</w>
non perfused</w>
non painful</w>
non myocyte</w>
non melanoma</w>
non matching</w>
non lymphoblastic</w>
non lactating</w>
non injected</w>
non inferior</w>
non haematological</w>
non glomerular</w>
non glandular</w>
non existent</w>
non dyskinetic</w>
non drug</w>
non diagnostic</w>
non arteriosclerotic</w>
non adrenergic</w>
non acetylated</w>
noi se.</w>
nod ulo
nocicept in
nociceptin (1-1
nociceptin(1-1 3)
nociceptin(1-13) NH
noc tamide</w>
no stri
no on</w>
no des.</w>
no .</w>
nmol/ h</w>
nmol/ 5</w>
nmol ;</w>
niz atidine</w>
nitroglycerin- stimulated</w>
nitroglycer in-</w>
nitro- L-arginine,</w>
nitro sam
nitro blue</w>
nitrit es</w>
ninety- seven</w>
nine teen</w>
nightma res</w>
nightma res,</w>
nifekal ant</w>
nicotine- exposed</w>
nicardi pine-,</w>
ni ac
ng/ml/ hr.</w>
ng/ml/ 16</w>
ng/d L</w>
ng/ mouse)</w>
new spaper</w>
new est</w>
nevirap ine-based</w>
neurotrop ic</w>
neurotransmit ter
neurotoxic ity;</w>
neurotoxic .</w>
neuropsych ometric</w>
neuropath y)</w>
neuropath y).</w>
neuropath ies,</w>
neuron s:</w>
neurolog ists</w>
neurolep tic-like</w>
neuroblast oma,</w>
neuro tic</w>
neuro stimulation</w>
neuro secretory</w>
neuro psychiatric-like</w>
neuro protection.</w>
neuro protect
neuro plasticity</w>
neuro phy
neuro peptide,</w>
neuro inflammatory</w>
neuro hormonal</w>
neuro filamentous</w>
neuro fibrom
neuro chemistry</w>
neur ulation,</w>
neur algia.</w>
nest in,</w>
nephropath y;</w>
nephro sis:</w>
nephro logy</w>
nephro angiography</w>
nephri tis;</w>
nephrectom y,</w>
neostriat um.</w>
neocortex ,</w>
nelfin avir,</w>
negati ve)</w>
needle- free</w>
need s.</w>
need les</w>
need l
need ing</w>
necro sis:</w>
necro genic</w>
nec tic
near- fatal</w>
near -term</w>
ne omycin.</w>
ne omycin,</w>
ne obladder</w>
ne f
nef opam,</w>
ne )</w>
ne 's</w>
navig ation</w>
nause a)</w>
nation ally</w>
nat i</w>
nas al,</w>
narrow ing.</w>
narrow ing,</w>
narrow er</w>
nar atriptan</w>
naph tho
nanop article</w>
naloxon azine</w>
nalox one],</w>
nal- fetal</w>
nal orphine,</w>
nail s.</w>
nabil one,</w>
n- rump</w>
n- SOD</w>
n t-
n s-Sayre</w>
n mole</w>
n lein</w>
n ipec
n ing-
n al,</w>
n .)</w>
myri ad</w>
myonec rosis.</w>
myoglobin uria.</w>
myocyt olysis,</w>
myo pathies.</w>
myo fibroblasts</w>
myo fibre</w>
myelos chisis</w>
myelomening ocele</w>
myelo- optic</w>
myelo peroxidase,</w>
myelo encephalopathy</w>
myelo dysplasia.</w>
myelin olysis</w>
myelin oid</w>
mye logram
myco ses.</w>
myasthen ia.</w>
myasthen ia,</w>
myalg ic</w>
my oton
my ocyte.</w>
my oblasts</w>
my enteric</w>
my dricaine</w>
mutag en
muscul ature.</w>
muscle -
mumol/ liter</w>
mumol/ kg),</w>
multiplex ,</w>
multiple -drug</w>
multin ational</w>
multifor me.</w>
multifactori al,</w>
multi- institutional</w>
multi lamellar</w>
mug/ kg)</w>
muc in</w>
mu M)</w>
mt DNA.</w>
mt DNA,</w>
moxon idine,</w>
movement -related</w>
mouth washes</w>
mouse ),</w>
moun ted</w>
mos m/kg</w>
mos apride</w>
morpho functional</w>
morph ometrically</w>
morph ological,</w>
morph ogenetic</w>
morph ine;</w>
morph ine)</w>
more over</w>
mor tem.</w>
mor bidi
month s-old)</w>
month s);</w>
month ;</w>
monos odium</w>
mononucle osis-like</w>
mononit rate,</w>
mononeur itis</w>
monoc rotaline-induced</w>
mono oxygen
mono arthritic</w>
mon ozygotic</w>
mon oxide.</w>
mon oter
mon ocular</w>
mon idine</w>
mon -induced</w>
molecul es,</w>
molecul e-1</w>
molec ule
molar s.</w>
mol/ l).</w>
mol ars</w>
modific ations,</w>
modific ation.</w>
moderate- severe</w>
moder ate;</w>
modell ing.</w>
moclobem ide,</w>
mobil ization,</w>
mobil isation</w>
mo- epidermal</w>
mo tion,</w>
mo s</w>
mo bile</w>
mmol/ kg),</w>
mmol ,</w>
mm(3 ))</w>
mm ug.
ml/min/ kg</w>
ml/min/ kg,</w>
ml/min/ g)</w>
ml/g/ min,</w>
ml/ min),</w>
ml/ kg).</w>
ml. min-1.
ml. 100</w>
mixt ure-induced</w>
mixed- action</w>
mitot ane</w>
mit ozantrone</w>
mis lead
mislead ing.</w>
mis interpreted</w>
mis diagnosis</w>
mis carri
minut e
minimal- type</w>
min(-1 )),</w>
min or.</w>
min or,</w>
min idose</w>
min d.</w>
min ]</w>
min .,</w>
min -1
min -
milnacipran -treated</w>
millisecond s,</w>
milli on.</w>
milli gram</w>
mil tiorrhiz
mil k,</w>
migraineur s,</w>
migra ines</w>
migra ine-
mig rating</w>
midazolam ;</w>
midazolam 's</w>
midazol am-
mid zonal</w>
mid agli
mid -</w>
micturi tion,</w>
micron s)</w>
micron e
micromol/ min/100</w>
micromol/ L/
micromol/L/ mg</w>
micromol es;</w>
microm olar</w>
microm .</w>
microliter ),</w>
microl/ side)</w>
micrograms/m L,</w>
micrograms/ ml),</w>
micrograms/ g)</w>
micrograms/ g
micrograms.kg-1. min-1).</w>
micrograms. kg-1)</w>
microgram/kg/ min.</w>
microgram/ liter</w>
microgli a/
microgli a-
microg/mL );</w>
microg/m L),</w>
microg/kg/ minute</w>
microg/kg/ min.</w>
microg/ ml.</w>
microg/ l</w>
microg/ kg;</w>
microg/ hour.</w>
microg/ day,</w>
microg/ day)</w>
microg/ d</w>
microg. /
microg x
microcephal y.</w>
microcephal y,</w>
micro villi</w>
micro villi
micro surgery.</w>
micro prolactinoma.</w>
micro l.</w>
micro l--
micro l).</w>
micro hematuria</w>
micro crystals</w>
micro array</w>
micro V,</w>
micro -opioid</w>
mic e),</w>
mic e
mic afun
mic -
mi pafox
mi gran
mi ght,</w>
mi as.</w>
mi anser
mgI/ ml</w>
mg/m2/ wk</w>
mg/m2/ week.</w>
mg/m(2) ),</w>
mg/m(2 );</w>
mg/m mol</w>
mg/kg/ in
mg/kg/in j</w>
mg/kg/ dose)</w>
mg/kg/ d,</w>
mg/kg/ d).</w>
mg/kg/ d),</w>
mg/kg -
mg/kg )/
mg/K g)</w>
mg/100 g</w>
mg/ twice</w>
mg/ liter)</w>
mg/ l),</w>
mg/ g
mg/g m),</w>
mg/ 8</w>
mg/ 0.5</w>
mg. kg-1.</w>
mg. h-1</w>
mg. %</w>
mg I</w>
mg -
mg );</w>
metri f
methysergi de,</w>
methylphenid ate-induced</w>
methyleth yl)
methylenedioxy- 5H-
methyl- glutaryl-coenzyme</w>
methyl scopolamine</w>
methyl lyc
methyllyc aconitine</w>
methyl ene
methyl ation,</w>
methoxyp soralen</w>
methoxy-4- iodo
methoxy- idazoxan</w>
methoxy flur
methox y</w>
methox amine-induced</w>
method )</w>
method ),</w>
methiaz ide</w>
methazol amide,</w>
methamphetamine- related</w>
methamphet amine-treated</w>
methadone- related</w>
methadone- exposed</w>
meth ylester</w>
meter gol
metalloproteinase- 2</w>
metabol izes</w>
metabol ize</w>
metabol ising</w>
met ocur
met keph
met at
metat ar
metatar sal</w>
mesulerg ine</w>
mess ages</w>
mess age</w>
mesotheli oma.</w>
mesocortic olimbic</w>
mesenter y</w>
mesenter ic,</w>
mes ocortical</w>
mes na
meropenem -treated</w>
merg ing</w>
mercur ic</w>
mercap tosuccinic</w>
mer ,</w>
meq/ kg</w>
mephed rone</w>
meperid ine-associated</w>
menorrhag ia.</w>
mening ococcal</w>
mening itic</w>
mening ism</w>
mening es</w>
mening es.</w>
men tioning</w>
men ian</w>
men ).</w>
memor y:</w>
memor ies</w>
memb ers,</w>
memant ine,</w>
melphalan- prednisone</w>
meglum ine/
meglumine/ sodium</w>
megakary ocyte</w>
mefloqu ine,</w>
medulloblast oma</w>
medication- overuse</w>
medic ations)</w>
mediast inum</w>
medi ate,</w>
mechano- hyperalgesia</w>
mechano receptor</w>
mechanism s:</w>
mechanism :</w>
mechanism (s).</w>
mechanis m)</w>
mechan ics.</w>
measur able,</w>
mean +/-
me trorrhag
me re-
me quit
me prob
me et
me droxy-
me als</w>
me ag
mc a</w>
mc M</w>
may a</w>
max .</w>
matri x-
matche d-
mast ocytosis</w>
massi ve,</w>
masquer ading</w>
mascul ine</w>
mas tic
mas ker</w>
mas k.</w>
mas ,</w>
mark ers:</w>
map s,</w>
manufacture r,</w>
manipul ations.</w>
maneu vers</w>
man ia:</w>
man assantin</w>
man :</w>
malon ate-induced</w>
malign ant-like</w>
male/ female</w>
male ate-induced</w>
male ate)</w>
malar ia:</w>
mal nutrition,</w>
mal function.</w>
mal absorption</w>
mak ing,</w>
magnesi um-dependent</w>
magne t</w>
mag noc
macrophage- derived</w>
macroph ag
macro -
machin ery</w>
mac ulopathy</w>
ma il</w>
ma de:</w>
ma d</w>
mT OR</w>
mOsm/ kg)</w>
mL/min/ kg,</w>
mL/ s,</w>
mL/ kg/
mL/ kg,</w>
mL .g-1.
mIU/ ml</w>
mEq .</w>
mE q.
mE C</w>
m- PW
m- 2;</w>
m- 2,</w>
m- 2)</w>
m uricholic</w>
m s/
m s
m oxi
m ith
m entin</w>
m bil
m atical</w>
m app
m ant
m U/L</w>
m TLE</w>
m PFC</w>
m IPSC</w>
m AMPH
m 2/day</w>
m .),</w>
lys ine,</w>
lymphaden opath
lymph openia,</w>
lymph edema</w>
lymph -
ly sis,</w>
lumin a</w>
luk ast
lu x
lower- extremity</w>
low- output</w>
low- income</w>
low er)</w>
low )</w>
low "</w>
losart an-treated</w>
losart an),</w>
los s:</w>
los s-of-function</w>
los oxantr
lorat adine.</w>
lop ontine</w>
loop ,</w>
long-ter m
long- sleep</w>
long- lasting,</w>
long- infusion</w>
long- access</w>
long er,</w>
long -</w>
log- linear</w>
log is
log ies</w>
loco regional</w>
lock ed-in</w>
local izes</w>
local izations</w>
local ization,</w>
lob ule</w>
lob az
lo targ</w>
lo st.</w>
lo mustine</w>
lo in</w>
lo caine</w>
liver- spleen</w>
litter s.</w>
lithotrip sy</w>
lithium- containing</w>
lith ocholic</w>
lith iasis:</w>
lit res
lis dexamfet
lipos ome</w>
lipoprotein- cholesterol</w>
lipoprotein- X</w>
lipo philicity</w>
lipo peroxidative</w>
lipid- containing</w>
lip oxygenation</w>
lingu al-
linezol id-associated</w>
line ).</w>
lin iske</w>
limon exic</w>
limit ation.</w>
lim bic
lik el
lignoca ine)</w>
lightheade dness.</w>
ligh t/
ligand- binding</w>
lig ent</w>
lig ations</w>
lig ation/
ligation/ reperfusion</w>
life- long</w>
lidoca ine:</w>
lic hen</w>
liber ation</w>
liber ated</w>
li sting</w>
li o
li es</w>
li brary</w>
levof loxac
levodopa -associated</w>
levetir acetam,</w>
level :</w>
lev acetylmethadol</w>
leukotri enes</w>
leukopen ic</w>
leuk aem
leucine- enkephalin</w>
leucine- enkephal
leuc ocytes</w>
lethal ities</w>
leth al,</w>
lessen ing</w>
less ;</w>
lepro sum</w>
lepirud in.</w>
lep tin</w>
length s.</w>
lenalidomide- based</w>
len ticular</w>
len s.</w>
leiomyosarcom as.</w>
leiomy osarcoma,</w>
leg ally</w>
left- to-right</w>
lef t.</w>
lef rine</w>
leak age,</w>
le- closure</w>
le tro
le ster
le mon</w>
le dge
later odorsal</w>
late- gestation</w>
late x</w>
last- observation-carried-forward</w>
laser- evoked</w>
laryng oscopy.</w>
large- scale,</w>
laparotom y.</w>
laparotom y,</w>
laparo scopy</w>
lamivudine- refractory</w>
lamb da</w>
lam p</w>
lact o
lac king,</w>
lac idipine</w>
lac hr
lachr ym
labour ,</w>
laborator y-based</w>
label ing.</w>
label -
label- restricted</w>
lab yr
lab ouring</w>
lab oration</w>
lab ial</w>
la uric</w>
l- carnitine</w>
l- bucindolol</w>
l t,</w>
l o</w>
l m
l ine-induced</w>
l ine-
l ergotrile</w>
l er</w>
l c
l aw
l ate"</w>
l as</w>
l ands</w>
l ab</w>
l Co
l (-1))</w>
know ledge
kinase- 3
kin in-1</w>
kin d.</w>
kin ase)</w>
kilogram )</w>
kilo dal
kil led,</w>
kidne y:</w>
kidne y/
ki ren
kg/ h</w>
kg -1;</w>
ketamine/ xylazine</w>
ket olide</w>
ket amine)</w>
kerat ocon
kerat ectomy</w>
ker atitis,</w>
ke- K
ke-K orsak
kappa- receptor</w>
kanam ycin-
kallikrein- kinin</w>
kala-az ar</w>
kal i
ka ol
kHz ).</w>
k ward</w>
k ur
k out</w>
k o-
k leptom
k la
k i</w>
k he
k en,</w>
k d</w>
k b</w>
k Hz)</w>
k B</w>
juxtam edullary</w>
justifi es</w>
justi fication</w>
jun -D</w>
jud icious</w>
jud ici
judici ously</w>
join ts</w>
join t:</w>
jejun um.</w>
jaw- stretch</w>
jaw ,</w>
jaundic ed,</w>
j as
jas plakin
j a</w>
j a
ja 1
j )</w>
iz oribine</w>
iz ation)</w>
iz ation),</w>
iz ant</w>
iv .)</w>
iv ).</w>
ity "</w>
iti es;</w>
item s.</w>
it rulline</w>
it rat
it inase</w>
it in,</w>
it ful</w>
it ed,</w>
it )</w>
it 's</w>
istr y.</w>
ister ia</w>
isradi pine.</w>
isotretino in.</w>
isot op
isoquinol inium</w>
isopuleg ol</w>
isoproterenol- mediated</w>
isoproterenol -</w>
isoproteren ol;</w>
isoprost anes</w>
isoprenal ine-
isoniaz id
ison dam
isoc itrate</w>
iso pro
iso forms,</w>
ischaem ia-induced</w>
is seria</w>
is ophosphamide</w>
is ocarboxaz
is ms,</w>
is -
irt ually</w>
irrit ative</w>
irin otec
ir on/
ipen em</w>
ip unct
ioxag late.</w>
ioprom ide</w>
iopent ol,</w>
iodo phenyl</w>
iodo antipyrine</w>
iodix anol,</w>
iodine -1
io versol</w>
io thalam
io l</w>
involve d-
investigator 's</w>
investig ator-
inv oked</w>
inv ading</w>
introduc tion,</w>
introduc ing</w>
intraventric ularly,</w>
intras ub
intrapl atelet</w>
intraperitoneall y),</w>
intrap allidal</w>
intrane uronal</w>
intram yelinic</w>
intram ucosal</w>
intram edullary</w>
intral umbar</w>
intracerebr ally</w>
intrac ol
intra- striatal</w>
intra- atrial</w>
intra- arterially</w>
intra- VTA</w>
intra oral</w>
intra operatively.</w>
intra operatively,</w>
intra epidermal</w>
intra arterially</w>
intr insi
intrinsi cally</w>
intr apor
intr aly
intraly sosomal</w>
intest in
interval s;</w>
interval s:</w>
interval s).</w>
interval ).</w>
interstiti um,</w>
interrup ted,</w>
intern us</w>
intermediate- risk</w>
intermedi ates</w>
intermedi ary</w>
interferon/ ribavirin</w>
interferon- alpha-2b</w>
interferen ce.</w>
intercal ating</w>
interac tion?</w>
inter spike</w>
inter spersed</w>
inter relationship</w>
inter posed</w>
inter national,</w>
inter digit
inter dependence</w>
inter course,</w>
inter costal</w>
inter atrial</w>
inter -</w>
intention -to-
intensi ties.</w>
intelligen ce,</w>
integrin- linked</w>
integr ins,</w>
integr in,</w>
integr ative</w>
intake ;</w>
int romis
insul ts.</w>
insul ts,</w>
insul in-induced</w>
insuff lation.</w>
instrum ents</w>
instrum entation</w>
instrum ent
insti lling</w>
insomn ia)</w>
inser ting</w>
inser t</w>
inotrop e</w>
inosit ol.</w>
inosit ol-
ino sis,</w>
injur y)</w>
inj in
inj ected,</w>
inib -induced</w>
ini um.</w>
inhibitor ;</w>
inhibitor ).</w>
inhibi tion:</w>
inhabit ants</w>
inh ale</w>
ingest ed.</w>
ing s;</w>
ing er-
ing e</w>
ing -</w>
inform al</w>
influ ences.</w>
influ ences,</w>
influ ence
inflamm ation:</w>
infarc tions.</w>
infarc tion),</w>
infarc t-related</w>
infanc y.</w>
inf used,</w>
inf low</w>
inf eren
inf er</w>
inf ecting</w>
ines capable</w>
ine- controlled</w>
ine- 2,4-
ine mia;</w>
ine d;</w>
ine +
industr y</w>
induc tion:</w>
indole amine</w>
indol ent</w>
indo profen</w>
individual s:</w>
indinavir -related</w>
indic a</w>
index :</w>
index )</w>
indefinit ely.</w>
inde red</w>
indap amide,</w>
ind oline</w>
ind ole-
incub ating</w>
increas es)</w>
increas ed;</w>
increas e;</w>
incorrec tly</w>
inclu sive.</w>
incid ent,</w>
incid ent
incid ence)</w>
inc urable</w>
inc ture</w>
inc arc
in- diabetic</w>
in- depth</w>
in- clavulan
in- IR</w>
in- 6-
in wardly</w>
in verte
in stead.</w>
in soluble</w>
in sk
in significantly</w>
in qui
in nov
in nati</w>
in ization</w>
in homogeneous</w>
in homogene
in es:</w>
in directly,</w>
in direct,</w>
in comitant</w>
in as
inas much</w>
in apar
in activation,</w>
in activate</w>
in a.</w>
in :
impul sive</w>
impul si
improvement ;</w>
implic ations,</w>
implement ed.</w>
imple ment</w>
implant s,</w>
implan ted.</w>
impairment :</w>
impair ments,</w>
immunosuppres si
immunoglobul ins.</w>
immuno gold</w>
immuno assay,</w>
immuno adsorption</w>
immune ,</w>
immun ization,</w>
immun ity.</w>
immun ity,</w>
imidazole-4- carboxamide</w>
imidaz opyridine</w>
imidaz obenzodiazepine</w>
imid aprilat</w>
ime x</w>
im pressed</w>
im possible.</w>
im minent</w>
im aged</w>
im age.</w>
illness ;</w>
ill- defined</w>
ill s</w>
il/ folinic</w>
il- sparing</w>
il y.</w>
il vie's</w>
il ly</w>
il -related</w>
il ).</w>
ifosfamide -related</w>
ific ations</w>
ido thymidine</w>
idiosyncr as
identic al.</w>
ide ation.</w>
ide /
ide -</w>
ide ).</w>
idazox an.</w>
id otomy</w>
id ofovir</w>
id er
id ase</w>
id ).</w>
icter us,</w>
iclo vir</w>
ick y</w>
ick man</w>
icill in-resistant</w>
ici ent</w>
icalTrial s.gov,</w>
ic- mediated</w>
ic in-treated</w>
ic ho
ic ana</w>
ib all
ia --a</w>
i. th
i. d.)</w>
i. c.),</w>
i. a.)</w>
i podate</w>
i es)</w>
i e</w>
i bo
ibo g
ibog a</w>
i ance</w>
i 3</w>
i ),</w>
hyth mic</w>
hyste rectomized</w>
hypox emic</w>
hypoton ous</w>
hypothesi sed</w>
hypother mic,</w>
hypothe ses.</w>
hypothalam us-
hypophosphat emia.</w>
hypophosphat aemic</w>
hypoparathyroidis m.</w>
hypoparathyroidis m,</w>
hypoman ia,</w>
hypom otility</w>
hypom ethyl
hypoinsul inemia,</w>
hypogly caemia.</w>
hypogly caemia,</w>
hypochol ester
hypocholester ol
hypocap nia.</w>
hypocap n
hypocalci uric</w>
hypo uric
hypo thyroidis
hypo ren
hypo perfusion.</w>
hypo perfusion,</w>
hypo fibrinogen
hypo algesi
hypo albumin
hypo activity.</w>
hypo -</w>
hypo -
hypno tic.</w>
hypno sis</w>
hypervol aemic</w>
hyperuric emia</w>
hypertricho sis.</w>
hypertension -related</w>
hypertensi ve.</w>
hypersensi vity</w>
hyperren inemia</w>
hyperprolactin aemic</w>
hyperpolar izing</w>
hypernat remia,</w>
hypermagne semia</w>
hyperlactat aemia</w>
hyperkine sias</w>
hyperinsul inism.</w>
hyperhid rosis</w>
hypergly caemia</w>
hyperexcit ability,</w>
hypereosinophil ia</w>
hypereosinophil ia.</w>
hypercap nia.</w>
hyperammon emia,</w>
hyperalgesi a;</w>
hyper ventilation.</w>
hyper somn
hyper secretory</w>
hyper pyrexia,</w>
hyper pyrex
hyper prostaglandin</w>
hyper osmolality,</w>
hyper magnesi
hyper locomotor</w>
hyper lip
hyper homocyste
hyper amyl
hyperamyl as
hyper adrenocortic
hyper -</w>
hyp nagogic</w>
hydroxyquinol ines</w>
hydroxyl ysine</w>
hydroxy-2- acetylaminofluorene</w>
hydroxy methylglutaryl</w>
hydroxy chloroquine-induced</w>
hydrox yn
hydrox ylated</w>
hydrox yc
hydrox amic</w>
hydrox am
hydroure ter</w>
hydrochlor ide-induced</w>
hydro pic</w>
hydro philicity</w>
hydro peroxide</w>
hydro pen
hydro ce
hydroce les</w>
hydralaz ine-induced</w>
hy 926</w>
human -
hum an,</w>
huPBL- SCID</w>
hr ;</w>
hr /
hour /
host )</w>
hos pice</w>
hormone- resistant</w>
hormon ally</w>
horiz ont
homogen ates,</w>
homo e
homoe opathic</w>
hom icidal</w>
ho st-
hmt 2</w>
histid ine-rich</w>
histamine 2</w>
hir udin,</w>
hippocampal- entorhinal</w>
hippocamp us:</w>
hind paws</w>
hind paws.</w>
hind -
hin olaryng
him achalol</w>
hil us
high- voltage</w>
high- power</w>
high- flux</w>
high- efficacy</w>
high- altitude</w>
hiccup s,</w>
hic cup</w>
hi sian</w>
hi p.</w>
hexy loxy
hexameth onium.</w>
hexachloro phene.</w>
hex obarbital</w>
hex obarbital,</w>
hex obarbit
hex apeptide</w>
hex ane-
hex afluoro
herni orrhaphy.</w>
herit able</w>
her petiform
her p
hept a
hepatosplen omegaly,</w>
hepatocellular- cholestatic</w>
hepati s,</w>
hepat otoxin</w>
hepat omas,</w>
hepat oblastoma</w>
hepat ectomy.</w>
heparin oid</w>
hemorrh aging</w>
hemorrh age;</w>
hemorrh age)</w>
hemorhe ological</w>
hemor rhoids</w>
hemodialy sis;</w>
hemo therapy.</w>
hemo therapy,</w>
hemo philic</w>
hemo perfusion</w>
hemo gram</w>
heme- L-lysin
hematocrit .</w>
hemat ology,</w>
hem olysis:</w>
hem iball
hem angio
hemangio endotheli
hel ical</w>
heighten s</w>
heigh t.</w>
heavi er</w>
heat -induced</w>
heart/ body</w>
heart burn</w>
heart beats</w>
hear t)</w>
heal ing,</w>
headache -free</w>
head-to- head</w>
he ver</w>
he ta
he loder
he li
harvest ed.</w>
harvest ed,</w>
harm ful
har ml
har ,</w>
happ ened</w>
hamar toma.</w>
ham mock</w>
haloperidol ).</w>
haloperidol 's</w>
hallucin osis</w>
hallucin ations;</w>
hallucin ation.</w>
hal ved</w>
hal ted</w>
hal f.</w>
hair ,</w>
haemorrh ages.</w>
haemodynam ically</w>
haemodynam ic,</w>
haemat uria,</w>
haemat ologic</w>
haem olysis,</w>
had :</w>
habil itation</w>
hab its,</w>
hab it</w>
ha ron</w>
ha em</w>
h/ day</w>
h y</w>
h t
h p
h indered</w>
h at</w>
h ass
h -1.</w>
guar ante
guanfac ine.</w>
guanabenz .</w>
guan osine-
guan ine-
group s--
group --
group ):</w>
group 's</w>
gro unds.</w>
gro o
gren 's</w>
great ly,</w>
gravi d</w>
graph y;</w>
granulocyte- monocyte</w>
granulo cytopenic</w>
gran /
gra y.</w>
gra ded,</w>
gr as
gr ac
gp ),</w>
govern ment</w>
gonad otrophin</w>
go- go
go-go -related</w>
go od
go at
go al.</w>
go al-
go al,</w>
glycogen osis</w>
glycer ophosph
glycer ides</w>
glycer aldehyde-
glyc olytic</w>
glyc ine.</w>
gly cyr
gluteth im
glutathione- dependent</w>
glutamate- mediated</w>
glucuronid ase,</w>
glucose-6- phosphate-dehydrogenase</w>
glucose- free</w>
glucocorticoid -mediated</w>
glucocortico ids,</w>
gluc ar
glot tis</w>
glomeruloneph ro
glomerulo pathies</w>
glomerulo pathies.</w>
glitaz one-induced</w>
glibencl amide.</w>
gir ls,</w>
gir dle</w>
gingi vitis</w>
gestod ene,</w>
germ line</w>
germ -cell</w>
gentamicin- cephalothin</w>
gentamic in-resistant</w>
general ize</w>
general ization.</w>
gene (s)</w>
gen otype
gen ioglossus</w>
gen icity.</w>
gen ation</w>
gemcitab ine/
gemcitab ine-associated</w>
gel ser</w>
ge ot
gav aged</w>
gau ze</w>
gastroenter itis.</w>
gastroenter itis,</w>
gastro stomy</w>
gastro intestin
gangren os
gangli on-
gangli on,</w>
gangli on
gammag lut
gamma-hydroxybut yric</w>
gamma-D-glutam yl
gamma- globulin</w>
gamma- butyro
gamma- acetylenic</w>
gamma- G
gam mopathy</w>
gall amine,</w>
gal lopamil</w>
gadolinium- based</w>
gadodi amide-related</w>
gab acul
ga stric,</w>
g/m L,</w>
g/m 2).</w>
g/m (2)/
g/d l;</w>
g/d l.</w>
g/ min.</w>
g/ min)</w>
g/ l)</w>
g/ kg/min</w>
g/ kg).</w>
g/ day,</w>
g/ d.</w>
g/ L</w>
g/ 100</w>
g. kg(-1).
g wheel</w>
g st</w>
g in
g ilvie's</w>
g g</w>
g epir
gepir one</w>
g c
gc d-
g aps</w>
g and
further more,</w>
furosem ide:</w>
furazol id
fur an
fundus cop
function s:</w>
fum ar
fulmin ating</w>
fuc ose</w>
frusem ide,</w>
frusem ide)</w>
fructo se-pretreated</w>
fru st
fru its</w>
fru itful</w>
frontop ari
frontopari etal</w>
front- loading</w>
front ally</w>
fri end</w>
frequency )</w>
freeze- fracture</w>
free- field</w>
free base</w>
fram e.</w>
frag ments.</w>
frag ments,</w>
fraction s;</w>
four- week</w>
four- gland</w>
four )</w>
fos phenytoin.</w>
forty- six</w>
forty- seven</w>
forty- eight</w>
fortun ately</w>
forti fied</w>
fort nightly</w>
formul a,</w>
formul a)</w>
formal in.</w>
formal in-</w>
form yl</w>
form aldehyde</w>
form )</w>
fore paws</w>
fore head.</w>
for ward.</w>
for ni
for maz
for got
foot shock</w>
food- reinforced</w>
fondaparinu x</w>
follow-up ;</w>
follow-up :</w>
follic le</w>
fol ds,</w>
fol ding</w>
fol d),</w>
fol ate.</w>
foc us
fo ods</w>
fo od,</w>
fo etuses</w>
fmol/ micromol</w>
flut amide-induced</w>
flush ing.</w>
flush ed</w>
flupirt ine.</w>
fluphenaz ine-
fluoroquinol ones:</w>
fluoroquinol one,</w>
fluoro- beta-
fluoro metric</w>
fluoresce in.</w>
fluoresc ence,</w>
fluores cent
fluorescent -labeled</w>
fluor ine</w>
flud ro
flud arab
flu tre
flu ocin
flu indi
flu id)</w>
flow s.</w>
flin ching</w>
flexi bility</w>
flatten ed</w>
flash es,</w>
fl y,</w>
fl uroxene,</w>
fixed- interval</w>
fix ation,</w>
five- day</w>
fistul as</w>
fistul a.</w>
fir st.</w>
fir m</w>
fing er.</w>
fine- motor</w>
finaster ide.</w>
filgrastim ,</w>
fil ter.</w>
fil ms</w>
fifty- six</w>
fiel d-
fibros ar
fibro proliferative</w>
fibro elast
fibrin opeptides</w>
fib re
fi ve.</w>
ffe inated</w>
ff ective</w>
fex ofenadine</w>
fer tile</w>
fer ric</w>
fentanyl :</w>
fentanyl /
fenob am</w>
feno profen,</w>
feno fibrate.</w>
fenflur amine;</w>
fen pro
fen est
fen adine</w>
femoro femoral</w>
femal es).</w>
fem ur</w>
fem ur.</w>
felodip ine,</w>
fell .</w>
fel low</w>
feed back.</w>
feat ure,</w>
fear s</w>
fear -associated</w>
fea red</w>
fe barb
faz ad
favour able.</w>
fast ,</w>
fasci otomy</w>
fasci otomy.</w>
fasc ia</w>
famoti dine,</w>
famili es,</w>
famili arity</w>
famil y-based</w>
fam ciclovir</w>
fall s.</w>
fain tness</w>
failure ?</w>
failure )</w>
failure ).</w>
failure ),</w>
fail ures,</w>
faec alis</w>
factor- beta
factor- alpha,</w>
factor s;</w>
fact .</w>
facilit ation.</w>
facil ity.</w>
fa ulty</w>
f usional</w>
f uch
f ratax
f oster</w>
f onad</w>
f man</w>
f ather
f ang
fang chin
fangchin oline</w>
f alle
falle n</w>
f .
eye drops</w>
eye blink</w>
eye balls,</w>
extrac erebral</w>
extra uterine</w>
extinc tion.</w>
exten sive,</w>
exten sion,</w>
expres sions.</w>
expres ses</w>
exposure ).</w>
exposure ),</w>
explor ations</w>
explo sive</w>
explo red,</w>
explan ations,</w>
explan ation,</w>
expl ained.</w>
experiment ally-induced</w>
experim enter
expect ation</w>
exp 1</w>
exempl ifies</w>
excre tion;</w>
exclu sively,</w>
excipi ents.</w>
excep tions,</w>
exceede d.</w>
exc ruciating</w>
exc iting</w>
examin ers</w>
evolu tion.</w>
evolu tion,</w>
evi prostat
ev es</w>
ev ening,</w>
euthan ized,</w>
euphor ia.</w>
euc alce
eu thanasia.</w>
etretin ate.</w>
etoric oxib,</w>
etopo side)</w>
etop yraz
etomid ate:</w>
etodol ac.</w>
etidoca ine.</w>
eti lefrine</w>
ethylenedi amine</w>
ethyl]- 4-(3-
ethyl]-4-(3- phenylpropyl)
ethyl] -1,4-
ethyl]-1,4- diazabicyclo
ethyl]-1,4-diazabicyclo [4.
ethyl]-1,4-diazabicyclo[4. 3.0
ethyl]-1,4-diazabicyclo[4.3.0 ]
ethyl]-1,4-diazabicyclo[4.3.0] non
ethyl phosphorothioic</w>
ethopropa zine</w>
ethnic ity,</w>
ethmo zin</w>
ethinylo estradiol.</w>
ethinylestradi ol.</w>
ethanol 's</w>
eth es
eth chlor
ethchlor v
et ri
et orphine,</w>
et am
et a</w>
estrogen- progestogen</w>
estrogen- progestin</w>
estrogen -related</w>
estradiol-17 beta-glucuronide</w>
estradi ol)</w>
estim ates.</w>
ester -
esophag itis,</w>
escap ed</w>
es omeprazole</w>
erythropoiet in,</w>
erythropoi e
erythromel algia-like</w>
erythrom yc
erythrodysesthesi a,</w>
erythroder ma</w>
erythro n</w>
erythro cytosis</w>
erythro blast</w>
ery thermalg
erup tions.</w>
ertap enem</w>
erlotin ib</w>
erlotin ib
ergotamine/ caffeine.</w>
ergot amine-induced</w>
erg ocryptine</w>
erg ic)</w>
erb in
er- equipped</w>
er t-Eaton</w>
er ine,</w>
er culo
er ated</w>
equival ently</w>
equival ent
epti fibati
epti de,</w>
epo prosten
epo i
epo etin.</w>
epitheli oid</w>
epitheli a</w>
epit ope</w>
epirubic in-treated</w>
epinephr ine:</w>
epinephr ine-</w>
epilept oid</w>
epilept ogene
epilept ogen
epilepsy ;</w>
epid erm
epicardi um.</w>
epic anth
epi me-induced</w>
ephed ra,</w>
ep run
ep im
ep end
enzyme- inducing</w>
enzyme -1</w>
enzym uria</w>
enzym es;</w>
entr ap
enti rely.</w>
enti al,</w>
enterocol itis,</w>
entero pathy</w>
enter ococci</w>
entail s</w>
ent of
ent ered.</w>
ent '</w>
ens it
enro ll</w>
enox acin,</w>
enol ase</w>
enlarge d,</w>
enkephal in
engraft ment.</w>
energe tics.</w>
enem as</w>
enedi one</w>
enedi amine</w>
ene- 23-
endotox in-induced</w>
endothel in-3</w>
endomy ocardium</w>
endometri um.</w>
endom ysial</w>
endolym ph</w>
endocardi tis,</w>
endo don
endodon tic</w>
endo -
endarte rectomy.</w>
end- points</w>
end rin</w>
end ing,</w>
encour aging.</w>
encour ages</w>
encomp assing</w>
enco ding.</w>
encephalo pathies</w>
encephalo graphic</w>
encephal ocele</w>
encephal itis,</w>
ence /
encap sulation</w>
enc losed</w>
en yl)
en suring</w>
en surate</w>
en ough
en ess.</w>
emul sion.</w>
empt ying.</w>
employ ed:</w>
emplo y</w>
emphyse ma</w>
emphasi ses</w>
emphasi sed.</w>
emphasi se</w>
emph ig
emo tionally</w>
emo tion</w>
emergen ce,</w>
emerg ed,</w>
embryoleth ality,</w>
embry otoxicity.</w>
embry os
embran es</w>
embol i.</w>
embol i,</w>
emb usartan</w>
em ide,</w>
em ia:</w>
em an
elucid ated,</w>
elong ation</w>
elo da
ell enic</w>
ell a-
elimin ation.</w>
elic ited.</w>
elev enth</w>
electroretin ography</w>
electrophysi ologically,</w>
electron ystagmo
electron ically</w>
electromyo graphy,</w>
electromyo graphical</w>
electroly tes.</w>
electrocardio graphically</w>
electrocardio graphic,</w>
electro- ocu
electro- diagnostic</w>
electr oneuro
electr ical-
elberg er</w>
elast olytic</w>
elan dopam</w>
el ym
el ution</w>
eighty- one</w>
effor ts,</w>
efflu x.</w>
effici ent.</w>
efficaci ous.</w>
effec tively.</w>
effec tive;</w>
eff usions.</w>
eff u
efarox an,</w>
ef oni
edroph onium-
edema :</w>
ede mat
ed rine</w>
ed .(ABSTRACT</w>
ectom ies</w>
ect o-
ecstas y/
eclamp sia</w>
echo genicity</w>
echo -
ecarbox amide)</w>
ec ortin</w>
ec onom
ec chy
ecchy mo
eat ers.</w>
easi er</w>
earli er);</w>
ear ns-Sayre</w>
ear ly
eIF2 alpha
e/ non-case</w>
e ther,</w>
e rence</w>
e perisone</w>
e in,</w>
e gu
e go
e gg
e astern</w>
e as
e ,"</w>
dystroph ic</w>
dystoni as.</w>
dystoni as,</w>
dysrhyth mogenicity</w>
dysphor ia,</w>
dysph onia.</w>
dyspep sia.</w>
dyspep sia,</w>
dyslipide mia.</w>
dyslipide mia,</w>
dyskinesi a).</w>
dyscrasi as.</w>
dys regulation.</w>
dys regulated</w>
dys pareun
dys morph
dys albuminemic</w>
dynam ite</w>
dur ability</w>
duplic ate</w>
duct ules</w>
duct or</w>
duc ted</w>
drug- using</w>
drug- refractory</w>
drug- induced.</w>
drug- adsorption</w>
drug s--
drug ?</w>
drug --
drople ts,</w>
drop out
dro oling</w>
dro mically</w>
dream ing</w>
drawbac ks</w>
draw n.</w>
dp p</w>
doxorubic in)</w>
dox il</w>
dox ifl
double- stranded</w>
double- masked</w>
double- labelled</w>
double -dose</w>
dose- titration</w>
dose- severity</w>
dose- range</w>
dos ing;</w>
dors ally</w>
dopamine- sensitive</w>
dopamine- blocking</w>
dopamine- beta-
dop ing</w>
domain .</w>
dom opredn
dom ain,</w>
dol icho
docetaxel/ carboplatin</w>
do thiepin</w>
do or</w>
do es.</w>
dn -
dn- sec(-1).m(2).cm
dizocil pine.</w>
dizocil pine-induced</w>
divertic ul
div or
dite kiren</w>
disulfir am
disulfi de,</w>
disturb s</w>
disturb anc
distribut ed.</w>
dist ally</w>
dist al,</w>
dissoci ation,</w>
disrup ted.</w>
displac ements</w>
disopyram ide-induced</w>
dismut ase.</w>
disease- -
discrimin ated</w>
disco vered,</w>
disco ver
disc ri
disc re
disappoint ing.</w>
disadvant ages.</w>
dis regarded</w>
dis placement,</w>
dis cordant</w>
dis car
direc tly.</w>
direc tions</w>
direc tion.</w>
dipyridamole- thallium-201</w>
dipy ron
diplop ia.</w>
dipivox il/
diphenylacetoxy-N-methyl piperidine</w>
diphenyl pyrrolidin-2-one</w>
dimethylethan olamine</w>
dimethylethan olamine-pretreated</w>
dimethyl hept
dimen sion,</w>
dilem ma.</w>
dihydroxy- 6-nitro-
dihydroxy-6-nitro- 7-
dihydroergocrist ine</w>
dihydro- 6
dihydro- 2-
dihydro quinidine</w>
dihydro lisuride</w>
dihydro chloride,</w>
digox in)</w>
digitox in.</w>
difluoromethyl ornithine</w>
difficult-to- treat</w>
differenti ation,</w>
differenti ated,</w>
diffe red.</w>
diethylstilbestrol- exposed</w>
diethylstilbestro l-induced</w>
diethylstilbestro l,</w>
diethyl carbamo
diethyl amino
dicyclo mine</w>
diclofenac /
dichloro methane</w>
dicarb oxy
dic umarol</w>
dic ho
dic arboxyl
diazepam )</w>
diaz emul
diatrizo ate)</w>
diastere omers</w>
diarrho e
dialy sis;</w>
diabetes- insipidus-like</w>
diabe tic,</w>
di potassium</w>
di oxopiperazine</w>
di op
di one)</w>
di methyl-4-
di methoxyphenyl)
di methoxy-
di mercaptosuccinic</w>
di ligent</w>
di hydralazine</w>
di folia</w>
di estrus</w>
di encephalon,</w>
di en
di aries</w>
di amin
di -n-propyl
dextromethorph an.</w>
dextro se.</w>
dextro amphetamine,</w>
dextro -
dexamethas one:</w>
dex ter
dex fenfluramine-induced</w>
dex ,</w>
devi sed.</w>
devi ation.</w>
detrus or.</w>
detom idine</w>
deterior ate,</w>
detail ,</w>
detach ments</w>
detach ment.</w>
desquam ation</w>
desogestrel -containing</w>
desmo id</w>
desig ned.</w>
desi pramine-induced</w>
desferri oxamine,</w>
descri pt
desc ended</w>
desbutyl bupivacaine</w>
desatur ation.</w>
desArg 9
desArg9 Leu
desArg9Leu 8-
des pair
des min,</w>
des flurane,</w>
des acetyl
dermat o
deri ving</w>
depolar iz
depolar isation</w>
deple tor</w>
depic ting</w>
depend ence;</w>
deoxy doxorubicin</w>
deoxy cortisol</w>
denti sts</w>
denomin ator</w>
dendrit es.</w>
dend rin</w>
den oted</w>
den ial</w>
demethyl ase</w>
demet on-
delta9- TH
delta-amino valeric</w>
delta- aminol
delta 9
delta .</w>
delta -</w>
deliver s</w>
deli vered.</w>
delay s,</w>
delay ed-
del a
dehydrogen ase)</w>
degre es.</w>
degran ulation.</w>
degrad ing</w>
degrad ation,</w>
degener ation)</w>
deform ity,</w>
deform ities.</w>
deform ations</w>
deficiency :</w>
defici encies,</w>
defer red</w>
defec ation</w>
def ines</w>
def ensi
decreas e).</w>
decreas e),</w>
decompens ation.</w>
declar ative</w>
decl ared</w>
deci sions.</w>
decel erations</w>
deced ent's</w>
decapit ated</w>
deca ffeinated</w>
dec hall
dec ayed</w>
debriso quine.</w>
deb ate.</w>
death ).</w>
deacetyl thymoxamine</w>
de- novo</w>
de synchronization</w>
de sensitization,</w>
de se
de phosphorylation</w>
de medull
de formed</w>
de duced</w>
de d)</w>
de anol</w>
de amino-
dd l,</w>
dd C-treated</w>
day- case</w>
day -1);</w>
day 's</w>
daugh ters.</w>
dat rexate</w>
dat as
dapsone- exposed</w>
dam ages,</w>
dac ryocystorhin
dab igatran</w>
dP/d t.</w>
d4T- based</w>
d- tubocurarine,</w>
d- propranolol</w>
d- penicillamine</w>
d- carnitine</w>
d- amphetamine-
d- PPH</w>
d welling</w>
d war
d ut
d uplex</w>
d ually</w>
d or.</w>
d k
d ing,</w>
d ence</w>
d Tc-
d L</w>
d B,</w>
d .,</w>
d -</w>
d -1)</w>
d 's</w>
cytostatic s.</w>
cytoskele ton,</w>
cytopen ias.</w>
cytomegalo virus,</w>
cytok ine-
cytok ine,</w>
cytochrome- c</w>
cyto protective.</w>
cyto keratin</w>
cyto architect
cytarab ine-induced</w>
cyt ologically</w>
cysticer cus</w>
cyste ine)</w>
cyste amine</w>
cyst s,</w>
cyst ometry</w>
cyst oid</w>
cyclophosphamide :</w>
cyclophosphamide -associated</w>
cyclophosphamide )</w>
cyclopent enyl</w>
cyclop legic</w>
cyclohex anec
cyclase- activating</w>
cycl ed</w>
cyano sis.</w>
cyano acrylate</w>
cy clin
cyclin -dependent</w>
cut- points</w>
cut off
cut aneously</w>
cur tailed</w>
cups/ day,</w>
cumul ative,</w>
cumul ating</w>
cum st
cul tur
cul pr
cul atory</w>
cu st
cu prolinic</w>
cu pational</w>
cryo globul
crush ed</w>
crow n-rump</w>
cross- tolerant</w>
cross- reaction</w>
cross- reacting</w>
cross- reacted</w>
cros s.</w>
cromakal im
cro uch
cro cin
creatin ine:</w>
creatin ine)</w>
cre dence</w>
cre ati
creati vity,</w>
crav ings</w>
cranio facial,</w>
crac k,</w>
cr ying</w>
cr ushed,</w>
cr assi
crassi pes</w>
cow s.</w>
cour ses;</w>
counter puls
counter -
counsel ed</w>
coun ts)</w>
cough ing,</w>
cou ple</w>
cot rimox
cot reated</w>
cost s.</w>
cortis one.</w>
corticotrop in-secreting</w>
cortico -striatal</w>
cortex ;</w>
corrobor ated</w>
correl ations.</w>
correl ated,</w>
correc tion.</w>
correc tion,</w>
cor ds,</w>
cor difolia</w>
cop per,</w>
convuls ants,</w>
convuls ant
convinc ingly</w>
conver s
conval escent</w>
contribut ory.</w>
contract ure,</w>
contracepti ve.</w>
continu es.</w>
continu ally</w>
consump tion;</w>
consu mers.</w>
const ant-
consist ent,</w>
conserv atively.</w>
conserv atively,</w>
consec uti
cons ent.</w>
connec tion.</w>
configur ation.</w>
confer ring</w>
conf used,</w>
conduc tive</w>
condu its</w>
condition s;</w>
condition ing,</w>
condition ;</w>
condition )</w>
condens ation</w>
concurren tly,</w>
concl usion.</w>
concentration s)</w>
concentration /
conc ur</w>
con us</w>
con tempor
con stituting</w>
con serving</w>
con served</w>
con genic</w>
computer- generated</w>
compres sion,</w>
compassion ate</w>
compac ta.</w>
comp rises</w>
communic ations</w>
communic ation:</w>
communic ating</w>
communic ate</w>
commun ity,</w>
common :</w>
commissu re,</w>
commence d.</w>
comm ensurate</w>
comfor table</w>
comedic ation</w>
combine d-modality</w>
com mentary</w>
colum ns</w>
colum nar</w>
colon oscopy.</w>
colon ization</w>
colon ies</w>
collicul us,</w>
collater al-
collagen /
cold- pressor</w>
col pos
col on,</w>
col li
col laborative</w>
col icky</w>
col i,</w>
coincid ental</w>
coincid ent
coinc ide</w>
cohor t)</w>
cognitive- behavioral</w>
cogniti vely</w>
cogni tion-
cogn izant</w>
coffe e,</w>
coer uleus,</w>
coeffici ents</w>
coeffici ent.</w>
coeffici ent,</w>
code ine-induced</w>
coccidi oidal</w>
cocci .</w>
cocaine/ heroin</w>
cocaine- stimulated</w>
cocaine- paired</w>
cocaine- only</w>
cocaine- alcohol</w>
coc atropine</w>
cobal amin</w>
cob ble
cobble stone-like</w>
coarsen ing</w>
coal es
co- morbidi
co- medication</w>
co- ingestion</w>
co- ingested</w>
co vit
co variate</w>
co it
co incidence</w>
co eliac</w>
co at</w>
cm 3)</w>
cm ).</w>
cm (3)</w>
clu sive</w>
clozap ine/
cloxacill in.</w>
cloxacill in-induced</w>
clorg yline,</w>
clorazep ate,</w>
clon ogenic</w>
clon es.</w>
clomi pramine,</w>
clomi phene.</w>
clofil ium</w>
clofil ium,</w>
clofaz im
clo thing</w>
clo thiapine</w>
clioquinol -treated</w>
clinic oradi
clinic al/
cli pped</w>
cli ent</w>
clef ts</w>
clef t,</w>
cleare d.</w>
clear ance)</w>
claudic ation.</w>
classi fying</w>
classi cal
classical "</w>
clarithrom ycin-induced</w>
cl av
cl aim
cisterna e</w>
cisterna e,</w>
cisplat in:</w>
cis- platinum.</w>
cis- dichlorodiammineplatinum</w>
circumferen ces</w>
circumci sion.</w>
circum vent</w>
circul ations</w>
circuit ry.</w>
cir in,</w>
ciprofloxac in:</w>
cinnar izine.</w>
cinacalce t.</w>
cin oxacin</w>
cilost azol.</w>
cilost amide</w>
cilni dip
cilastat in.</w>
cilastat in,</w>
cidofovir .</w>
ciclospor in</w>
chylo us</w>
chron otrop
chron icity</w>
chromatography/ mass</w>
chorio retinal</w>
choreoathe tosis.</w>
chor nea</w>
cholester ol-
cholestatic -
cholestatic- hepatocellular</w>
cholecystokin in,</w>
cholecysti tis,</w>
cholangiopancreat ography,</w>
chol angiographic</w>
choic e,</w>
cho w.</w>
chlorthalid one.</w>
chlorpro thixene</w>
chlorpro thixen
chlorphenir amine.</w>
chlorothiaz ide,</w>
chloroform -induced</w>
chloro but
chloramphenic ol-induced</w>
chlor tal
chlor isondam
chlor imipramine,</w>
chlor ide-
childho od
chick en</w>
chi 2</w>
chemotherapy- evoked</w>
chemotherapeu tics</w>
chemo receptor</w>
chemilumin escence</w>
chem istry,</w>
check- up</w>
chec king</w>
che lidonine</w>
che lation.</w>
che late</w>
che ek</w>
charybdot oxin</w>
charco al/kg</w>
chang es'</w>
ch ond
ch o</w>
ch ard</w>
ch aper
ch ap
ch am
cham bered</w>
ch alaz
cervi x
cerv ical,</w>
certific ates</w>
cerebro cortical</w>
cerebel lopontine</w>
cerebel lopathy</w>
cer uleus,</w>
cepti ble</w>
cephalothin- gentamicin</w>
cephalor idine-induced</w>
cephal y</w>
ceph radine</w>
centur y.</w>
centro phen
centro lobular</w>
central- acting</w>
cent s,</w>
cent re,</w>
cent ),</w>
cellular ity,</w>
cells/micro L,</w>
cells/micro L)</w>
cells/ l.</w>
cell s).</w>
cell -specific</w>
cefuroxi me.</w>
ceftazidi me.</w>
ceftazidi me-induced</w>
ceftazidi me
cefox itin.</w>
cefotetan- coated</w>
cefotaxime ,</w>
cefamand ole.</w>
cefaclor ,</w>
ceas ing</w>
ce mia,</w>
ce :</w>
cd k5</w>
cc/ 100</w>
cavernos um</w>
cave olin-1alpha</w>
cause- effect</w>
caus ative.</w>
caus ation.</w>
caudate- putamen.</w>
caud ate,</w>
caud ally</w>
categor y.</w>
categ ories,</w>
catecholamine- facilitated</w>
catechol amine-</w>
catalyst s</w>
cataly zed</w>
catabol izing</w>
cat en
cat apl
cat ,</w>
cast rate</w>
case- controlled</w>
casca de,</w>
cas es:</w>
cas e/non-case</w>
carri ers,</w>
carrageen an-</w>
carnit ine-treated</w>
carmust ine,</w>
caregi vers</w>
cardioverter- defibrillator</w>
cardiover ter/
cardiomyopath y-induced</w>
cardiomyo pathies.</w>
cardio vascularly</w>
cardio vascular
cardio selectivity</w>
cardio protection.</w>
cardi ological</w>
cardi o</w>
carcinom a)</w>
carcinogen s,</w>
carboxyp eptidase</w>
carboxy methylcell
carboxy lester
carboxy cyclo
carbon yl)
carbidopa ,</w>
carbenicill in.</w>
carbamazep ine-treated</w>
carbamazep ine-associated</w>
carbach ol-
carb amide</w>
car ies</w>
car ies.</w>
car cas
capsaic in)</w>
cap abilities.</w>
cannabin ol</w>
candi de
candi dat
cancer ;</w>
canalicul i.</w>
calretin in,</w>
callo sum,</w>
calcium/ creatinine</w>
calcitri ol)</w>
calcineur in-
calbindin-D(28 K)</w>
calbindin- immunoreactive</w>
calbindin- D28
cal ori
cad a
cada ver</w>
ca ine.</w>
cAMP- mediated</w>
cAMP- dependent</w>
c.v .</w>
c- AMP</w>
c ures</w>
c n</w>
c m.</w>
c ec
c c
c ation.</w>
c ally.</w>
c ally,</w>
c age.</w>
c RNA</w>
c PKCgamma</w>
c PKC</w>
c BLA</w>
c AV
cAV B</w>
bypas ses</w>
bypas s,</w>
by- time</w>
by- product</w>
buttoc ks</w>
butano yl
but yrate</w>
busulf an-induced</w>
burst- spiking</w>
burst /
burrow ing,</w>
bur ning,</w>
bupropi on-only</w>
buprenorph ine's</w>
bupivacaine- sufentanil</w>
bupivacaine- morphine</w>
buni onectomy</w>
bund le.</w>
bund le,</w>
bumetan ide,</w>
bulb ectomy</w>
bul ls</w>
bul la</w>
bul ky</w>
bul b</w>
build up</w>
buil ders</w>
buil der</w>
buil der.</w>
budeson ide,</w>
brux ism,</w>
brush ing</w>
bruc ellar</w>
bronchodilat or.</w>
bronchodilat ation.</w>
bronchoconstric tion.</w>
bronch opneum
bronch i</w>
bromo phenyl)
bro ther
briefl y.</w>
brie f.</w>
breast feeding</w>
breakthrough .</w>
bre aking</w>
bran ds</w>
bran ched-chain</w>
brain- damaged</w>
bradycardia :</w>
brady arrhythmic</w>
brad y-
brac ket
bra ins,</w>
bra in;</w>
bra in:</w>
br ary,</w>
bound aries</w>
boun d,</w>
boun cing</w>
bot tled</w>
bortezomib ,</w>
border zone</w>
bor naprolol</w>
boo ks</w>
bolus- injected</w>
bol us;</w>
body weights</w>
bob b
bobb ing,</w>
bo ys,</w>
bo wing</w>
bo wel
bo otstrap</w>
blot ting,</w>
blood stream.</w>
blood less</w>
block s,</w>
block ing)</w>
block age,</w>
block :</w>
blo t,</w>
blin king</w>
bleed ings.</w>
bleed ing:</w>
blast ogenesis</w>
blad ders,</w>
blac k-
bl ade</w>
bisulfit e,</w>
bis pectral</w>
bis dioxopiperazine</w>
birth s</w>
birth s,</w>
biotrans formed</w>
biopsy- proved</w>
biopsi es),</w>
biop terin</w>
biom embranes</w>
bio prosthetic</w>
bio phase</w>
bio genesis</w>
bio degradable</w>
bio activation</w>
bing e"</w>
bind ing)</w>
bim od
bili protein</w>
bile- duct</w>
bil li
bifur cation</w>
bif eprun
bicyclo l</w>
bibli ographic</w>
bi refr
bi ochemistry,</w>
bi dimensionally</w>
bi ases</w>
bi as,</w>
bethanech ol.</w>
betamethas one.</w>
betamethas one-induced</w>
beta2- microglobulin</w>
beta-lactam ase-
beta-endorph in,</w>
beta-caroten e,</w>
beta-blocker /
beta-D- arabinofuranos
beta- thalassemic</w>
beta- mimetic</w>
beta- methyl
beta- glucosidase,</w>
beta- ENaC</w>
beta(2)- adrenoceptor</w>
beta(2)- adrenergic</w>
beta 1-selective</w>
beta -induced</w>
beta (3)</w>
beta (2)</w>
bet ter.</w>
bet am
bet acy
berg ,</w>
bepri dil.</w>
benzyl penicillo
benzyl isoquinolinium</w>
benzyl iden
benzoylecgon ine,</w>
benzo[ f]
benzo thiazol
benzo (
benzo( a,
benzo(a, d
benzil ate,</w>
benz amides</w>
benser az
benflu orex</w>
bel ly</w>
behaviour s,</w>
beg in
beg an.</w>
befun olol</w>
before )</w>
beats/min .)</w>
beats/ minute</w>
beats/ min;</w>
beats/ min).</w>
beat ing,</w>
beat ,</w>
beagl es,</w>
be side</w>
be low-
be long</w>
be line</w>
be e</w>
be dd
be ad</w>
batan opride</w>
bas ophil</w>
bas al,</w>
bas al)</w>
baroreceptor- denervated</w>
baro reflex-
baro receptors.</w>
bar ,</w>
band s,</w>
ban ned</w>
bacterio logically</w>
backgro unds.</w>
back ward</w>
back crosses</w>
back bone</w>
back "</w>
bacill i</w>
ba g</w>
b/ ribavirin</w>
b.w t.,</w>
b.i.d .),</w>
b w
b urg
b unitro
b um</w>
b roncho
b right</w>
b ond</w>
b is</w>
b id,</w>
b d</w>
b ati
b ant</w>
b and.</w>
b an</w>
b ]</w>
b -exposed</w>
b ,
azole- dependent</w>
azol e)</w>
az osin
az obenz
az ine)</w>
az et
axit inib</w>
ax .</w>
awaren ess,</w>
aw ai
avoid ance,</w>
avoid able</w>
avid in-
aver age.</w>
autoradi ography.</w>
autoradi ography,</w>
autoradi ographically</w>
autopsy ;</w>
auto immunity</w>
auro thiomalate</w>
aure us,</w>
augment ation,</w>
audit ory,</w>
audio visual</w>
audi ometry,</w>
atrop ine-like</w>
atre sia,</w>
atrac heal</w>
atosib an</w>
atorvastat in-related</w>
ator y,</w>
ator ial</w>
atom s</w>
atipame zole,</w>
ation s--
ation s).</w>
ation --a</w>
ation '</w>
atid ine,</w>
atic s</w>
ati bant</w>
athyro id</w>
atheros permin
ateg or
ate-3-O- glucuronide</w>
ate d).</w>
ate d),</w>
atazanavir .</w>
atazanavir -associated</w>
at ubular</w>
at ovaqu
at ors'</w>
at om</w>
at oid</w>
at es;</w>
at al
at a,</w>
at /
at -to-beat</w>
at )</w>
asym metry</w>
ast atic</w>
associ ates</w>
assist ance.</w>
assign ment,</w>
aspiro dec
aspirin- use</w>
aspir ation.</w>
aspir ation,</w>
asphy xia,</w>
aspergillo sis</w>
aspergillo sis.</w>
aspect s,</w>
ase olus</w>
as ynchron
as sum</w>
as ole</w>
as emia,</w>
as ed-
artic le.</w>
arthrogr ypo
arthro scopy</w>
arthro pathy.</w>
arterio lopathy</w>
arterialized- venous</w>
arter y)</w>
artemis in
arteme ther</w>
art an-induced</w>
arri val.</w>
arri val,</w>
arrhythmo genesis</w>
arrhythm ia
arrhyth mic
arginine- aspartate</w>
argin ine,</w>
argatrob an.</w>
arg uments</w>
arg assum</w>
arec oline</w>
arec oline-induced</w>
are a)</w>
architect ure,</w>
arch es</w>
arch es,</w>
arch .</w>
arbox amide</w>
arb onate</w>
arb er</w>
arachid onate</w>
arabinoside :</w>
ara- C,</w>
ar ylation</w>
ar y)</w>
ar resting</w>
ar m).</w>
ar m
ar ),</w>
aqu eductal</w>
apraclon idine.</w>
approxim ating</w>
appreci ate</w>
appra isal.</w>
applic ability.</w>
appl ies</w>
appear ,</w>
appe d.</w>
apparen t;</w>
apopto sis:</w>
apomorph ine-</w>
apomorph ine-
apne as.</w>
apl asia,</w>
aphasi a,</w>
apart )</w>
aparo id</w>
ap ocynin</w>
ap ipuncture</w>
ap ing</w>
ap ex.</w>
ap amin</w>
aorto- femoral</w>
aor to
any one</w>
antr um</w>
antipyre tics</w>
antipy retic
antioxid ant
antimicrobi al,</w>
antihist one</w>
antihist amine-induced</w>
antigen emia</w>
anticoagul ation-associated</w>
anticoagul ant
antici pation</w>
antibody -associated</w>
antibody -
anti-L SP</w>
anti-HB e.</w>
anti- viral</w>
anti- tremor</w>
anti- thyroid</w>
anti- smooth</w>
anti- retroviral</w>
anti- hepatitis</w>
anti- dyskinetic</w>
anti- cefamandole</w>
anti- MR
anti-MR BC</w>
anti- LH-RH</w>
anti- IgG</w>
anti- Fas</w>
anti- DNP</w>
anti- B19</w>
anti thromb
anti smooth</w>
anti sen
anti platelets</w>
anti mycobacterial</w>
anti hypertensives</w>
anti fibrotic</w>
anti dromically</w>
anti asthmatic</w>
anti arryth
anthracycl ine,</w>
anthracenedi one</w>
anthra quin
anteri or.</w>
anteri or-
ante partum</w>
antagonist s;</w>
antagonist s)</w>
ant /
anorexigen s</w>
anorexigen -exposed</w>
anorexi ant</w>
ano rectal</w>
ann ulus</w>
anis otropy</w>
anis otropic</w>
anhedon ia</w>
angiotensin- (1-7)</w>
angioedema :</w>
angiocardi ography.</w>
angio genesis.</w>
angio genesis,</w>
angin a-like</w>
angin a)</w>
ang ular</w>
ang le-closure</w>
anecdot ally</w>
ane- anesthetized</w>
ane uplo
and ;</w>
anciclo vir</w>
ance /
anc ou
anastom otic</w>
anaphyl axis
analy sis
analogu e.</w>
analog s,</w>
analgesi a:</w>
analbum inemic</w>
anal ge
anaesthe sized</w>
anabol ic-androgenic</w>
ana emic</w>
an-3- yl)
an the
an sw
an oti
an od
an ococ
an o-
an isol
an ir
an hydro
an amnestic</w>
an amne
amylo id-
amput ations</w>
amput ations,</w>
amput ation,</w>
amphet amin
amp shi
amoxycill in-clavulanic</w>
amoxycill in-clavulan
amoxicill in-induced</w>
amox apine.</w>
amoun ts.</w>
amoun t.</w>
amodi aqu
amne sias</w>
amne sia:</w>
amlodipine/ benazepril</w>
aminophen ol</w>
aminom ethyl
aminoind an</w>
aminoglyco sides,</w>
aminoc yclopentane
aminoacid uria</w>
aminoacid uria.</w>
amino- terminal</w>
amino- 5-bromouracil</w>
amino -1-
aminid ase</w>
amin opyrine</w>
amifost ine,</w>
amide -type</w>
amer icana</w>
amend ment</w>
amen orrhea.</w>
amen orrhe
ame zin
ambul ation,</w>
amant ad
am ed</w>
am ate.</w>
aly )</w>
altern atively,</w>
altern ative,</w>
alte plas
alpha2ABC- knockout</w>
alpha2ABC- /-</w>
alpha1- subunit</w>
alpha-synucle in</w>
alpha-naphthylisothiocyan ate</w>
alpha-methyl-p- tyrosine,</w>
alpha-methyl-p- tyros
alpha-methyl- 5-HT</w>
alpha-methyl dopa
alpha- tropyl</w>
alpha- smooth-muscle</w>
alpha- reductase</w>
alpha- lipoprotein</w>
alpha- hydroxyvitamin</w>
alpha- fluoro-beta-
alpha- ethinylestradiol</w>
alpha- antagonist</w>
alpha- antagonism</w>
alpha- actin</w>
alpha- OH-
alpha- MD</w>
alpha- (
alpha, alpha
alpha,alpha '-
alpha(1 D
alpha 4-
alpha 2A</w>
alpha 2-adrenoceptor</w>
alpha 1-</w>
alpha (q
alpha (4)
alph ax
alph as)</w>
alone .(ABSTRACT</w>
alo id</w>
allopurin ol.</w>
allodynia/ hyperalgesia.</w>
allodyn ia;</w>
allo thionein</w>
allo genic</w>
allergi es,</w>
all- or-
all yl</w>
all idotomy</w>
alkyl xanthines</w>
alkalo id.</w>
alk ylation</w>
alk yl-
ali ke</w>
aler t,</w>
alcohol -dependent</w>
albuter ol-induced</w>
alaz ine-associated</w>
alas in</w>
al- to-
al titu
al one),</w>
al mo
al location</w>
al ised</w>
al im
al ia</w>
al bic
al am
al -associated</w>
al )-induced</w>
akine tic-rigid</w>
ajmal ine.</w>
ain st</w>
ain .</w>
agonist/ antagonist</w>
agonist- antagonist</w>
agonist s)</w>
agl es.</w>
aggreg ates.</w>
aggrav ation.</w>
agent s:</w>
aged- matched</w>
age- dependent.</w>
age al,</w>
ag ree</w>
ag ing:</w>
afterwar ds,</w>
afterdepolar izations,</w>
affect ,</w>
aeruginos a,</w>
aer t
advance ment</w>
adult- onset</w>
adrenal ectomy.</w>
adolescent -onset</w>
adnex al,</w>
admit ted.</w>
admit ted,</w>
adjuv ants</w>
adjuv ant.</w>
adenotonsill ectomy.</w>
adeno pathy</w>
adeno fibrom
aden yl
aden omas,</w>
aden om
aden oid
aden itis</w>
addiction -related</w>
addiction -like</w>
addi tively</w>
ad versity</w>
ad ur
ad option</w>
ad odiamide</w>
ad ducts.</w>
ad .</w>
acyclo uridine</w>
acut ely.</w>
acut e"</w>
acumin ata.</w>
activity- increasing</w>
active- controlled</w>
activ ity.(ABSTRACT</w>
activ ator,</w>
activ ation/
activ ation-
activ ated.</w>
actin omycin-
acti ve
acti tol</w>
act olol</w>
act )</w>
acrole in,</w>
acro dermatitis</w>
acri dine</w>
acr ylic</w>
acqu i
acid ity</w>
acid -</w>
ach usetts</w>
ach lor
acetyl- carnitine</w>
acet oxy
acet one,</w>
acet ate:</w>
acet amides</w>
acet abul
acetabul um</w>
acen oc
acen aph
ace us</w>
accumul ates</w>
accoun t.</w>
acces sibility</w>
accept ability,</w>
acceler omyography</w>
acceler ometer</w>
acceler atory</w>
acc red
acampros ate</w>
ac tion)</w>
ac teric</w>
ac lam
ac iclovir</w>
ac emide</w>
ac cumulative</w>
ac clim
ac cept</w>
ac al
ac -treated</w>
ac -
abstin ent,</w>
absorp ti
absor b</w>
absces ses.</w>
abs ences,</w>
abol ism</w>
able :</w>
able )</w>
ablact ation.</w>
abl ation,</w>
abil ity/
abil is</w>
abdomin is</w>
abac avir</w>
ab sen
ab ductor</w>
aF GF</w>
a-actin in</w>
a- inducing</w>
a- -a</w>
a, 5,6,
a side</w>
a phasic</w>
a pati
a evulinic</w>
a D</w>
a 5
a5 GABAA</w>
a );</w>
[Mg2+ ]</w>
[HR ],</w>
[4-(2- methoxyphenyl)
[3H]- taurocholate</w>
[3H] nicotine</w>
[3H] muscimol</w>
[3H] HCh
[3H]HCh -3</w>
[3H] GABA</w>
[3 1]
[2-(3,4-dichlorophenyl) ethyl]-1,4-diazabicyclo[4.3.0]non
[15 O]
[15O] H2O</w>
[14C] sucrose</w>
[11C] raclopride</w>
[1-11C] acetate</w>
[1,2,4 ]
[ verapamil]o</w>
[ p</w>
[ interquartile</w>
[ c]
[ V
[ MAP
[ Leu
[ LVE
[ IV
[ ID
[ID (50)=
[ ASA
[ 4
[ 3</w>
[ 2</w>
[ 22
[ 10</w>
[ 1,</w>
[ 1
[ 0.
[ (R,S)-
[ (+)-
[ (+)
[ (
ZT P.</w>
Z uc
Z op
Z iprasid
Z af
Z S
ZS F1</w>
Yohimb ine,</w>
YM-0 9
YM-09 15
YM-0915 1-2</w>
YM-0 80
YKP14 47</w>
Y-23,0 28</w>
Y- 79</w>
Y- 40
Y JT</w>
Y 12
Y12 28</w>
Y -14,
Y -14
Y-14 802</w>
Y ).</w>
X-ra y,</w>
X+ Isoflurane</w>
X+ CH
X+CH R
X imel
X I</w>
X AC</w>
Work place</w>
Wor king</w>
Withdraw als</w>
With holding</w>
Wh ich</w>
Wh ere</w>
Wernic ke-Korsak
Well butr
Weigh ts</w>
We an
We ak
Walden strom's</w>
Wal sh</w>
Wal es</w>
Wa iting</w>
WR2425 11,</w>
WR 330
WR330 63</w>
WIN55,212- 2,</w>
WI N-
WH AT</w>
WF- CP</w>
WB Cs/HP
WAI CH</w>
W- 7</w>
W y
W ong-Baker</w>
W ild
W arm</w>
W all</w>
W Y-14,
W O</w>
W DR</w>
W .
Volume tric</w>
Viro logical</w>
Viro logic</w>
Vinc a</w>
Vic tor
Vi sion</w>
Vi rus</w>
Vaso active</w>
Var ic
Val ette</w>
Val acyclovir</w>
Vacu ol
VT VF</w>
VP- sensitive</w>
VP -16-
VN B.</w>
VMR T</w>
VI G
VIG OR</w>
VEGF /
VE N</w>
VE D</w>
V232 I
V232I +
V232I+ L1308F</w>
V1 I,</w>
V/ LAM</w>
V omiting</w>
V ocal</w>
V mca</w>
V irtually</w>
V enti
V ancou
V ]</w>
V X2</w>
V WF-CP</w>
V RS</w>
V R-
V PDs</w>
V PC
VPC s</w>
V KA</w>
V II,</w>
V I.</w>
V HD.</w>
V GLUT
V FC</w>
V DR</w>
V DB
V C,</w>
V BL</w>
V 2
V2 I,</w>
V (max)</w>
Utili zation</w>
Usu ally,</w>
Urticar ia</w>
Ureth ane-anesthetized</w>
Upjohn )</w>
Univer sity-
Un intentional</w>
Un ineph
USPI O</w>
US A)</w>
UR B
URB 59
UL AR
ULAR IT
UG S</w>
UF T.</w>
U/ mL</w>
U/ kg,</w>
U/ h)</w>
U/ L;</w>
U/ L).</w>
U-4 30
U- E)</w>
U- 99
U-99 194
U-99194 A</w>
U ri
U ppsal
U niqu
U mbil
U gand
U d
U ST
U I/
U A,</w>
U 83836E</w>
U 69
U 5048
U 50,48
Tyr -M
Tyr-M IF-1</w>
Tyr -
Turke y.</w>
Tub ocurarine</w>
Tsukub a,</w>
Trx R</w>
Tro vafloxacin</w>
Tri phasic</w>
Tri gg
Tri angle</w>
Treatment -
Treatment- emergent</w>
Treat ing</w>
Tre mens</w>
Traum a</w>
Transit ory</w>
Trans fusion</w>
Trans amin
Tramad ol,</w>
Tr ypt
Tr p-
Top ically</w>
Tol u
Tol terodine</w>
Tit ration</w>
Tim ed</w>
Tie 2-
Tie2- Cre
Tie2-Cre ;
Tic arc
Tiaz ofurin</w>
Thyro xine</w>
Thromb in</w>
Thomson ide</w>
Thi 5,
There after</w>
Theore tical</w>
Thalidom ide,</w>
Thal lium-201</w>
Th r</w>
Tet /
Terat ology</w>
Ten ofovir</w>
Temper ament</w>
Temozolom ide</w>
Te mazepam</w>
Te icoplan
Td p.</w>
Target ing</w>
Tan dem</w>
Tam sulos
Taipe i</w>
Tacrolim us-associated</w>
Ta uro
TV 3
TTP/ HUS.</w>
TTP/ HUS,</w>
TSC M</w>
TS ST</w>
TRO 196
TREAT MENT</w>
TPV/ r</w>
TP T</w>
TMP Z</w>
TM P,</w>
TL CA-induced</w>
TJ-80 14</w>
TI- 201</w>
TI N)</w>
TI MP-
TI A,</w>
TI ),</w>
TH P)</w>
TH IP</w>
TGR(A1-7)3 292</w>
TFMP P</w>
TF (max)</w>
TEO AEs</w>
TE P)</w>
TE OAE</w>
TD s</w>
TD ).</w>
TC -treated</w>
TB I.</w>
TB AR
TAS ,</w>
TAF I,</w>
TA- 606</w>
T9- T
T- type</w>
T- lymphocyte</w>
T- containing</w>
T- amplitude</w>
T- UDCA</w>
T wel
T s)</w>
T oni-Debr</w>
T ocain
T h</w>
T erbin
T ask</w>
T ar
T UR</w>
T S.</w>
T S-
T NG.</w>
T N-
TN- R</w>
T MT.</w>
T J</w>
T G.</w>
T CA
T 4/
T 1)</w>
T )-
T (2)-
T(2)- weighted</w>
Syst olic,</w>
Synerg ism</w>
Syn copal</w>
Switzer land.</w>
Sus pected</w>
Surviv ors</w>
Surve y.</w>
Sulph asalaz
Sulfon amides</w>
Sulfasalaz ine-induced</w>
Sul ind
Succ ess</w>
Subst antial</w>
Subject s'</w>
Sub- chronic</w>
Sub tle</w>
Sub groups</w>
Sub chronic</w>
Su icide</w>
Su gg
Stud y).</w>
Stud ent</w>
Stro op</w>
Stro k
Stric t</w>
Stri dor</w>
Stres s-induced</w>
Stres s
Strept omyces</w>
Str ych
Str onger</w>
Stom atitis</w>
Stimul ants</w>
Stim Veh</w>
Stim Cap</w>
Sti ll
Ster oid
Ster n
Ste ady</w>
State- Trait</w>
Stat 5</w>
Stan ford</w>
St urge-Weber</w>
St atin</w>
St able</w>
Sprague- Daw
Spi elberger</w>
Spec imens</w>
Spas ms</w>
Spas m</w>
Span ish</w>
Sot alol-induced</w>
Smo k
Sleep iness</w>
Singap ore
Sim vastatin-induced</w>
Si ve
Sham Veh</w>
Sham Cap</w>
Seventy- three</w>
Seventy- six</w>
Seventy- four</w>
Separ ation</w>
Self- reported</w>
Sel f</w>
Seiz ure-induced</w>
Seiz ure
Second- line</w>
Second -</w>
Sec retion</w>
Sci atic</w>
Scat chard</w>
Scal e)</w>
Sc S
ScS n</w>
Satis faction</w>
Salv age</w>
Sal vianolic</w>
Sal via</w>
Sal ine-treated</w>
Saf e</w>
SW R</w>
SV R.</w>
SUN-1334 H,</w>
SULT1 A1</w>
SULT 1</w>
SU R1</w>
ST I</w>
SSRI s,</w>
SRL- CsA-
SR S,</w>
SR L.</w>
SR 141716
SQ 29
SQ29 548</w>
SPEC T,</w>
SP V</w>
SP PI</w>
SP N,</w>
SP K,</w>
SP IR
SPIR O</w>
SP +
SOUR CE:</w>
SOD 2-
SOCS -3,</w>
SO S</w>
SO ;</w>
SO ),</w>
SNH L.</w>
SN GFR</w>
SMemb -positive</w>
SM A</w>
SM 3</w>
SM 2</w>
SLV 3
SLE -like</w>
SK F-
SI .</w>
SI -
SI ),</w>
SHR s.</w>
SHR ;</w>
SH RS
SHRS P,</w>
SH R-
SHR- STZ</w>
SH C</w>
SH AM-
SER T-
SE R</w>
SE NSU
SE D</w>
SE ;</w>
SDS- PA
SD ]</w>
SD N</w>
SD I</w>
SD I-
SCL-90- R</w>
SCL C,</w>
SCH Z</w>
SC-36 602</w>
SC h</w>
SC P</w>
SB-2699 70</w>
SA S</w>
SA M</w>
SA H-
S100 A
S100A 6</w>
S.D .,</w>
S. D.</w>
S-adenosyl methionine</w>
S-2- (3-
S- allyl</w>
S)-1- aminoindan-1,5-dicarboxylic</w>
S(c) O(2)</w>
S(c) O(2).</w>
S(+)- norketamine</w>
S(+ )-</w>
S usta
S traub</w>
S ten
S s</w>
S plenic</w>
S pin
S pain.</w>
S olid</w>
S odi
S mad</w>
S lc
S k
S j</w>
S ite</w>
S ick</w>
S har
S ens
S e-
S at
S argassum</w>
S arc
S ap
S an-
S V</w>
S SPPI</w>
S SI
S SH
S O</w>
S LA</w>
S L.</w>
S K-
S G)</w>
S F-
S D-
S AEs</w>
S A/
SA/ -</w>
S 24
S24 8
S )
Ry R2</w>
Ru thenium</w>
Rous sel</w>
Rot ter
Rosu vastatin</w>
Rom an</w>
Roche ,</w>
Riton avir</w>
Risperid one-associated</w>
Ring er</w>
Rig idity</w>
Ri vas
Ri j</w>
Rheum atoid</w>
Rg b</w>
Rey e-like</w>
Reticulo cyte</w>
Ret urn</w>
Ret in
Restric tive</w>
Respon siveness</w>
Res veratrol</w>
Relax ation</w>
Recor ding</w>
Recomm ended</w>
Real- time</w>
Re y</w>
Re verse</w>
Re ferences</w>
Re b
Re administration</w>
Re ad
Re activation</w>
Rat ings</w>
Rash es</w>
Radi ologic</w>
Radi ographic</w>
Rabb it</w>
Rab ep
Ra f</w>
RV M.</w>
RU 38
RTI-1 77</w>
RT- PCR,</w>
RT I</w>
RS 86</w>
RP C)</w>
RO P,</w>
RO CK</w>
RO -induced</w>
RO )</w>
RI As</w>
RI A,</w>
RG N</w>
REVIEW ER
REVIEWER '
REVIEWER' S</w>
RESULT (S):</w>
REG ULARIT
RE S</w>
RB Cs,</w>
RANK L/
RANKL/ OPG</w>
R-1 29
R-129 09</w>
R- AAP</w>
R- 2</w>
R,4 R)-
R(-)- fluoxetine</w>
R us
R s).</w>
R im
R il
R enin</w>
R arely</w>
R af
R WM</w>
R U-430
R S),</w>
R R,</w>
R IST</w>
R CM-induced</w>
R AR
R AD00
R 599
R599 49</w>
R 3</w>
R 1)</w>
R -</w>
Quin ine-associated</w>
Quin ine,</w>
Quer cet
Qualit ative</w>
Qu e
QTc- interval</w>
QT(Fri d),</w>
QT(Fram )</w>
QT( u)</w>
QT vi</w>
QT /
Q X.</w>
Q U
Q T)</w>
Pyraz inamide</w>
Pyr rolidine</w>
Pur pur
Pur ple</w>
PubM ed,</w>
Psych osis-
Provid ers</w>
Prot amine</w>
Propafen one-induced</w>
Progest ogens</w>
Proble ms</w>
Pro tracted</w>
Pro ton</w>
Pro pri
Pro lact
Pro gram.</w>
Pro g</w>
Pro duction</w>
Pro M
ProM ACE-
ProMACE- Cy
ProMACE-Cy taBOM</w>
Prim ing</w>
Pri locaine</w>
Pres yn
Preg S</w>
Pre vent</w>
Pre treatments</w>
Pre menopausal</w>
Practition ers'</w>
Prac tical</w>
Pr actolol</w>
Pp IX</w>
Post- treatment</w>
Post- training</w>
Post operatively</w>
Post infarction</w>
Pos tischem
Por t-A-Cath</w>
Pop ulation-
Polymorph ous</w>
Poly neuropathy</w>
Po isons</w>
Pneumon itis,</w>
Plo ugh
Plas ma
Plaqu enil</w>
Placebo -controlled</w>
Pl a</w>
Pitts burgh</w>
Piribe dil</w>
Pir acetam</w>
Pir acetam,</w>
Pinacidi l</w>
Pil si
Pi renperone</w>
Physi ologic</w>
Phosphor ylated</w>
Phosphodi esterase</w>
Phenylpropan ol
Phenprocou mon-induced</w>
Phen oxybenzamine</w>
Phen o
Phe n</w>
Pharmacokine tic/pharmacodynamic</w>
Pharmac ogenetic</w>
Pharmac ists</w>
Ph aseolus</w>
Ph aryngeal</w>
Ph B</w>
Person al</w>
Perman ente</w>
Peri partum</w>
Perce ived</w>
Per sea</w>
Per flutre
Pentam idine-induced</w>
Pent agastr
Pem oline-induced</w>
Peg interferon</w>
Pear son's</w>
Pe floxacin</w>
Patter n</w>
Patient -
Patient- reported</w>
Pas sive</w>
Paren ts</w>
Parap legia</w>
Par is,</w>
Par athyroid</w>
Par ano
Papaver ine</w>
Pap io</w>
Pan curonium</w>
PaO2/ FIO2</w>
Pa rom
Pa O</w>
PW L</w>
PV C</w>
PV C
PV ),</w>
PTZ .</w>
PTHr P,</w>
PTA- AM</w>
PT E</w>
PT A,</w>
PS VT</w>
PS A-
PRL- R,</w>
PRL- AB</w>
PRIN CIPA
PRINCIPA L</w>
PR A.</w>
PR 2</w>
PR ),</w>
PPA R-
PP Is,</w>
PORT AN
PON V.</w>
PO- PL
PO R
PO M.</w>
PO ,</w>
PO ),</w>
PN 21</w>
PM/ DM</w>
PM s</w>
PLA/ DZR</w>
PK R1</w>
PK )</w>
PJ 34</w>
PIP C</w>
PI3K gamma-deficient</w>
PH T-induced</w>
PH T,</w>
PH A</w>
PH -treated</w>
PH -induced</w>
PGF (2
PGE 1,</w>
PG P</w>
PG E</w>
PF C)</w>
PEG- IFN/RBV</w>
PEG- IFN-
PE S
PE H</w>
PE F
PD A,</w>
PCR -
PCO S</w>
PC s)</w>
PC NS
PC 1</w>
PB SCT</w>
PB SCT.</w>
PATIENT (S):</w>
PAR P.</w>
PAN/ procysteine</w>
PAC U</w>
PA- nephrotic</w>
PA I
PA ED</w>
P= 0.01)</w>
P= 0.001)</w>
P= 0.000
P< 0.01),</w>
P: <
P:< 0.001;</w>
P450 s</w>
P450 -mediated</w>
P2X 2/3</w>
P2- deficient</w>
P/ Q
P/ MAP</w>
P/ J</w>
P/ D</w>
P-S V</w>
P-BM 5</w>
P- containing</w>
P tio
P ronounced</w>
P retest</w>
P mO
P leural</w>
P is
P indo
P ick's</w>
P en</w>
P emphig
P b-exposed</w>
P antop
P allidotomy</w>
P SS</w>
P SP
P SG</w>
P PO
P PE.</w>
P PE,</w>
P PA,</w>
P M.</w>
P M)</w>
P I.</w>
P CT-induced</w>
P CI.</w>
P CB
P 8</w>
P 75</w>
P 7,</w>
P 4</w>
P 21</w>
P 200</w>
P 14</w>
P 12</w>
P 10</w>
P -1.5</w>
P (+)</w>
Oxali platin</w>
Ox ford</w>
Over drive</w>
Otot oxic</w>
Or phenadrine</w>
Or gan</w>
Oper ation</w>
Open ,</w>
One-hundred- and-
One- third</w>
Ondan setron,</w>
On tario,</w>
On '</w>
Om maya</w>
Oligo hydramnios</w>
Ol mesartan</w>
Ol factory</w>
Ol esoxime</w>
Octreoti de,</w>
Oc cupational</w>
Obses sive</w>
Obses sive-compulsive</w>
Obser ver's</w>
Oatp 2</w>
OXO -16ene
OX C.</w>
OX C,</w>
OX 4
OX4 2+</w>
ORX T</w>
OR -
ONO- 87
OLT ,</w>
OK T3</w>
OI H.</w>
OF F-
ODN s</w>
OB M</w>
OB )</w>
OATP- C</w>
OA A/
OAA/ S</w>
O- Bu</w>
O- 2</w>
O tolaryng
O sc
O rolingual</w>
O rac
O lig
O esophageal</w>
O UA</w>
O T-
O L
O HR</w>
O H)</w>
O G
O E
O CD.</w>
O CD-
OCD- like</w>
O AL
OAL I</w>
O (6)-
Numb er</w>
Nucle us</w>
Nucle oside</w>
Nov .</w>
Nor plant.</w>
Non- convulsive</w>
Non alcoholic</w>
No w</w>
No v</w>
No otropic</w>
No DCE-
Nitroglycer in-induced</w>
Niger ia</w>
Nifedi pine-induced</w>
Nifedi pine,</w>
Nicot ine,</w>
New -onset</w>
Nevir apine-induced</w>
Neutropen ic</w>
Neuro physiologic</w>
Neuro pathologic</w>
Neuro inflammation</w>
Neuro cognitive</w>
Neuro active</w>
Net work.</w>
Nesac aine-
Necro tic</w>
Ne vertheless</w>
Ne oral</w>
Ne o-
Ne isseria</w>
Ne fopam</w>
Ne fir
Nd1- L</w>
Nd :YAG</w>
Nar co
Nag ase</w>
Naf c
Na/ H</w>
Na- Cl</w>
Na+- binding</w>
Na+ K+</w>
Na Cl)</w>
Na B
Na ),</w>
NTS 1(-/-)</w>
NT- pro-ANP</w>
NT S.</w>
NT S,</w>
NT PP</w>
NT G,</w>
NT Ds.</w>
NT A</w>
NSU D</w>
NR V
NR TIs</w>
NR P</w>
NR M,</w>
NR H.</w>
NR 2
NR 1</w>
NR /N
NR/N p</w>
NPY- LI</w>
NP O</w>
NP FT</w>
NOS 3-/-</w>
NOC -18</w>
NO -mediated</w>
NN G)</w>
NK CC1</w>
NK -1</w>
NHB D</w>
NH ANES</w>
NG- monomethyl-L-arginine</w>
NF kappaB</w>
NF kB</w>
ND I1</w>
ND E</w>
NCA M</w>
NC V</w>
NC V)</w>
NBQ X.</w>
NBQ X,</w>
NASH .</w>
NADPH d</w>
NADPH d-positive</w>
NAD +</w>
N6- cyclopentyladenosine</w>
N363 S</w>
N0 M
N-nitrosou rea</w>
N-nitroso- N-methyl
N-nitro som
N-methylox azepam</w>
N-methyl- D:</w>
N-ethyl- N-
N-ethyl-N- hydroxyethyl
N-butyl-N-(4-hydroxybutyl) nitrosamine</w>
N-acetyl glucosaminidase,</w>
N-2-fluorenyl acetamide</w>
N-(2- propylpentanoyl)urea</w>
N- sulfated</w>
N- pyrimidinyl-2-phenoxy
N- propyl
N- phosphonacetyl-L-
N- ethyl</w>
N- de
N, N'-
N r1(neo-/-)</w>
N onionic</w>
N omifens
N ocicept
N o.</w>
N inth</w>
N igral</w>
N ested</w>
N em
N ad
N SI,</w>
N LA</w>
N I</w>
N FLX</w>
N F</w>
N ER
N EF</w>
N EA</w>
N CI</w>
N CI-
NCI- CTC</w>
N C,</w>
N AI
N AC.</w>
N AC,</w>
N ;</w>
N :</w>
N 1
N -10
N (M
Myoglob inuria</w>
Myo pathy,</w>
Myco plasma</w>
My xedema</w>
My lotarg</w>
Mul tiv
Morph ine,</w>
Mon onuclear</w>
Modi fications</w>
Mode lling</w>
Mo(t)/ B(t)</w>
Mo del
Mn SOD</w>
Mit ochondria</w>
Mit o
Mis sour
Mil d,</w>
Mil an,</w>
Mid dle</w>
Micro scopy</w>
Mibefradi l</w>
Mg+ 2</w>
Mg+ +,</w>
Mg(2+ )/
Mg(2+)/ Ca(2+)</w>
Mg(2+ )-
Mg Cl
Metoclopram ide-induced</w>
Metoclopram ide,</w>
Methotrex ate-related</w>
Methad one,</w>
Meth yser
Meth oxamine</w>
Meth icillin-resistant</w>
Meth azol
Met allothionein</w>
Mes na.</w>
Mes alazine-associated</w>
Men delian</w>
Melat onin,</w>
Mel phal
Mel bour
Mei ge</w>
Meflo quine</w>
Medic are</w>
Medi ation</w>
Med iterranean</w>
Me trazol</w>
Me detomidine</w>
McN- A-3
McN-A-3 43</w>
Mc Nem
Mc G
McG ill</w>
Maz indol</w>
Matri x</w>
Mat ched</w>
Mass achusetts</w>
Maryl and,</w>
Mar ital</w>
Mal on
Mal es</w>
Mal ay
M_ M.</w>
MTX-N tox</w>
MTX -related</w>
MT S</w>
MT /
MSO -induced</w>
MRI- 8
MRI-8 27
MRI-827 3-
MR P2-deficient</w>
MR N-lesioned</w>
MR Is</w>
MPT )</w>
MP S</w>
MP R</w>
MP ;</w>
MP 15</w>
MP ).</w>
MN CV,</w>
MMP -1</w>
MM C-induced</w>
MLM -160</w>
MK80 1.</w>
MK-9 12</w>
MK -1
MK-1 42</w>
METHODOLO G
METHODOLOG Y:</w>
MEASURE (S):</w>
ME T-induced</w>
ME SNA</w>
ME Q</w>
ME Ps</w>
ME D
ME )</w>
MDS- CAs</w>
MDMA )</w>
MDMA (-)</w>
MD R</w>
MD ).</w>
MCI-1 54,</w>
MC T)</w>
MB F)</w>
MB As)</w>
MB -
MB ,</w>
MAOI s.</w>
MA PK
MA NEA</w>
MA EA</w>
MA -dependent</w>
MA -
M16 28
M16 209</w>
M s)</w>
M ove
M others</w>
M ot
M ix
M g,</w>
M epi
M d</w>
M ature</w>
M ariju
M apro
M apping</w>
M an</w>
M PA-
M PA
M OPP</w>
M O-induced</w>
M Is</w>
M IP
MIP -1
M IC
M HS</w>
M HD</w>
M HC
MHC -I</w>
M CT-induced</w>
M CS</w>
M CR
MCR C</w>
M CD</w>
M C-
M ACE</w>
M AC,</w>
M 65</w>
M 552
M 2-
M 2)</w>
M 2).</w>
M )-induced</w>
Lys (15
Lys(15 )]
Lou is,</w>
Loracar bef</w>
Lor azepam,</w>
Long er</w>
Lond on.</w>
Lofex idine</w>
Lo beline</w>
Lis sau
Lip id-
Linezol id-associated</w>
Lim iting</w>
Lim b</w>
Ligh t-
Li/D VP</w>
Li/ Li</w>
Li/ C</w>
Li- uraemic</w>
Li- pilocarpine</w>
Li- PC
Li brary</w>
Levo simendan</w>
Le ak
Ld T.</w>
Latano prost</w>
Lamivud ine,</w>
Lamb ert-Eaton</w>
Lab or</w>
LY3547 40</w>
LY 34
LY34 14
LY -17
LVE Fr
LV DP</w>
LV ,</w>
LT D4</w>
LQT 1</w>
LP SPs</w>
LOU/M/W sl</w>
LO S
LO ,</w>
LNa+ HCa</w>
LN D-
LND- 6
LL L</w>
LID/ MET</w>
LI PFC</w>
LI M</w>
LG B</w>
LD -induced</w>
LD ,</w>
LD +BZ</w>
LD (con
LCB F/
LCBF/ delta</w>
L. min-1.
L. min(-1
L-argin ine:</w>
L-argin ine/
L-OH P</w>
L-NO Arg</w>
L-NI L</w>
L- isomer</w>
L- cysteine</w>
L- T</w>
L- 6
L- 2-oxothiazolidine-4-
L ocomotion</w>
L ob
L isteria</w>
L ist
L illy</w>
L ig
L aryngeal</w>
L an
L RS</w>
L O)</w>
L N</w>
L N,</w>
L L)</w>
L K
L I)</w>
L D-
L C-
L BUP,</w>
L BBB</w>
L AD
L 6/
L 4,</w>
L 3</w>
L 2)</w>
L .,</w>
L (L
Kreb s-
Kore a,</w>
Kit (Y567F/Y567
Ki- 67</w>
Ket otifen</w>
Ker at
Ka iser</w>
KRN23 9
KOP- r</w>
KO s</w>
K/ liver-/-</w>
K- variant</w>
K- MB</w>
K+- evoked</w>
K+ ATP</w>
K+ .</w>
K(v) 7</w>
K(i )=
K ynuren
K yn
K v</w>
K ind
K i=
K earns-Sayre</w>
K appa</w>
K amp
K RT
K IT-
K CH</w>
K B-24
K 3</w>
K (+
K(+ )-induced</w>
Jo h
Jcl :ICR</w>
J uly,</w>
J ud
J our
J ordan</w>
J an</w>
J AK-
J AK
J -
Ital ian
Isra el.</w>
Isosorb ide</w>
Iso .</w>
Iso -induced</w>
Isl and</w>
Ishihar a</w>
Is ob
Irel and</w>
Iran .</w>
Ir-CP I</w>
Ir besartan</w>
Ir b
Invent ory.</w>
Intrapl antar</w>
Intran igral</w>
Intra uterine</w>
Inter view.</w>
Inter -
Inte rest</w>
Inos itol</w>
Ing estion</w>
Influ ences</w>
Infarc t</w>
Indinavir -associated</w>
Incid ence,</w>
Inc re
Inc ,</w>
In surance</w>
In complete</w>
Immun oreactive</w>
Imi pramine-induced</w>
Imag es</w>
Im pulse</w>
Im pul
Im plementation</w>
Im plan
Ile 105
Ile105 Val</w>
Ile /
IgG- saporin</w>
IgG IR</w>
Idiosyncr atic</w>
Idazox an,</w>
Ic tal</w>
Ib/ IX</w>
IV U,</w>
IV H.</w>
IT A</w>
ISO s</w>
IS G</w>
IS ),</w>
IR REGULARIT
IR AEs</w>
IPR -induced</w>
IP SS</w>
IP RO-induced</w>
IO Ps</w>
INTERVENTION (S):</w>
INH -related</w>
IN H-induced</w>
IMPA 1-
IMPA1- /-</w>
IM/ oral</w>
IM PORTAN
IM N</w>
IL- 8</w>
IL- 6/
IL- 4,</w>
IL P</w>
IL K/liver-/-</w>
IL -1,</w>
III- V</w>
IIE 0
II- A</w>
IH 636</w>
IF OS</w>
IF O.</w>
IF O
IF -
ID Z</w>
ID PN</w>
ID ,</w>
IC U,</w>
IC U)</w>
IC P/MAP</w>
IC P,</w>
IC :</w>
IC ,</w>
IB-ME CA</w>
IB S</w>
IB 4-
IB 4
I/ mg</w>
I. P
I- II,</w>
I- Bu</w>
I- 3
I vermectin</w>
I trac
I rin
I psapir
I opamidol</w>
I fenpro
I de
I d
I b</w>
I U,</w>
I U)</w>
I R-AAP</w>
I QR:</w>
I P-
I B,</w>
I A.</w>
I -associated</w>
I );</w>
I (Na)</w>
Hypox emia</w>
Hypo thyroidism</w>
Hypo kalemic</w>
Hyperlipide mia</w>
Hyper vitaminosis</w>
Hyper triglyceride
Hyper thermia</w>
Hype remic</w>
Hy pot
Hy oscine</w>
Hy bri
Hun g
Hu EPO-
Hos tility</w>
Hol tzman</w>
Ho ff
His panic,</w>
Hippocamp us</w>
High- risk</w>
High- frequency</w>
Hg/ min]</w>
Hg .
Hex achloro
Heter ogeneity</w>
Hepat otoxicity,</w>
Hepat obiliary</w>
Henoch -S
Henoch-S ch</w>
Hem i
Haz ards</w>
Haloth ane-
Hal o</w>
HTN ,</w>
HT X</w>
HT N</w>
HR P)</w>
HR C</w>
HLA-B 8</w>
HLA-B *
HLA-B* 57
HIV/ HCV</w>
HIV-1- positive</w>
HIV -1.</w>
HITT S,</w>
HIT ;</w>
HIT /
HIT -related</w>
HER 2-
HE M</w>
HDL- mediated</w>
HD M
HD L1</w>
HD I</w>
HD C</w>
HCO -3</w>
HC l-induced</w>
HC FCs</w>
HBsAg -
HBeAg- seropositive</w>
HBI G.</w>
HBI G,</w>
HB V-related</w>
HB -7</w>
HAM- D,</w>
HAM D(1
HAMD(1 7)</w>
HA L-
H3- receptor</w>
H2- receptors</w>
H(2)O (2)-
H(2)- histamine</w>
H ickman</w>
H ellenic</w>
H awai
H as
H ap
H ampshi
H am
H _
H VOD</w>
H SI,</w>
H SC</w>
H PV
H PD
H O</w>
H O)</w>
H MS</w>
H L-
H K-2</w>
H FO</w>
H AC-
H 1-</w>
H .
H -</w>
H ,
Guan fac
Gu aneth
Grou ps.</w>
Granulo cytopenia</w>
Gr aft</w>
GnRH- antagonist</w>
Glutam atergic</w>
Glucar pidase</w>
GluR 2-
GluR2- immunoreactive</w>
GluR -1</w>
Glomer ulosclerosis</w>
Gi -
Gest ational</w>
Gemfibro zil</w>
Gefit inib</w>
Gd- containing</w>
Gd- DTPA-
Gas 6-
Gadol inium-
GY/ TR-</w>
GW29 74</w>
GT P-
GSPE +
GSK-3 b</w>
GSH /
GSH/ GSSG</w>
GPT L4</w>
GP E</w>
GM 1-treated</w>
GL- PS</w>
GL AST</w>
GHB -induced</w>
GG T,</w>
GF- 2</w>
GF P-
GE N-induced</w>
GC- MS</w>
GB T</w>
GB R-12909</w>
GAM S,</w>
GABA(B (1))</w>
GABA mimetic</w>
GABA ergic,</w>
GABA -</w>
G-6- PD-deficient</w>
G- proteins</w>
G( alphas)</w>
G y).</w>
G ray</w>
G ordon</w>
G om
G o</w>
G ly.</w>
G le
G ingi
G gg</w>
G aert
G adodiamide</w>
G ST</w>
G PT,</w>
G N</w>
G MBF</w>
G J
G H
G G</w>
G E)</w>
G DE
G D1</w>
G D,</w>
G D
G 4:</w>
G 3:</w>
G 2:</w>
G -treated</w>
G (i
Fur azol
Func tioning</w>
Free dom</w>
Francis co</w>
Fran ce,</w>
Four th</w>
Foscar ne
Fos B/
FosB/ Delta
For t</w>
For ce</w>
Foc ally</w>
Flup enthixol</w>
Fluoro quinolone</w>
Flunit razepam</w>
Flud rocortisone</w>
Flu phenazine</w>
Flu -like</w>
Fl urothyl</w>
Fl are</w>
First -dose</w>
Fin n
Ficol l</w>
Fibr in</w>
Fib rous</w>
Fi brom
Fer tility</w>
Fen- Phen</w>
Femoden e</w>
Fel bamate</w>
Fas- L</w>
Famoti dine-associated</w>
Fac es</w>
FX II</w>
FV R,</w>
FV C</w>
FR1736 57.</w>
FR L</w>
FR 1</w>
FP- CI
FLA- 63</w>
FITC- albumin</w>
FG S</w>
FF R</w>
FD G-
FD G)</w>
F- kappa
F- 9
F-9 70
F-970 13-
F- 344</w>
F ur</w>
F un
F ro
F rag
F ound
F ine</w>
F ddI</w>
F d-PPH</w>
F ]</w>
F U/
F U.</w>
F TI
F Rs</w>
F Q/
F J</w>
F GF-2</w>
F G-
F A/
F 2,</w>
F 0</w>
F )]</w>
Extra vasation</w>
Extra hepatic</w>
Ex pl
Everolim us</w>
Ev ents</w>
Eth ics</w>
Escitalop ram</w>
Ery th
Er got
Epo prostenol</w>
Epo -treated</w>
Epi thelial</w>
Epac 2</w>
Epac 1</w>
Ep silon</w>
Ep omediol</w>
Entec avir</w>
Enalapri lat</w>
En rollment</w>
Embry otoxicity</w>
Electroencephalo gram</w>
Electro graphic</w>
Electro convulsive</w>
Eight- week-old</w>
Efficac y,</w>
Eff orts</w>
Ech o</w>
Ear ly-
Ea hy926</w>
EXPOSURE :</w>
EV -treated</w>
ET A</w>
ET (B)</w>
ER- alpha</w>
EPI-ex t</w>
EP s</w>
EP H</w>
EP 1(-/-)</w>
EP /LVE
EP/LVE T)</w>
EP (3)</w>
EN U</w>
EN L</w>
EM Ggg</w>
EM G,</w>
EM D</w>
EI TRs</w>
EF F
EE /
EDT A.</w>
ED(50) s</w>
ED s</w>
ED V</w>
ED 50)</w>
ED (50)=
ECG ;</w>
EC G-
EC AM
EB+ P</w>
EB GM</w>
EA B</w>
E. G.</w>
E. E.G.</w>
E- enriched</w>
E- containing</w>
E- 40
E y
E vid
E todolac</w>
E scal
E datrexate</w>
E d
E R)</w>
E ON</w>
E ME
E L.</w>
E HE
E A.</w>
E 6</w>
E 15</w>
E 13</w>
E 13.
E 1,</w>
E -</w>
E (1)-induced</w>
E 's</w>
Dys ph
Dy sport</w>
Dup uytren's</w>
Drug- Induced</w>
Dox epin</w>
Dox apram</w>
Dox -treated</w>
Dox ,</w>
Dow n
Dose- finding</w>
Dop amine,</w>
Donepez il.</w>
Doc um
Do g</w>
Diure tic-induced</w>
Diure sis</w>
Dist ribution</w>
Dist al</w>
Dissoci ated</w>
Disor ders,</w>
Discri minant</w>
Dis continuing</w>
Dis ability</w>
Diprivan .</w>
Diphenylhydanto in-induced</w>
Dil at
Dihydro pyrimidine</w>
Dihydro ergotoxine</w>
Dig ital</w>
Difficul ty</w>
Dic hloro
Diazepam -induced</w>
Diazepam -,</w>
Diaz oxide</w>
Di lev
Dex ,</w>
Develop ing</w>
Det rimental</w>
Descri ptive</w>
Descri ption</w>
Desc ribed</w>
Des -
Des- Arg
Des-Arg 9-
Dermat ologists</w>
Depo- Provera</w>
Depart ment,</w>
Den mark
Den +
Delta Hb</w>
Delta APD</w>
Delta (9
Delta(9 )-
Dele terious</w>
Del usional</w>
Defin itive</w>
Deb riso
De oxy
De generation</w>
De generating</w>
De feroxamine</w>
Dap son
Dan aparoid</w>
Dac arb
DZ P)</w>
DYRK 3-/-</w>
DTI s</w>
DT Z</w>
DR Rs</w>
DR R)</w>
DPCP X+Isoflurane</w>
DPA -induced</w>
DP H.</w>
DP )-induced</w>
DOCA- saline</w>
DOCA- hypertensive</w>
DO CA,</w>
DO C,</w>
DO )</w>
DNA- polymerase</w>
DN L</w>
DN ,</w>
DMB A-
DM- 9
DM CM,</w>
DM -induced</w>
DL B
DII HA</w>
DHA- paclitaxel</w>
DH T,</w>
DH EC
DH B</w>
DG C</w>
DF U</w>
DF P-treated</w>
DF P-
DENA- initiated</w>
DEH P.</w>
DE X.</w>
DDP M</w>
DD T,</w>
DD D</w>
DD Abs</w>
DCE ,</w>
DC F</w>
DBA/2 J,</w>
DB N.</w>
DAB A</w>
DA SI
DA -related</w>
D5 W</w>
D3- treated</w>
D2 F1</w>
D-penicill amine-treated</w>
D-Trp 6-
D- dimer</w>
D- amphetamine-evoked</w>
D- Penicillamine</w>
D- Glucar
D- Arg-
D(3 )-treated</w>
D(2)/ 5-HT(1A)</w>
D(2) (-/-)</w>
D(2 -like</w>
D(1 -like</w>
D up</w>
D rowsiness</w>
D rd
D oxy
D ev
D ent's</w>
D endritic</w>
D ang
D ak
D VT/
D VT.</w>
D SG</w>
D SE-induced</w>
D S.</w>
D R-
D R)</w>
D P,</w>
D ID.</w>
D CMP</w>
D As</w>
D AVA</w>
D AC</w>
D 3)</w>
D 2,</w>
D 1-receptor</w>
D .,</w>
D .
D -</w>
D +
D (2-
D(2- like)</w>
Cyt osine</w>
Cy tos
Cu /
Cu ,</w>
Cu ,
Cs A-induced</w>
Cs A),</w>
Criter ia,</w>
Cri tical</w>
Cr ry</w>
Cr ry,</w>
Cox 's</w>
Cour se</w>
Coun ty,</w>
Coumad in-induced</w>
Cou mar
Cortico steroid</w>
Correc ted</w>
Cor relations</w>
Cor d</w>
Convul sant</w>
Contro versy</w>
Contro l-
Contra st-
Consequ ences</w>
Conner s'</w>
Condi tions</w>
Con stric
Con sti
Con stant</w>
Con sensus</w>
Con nectic
Con currently,</w>
Con ce
Compl iance</w>
Compl ain
Com pon
Col onic</w>
Col on
Coca ine-</w>
Co- trimox
Co oling</w>
Clozap ine-related</w>
Clozap ine,</w>
Clon idine,</w>
Clomi pramine-induced</w>
Clin icalTrials.gov,</w>
Cl- Kyn
Cl enbuterol</w>
Cl ).</w>
Cisplat in-based</w>
Cir cumst
Ciprofloxac in-associated</w>
Cinc innati</w>
Cin nam
Chromos ome</w>
Chol angiograms</w>
Cho ice</w>
Chlorpromaz ine-induced</w>
Chloro quine,</w>
Chlor methiazole</w>
Checkli st.</w>
Checkli st-
Cephalospor ins</w>
Cefotet an</w>
Ce fixime</w>
Cd A.</w>
Cc r</w>
Cc O</w>
Caud al</w>
Caucasi ans.</w>
Cau tious</w>
Catech olamines</w>
Catalep sy,</w>
Catal eptogenic</w>
Cat astrophic</w>
Carmofur -induced</w>
Cardio selective</w>
Carcin ogenesis</w>
Carbamazep ine,</w>
Car mustine</w>
Capsa ic
Cap sicum</w>
Cap illary</w>
Califor nia,</w>
Cal culated</w>
CaMKII alpha</w>
CaMK II</w>
CaCl(2)- untreated</w>
CaCl(2)- treated,</w>
CaCO 3</w>
Ca val
Ca stration</w>
Ca S</w>
Ca EDTA</w>
CZ P.</w>
CYP3A 4.</w>
CYP2D 6,</w>
CYP2C9 *
CYP2C8 *
CYP2C 19,</w>
CYP2 B
CYP 450</w>
CYP 4
CV- IBS</w>
CV VHD
CTR L</w>
CTR ;</w>
CT/ LC
CT LD</w>
CT -treated</w>
CT -1</w>
CSF- flow</w>
CSF P</w>
CS s)</w>
CS S
CS A,</w>
CS -treated</w>
CS ).</w>
CS ),</w>
CRE -mediated</w>
CR- VPA</w>
CR F2</w>
CR D</w>
CP-101, 60
CP- injected</w>
CP R</w>
CP M</w>
CP L</w>
CP K-MB</w>
CP K),</w>
CP /
COX- 2,</w>
CORM- 3</w>
CONTRO L</w>
CONTRO L-
CONCLUSION (S):</w>
CO PA</w>
CO 2-
CN I.</w>
CN ,</w>
CM N,</w>
CM L.</w>
CL IP</w>
CL C-
CLC- 2</w>
CK- ISOs</w>
CK .</w>
CK )</w>
CI-9 24</w>
CI-9 21</w>
CI ],</w>
CI S
CI H,</w>
CI ;</w>
CI -free</w>
CES- D,</w>
CE Z</w>
CE L)</w>
CD4 (+)</w>
CD34 +</w>
CD- 25</w>
CD P-
CD H</w>
CCNU -treated</w>
CCN U,</w>
CC r</w>
CC ).</w>
CBF hypercapnia</w>
CB(1) KO</w>
CB Z-
CB Z
CB C</w>
CB )</w>
CAP+ HS</w>
CA T.</w>
CA RT-
CA LGB</w>
CA E</w>
CA DASI
CA C</w>
CA B</w>
CA .
CA. OC</w>
CA -treated</w>
CA (F)</w>
C> T,</w>
C57Bl/ 10</w>
C57BL/6 N</w>
C57BL/10 ScSn</w>
C57B 1/
C3 d</w>
C/ I.</w>
C- sires</w>
C- MM</w>
C+ E</w>
C ymbopogon</w>
C res
C rataegus</w>
C p
C lobaz
C ity,</w>
C itrate</w>
C idofovir</w>
C hemic
C h</w>
C eti
C etam
C el</w>
C e</w>
C ats</w>
C ategor
C ann
C af
C W</w>
C U
C Q-treated</w>
C PA-
C NTF</w>
C MT.</w>
C ER
C Ch-induced</w>
C CSs</w>
C CAC</w>
C CA.</w>
C 57,</w>
C 4
C 2-
C -associated</w>
C -</w>
C '
But ea</w>
But ,</w>
Bus pirone,</w>
Bupren orphine,</w>
Bu ffered</w>
Bt x</w>
Brugada- ECG</w>
Bro mo
Brn-3 a</w>
Brit ain</w>
Bri monidine</w>
Bortezomib -induced</w>
Blo od-
Bimoclo mol</w>
Bic arbonate</w>
Bet ween-
Ber lin,</w>
Ben dectin</w>
Belgi um.</w>
Be at-to-beat</w>
Be agles.</w>
Bcl- 2.</w>
Bcl xL</w>
Batter y</w>
Barbit urate</w>
Balti more,</w>
Ballo on</w>
BX D</w>
BW W</w>
BW 37
BW37 3
BW373 U
BW ).</w>
BU O</w>
BT Z</w>
BT MPS</w>
BR M</w>
BR E</w>
BR -16
BR-16 A</w>
BP ]</w>
BP C.</w>
BMS-181 174</w>
BM Y-40
BM Y-14802</w>
BM PR2</w>
BM IP
BM I.</w>
BM C-treated</w>
BM +
BL-345 9,</w>
BL -10
BIP N.</w>
BH T-treated</w>
BF V</w>
BEAC OPP</w>
BD10 18,</w>
BD L.</w>
BD I</w>
BCNU -induced</w>
BCN U.</w>
BB- 94</w>
BALB/c J</w>
BACKGROUND/ PURPOSE:</w>
B6 D2F1</w>
B1 R</w>
B retylium</w>
B hmt2</w>
B ethes
B est</w>
B e</w>
B cr
B azet
B asic</w>
B am
B U-
B REM</w>
B PO
B MT,</w>
B E.</w>
B D.</w>
B CPT-P
B 12-
B 1-
Az idothymidine</w>
Az a</w>
Ay urvedic</w>
Ay urve
Aut ologous</w>
Aug mentin</w>
Au -induced</w>
Asc ending</w>
Arterio graphy</w>
Arter itis</w>
Arn old-
Aripiprazol e-induced</w>
Arg 10</w>
Arg -16</w>
Ara- C,</w>
Ara C.</w>
Ar menian</w>
Ar c</w>
Aqu e
Apr indine</w>
Apparen tly,</w>
Antine oplastic</w>
Anticoagul ants</w>
Anticoagul ant</w>
Antic ancer</w>
Anti tuberculosis</w>
Anti retroviral</w>
Anti parkinsonian</w>
Anti diuretic</w>
Anti cholinergics</w>
Anti E</w>
Anthrac ycline-induced</w>
Anthrac ycl
Anorex ia,</w>
Anesthesi ology,</w>
Anaphyl actoid</w>
Analo gue</w>
An nexin</w>
An imex</w>
An dro
An agreli
Amy g
Amphet amine,</w>
Amoxic illin</w>
Amoxic illin-induced</w>
Amon gst</w>
Amitript yl
Amisul pri
Amiodar one,</w>
Amino guanidine</w>
Amin opyridine</w>
Amik acin</w>
Americ a.</w>
Ameli orative</w>
Am ox
Am ount</w>
Alf uz
Aler tness/Sedation</w>
Alend ron
Al together</w>
Al le
Al fentan
Al chornea</w>
Al bendazole</w>
Aj maline</w>
Ag itation</w>
Ag es</w>
Ag ainst</w>
Afric a</w>
Aff inity</w>
Adul t,</w>
Adren ocortic
Adjust ment</w>
Adju sting</w>
Aden osis</w>
Ad renal</w>
Actu arial</w>
Acit retin</w>
Acet ate</w>
Acce pt
Ac tions</w>
Ac tin
Ac romegal
Ac ral</w>
Ac compan
Ac b</w>
Ac )</w>
Abstr act
Abstin ence</w>
Abeta- afferents</w>
AZT- exposed</w>
AZT ;</w>
AZ T)</w>
AZ M</w>
AV- nodal</w>
AV M.</w>
AUC (0-
AU C)</w>
ATP- ase</w>
ATP ase-
AT R</w>
AT 877</w>
ASI Cs</w>
ASA- sensitive</w>
ASA +MR-
ASA+MR- DP</w>
AS1892 802</w>
AS/ KS</w>
AS S</w>
ARB s.</w>
ARA- C</w>
AR s)</w>
AR B.</w>
AQP 1</w>
APO E</w>
APA P)</w>
AP- 5</w>
AP 7</w>
AP 3</w>
AN P)</w>
AN GPTL4</w>
AN -1
AMPH/ CDP-induced</w>
AM P),</w>
AM L,</w>
AM D
AM ),</w>
ALN+D28 00</w>
AL- IF</w>
AK-FLU OR</w>
AK BR</w>
AIM S/HYPOTHESIS:</w>
AI R)</w>
AI HA.</w>
AI EMs</w>
AI B</w>
AI AI</w>
AH S</w>
AH ),</w>
AGE s</w>
AF- TOC</w>
AF L.</w>
AF B1-
AER s,</w>
AED ,</w>
ADR-E NA</w>
ADR- injected</w>
ADR- CM</w>
ADR+ LOS
ADR s,</w>
ADP/ O</w>
ADP/ ATP</w>
ADOR A2A</w>
ADAM -17</w>
ADAM -10</w>
AD V/LAM</w>
AD V.</w>
AD P-induced</w>
AD L</w>
AD H-
ACTH- Z</w>
ACPT -I</w>
ACPT -1</w>
AC(-O Ho
AC TI
AC S.</w>
AC R-induced</w>
AC M</w>
ABT- 431</w>
AB LC</w>
AB A</w>
AA PD
AA F,</w>
A/ a</w>
A-8 69
A- selective</w>
A(2 a)</w>
A void
A tom
A side</w>
A sia,</w>
A s.</w>
A rom
A rea</w>
A pri
A neur
A kinetic</w>
A dams</w>
A dam
A Y-23,028</w>
A X.</w>
A X-
A VT</w>
A II-A</w>
A ECA</w>
A A/
A 2780</w>
A 1-receptor</w>
A 1-
>or= 2</w>
> 90</w>
> 60</w>
> 20</w>
> 200</w>
> 2.5</w>
> 100</w>
=.0 2),</w>
= 70</w>
= 5</w>
= 4.
= 1.4</w>
= .001).</w>
< 80</w>
< 200</w>
< 1</w>
< 12</w>
< 1%</w>
< 0.001,</w>
< 0.0001).</w>
< .0001),</w>
: P</w>
99mTc- MAG
99m Tc
99 9/
99 %).</w>
95% CI:</w>
90- day-old</w>
90 Y-
90 ;</w>
90 ),</w>
90 %).</w>
9. 8)</w>
9. 7)</w>
9. 7%</w>
9. 38</w>
9. 3%</w>
9-1 3</w>
9- wk</w>
9- di
9- cis-RA</w>
9- TH
9- 3.
9 8).</w>
9 7;</w>
9 7.</w>
9 7,</w>
9 5th</w>
9 5-
9 5+/-
9 5%,</w>
9 4.</w>
9 4,</w>
9 4).</w>
9 3-
9 3)</w>
9 2;</w>
9 20,</w>
9 18</w>
9 1).</w>
9 1),</w>
9 )
88 4,</w>
86 %),</w>
80 6</w>
80 -induced</w>
8. 7)</w>
8. 1%</w>
8. 0;</w>
8-cyclopentyl-1,3-dipropyl xanthine</w>
8-OH-DPA T.</w>
8-OH dG</w>
8-1 4</w>
8-1 2)</w>
8- month</w>
8- day-old</w>
8- 9</w>
8- 35</w>
8- ,</w>
8, 9-
8, 5
8 ]</w>
8 :00</w>
8 80</w>
8 8%),</w>
8 7,</w>
8 6-year-old</w>
8 5,</w>
8 5),</w>
8 5%.</w>
8 3).</w>
8 25</w>
8 2.4%</w>
8 2)</w>
8 2
8 1,</w>
8 00/
8 -1.
8 +</w>
8 +/-1
78 ;</w>
714 2.</w>
70- 80%</w>
70 1</w>
70 .</w>
70 ).</w>
70 %).</w>
7/ 8</w>
7/ 7/7</w>
7.5- 75</w>
7. 9%</w>
7. 6,</w>
7. 6),</w>
7. 5)</w>
7. 4%</w>
7. 2+/-
7-chloro kynurenic</w>
7-OH- MTX</w>
7-F 6-
7- hydroxy-2-acetylaminofluorene</w>
7- hydroxy
7- chloro-
7- Cl-Kyn
7- 2
7- (4-
7, 12-dimethylbenz
7 ].</w>
7 99</w>
7 92</w>
7 9).</w>
7 8,</w>
7 8).</w>
7 70</w>
7 7-
7 7%,</w>
7 5.</w>
7 5%)</w>
7 48</w>
7 46</w>
7 4-
7 4).</w>
7 30</w>
7 3.5%</w>
7 3,</w>
7 3%,</w>
7 2h</w>
7 28</w>
7 20</w>
7 2-hour</w>
7 2-h</w>
7 2,</w>
7 19
7 1.4</w>
7 1+/-
7 1%.</w>
7 0.1</w>
69 ]</w>
69 76</w>
69 %,</w>
69 %).</w>
67. 3%</w>
67 +/-
63 5.</w>
61- yr-old</w>
60- 75</w>
60- 70</w>
60- 0
60 9</w>
60 -</w>
60 -100</w>
6. 9)</w>
6. 8
6. 7
6. 4)</w>
6-keto-PGF (1
6-keto-PGF(1 alpha)</w>
6-hydroxydopamine- lesioned</w>
6-hydroxy dopamine,</w>
6-OHD A,</w>
6- months</w>
6- mg</w>
6- hr</w>
6- [
6- Thioguanine</w>
6- TG
6- (N-
6, 6-tetramethyl
6 9.8</w>
6 9-
6 75</w>
6 6,</w>
6 59</w>
6 47</w>
6 4.5</w>
6 4,</w>
6 4)</w>
6 3),</w>
6 26</w>
6 25,</w>
6 22</w>
6 19</w>
6 15</w>
6 14
6 12</w>
6 10</w>
6 1).</w>
6 -10</w>
6 ,000</w>
6 )-induced</w>
6 %-
59 1</w>
59 ).</w>
58 9</w>
58 8</w>
57 +/-
57 ),</w>
57 %;</w>
56 C</w>
56 /
55212- 2</w>
55- 65</w>
55,212- 2,</w>
55 %),</w>
54 %.</w>
5246 6.</w>
5246 6,</w>
51 Cr
500- 600</w>
50- 55</w>
50- 400</w>
50 :</w>
50 -</w>
50 -100</w>
50 -1000</w>
50 's.</w>
5. 9%</w>
5. 8).</w>
5. 7%,</w>
5. 3%</w>
5. 3
5-methoxy tryptoline</w>
5-hydroxytryptoph an-induced</w>
5-hydroxytrypt aminergic</w>
5-hydroxy indole</w>
5-fluorourac il-based</w>
5-azacy tidine.</w>
5-az acitidine</w>
5-HT-1 A</w>
5-HT(1A)- receptors</w>
5-HT(1 B)
5-HT T</w>
5-HT )</w>
5-H PQ</w>
5-H P
5-FU/ FA</w>
5-FU- based</w>
5-F(2t)- Iso
5-CHO- THF</w>
5-Az acytidine</w>
5-Az C</w>
5- mg/kg</w>
5- dimethyl
5- 5.
5- 2.
5- (3-
5,6, 7,8-
5) S]
5'-O-(2-thiodiphosph ate),</w>
5'- dideoxy
5 c</w>
5 SCD</w>
5 FU.</w>
5 :</w>
5 8.3</w>
5 72</w>
5 7.7</w>
5 67</w>
5 55</w>
5 5).</w>
5 4;</w>
5 4.5</w>
5 38
5 36</w>
5 3.2</w>
5 3).</w>
5 3),</w>
5 28</w>
5 23</w>
5 20</w>
5 2.</w>
5 2%.</w>
5 2%)</w>
5 10</w>
5 1.
5 1%,</w>
5 0.0%</w>
5 -100</w>
5 '</w>
49 -induced</w>
48 A</w>
48 .</w>
48 %).</w>
47. 3%</w>
47 %.</w>
46 5)</w>
46 %.</w>
45 6</w>
45 %.</w>
45 %).</w>
44 +/-
43- kd</w>
42. 8%</w>
400- 500</w>
400 /
40- micrograms/kg</w>
40- 50%</w>
40- 380</w>
40 7</w>
40 5</w>
40 2</w>
40 %;</w>
40 %),</w>
4.0 5</w>
4. 8,</w>
4. 6;</w>
4. 6+/-
4. 5,</w>
4. 5%,</w>
4. 4.</w>
4. 4%.</w>
4. 2;</w>
4. 2+/-
4. 14</w>
4. 1).</w>
4-hydroxy glutethimide</w>
4-4 60
4-1 99
4- hydroxy</w>
4- diphenylacetoxy-N-methylpiperidine</w>
4- Aminopyridine</w>
4- 4.
4,5, 6,7-
4, 7
4, 4
4'-iodo- 4'-
4'- epidoxorubicin</w>
4'- deoxy-
4'- 0-
4'-0- tetrahydropyranyl
4 h</w>
4 ];</w>
4 C]
4 ;
4 95</w>
4 9%,</w>
4 8.3</w>
4 75</w>
4 74</w>
4 7.4</w>
4 7+/-
4 6;</w>
4 69</w>
4 63</w>
4 6.5</w>
4 54</w>
4 500</w>
4 5.2</w>
4 49</w>
4 45</w>
4 41</w>
4 33</w>
4 3.3</w>
4 3.2</w>
4 3.1</w>
4 20,</w>
4 15</w>
4 13</w>
4 12</w>
4 12
4 1.7</w>
4 1.7%</w>
4 1.5</w>
4 1.4</w>
4 00-mg</w>
4 0.5</w>
4 %-
39. 2%</w>
39 ;</w>
39 5</w>
39 %;</w>
39 %).</w>
38. 2%</w>
38 8,</w>
38 ),</w>
38 %;</w>
378 49-induced</w>
37. 8</w>
37. 7</w>
37. 4</w>
37. 4%</w>
37. 3</w>
37. 1</w>
37 1</w>
37 0.</w>
37 0
37 %),</w>
36. 9</w>
36. 6</w>
36- yr-old</w>
36 4</w>
36 1</w>
36 /
36 .</w>
35 6</w>
35 1</w>
34 34
34 3-
315 40</w>
3036 6,</w>
300 0,</w>
300 /
30- 45</w>
30 s</w>
30 :</w>
30 4</w>
3/ 6</w>
3. 92</w>
3. 9-
3. 9).</w>
3. 8-
3. 8,</w>
3. 8%;</w>
3. 78</w>
3. 67</w>
3. 6-
3. 6)</w>
3. 5;</w>
3. 21</w>
3. 13,</w>
3. 1)</w>
3-methylchol anthrene</w>
3-methyl xanthine</w>
3- wk</w>
3- way</w>
3- monthly</w>
3- min</w>
3- kinase</w>
3- hr</w>
3- [(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine</w>
3- NP</w>
3- NP
3- ,</w>
3- (4-
3- (2-
3,7-disulf ate</w>
3,4- dicarboxy
3,3- diphenylpyrrolidin-2-one</w>
3, 20-
3, 000/
3, 00
3'- deamino-
3'- (2-
3 r
3 alpha-hydroxy-
3 alpha,</w>
3 ].</w>
3 OMD</w>
3 6.5</w>
3 54</w>
3 5-year</w>
3 49</w>
3 47</w>
3 46</w>
3 40-380</w>
3 4%)</w>
3 3;</w>
3 39</w>
3 3/
3 3.</w>
3 3.0</w>
3 21</w>
3 2.</w>
3 2.1</w>
3 2%;</w>
3 2%.</w>
3 19</w>
3 16</w>
3 15</w>
3 1.2</w>
3 0.4</w>
3 0.4%</w>
3 -16</w>
3 -100</w>
3 -10
2n d,</w>
2D 6.</w>
29 th</w>
29 ,
28. 8</w>
28. 3</w>
28 1</w>
27. 5%</w>
27. 0</w>
27 4</w>
27 3,</w>
27 1</w>
27 ,
26. 5%</w>
26. 4</w>
26. 2%</w>
26. 1</w>
26 6</w>
26 30
26 ,2
26,2 7-F6-
26 %;</w>
26 %),</w>
25. 4</w>
25. 2</w>
25- year</w>
25- 35</w>
25 ,000</w>
25 );</w>
25 %).</w>
24/ 76</w>
24. 4</w>
24. 3%</w>
24- month</w>
24- dihydroxyvitamin</w>
24,25- (OH)2D
24 h,</w>
24 OXO-16ene
24 %;</w>
23. 8</w>
23. 5%</w>
23. 3%</w>
23- month-old</w>
23 2,</w>
23 ,000</w>
23 %.</w>
23 %).</w>
22. 2%</w>
214 20</w>
21. 7%</w>
21. 6%</w>
21 days</w>
201-99 5</w>
200- mg</w>
200 5);</w>
200 4;
200 4)</w>
200 ,000</w>
20/ 20</w>
20/ 200</w>
20- hydroxyeicosatetraenoic</w>
20- gauge</w>
20- 40%</w>
20 7
20 %).</w>
2/ 57
2/ 1</w>
2.8 %;</w>
2.5- 20</w>
2.5 %;</w>
2.0 9</w>
2.0 8</w>
2.0 4</w>
2.0 .</w>
2. 90</w>
2. 9)</w>
2. 9%</w>
2. 85</w>
2. 8-fold</w>
2. 64</w>
2. 61</w>
2. 5%,</w>
2. 5%)</w>
2. 4-fold</w>
2. 4-
2. 3;</w>
2. 39</w>
2. 29</w>
2. 2),</w>
2. 11</w>
2. 0)</w>
2-methyl-6-(phenylethyn yl)-pyridine</w>
2-chloroprocaine- CE</w>
2-amino-7-phosphonoheptano ate</w>
2-amino-5-phosphono valeric</w>
2-amino-5- phosphonopentanoic</w>
2-1 6</w>
2- yr</w>
2- yr-old</w>
2- receptors</w>
2- phenylamino
2- microglobulin</w>
2- mg</w>
2- hydroxy-
2- bromo
2- [4-
2- CP</w>
2- Br-
2- APH,</w>
2- AAF,</w>
2- 2.5</w>
2- (p-
2-(p- bromophenyl)
2- (2-
2,3- quinoxaline
2,3- benzodiazepine</w>
2,3- benzodiazep
2,3,4,5- tetrahydro-1H-3-benz
2,3, 5-
2,2,2- trifluoroethane</w>
2,2, 6,6-tetramethyl
2, 6-
2, 2-
2, 0
2+ ,</w>
2) IgG-saporin</w>
2', 5'-dideoxy
2 S</w>
2 R</w>
2 R,4R-
2 PAM</w>
2 K1C-
2 DG</w>
2 :00</w>
2 80
2 3.5</w>
2 2nd</w>
2 2;</w>
2 25,</w>
2 20,</w>
2 2.9</w>
2 1:
2 1.0</w>
2 1%),</w>
2 0.6%,</w>
2 -10</w>
2 %]</w>
2 %-
1A- adrenoceptor</w>
1: 1000</w>
1: 100,00
1991-1 99
199 1.</w>
199 0-199
1980 s</w>
1980 s.</w>
1980 .</w>
198 2.</w>
198 1</w>
198 1.</w>
198 1,</w>
197 7.</w>
19. 7</w>
19. 2%</w>
19- NTPP</w>
19 60</w>
19 6)</w>
19 -</w>
180- minute</w>
18. 8%</w>
18. 6</w>
18- yr-old</w>
18- h</w>
18 th</w>
18 F-
18 :
18 81</w>
18 25
18 0/
18 ,
17beta- estradiol,</w>
17beta- Estradiol</w>
17. 9</w>
17. 4</w>
17. 2%</w>
17. 1%</w>
17 p11.
17 %)</w>
16. 1</w>
16. 1%</w>
16- fold</w>
16- 2
16 0/
16 0,</w>
1555 A</w>
150 /
15/ 44</w>
15. 8%</w>
15. 5,</w>
15. 3%</w>
15. 2%,</w>
15. 1</w>
15-45 13,</w>
15- month</w>
15- fold</w>
15- ,</w>
15 7,</w>
15 56C</w>
15 4
15 13</w>
15 00/
15 %.</w>
1429 48A</w>
14. 7</w>
14. 0
14- 21</w>
14 5,</w>
14 45
14 00
14 0.</w>
14 0)</w>
14 +/-
14 %).</w>
14 %),</w>
133 X
13. 3%</w>
13- cis</w>
13- cis-
13 92</w>
13 2.6</w>
13 %;</w>
13 %).</w>
125 48
120- mg</w>
120 4</w>
12. 9%</w>
12. 2%</w>
12. 0%</w>
12- week-old</w>
12- month-old</w>
12- day</w>
12 909</w>
12 6,</w>
12 3)</w>
12 );</w>
12 %;</w>
12 %)</w>
11. 9%</w>
11. 5,</w>
11. 3%</w>
11. 2%</w>
11-dehydro -
11- fold</w>
11- deoxycortisol</w>
11 beta-HSD</w>
11 -13</w>
11 -1
11 +/-1
11 %).</w>
107 18</w>
100 6
100 0/
100 0-1
100 0-
100 /
100 -150</w>
100 -1
100 %;</w>
10.0 %</w>
10. 6%</w>
10-1 9</w>
10- second</w>
10- month-old</w>
10- 50</w>
10- 40</w>
10- ,</w>
10(9)/ L).</w>
10(3)/ mm3</w>
10(3)/ mm3.</w>
10(3)/ microL</w>
10(-1 0)</w>
10 :
10 7,</w>
10 50</w>
10 4)</w>
10 139</w>
10 1,</w>
10 1),</w>
10 0.0</w>
10 +/-
10 (8)</w>
10 (4)</w>
10 (10)</w>
10 %),</w>
1/ epsilon</w>
1/ 2/
1.7 3%</w>
1.5 %;</w>
1.4 +/-
1.3- 5.
1.1- 8.
1.1- 5.
1.1- 3.
1.0- 5.
1.0 9-1.
1.0 6-1.
1.0 2-
1.0 2,</w>
1.0 .</w>
1.0 )</w>
1.0 ).</w>
1.0 %,</w>
1. 9;</w>
1. 99</w>
1. 98</w>
1. 93</w>
1. 90</w>
1. 9%;</w>
1. 8;</w>
1. 76</w>
1. 66</w>
1. 63</w>
1. 60</w>
1. 6).</w>
1. 46</w>
1. 40</w>
1. 37</w>
1. 33</w>
1. 32</w>
1. 3+/-
1. 26,</w>
1. 2%;</w>
1. 2%,</w>
1. 16-
1. 11-
1. 1%,</w>
1. 1%)</w>
1-{3- [4-(2-
1-methyl-4-phenyl-1,2,3,6-tetrahydropyrid ine-treated</w>
1-methyl-4- phenyl
1-methyl uric</w>
1-1 4,</w>
1- immunopositive</w>
1- amino-5-bromouracil</w>
1- adrenoceptors</w>
1- 8
1- 4
1- 30</w>
1- 2%</w>
1,3- DM
1,25-(OH)2- 24OXO-16ene
1,25-(OH)2 -16ene
1,25(OH)2D 3-induced</w>
1,25(OH)2 D</w>
1,25(OH)2 -16ene-23
1,25(OH)(2) D(3)</w>
1,24-(OH)(2) D(3)</w>
1,2- dimethyl
1,0 22</w>
1, 350</w>
1, 24-dihydroxyvitamin</w>
1, 2,3,4,
1, 000,000</w>
1 x</w>
1 b/
1 a,</w>
1 C</w>
1 A,</w>
1 ;
1 50%</w>
1 18)</w>
1 17
1 14)</w>
1 10,</w>
1 1%)</w>
1 )-induced</w>
1 (I)</w>
1 %]</w>
1 %/
1 %-
00 ;</w>
00 0)</w>
00 0).</w>
00 ),</w>
0.9 9).</w>
0.9 8)</w>
0.9 7).</w>
0.9 3;</w>
0.9 3)</w>
0.9 2,</w>
0.9 0.</w>
0.9 0,</w>
0.9 .</w>
0.8 7)</w>
0.8 2+/-
0.8 2).</w>
0.8 0,</w>
0.8 ).</w>
0.7 5%.</w>
0.7 5%,</w>
0.7 1</w>
0.6 8,</w>
0.6 7</w>
0.6 5;</w>
0.6 50</w>
0.6 4)</w>
0.6 ).</w>
0.5- 2.0</w>
0.5- 1</w>
0.5 8;</w>
0.5 7,</w>
0.5 6-1.
0.5 6,</w>
0.5 3,</w>
0.5 2,</w>
0.5 %).</w>
0.5 %),</w>
0.4 7,</w>
0.4 5)</w>
0.4 5%</w>
0.4 1)</w>
0.4 1).</w>
0.4 %),</w>
0.3- 3</w>
0.3 4)</w>
0.2 7,</w>
0.2 6,</w>
0.2 3,</w>
0.2 2).</w>
0.06 25</w>
0.05 ]</w>
0.04 9)</w>
0.03 5).</w>
0.03 4).</w>
0.03 1)</w>
0.014- unit</w>
0.01 ].</w>
0.000 7)</w>
0.000 5,</w>
0.000 2),</w>
0.000 1);</w>
0.00 7),</w>
0.00 5;</w>
0.00 25).</w>
0.00 2);</w>
0.00 12).</w>
0.0 9-
0.0 9,</w>
0.0 9)</w>
0.0 8-
0.0 8),</w>
0.0 7,</w>
0.0 6%</w>
0.0 4;</w>
0.0 3;</w>
0.0 39).</w>
0.0 36).</w>
0.0 31</w>
0.0 30</w>
0.0 3%,</w>
0.0 29,</w>
0.0 27</w>
0.0 19</w>
0.0 16)</w>
0.0 15),</w>
0. 80
0. 5)</w>
0. 4)</w>
0. 300</w>
0. 2;</w>
0. 29
0. 25;</w>
0. 25
0. 2%,</w>
0. 1;</w>
0. 15
0. 14).</w>
0. 125,</w>
0. 11).</w>
0- 7</w>
0- 5.
0 :</w>
0 2,</w>
0 19</w>
0 %-
/d tmax</w>
/d t</w>
/d l.</w>
/ kg)</w>
/ g</w>
/ day)</w>
/ AT</w>
/ +</w>
.00 5),</w>
.00 4),</w>
.00 1);</w>
.0 28).</w>
.0 1;</w>
. A</w>
. 7</w>
. 6.</w>
-2 4%</w>
-1H- pyrazole-3-carboxamide
-19- nor-
-16- ene-23-
-10 ,000</w>
-1. 9</w>
-1. 1</w>
-1- nitrosourea</w>
-1- mediated</w>
-1- [2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]non
-1,2-bis(3, 5-di
-1, 3,4-
-1 K-
-1 98
-1 8-
-1 3)</w>
-1 16</w>
-1 13
-1 1-
-1 .0
-- with</w>
-- are</w>
- ph
- made</w>
- domain</w>
- dP/dt</w>
- aspartate</w>
- administered</w>
- Fanconi</w>
- DX
- 9</w>
- 5.
- 40</w>
- 4.
- 30</w>
- 25.
- 0.9</w>
,000/ micro
,00 0-
,00 0).</w>
, 593</w>
+/- 3</w>
+/ T</w>
+/ +)</w>
+ LD</w>
+ H
+ B
* NO</w>
)dt/ B(t
)/ kg</w>
)-- and</w>
)- stimulated</w>
)- immunopositive</w>
)- amisulpride</w>
) R</w>
) 2</w>
) -1,</w>
(vehicle ),</w>
(t PA),</w>
(t 1/2)</w>
(s gk1
(rh o</w>
(r t-PA)</w>
(r -
(r )</w>
(p=0.0 4)</w>
(p=0.0 4
(p< or=
(p< 0.001</w>
(p ut
(p H
(p GT</w>
(p ANCA)</w>
(p A2</w>
(nACh R)</w>
(n= 6,</w>
(n= 24
(n= 22)</w>
(n= 16
(n= 13
(median =
(mca )</w>
(mGlu R)</w>
(m TOR)</w>
(m Ab)</w>
(m ACh
(iox aglate</w>
(iNO S),</w>
(i.c.v .).</w>
(i. d.)</w>
(i ))</w>
(gamma- GT)</w>
(f )</w>
(doxorubic in)</w>
(didanos ine;</w>
(dd C).</w>
(d Tc)</w>
(control );</w>
(control ).</w>
(c) O(2))</w>
(c ure</w>
(adriamyc in)</w>
([Ca2+] i)</w>
(ZD V)</w>
(Y MDD)</w>
(X eloda
(X O),</w>
(WK Y),</w>
(WH I)</w>
(W e
(W M)</w>
(W -
(VOD ).</w>
(VL BW)</w>
(VE )</w>
(V TA)</w>
(V PA</w>
(V LD
(V IP)</w>
(V DS)</w>
(V CR)</w>
(V A)</w>
(U LN)</w>
(U F
(Tx B2)</w>
(TUNE L</w>
(TUNE L)</w>
(TTP/ HUS)</w>
(TT P-
(TNF- alpha),</w>
(TN F)</w>
(TMP /SM
(TM S)</w>
(TI DA)</w>
(TH C)</w>
(TGF-beta 1)</w>
(TGF-beta )</w>
(TE M)</w>
(TD R)</w>
(TCD D)</w>
(TBAR S),</w>
(TB I)</w>
(TB I).</w>
(T ri
(T ren
(T r
(T n
(T alw
(T able</w>
(T UR
(T TP).</w>
(T P)</w>
(T G
(T EE)</w>
(T D).</w>
(T BP
(T AC)</w>
(T 3
(T +
(T ),</w>
(Spear man</w>
(ST Z)-
(ST A)</w>
(SN R)</w>
(SN P,</w>
(SN P),</w>
(SK F</w>
(SIAD H),</w>
(SHR s)</w>
(S)- 2-
(S yn
(S ig
(S h
(S el
(S ando
(S Z)</w>
(S W)</w>
(S VR
(S OD</w>
(S G)</w>
(S CI
(S AH).</w>
(S .
(S (c)O(2))</w>
(R,S)-AM12 41</w>
(R,S)- 3,4-DCPG</w>
(R)- alpha-methylhistamine</w>
(R oc
(R o</w>
(R o
(R S)-1-aminoindan-1,5-dicarboxylic</w>
(R S)-
(R IA)</w>
(R I
(R G
(R CA)</w>
(R AMP
(Qo L)</w>
(PV R)</w>
(PV Cs)</w>
(PV ),</w>
(PTH ),</w>
(PT X).</w>
(PT X),</w>
(PT SD)</w>
(PP H)</w>
(PP E)</w>
(PO G)</w>
(PN D</w>
(PN D)</w>
(PL D)</w>
(PK C)</w>
(PI SE).</w>
(PH A-
(PF S),</w>
(PEF R)</w>
(PE G)-
(PE ).</w>
(PD A)</w>
(PCP ).</w>
(PC PA)</w>
(PC NA).</w>
(PC E)</w>
(PB N)</w>
(PAN ,</w>
(PA H)</w>
(PA F)</w>
(P=0.0 2).</w>
(P=0.0 2),</w>
(P= .
(P< 0.01,</w>
(P< 0.0
(P< .001)</w>
(P- gp)</w>
(P osm</w>
(P l
(P ir
(P arkinson's</w>
(P UFA)</w>
(P SA),</w>
(P RO
(P PI
(P PAR
(P PA
(P M)</w>
(P M),</w>
(P L)</w>
(P IP
(P IIIN
(P I</w>
(P HT),</w>
(P G),</w>
(P EP/LVET)</w>
(P CT
(P CP),</w>
(P BM
(P AN</w>
(P AI
(P >
(P 400
(P ).</w>
(OX C)</w>
(OV X+CHR
(OCT ),</w>
(O m
(O S),</w>
(O R),</w>
(O LT).</w>
(O H)</w>
(O E
(O AB)</w>
(O A)</w>
(O -
(Na velb
(NT G
(NT E)</w>
(NT D)</w>
(NSAID ),</w>
(NMD A</w>
(NMD A,</w>
(NM S),</w>
(ND I).</w>
(NA PA)</w>
(N O</w>
(N MBAs)</w>
(N IC)</w>
(N F-kappa
(N AS)</w>
(N AC),</w>
(N 2
(N ).</w>
(Mg SO
(MVO 2)</w>
(MTX )-induced</w>
(MT X),</w>
(MR I),</w>
(MPO- ANCA)</w>
(MPO ).</w>
(MMP- 9)</w>
(MD MA</w>
(MCA O)</w>
(MC T)</w>
(MC E)</w>
(MAO I)</w>
(MADR S),</w>
(MA O-
(M SA)</w>
(M S).</w>
(M PA</w>
(M NNG)</w>
(M K
(M IB
(M G)</w>
(M CT
(M B)</w>
(M -
(M )</w>
(Li Cl)</w>
(LY 16
(LVE F).</w>
(LV F
(LV ),</w>
(LHR H)</w>
(LE V)</w>
(LDL- C)</w>
(L-N MMA
(L V</w>
(L SE
(L PO)</w>
(L P),</w>
(L Na+
(L EV
(L AM)</w>
(L AM
(L AB
(L 6-
(L /
(K i</w>
(K Cl)</w>
(K A)</w>
(K +)</w>
(K (ATP
(K(ATP ))</w>
(IV- rhHGF</w>
(ISO ).</w>
(ISO ),</w>
(IR :</w>
(IO P),</w>
(IL )-1
(IF X)</w>
(IC P).</w>
(IC I)</w>
(IB D)</w>
(I. P)</w>
(I so
(I OP
(I NR
(I HA)</w>
(I GF-
(I E
(I CAM
(HR T)</w>
(HR )=
(HO E</w>
(HIV -1)</w>
(HIT ).</w>
(HD L-
(HCF C</w>
(HCC s)</w>
(HAM- D)</w>
(H y
(H e
(H PS)</w>
(H Cl)</w>
(H CV
(GnR H)</w>
(GV HD)</w>
(GV HD).</w>
(GSH P
(GABA) (A)</w>
(GABA(A ))</w>
(GABA ).</w>
(GABA ),</w>
(G6 PD</w>
(G- CSF).</w>
(G lasgow</w>
(G d-
(G Y
(G R
(G O
(G M)</w>
(G HB)</w>
(G F)</w>
(G C-
(G AM
(Fos -
(FS GS).</w>
(FL AIR)</w>
(FK50 6).</w>
(FF A)</w>
(F ig
(F e
(F UDR)</w>
(F SH)</w>
(F S),</w>
(F R)</w>
(F HR)</w>
(Estr acy
(Em blica</w>
(EX CEL)</w>
(EX :</w>
(ESR D),</w>
(ERP s)</w>
(ER K)</w>
(EP R)</w>
(EP I)</w>
(EE )-induced</w>
(ED(50) =</w>
(E po)</w>
(E po
(E pi)</w>
(E S)</w>
(E R</w>
(E O)</w>
(E A)</w>
(E (2)17
(Diazemul s)</w>
(Dex )-induced</w>
(Delta 9-TH
(DOPAC ),</w>
(DO CA)</w>
(DH A)</w>
(DF P),</w>
(DE SAD)</w>
(DE S),</w>
(DA 1)</w>
(D ec
(D X)</w>
(D PD)</w>
(D N)</w>
(D MB
(D IC),</w>
(D EC)</w>
(D CM)</w>
(D AT
(D 2)</w>
(Cs A)-
(Cs A),</w>
(Co omb
(Ch AT)</w>
(Ca Cl
(CYP2 D
(CV R)</w>
(CR ;</w>
(CP u)</w>
(CO MT)</w>
(CNI )-based</w>
(CL O
(CL L)</w>
(CK- MB),</w>
(CH EOP
(CG P</w>
(CE I)</w>
(CBD CA)</w>
(CB F).</w>
(CB 1
(CB ),</w>
(CA P)</w>
(C57B L/
(C or
(C on
(C max)</w>
(C V)</w>
(C PD
(C PA),</w>
(C P),</w>
(C N)</w>
(C IN)</w>
(C H)</w>
(C G)</w>
(C CO-
(C CNU
(C CA)</w>
(C AL
(C /
(BoNT/ A)</w>
(BZ D)</w>
(BT X)</w>
(BPR S),</w>
(BF U-E)</w>
(BBB ).</w>
(BA EPs)</w>
(B rom
(B otox
(B W)</w>
(B S
(B RS)</w>
(B PH).</w>
(B PA
(B MI),</w>
(B M)</w>
(B IS)</w>
(B I
(B A)</w>
(An g
(Al lium</w>
(AZ T)-induced</w>
(AUC ),</w>
(AQP 2)</w>
(APA P),</w>
(AOA A),</w>
(ANOV A)</w>
(AN G</w>
(AM L).</w>
(AL LH
(AL L),</w>
(AK I)</w>
(AID S).</w>
(AI r</w>
(AE s).</w>
(ADR ).</w>
(AD L)</w>
(AC T)</w>
(A- V)</w>
(A rfonad
(A TIN)</w>
(A SP
(A P),</w>
(A M)</w>
(A IN).</w>
(A II)</w>
(A H)</w>
(A GE
(A FB
(A AP)</w>
(A /
(>/ =</w>
(> or=</w>
(> 3</w>
(> 1</w>
(< 12</w>
(99m Tc-
(97. 3%),</w>
(95% CI</w>
(9. 0</w>
(9 9.
(9 8</w>
(9 8%)</w>
(9 7</w>
(9 6.
(9 6%</w>
(9 3</w>
(9 3.
(9 00</w>
(9 0%).</w>
(9 -1
(8S, 15S)-diHETE</w>
(8R, 15S)-diHETE</w>
(8. 1%)</w>
(8. 0%</w>
(8- S
(8 8%).</w>
(8 8%),</w>
(8 7</w>
(8 6</w>
(8 6%</w>
(8 5.
(8 5%</w>
(8 5%).</w>
(8 5%),</w>
(8 2</w>
(8 25</w>
(8 2%).</w>
(8 1%).</w>
(8 00
(7. 8</w>
(7. 8%)</w>
(7. 5%)</w>
(7. 4</w>
(7. 4%),</w>
(7. 2%)</w>
(7- NI;</w>
(7 8%),</w>
(7 5.9</w>
(7 5%).</w>
(7 5%),</w>
(7 1%).</w>
(7 ,</w>
(7 %).</w>
(66. 7%)</w>
(6. 9</w>
(6. 9%)</w>
(6. 5</w>
(6. 4</w>
(6 9</w>
(6 8%).</w>
(6 7%).</w>
(6 6%),</w>
(6 3.
(6 2%</w>
(6 1%).</w>
(6 ,</w>
(50 00</w>
(5. 9</w>
(5. 8%</w>
(5. 8%)</w>
(5. 5%)</w>
(5. 3%)</w>
(5. 2</w>
(5 mg/kg,</w>
(5 9%</w>
(5 9%).</w>
(5 7%),</w>
(5 6%</w>
(5 5%</w>
(5 4%).</w>
(5 3-
(5 2%</w>
(5 2%).</w>
(5 '-
(46. 4%)</w>
(40- 60</w>
(4.0- 8.0</w>
(4. 9</w>
(4-chloro phenyl)-1-
(4-aminophenyl)-4-methyl-7,8- methylenedioxy-5H-
(4- 5</w>
(4'- fluorophenyl)
(4 8%),</w>
(4 6%</w>
(4 50</w>
(4 5-
(4 4%),</w>
(4 0%).</w>
(4 0%),</w>
(4 ).</w>
(35. 7%)</w>
(30- 90</w>
(30 -100</w>
(3. 4</w>
(3. 45</w>
(3-chloro styr
(3- M
(3- 5</w>
(3, 5-
(3)H- MK-801</w>
(3 H)-
(3 8%),</w>
(3 7%).</w>
(3 4%</w>
(3 3.3</w>
(3 1%</w>
(3 00-
(3 00
(3 0)</w>
(27. 5%)</w>
(25- 200</w>
(200- 400</w>
(200 2)</w>
(20- 80</w>
(2. 9%)</w>
(2. 85</w>
(2. 8%)</w>
(2. 5-10</w>
(2. 4%</w>
(2-mercapto ethane</w>
(2-chloroethyl)-1- nitrosoure
(2-Cd A)</w>
(2- hydroxy-3-
(2- fold</w>
(2- 6</w>
(2, 4-dichloro
(2, 4,6-
(2 mg/kg,</w>
(2 R,4R)-
(2 9%</w>
(2 9%),</w>
(2 8%</w>
(2 6%;</w>
(2 50,</w>
(2 )-induced</w>
(2 '-
(1966- January</w>
(19 80</w>
(19 80-
(19 2)IgG-saporin</w>
(18. 6%)</w>
(17. 5%)</w>
(16. 4</w>
(16. 1%),</w>
(150- 200</w>
(14. 1%),</w>
(12. 5-25</w>
(12. 5,</w>
(11. 7%)</w>
(100- 400</w>
(100 mg/kg,</w>
(100 0-1
(100 -150</w>
(100 %,</w>
(10. 5%)</w>
(10(- 8)</w>
(10(- 4)</w>
(10(- 3)</w>
(10 mg/kg)</w>
(10 9</w>
(10 5</w>
(10 -1
(10 %,</w>
(1. 8%)</w>
(1. 5%</w>
(1. 4
(1. 17
(1. 15</w>
(1. 1)</w>
(1. 1%).</w>
(1- 8</w>
(1- 7
(1- 6</w>
(1- 50</w>
(1, 25
(1, 200</w>
(1, 2-
(1) H-
(1 S,3
(1 92</w>
(1 9%</w>
(1 78</w>
(1 74</w>
(1 65</w>
(1 6.7</w>
(1 6-1
(1 6%</w>
(1 56</w>
(1 5.5</w>
(1 5%</w>
(1 5%,</w>
(1 33</w>
(1 27</w>
(1 26</w>
(1 21</w>
(1 200</w>
(1 2.1</w>
(1 19</w>
(1 11</w>
(1 1.8</w>
(1 1.6</w>
(1 1-
(1 0.8%)</w>
(1 0.7</w>
(1 0.4</w>
(1 0.0
(1 %,</w>
(0.5- 3</w>
(0.3- 30</w>
(0.1- 5</w>
(0.05- 1</w>
(0.01- 0.3</w>
(0.01- 0.03</w>
(0.00 5</w>
(0.0 3,</w>
(0.0 25-
(0. 84</w>
(0. 8-
(0. 65</w>
(0. 6%)</w>
(0. 5%),</w>
(0. 44</w>
(0. 41</w>
(0. 40</w>
(0. 4-
(0. 4%)</w>
(0. 3%)</w>
(0. 28</w>
(0. 2%)</w>
(0. 1%</w>
(0. 1
(0-1 2
(0- 2</w>
(-1 5</w>
(-1 )),</w>
(-)- spect
(-)- nicotine,</w>
(-)- cibenzoline</w>
(-) PTT</w>
(- 32</w>
(+/-)- propranolol</w>
(+/ +
(+)-5-methyl-10,11-dihydro-5H-di benzo(a,d
(+)- MDMA</w>
(+ 4
(+ ))</w>
( y
( withdrawal</w>
( white</w>
( vs</w>
( vs.</w>
( urine</w>
( tubular</w>
( tri
( treated</w>
( theophylline
( that</w>
( summary</w>
( sub
( stratum</w>
( significantly</w>
( sigma
( sevoflurane</w>
( sc)</w>
( sc
( safety</w>
( resulting</w>
( referred</w>
( received</w>
( pulmonary</w>
( pts)</w>
( propranolol)</w>
( probably</w>
( prevalence</w>
( predominantly</w>
( pos
( phenytoin</w>
( perhaps</w>
( penicillamine)</w>
( pegIFN)</w>
( partial</w>
( onset</w>
( one),</w>
( olanzapine,</w>
( octreotide)</w>
( normal,</w>
( nor
( nicotinic</w>
( new</w>
( n-
( motor</w>
( ml/min/g)</w>
( min)</w>
( men</w>
( mechanical</w>
( low-
( losartan),</w>
( log</w>
( lind
( leukocyte</w>
( indomethacin</w>
( incidence:</w>
( ic
( i.p)</w>
( hypertension,</w>
( host)</w>
( highest</w>
( higher</w>
( headache,</w>
( head</w>
( haloperidol)</w>
( glutathione</w>
( glutamate,</w>
( gamma</w>
( frusemide)</w>
( free</w>
( exp
( exencephaly
( encoding</w>
( encainide</w>
( ejection</w>
( effective</w>
( dosage</w>
( donor)</w>
( diazepam,</w>
( diameter</w>
( dexrazox
( derived</w>
( daily</w>
( dP/dt</w>
( dP/dt
( cycle</w>
( continuous</w>
( combined</w>
( clinical</w>
( characterized</w>
( cerebral</w>
( carboplatin</w>
( calculated</w>
( bupropion</w>
( bupivacaine,</w>
( bpm)</w>
( body</w>
( bicuculline,</w>
( below</w>
( baseline).</w>
( bF
( aver
( anti
( anterior</w>
( anesthetized</w>
( alone</w>
( all,</w>
( age:</w>
( ad
( acetylsalicylic</w>
( aPTT
( [35S]TBP
( The</w>
( SU
( S</w>
( ON
( Ins1
( II
( H</w>
( Group-
( D</w>
( ACE</w>
( 7-N
( +</w>
( (+/-)-
', 3'-
' t</w>
' on'</w>
' minimal</w>
' a'</w>
' On'</w>
' ).</w>
% ];</w>
% ).(ABSTRACT</w>
"sub therapeutic"</w>
"sinus "</w>
" sil
" saf
" other"</w>
" meth</w>
" low-
" low"</w>
" late"</w>
" good</w>
" cow's</w>
" coronary</w>
" classical"</w>
" binge"</w>
" acute"</w>
" :</w>
zyme -
zotoc in</w>
zotep ine,</w>
zopiclon e.</w>
zol e).</w>
zinc .</w>
zinc -induced</w>
zinc ,</w>
zin ophthal
zinophthal az
zinophthalaz ine-treated</w>
zidovud ine-
zicon oti
ze al
zeal ous</w>
zatebr adine.</w>
zalepl on.</w>
z otan</w>
z ocine</w>
z i
z ep
z eniplatin</w>
z elandopam</w>
z el
zel and
zeland opam,</w>
z =</w>
z -
yst onia</w>
yros ine-
yro philic</w>
yri dine</w>
yr ylcholinesterase</w>
yr s,</w>
yr -
yp tin</w>
young er.</w>
young -onset</w>
youn ger
youn g-
you th</w>
yo s</w>
yo -
yno l</w>
yno diol</w>
yne- vitamin</w>
yne -19-nor-
yne-19-nor- 26,27-F6-
ym is</w>
yloxy )
ylo estradiol</w>
ylestradi ol,</w>
yl]-1- isopropyl
yl]-1-isopropyl pyridine-
yl]-1-isopropylpyridine- 2
yl]-1-isopropylpyridine-2 (1H)-
yl]-1-isopropylpyridine-2(1H)- one</w>
yl]- form
yl]- L-
yl] benzene
yl-L- proline</w>
yl-L- leuc
yl-4- pyrimidinyl)
yl- lysozyme</w>
yl- 2'-
yl)- propyl-1-phosphonic</w>
yl)- piperaz
yl) pyridine</w>
yl) oxy]-
yl) -1,2-
yl us</w>
yl sucrose</w>
yl methion
yl ene</w>
yl ene
yl cypromine</w>
yl carbonyl)
yl ates</w>
yl .</w>
yellow ish</w>
yeast .</w>
year-old- female</w>
year s:</w>
year s-old)</w>
yclo [3.
yaw ning,</w>
y- specific</w>
y- moving</w>
y- -a</w>
y rate)</w>
y over</w>
y et-
y ed,</w>
y R
y ="
y ,"</w>
y ")</w>
xylo caine</w>
xyl yl-6-AzUd</w>
xyl azine.</w>
xyl azine-induced</w>
xy quinoline</w>
xipar ine</w>
xen on-
xen on
xenon -1
xenon-1 33</w>
xanth ine)</w>
xam oter
xamoter ol,</w>
x odes</w>
x ide</w>
x heim
xheim er</w>
x anol</w>
x D2</w>
x 4</w>
x 10(9)/l</w>
wri st,</w>
worth whi
worthwhi le.</w>
worsen ,</w>
worl d,</w>
work place</w>
wor se,</w>
wor ris
wor m</w>
wor d
woman- years</w>
wom an's</w>
wk -old</w>
within- patient</w>
within- group</w>
withdrawal- emergent</w>
withdraw n;</w>
with standing,</w>
with out
with /
with/ without</w>
wit ch</w>
wis dom</w>
window s</w>
win ter</w>
wild- type,</w>
wild- type)</w>
wid th.</w>
wi se.</w>
wi res</w>
whic hever</w>
whe y</w>
whe at
wh om,</w>
well-be ing,</w>
well- recognised</w>
well- nourished</w>
well- matched</w>
well- functioning</w>
well- demarcated</w>
well ;</w>
weight- lif
weight-lif ter</w>
weigh ts.</w>
weig he
weighe d.</w>
week- long</w>
week s-
week ends.</w>
week end</w>
week ;</w>
weak ens</w>
weak en</w>
we re;</w>
we b
way s:</w>
wave )</w>
water- immersion</w>
water ;</w>
water ).</w>
wat ched</w>
wat ch
wast age.</w>
wash out.</w>
wash -
warfar in:</w>
warfar in-treated</w>
warfar in's</w>
war med,</w>
war d-
wan ing</w>
wa vel
wavel ength</w>
wa ist
wa b</w>
w/ v</w>
w t.</w>
w s</w>
w oun
w ishes</w>
w ing
wing ed</w>
w in</w>
w ill
will in
willin gn
willingn ess</w>
w b
wb c</w>
w ays,</w>
w ash</w>
w ann
wann oma</w>
w ak
wak e-
vulgar is,</w>
vouch ers</w>
voltam metry</w>
volt age-</w>
volt age,</w>
vol u
vol i
vol %,</w>
vogli b
voglib ose</w>
vl PAG</w>
vl PAG)</w>
viz .,</w>
viz ,</w>
vitro ;</w>
vitre oret
vitreoret inal</w>
vit rectomy</w>
visual- evoked</w>
visu al,</w>
viru ses.</w>
viro logic,</w>
viral- hepatitis-like</w>
vir us:</w>
vir g
vir al-induced</w>
vir al,</w>
vir -associated</w>
viol et
viol ent,</w>
viol ence.</w>
vinyl- GABA</w>
vinc ulin,</w>
vil le,</w>
vigil ance.</w>
vigil ance,</w>
vigabatr in-induced</w>
video- recorded</w>
video /
video/ EEG</w>
vid one</w>
vibris sa.</w>
vi ties</w>
vi sed)</w>
vi ously,</w>
vi lox
vi ation</w>
vi als</w>
veter an</w>
vestibulo- ocular</w>
vestibulo toxicity</w>
vesti bu
ves narinone</w>
vertebra e,</w>
verte br
vers a,</w>
verapamil/ beta-blocker</w>
ver sive</w>
ver sion,</w>
ver sing</w>
ventro- medial</w>
ventric ularly</w>
ventric le).</w>
ventr ally</w>
ventr al-
ventilat or.</w>
venlafax ine-
ven ules.</w>
ven ue</w>
ven o-
veget ables</w>
vec tion-
vection- enhanced</w>
ve st
ve in
vasospas m:</w>
vasopress in-mediated</w>
vasopress in-
vasopress in)</w>
vasoconstrict ors.</w>
vaso relaxing</w>
vaso depressive</w>
vascular ization</w>
vascular is</w>
vas o-
vas a</w>
varic ella-
varicella- zoster</w>
vari eties</w>
vari ed;</w>
vari ates</w>
vari ants.</w>
vari ant,</w>
vaporiz er-equipped</w>
vap tan
vaptan -treated</w>
van ish
van ill
valu es).</w>
valu es
values ):</w>
valu e).</w>
valsart an;</w>
valid ity.</w>
valid ity,</w>
val vul
val ve,</w>
val noctamide</w>
val ine</w>
val bumin</w>
val acyclovir
vagotom ies</w>
vag otonic</w>
vag al-
vag al)</w>
vaccin es</w>
vaca ine,</w>
va2] TRH</w>
v oids</w>
v ism</w>
v icular</w>
v ented</w>
v ault</w>
v ary,</w>
v ar</w>
v af
v O2</w>
v ),</w>
v (mean
uz umab</w>
uve itis.</w>
uve itis,</w>
utroph ils</w>
utili zes</w>
util ising</w>
uti tion</w>
uti ta</w>
utero placental</w>
uter o-
utero- placental</w>
ut ley,</w>
ut es</w>
ut ectic</w>
ust om
useful ness.</w>
use -related</w>
use ).</w>
us+ taste</w>
us tion</w>
us tin</w>
us sus
ussus ception</w>
us cri
uscri pt</w>
us carinic</w>
us al,</w>
us al
urticar ia-
urticar ia
ursodeoxychol ate-3-O-glucuronide</w>
urolog ist</w>
uro xi
uro protection.</w>
uro flow</w>
uro fen</w>
uro [2,3-
uro[2,3- e]
uro[2,3-e] pyrido[1,
uro[2,3-e]pyrido[1, 2-a]
uro[2,3-e]pyrido[1,2-a] [1,
uro[2,3-e]pyrido[1,2-a][1, 3
uro[2,3-e]pyrido[1,2-a][1,3 ]
uro[2,3-e]pyrido[1,2-a][1,3] diazep
uro[2,3-e]pyrido[1,2-a][1,3]diazep in-1
uro[2,3-e]pyrido[1,2-a][1,3]diazepin-1 2-
uro[2,3-e]pyrido[1,2-a][1,3]diazepin-12- ium</w>
urk ish</w>
urin ol</w>
uri x</w>
uri ents</w>
urgen cy,</w>
urg ed</w>
ureter s,</w>
ureter itis</w>
ures ),</w>
ure- effect</w>
ure- activity</w>
ure than</w>
ure ter,</w>
ure d,</w>
ur ring</w>
ur idine,</w>
ur ia:</w>
ur -
uptake ),</w>
uptak es</w>
upregul ates</w>
upper- quadrant</w>
up wards</w>
up titration</w>
up slope</w>
up on.</w>
up dates</w>
up date</w>
up dat
unpredict able.</w>
unpredict ability</w>
univer sal
units/ L</w>
unit- erythroid</w>
unit ),</w>
unilater al.</w>
unif ocal</w>
uni variable</w>
unexpl ained,</w>
unexpect ed.</w>
unexpect ed,</w>
une valuable</w>
under studied.</w>
under perfusion</w>
under nutrition.</w>
under ly</w>
und- glass</w>
und- Wistar</w>
un well</w>
un targeted</w>
un stimulated</w>
un specific</w>
un safe</w>
un responsive,</w>
un resect
un rel
un record
unrecord able</w>
un ra
un pleas
un obstructed</w>
un likely,</w>
un labeled</w>
un iti
un involved</w>
un influenced</w>
un identified.</w>
un happ
unhapp iness,</w>
un folded</w>
un due</w>
un documented</w>
un diminished</w>
un defined.</w>
un damaged</w>
un controlled,</w>
un classified</w>
un blinde
un available</w>
un ambigu
umb er
umb ent</w>
um- replete</w>
um- based</w>
um on
um er
um "</w>
ultrason ographically</w>
ultrafiltr ation.</w>
ultra- low-dose</w>
ultra violet</w>
ultra structurally</w>
ulph ate</w>
ulo us</w>
ulcer ations.</w>
ulcer ations,</w>
ulcer ated</w>
ul trac
ultrac ent
ultracent rifugation</w>
ul nar
ul l,</w>
ul ine)</w>
ul eus.</w>
uge e</w>
ucindo lol</w>
uc ky</w>
uc ella</w>
ub 's</w>
u zole</w>
u vular</w>
u ous,</w>
u n</w>
u minal</w>
u log
u g</w>
u .</w>
u ,</w>
tyrosine-methionine-aspartate- aspartate</w>
tyros ine.</w>
typh oid</w>
type 2</w>
type -I</w>
typ ical"</w>
typ es;</w>
typ es:</w>
ty -</w>
twor m</w>
two- phase</w>
two- period,</w>
two- kidney,</w>
two- day</w>
twitch ing.</w>
twel f
twelf th</w>
tw ist</w>
tw ins.</w>
turb in
tur ition</w>
tun ed</w>
tumo rous</w>
tubul o</w>
tubul es)</w>
tubocurar ine-induced</w>
tuber cles</w>
tu it
tu be
ttp:// www.
trou ble</w>
troponin- T,</w>
tropon in.</w>
tropon in,</w>
tropan yl</w>
troglitaz one,</w>
tro lox</w>
tro fosfamide</w>
tro ch
troch anter
trochanter ic</w>
tro car</w>
tris mus.</w>
tript ans.</w>
tript an
triple- vessel</w>
trinit rate-induced</w>
trimethoprim- sulfadiazine</w>
trimethadi one,</w>
trimetaph an-induced</w>
trimeta z
trigu ingly,</w>
triglycer ide-
trigemin o-
trifluoromethyl phenylpiperazine</w>
tricycl ics,</w>
trichotillo mania</w>
trichloroethan e.</w>
trichloro acetic</w>
trich ro
tric eps</w>
tric eps,</w>
triaz in-
triaz eno
triamterene -
triamcin ol
trial s;</w>
trial s)</w>
tri- hom
tri-hom o-
tri-homo- 22,
tri-homo-22, 24-
tri-homo-22,24- di
tri phosphate.</w>
tri phosphatase.</w>
tri peptide</w>
tri mi
tri hydroxy
tri dec
tri anis
trianis ene</w>
tri al)</w>
tren ds.</w>
tremulous ness</w>
tremulous ness.</w>
tremoro lytic</w>
tremor ;</w>
tremor :</w>
tremor -
treatment- seeking,</w>
treat ed-
tre phine</w>
tre mens</w>
tre mely</w>
tre es</w>
trazod one:</w>
traz ol,</w>
travell ers</w>
trast -induced</w>
tranylcyprom ine.</w>
transt ubular</w>
transport ation</w>
transport -
transport- competent</w>
transplant ),</w>
transplan ted.</w>
transketol ase</w>
transi tion.</w>
transi s
transis th
transisth mic</w>
transfer ,</w>
transf ection</w>
transe pithelial</w>
transcriptase- polymerase</w>
transcri ption.</w>
transamin asemia,</w>
transamin ase.</w>
trans-1,2-cyclohexanedi ol</w>
trans- 3,4-
trans ves
trans ver
trans sectional</w>
trans placentally</w>
trans it.</w>
trans it,</w>
trans it
trans glut
transglut amin
trans ection.</w>
trans ection,</w>
tranquil ization</w>
trandol apri
train ing)</w>
traff ic</w>
tract- involved</w>
trache otomy.</w>
trache oesophageal</w>
trac k</w>
trac hom
trachom ati
trachomati s</w>
tra versing</w>
tra ject
tra its,</w>
tr ics</w>
tr ading</w>
tr aben
traben azine</w>
toxic- metabolic</w>
toxic ology,</w>
toxic in-induced</w>
toxic "</w>
tox .</w>
tot aled</w>
tot al).</w>
torsa de.</w>
toremif ene-induced</w>
top otec
top ographically</w>
top ographical</w>
top ical,</w>
tonsill ectomy</w>
tonic-clon ic,</w>
ton us</w>
ton sil
ton ometry.</w>
ton ic
ton -H
ton-H all</w>
ton -
tolterod ine.</w>
tolbut amide.</w>
tolazol ine-induced</w>
tol vaptan-treated</w>
tocotrien ol</w>
toc olysis,</w>
tobram ycin-induced</w>
tobacco .</w>
tobacco -related</w>
to- face</w>
to- apex</w>
to phoresed</w>
to ols,</w>
to ol.</w>
to ol,</w>
to m</w>
to day.</w>
to -1</w>
to -1
to-1 2-hour</w>
tiz ed,</w>
tivi ties,</w>
tiven ess,</w>
tive /
titr atable</w>
tissue- specific</w>
tis m,</w>
tir pation</w>
tion/ reinstatement</w>
tion- potential</w>
tion s/
tion -</w>
tinnit us+taste</w>
ting- up.</w>
ting ling,</w>
tin ent</w>
tin -</w>
timolo l-treated</w>
timolo l-related</w>
time-of- flight</w>
time-of- day</w>
time- release</w>
time- points</w>
time- point</w>
time- effect</w>
time- dependently</w>
time- courses</w>
time "</w>
tim es:</w>
tim es-
tim ate</w>
tilmic in</w>
til ts</w>
til ting-up.</w>
tigh tness.</w>
tigh tness,</w>
tig o</w>
tid ine-induced</w>
tid al)</w>
ticryn af
ticarc illin-induced</w>
ticarc illin,</w>
tic us</w>
tic s)</w>
tic es</w>
tic ).</w>
tib ia.</w>
tiapri de.</w>
ti ps</w>
ti ps.</w>
ti ously</w>
ti form
ti d.</w>
ti com
ti bol
ti ar
ti april</w>
ti a
tia profen
tiaprofen ic</w>
thyroidi tis,</w>
thyro troph
thyro idal</w>
thymid ine;</w>
thymid ine)</w>
thym ol
thymol eptic</w>
thym idine-induced</w>
thyl enyl)
thy mic,</w>
thumb s</w>
thrombot est</w>
thromboly sis-related</w>
thromboembol ism:</w>
thrombocytopen ia-
thrombocyto paenia</w>
thrombo- embolism</w>
thrombin- antithrombin</w>
thromb olysis,</w>
threshol d)</w>
threshol d).</w>
three- way</w>
three- drug</w>
three- dose</w>
three- day</w>
threat ening,</w>
thorac otomy,</w>
thorac o-
thor ax.</w>
third- order</w>
thir st
thioure a.</w>
thiotepa .</w>
thiopent one/
thiopentone/ propofol</w>
thiopent al/
thiocolchico side.</w>
thiobutyro lactone</w>
thio phene</w>
thio TE
thin- layer</w>
thin king</w>
thien opyridine</w>
thick ness/
thick er</w>
thick ening.</w>
thiazol e-
thiaz ides,</w>
thiaz ide.</w>
thiaben dazole.</w>
thi os
thios ulphate</w>
thi oc
thioc itrulline</w>
thi ep
thi amphenic
theta (
thesi as</w>
thermodi lution</w>
thermo regulation,</w>
thermal -
thereafter ;</w>
therap y.(ABSTRACT</w>
ther mon
ther mia,</w>
ther m
theophylline- ephedrine</w>
theophyll ine-related</w>
theophyll ine-associated</w>
the ory,</w>
the at
the astern</w>
than- expected</w>
thalidomide- dexamethasone</w>
thalidom ide-treated</w>
thalas semic
thalamo- striatal-
thalam otomy.</w>
th s.</w>
th is
th ine</w>
th enal
th ;</w>
tezos entan</w>
tezos entan,</w>
tex t</w>
tetrofos min,</w>
tetrodotox in-resistant</w>
tetrap eptide</w>
tetramethyl cyclo
tetramethylcyclo propyl</w>
tetrahydro-7,8- dihydroxy
tetrahydro-7,8-dihydroxy -1-
tetrahydro-7,8-dihydroxy-1- phenyl
tetrahydro- 3-methyl-5-
tetrahydro-3-methyl-5- phenyl
tetrahydro corticosterone</w>
tetraethylammon ium,</w>
tetrachlor ide-induced</w>
tetrac ycline-induced</w>
tetra k
testoster one-induced</w>
test ed:</w>
test );</w>
test "</w>
tes tis,</w>
tert-butyl nitrone</w>
tert-butyl amino-
tert- butyl</w>
terodi line).</w>
termin us</w>
termin ations</w>
teratogen ically</w>
teratogen .</w>
teratogen -exposed</w>
ter tile</w>
tenu ifoli
tenuifoli side</w>
tent atively</w>
tent -to-treat</w>
tension- time</w>
tenofovir -containing</w>
tender ness.</w>
tend ino
tend ency,</w>
ten- year-old</w>
ten tion</w>
ten ess</w>
ten ed</w>
ten ,</w>
temporo parietal</w>
tempor al,</w>
temperat ures.</w>
temperat ure;</w>
temperat ure-effect</w>
temozolom ide,</w>
telo mere-
teleph one,</w>
tel encephalon</w>
teicoplan in-induced</w>
teg ment
teeth .</w>
teenag er</w>
teen age</w>
techniqu e).</w>
techniqu e),</w>
te ms</w>
te d).</w>
te am.</w>
tc PCO2</w>
tax ane-
tauro deoxycholic</w>
tau ght</w>
tast atin</w>
target ing,</w>
tap s</w>
tandos pirone,</w>
tamsulos in)</w>
tamoxifen -related</w>
tal ipexole</w>
tak ing,</w>
tak en;</w>
tail- pinch</w>
taglu timide</w>
tacrine- loaded</w>
tachykin in-A</w>
tachycardia/ fibrillation</w>
tachy systole,</w>
tachy arrhythmic</w>
tachy arrhythmias:</w>
tachy arrhythmia,</w>
tac rine.</w>
table ts).</w>
table ts),</w>
ta i
ta e</w>
t. ;</w>
t-MDS/ AML</w>
t- test</w>
t- ox</w>
t- dependent</w>
t- butylbicyclophosphorothionate</w>
t- butyl</w>
t z</w>
t ulo
t ual</w>
t resp
t or-
t one-
t ly-
t ing:</w>
t es)</w>
t ation,</w>
t ang
t ane</w>
t ally</w>
t abuse
t Cr</w>
t 1,</w>
t 0,</w>
t -1,2-
t (3
t(3 ;
systolic/ diastolic</w>
systematic ally.</w>
system atic,</w>
syring e.</w>
synthe t
synthe ses</w>
synovi tis.</w>
synergis tic,</w>
synerg izes</w>
syndrome -like</w>
syndrome '.</w>
syncop e;</w>
syncop al)</w>
synchron ization.</w>
synapto phy
synapto genesis.</w>
syn ergic</w>
syn carcinogenic</w>
symptom- free.</w>
symptom s"</w>
symptom atic
sympathomime tics,</w>
sympatho excitation</w>
sympath one
sympathone ural</w>
sympath ectomy,</w>
symmetr ically</w>
sy s
sy l
switch over</w>
switch ing.</w>
switch .</w>
swell ings,</w>
sweet ened</w>
sweet en
swe at
sw ings.</w>
sw allow</w>
suxameth oni
suspici on.</w>
suspen sions.</w>
suspen sion,</w>
susp ending</w>
survival ;</w>
survival /
surpris ing,</w>
surger y;</w>
surger y).</w>
surge ons.</w>
surfac ed</w>
suprac lin
supraclin oid</w>
supra- ventricular</w>
supra- therapeutic</w>
suppres sible</w>
suppor ted.</w>
supplement ing</w>
supplement ed,</w>
superven ed.</w>
superf icially</w>
superf amil
superfamil y.</w>
superf am
superfam ily</w>
sup rap
suprap ubic</w>
sup radi
supradi aphrag
supradiaphrag matic</w>
sup position</w>
sup pose</w>
sunit inib.</w>
sun bur
sulphon ylurea</w>
sulphon yl
sulphadi azine-induced</w>
sulph oxide</w>
sulph amethox
sulfoxim ine,</w>
sulfonyl ureas.</w>
sulfonamide -containing</w>
sulfinpyraz one.</w>
sulfamethox azole.</w>
sulfamethox azole,</w>
sulfamethox azol
sulfam etopyraz
sulfadi azine,</w>
sulf ur</w>
sulf otransferase</w>
sulf ate-
sulf apyri
sul c
sul bac
sulbac tam</w>
suic ides</w>
suic ide,</w>
suic id
suggest s,</w>
sugar ,</w>
suffici ent.</w>
suffere r
sudden ly,</w>
sucralf ate.</w>
succe eding</w>
suc rose,</w>
suc ro
sucro se-
suc cum
suburo thelium</w>
subunit -containing</w>
subtype -specific</w>
subtype )</w>
substra in</w>
substitu tions,</w>
substanti ally,</w>
substance -dependent</w>
substance (s)</w>
subst rat
subsequ ent,</w>
subo- like</w>
sublingu ally)</w>
subj ecti
subicul um;</w>
subep imy
subepimy ocardium</w>
sub- regions</w>
sub- additive</w>
sub tests</w>
sub stituted.</w>
sub stitut
sub sid
sub seizure</w>
sub score</w>
sub scale,</w>
sub sarcolemmal</w>
sub sample</w>
sub regions.</w>
sub paralyzing</w>
sub nucleus</w>
sub mucous</w>
sub mitochondrial</w>
sub lux
sub intimal</w>
sub hypnotic</w>
sub groups:</w>
sub group.</w>
sub group--
sub fulminant</w>
sub fractions</w>
sub for
subfor nical</w>
sub fields</w>
sub endomyocardium</w>
sub endocardium</w>
sub endocardi
sub chronically</w>
sub arachno
sub aortic</w>
su profen,</w>
su perfusion</w>
su e</w>
styr yl-
stupor '</w>
stud y),</w>
stud y's</w>
structure- function</w>
structur ally-
struc tive</w>
stroph anth
stron gly,</w>
stroke/ TIA</w>
stroke- associated</w>
strok es)</w>
stro me
strict ure.</w>
striat opallidal</w>
stri ational</w>
stret ch.</w>
stress/ rest</w>
stres s:</w>
streptozoc in-diabetic</w>
strepto kinase.</w>
strept avidin-
stre et-
stre ak
strati fy</w>
strati fication.</w>
strate gic</w>
stra in-
stra Z
straZ enec
straZenec a,</w>
str ingent</w>
stor m</w>
stoppe d;</w>
stop- exposure</w>
stomat ocytosis</w>
stom atitis.</w>
sto res.</w>
sto ols,</w>
sto ichi
stimuli --the</w>
stimulant -dependent</w>
stimul us-
stimul ations.</w>
stimul ant.</w>
stilbo estrol</w>
stig mata</w>
stiff -
stiff- person</w>
sti pul
steroid s:</w>
steroid -related</w>
stereospecific ity</w>
stere ology</w>
ster ified</w>
ster ically</w>
stenosi s)</w>
steep ness</w>
steato hepatitis
stear ic</w>
ste el</w>
stay ing</w>
statis tics.</w>
statis tically,</w>
stat ure,</w>
stat es:</w>
starv ation,</w>
starch ,</w>
star tle,</w>
staphylococci .</w>
standardi zed.</w>
stand- alone</w>
stand s</w>
stand point</w>
stand ing.</w>
stain s.</w>
stain s,</w>
stain ings</w>
stain ing)</w>
stabiliz ers,</w>
stabil izations</w>
stabil ised</w>
stabil is
sta phylococcus</w>
st- cell</w>
st uzumab</w>
st s'</w>
st rib
strib uted</w>
st r</w>
st on</w>
st ine</w>
st eth
steth oscop
st ented</w>
st ate)</w>
st ate
st an
st air
stair case</w>
st aged</w>
st ably</w>
st ab
spur t</w>
spread s</w>
sporad ically</w>
spondylo tic</w>
splen omegaly.</w>
splen ium</w>
splen ectomy.</w>
spir ulina</w>
spin es,</w>
sphingomyel in,</w>
sphincter otomy</w>
sphincter otomy.</w>
sphinc ter,</w>
spher ical</w>
spermid ine,</w>
sperm ine,</w>
sperm ine)</w>
speedball ing.</w>
spectro scopy.</w>
spectro metry,</w>
spectac le</w>
specific ation</w>
special ists</w>
special ists.</w>
spec kle</w>
spec ified,</w>
spe eded</w>
spas mo
sparte ine.</w>
spacef light</w>
spac ing</w>
sp ine.</w>
sp icy</w>
sp ects</w>
sour ce,</w>
sound- source</w>
sou th-west</w>
sorafenib .</w>
sor iasis</w>
sor hythmic</w>
son ic
sonic ated</w>
son .</w>
son ,</w>
somno graphic</w>
somnambul ism,</w>
some what
some time</w>
somatotop y</w>
somato stat
som eth
someth ing</w>
som atiz
somatiz ation,</w>
solvent s,</w>
solv able</w>
solution -treated</w>
solut es</w>
solitari us.</w>
sol es</w>
sol es.</w>
sol ecith
sodi um:</w>
soci ally</w>
soci al,</w>
soci ability</w>
so reness</w>
so gelser</w>
sne ezing,</w>
smok ing-
smok er,</w>
small er.</w>
sm R
slowe d.</w>
slowe d,</w>
slow- twitch</w>
slow ly,</w>
slow est</w>
slow .</w>
slic e.</w>
sleepl essness</w>
skin- structure</w>
skin- nerve</w>
skele tally</w>
sk ill</w>
siz ed,</w>
siz e;</w>
siz e-
sixty- six</w>
sixty- seven</w>
six- year</w>
sive/ defensive</w>
situ ational</w>
situ ated</w>
sit ting,</w>
sit osterol</w>
sit e)</w>
sist ers</w>
sis/ HCC</w>
sis tive</w>
sirolimus- tacrolimus</w>
sirolim us-associated</w>
sion --
sinus oid
sinu ses.</w>
sinu ses,</w>
single-bl inded,</w>
single- subject</w>
single- strand</w>
single- day</w>
single- bolus</w>
single -</w>
sing -
sine sis</w>
sin ensis,</w>
similar ;</w>
silver- stained</w>
sil ica</w>
sil encing</w>
significant ;</w>
significant :</w>
signific ative</w>
signal- to-
sign s;</w>
sign ify</w>
sign all
sign al,</w>
sigmoid oscopy</w>
sigmoid oscopy.</w>
sider oblasts</w>
sider oblast
sic .</w>
sib ly,</w>
sial omet
sialomet aplasia</w>
si ve"</w>
si um.</w>
si tis,</w>
si s.(ABSTRACT</w>
si rol
sirol mus</w>
si lo
si li
si ght</w>
si eh
si di
si al</w>
si a;</w>
si a-
si a)</w>
shut tle</w>
shun ts.</w>
shrun ken,</w>
shoul ders,</w>
shoul der,</w>
shoul d,</w>
shorten ed.</w>
short-ter m)</w>
short- li
shor ter,</w>
shock :</w>
shock -like</w>
shoc ks.</w>
shoc ks,</w>
shoc k-
shi k
shi el
shel ves</w>
sheath s.</w>
she ets</w>
she ds</w>
sham- oper
sham- betagal</w>
shad owing</w>
sh engmai-y
sh af
sexu ally-
sex ;</w>
severe );</w>
severe ),</w>
sever ities</w>
seventy- five</w>
seven- year-old</w>
seven- day</w>
set tle</w>
set )</w>
sesqu iterpen
sesquiterpen es</w>
ses sions;</w>
ses am
sesam ol</w>
ses ),</w>
servic es,</w>
servic e,</w>
serotonin 1A</w>
seroton in-induced</w>
seroconver sions</w>
sero- negative</w>
serious "</w>
ser um)</w>
ser um),</w>
ser oprevalence</w>
ser ine/
ser ine-
sequest r
sequenti ally,</w>
sequ ences.</w>
sequ ences,</w>
sequ ence
sequ el</w>
septo hippocampal</w>
sept al/
sepi apterin</w>
separ ation,</w>
separ atel
separ ate,</w>
sep sis;</w>
sensori um,</w>
sensitiz er,</w>
sensitiz ation).</w>
sensitive )</w>
sensi tis
sens ors</w>
sen sibility</w>
sen se,</w>
semi- quantitatively</w>
semi quantitatively</w>
semi purified</w>
sematili de,</w>
sem ia,</w>
self- sustaining</w>
self- ratings</w>
self- poisoning</w>
self -</w>
seleni um-replete</w>
selecti ve)</w>
seizures ),</w>
seizure- resistant</w>
seizure ;</w>
seiz uring</w>
seiz ured</w>
seiz e</w>
segreg ate</w>
segment al,</w>
seg mentation</w>
seg mentally</w>
seek ers.</w>
see ks</w>
sedi ment.</w>
sedi ment
sedent ary-
sedative/ hypnotic</w>
sed ations</w>
sed ation:</w>
sed ated.</w>
section ed,</w>
secretago gue</w>
secre tions.</w>
secre tion)</w>
second s)</w>
second ary,</w>
sec t</w>
sec ;</w>
sec 1/2</w>
sec /
sec -
seas on.</w>
se ts,</w>
se tiform
se ret
se p</w>
se lia</w>
se ed
se dat
se bum</w>
se am</w>
se a-
sea- level</w>
se -treated</w>
screen ings</w>
scre en.</w>
scotom as.</w>
scotom a,</w>
scores :</w>
score ),</w>
scopol amine:</w>
scop y,</w>
scolio sis.</w>
scleroder ma,</w>
sclero therapy.</w>
sclero sis-like</w>
scler osed</w>
scinti llation</w>
scientif ically</w>
scienti sts</w>
scho ols</w>
schizophren ics.</w>
schistosom iasis</w>
schistos ome</w>
sch wannoma</w>
scenario s</w>
scaveng es</w>
scat ter.</w>
scar ce,</w>
scar ce
scarce ly</w>
scan ner</w>
scal p.</w>
scal p,</w>
scal e-
scal a</w>
sca -1
sca-1 (pos
sca-1(pos )</w>
sc ri
sc /
sav ing.</w>
satur ating</w>
satur ate</w>
sativ um</w>
satis fying</w>
satellit e</w>
sarcom eric</w>
sarcom eres</w>
sarco idosis.</w>
sand w
sampl ing,</w>
salt- losing</w>
saliv ation.</w>
saline- infused</w>
saline +
salicylazosulf apyridine</w>
salbutam ol-induced</w>
sal t.</w>
sal t-</w>
sal sol
sal mon</w>
sal ine/
sal e</w>
sairei- to-treated</w>
sad ness,</w>
sacchar in-
sac lofen</w>
sac he
s/ s</w>
s/ mm3)</w>
s/ min/
s/ g</w>
s/ cm-
s/ THE</w>
s/ Q
s.c. -</w>
s.c m-
s- per
s-per ill
s-perill yl</w>
s- based</w>
s- associated</w>
s- Sto
s-Sto kes</w>
s, tot
s weet</w>
s ular</w>
s tick</w>
s po
s opharyngeal</w>
s oph
soph is
s ob
s mell
smell ing</w>
s lu
slu gg
slugg ish
s lit
s chol
schol astic</w>
s carr
scarr ing.</w>
s arrhythmia</w>
s age</w>
s add
s ICAM-1</w>
s EPSCs</w>
s EPO</w>
s E-
s 47</w>
s /</w>
s .,</w>
s ))</w>
s )
s ')</w>
s '
s %,</w>
s ".</w>
ry anod
rut in.</w>
rus /
rup tio</w>
run way</w>
rul e-
rug inea</w>
rudi mentary</w>
rub omycin</w>
rtL180 M/
rt M204
rs 727
rs727 0
rs 29
roxyl in</w>
row n-
rough s</w>
rota rod,</w>
rosi ri
rosiri us</w>
rosace a.</w>
rosace a-like</w>
ros covit
ros a</w>
ropi setron</w>
rophag ocytosis</w>
rop uncture</w>
room s</w>
ron ell
ron ate)</w>
ron al</w>
ron .</w>
ron -
ron- emission</w>
rom y
rom met
rom ine</w>
roll man</w>
rolipr am.</w>
rolim us)</w>
roentgen ographic</w>
rod mann</w>
rocur onium-induced</w>
rocur oni
robu st.</w>
ro unding</w>
ro str
ro r
ro l,</w>
ro g
ro di
ro bi
ro ,</w>
riz onal</w>
riz ine-induced</w>
rituximab ,</w>
risperid one;</w>
risperid one:</w>
risperid one-associated</w>
risk y</w>
ris h</w>
ris b
ring ton</w>
rin sing.</w>
rim ant
rim -induced</w>
rilmen idine,</w>
rig ors</w>
rig ors.</w>
rifampic in:</w>
rifampic in-
rifabut in-related</w>
rifabut in-associated</w>
ric t</w>
ric in
ric h,</w>
ric et
ricet ulus</w>
riboflav in</w>
ri x</w>
ri form</w>
ri dg
rhyth m;</w>
rhodamine 123</w>
rhizom es</w>
rhin orrhoea,</w>
rhe tic</w>
rh o</w>
rh am
rh achi
rhachi a</w>
rewar ming</w>
rewar ming,</w>
rewar ded</w>
revisit ed:</w>
reversib le
reverse- phase</w>
revers als</w>
revascular ization,</w>
retur ned,</w>
retro virus</w>
retro spect</w>
retrie ved.</w>
retin ol,</w>
retin oids.</w>
retin oid,</w>
retin ide</w>
retin amide</w>
retin a.</w>
retin a,</w>
reticulo cytosis</w>
reticulo cytosis.</w>
reticulo -
retar d,</w>
ret initis,</w>
resume d,</w>
resum ing</w>
resum e</w>
restric ted,</w>
restrain t.</w>
restra int
restra ined,</w>
restless ness
response --
respond ent</w>
respon ds,</w>
resp .</w>
resorufin-O-de ethyl
resorufin-O-deethyl ase</w>
resol ve;</w>
resist ances,</w>
resid u
resi dent
resi den
residen tial</w>
reservoir s</w>
reserpine- enhanced</w>
reser ves</w>
research es</w>
resear ched</w>
rescu e,</w>
res veratro
res thesias</w>
res orbed</w>
res in.</w>
res ections</w>
res ection,</w>
res ec
reproduc tive,</w>
repor ts/
replic ates</w>
replacem ent
replac ements</w>
reperto ire</w>
reperfu sion:</w>
repeated- measures</w>
repe ats</w>
repe ating</w>
repe at
renal/ adrenal</w>
ren tiapril</w>
ren in.</w>
remis sions,</w>
rema zocine</w>
rem ia/
relie f
reli eves</w>
reli es</w>
relev ance,</w>
relent less</w>
releas ed,</w>
releas e)</w>
releas able</w>
relationship :</w>
relap sing-
relap ses.</w>
rel ay</w>
rel atives</w>
rel ations.</w>
rel ations,</w>
rel ated;</w>
rel ,</w>
rejec tions,</w>
reinforce ment
reinforce d.</w>
rein stituted.</w>
rehabilit ation.</w>
regurgit ation:</w>
regurgit ation)</w>
regurgit ant</w>
regres sive</w>
regres sions.</w>
registr ations</w>
regist ries</w>
regimens ;</w>
regimen ;</w>
regimen -related</w>
regi me,</w>
regi me
regener ate</w>
regar d,</w>
reg ate</w>
refractor iness,</w>
reflex ia</w>
refl ect
reflect ance</w>
referen ced</w>
ref ugee</w>
ref illing</w>
ref action</w>
ref .</w>
reduct ase.</w>
reduced- intensity</w>
reduc tive</w>
reduc tions,</w>
reduc tion).</w>
reduc es,</w>
reduc ed;</w>
reduc e,</w>
red- stained</w>
recur s</w>
recur ,</w>
rect ally</w>
recre ation
recover y)</w>
recover able</w>
recorde d:</w>
recon stitution</w>
recomm enced</w>
reco ve
receptor/ G-protein</w>
receptor- knockout</w>
receptor- deficient</w>
receptor -induced</w>
receptor -associated</w>
recei ver</w>
rece ded</w>
recapit ulate</w>
recanal ization.</w>
rec utita</w>
rec ir
rec idi
recidi vism</w>
rec alle
reboxet ine,</w>
reasses sed.</w>
reas surance</w>
reas e</w>
real- life</w>
read mill</w>
read ers</w>
react ors</w>
reac tion-
re-in-an o</w>
re- evaluate</w>
re- challenged</w>
re- challenge</w>
re y</w>
re xi
re treatment</w>
re transplantation.</w>
re tig
re t</w>
re studied</w>
re sistive</w>
re set</w>
re r
rer gic</w>
re production</w>
re producing</w>
re pressor</w>
re pres
re plen
re pl
re ph
reph inephrine</w>
re paired</w>
re operation.</w>
re opening</w>
re mediation</w>
re jections</w>
re iter
re initiation</w>
re initiated.</w>
re infarction,</w>
re hydration</w>
re hydration,</w>
re hospitalized</w>
re hemorrhage,</w>
re generated</w>
re examination</w>
re dness,</w>
re distributed</w>
re conc
re challenging</w>
re appeared.</w>
re agent</w>
re affir
re ader</w>
re activity;</w>
re activity:</w>
re absorbable</w>
re a,</w>
re /
re ),</w>
raz ine</w>
ration ale,</w>
rati a</w>
rate -</w>
rat ing.</w>
rat es;</w>
rat es
rat a.</w>
rat /
rash es.</w>
rasagil ine.</w>
ras u
rare r</w>
raph e,</w>
rapamyc in)</w>
rap h</w>
ranol azine.</w>
random ized;</w>
random ized-
random isation.</w>
random ,</w>
ran k-
ran cid</w>
ram one</w>
ram ,</w>
raloxifene- associated</w>
radiotele metered</w>
radiolab el</w>
radioimmuno assay,</w>
radiograph s,</w>
radiograph ically</w>
radiograph ic,</w>
radiograph .</w>
radiograph ,</w>
radiocon trast-induced</w>
radio iodinated</w>
radio allerg
radioallerg os
radioallergos orbent</w>
radic al.</w>
radi ologically</w>
radi ologically,</w>
radi ography,</w>
raclopri de.</w>
race/ethnic ity</w>
rabep razol
rabb it
ra y,</w>
ra w</w>
ra sion</w>
ra refaction</w>
rIFN alpha2b</w>
rIFN alpha2
rCMR glc</w>
r- 34</w>
r yst
r ying</w>
r y-
r ush</w>
r n
r ino
r VIIa</w>
r -based</w>
quinpi role-induced</w>
quinoxalin-1- one</w>
quinoxal ines</w>
quinol ones.</w>
quinol one-induced</w>
quinol in
quinid ine-associated</w>
quin tile</w>
quin ox
quin ol</w>
quin april.</w>
questionnai res,</w>
question s:</w>
quer cit
quercit rin</w>
quasi- experimental</w>
quantit atively.</w>
quanti fi
qual ification</w>
quadripleg ia.</w>
quadr ant.</w>
quadr ant,</w>
quad azocine</w>
qu ine/
quine/ sparteine</w>
q 4
q 3
q .</w>
pyrrolidinyl)methyl]- 2-
pyrrolid ino
pyro phosphatase</w>
pyrimethamine- sulfadoxine</w>
pyrimeth amine.</w>
pyridox amine</w>
pyrido [2,1-
pyrido[2,1- b]
pyridazin one</w>
pyridazin on-
pyrid yl)
pyrid yl
pyre tic</w>
pyrazolo [1,5-
pyrazolo -
pyrazin obut
pyrazin amide,</w>
pyraz in-2-
pyrazin-2- yl]-1-isopropylpyridine-2(1H)-one</w>
pyr rol
pylo romy
pye lography,</w>
pye logram</w>
pust ulo
purpo ses,</w>
purpo se
puromyc in,</w>
pur ported</w>
pur ified,</w>
puppi es.</w>
pup il.</w>
pup il-sparing</w>
pump ;</w>
pum p)</w>
pulmonary- renal</w>
pul sus</w>
pul p,</w>
pud end
pudend al</w>
puber ty,</w>
pu ff
puff s</w>
pt az
pt ake</w>
pt ain
psychotri dine</w>
psychomot or-
psychomotor- stimulating</w>
psycho therapeutic</w>
psycho pathic</w>
psychiatri sts,</w>
psychiatr ically</w>
psychiatr ic,</w>
psychiat rist</w>
psych ophysical</w>
psych ophysi
psych ologic</w>
psor iasis:</w>
psi lateral</w>
psi ,</w>
pseudoc ocaine</w>
pseudo- Bartter</w>
pseudo ephedr
pseudo allergic</w>
pseudo agouti</w>
pseud olym
pseudolym ph
pseud ocystic</w>
pseud obul
pseudobul bar</w>
prox y</w>
provid ers.</w>
protrac ted.</w>
protr uding</w>
protoporphy rin</w>
proton- pump</w>
protocol- defined</w>
proto- oncogene</w>
proteinase- 3</w>
protein/ mg</w>
protein/ h</w>
protein- unbound</w>
protein- mediated</w>
protein- III</w>
protein- 2</w>
protein urea</w>
protein s)</w>
protein :
protein: creatinine</w>
protec tion"</w>
prote ome</w>
prote ic</w>
prot ,</w>
prosthe sis.</w>
prostan oids.</w>
prostagland in-mediated</w>
prosencephal on</w>
propyl}- pyrrolidin-2-one</w>
propyl )-2-
propri onic</w>
propoxy phene.</w>
proportion ality</w>
proportion al-
proportional- hazards</w>
propor tions.</w>
propor tion.</w>
propofol- remifentanil-based</w>
propofol ;</w>
propofol -evoked</w>
properti es;</w>
proparg yl-1-
propag ation,</w>
prop entof
prop an-2-
pron eth
pron e,</w>
pron ation-
pronation- supination</w>
promoter s,</w>
promot er.</w>
promo tional</w>
promin ent,</w>
promin ence</w>
prometh azine.</w>
prolin tane</w>
prolifer ators.</w>
prolifer ative,</w>
prolactin oma,</w>
prol yl</w>
prol ap
prolap se.</w>
prohib itive</w>
progres sion;</w>
programm es</w>
progest ogens</w>
progest ogen,</w>
progest ogen
progest ins.</w>
progest in,</w>
progest agen</w>
profoun d.</w>
profen -treated</w>
profen -induced</w>
produc tion;</w>
prochlorper azine-induced</w>
proced ure)</w>
proced ure
procarb azine</w>
proca ine-induced</w>
probuc ol-induced</w>
probuc ol)</w>
probenec id-treated</w>
prob es,</w>
proanthocyanid ins</w>
pro- oxidant</w>
pro- conflict</w>
pro- arrhythmia.</w>
pro triptyline</w>
pro survival</w>
pro ptosis,</w>
pro posing</w>
pro oxidant</w>
pro n</w>
pro ischemic</w>
pro hormone</w>
pro hemorrhagic</w>
pro drugs,</w>
pro convulsant,</w>
pro cer
procer a</w>
prior ity.</w>
prin ts</w>
primin g,</w>
primin g
prima quine.</w>
prim e</w>
previous ly).</w>
prevail ing</w>
prev ent,</w>
presynap tically</w>
presyn cop
presum e</w>
pressure- rate</w>
pressure /
pressure .(ABSTRACT</w>
pressure -dependent</w>
pressure ),</w>
pressu res;</w>
present ation;</w>
prescrip tion
prescrib ers</w>
prescri ption,</w>
preschool- sevoflurane</w>
pres ymptomatic</w>
pres ence,</w>
prepro tachykinin-A</w>
prepro somatostatin</w>
prepro TRH</w>
pren yl
prematur ity.</w>
prefer red.</w>
predomin ates</w>
predomin ated</w>
predict ors,</w>
predict able.</w>
predict able,</w>
precurs ors,</w>
precipit ations</w>
pre- specified</w>
pre- procedure</w>
pre- operatively</w>
pre- nephrotic</w>
pre- morbid</w>
pre- methotrexate</w>
pre- exposed</w>
pre- administration</w>
pre- ADR</w>
pre- ,</w>
pre weanling</w>
pre therapy,</w>
pre term,</w>
pre septal</w>
pre packed</w>
pre load.</w>
pre incubation</w>
pre frontal,</w>
pre formed</w>
pre discharge</w>
pre d
pre conditioned</w>
pre coc
pre clinically</w>
pre chronic</w>
pre caution</w>
pre cau
precau tions,</w>
pre bypass</w>
prazosin- controlled</w>
pran oprofen</w>
pran olol-induced</w>
pran ol</w>
pramipex ole.</w>
practition ers.</w>
practic es.</w>
practic es,</w>
practic al.</w>
practic able</w>
pract olol.</w>
pp m),</w>
pow der.</w>
pow der,</w>
pover ished</w>
poten cies,</w>
potassi um;</w>
potassi um-dependent</w>
pot ting</w>
pot ropic</w>
postpartum ,</w>
postisoproteren ol,</w>
postischem ia.</w>
postis ch
postisch aemic</w>
postero ventral</w>
poster o-lateral</w>
post-nat ally.</w>
post-LT .</w>
post- transplantation.</w>
post- transfusion</w>
post- therapy,</w>
post- suxamethonium</w>
post- stress</w>
post- natally</w>
post- methotrexate</w>
post- menopausal</w>
post- ischemia.</w>
post- ischemia,</w>
post- injection,</w>
post- ingestion.</w>
post- ictal</w>
post- hoc</w>
post- dose.</w>
post- chemotherapy</w>
post- challenge</w>
post- bilateral</w>
post- baseline</w>
post- admission</w>
post- SE)</w>
post- PCB</w>
post- MTX</w>
post- HDT</w>
post- ECT</w>
post- EA</w>
post- ADR</w>
post uring</w>
post ures,</w>
post ure,</w>
post translational</w>
post therapy</w>
post systolic</w>
post rest</w>
post rema
post rans
post randomization</w>
post necrotic</w>
post injection.</w>
post inhibitory</w>
post dose)</w>
post delivery</w>
post anaesthetic</w>
post al</w>
possibil ity,</w>
posit ron-emission</w>
posi tions,</w>
posi s,</w>
por to-systemic</w>
por tion.</w>
popul ation),</w>
popul ar,</w>
pon tis</w>
pon tis,</w>
polyur ia-
polyuria- polydipsia.</w>
polysomno graphy</w>
polyradicul oneuropathy</w>
polypo sis</w>
polypepti de
polyp s.</w>
polyp s,</w>
polyp eptides</w>
polymyosi tis/dermatomyositis</w>
polymorph ism.</w>
polymer ized</w>
poly- L-
poly vidone</w>
poly sulphated</w>
poly spike</w>
poly serositis</w>
poly phenolic</w>
poly neuropathy:</w>
poly m
poly galasap
poly dy
polydy p
poly arthritis</w>
poly arthralgia,</w>
pollak i
pol e.</w>
pol e-
poison ings</w>
poison ing:</w>
point s]),</w>
point s;</w>
point s)</w>
point s).</w>
poin te</w>
poikilo ther
poi esis</w>
podocyte -associated</w>
podocalyx in,</w>
podocaly xin</w>
pod ocyturia</w>
pod ocyte.</w>
po x</w>
po rous</w>
po ol,</w>
po ol
po dox
podox ime</w>
po do
po dium</w>
po 2</w>
po -
po- entorhinal</w>
pneumon iti
pneum ocystis</w>
pmol/ g</w>
pmol es</w>
plus- maze.</w>
plus- maze,</w>
plex uses</w>
plex us.</w>
pleuro pericarditis</w>
pleur itis</w>
pleur a,</w>
plethysmo graphy.</w>
plethysmo graphic</w>
plei otropic</w>
ple omorphic</w>
ple omorph
ple dg
ple d
pled get</w>
play er</w>
platinum- sensitive</w>
platinum- refractory</w>
platinum- free</w>
platin um-induced</w>
platform -
platelet- associated</w>
plat form.</w>
plas ties</w>
plas ticity,</w>
plas mas</w>
plas mal
plasmal em
plasmalem ma</w>
plaqu e.</w>
plant )</w>
planne d,</w>
plan e,</w>
placent ae.</w>
placebo /
placebo );</w>
plac em
pl ate.</w>
pl ans</w>
pl agu
piroxicam -treated</w>
piribe dil,</w>
piri form,</w>
pir arubicin,</w>
pir acetam
piperox an,</w>
piperid ino
piperazin yl</w>
piperaz ines</w>
piperacill in,</w>
piper ate</w>
pineal ectomy,</w>
pindo lol-induced</w>
pinacidi l,</w>
pin pricks</w>
pin prick,</w>
pin na</w>
pilocarp ine)</w>
pilo- GVG</w>
pilo erection,</w>
pigment osa</w>
piec e</w>
pict ures.</w>
picrotoxin- threshold</w>
picrotox in-treated</w>
picrotox in
picro toxicin-induced</w>
pic rosirius</w>
pi pe</w>
pi ents</w>
pi e
pie bal
piebal d</w>
pi dic</w>
phytom en
physostigm ine-
physi ology.</w>
physi ologically,</w>
phyl l
phy sis</w>
photo thrombotic</w>
photo beam</w>
phot otoxic</w>
phot ographic</w>
phot odi
phosphot yrosine-
phosphoryl ase</w>
phosphoramid on</w>
phosphor ic</w>
phospholip id,</w>
phosphofructo kinase</w>
phosphodiester ase-
phosphodiesterase- 5</w>
phosphatidyl inositol-
phosphatidylinositol- specific</w>
phosphatidyl choline,</w>
phosphat es.</w>
phosphat es,</w>
phosphat emia</w>
phosphat ases.</w>
phosphat ases,</w>
phosph omon
phosph ol
phosphol amb
phospholamb an</w>
phosph o</w>
phosph atid
phorbol -1
phon ocardi
phon ation.</w>
phil ia.</w>
pheochromocyt oma:</w>
phenyto in
phenylpropanol amine:</w>
phenylisopropyl adenosine</w>
phenylethyl amine</w>
phenylethanolamine- N-methyl</w>
phenylethanolamine- N-methyl
phenylephr ine-</w>
phenylbiguan ide</w>
phenylbiguan ide-induced</w>
phenyl- 3-
phenyl)-piperazin-1-yl]- propyl}-pyrrolidin-2-one</w>
phenyl)-2- amino
phenyl hydrazine</w>
phenyl di
phenyl benzo
phenyl -2
phenterm ine-
phenoxy )
phenothiaz ines.</w>
phenomen on)</w>
phenobarbit one.</w>
phenobarbit al-treated</w>
phendimetraz ine.</w>
phencycl idine-induced</w>
phencycl idine,</w>
phencycl id
phenacet in/
phenacetin/ aspirin</w>
phen otype
phen indione</w>
phased- array</w>
phase- I</w>
phas es:</w>
phas es)</w>
phas e),</w>
pharmacologic ally-induced</w>
pharmaco epidemiologic</w>
pharmaco dynamics.</w>
pharmac ists,</w>
phal ic</w>
phag ocytes</w>
phaclofen ,</w>
ph rag
ph o
ph lor
ph iltr
philtr um,</w>
ph en</w>
ph atic</w>
ph ,</w>
ph )</w>
pg/ ml),</w>
pg/ g</w>
perturb ed</w>
perturb ations.</w>
person ,</w>
persist ence,</w>
persever ative</w>
persever ation</w>
perphenaz ine-</w>
perpetr ation</w>
peroxy nitrite-
perox ide
perman ently,</w>
peritone al,</w>
periton sillar</w>
periton itis,</w>
perit ransplant</w>
peripher y,</w>
peripher ally.</w>
perioper atively.</w>
periodic ally.</w>
perio d:</w>
perio d/
period/ left</w>
perio d),</w>
perim en
perikary a</w>
pericon ception</w>
pericardi ocent
peric entral</w>
peric ellular</w>
peri- infarct</w>
peri venous</w>
peri or</w>
peri meter</w>
peri arterial</w>
perfusion- cultured</w>
perfus ate.</w>
perf used.</w>
perf used,</w>
perf ect</w>
percenti le)</w>
per- visit</w>
per- protocol</w>
per version</w>
per su
per one
perone al,</w>
per ineph
perineph ric</w>
per hex
perhex il
per ceptible</w>
per .</w>
peptidom imetic</w>
peptide -1</w>
peptide (1-
pep pers,</w>
pentylenetetrazole- kindled</w>
pentylenetetrazol- kindled</w>
pentylene trazol</w>
pentoxif ylline,</w>
pentoth al</w>
pentobarbital- anesthetized,</w>
pentobarbital- anaesthetized</w>
pentobarbit one.</w>
pentobarbit one-induced</w>
pentobarbit one-
pente trazol-induced</w>
pentano yl</w>
pentagastr in,</w>
penta acetic</w>
pent acyclic</w>
pent achloro
penicill inase-
penicill in-resistant</w>
penetr ation.</w>
penetr ated</w>
pene tran
pend ular</w>
penc il</w>
penc il-
pencil- point</w>
pen um
pen is.</w>
pemiro last</w>
pelle ts,</w>
pelle t.</w>
pegylated- interferon</w>
pedicel s</w>
pedic le</w>
pediatric s.</w>
peculi arities</w>
pector is:</w>
peak /
pe floxacin.</w>
pe bral</w>
pct x-then-cisDD
paw- lick
paw-lick /
pattern ).</w>
patter ning</w>
patter ned</w>
patient- years.</w>
patient s],</w>
patient s.(ABSTRACT</w>
patient );</w>
pathway s)</w>
pathophysi ologically</w>
patholog ist</w>
pathogene ses</w>
path y?</w>
path omorphological</w>
path ologically.</w>
patch- clamping</w>
partum .</w>
participat e.</w>
partici pation.</w>
parti tioning</w>
parti alis</w>
part s,</w>
part ment</w>
paroxet ine-controlled</w>
parkinsoni ans.</w>
parkinson ism:</w>
pariet al-
paren ts.</w>
parasympath olytic</w>
parasit es,</w>
parasit emia</w>
paras omni
parasomni as,</w>
paras ites</w>
paraphil ia</w>
parap legic</w>
parameter s;</w>
paraly sis:</w>
parallel- design</w>
paraffin- embedded</w>
paraf oveal</w>
paraf orm
paraesthesi ae</w>
paraesthe sia.</w>
para- aminohipp
par ting</w>
par ity</w>
par aver
par ath
parath or
parathor mon
par alimbic</w>
paqu e-
papillo pathy</w>
paper s.</w>
pap io
pantoprazol e,</w>
pannicul itis</w>
panic king</w>
pancur onium-
pancur onium)</w>
pancreas -
pancreas- kidney</w>
panames ine,</w>
pan lobular</w>
pan ic-
panic- inducing</w>
pan hypopituitar
pan el,</w>
pan cytopenic</w>
pamidron ate-associated</w>
palmito yl
palm -like</w>
pallid um,</w>
pair s,</w>
pair -matched</w>
pair )</w>
paeoniflor in</w>
paedi atrici
paclitaxel -containing</w>
paclitaxel )</w>
pac hy
pachy meningitis</w>
pa ying</w>
pa vine</w>
pa uses,</w>
pa emic</w>
p=0.00 6,</w>
p=0.00 5).</w>
p= 0.7
p= 0.001)</w>
p< 0.0001),</w>
p75NT R</w>
p. p.
p-benzo quinoneimine</w>
p-aminohipp urate</w>
p- nitro
p- EGFP</w>
p- ANCA</w>
p- 3</w>
p,p'- DDT</w>
p us</w>
p under
p tion/
p ont
p ond
p om
p iz
piz otifen</w>
p io
p ins</w>
p g)</w>
p elic
pelic ans</w>
p ear
p d</w>
p ating</w>
p anto
p an</w>
p NR1</w>
p Ki</w>
p H-
p CR</w>
p CO2</w>
p A2</w>
p A(2)</w>
p 75</w>
p 53-
p 450</w>
p 38+</w>
p 19
p19 q</w>
oyl- dopamine</w>
oxytoc in.</w>
oxytoc in-
oxytoc ic</w>
oxyphen butaz
oxypert ine.</w>
oxyp urines,</w>
oxyl ic</w>
oxygen )</w>
oxy n
oxyn ol-
oxy me
oxy hemoglobin,</w>
oxy flurane</w>
oxy demeton-
oxydemeton- methyl</w>
oxy )
oxo plasma</w>
oxit ropium</w>
oxidoreduct ase</w>
oxide- releasing</w>
oxide- blocked</w>
oxidase- deficient</w>
oxic ,</w>
oxib -induced</w>
oxi metry.</w>
oxi me
oxazol idinedione</w>
oxaz olo[3,2-a]
oxaproz in-induced</w>
oxamniqu ine.</w>
oxal dine</w>
oxal ate-
oxal acetic</w>
oxadi azol
ox prenolol.</w>
ox prenolol,</w>
ox ide)</w>
ox azepam,</w>
ox acin,</w>
ox abenz
ox .</w>
ox )</w>
ow ner</w>
ow n,</w>
oves tibular</w>
overshoot .</w>
overlap .</w>
over- activation</w>
over zealous</w>
over weight,</w>
over used</w>
over ri
over medication</w>
over ly</w>
over loading</w>
over flow.</w>
over dosing</w>
over dose)</w>
over dosage,</w>
over coming</w>
over all
overall ),</w>
over activity,</w>
ovari ectomized,</w>
ov um</w>
outcom e:</w>
outcom e).</w>
out standing</w>
out patients,</w>
out l
outl ined.</w>
out break
ouma rol</w>
ouabain- infused</w>
ouabain- displacing</w>
ouabain -like</w>
ou ve
ou mad
ou los</w>
ou l</w>
ou ber
ouber t</w>
otum ori
otrop is</w>
ototoxic ,</w>
otop oulos</w>
otom ous</w>
otom ies,</w>
otolaryng ology</w>
oto protective</w>
oti lit
otilit y,</w>
other ).</w>
other 's</w>
ot ria</w>
ot a
ostri ec
ostri atal</w>
osteosarcom a:</w>
osteoporo tic</w>
osteop ontin</w>
osteo arthritis,</w>
ost oma</w>
ost en
osper mia</w>
osmo tically</w>
osin or</w>
osi tis</w>
osi s;</w>
oscill ations,</w>
osalic ylates</w>
os us</w>
os odium</w>
os mium</w>
os mia</w>
os ity.</w>
os ine-induced</w>
os ant</w>
ory- Den
ory-Den k</w>
orubic in)</w>
orthop edic,</w>
ortho dromic</w>
orth ostasis</w>
orth obenzo
orth o-
orrh age</w>
orphan ol.</w>
oro- pharyngeal</w>
oro pharynx,</w>
orm ous</w>
orm al</w>
orm ad
oric e,</w>
ori pavine</w>
organell es,</w>
organ otypic</w>
organ o
organ izing</w>
organ ization.</w>
organ ization,</w>
organ ism.</w>
ore xin</w>
ore x.</w>
ore x,</w>
ore m
orch io
orchio ides</w>
or s:</w>
or n</w>
or me
or list
orlist at</w>
or dering</w>
or ange</w>
or al.</w>
or adic
or ).</w>
opyr rolid
optim al.</w>
oporphy rin</w>
opolysacchar ide</w>
opoi et
opisthoton us</w>
opioid- na</w>
opioid s:</w>
opini role</w>
opi riform</w>
opi perid
opi ate-dependent</w>
ophthalmop legia,</w>
ophthalmolog ist</w>
ophthalm oscopic</w>
ophil ized</w>
oph y
opex in</w>
oper ational</w>
oper able,</w>
open- ended</w>
open ly</w>
open er,</w>
open ed,</w>
opath y:</w>
opac ity</w>
opa usal</w>
op pon
op le's</w>
op kins</w>
op ip
op epti
op apillary</w>
onychomy cosis.</w>
onucle ase-
onit ri
ong -
oneph ritis</w>
one/ joint</w>
one- kidney</w>
one- fourth</w>
one- day</w>
one- containing</w>
one- compartment</w>
oncostatin- M</w>
oncolog y.</w>
once )</w>
onat remia</w>
on- off'</w>
on- drug</w>
on ward</w>
on nai
on ly-
only- treated</w>
on ing</w>
on in.</w>
on es)</w>
on chocer
onchocer c
on c
on azol
on acc
onacc i</w>
on ab
on -</w>
omycin/ vinblastine</w>
omycin- detectable</w>
omy oclonic</w>
omo tion</w>
omo ses</w>
omit ted.</w>
ometh yl</w>
ometh oxy-
omega- con
omega-con otoxin</w>
ome ter.</w>
ome )</w>
omat oid</w>
oma- bearing</w>
om y,</w>
om epirac</w>
om e,</w>
om as:</w>
om a;</w>
oly sis)</w>
ology- Head</w>
ologist ,</w>
ologic al.</w>
olog y/
olo g</w>
olo cal
olocal ization</w>
olipo protein</w>
oligodendro gliomas</w>
oligodendro glial</w>
oligo- anuric</w>
oligo anuric</w>
ole- coated</w>
ole oyl-dopamine</w>
ole amide,</w>
older -onset</w>
olanzap ine:</w>
olanzap ine/
ol uminal</w>
ol ta
ol mes
olmes art
ol li
ol enic</w>
ol e:</w>
ol ate,</w>
ol amine-</w>
ol amide</w>
ol .,</w>
ol -related</w>
ol "</w>
oil s,</w>
oid omy
ograph s</w>
ogen icity,</w>
ogen ic,</w>
offic ial</w>
off- therapy</w>
off ici
offici als</w>
off )</w>
of uro[2,3-e]pyrido[1,2-a][1,3]diazepin-12-ium</w>
of loxac
oest rus.</w>
odi xanol</w>
odi phenyl
odi gestive</w>
odi encephalic</w>
od rine,</w>
od d
od ar
od )</w>
ocytopen ia.</w>
ocyt es/
ocy tin</w>
ocy stine</w>
octreoti de-induced</w>
octahydro -5-
ocr yptin</w>
ocon ut</w>
oco elo
ocoelo mic</w>
ocicep tin</w>
oci verine</w>
och ronal</w>
oce phalic</w>
oce le,</w>
occur ring.</w>
occul t-positive</w>
occlu sion-induced</w>
occl uding</w>
occa sion.</w>
occ i</w>
ocarcin omas</w>
ocap illary</w>
ocalci uria</w>
ocal cemia</w>
oc urine</w>
oc tion</w>
oc occi
oc ia</w>
oc ho
ocho duodenal</w>
oc erebral</w>
oc el
obtun ded.</w>
obtun ded,</w>
obt und</w>
obstruc ting</w>
observer -bl
obliter ation.</w>
oblig atory</w>
oblast osis.</w>
object- recognition</w>
obic yclo[3.
obe se.</w>
ob tur
ob ronch
ob asal</w>
ob act
o-t subo-like</w>
o- vascular</w>
o- physiologic</w>
o- associated</w>
o- Nov
o-Nov um</w>
o- Dur
o val</w>
o sides,</w>
o olong</w>
o ils</w>
o ileal</w>
o il)</w>
o gram.</w>
o gram,</w>
o gest
o estrogen-induced</w>
o estrogen
o es</w>
o dul
o do
o ate</w>
o /
o -1
o )
nurser y</w>
nur se.</w>
number-needed-to- treat</w>
number-needed-to- harm</w>
nul lif
nullif ied</w>
nucleo side-induced</w>
nucle us)</w>
nucle osomal</w>
nucle olus</w>
nucle ated</w>
nucle ar-
now ad
nowad ays</w>
nov ar</w>
notochor d
notice d,</w>
noti fied</w>
not ed;</w>
not e,</w>
not ;</w>
not -
nose- throat</w>
norveg ic
nortriptyl ine-treated</w>
normoten sive.</w>
normoten si
normocalce mic</w>
normo vol
normo kal
normo glycemic</w>
normal- salt</w>
normal iz
normal ises</w>
norm s.</w>
norm ochromic</w>
norm ally,</w>
norepinephrine- selective</w>
nor pethidine.</w>
nor mon
normon at
normonat remic</w>
nor apomorphine</w>
none theless</w>
non- users.</w>
non- users,</w>
non- sustained,</w>
non- surviving</w>
non- substance</w>
non- smoking</w>
non- severe</w>
non- seizure</w>
non- responding</w>
non- responders.</w>
non- responder</w>
non- resectable</w>
non- psychiatric</w>
non- pretreated</w>
non- parkinsonian</w>
non- nociceptive</w>
non- nephrotic</w>
non- malignant</w>
non- lymphocytic</w>
non- lithium-treated</w>
non- linear</w>
non- kindled</w>
non- innervated</w>
non- injecting</w>
non- immune</w>
non- hypertensive</w>
non- hereditary</w>
non- genotoxic</w>
non- ergot-derived</w>
non- dose-related</w>
non- diagnostic</w>
non- cardioembolic</w>
non- abusers</w>
non- ST</w>
non- ST-segment</w>
non- NSAID</w>
non- AT</w>
non- APAP</w>
non- A,</w>
non white</w>
non verbal</w>
non use</w>
non treatment</w>
non synonymous</w>
non serious</w>
non selective,</w>
non renal</w>
non reabsorbable</w>
non randomly</w>
non psychotic</w>
non prophylactic</w>
non preferring</w>
non platinum-based</w>
non oxynol-
non obstructive</w>
non nucleoside</w>
non naproxen</w>
non lesioned</w>
non injurious</w>
non infectious</w>
non inbred</w>
non immobil
non hypotensive</w>
non hypertensive</w>
non hepatic</w>
non functional</w>
non fatal.</w>
non e.</w>
non contrast</w>
non compliance.</w>
non comparative</w>
non clipped</w>
non cholinergic</w>
non caseating</w>
non cardioselective</w>
non blind</w>
non azotemic</w>
non anemic</w>
non ambulatory</w>
non addictive</w>
nom inal</w>
noi se,</w>
noc tur
no sid
no rephinephrine</w>
no do
nodo ventricular</w>
no de
no ,</w>
nmol/ kg)</w>
nmol/ kg),</w>
nmol/ L)</w>
nmol e/
nmol .</w>
nitroso- vasodilators</w>
nitros amino)
nitroprusside :</w>
nitroprusside ).</w>
nitroglycer in;</w>
nitrofur an</w>
nitro- arginine</w>
nitro phenyl</w>
nitro flurbiprofen</w>
nitrazep am.</w>
nitrazep am,</w>
nit rergic</w>
nit rate-induced</w>
nisoldip ine;</w>
nis can</w>
nipec otic</w>
ninety- three</w>
ninety- nine</w>
nine- year-old</w>
nimesulide-beta-cyclodextr in,</w>
nigro -
nifedip ine/
nifedipine/ beta-blocker</w>
nid us</w>
nicotin amide.</w>
nicot ine-related</w>
nicoran dil.</w>
nic ergoline.</w>
nic arb
ni dipine</w>
ni acin-induced</w>
ni acin,</w>
ng/d l</w>
ng/d l.</w>
ng/ side)</w>
ng/ mouse,</w>
ng/ l</w>
ng. ml-1</w>
ng. kg-1.
newbor n
nevirap ine,</w>
neutrophil s/mm3)</w>
neutropen ic.</w>
neutropen ia;</w>
neutropen ia)</w>
neutr al
neut ro
neurotoxic ity)</w>
neuroten sin,</w>
neuropo re,</w>
neuropath y?</w>
neuropath y),</w>
neuron s).</w>
neuron es.</w>
neuroleptic -</w>
neurohypophy seal</w>
neuro- ophthalmology</w>
neuro- ophthalmic</w>
neuro toxicities</w>
neuro stimulation.</w>
neuro retinitis</w>
neuro protective,</w>
neuro protection,</w>
neuro physiology</w>
neuro peptides,</w>
neuro myopathy.</w>
neuro modulatory</w>
neuro modulators</w>
neuro lysis</w>
neuro kinin-1</w>
neuro imaging.</w>
neuro hypophysial</w>
neuro hormon
neuro filaments</w>
neuro filam
neuro fibrillary</w>
neuro epithelium.</w>
neuro development</w>
neuro cortical</w>
neuralg ia,</w>
neur al,</w>
nervos a.</w>
nerv ous,</w>
ner ve)</w>
nephrotoxic ity;</w>
nephrolith otomy</w>
nephro toxins</w>
nephro tics</w>
nephro sclerosis.</w>
nephro pathies</w>
nephro logical</w>
nephro gram</w>
nephro angiography.</w>
nephri tis:</w>
neph roure
neovascular ization</w>
neoplasi as</w>
neoplasi as.</w>
neo form
neo adjuv
nelfin avir.</w>
nel len</w>
negl ected.</w>
negl ect</w>
negati ve;</w>
negati ve/
neg ligible,</w>
neg ated</w>
nefir acetam,</w>
nefazod one-treated</w>
nefazod one,</w>
needl estic
needlestic k</w>
need les,</w>
nedocrom il.</w>
necros ectomy</w>
necro tic.</w>
necro sis),</w>
necro -
necess ary
near- syncope.</w>
near- maximal</w>
near by</w>
ne ys</w>
ne ver-
ne pic
ne op
ne me
neme str
ne mat
ne biv
ne ap
nausea/ vomiting.</w>
nause ated</w>
natur ally-
naturally- occurring</w>
nation wide,</w>
nas ally</w>
narco tics,</w>
narco tic-
naphthal en-2-
naphthal en
nam ing</w>
nam ese</w>
naltrexone- precipitated</w>
naloxone- sensitive.</w>
nalox onium</w>
nalbuph ine,</w>
nal tr
nal )</w>
nai ;
nai; ve</w>
nafcill in-induced</w>
nafcill in-associated</w>
nafcill in,</w>
nabil one</w>
nM/ 0.5</w>
n= 5),</w>
n= 15)</w>
n-hex ane</w>
n- superoxide</w>
n- methyl
n- butyl-
n- butyl
n y</w>
n us
n orgest
n org
n m.</w>
n m),</w>
n l</w>
n ith
nith ine</w>
n ine.</w>
n i</w>
n d</w>
n able</w>
n SM
n NOS,</w>
myotub es,</w>
myoton ia.</w>
myosi tis:</w>
myop ia,</w>
myoglob in,</w>
myofibri ls</w>
myocardi um;</w>
myocardi um:</w>
myocardi al-
myocardial- infarcted</w>
myocardi a.</w>
myo relaxant</w>
myo pathology</w>
myo fibers.</w>
myeloperoxidase- antineutrophil</w>
myelogram .</w>
myelo- optico-
myelin ation.</w>
myel oradic
myel in.</w>
mye lography,</w>
mye logram</w>
myco tic</w>
myc in</w>
my oneuropathy.</w>
my omas</w>
my ographic</w>
my oblast</w>
my c</w>
mut ed</w>
muscul ature</w>
muscle -specific</w>
muscle -related</w>
mus h
mus culo
murmur s</w>
mur m
murm ur</w>
mur aglitaz
mumol/ mouse)</w>
mumol/ l.</w>
mumol/ l,</w>
mumol/ kg).</w>
mumol/ g</w>
mumol ),</w>
mum ol,</w>
multis ite,</w>
multifor me,</w>
multi tude</w>
multi systemic</w>
multi spike</w>
multi plying</w>
multi focal,</w>
multi drug-
multi discipl
multi day</w>
multi channel</w>
mul tim
mul ti</w>
mug/ ml,</w>
mug/ min)</w>
mug/ kg/min)</w>
mug/ kg,</w>
mug/ g</w>
mu sic.</w>
mu /kg)</w>
mu -</w>
mt BER</w>
msec ;</w>
moxisyly te</w>
moxi role</w>
mouthrin ses</w>
moun ting</w>
moun tain</w>
mou se-
motiv ational,</w>
motiv ating</w>
mother -to-
mot orized</w>
mot or)</w>
mosmol/ kg
mortal ity:</w>
mortal ity
morphometr ical</w>
morpholin o-
morphol ino</w>
morphine- sensitized</w>
morphine- neostigmine</w>
morphine- chloralose</w>
morphin an</w>
morph ine/
morph ine-</w>
morph ic
moric izine.</w>
mor ib
morib und</w>
mood- stabilizing</w>
monoter pene</w>
monom ers</w>
monolay ers</w>
mono- ADP-ribosylation</w>
mono therapy-induced</w>
mono oxygenase</w>
mono hydrated</w>
mono amines,</w>
mono -</w>
monni era,</w>
monke y,</w>
monitor ing)</w>
monitor ,</w>
mon ofilam
mon ocyto
mon ocytes/
mon oblastic</w>
mon ,</w>
molsidom ine</w>
molec ular,</w>
mol/ L.</w>
mol/ L,</w>
mol/ L)</w>
mol/ L),</w>
mol et
mol .</w>
modul es</w>
modul ators.</w>
modul ation,</w>
modific ation,</w>
model s;</w>
mode )</w>
moclobem ide.</w>
mo pathy,</w>
mo ).</w>
mmug. /ml.</w>
mmol/L ];</w>
mmol/ kg/
mmol/ kg.</w>
mmol/ day</w>
mmol/ L),</w>
mmHg ]</w>
mm 2,</w>
mm (3),</w>
mm (2)</w>
ml/ minute,</w>
ml/ h).</w>
ml/ 10</w>
ml.min-1. 100</w>
ml U/ml,</w>
ml (-1).</w>
ml (-1))</w>
mitr al,</w>
mitoxantr one-induced</w>
mitomycin- c</w>
mitomycin- C.</w>
mitochondri a-
miti gates</w>
mit rine</w>
mit osis</w>
mit ogens</w>
mit ogenesis</w>
mis sing.</w>
mis adv
misadv ent
mio tic</w>
mio sis;</w>
mio -
mio- Aque
mio-Aque ous)</w>
minut e).</w>
minim um-
minim ising</w>
mini- pumps</w>
mini- dose"</w>
mini -dose</w>
mineralocortico ids.</w>
miner als,</w>
min/ m2,</w>
min/ g</w>
min(-1 );</w>
min ido
min ating</w>
milrin one-associated</w>
millisecond s;</w>
millilit er.</w>
mill ary</w>
mil k
mil der.</w>
migra ines,</w>
migra ine
midagli zole</w>
mid- papillary</w>
mid pontine</w>
mid brain.</w>
mid -to-
mid-to- apical</w>
mid ,</w>
micturi tion;</w>
microtubule- stabilizing</w>
microscop y)</w>
microscop e,</w>
micron s.</w>
micron s,</w>
micron g)</w>
micromol/ l),</w>
micromol/ kg),</w>
micromol/ L
microm )</w>
microliters/ min/100</w>
micrograms/kg/ min),</w>
micrograms/kg/ hr</w>
micrograms/kg/ day,</w>
micrograms/kg/ day)</w>
micrograms/ rat).</w>
micrograms/ min,</w>
micrograms/ min)</w>
micrograms/ kg
micrograms/ h</w>
micrograms/ day.</w>
micrograms/ day,</w>
micrograms/ day)</w>
micrograms/ day),</w>
micrograms/ L</w>
micrograms/ 50</w>
micrograms/ 100</w>
micrograms.kg-1. min-1,</w>
micrograms.kg-1. min-1),</w>
micrograms. ml-1</w>
micrograms. kg
micrograms.kg -1/
micrograms.kg-1/ day,</w>
microgram/ liter)</w>
microgram. /ml.</w>
microgram ,</w>
microgram ).</w>
microgram ),</w>
microglobul inuria,</w>
microglobul in,</w>
microglobul in)</w>
microglia- conditioned</w>
microgli a.</w>
microg/paw )</w>
microg/m L).</w>
microg/kg/ hour.</w>
microg/ week</w>
microg/ paw,</w>
microg/ ml);</w>
microg/ min</w>
microg/ kg
microg/ d
microg/ 24</w>
microg /</w>
microfilare mia</w>
microfil ariae</w>
microcephal ic</w>
microbub ble</w>
micro villous</w>
micro tubules,</w>
micro transplanted</w>
micro stom
micro particles</w>
micro organisms</w>
micro micron
micro filaments</w>
micro environment</w>
micro encapsulated</w>
micro dialysis,</w>
micro cytic</w>
micro cysts</w>
micro bi
micro arra
micro M
microM )-
micro Ci</w>
micro -</w>
micafun gin</w>
mianser ine</w>
mi le
mi anserin.</w>
mg/ml/ hr</w>
mg/m2/ wk.</w>
mg/m2/ week,</w>
mg/m2/ week)</w>
mg/m2/ d,</w>
mg/m(2)/ day.</w>
mg/m l),</w>
mg/m /
mg/kg/ min.</w>
mg/kg/ injection</w>
mg/kg/ i.p.,</w>
mg/kg/ i.p.)</w>
mg/kg/ hr)</w>
mg/kg/ h,</w>
mg/kg/ day
mg/kg/ 4</w>
mg/kg ]</w>
mg/kg :</w>
mg/kg /</w>
mg/kg ):</w>
mg/d ),</w>
mg/K g,</w>
mg/(kg. d).</w>
mg/ rat</w>
mg/ min,</w>
mg/ min),</w>
mg/ mg</w>
mg/ infusion)</w>
mg/ hour.</w>
mg/ h/rat</w>
mg/ eye
mg/ day
mg/ M2</w>
mg/ 24
mg/ 150</w>
mg.kg-1. min-1)</w>
mg./kg .;</w>
mg. l-1</w>
mg. kg</w>
mg. kg-1),</w>
mg. kg(-1).</w>
mg. ).</w>
mg s%,</w>
mg %,</w>
metyrap one</w>
metrizo ate,</w>
metra zole-induced</w>
methylprednisol one-induced</w>
methylenedioxy methamphet
methylene tetrahydrofolate</w>
methyl-6- oxo-
methyl-5- phosphono-3-
methyl sulphon
methyl nitrosourea</w>
methyl nitrosamino)
methyl histamine,</w>
methyl ergonov
methyl ergometrine</w>
methyl ergometr
methyl ]
methyl -1-phenyl-
methoxy-4-iodo phenyl)-2-amino
methoxy naphthalen-2-
methoxy ch
methoxych lor</w>
methoxy ]
methotrex ate:</w>
methotrex ate-related</w>
methodolog ies</w>
methodolog ically</w>
methodo logic</w>
method s:</w>
methiodi de-induced</w>
methemoglob inemia.</w>
methan esulfonate</w>
methamphetamine- exposed</w>
methaemo globin</w>
methad one:</w>
metergol ine,</w>
metaproteren ol,</w>
metam orph
metabolit e)</w>
metabolit e
metab onom
metab olomic</w>
meta- iodobenzyl
met/ dex
met- enkephalin</w>
met ocurine</w>
met ine</w>
met in-induced</w>
met aplastic</w>
met a</w>
mesotheli oma,</w>
meso dermal</w>
meso accumbens</w>
mesi late,</w>
mesench yme
mesangi olysis.</w>
mesangi ocapillary</w>
mes ostriatal</w>
mes op
mes odiencephalic</w>
mes ine</w>
mes encephalon,</w>
meropen em,</w>
mercaptop urine.</w>
mequit azine</w>
meq/ lt,</w>
meq/ kg,</w>
meq/ day</w>
mepivaca ine-treated</w>
mephed ron
meperid ine-related</w>
meperid ine)</w>
meperid ine's</w>
ment )</w>
menstru ating</w>
menopa use</w>
menopa use.</w>
menopa use,</w>
meningo encephalitis.</w>
meningiti s-like</w>
membrane- permeable</w>
membran es;</w>
mem antine
melphalan- platinum</w>
meloxic am,</w>
mellit us;</w>
melatonin- injected</w>
melanchol ia,</w>
melan oma:</w>
melan ocor
mel perone</w>
mel a
mela en
meg estrol</w>
mefloqu ine:</w>
medulloblast oma.</w>
medull a),</w>
medroxy- acetate</w>
medoxom il-induced</w>
medium -dose</w>
medic ines.</w>
medic ine-
medic ation;</w>
medic ation)</w>
medi ator,</w>
medi ated)</w>
medi al,</w>
mecli zine</w>
mechano- responsive</w>
mechano receptive</w>
mechano -</w>
mechan omyo
mecamyl amine.</w>
mec lofen
measurement s)</w>
measure ),</w>
me therg
me test
me tach
me q</w>
me phenteramine</w>
me lit
melit tin</w>
me ga
me anti
meanti me,</w>
me an-
me al.</w>
me al,</w>
me al
mdr 1
mc g,</w>
may onnai
maxim um)</w>
maxim ized</w>
maxim al,</w>
maxim a</w>
max ;</w>
max ).</w>
matur ity.</w>
matrix- assisted</w>
matic s</w>
mathem atical</w>
mater nal-fetal</w>
mater nal,</w>
match -to-
mat uring</w>
mat es</w>
mat er</w>
mast at</w>
mass age.</w>
mas ses,</w>
marrow -derived</w>
market ing.</w>
market ing,</w>
mark et,</w>
mark er.</w>
mark er)</w>
marg in,</w>
mar a</w>
maprotil ine,</w>
mapp ing,</w>
manufact uring</w>
manufact ures</w>
manipul ative</w>
manipul ation,</w>
manipul ating</w>
manifest .</w>
mang ane
mangane se,</w>
maneu vers,</w>
mandat ory,</w>
manage able,</w>
man uscript</w>
man si</w>
man nose</w>
man date</w>
malondi aldehy
malign ant,</w>
malform ations:</w>
male :
male: female</w>
malar ia-
mal onate</w>
mal es),</w>
mal distribution</w>
mal ate,</w>
mal absorption.</w>
mal -
maj or,</w>
magnoc ellular</w>
magne to
macroscop ic,</w>
macroli de-
macrolide- resistant</w>
macroglobul inemia.</w>
macro structural</w>
macro prolactinoma.</w>
mach ines.</w>
ma st-cell</w>
ma ine</w>
mM/ L)</w>
mL/ minute</w>
mL/ min)</w>
mL/ h</w>
mL/ g/min</w>
mL/ d</w>
mL. min-1.
mL (-1),</w>
mGluR 1-
mGluR 1,</w>
mGlu 2/3</w>
mGlu 1a</w>
mEq/ kg/day</w>
mEq/ kg/
mEq/ kg,</w>
mEq/ d</w>
mEq. L-1</w>
m/ mg</w>
m/ day</w>
m. w.
m- CP
m- 2.</w>
m ul</w>
m t</w>
m nesic</w>
m itis.</w>
m itis,</w>
m i</w>
m es</w>
m echloreth
m d
m arc
m V,</w>
m V)</w>
m V).</w>
m U</w>
m RCC</w>
m N</w>
m L-1</w>
m CD</w>
m CAT</w>
m A,</w>
m A)</w>
m -induced</w>
m --a</w>
lysophosphatidyl choline</w>
lysine- vasopressin</w>
lymphoplasmacy tic</w>
lymphom a;</w>
lymph- node</w>
lymph oma:</w>
lymph ocytosis,</w>
lymph ocytopenia</w>
lymph ocele</w>
ly- tail</w>
ly ophilized</w>
lun ted</w>
lumirac oxib</w>
lum ens</w>
lum en,</w>
luc ifer
lozeng e.</w>
lox apine,</w>
low- signal</w>
low- normal</w>
low- intensity</w>
low- fat</w>
low- doses</w>
low- back</w>
low- K(+)-induced</w>
low :</w>
los s/
los s),</w>
lorat adine,</w>
loracarbef ,</w>
lor id
lopin avir</w>
loop s,</w>
loop .</w>
loo ks</w>
loo k-
look- ali
look-ali ke
look-alike "</w>
longitud inally</w>
long- observation</w>
long- latency</w>
long- lasting.</w>
long ,</w>
lon gl
longl ast
longlast ing</w>
lon a,</w>
lograf t</w>
logar ith
log rank</w>
lofex idine.</w>
lofex idine,</w>
loci .</w>
local ized,</w>
local isation</w>
lob ectomy</w>
load ing)</w>
lo vastatin.</w>
lo tion</w>
lo tion.</w>
lo peramide</w>
lo l-
lo l)</w>
lo del</w>
lm Categor
lmCategor y="
lixim ab
liver s,</w>
liver /
littermat es,</w>
litter s,</w>
litres /
litre -1)</w>
lithium- pilocarpine.</w>
lithium :</w>
lithium -related</w>
lith rix</w>
liter ;</w>
lit ter,</w>
lit res</w>
list ening</w>
list ed,</w>
lipopolysacchar ide,</w>
lipofus cin
lipo protein,</w>
lipo peroxides,</w>
lipo peroxidation</w>
lip iz
lip idosis</w>
lip ase,</w>
lingual- faci
lingual-faci al-
lingual-facial- buccal</w>
line :</w>
lind ane-treated</w>
lin olenic</w>
lin k.</w>
limit ation,</w>
limit .</w>
lim ination</w>
lim aprost</w>
lignocaine/ ketamine</w>
ligi ble
light-heade dness</w>
light- microscopic</w>
light- chain</w>
ligand- gated</w>
ligand -</w>
ligam ent</w>
lig ature</w>
life- table</w>
life- support</w>
lif ting</w>
lif e;</w>
lie u</w>
lid ine,</w>
lic ular</w>
lic l
lic kin
lickin g/
lic ation</w>
lic arbazepine</w>
li ving,</w>
li ves.</w>
li v
li sten
li st.</w>
li potropic</w>
li pidic</w>
li ability,</w>
levonorgestrel -containing</w>
levome promazine.</w>
levof loxacin-induced</w>
levodopa :</w>
levo- isomer</w>
lever- pressing</w>
level s).</w>
level ed</w>
level ).</w>
level ),</w>
levamisol e,</w>
lev it
leupro relin,</w>
leukocyt uria,</w>
leuko encephalopath
leukem ias</w>
leukem ias,</w>
leuk ocyte-integrins
leuk aemic</w>
leucovor in.</w>
leucine-enkephal in,</w>
leuc oencephalopathy</w>
letharg y.</w>
lest at</w>
less on</w>
less ness</w>
less ly</w>
lesion ing.</w>
lept in,</w>
lepro sum.</w>
lepro sum,</w>
length ;</w>
leng then</w>
leiomy omas</w>
lect ins.</w>
leb bec
least -
least- squares</w>
learn ing:</w>
leaf lets</w>
le y's</w>
le ver.</w>
le rene</w>
le mon
le ine-
leine- Lev
leine-Lev in</w>
le gi
le av
le ase</w>
le aping</w>
lay er-
layer- specific</w>
later ality</w>
later )</w>
later ).</w>
late- phase</w>
lat encies,</w>
lat .</w>
las tic,</w>
laryn x,</w>
large- tumor</w>
large- conductance</w>
large- artery</w>
large ment</w>
large -cell</w>
larg e.</w>
langu age-
land ing</w>
lan der</w>
lamotrig ine-associated</w>
lamin ar</w>
lam el
lamel lipo
lacunosum- moleculare</w>
lacunos um</w>
lacun ar</w>
lact ulose,</w>
lact ofer
lac -induced</w>
labyr in
labyrin thine</w>
lab d
labd ane</w>
l. min-1,</w>
l. m.w.
l- propranolol</w>
l- propranolol,</w>
l- methyl
l- isoproterenol</w>
l- dopa</w>
l- bun
l-bun olol</w>
l- baclofen</w>
l- DO
l- CMRg</w>
l- B
l- 201</w>
l s.</w>
l d
l b,</w>
l ass
l apsed</w>
l ant
l ag
l :
l -like</w>
l -1,</w>
l '
kynuren ate</w>
know .</w>
know ,</w>
knock- down</w>
knock out
kinin ogen
kine matical</w>
kind le
kinase- 1</w>
kin inogen</w>
kilogram s</w>
kilodal ton</w>
kill ing.</w>
kidney/ pancreas</w>
kidney- pancreas</w>
kidney s)</w>
kidne y;</w>
khe ll
kg/m (2))</w>
kg(-1) day(-1),</w>
kg .,</w>
keto profen.</w>
keto acidosis</w>
ketamine- alfentanil</w>
ket ones</w>
ket anserin.</w>
ket amine:</w>
ket amine),</w>
kerat ouve
kerat inocyte</w>
kerat in,</w>
kary otyp
kaol in-induced</w>
kanam ycin-induced</w>
kali ure
kPa -1,</w>
kP a.</w>
kP a,</w>
kD a-
k- up</w>
k tail</w>
k it
k en
k ed:</w>
k dynes/cm
k dyn
k a-
k J</w>
k 2</w>
k /
jux tac
justi fying</w>
junc tivi
jun ,</w>
jump ing.</w>
jug ated</w>
judg ments</w>
judg e</w>
join ts.</w>
jo ules</w>
jo ining</w>
jirovec ii</w>
jer k</w>
jejun oileal</w>
je al
jaundic ed.</w>
jat mansi</w>
jasplakin olide</w>
jac ulatory</w>
jac ch
j ump</w>
j ect</w>
iz er,</w>
iz able</w>
ity ,"</w>
ity '</w>
itrat uria</w>
itrac onazole.</w>
itrac in</w>
ithrom ycin,</w>
ith ful</w>
iter ative</w>
it tin</w>
it rile</w>
it ori
it ol-
it ching,</w>
it ch.</w>
it ;</w>
it /
it/ explicit</w>
ist ostatin</w>
isozym es</w>
isoxazol -5-
isotretino in,</w>
isoproterenol- stimulated</w>
isoproterenol- sensitive</w>
isoproterenol- pretreated</w>
isoproteren ol/
isoprenal ine-treated</w>
isom eric</w>
isol ect
isolect in-
isol ates),</w>
isol ate),</w>
isoflurane -</w>
isobut yl
isob olog
iso- PGF(2
iso thermal</w>
iso form
iso flav
ischemia/ reperfusion-induced</w>
ischem ia)</w>
ischaem ia-reperfusion</w>
isch -
isch- Her
isch-Her xheimer</w>
is s</w>
is ole</w>
is ochrom
is lets</w>
is le
is lands</w>
is ),</w>
irrit ation),</w>
irrig ated</w>
iron/ HCB</w>
iron- mediated</w>
irCR F)</w>
ir regularly</w>
ir rational</w>
ir on
ir i</w>
ir bes
ir algia</w>
ir al</w>
ipsilater al,</w>
ipsi -</w>
ipsapir one</w>
ipsapir one,</w>
ip pin
ioxil an,</w>
iotrol an</w>
iotrol an,</w>
iothalam ate</w>
ioprom ide,</w>
iontophore tic</w>
ion tophoresed</w>
ion s,</w>
ion ization</w>
iodine-1 25-
iod ine/
io sis</w>
io din
investigator-bl inded,</w>
investig ators'</w>
investig ate,</w>
inverte d-
inverted- screen</w>
intub ation-induced</w>
intravesi cal
intravesical ),</w>
intraventric ularly.</w>
intravenous ly).</w>
intravenous ly),</w>
intravenous )</w>
intrasub ject</w>
intraplant arly</w>
intranigr ally</w>
intranas ally</w>
intranas al,</w>
intramuscular ly.</w>
intramuscular ly)</w>
intramuscul ar,</w>
intram y
intram embranous</w>
intral ymphatic</w>
intral amin
intralamin ar</w>
intracol licular</w>
intracerebroventric ular
intrac aud
intracaud ate</w>
intra- raphe</w>
intra- group</w>
intra- amniotic</w>
intra- CP</w>
intra vesicular</w>
intra urethral</w>
intra thoracic</w>
intra jugular</w>
intra abdominal</w>
intr ic
intr atracheal</w>
intr alip
intr afascicular</w>
intoxic ated.</w>
intim ate</w>
intest ines</w>
intervie wed.</w>
intervie wed,</w>
interrup ted.</w>
interru ption.</w>
interpre tation.</w>
interpre table</w>
internal ization</w>
intermitt ently.</w>
intermediate- duration</w>
intermediate- acting</w>
intermedi ate.</w>
intermedi ate,</w>
interleukin-1 beta,</w>
interferon- gamma,</w>
interferon- alpha2a</w>
interferon- alpha.</w>
interferon- alpha-2
intercros s,</w>
interac tion)</w>
interac tion
inter rog
inter pol
inter personal</w>
inter nucleosomal</w>
inter menstrual</w>
inter body</w>
intensi fication.</w>
intensi fi
integr ins</w>
intact )</w>
int y.</w>
int ussusception</w>
insul t,</w>
insul in/
insul a</w>
insufficiency ;</w>
insuffici ently</w>
insuffici ent.</w>
instrum ent,</w>
institution 's</w>
institut e.</w>
institu tions,</w>
inst atement</w>
inst anc
inst all
inspi red)</w>
insidi ous,</w>
inser tions</w>
inser tion,</w>
insectic ides</w>
insectic ide,</w>
inqu iry</w>
inotrop y.</w>
inotrop ism.</w>
ino ]
innov ative</w>
innoc ent</w>
injection s;</w>
injection s:</w>
injection s).</w>
injection -associated</w>
inject ed;</w>
inj ures</w>
initi atives</w>
inhibitor s)</w>
inhibitor :</w>
inhib in</w>
ingre di
ing- Bre
ing-Bre uer</w>
ing ual</w>
ing row
ing iv
ing es</w>
ing a</w>
ing ?</w>
ing ."</w>
infusion s;</w>
infusion s)</w>
infra- Hisian</w>
infra- His</w>
inform ative</w>
inflamm ation-induced</w>
infl ation.</w>
infl ation,</w>
inferi or,</w>
infer oposterior</w>
infec tion;</w>
infarct- like</w>
infarc tion?</w>
infarc tion).</w>
inf liximab</w>
inf lexi
inf est
inf erence</w>
inf ected,</w>
inf ected
infected ).</w>
inf -DXR</w>
inexpen sive,</w>
ine- trimethoprim</w>
ine- pancuronium</w>
ine- dinucleotide</w>
ine- N-
ine- -a</w>
ine mic,</w>
ine /</w>
ine '</w>
industr y.</w>
induc tively</w>
induc tion;</w>
induc ed;</w>
induc ed:</w>
indor amin
indoramin .</w>
indomethac in:</w>
indomethac in
indomet acin</w>
individual s)</w>
individual ize</w>
individu ally.</w>
indinavir /
indinavir -containing</w>
indic ator.</w>
index -
index ),</w>
ind opril</w>
incub ations</w>
incub ation.</w>
increas ed:</w>
increas ed
increas e),</w>
incre ments,</w>
incre menting</w>
incre ment
incorpor ates</w>
incoordin ation,</w>
include s:</w>
includ ing,</w>
incid ences.</w>
inci sion.</w>
inc urring</w>
inc ised</w>
inc en
incen tive</w>
inapar sin</w>
inadver t
in/ platelet</w>
in/ plasma</w>
in/ clavulanic</w>
in-3- ol</w>
in- house</w>
in- fibrate</w>
in- conjugated</w>
in- aden
in-aden ine-dinucleotide</w>
in- 4</w>
in- 2</w>
in surance</w>
in sur
in operable,</w>
in ism</w>
in ine,</w>
in hospital</w>
in distinguish
in direct-acting</w>
in dig
indig es
in dependently.</w>
in depend
in conveni
in comprehen
incomprehen sible</w>
in bre
in appropriate,</w>
in apo
inapo ylsucrose</w>
in aemia,</w>
in adequate.</w>
in activates</w>
in accuracy</w>
in (1-
in(1- 31)</w>
impul ses.</w>
improve d"</w>
impregn ation</w>
implic it/explicit</w>
impe ded</w>
imp act,</w>
immunost ained</w>
immunore active.</w>
immunofluoresc ence.</w>
immunocyt ochemistry,</w>
immunoblot ting,</w>
immunoblo ts</w>
immuno- electrophoresis</w>
immuno- allergic</w>
immuno therapy,</w>
immuno expression</w>
immuno deficient</w>
immune -related</w>
immun opathogenesis</w>
immun opath
immun ologic,</w>
immun ochemically</w>
imipr amine-
imipr amine)</w>
imidazol e,</w>
imidaz o</w>
imidaz o-
imidaz o
imidaz enil,</w>
imatinib ,</w>
imat inib.</w>
imag ing)</w>
imag e-
im yelo
im purities</w>
im poverished</w>
im potent</w>
im post
im pose</w>
im perfor
im m</w>
im ido
ilo prost.</w>
illu mination</w>
illo pharmacological</w>
illic itly</w>
ile ostoma</w>
ilater al,</w>
il- sensitive</w>
il ine-induced</w>
il ic
igno red.</w>
ig mesine</w>
ifosfamide -containing</w>
ifenpro dil.</w>
idiosyncrati c.</w>
idi tis</w>
idi aphrag
idiaphrag m</w>
ider oblastic</w>
identi f
ide ation,</w>
id- rifampin</w>
id ystonia</w>
id ine)</w>
id ine's</w>
id ergic</w>
id ectomy</w>
id din
id ;</w>
id ),</w>
icul us</w>
icter us.</w>
iclo zotan</w>
ichthyo sis</w>
ichi 's</w>
ic- type</w>
ic- clonic</w>
ic- acid-induced</w>
ic v.</w>
ic one</w>
ic le</w>
ic idin</w>
ic ide,</w>
ic ene</w>
ic eb
iceb erg
iceberg ?</w>
ic ation</w>
ic atibant</w>
ic aria</w>
ic als,</w>
ic a.</w>
ibuprofen -treated</w>
ibuprofen -related</w>
ibuprofen -associated</w>
ibu tilide-induced</w>
iberi otoxin</w>
ia- hypercalciuria</w>
ia .(ABSTRACT</w>
iK r</w>
i.v )</w>
i.th .)</w>
i.t .,</w>
i.t .),</w>
i.pl .</w>
i.p. )-
i.p ,</w>
i.p ).</w>
i.m .),</w>
i.c.v .;</w>
i.c.v .-
i. t.
i. d
i. c.
i verm
i u</w>
i tion,</w>
i po
i otopoulos</w>
i os
i ii)</w>
i ence</w>
i atrogenically</w>
i NOS,</w>
i NO</w>
i CCD</w>
i AVP</w>
i -like</w>
hysterosalping ography</w>
hyster oscopy</w>
hypoxia- responsive</w>
hypox ia-related</w>
hypox aemia,</w>
hypovol emic,</w>
hypovol aemia</w>
hypoton y,</w>
hypother mia;</w>
hypother m
hypothe ses,</w>
hypothalamo- pituitary</w>
hypotension- sensitive</w>
hypotension- evoked</w>
hypos ensi
hyposensi tivity</w>
hyporen inaemic</w>
hypopituitar ism.</w>
hypophysi otropic</w>
hypophys ectomy</w>
hypomethyl ation</w>
hypomania/ mania</w>
hypoman ia.</w>
hypomagnesem ia-hypercalciuria</w>
hypomagne semic</w>
hypom otility,</w>
hypokalem ia;</w>
hypokalem ia:</w>
hypokal aemic</w>
hypogonadis m,</w>
hypocholesterol emic</w>
hypocalce mic</w>
hypoc itraturia</w>
hypoc arb
hypocarb ia</w>
hypoalbum inemic</w>
hypo vitaminosis</w>
hypo ventilation,</w>
hypo gastric</w>
hypo fractionated</w>
hypo estrogen
hypo der
hypoder mic</w>
hypo activity,</w>
hypo activations</w>
hypno tics,</w>
hypno s</w>
hyperuric emia.</w>
hyperuric emia,</w>
hyperuric aemia</w>
hypertrophy ;</w>
hypertricho sis,</w>
hyperton us</w>
hyperton ia,</w>
hyperthyrox inemia</w>
hyperther mia-induced</w>
hypertension ,"</w>
hypertensin ogenic</w>
hypertensi ves,</w>
hyperten sion-induced</w>
hyperten sion).</w>
hypersensitiv ity)</w>
hyperprolactine mia:</w>
hyperprolactin aemia.</w>
hyperplasi a:</w>
hyperoxal uria.</w>
hypernat raemic</w>
hypermagnesi uria</w>
hyperlipid aemic</w>
hyperlipid aemia</w>
hyperlipid aemia,</w>
hyperlip emia,</w>
hyperkine sis</w>
hyperkine sis,</w>
hyperkal aemia,</w>
hyperkal aem
hyperinsul inemic</w>
hyperinsul inemia,</w>
hyperhid rosis,</w>
hyperglyc inemia</w>
hyperestrogen emia</w>
hypereosinophil ia,</w>
hypercoagul ability,</w>
hypercholesterol aemia.</w>
hypercalce mia;</w>
hypercalce mia:</w>
hyperal im
hyper- responsive</w>
hyper- reactivity</w>
hyper- prolactinemia</w>
hyper volemic</w>
hyper thyroid</w>
hyper thymic</w>
hyper salivation,</w>
hyper production</w>
hyper pigmentation</w>
hyper pigmentation,</w>
hyper physiological</w>
hyper phosphorylated</w>
hyper phagia,</w>
hyper p
hyper motility,</w>
hyper fractionated</w>
hyper filtration,</w>
hyper androgen
hyper aemia</w>
hyper adrenergic</w>
hyper activity:</w>
hype resthesia</w>
hyp sarrhythmia</w>
hyp oxic,</w>
hydroxyl ation.</w>
hydroxyeicos a-
hydroxychloroquine-plus- piroxicam-treated</w>
hydroxychloroquine-plus- piroxicam,</w>
hydroxybut yrate</w>
hydroxy-3- [4-
hydroxy- ethoxy)
hydroxy-ethoxy) tropane</w>
hydroxy- DA-
hydroxy urea,</w>
hydroxy proline,</w>
hydroxy apati
hydroxy anisol
hydroxyanisol e,</w>
hydroxam ates</w>
hydrox yl-
hydroureteroneph rosis</w>
hydropen ia</w>
hydromorph one,</w>
hydroly zes</w>
hydrochlorothiazide- triamterene</w>
hydrochlorothiaz ide-induced</w>
hydrochlor ide;</w>
hydrochlor ide),</w>
hydro peroxy
hydro peroxide
hydro ethanol</w>
hydro cod
hydro carbons</w>
hydro bromide,</w>
hydramni os,</w>
hydra zone</w>
hydra zinophthalazine-treated</w>
hydr o</w>
hydr ation)</w>
hydantoin )</w>
hybri dis
hyaluron idase</w>
hyalin ization</w>
hy oscyamine</w>
hy osc
hum oral,</w>
huPB L</w>
hr -1)</w>
hot plate</w>
hospital izations.</w>
hospital isation.</w>
hospital is
hospit al-
hormone- treated</w>
hormone- secreting</w>
hormone- related</w>
hormone- producing</w>
hormone- independent</w>
homozyg ot
homolog ue</w>
homoiother ms.</w>
hom ota
hom e-
hom e,</w>
holid ays</w>
hol low</w>
hodgkin s
ho st.</w>
histolog y)</w>
histi ocytosis</w>
histi ocytosis.</w>
histi ocytes.</w>
histamine- 1</w>
histamin erg
hist oplasmo
hist omorph
hist ologically,</w>
hist ologic,</w>
hist ocompatibility</w>
hist ochemistry,</w>
hist ochemically.</w>
hist ochemical,</w>
hist ine,</w>
hippocampi .</w>
hippocamp us-dependent</w>
hippocamp us)</w>
hippocamp us
hippocam po-entorhinal</w>
hind quarter</w>
hind quarter
hin der</w>
him self</w>
hilus =
high- risk,</w>
high- quality</w>
high- normal</w>
high- level,</w>
high- fat</w>
high )</w>
hierarch ical</w>
hexos amine,</w>
hexobarbit al-induced</w>
hexo se,</w>
hexamethyl melamine</w>
hexafluoro cyclo
hexafluorocyclo but
hexa relin</w>
hex atri
hexatri ene</w>
hex achlor
heterozyg otes</w>
heterotop ically</w>
heterogene ous.</w>
heterogene ity.</w>
heter ocyclic</w>
heta starch
herp es
herni as</w>
her nia.</w>
her nia,</w>
heptano ate</w>
hept aminol</w>
hepatocyt es;</w>
hepatocell ular.</w>
hepatoc arc
hepatocarc inogen</w>
hepatoblast oma,</w>
hepatitis ).</w>
hepati tic</w>
hepati cally</w>
hepat otrophic</w>
hepat oma,</w>
hepat ectomy,</w>
heparin ization</w>
heparin isation</w>
heparin :
heparin: PF4</w>
hepar ins.</w>
hepar in:</w>
hepar in-related</w>
hepar in)</w>
hemosider osis</w>
hemorrhag ic,</w>
hemorrh age
hemorrhage -induced</w>
hemoglob inuria.</w>
hemoglob inuria,</w>
hemoglob inemia</w>
hemodialy sis)</w>
hemo stasis,</w>
hemis uccin
hemif acial</w>
hemicholinium- 3,</w>
hemiball ism</w>
hemi parkinsonism</w>
heme-L-lysin ate</w>
hematopoi esis,</w>
hemat oxylin-eosin</w>
hemat ospermia</w>
hemat opoetic</w>
hemat omyelia</w>
hemat oma:</w>
hemat oma,</w>
hemangioendotheli oma</w>
hem oconcentr
hem idystonia</w>
hem idiaphragm</w>
helpl ess
heat- stable</w>
heat- pain</w>
heat- inactivated</w>
heat stroke</w>
heart- valve</w>
heart s:</w>
hear t:</w>
headache /
headache "</w>
head- weaving</w>
he v
hazard ous?</w>
hasten s</w>
hasten ed</w>
harm less</w>
harm ful.</w>
hard wood</w>
har monic</w>
har mal
haptoglob in.</w>
hap ten
hand- eye</w>
hand led</w>
hand ful</w>
hand )</w>
hampe red.</w>
halothane- treated</w>
halothane- exposed</w>
halothane- MIF</w>
halothane- -
halothane-- epinephrine</w>
halothane -</w>
haloth ane)</w>
haloperidol- increased</w>
haloperidol- enhanced</w>
haloperidol ),</w>
halo alk
hallucin ator
hallucin ation,</w>
hallucin ating</w>
hall uc
half-li ves,</w>
hal ting</w>
hal ide</w>
hair s</w>
haemodynam ics.</w>
haemodilu tion.</w>
haemo filtration</w>
haemo filtration.</w>
haemat oxylin</w>
haemat ological,</w>
haemat ob
haem opexin</w>
habit ually</w>
hab its</w>
hab its.</w>
ha v</w>
ha sten</w>
ha ,</w>
h/ day)</w>
h.p. f.</w>
h us
h un
h s</w>
h ou
h opes</w>
h mi</w>
h inal,</w>
h es
h MT</w>
h G
h CGRP8-37</w>
h -1,</w>
h ))</w>
h )
h 's</w>
gyr us;</w>
gyr us)</w>
gy pt
guy ann
guyann ensis</w>
gut ,</w>
guinea- pigs.</w>
guarante e</w>
guaneth idine.</w>
guaneth idine-induced</w>
guan oxabenz
gu vac
grow s,</w>
grow n</w>
group s
group 1</w>
group -1</w>
group "</w>
groom ing,</w>
groom ing),</w>
groo ve</w>
gro und-glass</w>
griseofulv in.</w>
gri mac
greml in,</w>
gre pa
gravid as</w>
grav ity,</w>
graph y:</w>
graph y)</w>
graph ically.</w>
graph .</w>
granulomat osis:</w>
granulo cytopenia.</w>
granulo cytopenia,</w>
granulo cytic</w>
gran/ dex</w>
gram icidin</w>
gram -
graf ting,</w>
graf ine</w>
grad uate</w>
grad ing.</w>
gra y-
gr ati
gr anted</w>
gr /
gose relin,</w>
good- quality</w>
gonadotrop ins</w>
gonad ectomy</w>
gonad ally</w>
gonad al,</w>
gol den</w>
gol d.</w>
gol d
goat s.</w>
goal- directed</w>
gnaw ing,</w>
gm/ m2</w>
glycos ylation</w>
glycos uria.</w>
glycopyr rol
glyco sides.</w>
glyco side,</w>
glyco fer
glycofer ol-
glyceraldehyde- 3-
glyceraldehyde-3- phosphate</w>
glycer ol-induced</w>
glyc ol.</w>
glyc ol
glyc ine-induced</w>
glyc ine-
glyc inamide</w>
glyc in
glybur ide.</w>
gly caemic</w>
glutethim ide.</w>
glutamat ergic,</w>
glutam ine.</w>
glutam ate)</w>
glucuronid ation,</w>
glucuronid ase</w>
glucuron yl</w>
glucosid ase</w>
glucose- mannose</w>
glucose- insulin</w>
glucocorticoid- regulated</w>
glucocorticoid -like</w>
glucocortico steroid</w>
glucocortico id,</w>
gluco se)</w>
gluc oside</w>
gluc oron
gluc opri
gluc onate.</w>
glos sopharyngeal</w>
glos sal</w>
glomerulosclero tic</w>
glomerul us.</w>
glob ular</w>
glioblast omas</w>
glicl azide-induced</w>
glibencl amide),</w>
gli stening</w>
gli oma,</w>
gli oblastoma.</w>
gli o-vascular</w>
gli a-
glab rous</w>
gl utition</w>
given ;</w>
girl s:</w>
ginseno sides.</w>
gi ardi
gh t-
gh rel
gest ations</w>
gerbil s.</w>
gerbil s,</w>
geran yl
ger minal</w>
ger min
genit o-urinary</w>
general izes</w>
gener ations.</w>
gene sis:</w>
gen u</w>
gen s</w>
gen omes</w>
gen om
gen ic.</w>
gen ase</w>
gemcitab ine-containing</w>
gemcitab ine-
gelat inase</w>
gelat in
gel .</w>
ge ographic</w>
ge les</w>
ge dly</w>
gcd- null</w>
gaz e-
gaze- evoked</w>
gati floxacin,</w>
gastroenter itis</w>
gastrocnemi us)</w>
gastro protective</w>
gar lic
gap .</w>
gangli a-
ganglia- thalamocortical</w>
gan da.</w>
gan )</w>
gammaglut amyl
gammaglutamyl transferase</w>
gamma-glutamyltranspeptid ase-positive</w>
gamma-glutamyl transferase,</w>
gamma-butyro lactone</w>
gamma-aminobut yrate</w>
gamma-G T-positive</w>
gamma- thiobutyrolactone</w>
gamma- HC
gamma- GT</w>
gam et
gallo tannin</w>
gallo catechin</w>
gall amine.</w>
galant amine,</w>
galan in-IR</w>
galact ose</w>
gal oblastic</w>
gadolinium- enhanced</w>
gadol inium.</w>
gadodi amide,</w>
gabapent in-induced</w>
ga x</w>
ga ren
ga ined.</w>
g/m2/ d</w>
g/m 2;</w>
g/kg/ day,</w>
g/ sq</w>
g/ ml),</w>
g/ minute</w>
g/ l</w>
g/ day),</w>
g/ d)</w>
g/ body</w>
g/ L),</w>
g. kg-1</w>
g-1. min-1</w>
g un
g um),</w>
g th</w>
g s.</w>
g rommet
g ous</w>
g one</w>
g lipiz
g ingiv
g iddin
g est</w>
g d)</w>
g b)</w>
g at
g al,</w>
g );</w>
g (-1).</w>
g (-1),</w>
fusi form</w>
furosem ide-treated</w>
fur yl)-
fung icidal</w>
funduscop ic</w>
fundus copy</w>
function /
fun dic</w>
fun al
funal trex
fulfil led.</w>
ful ly.</w>
ful ly-
ful lerene</w>
ful fi
fulfi l</w>
fuch sin</w>
fuc osid
fuc oid
fu gax</w>
frust e</w>
fructo se-induced</w>
fronto- parietal</w>
front line</w>
frequ enc
free- water</w>
free- radical</w>
free- moving</w>
free- flow</w>
fre el
freel y-moving</w>
fre e)</w>
fragment ed.</w>
fourth- order</w>
four- week-old</w>
four teenth</w>
foti amine</w>
fosinopri l.</w>
fosfob ion</w>
foscarne t-induced</w>
forty- four</w>
forskol in-stimulated</w>
formul ary</w>
formul ae</w>
form ular
form s:</w>
form ers</w>
form ation:</w>
form ation)</w>
form ally</w>
fore brain,</w>
fore arms.</w>
fore arms,</w>
fore ar
forced- swimming</w>
force- interval</w>
force ment</w>
for med.</w>
foot pad</w>
food- taking</w>
food )</w>
follow-up )</w>
follic les</w>
foli aceus</w>
focus sed</w>
fo ve
fo et
fluspiril ene,</w>
flur idine</w>
flur azepam.</w>
flur azepam,</w>
flup enti
flupenti x
fluoxet ine:</w>
fluoroquinol ones,</w>
fluoro uracil.</w>
fluocin olone</w>
flunitrazep am,</w>
flumazen il-induced</w>
flucytos ine,</w>
fluctu ations,</w>
fluctu ated</w>
flucloxacill in-induced</w>
flu- like"</w>
flu xes</w>
flu x.</w>
flu x,</w>
flu vastatin,</w>
flu parox
flu oxyme
flu ency,</w>
flox uridine.</w>
flow- limiting</w>
flow metry,</w>
flow meter,</w>
flow ed</w>
flow ;</w>
flow :</w>
flor id</w>
flor a,</w>
flo s</w>
flo ating</w>
flin ch
flexible -
flexi bly</w>
flavon oids</w>
flatul ence</w>
flatul ence,</w>
flat ter</w>
flat ,</w>
flare -up</w>
fl u</w>
fl orum</w>
fl ame</w>
fl accid
fix ation.</w>
five- mutation</w>
five- fold</w>
fistul ae</w>
fissu re,</w>
first- cycle</w>
first- choice</w>
first ;</w>
first )</w>
fir ing.</w>
finding s;</w>
find s</w>
fin anc
financ ial</w>
filgrastim .</w>
fil tering</w>
fil ter,</w>
fil es,</w>
fifty- eight</w>
fiel d;</w>
fibrosar coma</w>
fibromy algia.</w>
fibroelast osis</w>
fibroblast -like</w>
fibro tic,</w>
fibro sis-associated</w>
fibro sis).</w>
fibro adenomas</w>
fibrinogen ating</w>
fibrin- rich</w>
fibrin olysis,</w>
fibrin oly
fibrill ation),</w>
fibrill ating</w>
fibri ls</w>
fibri ls,</w>
fiber optic</w>
fib rate-
fib er-
fib er,</w>
fib er)</w>
fi ve)</w>
fi del
fidel ity</w>
fet otoxic</w>
fertili z
ferrit inemia,</w>
ferrit in,</w>
feren tial</w>
fer tility.</w>
fer tility,</w>
fer ruginea</w>
fer ro
fentanyl/ bupivacaine</w>
fentanyl- supplemented</w>
fentanyl ;</w>
fentanyl -associated</w>
fentanyl )</w>
fenoter ol,</w>
fenoldop am.</w>
fenoldop am
feno profen.</w>
fenfluramine- related</w>
fenflur amines,</w>
fenflur amine)</w>
fenflur amine
fenest rated</w>
fenbufen ,</w>
fen retinide</w>
fen ac</w>
femal e's</w>
fell ,</w>
fel bam
fed rine</w>
feat ures:</w>
fear -related</w>
fear -
fear ,</w>
fe ed-forward</w>
fe bri
fazad inium</w>
favour able,</w>
fav ouring</w>
fatal ity.</w>
fat al)</w>
fat .</w>
fat -free</w>
fast ing.</w>
fashi on;</w>
fashi on:</w>
fascicularis ).</w>
fascicul us</w>
fascicul ating</w>
fascicul aris</w>
fasc ic
far nes
far -
famoti dine-induced</w>
famili al,</w>
famil ies.</w>
fall s,</w>
falcipar um.</w>
fal x</w>
fal sely</w>
failure -free</w>
fail s.</w>
faec alis.</w>
factor- alpha.</w>
factor )</w>
face- to-face</w>
fac ing</w>
fac et</w>
fa romine</w>
fa ithful</w>
fEP SPs</w>
f. =
f usion,</w>
f ran
f ostriec
f ore,</w>
f mol</w>
f mol
f mann</w>
f loc
f it,</w>
f ish,</w>
f ep
fep ramone</w>
f ed.</w>
f are</w>
f ade
f PD</w>
ez ing.</w>
ey ond</w>
exud ates</w>
extub ate</w>
extrasystol es,</w>
extrastimul i.</w>
extrane uron
extrac tion,</w>
extra- pontine</w>
extr asystole</w>
extr an</w>
extr acts,</w>
extinc tion/reinstatement</w>
exter nal-
exter na.</w>
exter i
exten sively.</w>
ext ents</w>
expul sion</w>
expres sion:</w>
expres sed,</w>
exposure -
expo sed.</w>
expo sed)</w>
expo sed
explo it</w>
explic itly</w>
explan ations.</w>
expl ained,</w>
experimenter -administered</w>
experiment al,</w>
experi ence
experi enc
exper ts</w>
expedi tious</w>
expect ed)</w>
expect ations</w>
expan sive</w>
exist ence,</w>
exhaus tive</w>
exhaus tion</w>
exhaus tion.</w>
exha ust
exercise -related</w>
exercise -</w>
exerci ses</w>
exer tion.</w>
exec uted</w>
exec ute</w>
exclu des</w>
excitation- contraction</w>
excit otoxin</w>
excit ator
excit ations</w>
exci sed,</w>
excep tional.</w>
excep tion,</w>
exc ite</w>
exc es
exanth ema</w>
examin ation)</w>
exam s,</w>
exam isole</w>
exam ine
exam ,</w>
exagger ation</w>
exagger ates</w>
exacerb ations,</w>
exacerb ation,</w>
ex tirpation</w>
ex stroph
ex sangu
ex ovascular</w>
ex ocoelomic</w>
ex anthe
exanthe ma,</w>
ex ,</w>
evol ves</w>
evol ve</w>
evo ked,</w>
evid encing</w>
every- 3-week</w>
event s).</w>
ev inced</w>
ev en
euph oric</w>
euph ori
eucalce mic</w>
eu thyroid</w>
etretin ate,</w>
etodol ac,</w>
eti din
ethylket azoc
ethylenedi amine
ethylene imine</w>
ethyl]-4-(3-phenylpropyl) piperazine</w>
ethyl]- 2-
ethyl sulfonylnaphthalene-1-sulfonamide,</w>
ethyl ]</w>
ethyl ,</w>
ethoxyqu in</w>
ethoxyqu in,</w>
ethoxy resorufin-O-deethylase</w>
ethinylo estradiol-treated</w>
ethinylo estradiol,</w>
ethchlorv ynol</w>
ethan ol/
eth ological</w>
etexil ate</w>
et orphine</w>
et ofibrate</w>
et namese</w>
et c.)</w>
et c
etc .,</w>
esul erg
esulerg ine</w>
estrogen -like</w>
estrogen -containing</w>
estram ust
estradiol-17 beta</w>
estradiol :</w>
estim ated,</w>
ester ified</w>
ester ase,</w>
ester -type</w>
est rus/
est ers.</w>
est ,</w>
essenti al,</w>
esophag ogastric</w>
esoph ageal,</w>
esc ence.</w>
es. s.cm-
es s)</w>
es orub
es ol
es na</w>
es licarbazepine</w>
es er
es cul
escul ent
es ch
es ,
erythroder mic</w>
erythro leukemia</w>
eryth rophagocytosis</w>
ery ptosis.</w>
ery ptosis,</w>
erro r,</w>
ero sion,</w>
ero ben</w>
ergot s</w>
ergol ine-induced</w>
erg ometer</w>
erec tions,</w>
ere brate</w>
erculo sis</w>
er/ density</w>
er- based</w>
er istostatin</w>
er ing.</w>
er ing-
er al
er a-
equival ent,</w>
equi setiform
equi sedative</w>
equ imyelo
equ als</w>
equ ally.</w>
eptid ase,</w>
epti n</w>
epsilon- amino</w>
epsilon ,</w>
epomedi ol.</w>
epoi etin-beta</w>
episode s;</w>
episi otomy</w>
epirubicin/ paclitaxel</w>
epirubic in-based</w>
epinephr ine/kg</w>
epinephr ine).</w>
epinephr ine),</w>
epileptic us;</w>
epileptic us)</w>
epileptic us).</w>
epilepsy -induced</w>
epilepsy ).</w>
epilep sia</w>
epidemio logy,</w>
epi gallocatechin</w>
epi apterin</w>
ephed rine-
ep pra
ep oxy-
ep o-
ep i</w>
ep ensis</w>
ep al
ep -
eosinophil uria.</w>
enzyme- altered</w>
enzyme ),</w>
enzym uria,</w>
enzym es:</w>
enzym es'</w>
enti ties.</w>
enti rely,</w>
enti a</w>
enthusi astic</w>
enteropath ica</w>
enter otoxins</w>
enter ococcus</w>
entec avir.</w>
ent ucky</w>
ensit ometry</w>
ensi tive</w>
enrol ment</w>
enro lling</w>
enoxapar in-treated</w>
enox acin-induced</w>
eno tic</w>
eno gest</w>
enlarge d.</w>
enlarg ing</w>
enkephal in-
enhance ments</w>
enhanc er.</w>
engraf ted</w>
engorg ement.</w>
eng e,</w>
eng aging</w>
eng age</w>
enflur ane/nitrous</w>
energ y-
enedi oxymethamphetamine</w>
ene- 3,20-
endpoint ;</w>
endpoint )</w>
endotox in-treated</w>
endotox in-
endothelium- intact</w>
endothelin -1.</w>
endothel in-
endosulf an.</w>
endorph inergic</w>
endorph in,</w>
endor sed</w>
endocrin ologic</w>
endoc rino
endoc rine,</w>
endo /
endo/ epi</w>
end-of- treatment</w>
end- products</w>
end- inspiratory</w>
end tidal</w>
end orphin</w>
end opiriform</w>
end onuclease-
end oluminal</w>
end ang
encour aged.</w>
encephalo graphy</w>
ence -based</w>
enantiom ers,</w>
enanti o
enalapri lic</w>
en-3- one,</w>
en- VPA
en se</w>
en profylline,</w>
en ormous</w>
en etri
en em,</w>
en ed.</w>
en di
en de
en chymal</w>
en ching</w>
en a
emul sive</w>
emul sions</w>
emo tional,</w>
emis sion.</w>
emin gly,</w>
emergency -
emergen cy,</w>
emerg ently</w>
eme sis;</w>
embryo ,</w>
embran oids</w>
embol us,</w>
embol ism
em pye
em it
em ic.</w>
em ia)</w>
em ia),</w>
em ents.</w>
em ent-
elym oclavine</w>
elsewhe re.</w>
ell ular-
ell aria</w>
electron- microscope</w>
electron ically.</w>
electromyo grams</w>
electroly te,</w>
electroencephalo graph</w>
electroencephalo gic</w>
electrocortico graphy</w>
electrocardio graphical</w>
electrocardio grams.</w>
electro graphic,</w>
electro gram</w>
electro convulsions</w>
electro convulsions.</w>
electr ical,</w>
ele ments,</w>
elast olysis.</w>
elast ase,</w>
elabor ated</w>
el vic</w>
el lip
el li
el fare</w>
el ="
el )</w>
el 's</w>
ejac ulation.</w>
ejac ulation,</w>
eighty- six</w>
eight- week</w>
eigh ner</w>
ei ther:</w>
ei j
ego ,</w>
eg ocentric</w>
effor ts.</w>
effor t.</w>
efficac y;</w>
effect s),</w>
effect s"</w>
effect -
effect (s)</w>
effe ren
effac ement,</w>
eff er</w>
efarox an.</w>
edroph onium,</w>
edi tion</w>
edi tion)</w>
ede mas</w>
edarav one.</w>
ed d
edd 4-
ed /
ed .
ed --
ecz ematous</w>
ecz ema</w>
ectro pi
ectom ised</w>
ecto- ATPase</w>
ect s,</w>
ect or</w>
ecstasy/ cocaine-induced</w>
eclo cycline</w>
eclamp sia.</w>
echocardiograph y;</w>
echocardiograph ically.</w>
echo genicity,</w>
ech in
ec yst
ec tiveness,</w>
ec opip
ec ol</w>
ec ity</w>
ec ham</w>
ec c
ecc rine</w>
ec ,</w>
eat ers,</w>
early- gene</w>
ear- nose-throat</w>
ear s.</w>
ear ned</w>
e. c.
e- type</w>
e- seropositive</w>
e- restricted</w>
e- related</w>
e- free</w>
e- antigen</w>
e- -
e+ APAP)</w>
e version</w>
e ved</w>
e timide</w>
e ther.</w>
e osin-
e metine</w>
e k
e g,</w>
e fly,</w>
e bo
ebo witz</w>
e -1
dystroph in-
dyston ia;</w>
dyston ia-
dyst ocia</w>
dysr rhythmias</w>
dysplasi as</w>
dyspareun ia</w>
dyskinesi a)</w>
dyskine tic)</w>
dyskine sis</w>
dyserythropoi etic</w>
dyscrasi as,</w>
dyscra sia</w>
dyscra sia.</w>
dyschromatop sia,</w>
dys thymic</w>
dys thymia</w>
dys synerg
dys raphic</w>
dys raph
dys phasi
dys morphogenesis</w>
dys metabolic</w>
dys germin
dys genesis</w>
dys functioning</w>
dynes/ s/cm-
dynam ic,</w>
dyn ia</w>
dyn es.s.cm-
dy stro
dwar f
dut y</w>
dul l</w>
duct us-dependent</w>
duct openia.</w>
duc t-
dual- pathway</w>
drug- independent</w>
drug ),</w>
drug (s)</w>
drox idopa</w>
drop outs</w>
drop out</w>
dronedar one.</w>
dronedar one,</w>
dro ptain
dro pping</w>
drink ers.</w>
dri ving,</w>
dres sings</w>
dre am</w>
dram atic,</w>
dr af
draf t)</w>
dp/d t:</w>
dp/d t,</w>
doxy cycl
doxorubicin/ paclitaxel</w>
doxorubicin/ kg.</w>
doxorubicin/ kg,</w>
doxorubicin- treated-
doxorubicin- pretreated</w>
doxorubic in).</w>
doxep in,</w>
dox azosin.</w>
down- regulation.</w>
down- regulates</w>
down regulates</w>
doubt ful.</w>
double- labelling</w>
double- labeling</w>
double -</w>
doubl ecortin</w>
doub ts</w>
dose-rel ated
dose-related ly.</w>
dose-depend ently,</w>
dose- reduction</w>
dose- normalized</w>
dose- limiting,</w>
dose- independent</w>
dose- dependence</w>
dose '</w>
dos ing-
dos ing).</w>
dos age;</w>
dos age:</w>
dor zolamide</w>
dor sum.</w>
dopaminerg ic-
dopamine/ norepinephrine</w>
dopamine/ norepinephrine-selective</w>
dopamine- replacement</w>
dopamine- like</w>
dopamin omimetics</w>
dopamin omimetic</w>
donor- strain</w>
domperid one-induced</w>
domin ate</w>
domin ant,</w>
domain s,</w>
dol ase
dolase tr
dog s.
dodec yl</w>
document ation.</w>
docetaxel -
doc tor.</w>
do t</w>
do familial</w>
dn-sec(-1).m(2).cm (5
dn-sec(-1).m(2).cm(5 ))</w>
dl -</w>
dizocil pine)</w>
diz ygotic</w>
divor ce
divorce d/
diuretic -treated</w>
dithio thre
disulfi des,</w>
distribu tive</w>
distr acted</w>
distinc t,</w>
dissoci ating</w>
dissoci able</w>
dissi pation</w>
dissemin ation</w>
disru ption,</w>
disper sion.</w>
disorder s"</w>
disorder ;</w>
disodi um-induced</w>
dismut ase)</w>
disease- like</w>
diseas es:</w>
diseas e?</w>
diseas e/
discus sed:</w>
discrimin ation-
discrimination- reversal</w>
discrimin ates</w>
discri minant</w>
discover ies</w>
discour aged.</w>
discontinu ation)</w>
discharge -
discer nable</w>
disc s</w>
disc .</w>
disc ,</w>
dis solution,</w>
dis sections</w>
dis sect</w>
dis missed</w>
dis integrin</w>
dis inhibited</w>
dis inapoylsucrose</w>
dis agreement</w>
dis abilities.</w>
dis abil
direc tions.</w>
direc tions,</w>
dips tick</w>
dips ogenic</w>
dipivoxil/ lamivudine</w>
diphosph onate</w>
diphen idol</w>
diph ther
dioxo- benzo[f]
dioxo-benzo[f] quinoxaline-7-
dinitro quinoxaline-2,3-dione</w>
dimethylamino )</w>
dimethyl uric</w>
dimethyl nitrosamine</w>
dimeth adione</w>
dimension al,</w>
dimen sions.</w>
dimeglum ine;</w>
dimeglum ine.</w>
dimeglum ine,</w>
dile mm
dil ation,</w>
dil ated.</w>
dil ated,</w>
dihydroxy-6-nitro-7- sulfamoyl-
dihydropyridine- class</w>
dihydro-6 H-benz
dihydro-6H-benz ofuro[2,3-e]pyrido[1,2-a][1,3]diazepin-12-ium</w>
dihydro-2- acenaph
dihydro-2-acenaph thylenyl)
dihydro- beta-
dihydro-beta- erythro
dihydro- 5-azacytidine</w>
dihydro- 5-
dihydro- 2,3-quinoxaline
dihydro testosterone</w>
dihydro pyridines</w>
dihydro ergotoxine</w>
dihydro alprenolol</w>
digoxigen in-labeled</w>
digitalis- toxic</w>
digitalis- provoked</w>
digitalis -like</w>
digit al
dig its</w>
difficul ty,</w>
differenti ates</w>
difference =
difference :</w>
diffe red,</w>
diethyl nor
diethyl nitrosamine.</w>
diethyl nitrosam
diethyl enetri
diethyl ene</w>
diet -induced</w>
diet -dependent</w>
diet -
diet ).</w>
dideoxyinos ine.</w>
dideoxy cytidine.</w>
didanos ine/
didanos ine,</w>
dicho tic</w>
dichloro platinum</w>
dichloro kynurenic</w>
dichloro hexafluorocyclobut
dic ated</w>
dibutyr yl</w>
diazepam- ketamine</w>
diazepam ;</w>
diazepam -dependent</w>
diazep oxide</w>
diast ole,</w>
diast emat
diarrhoe a)</w>
diarrhe a)</w>
diaphrag ms</w>
diaphor ase,</w>
diammine dichloroplatinum</w>
diamin odiphenyl
diameter -
dialy sis-
diagnos tics</w>
diagno sis:</w>
diagno sis)</w>
diabet ogenic</w>
di(2-ethylhex yl)phthalate</w>
di se</w>
di ps</w>
di ol)</w>
di o
di mesylate.</w>
di mesylate,</w>
di i</w>
di ed:</w>
di butyl
di benzo[
di athe
di as
dias chisis</w>
di aries,</w>
di ant
di acetolol</w>
dextro mor
dex -treated</w>
detox ified</w>
detox ification.</w>
determin ant.</w>
determin ant"</w>
determ ined:</w>
determ ine,</w>
deterior ate.</w>
detect or</w>
detect ,</w>
destro ying</w>
dest ination</w>
desquam ation.</w>
despair "</w>
desmopress in.</w>
desmethyl astemizole</w>
desi pramine)</w>
describe d;</w>
describe ,</w>
descri ptive,</w>
desc ending,</w>
desArg9Leu8- BK</w>
des-Arg9- BK</w>
des per
des or
dermat opathology</w>
dermat omes</w>
derivati zation</w>
derivati ves)</w>
deriv es</w>
deriv ates</w>
deri ved,</w>
dere pression</w>
derang ements.</w>
der mo-epidermal</w>
der line</w>
der ic
depression /
depression/ anxiety</w>
depress ants,</w>
depren yl,</w>
depolymer izing</w>
depolariz ation-induced</w>
depolar ising</w>
deple tor,</w>
depend s,</w>
depend ent:</w>
depend ency,</w>
depart ment:</w>
depart ment
dep th.</w>
dep th,</w>
dep icted</w>
deoxycorticosterone- NaCl-treated</w>
dentistr y.</w>
densit ometry</w>
densi ties.</w>
densi ties,</w>
den opamine</w>
den op
demethyl ated</w>
dementi a:</w>
demeclo cycline-induced</w>
dem y</w>
delta9- tetrahydrocannabinol</w>
delta9- THC.</w>
delta-aminol aevulinic</w>
delta- AV
deliver y:</w>
deliver ies.</w>
deliri ous.</w>
dele tions.</w>
dele ting</w>
delay ed-type</w>
del usion,</w>
del ays.</w>
del T
delT 96
delT96 1
dehydrogenase- deficient</w>
dehydro emetine</w>
dehydro cholate</w>
degran ulation,</w>
degener ation-
deform ities,</w>
defici ent,</w>
defen ses</w>
defen se.</w>
defect s;</w>
def ence</w>
deep ,</w>
decur sin</w>
decreas es,</w>
decont amination</w>
decompens ation,</w>
decom pressive</w>
decline d,</w>
decl ine,</w>
decision- making,</w>
deci sion.</w>
deci bel
deci be
decibe ls</w>
decapit ation.</w>
dec erebrate</w>
debriso quine/sparteine</w>
debriso quine,</w>
debri s,</w>
debri de
deb ated</w>
deb at
death s:</w>
dead ly</w>
deacetyl ation</w>
de/ RR</w>
de- de-
de ter</w>
de tention</w>
de synchronized</w>
de stabilizing</w>
de personal
de methoxy-
de menting</w>
de hydrated</w>
de grades</w>
de fibrinogenating</w>
de dicated</w>
de d-
de buffered</w>
de activated</w>
de -associated</w>
de ),</w>
de 's</w>
dd I,</w>
dd C.</w>
day (-1).</w>
day (-1));</w>
daun omycin,</w>
datab ases.</w>
dat a-
dark -
dar ub
dar inaparsin</w>
dar ifenacin</w>
dapsone- related</w>
danger ous,</w>
dampen s</w>
dam s,</w>
dam age:</w>
dam age)</w>
dam age),</w>
daily- half</w>
dact yl
dacryocystorhin ostomy</w>
dacarb azine.</w>
dTc- lidocaine</w>
d. f.=
d. f.</w>
d- sotalol</w>
d- pregnant</w>
d- degree</w>
d- chlorpheniramine</w>
d- B
d- AMPH-induced</w>
d(CH2)5 D
d s).</w>
d pp
d orm
d ine)</w>
d i</w>
d ating</w>
d ane)</w>
d Tc
dTc -induced</w>
d PI/
d P</w>
d B;</w>
d B).</w>
d A</w>
d ?</w>
d (-1));</w>
cytotoxic /
cytotoxic/ suppressor</w>
cytot oxin</w>
cytoskeleton -associated</w>
cytoplas mic-
cytochrome- P450</w>
cyto reductive</w>
cyt oly
cyt .
cystin uria,</w>
cysticer cosis</w>
cysticer cosis.</w>
cysti tis:</w>
cyste inyl
cyste ine,</w>
cyst ostomy</w>
cyst oscopy.</w>
cyst oscopy,</w>
cyst ometric</w>
cyclospor ine-</w>
cyclophosphamide -related</w>
cyclophosphamide -based</w>
cyclophosphamide -</w>
cyclohexanec arboxamide</w>
cyclohex yl]benzene
cyclohex yl)
cyclohex en
cyclo cytidine</w>
cyclic- GMP</w>
cyclic- AMP</w>
cycle -
cycl es),</w>
cycl ase;</w>
cycl ase.</w>
cycl amate</w>
cyanocobal amin</w>
cyano acryl
cyanoacryl ate)</w>
cyan opindo
cy geal</w>
cut ellaria</w>
current- clamp</w>
curren ts,</w>
curcu min.</w>
curcu min,</w>
curar ized</w>
cur ves,</w>
cur ly-tail</w>
cup -to-
cup-to- disc</w>
cune ate</w>
culpr it.</w>
culmin ated</w>
cul igo</w>
cuff )</w>
cu. mm</w>
cu .</w>
cryo therapy</w>
cryo therapy.</w>
cryo stat</w>
cross- tal
cross- sensitivity</w>
cross- react</w>
cross- links</w>
cross- linked</w>
cross- fostered</w>
cross- correlation</w>
cross reactivity</w>
cross over.</w>
cross ings</w>
cros ses.</w>
crocin s</w>
criteri on.</w>
criteri on,</w>
criter ia).</w>
cri mes</w>
cri be</w>
cres cents,</w>
creatinine >5.0</w>
creatin ine),</w>
creat ine-
creat ine,</w>
cre ws</w>
cre vicular</w>
cre ative</w>
cre am
crani otomy.</w>
crani otomy,</w>
crani ocerebral</w>
crani ectomy.</w>
crani ectomy,</w>
cra w
cr ying,</w>
coxib s.</w>
coupl ing.</w>
counterpuls ation</w>
counter ing</w>
counter clockwise</w>
counter ,</w>
counsel ing.</w>
coun ting.</w>
coumar in-induced</w>
cotranspor ter,</w>
cotranspor t</w>
cos ol
corticosteroid -treated</w>
corticosteroid -</w>
cortico id</w>
cortic al-
cortex -to-
cortex-to- serum</w>
cortex -
corrobor ates</w>
correl ation,</w>
correl ates,</w>
correc tive</w>
corne a,</w>
corn u</w>
cor ticom
cor rhachia</w>
cor ii</w>
copies/ mL,</w>
copi pam</w>
coordin ation)</w>
coordin ates</w>
cool ing.</w>
cool ing,</w>
convuls ant.</w>
convul sion-inducing</w>
convol u
conver tases</w>
conven tional-dose</w>
conval escence</w>
controlled- onset,</w>
control s:</w>
control --
control-- --
control "</w>
contribut e,</w>
contrast- enhancing</w>
contradic tor
contradic ted</w>
contracep tion,</w>
contrac tilit
contra versive</w>
contra indicate</w>
contra indic
continuous- wave</w>
contex tu
contamin ant</w>
cont acts;</w>
cont acts,</w>
cont act,</w>
consum ptive</w>
consum er</w>
consult ation,</w>
consul t</w>
consu med.</w>
constric ting</w>
constitu ent,</w>
constipati on;</w>
constant- rate</w>
consider s</w>
consider ations,</w>
consider ation,</w>
consequ ential</w>
consecuti vely.</w>
conn ects</w>
conjunctivi tis.</w>
conjunctiv a</w>
congenit ally</w>
congenit al,</w>
cong ested</w>
confron ted</w>
conflu ence</w>
conflic t"</w>
confirm ation,</w>
confid ently</w>
conf usion
condylo mata</w>
conduct ance,</w>
conduc tivity</w>
conduc ive</w>
conditioned- hyperactivity</w>
condition s).</w>
concomit antly,</w>
conclu sive,</w>
concer ted</w>
concer t</w>
concer ns,</w>
concer ned.</w>
concentration- dependently</w>
concentration ).</w>
conce aled</w>
con specific</w>
con nexin</w>
con nex
con cise</w>
con 1</w>
con -
computer .</w>
computer -based</w>
comput ational</w>
compromi sed,</w>
compres sions,</w>
compres sion-
complic ated.</w>
complex :</w>
comple tion,</w>
comple ment,</w>
complain s</w>
compati bility</w>
compassion ate-
compassionate- use</w>
compart ments.</w>
compart ments,</w>
comparison ).</w>
comparison ),</w>
compan ies</w>
comp iled</w>
comp iled.</w>
comp anion</w>
comorbidi ties.</w>
communic ated</w>
common ;</w>
committe e</w>
committe e.</w>
commis sure</w>
comman ds</w>
comman ds.</w>
comm and</w>
comfor t.</w>
comedic ation.</w>
combination- therapy</w>
combin ation)</w>
comb ating</w>
comato se,</w>
com ment</w>
com a:</w>
collo id)</w>
collater als.</w>
collagen/ epinephrine-induced</w>
collagen- epinephrine</w>
collagen ase-
collagenase- like</w>
collagen -induced</w>
coll a</w>
cold- water</w>
col orimetric</w>
col oni
col itis:</w>
col iti
col ic.</w>
col d.</w>
cohor ts,</w>
code ine-containing</w>
cochle ae</w>
coccidi oidomy
cocaine- taking</w>
cocaine- negative</w>
cocaine- injected</w>
coc ult
coc ktail</w>
cobal t</w>
coales ced</w>
coagulo pathic</w>
coagulo path
coagul ability</w>
co-trimox azole,</w>
co- pretreatment</w>
co- ordin
co- incubation</w>
co- factors</w>
co- existing</w>
co- administer</w>
co vers</w>
co varied</w>
co protein</w>
co oper
co ital</w>
co injection</w>
co infused</w>
co gwheel</w>
co factor,</w>
co existent</w>
co ast
co al</w>
co administration.</w>
cm/ s)</w>
cm 3</w>
cm 2/
club s</w>
clu stering</w>
clozapine/ olanzapine</w>
clozap ine),</w>
clotrimaz ole</w>
cloti azepam</w>
closed- question</w>
clopidogrel :</w>
clopidogrel -treated</w>
clon ing</w>
clon ed.</w>
clofib ric</w>
clofaz imine</w>
cloc k</w>
clo tted</w>
clo sest</w>
clo sed,</w>
clo se,</w>
clo but
clinicoradi ologic</w>
clinici ans.</w>
clinic s,</w>
clinic al-
clim acteric</w>
clear ance),</w>
clea ving</w>
cle mast
cle av
clau strum</w>
classi fied.</w>
classi fi
classi cal'</w>
cl ick
cl asses
cit ronell
cit rate-
cisterna e.</w>
cister ns</w>
cisplatin- etoposide</w>
cisplat in;</w>
cis- platinum,</w>
cis- diamminedichloroplatinum</w>
cis atracurium.</w>
cis -</w>
cirrho sis/HCC</w>
circumst anti
circumstanti al,</w>
circumci sion</w>
circum vention</w>
circum scribed</w>
circul ating,</w>
circuit s,</w>
circl ing,</w>
cipro fibrate,</w>
cine angiography,</w>
cin ti
cin ation</w>
cid ol</w>
ciclospor in-induced</w>
ci razol
ci proxif
chron ology</w>
chron ic)</w>
chromos om
chrom ati
chromati d</w>
chro tron</w>
chorio retinopathy</w>
chore omyoclonic</w>
chore atic</w>
chore a;</w>
chore a:</w>
chondro sarcoma</w>
chond rification</w>
cholinoc eptors</w>
cholinester ase-
cholinerg ically-
cholinerg ic-induced</w>
cholinerg ic-
cholin olytic</w>
cholest -4-
cholest-4- en-3-one,</w>
choled ochoduodenal</w>
chole lithiasis,</w>
cholangi olitis</w>
chol ing
cho ic</w>
chlortal idone</w>
chlorprothixen e.</w>
chlorpromaz ine)</w>
chloroquine- resistant</w>
chloroqu ine:</w>
chloroethyl clonidine</w>
chloroethyl clonidine,</w>
chloro- 7-
chloro trianisene</w>
chloro phenylalanine</w>
chlor phenylpiperaz
chlor phentermine,</w>
chlor ide),</w>
chin chill
children ;</w>
children ),</w>
chic k.</w>
chi (2),</w>
chest- pain</w>
cheno deoxychol
chemotherapy- naive,</w>
chemotherap y).</w>
chemotherap ies,</w>
chemosensitiz er</w>
chemosensi tivity</w>
chemon aive</w>
chemoconvuls ants.</w>
chemoconvuls ants,</w>
chemoconvul sions</w>
chemo prophylaxis.</w>
chemo kines</w>
chemo hormonal</w>
chemo -</w>
chemist ries,</w>
chem otoxic</w>
chem osensory</w>
check- up,</w>
che st.</w>
che l
chatter ing</w>
chatter ing,</w>
charybdot ox
charge -
charg es</w>
characteris tic.</w>
characteris tic,</w>
character ised.</w>
character .</w>
chap ters</w>
chang e;</w>
chamb ers,</w>
challenge d,</w>
challenge )</w>
challeng ing.</w>
ch y</w>
ch oring</w>
ch iral</w>
ch ause
chause n</w>
ch al
chal epensis</w>
cervic itis.</w>
certain ty</w>
cerebro ventricular</w>
cerebro ventricle-
cerebro vasomotor</w>
cerebro -
cerebri )</w>
cerebr um,</w>
cerebell um)</w>
cephalospor in.</w>
cephalor idine.</w>
cephalex in.</w>
centrophen oxine</w>
centrally- acting</w>
cent rizonal</w>
cent rifugation</w>
cent ered</w>
cent er's</w>
cells/micro liters</w>
cells/micro L).</w>
cells/ mm3,</w>
cells/ mm3)</w>
cell -to-
cell-to- granule</w>
cell -derived</w>
ceftriax one:</w>
ceftizoxi me.</w>
cefotaxime -treated</w>
cefamand ole-coated</w>
cefamand ole,</w>
cef podoxime</w>
ce lona,</w>
ce ).</w>
cavernos um.</w>
cave ats</w>
caud ate/
caudate/ putamen</w>
caud at
catheter isation.</w>
cathep sin-
catecholamine- sensitive</w>
catecholamine- depleted</w>
catechol-O- methyl</w>
catechol amine.</w>
cataton ia:</w>
catar acts.</w>
catar act,</w>
catar act
catapl ectic</w>
catalep tic,</w>
catalep sy-
catabol ism,</w>
cat nip</w>
cat astroph
caspase- 3,</w>
cases/ 100</w>
case- series</w>
case in;</w>
cas ual</w>
cas e;</w>
cas e),</w>
carrageen an/
carr yover</w>
carmofur .</w>
carmin omycin</w>
careful ly,</w>
cardioverter/ defibrill
cardiover ter</w>
cardiomy ocyt
cardiomegal y.</w>
cardio selectivity.</w>
cardio protective.</w>
cardio hemodynamic</w>
cardio graphic</w>
cardio angiography</w>
cardiac -related</w>
cardia .</w>
cardi tis,</w>
cardi otomy</w>
cardi ostimul
cardi ologists</w>
cardi ologist</w>
carcinom as
carcinogen s.</w>
carcinogen .</w>
carcin osarcom
carboxy- 3-hydroxy
carboxy l</w>
carbox amide,</w>
carboplatin/ taxane</w>
carboplatin/ paclitaxel</w>
carboplatin :</w>
carboplat in-treated</w>
carboplat in-based</w>
carbon s.</w>
carbohyd rates,</w>
carbim azole-induced</w>
carbidopa .</w>
carbet ocin</w>
carbenicill in,</w>
carbamazepine-10,11- epoxide</w>
carbamazep ine's</w>
carb ocyste
carb ac
carbac eph
car umon
captopri l-
capsul es,</w>
capsul ar,</w>
capsaicin- pretreated</w>
caps azepine,</w>
caps azep
capre omycin</w>
capre omycin,</w>
capillar itis</w>
capillar itis.</w>
capecitab ine:</w>
cap ut</w>
cap itis.</w>
cap abilities</w>
cannul ation.</w>
cannul ation,</w>
cannul ated.</w>
cannabin oids.</w>
candidi asis.</w>
candide mia</w>
cancer s;</w>
cancer s:</w>
cancer ).</w>
cancell ation</w>
campt othecin</w>
cam pa
cam era-
calori e-restricted</w>
caldi amide,</w>
calcul i,</w>
calcul ated,</w>
calcium- free</w>
calcium- containing</w>
calcit onin,</w>
calci um:</w>
calc imimetic</w>
cal ves</w>
cal ves.</w>
cal ories</w>
cal f.</w>
caffeine- exposed</w>
caffe ine;</w>
caffe ine-</w>
caffe ine)</w>
ca used,</w>
ca re;</w>
ca p</w>
cTn T,</w>
cGM P,</w>
c-fos .</w>
c- jun,</w>
c umber
c s
c rown</w>
c roft-Gault</w>
c rest
c remophor</w>
c oxib</w>
c or</w>
c on</w>
c oconut</w>
c occi</w>
c k's</w>
c ic
c ence</w>
c ations.</w>
c ations,</w>
c ation-
cation- selective</w>
c ass
c ant</w>
c ages.</w>
c ac
c ]</w>
c TB
cTB S</w>
c AM
cAM P-induced</w>
byp ass
butyrophen ones</w>
butyr yl
butyl ]
buttoc ks,</w>
buter ol-induced</w>
butanoyl morphine</w>
but yrate,</w>
but en
but aclam
busulph an.</w>
busulf an/
burst s/min,</w>
burg ,</w>
burden ,</w>
bupropi on's</w>
bupivaca ine;</w>
bupivaca ine)</w>
bunitro lol</w>
bund les.</w>
bumetan ide.</w>
bull ae</w>
bulb s</w>
bul b,</w>
buil t</w>
bu ying,</w>
bt b</w>
brux ism</w>
brucello sis</w>
bronchopneum onia.</w>
bronchodilat ory</w>
bronchodilat ors,</w>
bronchodi lation,</w>
bronch oscopy.</w>
bronch oconstriction</w>
bromocript ine-related</w>
brom o</w>
brom ide)</w>
broaden s</w>
bro xyquinoline</w>
bro faromine</w>
bro benz
brobenz oxaldine</w>
brie fer</w>
bridg ing.</w>
bridg es</w>
bri dge
brevi ation</w>
breath -
breast- feeding.</w>
break points</w>
bre wer's</w>
branch es,</w>
bran ching</w>
brainst em-
brain- microvascular</w>
brain- injured</w>
bradyp nea</w>
bradykin in-induced</w>
bradycardia -
brady kinetic</w>
brady dysrhythmias</w>
brady asystolic</w>
brachi ocephalic</w>
brac ing</w>
brac hy
bra in/plasma</w>
br yos</w>
bp m;</w>
bp m).</w>
boy s)</w>
box ,</w>
bowel s</w>
boun ded</w>
boun d)</w>
bother som
bot tom</w>
border ing</w>
bor ders</w>
bol i</w>
body- weight</w>
body- builder</w>
body building</w>
bodi es:</w>
bob bing</w>
boar d,</w>
bo oster</w>
bo ok</w>
blur ry</w>
blue- yellow</w>
blu e.</w>
blood- perfused</w>
blood- filled</w>
blood- borne</w>
blood stream</w>
blocker s)</w>
blockade ;</w>
block ing,</w>
blind ness:</w>
blin d.</w>
bli stering</w>
blepharo spasm.</w>
blepharo spasm,</w>
bleb s</w>
ble omycin-detectable</w>
ble ed.</w>
ble b</w>
blastocy st</w>
blan ching</w>
blad der-
black ),</w>
bl y,</w>
bl ation</w>
bl and</w>
biv udine</w>
bisphosphonat es,</w>
bis(1- methylethyl)
bis mu
birefr ingent</w>
bir thing</w>
biotrans formation.</w>
biotin ylated</w>
biopsi ed.</w>
biolog y,</w>
bio impedance</w>
bio equivalence</w>
bio energetics</w>
bio energetic</w>
bio artificial</w>
binucle ation</w>
bing e
bin uclear</w>
billi on/
bilirub inemia</w>
bil ity.</w>
biguan ide</w>
bifur cation.</w>
bifeprun ox</w>
bicarbon ate;</w>
bicarb onat
bic yt
bi variate</w>
bi phenyl</w>
bi ocytin</w>
bi ochemist
bi g-
between- treatment</w>
between- subjects</w>
bethan idine.</w>
betagam ma</w>
beta4- subunit</w>
beta4- /-</w>
beta2- leukocyte-integrins
beta2- /-</w>
beta2 (-/-)</w>
beta-methyl- iodophenyl</w>
beta-methyl- 5alpha-pregnan-20-
beta-lactamase- positive
beta-carboline-3- carboxylic</w>
beta-carboline-3- carboxylate</w>
beta-D- glucuronide,</w>
beta-CC M</w>
beta- thalassaemia</w>
beta- sympathomimetic</w>
beta- pregnan-20-
beta- oxidation,</w>
beta- modified</w>
beta- glucuronide.</w>
beta- glucuronidase</w>
beta- funaltrex
beta- antagonists</w>
beta- amyrin</w>
beta- amino</w>
beta- adrenoceptors.</w>
beta- PCT</w>
beta- OH
beta- HCH</w>
beta- Adrenergic</w>
beta ine.</w>
beta M</w>
beta 2-adrenergic</w>
beta 2,</w>
beta 1-adrenergic</w>
beta 1-</w>
beta ).</w>
beta ),</w>
bet we
bet anin</w>
bet ame
bet ab
betab lock
best- corrected</w>
bes ylate,</w>
bepridil )</w>
bepri dil,</w>
benzyl acyclouridine</w>
benzopyran o
benzofur an
benzodiazep ine-like</w>
benzodiazep ine-3-
benzodi ox
benzo flavone</w>
benzo ate)</w>
benzo (f
benzo(f )
benzil ate</w>
benz ylthio
benz yloxy
benz en
benz ar
benz amil</w>
benseraz ide)</w>
benser azide,</w>
benefit /
benefici al,</w>
bene ath</w>
beme gri
belong ed</w>
behaviour ally</w>
behavior s:</w>
behavior s)</w>
behavior ally.</w>
behavior ;</w>
behavior ).</w>
begin ning,</w>
bedd ing.</w>
beats/ mm</w>
beat .</w>
bead s</w>
be st.</w>
be st
be low.</w>
be li
be ings.</w>
be ings,</w>
be having</w>
be et
be er.</w>
be d-
be d)</w>
be ars</w>
be -induced</w>
bath ing</w>
basichondro cranium</w>
basi cally</w>
basel ine);</w>
base- to-apex</w>
bas es.</w>
barri ers,</w>
barri er;</w>
barri er)</w>
baro receptor-mediated</w>
bark s</w>
bari um-exposed</w>
barbitur ate-
barbitur ate,</w>
bar r
band s.</w>
ball istic</w>
balance d,</w>
bal dness.</w>
bacte remia/
baclofen 's</w>
back cros
back ache</w>
bac ulo
bac ter</w>
bac itracin</w>
babo on</w>
bab ies.</w>
bab ies,</w>
b/ Fe
b/Fe J</w>
b.w. t.)</w>
b.w. /
b.w .).</w>
b.i.d .,</w>
b.i.d .).</w>
b. p.m.</w>
b) beta(3)</w>
b) )(-/-)</w>
b y:</w>
b y
b udg
b ts</w>
b risk</w>
b remazocine</w>
b ought</w>
b one/joint</w>
b one.</w>
b inary</w>
b illing</w>
b ic</w>
b er,</w>
b c
b ax
b alb
balb /c</w>
azosin )</w>
azobenz ene</w>
azo semide</w>
azo o,</w>
azithrom ycin-induced</w>
azido thymidine-induced</w>
az oxymeth
az one,</w>
az etidin
az etid
az aspirodec
az alide</w>
az ad
az abicyclo
ay iotopoulos</w>
ay asu
ayasu 's</w>
ax oplas
ax o-
ax ial,</w>
ax i
awaren ess.</w>
awaken ings</w>
awak ening.</w>
awak en</w>
awa ke
aw a</w>
averm ectin</w>
aver ted</w>
avail ability.</w>
av al</w>
autotrans planted</w>
autoradiograph ically.</w>
autom atism</w>
autom atism
auto- receptor</w>
auto- immune</w>
auto fluorescence</w>
auto antibody,</w>
author ization</w>
aut os
aut ac
auro sis</w>
aur a)</w>
augh an</w>
audit ory-
audio grams.</w>
audio grams,</w>
audi ometr
aud ited</w>
attribut ed,</w>
attri tion</w>
atten tive</w>
attemp ted,</w>
attack -like</w>
atroph ic,</w>
atrop ine-induced</w>
atrop ine-</w>
atriure sis</w>
atri al-
atri a-
atran ,</w>
atracuri um-induced</w>
atracuri um-
atr ics</w>
atovaqu one/
ator vastatin.</w>
ator vastatin-induced</w>
ator va</w>
atop y</w>
atop ics</w>
aton ic,</w>
ativel y-
atipame zol
ation- mediated</w>
ation- matched</w>
ation- approved</w>
ation s/
ation s),</w>
atic -
ati zation</w>
ati veness</w>
ati veness,</w>
ati form</w>
ati dyl</w>
atherospermin ine</w>
ather ogenesis.</w>
athe toid</w>
ater -
atebr adine</w>
ate- type</w>
ate- exposed</w>
ate- Lip
ate -like</w>
atax ia:</w>
atal eptic</w>
at ympanic</w>
at trac
at titude</w>
at ry</w>
at ony</w>
at las</w>
at in,</w>
at i</w>
at es)</w>
at :</w>
at ),</w>
asystol e)</w>
asynchron y</w>
astro cytosis</w>
astr agalus</w>
asthmatic us.</w>
asthmatic s,</w>
asthen ic</w>
asthen ia/
asthen ia.</w>
astemiz ole-induced</w>
ast ressin</w>
ast er</w>
associ ating</w>
assign ment.</w>
assess able.</w>
assem bly,</w>
asse mble</w>
assay ).</w>
assa h</w>
ass ault</w>
aspirin/ NSAID</w>
aspir in:</w>
aspir in-treated</w>
aspir in's</w>
aspi rates</w>
aspi rate</w>
aspart ate-dependent</w>
aspart ate)</w>
asle ep</w>
asi a:</w>
ased- fiber</w>
ase -</w>
ascorb ate,</w>
asc rib
asc iculation</w>
as tigm
as one,</w>
as king</w>
as cribe</w>
aryl piperazines</w>
aryl pempid
ary- prevention</w>
arub icin.</w>
arti caine.</w>
arthro scopy.</w>
arthri tis)</w>
arthralgias/ myalgias</w>
arterio pathic</w>
arterio grams.</w>
arterio -
arteri es;</w>
artemisin in-based</w>
art urients</w>
arrest ).</w>
arrang ement.</w>
arous al,</w>
ark e
ari l</w>
ari b
ari als</w>
arginine- methyl</w>
arg yrophilic</w>
arec oline.</w>
are a;</w>
are a/
ard y</w>
ard ing,</w>
ard 's</w>
architect ural</w>
arc hed,</w>
arb our</w>
arb or
arachnoidi tis,</w>
arachid on
arac his</w>
ar ms:</w>
ar mit
ar isch-Herxheimer</w>
ar is,</w>
ar caine</w>
ar ap
aprotin in.</w>
aprind ine.</w>
appro val.</w>
appra isal</w>
appoint ments</w>
append ectomy.</w>
appe aling</w>
apoptosis- inducing</w>
apomorph ine).</w>
apolipo proteins.</w>
apo C-
apnoe ic</w>
apne as,</w>
aphasi a.</w>
apart ),</w>
aparo scopic</w>
ap prehen
ap position,</w>
ap eptide,</w>
ap amin,</w>
aort as.</w>
aor titis</w>
anxiogen ic.</w>
anxiet y:</w>
antiretrovir al-induced</w>
antineoplast ons</w>
antineoplast on</w>
antine utrophilic</w>
antine oplas
antin ause
antimicrobi al-induced</w>
antimalari als,</w>
antihist amine,</w>
antigen -specific</w>
antieme tics.</w>
antidot e.</w>
antidepressant /
antidepressant/ anxiolytic</w>
anticoagul ant-induced</w>
anticoagul ant,</w>
anticip ated,</w>
antibiom an
antibioman ia
antibio tic
antibacteri als,</w>
antiarryth mic</w>
anti-eme tics</w>
anti-L K
anti-HB e-seropositive</w>
anti-HB c,</w>
anti- tuberculous</w>
anti- substance</w>
anti- stress</w>
anti- proliferative</w>
anti- oxid
anti- mouse</w>
anti- malarial</w>
anti- infective</w>
anti- hypoxic</w>
anti- fibrotic</w>
anti- factor</w>
anti- e</w>
anti- depressant</w>
anti- catatonic</w>
anti- atrophic</w>
anti- allergic</w>
anti- aggreg
anti- acetylcholine</w>
anti- S
anti-S SG</w>
anti- Parkinsonian</w>
anti- HBs
anti- GBM</w>
anti- DNA</w>
anti- CD
anti- C3d</w>
anti tubercular</w>
anti thrombosis</w>
anti tachycardiac</w>
anti striational</w>
anti serotonergic</w>
anti rifampicin</w>
anti pyr
anti porter</w>
anti obsessive</w>
anti mon
anti mitochondrial</w>
anti metabolite</w>
anti leukemic</w>
anti leukemia</w>
anti hypertensive,</w>
anti hepatitis</w>
anti glomerular</w>
anti estrogens,</w>
anti epileptics.</w>
anti diuresis</w>
anti de</w>
anti cholinesterases</w>
anti blastic</w>
anthracycl ine-pretreated</w>
anthracycl ene</w>
anth ropometric</w>
anth ran
anteced ents</w>
ante dated</w>
antagonist :</w>
antagon ized,</w>
antagon ising</w>
antagon is
ant adine-induced</w>
ant -associated</w>
anoti a</w>
anos mia</w>
anorexi genic</w>
anorec tics,</w>
anop thal
anococ cygeus</w>
ano- Ward</w>
ano [
ann ulo
ann ular</w>
anis omycin</w>
anis omet
animal s:</w>
animal s.(ABSTRACT</w>
animal s)</w>
anim ation</w>
ani on.</w>
angu ard</w>
angiotensin- II</w>
angiotens in.</w>
angioedema )</w>
angio- oedema</w>
angio pathy,</w>
angio grams.</w>
angi oten
angi opo
ang itis</w>
aneth ole</w>
aneth ole,</w>
anestheti st</w>
anesthesia ?</w>
anesthe tic-
anem ic.</w>
anem ia-related</w>
ane ]</w>
ane ;</w>
ane :
ane -1-
androst enedione</w>
androgen s.</w>
androgen -
andall-Selit to</w>
and amide</w>
ance str
anc rod,</w>
anc ient</w>
anatom ic,</w>
anat abine,</w>
anast omoses</w>
anamne sis</w>
analyz er</w>
analyz er,</w>
analy sis)</w>
analy ses;</w>
analy ser
analy sed,</w>
analogu e),</w>
analgesic- antipyretic</w>
analgesic /
analgesi a;</w>
analgesi a
analge tic</w>
anaestheti st.</w>
ana deine</w>
ana -F
ana-F arber</w>
an- subcontinent</w>
an- cyclophosphamide</w>
an- Wistar</w>
an us.</w>
an uric,</w>
an tion</w>
an onym
an one</w>
an ome
an ner</w>
an ions.</w>
an iline</w>
an i</w>
an ex
an cy
an ap
amyr in,</w>
amylo id-associated</w>
amrin one.</w>
amput ation.</w>
amplitu de/RR</w>
ampl ify</w>
amphoter icin-induced</w>
amphetamine- type</w>
amphetamine- associated</w>
amphet amine;</w>
amph oB</w>
amoxicillin/clavulan ate</w>
amoxicillin/clavulan ate.</w>
amo eb
ammon is</w>
ammon ia.</w>
ammon ia,</w>
ammon i
amlodip ine;</w>
amiodar one-related</w>
amiodar one-
aminotransfer ases.</w>
aminotransfer ases,</w>
aminophylline -</w>
aminop ter
aminonucleo side-
aminoglyco side,</w>
aminocyclopentane -1,3-
amino-8-D- arginine</w>
amino- n-
amino guanidine,</w>
amino adamant
amino acridine</w>
amine ]</w>
amin otetralin</w>
amin opyridine</w>
amin obicyclo[3.
amin ergic,</w>
amide s.</w>
amide s,</w>
amide ;</w>
amen orrhoea</w>
amen orrhea,</w>
amelior ative</w>
amelior ated,</w>
ambul ated</w>
ambul ant</w>
ambi valence</w>
amant adine-induced</w>
am yl</w>
am ustin</w>
am po
am orph
am obarbital,</w>
am aurosis</w>
am ate,</w>
am a
am B</w>
alveol i</w>
altern ans.</w>
alprostadi l,</w>
alprazol am
alpha2- adrenoceptors,</w>
alpha2 A-
alpha1- preferring</w>
alpha-tocopher ol.</w>
alpha-tocopher ol)</w>
alpha-methyl- para-tyrosine</w>
alpha-methyl norepinephrine</w>
alpha-mang ost
alpha-keto glutarate</w>
alpha-fluoro-beta- alanine</w>
alpha-amino-3-hydroxy-5-methylisoxazole-4- propionic</w>
alpha-amino-3-hydroxy-5-methyl-4- isoxazole</w>
alpha-actin in</w>
alpha-2 b)</w>
alpha- tropan
alpha- phenyl-N-
alpha- methyl</w>
alpha- mediated</w>
alpha- glucosidase</w>
alpha- ethyl-
alpha- blockade</w>
alpha- adrenoreceptors</w>
alpha- adrenoreceptor</w>
alpha- adrenolytic</w>
alpha- Methyl
alpha- M
alpha- HCH,</w>
alpha- D-
alpha- A
alpha- 7</w>
alpha,beta-me ATP)</w>
alpha,beta- methylene</w>
alpha, betame
alpha, 25-
alpha(4) beta(2)</w>
alpha(2)- adrenoceptors</w>
alpha(1D )-
alpha(1 B
alpha(1 A)-
alpha(1A)- adrenoceptor</w>
alpha(1 )-</w>
alpha 5-</w>
alpha 5-
alpha (II
alpha(II b)beta(3)</w>
alph acal
alphacal cidol</w>
alph ab
alone );</w>
almo kal
allo we
allo tted</w>
allo sterically</w>
allo cortical</w>
allevi ated.</w>
aller ian</w>
alle le.</w>
alle le,</w>
alle gedly</w>
all- trans
all y-</w>
all y),</w>
all mann's</w>
all ine</w>
all 's</w>
alkyl /
alkyl/ aryl-
alkal isation</w>
alis )</w>
alim entary</w>
align ed</w>
ali um)</w>
alg ia,</w>
alfuz osin,</w>
alfa-2 a,</w>
alf athesin</w>
alf a
alepl on</w>
aldoster one-treated</w>
aldehy de.</w>
alcohol- free</w>
alcohol ic.</w>
alcohol ic,</w>
albumin- bound</w>
alaprocl ate,</w>
alam azoo,</w>
al-to- apical</w>
al- variant</w>
al- anesthetized</w>
al together</w>
al ston
al s),</w>
al ol.</w>
al o</w>
al mitrine</w>
al location.</w>
al ization.</w>
al ga
al d
al ar</w>
akine sia/
akathi sia:</w>
air way.</w>
air e</w>
air -
aim iri</w>
ai robi
ai ko-
agoraph obia.</w>
agoraph ob
agonist ).</w>
agonist "</w>
agon ism.</w>
aggreg ations</w>
aggreg ate,</w>
agglutin ins,</w>
agent s--
agent s)</w>
agent 's</w>
age- dependent,</w>
age ing-induced</w>
age ?</w>
age /
ag ra</w>
ag ing"</w>
ag iline</w>
ag encies</w>
ag ed,</w>
ag atran,</w>
ag )</w>
affili ated,</w>
aff ectively</w>
afe brile</w>
afe bri
aeros ols</w>
aeros ol,</w>
aer odigestive</w>
aem ia:</w>
advis ability</w>
adver se-
adur abol
adult- generated</w>
adul ts)</w>
adriamycin- cardiomyopathy.</w>
adrenocortic otrophin</w>
adrenocor tico
adrenoceptor- selective</w>
adrenal in</w>
adrenal ectomized,</w>
adren ic</w>
adren als</w>
adren al,</w>
adolescent s:</w>
adolesc ence:</w>
admis sion;</w>
admis sion).</w>
administere d)</w>
adjust ment.</w>
adjust ed.</w>
adipos ity,</w>
adheren ce,</w>
adenyl ate-
adenos ine)</w>
adenomyo sis</w>
adenofibrom as</w>
adenocarcin omas,</w>
adeno virus-mediated</w>
adeno hypophy
aden yl</w>
aden osis,</w>
adefovir -
adefovir- resistant</w>
adefovir ,</w>
ade l</w>
addi tives.</w>
addi tions</w>
add- on.</w>
adap tative</w>
adal afil</w>
ad vised,</w>
ad sorbent</w>
ad ol,</w>
ad o</w>
ad mixture.</w>
ad mixture,</w>
ad mit</w>
ad joining</w>
ad j</w>
ad ducted</w>
ad assah</w>
activity- regulated</w>
activi ti
active- treatment</w>
activ ity).</w>
act ing)</w>
acrole in.</w>
acro phase</w>
acri din
acqu iring</w>
aconit yl-lysozyme</w>
aconit ase</w>
acne form</w>
acide mia,</w>
acid/ l</w>
acid- sensing</w>
acid- Schiff</w>
acid- ,</w>
acid ].</w>
acid ;</w>
acid -mediated</w>
acid --
acid (A)</w>
ach es,</w>
acetyl- CoA</w>
acetyl transferase,</w>
acetyl salicylate</w>
acetyl morphine</w>
acetyl cysteine.</w>
acetaminophen- protein</w>
acetaminophen ;</w>
acetaminophen :</w>
acetaminophen -treated</w>
acetaminophen -containing</w>
acet y
acet ophen
acet ate;</w>
acet ate-induced</w>
acet amide.</w>
acepif ylline</w>
acea e),</w>
ace promaz
accur ate,</w>
accred ited</w>
accord ingly</w>
accommod ative</w>
accid ents,</w>
acchar ide</w>
acces sioned</w>
acces sible</w>
accept or</w>
accept ance,</w>
accentu ating</w>
accelerome ters</w>
accelerome ter.</w>
acc ine</w>
acc ess,</w>
ac tion-potential</w>
ac ted,</w>
ac re</w>
ac )</w>
abuse/ dependence</w>
abuse ;</w>
abund ance,</w>
abu tin</w>
abu met
abs ent;</w>
abor tive</w>
abor tion,</w>
abor ti
abor ted</w>
abor t</w>
abnormaliti es)</w>
able "</w>
abl ing</w>
abil ity;</w>
abil ity:</w>
abecarn il.</w>
abecarn il,</w>
ab users:</w>
ab used,</w>
ab stained</w>
ab ruptio</w>
ab rasion</w>
ab breviation</w>
ab ated.</w>
ab '
ab' )2</w>
a- tri-homo-22,24-di
a- determinant"</w>
a,5,6, 7,
a,5,6,7, 8
a,5,6,7,8 ,8
a,5,6,7,8,8 a,
a,5,6,7,8,8a, 9-
a, 27
a,27 a-tri-homo-22,24-di
a, 26
a,26 a,27a-tri-homo-22,24-di
a use,</w>
a stral</w>
a relin</w>
a phen
a is</w>
a ine,</w>
a ids.</w>
a etiologies</w>
a esthesia</w>
a effer</w>
a e).</w>
a ]-
a [1,
a T</w>
a MIBI</w>
a L</w>
a H
aH sd</w>
a GVHD</w>
a 5</w>
a 2</w>
a -treated</w>
a ")</w>
]- FDG-
] -induced</w>
] -</w>
[bis (4-fluorophenyl)
[bis(4-fluorophenyl) methoxy]
[SD ],</w>
[N va2]TRH</w>
[Mg2+ ]
[A OR
[AOR ]</w>
[5-amino- 3-
[4-(2-methoxyphenyl) -1-piperazinyl]
[4-(2-methoxyphenyl)-1-piperazinyl] ethyl]-
[3H]- thymidine</w>
[3H]- QNB</w>
[3H]- GABA</w>
[3H] ryanodine</w>
[3H] quinuclidinyl</w>
[3H] choline</w>
[3H] TRH</w>
[3H] PRL</w>
[3H] MK-801</w>
[35S] GTPgammaS</w>
[31] )
[31]) P</w>
[3- (4-
[2-(3,4-dichlorophenyl)ethyl]- N-methyl-2-
[2- [4-
[2- (6-
[199 8
[19 69]</w>
[18 ]-FDG-
[14C] succinate</w>
[14C] iodoantipyrine</w>
[14C] 5-HT</w>
[14 C]</w>
[11 C]-
[11C]- car
[1,2,4 ]-
[1, 4
[1,4 ]
[(3)H] albumin</w>
[(3 5)S]
[ range</w>
[ range,</w>
[ d.f.=
[ beta-
[ alanine</w>
[ adjusted</w>
[ [2-
[ [
[ X
[ Sar
[ SI
[ SD</w>
[ RRs</w>
[ Na+
[Na+ ],</w>
[ Met
[Met 5]
[Met5] enkephalin</w>
[ M
[ Hyp
[ H]</w>
[ H
[ GSH
[GSH ]</w>
[ F
[ DBP
[ D-
[ CMF
[ B
[ Arg
[Arg (14),</w>
[ ></w>
[ 9]</w>
[ 95.
[ 5
[ 4,5-
[ 27
[ 12
[ 11.
[ 1.5</w>
[ 1,25(OH)2D
[ 0.7
[ 0.2
[ -1
[ +/-</w>
[ +
[ (p
[(p F
[(pF )
[(pF) Phe
[ (3-
[ "
Zyb an,</w>
Zuc ker</w>
ZO -1,</w>
Z)- tetraenoic</w>
Z ung</w>
Z omepirac</w>
Z n,</w>
Z atebradine</w>
Z aleplon</w>
Z I-
Z -dependent</w>
Z -2
YM-080 50</w>
YM 4
YM4 30,</w>
Y- containing</w>
Y el
Y ang
Y U</w>
Y PE</w>
Y OH,</w>
Y MSM</w>
Y MR
YMR S,</w>
Y L</w>
Y 1204</w>
Y -like</w>
Ximel agatran</w>
XI AP</w>
X- irradiation</w>
X- A)</w>
X R)</w>
Work up</w>
Wor k-up</w>
Wist ar/
Wis con
Wild -type</w>
Wilcox on's</w>
Whole- cell</w>
Whit acre</w>
Whe reas,</w>
Wernicke-Korsak off</w>
Wellbutr in</w>
Well- designed</w>
Well come</w>
Wean ling</w>
Weak ness</w>
We b</w>
Wal es.</w>
Wal es,</w>
WY-14, 643</w>
WR 300
WR300 90</w>
WIN55,212- 3,</w>
WB M</w>
WB H.</w>
WB 4
WAY-100 635</w>
WAY-100 135</w>
WAY 100635</w>
WAR s</w>
W. H.
W.H. O.</w>
W- ICH</w>
W- 30</w>
W- 24</w>
W it
W ide</w>
W i
W est
W elfare</w>
W ater-
W allerian</w>
W U
WU BR</w>
W T.</w>
W T)</w>
W R</w>
W O
WO MAC</w>
W MA
WMA s</w>
W M
W K</w>
W IT
WIT H</w>
W IL
W G.</w>
W ),</w>
Volum es</w>
Vol t
Vir gin
Vir acept</w>
Viol ent</w>
Vindes ine,</w>
Vigi base,</w>
Vic tim
Vi etnamese</w>
Vi agra</w>
Veter inary</w>
Veter ans'</w>
Ves narinone</w>
Verapam il-sensitive</w>
Ver sion</w>
Ver a</w>
Venti lation</w>
Ven ipuncture</w>
Ve loc
Vc f.</w>
Vasodilat ation</w>
Vas urix</w>
Vas ospas
Vas omotion</w>
Vari ant</w>
Vari able</w>
Vari ability</w>
Var ying</w>
Var denafil</w>
Vancou ver</w>
VR CZ</w>
VR 1-
VR (1)</w>
VP- HNP</w>
VP F</w>
VP 16</w>
VP -1
VO 2
VII a)</w>
VII I.</w>
VG B.</w>
VEGF/ VPF</w>
VEC P</w>
VEC -
VE LO
VELO CI
VELOCI T
VE H</w>
VE BEP</w>
VAS- Sedation</w>
VAN .</w>
VAN -induced</w>
VAC TER
VACTER L</w>
V/ Delta
V o
V itamins</w>
V it</w>
V in
V ide
V ed
V anguard</w>
V alg
V al,</w>
V accine</w>
V ac
V SM
V R,</w>
V P.</w>
V P).</w>
V M,</w>
V M
V K</w>
V III,</w>
V F)</w>
V BD
V AC</w>
V 1,</w>
V .
V )-
V (mca)</w>
V (EN
V(EN DO)</w>
Usu ally</w>
Uro thelial</w>
Uro logists</w>
Uro logic</w>
Uro cortin</w>
Uri dine</w>
Ur d)</w>
Ur ban</w>
Uppsal a</w>
Upjoh n,</w>
Univer sal</w>
Unit ,</w>
Uniqu e</w>
Uni on</w>
Under sogelser</w>
Un less</w>
Un fractionated</w>
Un changed</w>
Umbil icaria</w>
Ul cer
Ugand an</w>
Ud valg</w>
US ,</w>
URB59 7</w>
UR R</w>
UPD RS-
UMD M)</w>
UM- 27
UM-27 2.</w>
UL N,</w>
UK-61,26 0,</w>
UK U</w>
UDP- glucuron
U69 ,593</w>
U5048 8
U50488 h</w>
U/ l</w>
U/ l.</w>
U/ l,</w>
U/ kg/h</w>
U-4 3,4
U-43,4 65</w>
U- wave</w>
U tility</w>
U sage</w>
U ric</w>
U re
U pr
U ne
U ganda.</w>
U cn</w>
U S.</w>
U S-
U MB</w>
U L</w>
U K)</w>
U F</w>
U C</w>
Typ ically,</w>
Tx nip</w>
Two- hundred</w>
Two- dimensional</w>
Twel ve-
Tw ice</w>
Tw ice-
Tubulo -interstitial</w>
Trp- P-2</w>
Trop onin-
Tro glitazone-induced</w>
Triphasi l</w>
Trimethop rim-induced</w>
Trimeth aph
Triazol am</w>
Triazol am-induced</w>
Triam cin
Tremor ,</w>
Treatment -induced</w>
Treat ment,</w>
Transi tional</w>
Transc ri
Trans thoracic</w>
Trans national</w>
Trans f
Tran ylcypromine</w>
Trac t</w>
Tra stuzumab</w>
Tra ining</w>
Tou hy</w>
Tot al,</w>
Tor sa
Topir am
Ton ic-clonic</w>
Tolu ene</w>
Tol metin-induced</w>
Tol azoline</w>
Tol az
To ichi's</w>
Time- averaged</w>
Tim ing</w>
Tim es</w>
Tig ason</w>
Tie2-Cre; Lox
Tie2-Cre;Lox p-EGFP</w>
Ticarc illin</w>
Ti apride</w>
Ti ag
Thromb opoietin</w>
Three- month</w>
Thior idaz
Thiop urine</w>
Thiaz ide-induced</w>
The o-Dur
Thal amic</w>
Thal am
Thail and,</w>
Th y</w>
Th r-34</w>
TgR[hAI] high</w>
Tex t</w>
Tetrahydro cannabinol</w>
Tetrac ycline</w>
Tet/ Dox</w>
Tet any</w>
Terbut aline,</w>
Terbin afine</w>
Ter son's</w>
Ter fenadine</w>
Tenofovir -related</w>
Temper ature</w>
Tem oc
Tel bivudine</w>
Teicoplan in</w>
Te trandrine</w>
Te trabenazine</w>
Te acher</w>
Td P-
Tc- IDA</w>
Tc- 99m-
Tax Ch.</w>
Taq IB,</w>
Tamsulos in</w>
Tak ayasu's</w>
Taiw an,</w>
Tail- tremor</w>
Tacrolim us-related</w>
Tacrolim us-induced</w>
Tachy phylaxis</w>
Tac rine,</w>
Ta us
Ta ur</w>
TX A
TX ).</w>
TW LI</w>
TV3 279</w>
TTX- resistant</w>
TT C</w>
TT ),</w>
TS- MO
TS-MO ST</w>
TRPV1 b</w>
TRPV 1-
TRPV (1)</w>
TRO196 22</w>
TR PM
TR P</w>
TR I.</w>
TR H-
TP P,</w>
TP N,</w>
TOR ),</w>
TOF- ratio</w>
TNS s.</w>
TNP- ATP</w>
TMPy P</w>
TMP-SM Z.</w>
TM O</w>
TLP R)</w>
TJ M
TI T</w>
TI D)</w>
TI C</w>
TI A.</w>
TH I</w>
TH F)</w>
TH F
THF s/THE</w>
TH C,</w>
TH ,</w>
TGF- beta-modified</w>
TGF- beta,</w>
TG M.</w>
TF C)</w>
TER T</w>
TEM -treated</w>
TE N</w>
TE C</w>
TD (50)</w>
TCD D
TB I,</w>
TAM -related</w>
TA G</w>
TA A-
TAA- rats</w>
TA ).</w>
T4/ T1</w>
T1 W</w>
T/ T</w>
T- amplitude/RR</w>
T- A</w>
T- 82</w>
T- 2</w>
T w</w>
T urkish</w>
T rough</w>
T ropisetron</w>
T ris
T rin
T readmill</w>
T racheal</w>
T oxoplasma</w>
T oxin</w>
T orem
T oc
T l-201</w>
T issues</w>
T g)</w>
T esticular</w>
T es
T en-
T ear</w>
T arget</w>
T anz
T adalafil</w>
T YPE</w>
T T-containing</w>
T T,</w>
T SH
T S:</w>
T S)</w>
T R)</w>
T PE,</w>
T OR</w>
T NS.</w>
T MTX/
T MB-
T DF
T CV-1
T CI</w>
T BM
T AM-
TAM- containing</w>
T AM,</w>
T AC
T A),</w>
T 30</w>
T 10.</w>
T 1/2</w>
T 1,</w>
T 0</w>
T -</w>
T (>
T(> 0.05)</w>
T (1)</w>
T (
T 's</w>
System ically</w>
Syst em,</w>
Syn ap
Symptom s.</w>
Switzer land</w>
Switzer land
Suxameth onium-induced</w>
Susta ined-release</w>
Suspici ousness</w>
Suspici on</w>
Surve ys</w>
Surg er
Sup pressive</w>
Sup ple
Sum atript
Sulind ac-induced</w>
Sulfadi azine-induced</w>
Sulfadi az
Sulf hemoglobinemia</w>
Substanti a</w>
Subj ect</w>
Sub optimal</w>
Sub cortical</w>
Su perior</w>
Struct ure-activity</w>
Stress ful</w>
Streptozotoc in-
Stren uous</w>
Stren gth</w>
Stra ub's</w>
Str uc
Still 's</w>
Stern berg</w>
Ste p</w>
Statis tically,</w>
Stat in-induced</w>
Stat in-fibrate</w>
Stat es)</w>
Sta phylococcal</w>
St esolid</w>
St aging</w>
St ability</w>
Sprague-Daw ley,</w>
Spe ed</w>
Spas ticity</w>
Sp /+</w>
Somnol ence,</w>
Som atic</w>
Sodi um-
So-1 100</w>
Smok eless</w>
Smo oth</w>
Sm ith
Sle eping</w>
Six- week-old</w>
Six- month</w>
Six -</w>
Sive lestat</w>
Sirolim us-associated</w>
Sirolim us,</w>
Sing le
Sine met</w>
Sine met
Sin ce,</w>
Simp son</w>
Simil ar,</w>
Sim vastatin,</w>
Sildenaf il-associated</w>
Signific ance</w>
Sign al</w>
Sig ma</w>
Sig ma
Sh A)</w>
Sevo flurane-induced</w>
Sest amibi</w>
Sest aMIBI</w>
Sertr aline-induced</w>
Ser vic
Ser ratia</w>
Sequ encing</w>
Septem ber,</w>
Semi- structured</w>
Semi- Structured</w>
Self- reports</w>
Seizure -P
Seizure-P rone</w>
Sed ative</w>
Second ly,</w>
Sear ch</w>
Se emingly,</w>
Scot tish</w>
Scop olamine,</w>
Sclero der
Sci ences</w>
Schwar tz</w>
Schedul ed</w>
Sch le
Sch aeffer</w>
Scat tered</w>
Scan ning</w>
Scal p</w>
Sarc openia</w>
Sar alasin</w>
Sando z)</w>
Sando statin</w>
Sal t</w>
Sal iv
Saf ety,</w>
Sa O
SaO 2
SW V.</w>
SW OG</w>
SV P</w>
SV I</w>
SV I/
SVI/ blindness</w>
SU ES:</w>
SU D</w>
STZ- injected</w>
STZ- SHRs</w>
STZ ,</w>
STN- DBS</w>
ST S,</w>
ST R</w>
ST OR
STOR Y:</w>
ST M</w>
ST 36</w>
SSR18150 7,</w>
SSR T</w>
SSH L</w>
SS TIs</w>
SS SI
SS G)</w>
SRS s.</w>
SR s</w>
SR C</w>
SR ;</w>
SR :</w>
SR 142801</w>
SR ),</w>
SP SS</w>
SP L.</w>
SP K</w>
SP H</w>
SP 4</w>
SOD2- OX</w>
SOD -like</w>
SO L</w>
SO FA</w>
SNZ c</w>
SNC V</w>
SN F</w>
SM T</w>
SM ON.</w>
SLE ;</w>
SKF 38393</w>
SK- N-
SJ L/
SJL/ J</w>
SIAD H-induced</w>
SI S3</w>
SI ON</w>
SI B
SHR s,</w>
SHB G,</w>
SH E</w>
SH (-)</w>
SH (+)</w>
SF P</w>
SETTI NG</w>
SER M</w>
SENSU S</w>
SEM :</w>
SE D+
SDS-PA GE</w>
SD s,</w>
SD F</w>
SD ):</w>
SCO P</w>
SCO P-treated</w>
SCL C.</w>
SCH- 23390</w>
SC- 560</w>
SC s,</w>
SC r.</w>
SC )-induced</w>
SB 36
SB36 67
SB 20655
SAP S</w>
SAP S-
SAH- hydrolase</w>
S9 78
S3 (30)</w>
S3 (0)</w>
S248 F</w>
S14G- HN,</w>
S/ QT)</w>
S/ Ibg</w>
S.D .
S. E
S-methyl iso
S-2-(3- aminopropyl
S-145 2-
S-1452- treated</w>
S-145 2,</w>
S- phase</w>
S- nitroso-
S- myosin</w>
S- mephenytoin</w>
S- lesioned</w>
S- dams</w>
S- Li</w>
S- I</w>
S- A</w>
S- 508</w>
S- 204
S-204 352</w>
S- 20
S-20 68
S- (+)-
S ymbol</w>
S s)</w>
S pre
S potting</w>
S pati
S par
S omat
S lowing</w>
S lightly</w>
S kin
S itu
S ideroblastic</w>
S h</w>
S gcd-null</w>
S er</w>
S eptal</w>
S epiapterin</w>
S ene
S cutellaria</w>
S cler
S c</w>
S ample</w>
S SL</w>
S SE
S S).</w>
S OR
SOR BA</w>
S OD)</w>
S NS
SNS -induced</w>
S N-
S LC6
S CIS</w>
S CI</w>
S CBF,</w>
S ABP</w>
S A,</w>
S 2)</w>
S 1.</w>
S 1
S .)</w>
S -14
S-14 52</w>
S ,2
S ):</w>
S )-induced</w>
S (-)</w>
S (-)-
Rut a</w>
Rus selia</w>
Rosi glitazone</w>
Rom ano-Ward</w>
Rod ents</w>
Rod ent</w>
Roche ster</w>
Roc he</w>
Rivas tigmine</w>
Rit odrine</w>
Rit anserin</w>
Ril uzole</w>
Rifamp icin-associated</w>
Rifamp ic
Rif abut
Ribavir in,</w>
Rhabdomy osarcoma</w>
Rh o</w>
Rg3 (R
Rg l</w>
Rev ised</w>
Retro peritoneal</w>
Resul ts.</w>
Reser pine-induced</w>
Res ource</w>
Reproduc ible</w>
Reproduc ibility</w>
Ren in-
Ren in,</w>
Remifentan il-induced</w>
Rem ote</w>
Relev ance</w>
Rel ton-Hall</w>
Rel ated</w>
Regist ration</w>
Reg ulatory</w>
Reg imens</w>
Reg 2-
Reg2- /-</w>
Recon sider
Reci pients</w>
Recei ver</w>
Rec all</w>
Reb oxetine</w>
Re- exposure</w>
Re sistant</w>
Re plic
Re instatement</w>
Re habilitation</w>
Re ference</w>
Ras ay
Ras agiline</w>
Raniti dine,</w>
Randall-Selit to.</w>
Ran ol
Ran cho</w>
Rami pri
Radi onuclide</w>
Radi ographs</w>
Radi o
Rac lopri
Rac ine's</w>
Rac em
Rabep razole</w>
RVOT- VT.</w>
RV R</w>
RV L
RVL M.</w>
RU38 486</w>
RU-430 44</w>
RTI -
RT V</w>
RT ),</w>
RP M</w>
RP F</w>
RP :</w>
ROM-1 26</w>
RO Is</w>
RO 4-4602</w>
RO 2)</w>
RO .</w>
RN- lesioned</w>
RN V</w>
RN Es</w>
RK P</w>
RIS -induced</w>
RG H-
RGH- 2
RGH-2 202</w>
RG 76</w>
RF s</w>
RF s.</w>
RF +
REVIEW :</w>
RE AD
RCT N
RB V.</w>
RB V
RB Fs</w>
RB F.</w>
RAR S,</w>
RAL D</w>
RAE B,</w>
RAD00 1</w>
R-(+)- 8-OHDPAT</w>
R- tropanyl</w>
R- C</w>
R- 3)</w>
R- 24
R-24 03</w>
R,4 S)-1-
R upt
R ub
R ox
R opinirole</w>
R ol
R ociverine</w>
R e</w>
R d,</w>
R ash</w>
R YU</w>
R Y</w>
R VT</w>
R SI.</w>
R SDS</w>
R SD
R P.</w>
R J
RJ R-2403</w>
R CA.</w>
R A),</w>
R :</w>
R 76,</w>
R 4</w>
R (-/-))</w>
Queti apine,</w>
Questionnai res</w>
Questionnai re.</w>
Questionnai re,</w>
Ques tions</w>
Quercet in,</w>
Quanti tation</w>
Qu a
QTc d</w>
QT/ QTc</w>
QT- RR</w>
QT(Fram ),</w>
QT c.</w>
QT btb</w>
QT P</w>
QT L
QT -3</w>
QT (B
QT(B ),</w>
QS 2
Q max</w>
Q _
Q X,</w>
Q M
Q D.</w>
Q A</w>
Q A-treated</w>
Q ;</w>
Q 10,</w>
Py ramidal</w>
Purpur a</w>
Puer ariae</w>
Ptio 2</w>
Psychi atry</w>
Psych otropic</w>
Psych otria</w>
Psych opathy</w>
Psych opathology</w>
Psych ometric</w>
Pseudo- allergic</w>
Pseudo ephedrine-induced</w>
Ps A</w>
Provid ed</w>
Prote us</w>
Propylthio urac
Propri ospinal</w>
Propofol-Lip uro
Propofol -induced</w>
Propafen one,</w>
Prop ylene</w>
Prolong ing</w>
Progres sion-free</w>
Program me</w>
Program me.</w>
Prog ress</w>
Prochlorper azine</w>
Pro ven</w>
Pro tium</w>
Pro thrombin</w>
Pro static</w>
Pro s
Pro por
Pro file</w>
Pro duct</w>
Pro ,</w>
Prinzmet al-variant</w>
Prima quine</w>
Prima quine-induced</w>
Presyn aptic</w>
Pres enting</w>
Pren atally</w>
Prednis one,</w>
Predic tion</w>
Pre- natal</w>
Pre ven
Pre term</w>
Pre morbid</w>
Pre dominant</w>
Praz osin-induced</w>
Prac tices</w>
Pr ince</w>
Potenti als</w>
Pot ent</w>
Post- operative</w>
Post- marketing</w>
Post ulated</w>
Post synaptic</w>
Post menopausal</w>
Pos sibly</w>
Pos sibly,</w>
Pos ms</w>
Poly therapy</w>
Poly somnographic</w>
Poly radicul
Poly godi
Poly cystic</w>
Poin tes,</w>
Po stres
Po C</w>
Po (2)</w>
PmO (2)</w>
Plough )</w>
Plat es</w>
Plasma pheresis</w>
Plac ental</w>
Pis a</w>
Pinsch ers</w>
Pi rox
Pi renzep
Phy ll
Phot ophobia</w>
Phil ippin
Phenyl butaz
Pheny leth
Phenobarbit one</w>
Phenobarbit al,</w>
Phe -
Pharmacokine tic-pharmacodynamic</w>
Pharmaco Vigilance</w>
Pharmac ologically</w>
Pharmac ol.</w>
Ph arm.</w>
Ph ar
Peroxis ome</w>
Perit ubular</w>
Perio d</w>
Peri- operative</w>
Peri pher
Perflutre n</w>
Per tinent</w>
Per t
Per iod
Per indopril</w>
Pepti care</w>
Pentobarbit one</w>
Pentagastr in</w>
Penicill amine-associated</w>
Pemphig us</w>
Peg filgrastim</w>
Pedi atricians</w>
Pear l</w>
Pe ople</w>
Pe ople's</w>
Pe king</w>
Pe g-
Pe ak
Patient 's</w>
Pathophysi ologic</w>
Path ology,</w>
Path ogens</w>
Pat ent</w>
Parom omycin</w>
Parkinson ian-like</w>
Paras ympathetic</w>
Parano ia</w>
Parad oxic</w>
Par lodel</w>
Pap ua</w>
Pap illary</w>
Pantop razole</w>
Pan ayiotopoulos</w>
Pan am
Palli ation</w>
Pal atal</w>
Paclitaxel /
Pab 2-
Pa yments</w>
Pa resthesia</w>
Pa ediatric</w>
Pa CO
PY 343</w>
PW P,</w>
PVC 's</w>
PV Ts</w>
PV N,</w>
PV ,</w>
PTZ -</w>
PTZ -,</w>
PTZ -
PTH .</w>
PT SD.</w>
PT Rs</w>
PT P</w>
PT CA,</w>
PT C</w>
PT B</w>
PT /
PT -1
PSV T.</w>
PSV T,</w>
PR3- ANCA-positive</w>
PR s).</w>
PR OD
PROD ACT</w>
PR ACTI
PPO H</w>
PPARbeta/ delta</w>
PPARbeta/ delta.</w>
PPAR- y</w>
PPAR alpha-
PP Is.</w>
PP F</w>
POR C</w>
PO EE</w>
PO CD</w>
PO AG</w>
PNU-159 54
PNU-15954 8,</w>
PN P.</w>
PN L</w>
PN ),</w>
PMS F,</w>
PM VT</w>
PM P,</w>
PM ;</w>
PL P.</w>
PL MS</w>
PL K</w>
PL D-
PLD- docetaxel</w>
PL A(2)</w>
PL 37</w>
PL 37,</w>
PKC epsilon,</w>
PKC beta2,</w>
PKC beta1,</w>
PK Rs</w>
PHAR M
PH Z</w>
PH T-treated</w>
PH H</w>
PH EN
PH A-
PH )-induced</w>
PGP 9.
PGP9. 5-
PGP9.5- positive</w>
PGI- M</w>
PGF 2
PGF2 alpha</w>
PGE (2).</w>
PG s,</w>
PG S.</w>
PG N)</w>
PG D</w>
PF C,</w>
PES B.</w>
PEP .</w>
PEF R,</w>
PE I</w>
PE GS
PE C</w>
PDE -
PDE- inhibitor</w>
PD-1 233
PD- like</w>
PD IE</w>
PD H</w>
PD :</w>
PD 9
PD 56,</w>
PC Z</w>
PC W
PC V</w>
PC V.</w>
PC V,</w>
PC NA
PCNA +</w>
PC 12</w>
PC ),</w>
PB- inducible</w>
PANS S,</w>
PAN/ temocapril</w>
PAN- FSGS</w>
PAN K2</w>
PAN ).</w>
PACAP (-/-)</w>
PAC P
PAC HE)</w>
PAC (1)</w>
PA/ caffeine</w>
PA s</w>
PA ]</w>
PA P)</w>
PA M)</w>
PA F,</w>
P=0.00 8),</w>
P=0.00 3),</w>
P=0.0 3)</w>
P=0.0 1),</w>
P= 0.001).</w>
P<0.00 1
P< 0.05;</w>
P< 0.01</w>
P< 0.001);</w>
P< 0.0001)</w>
P< .01).</w>
P2X (4)</w>
P2 R-
P2 1.</w>
P/Q -type</w>
P-glyco protein.</w>
P-glyco protein-mediated</w>
P-450 -mediated</w>
P-450 (11)</w>
P-1 302</w>
P- wave</w>
P- pretreated</w>
P- lowering</w>
P- associated</w>
P- R</w>
P- NS</w>
P- NMR</w>
P(2y 2)</w>
P uro
P soriasis</w>
P s,</w>
P s).</w>
P resc
P refrontal</w>
P red</w>
P rec
P rasu
P ow
P lication</w>
P ill</w>
P ig
P iclozotan</w>
P hob
P g</w>
P f
P eroben</w>
P ene</w>
P co
P arturients</w>
P allidal</w>
P air
P ain,</w>
P ad
P V</w>
P UF
P SAD</w>
P S/
P S),</w>
P PA/caffeine</w>
P P)</w>
P NPO</w>
P MS</w>
P M),</w>
P LT
P K-
P III</w>
P ChE</w>
P Ca
P CP/
PCP/ sigma</w>
P CP-induced</w>
P CP,</w>
P CN
PCN A-
P CI,</w>
P C)</w>
P B)</w>
P 9,</w>
P 8,</w>
P 600</w>
P 50,</w>
P 400
P 3</w>
P 3,</w>
P 17</w>
P 12,</w>
P 1-
P 1)</w>
Oxy genation</w>
Ox prenolol</w>
Ox azepam</w>
Ox aproz
Ox amniqu
Ox acillin</w>
Ox -ph
Over- expression</w>
Otolaryng ology-Head</w>
Oste oporosis</w>
Os m</w>
Orth o-Novum</w>
Organ ophosphate</w>
Organ izations</w>
Orac on</w>
Or nithine</w>
Or gas
Ophthalmo logy</w>
Ophthalmo logical</w>
Open- label,</w>
Op posite</w>
One -,</w>
Omni paque.</w>
Omeprazol e-induced</w>
Om niscan</w>
Olig uria</w>
Ol aHsd</w>
Off '</w>
Od di
Octreoti de-induced</w>
Ob viously,</w>
Ob structive</w>
Oat ps</w>
OX 8+</w>
OX 39
OX39 +</w>
OV X</w>
OUTCOME S:</w>
OS CS-
OSCS- contaminated</w>
OS A.</w>
OR X</w>
OR AC(-OHo
ORAC(-OHo )</w>
OR ).</w>
OPID N.</w>
OP P,</w>
ONO-87 11</w>
ON RYU</w>
ON -
ON- state</w>
ON ,</w>
ON +
OFF- period</w>
OF R</w>
OF Q/
OD T</w>
OD Q</w>
OD Q,</w>
OBJECTIVE S</w>
OBJEC TS:</w>
OBJEC T:</w>
OB E</w>
OAT- ICH.</w>
O. S.</w>
O-de alkylase</w>
O- Methyldopa</w>
O vid</w>
O roxylin</w>
O rig
O reg
O raVer
O mitting</w>
O mission</w>
O le
O kla
O ic
O ]</w>
O TC</w>
O S.</w>
O S,</w>
O P-
O P,</w>
O HC
O EF
O Cs,</w>
O CT-treated</w>
O AC.</w>
O 2).</w>
O )-induced</w>
O 's</w>
O '
Nutri tional</w>
Nur sing</w>
Nur ses</w>
Numb ers</w>
Nrf 2
Not able</w>
Norplant -2</w>
Norm alised</w>
Nor- Prog
Nor way
Nor triptyl
Nor m</w>
Non- haematological</w>
Non sustained</w>
Non selective</w>
Non randomized</w>
Non hematological</w>
Non fatal</w>
Non cirrhotic</w>
Non arteritic</w>
Nomifens ine</w>
Noc turnal</w>
Nitroglycer in,</w>
Nissl- stained</w>
Nigeri ans.</w>
Nicardi pine-induced</w>
Nex t-day</w>
Nevir apine</w>
Neuro ten
Neuro pathological</w>
Neuro path
Neuro l</w>
Neuro l.</w>
Neuro genesis</w>
Neuro degeneration</w>
Neuro anatomical</w>
Neu tr
Neu /
Neu/ Erb
Netherland s,</w>
Nesac aine</w>
Nephro logy</w>
Nel fin
Nefir acetam</w>
Need le</w>
Need le-
Ne utrophils</w>
Ne utrophil</w>
Ne u</w>
Ne tilmicin</w>
Ne t</w>
Ne oplastic</w>
Ne odolpas
Ne fazod
Naprox en-induced</w>
Naprox en-associated</w>
Nalox one,</w>
Nalbu phine</w>
Nal orphine</w>
Nafc illin</w>
NaHCO 3,</w>
Na-K- ATPase,</w>
Na+/ K+-
Na+- K+</w>
Na+, K+-
Na Cl-
NT- A)</w>
NT S-lesioned</w>
NT D
NTD s,</w>
NT 79</w>
NT ),</w>
NSAID- sensitive</w>
NSAID- related</w>
NS VT</w>
NS F
NSF -like</w>
NS AI</w>
NRV L</w>
NR M</w>
NPY -induced</w>
NP Y.</w>
NP H</w>
NOS 3-
NO 3</w>
NO /
NN NS</w>
NMD OH</w>
NMD LA</w>
NMD A
NM U-
NKH 477</w>
NKH 47
NKH47 7,</w>
NK 3-
NJ ),</w>
NID DM</w>
NIC .</w>
NI H-
NI F</w>
NI AI
NIAI D</w>
NH X</w>
NH L,</w>
NH 2-
NH2- terminal</w>
NH (4
NH(4 +
NH(4+ )-treated</w>
NG C</w>
NCQ 436</w>
NC SE.</w>
NC S</w>
NC G</w>
NC E</w>
NC C</w>
NC ;</w>
NB I
NB F</w>
NB ),</w>
NAc ,</w>
NASH -like</w>
NAI ON</w>
NADPH- d</w>
NAD(P) H</w>
NA SCIS</w>
NA R</w>
NA P</w>
NA L</w>
N2O/ 30%</w>
N2O- O2</w>
N2O- O2-
N2 O.</w>
N2 O,</w>
N/ P-3.0</w>
N/ OF
N-propyl nor
N-nitrosodiethyl amine.</w>
N-nitro so</w>
N-methyl-D- aspartate.</w>
N-methyl-D- aspartate-dependent</w>
N-desmethyl tamoxifen</w>
N-acetyl-beta-D- glucosaminidase,</w>
N-acetyl-beta-D- glucosaminid
N-acetyl- p-benzoquinoneimine</w>
N-acetyl transferase</w>
N-acetyl glucosaminidase</w>
N-[4-(5-nitro-2-furyl)-2-thiazol yl]-form
N-[(1- ethyl-2-
N-S SEP</w>
N-2-fluorenyl acetamide.</w>
N-10 55</w>
N-(2- pyridin
N- tert-butyl-
N- propargyl-1-
N- oleoyl-dopamine</w>
N- Me-
N- (2,
N, N,
N,N, N
N,N,N ',
N,N,N', N'-
N(M HC)</w>
N(6)- cyclopentyladenosine</w>
N(2) O</w>
N utley,</w>
N urofen</w>
N or</w>
N ociceptin</w>
N mt</w>
N lmCategory="
N injin
N erv
N edd4-
N cAMP</w>
N ative</w>
N ation
N as
N airobi
N RTI</w>
N PH
N PDG,</w>
N NA</w>
N MRI-
N IN</w>
N GF.</w>
N EC</w>
N CA</w>
N AC-
N 20/
Myo- inositol</w>
Myo sitis</w>
Myelo pathy</w>
Myalgi as</w>
My elin</w>
Mun chausen</w>
Multiv essel</w>
Multicent ric</w>
Multicent er,</w>
Multi plic
Multi phasic</w>
Muc ositis</w>
Muc osal</w>
MuMT V</w>
Mt 3-
Mt3- null</w>
Move ments</w>
Morph ometry</w>
Moric izine</w>
Mor inga</w>
Mon te
Mon otherapy</w>
Mon osodium</w>
Mon ocyte</w>
Mon grel</w>
Mon astral</w>
Modul atory</w>
Modi fying</w>
Model s</w>
Mode st</w>
Mo de</w>
Misoprost ol,</w>
Mirta zap
Mipafox ,</w>
Mini -
Min neap
Min aprine</w>
Mill ar</w>
Microscop ically,</w>
Micro vascular</w>
Micro tubule</w>
Micro perfusion</w>
Micro glial</w>
Micro cephaly</w>
Michi gan)</w>
Mic turition</w>
Mic ros
Mic ropuncture</w>
Mi anserin</w>
Mg(2+)- free</w>
Mex ico</w>
Mex ican</w>
Metoclopram ide-treated</w>
Methyser gide</w>
Methylphenid ate-induced</w>
Methyl enedioxymethamphetamine</w>
Methyl dopa-induced</w>
Methotrex ate,</w>
Methazol amide</w>
Methad one-associated</w>
Methad one-
Meth yl</w>
Meth oxyflurane</w>
Meth ohex
Meth imazole</w>
Metfor min-associated</w>
Metam izole</w>
Met riz
Mes enchymal</w>
Meropen em
Mepi vacaine</w>
Men thol</w>
Melphal an</w>
Mel ittin</w>
Medic us</w>
Medic ines.</w>
Medic am
Medic aid</w>
Med line,</w>
Me sial</w>
Me galoblastic</w>
Me dium</w>
Me CCNU</w>
McNem ar
Mass on</w>
Mass on's</w>
Maryl and</w>
Mark et
Mark ers</w>
Mark edly</w>
Mariju ana-dependent</w>
Mar mara</w>
Mapro tiline</w>
Manifest ation</w>
Mang iferin</w>
Man u
Man ip
Man assantin</w>
Malon dialdehyde</w>
Mall ory-Denk</w>
Mal ay</w>
Magne vist</w>
Magne si
Mag nus
Macroph age</w>
Macroph age-
Macro cytosis</w>
M_ M</w>
MVO (2)</w>
MTX-N tox.</w>
MTX- LV</w>
MTX -treated</w>
MT s</w>
MT Ds</w>
MT -/-</w>
MT +/+</w>
MSO -treated</w>
MS NA,</w>
MS G</w>
MR SA.</w>
MR I/
MRI/ MR
MR A-
MRA- MT</w>
MPP +</w>
MP- CDZP</w>
MP T</w>
MP H.</w>
MP FC</w>
MO AT</w>
MN U-
MN G</w>
MN ),</w>
MMP- 3</w>
MMP 1</w>
MMP /
MMP/ TIMP</w>
MMP -13</w>
MMP -1,</w>
MM R</w>
MM NC</w>
MM I,</w>
MM C.</w>
MM C-related</w>
MK80 1-induced</w>
MK80 1,</w>
MK-9 12,</w>
MK -14
MI P</w>
MI D)</w>
MH PG,</w>
MH N</w>
MF S,</w>
METHODS/ RESULTS:</w>
METHODS/ MATERIALS:</w>
METHODOLO GY/
METHODOLOGY/ PRINCIPAL</w>
ME MA
ME LAS</w>
ME L,</w>
ME K
ME D,</w>
ME Cs</w>
MDMA .</w>
MDMA +</w>
MD P,</w>
MD L
MD I,</w>
MD D,</w>
MCP-1 (-/-)</w>
MCP-1 (+/+)</w>
MCL ),</w>
MCA v(mean
MCA O.</w>
MCA ,</w>
MC- 26</w>
MC U</w>
MB H</w>
MB Fs</w>
MAO Is</w>
MA40- 4</w>
MA40- 2</w>
MA PD
MA P;</w>
MA O,</w>
MA MP-CDZP</w>
MA MP
MA HA.</w>
MA H)</w>
MA DR
MADR S,</w>
MA ;</w>
MA -</w>
MA ).</w>
M3 G-induced</w>
M. D.</w>
M-6- G</w>
M-6- G/
M-6-G/ MOR</w>
M ur
M rp
M izoribine</w>
M iosis</w>
M eti
M ethan
M esulergine</w>
M embranous</w>
M embrane</w>
M ed</w>
M atric
M arg
M ann
M W</w>
M U/
M PA-induced</w>
M O,</w>
M O)</w>
M NCV</w>
M N-SSEP</w>
M MR
M MECs</w>
M LA,</w>
M IF
MIF 's</w>
M Hz).</w>
M H-
M CC</w>
M AC.</w>
M AC-
M 1/
M .,</w>
M -treated</w>
M (3)</w>
M (1)</w>
Lymph ocytes</w>
Ly sosomal</w>
Lu ke's</w>
Los oxantrone</w>
Los artan-induced</w>
Loc ation</w>
Lob und-Wistar</w>
Lo op</w>
Lo g</w>
Lo est
Lithium- associated</w>
Lithi um,</w>
List er</w>
Lipos ome</w>
Lipid- Lowering</w>
Lip opolysaccharide</w>
Lim itation</w>
Lig ation</w>
Lid dle</w>
LiCl/ pilocarpine</w>
Li-PC -treated</w>
Li- treatment</w>
Li- l</w>
Li ebowitz</w>
Li brary,</w>
Li Cl-
Lev osul
Lev ofloxacin,</w>
Leuk otri
Leuk openia,</w>
Leuk ocytes</w>
Lenalidom ide,</w>
Leak age</w>
Le o)</w>
Le g</w>
Lat in-
Langendor ff-
Labet alol-induced</w>
Lab el="
LY3414 95</w>
LY2359 59</w>
LVF X-induced</w>
LVF X,</w>
LVEFr n</w>
LVE Fs</w>
LV dP/dt</w>
LV P,</w>
LV H,</w>
LV F</w>
LV AD</w>
LT X)</w>
LR D</w>
LR 172</w>
LQT S.</w>
LQT S-related</w>
LQT 2</w>
LP S-
LOU/M/W SL</w>
LO FG</w>
LO C.</w>
LND-6 23</w>
LMW H.</w>
LMW H,</w>
LM V</w>
LL LT</w>
LI L
LI .</w>
LF P,</w>
LF /
LF/ HF</w>
LE G/
LE F</w>
LE F-
LE A</w>
LE A.</w>
LD(con v)</w>
LD X</w>
LD U</w>
LD MF</w>
LD L,</w>
LD H-
LD H
LD 50's.</w>
LC- PUFA</w>
LC x.</w>
LC X</w>
LC 3</w>
LA AM.</w>
L1- L2</w>
L/ min).</w>
L/ h,</w>
L/ S</w>
L/ N-type</w>
L.min-1. %
L.min-1.% SaO2
L-arginine- NO</w>
L-argin ate</w>
L-NOAR G.</w>
L-N NA</w>
L-DOPA -treated</w>
L-DOPA -
L- dopa-
L- disopyramide</w>
L- asparaginase</w>
L- alpha-
L- 44408</w>
L(L act)</w>
L yme</w>
L ess
L atin</w>
L are
L aparoscopic</w>
L ac
L a</w>
L ZRs</w>
L ZRs.</w>
L UT
L SP</w>
L SM
L SI,</w>
L PDG,</w>
L P/J</w>
L P-BM5</w>
L L</w>
L H)</w>
L GE</w>
L F)</w>
L ENT
L DOPA</w>
L Cs</w>
L CH</w>
L C.</w>
L AR.</w>
L AR,</w>
L ABA</w>
L A-induced</w>
L A),</w>
L 5-
L 250
L250 T</w>
L 20/
L20/ F
L 1825
L1825 P</w>
L -induced</w>
L -1.</w>
L (+)-
Kynuren ic</w>
Kv 1.5</w>
Krebs- Ringer</w>
Kit(Y567F/Y567 F)</w>
Ketoro lac-induced</w>
Ketocon azole-induced</w>
Kerat inocyte</w>
Keny a.</w>
Kappa -
Kamp o</w>
KW-39 02,</w>
KW- 6002</w>
KRN23 91,</w>
KCC 2.</w>
K- 49
K+ -2
K(v) 7.
K ras</w>
K noc
K liniske</w>
K line</w>
K leine-Levin</w>
K ing</w>
K i
K g</w>
K entucky</w>
K au
K allmann's</w>
K alamazoo,</w>
K Y</w>
K T.</w>
K T-induced</w>
K Cl.</w>
K B</w>
K A-induced</w>
K A)</w>
K 293</w>
K .,</w>
K ).</w>
Jud kins</w>
Jour nal</w>
Jo- 1</w>
Jack son</w>
Jack son-Rees</w>
JAK- STAT</w>
JAK /
JAK/ STAT3</w>
J oubert</w>
J ewish</w>
J e
J arisch-Herxheimer</w>
J ama
J P-1302</w>
J .,</w>
J .
Italian o</w>
It aly)</w>
Isra el</w>
Isov ue</w>
Isov ue-
Isoniaz id-related</w>
Isob olographic</w>
Isch aemic</w>
Irin otecan</w>
Ir rit
Ir radiation</w>
Ipsapir one</w>
Iontophore sis</w>
Intub ation</w>
Intub ating</w>
Intrad ermally</w>
Intracaver nosal</w>
Intra- amniotic</w>
Intra vital</w>
Intra vertebral</w>
Intr atympanic</w>
Intoxic ation</w>
Interleuk in-1</w>
Interleuk in-
Inter view
Inter ventional</w>
Inter strain</w>
Intensi fication</w>
Integr ated</w>
Insul in-like</w>
Institut e.</w>
Institu tional</w>
Institu t</w>
Ins1 P-
Inj ected</w>
Inf ections</w>
Inf antile</w>
Inf ant</w>
Indometh ac
Indinavir -induced</w>
Indic ation</w>
Indi an-subcontinent</w>
Incre mental</w>
In ver
In triguingly,</w>
In tras
In tolerance</w>
In tent-to-treat</w>
In take</w>
In tact</w>
In strum
In novar</w>
In her
In formed</w>
In adequate</w>
Impul sivity</w>
Improve ment,</w>
Impression- Improvement</w>
Immunohist ochemically,</w>
Immun olocalization</w>
Imidaz enil,</w>
Imi pramine.</w>
Imi .</w>
Im mature</w>
Im i</w>
Ill ino
Ile/ Ile</w>
Ifosfamide -M
Ifosfamide-M esna</w>
Ifenpro dil</w>
Identi fying</w>
Identi fied</w>
Ibuprofen -associated</w>
Ibu profen,</w>
IV- L</w>
IV U.</w>
IV S</w>
IV RA</w>
IV PMP,</w>
IV C</w>
IV ;</w>
IU/ mL</w>
IU/ kg)</w>
IU/ day</w>
IU/ d)</w>
IU/ L),</w>
IU GR</w>
IT- MTX</w>
IT- BUP</w>
IT ,</w>
ISO M,</w>
ISO -</w>
IS/ TIA</w>
IS- 5-M
IS SUES:</w>
IS S</w>
IS RCTN
IS M
IS H</w>
IS B</w>
IS .</w>
IS -5-
IS-5- MN</w>
IR F</w>
IPR O</w>
IPR .</w>
IPR -treated</w>
IP- 3</w>
IP SCs)</w>
IP K</w>
IP )-induced</w>
IO T</w>
IO R</w>
IO P.</w>
IND O</w>
IN PEA</w>
IN ),</w>
IMA RY</w>
IM L,</w>
IM -induced</w>
IL-10/ TGF-beta</w>
IL-10/ TGF-beta-modified</w>
IL-1 b</w>
IL-1 2,</w>
IL- 6.</w>
IL- 4</w>
IL P.</w>
IL ).</w>
IK r,</w>
III ;</w>
IIE0 24
II- inactive</w>
II- III</w>
II B-
II ;</w>
II --
IH SA</w>
IH G-
IH A.</w>
IGFBP- 3</w>
IGF -1.</w>
IFO -mediated</w>
IFN/ ribavirin</w>
IF S.</w>
IF N.</w>
IF N-induced</w>
IF N,</w>
IF G</w>
IF F</w>
IF ,</w>
IDV -treated</w>
IDV -associated</w>
ID XR</w>
ID C,</w>
ID A-related</w>
ICRF-1 61</w>
ICA -
ICA- 27
IC a</w>
IC V,</w>
IC V)</w>
IC R:
IC I
IC E</w>
IC D.</w>
IC D
I/ ml)</w>
I/ R</w>
I/ R-induced</w>
I/ O</w>
I/ III</w>
I/ II,</w>
I/ GI</w>
I/ ARB</w>
I. c.v.</w>
I. P.</w>
I- III,</w>
I- III)</w>
I(Na L)</w>
I xodes</w>
I tems</w>
I tem</w>
I t's</w>
I stan
I sorhythmic</w>
I som
I rish</w>
I odixanol</w>
I o
I f,</w>
I deal</w>
I darub
I atrogenically</w>
I U.</w>
I RR</w>
I R.</w>
I Q.</w>
I Q,</w>
I Q
I PRL</w>
I PH-treated</w>
I PD</w>
I P.</w>
I ON
I MS</w>
I L)</w>
I HD.</w>
I H).</w>
I GT</w>
I G
I E-containing</w>
I E)</w>
I BM
I A,</w>
I 2,</w>
I 1-receptor</w>
I (k
I(k r)</w>
Hz ),</w>
Hypox aemia</w>
Hypot ony</w>
Hypom agne
Hypo thalamic</w>
Hyper tonic</w>
Hyper thyroidism</w>
Hyper thermia,</w>
Hyper parathyroidis
Hyper kalemic</w>
Hyper kal
Hyper insul
Hydroxy ure
Hydroxy chloroquine-induced</w>
Hydrox yl</w>
Hydro codone</w>
Hyd roneph
Hyd antoin</w>
Hy paque-
Hum ph
Hu EPO)</w>
Hsp 70</w>
Hom ozygous</w>
Hom ozyg
Hol land</w>
Hoff mann</w>
Ho ward</w>
Ho ign</w>
Ho e-1
Hist ological,</w>
Hist amine-
Hippocamp i</w>
High- performance</w>
Hg/ sec</w>
Hg/ s</w>
Hg/ min;</w>
Hg :</w>
Hex arelin</w>
Her ing-Breuer</w>
Hep ato
Hen ry</w>
Hemorrh ages</w>
Hemo pericardium</w>
Hem occult-positive</w>
Head aches</w>
He b/FeJ</w>
Hb O2</w>
Hb A1
Has haron</w>
Har rington</w>
Halo -treated</w>
Haem orrhagic</w>
Haem olytic</w>
Haem acce
Habit ual</w>
Ha ving</w>
H_ E</w>
HVA/ DA</w>
HV A.</w>
HV ,</w>
HTN- ESRD</w>
HTN :</w>
HT LV-
HSV-t k</w>
HSP- 27</w>
HS +
HR- 592,</w>
HR s</w>
HR T,</w>
HR G</w>
HPV -16</w>
HPD G</w>
HP T</w>
HP S.</w>
HO ),</w>
HLA-B*57 01</w>
HLA- identical</w>
HL- 60</w>
HL GD</w>
HIV- uninfected</w>
HIV- RNA</w>
HIV- HCV-coinfected</w>
HIT T.</w>
HIP/ PA
HI STORY:</w>
HF M</w>
HER 2.</w>
HE TE
HE N)</w>
HE K293</w>
HE 3),</w>
HDAR AC</w>
HD- fed</w>
HD S</w>
HD C-
HDC- 9
HCT -116</w>
HCO 3-</w>
HC l)</w>
HC V.</w>
HC Q,</w>
HC M,</w>
HC L</w>
HC H),</w>
HC FU</w>
HBsAg .</w>
HBeAg (-)</w>
HBc Ab
HBD T</w>
HB V
HB E</w>
HAL O</w>
HAC- 911</w>
H9 C2</w>
H2O ;</w>
H2 O)</w>
H1- antihistamines</w>
H1- antihistamine-induced</w>
H1- antagonists</w>
H/ PF4</w>
H/ C</w>
H(2)O(2)- (.
H(2)O(2)-(. )
H(2)O(2)-(.) OH</w>
H(2) O</w>
H(2) O.</w>
H ousehold</w>
H omer
H ind
H ill</w>
H erbal</w>
H an-Wistar</w>
H adassah</w>
H Y</w>
H W</w>
H TG</w>
H SOS</w>
H SG</w>
H SCT.</w>
H OR
H NR</w>
H NP.</w>
H M</w>
H EP</w>
H E.</w>
H CBD
HCBD -induced</w>
H CB
H AS/
HAS/ LAS</w>
H ;</w>
H 3,</w>
H 1,</w>
H (1)-
Gynec omastia</w>
Gy naec
Guanfac ine</w>
Guaneth idine</w>
Grow ing</w>
Gre ec
Grad ually</w>
Gr af
Gpx 1
Gpx1 +/+</w>
Golgi- Cox</w>
GnRH- a</w>
Glycyrrhiz in</w>
Glyc opyr
Glybur ide-induced</w>
Gluc osuria</w>
GluR 5</w>
GluR 2/
GluR 1-immunopositive</w>
Glu R</w>
Glomerul onephritis</w>
Gli oblastoma</w>
Gli al</w>
Gli adel</w>
Gli 3</w>
Gl auc
Ginsen g</w>
Gingi val</w>
Gi HUS</w>
Gi /
German y.</w>
Gentam icin-treated</w>
Gentam icin-associated</w>
Gen ipin</w>
Gemfibroz il-induced</w>
Gemcit abine-associated</w>
Gd- based</w>
Gd- DTPA</w>
Gas6- Rs</w>
Gangli onic</w>
Gangli on</w>
Gam ma</w>
Gal act
Gadolinium- based</w>
G_ C_
G_C_ G_
GYKI- 41</w>
GV HD).</w>
GTP- gamma-
GST- Pi</w>
GSK3 beta</w>
GSHP x</w>
GSH .</w>
GS P</w>
GR 113
GP x,</w>
GP s</w>
GP p</w>
GP i.</w>
GP a</w>
GP V</w>
GO S</w>
GO G</w>
GM- CSF,</w>
GM P.</w>
GM P)</w>
GM -mediated</w>
GM +
GL Y</w>
GL OBE</w>
GFP- BMC</w>
GFAP- positive</w>
GF P)</w>
GF P(+)</w>
GE ,</w>
GB CA</w>
GAP 43</w>
GAL- WT</w>
GAL- KO</w>
GABAA/ alpha1-preferring</w>
GABA- modulatory</w>
GABA- mimetic</w>
GABA- dependent</w>
GABA- T</w>
GABA(B(1 b))(-/-)</w>
GABA(A)- Rs</w>
GABA erg
GABA a</w>
GABA /
G6 60</w>
G- mediated</w>
G- CSF)</w>
G- B</w>
G(i /
G(i/ o)</w>
G y/
G y)</w>
G usta
G rollman</w>
G ro
G rape</w>
G old</w>
G licl
G i</w>
G eme
G betagamma</w>
G ati
G XR</w>
G V</w>
G UST
G SI
G SAD</w>
G S,</w>
G PR
G LA</w>
G ICAL</w>
G D3,</w>
G CSF</w>
G CS.</w>
G CH
GCH 1</w>
G CB</w>
G CB
G AT
GAT A-
G ALF</w>
G AL
G 4</w>
G 4
G4 34
G 3</w>
G 20
G20 210
G20210 A</w>
G 2)</w>
Furosem ide-induced</w>
Furazol idone</w>
Fur th</w>
Func tionally,</w>
Fru semide</w>
Fro zen</w>
Fri deric
Frequ ently</w>
Frequ ency
France :</w>
France )</w>
Fr ucto
Fr act
Fr 1</w>
Four- week-old</w>
Four ty-
Found ation</w>
Foscarne t-induced</w>
FosB/Delta FosB</w>
Fos ,</w>
Form al
For m</w>
For ce.</w>
Fol inic</w>
Foc al,</w>
Fo ot</w>
Fo etal</w>
Flut amide-induced</w>
Flut ,</w>
FluoroJ ade
Fluoro-Jade .</w>
Fluoro uracil</w>
Fluoro quinolones</w>
Flu v</w>
Flo sequinan</w>
Flecain ide-induced</w>
Fl u</w>
Fl k
First ly,</w>
Finn ish</w>
Ficol l-
Fibro blasts</w>
Fibr inogen</w>
Fib rate</w>
Fib onacci</w>
Fi ve,</w>
Fer ol.</w>
Fenol dopam</w>
Feno fibrate</w>
Feno fibrate,</w>
Fe lodipine</w>
Fe eding</w>
Fe ar</w>
Fe TMPyP</w>
Fe Na
FcgammaRII A/
FcgammaRIIA/ hPF4</w>
FcgammaR IIA</w>
Fast -
Famoti dine</w>
Fam ciclovir</w>
FX II-
FVII a.</w>
FUD EC
FU/ LV</w>
FS G.</w>
FR 139317</w>
FP-CI T</w>
FM LP</w>
FM L</w>
FLA- 63,</w>
FL A
FKBP 51</w>
FKBP 12/
FKBP12/ 12.6</w>
FK506- based</w>
FK S-508</w>
FK 97
FK 9
FK9 73</w>
FK 664</w>
FGIN -1</w>
FG- 7142</w>
FEV (1)</w>
FEF 25-
FE NA</w>
FD I</w>
F2- alpha</w>
F1- dams</w>
F/Y56 9
F/ P</w>
F/ CO</w>
F-97013- GD</w>
F- N</w>
F u
F s)</w>
F lox
F lorid
F inger</w>
F eighner</w>
F d</w>
F as,</w>
F Z.</w>
F Z-2
F V</w>
F S)</w>
F NG</w>
F N
F IM</w>
F GH</w>
F E</w>
F DE
F CZ</w>
F C
F AS</w>
F AMP</w>
F AM
F AA.</w>
F A.</w>
F A-treated</w>
F :</w>
F 100
F 1,</w>
F -treated</w>
F -</w>
F (2)</w>
Expl oratory</w>
Excl uding</w>
Excl uded</w>
Exc retion</w>
Exagger ated</w>
Ex tremely</w>
Ex ten
Ex pressed</w>
Ex posed</w>
Ex per
Ex ecutive</w>
Ex act</w>
Evol ving</w>
Evol ution</w>
Evid ence-based</w>
Event ually,</w>
Event -free</w>
Evalu able</w>
Eu phor
Eu hypnos</w>
Etomid ate,</w>
Eth yl
Eth anol,</w>
Eth acrynic</w>
Estradiol -17
Estradiol-17 beta-D-glucuronide</w>
Estim ation</w>
Est abl
Es ophageal</w>
Erythropoi etic</w>
Erythro mel
Erythro cytes</w>
Erb a,</w>
Equi valent</w>
Equ imolar</w>
Episo dic</w>
Epinephr ine-
Epidemio logy</w>
Enter obacter</w>
Enox acin</w>
Engl and.</w>
Endo grafine</w>
End- diastolic</w>
End- Stage</w>
End MT</w>
Enalapri l-induced</w>
Enalapri l-associated</w>
En largement</w>
Em base,</w>
Electrocardio gram,</w>
Ele ments</w>
El i</w>
Eighty- three</w>
Eighty- nine</w>
Eff iciency</w>
Eff ectiveness,</w>
Educ ation</w>
ET ).</w>
ER- beta</w>
ER Ps</w>
ER PF</w>
ER G.</w>
ER G)</w>
ER CP</w>
ER CC1</w>
ER 22/
ER22/ 23
ER22/23 E
EP3 (+/+)</w>
EP SCs)</w>
EP S-related</w>
EP ;</w>
EP 3.</w>
EP 2</w>
EP (1)</w>
EO AEs)</w>
ENT AN
ENTAN YL</w>
EN M</w>
EME RALD</w>
EMBA SE,</w>
EMB 's</w>
EM PO
EM G-
EM F</w>
ELIS A,</w>
EK C</w>
EHX A-treated</w>
EHE N</w>
EGT A</w>
EGF- R</w>
EG Cs</w>
EFF ECTS</w>
EF V</w>
EF S.</w>
EF <
EF< 45%</w>
EE/ DNG</w>
EE LV</w>
EE H</w>
EE G),</w>
EDT A,</w>
ED P</w>
ED Ds</w>
ED (9
ECE-1 (+/-)</w>
EC HO</w>
EC G)</w>
EC 30</w>
EC .</w>
EC (50)</w>
EB F.</w>
EAD s.</w>
EA As</w>
EA -10
E-9, 11,
E-9,11, 13
E- I</w>
E- Ferol.</w>
E- 20
E(2)17 G-mediated</w>
E(2)17 G-induced</w>
E tude</w>
E t
E s)</w>
E pidemic</w>
E motion</w>
E limination</w>
E droph
E din
E copipam</w>
E ating</w>
E U</w>
E TH
E SR</w>
E S,</w>
E N,</w>
E H</w>
E GFR</w>
E GF,</w>
E G</w>
E AE,</w>
E AC</w>
E 60
E60 9
E 23
E23 G</w>
E 15,</w>
E 12</w>
E 1.</w>
E 1)</w>
E -induced</w>
E (2),</w>
E (1)</w>
Dys regulation</w>
Dx MD</w>
Duct openia</w>
Duchen ne's</w>
Dro peridol</w>
Dr ymis</w>
Dox il)</w>
Down regulation</w>
Dow n</w>
Double -
Dou bts</w>
Doppler- derived</w>
Doppl er.</w>
Doppl er)</w>
Don or</w>
Dofetili de)</w>
Do thiepin</w>
Dizzin ess,</w>
Distinc t</w>
Dist urb
Dist rict</w>
Dist ortion</w>
Dise ases,</w>
Dis sociation</w>
Dis cus
Diphen hydram
Dim er-
Dilat ation</w>
Dil ant
Digox in,</w>
Digit oxin</w>
Difficul ties</w>
Differenti ation</w>
Diff usion</w>
Diethylstilbestro l,</w>
Dideoxy inosine</w>
Diclofen ac
Dialy s
Diagnos tics,</w>
Diagno ses</w>
Dia phrag
Di vision</w>
Di ego,</w>
Dextromethorph an,</w>
Dex- hypertension</w>
Dex a-induced</w>
Dex CE</w>
Desi pramine-induced</w>
Des ensi
Dermatomyosi tis-like</w>
Der ived</w>
Dep ot</w>
Den/ morph</w>
Dem entia</w>
Dem eclocycline</w>
Delta9-TH C-induced</w>
Delta9- tetrahydrocannabinol</w>
Delta(9)- tetrahydrocannabinol</w>
Delta N(MHC)</w>
Delta MM</w>
Delta -
Deli ri
Del usions</w>
Del ay</w>
Decreas ing</w>
Dec om
Dec aD</w>
Debriso quine</w>
De sign</w>
De pakine</w>
De hydro
De generative</w>
De ep-
De c</w>
De Ba
DeBa key</w>
Datab ase,</w>
Dan azol,</w>
Dak ot
DZ R.</w>
DY T1</w>
DX M</w>
DX -treated</w>
DVT/ PE</w>
DTI C-induced</w>
DT PA)</w>
DSM-IV- defined</w>
DSM-III- R.</w>
DSM-III- R,</w>
DSM- IV,</w>
DS I</w>
DR- 33
DR D3</w>
DR /
DP max</w>
DP V</w>
DP ;</w>
DP -related</w>
DOX/ SED</w>
DOX/ GW2974</w>
DOX Y
DOX ;</w>
DOPAC /
DO X)</w>
DO I-induced</w>
DO D</w>
DNP- SG</w>
DNA ),</w>
DN X</w>
DN B</w>
DMT U
DMI -induced</w>
DMB A</w>
DM-9 384</w>
DM SO
DM D</w>
DM -1K-
DLT s.</w>
DI AN</w>
DHC -1</w>
DH E,</w>
DH C</w>
DH AD</w>
DH A.</w>
DH ),</w>
DF P/
DF P,</w>
DF P);</w>
DES- lineage</w>
DENA- only-treated</w>
DE R</w>
DE NA-treated</w>
DE .</w>
DDP +
DCG- IV</w>
DBA/2 NCr</w>
DB V</w>
DB S.</w>
DB P.</w>
DB A-
DAR s</w>
DA- terminal</w>
D-Glucar ates</w>
D- pen
D- isomer</w>
D- Tic
D- Penicillamine-induced</w>
D- AP5</w>
D- 32</w>
D- 2,</w>
D(2) (+/-)</w>
D ub
D re
D ra
D orme
D omin
D imen
D extran</w>
D examisole</w>
D ermal</w>
D entate</w>
D ensitometry</w>
D ay
D ana-Farber</w>
D U
D SP4</w>
D SIP</w>
D S-
D Q
D P),</w>
D ONRYU</w>
D OB
D MD.</w>
D M.</w>
D IL
D I.</w>
D G,</w>
D D.</w>
D CM.</w>
D CA-
D C.</w>
D AV
D A1</w>
D 3:</w>
D 1-</w>
D 0</w>
D -15</w>
D -1/
D-1/ D-2</w>
D ,
D (3)/
D(3)/ D(2)</w>
D (1-
D(1- like)</w>
D (-)-
D (-)
D(-) AP5</w>
Cyto genetic</w>
Cyt ochemical</w>
Cyst oscopy</w>
Cyclophosph amide
Cy tot
Cy t-ox</w>
Cy anide</w>
Cx LP</w>
Cur culigo</w>
Cult ures</w>
Cu/ Zn</w>
Cu -
Ctr l</w>
CsA- Pred</w>
Crypt ococcus</w>
Cross- reactivity</w>
Cres yl</w>
Crac k</w>
Cr l:
Cr .</w>
Cr ,</w>
Cox -2</w>
Coun ter
Cost -
Cost- effectiveness</w>
Cor ti.</w>
Cor relative</w>
Cor por
Copenh ag
Coomb s</w>
Coomb 's</w>
Conver ting</w>
Continu ous-
Continu ing</w>
Consider ation</w>
Condi tioning</w>
Condi tional</w>
Concomit antly</w>
Concentration- response</w>
Con temporary</w>
Con sul
Con fir
Compon ents</w>
Complic ated</w>
Comple xes</w>
Comple ment</w>
Complain ts</w>
Committe e,</w>
Com partment</w>
Colon oscopy</w>
Coll agen</w>
Colchic ine,</w>
Col on</w>
Col laborating</w>
Cock croft-Gault</w>
Cocaine- using</w>
Coc E's</w>
CoA- SH,</w>
Co-trimox azole</w>
Co- perfusion</w>
Co uld</w>
Co Q10,</w>
Co ,</w>
Clu ster</w>
Clopido grel,</w>
Clon idine's</w>
Clobaz am</w>
Clin icalTrials.gov</w>
Clar ithromycin-induced</w>
Cl- APB</w>
Cl- /
Cl-/ HCO-3</w>
Cl ure</w>
Cl Br
Cl ),</w>
Cl (-)-
Cisplat in,</w>
Cisapri de-induced</w>
Cis atracurium</w>
Circumst ances</w>
Cir culatory</w>
Ciprof loxacin,</w>
Cin acalce
Cil nidipine</w>
Cil azapril</w>
Chron ically</w>
Chore iform</w>
Chore ic</w>
Children ,</w>
Chi -square</w>
Chemo therapy-na</w>
Char t</w>
Char les</w>
Chang ing</w>
Ch oline</w>
Ch T</w>
Ch E-
Ch E)</w>
Ceti rizine</w>
Cephalospor in</w>
Centr al-
Cent re.</w>
Celec oxib-induced</w>
Ceftriax one-related</w>
Ceftriax one,</w>
Cef tazidi
Ce A</w>
Cd Cl2</w>
Caucasi an,</w>
Cathe ters</w>
Cathe ter
Catat onic</w>
Cas pase-
Carolin a</w>
Carolin a.</w>
Carolin a,</w>
Cardi Pro</w>
Carboxyp eptidase</w>
Carboxyp eptidase-G2</w>
Carb aryl</w>
Car lo</w>
Captop ri
Capsa icin-
Cannabin oids</w>
Cannabin oid</w>
Cannab idiol</w>
Canc er.</w>
Cam pt
Calcineur in-
Calci um-
Cal otropis</w>
Caffe ic</w>
Caf ergot</w>
CaCl 2,</w>
Ca2+ -free</w>
Ca2+ ,</w>
Ca2 +/
Ca+ +
Ca++ --
Ca++-- binding</w>
Ca(2+)] (i))</w>
Ca(2+)- independent</w>
Ca(2+) (i)</w>
Ca ulophine</w>
Ca strated</w>
CYP2D6* 10</w>
CYP2C9* 3/
CYP2C9*3/ *3</w>
CYP2C 19*
CYP2 B</w>
CYP1A 1,</w>
CYP 3
CX CL
CV-1 808</w>
CV- C</w>
CV P,</w>
CV B3</w>
CTR- 05</w>
CTR .</w>
CT/LC T)</w>
CT/ MCT)</w>
CT C)</w>
CS T</w>
CS P-associated</w>
CS CR</w>
CS A.</w>
CS -mediated</w>
CRL :
CRL: (WI)
CRL:(WI) WUBR</w>
CRF (2)</w>
CR T,</w>
CPU 2
CPT-1 1/
CPF X</w>
CP-101,60 6,</w>
CP-101, 606</w>
CP Z,</w>
CP Pene</w>
CP NN</w>
CP NE</w>
CP 55,940</w>
COX-2- specific</w>
CONCLUSIONS/ SIGNIFICANCE:</w>
CON T</w>
CON SENSUS</w>
CO2- response</w>
CO L</w>
CO C-related</w>
CO (2)
CNSB 00
CNS- active</w>
CN S)</w>
CN 5</w>
CN .</w>
CN ).</w>
CMV- T</w>
CM MG</w>
CM M
CM Hs</w>
CM F.</w>
CM A</w>
CM -
CM ).</w>
CM (i)</w>
CLO CK</w>
CL T</w>
CL IN</w>
CL CN5</w>
CI- CTC)</w>
CI P,</w>
CI Na</w>
CI NC
CI N.</w>
CI H</w>
CHF :</w>
CH X</w>
CH X+
CH T</w>
CH OP</w>
CH O
CH E)</w>
CH -C</w>
CH ),</w>
CF R,</w>
CF -1</w>
CF ),</w>
CER -induced</w>
CE A</w>
CE .</w>
CD40- CD154</w>
CD4 +
CD R3</w>
CD I</w>
CD DP.</w>
CD 45
CD 3</w>
CD 25</w>
CD 25
CD /AT</w>
CCl 4.</w>
CCR 8,</w>
CCR 7-10</w>
CCNU -induced</w>
CCK- 5-8</w>
CCK- 2-
CCK-2- 8-
CCK-2-8- SE</w>
CCB s.</w>
CCB F/CO</w>
CC W</w>
CC S</w>
CC F</w>
CC ),</w>
CBF rest
CBF hypotension</w>
CB C.</w>
CB A/
CB 1R</w>
CB 1-receptor</w>
CB 1-
CB -2</w>
CB -1</w>
CA s).</w>
CA S.</w>
CA RE
CA RB
CA R,</w>
CA R
CA PD.</w>
CA L</w>
CA As</w>
CA 5</w>
CA 4
CA4 P</w>
CA 3=
CA 3.</w>
CA 3-
CA 10</w>
CA 1-
C57Bl/ 10
C57BL/6 NCr</w>
C57BL/6 J
C57BL/ Tw</w>
C57BL/ 10</w>
C57B1/ 6</w>
C57 /B
C57 .</w>
C3H/He N</w>
C3 Heb/FeJ</w>
C/ s</w>
C/ GFR</w>
C- urea</w>
C- terminus</w>
C- fibers.</w>
C- cells</w>
C- cells,</w>
C- LEPs</w>
C- APB</w>
C- 3</w>
C- ->
C' 3</w>
C ys
C ycl
C ul
C ub
C s;</w>
C ross</w>
C res</w>
C remoph
C re</w>
C ph</w>
C oupl
C ough</w>
C ore</w>
C ol,</w>
C ob
C o</w>
C max,</w>
C loxacillin-induced</w>
C lio
C hel
C embranoids</w>
C ause</w>
C ard</w>
C anine</w>
C Z)</w>
C TE
C PG
C ODE</w>
C Na
C NA</w>
C MAP</w>
C F,</w>
C CT</w>
C CNU)</w>
C CMA</w>
C CD.</w>
C 600</w>
C 6,</w>
C 4/
C 2)</w>
C 118
C118 T</w>
C 10</w>
C 1,</w>
C .,</w>
C )-induced</w>
C (s
C (P)</w>
By J,</w>
By J)</w>
Bv 8</w>
But yrylcholinesterase</w>
Burkit t's</w>
Bur st</w>
Bupropi on-induced</w>
Bupivaca ine-induced</w>
Bupivaca ine,</w>
Bu ff
Bromocript ine,</w>
Bromo -treated</w>
Brom o</w>
Bro modeoxyuridine</w>
Bro ca</w>
Bri efly,</w>
Break points</w>
Bra hmi</w>
Br ucella</w>
Br of</w>
Bost on,</w>
Bos entan</w>
Bor g</w>
Bor derline</w>
BoNT/ A-induced</w>
Bo dy
Blood- brain</w>
Block ers</w>
Bi periden</w>
Bi ochem
Bi har,</w>
Between- group</w>
Beta- adrenoceptor</w>
Ber aprost</w>
Bene fit</w>
Bend amustin</w>
Ben flu
Be side</w>
Be h
Bc l</w>
Bazet t's</w>
BayK- 8644</w>
BayK- 8644.</w>
Bay ley</w>
Bay esian</w>
Bax ,</w>
Bart ter
Bar rier</w>
Bar celona,</w>
Bang ko
Bam buterol</w>
Balti more</w>
Bacter oides</w>
Backgro und</w>
Bac osides</w>
Bab insk
Bab esia</w>
Ba Cl
Ba 2+</w>
BZ Ds</w>
BZ 1</w>
BZ .</w>
BX L
BW373U 86</w>
BW G</w>
BT 4
BSI F</w>
BSE R</w>
BSE Q</w>
BS- CB</w>
BS I</w>
BRL 35
BR S,</w>
BR L-44408</w>
BP s</w>
BP R</w>
BO S</w>
BN I</w>
BN I.</w>
BN 520
BM+ PBSC</w>
BM S-204352</w>
BM Is</w>
BL-10 20</w>
BL A.</w>
BK -induced</w>
BIP N</w>
BH T.</w>
BH T-induced</w>
BH T,</w>
BH R,</w>
BH (4),</w>
BF ;</w>
BE- TOC</w>
BCh E-/-</w>
BCPT-P -1</w>
BCN U,</w>
BCA A.</w>
BB s</w>
BB N,</w>
BB B,</w>
BB B)</w>
BALB/c ByJ</w>
BAL .</w>
BAL )</w>
BACKGROUND/ AIM:</w>
BA B</w>
B6NCr l</w>
B6 xD2</w>
B2 KO</w>
B- chronic</w>
B sep</w>
B rown-
B risb
B reath</w>
B pd</w>
B omb
B lunted</w>
B isoprolol</w>
B ifen
B eyond</w>
B ev
B ethan
B eij
B ech
B SC
B S.</w>
B PH,</w>
B P/
B NP,</w>
B N.</w>
B MMNC</w>
B MA
B L)</w>
B K.</w>
B K-
B ID)</w>
B HR.</w>
B H-
B F)</w>
B ECTS</w>
B CPNN</w>
B CP</w>
B C.</w>
B AP
BAP N</w>
B 2,</w>
B "</w>
Az imil
Avoid ance</w>
Autoradi ographic</w>
Aut om
Augment in-induced</w>
Aug mentation</w>
Audi ologic</w>
Audi ogenic</w>
Au stri
Atten tion-
Atrop ine,</w>
Atri oventricular</w>
Ator vastatin-induced</w>
Astro glial</w>
Asth matics</w>
Asth ma</w>
Astemiz ole</w>
Aspir ation</w>
Asc ites</w>
Asac ol.</w>
Arti caine</w>
Arte par
Arom atase</w>
Arg ;</w>
Ar g,</w>
Ar fonad</w>
Ar den</w>
Ar -125
Ar-125 4-
Ar-1254- promoted</w>
Aqu apor
Ap plying</w>
Ap plied</w>
Ap olipoprotein</w>
Ap ocynin</w>
Ap noea</w>
Anx io
Antine oplast
Antimal arials</w>
Antimal arial</w>
Antim uscarinic</w>
Antidepress ant-associated</w>
Anticoagul ant-induced</w>
Antic ataleptic</w>
Antibio tic</w>
Antibio tic-associated</w>
Anti- oxidant</w>
Anti- infective</w>
Anti- epileptic</w>
Anti- convulsant</w>
Anti- arrhythmic</w>
Anti thrombin</w>
Anti proteinuric</w>
Anti cholinesterase</w>
Ant agon
Anorex ia</w>
Ano rexi
Angiovist- 370</w>
Angel es.</w>
Angel es,</w>
Ang ptl
Aneur ysmal</w>
Anesthe tics,</w>
Anatom ical</w>
Analo gous</w>
Analgesic -induced</w>
Anaesthe tized</w>
Anaesthe tic</w>
Anaesthe si
An geles</w>
An c
An agrelide</w>
Amyg dal
Amphet amines</w>
Amoxic ill
Amne sic</w>
Aminophyll ine,</w>
Aminoglyco sides</w>
Am rinone,</w>
Am plit
Am antadine-induced</w>
Alpha- 2</w>
Alpha 2
All- trans</w>
All yl
Alfuz osin</w>
Alfentan il-induced</w>
Aldo -
Alco holic</w>
Alco hol
Ala- Gly-
Al thesin</w>
Al lograft</w>
Al buterol-induced</w>
Agon ists</w>
Agon ist</w>
Age ing</w>
Ag ed</w>
Ag SD</w>
Ag -
Afric ans.</w>
Aff ected</w>
Adriamycin- ---
Adriamycin---- CMF</w>
Adriamyc in-treated</w>
Adriamyc in-mediated</w>
Adrenal ine-induced</w>
Adol escent</w>
Administr ation-approved</w>
Aden osine-induced</w>
Aden ocarcinoma</w>
Addi tionally</w>
Adam s-Stokes</w>
Ad.N ull</w>
Ad ria</w>
Ad mixture</w>
Ad ap
Acut ely</w>
Acut ely,</w>
Acut e-
Acromegal y</w>
Aci dic</w>
Acetyl salicylic</w>
Acetyl choline</w>
Acetyl choline-induced</w>
Acetyl ator</w>
Acet yl</w>
Accur ate</w>
Accur acy</w>
Aca demy</w>
Ac- CCK-2-8-SE</w>
Ac tual</w>
Ac ta</w>
Ac t-
Ac id-
Ac cumulating</w>
Ac Neu</w>
Abstract Text</w>
Abs ent</w>
Ab sorption</w>
Ab normally</w>
Ab breviated</w>
AZT +
AZ A.</w>
AV- block</w>
AV B)</w>
AUC 0-
AUC0- infinity</w>
AUC (0-12
AUC(0-12 h)
ATP -</w>
AT RA,</w>
AT R
AT E</w>
AT D</w>
AT 2.</w>
AT 1a</w>
AT 1a
AT1a R(-/-)</w>
AT 1-receptor</w>
AST -120</w>
ASL- 812
AS+ A
AS+A Q</w>
AS Y
AS D</w>
AS CT</w>
AS A/
AR S),</w>
AR G,</w>
AR DS</w>
AR Cs</w>
AR CCS</w>
AR -3</w>
AR -
AR- R</w>
AR ).</w>
AQ E</w>
AQ +
AQ+ SP</w>
APPROAC H</w>
APO .</w>
AP- 43)</w>
AP V</w>
AP T</w>
AP S</w>
AP L,</w>
AP HC1</w>
AP H</w>
AO M</w>
AO D</w>
ANOV A).</w>
ANCA -
ANCA ),</w>
AN-1 32</w>
AN P,</w>
AN LL</w>
AMPH- sensitized</w>
AMPA- KA</w>
AMP- system</w>
AMP H)</w>
AMP ;</w>
AMP ).</w>
AM12 41,</w>
AM/ CL</w>
AM NS</w>
AM L/
AM I/GI</w>
AM H)</w>
AM CA)</w>
AM 17
AL- 369</w>
AL P</w>
AL LO</w>
AL L-
AL F-induced</w>
AL E</w>
AL B</w>
AL A,</w>
AK T</w>
AK I.</w>
AIM S.</w>
AI P.</w>
AI HA</w>
AI C</w>
AI C
AI A,</w>
AI ,</w>
AH-10 58,</w>
AH SCT.</w>
AH N-1055</w>
AH I</w>
AH /
AH/ PO</w>
AF F</w>
AEG35 15
AEG3515 6.</w>
AED .</w>
AE R</w>
ADR- pretreated</w>
ADR- nephropathy</w>
ADR+ MR1</w>
ADR+ IgG</w>
ADR+ G-CSF</w>
ADR /
ADAMTS -13</w>
AD s</w>
AD R)</w>
AD P,</w>
AD M,</w>
AD D
AD 50</w>
ACh Rs</w>
ACh E-/-</w>
ACP-10 3,</w>
ACEA-10 21,</w>
ACEA -13
ACE- inhibitors.</w>
AC s</w>
AC h,</w>
AC T.</w>
AC S/
AC S,</w>
AC Rs</w>
AC EA</w>
ABT- 59
AB VD</w>
AB RS</w>
AB P,</w>
AB C/2</w>
AAV 2-
AAPD s.</w>
A5 MB.</w>
A-869 29</w>
A- sensitive</w>
A- receptor</w>
A- based</w>
A- II</w>
A- CHF</w>
A- 77
A(2A) R-mediated</w>
A(2A) R(-/-)</w>
A sh
A s,</w>
A round</w>
A modi
A men
A i
A gency</w>
A etiological</w>
A blation</w>
A beta-induced</w>
A and</w>
A ])</w>
A ]).</w>
A VPA</w>
A RE
A PTT</w>
A PA</w>
A G-
A As</w>
A AL
A :
A 23
A 1555
A1555 G</w>
A 1/
A .,</w>
A )-</w>
? )</w>
>or= 4</w>
>/= grade</w>
>/= 60</w>
> 90%</w>
> 8</w>
> 5</w>
> 30</w>
> 30%</w>
> 150</w>
> 120</w>
=.0 2).</w>
= grade</w>
= 6</w>
= 300</w>
= 30%</w>
= 24</w>
= 22</w>
= 0.9
= -
</= 0.7</w>
< AbstractText</w>
< 5</w>
< 40%</w>
< 15</w>
< 0.006)</w>
< 0.005).</w>
< 0.001),</w>
< 0.0001)</w>
< .01)</w>
< .001,</w>
< .000
< .00
: 30</w>
: 12
999/ mm3)</w>
99 6</w>
99 ).</w>
97 -induced</w>
96. 6%</w>
95% :</w>
90/ 60</w>
90 8</w>
9/ 8
9/ 32
9. 9%</w>
9. 9
9. 8%,</w>
9. 7%,</w>
9. 4%</w>
9. 1/
9. 0,</w>
9. 0)</w>
9-di en-3-
9-1 0-
9- week-old</w>
9- to-12-hour</w>
9- 5
9- 4.
9- 2.
9 ].</w>
9 F/Y569
9 :</w>
9 9.0</w>
9 82</w>
9 8.
9 8+/-
9 8),</w>
9 8%),</w>
9 77</w>
9 75</w>
9 70</w>
9 61</w>
9 60</w>
9 6.9</w>
9 6).</w>
9 6%),</w>
9 59</w>
9 58</w>
9 5.</w>
9 5-1
9 5).</w>
9 4.0</w>
9 4%.</w>
9 4%,</w>
9 4%),</w>
9 38
9 3.3%</w>
9 3.
9 3),</w>
9 3%.</w>
9 25</w>
9 20
9 1.3</w>
9 -</w>
9 -10</w>
9 -1.6
9 );</w>
9 %/
89. 5%</w>
88. 9%</w>
87 2,</w>
86. 6%</w>
86 5)</w>
86 44
86 %.</w>
85/ 85</w>
82.07 15,</w>
80- 200</w>
80 ;</w>
80 9</w>
80 8)</w>
80 1,</w>
80 1)</w>
80 %;</w>
8. 8),</w>
8. 7).</w>
8. 6;</w>
8. 6,</w>
8. 6%,</w>
8. 6%).</w>
8. 5)</w>
8. 3,</w>
8. 0)</w>
8-hydroxy-2-(di-n-propyl amino)</w>
8-hydroxy-2- di-n-propyl
8-OHD PA
8-OH Gu
8- mg</w>
8- hydroxy
8- PT,</w>
8- (p-
8- (
8 c</w>
8 a</w>
8 :</w>
8 98</w>
8 9)</w>
8 9),</w>
8 8.1</w>
8 8-year-old</w>
8 8-
8 8).</w>
8 75</w>
8 68</w>
8 63</w>
8 6,</w>
8 5%).</w>
8 48</w>
8 4.1%</w>
8 4+/-
8 4)</w>
8 4).</w>
8 3
8 245</w>
8 23
8 2).</w>
8 18
8 13</w>
8 1.8%</w>
8 1.5</w>
8 1%.</w>
8 1%)</w>
8 00-
8 00,</w>
8 0.0</w>
8 0.0%,</w>
8 -16</w>
8 )).</w>
78 1</w>
78 %;</w>
78 %),</w>
77 %.</w>
76 1,</w>
76 ,000</w>
75 %;</w>
72- 96</w>
70 9</w>
70 7</w>
70 );</w>
70 %;</w>
7.0 5</w>
7. 8,</w>
7. 8),</w>
7. 7,</w>
7. 67</w>
7. 5.</w>
7. 5%,</w>
7. 4)</w>
7. 4).</w>
7. 4),</w>
7. 3%)</w>
7. 2;</w>
7. 2,</w>
7. 1;</w>
7. 1%,</w>
7-nitroinda zole,</w>
7-OH- DPAT</w>
7-Cl-Kyn A,</w>
7-1 3</w>
7- week,</w>
7- nitro</w>
7- ethoxyresorufin-O-deethylase</w>
7- 2.
7- (2-
7,8- benzoflavone</w>
7, 13-
7,13- dihydro-6H-benzofuro[2,3-e]pyrido[1,2-a][1,3]diazepin-12-ium</w>
7 th-
7 alpha-hydroxylase</w>
7 alpha-
7 ]</w>
7 LiCl</w>
7 H-
7 :</w>
7 97
7 80</w>
7 7%;</w>
7 7%)</w>
7 68</w>
7 6.5</w>
7 6%,</w>
7 56</w>
7 500</w>
7 50,</w>
7 5-mg</w>
7 41</w>
7 4,</w>
7 4%;</w>
7 38</w>
7 36</w>
7 34</w>
7 3.</w>
7 3.6</w>
7 3,
73, 806</w>
7 3),</w>
7 20
7 2.2%</w>
7 2).</w>
7 2%,</w>
7 2%).</w>
7 12</w>
7 11</w>
7 1.3</w>
7 -1.
7 +/-1
7 %);</w>
69 8</w>
69 ),</w>
68. 6%,</w>
68 %.</w>
67 580</w>
66 %.</w>
65- 85</w>
65 Zn</w>
64 139.</w>
63- yr-old</w>
63 );</w>
62. 2%</w>
62. 1%</w>
600 /
60-0 175</w>
60- s</w>
60- minute</w>
60- mg</w>
60 8</w>
60 6
60 4</w>
60 /
60 %;</w>
6.0 4</w>
6. 9;</w>
6. 8%</w>
6. 7;</w>
6. 7%;</w>
6. 6;</w>
6. 6%</w>
6. 6%,</w>
6. 6
6. 2-
6. 2%;</w>
6. 0,</w>
6. 0)</w>
6-thioguan ine.</w>
6-n-propyl- TDHL</w>
6-hydroxy dopamine-induced</w>
6-hydroxy dopa</w>
6-hydroxy dop
6- week-old</w>
6- phenyl
6- min</w>
6- hydroxy-DA-
6- chloro-
6- az
6- OH</w>
6- 9</w>
6- 7).</w>
6- ,</w>
6- (2-
6,7-dimethoxy-4- ethyl-
6,7- dinitroquinoxaline-2,3-dione</w>
6+/- 2</w>
6) Cl(-)</w>
6'- disinapoylsucrose</w>
6 h</w>
6 ],</w>
6 LiCl</w>
6 LiCl,</w>
6 J)</w>
6 B
6 ;
6 91</w>
6 90</w>
6 9.7</w>
6 9.0</w>
6 87</w>
6 83</w>
6 81</w>
6 8.4</w>
6 8),</w>
6 79</w>
6 7/
6 7%).</w>
6 60</w>
6 6.6</w>
6 6.0</w>
6 6).</w>
6 6%,</w>
6 52</w>
6 5/
6 5.2</w>
6 42</w>
6 4.8</w>
6 4).</w>
6 4%,</w>
6 31</w>
6 3.7</w>
6 3.6%</w>
6 3.3</w>
6 3+/-
6 24</w>
6 20</w>
6 20
6 2.5</w>
6 2%;</w>
6 2%.</w>
6 2
6 15
6 11</w>
6 1.8</w>
6 1+/-
6 1%)</w>
6 00-mg</w>
6 0.9</w>
6 -17</w>
5alpha- pregnan-
5] dec
59. 9%</w>
59 Fe</w>
59 ;</w>
59 -1
59 %).</w>
58. 6%</w>
58 54),</w>
58 3</w>
57- yr-old</w>
57 8</w>
57 4</w>
56. 9%</w>
56 %;</w>
55 7</w>
55 3</w>
55 ),</w>
55 %).</w>
54. 5%</w>
54. 2%</w>
54 %;</w>
53. 7%</w>
52 256</w>
52 %-
500/ mm3</w>
50/ ED50)</w>
50- fold</w>
50- day-old</w>
50- 80</w>
50- 65</w>
50- 450</w>
50 mg/kg,</w>
50 9</w>
50 7</w>
50 6-</w>
50 -150</w>
50 's</w>
5/ 90</w>
5/ 80</w>
5. 81</w>
5. 8%;</w>
5. 6+/-1
5. 5-
5. 5).</w>
5. 4,</w>
5. 3%)</w>
5. 25</w>
5. 0%,</w>
5-hydroxytrypt amine-
5-fluorourac il/folinic</w>
5-fluorourac il-associated</w>
5-fluoro deoxyuridine</w>
5-fluoro cytosine</w>
5-di methoxy-4-iodophenyl)-2-amino
5-HT1 A/
5-HT(2A/ 2C)</w>
5-HT(2 B)
5-HT 1</w>
5-HT -</w>
5-HT -2</w>
5-H z</w>
5-H y
5-Fluoro uracil-induced</w>
5-FU/ FA/
5-F u
5-1 4</w>
5-1 3</w>
5-1 0%</w>
5- month-old</w>
5- micrograms/kg</w>
5- d</w>
5- amino</w>
5- [5-amino-3-
5- LO</w>
5- 75</w>
5- 32</w>
5- 30</w>
5- /-</w>
5- -
5,7- dichlorokynurenic</w>
5,7- DHT,</w>
5,7- DCK
5, 6
5+/- 9</w>
5+/- 0.8</w>
5'- diphosphate</w>
5 x</w>
5 x
5 n</w>
5 mg)</w>
5 j</w>
5 g</w>
5 beta-pregnan-20-
5 b,</w>
5 a</w>
5 V</w>
5 A</w>
5 :1</w>
5 9.7</w>
5 9%)</w>
5 87</w>
5 85</w>
5 68</w>
5 6.</w>
5 6.7</w>
5 52</w>
5 47</w>
5 46</w>
5 41</w>
5 4.</w>
5 4.7</w>
5 4%).</w>
5 35</w>
5 32</w>
5 31</w>
5 3%,</w>
5 3%).</w>
5 2.5</w>
5 2.4</w>
5 2.3</w>
5 2).</w>
5 18
5 16</w>
5 15
5 1.8</w>
5 1.6%</w>
5 1.3</w>
5 1),</w>
5 0.9</w>
5 0.8%</w>
5 0.6</w>
5 ).(ABSTRACT</w>
5 ))</w>
49. 7</w>
49. 6</w>
49 465)</w>
49 );</w>
49 %.</w>
48/ 80,</w>
48-67 91,</w>
48 h</w>
48 8</w>
48 3</w>
48 ,6
48 %.</w>
47. 5%</w>
47. 4%</w>
450 ,000</w>
45. 5%</w>
45. 1%</w>
45- 60</w>
45 Ca</w>
45 9</w>
45 7</w>
45 %;</w>
42. 2%</w>
42- day-old</w>
412 348</w>
4030W 92</w>
4030W 92,</w>
400 mg</w>
400 mg/kg,</w>
400 ,000</w>
40/ 340</w>
40-7 592</w>
40-59 67</w>
40 6</w>
40 11</w>
40 ,
4/ 94</w>
4.6+/- 0.3</w>
4.0 ;</w>
4.0 9</w>
4.0 7</w>
4.0 6</w>
4.0 2</w>
4. 9;</w>
4. 93</w>
4. 9,</w>
4. 9).</w>
4. 8%,</w>
4. 5)</w>
4. 5).</w>
4. 4;</w>
4. 4%;</w>
4. 4
4. 3%)</w>
4. 3
4. 2+/-1.
4. 18)</w>
4. 12</w>
4. 10</w>
4. 1+/-
4. 0)</w>
4. 0%</w>
4-amin opyridine.</w>
4-amin opyridine,</w>
4-Cl-BZ T.</w>
4- quinoline</w>
4- phosphate</w>
4- methyl-
4- hydroperoxy
4- ethylsulfonylnaphthalene-1-sulfonamide,</w>
4- MC</w>
4- AAF</w>
4- 8
4- 67
4- 6)</w>
4- 3.
4- (2-
4- (
4,5,6,7- tetrahydro
4,4 a,5,6,7,8,8a,9-
4, 9-dien-3-
4+/- 4</w>
4'-iodo-4'- deoxydoxorubicin</w>
4 :00</w>
4 9;</w>
4 97</w>
4 8.8</w>
4 8.2</w>
4 8%)</w>
4 70</w>
4 7),</w>
4 7%)</w>
4 7%).</w>
4 61</w>
4 6.8</w>
4 6,
4 6+/-
4 6).</w>
4 6%,</w>
4 50-
4 5.</w>
4 5.8</w>
4 5.4</w>
4 48</w>
4 44</w>
4 43</w>
4 4.6</w>
4 4.5</w>
4 4.2</w>
4 4.1</w>
4 38</w>
4 37</w>
4 3.</w>
4 3.8</w>
4 3.5</w>
4 3.0</w>
4 3%)</w>
4 3
4 26</w>
4 22</w>
4 20-
420- 600</w>
4 2.4</w>
4 2.3</w>
4 2.2</w>
4 2),</w>
4 2%.</w>
4 17</w>
4 16</w>
4 1.8</w>
4 1+/-
4 0.8%</w>
4 0.2</w>
4 -16</w>
4 -10
4 +/-1.
4 +/-1
4 )-
3H- thymidine</w>
3H- digoxin</w>
39. 8</w>
39. 6</w>
39. 1</w>
39. 1%</w>
39 6</w>
39 166</w>
39 0)</w>
39 .</w>
39 +/-
39 %)</w>
38. 7</w>
38. 7%</w>
38. 6</w>
38. 3</w>
38. 1</w>
38. 0</w>
38 92)</w>
38 2</w>
38 /
38 +/-
37. 9</w>
37. 7%</w>
37. 0</w>
37 5
37 3</w>
37 ,
37 +/-
37 %.</w>
37 %).</w>
36 ]</w>
36 Cl-</w>
36 3</w>
36 0,</w>
36 +/-
36 %;</w>
35S- sulfate</w>
35. 7%</w>
35. 6%</w>
35- 40</w>
35 8</w>
35 3</w>
35 %;</w>
343- Stat5</w>
34. 8%</w>
34. 4%</w>
34 ]-
34 1
34 +/-
34 %.</w>
33. 0,</w>
33- month-old</w>
33 +/-
32. 4%</w>
32 +
32+ 33</w>
31. 8%</w>
31. 7%,</w>
31. 4%</w>
31. 2%,</w>
31 P-NMR</w>
300- 400</w>
300- 350</w>
30- s</w>
30- 40%</w>
30 761</w>
30 276</w>
30 %),</w>
3/ 7</w>
3/ 16</w>
3.5- 4.0</w>
3.0 9</w>
3.0 3</w>
3.0 2</w>
3.0 +/-
3. 94</w>
3. 93</w>
3. 91</w>
3. 87</w>
3. 7;</w>
3. 77</w>
3. 73</w>
3. 7-
3. 7).</w>
3. 62</w>
3. 6%,</w>
3. 51</w>
3. 5-fold</w>
3. 42</w>
3. 4)</w>
3. 4%;</w>
3. 4%,</w>
3. 35</w>
3. 3-fold</w>
3. 3).</w>
3. 27</w>
3. 2-
3. 2+/-
3. 2).</w>
3. 16</w>
3. 10;</w>
3. 1+/-
3. 1).</w>
3-phenyl tropane</w>
3-PP P,</w>
3-OH-H Q</w>
3-OH KY</w>
3-O- methyldopa</w>
3-1 4</w>
3-- 4</w>
3-( methylnitrosamino)
3-( (+/-)-2-carboxypiperazin-4-
3- week-old</w>
3- phosphono
3- mg</w>
3- isobut
3- desacetyl
3- day-old</w>
3- but
3- bromo-
3- antineutrophil</w>
3- M
3- 60</w>
3- 4),</w>
3- 30</w>
3- 21</w>
3- /
3,5- DHPG</w>
3,4-dicarboxy phenylglycine</w>
3,4-di aminopyridine</w>
3,4-DC PG
3,4- methylenedioxyamphetamine</w>
3,4- dihydro-
3, Thi5,
3, 8
3, 6-dimethyl
3, 6'-disinapoylsucrose</w>
3, 500</w>
3, 3'-
3+/- 3</w>
3+/- 0.
3) %</w>
3(2H)- pyridazinon-
3'U TRs</w>
3'U TR
3'-deamino- 3'-(2-
3'-azido-3'-deoxy thymidine</w>
3 beta-methyl-5alpha-pregnan-20-
3 beta-(4-
3 a-
3 D</w>
3 80
3 7-day</w>
3 7%)</w>
3 6.0</w>
3 6%)</w>
3 50)</w>
3 50%</w>
3 5.</w>
3 40/340</w>
3 4.8</w>
3 4.3</w>
3 4.1</w>
3 4.0</w>
3 389</w>
3 35</w>
3 35
3 3.8</w>
3 3.5</w>
3 3-year</w>
3 3%).</w>
3 200</w>
3 20
3 2.2</w>
3 1st</w>
3 17</w>
3 12
3 1.8</w>
3 1.7</w>
3 1.25</w>
3 1,
3 0.5</w>
3 0.3</w>
3 0.2</w>
3 0.0
3 +)</w>
3 ',</w>
2K1C- betagal</w>
2B 1/
29. 9</w>
29. 8</w>
29. 7</w>
29. 3%</w>
29. 2</w>
29. 1</w>
29. 0</w>
29- yr-old</w>
29 2)</w>
29 00</w>
29 %.</w>
29 %)</w>
29 %).</w>
28. 9</w>
28. 8%</w>
28. 6%</w>
28. 4%</w>
28. 2</w>
28. 0</w>
28- week</w>
28 7)</w>
28 2)</w>
28 1)</w>
28 0-
28 %)</w>
28 %).</w>
27. 9</w>
27. 7%</w>
27. 3</w>
27. 1</w>
27 /
27 -1
27 %;</w>
27 %.</w>
26. 9</w>
26. 7+/-
26. 0</w>
26 th</w>
26 5)</w>
26 4,</w>
26 0-
26 %).</w>
25/ 100</w>
25. 7</w>
25- mg/m2</w>
25- 50</w>
25(OH) D
25 th</w>
25 2</w>
25 00-
25 00,</w>
25 -100</w>
25 ,
25 %),</w>
240- 300</w>
24. 7</w>
24. 6</w>
24. 6%</w>
24. 4%</w>
24. 3%,</w>
24. 1%</w>
24- hydroxylase</w>
24- hr</w>
24- 72</w>
24 a,26a,27a-tri-homo-22,24-di
24 3
24 213</w>
24 20
2420 84</w>
24 13
24 0,</w>
24 %.</w>
24 %).</w>
24 %),</w>
23390 -</w>
23. 8%</w>
23. 5),</w>
23. 2</w>
23. 00</w>
23 6
23 3-
23 %;</w>
23 %)</w>
23 %),</w>
22. 8</w>
22. 6%</w>
22. 6%,</w>
22. 5%</w>
21- d</w>
21 C-->
21 +/-1
207 12
200- mg/m(2)</w>
200- 500</w>
200 mg</w>
200 mg/kg</w>
200 9)</w>
200 4).</w>
200 3-
200 2)</w>
200 1)</w>
200 1),</w>
200 ,00
200 ).</w>
20- tetrak
20- month</w>
20- mg/day</w>
20- 80</w>
20- 60</w>
20- 30%</w>
20- 25</w>
20 mg/kg.</w>
20 :1.</w>
20 :
20 5,</w>
20 10)</w>
2/ CM
2/ 8</w>
2.8 %.</w>
2.5 %.</w>
2.0 8,</w>
2.0 3</w>
2. 9-fold</w>
2. 9%,</w>
2. 9%).</w>
2. 88</w>
2. 87</w>
2. 8+/-
2. 8)</w>
2. 7),</w>
2. 7%;</w>
2. 7%,</w>
2. 67</w>
2. 62</w>
2. 6-1
2. 6).</w>
2. 53</w>
2. 50</w>
2. 44</w>
2. 41</w>
2. 4+/-
2. 4%,</w>
2. 33</w>
2. 31</w>
2. 30,</w>
2. 3-fold</w>
2. 3-
2. 3)</w>
2. 27</w>
2. 26,</w>
2. 23</w>
2. 2%,</w>
2. 2%)</w>
2. 19</w>
2. 18</w>
2. 17</w>
2. 14</w>
2. 11;</w>
2. 1%)</w>
2. 0%)</w>
2-methyl-6-(phenylethyn yl)pyridine</w>
2-mercapto ethan
2-hydroxy estradiol</w>
2-chloro deoxy
2-chloro adenosine,</w>
2-amino-4-phosphon obutyric</w>
2-amino-4-phosphon obut
2-amino-4- methyl-5-phosphono-3-
2-amino- 3-phosphono
2-Br- LIS</w>
2-1 4</w>
2-1 26</w>
2- week,</w>
2- stage</w>
2- day-old</w>
2- antagonists</w>
2- aminobicyclo[3.
2- adrenoreceptors.</w>
2- adrenoceptors,</w>
2- ME,</w>
2- Chloro
2- B
2- 9</w>
2- 7</w>
2- 3)</w>
2- 3
2- 2.6
2- 0
2- )</w>
2,4 18</w>
2,3-dihydroxy benzoic</w>
2,3-dihydrobenzofuran-7- carboxamide
2,3,5- triphenyltetrazolium</w>
2,3,4-tetrahydro- 6-nitro-
2,3,4,5- tetrahydro-7,8-dihydroxy-1-phenyl
2, 800</w>
2, 228</w>
2'- deoxyguanosine</w>
2',5'-dideoxy adenosine</w>
2 microg/rat)</w>
2 ])</w>
2 C-
2 C,</w>
2 B2</w>
2 7%)</w>
2 6%)</w>
2 4.5</w>
2 26
2 2%),</w>
2 16)</w>
2 1.4</w>
2 1.1</w>
2 0.9</w>
2 0.8%</w>
2 0.5</w>
2 0.4</w>
2 0.4%,</w>
2 0.2%</w>
2 ):</w>
2 ).(ABSTRACT</w>
2 )-
2 (+/-)</w>
1alpha- immunoreactive</w>
1A 1/
1:200 ,000,</w>
1: 400,000</w>
1997- 2001</w>
199 3).</w>
199 2-
1980 -199
198 6.</w>
198 5
198 4.</w>
198 2,</w>
197 8,</w>
197 7,</w>
197 5,</w>
197 3,</w>
197 2-1
197 1).</w>
197 0,</w>
196 6,</w>
19. 9%</w>
19. 5%</w>
19. 1</w>
19- nor-
19- fold</w>
19 th</w>
19 :
19 78.</w>
19 69</w>
19 53</w>
19 50</w>
19 5)</w>
19 43</w>
19 40</w>
19 0/
19 -1.
19 ,
19 %;</w>
19 %)</w>
18F- FDG</w>
180- 220</w>
18. 9%</w>
18. 4%</w>
18. 1%</w>
18-hydroxy deoxycorticosterone</w>
18- day-old</w>
18- 70</w>
18- 65</w>
18 93</w>
18 884,</w>
18 0)</w>
18 0).</w>
18 -</w>
18 +/-
18 %;</w>
18 %.</w>
17p11. 2-12</w>
17. 7%</w>
17. 6</w>
17- year</w>
17- month-old</w>
17 th</w>
17 779</w>
17 7)</w>
17 00</w>
17 0
16/ 20</w>
16. 00</w>
16- week-old</w>
16,23- D3-treated</w>
16 :
16 37
16 3)</w>
16 0.</w>
16 %)</w>
1500/ 30</w>
150- day-old</w>
15- week</w>
15- s</w>
15- day-old</w>
15- 21</w>
15 O-
15 :
15 55,</w>
15 5)</w>
15 00
1500 IU</w>
15 );</w>
1429 7,</w>
141716 A,</w>
1417 16)</w>
14. 9%</w>
14. 5,</w>
14. 5%</w>
14. 4%,</w>
14. 1%</w>
14. 0%</w>
14. 0%,</w>
14- day-old</w>
14 C]
14 9),</w>
14 7)</w>
14 4/
14 0-1
14 0,</w>
14 -18</w>
14 %;</w>
14 %)</w>
133X e</w>
131I- ferritin</w>
131I- MIBG</w>
13-cis- isomers</w>
13 90</w>
13 4)</w>
13 0%</w>
129/ OlaHsd</w>
128 130</w>
125 IHSA</w>
120- hour</w>
120 -1
120 ),</w>
12. 7%</w>
12. 6%</w>
12. 5+/-
12. 2+/-
12. 0,</w>
12- year</w>
12- mm</w>
12- ,</w>
12 h,</w>
12 99</w>
12 9%</w>
12 9
12 4).</w>
12 -16</w>
12 +/-
11- year-old,</w>
11- month-old</w>
11- A</w>
11 2,</w>
109/ l),</w>
100- mg</w>
100- 500</w>
100- 400</w>
100 635.</w>
100 00</w>
100 0,</w>
100 0)</w>
10/ group)</w>
10/ 16</w>
10.0 %,</w>
10. 8)</w>
10. 7%</w>
10. 4%</w>
10. 1,</w>
10. 1%</w>
10-1 1.</w>
10- week,</w>
10- minute</w>
10- fold)</w>
10- 3</w>
10- 20%</w>
10,00 0)</w>
10,00 0),</w>
10(9)/ l)</w>
10(9)/ l).</w>
10(3)/microliter s,</w>
10(- 3)
10 h</w>
10 b-
10 D2/
10 9)</w>
10 83</w>
10 8
10 71</w>
10 65</w>
10 47</w>
10 4.</w>
10 3)</w>
10 17</w>
10 ,0
10 );</w>
10 (5)</w>
10 %).</w>
1/ 75</w>
1/ 3
1/ 2.</w>
1.7 3
1.6 3;</w>
1.6 2;</w>
1.5 8,</w>
1.5 3;</w>
1.5 %.</w>
1.4 2-
1.4 %;</w>
1.3 6,</w>
1.3 %.</w>
1.25- 5</w>
1.00 ),</w>
1.0 ]</w>
1.0 8;</w>
1.0 8,</w>
1.0 7-
1.0 7,</w>
1.0 4-4.
1.0 4,</w>
1.0 2-1.
1.0 1-
1.0 ),</w>
1.0 %.</w>
1. 99,</w>
1. 94</w>
1. 91</w>
1. 9%).</w>
1. 82</w>
1. 81</w>
1. 8-fold</w>
1. 8%)</w>
1. 79</w>
1. 74</w>
1. 71</w>
1. 7-fold</w>
1. 6-fold</w>
1. 6)</w>
1. 6%,</w>
1. 5;</w>
1. 58</w>
1. 57</w>
1. 56
1. 55
1. 51</w>
1. 5+/-
1. 4%,</w>
1. 39</w>
1. 36
1. 3)</w>
1. 3%)</w>
1. 29;</w>
1. 25,</w>
1. 21,</w>
1. 2)</w>
1. 2),</w>
1. 2%).</w>
1. 19-1.
1. 18
1. 16</w>
1. 14-
1. 11
1. 1
1-methyl-4-phenyl-1,2,3,6-tetrahydropyrid ine.</w>
1-1 5</w>
1- year,</w>
1- mm</w>
1- minute</w>
1- fold</w>
1- and</w>
1- agonist</w>
1- [3-(4-
1- 8)</w>
1- 5,</w>
1- 2;</w>
1- 2
1- -3</w>
1- (2-chloroethyl
1,4- benzodiazepines</w>
1,3-DM UA</w>
1,3- dimethyluric</w>
1,25-(OH)2D 3,</w>
1,25-(OH)2-24OXO-16ene D3,</w>
1,25(OH)2-16ene-23 yne-19-nor-26,27-F6-
1,25(OH)(2) D(3)-treated</w>
1,24-(OH)(2) D(2)</w>
1,2-dimethyl hydrazine</w>
1, 800</w>
1, 750</w>
1, 378</w>
1, 300</w>
1, 2,
1, 100</w>
1+/-1. 2</w>
1+/- 5</w>
1) Cr
1 p19q</w>
1 mg/kg/day</w>
1 ])</w>
1 ]),</w>
1 D</w>
1 5-F(2t)-Iso
1 20)</w>
1 187</w>
1 16,</w>
1 10-1
1 10)</w>
1 10).</w>
1 10
1 0.9
1 0.7%,</w>
1 0.3
1 +
1 )-
000/ microL</w>
00- 2000</w>
00 88-
00 ).</w>
0.90 -1.
0.9 9;</w>
0.9 9,</w>
0.9 5-
0.9 4)</w>
0.9 3-1.
0.9 1-1.
0.9 %;</w>
0.8 9),</w>
0.8 8),</w>
0.8 7,</w>
0.8 6;</w>
0.8 5;</w>
0.8 4;</w>
0.8 4.</w>
0.8 2-1.
0.8 1),</w>
0.8 ),</w>
0.8 %),</w>
0.7 9)</w>
0.7 8).</w>
0.7 7;</w>
0.7 5-
0.7 4,</w>
0.7 3).</w>
0.7 2;</w>
0.7 -1.
0.7 ).</w>
0.7 %).</w>
0.6 8)</w>
0.6 8).</w>
0.6 6,</w>
0.6 5).</w>
0.6 4;</w>
0.6 2).</w>
0.6 0.</w>
0.6 0
0.6 %.</w>
0.6 %).</w>
0.6 %),</w>
0.5- 4.0</w>
0.5- 4.
0.5 8)</w>
0.5 6-
0.5 6+/-
0.5 5-
0.5 4).</w>
0.5 35%</w>
0.5 3).</w>
0.5 1).</w>
0.5 .</w>
0.4 7-
0.4 4),</w>
0.4 3)</w>
0.4 2-
0.3 8)</w>
0.3 4,</w>
0.3 3).</w>
0.3 0,</w>
0.3 -1.
0.3 -1
0.2- 0.3</w>
0.2 6)</w>
0.2 4%</w>
0.2 1,</w>
0.2 %),</w>
0.12 5-
0.05 )).</w>
0.04 6).</w>
0.04 3)</w>
0.03 6)</w>
0.03 5,</w>
0.03 3).</w>
0.02 1)</w>
0.02 1).</w>
0.001 ):</w>
0.0000 1</w>
0.0000 1)</w>
0.000 7).</w>
0.000 6)</w>
0.000 6).</w>
0.000 5</w>
0.000 5),</w>
0.000 4,</w>
0.000 2)</w>
0.000 ),</w>
0.00 9</w>
0.00 9,</w>
0.00 9)</w>
0.00 8,</w>
0.00 8)</w>
0.00 4</w>
0.00 45)</w>
0.00 3,</w>
0.00 2;</w>
0.00 17).</w>
0.00 11).</w>
0.0 9+/-
0.0 82</w>
0.0 75%</w>
0.0 50</w>
0.0 49</w>
0.0 48</w>
0.0 48).</w>
0.0 47</w>
0.0 38).</w>
0.0 37).</w>
0.0 36),</w>
0.0 35),</w>
0.0 34
0.0 26).</w>
0.0 24</w>
0.0 21</w>
0.0 19).</w>
0.0 19
0.0 18</w>
0.0 16</w>
0.0 16),</w>
0.0 15-
0.0 14
0.0 13)</w>
0. 80).</w>
0. 50)</w>
0. 50%</w>
0. 50
0. 30).</w>
0. 3).</w>
0. 3%)</w>
0. 29;</w>
0. 27
0. 25),</w>
0. 20).</w>
0. 19).</w>
0. 18-
0. 175</w>
0. 16,</w>
0. 150</w>
0. 15-
0. 14,</w>
0. 14),</w>
0. 12-
0. 12%</w>
0. 11)</w>
0. 11%</w>
0. 10%</w>
0. 1-1.0</w>
0. 1-1
0. 1%.</w>
0-1 60</w>
0-1 40</w>
0- ppm</w>
0- fold,</w>
0- U</w>
0- 6</w>
0- 6.
0- 5</w>
0- 20:
0- 2.</w>
0- 2)</w>
0 8.
0 7
0 4</w>
0 4-67
0 2:00</w>
0 20</w>
0 -</w>
0 ,0
0 +/-1
/N =
/ year</w>
/ ml)</w>
/ min</w>
/ day,</w>
/ d)</w>
/ T)</w>
/ E</w>
/ ARB</w>
.000 6).</w>
.000 5),</w>
.00 8),</w>
.00 7).</w>
.00 6).</w>
.00 3,</w>
.00 2),</w>
.00 1;</w>
.0 8).</w>
.0 5;</w>
.0 5.</w>
.0 4),</w>
.0 3,</w>
.0 26).</w>
.0 25).</w>
.0 12).</w>
. We</w>
. 7.</w>
. 4</w>
. 2</w>
. 2.</w>
. 125</w>
-2- deoxyuridine</w>
-17 G),</w>
-16-ene-23- yne-vitamin</w>
-15- labeled</w>
-1. 8</w>
-1. 210</w>
-1-piperazin yl)
-1- pyrrolidin
-1,3- di
-1,3,4- tricarboxylic</w>
-1,2-bis(3,5-di oxopiperazinyl-1-yl)prop
-1,2- diphenyl</w>
-1, 2</w>
-1, 200</w>
-1, 1-
-1 :
-1 9.
-1 808)</w>
-1 8.9</w>
-1 8.4</w>
-1 6.0</w>
-1 254</w>
-1 2,</w>
-1 -</w>
-1 ,000</w>
-0. 50
-- IP</w>
- tail</w>
- sensitive</w>
- r
- kinase</w>
- j
- independent,</w>
- dP/dt(max).</w>
- c
- arterial</w>
- aminocaproic</w>
- Re
- LD</w>
- K+</w>
- K
- IV
- ATPase,</w>
- ALA-D</w>
- ALA-
- 7-
- 65</w>
- 5</w>
- 520
- 5)</w>
- 33</w>
- 3.7</w>
- 20</w>
- 0.9
- )
+/-1. 8</w>
+/-1 8</w>
+/-1 5.
+/- 6</w>
+/- 0.04</w>
+/- )</w>
+ dP/dt(max)</w>
+ HS+
+ HF</w>
+ 28</w>
* 0
* )</w>
)- responsive</w>
)- negative</w>
)- atropine</w>
) n</w>
) agonists</w>
) M</w>
) F1</w>
) C-
) >/=
) ,
(y es/
(two -</w>
(two )</w>
(two ).</w>
(thre e)</w>
(stat in)</w>
(sham )</w>
(sc Met
(s. p.)</w>
(s. e.
(responder s)</w>
(r= 0.4
(r t
(r SO
(r CB
(r (2)</w>
(pseud otumor</w>
(pro )
(pre infusion:</w>
(paracetam ol
(p=0.00 5).</w>
(p=0.0 3)</w>
(p= 0.8
(p= 0.01)</w>
(p< 0.05),</w>
(p< 0.02),</w>
(p< 0.005).</w>
(p- value</w>
(p- chloro
(p ERK
(p <</w>
(p .)</w>
(nor-B NI),</w>
(n= 9)</w>
(n= 9).</w>
(n= 8).</w>
(n= 5)</w>
(n= 5).</w>
(n= 5),</w>
(n= 4).</w>
(n= 4),</w>
(n= 36),</w>
(n= 29)</w>
(n= 20),</w>
(n= 17)</w>
(n= 15).</w>
(n= 14)</w>
(n= 13)</w>
(n= 12).</w>
(n= 1),</w>
(n /N=
(mes na)</w>
(median= 0)</w>
(median =0.0
(medi an)</w>
(mean+/- SEM:</w>
(max ),</w>
(mGlu )</w>
(m ifeprist
(m TOR),</w>
(m RS</w>
(m CPP)</w>
(low- dose)</w>
(lind ane)</w>
(l- NAME
(iox aglate)</w>
(i. pl
(i. m.)</w>
(i opamid
(i omeprol
(gamma- HCH),</w>
(fMR I),</w>
(f ))</w>
(doxorubic in;</w>
(doxorubic in),</w>
(diphenyl methoxy)
(dexrazox ane).</w>
(d4 T)</w>
(d4 T
(d p
(d B)</w>
(control ;</w>
(chi (2)=
(c GMP)</w>
(bF GF)</w>
(ara- C).</w>
(apo )</w>
(anti- LK
(alpha- T
(aPTT s)</w>
(a )
([35S]TBP S)</w>
([ Ca(2+)](i))</w>
(Z n)</w>
(Z O
(We ek</w>
(WA Y</w>
(WA Y
(W SR)</w>
(W SP)</w>
(W R-27
(W MD)</w>
(W G)</w>
(W G),</w>
(W DR)</w>
(W BC</w>
(Viagra ).</w>
(VE Ps)</w>
(VE H),</w>
(VE GF
(V olta
(V mca
(V is
(V er
(V alium)</w>
(V al
(V T/
(V RS)</w>
(V PCs)</w>
(V NTR)</w>
(V M)</w>
(V FT)</w>
(V CR).</w>
(V AS,</w>
(V AS),</w>
(V AN)</w>
(V AC
(V (MCA
(V(MCA ))</w>
(UPD RS),</w>
(UF H)</w>
(U K-
(U DS)</w>
(U C)</w>
(Tr x
(Td p)</w>
(Tax ol).</w>
(Talw in)</w>
(Tac rolimus)</w>
(TUR P)</w>
(TTP- HUS)</w>
(TT P)</w>
(TT C)</w>
(TRPV 1).</w>
(TP P)</w>
(TP MT)</w>
(TNF )-
(TM Z)</w>
(TM X)</w>
(TI MP
(TH P)</w>
(TH ),</w>
(TGF )-
(TD 50</w>
(TB Z)</w>
(TAS S)</w>
(T imm</w>
(T gR[hAI]
(T e
(T anner</w>
(T V
(T PV/
(T NS).</w>
(T L)</w>
(T EOAEs)</w>
(T EMPO
(T E)</w>
(T CP)</w>
(T CD)</w>
(T CAs)</w>
(T BM
(T AC
(T 4/
(T 4)</w>
(T 30:</w>
(T 2-
(Ser ies</w>
(Sel dane)</w>
(Sando statin</w>
(SV R),</w>
(STZ)- diabetic</w>
(STR ),</w>
(ST Z).</w>
(ST S)</w>
(SSRI s),</w>
(SO 3
(SNP ).</w>
(SNH L)</w>
(SNH L),</w>
(SN A)</w>
(SM ON
(SI )</w>
(SGO T),</w>
(SER T)</w>
(SCO P)-induced</w>
(SAM e+APAP)</w>
(SAM e)</w>
(S)-2- (6-
(S)-2-(6- methoxynaphthalen-2-
(S)- (-)-
(S te
(S o-1
(S ch)</w>
(S VT)</w>
(S V),</w>
(S T)</w>
(S NP</w>
(S N)</w>
(S LE),</w>
(S J
(S H)</w>
(S DRR)</w>
(S D).</w>
(S Ch
(S CD)</w>
(S C-
(S C
(S BP
(S AS
(S AL)</w>
(S ,</w>
(Roc he</w>
(RW M)</w>
(RVL M)</w>
(RV M)</w>
(RR :</w>
(RO CK)</w>
(RO C)</w>
(RCT s)</w>
(R- (+)-
(R) aminoindan</w>
(R yR
(R ox
(R is
(R enograf
(R andall-Selitto</w>
(R U
(R S
(R PL
(R NF
(R L
(R IS)</w>
(R CC)</w>
(R AS
(R AMH)</w>
(R AD00
(R A
(R :</w>
(R ))</w>
(R (2)=
(QT c),</w>
(QT c
(QO L)</w>
(Q S/QT)</w>
(Pa CO2)</w>
(Pa (O
(PW V)</w>
(PTU ).</w>
(PTU )-associated</w>
(PT R)</w>
(PT A),</w>
(PR s)</w>
(PR M),</w>
(PR L-
(PR L),</w>
(PPAR alpha)</w>
(PON V).</w>
(PO M)</w>
(PK C
(PK A)</w>
(PIIIN P)</w>
(PGE 2
(PGE 1)-induced</w>
(PG AD
(PF S)</w>
(PE NK)</w>
(PE G)</w>
(PE ),</w>
(PDT C)</w>
(PD T)</w>
(PD E</w>
(PC W
(PC PA),</w>
(PC C)</w>
(PB SCT)</w>
(PB SC)</w>
(PB ;</w>
(PB ).</w>
(PAC AP)</w>
(PA R)</w>
(PA L-
(PA )-induced</w>
(P=0.00 9).</w>
(P=0.0 11),</w>
(P=0.0 1),</w>
(P= 0.0001).</w>
(P< 0.02)</w>
(P< 0.005)</w>
(P< 0.005).</w>
(P< 0.0005)</w>
(P< .01)</w>
(P< .001</w>
(P t
(P r
(P pa
(P SV
(P SE)</w>
(P SA).</w>
(P RE
(P R,</w>
(P PE).</w>
(P PA),</w>
(P O)</w>
(P N</w>
(P GF
(P F)</w>
(P ET).</w>
(P ED
(P DE)</w>
(P CR),</w>
(P CNS
(P CE
(P AS)</w>
(P AL
(P AE,</w>
(P :</w>
(P /
(P '
(Om niscan
(OVX+CHR ON+
(OR adj</w>
(OD C)</w>
(O gilvie's</w>
(O T)</w>
(O PC
(O LTX)</w>
(O L
(O IH).</w>
(O G
(O CT)</w>
(O CS)</w>
(O 2-)</w>
(O 2)</w>
(Ne w</w>
(NTG )-induced</w>
(NT S).</w>
(NSC -1
(NRTI s),</w>
(NO )-deficient</w>
(NO (
(NMD A)-
(NM S).</w>
(NF )-
(NC SE)</w>
(NB U)</w>
(NAS H).</w>
(NA G),</w>
(N2 O)</w>
(N-methyl- D-
(N- acetyl-
(N o
(N Z
(N VP)</w>
(N S-
(N REM)</w>
(N R)</w>
(N IC
(N HE3),</w>
(N G)</w>
(N G),</w>
(N G
(N CI-CTC)</w>
(N ADH</w>
(N AC
(N ),</w>
(MTX )-related</w>
(MT Ds)</w>
(MS SA)</w>
(MR S)</w>
(MPT P).</w>
(MPT P)-induced</w>
(MPT P
(MPO )-
(MPE P,</w>
(MP EP),</w>
(MN U)</w>
(MN CV),</w>
(MM SE)</w>
(MM S)</w>
(MIB G)</w>
(MF S)</w>
(ME T)</w>
(ME SNA)</w>
(ME M)</w>
(ME LD)</w>
(ME D,</w>
(MDMA ).</w>
(MC R)</w>
(MAO- B)</w>
(MADR S)</w>
(MA Ps)</w>
(MA PK)</w>
(MA MP)</w>
(MA ),</w>
(M it
(M in
(M et
(M an
(M TEP)</w>
(M SNA)</w>
(M P),</w>
(M O)</w>
(M NCV)</w>
(M H)</w>
(M CT/LCT)</w>
(M CF
(M :
(M 1)</w>
(Li )-induced</w>
(LY16 3892)</w>
(LY 3547
(LVE DP)</w>
(LVE DP).</w>
(LV dP/dt
(LV P),</w>
(LV ).</w>
(LT G,</w>
(LQT S)</w>
(LQT S).</w>
(LQT S),</w>
(LH ON)</w>
(LF P)</w>
(LEV ),</w>
(LDH ,</w>
(LDH ).</w>
(LC x)</w>
(LC V)</w>
(LAM )-resistant</w>
(L6- S1)</w>
(L1- L2)</w>
(L-dopa )</w>
(L-NOAR G),</w>
(L-NMMA ),</w>
(L-NAME ).</w>
(L-DOPA ),</w>
(L- NO
(L- Dopa
(L ami
(L VP
(L P)</w>
(L CT/MCT)</w>
(L AS)</w>
(K i)</w>
(K eppra
(K Y
(K T)</w>
(K A).</w>
(J M40
(IV R)</w>
(IOP )-
(INR ),</w>
(IL)- 6</w>
(IL)- 6,</w>
(IL K)</w>
(IIE F),</w>
(IFN)- gamma,</w>
(IF S).</w>
(IF N</w>
(ID V)</w>
(ID 50</w>
(IC R)</w>
(IC 50)</w>
(IC ).</w>
(IB IS-
(I/ R)</w>
(I mg/kg)</w>
(I ST)</w>
(I SI)</w>
(I PR
(I PD)</w>
(I OR/OS-
(I MID)</w>
(I HD)</w>
(I HC)</w>
(I C</w>
(Hol ter)</w>
(Hol lander</w>
(HV A),</w>
(HR =
(HPL C).</w>
(HIV )-associated</w>
(HIV ),</w>
(HD C)</w>
(HD AC)</w>
(HC M)</w>
(HBsAg ).</w>
(HBeAg ).</w>
(HBeAg )-negative</w>
(HBI G).</w>
(HB Ig
(HAM- D</w>
(HAM- D-1
(HAM- D).</w>
(HAM- A)</w>
(H sp
(H i
(H em
(H c
(H b),</w>
(H V)</w>
(H S
(H RPC)</w>
(H N)</w>
(H L
(H IC)</w>
(H CN)</w>
(H AT)</w>
(H AI)</w>
(H -
(Glu )</w>
(GY KI</w>
(GT S)</w>
(GT )n</w>
(GSHP x)</w>
(GM- CSF)</w>
(GF R).</w>
(GF P)</w>
(GF AP
(GBM ).</w>
(GBM ),</w>
(GABA)- ergic</w>
(GABA )-mediated</w>
(G px
(G la
(G d
(G ST
(G S)</w>
(G PR
(G OS)</w>
(G M)-induced</w>
(G ITS)</w>
(G EC)</w>
(G DNF)</w>
(G D</w>
(G Cs)</w>
(G C
(G AP-43)</w>
(G A
(G :</w>
(G 1:</w>
(G ),</w>
(FSG S)</w>
(FF P)</w>
(FEV 1),</w>
(FE N)</w>
(FD A).</w>
(F(1, 8)</w>
(F(1, 10)</w>
(F isch
(F i
(F ast
(F P
(F N)</w>
(F J
(F C)</w>
(F BAL)</w>
(F B
(F AA)</w>
(F A
(F ),</w>
(Estracy t)</w>
(ET )-1</w>
(ESR D).</w>
(ER G)</w>
(EP SCs)</w>
(EP S).</w>
(EP I</w>
(EP I).</w>
(EP (1)</w>
(EM G).</w>
(EM G),</w>
(EM B)</w>
(ELIS A).</w>
(EF S)</w>
(EE Gs)</w>
(ED s)</w>
(ED L)</w>
(ED 50,</w>
(ED 50),</w>
(ED (min)</w>
(ED (50))</w>
(EC OG</w>
(EC HO)</w>
(EC Gs)</w>
(EB GM</w>
(EB F)</w>
(EAD s)</w>
(E)- 2-amino-4-methyl-5-phosphono-3-
(E)- 2-
(E thy
(E V
(E SW
(E R-
(E P</w>
(E OG)</w>
(E H
(E GF)</w>
(E A),</w>
(E A
(E -
(E (2))</w>
(Dox il)</w>
(DP CP
(DOX /
(DOX ).</w>
(DO PA)</w>
(DO CA-
(DO C)</w>
(DN Q
(DN L)</w>
(DN ),</w>
(DMT U),</w>
(DMP X),</w>
(DMB A)</w>
(DM P-
(DL ST)</w>
(DH T)</w>
(DH E)</w>
(DG Cs)</w>
(DF X)</w>
(DF O),</w>
(DE X),</w>
(DE S,</w>
(DE NA
(DE N).</w>
(DE H
(DD T)</w>
(DD P)</w>
(DB H)</w>
(DB A/
(D- pen
(D epo-
(D aun
(D Y
(D S)</w>
(D M),</w>
(D LT
(D E)</w>
(D DP
(D CE)</w>
(D C)</w>
(D C
(D AV
(D AD
(D AB
(D 2R)</w>
(D 2</w>
(D (2))</w>
(Cytox an)</w>
(Cs A</w>
(Cs A).</w>
(Cs A)-induced</w>
(Cr Cl)</w>
(Con tro
(Co Q
(Ch E)</w>
(Cal lithrix</w>
(Ca(2+ )
(Ca 2+
(CYP2D 6)</w>
(CV P)</w>
(CV D)</w>
(CV -1808)</w>
(CTR L,</w>
(CT B)</w>
(CS F
(CR H),</w>
(CP R)</w>
(COX )-2</w>
(COR T)</w>
(CO PD)</w>
(CO P)</w>
(CM P)</w>
(CM I)</w>
(CL Z)</w>
(CL E)</w>
(CL D)</w>
(CK D)</w>
(CIP N)</w>
(CH L)</w>
(CGI- S),</w>
(CGI- I)</w>
(CG RP).</w>
(CE Q)</w>
(CD C)</w>
(CD 4,</w>
(CCl 4</w>
(CCl 4)</w>
(CCK-8- SE)</w>
(CCK-8- NS)</w>
(CCK- 8)</w>
(CB F),</w>
(CAP +HS+
(CAP ).</w>
(CAM I)</w>
(CA A)</w>
(CA 10)</w>
(C57BL/ 6J)</w>
(C x
(C oumad
(C hr.</w>
(C cr)</w>
(C Z
(C Y</w>
(C V</w>
(C T).</w>
(C S</w>
(C S)</w>
(C S).</w>
(C PT-1
(C PR
(C PP
(C PA)-induced</w>
(C MT)</w>
(C MAP)</w>
(C ID
(C HD).</w>
(C F)</w>
(C DZP)</w>
(C CI)</w>
(C C),</w>
(C AVB)</w>
(C ;</w>
(C :</w>
(C (s
(Brom age</w>
(Bo NT-A)</w>
(BZ 1)</w>
(BU N</w>
(BT X-A)</w>
(BS O)</w>
(BR S),</w>
(BI H)</w>
(BD L)</w>
(BB N)</w>
(BB N).</w>
(B rattleboro</w>
(B r
(B max)</w>
(B as
(B TS</w>
(B SE
(B SC
(B P).</w>
(B MT).</w>
(B MD)</w>
(B HA)</w>
(B F)</w>
(B CHE)</w>
(B CA
(B 1
(B (t
(Ara- C).</w>
(Ara- C),</w>
(An tabuse
(Al f
(Adriamyc in).</w>
(Ad C)</w>
(AUC (0-
(AU C,</w>
(AT P</w>
(AT (1))</w>
(ASP 5854),</w>
(ARF ),</w>
(ARB s)</w>
(AR V)</w>
(AR T)</w>
(APT T),</w>
(APO )-induced</w>
(AP s)</w>
(AP S)</w>
(AP D)</w>
(AOA A,</w>
(AOA A)</w>
(AN R</w>
(AN LL)</w>
(AMP ),</w>
(AM L),</w>
(AL F).</w>
(AIM S),</w>
(AID S)-
(AID A),</w>
(AI HA)</w>
(AGE s)</w>
(AE s),</w>
(ADR- 5
(ADR s).</w>
(ADR AC).</w>
(ADH D-
(AD M).</w>
(AD ),</w>
(ACh R)</w>
(ACE Is)</w>
(ACE I)</w>
(ACE I
(AC Z)</w>
(AC S)</w>
(AC S
(AC I)</w>
(AC EA-10
(AC E),</w>
(AB P)</w>
(AB D)</w>
(AB C)</w>
(AAP )-induced</w>
(A(2A) R)</w>
(A ra</w>
(A ng)</w>
(A mio-Aqueous)</w>
(A d-
(A b)</w>
(A T)</w>
(A ST
(A SI
(A SA),</w>
(A S)</w>
(A PO)</w>
(A PI
(A PD
(A PACHE)</w>
(A P-
(A NT)</w>
(A MI).</w>
(A L)</w>
(A H</w>
(A G
(A F),</w>
(A A).</w>
(A :</w>
(> 50%</w>
(> 25%</w>
(> 100</w>
(< 500</w>
(< 1</w>
(< 150</w>
(95% CI)</w>
(9. 8%)</w>
(9. 6%)</w>
(9. 5%</w>
(9. 5%)</w>
(9. 4%)</w>
(9. 2</w>
(9 9%)</w>
(9 7%</w>
(9 6%),</w>
(9 5.
(9 4.
(9 4%</w>
(9 2%),</w>
(9 1.7%)</w>
(9 00
(9 0.2%)</w>
(9 0%</w>
(8R, 15S)-di
(8R, 15S)-
(89. 2%)</w>
(88. 6%)</w>
(8. 7%)</w>
(8. 5</w>
(8. 4</w>
(8. 1%),</w>
(8-S PT)</w>
(8-OH-DPA T),</w>
(8- OH
(8 8</w>
(8 7%),</w>
(8 6%).</w>
(8 50</w>
(8 4</w>
(8 4.4%)</w>
(8 4%).</w>
(8 0%),</w>
(8 ,</w>
(8 ).</w>
(8 %;</w>
(75- 250</w>
(7. 9%)</w>
(7. 7%)</w>
(7. 6</w>
(7. 5-15</w>
(7. 4%).</w>
(7. 3%)</w>
(7. 2</w>
(7-OH- AAF)</w>
(7-N I)</w>
(7- methyl
(7- NI),</w>
(7 7.1</w>
(7 7%).</w>
(7 7%),</w>
(7 6%),</w>
(7 40</w>
(7 4%).</w>
(7 3%),</w>
(7 2%),</w>
(7 1</w>
(7 0%).</w>
(6. 7%</w>
(6. 6%</w>
(6. 5%),</w>
(6. 4%)</w>
(6. 3%)</w>
(6. 1%</w>
(6-OHD A).</w>
(6-OHD A)-
(6- MP)</w>
(6 8%),</w>
(6 7%),</w>
(6 6%).</w>
(6 6
(6 5%),</w>
(6 4.
(6 25</w>
(6 1.6</w>
(6 1.4</w>
(6 1.4%)</w>
(6 1%</w>
(6 00-
(6 00,</w>
(54. 4%</w>
(52. 6%)</w>
(50- 400</w>
(5. 9%)</w>
(5. 7</w>
(5. 7
(5. 4</w>
(5-HT) 2A</w>
(5-HT TLPR)</w>
(5-HT T)</w>
(5-HT (2
(5-FU )-based</w>
(5- methyl
(5- 50</w>
(5- 25</w>
(5 HT
(5 E-9,11,13
(5 7.1%)</w>
(5 7%).</w>
(5 4%</w>
(5 1/
(5 1)Cr
(5 00/
(5 00,</w>
(5 -</w>
(5 -15</w>
(5 -1
(45. 8%)</w>
(41. 2%)</w>
(4. 9%</w>
(4. 8%)</w>
(4. 7</w>
(4. 3%</w>
(4. 3%).</w>
(4. 2%</w>
(4. 1%),</w>
(4-fluoro phenyl)</w>
(4-fluoro phenyl
(4-D AMP)</w>
(4-(2- methoxyphenyl)
(4- iodo
(4- OH-
(4- 8</w>
(4- 7</w>
(4 9%).</w>
(4 9%),</w>
(4 80</w>
(4 62</w>
(4 6/
(4 6%),</w>
(4 5.1</w>
(4 4%).</w>
(4 3/
(4 20</w>
(4 2%),</w>
(4 1.8</w>
(4 1.4%)</w>
(4 0,</w>
(4 0%,</w>
(4 -1
(39. 8%)</w>
(37. 5%)</w>
(35. 3%)</w>
(34. 6%)</w>
(32. 1%)</w>
(3. 82</w>
(3. 8%)</w>
(3. 8%).</w>
(3. 7%).</w>
(3. 7%),</w>
(3. 4)</w>
(3. 2%),</w>
(3. 2
(3. 0-
(3-M PA)</w>
(3,4- dimethoxyphenyl)
(3'- azido-3'-deoxy
(3 rd</w>
(3 beta-
(3 H)
(3 9-
(3 8%</w>
(3 7.5,</w>
(3 6)Cl(-)</w>
(3 5.0</w>
(3 40</w>
(3 3.3%</w>
(3 2-
(3 00,</w>
(3 0.9</w>
(3 0.4%)</w>
(3 0),</w>
(3 -18</w>
(3 -100</w>
(3 );</w>
(28. 9%)</w>
(26. 6%)</w>
(25- 75</w>
(25- 40</w>
(24 h)</w>
(23. 1%)</w>
(22. 5%)</w>
(21. 4%).</w>
(200- 300</w>
(20- 60</w>
(20- 30</w>
(20 mg/kg,</w>
(2.5- 20</w>
(2.0 %)</w>
(2. 8%</w>
(2. 8
(2. 74</w>
(2. 6%</w>
(2. 5%</w>
(2. 3%),</w>
(2- DG)</w>
(2- 20</w>
(2, 5-dimethoxy-4-iodophenyl)-2-amino
(2, 400</w>
(2, 3-
(2) ).</w>
(2) ))</w>
(2 b).</w>
(2 S,
(2 D)</w>
(2 :
(2 8%).</w>
(2 7/
(2 7%</w>
(2 6%,</w>
(2 5th</w>
(2 57</w>
(2 56</w>
(2 4%),</w>
(2 3.3%)</w>
(2 20</w>
(2 2.6</w>
(2 10</w>
(2 0.2%)</w>
(2 -1
(2 ,000</w>
(1S,3 R,4S)-1-
(1H)- quinol
(1: 200,00
(1: 1,</w>
(199 0)</w>
(1966- February</w>
(19. 2%)</w>
(18. 8%)</w>
(17. 6%)</w>
(17. 4%)</w>
(17 beta-estradiol</w>
(16. 6%)</w>
(15. 8%).</w>
(15. 7%)</w>
(15. 6%)</w>
(15. 5%)</w>
(15. 0%)</w>
(15 )
(14. 5%),</w>
(14. 3%).</w>
(13- cis-retinoic</w>
(13) N-ammonia</w>
(12. 8%)</w>
(11. 7%).</w>
(11. 6%)</w>
(11. 2%)</w>
(11 )C-
(1000-1 200</w>
(10- 80</w>
(10- 60</w>
(10- -100</w>
(10(-6) M</w>
(10 8</w>
(10 7</w>
(10 3</w>
(10 1</w>
(10 (-10
(1/ 2))</w>
(1/ 10)</w>
(1.0 8</w>
(1.0 7</w>
(1.0 3</w>
(1. 9%)</w>
(1. 9%).</w>
(1. 82</w>
(1. 8%</w>
(1. 7)</w>
(1. 61</w>
(1. 51</w>
(1. 5,</w>
(1. 4-
(1. 4%</w>
(1. 4%),</w>
(1. 35%)</w>
(1. 3-
(1. 22</w>
(1. 2-
(1. 2%).</w>
(1. 13</w>
(1. 11</w>
(1. 0%)</w>
(1-1 3),</w>
(1,2- dihydro-2-acenaphthylenyl)
(1, 500</w>
(1, 5-
(1, 3,3-
(1)/ A(2A)</w>
(1 mg/kg</w>
(1 mg/kg)</w>
(1 R,3
(1 H-
(1 96</w>
(1 87</w>
(1 83</w>
(1 8.7</w>
(1 8%,</w>
(1 70</w>
(1 7.5</w>
(1 7,</w>
(1 7),</w>
(1 6.5</w>
(1 6),</w>
(1 500</w>
(1 50
(1 5)</w>
(1 48</w>
(1 47</w>
(1 44</w>
(1 42</w>
(1 4)</w>
(1 38</w>
(1 34</w>
(1 31
(1 3,</w>
(1 25,</w>
(1 12</w>
(1 1.7</w>
(1 0.9%)</w>
(1 0.1</w>
(1 0.0%)</w>
(1 )-</w>
(0.7 -1.
(0.5- 4</w>
(0.5 -1.25</w>
(0.4 2+/-
(0.3- 3.0</w>
(0.25- 0.75</w>
(0.25 -1.0</w>
(0.25 %)</w>
(0.2- 0.5</w>
(0.1- 3.0</w>
(0.1- 0.2</w>
(0.03- 1</w>
(0.01- 2.5</w>
(0.003- 0.1</w>
(0.0 8)</w>
(0.0 6-
(0.0 35</w>
(0.0 25%)</w>
(0.0 2-
(0.0 1,</w>
(0.0 1%</w>
(0. 95</w>
(0. 93</w>
(0. 9%).</w>
(0. 87</w>
(0. 79</w>
(0. 74</w>
(0. 70</w>
(0. 6-
(0. 50</w>
(0. 49</w>
(0. 46</w>
(0. 4,</w>
(0. 4%</w>
(0. 38</w>
(0. 37</w>
(0. 35</w>
(0. 33</w>
(0. 31</w>
(0. 24</w>
(0. 22</w>
(0. 21</w>
(0. 20</w>
(0. 19</w>
(0. 18</w>
(0. 15,</w>
(0. 14</w>
(0. 13</w>
(0. 11</w>
(0. 1-1.
(0. 1%,</w>
(0. 1%),</w>
(0 mg,</w>
(-4 9%)</w>
(-1 2.2</w>
(-/- )).</w>
(--)- 3-PPP</w>
(-)-spect aline</w>
(-)- enantiomer</w>
(-)- Sulpiride</w>
(-) isoproterenol-induced</w>
(-) isoproterenol,</w>
(- 6
(- 50</w>
(- 30%)</w>
(- 21</w>
(- )-</w>
(- ),</w>
(+/-) 8-OH-DPAT</w>
(+/- )-1-
(+/ +),</w>
(+)-5-methyl-10,11-dihydro-5H-di benzo[a,d]cyclohepten-5,10-imine</w>
(+)- tubocurarine</w>
(+)- cibenzoline</w>
(+)- MK-801</w>
(+)- 2-aminobicyclo[3.
(+) ]
(+ dP/dt(max))</w>
(+ 3
(+ )/
(* )
( zero</w>
( y</w>
( women,</w>
( wherein</w>
( where</w>
( w/v)</w>
( visual</w>
( ven
( vehicle</w>
( tumour</w>
( tumor</w>
( trifluoro
( total,</w>
( timolol</w>
( thiobarbituric</w>
( thermal</w>
( theophylline</w>
( thalidomide</w>
( th)</w>
( tetracaine</w>
( test</w>
( target</w>
( systolic,</w>
( symptomatic</w>
( sustained</w>
( surgical</w>
( stroke,</w>
( still</w>
( started</w>
( some</w>
( sitting</w>
( sit
( since</w>
( similar</w>
( signal</w>
( short-term)</w>
( severe)</w>
( seven
( sensory</w>
( saline),</w>
( saline
( s.c.
( round</w>
( representing</w>
( reported</w>
( related</w>
( reflecting</w>
( rats).</w>
( rat</w>
( rapid</w>
( ranging</w>
( radial</w>
( proved</w>
( protein</w>
( proportion</w>
( prior</w>
( previous</w>
( prevention</w>
( presumed</w>
( premature</w>
( potency</w>
( post
( possibly</w>
( poor</w>
( plug</w>
( pl
( perfusion</w>
( performed</w>
( paw-pressure</w>
( paroxysmal</w>
( pain</w>
( orthostatic</w>
( or)</w>
( one-way</w>
( omega</w>
( normal)</w>
( non-selective</w>
( nimesulide-beta-cyclodextrin,</w>
( ng/ml)</w>
( neutrophil</w>
( neurogenic</w>
( nephrectomized-
( nearly</w>
( ne
( myofibroblasts,</w>
( muscarinic</w>
( mossy</w>
( morphine</w>
( morning</w>
( moderate-
( ml/min/100</w>
( min</w>
( mild</w>
( mg/kg)</w>
( meperidine)</w>
( men:</w>
( memory</w>
( maternal</w>
( malondialdehyde</w>
( malondialdehy
( lowest</w>
( low-dose</w>
( long</w>
( locomotor</w>
( lithium</w>
( linezolid,</w>
( lignocaine)</w>
( lidocaine,</w>
( levels</w>
( lepirud
( lef
( ketamine)</w>
( isolated</w>
( isoflurane</w>
( ischemic</w>
( irCRF)</w>
( iohexol)</w>
( intraperitoneally</w>
( intact-
( inf
( indicating</w>
( increasing</w>
( incidence,</w>
( immediately</w>
( hypersensitivity)</w>
( hyperalgesia)</w>
( hydroxylation</w>
( hours</w>
( high-dose</w>
( guinea</w>
( good</w>
( generalized</w>
( gd)</w>
( frequency</w>
( fourth</w>
( following</w>
( folic</w>
( fluoxetine</w>
( fluoro-
( fixed-effect</w>
( female</w>
( fatal</w>
( external</w>
( exposed</w>
( experiment
( esmolol</w>
( es
( erythema</w>
( end</w>
( duration</w>
( duration,</w>
( due</w>
( draft)</w>
( dizocilpine)</w>
( differences</w>
( diazepam
( delayed</w>
( cyclic</w>
( creatine</w>
( colloid)</w>
( cocaine-induced</w>
( clozapine</w>
( caudate</w>
( carbidopa
( captopril,</w>
( bupivacaine</w>
( beta
( because</w>
( basi
( baseline:</w>
( basal)</w>
( autoregulatory</w>
( atropine,</w>
( assessed</w>
( aspirin</w>
( aspartate</w>
( arterial</w>
( approximate</w>
( approx.</w>
( apomorphine)</w>
( apo</w>
( antiepileptogenic</w>
( anticonvulsant</w>
( another</w>
( annual</w>
( analgesi
( amlodipine</w>
( alpha,beta-meATP)</w>
( all-trans-
( adrenal
( adjuv
( adenosine</w>
( abdominal</w>
( [31])P</w>
( Y-
( U-
( Theo-Dur
( SUN</w>
( Re
( Q-
( OD)</w>
( OB
( International</w>
( III)</w>
( 5-hydroxytrypt
( /
( (R)-
( (+)-
' very</w>
' s-like</w>
' s).</w>
' probable
' on-off'</w>
' low-
' dyston
' classical'</w>
' acute</w>
' Off'</w>
' C
' '
%/ year.</w>
%/ y</w>
%.mmHg -1,</w>
% ]);</w>
% FS</w>
% +/-1
# 1</w>
"spontaneous "</w>
"sil ent"</w>
"normal "</w>
" very</w>
" st
" specific</w>
" sof
" serious"</w>
" sensitiz
" retinoic</w>
" pre
" over
" on</w>
" non-
" neuro
" mini-dose"</w>
" look-alike"</w>
" high</w>
" g
" flu-like"</w>
" drug-
" clinical</w>
" at</w>
" agonist"</w>
" acute</w>
" a-determinant"</w>
" Torsade</w>
" >
}- 2,2-
}-2,2- dimethyl
}-2,2-dimethyl propyl)-2-
}-2,2-dimethylpropyl)-2- (3,4-dimethoxyphenyl)
}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl) acet
{ [(
{[( cyano
{[(cyano imino
{[(cyanoimino )
{[(cyanoimino) (5-
{[(cyanoimino)(5- quinol
{[(cyanoimino)(5-quinol inyl
{[(cyanoimino)(5-quinolinyl amino)</w>
zyme- linked</w>
zym osan</w>
zym os
zotep ine.</w>
zopiclon e,</w>
zon ation</w>
zomepir ac,</w>
zolpide m
zolmitript an,</w>
zolamide/ timolol.</w>
zol ine</w>
zol i</w>
zol e:</w>
zol e-
zol amide,</w>
zol )</w>
zofen opril,</w>
zo ster,</w>
ziprasid one-</w>
ziprasid one)</w>
zinc -pretreated</w>
zimel dine,</w>
zidovudine- experienced</w>
zidovud ine-related</w>
zidovud ine)</w>
zi one</w>
zebraf ish,</w>
ze hn
zehn t
zehnt ner
zehntner i</w>
zalcit ab
z- body</w>
z ymo
z y</w>
z oxazol
zoxazol amine</w>
z one,</w>
z omal</w>
z ine:</w>
z ine)</w>
z ime
z i,</w>
z et
z er</w>
z ech</w>
z am
zam be
zambe sic
z able</w>
z .</w>
z -type</w>
z --
z-- K</w>
z ).</w>
ysti tis</w>
ysm s.</w>
yros ine,</w>
yrimid ines,</w>
yr s;</w>
yr s),</w>
younger ;</w>
young sters</w>
youn g.</w>
you th.</w>
yohimb ine's</w>
yoeit o</w>
yo u</w>
yo tic</w>
yo pathic</w>
yo him
yohim be</w>
yo ff</w>
yno sto
ynosto sis,</w>
yne tic</w>
ynchron ous</w>
yn yl)
ynyl) est
ynyl)est ra-
ynyl)estra- 4,9-dien-3-
ynyl)estra-4,9-dien-3- one],</w>
ymo blastoma</w>
ym pathe
ym ous</w>
ym me
ymme tre
ym arin</w>
ylthio uracil</w>
yloxy- 4-
yloxy-4- methoxy
yloxy-4-methoxy methyl-
yloxy) phenylmethyl
yloxy)phenylmethyl )</w>
yloxy )-
ylo caine</w>
ylidene )-1-
ylene tetra
yle st
ylest radio
ylestradio 1/75</w>
ylcarbonyl) piperidine</w>
ylcarbamo yl-
ylcarbamoyl- 5-fluorouracil</w>
ylcarbamo yl)-1,2-
ylcarbamoyl)-1,2- meth
ylcarbamoyl)-1,2-meth ano[
ylcarbamoyl)-1,2-methano[ 60
ylcarbamoyl)-1,2-methano[60 ]
ylcarbamoyl)-1,2-methano[60] fullerene</w>
yl]-L- alan
yl]- N'-
yl]-N'- methyl
yl]-N'-methyl urea</w>
yl]- 4-
yl]- 3-phenyl
yl]-3-phenyl propan-2-
yl]-3-phenylpropan-2- ol</w>
yl] tropane</w>
yl] ethyl]
yl-L-leuc yl-L-proline</w>
yl-6- non
yl-6-non en
yl-4- chloro-
yl-4-chloro- N-methyl-
yl-4-chloro-N-methyl- N</w>
yl-3- pyrrolidin
yl-3-pyrrolidin yl)-5-
yl-3-pyrrolidinyl)-5- chloro-
yl-3-pyrrolidinyl)-5-chloro- 2-methoxy-4-
yl-3-pyrrolidinyl)-5-chloro-2-methoxy-4- methyl
yl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methyl amin
yl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methylamin obenzamide</w>
yl-2'- hydroxy-ethoxy)tropane</w>
yl-1- methylxanthine</w>
yl- poly-
yl-poly- L-lysine</w>
yl- glycinamide</w>
yl- carnitine</w>
yl- 5-fluorourac
yl- 4-hydroxy
yl-4-hydroxy butyl
yl)prop en
yl)butyl]- 2-
yl)butyl]-2- naphth
yl)butyl]-2-naphth amide]</w>
yl)amino] phenyl]
yl)amino]phenyl] amino
yl)amino]phenyl]amino ]</w>
yl)amino] -</w>
yl)-piperaz ine],</w>
yl)-N- substituted</w>
yl)-2- (2-
yl)-2-(2- furyl)-
yl)-2-(2-furyl)- pyrazolo[4,3-
yl)-2-(2-furyl)-pyrazolo[4,3- epsilon
yl)-2-(2-furyl)-pyrazolo[4,3-epsilon ]
yl)-2-(2-furyl)-pyrazolo[4,3-epsilon] -1,2,4-
yl)- phthalate</w>
yl)- doxorubicin</w>
yl)- N'-
yl)-N'- (4-(2-
yl)-N'-(4-(2- methyl
yl)-N'-(4-(2-methyl prop
yl)-N'-(4-(2-methylprop yloxy)phenylmethyl)</w>
yl)- 6
yl)-6 H-
yl) thiaz
yl)thiaz olo[
yl)thiazolo[ 5,
yl)thiazolo[5, 4-
yl)thiazolo[5,4- e]
yl)thiazolo[5,4-e] [1,2,4]
yl)thiazolo[5,4-e][1,2,4] triazolo[1,5-c]pyrimid
yl)thiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimid ine-
yl)thiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine- 2
yl)thiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2 (3H)-
yl)thiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)- thi
yl)thiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thi ones</w>
yl) piperidino
yl)piperidino ]-
yl)piperidino]- p-
yl)piperidino]-p- xyl
yl)piperidino]-p-xyl ene</w>
yl) -1H-pyrazole-3-carboxamide
yl)-1H-pyrazole-3-carboxamide ],</w>
yl sulfon
ylsulfon yl)
yl methyl)-
yl methyl)
yl methoxy
ylmethoxy )-2-
ylmethoxy)-2- chlo
ylmethoxy)-2-chlo ropyri
ylmethoxy)-2-chloropyri dine)</w>
yl line.</w>
yl line)</w>
yl hydraz
ylhydraz yl</w>
yl guanidine</w>
yl glycerol</w>
yl en
yl benzamides</w>
yl ation,</w>
yl acetyl
yet- unidentified</w>
yel ination</w>
year-old- man</w>
year- old.</w>
year s
ye w</w>
ye w,</w>
ycl o</w>
ycin- induced,</w>
ycin- impregnated</w>
yc le.</w>
yc in-related</w>
yc anth
ycanth a),</w>
yb an)</w>
yaw ns</w>
yaw ning.</w>
y/ short</w>
y/ radio
y/radio therapy)</w>
y/ motor</w>
y/ jitter
y/ efficacy</w>
y/ ar
y/ar hin
y/arhin encephaly</w>
y. Post-mortem</w>
y- to-
y- responsive</w>
y- interposed</w>
y- guided</w>
y- bound</w>
y- associated</w>
y- aminobutyric</w>
y- Sch
y-Sch mid
y-Schmid t</w>
y- Glycyrrhiza</w>
y- -19</w>
y van
y tol
y rone,</w>
y rate),</w>
y pre
ypre x
y posis,</w>
y our</w>
y otonia</w>
y op
yop ia.</w>
y ner
y lethan
ylethan olamide</w>
y ing),</w>
y do
ydo akathisia</w>
y codon</w>
y chol
y benz
y ant</w>
y ance</w>
y amo
y algia</w>
y 1</w>
y ',</w>
y ').</w>
y ".</w>
xylo metazoline</w>
xylo choline</w>
xylaz ine/
xylazine/ ketamine-treated</w>
xylaz ine-treated</w>
xyl azine,</w>
xip amide,</w>
ximel agatran,</w>
xer osis</w>
xenograf ts.</w>
xenobio tics.</w>
xeno grafts</w>
xen ogene
xenogene ic</w>
xanth ine-
xanth ine),</w>
x/ minute,</w>
x- maze,</w>
x oten
x iv
x ing</w>
x illic</w>
x ia.</w>
x 9</w>
x 2</w>
x 15</w>
x 10(9)/L,</w>
x 10
x ))</w>
x (L)</w>
x "</w>
wt/ wt)</w>
wt/ day,</w>
wt/ day),</w>
wt -1</w>
writh ing,</w>
worsen ing).</w>
worsen .</w>
worris ome,</w>
worm s,</w>
worldwide ,</w>
work- up.</w>
work- up,</w>
work load,</w>
work ing,</w>
wor rying</w>
wor n</w>
wor ks.</w>
women /year</w>
woman- months</w>
wo A</w>
wk :</w>
wk ),</w>
without )</w>
within- subjects,</w>
withdraw als,</w>
withdraw al-related</w>
withdraw al
with -
winterian us</w>
window ,</w>
window "</w>
wild type</w>
wif e,</w>
widen ing)</w>
wide- range</w>
wide st</w>
wide ly-
wide -based</w>
wid th,</w>
wid ens</w>
wi se:</w>
wi re,</w>
whor led</w>
whole- kidney</w>
whole- embryo</w>
whole- animal</w>
whit es,</w>
whit es)</w>
whit e.</w>
whit e)</w>
whi tish</w>
wheel ch
wheelch air</w>
whe ther,</w>
whe ezing.</w>
whe ezing,</w>
wh en,</w>
wh ate
well- validated</w>
well- tolerated;</w>
well- standardized</w>
well- reported</w>
well- established.</w>
well- established,</w>
well- documented.</w>
well- developed</w>
well- compensated</w>
well known</w>
well being</w>
well be
well )</w>
well 's</w>
weight- matched,</w>
weight- loss</w>
weight );</w>
weigh ted,</w>
weigh t:</w>
week s);</w>
week ly-
week :</w>
week 's</w>
wedg e,</w>
weav ing.</w>
weav ing,</w>
wearing- off.</w>
wean ing.</w>
weak ness
weakness ;</w>
weak nes
weaknes ses</w>
we zi,</w>
we t/
wet/ dry</w>
we e</w>
we ap
we ane
weane d.</w>
we alth</w>
wax y</w>
wax ing</w>
wave- to-
wave-to- R-wave</w>
wave- break</w>
wave let</w>
wave front</w>
wave fron
wave form,</w>
water- deprived</w>
watch ful</w>
wat ery</w>
wast e</w>
wast age</w>
wash- out
wash ing.</w>
wash -in</w>
warr ants,</w>
warm- water</w>
warfar in;</w>
warfar in)</w>
war n
war ming.</w>
war ming,</w>
war dam
wardam ang
wardamang ia,</w>
war /
war/ tropical</w>
war .</w>
wan da.</w>
wall- to-
wall ;</w>
walk ing.</w>
walk er.</w>
wal k,</w>
wakeful ness
wakefulness -
wakefulness- sleep</w>
waist /
waist/ hip</w>
wa y-
w/ w</w>
w- a-
w-a- Man</w>
w thor
wthor n</w>
w t.)</w>
w r
wr apped</w>
w l</w>
w ist
wist ar</w>
w iring</w>
w ip
wip ing</w>
w ine.</w>
w ind
w in-
win- shift</w>
w il
wil for
wilfor dii</w>
w as
w ant</w>
w ag
wag and
wagand h
wagandh a</w>
w a</w>
w 4</w>
w 's</w>
w '</w>
vulner ability,</w>
vul sant</w>
vul on</w>
vs- host</w>
vox el</w>
vouch er.</w>
voric onazole-associated</w>
vomit ing:</w>
vomit ing
vomit .</w>
volunte ering</w>
volunte ered</w>
volume /
volume -related</w>
volume -</w>
volume ).</w>
volume ),</w>
volu tion
volution ized</w>
voltam metry,</w>
voli tional</w>
volati les</w>
vol %.</w>
void s,</w>
void ing.</w>
void ed</w>
vocal izing</w>
vocal ization.</w>
vocal ization,</w>
vocal ization).</w>
vivo- antigen
vivo-antigen -dependent</w>
vivo ;</w>
vivo 1H-NMR</w>
vivo /
vivo '</w>
vitro :</w>
vitro )</w>
vitro ),</w>
vitamin- D</w>
vitamin- D2-induced</w>
vitamin .</w>
vit el
vitel line</w>
vit ality</w>
visual izing</w>
visu ally,</w>
visit s)</w>
visit ).</w>
viscer on
visceron ociceptive</w>
visc osity.</w>
vis -a-
vis-a- vis</w>
virus- free</w>
virus /
virt ual</w>
viro logy</w>
viro log
virolog ical,</w>
viri on
virion s/
virg in,</w>
viral- like</w>
vir us)</w>
violet -</w>
viol ence;</w>
viol ation.</w>
viol ated</w>
vinyl- GABA,</w>
vinorelbine/ trastuzumab</w>
vincristine- induced)</w>
vincrist ine-</w>
vinc ulin</w>
vinc ristin</w>
vinblast ine-
vinblastine- bleomycin</w>
vin ce,</w>
vin (GF)</w>
vilox azine,</w>
vigabatr in-treated</w>
vig net
view point</w>
view ing</w>
videotap es</w>
video intensity</w>
video fluoroscopic</w>
vide oradi
videoradi ography</w>
vid one-
vidone- iodine</w>
vid a,</w>
vid ,</w>
victim s.</w>
vibris sa</w>
vibris sa
vibr ation-induced</w>
vib rat
vibrat ome</w>
vi vid,</w>
vi st
vi sion-
vision- threatening</w>
vi sibility</w>
vi remic</w>
vi remia.</w>
vi era</w>
vi duct,</w>
vi agra
vi a,</w>
vi ,</w>
vestibulo toxicity.</w>
vestibu loc
vestibuloc ochlear</w>
vesti bul
vessel s'</w>
vesico stomy</w>
vesico prostatic</w>
vesi culated</w>
vesi co-
vesi cl
vesicl es)</w>
vesi cant</w>
very- low-density</w>
very- low-birth-weight</w>
very- high-dose</w>
vertic is</w>
vertebra e</w>
vertebr al,</w>
verte brate</w>
verte b
versus- time</w>
vers ine),</w>
verat rum</w>
verapamil- sensitive,</w>
verapamil- ,</w>
verapamil ;</w>
verapamil :</w>
verapamil -related</w>
verapamil -</w>
ver- operating</w>
ver- function</w>
ver s.</w>
ver mis,</w>
ver ification</w>
ver bal
ver a,</w>
ver -treated</w>
ventro- rostral</w>
ventro basal</w>
ventriculo stomy</w>
ventricular- wall</w>
ventricu lography.</w>
ventric le:</w>
ventral- lateral</w>
ventr alis</w>
ventil ation-
ventilation- perfusion</w>
ventil ation)</w>
venti ve"</w>
vent .)</w>
venodilat or</w>
venodilat ation</w>
veno- venous</w>
venlafax ine-induced</w>
ven ule</w>
ven ul
ven ogram</w>
ven oconstric
ven occlusive</w>
ven ly</w>
ven ipunct
ven ep
ven dor.</w>
velb ine)</w>
vel y:</w>
vehicle/ METH</w>
vehicle :</w>
vedac lidine,</w>
vecuroni um's</w>
vecur onium)</w>
vect or-
vect or,</w>
vect or
ve- care</w>
ve t
vet ta</w>
ve ret
ve loci
ve in).</w>
ve d;</w>
ve d-
ve d)</w>
ve :</w>
ve .)</w>
ve -associated</w>
ve -</w>
ve ),</w>
ve (inf
ve(inf )</w>
vastatin- gemfibrozil</w>
vastat in-treated</w>
vasopress or-
vasopressor- SNP</w>
vasopress in-like</w>
vasopress in-induced</w>
vasop legia</w>
vasop ar
vasomo tion.</w>
vasodilat atory</w>
vasodil ative</w>
vasodil ation)</w>
vasoconstrict or,</w>
vasoconstric tions</w>
vasoconstric t</w>
vaso- active</w>
vaso pressive</w>
vaso depression</w>
vasculo toxicity</w>
vascular ized</w>
vascular ity,</w>
vascular -
vascul aris.</w>
vas omot
varic ocele.</w>
variable- pa
variable-pa yoff</w>
variable- cost-
variable-cost- variable-payoff</w>
vari ously</w>
vari es.</w>
vari ation,</w>
var us.</w>
var denaf
var .</w>
vapt an,</w>
vapor izer</w>
vap our</w>
vap ors</w>
vanish ing.</w>
vanilloid -type</w>
vanill yl-6-nonen
vancomyc in-related</w>
vancomyc in-associated</w>
van ished</w>
van illin,</w>
valvul itis</w>
valv ar</w>
valu es:</w>
valu ed</w>
valu able,</w>
valsart an.</w>
valsart an)</w>
vals pod
valspod ar</w>
valpro ate-related</w>
valpro ate-associated</w>
valid ation.</w>
valid ated.</w>
valid ated,</w>
valer ate-induced</w>
valacyclovir -related</w>
val ves:</w>
val ley</w>
val ine
valine 2-
val in</w>
val id.</w>
val id,</w>
val acyclovir,</w>
val ;</w>
vagin ally.</w>
vagin ally,</w>
vagin alis</w>
vagin al-
vagal- mediated</w>
vag us,</w>
vag i</w>
vacuol ization;</w>
vacuol es,</w>
vacuol ations</w>
vacuol ation.</w>
vaccin ated.</w>
va h's</w>
v x)</w>
v s.
v p
v one</w>
v ing;</w>
v aul
vaul t,</w>
v O2),</w>
v AV3V</w>
v 2.0</w>
v /
v .)</w>
uz zy</w>
uz est
uzest an
uzestan ica</w>
uz en-
uzen- tai
uzen-tai ho
uzen-taiho -
utiliz ed:</w>
util ised</w>
uti ve)</w>
uti loba</w>
uter ine-
ut most</w>
ut me
ut ing-
uting- bead</w>
ut esc
ut e
ut ative</w>
usu ally,</w>
usu al.</w>
ustom ed</w>
usion s;</w>
usion -related</w>
usion ),</w>
usid ),</w>
ush ing</w>
ush ing
ushing oid</w>
user s)</w>
user s).</w>
use/ non-use</w>
use/ abuse</w>
use- dependent,</w>
use d--
use d-
use ),</w>
uscit ation,</w>
us- soleus</w>
us sis-
ussis- tetanus</w>
us s.</w>
us nit
usnit z--K</w>
us ness</w>
us ch
us an
us al.</w>
us aid</w>
us acral</w>
us "</w>
urticaria/ angioedema,</w>
uroxi me-induced</w>
urotheli um:</w>
urotheli um-
urothelium- denuded</w>
uroprotect or.</w>
uro protectant</w>
uro prophylaxis</w>
uro pathy,</w>
uro lithiasis:</w>
uro epithelial</w>
uro cor
urocor tin-</w>
uro -
urkinj e's</w>
urine- concentrating</w>
urine- analysis</w>
urin es.</w>
urin ate.</w>
uridine- positive</w>
uricos uric</w>
uri e</w>
urgen cy.</w>
urge d.</w>
urg es</w>
urg ery</w>
urethane- anesthetized,</w>
ureth ro
ureth ritis</w>
ureth ritis,</w>
ureter oscopic</w>
ureter o
uretero vesical</w>
ure t
ure sis</w>
ure mic
ure ment</w>
ure ja</w>
ure as</w>
ure :</w>
ure -treated</w>
ure ),</w>
uran ium</w>
urac eae)</w>
ur tic
urtic ation,</w>
ur sodi
ur so
ur onate</w>
ur ine)</w>
ur ine),</w>
ur idine)</w>
ur ide)</w>
ur ia;</w>
ur g</w>
ur ate-
ur al,</w>
ur a's</w>
ur )</w>
uptake )</w>
upregul ating</w>
upper- tract</w>
up- regulating</w>
up- regulated,</w>
up- regulate</w>
up uncture</w>
up to</w>
up surge</w>
up set</w>
up s.</w>
up ron
upron )</w>
up ont
up date.</w>
up an
upan ine-2-
upanine-2- pyrrol
upanine-2-pyrrol carbonic</w>
unresect able,</w>
unra vel</w>
unpro ven.</w>
unpro ved,</w>
unpredict able;</w>
unpleas ant
unnet t,</w>
unnet t's</w>
unmas ks</w>
university- affiliated,</w>
universal .</w>
units/ mL</w>
units/ kg/day</w>
units/ day</w>
units- erythroid</w>
units- erythro
units-erythro id,</w>
unit z-type</w>
unit s)</w>
unit s).</w>
unit :</w>
uniqu e,</w>
unineph rectom
uninephrectom ised</w>
uniform .</w>
uni variates</w>
unfortun ately</w>
unfortun ately,</w>
unex posed.</w>
unex po
unexpo sed)</w>
une venly</w>
une sterified</w>
une ,</w>
undoub ted</w>
undesirab le.</w>
undesirab le,</w>
undesi red</w>
underestim ating</w>
underestim ated.</w>
under- estimation</w>
under way</w>
under taking</w>
under take</w>
under stand
under sho
undersho ot</w>
under reported</w>
under recognized,</w>
under pin
underpin nings</w>
under ne
underne ath</w>
under min
under lined</w>
under lich</w>
under diagnosed</w>
under developed</w>
unde rem
underem phasi
underemphasi zed</w>
unde d-
unded- back</w>
und- the-
und-the- clock</w>
und um</w>
und s,</w>
und a</w>
uncoupl ed</w>
uncommon ;</w>
unchang ed;</w>
unchang ed.(ABSTRACT</w>
unchang ed)</w>
unc tional</w>
unc h</w>
unc an</w>
unblinde d'</w>
unambigu ously</w>
un well,</w>
un warranted</w>
un ve
un vaccinated</w>
un treated),</w>
un surpassed</w>
un supervised</w>
un stenosed</w>
un solved</w>
un separated</w>
un scar
unscar red</w>
un satisfactory,</w>
un reveal
un restrained,</w>
un rest</w>
un responsiveness.</w>
un responsive.</w>
un responsi
un resolved.</w>
un resected</w>
un reporte
un remitting</w>
un relent
unrelent ing,</w>
un related.</w>
un reasonable</w>
un punished</w>
un proven</w>
un preced
unpreced ented</w>
un perturbed</w>
un pac
un necessarily</w>
un k</w>
un impres
un ilam
unilam ellar</w>
un ified</w>
un g-
ung- Con
ung-Con de</w>
un filtered</w>
un favorably</w>
un enhanced</w>
un dul
undul ating</w>
un disturbed</w>
un differenti
un diagnosed.</w>
un determined,</w>
un detect
un descended</w>
un covering</w>
un coordinated</w>
un conditional</w>
un comfortable</w>
un classifi
unclassifi able.</w>
un charged</w>
un born</w>
un blinding</w>
un availability</w>
un answered</w>
un altered,</w>
un acc
unacc ustomed</w>
un a</w>
un -
umer ically,</w>
um/ urine</w>
um/ gri
um/gri d'</w>
um- supplemented</w>
um- na
um-na velbine</w>
um- intracell
um-intracell ul
um- fed</w>
um- derived</w>
um ption</w>
um oral</w>
um mon
ummon d,</w>
um ?</w>
um (II)</w>
ultrasound- mediated</w>
ultrasoun d)</w>
ultrason ograms</w>
ultras m
ultrasm all</w>
ultras hort</w>
ultrafiltr ates</w>
ultrafiltr ate</w>
ultrafiltr able</w>
ultra- performance</w>
ultra distal</w>
ultr arap
ultrarap id</w>
ult ative</w>
ulog en</w>
ulo usness</w>
ulo -
ulo ,</w>
ulnar ,</w>
ull ar</w>
ulcer s)</w>
ulcer ous</w>
ular is</w>
ular -</w>
ul ts</w>
ul tram
ultram icro
ul l)</w>
ul et</w>
ul es/
ul ,</w>
udi l,</w>
ud otox</w>
ucin ous</w>
ubiquit ous</w>
ubi quinone
ubiquinone -10</w>
ub le</w>
ub itus</w>
ual a</w>
u tion,</w>
u sive</w>
u sis.</w>
u rease</w>
u reas,</w>
u porous</w>
u ph
u oden
u kot
ukot su
ukotsu -
ukotsu- bo
ukotsu-bo rei-
u hyp
uhyp nos
uhypnos )</w>
u g/
u dex
udex )</w>
u L
uL IF,</w>
u IPSCs</w>
u /
u .
u. v.</w>
u ))</w>
tyram ine-
tyramine- restricted</w>
type- III</w>
type- II</w>
type ;</w>
type -2</w>
type --
type '</w>
typ ical,</w>
ty- acid</w>
ty po
typo logies</w>
ty ?</w>
ty -induced</w>
two- trial</w>
two- tailed</w>
two- ta
two-ta ile
two- part</w>
two- month</w>
two- month-old</w>
two- minute</w>
two- fold.</w>
two- centre</w>
twitch es,</w>
twit ching,</w>
twic e)</w>
twenty- three</w>
twenty- six</w>
twelve- week</w>
tw in-
tw ig
twig -M
twig-M agen
twig-Magen die</w>
turbin ates</w>
turb idom
turbidom etric</w>
tur ns.</w>
tur ns,</w>
tur key</w>
tur c
turc ica</w>
tur b</w>
tur ally</w>
tun ica</w>
tumour s:</w>
tumour i
tumour -
tumour- bearing</w>
tumor- protective</w>
tumor ;</w>
tum oric
tumoric idal</w>
tum escence</w>
tum .</w>
tulo buterol</w>
tuf ts.</w>
tubulo reticular</w>
tubulo pathy,</w>
tubulo interstitium</w>
tubulo capillary</w>
tubul itis</w>
tubul in.</w>
tubul i</w>
tubul ar-
tubular- interstitial</w>
tubul ar,</w>
tuberculo static</w>
tuberculo id</w>
tubercul in-
tuberculin- syringe</w>
tuber cles.</w>
tube )</w>
tub er</w>
tu bo
tu ations</w>
ttp:// clinicaltrials.gov</w>
ts/ mm3</w>
tryptoph an.</w>
trypt ase,</w>
trypt aminergic</w>
trypt amine-induced</w>
tru xillic</w>
tru e.</w>
trox idone</w>
trox id
troponin- I</w>
troponin- I.</w>
tropic s.</w>
tropi setron,</w>
troph y</w>
troph ozo
trophozo ites</w>
troph in</w>
tropan e-
trop olone</w>
troleandom ycin</w>
tro vaf
tro pin
tro glo
troglo dy
troglody tes)</w>
tro fosf
triterpen es</w>
tris phosphate</w>
triptyl ine.</w>
tript yline,</w>
tript an.</w>
triple d.</w>
trinitro glycerin</w>
trinitro glycer
trinitroglycer in.</w>
trin or</w>
trimi pramine.</w>
trimethoprim- sulphamethox
trimethadi one)</w>
trimeth oxy
trimeth obenzamide</w>
trimetaz idine</w>
trimeta phan,</w>
trimester ,</w>
trimester ).</w>
trime trex
trime pranol</w>
triiodo thyron
trihexyphenid yl.</w>
triglyceride- lowering</w>
triglycer ide.</w>
trigemino- parasympathetic</w>
trigemin ovascular</w>
trifluoro acetyl-
trifluoroacetyl- altered</w>
trifluoper azine,</w>
tridec apeptide</w>
tricycl ics.</w>
tricycl ic-
tricuspid :</w>
tricuspid ,</w>
trichro me
trichotillo mania.</w>
trichomon iasis.</w>
tric olo
tricolo r</w>
tric hlor
trichlor methiazide</w>
tric eps.</w>
tric apr
tricapr yl
tric ally.</w>
triazolo benzodiazepine</w>
triazolo (1,5-
triazol o</w>
triazol ep
triazolep yridine</w>
triazol am-induced</w>
triazin- 3,5-
triazin-3,5- dione</w>
triazeno )
triazeno) imidazole-4-carboxamide</w>
triaz o
triazo lop
triaz en
triax ial</w>
triamterene- hydrochlorothiazide.</w>
triamcin olone,</w>
trial s),</w>
trial ),</w>
triad in</w>
triacylglycer ols</w>
tri- o-
tri-o- cresyl</w>
tri vial</w>
tri um
tri synaptic</w>
tri s</w>
tri phosphate-
tri phosphate,</w>
tri phosphatase,</w>
tri mid
trimid ox</w>
tri methyl-2-
trimethyl-2- ox
tri methyl-
tri logy</w>
tri foli
trifoli atus</w>
tri exponential</w>
tri eth
tri ent
tri ed.</w>
tri amine
triamine pentaacetic</w>
tri al-
tri age</w>
tri aL</w>
tretino in.</w>
tresp ass</w>
tren d)</w>
tremulous ness,</w>
tremor- dominant</w>
tremor ing</w>
treatment- termin
treatment s).</w>
treatment ?</w>
treatment (EPI</w>
treat able,</w>
tread ing</w>
tread ing,</w>
tre zol</w>
tre es.</w>
tre de
trede kin</w>
tre ach</w>
travell ers.</w>
trau ma:</w>
trau ma
trauma -induced</w>
trastuzumab ;</w>
trastuzumab .</w>
transver sal</w>
transport -deficient</w>
transpor ting</w>
transpor ters,</w>
transpor ter.</w>
transplant ations.</w>
transplant -related</w>
transpeptid ase-positive</w>
transmit ting</w>
transluc ency</w>
translo case</w>
translo case,</w>
transit ory,</w>
transi ently.</w>
transglutamin ase,</w>
transfu sion-
transfusion- chelation</w>
transfer s,</w>
transf usional</w>
transduc er,</w>
transcript ,</w>
transcri ption,</w>
transamin itis</w>
trans-nicotine-N'- oxide</w>
trans-nicotine-N'- oxide,</w>
trans-nicotine-N'- oxide
trans-nicotine-N'-oxide s.</w>
trans-3,4- dichloro-
trans- resveratrol</w>
trans- 4-methyl
trans-4-methyl cyclohexyl)
trans-4-methylcyclohexyl) -1-nitrosourea</w>
trans- 3,4
trans-3,4 a,
trans-3,4a, 10b-
trans-3,4a,10b- tetrahydro
trans-3,4a,10b-tetrahydro -4-
trans-3,4a,10b-tetrahydro-4- propyl-2
trans-3,4a,10b-tetrahydro-4-propyl-2 H,
trans-3,4a,10b-tetrahydro-4-propyl-2H, 5H-
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H- [
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[ 1]
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1] benzopyrano
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano [4,3-
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3- b]
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b] -1,4-
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4- oxaz
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxaz in-
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin- 9-
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9- ol
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol )]</w>
trans sexual</w>
trans sarcolemmal</w>
trans mur
trans mit</w>
trans methylation</w>
trans membran
transmembran eous</w>
trans glomerular</w>
trans genesis.</w>
trans forms</w>
trans ections</w>
trans ected</w>
trans dihydrolisuride</w>
trans cellular</w>
trans catheter</w>
tranquiliz ers.</w>
tranquil izing</w>
tranquil izer</w>
tran dr
tramadol/ acetaminophen</w>
tramadol )</w>
traject ory</w>
traff ick
tract )</w>
tracheostom y.</w>
tracheostom y,</w>
trache otomy,</w>
trache obronch
tracheobronch ial</w>
trache al,</w>
trac ker</w>
trac es</w>
trac es.</w>
trac e-
trac e,</w>
trab amate</w>
tra y.</w>
tra its.</w>
tra ine
traine e</w>
tra il</w>
tr itan</w>
tr it
tr ine.</w>
tr ap
tr amine,</w>
tr agic</w>
tr af
tr acting</w>
toxoplasmo sis,</w>
toxico kinetic</w>
toxico dynamic</w>
toxic ologically</w>
toxic ity.(ABSTRACT</w>
toxic ity-related</w>
toxic ity)</w>
toxic ity
toxic iti
toxic ant</w>
tox in
tourniquet -induced</w>
tourniqu ets</w>
tourniqu et.</w>
touc h.</w>
tot ally.</w>
tot alling</w>
tot al:</w>
tos omal</w>
tortic olli
torticolli s.</w>
torsa des.</w>
torsa de
toremif ene.</w>
toremif ene-
toremifene- treated</w>
toraf ur</w>
tor- containing</w>
tor tu
tor so</w>
tor so.</w>
tor sion</w>
tor sin
tor hinolaryng
tor hinal</w>
top y</w>
top ped</w>
top ography,</w>
top ically.</w>
top ic.</w>
top ic
tonsil litis</w>
tonic oclonic</w>
ton- pump</w>
ton sur
tonsur ans</w>
ton otopic</w>
ton ometry</w>
ton es</w>
tomograph y)</w>
tom ograms</w>
tom at
tolu ene,</w>
tolmet in-dependent</w>
toler ances</w>
toler ance;</w>
toler ance:</w>
toler able,</w>
tolaz amide-induced</w>
tol ylguanidine</w>
tol vaptan</w>
tol i</w>
tol am
toge ther
toddl ers</w>
toddl er</w>
tocoph er
tocopher ols</w>
tocain ide/
tocainide/ lidocaine</w>
tocain ide,</w>
toc oly
tobram ycin-treated</w>
tobram ycin,</w>
tob i
tobi prof
tobiprof unda</w>
to- mild</w>
to- mesenchymal</w>
to- high-dose</w>
to- end</w>
to- GU</w>
to y</w>
to ols.</w>
to o,</w>
to graph
to genicity</w>
to day;</w>
to day's</w>
to ad</w>
tive/ disruptive</w>
tiv es,</w>
tiv al</w>
tit res,</w>
tit ating</w>
tissu es:</w>
tissu e/
tis sular</w>
tis ocial</w>
tis m.</w>
tis ine,</w>
tis -induced</w>
tis --
tipran avir</w>
tipran avir/
tion- progression</w>
tion- limiting</w>
tion- Event</w>
tion s:</w>
tion ine</w>
tion >=</w>
tion .(ABSTRACT</w>
tion --an</w>
tion '</w>
ting ia</w>
ting en</w>
tin idazole</w>
timul atory</w>
timolol- latanoprost</w>
timolol- hydrochlorothiazide</w>
times/ week)</w>
times- daily</w>
time-to- peak</w>
time-to- onset</w>
time-to- event</w>
time- weighted</w>
time- velocity</w>
time- varying</w>
time- sequence</w>
time- on-
time-on- task</w>
time- limited</w>
time- domain</w>
time- dependence</w>
time- density</w>
time points</w>
time d-pregnant</w>
time ),</w>
tim ulated</w>
tim ide,</w>
tim es;</w>
tim es).</w>
tilit y;</w>
tilit y:</w>
til t).</w>
til es.</w>
til be
til agin
tilagin ous</w>
til ,</w>
tigh tened</w>
tigh t-
tig er</w>
tig ation</w>
tifluad om</w>
tifluad om,</w>
tid ine's</w>
ticulo us</w>
ticrynaf en</w>
ticlopid ine;</w>
ticlopid ine:</w>
ticlopid ine-related</w>
ticlop ride</w>
ticarc ill
tic- zone</w>
tic- resistant</w>
tic- regression</w>
tic- drug-induced</w>
tic- acid-induced</w>
tic ularis</w>
tic s;</w>
tic osus</w>
tic ine</w>
tic entr
ticentr e</w>
tic ation</w>
tic :</w>
tic -type</w>
tic ),</w>
tic (s)</w>
tibol one</w>
ti vely,</w>
ti tre
ti ters,</w>
ti ter,</w>
ti ses</w>
ti pame
tipame zole</w>
ti ming.</w>
ti ming
timing "</w>
ti le-
ti dyl</w>
ti di
ti des.</w>
ti de</w>
ti d,</w>
ti ca,</w>
ti bio
ti ation</w>
ti a,</w>
thyrotroph ic-
thyrotrophic- releasing</w>
thyrotoxic osis:</w>
thyroidi tis.</w>
thyroid ectomized</w>
thyro parathyroid</w>
thyro id.</w>
thyro ary
thyroary ten
thyroaryten oid</w>
thym us.</w>
thym ulin</w>
thym ia.</w>
thym ia,</w>
thy mus,</w>
through out
throughout ),</w>
through -
through- and-
through-and- through</w>
thrombot est.</w>
thromboly zed</w>
thromboembol ism;</w>
thrombocytopenia- thrombosis</w>
thrombocytopen ia).</w>
thrombocytopen ia
thrombocyth aemia,</w>
thrombocy themia</w>
thrombo tics</w>
thrombo tic,</w>
thrombo ses.</w>
thrombo prophylaxis</w>
thrombo plast
thromboplast in-induced</w>
thrombo phleb
thrombo philic</w>
thrombo philia.</w>
thrombo hemorrhagic</w>
thrombin- activ
thrombin-activ atable</w>
thromb open
thrombopen ia)</w>
thromb omodul
thrombomodul in</w>
thromb ocytosis.</w>
thromb in,</w>
throm ycin-induced</w>
thro id,</w>
thro b
throb bing</w>
thrice- daily</w>
threshol d:</w>
threo- 3-hydroxy
threo-3-hydroxy aspartic</w>
threo- 3,4-dihydroxyphenyl
threo-3,4-dihydroxyphenyl serine</w>
three- step</w>
three- hour</w>
three- combined</w>
three- ,</w>
threat ens</w>
thre onine</w>
thre e)</w>
thr ust</w>
thr ush</w>
thr in,</w>
though t
thorough ly.</w>
thorough ly,</w>
thoraco- abdominal</w>
thor ity.</w>
tho propa
thopropa zine</w>
thix ene,</w>
this .
this. Aminoglycoside</w>
thirty- two</w>
thirty- one</w>
thirty- five</w>
thirty- eight</w>
thirst y</w>
third- generation,</w>
thir teenth</w>
thir st.</w>
thioridaz ine)</w>
thioredox in,</w>
thiopentone- vecuronium</w>
thiopentone- suxamethonium</w>
thiopental- halothane</w>
thiopental- anesthetized</w>
thion ine-
thioguan ine.</w>
thioguan ine-related</w>
thiocyan ate</w>
thio thixene,</w>
thio phosphoric</w>
thio glucose.</w>
thio glucose
thio fen
thiofen -2-
thio ate</w>
thio acetamide</w>
thio ]
thin- 3-O-
thin-3-O- gallate</w>
thigh s,</w>
thigh .</w>
thiethylper azine</w>
thiep in-1
thiepin-1 0-
thiepin-10- yl)oxy]-
thickness/ LV
thicknes ses</w>
thiazolidinedi ones,</w>
thiazole- 2-
thiazole-2- carboxamide,</w>
thiazol idinedione</w>
thiazol -2-
thiazol-2- amine</w>
thiazide -like</w>
thiaz olo[3,2-a]
thiamylal- enflurane</w>
thiam azole</w>
thiam azole-induced</w>
thiadi azol
thiadi azepine</w>
thia -1-
thia-1- azabicyclo
thi omorph
thi ols.</w>
thi ol,</w>
thi ol
thiol -1
thiol-1 1-des
thiol-11-des oxy</w>
thi ocy
thi amin,</w>
theta( albumin)</w>
theta 1</w>
thesi a,</w>
thermon ociceptive</w>
thermodi lu
thermo regulation</w>
thermo graphic</w>
thermist or-
thermistor- tipped</w>
thermal- pain</w>
therm ally</w>
thereafter )</w>
there of.</w>
there in</w>
there by,</w>
there -
therapeu tics</w>
therapeu tically.</w>
therapeu tic.</w>
therapeu tic-
therapeu tic,</w>
therap y?</w>
therap y.Post-mortem</w>
therap y's</w>
therap ists</w>
ther mode</w>
ther ization</w>
ther ing</w>
theophylline- intoxicated</w>
theophylline /kg</w>
theophylline -</w>
theophyll ine-containing</w>
thenal idine</w>
then uria,</w>
then ia</w>
then ate</w>
themo glob
them y
thec olamine-induced</w>
the- tiger</w>
the ta,</w>
the sis,</w>
the sia.</w>
the ses</w>
the ory.</w>
the orized</w>
the ob
theob rom
theobrom ine,</w>
the dium</w>
thalidomide- affected</w>
thalidomide -related</w>
thalassemic s</w>
thalamo-striatal- cortical,</w>
thalam us)</w>
thalam i</w>
thal li
th- 5th</w>
th yl</w>
th ump</w>
th row</w>
th ol.</w>
th es
th enic</w>
th ation
thation e</w>
th -associated</w>
th -10
th-10 th</w>
text books</w>
tex t.</w>
tex -
tetrodotox in-sensitive</w>
tetrodotox in,</w>
tetro xide</w>
tetrazol ium.</w>
tetrapare sis,</w>
tetrap legia.</w>
tetramethyl- p-
tetramethyl- 2
tetramethyl-2 H
tetramethyl-2H -1-
tetramethyl-2H-1- benzopyran
tetramethyl-2H-1-benzopyran -
tetramethyl-2H-1-benzopyran- 6-
tetramethyl-2H-1-benzopyran-6- ol,</w>
tetramethyl pyrazine</w>
tetrahydropyranyl adriamyc
tetrahydropyranyladriamyc inol</w>
tetrahydroisoquinol ine,</w>
tetrahydrocannabinol- dimethylhept
tetrahydrocannabinol-dimethylhept yl</w>
tetrahydrocannabin ol.</w>
tetrahydro-3-methyl-5-phenyl -1H-3-benz
tetrahydro progesterone</w>
tetrahydro pal
tetrahydro isoquinoline</w>
tetrahydro folic</w>
tetrahydro cortisone</w>
tetrahydro cortisol,</w>
tetrahydro aminoacridine</w>
tetrafluoro ethane</w>
tetraethylammon ium.</w>
tetracycline- class</w>
tetrachloro bi
tetrachlorobi phenyl)</w>
tetraca ine),</w>
tetraben azine.</w>
tetrab amate</w>
tetrab am
tetra si
tetrasi lox
tetrasilox ane</w>
tetra d</w>
tetr adec
tetr abut
tetrabut yl
testosterone- replacement</w>
testosterone- 6</w>
test s),</w>
test ings</w>
test es.</w>
test ed)</w>
test ed
test --
test -
tes un
tes ol
tert-butylamino- 2-hydroxy
tert-butylamino-2-hydroxy )
tert-butylamino-2-hydroxy) prop
tert-butylamino-2-hydroxy)prop oxy-
tert-butylamino-2-hydroxy)propoxy- 3,4-dihydro
tert-butylamino-2-hydroxy)propoxy-3,4-dihydro carbo
tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbo sty
tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbosty ril</w>
tert-butyl amino)
tert-butylamino) propoxy
territ ory,</w>
territ ories,</w>
termin ated,</w>
termin als),</w>
termin alis</w>
termin al-
terfen adine-induced</w>
terbutal ine)</w>
teratogen -induced</w>
terat ology</w>
terat oid/
teratoid/ rh
teratoid/rh ab
teratoid/rhab do
teratoid/rhabdo id</w>
terat ogenesis,</w>
ter- fibrillation</w>
ter s)</w>
ter nal</w>
ter ms:</w>
ter ms.</w>
ter ms,</w>
ter m)</w>
ter in,</w>
ter azos
terazos in-treated</w>
ter ;</w>
ter -type</w>
tenu ifolia</w>
tension- velocity</w>
tenofovir -related</w>
tenofovir -associated</w>
tenidap -treated</w>
tend ency.</w>
tend encies</w>
ten- week</w>
ten- month</w>
ten us</w>
ten ths</w>
ten sions.</w>
ten se</w>
ten oxicam</w>
ten ipo
tenipo side</w>
ten don
tendon itis</w>
ten der,</w>
ten asc
tenasc in-
tenascin- R</w>
ten able</w>
tempt ed</w>
temporo -
tempor ar
tempor alis</w>
temperam ent,</w>
temozolom ide-induced</w>
temoc apri
tem af
telomere- stabilizing</w>
telo mere</w>
telmis art
telmisart an-treated</w>
teleph oned</w>
teleph one-
tele metered</w>
telangiect ases,</w>
tel encephalic</w>
teicoplan in,</w>
tegaf ur,</w>
techno logy.</w>
techno logies</w>
technic al-
technical- grade</w>
technetium- 99m-
techne tate</w>
te- macrophage</w>
te ur
te trezol</w>
te thering</w>
te red,</w>
te rectomy</w>
te re
tere ff
te olol,</w>
te ment</w>
te lor
te en.</w>
te en,</w>
te d-
ted- diet,</w>
te ased-fiber</w>
te ams</w>
te acher</w>
te a.</w>
te )</w>
taz obactam</w>
taz obact
tax ane/
taxane/ trastuzumab</w>
tax ane-induced</w>
tax ane-based</w>
taurochol ate.</w>
tauro ursodeoxychol
tauro lithocholic</w>
taur ine-treated</w>
tast es</w>
tas ks,</w>
tartr ate.</w>
tari qu
tariqu id
tariquid ar</w>
target- vessel</w>
target- concentration</w>
target -free</w>
tar traz
tap .</w>
tan nic
tannic -
tannic- acid</w>
tamsulos in.</w>
tamoxifen :
tamoxifen ),</w>
tamoxif en-
talipex ole.</w>
tal- like</w>
tal ip
talip es</w>
tal in,</w>
tal ),</w>
tak o-tsubo</w>
tak ing.</w>
tak ers</w>
tak ers.</w>
tak er
taker s'
takers' '</w>
tailo r</w>
tail- vein</w>
tail- tremors</w>
tail ;</w>
tag lomerular</w>
tadalaf il-induced</w>
tadalaf il,</w>
tacrolimus- based</w>
tachykin in-mediated</w>
tachykin ergic</w>
tachycardia/ ventricular</w>
tachycardia -induced</w>
tachycardia -
tachycardia ).</w>
tachy dysrhythmia.</w>
tachy cardic,</w>
tacalcit ol</w>
tac y</w>
table ts:</w>
table ts)</w>
table )</w>
tab un</w>
tab ulated</w>
tab ular</w>
ta u)</w>
ta h</w>
ta g</w>
ta )</w>
t/ anxiety</w>
t.i. d.,</w>
t.i. d.)</w>
t-1,2- CHD</w>
t- tubular</w>
t- tests).</w>
t- of-dose</w>
t- butyl-
t-butyl- bicyclophosphoro
t- butyl
t-butyl amino-
t-butylamino- propoxy
t-butylamino-propoxy )</w>
t- be
t- avid</w>
t- 5
t-5 36
t-536 93</w>
t- 2-
t-2- ene-
t-2-ene- 2-
t y)</w>
t x)</w>
t ures</w>
t tingen</w>
t s--
t ous</w>
t ochemical</w>
t mann
t m</w>
t ly;</w>
t ly:</w>
t les</w>
t le.</w>
t ins</w>
t inic</w>
t incture</w>
t estic
t es:</w>
t ect
tect a</w>
t ds</w>
t ated</w>
t at
t apped</w>
t angles</w>
t angi
tangi ble</w>
t ance.</w>
t ally.</w>
t ally,</w>
t aller</w>
t al)</w>
t able.</w>
t able,</w>
t RNA.</w>
t NSAID.</w>
t AM
tAM CA.</w>
t 5</w>
t 30,</w>
t 3,</w>
t 2</w>
t +
t (L)</w>
t (2)=
t (1/2)</w>
t (1/
systol ic)</w>
systematic ally,</w>
system s)</w>
system ic-
system );</w>
system ).</w>
system 's</w>
syst ole-
systole- specific</w>
sys kinetic</w>
syring omyelia</w>
syring e,</w>
syphil is,</w>
synthet ase,</w>
synthesis/ secretion</w>
synthesi zed,</w>
synthe tized</w>
synthe tas
synthase- dependent</w>
synth ases</w>
synth ase/
synergis tic.</w>
synerg ized</w>
synechi a</w>
syndrome ?)</w>
syndrome -
syndrome ,"</w>
syndrome (s).</w>
syndrome ")</w>
syndrom ic</w>
syncop e)</w>
synchron ize</w>
synchron ised</w>
synaptos ome</w>
synaptophy sin.</w>
synap tically</w>
synap se.</w>
syn trophin</w>
syn chrotron</w>
symptom- free,</w>
symptom s/
symptom ology</w>
sympatho- inhibitors</w>
sympatho- excitatory</w>
sympatho inhibition</w>
sympatho excitatory</w>
sympatho excitation,</w>
sympatho adrenomedullary</w>
sympathetically- mediated</w>
sympathetically- maintained</w>
sympath ic
symmetric ally.</w>
symmetric .</w>
sym tom
sym podi
sympodi alis</w>
syl ated</w>
sych iatric</w>
sy ph
syph ili
syphili s.</w>
sy m</w>
switching- off</w>
switch ing,</w>
switch es.</w>
switch ers.</w>
swim ming.</w>
swim ming,</w>
swim .</w>
swe et,</w>
swallow ing,</w>
sw anger</w>
sw ab
sut uring</w>
sut ures.</w>
suspici ousness,</w>
suspici on,</w>
suspen sion)</w>
suspen ded.</w>
suspen ded,</w>
suspect .</w>
suscepti ble,</w>
sus )</w>
survival/ repair</w>
surviv or</w>
survi ved)</w>
surveill ance,</w>
surger y/radiotherapy</w>
surger y/radiotherapy)</w>
surger y),</w>
surger y').</w>
surge ons,</w>
surg ically,</w>
surface- area</w>
surfac es,</w>
sur passes</w>
sur mise</w>
supraspin ally</w>
supras ystolic</w>
supran ormal</w>
supramam millary</w>
suprag lot
supraglot tic</w>
suprac on
supracon vulsant</w>
suprac hi
suprachi as
suprachias matic</w>
supra- additive</w>
supra op
supraop tic,</w>
suppress or,</w>
suppress ant
suppres sion;</w>
suppres sion:</w>
suppres sed,</w>
supposit ories.</w>
supposit ori
support ;</w>
suppor tive.</w>
suppl y,</w>
suppl ies</w>
superven ed,</w>
superim pos
superimpos able</w>
superi or,</w>
superi or
super paramagnetic</w>
super hydroxide</w>
super antigen
superantigen -related</w>
sup ral
supral im
supralim inal</w>
sup pur
suppur ative</w>
sunit inib
sunbur n.</w>
sun light.</w>
summari sed.</w>
summari es:</w>
summar iz
summar ised</w>
summ ated</w>
sumatript an-treated</w>
sumatript an-associated</w>
sum -
sum- score</w>
sulpiride ).</w>
sulphon yl)</w>
sulphasalaz ine-related</w>
sulph oxidi
sulphoxidi sers</w>
sulph ate/
sulind ac
sulfoxim ine.</w>
sulfonylure a-induced</w>
sulfonamide s.</w>
sulfon ate)</w>
sulfon amide-induced</w>
sulfon amide)</w>
sulfo phenyl)
sulfhydr ylic</w>
sulfhydr yl-
sulfhydr yl)</w>
sulfhyd ril
sulfhydril s,</w>
sulfhyd ri
sulfhydri ls</w>
sulfamethoxazole- trimethoprim</w>
sulfamethoxazol e;</w>
sulfadox ine.</w>
sulfadi az
sulf ur-
sulf onic</w>
sulf ate-treated</w>
sulf ate)</w>
sulf atase</w>
sulf anil
sulc i</w>
sulbact am-
sul cus</w>
sul cular</w>
suicid ality</w>
suic ides,</w>
suggest ed;</w>
suggest :</w>
sufferer s,</w>
sufentanil/ propofol</w>
sufentanil/ midazolam.</w>
sufentan il:</w>
sud ative</w>
sud ation</w>
succumb ing</w>
succum b</w>
succin ate.</w>
succes sion</w>
suc rose.</w>
subunit )</w>
subtype (s)</w>
substrat um</w>
substitu tion.</w>
substitu tion,</w>
substitu tion)</w>
substitu ent</w>
substanti ates</w>
substanti al.</w>
subsid ence</w>
sublux ation</w>
sublingu al)</w>
subjecti vely.</w>
subfiel ds,</w>
subepicardi um</w>
sube ffective</w>
subcutaneous ly).</w>
subcutaneous ly),</w>
subcutaneous ).</w>
sub- region</w>
sub- items.</w>
sub- group</w>
sub- epithelial</w>
sub- divided</w>
sub- convulsant</w>
sub- clinical</w>
sub- cataleptic</w>
sub- analysis</w>
sub- Sa
sub-Sa har
sub-Sahar an</w>
sub urban</w>
sub tractive</w>
sub tracting</w>
sub tle,</w>
sub thalamus.</w>
sub test</w>
sub tend</w>
sub sets.</w>
sub set,</w>
sub scale.</w>
sub retinal</w>
sub region</w>
sub populations.</w>
sub population.</w>
sub plant
sub ototoxic</w>
sub occipital</w>
sub myoclonic</w>
sub merging</w>
sub membranous</w>
sub medi
submedi us</w>
sub maximally</w>
sub fove
subfove al</w>
sub family,</w>
sub cutis</w>
sub critical</w>
sub cortex</w>
sub corneal</w>
sub classes,</w>
sub car
subcar inal</w>
sub acutely</w>
sub -</w>
su tism</w>
su tility</w>
su stains</w>
su profen.</w>
su nif
sunif ir
su n</w>
su es</w>
styrene -exposed</w>
stupo ro
stuporo us,</w>
stun ted</w>
stun ning,</w>
study ]</w>
study ):</w>
studi es;</w>
studi es:</w>
studi es
stud y/short</w>
stud ents.</w>
strychn ine-sensitive</w>
strugg le</w>
structure d,</w>
structure -specific</w>
structurally- related</w>
strong -
strome lys
stromelys in-1</w>
stroke/ transient</w>
stroke/ systemic</w>
stroke- resistant</w>
stroke- related</w>
stroke )</w>
striat um:</w>
stri king.</w>
stri kes</w>
stri dor.</w>
stretch ing-
stretching- yawning</w>
stret ches</w>
stress- velocity</w>
stress- responsive</w>
stress- regulatory</w>
stress ogenic</w>
stress "</w>
stres sed,</w>
streptozotocin- induced)</w>
streptozotoc in)</w>
strept omycin-
strept ococcus</w>
street- ketamine</w>
streak s</w>
stre et
strategi es:</w>
strateg y,</w>
strate gy
strain- gauge</w>
strain s;</w>
strain s:</w>
strain s)</w>
strain s).</w>
strai ght-
strai ght
strabis mus,</w>
stra ined</w>
stra in)</w>
str um,</w>
str ings</w>
str ation,</w>
str ange</w>
storm .</w>
stopp age</w>
stop- watch</w>
stop- signals</w>
stop- signal</w>
stop- flow</w>
ston es).</w>
stomach aches,</w>
stomach :</w>
stom ati
stoichi ometry</w>
stoc k.</w>
stoc k
stob adine</w>
sto ol,</w>
sto od</w>
stitut ed,</w>
stipul ated</w>
stippl ed</w>
stimuli ;</w>
stimul us).</w>
stimul ators</w>
stimul ation;</w>
stimul ated.</w>
still born</w>
still birth</w>
still ,</w>
stilbo estro
stilboestro l,</w>
stil bene
stiff ening</w>
stiff ening.</w>
sti llation</w>
steroid- responsive</w>
steroid- responsive,</w>
steroid s;</w>
steroid ogenic</w>
steroid ogenesis</w>
steroid ogenesis.</w>
steroid al,</w>
steroid -</w>
steri le,</w>
stereotyp y-like</w>
stereoty ped,</w>
stereot ac
stereospecific ally</w>
stereo selectivity</w>
stereo selectivity.</w>
stereo selectively</w>
stereo selective,</w>
stere oscopic</w>
stere olog
ster osalping
sterosalping ography</w>
ster not
sternot omy,</w>
ster n
stern um.</w>
ster dam,</w>
ster .</w>
step- wise</w>
step s.</w>
stenosi s-
stenosis- occlusion</w>
steno ses:</w>
stem ming</w>
stem -evoked</w>
steep ly</w>
steatohepatitis -inducing</w>
ste trics</w>
ste in</w>
ste ers</w>
ste al
steal ."</w>
ste adi
stavud ine:</w>
staurospor ine,</w>
static )</w>
stat .</w>
star vation</w>
star ts</w>
star ts.</w>
star ch.</w>
standardi ze</w>
standard- induction</w>
standard -</w>
stand ing),</w>
stain less</w>
stain ings,</w>
stagge red</w>
stage- 3</w>
stag n
stag horn</w>
stag es:</w>
staff .</w>
staff 's</w>
stabiliz er,</w>
stabilis ers.</w>
stabil izes</w>
sta ined,</w>
sta b</w>
st- time</w>
st ump</w>
st rep
st razine</w>
st rating</w>
st ore</w>
st one,</w>
st omal</w>
st ner</w>
st mann</w>
st ly.</w>
st esolid</w>
st esol
stesol id.</w>
st atic,</w>
st atement</w>
st ated.</w>
st and.</w>
st all</w>
st agg
stagg ering</w>
st age;</w>
st able;</w>
squa res
squares -
squares- discriminant</w>
squ e
squ are,</w>
squ are
spur ious</w>
sprout ing;</w>
spread she
spreadshe et</w>
spra yed</w>
spra y,</w>
spot ty</w>
sporad ic.</w>
spontaneous -like</w>
spondylo myelopathy</w>
spondylo arthro
spondyloarthro pathy,</w>
spon gi
spongi ous</w>
spo ro
sporo trichosis</w>
splin t</w>
splic e</w>
splen ectomy,</w>
sple ens</w>
spl it
spiro peridol,</w>
spiper one-induced</w>
spiper one-
spiper one,</w>
spinal- block
spinal-block -induced</w>
spin ous</w>
spin ocerebellar</w>
spin al.</w>
spillo ver.</w>
spik ing,</w>
spik es/
spik e.</w>
spik e,</w>
spi ke
sphingos ine-1-
sphingosine-1- phosphate.</w>
sphingomyel inase</w>
spher oid</w>
spermatozo a,</w>
sperm ine-induced</w>
sper matic</w>
spell .</w>
spectrophot ometry</w>
spectrophot ometer</w>
spectra ,</w>
spectr atyp
specti vely</w>
spectac ular</w>
spect abilis</w>
specific ity:</w>
speci es)</w>
spec ulation</w>
spec tion.</w>
spec ified.</w>
spec ifi
specifi ed)</w>
speak ing.</w>
speak ing,</w>
spe ed;</w>
spe aking</w>
spe ak</w>
spasm -induced</w>
spas tic,</w>
spas m;</w>
sparte ine/
sparteine/ debrisoquine</w>
spar ing,</w>
spac es;</w>
spac e)</w>
spa yed</w>
spa red,</w>
sp urred</w>
sp rin
sprin k
sprink les</w>
sp p.</w>
sp in-
sp id
sp antide</w>
sp a</w>
soy ab
soyab ean</w>
soy a</w>
sour ce;</w>
sour ,</w>
sound- silence</w>
sound- pressure</w>
sound- evoked</w>
soun ds.</w>
soun d.</w>
sough t,</w>
sou theast</w>
sos omes</w>
sorb ed</w>
sorafenib -
sorafenib- refractory</w>
sor tium</w>
sor )</w>
sophis ticated</w>
sop razole</w>
sop oro
sonomicro meter</w>
son ville,</w>
son s</w>
son or
sonor nicotine</w>
son ography.</w>
son ographically</w>
son ographical</w>
son o
sono grams.</w>
somnambul ism.</w>
somit es)</w>
somewhat )</w>
somatostat in/
somato statin,</w>
somat omotor</w>
som itic</w>
som an.</w>
som an,</w>
som al</w>
solvent s.</w>
solution s:</w>
solution ]</w>
solut es.</w>
solut e-free</w>
solubil ized</w>
solu tions,</w>
solu tion:</w>
solu tion).</w>
solid- phase</w>
solecith in</w>
sole us,</w>
sol e-
sole- plate</w>
sodium/ potassium</w>
sodium/ myo-inositol</w>
sodium- rich</w>
sodium- pump</w>
sodium- myo-inositol</w>
sodium- dosed</w>
sodi um-</w>
socio- economic</w>
soci ety</w>
soci ety.</w>
sob ri
soa king</w>
so ventral</w>
so therapy</w>
so guvac
sna ke</w>
sna k
sn out</w>
smooth- surfaced</w>
smoo th
smok ing)</w>
smok er.</w>
smear s.</w>
small- fiber</w>
small- caliber</w>
small- bore</w>
sluggish "</w>
sludg ing,</w>
slow- onset,</w>
slow- acetylator</w>
slow '</w>
slop ing</w>
slop e.</w>
slop e
slope =
slope= -0.
slit -
sligh t.</w>
sligh t-
sli pide
slipide mia</w>
sleep ;</w>
sleep /
sleep -related</w>
sl er,</w>
skin- twitch</w>
skin /
ske w</w>
sk y-
size- dependent,</w>
siz eable</w>
sixty- three</w>
sixty- four</w>
sixty- eight</w>
sixty- eigh
sixty-eigh t)</w>
six- year-old</w>
six- months</w>
six- fold</w>
six )</w>
sive- stage</w>
sive- compul
sive-compul si
sive-compulsi ve-like</w>
sive- Compulsive</w>
site- directed</w>
site (s),</w>
sit e?</w>
sit e;</w>
sis/ meningitis</w>
sis- stimulating</w>
sirolim us-related</w>
sion- converting</w>
sion s).</w>
sion ate</w>
sion ary</w>
sion /
sion -related</w>
sion -</w>
sion );</w>
sion "</w>
sinusi tis,</w>
sinus ;</w>
sinu atrial</w>
single- stage</w>
single- lung</w>
single- labeling</w>
single- institution</w>
single- injection</w>
single- ingredient</w>
single- case</w>
single- arm</w>
single- agent,</w>
sing ult
sin- Tang</w>
sin- II</w>
sin us-
sin om
sinom )</w>
sin ki</w>
sin ia</w>
sin ergic</w>
sin ensis</w>
sin ce.</w>
sin ce,</w>
sin apo
sinapo yl</w>
simvastatin- ezetimi
simultaneous ly;</w>
simult ane
simplic ity,</w>
simpl ify</w>
simpl ification</w>
simpl est</w>
similar ity,</w>
similar ities.</w>
silon -aminocaproic</w>
silo sis</w>
sildenaf il)</w>
sildenaf il
sildenafil 's</w>
sil k</w>
sil icone</w>
sil ico</w>
sil ent-
significant ly;</w>
significant ly:</w>
significant ly)</w>
signall ing,</w>
signal-to- noise</w>
signal ing)</w>
sign ified</w>
sign fic
signfic antly</w>
sigma- oscillations</w>
sigma- augmentation</w>
sigma ST</w>
sigh ts</w>
sig ne
signe d-
sig -B
sig-B ing</w>
sieh -H
sieh-H sin-Tang</w>
sie ve</w>
sie h,</w>
sidi ous</w>
sideroblast s.</w>
sider osis.</w>
sider osis,</w>
side- in</w>
side- F
side red</w>
side effects</w>
side /
side -</w>
side ).</w>
sick ling</w>
sib il
sialo protein</w>
sialo gangliosides</w>
sial orrhea</w>
sial orrhea,</w>
si ties</w>
si rag
sirag u
si osis</w>
si genic</w>
si form</w>
si dine</w>
si dar
sidar ).</w>
si cal</w>
si ae,</w>
si ac</w>
si a),</w>
si RNA</w>
shun ts</w>
shun ted</w>
show ,</w>
shoul ders</w>
shoul der.</w>
short-term '</w>
short-ter m-
short-li ved,</w>
short- lasting,</w>
short- infusion</w>
short- ch
short-ch ain-
short-chain- fatty</w>
shock -treated</w>
shock -</w>
shock )</w>
sho t</w>
shiver ing.</w>
shik aw
shiel d</w>
shengmai-y in</w>
shell .</w>
she pherd</w>
sharp- wave</w>
shap es</w>
shap e.</w>
shap e,</w>
sham-oper ated,</w>
sham- eNOS</w>
sham- RN-x</w>
sham- ECS.</w>
sham ;</w>
shak y/jitter
shadow s</w>
sha ved</w>
sha king,</w>
sha k</w>
sh outs</w>
sh op
sh in
sh am,</w>
sexually- dimorphic</w>
sexu alized</w>
sex/ group)</w>
sex- adjusted</w>
sex ecutive</w>
sex -dependent</w>
sevoflurane- sparing</w>
sevoflur ane/nitrous</w>
sever ity;</w>
seventy- six</w>
seventy- seven</w>
seventy- four</w>
seve rest</w>
seve rely,</w>
sett led.</w>
sett ings;</w>
sett ing;</w>
setr on.</w>
setr on-induced</w>
sest ami
sestami bi
ses sions:</w>
ses /
serum- ratio</w>
serum- free</w>
serotonin- release</w>
serotonin- norepinephrine</w>
serotonin- dopamine</w>
serotonin- depleted</w>
serotonin- 2</w>
serotonin erg
serotonerg ic/
seroton in-1</w>
seroton in-1
seroton in)</w>
serosi tis.</w>
serosi tis,</w>
serone gati
seronegati vity,</w>
seroconver ters</w>
seroconver sion;</w>
serine/ phosphatidylcholine</w>
seret sky</w>
ser um;</w>
ser um-</w>
ser tion</w>
ser ot
serot inergic</w>
ser oposi
ser ologies,</w>
ser ological,</w>
ser ologic,</w>
sequin an,</w>
sequenti al,</w>
sequence -dependent</w>
sequell ae</w>
sequ ence-
septal/ diagonal</w>
sept o-
septo- hippocampal</w>
sept ation</w>
separ ation.</w>
sep sis/meningitis</w>
seoful vin(GF)</w>
sensory- evoked</w>
sensory- discriminative</w>
sensory- conduction</w>
sensori um.</w>
sensor y/motor</w>
sensor ial</w>
sensitiz er</w>
sensitiz ed-
sensitized- state</w>
sensitiz ation:</w>
sensitiz ation)</w>
sensitiz ation
sensitiv ity).</w>
sensi tively</w>
sensi tises</w>
sens ations,</w>
sens ation
sen ticosus</w>
sen su
sen se-
sen ior</w>
semic ir
semicir cular</w>
semi- purified</w>
semi quinone</w>
sematili de.</w>
sem ustine</w>
sem ide,</w>
sell a</w>
self- tuning</w>
self- perpet
self- perception</w>
self- limiting,</w>
self- injury.</w>
self- injur
self- injection,</w>
self- identified</w>
self- harm</w>
self- dosing</w>
self- control</w>
self- control.</w>
seleni um)</w>
selen -treated</w>
selective ),</w>
selective '
selective' ),</w>
sel y-bound</w>
sel s</w>
sel ectively,</w>
sel ective.</w>
seizures /
seizures --
seizure- producing</w>
segreg ates</w>
segment s)</w>
seg res
seen ;</w>
seem ing</w>
seed s,</w>
sediment able</w>
sedi ments</w>
sedi ments,</w>
sedi mentation,</w>
sedentary- isoproteren
sedentary-isoproteren ols</w>
sedent ary.</w>
sedative- antianxiety</w>
sed ative.</w>
sed .(ABSTRACT</w>
secretago gu
secret ing,</w>
secre tion:</w>
secre t</w>
second- messenger</w>
second- look</w>
second s;</w>
second ly</w>
second ary-prevention</w>
second arily,</w>
sec uring</w>
sec undum</w>
sec tions)</w>
sec tioned.</w>
sec tion:</w>
sec tion)</w>
sec s</w>
sec -1</w>
sec ).</w>
seas on</w>
seal ant</w>
se- exposed</w>
se- control</w>
se- Ell
se-Ell s
se-Ells worth</w>
se ydoakathisia</w>
se viera</w>
se vered</w>
se ver</w>
se lol</w>
se lling</w>
se e-
see- sa
see-sa w'</w>
se bos
sebos up
se arched,</w>
se aled</w>
se ),</w>
se )
se '</w>
scrutin ized</w>
scro tum,</w>
screen ing/
screening/ weaning</w>
screen ed,</w>
scrat ch
scratch ing.</w>
scram bled</w>
scot oma.</w>
score rs</w>
score ).</w>
scor pi
scopol amine;</w>
scopol amine-
scopol amine)</w>
scopol amine
scop ical</w>
scop -treated</w>
scop -induced</w>
scler osant</w>
scler itis,</w>
scinti graphy;</w>
sci ure
sci atic-
sciatic- tibial</w>
school- halothane</w>
schizophren ic-like</w>
schizophren i-
schizophreni- form</w>
schiz o-
schizo- affective</w>
schistos omes</w>
schist ocytes</w>
schem es</w>
schem es.</w>
schem a</w>
schedul e;</w>
sche me.</w>
sche me,</w>
scenari os,</w>
scaveng ers.</w>
scaveng er.</w>
scaveng ed</w>
scat tered,</w>
scant y</w>
scant y.</w>
scal p-
scalp- recorded</w>
scal ing</w>
scal es;</w>
scal es:</w>
scal ar</w>
scabic ides</w>
scabic ide</w>
scabic ide.</w>
sca ff
sc roll
sc hemic
sc atter
scatter ),</w>
sc apular</w>
sc ap
sau .</w>
sativ us</w>
satisfactor ily,</w>
satis fi
sat urable</w>
sarizot an,</w>
sarcoplas m.</w>
sarcom e
sarcom as:</w>
sarcolem ma.</w>
sarcoglyc an-
sarcoglycan- deficient</w>
saralas in.</w>
sampl es;</w>
sam pe
sampe los</w>
sam e-
salure tic</w>
salt- depleted,</w>
salsol inol</w>
salsal ate,</w>
saliv atory</w>
saline- perfused</w>
saline- ,</w>
salicylazosulf apyri
sal utory</w>
sal t-induced</w>
sal ience</w>
sal en</w>
sal azosulf
salazosulf apyridine</w>
sal azide</w>
safet y/efficacy</w>
saf egu
sadd le</w>
sacrific es</w>
sache ts/
sacchar in.</w>
sacca des.</w>
sac s</w>
sac cular</w>
sac -derived</w>
sa ved</w>
sa u</w>
sa si
sa id,</w>
sa ;</w>
sP120 T,</w>
sE- Sel
sE-Sel ectin</w>
s/min/ 1.73
s/min/1.73 m2</w>
s/R Ds)</w>
s/ year)</w>
s/ neuromodulators</w>
s/ h)</w>
s/ gender
s/ day,</w>
s/ MB
s/MB Cs</w>
s/ 10(8)</w>
s.e. m.),</w>
s.c )</w>
s. p.</w>
s. n.</w>
s. n.)</w>
s. e.</w>
s. e
s. d.</w>
s. d.)</w>
s. The</w>
s. 5.</w>
s-- were</w>
s-- also</w>
s- transferase,</w>
s- positive</w>
s- limon
s-limon ene</w>
s- infected</w>
s- in-
s- generating</w>
s- a</w>
s- O
s-O seretsky</w>
s,tot )</w>
s tic</w>
s sue</w>
s quin
s paper,</w>
s ocket</w>
s mol
smol dering</w>
s m</w>
s lo
s lack</w>
s in-induced</w>
s field</w>
s ent
s cur
s as</w>
s apor
s an</w>
s an,</w>
s alu
salu bri
salubri ous</w>
s ])</w>
s ICH.</w>
s G
s EPO,</w>
s Cr</w>
s Cr,</w>
s AD</w>
s AD.</w>
s ?
s 42</w>
s -1.</w>
s -1).</w>
s )],</w>
s )-
s '-
s'- positive</w>
s ":</w>
ryst alline</w>
ry- aggressive</w>
ry ukotsu-borei-
ry u</w>
ry sotherapy</w>
ry os
ryos urgical</w>
ruv ate</w>
rut in,</w>
rupt ures</w>
rupt ured.</w>
runc al</w>
run k</w>
rul es.</w>
rul e.</w>
rubidaz one,</w>
rub b
rubb ing-
rubbing- scratching</w>
ru re
rure tic</w>
ru pp
rupp o</w>
ru in
ruin ink
ruinink s-Oseretsky</w>
ru ed</w>
ru bra</w>
ru b</w>
rtM204 V)</w>
rtL180M/ rtM204V)</w>
rt N
rtN 236
rt 204
rs7270 101</w>
rs6 277</w>
rs6 275</w>
rs29 75
rs 46
rs 44
rs44 36
rs4436 57
rs443657 8-
rs 113
rs113 58
rs11358 40</w>
roxyl on</w>
rox -
rout ine
rout e).</w>
rou sed.</w>
roten one-
roten e</w>
rota virus</w>
rota rod
rot teur
rot atory</w>
rot ating</w>
rot ated</w>
rot aline</w>
rosu vastatin.</w>
rosu vastatin-associated</w>
rosu vastat
rostro ventral</w>
rostr ally</w>
rosiglitaz one-associated</w>
rose um,</w>
roscovit ine</w>
ros al</w>
ror rhiz
rorrhiz a</w>
ropyri dy
ropyridy loxy
ropyridyloxy )]
ropyridyloxy)] benzene</w>
ropivaca ine-treated</w>
ropivaca ine)</w>
ropini role.</w>
ropi um,</w>
ropi on</w>
roph im
rophim osis,</w>
rop yrimidines,</w>
rop ia</w>
root s.</w>
root .</w>
root -
root- mean-
root-mean- square</w>
room s.</w>
ron tal,</w>
ron ous</w>
ron ini</w>
ron in</w>
ron iaz
roniaz id-induced</w>
ron -induced</w>
ron ,</w>
rom b
romb encephalon</w>
rolipr am-induced</w>
role ;</w>
rofecoxib ;</w>
rodi siac</w>
rod on</w>
robu stly</w>
robu st,</w>
robu st
ro unded-back</w>
ro t-be
ro strum</w>
ro striatal</w>
ro of</w>
ro of.</w>
ro log
rolog ie</w>
ro line</w>
ro l.</w>
ro it</w>
ro fil
rofil aria</w>
ro ds</w>
ro d.</w>
ro d-
ro c
roc ket</w>
ro ad</w>
ro a</w>
rn r-
rnr- r1</w>
rizatript an.</w>
rivas tigmine.</w>
ritonavir -induced</w>
ritonavir -containing</w>
ritonavir )</w>
ritod rine-
ritod rin-
ritodrin- HCl</w>
rit on</w>
rit anserin.</w>
rist in.</w>
rist ate-
ristate- stimulated</w>
risperidone- compared</w>
risperid one).</w>
risperid one's</w>
risk- set</w>
risk :
risk: benefit</w>
risk )</w>
ris tic,</w>
ris -
ris- Bene
ris-Bene dic
ris-Benedic t</w>
ripen ing,</w>
ring ).</w>
rin- alpha</w>
rin- IX</w>
rin sing,</w>
rin sed</w>
rin king</w>
rin i
rini ol)</w>
rimant adine.</w>
rim ary</w>
rim )</w>
rigid ity?</w>
rigid ity-
rigid ity)</w>
rigid ,</w>
right- heart</w>
right- hand
right-hand ed</w>
righ ting,</w>
righ t)</w>
rig ors,</w>
rig or</w>
rif abutin</w>
ridg es</w>
rid ol,</w>
rid den</w>
ricin us,</w>
ric- reducing</w>
ric hed,</w>
ric h.</w>
ribos ome-
ribonucle oprotein</w>
ribo se)
ribavir in/
rib es</w>
rib ers</w>
rib bl
ri pen</w>
ri l)</w>
ri goro
ri din
rhyth ms,</w>
rhyth mic
rhyth m:</w>
rhyth m-
rhythm- qualified</w>
rho -kinase</w>
rheumat ology:</w>
rheumat ologists</w>
rheumat ological,</w>
rham nos
rhamnos yl</w>
rhabdomyoly sis-induced</w>
rhabdomy osarcom
rhabdomy olysis:</w>
rh initis,</w>
rh SOD</w>
rh G-CSF.</w>
rh -
rewar d,</w>
reviewe d:</w>
review s.</w>
review s,</w>
review er</w>
review :</w>
reversible ?</w>
reversib le;</w>
reversib le)</w>
rever sions.</w>
rever ses,</w>
reve i
revascular ised</w>
revascular isation</w>
retrospecti vely,</w>
retro peritoneal,</w>
retro gnath
retro coll
retrocoll is,</w>
retro -
retro- orbital</w>
retriev als</w>
retri ever</w>
retrac tion,</w>
retrac tement</w>
retin oid-induced</w>
retin amides</w>
retin amide,</w>
retin aldehyde</w>
retig abine</w>
reticulo- thalamic</w>
reticulo cytosis,</w>
reticular is:</w>
reticular is,</w>
reticular is
reticularis -like</w>
reticul um)</w>
reticul aris.</w>
retard ation:</w>
retard ation),</w>
retar ding</w>
retar ded.</w>
retar d.</w>
ret s.</w>
ret a</w>
resveratro l,</w>
resuscit ations</w>
resul ted,</w>
restric ting</w>
restric ted-diet,</w>
rest ed</w>
rest at</w>
response -
response- contingent</w>
responder s),</w>
respondent s,</w>
respond ingly,</w>
respon ses:</w>
respon ses).</w>
respon ses
respon der.</w>
respon ded)</w>
respirat ory-
respiratory- chain</w>
respir ations,</w>
respectively ]</w>
respectively .(ABSTRACT</w>
resp ected</w>
resorufin-O-de alkylase</w>
resorp tion;</w>
resor ptions</w>
reson ance.</w>
reson ance,</w>
resol ved;</w>
resol ve.</w>
resisti ble</w>
resist s</w>
resist ant,</w>
resist ant)</w>
resist ant"</w>
resist ances.</w>
resident s,</w>
resi li
resh ly</w>
reservoir .</w>
reserpine- increased</w>
reserpin ised</w>
reser ve;</w>
resec tion>=</w>
research ers,</w>
resear ching</w>
rescu es</w>
rescu e)</w>
resc ine,</w>
res in,</w>
res ected.</w>
res al)</w>
res ).</w>
request ing</w>
reput edly</w>
reproducibil ity.</w>
reproduci ble.</w>
represent ativeness</w>
repres sive/defensive</w>
repor ts:</w>
repor ting,</w>
repor ters</w>
repor t;</w>
repor t).</w>
repolar izing</w>
replic ation,</w>
reple tion.</w>
reple ted</w>
replacement -induced</w>
repl ies</w>
repeti tive,</w>
reperto i
reperfu sion;</w>
reperfu sion)</w>
repeat ers</w>
repe atable</w>
repair s.</w>
rep ancies</w>
reorgan ized</w>
reno protection</w>
renin- aldosterone</w>
renew al</w>
rene ,</w>
renal- sparing</w>
renal- cell</w>
ren yl</w>
ren perone,</w>
ren ders</w>
ren de
rende red.</w>
ren al.</w>
remoph or,</w>
remodel ed</w>
remo vals</w>
remit ters)</w>
remit ted,</w>
remis sions;</w>
remis sion:</w>
remin ded</w>
remifentanil- isoflurane-
remifentanil-isoflurane- based</w>
remifentanil -</w>
remifentanil );</w>
remedi es.</w>
remedi es,</w>
remedi able</w>
remain s,</w>
remac emide,</w>
rem ot
rem it</w>
rem ia:</w>
relocation/ observation</w>
relie ved.</w>
relie ved,</w>
reli ably,</w>
releas er,</w>
rele ase-
release- inhibiting</w>
relationship ?</w>
relati ves.</w>
relati ves,</w>
relapsing- remitting</w>
relap sing,</w>
relap sed.</w>
rel ying</w>
rel l</w>
rel ess</w>
rel ax</w>
rel atively-
relatively- safe</w>
rejec tion;</w>
rejec tion)</w>
reinforcement ).</w>
reinforc ing,</w>
reinfor cer
rein stituted,</w>
rehabilit ative</w>
regular .</w>
regul ar-
regres sion)</w>
regres ses</w>
regres sed,</w>
region s;</w>
region ally-
regionally- specific</w>
region )</w>
region ).</w>
regener atory</w>
regener ation,</w>
reg ut</w>
reg ma</w>
reg ained.</w>
refractor y/
refrac tion,</w>
reflu x,</w>
reflex- linked</w>
reflex- enhancing</w>
reflex ly</w>
reflex ia.</w>
reflex -induced</w>
reflex ).</w>
refl ective</w>
refine ment</w>
referr al.</w>
referr al-based</w>
referen ces.</w>
refer able</w>
ref using</w>
ref ining</w>
ref ill</w>
ref ed</w>
redund ant</w>
reductas e-
reduc tion),</w>
reduc ed)</w>
redox -active</w>
red- green</w>
red- dose,</w>
red dish</w>
recur s.</w>
recuper ate</w>
rect angular</w>
rect ally.</w>
recru its</w>
recru it</w>
recreation al"</w>
recover y;</w>
recove red;</w>
recorde d;</w>
recor dial</w>
recor der</w>
recor d-
reconstruc tion.</w>
reconstruc ting</w>
reconc ili
reconcili ation</w>
recon cil
reconcil ed</w>
recommend ation.</w>
recommend ,</w>
recogniz ed:</w>
recogn izes</w>
recogn ising</w>
recogn ised,</w>
recir culating</w>
recipient --case</w>
reci proc
reci eved</w>
rechallenge ;</w>
rechallenge )</w>
receptors .
receptors ),</w>
receptor-medi ated
receptor-mediated );</w>
receptor- regulated</w>
receptor- phosphotyrosine-
receptor-phosphotyrosine- 343-Stat5</w>
receptor- negative</w>
receptor- linked</w>
receptor- ionophore</w>
receptor- Cl</w>
receptor s).</w>
receptor ial</w>
receptor -1</w>
recei ver-operating</w>
recei ve,</w>
rece ption</w>
recanal ization,</w>
recalle d,</w>
rec ta</w>
rec es
rec alls</w>
rec ace
recace ae</w>
reboxet ine-treated</w>
reboun d,</w>
reassess ment.</w>
rear s)</w>
rear ings</w>
real ization,</w>
real isation</w>
reaffir ms</w>
read ings,</w>
read ing,</w>
reaction s)</w>
reaction .A</w>
react ants</w>
reac tivities</w>
re/ core</w>
re- started</w>
re- operation</w>
re- occurred</w>
re- observed</w>
re- introduction</w>
re- infarction,</w>
re- examined.</w>
re- examine</w>
re- established</w>
re- emphasizes</w>
re- elevate</w>
re- biopsy</w>
re x</w>
re wards</w>
re volutionized</w>
re vised.</w>
re vi
re uptake),</w>
re uni
re ti
re testing</w>
re tastatin</w>
re side</w>
re sedation</w>
re randomized</w>
re r</w>
re pressive</w>
re presentations</w>
re population,</w>
re perfused</w>
re percussion</w>
re percus
re occur.</w>
re myelination.</w>
re modelling.</w>
re model</w>
re ment</w>
re mediated</w>
re location,</w>
re intubation.</w>
re introduced,</w>
re initiated,</w>
re infection.</w>
re infection,</w>
re infected</w>
re ich
reich 's</w>
re hemorrhage</w>
re heating</w>
re hear
rehear sal</w>
re fe
refe rent</w>
re exploration</w>
re evaluation.</w>
re evaluated.</w>
re established</w>
re ement</w>
re distribution,</w>
re developed</w>
re d).</w>
re cycled</w>
re conversion</w>
re constructed</w>
re constituted</w>
re consideration</w>
re clin
reclin ing</w>
re challenges</w>
re challenges.</w>
re bleeding.</w>
re bleeding,</w>
re at</w>
re appraisal.</w>
re analysis</w>
re alization</w>
re alistic</w>
re al.</w>
re agents,</w>
re admission</w>
re admission,</w>
re administration.</w>
re administered</w>
re adi
re activator</w>
re activation/
re absorp
re absorb</w>
re -induced</w>
re "</w>
razol e-induced</w>
raz ep
rauwolsc ine.</w>
rauwolsc ine,</w>
rauwol f
rauwolf ia</w>
rats-- DFU</w>
ratios )</w>
ratios ).</w>
ratio >
ratio ;</w>
rati o-
rates =
rate- related</w>
rate ]</w>
rate .(ABSTRACT</w>
rat s?</w>
rat s-
rat or</w>
rat es)</w>
rat ?</w>
rash ),</w>
rasagil ine,</w>
rasagil ine)</w>
ras mus</w>
rare r.</w>
rar ae</w>
rapid- eye-
rapid-eye- movement</w>
raph ites</w>
rap tor-containing</w>
rank- sum</w>
rank ).</w>
range ]</w>
range )]</w>
rang ing,</w>
rang es,</w>
rang es)</w>
rang e).</w>
random- assignment,</w>
random ly,</w>
ran io
ranio facial</w>
ran d's</w>
ramipri l;</w>
ram ifications</w>
ram ide,</w>
ram id
ram er</w>
ram atic</w>
raloxifene :</w>
ral "</w>
radiotele metry</w>
radiotele metric</w>
radiot rac
radiosensi tizing</w>
radiopharmac y</w>
radiopharmac eutical</w>
radiopharmac eutic
radiopharmaceutic als</w>
radioimmuno assay)</w>
radiograph s.</w>
radio- raclopride</w>
radio protective</w>
radio paque</w>
radio immun
radio activities</w>
radic al-induced</w>
radi x</w>
radi us.</w>
radi onuc
radionuc li
radionucli de-
radi ology</w>
radi ography.</w>
radi ocalci
radiocalci um</w>
radi oc
radioc hemotherapy</w>
radi i</w>
radi ation-related</w>
radi ant-
radiant- heat-induced</w>
radi al,</w>
rad s)</w>
rad or</w>
rad ically</w>
rad ecol</w>
rache ally</w>
rach ta</w>
racem ic,</w>
race- matched</w>
race- ,</w>
rac lavicular</w>
rac ing</w>
rac es</w>
rac e.</w>
rabeprazol e,</w>
rabbit s:</w>
ra xia,</w>
ra ther,</w>
ra red</w>
ra re:</w>
ra phy
ra def
radef ylline)</w>
rSO 2.</w>
rIFNalpha2 b
rIFNalpha2b -based</w>
r= 0.7
r-pro UK
r-proUK -treated</w>
r- processing</w>
r ypt
r yp
r ylhydrazyl</w>
r ush
r uria</w>
r l)</w>
r k-
rk- Shi
rk-Shi ley</w>
r ing-
r b),</w>
r atic</w>
r ]</w>
r TPA</w>
r TM
rTM S,</w>
r P)</w>
r HuEPO-
rHuEPO- beta</w>
r FVIIa.</w>
r ATG</w>
r ACC</w>
r 2</w>
r /
r/ ATP</w>
r (21)</w>
quit ting</w>
quit oes</w>
quipa zine</w>
quipa zine,</w>
quinupristin/dalfop ristin.</w>
quinoxaline-2,3- dione)</w>
quinoxal in
quinox aline</w>
quinol one-associated</w>
quinol one-
quinol in-6-
quinid ine-treated</w>
quinid ine-related</w>
quineth olate</w>
quineth olate,</w>
quin tile,</w>
quin ti
quin one-induced</w>
quin one,</w>
quin ine-containing</w>
quin ine-
quin ine)</w>
quin azol
quinazol in
quinazolin ones</w>
qui et,</w>
quetiap ine:</w>
quetiap ine-induced</w>
quetiap ine)</w>
questionnai re;</w>
ques tions,</w>
quer cet
quercet in.</w>
quater nar
quaternar y-
quarter ly</w>
quar tiles.</w>
quantit ating</w>
quanti fication.</w>
quant um</w>
qualit ative/
qualitative/ quantitative</w>
qual ify</w>
quadric eps,</w>
quadr atic</w>
quadr ants.</w>
quad rap
quad azoc
qu it</w>
qu isi
quisi tion</w>
qu ifoli
quifoli aceae)</w>
qu enching</w>
qu amous</w>
q3 wks</w>
q12 h.</w>
q/ min</w>
q/ m2).</w>
q. d.</w>
q. d.
q od</w>
q i</w>
pyrrolo [
pyrrolo -
pyrrolidinyl) isoxazole</w>
pyrrolidino indoline</w>
pyrrolid ine-2,4-
pyrrolidine-2,4- dicarboxylic</w>
pyrro liz
pyrroliz idine
pyrrolizidine acetamide</w>
pyrimid ine,</w>
pyrimid in-4-
pyrimethamine- sulfadoxine.</w>
pyrilam ine,</w>
pyridyl) porphyrin
pyridyl)porphyrin ato</w>
pyridoxine- responsive</w>
pyridox ine-treated</w>
pyridox ine-dependent</w>
pyrido[2,1-b] oxazine</w>
pyridine- class</w>
pyrid yl)-
pyrid ine-induced</w>
pyrid in-3-ol</w>
pyri l
pyril amine</w>
pyri daz
pyrex ia.</w>
pyre throid,</w>
pyrazolo[4,3- e]
pyrazolo[4,3-e] -1,2,4-
pyrazolo[1,5- d]
pyrazol o</w>
pyrazinobut azone</w>
pyramid ale,</w>
pyloromy otomy</w>
pylori -positive</w>
pylori -negative</w>
pylori ,</w>
pye lography.</w>
py uria.</w>
py ema</w>
puzz ling</w>
puzz le</w>
putam en)</w>
put atively</w>
pust ules.</w>
purpura/ haemolytic</w>
purpur a;</w>
purpur a.</w>
purpo se-
pure- line</w>
pur ulent</w>
pur inoc
purinoc eptor</w>
pur ine-
pur ify</w>
pur ged</w>
pupil s.</w>
pup illopharmacological</w>
punc h</w>
pum p-
pump- perfused</w>
pulse- spray</w>
pulmon ale</w>
pul sel
puerperi um.</w>
puerperi um,</w>
puer ile</w>
publ icity</w>
pu ter</w>
ption/ ionization</w>
ptaz inol</w>
pt ual</w>
pt ing</w>
pt )</w>
pt ).</w>
psychotri dine.</w>
psychostimul ant,</w>
psychomot or
psycho therapy.</w>
psycho sis-
psycho sis)</w>
psycho pathology,</w>
psycho -active</w>
psycho -
psychiatri sts'</w>
psych omimetic</w>
psych ological,</w>
psi .</w>
pseudotum or,</w>
pseudo- randomized</w>
pseudo- allergy</w>
pseudo prolactinoma</w>
pseudo glandular</w>
pseudo ginseno
pseudoginseno side-F
pseudo ephedrine-induced</w>
pseudo ain
pseudoain h
pseudoainh um</w>
pseud ox
pseudox anth
pseud otonic</w>
pseud ocy
ps s)</w>
prun ing</w>
prun e</w>
proxymetac aine,</w>
proxim ally</w>
prox y.</w>
prox etil</w>
provo ked:</w>
provo ked.</w>
provid er-
provider- rated</w>
provi de,</w>
prov in
protr usions,</w>
protoporphy rin-IX</w>
protoporphy ria.</w>
protoc ol;</w>
protoc ol)</w>
proto oncogene</w>
proteoglyc ans</w>
proteinur ic.</w>
proteinur ia/
proteinuria/ day.</w>
proteinur ia-associated</w>
proteinur ia)</w>
proteinur ia).</w>
proteinur ia),</w>
protein/ creatinine</w>
protein- stabilized,</w>
protein- restricted</w>
protein- overload</w>
protein- based</w>
protein- 27</w>
protein s;</w>
protein s:</w>
protein ase,</w>
protein -1.</w>
protein -1,</w>
protein -1)</w>
protective '</w>
protective "</w>
protect ors</w>
protect or.</w>
protect ants</w>
prote us</w>
prote omic</w>
prote inemia,</w>
prote ase-
prote ase,</w>
prote an</w>
prot ected.</w>
prot amine,</w>
prostigmine- morphine</w>
prostigmine- morphine-induced</w>
prosthe ses</w>
prostan oids,</w>
prostagland in-treated</w>
prostagland in
prostadi l</w>
prost rate</w>
prost one,</w>
prost atitis.</w>
prost atic
prost ate:</w>
prost a
prospecti vely,</w>
pros ap
prosap osin-
prosaposin- derived</w>
propyl}- 3,3-diphenylpyrrolidin-2-one</w>
propylthiourac il-associated</w>
propyl- di
propyl-di ethoxy-
propyl-diethoxy- methyl-
propyl-diethoxy-methyl- phosph
propyl-diethoxy-methyl-phosph inic</w>
propyl) glycine</w>
propyl ene
propri ospinal</w>
propri onate</w>
propri oceptive</w>
propri oc
proprioc eption</w>
propranolol- pretreated</w>
propranolol- premedicated</w>
propranolol- insulin</w>
propranolol- ,</w>
propranolo l;</w>
propranolo l).</w>
propoxy phene,</w>
propos al.</w>
proportion ately</w>
proportion ality,</w>
propor tion,</w>
propofol/ mixtures</w>
propofol- suxamethonium</w>
propofol -associated</w>
propofol ).</w>
propion yl</w>
propion yl-CoA</w>
propion yl)
propion ate),</w>
propion aldehyde</w>
prophylac tics</w>
propentof ylline</w>
propen yl)-piperazine],</w>
proparac aine</w>
propan amide</w>
propafen one-induced</w>
propacetam ol:</w>
prop ul
prop ens
propens ity.</w>
prop ane-
prop -2-
prop -1-
proneth alol,</w>
pron or
pronor mo
pron ociception</w>
pron eness.</w>
promyelo cytes</w>
prompt s</w>
prompt ,</w>
promot er,</w>
promo tion-progression</w>
promo tion,</w>
promi se.</w>
promaz ine-
promazine- fluvoxamine</w>
prolong ations</w>
prolong ation:</w>
proligest one.</w>
prolifer ator
proliferator -induced</w>
prolifer ated</w>
prolactin- raising</w>
prolactin- producing</w>
prolactin- positive</w>
prolactin- lowering</w>
prolactin- elevating</w>
prolactin aemia,</w>
prolactin 's</w>
prolact inemic</w>
prolact in-induced</w>
prokinetic in</w>
project .</w>
project ,</w>
projec tions.</w>
proj ects</w>
progres sing,</w>
progres ses,</w>
progres sed,</w>
programm es.</w>
programm able</w>
program s,</w>
program ming.</w>
program me.</w>
progestogen -only</w>
progester one-
progester one)</w>
progester one's</w>
progestag ens,</w>
progestag en
progestagen s.</w>
progest ogens.</w>
progest ational</w>
progenit ors,</w>
progen y.</w>
progab ide.</w>
profil es:</w>
profession als.</w>
profen ),</w>
produc ts)</w>
produc tive</w>
produc ed:</w>
produc e.</w>
process or.</w>
proces ses:</w>
procedure -related</w>
procedur ally.</w>
procedur al,</w>
proced ures;</w>
proce ed
proc urement</w>
proc umbent</w>
proble ms:</w>
proble m;</w>
probenec id.</w>
probenec id-like</w>
probe -</w>
probable ],</w>
probable )</w>
prob it</w>
prob ing,</w>
prob ands</w>
prob and</w>
prob ability.</w>
prob ability,</w>
prob ab
probab ly"</w>
proanthocyanid ins,</w>
pro- opiomelanocortin</w>
pro- drug,</w>
pro- convulsive</w>
pro- brain</w>
pro- atherogenic</w>
pro- apoptotic</w>
pro- absence</w>
pro ved,</w>
pro states</w>
pro spects</w>
pro ptosis</w>
pro of-
proof- of-
proof-of- concept</w>
pro mul
pro gnos
prognos tic
pro glum
pro dysrhythmic</w>
pro collagen.</w>
pro cognitive</w>
pro arrhythmic
pro active</w>
pro acceler
proacceler in</w>
pro BNP</w>
pro BNP)</w>
pro )</w>
privan )</w>
priv an,</w>
pris ingly</w>
prior ;</w>
princip le
principle (s)</w>
prin t</w>
primin g)</w>
primigra vida,</w>
primi par
primat es:</w>
prima quine,</w>
prim ary.</w>
prim aries</w>
priloca ine.</w>
pric es,</w>
pric ed</w>
pri or/
prior/ sequential</w>
pri mer
primer s,</w>
pri me-induced</w>
pri ma</w>
prevent ed?</w>
prevent atively</w>
preven tion)</w>
preval ence.</w>
prevail s</w>
prevail .</w>
presyncop e.</w>
presum ptively</w>
presum able</w>
pressure- work</w>
pressure- pain</w>
pressure- natriuresis</w>
press ors.</w>
press ing,</w>
press in-resistant</w>
preserv atives</w>
present ed:</w>
present ative</w>
present ations.</w>
present ).</w>
prescription s).</w>
prescrip tions)</w>
prescrib ing,</w>
prescrib er</w>
preschool- halothane</w>
pres ystolic</w>
pres witch</w>
pres sions</w>
pres ence.</w>
pres age</w>
preponder ant</w>
prepar tum.</w>
prepa red.</w>
prepa re,</w>
prenyl amine.</w>
prenat ally.</w>
prenat ally,</w>
prenalter ol,</w>
premedic ated,</w>
premedic ants</w>
premedic ant</w>
premature ly;</w>
prematur ity</w>
prelimin arily</w>
pregnancy ).</w>
pregnanc ies)</w>
pregn enol
pregnenol one
pregnenolone -16</w>
pregn ane-
pregn an</w>
pregn a
preferen ces,</w>
preeclamp tic</w>
predomin ently</w>
predomin ated.</w>
predomin ant.</w>
prednisol one-treated</w>
prednisol one)</w>
prednis one;</w>
prednis one)</w>
prednis one),</w>
predis position,</w>
predis posed.</w>
predict ors.</w>
predic tive.</w>
predic ted.</w>
predic ted).</w>
pred nicarb
precur sor)</w>
precur ar
precurar ization.</w>
precoc ity.</w>
precipit ously</w>
precipit ant.</w>
preci sion</w>
preci sely,</w>
preci se,</w>
preced ent</w>
prece des,</w>
pre- treatment,</w>
pre- translational</w>
pre- training,</w>
pre- therapeutic</w>
pre- papaverine</w>
pre- neoplastic</w>
pre- infusion</w>
pre- incubation</w>
pre- hypotensive</w>
pre- haemodilution</w>
pre- exposure</w>
pre- established</w>
pre- defined</w>
pre- OLT</w>
pre- IVU</w>
pre- I</w>
pre- HDT</w>
pre- BMT</w>
pre- AMB</w>
pre trial</w>
pre treatment(EPI</w>
pre treated.</w>
pre transplantation</w>
pre study,</w>
pre set</w>
pre retinal</w>
pre randomization</w>
pre proteinuric</w>
pre pro</w>
pre planned</w>
pre partum</w>
pre pare
prepare dness</w>
pre pacing</w>
pre operativel
pre occlusion</w>
pre motor</w>
pre monit
premonit ory</w>
pre molar</w>
pre leukemic</w>
pre kallikre
prekallikre in,</w>
pre incubated</w>
pre incision</w>
pre hydration</w>
pre h
preh end</w>
pre expanded</w>
pre excited</w>
pre excitation.</w>
pre excitation,</w>
pre drug)</w>
pre dialysis</w>
pre dec
predec ess
pre dat
pre contrast</w>
pre communicating</w>
pre co
preco re/core</w>
pre central</w>
pre angiographic</w>
prazosin ;</w>
prazosin 's</w>
prazos in-treated</w>
pran olol.</w>
pralid oxime</w>
pralid oxime
pralidoxime -2-
pralidoxime-2- chloride</w>
practition ers;</w>
practition ers'</w>
practition er.</w>
practic al,</w>
practi ce:</w>
practi ce-
practice- based</w>
pra vastatin-induced</w>
pr amine-
pp(NH) p</w>
pp m
ppm PB</w>
power fully</w>
power ful
powerful ,</w>
pow ers</w>
pow er)</w>
potenti ation)</w>
potency :</w>
potassium- stimulated</w>
potassium- losing</w>
potassium- depleted</w>
potassium- conserving</w>
potassi um)</w>
pot entate</w>
postur al,</w>
postul ates</w>
postsynap tically.</w>
postrema .</w>
postrans plant)</w>
postpon ing</w>
postnat ally.</w>
postnat al.</w>
postischem ia,</w>
posthyp notic</w>
posteri or,</w>
poster obasal</w>
post-LT x</w>
post-CA B</w>
post-CA B).</w>
post- viral</w>
post- ventilatory</w>
post- treatment,</w>
post- transplant.</w>
post- status</w>
post- spinal</w>
post- renal</w>
post- paracetamol</w>
post- occlusive</w>
post- mortem.</w>
post- lidocaine</w>
post- ischaemic</w>
post- insult</w>
post- injury</w>
post- injection</w>
post- injection.</w>
post- infusion,</w>
post- implantation</w>
post- hepatectomy</w>
post- first</w>
post- exposure,</w>
post- exercise</w>
post- error</w>
post- dosing.</w>
post- discharge</w>
post- consolidation</w>
post- conceptual</w>
post- cocaine</w>
post- bone</w>
post- STEP</w>
post- SNP</w>
post- SE.</w>
post- SC</w>
post- OLT.</w>
post- IVU</w>
post- I</w>
post- HBIG</w>
post- DEC</w>
post urography</w>
post treatments</w>
post trauma.</w>
post transplantation.</w>
post transplant.</w>
post training</w>
post therapy.</w>
post test.</w>
post surgery</w>
post stress</w>
post steroid</w>
post resuscitation</w>
post remission</w>
post recumbency</w>
post pump</w>
post pubertal</w>
post procedure</w>
post procedural</w>
post phlebo
postphlebo graphic</w>
post operative,</w>
post occlusion</w>
post morphine</w>
post lesion</w>
post learning</w>
post intervention</w>
post injury</w>
post inflation,</w>
post industrial</w>
post fertiliz
postfertiliz ation)</w>
post exercise</w>
post epileptic</w>
post en
posten uria,</w>
post embed
postembed ding</w>
post ed</w>
post dural</w>
post dosing.</w>
post dobutamine</w>
post dialysis</w>
post conversion</w>
post coit
post cocaine</w>
post closure</w>
post cholecystectomy</w>
post chemotherapy</w>
post cardiotomy</w>
post capillary</w>
post bunionectomy</w>
post angiography</w>
post anaesthesia</w>
post alcoholic</w>
post /
post -treated</w>
possible '</w>
possible "</w>
possib le;</w>
positive/ disorganized</w>
positive ;</w>
position ing.</w>
posi tively.</w>
posi tion)</w>
posi t</w>
pos tic
pos thy
pos ses</w>
portun istic</w>
port .</w>
porphyrin ogenicity</w>
porphyr ins</w>
por ts</w>
por tray</w>
por tions.</w>
population- attributable</w>
popular ity.</w>
pop ularly</w>
poor- prognosis</w>
poor- metabolizer</w>
pool ed,</w>
pont ine-
pontine- cerebellar</w>
pon tis.</w>
pon s-
pon cirin,</w>
pom pic</w>
polysomno graphy.</w>
polysomno graphically</w>
polyribos ome</w>
polypo sis.</w>
polypeptide -</w>
polyp lo
polyp ectomy</w>
polymyosi tis:</w>
polymyosi tis,</w>
polymorph isms,</w>
polymorph ism)</w>
polymer ic</w>
polymer ases</w>
polym ers</w>
polygalasap onin</w>
polydyp sia,</w>
polyc hemotherapy,</w>
polyc ation</w>
poly-L- lacti
poly-L-lacti d</w>
poly- ADP-
poly-ADP- ribose</w>
poly- (ADP-ribose)</w>
poly valent</w>
poly urethane</w>
poly therapy.</w>
poly therapy,</w>
poly styrene</w>
poly specific</w>
poly serositis.</w>
poly phen
poly phasic</w>
poly pharmacy.</w>
poly pharmacy,</w>
poly p</w>
poly neuropathic</w>
poly neuritis</w>
poly graphically</w>
poly ethyleneimine</w>
poly disper
polydisper se</w>
poly dactyl
polydactyl y/arhinencephaly</w>
poly chlorinated</w>
poly bre
polybre ne
polybrene .</w>
poly -drug</w>
poly (ADP-
poly(ADP- ribose)
poly (
poly( butyl</w>
pollic is,</w>
pollaki uria,</w>
polar izing</w>
pol y</w>
pol ici
polici es</w>
pol ic
polic y.</w>
pol aro
poison s.</w>
poison ings.</w>
point s"</w>
point es'</w>
point ).</w>
poin te.</w>
poikilo thermic</w>
poi etin-
podocyte )</w>
podo phyl
podophyl lo
podophyllo toxin</w>
podi um/grid'</w>
podi atric</w>
pod ocyt
po we
po vidone-iodine</w>
po o
poo rest</w>
po .</w>
pneumoniti s;</w>
pneumon itis).</w>
pneumon ia;</w>
pneumon ectomy</w>
pneumon ectomised</w>
pneumo thorax</w>
pneumo peritoneum</w>
pneum ot
pneumot ac
pneumotac ho
pneumotacho graph.</w>
pneum ococci
pneum ocardi
pmol/ rat)</w>
pmol/ ml</w>
pmol/ L,</w>
pmol/ L
pmol/L -1;</w>
pmol/ 0.5</w>
pmol .
pmol. mm
pmol.mm -1.
pmol.mm-1. min-1,</w>
plus- lorazepam</w>
plug s.</w>
plug s,</w>
plic or</w>
plic it</w>
plex opathy</w>
plex itis.</w>
plex iform</w>
pleur is
pleur a.</w>
plethysmo graphy,</w>
plethysmo graph</w>
plekhh 2,</w>
pledg ets</w>
ple ocytosis,</w>
ple ased</w>
play ers</w>
plausib ility,</w>
plau sibility</w>
platypnea-orthodeox ia-like</w>
platypnea-orthodeox ia,</w>
platin um(II)</w>
platin ating</w>
platform- size</w>
platelet- reactive</w>
platele ts/mm3</w>
platele ts)</w>
platele t/
platele t,</w>
plateau ing</w>
plateau .</w>
plate -like</w>
plat in-related</w>
plat form,</w>
plat es.</w>
plasmacy tosis</w>
plasmacy tosis.</w>
plasmacy toma.</w>
plasma- level</w>
plasma perfusion</w>
plasma :</w>
plasma -derived</w>
plasma -cell</w>
plasm alo
plasi c</w>
plas ties.</w>
plas tic,</w>
plaqu es,</w>
plaqu e-like</w>
plaqu e,</w>
plant 's</w>
plani metry</w>
placent a.</w>
placebo- baseline</w>
plac ed.</w>
pl uri
pl ants,</w>
pkr 1</w>
pituitary- testicular</w>
pituitary- ovarian</w>
pituitary- gonadal</w>
pituit aries,</w>
pituit ari
pituitari es.</w>
pith ing</w>
pith ing.</w>
pit fall</w>
pit ch</w>
pit ation</w>
pit al</w>
piroxicam )</w>
piroxantr one,</w>
piribe dil</w>
piri de.</w>
piri de,</w>
piret an
piracetam 's</w>
pir acetam.</w>
piperidine- 3alpha-
piperidin-4- yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)</w>
piperidin-1- yl-
piperidin-1- yl)</w>
piperid inyl)
piperidinyl) hexyloxy
piperidinyl)hexyloxy ]-
piperidinyl)hexyloxy]- 3-methyl
piperidinyl)hexyloxy]-3-methyl flavone</w>
piperid ine-based</w>
piperid ine-1-
piperidine-1- oxyl</w>
piperazin-1- yl)-2-
piperazin-1- yl)
piperazin yl]-3-phenylpropan-2-ol</w>
piperazin yl)butyl]-2-naphthamide]</w>
piperaz ino]
piperazino] butyl]-
piperazino]butyl]- 4-methyl-
piperazino]butyl]-4-methyl- 2
piperazino]butyl]-4-methyl-2 H,
piperazino]butyl]-4-methyl-2H, 4H
piperazino]butyl]-4-methyl-2H,4H -1,2,4-
piperazino]butyl]-4-methyl-2H,4H-1,2,4- triazin-3,5-dione</w>
piperaz ine),</w>
piperaz ine
piperazine dione</w>
piperacill in/
piperacill in-
piper oxane</w>
pinacidi l's</w>
pin- prick</w>
pin ching</w>
pin ch
pimoz ide-treated</w>
pilocarpine- stimulated</w>
pilocarpine- epileptic</w>
pilocarp ine;</w>
pilocarp ine/
pilocarpine/ timolol</w>
pilocarp ine),</w>
pilo- saline</w>
pilo ts.</w>
pilo t-
pill -related</w>
pide m,</w>
picrotoxin in,</w>
picrotox in)</w>
pic tro
pic rylhydrazyl</w>
pic om
pic obenz
picobenz ide</w>
pic ked</w>
pic a,</w>
pi val
pi rosis</w>
pi renperone</w>
pi r</w>
pi pet
pipet te</w>
pi pem
pipem idic</w>
pi p</w>
pi on
pi g,</w>
pi -
phytomen adi
phyto therapeutic</w>
phyto hem
phyto haem
phytohaem agglutinin</w>
phyto estrogens</w>
phyto estrogens,</w>
physiopath ologic</w>
physician- reported</w>
physic ally-
physically- limited</w>
physi opathological</w>
physi ologically.</w>
physi ol.</w>
phyll um</w>
phy ton</w>
phy g
phyg mo-
phthal mitis</w>
phthal imido
phthalimido )
phthalimido) butyl]
phthalimido)butyl] piperazine</w>
photosensi tivity,</w>
photograph s,</w>
photograph ed</w>
photodi stributed</w>
photoc o
phot otoxicity</w>
phot otoxicity,</w>
phot ostimulation</w>
phot ore
phot ometry.</w>
phot ometric</w>
phot ography</w>
phot o-
phosphoryl choline</w>
phosphoryl ation,</w>
phosphoryl ated
phosphorylated :
phosphorylated: total</w>
phosphoramid on,</w>
phosphono- heptanoate</w>
phosphono valeric</w>
phosphono phenylglycine</w>
phosphon ate,</w>
phosphomon o
phospholipid- laden</w>
phospholip idosis.</w>
phosphoinositi de-
phosphoinositide- coupled</w>
phospho- Thr-34</w>
phospho- ERK1/2</w>
phospho kinase-MB</w>
phospho hydrolase</w>
phospho ERK</w>
phosphatidylethan olamine</w>
phosphatidyl serine/phosphatidylcholine</w>
phosphatid yl-
phosphati dic</w>
phosphate- supplemented</w>
phosphat uria,</w>
phosph oline</w>
phosph in
phosph ate)</w>
phorbol-1 2,
phorbol-12, 13-
phorbol-12,13- di
phor a</w>
phon oph
phlor acetophen
phloracetophen one</w>
phlebo graphy</w>
phleb otomy</w>
phleb it
phlebit ogenic</w>
pherom one</w>
pheochromocyt omas,</w>
phenytoin "</w>
phenyto in;</w>
phenyto in:</w>
phenylpropanol amine)</w>
phenylpiperaz ine.</w>
phenylmethyl sulfonyl</w>
phenylethyl malon
phenylethylmalon amide</w>
phenylethanolamine-N-methyl transferase</w>
phenyleth yl-6-AzUd</w>
phenyleth yl)-2-(2-furyl)-pyrazolo[4,3-epsilon]-1,2,4-
phenyleph edrine</w>
phenyldi guan
phenylbiguan ide-</w>
phenylbenzo quinone-induced</w>
phenylalan ine-
phenyl-3- piperidin
phenyl-2- propenyl)-piperazine],</w>
phenyl-2 (5
phenyl-2(5 H)-
phenyl-2(5H)- furan
phenyl-2(5H)-furan on)</w>
phenyl-1,3- dise
phenyl-1,3-dise len
phenyl-1,3-diselen ole</w>
phenyl-1,2,3,6-tetrahydro pyridine</w>
phenyl-1, 3,
phenyl-1,3, 8-
phenyl-1,3,8- triaz
phenyl- 4-
phenyl- 4,</w>
phenyl- 3,
phenyl-3, 3a-
phenyl-3,3a- dihydro-
phenyl-3,3a-dihydro- 4-
phenyl-3,3a-dihydro-4- oxo-5-
phenyl)-piperazin-1-yl]- 2-hydroxy-
phenyl)-piperazin-1-yl]-2-hydroxy- propyl}-3,3-diphenylpyrrolidin-2-one</w>
phenyl)-8- pyrrolizidineacetamide</w>
phenyl)-4- methyl
phenyl)-4-methyl -1H-pyrazole-3-carboxamide
phenyl)-4- [4-(2-
phenyl)-4-[4-(2- phthalimido)butyl]piperazine</w>
phenyl)-4- (4-methyl
phenyl)-4-(4-methyl sulphonyl)</w>
phenyl)- 8,9-
phenyl)-8,9- dihydro-
phenyl)-8,9-dihydro- 8-
phenyl)-8,9-dihydro-8- methyl-
phenyl)-8,9-dihydro-8-methyl- 7H
phenyl)-8,9-dihydro-8-methyl-7H -1,3-di
phenyl)- 3-
phenyl)- 3,5-
phenyl)- 3(2H)-pyridazinon-
phenyl)-3(2H)-pyridazinon- 2-propion
phenyl)-3(2H)-pyridazinon-2-propion amide</w>
phenyl nitrone</w>
phenyl ind
phenyl enediamine</w>
phenyl acetyl
phenyl -2'-
phenyl-2'- cyclopent
phenyl-2'-cyclopent yl-2'-hydroxy-ethoxy)tropane</w>
phentermine- fenfluramine</w>
phenterm ine).</w>
phent o
phenoxy) butyrate</w>
phenoxy methyl</w>
phenoxy isobut
phenoxy )-
phenotyp ing.</w>
phenotyp ically</w>
phenothiaz ine-associated</w>
phenomen on;</w>
phenomen ological</w>
phenobarbital- like</w>
phenobarbital- containing</w>
phenobarbit one-</w>
phenethyl ene
phenethylene glycol</w>
phenethyl biguanide</w>
phenethyl amine</w>
phenelz ine-induced</w>
phenelz ine-associated</w>
phenelz ine-
phencyclid ine/
phencyclidine/ NMDA</w>
phenaz opyridine.</w>
phenacetin- fed</w>
phenacet in-induced</w>
phen ol,</w>
phen ol
phen oid</w>
phen for
phen erg
phen azone</w>
phen anthrene</w>
phen anth
phenanth ridin
phe lebitis</w>
phasi cally</w>
phasi c,</w>
phased- tracking</w>
phase- contrast</w>
phas e
pharyng itis.</w>
pharmacore sistant</w>
pharmacologic al-induced</w>
pharmacologic al)</w>
pharmacokine tically</w>
pharmacokine tic/
pharmacokine tic-dynamic</w>
pharmaco economic</w>
pharmac omechan
pharmacomechan ical</w>
pharmac ologically.</w>
pharmac ologically,</w>
pharmac ologic,</w>
pharmac ist.</w>
pharmac ies</w>
pharmac eutic</w>
phag ocytosis.</w>
phag ia.</w>
phaeochromocyt oma,</w>
phacoemulsi fication.</w>
ph ox</w>
ph ox,</w>
ph oton
ph osis</w>
ph orb
phorb ol</w>
ph ocamp
phocamp ylus</w>
ph ine,</w>
ph ased</w>
ph ar
ph al</w>
ph 1(-/-)</w>
pg/m L.</w>
pg/m L);</w>
pg/ ml/
peth id
pet rosal</w>
pess ary</w>
perturb s</w>
perturb ations,</w>
perturb ation.</w>
pertin )</w>
pert ussis-tetanus</w>
perspec tives</w>
personne l,</w>
person- years;</w>
person- years).</w>
person ally</w>
person ality,</w>
person 's</w>
persist ant</w>
persec utory</w>
peroxy nitrite.</w>
peroxy nitrite,</w>
peroxy l</w>
peroxisom es.</w>
peroxisom es,</w>
peroxidase- anti
peroxidase-anti peroxidase</w>
peroxidase- 1</w>
peroxid ative,</w>
peroxid ation/
peroxidation/ oxidant</w>
peroxid ase)</w>
pernio sis,</w>
permit s.</w>
perme ant</w>
perme ability/
permeability/ injury,</w>
perman ently.</w>
perman ent.</w>
perman ence</w>
peritone um.</w>
peristal sis</w>
peristal sis,</w>
peripheral- vascular</w>
peripher al)</w>
periodic ,</w>
period s:</w>
period s).</w>
period .(ABSTRACT</w>
perinuclear- ANCA</w>
perineur ial</w>
perind opril,</w>
perin ates</w>
perimen opausal</w>
peril ymph
perikary al</w>
perid ol.</w>
pericon cep
periconcep tional</w>
pericardiocent esis.</w>
pericardi tis;</w>
peric y
peric ranial</w>
peric aval</w>
peric ard
peria ortic</w>
peri- sinusoidal</w>
peri ventricular,</w>
peri vascular
peri par
peripar tal</w>
peri oc
perioc ularly</w>
peri metric</w>
peri hemat
perihemat omal</w>
peri bronchial</w>
peri apical</w>
peri anal</w>
perhexil ine,</w>
perform ances,</w>
perform ance
perfor ations</w>
perfor ant-
perf using</w>
perf used-
percept ual,</w>
percenti le;</w>
percenti le:</w>
percenti le
percent ual</w>
percent age,</w>
per- kilogram</w>
per- and-
per-and- pencil</w>
per turb</w>
per technetate</w>
per pend
perpend icular</w>
per ical
perical losal</w>
per col
percol ated</w>
per ative.</w>
per amide,</w>
peptide- Y</w>
peptide(1- 42
peptide(1-42 )-
peptide(1-42)- infused</w>
peptide -like</w>
pepti de-induced</w>
pepti d
peop le:</w>
penum bra</w>
pentylenetetrazole- ,</w>
pentylene tetrezol</w>
pentoxy resorufin-O-dealkylase</w>
pentoxy if
pentoxyif ylline</w>
pentobarbitone- anaesthetized</w>
pentobarbital- ,</w>
pentobarbit alized</w>
pentetra zole</w>
pentetra zole,</w>
pentazoc ine-treated</w>
pentamid ine-
pentamidine- associated.</w>
pentamid ine's</w>
pentagastr in-stimulated</w>
pentadec apeptide,</w>
pentachloro biphenyl</w>
penta valent</w>
pent o
pent ane
pentane -1,3,4-tricarboxylic</w>
penicillinase- resistant</w>
penicillin- allergic</w>
penicillin- G,</w>
penicill ins,</w>
penetran ce</w>
penetr ation,</w>
penetr ation)</w>
penetr ant</w>
pen is,</w>
pen but
pen al
pen -shaped</w>
pemph i
pemphi gu
pemphigu s.</w>
pem oline,</w>
pelv oc
pelvoc aly
pelvocaly ce
pelvocalyce al</w>
pellet s)</w>
pellet /
pellet/ supernatant</w>
peg ylation</w>
peg interferon.</w>
peg IFN-alpha</w>
peer- review.</w>
pedunc les</w>
pedic led</w>
pedi s</w>
pedi atrics</w>
pedi atrici
ped ance</w>
pec ac</w>
peak- to-
peak- plasma</w>
peak- forming</w>
peak- diastolic</w>
peak- T
peak-T end</w>
pea ks.</w>
pe sia</w>
pe floxacin,</w>
pe eled</w>
pe el-
peel- away</w>
pe dig
pe d.</w>
pctx-then-cisDD P,</w>
paw-lick/ lift</w>
paw- pad.</w>
pattern s:</w>
pattern ;</w>
pattern :</w>
patter n-
patient- year)</w>
patient- months</w>
patient s]</w>
patient s--a</w>
patient s"</w>
pati c</w>
patholog y;</w>
patholog y-proven</w>
patholog ist.</w>
pathogn omon
pathognomon ic,</w>
pathogene tical</w>
path ies,</w>
path ia.</w>
pat z</w>
pat ory</w>
pat er
pater nal</w>
past ),</w>
pass age.</w>
pas sionate</w>
pas sed.</w>
pas es</w>
parvalbumin -</w>
parvalbumin -
parturi tion,</w>
parturi ents,</w>
parturi ent.</w>
participant s;</w>
partic ular
parti ally.</w>
parti al.</w>
part ne
partne red</w>
part ly.</w>
part )</w>
paroxet ine;</w>
parox ysms.</w>
parox ys
parom omycin.</w>
parom omycin,</w>
paro us,</w>
parietal- occipital</w>
pariet al,</w>
paresthesi as)</w>
paresthesi ae.</w>
paresthe sia.</w>
paren the
paren t-
parec oxib</w>
parec oxib,</w>
paraver tebral</w>
parathyroid ectomy.</w>
parathyro ids</w>
parat yrosine,</w>
parasit emia.</w>
paras ympathe
paras om
parasom nia</w>
paras agittal</w>
paraphil ia.</w>
paraph ilic</w>
paraph er
parapher nal
paraphernal ia</w>
parap silosis</w>
parap legia.</w>
parap are
parano ia:</w>
paran oidal</w>
paran asal</w>
parameter s)</w>
parameter ),</w>
param yotonia</w>
param edical</w>
paralle lled</w>
paralle l.</w>
paraff in</w>
paraesthesi as,</w>
paraesthe sias</w>
paradig ms:</w>
paradig matic</w>
paradig m;</w>
paradig m),</w>
parad ox</w>
paracetam ol/
paracetamol/ day.</w>
paracetam ol)</w>
parac rystalline</w>
para-aminohipp uric</w>
para- chlorophenylalanine</w>
para ventricular,</w>
para ox
para aminohipp
par v
par ty</w>
par rot-be
par onych
par ity.</w>
par gly
par axial</w>
par ations</w>
par ati
par aspinal</w>
par aqu
par amethas
paramethas one.</w>
par aldehyde.</w>
papio .</w>
papillo toxic</w>
papillo edema</w>
papill ae,</w>
pap io</w>
pap a
papa veret
pantoprazol e-induced</w>
panto thenate</w>
pannicul itis)</w>
panick ers,</w>
panhypopituitar ism</w>
pancuronium- narcotic</w>
pancreatitis ).</w>
pancreati co
pancreatico biliary,</w>
pancre atic,</w>
pancre atic
panc reat
panc reas,</w>
panames ine</w>
pan- gastrointestinal</w>
pan- caspase</w>
pan ze
pan or
pan ipenem</w>
pan el.</w>
pan .</w>
pan ,</w>
pamidron ate.</w>
pamidron ate,</w>
pame zole.</w>
palsy ;</w>
palmit ate.</w>
pallid otomy,</w>
pall or.</w>
pall ido
pallido thalamic</w>
pal sies,</w>
pal pebral</w>
pal pation,</w>
pal mi
palmi tic</w>
pal at
paired- click</w>
pair ings</w>
painful .</w>
pain/ haematuria</w>
pain- signaling</w>
pain- relieving</w>
pain- producing</w>
pain- on-
pain-on- injection</w>
pain- modulating</w>
pain- inten
pain-inten sity-
pain- inducing</w>
pain t</w>
pain s)</w>
pain kill
pain ?</w>
paedi atricians</w>
pad s.</w>
pad )</w>
paclitaxel/ cisplatin.</w>
paclitaxel- cisplatin-etoposide</w>
paclitaxel );</w>
paclitaxel ).</w>
paclitaxel 's</w>
pacemak er;</w>
pace ).</w>
pac ket</w>
pac ing;</w>
pac e</w>
pac e,</w>
pa z</w>
pa yment</w>
pa yer</w>
pa ve</w>
pa uses.</w>
pa use.</w>
pa statin</w>
pa ron</w>
pa r</w>
pa per-and-pencil</w>
pa kot
pa k
pa 1-
pH- dependent</w>
p=0.00 8)</w>
p=0.00 7).</w>
p=0.00 2).</w>
p=0.0 7).</w>
p= ns).</w>
p= 0</w>
p= 0.9
p= 0.05
p= 0.01).</w>
p= 0.001).</w>
p= 0.001),</w>
p= 0.000
p< 0.05,</w>
p< 0.05),</w>
p< 0.02).</w>
p< 0.005).</w>
p< 0.002).</w>
p< 0.0001,</w>
p75NTR- containing</w>
p53- mediated</w>
p/ L
p.p. m.)</w>
p.o .
p. S9
p-coumar ate,</w>
p-chloro phenoxyisobut
p-chloro amphetamine,</w>
p-aminohipp uric</w>
p-aminohipp ur
p- sulfo
p- isopropyl-
p-isopropyl- iminodiacetic</w>
p- iodo
p- hydroxy
p- gp</w>
p- glycoprotein</w>
p- enhancing</w>
p- dimethylamino
p-dimethylamino azobenzene</w>
p- cre
p-cre sidine</w>
p- cho
p-cho loro
p-choloro aniline</w>
p- aminophenol</w>
p- F-
p-F- H
p-F-H H
p-F-HH Si
p- AP</w>
p- (2-
p-(2- carboxy
p-(2-carboxy ethyl)</w>
p,p- D
p,p-D DE,</w>
p y</w>
p ure
p tional</w>
p tion-Event</w>
p son</w>
p seydoakathisia</w>
p ox,</w>
p our</w>
p oun
poun ds,</w>
p oli
p ocket</w>
p mole</w>
p ing,</w>
p ine:</w>
p cid
p add
p ]</w>
p Rh</w>
p M</w>
p KB</w>
p K(i)=
p F)</w>
p En
p Cl
pCl Phe
p CPA-
pCPA- pretreated</w>
p ANCA</w>
p ANCA-positive</w>
p A</w>
p A2
pA2 gat
pA2gat a
pA2gata 1-
pA2gata1- DYRK3</w>
p 53.</w>
p 11.2</w>
p .,</w>
ozone- sparing</w>
ozone- depleting</w>
oxytocin- ergometrine</w>
oxytoc in-induced</w>
oxyphenbutaz one.</w>
oxyphen is
oxyp urinol</w>
oxymorph one-induced</w>
oxymeth olone,</w>
oxygen- 88%</w>
oxygen ated</w>
oxygen -15-labeled</w>
oxygen ).</w>
oxygen ),</w>
oxybu procaine.</w>
oxybu procaine,</w>
oxy]- tropane</w>
oxy resorufin</w>
oxy metazol
oxo-5- thia-1-azabicyclo
oxo glutarate</w>
oxide/ cyclic-GMP</w>
oxide- redox</w>
oxidase- negative</w>
oxidase- B</w>
oxidant /
oxidant/ anti-oxidant</w>
oxidant -mediated</w>
oxid ative-
oxidative- nitrosative</w>
oxid ase).</w>
oxid ability</w>
oxic ity,</w>
oxic am.</w>
oxic -induced</w>
oxib :</w>
oxi dised</w>
oxcarbazep ine-treated</w>
oxcarbazep ine-induced</w>
oxazolid inone</w>
oxazolid inone,</w>
oxazol idinedi
oxazolidinedi one,</w>
oxaproz in,</w>
oxantr one,</w>
oxandrolon e.</w>
oxandrolon e,</w>
oxalo acetate</w>
oxaliplat in-based</w>
oxalate- rich</w>
oxal ate.</w>
oxal act
oxalact am,</w>
oxadiaz olo-
oxadiaz olo
oxacill in.</w>
oxacill in-associated</w>
oxac in-treated</w>
ox- CBZ</w>
ox ycantha),</w>
ox orubic
ox onidine</w>
ox on-induced</w>
ox od
ox ip
ox ious</w>
ox genase</w>
ox azole</w>
ox azepam.</w>
ox amide.</w>
ox acin.</w>
ow ic
owic z,</w>
ow ,</w>
ovul ation.</w>
overwhel med</w>
oversho oting</w>
overri des</w>
overload ing.</w>
overload ing,</w>
overload )</w>
overlap )</w>
overex pressing,</w>
overex presses</w>
overex press</w>
overex posure</w>
overestim ation</w>
overestim ate</w>
overdose -induced</w>
over- the-
over weight.</w>
over tly</w>
over stimulation.</w>
over sion</w>
over sensitivity</w>
over production.</w>
over night,</w>
over medication.</w>
over loaded</w>
over flowing</w>
over dose;</w>
over contraction</w>
over came</w>
over activity:</w>
ovari ectom
ovari an/
ovarian/ peritoneal</w>
oval bumin
ovalbumin -induced</w>
ov x</w>
ov ic</w>
output s.</w>
output ;</w>
output )</w>
outcom es;</w>
outcom e)</w>
outbreak .</w>
out- patients.</w>
out- patients)</w>
out stretched</w>
out side-in</w>
out performs</w>
out patients:</w>
out numbered</w>
out lining</w>
out lier</w>
out door</w>
ous- system</w>
ous ;</w>
ous /
ous/ depressive</w>
our ,</w>
oun sfield</w>
ouma rol,</w>
ouabain- intoxicated</w>
ouabain :</w>
ouabain /kg</w>
ouab ag
ouabag enin</w>
ou treach</w>
ou sy.</w>
otroph in-induced</w>
otroph in-1</w>
otrop e</w>
otri meric</w>
otri dine</w>
otrans plantation</w>
otoxic ity-
otox ity</w>
ototoxic .</w>
otop ical</w>
oton ic,</w>
otom ized</w>
otom ies.</w>
otolaryng ological</w>
oto protection</w>
oto -</w>
other wise,</w>
other s)</w>
other ;</w>
other -
oth on
othon us,</w>
otet anus</w>
otax ime
otax ic</w>
ot ubular</w>
ot s</w>
ot runcal</w>
ot rin)</w>
ot rache
ot otopical</w>
ot or
otor hinolaryng
ot opi
ot ele
otele metric</w>
ot axis</w>
ot as
otas semia</w>
ot arizine</w>
ot age
ot -
osyn thesis</w>
osup pression</w>
osteosarcom as.</w>
osteop ont
osteopont in,</w>
osteomalac ic</w>
osteomalac ia.</w>
osteoc ar
osteocar tilaginous</w>
osteoc alc
osteocalc in</w>
osteo arthritis:</w>
osten sibly</w>
oste otomy.</w>
oste otomies.</w>
oste osarcoma,</w>
oste openia.</w>
oste openia,</w>
oste oid</w>
ost atics</w>
osper mia,</w>
ospec ific</w>
osom es,</w>
osom al-
osomal- dominant</w>
osmoly te</w>
osmolar ity.</w>
osmol ar)</w>
osmol )</w>
osi tioning</w>
osi tion</w>
osi s)</w>
osi s),</w>
osi er</w>
osclero derma</w>
oscillop sia.</w>
oscillop sia,</w>
oscill ation,</w>
oscil logram
oscillogram s</w>
osarcom as</w>
osarcom as,</w>
osa e),</w>
os ympathetic</w>
os ub
os pirosis</w>
os mio
osmio philic</w>
os ity,</w>
os ine,</w>
os ha
osha -j
osha-j ink
osha-jink i-
osha-jinki- gan</w>
os able</w>
os M</w>
os (t
os(t )
os(t) ide</w>
orthost asis,</w>
orthopa edic,</w>
orthop nea,</w>
orthop e
orthope dist
orthobenzo ate)</w>
orth otropic</w>
orth optic</w>
orth olog
ors --
ors "</w>
orrho e
orphenad rine.</w>
orph ine
oro tracheal</w>
oro t
oro stral</w>
oro pharynx</w>
oro logic</w>
ornith ine.</w>
ormad inone</w>
orm ic
ormic um)</w>
orlistat .</w>
orlistat -assisted</w>
origin ,"</w>
orig in;</w>
ori enting</w>
ori entate</w>
ori ens,</w>
ori -motor</w>
orgas mia,</w>
organophosph ates</w>
organophosph ate.</w>
organochlor inated</w>
organo platinum</w>
organ om
organ izations</w>
organ isms,</w>
organ -specific</w>
org an,</w>
ordin ately</w>
ord inal</w>
ord able</w>
orcipren al
orciprenal ine.</w>
orchi ectomy,</w>
orchi ectomized</w>
orch itis</w>
orb it.</w>
orb id</w>
oran dil</w>
orally- treated</w>
orally- administered</w>
or/ and</w>
or- promoting</w>
or- free,</w>
or yl
or y's</w>
or y"</w>
or s)</w>
or ly</w>
or g/
or derly</w>
or dered</w>
or den
orden -S
orden-S patz</w>
or ax
or ating</w>
or ;</w>
opyrrolid ine-2,4-
opyrrolidine-2,4- dicarboxylate</w>
opyri mid
opyri da
opyrida zine</w>
opyr one</w>
opyr in,</w>
optim ise</w>
optim al,</w>
opri de,</w>
oprecipit ate,</w>
opre vention</w>
oposi tivity</w>
opor tal</w>
opoiet in-like</w>
opisthoton us,</w>
opisthoton os,</w>
opiperid ine-2-
opiperidine-2- carbon
opiperidine-2-carbon yl-L-leucyl-L-proline</w>
opiper az
opiperaz inyl)
opiperazinyl) benz
opiperazinyl)benz imidazole</w>
opioid- tolerant</w>
opioid- receptor</w>
opioid- naive</w>
opioid- agonists,</w>
opioid /
opioid -mediated</w>
opioid -</w>
opiate- receptor</w>
opiate- naive</w>
opiate- exposed</w>
opi ate-like</w>
ophthalmolog y.</w>
ophthalmo pathy.</w>
ophthalmo pathy,</w>
ophthalm oscopy</w>
ophthalm oscopy.</w>
ophthalm itis,</w>
ophosph or
ophil ia</w>
oph ore
oph erol</w>
oph aryng
oph agic</w>
oph agen</w>
oper fused</w>
oper culo
operculo insular</w>
open- labele
open-labele d.</w>
open- chamber</w>
open ing.</w>
open ing,</w>
open ic</w>
open ers</w>
open ers,</w>
open er.</w>
open er)</w>
opath y"</w>
opath ies</w>
opac ities.</w>
opac ification.</w>
op ur
op ulation</w>
op tions,</w>
op tion,</w>
op tically</w>
op tica</w>
op t</w>
op sychiatric</w>
op poses</w>
op ontin</w>
op ont
opont ocerebellar</w>
op ium</w>
op ist
opist othonus,</w>
op ia</w>
op anax</w>
op 's</w>
onychomy co
onucle osis</w>
onset ;</w>
onset )</w>
onse ts</w>
onse t-to-
onse t-of-dose</w>
onorgest rel</w>
oni on
oni ine,</w>
ong- Tang</w>
ong .</w>
oneur ons</w>
oneph ro
one/ acetaminophen</w>
one- to-
one- supplemented</w>
one- sensitive</w>
one- on-
one-on- one</w>
one- forming</w>
one- ethinyl</w>
one- cyclophosphamide</w>
one- -a</w>
one utr
one urium</w>
one +
one )-treated</w>
oncolog y;</w>
oncolog ist</w>
oncolog ist.</w>
once-per- day</w>
once ;</w>
once /day</w>
once ),</w>
onc ocytic</w>
onab ant)</w>
on- specific</w>
on- period</w>
on- intron</w>
on y-Glycyrrhiza</w>
on wards</w>
on ous</w>
on our</w>
on ly:</w>
on lay</w>
on lay
on l
onl ays</w>
on ins</w>
on idazole</w>
on ic)</w>
on g,</w>
on en</w>
on d.</w>
on cirin,</w>
on be
onbe l)</w>
on ally</w>
on ally,</w>
on -related</w>
omyelo pathy</w>
omyelo ce
omyeloce le</w>
omyc in-associated</w>
omodul ator</w>
omni phagia.</w>
omni paque</w>
omin eral</w>
omicro scope</w>
omethoxy- 3
omet rium</w>
omet abolism</w>
omer s)</w>
omer ca
omerca zole).</w>
omeprazol e:</w>
omen orrhea</w>
omen cl
omega- oxidative</w>
omega- ag
omega-ag atoxin</w>
omega- Con
omega-Con otoxin</w>
omega -</w>
omega -1</w>
omediast in
ome trically.</w>
ome ter,</w>
ome promazine</w>
ome dic
omat osis:</w>
omasti a,</w>
omalac ia</w>
omal ies</w>
oma- -a</w>
om yst
om udex)</w>
om pa
om ized</w>
om inous</w>
om ial</w>
om ery</w>
om edical</w>
om agne
ology/ American</w>
ologist s;</w>
ologist 's</w>
ologic .</w>
olog us</w>
olog ously</w>
olo l)</w>
olmesart an)</w>
oll is</w>
oliv opontocerebellar</w>
olith iasis,</w>
olip ids</w>
oligonucleoti des,</w>
oligodendro glioma</w>
oligodendro glioma.</w>
olig ur
olig omenorrhea</w>
ole- treated</w>
ole ic</w>
ole board,</w>
olar ization</w>
olar -arterial</w>
olanzapine/ risperidone</w>
olab eling</w>
ol- unexposed</w>
ol- defined</w>
ol- containing</w>
ol- compared</w>
ol- 5-
ol s/
ol onic</w>
ol ones</w>
ol one-induced</w>
ol itis.</w>
ol itis,</w>
ol ite</w>
ol is,</w>
ol ine-</w>
ol ine-3-
oline-3- carboxylate</w>
ol id
ol icus</w>
ol i</w>
ol factor
olfactor y-
ol evulinic</w>
ol e)</w>
ol ds</w>
ol d;</w>
ol d
ol azone</w>
ol ac
olac oides</w>
oint ments.</w>
oid/ Susp
oid/Susp icious</w>
oid- lipofuscin
oid -mediated</w>
oh y</w>
oh onen</w>
oh land</w>
ograph ic,</w>
ogest rel</w>
ogen icity.</w>
ogen es,</w>
ogen -activated</w>
ogen )</w>
offic es.</w>
off- line.</w>
off- lic
off- label</w>
off- cells</w>
off ices</w>
off -cell</w>
of- the-tiger</w>
of- care</w>
of (B(t
of(B(t )dt/B(t
oestrogen ized</w>
oedema ;</w>
odul es.</w>
odo rous</w>
odilat or</w>
odi pir</w>
odd ball</w>
od s.</w>
od or,</w>
od on
od -dependent</w>
ocytopen ic</w>
ocyte- restricted</w>
ocyte -derived</w>
ocyte )</w>
ocycl azocine</w>
ocy tic.</w>
ocy clo
ocyclo -
ocyclo- pentane-1,3,4-tricarboxylic</w>
ocur rence</w>
oculog ram</w>
octahydro benzo(f)
octahydrobenzo(f) quinoline</w>
oct yl]-L-alan
oct ano
ocr atic</w>
ocorm ia,</w>
ocor onary</w>
ocon trac
ocom promised</w>
ococc us.</w>
oco e
ocil pine</w>
och ran
och le
ocel es,</w>
occurren ces.</w>
occurren ce
occurrence ?</w>
occupati onally</w>
occupati on.</w>
occlu sions.</w>
occlu sion;</w>
occlu sion-
occlu sion)</w>
occlu ded,</w>
occl udin</w>
occipit al,</w>
occasion ed</w>
occasion ally.</w>
occa sion,</w>
occ id
occid ent
occident alis)</w>
ocap ill
ocapill aris</w>
ocal orie</w>
oca val</w>
oca ine-induced</w>
oc ular-
oc t-2-ene-2-
oc rit
oc lobem
oclobem ide</w>
oc k</w>
oc ity</w>
oc iliary</w>
oc ellular-
oc E)</w>
obvi ating</w>
obvi ates</w>
obul lous</w>
obtur ators</w>
obtun ding</w>
obt use</w>
obstruc ted.</w>
obstetr ics</w>
obstac les</w>
obstac le</w>
obses sive-compulsive-like</w>
obses sions</w>
obses sion</w>
observer-bl inded</w>
observ able-
observable- effect</w>
obser ver-
obser ver,</w>
obliter ative</w>
obliter ation,</w>
obliter ated</w>
oblast omas</w>
oblast -
oblast- transplanted</w>
object s.</w>
obj ectively,</w>
obj ective,</w>
obit ridol,</w>
obes ity;</w>
obac ter
ob ta
ob scur
ob ligated</w>
ob li
obli que</w>
ob ic/
obic/ anaerobic</w>
ob ia)</w>
ob ex.</w>
ob ar</w>
oathe toid</w>
oX ome</w>
oX ome)</w>
o- tolylguanidine</w>
o- sulphate,</w>
o- proliferative</w>
o- dihydroxyphenyl
o-dihydroxyphenyl serine</w>
o- carboxy
o-carboxy ethyl-
o-carboxyethyl- phosphoramide</w>
o- based</w>
o- athetosis</w>
o- acet
o-acet ate/
o-acetate/ 3-
o-acetate/3- hydroxybut
o-acetate/3-hydroxybut yrate)</w>
o- M-
o-M- 60</w>
o- EEG</w>
o- AP</w>
o- ,</w>
o viduct,</w>
o sides.</w>
o selectivity</w>
o protein,</w>
o plasic</w>
o ocytes,</w>
o ocyte</w>
o kinetic</w>
o ke</w>
o is</w>
o il-induced</w>
o il-
o grams,</w>
o g
o fl
ofl azine</w>
o fibrate,</w>
o ffe
o estrogens</w>
o estrogenic</w>
o esophagitis</w>
o esophag
o embryonic</w>
o edemat
o dynamics</w>
o deoxycholic</w>
o de
o bu
o at</w>
o adjuvant</w>
o .),</w>
o .
o ),</w>
o '</w>
nystag mus
nutri tive</w>
nutri tionally</w>
nutri ents,</w>
numb ers.</w>
numb er:</w>
numb er
nucleoti des,</w>
nucleoti de
nucleolon ema</w>
nucleolon em
nucleolonem al</w>
nucleol us,</w>
nucleol i.</w>
nucleo side-
nuclear- encoded</w>
nucle us:</w>
nucle os(t)ide</w>
nucle i).</w>
nt -14
nt -1
novel ty-induced</w>
novel ty-
novel .</w>
nov a</w>
notochord al-
notochordal- basichondro
notochordal-basichondro cranial</w>
notice ably</w>
noti fy</w>
note worth
not withstanding</w>
not ed:</w>
not ching</w>
not ch</w>
not ations</w>
not ably,</w>
not )</w>
nostri ls,</w>
nostri l</w>
nosid ase</w>
norvegic us)</w>
normother mia.</w>
normokal emic.</w>
normocap nic</w>
normocalce mia.</w>
normo thymic</w>
normo phosphat
normo kalemia</w>
normo glyce
normo glycaemic</w>
normo -</w>
normaliz e.</w>
normal- salt,</w>
normal :</w>
normal -to-
norm s,</w>
norm oxia</w>
norm omagne
norm ocytic</w>
norm ocytic.</w>
norm ocellular</w>
norm ocalorie</w>
norm ocalciuria</w>
norm ally.</w>
norm .</w>
norgest rel</w>
norg estim
norepinephrine- driven</w>
norepinephr ine-</w>
noradrenaline- precontracted</w>
noradrenal in,</w>
nor-binaltorphim ine.</w>
nor-binaltorphim ine,</w>
nor- dexverapamil</w>
nor testosterone</w>
nor nicotine,</w>
nor met
normet aneph
normetaneph rine</w>
nor fluoxetine</w>
nor floxac
nor diazepam</w>
nor adrenergic-
nor adrenergic,</w>
nootrop ics</w>
nootrop ic
nootropic -treated</w>
nonoxynol- 9</w>
nonimmobil izer</w>
none theless,</w>
non- white</w>
non- warfarin</w>
non- vasculogenic</w>
non- vascular</w>
non- valvular</w>
non- uraemic</w>
non- tumor-bearing</w>
non- transgenic</w>
non- toxic.</w>
non- synonymous</w>
non- survivors</w>
non- substance-abusing</w>
non- stimulant</w>
non- smokers</w>
non- smoker</w>
non- sinus</w>
non- serious</w>
non- seizuring</w>
non- sedative</w>
non- reversible</w>
non- response</w>
non- response.</w>
non- responders,</w>
non- renal</w>
non- related</w>
non- rapid</w>
non- protective,</w>
non- prostanoid</w>
non- peptidic</w>
non- peptide</w>
non- parametric</w>
non- paracetamol</w>
non- opiate</w>
non- nucleoside</w>
non- neurological</w>
non- neurogenic</w>
non- myopathic</w>
non- myeloid</w>
non- meningitic</w>
non- married</w>
non- localized</w>
non- irradiated</w>
non- interventional</w>
non- infused</w>
non- inflammatory</w>
non- inflamed</w>
non- hypercalciuric</w>
non- hyperalgesic</w>
non- homogeneous</w>
non- heme</w>
non- generic</w>
non- fulminant</w>
non- fluorinated</w>
non- existent</w>
non- endothelial</w>
non- elevated</w>
non- drug-using</w>
non- dominant</w>
non- diabetics</w>
non- delayed</w>
non- dapsone-exposed</w>
non- cytotoxic</w>
non- cross-
non-cross- resistant</w>
non- compliance</w>
non- compli
non- coagulopathic</w>
non- clinical</w>
non- cases</w>
non- caseating</w>
non- block</w>
non- bacterial</w>
non- atopic</w>
non- aspirin</w>
non- arteriosclerotic,</w>
non- array</w>
non- anticoagulated</w>
non- antibiotics</w>
non- anaesthetic</w>
non- akathisia</w>
non- adherence</w>
non- abuser</w>
non- UI</w>
non- TAS,</w>
non- SH</w>
non- PD</w>
non- PB</w>
non- OAT-ICH</w>
non- NRTIs</w>
non- MI</w>
non- L-dopa-
non-L-dopa- responsive</w>
non- Hodgkin
non- Hispanic</w>
non- HIT</w>
non- H-P</w>
non- Cocaine-Induced</w>
non- CaCl(2)-treated</w>
non- CIP</w>
non viral</w>
non vasodilating</w>
non upregulated</w>
non trophoblastic</w>
non transplant</w>
non trained</w>
non thrombocytopenic</w>
non tender</w>
non synaptic</w>
non sustained,</w>
non survivors.</w>
non steroid</w>
non stenotic</w>
non steady-state</w>
non specific.</w>
non specific,</w>
non significant.</w>
non septic</w>
non sense</w>
non seized</w>
non sarcopenic</w>
non ruptured</w>
non reversible</w>
non responders,</w>
non regulated</w>
non regenerative</w>
non rapid</w>
non proteinuric</w>
non progressive,</w>
non premedicated</w>
non pitting</w>
non physiologic</w>
non phosphorylated</w>
non pharmacologic</w>
non perfusion</w>
non peptide,</w>
non paranoid</w>
non overdose</w>
non ototoxic</w>
non organic</w>
non opiate</w>
non nicotine</w>
non neural</w>
non myelosuppressive</w>
non myeloablative</w>
non mutant</w>
non metastatic</w>
non linearity</w>
non iodinated</w>
non invasive,</w>
non invasi
non intravenous</w>
non initiated</w>
non infused</w>
non inducible</w>
non induci
non immunologic</w>
non immune-mediated</w>
non hypotonous</w>
non hemorrhagic</w>
non filtr
nonfiltr ating</w>
non exposed)</w>
non exercise</w>
non episode</w>
non enzymic</w>
non enal</w>
non effective</w>
non e;</w>
non dividing</w>
non digitalized</w>
non diagnos
nondiagnos tic.</w>
non diabetics.</w>
non diabetic,</w>
non detectable</w>
non declarative</w>
non cumulative</w>
non crossover</w>
non convulsant</w>
non contingent</w>
non confusional</w>
non compressive</w>
non clear</w>
non cholestatic</w>
non carriers</w>
non carriers.</w>
non captopril</w>
non bullous</w>
non bipolar</w>
non benzodiazepine</w>
non antithrombotic</w>
non antimuscarinic</w>
non anesthetized</w>
non -</w>
nomifens ine),</w>
nom ograms</w>
noi se-exposed</w>
nodulo sis,</w>
nodulo cystic</w>
nodul aris.</w>
nodos um,</w>
nodos a-like</w>
nod al-
nodal- field</w>
nociceptin(1-13)NH (2),</w>
nocicept in/
nociceptin/ orphanin</w>
nocicept in-induced</w>
nocicep tive-
no- treatment</w>
no ver</w>
no tics,</w>
no th
no sis</w>
no se
no p
no j
noj iri
nojiri mycin</w>
no ise
no iditis</w>
no ea.</w>
no dd
no ble</w>
nmole/ liter</w>
nmol/min/ mg</w>
nmol/min/ g</w>
nmol/ paw)</w>
nmol/ mouse,</w>
nmol/ ml</w>
nmol/ min/100</w>
nmol/ l;</w>
nmol/ l,</w>
nmol/ l
nmol/ kg,</w>
nmol/ g),</w>
nmol/ 2.5</w>
nmol/ 0.2</w>
nmol. 100</w>
nmol. /
nmol./ l.</w>
nmol es</w>
nmol es)</w>
nmol )-induced</w>
niz atidine,</w>
nitrosoure a-induced</w>
nitrosoure a,</w>
nitrosou reas</w>
nitrosou reas.</w>
nitrosou reas,</w>
nitros amines,</w>
nitroprusside- evoked</w>
nitroprusside ;</w>
nitroprusside -treated</w>
nitroprusside -</w>
nitroprusside 's</w>
nitrogen -containing</w>
nitrofuranto ins</w>
nitrofur antion</w>
nitro- l-arginine</w>
nitro- L-arginine:</w>
nitro tyrosine,</w>
nitro sy
nitro soguvac
nitro propionic</w>
nitro phenyl-3-piperidin
nitro guanidine</w>
nitro gran
nitrogran ulogen</w>
nitro flurbiprofen,</w>
nitro flurbi
nitrite- treated</w>
nitrate/ nitrite,</w>
nitrate- stimulated</w>
nitr ation,</w>
nit rates:</w>
nit os
nisoldip ine,</w>
ning- dosed</w>
nine fold</w>
nimesul ide:</w>
nigro- neostriatal</w>
nigra -
night 's</w>
nigh ts.</w>
nifedip ine-treated</w>
nif e</w>
nicotine-N'- oxides</w>
nicotine- patch</w>
nicotine- like</w>
nicotine- deprived</w>
nicotine- dependent</w>
nicot ine;</w>
nicot ine:</w>
nicot ine-containing</w>
nicoran dil
nic titating</w>
niac inamide</w>
niac in's</w>
ni g-
nig- Hoffmann</w>
ng/ml/ hr</w>
ng/ml )+
ng/kg/ min</w>
ng/kg/ min;</w>
ng/kg/ min.</w>
ng/d L.</w>
ng/ min</w>
ng/ mg,</w>
ng/ kg)</w>
ng/ hr,</w>
ng/ h</w>
ng/ g</w>
ng/ day</w>
ng/ L)</w>
ng/ L).</w>
ng/ GP)</w>
ng/ 0.5</w>
ng.kg-1. min-1</w>
ng. ml-1,</w>
ng. h/
ng.h/ ml</w>
nex t,</w>
nex ate</w>
nex ,</w>
new spaper,</w>
new s"</w>
new er,</w>
nevirap ine-related</w>
nevirap ine-induced</w>
neutroph il,</w>
neutral izes</w>
neutr al,</w>
neurotroph ins</w>
neurotroph in-3</w>
neurotrop in</w>
neurotransmis sions</w>
neurotoxic ity--
neuroten sinergic</w>
neuroten sin.</w>
neuroten sin-induced</w>
neuroradi ologists.</w>
neuroprotect ant,</w>
neuropo res.</w>
neuropath ology.</w>
neuropath ic,</w>
neuron es,</w>
neuron ally</w>
neuron al-specific</w>
neuron .</w>
neuron -specific</w>
neuron -
neurolog ically,</w>
neuroleptic- naive</w>
neuroleptic- catalepsy</w>
neuroleptic s;</w>
neuroleptic -mediated</w>
neurolept analgesia</w>
neurolept anaesthesia.</w>
neurolep tics:</w>
neurohypophy s
neurohormon al,</w>
neurofilam ent-
neurofibrom at
neurofibromat osis</w>
neurofibrom a</w>
neuro- protective</w>
neuro toxins,</w>
neuro toxin.</w>
neuro toxicology</w>
neuro sis,</w>
neuro sensorial</w>
neuro retinopathy</w>
neuro radiologic</w>
neuro radiographic</w>
neuro psychotic</w>
neuro psychiatric,</w>
neuro protectant</w>
neuro physiological,</w>
neuro peptidergic</w>
neuro ophthalmologic</w>
neuro myopathy:</w>
neuro motor</w>
neuro mediated</w>
neuro matrix</w>
neuro intensive</w>
neuro immune</w>
neuro hormones</w>
neuro ethological</w>
neuro epithelium,</w>
neuro epithelial</w>
neuro carcinogenic</w>
neuro behavioural</w>
neuro behavioral,</w>
neuro anatomy</w>
neuro adaptive</w>
neuro adaptative</w>
neuro adaptation</w>
neuro -</w>
neuraminid ase,</w>
neuralg ic</w>
neur ulation.</w>
neur it
neur axis</w>
neur amin
neuramin ic</w>
neumo -
neumo- Can
neumo-Can c</w>
networ k,</w>
netilmic in,</w>
ness ).</w>
ness ),</w>
nes -J
nes-J ewish</w>
nervous ness/
nervous ness.</w>
nerve- mediated</w>
nerve- evoked</w>
nerv ous-system</w>
nerv es;</w>
ner ve;</w>
ner .</w>
nepic astat
nephroure terectomy</w>
nephrotoxic ant.</w>
nephron s,</w>
nephrolith ia
nephro tubular</w>
nephro toxins,</w>
nephro stom
nephro sis;</w>
nephro sis--
nephro protective</w>
nephro pathic</w>
nephro log
nephro blast
nephri tis)</w>
nephri tis
nephrectom y;</w>
neph rine</w>
neovascular ization.</w>
neovascular ization,</w>
neos tigm
neop oncirin,</w>
neon ate's</w>
neon at
neoform ans.</w>
neo vascular</w>
neo dy
nemat odes</w>
nel arabine</w>
nel arab
nelarab ine,</w>
neighbor ing</w>
neighbor hood</w>
negl ected</w>
negati vity.</w>
negati vity,</w>
negati ve-
neg ligi
negligi bly</w>
neg ate</w>
nefir acetam.</w>
needle- stick</w>
nedocrom il</w>
nedap lat
necrop sies</w>
necro- inflammation</w>
necro sis?</w>
necro sis).</w>
necro ses,</w>
necro genic,</w>
necess ity.</w>
necess ary)</w>
nebul isation</w>
near- syncopal</w>
near- infrared</w>
near- daily</w>
ne ver-treated</w>
ne stren
ne q/min</w>
ne pin</w>
ne monic</w>
ne mon
nemon apride</w>
ne ffective</w>
ne d;</w>
nausea/ dizziness</w>
nause a--
nause a),</w>
natur al-
natural- product</w>
natriure sis,</w>
nas ociliary</w>
nas endoscopy.</w>
narrow .</w>
narrow ,</w>
narco tics.</w>
narco tic-induced</w>
narco sis,</w>
nar ro
nar do</w>
nar atript
naprox en-associated</w>
naphth a[1,
naphtha[1, 2-
naphtha[1,2- d]
naphtha[1,2-d] thiazol-2-amine</w>
naph t
naph azoline</w>
nap e</w>
nanop articles.</w>
nam es</w>
naltrex ol</w>
naltr indole,</w>
naloxone- sensitive</w>
naloxon azine.</w>
nalox one;</w>
nalox one)</w>
nalmefen e,</w>
nail s</w>
nafenop in.</w>
nafenop in,</w>
nadi r.</w>
nadi r
nad olol.</w>
na velbine)</w>
na ked</w>
nNOS (-/-
nNOS (+/-)</w>
nM/ s.n.)</w>
n= 8).</w>
n= 7
n= 6;</w>
n= 4)</w>
n= 30)</w>
n= 26</w>
n= 18)</w>
n= 160)</w>
n= 12).</w>
n= 11,</w>
n= 10</w>
n= 10)</w>
n= 10).</w>
n-propyl amino)
n-propyl -4-
n-propyl-4- pentenoic</w>
n-propyl -2
n-propyl-2 H-
n-methyl serotonin</w>
n-hex yl-
n-hex ane:
n-hexane: ethyl</w>
n-butyl- (4-hydroxybutyl)
n-butyl -</w>
n- methyl-
n- injured</w>
n- butyl</w>
n- acetyl
n- D
n-D PA</w>
n y
n uciferine</w>
n ub
n s),</w>
n omencl
n omedic
n m,</w>
n m)</w>
n ide</w>
n ative-
native- valve</w>
n ations,</w>
n ation-
nation- wide</w>
n ally.</w>
n abumet
n VH</w>
n ST</w>
n NO
n M;</w>
n E</w>
n :</w>
n .s.).</w>
n .),</w>
n ),</w>
myx oid</w>
myop ia</w>
myonec rosis,</w>
myoglob in.</w>
myofilam ents</w>
myofilam ents,</w>
myofibri ls.</w>
myofibri l</w>
myoclon us)</w>
myocardi tis/
myocardi opathy,</w>
myocardi a,</w>
myoc ar
myocar idal</w>
myo- inositol,</w>
myo plasmic</w>
myo intimal</w>
myo globul
myoglobul inuria.</w>
myo fibroblast</w>
myo fibrillary</w>
myo fibers,</w>
myelosuppres sion;</w>
myelos chi
myeloradic ulography</w>
myelomening ocoe
myelo toxicity.</w>
myelo toxic</w>
myelo tom
myelo peroxid
myelo pathic</w>
myelo id,</w>
myelo fibrosis</w>
myelo fibrosis.</w>
myelo dysplasia,</w>
myelo cytic</w>
myelin olysis,</w>
myel oneuropathy</w>
myel oneuropathy.</w>
myel inating</w>
myel in,</w>
mye lographic</w>
mye lia</w>
mydri asis.</w>
myco sis</w>
myco bacterium</w>
myco bacterio
myalgias/ arthralgias,</w>
myalg ia)</w>
my ths</w>
my ristic,</w>
my ristate-stimulated</w>
my ot
my osm
my osin.</w>
my os
my ometrium</w>
my olysis,</w>
my ography.</w>
my ocyte-specific</w>
my ocellular</w>
my oblast-transplanted</w>
my es
myes thenia</w>
mutagen icity</w>
mut ually</w>
mut ation-
mustar d,</w>
mush rooms</w>
musculo ligam
musculoligam ental</w>
muscul e</w>
muscul ar,</w>
muscle -type</w>
muscimol- containing</w>
muscim ol-induced</w>
muscar ine-induced</w>
murmur .</w>
mumole/ kg)</w>
mumole/ kg),</w>
mumole/ L)</w>
mumol/kg/ min,</w>
mumol/kg/ hr)</w>
mumol/ min</w>
mumol/ min/100</w>
mumol/ min),</w>
mumol/ kg,</w>
mumol/ g.</w>
mumol/ L/
mumol/L/ h)</w>
mumol/ L),</w>
mumol s/g</w>
multiv itamins</w>
multiv al
multival vular</w>
multis l
multisl ice</w>
multis ite</w>
multiplic ities,</w>
multiple- gated</w>
multiple s</w>
multin odular</w>
multin ational,</w>
multim ers</w>
multidrug- resistance</w>
multidiscipl in
multidisciplin ary,</w>
multicentr ic,</w>
multi- vessel</w>
multi- transfused</w>
multi- system</w>
multi- level</w>
multi- generational</w>
multi- drug</w>
multi- disciplinary</w>
multi unit</w>
multi parametric</w>
multi modality</w>
multi dose</w>
multi directional</w>
multi deficient</w>
multi bacillary</w>
mul ite</w>
mul at
mug/ ml.</w>
mug/ ml)</w>
mug/ mL</w>
mug/ kg/min</w>
mucos al,</w>
muc olytic</w>
muc h
muc ate,</w>
mu- receptor</w>
mu- kappa</w>
mu- agonists</w>
mu sical</w>
mu g/m
mu g).</w>
mu M</w>
mu M,</w>
mu Ci</w>
mu /24</w>
mu ,</w>
mu ).</w>
msec ),</w>
ms/ mmHg,</w>
ms 1/2</w>
mouthrin ses.</w>
mouthrin ses,</w>
mouthrin se</w>
mouth wash
mouth s</w>
mouse- killing</w>
moun ts</w>
motor- training</w>
motor- sensory</w>
motiv ation/
motivation/ energy</w>
mother-to- infant</w>
mother s:</w>
mot tled</w>
mot t
mot or
mot oneurons</w>
mot axis</w>
most- frequent</w>
most- common</w>
mosmol/ kg</w>
mos mol</w>
mos ,</w>
mortal ity;</w>
morphometr ic,</w>
morpholin yl)-doxorubicin</w>
morphol inyl)
morphine/ bupivacaine</w>
morphine- sensitization,</w>
morphine- like</w>
morphine- ,</w>
morphic eptin</w>
morph ologies</w>
morph ologically.</w>
morph ogenesis,</w>
morph o-physiologic</w>
morph ine:</w>
morph ine-related</w>
morph ine).</w>
morph ea.</w>
morph :</w>
morph ,</w>
moric izine,</w>
moric iz
mor nings</w>
mor al</w>
month- long</w>
month s.
month s--
month s):</w>
month ly)</w>
month ).</w>
monophosph o
monophosph ate.</w>
monophosph ate-
monophosphate- activated</w>
monophosph at
monooxygen ases</w>
monom er</w>
monom el
monomel ic</w>
monofilam ents.</w>
monocyto genes,</w>
monocyte- macrophages</w>
monocyte- macrophage</w>
monoc rotaline</w>
monoc hemotherapy</w>
mono- methyl</w>
mono therapy;</w>
mono iodo
mono hydrochloride)</w>
mono acidic</w>
mono acetyl
monoacetyl morphine.</w>
monkey s;</w>
monkey s/gender
monke y:</w>
monke y)</w>
monit ors</w>
mon t</w>
mon oxide-releasing</w>
mon ospecific</w>
mon oneuropathy.</w>
mon omorph
mon ocytes.</w>
mon ocytes,</w>
mon ocyclic</w>
mon obactam</w>
mon gh
mongh olicus</w>
mon ey
mon et
mon e
molsidom ine.</w>
moles/ glomerulus</w>
moles/ glomerulus,</w>
molecule -1,</w>
mol/ L/
mol/L/ 12
mol/L/12 F;</w>
mol lus
mollus c
mollusc um</w>
mol ality</w>
moi eties</w>
modifi ed-release</w>
modifi ed-
modified- Krebs</w>
moderate- sized</w>
moder ators</w>
moder ation</w>
moder ating</w>
moder ates</w>
moder ately,</w>
moder ate:</w>
moder ate/
model ing,</w>
model ),</w>
mode x</w>
mode stly.</w>
mode st.</w>
mode lled</w>
mode .</w>
modal ity,</w>
modafin il.</w>
mod ular</w>
moclobem ide-
mobil ity.</w>
mobil ity,</w>
mobil ised</w>
mo ving,</w>
mo urs</w>
mo tional</w>
mo tion-</w>
mo pressin</w>
mo ods</w>
mo od
mo genesis</w>
mo dates</w>
mo at)</w>
mo -old</w>
mmol/kg/ SC
mmol/kg/SC /
mmol/kg/SC/ twice</w>
mmol/ liter)</w>
mmol/ l),</w>
mmol/ g</w>
mmol/ d);</w>
mmol. l-1</w>
mmol. L-1</w>
mmol e/
mmol .)</w>
mmHg/ s,</w>
mmHg/ s)</w>
mm/ year;</w>
mm(3 ).</w>
mm H
mm 3),</w>
mm 2).</w>
mm 2).(ABSTRACT</w>
mm /kg</w>
mm .
mm (-
mm 's</w>
ml/min/ year)</w>
ml/min/ kg;</w>
ml/kg/ min.</w>
ml/kg/ min).</w>
ml/kg/ hour</w>
ml/kg/ day)</w>
ml/g/ min).</w>
ml/ thiopentone</w>
ml/ s</w>
ml/ s)</w>
ml/ ng)</w>
ml/ m
ml/ kg),</w>
ml/ hr,</w>
ml/ h</w>
ml/ h.</w>
ml/ day).</w>
ml/ 100
ml/100 g/min.</w>
ml. min-1,</w>
ml. min-1)</w>
ml. kg-1.
ml.kg-1. hr-1</w>
ml. kg-1)</w>
ml. hr-1)</w>
ml. h-1</w>
ml. /24</w>
ml s/min/1.73m2</w>
ml U/ml</w>
ml /</w>
ml -1;</w>
ml -1).</w>
ml (-1),</w>
mixt ures,</w>
mixt ure-treated</w>
mixt ure)</w>
mixed- model</w>
mixed- function</w>
mix ed.</w>
mitte 's</w>
mitript an</w>
mitr al-
mitral- valve</w>
mitot ane,</w>
mitomycin- C-induced</w>
mitomycin- C,</w>
mitomycin- C)</w>
mitogen -induced</w>
mitochondrial- mediated</w>
mitochondrial- dependent</w>
mitochondri opathy</w>
mitochondri ally</w>
mito ses,</w>
miti s-infected</w>
miti gation</w>
mith ramycin</w>
mit ter</w>
mit omycin/vinblastine</w>
mit omycin-induced</w>
mit ogenesis.</w>
mistak e,</w>
mist ake</w>
misoprost ol-unexposed</w>
misoprost ol-treated</w>
misoprost ol-exposed</w>
miscarri age.</w>
mis onidazole</w>
mis matched</w>
mis judgment</w>
mis interpretation</w>
mis information</w>
mis h
mis directed</w>
mis const
misconst rued</w>
mis classification,</w>
mirtazap ine-associated</w>
mir abilis</w>
mipafox -treated</w>
mio tics</w>
minute/ m2</w>
minute (-1)</w>
minut es'</w>
minut e;</w>
minut e),</w>
minoxidi l
minoxidil +
minor ity,</w>
minocycl ine-related</w>
minipump s)</w>
minimum- type</w>
minimal- chang
minimal-chang e"</w>
minim um.</w>
minim um)</w>
minim ized,</w>
minim i</w>
minim ally.</w>
mini- pumps.</w>
mini- pump.</w>
mini osmotic</w>
mineralocortico ids</w>
mineralocortico ids,</w>
mineralocortico id-related</w>
mineralocortico id-induced</w>
mineralocortico id-</w>
min/ mmHg,</w>
min- minus</w>
min s.</w>
min s,</w>
min s)</w>
min osae),</w>
min gl
mingl ed</w>
min d,</w>
min ated</w>
min /</w>
min -treated</w>
min -1/
min-1/ 100</w>
min )]</w>
min )-atropine</w>
mimic ry</w>
mime tics.</w>
mime tics,</w>
mime tic,</w>
mim ick
miltiorrhiz a</w>
miltiorrhiz a)</w>
milrin one-
millisecond s.</w>
millilit er-
milliliter- per-kilogram</w>
millilit er,</w>
millilit er)</w>
milli on)</w>
milli metric</w>
milli meter</w>
milli me
millime tres</w>
milk -induced</w>
milieu ,</w>
mile stones</w>
mild- moderate</w>
mil k.</w>
mil it
mil dest</w>
mil d/
migran s</w>
migraine- inducing</w>
migra inos
migra ines.</w>
migra ine-associated</w>
migr ation.</w>
migr ated</w>
mig rate</w>
mifeprist one,</w>
midd le,</w>
midazol ine</w>
mid- thigh</w>
mid- shaft</w>
mid- segment</w>
mid- latency</w>
mid ventricular</w>
mid night</w>
mid night.</w>
mid line.</w>
mid line,</w>
mid course</w>
mid brain)</w>
micturi tion.</w>
microvilli .</w>
microvilli ,</w>
microtubule- disrupting</w>
microsphe res,</w>
microsphe res)</w>
microsph er
microsom ia</w>
microscop ic,</w>
microphthal mos</w>
microphthal mos,</w>
microphthal mia</w>
microphthal mia,</w>
microne uro
micron utri
micron ized</w>
micron g/ml</w>
micron .</w>
micron )</w>
micromol/L ]</w>
micromol/ site</w>
micromol/ site,</w>
micromol/ paw,</w>
micromol/ kg.</w>
micromol/ L),</w>
micromol/ 10</w>
micromol es/
micromol es),</w>
micromicron ./
microm ol)</w>
microm ol),</w>
microm anome
microliters/ min).</w>
microliter ,</w>
microl/ min/g</w>
microl/ min)</w>
microl/ min).</w>
microl-- IS)</w>
microl-- IS),</w>
microgx kg(-1)</w>
microgx kg(-1)
microgxkg(-1) x
micrograph s,</w>
micrograms/kg/ min).</w>
micrograms/kg/ h</w>
micrograms/kg/ d)</w>
micrograms/kg ]</w>
micrograms/ side),</w>
micrograms/ rat,</w>
micrograms/ rat)</w>
micrograms/ mouse</w>
micrograms/ mouse),</w>
micrograms/ ml/24</w>
micrograms/ l,</w>
micrograms/ l)</w>
micrograms/ l).</w>
micrograms/ g;</w>
micrograms/ day;</w>
micrograms/ L,</w>
micrograms/ 24</w>
micrograms/ 10</w>
micrograms/ (min</w>
micrograms. ml-1,</w>
micrograms. ml-1),</w>
microgram/kg/ day)</w>
microgram/ min)</w>
microgram/ h</w>
microgram/ day</w>
microgram/ cc</w>
microgram. ml-1)</w>
microgram. kg-1</w>
microgram s;</w>
microgram .</w>
micrognath ia</w>
micrognath ia,</w>
microglobul inuria</w>
microglobul inuria.</w>
microglia/ macrophages.</w>
microg/m (2)</w>
microg/kg/ min).</w>
microg/kg/ min)-atropine</w>
microg/kg/ hour,</w>
microg/kg/ day,</w>
microg/kg/ d,</w>
microg/kg --IP</w>
microg/ side</w>
microg/ side),</w>
microg/ ml,</w>
microg/ min)</w>
microg/ m2</w>
microg/ h)</w>
microg/ g)</w>
microg/ L;</w>
microg/ L,</w>
microg/ L).</w>
microg/ 100</w>
microg.kg(-1). min(-1)</w>
microg./ l.</w>
microg. kg-1</w>
microg. kg(-1)</w>
microfil arial</w>
microangio pathy:</w>
microangio pathies</w>
microV/ ms)</w>
microV/ ms).</w>
microM/ paw)</w>
microM/ L</w>
microM/ 0.5</w>
microM)- evoked</w>
microL/ min/100</w>
microL/ m2</w>
microL/ h)</w>
microEq/ min</w>
microEq/ 100</w>
micro- spectroscopy</w>
micro- injection</w>
micro- CT</w>
micro wave</w>
micro vessel</w>
micro vesicles.</w>
micro stimulation</w>
micro seizures</w>
micro peroxidase.</w>
micro particles,</w>
micro me
microme ters,</w>
micro hemorrhages.</w>
micro hematuria.</w>
micro gravity</w>
micro g;</w>
micro encephaly</w>
micro electrodes</w>
micro electrodes.</w>
micro electro
micro dissection</w>
micro deposits,</w>
micro crystal</w>
micro calcification,</w>
micro bridges</w>
micro bore</w>
micro bleed
micro biologically</w>
micro albuminuria</w>
micro albuminuria.</w>
micro adenoma.</w>
micro V]</w>
micro U/ml</w>
micro U/
micro L;</w>
micro L).</w>
micro L),</w>
micro L
micro A,</w>
mice .(ABSTRACT</w>
mic s</w>
mic onazole.</w>
mic el
micel le-
micelle- forming</w>
mic e/
mic e.
mibefradi l.</w>
mi rex</w>
mi on).</w>
mi as,</w>
mi an</w>
mi ),</w>
mgI/ ml).</w>
mg/m2/ h</w>
mg/m2/ dose</w>
mg/m2/ day)</w>
mg/m2/ d)</w>
mg/m2/ course</w>
mg/m2/ 24</w>
mg/m(2)/ day,</w>
mg/m(2)/ day)</w>
mg/m(2) over</w>
mg/m L.</w>
mg/m L),</w>
mg/m 2B
mg/m2B SA)</w>
mg/m 2);</w>
mg/m 2
mg/m2 BSA</w>
mg/kg/day ]</w>
mg/kg/ minute</w>
mg/kg/ minute.</w>
mg/kg/ min),</w>
mg/kg/ injection.</w>
mg/kg/ injection).</w>
mg/kg/ i.p.</w>
mg/kg/ h).</w>
mg/kg/ dose</w>
mg/kg/ d.</w>
mg/kg/ d
mg/kg/ 24</w>
mg/kg. h</w>
mg/kg- day</w>
mg/kg)/ min</w>
mg/kg ],</w>
mg/kg .(ABSTRACT</w>
mg/kg ,
mg/kg ).(ABSTRACT</w>
mg/eye /d)</w>
mg/dL ]</w>
mg/dL ],</w>
mg/dL ])</w>
mg/d l
mg/dl );</w>
mg/K g/day</w>
mg/K g/
mg/24 h).</w>
mg/ week).</w>
mg/ min).</w>
mg/ liter.</w>
mg/ liter,</w>
mg/ l
mg/ g).</w>
mg/ day);</w>
mg/ daily)</w>
mg/ caffeine</w>
mg/ L),</w>
mg/ 650</w>
mg/ 50</w>
mg/ 1</w>
mg/ 160</w>
mg/ 15
mg/15 5+/-1
mg/155+/-1 5</w>
mg/ 0.05</w>
mg.kg-1. min-1),</w>
mg.kg-1. hr-1</w>
mg.kg-1. h-1</w>
mg.kg-1. day
mg.kg-1.day -1),</w>
mg.kg-1. d-1)</w>
mg.kg(-1). min(-1)),</w>
mg./ m2</w>
mg. ml-1),</w>
mg. kg-1).</w>
mg. kg(-1),</w>
mg. kg(-1))</w>
mg s</w>
mg kg(-1)
mgkg(-1) day(-1));</w>
mg )-containing</w>
mg (-1),</w>
mg %),</w>
mez loc
mezloc illin,</w>
meval onic</w>
metyrap one.</w>
metrorrhag ia,</w>
metronidazol e-
metriz amide.</w>
metrif onate</w>
metri a,</w>
metrex ate</w>
metraz ol.</w>
metoprolo l/
metoprolo l)</w>
metoprolo l's</w>
metopro lol-induced</w>
metocur ine-pancuronium</w>
metoclopram ide:</w>
metoclopram ide),</w>
metkeph amid</w>
metkeph amid
metkephamid ,</w>
meti amide</w>
methysergi de.</w>
methylsulphon yl)amino]phenyl]amino]</w>
methylphenid ate-</w>
methylergonov ine,</w>
methylenedioxymethamphet amine;</w>
methylenedioxy methamphetamine,</w>
methylcell ulose</w>
methyl-8- (2-hydroxy-3-
methyl-8-(2-hydroxy-3- t-butylamino-propoxy)</w>
methyl-6-oxo- 7,13-dihydro-6H-benzofuro[2,3-e]pyrido[1,2-a][1,3]diazepin-12-ium</w>
methyl-6,7-dimethoxy-4- ethyl-beta-carboline-3-
methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3- carboxylate)</w>
methyl-4- phenyl-
methyl-2- styryl-
methyl-2- pyrrolidinyl)isoxazole</w>
methyl- atropine</w>
methyl- atropine.</w>
methyl- atropine,</w>
methyl- N,N-
methyl-N,N- dimethyl-4-
methyl-N,N-dimethyl-4- amino
methyl- L-arginine</w>
methyl- 4
methyl- 3,7-
methyl-3,7- dihydro
methyl-3,7-dihydro -1H-
methyl-3,7-dihydro-1H- purine-
methyl- ,</w>
methyl)- N-(1-
methyl)-N-(1- methyl
methyl)-N-(1-methyl piperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)</w>
methyl)- 8-
methyl)- 4-(3-
methyl)-4-(3- phenyl-2-propenyl)-piperazine],</w>
methyl) -1H-
methyl testosterone,</w>
methyl scopolamine),</w>
methyl quinoline</w>
methyl prednisone</w>
methyl piperidine-3alpha-
methyl nitrate</w>
methyl nitrate,</w>
methyl naloxonium</w>
methyl mal
methylmal onic</w>
methyl guanine-
methylguanine- DNA</w>
methyl dopa
methyl clo
methylclo fen
methylclofen ap
methyl chloroform</w>
methyl benz
methylbenz [c]
methyl atropine.</w>
methyl ated</w>
methyl amino-
methyl ]</w>
methyl ,</w>
methyl (
methyl( acetoxy
methyl(acetoxy methyl)
methy leph
methoxyflur ane.</w>
methoxy-4- morpholinyl)-doxorubicin</w>
methoxy-4- methylquinoline</w>
methoxy-4- [(
methoxy-4-[( methylsulphonyl)amino]phenyl]amino]</w>
methoxy- idazoxan,</w>
methoxy- 9
methoxy-9 H-
methoxy) ethyl</w>
methoxy tropane</w>
methoxy phenyl</w>
methoxy phenyl)-4-[4-(2-phthalimido)butyl]piperazine</w>
methoxy phenethylamine</w>
methoxy daunorubicin</w>
methoxy chlor
methoxychlor ,</w>
methoxy ben
methoxyben z</w>
methox salen</w>
methotrex ate-associated</w>
methodolog y.</w>
methodo logy,</w>
method :</w>
metho iodide</w>
methiodi de.</w>
methim azole,</w>
methim azol
methcath in
methazol amide-induced</w>
methan one</w>
methan amine</w>
methamphetamine- using</w>
methamphetamine- elicited</w>
methamphetamine- associated</w>
methaemo glob
methaemoglob inaemia</w>
methadone- stabilized</w>
methach oline.</w>
methach oline-</w>
methach oline,</w>
meth oxamine,</w>
meth iod
methiod al</w>
meth anandamide</w>
meth acrylate</w>
metfor min-associated</w>
metest rus</w>
meter s)</w>
meter -controlled</w>
mete red-dose,</w>
metastasi zed</w>
metast atic,</w>
metast as
metar amin
metamorph osis,</w>
metalloproteinase- 3</w>
metallo thione
metach ronous</w>
metac lop
metac ar
metacar pal</w>
metabonom ics</w>
metabolit es;</w>
metabolit es)</w>
metabolit e/
metabolite/ dopamine</w>
metabolit e"</w>
metabolism ).</w>
metabol iz
metabol ities</w>
metabol ic/
metabol ic-
metabol ic)</w>
meta- analysis,</w>
meta phan</w>
met oxy]-tropane</w>
met olazone</w>
met olaz
met aplasia.</w>
met amphetamine</w>
met al-
mesulerg ine.</w>
messen ger
mesop refrontal</w>
meso derm</w>
mesna -treated</w>
mesna +
mesi late.</w>
mesenter y.</w>
mesenchyme -like</w>
mesangi um.</w>
mesangi olysis</w>
mesalaz ine:</w>
mesalaz ine-induced</w>
mesal amine.</w>
mesal amine,</w>
meric an</w>
mercaptop urine</w>
mercapto- ethane</w>
mercapto propionyl</w>
mer itori
meritori ous,</w>
mer idi
meridi onal</w>
mer ch
merch an
merchan dise</w>
mer ase</w>
mer .</w>
mequiv/ 1.</w>
mequ iv</w>
meq/ liter,</w>
meq/ l.</w>
meprob amate</w>
meprob amate,</w>
mepivaca ine)</w>
meperid ine;</w>
ment- fix
ment-fix ing</w>
ment ary.</w>
ment al.</w>
ment al-
mental- status</w>
ment -dependent</w>
menstru ation</w>
menstru ation,</w>
menorrhag ia--
menopa usal,</w>
meningiti di
meningi omas</w>
meningi oma.</w>
mening omyelocele</w>
mening ococci</w>
mening is
men thol.</w>
men ses</w>
men n</w>
men delian</w>
men );</w>
men 's</w>
memory- enhancing</w>
memor y;</w>
memor y)</w>
membrane- spanning</w>
membrane- disordering</w>
membrane- cytoskeleton</w>
membrane- bounded</w>
membran o-proliferative</w>
memb er.</w>
melphalan- prednisone.</w>
melphalan- prednis
melphal an:</w>
melphal an/
melphalan/ prednisone</w>
melatonin- treated,</w>
melaton in-induced</w>
melaton in's</w>
melanocor tins</w>
melanchol ia</w>
melaen a</w>
mel perone,</w>
mel ic</w>
mel ano
megal y</w>
megal oblastosis.</w>
megakary ocytes</w>
megakary ocytes,</w>
mefloqu ine-related</w>
mefloqu ine-induced</w>
meet ings</w>
medull ectomy</w>
medull ary,</w>
medull aris</w>
medull a-
medium- to-high-dose</w>
medium- size</w>
medium -treated</w>
medicine- free</w>
medic ation-related</w>
medic ation-induced</w>
medic ation).</w>
medic ation),</w>
medic al/
medical/ surgical</w>
medic al-
medi um)</w>
medi ators,</w>
medi ate-dose</w>
medi an.</w>
medi a;</w>
medi a:</w>
medi a-
medetom idine-induced</w>
meclofen amate</w>
mecli zine,</w>
mechloreth amine</w>
mechano receptors</w>
mechanism ;</w>
mechanism ).</w>
mechan ically-
mechan ic
mecamyl amine-
meas ures;</w>
meas ures).</w>
meas ure,</w>
meas les</w>
meaning fulness</w>
meaning ful.</w>
mean+/- SD</w>
mean while</w>
mean s.</w>
meal s:</w>
meag er</w>
me x</w>
me tionine</w>
me til
me ticulous</w>
me tic,</w>
me the
me terol</w>
me ptazinol</w>
me lam
melam ine,</w>
me ets</w>
me droxy
medroxy progesterone.</w>
me at,</w>
me -related</w>
me 's</w>
mdr1 b</w>
mdr 1a</w>
md x</w>
mcg/ mL</w>
mcg/ kg)</w>
mcg/ kg(-1)</w>
mcg/ L</w>
mc g/mL,</w>
mc g.</w>
mazind ol:</w>
mazind ol.</w>
mazep am.</w>
mayonnai se,</w>
maxim um.</w>
maxim izes</w>
maxim al-
maximal- tolerated</w>
max ill
max /
matur ational</w>
matri x"</w>
materi als,</w>
mater ially</w>
matched- pair</w>
match-to- sample</w>
match ing
matching -to-
mat ured</w>
mat ure,</w>
mat ing,</w>
mat ine,</w>
mat h</w>
mat ches</w>
mastic atory</w>
mast ocytosis,</w>
mast algia</w>
massi vely</w>
mass ed</w>
mass age,</w>
mass -
mas ks</w>
mas k
mas )</w>
marrow- derived,</w>
marrow- ablative</w>
marmo sets.</w>
market s</w>
mark ed.</w>
marijuan a.</w>
mariju ana
margin al.</w>
marg ins</w>
marg ins.</w>
marg in.</w>
marc gravi
marcgravi i</w>
mar red</w>
mar anthus</w>
maprotil ine:</w>
maprotil ine)</w>
manufacture rs</w>
mant le</w>
mano eu
manoeu v
manipul ated,</w>
manip ulate</w>
manifest ations:</w>
manifest ,</w>
mang ifer
mangifer in,</w>
mang af
mangaf odipir</w>
maneu vers.</w>
maneu ver,</w>
mandi ble.</w>
man ometry,</w>
man idipine</w>
man idipine,</w>
man ic,</w>
man ia-like</w>
man dating</w>
man age.</w>
man ?</w>
man )</w>
mam mar
mam mal</w>
malon ate.</w>
malignanc ies:</w>
malform ations;</w>
male/ 15</w>
male ic</w>
male ).</w>
malaria- infected</w>
malaox on.</w>
malaox on-induced</w>
malaox on,</w>
mal to
mal oprim</w>
mal nutrition.</w>
mal nutri
mal functions</w>
mal es).</w>
mal e:</w>
mal ar</w>
mal ac
mal "</w>
major ity.</w>
major ity,</w>
major :</w>
maj us</w>
maj or)</w>
mainten ance:</w>
mainten ance)</w>
mainten ance).</w>
main ta
main ly,</w>
mai- san</w>
magnitu de:</w>
magneto encephalographic</w>
magnesium- containing</w>
magnesi um-treated</w>
magnesi um-induced</w>
magnesi um),</w>
magn ification.</w>
mag nified</w>
mag nif
mafosf amide.</w>
macul atum</w>
macul ae</w>
macul a.</w>
macroscop ically,</w>
macrophage- mediated</w>
macrophage- conditioned</w>
macroph age,</w>
macron odules.</w>
macromolec ules.</w>
macroli de.</w>
macro- papular</w>
macro prolactinomas.</w>
macro glos
macroglos sia</w>
macro electrodes</w>
macro adenoma</w>
macro adenoma,</w>
machin es)</w>
macaqu es.</w>
macaqu e.</w>
mac ro</w>
mac aw</w>
ma- subunits.</w>
ma- media</w>
ma sto
ma ph
ma .(ABSTRACT</w>
ma ),</w>
ma "</w>
mU/ mg</w>
mU/ mL,</w>
mU/ l</w>
mU/ kg</w>
mRNA s,</w>
mOsm/ kg;</w>
mOsm/ kg.</w>
mOsm/ kg),</w>
mOsm )</w>
mO sm</w>
mM/ kg)</w>
mM hr</w>
mM =
mM /kg</w>
mL/minute/ g,</w>
mL/minute/ 1.73</w>
mL/min/ kg</w>
mL/min/ g,</w>
mL/kg/ h
mL/ s.</w>
mL/ s)</w>
mL/ s).</w>
mL/ kg/min</w>
mL/ kg.</w>
mL/ day.</w>
mL/ cm</w>
mL/ beat/
mL/ 24</w>
mL.min-1. g-1</w>
mL.g-1. min-1,</w>
mL. -1.
mL.-1. g-1</w>
mL g
mLg (-1)
mL -1.
mL-1. min-1.
mIU/ L.</w>
mGluR1- EGFP</w>
mGluR s.</w>
mEq/kg/ day,</w>
mEq/ liter.</w>
mEq/ liter).</w>
mEq/ l),</w>
mAMPH -treated</w>
mAMPH ,</w>
m/ speech</w>
m/ s,</w>
m/ min</w>
m-chloro phenylpiperazine</w>
m-chloro phenyl
m-PW TT</w>
m-PW T
m-PWT T)</w>
m-CP B
m- nitrophenyl-3-piperidin
m- chlorphenylpiperaz
m- Nitro</w>
m- FOLFOX-4</w>
m- AIMS.</w>
m(2) ),</w>
m(- 2))</w>
m um</w>
m s.
m oxif
m osmol)</w>
m olytic</w>
m old</w>
m nemonic</w>
m mg</w>
m inced</w>
m ia-related</w>
m ative</w>
m arb
marb le</w>
m V/
m V.</w>
m T,</w>
m IU</w>
m CR</w>
m Abs</w>
m AMPH-induced</w>
m A),</w>
m 2),</w>
m .).</w>
m -like</w>
lysozym uria.</w>
lysozym uria,</w>
lysosom otropic</w>
lysosom es,</w>
lysophosph atidyl</w>
lyso zomal</w>
lyser gol
lyser gic</w>
lymphoplasmacy tosis</w>
lymphom a).</w>
lympho aden
lymphadenopath ies,</w>
lymphaden itis,</w>
lymph omatous</w>
lymph oid,</w>
lymph ocytosis.</w>
lymph ocytes)</w>
lymph oblast
lymph .</w>
lym oclavine</w>
lyc open
lyc ine</w>
ly solecithin</w>
ly nestren
ly T1)</w>
lut ination</w>
lusit rop
lung :</w>
lumin escence</w>
lumb usacral</w>
lumb ago.</w>
lum p</w>
lum ens,</w>
lukast -associated</w>
lucifer ase</w>
luc i
luci gen
lucigen in-
lucigenin- enhanced</w>
luc encies</w>
lu or
lu id</w>
lozeng es</w>
lozeng e,</w>
loxy dine</w>
lox ilic</w>
lower- limb</w>
lowe st;</w>
lowe st.</w>
low- to-
low- threshold</w>
low- temperature</w>
low- sodium</w>
low- set</w>
low- salt</w>
low- priced</w>
low- pressure</w>
low- incidence</w>
low- frequency,</w>
low- dosage</w>
low- avoidance</w>
low- K(+)-
low- ,</w>
low s</w>
low ly</w>
low ering,</w>
low er/
low ;</w>
low /
lot arg
losoxantr one/
losart an
losartan +
los ure</w>
los s).</w>
los er</w>
loro phenylalanine</w>
lorazepam -induced</w>
lorazepam -dependent</w>
lorazepam -
lor do
lopin avir
lopinavir -
lop es</w>
loop -tail</w>
loo sely-bound</w>
loo kout</w>
loo k.</w>
long-term '</w>
long-ter m)</w>
long- time</w>
long- term.</w>
long- medium</w>
long- duration</w>
long- bone</w>
long ev
long et
longet s)</w>
long .</w>
lonafarni b.</w>
lomust ine,</w>
lol- ANH</w>
logis tic-regression</w>
logarith mic</w>
log- unit</w>
log- transformed</w>
log s</w>
log it</w>
locomot or,</w>
locomo tive</w>
locomo tion)</w>
loco regionally</w>
lock ),</w>
loc us)</w>
loc ked</w>
loc ating</w>
loc ated.</w>
loc ate
locate thin-3-O-gallate</w>
loc ally-
loc ally,</w>
lobul ar,</w>
lob oma</w>
lob ectomy.</w>
lob ectomies,</w>
load s.</w>
load ;</w>
load -independent</w>
load -dependent</w>
lo vastatin-induced</w>
lo vastatin-gemfibrozil</w>
lo t,</w>
lo ropyridyloxy)]benzene</w>
lo od.</w>
lo l:</w>
lo l),</w>
lo in-
loin- pain/haematuria</w>
lo idal</w>
lo iasis</w>
lo d</w>
lo an-
loan- Ket
loan-Ket tering</w>
lo a</w>
lo ,</w>
liz ation.</w>
liz ab
lizab eth</w>
liximab .</w>
liver/ kidney</w>
liver- kidney</w>
liver- function</w>
liver s;</w>
liver .(ABSTRACT</w>
liver -derived</w>
liver -1;</w>
liver 's</w>
live stock.</w>
liv ing-related</w>
litres/ minute/m2</w>
litre (-1)</w>
lithotrip sy.</w>
lithocholate-3-O- glucuronide,</w>
lithium- uraemic</w>
lithium- quetiapine</w>
lithium- pretreated</w>
lithium- polyuric</w>
lithium- polyuria</w>
lithium- polyuria.</w>
lithium- olanzapine</w>
lithium- free</w>
lithium- effect
lithium-effect uated</w>
lithium- chlorpromazine</w>
lithium- carbamazepine</w>
lithium- antidepressant</w>
lithium ;</w>
lithium -</w>
lithium )</w>
lith otomy.</w>
literat ures.</w>
liter s).</w>
liter ary</w>
liter /day)</w>
lit re.</w>
listen ers</w>
list s,</w>
lisdexamfet amine.</w>
liquid- liquid</w>
liquid- filled</w>
liqu orice,</w>
liqu ids</w>
lipos omes.</w>
lipopolysacchar ide-
lipopolysaccharide- stimulated</w>
lipo proteins.</w>
lipo phil
lipide mia,</w>
lipid :
lipid: aqueous</w>
lip omatosis:</w>
lip omatosis.</w>
lip -DX
lip ,</w>
linole ate</w>
linole ate,</w>
link er.</w>
ling ering</w>
line ar,</w>
line ar
line ages.</w>
line age.</w>
lind ane:</w>
lind ane-
lin ker</w>
lin ked.</w>
lin k,</w>
lin ing.</w>
lin ing,</w>
lin ical</w>
lin es'</w>
lin astatin</w>
limit ed-
limbic -
limb- threatening</w>
limb- lead</w>
limb ing</w>
lim a
likeli ho
likel y)</w>
like wise.</w>
like ),</w>
lik e.</w>
lignocaine/ placebo</w>
lignoca ine-
lignoca ine),</w>
ligible ;</w>
light/ dark</w>
light- density</w>
ligh ten
ligh t-induced</w>
ligh t-</w>
ligh t+
ligh t"</w>
lig ation;</w>
lifes pan</w>
lifes aving</w>
life- saving.</w>
life -</w>
lif t,</w>
lif el
lifel ong</w>
lif e:</w>
lidocaine- propofol</w>
lidocaine- prilocaine</w>
lidocaine- induced,</w>
lidoca ine-treated</w>
lidoca ine-like</w>
lid onium</w>
lid oflazine</w>
licking/ lif
lic orice</w>
lic oric
lic it</w>
lic es</w>
lic ense</w>
lic .</w>
libit um-fed</w>
libit um,</w>
libid o.</w>
liber ica</w>
li ving.</w>
li tigation</w>
li st,</w>
li paemic</w>
li osis-like</w>
li gu
ligu strazine</w>
li e</w>
li berate</w>
li b</w>
li abilities.</w>
li a
lia ison</w>
li )</w>
lexi gl
lexigl as</w>
levothyrox ine.</w>
levothyrox ine-induced</w>
levosul piride</w>
levonorgestrel )</w>
levome promazine-fluvoxamine</w>
levome promazine,</w>
levofloxac in:</w>
levodopa- primed</w>
levodopa- carbidopa</w>
levodopa -related</w>
levodopa -derived</w>
levodopa )</w>
levodopa ),</w>
levo- naloxone</w>
levo- isomers</w>
levo- alpha-
levo fol
levofol inate</w>
levo bupivacaine-induced</w>
levit ated</w>
level s--
level s'</w>
level led</w>
level -dependent</w>
level -I</w>
lev oc
lev ator</w>
leuproli de.</w>
leukomalac ia</w>
leukomalac ia,</w>
leukocyt uria.</w>
leukocyt es/
leukocytes/ 100</w>
leuko encephalopathies.</w>
leukem ias.</w>
leuk ocytopenic</w>
leuk ocytoc
leuk ocyte)</w>
leuk apheresis</w>
leucovor in)</w>
leuc openia,</w>
leuc omalac
leuc ocyturia</w>
leuc ocytosis</w>
leuc ocytosis,</w>
leuc ocytopenia</w>
leuc ocytes.</w>
leuc emia</w>
letro zole</w>
lethal )</w>
lessen ed,</w>
less- than-
lesion s/
lesion s).</w>
lesion :</w>
lesion -only</w>
lesion -
ler 's</w>
leptomen inges</w>
lept ospirosis</w>
lept ophyll
lepro sy.</w>
lepro sy,</w>
leph one</w>
length s,</w>
length ening.</w>
length ened.</w>
leng thier</w>
len ticularis</w>
len s,</w>
lemon .</w>
leishman iasis,</w>
leg is
left- ventricular-wall</w>
left- side</w>
left- axis</w>
lebbec k,</w>
leb rex
leb rand's</w>
least -square</w>
learn ing),</w>
lear ner
leaf ,</w>
lead -treated</w>
lead -exposed</w>
lead -
lead ,</w>
le/ perfusate</w>
le/ drugs</w>
le- stimulating</w>
le- specific</w>
le- cell</w>
le t.</w>
le ming</w>
le ev
le d-release</w>
le bre
lebre x</w>
le -related</w>
le "</w>
lay er)</w>
lax ati
laxati ves,</w>
law ,</w>
lav age,</w>
laur yl</w>
laur ic,</w>
laur ate</w>
laud anos
laudanos ine,</w>
later oposterior</w>
later alization</w>
later :</w>
latency )</w>
late- stage</w>
latanoprost -treated</w>
latano prost.</w>
lat oxin</w>
lat ,</w>
last .</w>
lass itu
lassitu de,</w>
las co
lasco w</w>
laryng otrache
laryng ospas
laryn x</w>
laryn x.</w>
larg er.</w>
lar val</w>
lar s.</w>
laparotom ized</w>
lant a,</w>
lansoprazol e:</w>
lansoprazol e-induced</w>
language- delayed</w>
land mark</w>
lamivudine- resistance</w>
lamivudine- containing</w>
lamivud ine/
lamivud in</w>
lamin in,</w>
lamin ectomy</w>
lamin ectomies,</w>
lamellipo di
lamellipodi a/
lamellipodia/ cellular</w>
lamell ae</w>
lamb da
lam b</w>
lacunosum- molecul
lactat emia</w>
lact one.</w>
lact ational</w>
lact ation,</w>
lact ate/
lactate/ pyruvate</w>
lact acid
lachrym ation</w>
lac k,</w>
lac cid</w>
laborator y-proven</w>
labor ious</w>
labetal ol;</w>
labell ing,</w>
lab .</w>
lab ,</w>
lCo BF</w>
l/ min</w>
l/ min/
l/ m2,</w>
l/ hour/
l/hour/ m2.</w>
l. h)</w>
l-methyl but
l-methylbut yl)amino]-</w>
l-N NA-treated</w>
l-B ucindolol</w>
l- verapamil</w>
l- naloxone</w>
l- histidine</w>
l- based</w>
l- arginine-methyl</w>
l- Per
l-Per longets)</w>
l- NAME
l- Ephedrine</w>
l- DOPA</w>
l- 20
l-20 1)</w>
l' Etude</w>
l ump
l son</w>
l ic,</w>
l i</w>
l es)</w>
l az
laz aro
l aw</w>
l aun
laun ched</w>
l augh
l apse</w>
l anc
lanc inating</w>
l amino
lamino plasty</w>
l aid</w>
l a.</w>
l PBN</w>
l PB
l .(ABSTRACT</w>
l -1)</w>
l -1),</w>
kynuren ine/
kynurenine/ tryptophan</w>
kynuren ine,</w>
ky phosis</w>
kur roa</w>
knock out,</w>
kleptom ania.</w>
kit tens</w>
kiren -induced</w>
kinin ogen,</w>
kine tic-dynamic</w>
kine sis</w>
kine sis.</w>
kine sigenic</w>
kine sia,</w>
kindle d-
kindled- seizures</w>
kind reds</w>
kinase-3 beta</w>
kinase-3 b</w>
kinase- MB,</w>
kin ky</w>
kin inase</w>
kin es,</w>
kin ase;</w>
kin ase/
kill s</w>
kill er</w>
kidney- transplanted</w>
kidney s;</w>
ki hydrochloride</w>
khell in</w>
kh uzestanica</w>
kg/ min.</w>
kg/ min,</w>
kg/ m(2)</w>
kg/ day)</w>
kg/ d</w>
kg(-1) day(-1)</w>
kg ]).</w>
kg );</w>
ketotifen .</w>
ketotifen ,</w>
ketorolac -associated</w>
ketocon azole-associated</w>
keto acidosis,</w>
ketamine- related</w>
ketamine- propofol</w>
ket opiperidine-2-carbonyl-L-leucyl-L-proline</w>
ket ones,</w>
ket one:</w>
ket amine-</w>
keratouve itis.</w>
keratocon us</w>
keratocon junctivi
kerat osis</w>
kerat osis,</w>
kerat ectomy.</w>
keph amid</w>
ken az
kenaz ic</w>
kele tal,</w>
ke to</w>
ke 0)</w>
kdynes/cm 2)</w>
kdyn /cm2</w>
karyotyp es,</w>
kary otype</w>
kary omegaly</w>
kappa- opiate</w>
kappa- beta.</w>
kappa 1</w>
kanamycin- col
kanamycin-col is
kanamycin-colis tin</w>
kanam ycin.</w>
kan sasi
kan sas</w>
kaliure sis,</w>
kala-az ar)</w>
kain ate/
kain ate-type</w>
ka- ryukotsu-borei-
kPa ).</w>
kHz ;</w>
k- correlated</w>
k- He
k-He imer</w>
k- 8644</w>
k ynetic</w>
k r</w>
k owicz,</w>
k o,</w>
k nife</w>
k new</w>
k its.</w>
k it</w>
k ist
kist rodon</w>
k ine,</w>
k ill</w>
k es-
kes- Adams</w>
k es
kes ha,</w>
k er's</w>
k ep
k el's</w>
k ed-
k cal
k at/
k alo
k al</w>
k a</w>
k a,</w>
k Id
kId r</w>
k D</w>
k A
k :</w>
k 2,</w>
k 2),</w>
k /benefit</w>
k (mono
k(mono )</w>
juxtac analicular</w>
jux tap
jux taglomerular</w>
justifi ed?</w>
junc tival</w>
ju ic
journ als</w>
journ als.</w>
jour neys</w>
jo b</w>
jitter iness,</w>
jer king,</w>
jer k-correlated</w>
jeop ardy</w>
jeop ardi
jejun al</w>
jec tion-associated</w>
jeal ousy.</w>
jaw- thrust</w>
jaundic e;</w>
jacch us).</w>
jac k
ja1 (+/
ja1(+/ flox
j ))</w>
iz zia</w>
iz ine-induced</w>
iz ability.</w>
iverm ectin.</w>
iv c)</w>
iv astatin</w>
ity- based</w>
ity 's</w>
itsel f
itro bacter</w>
itol- 4-phosphate</w>
iti zing</w>
iti ve,</w>
iti l-Perlongets)</w>
ith rin-alpha</w>
iterpen oids</w>
item s)</w>
itch iness,</w>
itari an</w>
it s'</w>
it ron</w>
it ript
it ri
it ine</w>
it er's</w>
it ation-
it ate</w>
it able</w>
it abine</w>
it :</w>
it -drug</w>
it ).</w>
isth mal</w>
ister one-ethinyl</w>
ist radefylline)</w>
ist 's</w>
issu es:</w>
issu es.</w>
isoxsup rine.</w>
isoxazol-5- yl]tropane</w>
isoxazol e
isoxazole propionic</w>
isox az
isotretino in-induced</w>
isothiocyan ate</w>
isosorbide-5- mononitrate,</w>
isos thenuria</w>
isoquinol ines</w>
isopuleg ol,</w>
isoproterenol/ tilt-table</w>
isoproterenol- intoxicated</w>
isoproterenol- infused</w>
isoproterenol +
isoproterenol )-induced</w>
isoprost an
isoprostan es,</w>
isopropyl quinazolinones</w>
isopropyl -,</w>
isoniazid /kg</w>
isoniaz id-rifampin</w>
isoniaz id)</w>
ison itrile</w>
ison ar
isom er),</w>
isolectin- B
isolated- HIT;</w>
isolated- HIT.</w>
isol ation.</w>
isol ation,</w>
isol ating</w>
isoflurane- treated</w>
isoflurane- nitrous</w>
isoflurane ;</w>
isoflurane /
isoflurane ).</w>
isoflur ane)</w>
isoflur ance</w>
isoflav ones,</w>
isochrom atic</w>
isocarboxaz id</w>
isobutyl -1,2-diphenyl</w>
isobolog raph
iso-PGF(2 alpha)</w>
iso- osmolal</w>
iso- 6-
iso-6- cass
iso-6-cass ine</w>
iso zyme
iso thiocy
iso indole</w>
iso eth
isoeth ar
iso enzymes,</w>
iso enzyme.</w>
iso enzyme,</w>
iso electr
isoelectr ic.</w>
iso dium</w>
ism anal
isle ts.</w>
ishe d;</w>
ishe d:</w>
ish es,</w>
ischemic -
ischemic- reperfusion</w>
ischem ia-related</w>
is ur
is s,</w>
is otyp
is osmolar</w>
is or
is obutyric</w>
is m-
is land</w>
is ing,</w>
is ation.(ABSTRACT</w>
is ation,</w>
is ation)</w>
is al,</w>
is ;</w>
is -induced</w>
is ).</w>
is (N-methyl-
is(N-methyl- 4'-
is(N-methyl-4'- pyridyl)porphyrinato</w>
irrit ation)</w>
irrit ant.</w>
irrit ant,</w>
irrig ating</w>
irregular ity.</w>
irregular ity,</w>
irradi ation),</w>
irradi ated.</w>
iron- sulfur</w>
iron- deficiency</w>
iron- chelating</w>
iron -dependent</w>
iro ,</w>
irinotec an:</w>
irinotec an.</w>
irbes artan,</w>
ir reversibility</w>
ir reversib
ir resistible</w>
ir relevant</w>
ir regular,</w>
ir mer</w>
ir lukast
ir cling</w>
ipunct ure)</w>
ipsi laterally</w>
ipr indole</w>
ipec ac-treated</w>
ip sa
ip roniazid-induced</w>
ip onatremia</w>
ip ])</w>
ip ;</w>
ip -
ip- His-
ip-His- Leu</w>
ip )-induced</w>
ioxil an.</w>
iox agl
iopent ol</w>
iop ronin</w>
iontophore sis.</w>
iontophore sis,</w>
ion- channel</w>
ion izing</w>
ion it</w>
ion )</w>
iohex al</w>
iodo- 8-
iodo-8- hydroxyquinol
iodo-8-hydroxyquinol ine)</w>
iodo l</w>
iodo deoxyuridine</w>
iodixan ol.</w>
iodixan ol)</w>
iodine-125- labeled</w>
iodine -123</w>
iodi de.</w>
iodi de-
iodide- osmium</w>
iod ine/kg</w>
iod ine.</w>
io- alveolar</w>
io s</w>
io resal)</w>
io logic</w>
involved- nodal-field</w>
involved- field</w>
involve ments,</w>
involve ment
involve d:</w>
involun t
invol ve,</w>
invol v
investigator-bl inded</w>
investig ative</w>
investig ation
inver sions</w>
inver sion,</w>
inver se"</w>
inv entor
inv agin
inv aded</w>
intub ation;</w>
intub ated),</w>
intromis sive</w>
intric ate</w>
intravenous ly;</w>
intravenous ly-
intrathec ally-
intrathec al,</w>
intrat ympan
intrat umoral</w>
intras plenic</w>
intras eptal</w>
intraperitoneall y/
intraperitone al)-induced</w>
intraperitone al),</w>
intrap refrontal</w>
intranigr al,</w>
intrane urally</w>
intranas ally;</w>
intranas ally.</w>
intranas ally,</w>
intramy ometrial</w>
intralip id</w>
intral obar</w>
intrad uoden
intracor tically</w>
intracor tically.</w>
intracor poral</w>
intracister nally.</w>
intracister nal)</w>
intracerebroventric ular,</w>
intracell ularly,</w>
intrac ut
intrac rine</w>
intrac lass</w>
intra- peritoneally</w>
intra- peritoneal</w>
intra- patient</w>
intra- oral</w>
intra- ocular</w>
intra- day,</w>
intra- cranial</w>
intra- cellular</w>
intra- arteri
intra-arteri ally,</w>
intra- alveolar</w>
intra- LC</w>
intra- Hisian</w>
intra vertebral</w>
intra vascularly</w>
intra vaginally.</w>
intra ureteral</w>
intra thalamic</w>
intra ren
intra perit
intra orbital</w>
intra joint</w>
intra articular</w>
intra alveolar</w>
intr usive</w>
intr usions</w>
intr abil
intrabil i
intrabili ary</w>
intoxic ation;</w>
intoxic ating</w>
intoler ant/
intolerant/ allergic</w>
intoler able.</w>
intim al-
inti ma-media</w>
intest ine:</w>
interview s,</w>
interven e</w>
interrupt s</w>
interru ptions</w>
interpre ted,</w>
interpre tations</w>
interpre t
interpol ation</w>
internal ization,</w>
intern ists,</w>
intern a,</w>
intermediate- grade</w>
intermediate- ,</w>
intermedi ates.</w>
intermedi ates,</w>
interleukin-1 beta.</w>
interleukin- 6.</w>
interleukin- 3</w>
interferon/ ribavirin.</w>
interferon- ribavirin</w>
interferon- alpha-
interferon-alpha- 2B</w>
interfer ons</w>
interfer on-associated</w>
interest s.</w>
interdigit ations</w>
interaction s--also</w>
interac tions;</w>
interac e
interace ae).</w>
inter- systolic</w>
inter- person</w>
inter- peak</w>
inter- hospital</w>
inter trochanteric</w>
inter trial</w>
inter study</w>
inter space</w>
inter space.</w>
inter scapular</w>
inter rater</w>
inter pulse</w>
inter pedicel</w>
inter osseous</w>
inter neurons;</w>
inter neuron
inter net</w>
inter nally</w>
inter na</w>
inter na)</w>
inter myocyte</w>
inter molecular</w>
inter mingled</w>
inter lobar</w>
inter correlations</w>
inter connections</w>
inter chang
inter cept</w>
inter -dose</w>
intention-to- treat.</w>
intention-to- treat,</w>
intensit y/
intensit y).</w>
intensifi es</w>
intensi ve-care</w>
intensi ties,</w>
inten sively</w>
inten se.</w>
intellect .</w>
integr ity,</w>
integr ins.</w>
integr in.</w>
integr ation.</w>
integr ation,</w>
integ rating</w>
intake :</w>
intake ).</w>
intake ),</w>
insulin/ glucose</w>
insulin- syringe</w>
insulin- sensitizing</w>
insulin- group</w>
insul in:
insulin: glucose</w>
insul in-treated</w>
insul a.</w>
insuffici ent,</w>
insuff lating</w>
instrument ation.</w>
instrum ents,</w>
instruc tions.</w>
instruc tion</w>
instruc ting</w>
institut ed,</w>
instant aneously</w>
instanc es;</w>
install ation</w>
inst ant</w>
inst ance.</w>
inspir ation,</w>
inspi red
insp ected</w>
insomn iac</w>
insomn ia;</w>
inser tion;</w>
ins >
ins> del
ins>del ,</w>
inqui ries</w>
inpyraz one</w>
input s,</w>
input ,</w>
inoc ul
ino varus.</w>
ino therapy.</w>
ino pathy,</w>
ino ides</w>
ino atrial</w>
ino a</w>
innerv ates</w>
innerv ated)</w>
inner most</w>
inn ati
innati /
innati/ Northern</w>
injur y-</w>
injur y).</w>
injur ies;</w>
injur ied</w>
inject ors</w>
inj ured,</w>
inj ect</w>
initiation- promotion</w>
initiation- promotion-progression</w>
initi ative</w>
initi al,</w>
ini um,</w>
ini .</w>
inhomogene ity</w>
inhibitors -induced</w>
inhibitor s).</w>
inhibitor -1</w>
inhibit ,</w>
inhibi tion).</w>
inhibi tion),</w>
inherit ance,</w>
inhal ers.</w>
inhal ed,</w>
inhal ations</w>
inhabit ants.</w>
ingu ishing</w>
ingredi ents.</w>
ingest ed,</w>
ingest ants</w>
inges tion:</w>
inger- West
inger-West phal</w>
ing/ pruritus</w>
ing/ licking</w>
ing/ Dre
ing/Dre w</w>
ing- water</w>
ing- frequency</w>
ing- down</w>
ing- dosed</w>
ing- current</w>
ing s.(ABSTRACT</w>
ing s).</w>
ing est</w>
ing '</w>
infusion- produced</w>
infusion- dosed</w>
infusion .(ABSTRACT</w>
infrequ ent:</w>
infrequ ency</w>
infra hisian</w>
influence d.</w>
influence d,</w>
influ x,</w>
inflexi bility</w>
inflammat ory.</w>
infin ity)</w>
infin ity
inferen ce,</w>
infer tile</w>
infection s:</w>
infection -related</w>
infec tion)</w>
infarct- like"</w>
infarct- avid</w>
infarc ts,</w>
inf ratentorial</w>
inf raclavicular</w>
inf lating</w>
inf ero
inf ecti
infecti ous,</w>
inf anti
inf ancy
infancy -only</w>
inf -
inf- DXR.</w>
inex orable</w>
inevit ably</w>
ineth olate</w>
inester as
inesteras emia</w>
iness "</w>
ines s)</w>
ineff icient</w>
ineff ective
ine/ tripelennamine</w>
ine/ propofol/mixtures</w>
ine/ hydroxychloroquine</w>
ine. HCl</w>
ine-3- carboxylic</w>
ine-- an</w>
ine- tricyclic</w>
ine- to-
ine- soaked</w>
ine- mediated</w>
ine- injected</w>
ine- exposed</w>
ine- exacerbated</w>
ine- elicited</w>
ine- docetaxel</w>
ine- dihydrochloride</w>
ine- derived</w>
ine- depleted</w>
ine- converting</w>
ine- conjugated</w>
ine- aspartate</w>
ine- and</w>
ine- MK801</w>
ine- 6-
ine valuable</w>
ine t</w>
ine ous</w>
ine mia)</w>
ine like</w>
ine R</w>
ine )-mediated</w>
industr y-
induci ble
induc tive</w>
induc tion)</w>
induc ers.</w>
induc ers,</w>
induc er,</w>
indu ed</w>
indomethacin- exposed</w>
indomethac in).</w>
indomethac in),</w>
indomet acin-induced</w>
indomet acin,</w>
indole acetamides</w>
indol e)</w>
individual s;</w>
individual izing</w>
individual ized.</w>
indistinguish able,</w>
indinavir/ ritonavir-containing</w>
indinavir )</w>
indiges tion,</w>
indic ence</w>
indic ed</w>
indic ator-
indicator- dilution</w>
indic ator,</w>
indic ation).</w>
index- AI
independ ently,</w>
indap amide-induced</w>
ind us</w>
ind oxyl</w>
ind ole.</w>
ind ol-3-
ind an
indan amine,</w>
ind )</w>
increased ",</w>
increas ing;</w>
increas e
increase >500</w>
incre ments.</w>
incre ment.</w>
incorpor ation,</w>
incorpor ation),</w>
inconveni ence,</w>
incontin ence:</w>
inco herent</w>
include d;</w>
inclu sive</w>
incident ally,</w>
incid ents.</w>
incid ences,</w>
incid ence),</w>
incer ta.</w>
incarc erated</w>
incap able</w>
inc reta</w>
inase- like</w>
in/ eb
in/eb selen-treated</w>
in/ G
in/G HS-
in/GHS- R</w>
in-of- Four</w>
in-2- yl)
in-2- ones</w>
in-1- yl)
in-1 4-
in-14- valerate</w>
in- specific</w>
in- person</w>
in- losing</w>
in- hospital,</w>
in- gemfibrozil</w>
in- fed</w>
in- d
in-d alfop
in-dalfop ristin</w>
in- coated</w>
in- class</w>
in- Po
in-Po ong</w>
in- 7-
in- -
in visible</w>
in vest
in uria)</w>
in um-based</w>
in ulin,</w>
in ul
in to,</w>
in ter</w>
in sudative</w>
in su
in spection.</w>
in sensitivity,</w>
in sensitive.</w>
in patient,</w>
in ordinately</w>
in omas</w>
in oma</w>
in ol.</w>
in o-
in nom
in line</w>
in ized</w>
in ism,</w>
in ins</w>
in ine-aspartate</w>
in gency</w>
in enucle
inenucle otide</w>
in dur
indur ated</w>
in digestion</w>
in der</w>
in dependent)</w>
in dependence</w>
in convenience</w>
in conspicuous</w>
in consol
inconsol able</w>
in congru
in complete,</w>
in competent</w>
in coming</w>
in appropriate.</w>
in app
inapp et
in adequate,</w>
in activity</w>
in activation.</w>
in a,</w>
in .(ABSTRACT</w>
in -1,</w>
in +
imy osarcoma</w>
impulsi vity.</w>
impul se-control</w>
improvement /
improve ments.</w>
improve ments,</w>
improve d)</w>
improve d'</w>
impres sively</w>
impres sions</w>
impregn ation,</w>
implement ed,</w>
implant s)</w>
implant ation:</w>
implant -
implan ted,</w>
imperfor ate</w>
imped ance-
impedance- cardiography</w>
impairment/ amnesia</w>
impairment ;</w>
impairment )</w>
imp acts.</w>
imp act.</w>
immunosuppress ants.</w>
immunosuppress ants,</w>
immunosuppres sion;</w>
immunostain ing.</w>
immunostain ing,</w>
immunostain ing)</w>
immunostain ing),</w>
immunos u
immunolab eled</w>
immunoglobul in.</w>
immunoglobul in,</w>
immunocyt oma-bearing</w>
immunocyt ochemistry.</w>
immunoblot ting.</w>
immuno- suppressive</w>
immuno therapy:</w>
immuno hematologic</w>
immuno fluoro
immuno electrophoresis,</w>
immuno assays.</w>
immuno analysis</w>
immuno active</w>
immune- hematopoietic</w>
immun oprevalence</w>
immun opositivity</w>
immun ophil
immun opathology</w>
immun opathological</w>
immun oneutr
immun obullous</w>
immun o</w>
immun ization.</w>
immobil izing</w>
immobil isation</w>
immobil isation.</w>
immer sions</w>
immer sion,</w>
immediate- early</w>
immedi ate,</w>
imipr amine;</w>
imipr amine-treated</w>
imipr amine-</w>
imipenem/ cilastatin.</w>
imipenem- cilastatin,</w>
imipenem -induced</w>
imipen em.</w>
imino ]
imidazol e.</w>
imidazol e-based</w>
imbal ances,</w>
imatinib -induced</w>
im ura's</w>
im s</w>
im put
im potency</w>
im posed.</w>
im ported</w>
im port</w>
im perative.</w>
im part</w>
im par
im onabant)</w>
im mitis-infected</w>
im min
im ia,</w>
im azole-dependent</w>
im age,</w>
im achalol</w>
im )</w>
iltr ation.</w>
ilo prost,</w>
illu min
illo metric</w>
illness -induced</w>
illic it-drug</w>
illede ma</w>
ill s,</w>
ill ance,</w>
ilic ifolia</w>
iliac us</w>
ile us,</w>
ile um,</w>
ile t</w>
ile ostomy</w>
ile ostomy.</w>
il- resistant</w>
il- lovastatin</w>
il lip</w>
il legally</w>
il le,</w>
il iter
il in</w>
il ib
il er</w>
il c
ilc oxon</w>
il an</w>
il aire</w>
ig al
igal i,</w>
ifosfamide/ mesna.</w>
ifosfamide -associated</w>
ifosfamide -</w>
ifosfamide -
if ron
if lun
if ithrin-alpha</w>
if id
if ene-induced</w>
if e</w>
idopa .</w>
idiosyncrati cally</w>
idiosyncrati c)</w>
idiosyncras y,</w>
idine- di
idine-di gluconate</w>
idine- 6-(N-
idi zed</w>
idi otypic</w>
identifi er:</w>
identif y.</w>
identic al-
identical- appearing</w>
identi ties</w>
identi fication.</w>
iden tically.</w>
ide/ triamterene</w>
ide- hydrochlorothiazide</w>
ide- ethanol</w>
ide mia</w>
ide -related</w>
ide 's</w>
idazol e,</w>
id- pretreated</w>
id- osmotic</w>
id- inducible</w>
id ines</w>
id ene)</w>
id die</w>
id arubicin.</w>
id aceae)</w>
id able</w>
id a's</w>
icul um</w>
icul i</w>
icter ic"</w>
icro scopy.</w>
icos a
icosa (5E-9,11,13
icosa(5E-9,11,13 Z
icosa(5E-9,11,13Z )
icosa(5E-9,11,13Z) tetraenoic</w>
iclospor in</w>
ici encies</w>
ichthyo siform</w>
ically- defined</w>
icalcit ol-treated</w>
ical ein</w>
ical ."</w>
ical '</w>
ic/ thromboembolic</w>
ic/ systolic</w>
ic- inotropic</w>
ic- histologic</w>
ic- dopaminergic</w>
ic- astatic</w>
ic- acid</w>
ic tus</w>
ic to
ic tal-like</w>
ic s)</w>
ic ourea</w>
ic lid
ic it</w>
ic in)</w>
ic h,</w>
ic e,</w>
ic e,"</w>
ic ally),</w>
ic al.</w>
ic -dependent</w>
ic -associated</w>
iberi otox
ib wezi,</w>
ib oten
ib li
ia/ reperfusion</w>
ia/ hypotension,</w>
ia/ New</w>
ia- pertussis-tetanus</w>
ia- myalgia</w>
ia- inducing</w>
ia- Carlo</w>
ia 's</w>
ia '.</w>
ia '
ia' -like</w>
ia "</w>
i.v ,</w>
i.t. ]</w>
i.pl .)</w>
i.p. )-</w>
i.p ),</w>
i.c.v.- ouabain-treated</w>
i. v</w>
i. s.,</w>
i. p</w>
i. h
i.h -1/
i.h-1/ mg</w>
i. g.</w>
i- loaded</w>
i- butyl
i us,</w>
i um
i obitridol,</w>
i leu
i es
i ers</w>
i ans</w>
i ang
i als</w>
i ally,</w>
i U
iU P)</w>
i NOS)</w>
i ;</w>
i 1</w>
hyth mias</w>
hysterosalping ography.</w>
hystere sis).</w>
hyster ical</w>
hyste rectomy,</w>
hyste rectom
hypoxia- reoxygenation</w>
hypoxanth ine.</w>
hypox ia
hypovol aemic</w>
hypovol aem
hypouric emia,</w>
hypoton icity</w>
hypoton ia.</w>
hypothesi zed,</w>
hypothesi se</w>
hypothesi s:</w>
hypothesi s-generating</w>
hypothe tically</w>
hypothe tic.</w>
hypothalamus- zona</w>
hypothalamo- pituitary-adrenocortical</w>
hypothalamo- pituitary-adrenal</w>
hypothalamic- pituitary</w>
hypothalamic- pituitary-adrenocortical</w>
hypothalam ic,</w>
hypothalam i</w>
hypotension- prone</w>
hypotension- bradycardia</w>
hypotension /
hypotension .(ABSTRACT</w>
hypotension -related</w>
hypotension -mediated</w>
hypotension ),</w>
hypoten sion-induced</w>
hypospadi as,</w>
hypos thenuria</w>
hypoprote inemia.</w>
hypophysi tis</w>
hypophosphat aemia,</w>
hypop otassemia</w>
hyponat remia:</w>
hypomania/ mania.</w>
hypokine tic,</w>
hypokine sis,</w>
hypokalem ic.</w>
hypokalem ic,</w>
hypokalem ia)</w>
hypoinsul inemia</w>
hypogonadis m.</w>
hypogly corrhachia</w>
hypofibrinogen emia</w>
hypofibrinogen emia,</w>
hypoesthe sia.</w>
hypochol inesterasemia</w>
hypocapn ia/hypotension,</w>
hypocap nia,</w>
hypocal orie</w>
hypoc ellular
hypocellular ity</w>
hypoalgesi a,</w>
hypoalbumin aemia</w>
hypoalbumin aemia,</w>
hypoalbum inemia;</w>
hypo responsiveness</w>
hypo reflexia</w>
hypo pharynx,</w>
hypo phagia</w>
hypo osmolality,</w>
hypo locomotion.</w>
hypo intensity</w>
hypo gonadal</w>
hypo glossal</w>
hypo geusia</w>
hypo esthesia</w>
hypo dense</w>
hypo baric</w>
hypo activation</w>
hypno tics:</w>
hypno tics.</w>
hypno sis.</w>
hypno pompic</w>
hypno l</w>
hypervol emia</w>
hyperuric aemia,</w>
hypertrophy ).</w>
hypertroph ic,</w>
hypertriglyceride mic</w>
hypertriglyceride mia.</w>
hypertriglycerid aemia,</w>
hyperton icity</w>
hypertension ?</w>
hypertension +
hyperten tion</w>
hyperten sion-
hypersomn ia.</w>
hypersensitivity- type</w>
hypersensitivity- mediated</w>
hypersensitiv ity:</w>
hypersensitiv ity
hyperpyrex ial</w>
hyperplasi as,</w>
hyperplasi a/
hyperplasia/ dysplasia</w>
hyperplasi a)</w>
hyperplasi a),</w>
hyperphosphat aemia</w>
hyperparathyroidis m:</w>
hyperp nea,</w>
hyperlipoprote inemia,</w>
hyperlipide mia;</w>
hyperlipide mia)</w>
hyperlactat emia,</w>
hyperkal emia:</w>
hyperkal aemic</w>
hyperinsul inism</w>
hyperinsul inemic,</w>
hyperinsul inemia.</w>
hyperhomocyste inemia,</w>
hyperglyce mia-induced</w>
hypergly caemia,</w>
hypergammaglobul inaemia</w>
hypergammaglobul inaemia,</w>
hyperexcit able,</w>
hyperestrogen ism</w>
hyperestrogen emia.</w>
hyperem ia;</w>
hyperem ia:</w>
hyperem ia)</w>
hypere choic</w>
hypere ch
hypercortisol ism</w>
hypercortisol ism,</w>
hypercoagul ability</w>
hypercoagul ability.</w>
hypercoagul abil
hypercoagulabil ity"</w>
hypercap n
hypercalce mias</w>
hypercal caemia,</w>
hyperbilirub inemia.</w>
hyperandrogen ism,</w>
hyperalim entation</w>
hyperalgesi a),</w>
hyperalgesi a")</w>
hyperaldosteron ism.</w>
hyperal gic</w>
hyperal esia</w>
hyperadrenocortic ism</w>
hyperadrenocortic ism.</w>
hyper- vitaminosis</w>
hyper- CVAD</w>
hyper ventilated</w>
hyper thyroidis
hyper telor
hyper stimulation</w>
hyper splen
hyper somnolent</w>
hyper somnia</w>
hyper secretion.</w>
hyper salivation</w>
hyper salivation.</w>
hyper responsiveness.</w>
hyper pathia.</w>
hyper parathyroid</w>
hyper osmolality.</w>
hyper nociception</w>
hyper mineralocorticoid</w>
hyper methylation</w>
hyper intensity.</w>
hyper immune</w>
hyper gastr
hypergastr inemia</w>
hyper dense</w>
hyper contractility</w>
hyper coagulopathy.</w>
hyper chrom
hyper cholinergic</w>
hyper chlo
hyperchlo remic</w>
hyper cellularity,</w>
hyper cellular</w>
hyper carb
hyper aggression</w>
hyper aggression,</w>
hyper aemia.</w>
hyper activity;</w>
hyp oxic-ischemic</w>
hyp ometabolism</w>
hyp ocontrac
hyp ochromic</w>
hyp ochond
hyp o</w>
hyosc ine.</w>
hygi ene</w>
hygi ene,</w>
hydroxyure a-induced</w>
hydroxyquinol ines:</w>
hydroxyn or
hydroxyn al
hydroxynal idixic</w>
hydroxylase- like</w>
hydroxyl upanine-2-pyrrolcarbonic</w>
hydroxyl ase-positive</w>
hydroxyl amino-
hydroxylamino- 5-ethyl-5-
hydroxyl amino
hydroxyl amine-induced</w>
hydroxyl )</w>
hydroxyethyl starch</w>
hydroxyeicosa- (5,
hydroxyc oumar
hydroxyapati te</w>
hydroxy-3- methyl-1-phenyl-
hydroxy-3- allyl
hydroxy-3-allyl -1-phenyl-
hydroxy-3-allyl-1-phenyl- 2,3,4,5-tetrahydro-1H-3-benz
hydroxy- methyl-glutaryl-coenzyme</w>
hydroxy toluene.</w>
hydroxy steroid</w>
hydroxy saclofen</w>
hydroxy naphtho
hydroxy metoprolol</w>
hydroxy chloroquine.</w>
hydroxy chloroquine,</w>
hydroxy carbamide</w>
hydroxy -1,1-
hydroxy-1,1- diphosphonate</w>
hydroly zable</w>
hydroly tic</w>
hydroly sis.</w>
hydroly sing</w>
hydrolas e,</w>
hydrocod one/acetaminophen</w>
hydrochlorothiaz ide/triamterene</w>
hydrochlorothiaz ide)</w>
hydro thorax</w>
hydro static</w>
hydro soluble</w>
hydro quinone</w>
hydro phobic</w>
hydro phil
hydro peroxides,</w>
hydro osmotic</w>
hydro gen
hydro chlorofluorocarbons</w>
hydralaz ine-treated</w>
hydra zine,</w>
hydr ation-
hyd ride</w>
hyd rate,</w>
hybridis ation</w>
hybri ds.</w>
hybri ds,</w>
hyaluron an</w>
hyalin ized</w>
hyal uronic</w>
hyal uronate</w>
hyal inosis,</w>
hy postenuria,</w>
hy ph
hy odeoxycholic</w>
hy alin</w>
hus band</w>
hur ts</w>
hur t</w>
hun gr
human- equivalent</w>
human- cit
human-cit rated</w>
human s;</w>
human ized</w>
human itarian</w>
hum idity</w>
hum idity,</w>
ht 7</w>
ht 7
ht7 ?
ht7? ),</w>
hr s)</w>
hr s).</w>
hr inger</w>
hr an</w>
hr .
hr );</w>
hr (-1);</w>
hp f</w>
hp f.</w>
hour/ patient</w>
hour s:</w>
hour s'</w>
hour ;</w>
hour -old</w>
hour -
hour ),</w>
hour 's</w>
hot- plate,</w>
hot pl
host s.</w>
host s,</w>
hospitalis ations</w>
hospital izations,</w>
hospital ization;</w>
hospital ization).</w>
hospital ;</w>
hospital :</w>
hos tility,</w>
hormon otherapy</w>
hormon e:</w>
horizont ally</w>
hor ts</w>
hor ses,</w>
hor se.</w>
hor se,</w>
hor ns</w>
hor ns.</w>
hop ed</w>
homozygot es,</w>
homovan ilic</w>
homota urine</w>
homolog u
homoiother ms</w>
homogene ity).</w>
homogen ates)</w>
homogen ate,</w>
home- use</w>
home opathic</w>
home ;</w>
hom opiperazinyl)benzimidazole</w>
hom onymous</w>
hom ology</w>
hom olog</w>
hom olateral</w>
hom ocystine</w>
hom ic
hom e-like</w>
hom e-based</w>
hom atropine</w>
holid ay</w>
holid ay.</w>
holid ay
hol ter</w>
hodgkin sine</w>
hob nail</w>
ho vah's</w>
ho rea</w>
ho phyton</w>
ho arding,</w>
hn RNA</w>
hloro dibenzo-p-dioxin</w>
histor ical,</w>
histopath ologically.</w>
histo autoradi
histoautoradi ographical</w>
histamine- receptor</w>
histamine- mediated</w>
hist oly
hist ographic</w>
hist amines</w>
hist amine)</w>
his tidine,</w>
hirsu tism,</w>
hippocampi ,</w>
hippocampal- dependent</w>
hippocampal- dentate</w>
hippocamp us;</w>
hindquarter s,</w>
hind- limb</w>
hind ers</w>
hin ia</w>
him bac
himbac ine</w>
him ,</w>
hil um</w>
higher- than-expected</w>
higher- order</w>
higher- level</w>
highe st.</w>
highe st,</w>
high- tone</w>
high- sensitivity</w>
high- magnesium</w>
high- loading</w>
high- frequency,</w>
high- efficiency</w>
high- doses</w>
high- cholesterol</w>
high- amplitude,</w>
high- activity</w>
high ly.</w>
high ;</w>
high :</w>
hierarch y</w>
hiccup s;</w>
hiccup s:</w>
hi p,</w>
hi k
hexyloxy )-
hexyloxy)- 6-
hexyloxy)-6- methoxy-4-methylquinoline</w>
hexos amine</w>
hexane- 2,6-
hexamethyl melamine,</w>
hexameth onium)</w>
hexachloro phene-induced</w>
hexachloro phene,</w>
hexachloro -1:
hexachloro-1: 3-but
hexachloro-1:3-but adi
hexachloro-1:3-butadi ene</w>
hexachlor ide)</w>
hex ylcarbamoyl-5-fluorouracil</w>
hex yl
hex ose</w>
hex idine-digluconate</w>
hex estrol</w>
hex af
hexaf luor
hev in</w>
heterozyg osity,</w>
heterogene ously</w>
hetero sexual</w>
hetero receptors</w>
heter otrimeric</w>
heter otopi
heter osis</w>
heter ologously</w>
heter ologous</w>
heter ogenously</w>
heter odi
heter ochrom
herpetiform is</w>
herpes virus</w>
heroin- addicted</w>
hero ine</w>
hero in-related</w>
hero in-associated</w>
herni ation.</w>
herni ation,</w>
here by</w>
here after</w>
herb omineral</w>
herb als,</w>
herb ,</w>
her mitte's</w>
heptano in</w>
hepatotoxic ity;</w>
hepatotoxic ity:</w>
hepatotoxic ,</w>
hepatotox in.</w>
hepatotox in)</w>
hepatoc analicular</w>
hepato -</w>
hepatitis -B</w>
hepat otumori
hepat otropic</w>
hepat opulmonary</w>
hepat opathy.</w>
hepat onephro
hepat omas.</w>
hepat ology</w>
hepat olith
hepat ocyte.</w>
hepat o-
hepat ectomized</w>
hepat ectom
heparin- reactive</w>
heparin- mediated</w>
heparin- independent</w>
heparin- dihydro-
heparin-dihydro- ergotamine</w>
heparin oid,</w>
heparin ]</w>
heparan ase,</w>
hepar itinase</w>
hepar inotherapy.</w>
hepar in;</w>
hepar in/platelet</w>
hepar in-based</w>
hen oid</w>
hemosider in-positive</w>
hemorrhag ic/thromboembolic</w>
hemorrhag ic.</w>
hemophiliac s.</w>
hemophil ia.</w>
hemophil ia,</w>
hemoglob inuria)</w>
hemodynam ically.</w>
hemodilu tion.</w>
hemodilu tion-
hemodialy sis:</w>
hemodialy sis-induced</w>
hemodialy sed</w>
hemodiaf iltration.</w>
hemoconcentr ation</w>
hemo phagocytic</w>
hemo peritoneum</w>
hemo grams</w>
hemo filtration</w>
hemo diluted</w>
hemisphere )</w>
hemis ensory</w>
hemip leg
hemic horea</w>
hemi hydrate</w>
hemi arthroplasty</w>
heme- L-arginate</w>
hematologic al:</w>
hematologic ;</w>
hematologic .</w>
hematologic )</w>
hematoc he
hematoche zia</w>
hemat oporphyrin</w>
hemat opathology</w>
hemat oma)</w>
hemat om
hemangi osarcoma</w>
hemangi omatosis.</w>
hem otoxic</w>
hem opoiesis</w>
hem oly
hem lock),</w>
hem ime
hem il
helpl essness</w>
heli otrope</w>
hel d.</w>
heigh ten</w>
heigh t)</w>
heavi est</w>
heav iness</w>
heat- labile</w>
heat ing,</w>
heat ;</w>
heart ;</w>
hear tworm</w>
hear d</w>
health food</w>
health -related</w>
heal ed.</w>
heal ed,</w>
head- turning</w>
head- injured</w>
head ings</w>
head ")</w>
he ster</w>
he ren
he pcid
he min.</w>
he m</w>
he el
he als</w>
he -
he (1)
he(1) ]
haz y</w>
hass les,</w>
harml ess.</w>
harmful ,</w>
harmal ine-</w>
harb inger</w>
har ms.</w>
har ms,</w>
har mon
har m,</w>
haptoglob in,</w>
happ iness</w>
handling -related</w>
handic apped.</w>
handic ap</w>
hand writing</w>
hand le</w>
hand held</w>
hand gri
han g</w>
hamster .</w>
ham mer</w>
halothane- related</w>
halothane- epinephrine-induced</w>
halothane- based</w>
halothane- anesthetized,</w>
halothane ;</w>
haloperidol+ vehicle</w>
haloperidol+ idazoxan</w>
haloalk ane</w>
halo gen</w>
hallucin ations)</w>
halluc inosis,</w>
half-li ves.</w>
half- yr-old</w>
half- maximum</w>
half- hour</w>
half- disappearance</w>
half -dose</w>
half ).</w>
hal t</w>
hal er)</w>
hair s.</w>
hair .</w>
haemorrh ag
haemoglob inuria</w>
haemo siderosis</w>
haemo philus</w>
haemo philia</w>
haematob ium</w>
haemat omas</w>
haemat omas.</w>
haem opoiesis</w>
haem oconcentr
haem ate
haemate mesis</w>
haem angi
haemangi omas,</w>
habit uating</w>
haben ula,</w>
ha ze</w>
ha wthorn</w>
hG RE
hGRE .
hGRE. MMP1</w>
h/ mg</w>
h.p. f
h ttp://clinicaltrials.gov</w>
h s).</w>
h s
h ousehold</w>
h oleboard,</w>
h noiditis</w>
h its.</w>
h inge</w>
h en.</w>
h ash
h ang
h all</w>
h V
hV DR/
hVDR/ h
hVDR/h R
hVDR/hR XR</w>
h PF4/heparin</w>
h PA
h GH</w>
h ER
hER G-
h CG,</w>
h B
h -1;</w>
h (-1),</w>
gyr us:</w>
gynecomasti a,</w>
gynec ologist's</w>
gynaec omastia</w>
gy rata.</w>
guy an
guyan ensis</w>
gut tae</w>
gut .</w>
gun -treated</w>
guide wire</w>
guid ance.</w>
guar ana</w>
guanoxabenz -induced</w>
guanosine- 5'-
guanfac ine,</w>
growth- inhibitory</w>
growth- inhibited</w>
growth ).</w>
grow ,</w>
group 2</w>
group --a</w>
group ',</w>
groom ing)</w>
grommet ,</w>
gro unds,</w>
griseofulv in-induced</w>
griseofulv in,</w>
gri d.</w>
gri d)</w>
grepa floxacin,</w>
gray- scale</w>
gravi metry)</w>
gravi metric</w>
grati fying</w>
graph s</w>
graph ics,</w>
graph ,</w>
granulocyte- colony</w>
granulocy te
granulo poiesis</w>
granulo mas,</w>
granul e-
granule- cell-specific</w>
granul ated,</w>
grani setron.</w>
grandi ose</w>
grandi florum</w>
gran zyme
gran d-
grand- mal</w>
gram ;</w>
graft- vs-host</w>
graf t,</w>
graf t)</w>
gradi ents.</w>
gradi ent,</w>
grad ing,</w>
grad ation</w>
grac ile</w>
gra y,</w>
gra in</w>
gra ded.</w>
gr astim</w>
gr /dl.</w>
gp 130</w>
gover ned</w>
gover n</w>
good ;</w>
good '</w>
gonadotroph ins</w>
gonadotrop ins.</w>
gonadotrop in.</w>
gold- standard</w>
gold- salt</w>
gold thioglucose.</w>
gol d,</w>
goit er</w>
goit er.</w>
godi pine-induced</w>
go- go</w>
go ides</w>
go ats</w>
go at</w>
go als.</w>
go /
gnaw ing.</w>
gm/ M2</w>
gm /kg</w>
gm /d
glycyr rhetic</w>
glycyl glycine</w>
glycyl glycin
glycylglycin anilide</w>
glycosaminoglyc an-
glycosaminoglycan- degrading</w>
glycopyr ron
glycogen olysis.</w>
glycogen .</w>
glycoferol- water</w>
glyco side-
glyco protein.</w>
glycer ol.</w>
glycer ol-treated</w>
glycer ol,</w>
glycer ide</w>
glyce mia,</w>
glyc opeptide</w>
glyc opepti
glyc olate</w>
glyc inergic</w>
glyc ated</w>
glyc an,</w>
gly caemia</w>
glutathione-S- transferases</w>
glutathione-S- transferase,</w>
glutathione- s-transferase,</w>
glutathione- reduced</w>
glutathi one)</w>
glutathi on</w>
glutar imide</w>
glutar im
glutamat erg
glutamaterg ic-</w>
glutam yltransferase</w>
glutam ate-</w>
glutam ate
glutamate -1-
glucose-6- phosphatase</w>
glucosaminid ase)</w>
glucopri vic</w>
glucocorticoid -treated</w>
glucocortico steroids</w>
glucagon -like</w>
gluc uronic</w>
gluc ogen,</w>
gluc aric</w>
glu thatione</w>
glot tic</w>
glomerulonephro pathy</w>
glomerulonephro pathy.</w>
glomerulonephri tis:</w>
glomerul us).</w>
glomerul es</w>
glomer ulopathy,</w>
globul in:</w>
globul es</w>
glo be</w>
glioblast omas.</w>
glicl azide,</w>
gli me
gli a.</w>
glauc oma:</w>
glab ra,</w>
gl c)</w>
gl ati
glati ramer</w>
gl ans</w>
gl afen
glafen in</w>
given --
ginsen oside</w>
giddin ess.</w>
giardi asis</w>
gi gas</w>
gi g
gig ant
ghrel in/GHS-R</w>
gh t.</w>
gh ,</w>
geu sia,</w>
get fulness</w>
get ari
getari ans</w>
gestod ene.</w>
gestod ene)</w>
gest ation).</w>
geranyl geran
geranylgeran iol</w>
ger opsychiatric</w>
geot axis,</w>
gentamic in).</w>
gentamic in),</w>
gentamic in
genotype -
genotyp ically</w>
genit or</w>
genit alia</w>
general ized.</w>
general izability.</w>
gener ic,</w>
gener ator</w>
gener ated:</w>
gene- environment</w>
gene tically-
gene tic
gender -,</w>
gender -
gen ol</w>
gen ip
gen in</w>
gen ,</w>
geme prost.</w>
gemcitabine/ vinorelbine</w>
gemcitabine/ docetaxel</w>
gemcitabine- vinorelbine</w>
gelatin olytic</w>
gelat ine</w>
gelat inase-like</w>
gel s</w>
gel :</w>
gel -
gel- filtration</w>
gefit inib.</w>
gefit inib-induced</w>
ge usi
ge ometry,</w>
ge al,</w>
ge 's</w>
gav age-
gavage- fed</w>
gav age)</w>
gav age).</w>
gastrointestin al.</w>
gastroenter ological</w>
gastrocnemi us-soleus</w>
gastro- intestinal,</w>
gastro paresis.</w>
gastro paresis,</w>
gastro duoden
gastr in-stimulated</w>
gast ritis.</w>
gas es;</w>
gas eous</w>
gas 6)</w>
garen oxacin</w>
gap "</w>
gangrenos um,</w>
gangren ous</w>
ganglion- blocked</w>
ganglion ectomy.</w>
gangli osides.</w>
gangli onectomy</w>
gangli on.</w>
gangli a;</w>
ganax olone,</w>
gamma-hydroxybut yrate,</w>
gamma-glutamyltranspeptid ase.</w>
gamma-glutamyl- transpeptidase</w>
gamma-glutamyl- transferase</w>
gamma-aminobut y
gamma-HC H.</w>
gamma-D-glutamyl aminomethyl
gamma-D-glutamylaminomethyl sulphonate</w>
gamma- vinyl-GABA</w>
gamma- linolenic</w>
gamma- hexachlorocyclohexane</w>
gamma- epithelial</w>
gamma- carboxyl
gamma- amino-
gamma-amino- butyr
gamma-amino-butyr ic-acid</w>
gamma- Amin
gamma-Amin obutyric</w>
gall bladder.</w>
galant amine.</w>
galan in,</w>
galactosid ase,</w>
galactos yl</w>
galactos yl-
gal locatethin-3-O-gallate</w>
gal enic</w>
gal ect
gal actitol</w>
gal a</w>
gal ).</w>
gain /
gain/ edema</w>
gain -of-
gain-of- function</w>
gadolinium- containing</w>
gabacul ine</w>
gabacul ine,</w>
gaba ergic,</w>
gab ergic</w>
ga ther</w>
g/m2/ week</w>
g/m2/ h</w>
g/m2/ day;</w>
g/m2/ day)</w>
g/m(2)/ day</w>
g/m (2)).</w>
g/d l),</w>
g/d L),</w>
g/d ),</w>
g/cm (2))</w>
g/ ml).</w>
g/ min,</w>
g/ liter.</w>
g/ kg.</w>
g/ hr,</w>
g/ h/rat</w>
g/ g</w>
g/ day);</w>
g/ day
g/ L.</w>
g/ L,</w>
g/ L).</w>
g-1. min-1)</w>
g- Tang</w>
g- Jun
g-Jun g-Tang</w>
g ym
g ums</w>
g ree</w>
g rating</w>
g r</w>
g ol</w>
g m).</w>
g l</w>
g inkgo</w>
g in-1</w>
g estrol</w>
g ent
g el,</w>
g ay</w>
g ating,</w>
g ases.</w>
g as-
gas- liquid</w>
g as,</w>
g agg
g ag
gag /
gag/ pol
g TX</w>
g A)</w>
g -onset</w>
g -1,</w>
g (2),</w>
g (1)</w>
fusi motor</w>
fus aric</w>
further s</w>
furosem ide)</w>
furosem ide),</w>
furo ate.</w>
furazolid one-induced</w>
furan-2- ylsulfonyl)
furan-2- yl)thiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thiones</w>
fura- 2</w>
fura- 2/
fura- 2.</w>
fur in,</w>
fung emia</w>
fund us,</w>
fund i</w>
function ally,</w>
function al-
function .(ABSTRACT</w>
function --
function ),</w>
function ",</w>
fun iculus</w>
fun goides</w>
fun gi
fun doscop
fulmin ant,</w>
full- scale</w>
full- length</w>
ful ly,</w>
ful l,</w>
ful );</w>
fucosid ase,</w>
fucoid an</w>
fru strated</w>
front ocortical</w>
front al-
from :</w>
frequency :</w>
frequency -related</w>
frequency -domain</w>
frequ ent;</w>
free- bas
free ze</w>
free dom
freedom ,</w>
free bas
fratax in.</w>
fratax in,</w>
fran kly</w>
frag il
fraction s/
fraction s)</w>
fraction ator</w>
fraction ation.</w>
fractalk ine-
fractalk ine,</w>
fract ured</w>
frac tioned</w>
fra xiparine</w>
fra k's</w>
fr utesc
fr ic
fourth- line</w>
four- year</w>
four- way,</w>
four- vessel</w>
four- grade</w>
four- drug</w>
four th.</w>
four th,</w>
foun d.(ABSTRACT</w>
fostriec in</w>
fos phenytoin,</w>
fos amprenavir</w>
forti fication</w>
forskol in.</w>
forni x.</w>
formular y.</w>
formul ations,</w>
formul ation)</w>
formul ated.</w>
formalin- inactivated</w>
formalin- ,</w>
form idable</w>
form er,</w>
form ationally</w>
form at</w>
form aldehyde-
formaldehyde- fixed</w>
form ;</w>
form ),</w>
form (s)</w>
forgot ten</w>
forgot ten
forelimb .</w>
fore stomach.</w>
fore stomach,</w>
fore stall</w>
fore ign
fore head</w>
fore brain-
force ful</w>
for war
for tuit
for th
for te,</w>
for med
for getfulness</w>
for cing</w>
for cep
foot shock-induced</w>
foot shock
food s,</w>
food -</w>
follow-up .(ABSTRACT</w>
follow- on</w>
follow- back</w>
follow up,</w>
follow s;</w>
follow ing,</w>
follow -</w>
follic le-stimulating</w>
foli ac
foliac eus.</w>
fol d:</w>
fol d
fol ate,</w>
foet uses.</w>
foci /cm2</w>
foci )</w>
foc us,</w>
foc ally-
focally- evoked</w>
fo regut</w>
fo il.</w>
fmol/ 100</w>
fluvox amine-induced</w>
flut ter:</w>
flut ter-fibrillation</w>
flus h.</w>
flus h,</w>
fluroth yl-induced</w>
fluroth yl,</w>
flupirt ine,</w>
flupentix ol</w>
fluparox an</w>
fluoxyme sterone</w>
fluoxetine- risperidone</w>
fluoxetine- intolerant</w>
fluoxet ine-associated</w>
fluoxet ine)</w>
fluoroquinol one-induced</w>
fluoroquinol one-associated</w>
fluoro scopy.</w>
fluoro scop
fluoro ribose</w>
fluoro phenyl)-4-(4-methylsulphonyl)</w>
fluoro deoxyglucose</w>
fluoro citrate,</w>
fluoro benzyl
fluorobenzyl idene)</w>
fluoro acetyl-
fluoroacetyl- adducted</w>
fluoro acetic</w>
fluoro acetate</w>
fluoro -2
fluoro-2 ',3'-
fluoresce in-labeled</w>
fluoresce in,</w>
fluoresc ence),</w>
fluor quinolones</w>
fluor o</w>
fluor ination</w>
flunitrazepam -</w>
flunitrazepam ).</w>
fluindi one.</w>
fluid :</w>
fluid :
fluid: plasma</w>
fludro cortisone.</w>
fludarab ine,</w>
flucytos ine.</w>
fluctu ate</w>
flucloxacill in-associated</w>
flucloxacill in,</w>
fluc onazole-associated</w>
fluc onazol
flu- like'</w>
flu orimetric</w>
flu ori
flu ore
flu idized</w>
flu idity.</w>
flu ent</w>
flu ency.</w>
floxac in:</w>
flow- dependent</w>
flow metry)</w>
flow meter</w>
flow /
flow .(ABSTRACT</w>
flor a</w>
flor a.</w>
floc cul
floccul ent</w>
flick -related</w>
flexible -dose</w>
flest olol-induced</w>
fler oxacin-treated</w>
fler oxacin,</w>
flecain ide:</w>
flavon oids,</w>
flav ox
flav oprotein</w>
flav ine</w>
flav in-adenine-dinucleotide</w>
flav anone</w>
flash bac
flashbac ks.</w>
flash "</w>
flare -
flap s,</w>
flap .</w>
flap ,</w>
flan king</w>
flaccid ,</w>
flacc idity</w>
fla res,</w>
fla il</w>
fl ec
flec a</w>
fl ared</w>
fixed- dose,</w>
fixed- cycle</w>
fix ed.</w>
fix atives</w>
fix ative</w>
five- year-old</w>
five- month</w>
five- minute</w>
five- item</w>
five- frequency</w>
five- drug</w>
five ).</w>
fit s/h)</w>
fissu res.</w>
fissu re-in-ano</w>
fissu re
fir ing-frequency</w>
finger nails.</w>
fing er,</w>
fine- mapping</w>
finding s:</w>
finaster ide,</w>
fin ite</w>
filtr ate</w>
fill ing,</w>
filam ents,</w>
filam ent)</w>
fil ment</w>
fil ipin</w>
fil er
fil arial</w>
fil aria
fifty- two</w>
fifty- three</w>
fif th.</w>
fif teen.</w>
field- stimulated</w>
fiel d"</w>
fibro vascular</w>
fibro sis/
fibro plasia</w>
fibro ids.</w>
fibro calcification.</w>
fibrinogen -
fibrinogen- fibrin</w>
fibrin- degradation</w>
fibrin ous</w>
fibrill ation/
fibre optic</w>
fibrate- associated</w>
fibr in,</w>
fib res).</w>
fib rate-treated</w>
fib er's</w>
fi ve;</w>
fi lo
fi al
fferen t</w>
fever s.</w>
fever s,</w>
fever /
fever ),</w>
fetu ses;</w>
fetu ses).</w>
fet us?</w>
fet al/
fertili zation</w>
ferro cyanide</w>
fer tility:</w>
fer ric-reducing</w>
fer rets.</w>
fer ret</w>
fer oxamine,</w>
fer mentation</w>
fentanyl- nitrous</w>
fentanyl- etomidate-
fentanyl- dexamethasone,</w>
fentanyl +
fenoter ol-
fenoldopam -mediated</w>
fenfluramine .
fenflur amine:</w>
fenflur amine/
fen- phen</w>
fen- phen
fen nel</w>
fen bendazole</w>
femal e-
fem ur,</w>
fem or
felbam ate,</w>
fel y
fel d</w>
feed forward</w>
fed /low</w>
febarb amate</w>
febarb amate.</w>
feat ures;</w>
feat ured</w>
fear -like</w>
fe min
fe ed-
feed- back</w>
favour s</w>
favour able;</w>
fatigu e/
fatal ities,</w>
fatal ).</w>
fat ty-acid</w>
fast- track</w>
fast ing-induced</w>
fast ing)</w>
fast ed.</w>
fast ed-
fasted- refed</w>
fast -</w>
fascicul ations:</w>
fascicul ation,</w>
fascicul ata</w>
fasci otomies</w>
farnes yltransferase</w>
far mer</w>
far abine</w>
famil y),</w>
fam and
famand ole</w>
fain tness,</w>
fain ting</w>
failure [
failure[ 1]</w>
failure --
fail .</w>
faec ium</w>
faec al</w>
factor-beta 1/2</w>
factor- kappa</w>
factor- beta2</w>
factor s)</w>
factor ?</w>
factor :</w>
factor .(ABSTRACT</w>
factor -induced</w>
factor -1</w>
factor ),</w>
factor (s)</w>
fact ure
fact ors--
fact ored</w>
facilit ation,</w>
facil ity,</w>
facil ities.</w>
face- learning</w>
fac ultative</w>
fac ies,</w>
fac ient</w>
fa ir</w>
fa (c
fa(c p)</w>
f] thiepin-10-yl)oxy]-
f ts</w>
f s,</w>
f rotteur
f p).</w>
f omep
f lop
f light.</w>
f its.</w>
f ish
f inely</w>
f iciency</w>
f ic</w>
f avi
favi renz
f ancon
fancon i</w>
f an</w>
f aded</w>
f Ar
ezetimi be,</w>
eyel ids</w>
eyel ids,</w>
eye- of-the-tiger</w>
eye- head</w>
eye bro
eyebro w</w>
ey es).</w>
ey es),</w>
exud ate.</w>
extremit y:</w>
extrem ities;</w>
extrem is</w>
extrasystol es.</w>
extrastimul us</w>
extrapol ating</w>
extrap ontine</w>
extrap olate</w>
extrane uronal</w>
extrane ural</w>
extran eous</w>
extrac tions</w>
extrac tions.</w>
extrac ted.</w>
extra- stimulus</w>
extra- renal</w>
extra- oral</w>
extra- hippocampal</w>
extra thyroidal</w>
extra dimensional</w>
extra articular</w>
extra aortic</w>
extr uded</w>
extr apy
extrapy ramid
extr alimbic</w>
extr acts.</w>
external- beam</w>
extens ors</w>
extens ors.</w>
exten uates</w>
exten sively,</w>
exten sive.</w>
exten sive-stage</w>
exten sions,</w>
exsangu ination</w>
expres sional</w>
expres sion),</w>
expres sed.</w>
exposure- toxicity</w>
exposure -induced</w>
exposure );</w>
exposed ).</w>
expos ures).</w>
expon ent</w>
explo si
expl ant
expl ain
experiment s;</w>
experiment ally,</w>
experiment ;</w>
experience d.</w>
experienc es;</w>
exper ts,</w>
exper ti
expen sive.</w>
exped ited</w>
exped ite</w>
expector ant,</w>
expect ations,</w>
expect ation,</w>
expect ancy.</w>
expand ing.</w>
expan ded-
expanded- access</w>
exp elled</w>
exp ect</w>
exp 1,</w>
exist ed.</w>
exhib ited,</w>
exhib ite</w>
exhaust ing.</w>
exhaus tion,</w>
exfoli ation</w>
exercise- controls.</w>
exer tion,</w>
exencephaly ;</w>
exec utive)</w>
excre tion:</w>
excre ted.</w>
exclu sionary</w>
exclu sion.</w>
exclu de
excitator y/
excitation- inhibition</w>
excit otoxin,</w>
excit oneuro
excit ed.</w>
excit able</w>
excit abilities</w>
excipi ents</w>
exci sion.</w>
exchang er.</w>
exchang eable</w>
exces sive,</w>
excep tions.</w>
excep tional,</w>
excell ent:</w>
exanth ematous</w>
examin er's</w>
examin ations)</w>
examin able</w>
exam ples.</w>
exam ples,</w>
exam ined:</w>
exagger ate</w>
exacerb ated,</w>
ex- vivo-antigen-dependent</w>
ex- MDMA+</w>
ex position</w>
ex otropia</w>
ex ophthal
ex on-intron</w>
ex ocytosis</w>
ex ocytosis.</w>
ex o
ex itil-Perlongets)</w>
ex cur
ex changes.</w>
ex changed</w>
ex abri
ew es</w>
ew es.</w>
evul inate</w>
evo ked-
eviprostat -</w>
evidence d.</w>
evid ences.</w>
event uate</w>
event s/
even ing-dosed</w>
evalu ation;</w>
ev an
evan escent</w>
ev a</w>
euthan ization</w>
euk ar
eukar yotic</w>
eu thyroid.</w>
etra zole</w>
etoric oxib.</w>
etoposide -related</w>
etomidate- propylene</w>
etomid ate;</w>
etomid ate)</w>
etin- responsive</w>
etin- 2</w>
eti zed</w>
eti opathogenesis</w>
eti ologically,</w>
eti me.</w>
eti l.</w>
ethyn ylestradiol,</w>
ethyn yl-
ethylketazoc ine,</w>
ethylket ocyclazocine</w>
ethylket azocine</w>
ethylenediamine tetraacetic</w>
ethylenedi amine)</w>
ethyl] piperazinyl]-3-phenylpropan-2-ol</w>
ethyl- 3-methyl
ethyl-3-methyl pentanoyl</w>
ethyl- ,</w>
ethyl nitrosourea</w>
ethyl methionine</w>
ethyl line</w>
ethyl amine</w>
ethyl amine)</w>
ethyl )-2-
ethyl)-2- (4-methyl
ethyl)-2-(4-methyl -1-
ethyl)-2-(4-methyl-1- homopiperazinyl)benzimidazole</w>
ethoxy ethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole</w>
ethoxy estradiol</w>
ethoxy ]-
ethoxy )-
ethoxy)- 5-
ethoxy)-5- benzofuran
ethoxy)-5-benzofuran yl]-N'-methylurea</w>
ethnic ity.</w>
ethnic ities</w>
ethinylestradi ol-treated</w>
ethin ylestradio1/75</w>
ethin yl-
ether s,</w>
ether -a-
ether-a- go-go-related</w>
ether -</w>
ethanol- withdrawn</w>
ethanol- clonidine</w>
ethanol amine-
ethanolamine- o-sulphate,</w>
ethanol amide</w>
ethan ol-treated</w>
ethan ol)</w>
ethan e,</w>
ethambut ol:</w>
eth ynodiol</w>
eth nomedic
eth no
eth imide</w>
eth idine-associated</w>
eth ics</w>
eth ane-1-
ethane-1- hydroxy-1,1-diphosphonate</w>
eth ality,</w>
etexil ate,</w>
et ybenz
et t</w>
et kowicz,</w>
et amine</w>
esulf onic</w>
esulf on
estrus/ estrus</w>
estrogen- testosterone</w>
estrogen- receptor</w>
estrogen /
estrogen/ progesterone-induced</w>
estramust ine,</w>
estradiol-17 beta-glucuronide-induced</w>
estradiol-17 beta-D-glucuronide-induced</w>
estradiol -dependent</w>
estradiol -</w>
estradiol ).</w>
estim ates,</w>
estim at
estimat es).</w>
esthe tic</w>
esthe siae,</w>
ester- linked</w>
ester s,</w>
ester s)</w>
ester ases</w>
ester :</w>
est- corrected</w>
est riol</w>
est e
este em,</w>
est ants,</w>
est )</w>
est ).</w>
ess /
espec ially,</w>
esmo lol-ANH</w>
eser ine.</w>
escitalopram ;</w>
escitalopram :</w>
esch ar</w>
escap e,</w>
escal ate</w>
esc ing</w>
esc ents</w>
esc ence,</w>
es/ number</w>
es. 2.</w>
es tions</w>
es pesia</w>
es ne</w>
es fer
es capable</w>
es burg,</w>
es arian</w>
es ,"</w>
es "</w>
es ").</w>
erythropoie sis-stimulating</w>
erythropoi etin-responsive</w>
erythropoi esis,</w>
erythromyc ins</w>
erythromyc ins,</w>
erythromel algia</w>
erythrom ycin-treated</w>
erythrocy te.</w>
erythrocy te
erythroblast s,</w>
erythroblast ocytopenia</w>
erythroblast ocytopenia.</w>
erythro dys
erythrodys aesthesia</w>
erythermalg ia</w>
erythermalg ia.</w>
erythematos us-like</w>
erythemat ous,</w>
erythe ma
erv orden-Spatz</w>
erv ic
erule in,</w>
error s,</w>
error =
erro r.</w>
ero sions,</w>
ero onian</w>
ero ding</w>
erm B</w>
erlotinib -related</w>
erlotinib -induced</w>
ergotamine/ caffeine,</w>
ergometr ine-induced</w>
ergol ine-associated</w>
ergoc alc
ergocalc iferol</w>
erg uride</w>
erdo ste
erarch ical</w>
eral ocortico
eradic ation.</w>
eradic ation,</w>
er- tip</w>
er- than-
er- chromatid</w>
er sinia</w>
er s).</w>
er re</w>
er rati
er os
er field,</w>
er ation,</w>
er L
er '</w>
equisetiform is</w>
equip ment.</w>
equimyelo toxic</w>
equili bri
equili br
equi volume</w>
equi potent.</w>
equi potency</w>
equi hypotension</w>
equi effective,</w>
equ inovarus.</w>
equ ine-conjugated</w>
equ ilib
equ esne</w>
equ atorial</w>
equ ations.</w>
equ ation,</w>
equ al.</w>
eptifibati de</w>
eptifibati de-induced</w>
epti vely</w>
ept h</w>
ept )</w>
epsilon R
epsilonR AC
epsilonRAC K,</w>
epsilon )-
epsilon)- (
epsilon)-( carboxy
epsilon)-(carboxy methyl)
epsilon ),</w>
epoxy- car
epoxy-car vone</w>
epoprosten ol,</w>
epoch s,</w>
epl ase</w>
epitheli a.</w>
epist axis.</w>
epist axis,</w>
episode s).</w>
episi otom
epirubicin/ paclitaxel-containing</w>
epiphy ses</w>
epiphy seal</w>
epinephrine/ kg.</w>
epinephrine- secreting</w>
epinephrine- exacerbated</w>
epinephrine- augmented</w>
epinephr ine;</w>
epim ers</w>
epileptogene sis:</w>
epileptogene sis)</w>
epileptogen ecity</w>
epileptic us-associated</w>
epilept ogenicity</w>
epilepsy -associated</w>
epilep sies,</w>
epif lu
epidermi s.</w>
epiderm is</w>
epide mic,</w>
epicardi ally</w>
epicardi al,</w>
epicanth us,</w>
epicanth al</w>
epib atidine,</w>
epiandro sterone,</w>
epi membranous</w>
epi medium</w>
epi glottis</w>
ephedr ine/propofol/mixtures</w>
ephed ra</w>
epend ymal</w>
epal restat</w>
ep sin</w>
ep s)</w>
ep oxide,</w>
ep onate</w>
ep ineur
ep ine</w>
ep eta</w>
ep em
epem pidine</w>
eosinophil s).</w>
eosinophil ia-myalgia</w>
eosin- stained</w>
enzyme- inhibiting</w>
enzyme- dig
enzyme-dig ested</w>
enzym uria.</w>
enz berg,</w>
environ ments</w>
environ mentally</w>
enure tic</w>
enure sis,</w>
enucle ation</w>
entrop y.</w>
entrap ment</w>
entrap ment,</w>
entr apped</w>
entr ance</w>
entor hinal,</w>
enti ty?</w>
enti ties,</w>
enteropath ica.</w>
enter tained.</w>
enter ocytes</w>
enter ocutaneous</w>
entac ap
entacap one,</w>
ent- echo</w>
ent ropion</w>
ent ous</w>
ent ly;</w>
ent ly-
ent in.</w>
ent a</w>
ent -related</w>
ent ),</w>
ensu es</w>
ensu e</w>
ensu e.</w>
ensor ship</w>
ens ored</w>
enoxim one,</w>
enoxapar ine</w>
enoxapar in:</w>
enoxapar in-related</w>
enough ?</w>
enough ,</w>
enn ial</w>
enkephalin- catabolizing</w>
enkephalin ergic,</w>
enkephal ins,</w>
enhance ment.</w>
enh ance,</w>
engorg ed</w>
eng ulf
eng th
eng ine,</w>
eng agement</w>
eng ag
eng -
eng- mai-san</w>
enflur ane:</w>
enflur ane-based</w>
energ y,</w>
energ y"</w>
enem s</w>
enem as.</w>
ene-3,20- dione</w>
ene-1- alpha,25-
ene-1-alpha,25- (OH)2-
ene-1-alpha,25-(OH)2- D3</w>
ene- di
ene- VPA</w>
ene 's</w>
endotox in,</w>
endothelin -1
endothelial- to-mesenchymal</w>
endothel in.</w>
endothel in,</w>
endoscop ically.</w>
endoscop e</w>
endophthal mitis,</w>
endonuclease- dependent</w>
endometri um,</w>
endogen ous,</w>
endocrino pathies</w>
endocardi um,</w>
endoc apillary</w>
endo- diol)</w>
endo wed</w>
endi x</w>
ende av
endarte rectom
endang ering</w>
end- to-end</w>
end- tid
end- proximal</w>
end- point.</w>
end- plate</w>
end- labeling</w>
end ymoblastoma</w>
end tidal)</w>
end systolic</w>
end stage</w>
end points,</w>
end os
end oneurium</w>
end omicroscopy</w>
end ings,</w>
end feet</w>
end :</w>
encour aging:</w>
enco ding,</w>
encephalopath y;</w>
encephalopath y--19</w>
encephalopath y)</w>
encephalo gram</w>
encephalo gram,</w>
encephal y,</w>
encephal on.</w>
encephal itic</w>
ence/ abuse</w>
ence -related</w>
enc ircling</w>
enc es:</w>
enc as
encas ement</w>
enantiom er)</w>
enantiom er
enanth ate.</w>
enalapri lat.</w>
enalapri l:</w>
en-VPA ),</w>
en- Yang
en-Yang -R
en-Yang-R ong-Tang</w>
en- VPA)</w>
en- Sh
en-Sh en-Yang-Rong-Tang</w>
en- San-
en-San- Y
en-San-Y aun
en-San-Yaun g-Jung-Tang</w>
en sus</w>
en riched,</w>
en ote</w>
en jo
en ings</w>
en il.</w>
en iculum</w>
en ia,</w>
en forcement</w>
en ever</w>
en ess,</w>
en er</w>
en der</w>
en ded,</w>
en cain
encain ide,</w>
en c</w>
en bre
enbre l</w>
en adoline</w>
en adol
en :</w>
emul sions.</w>
emul sion"</w>
empye ma"</w>
emplo ys</w>
empir ically,</w>
emphasi zed,</w>
emphasi sed</w>
emotion ality</w>
emo tions</w>
emo dar
emit ted</w>
emis sions,</w>
emin ence.</w>
emin ence,</w>
emergency- department</w>
emergen cies,</w>
emerg ent).</w>
emerg e.</w>
ement- time</w>
eme togenicity</w>
embryos /
embryos/ fetuses</w>
embryol ethal</w>
embryo pathy,</w>
embry otoxic,</w>
embry ogenesis</w>
embran e-
embolism ),</w>
embol us.</w>
embol ization,</w>
embol ism;</w>
embol isation</w>
embol i)</w>
embol ectomy</w>
embed ment</w>
emb ark
emb )</w>
eman ate</w>
em s,</w>
em pyema</w>
em opamil</w>
em itting</w>
em it</w>
em ia/
em filer
em er
em ent)</w>
em barr
ely x)</w>
elu sive</w>
elu sive,</w>
elu ates</w>
elu ate.</w>
else where
elong ated</w>
ellular is</w>
ellip ticine</w>
elli si
ell ent</w>
ell ar
ell agic</w>
ell a.</w>
ell 's</w>
elimin ation,</w>
elimin ated,</w>
elimin ate,</w>
elic ited,</w>
elic anus</w>
elev ation)</w>
electroretino grams</w>
electroretino gram.</w>
electrophysi ologist</w>
electroneuro myographic</w>
electron- transport</w>
electroencephalo graphy.</w>
electroencephalo graphy,</w>
electroencephalo graphically</w>
electrocortico graphy.</w>
electrocardiogram )</w>
electro-ocu lography,</w>
electro- oscillograms</w>
electro pharmacological</w>
electro microscopic</w>
electro cerebral</w>
electro acupuncture</w>
electro -</w>
electrical- field-stimulated</w>
electrical- ,</w>
elec tivity</w>
ele mentary</w>
ele ment.</w>
elast ography</w>
elast ase</w>
elabor ate</w>
el zine</w>
el uting-bead</w>
el usive.</w>
el son</w>
el semi
el godipine-induced</w>
el der</w>
el bo
elbo w</w>
el ap
elap sed.</w>
el ).</w>
eighty- four</w>
eight- month</w>
eight- hour</w>
eight- fold</w>
eight- fold,</w>
eight- and-
eight-and- a-
eight-and-a- half-yr-old</w>
eicos an
ei ther,</w>
ei ro,</w>
ei omy
egu minosae),</w>
egg s</w>
efoni dipine</w>
efoni dip
effu sion)</w>
effor t,</w>
effor t
effici ency,</w>
effects-- such</w>
effect- site</w>
effect uating</w>
effect s?</w>
effect s.(ABSTRACT</w>
effect s).</w>
effect ?</w>
effect ,"</w>
effect ),</w>
effect "</w>
effec tive
effac ement.</w>
eff lo
efavirenz ,</w>
educ ation-matched</w>
educ ation-,</w>
edrophonium- provoked</w>
edroph onium.</w>
edroph onium-induced</w>
edi onbel)</w>
edema )</w>
ede tic</w>
ede mic</w>
ed side</w>
ed reich's</w>
ed al</w>
ed '</w>
ecz ko,</w>
ecyst ectomy</w>
ectom y-
ectom y)</w>
ectom ies.</w>
ecto domain</w>
ecti ve/
ect us</w>
ect ors</w>
ect asis</w>
ect asia.</w>
ecstasy )-related</w>
ecstas y.</w>
ecstas y-specific</w>
ecstas y-related</w>
ecopip am,</w>
eclamp sia,</w>
echocardiograph y-induced</w>
echocardiograph y-
echocardiograph ical</w>
echo- dobutamine</w>
echo ;</w>
echo ,</w>
ec otropic</w>
ec ation</w>
ec arin</w>
ec apone</w>
ec al</w>
eb ast
eb all</w>
eat en</w>
easi ly,</w>
eas y,</w>
early- systolic</w>
early -</w>
ear s)</w>
ear s),</w>
ear ly)</w>
ear lobes.</w>
ear lobe.</w>
ear ing</w>
eNO S.</w>
eIF2alpha (P)</w>
e.c. g.</w>
e- induced,</w>
e- containing</w>
e- 4-
e-4- phenyl-1,3-diselenole</w>
e thedium</w>
e siosis</w>
e se-Ellsworth</w>
e ligible,</w>
e j
e in.</w>
e hringer</w>
e det
e bro
e ating,</w>
e );</w>
dystrophin- deficient</w>
dystroph in.</w>
dystro glycan,</w>
dyston ia:</w>
dysphor ia.</w>
dysphasi a.</w>
dysphag ia:</w>
dysp noea.</w>
dysmorph ogen</w>
dysmen orrhea.</w>
dysmen orrhe
dyskinesi as
dyskinesi a;</w>
dyskinesi a-
dyskinesi a),</w>
dyskinesi a
dysgermin oma</w>
dysesthesi as,</w>
dyserythropoi esis</w>
dyserythropoi esis,</w>
dysarth ria.</w>
dys synergy</w>
dys morphism</w>
dys metric</w>
dys metria,</w>
dys maturation</w>
dys geusia,</w>
dys geusi
dys genesis,</w>
dys functions,</w>
dys fluency</w>
dys autonom
dysautonom ia</w>
dynorph in-related</w>
dynorph in,</w>
dynes/s/cm- 5),</w>
dynes/cm 5)</w>
dynes.s.cm- 5,</w>
dynam ically,</w>
dynam ic)</w>
dyn es</w>
dy ne
dy n</w>
dy ing-
dy es</w>
dy e-induced</w>
dy e-
dy azide</w>
dwarf ism.</w>
dur ation).</w>
dur ability,</w>
duplic ation.</w>
duloxet ine.</w>
duloxet ine-</w>
duct openia,</w>
duc t-positive</w>
dual- specificity</w>
dual- energy</w>
du ality</w>
du al,</w>
dt (s
dt(s z)</w>
drugs-- in</w>
drug- primed</w>
drug- paired</w>
drug- metabolizing</w>
drug- mediated</w>
drug- induced,</w>
drug- facilitated</w>
drug- exposed</w>
drug- environment</w>
drug- containing</w>
drug- attributable</w>
drug- adverse</w>
drug s-induced</w>
drug s--a</w>
drug s)</w>
drug s).</w>
drug s"</w>
drug .(ABSTRACT</w>
drug -</w>
drug '.</w>
dru s</w>
dru m</w>
drox idopa.</w>
drowsin ess/
drow sy.</w>
drow sy,</w>
drospiren one,</w>
dropout s,</w>
drople ts.</w>
drople t</w>
droperid ol:</w>
droperid ol-induced</w>
drop- outs</w>
drop- out.</w>
drop s:</w>
dro op
drink ing-water</w>
drin ks.</w>
drin ks,</w>
drin k.</w>
drin k,</w>
dri ven.</w>
dri ft</w>
dri d
drid den</w>
dream ing.</w>
draw s</w>
drain age.</w>
dra ining</w>
dr unk</w>
dr agon
dp/dt (max)</w>
doxy fluridine</w>
doxy cycline-induced</w>
doxorubicin/ dexamethas
doxorubicin/dexamethas one],</w>
doxorubicin-treated- catheterized</w>
doxorubicin- only</w>
doxorubicin- mediated</w>
doxorubicin- aconityl-lysozyme</w>
doxorubic inol</w>
doxifl uridine</w>
doxep in-induced</w>
dox azosin)</w>
down- titration</w>
down- regulating</w>
down- regulated.</w>
down ward,</w>
down regulation.</w>
down regulation,</w>
double-dumm y</w>
double- lumen</w>
double- immunolabeling</w>
double- ar
double-ar med</w>
double- J</w>
double d.</w>
doubl ings</w>
dot arizine</w>
dosing- time</w>
doses /day</w>
dose/ response</w>
dose-rel ated;</w>
dose-rel ate
dose-relate dly</w>
dose-depend ently;</w>
dose-depend ant</w>
dose- volume</w>
dose- responsive</w>
dose- ranging,</w>
dose- level</w>
dose- intensity,</w>
dose- escalated</w>
dose- dependency</w>
dose- comparison</w>
dose- and</w>
dose- additive</w>
dose- -a</w>
dose ]</w>
dose );</w>
dose ")</w>
dosage- limiting</w>
dos ings</w>
dos age-dependent</w>
dos age).</w>
dorsal -
dors orostral</w>
dorm ant</w>
dor zolamide/timolol.</w>
dor soventral</w>
dopaminerg ic-related</w>
dopamine-beta- oxidase</w>
dopamine- treated,</w>
dopamine- rich</w>
dopamine- replacing</w>
dopamine- innervated</w>
dopamine- containing</w>
dopamine- antagonistic</w>
dopamine- agonist</w>
dopamine- 2</w>
dopamine- 1</w>
dopamine 1</w>
dopa- mine</w>
dopa- estrogen</w>
dopa- decarboxylase</w>
dop maine</w>
dop am,</w>
donor- derived</w>
donor :</w>
donor ),</w>
don ation</w>
domopredn ate</w>
domopredn ate,</w>
domin ated.</w>
domin ant
dominant -negative</w>
dom et</w>
dom e</w>
dolicho ectasia</w>
dolasetr on.</w>
dol lars.</w>
dog s);</w>
dog '</w>
document s,</w>
docetaxel :</w>
docetaxel ).</w>
docetax al</w>
doc trine.</w>
doc tor</w>
doc tor
do- DHP</w>
do om</w>
do bry
dobry um</w>
do ,</w>
do )</w>
dn a</w>
dn 't</w>
dl- sotalol,</w>
dl- fenfluramine,</w>
dl (-1)</w>
dl (-1),</w>
dk 4</w>
dizziness/ syncope</w>
dizziness/ lightheadedness</w>
dizziness/ lightheadedness.</w>
dizziness +
dizzin ess)</w>
diz ation</w>
divorced/ separated</w>
diver ticular</w>
diver ted</w>
diver sion.</w>
diver sion,</w>
diver ging</w>
div ide</w>
diuretic s;</w>
dithiothre itol</w>
dithio uric</w>
dite kiren
dit sia</w>
disulfiram -like</w>
disulfi des</w>
disulfi de.</w>
disulfi de-
disulfi de)</w>
disulf onic</w>
disturbanc es;</w>
distribut ed,</w>
distribu tional</w>
distrib ute</w>
distres sed</w>
distr action</w>
distr action.</w>
distor tion.</w>
distor tion,</w>
distinguish es</w>
disten tion.</w>
disten sion.</w>
disten sion-induced</w>
disten sion,</w>
disten sibility</w>
dist ances.</w>
dist ally.</w>
dissemin ated,</w>
diss ector</w>
disput ed.</w>
disproportion ality</w>
displac ement-time</w>
disper sion,</w>
disp ute</w>
disp osable</w>
disp en
disorder s)</w>
disorder )</w>
disorder ),</w>
disopyram ide-associated</w>
disodi um.</w>
disease- specific</w>
disease- directed</w>
disease- -a</w>
diseas e),</w>
discrimin ations.</w>
discrep ant</w>
discre tion,</w>
discontinu ous,</w>
discontinu ities</w>
discontinu ance.</w>
discolor ation.</w>
disco vering</w>
discharge- ready</w>
discharge ;</w>
discharg es;</w>
discer ned</w>
discar ding</w>
discar ded</w>
disc -shaped</w>
disappoint ing,</w>
disappear ances</w>
disappea red;</w>
disappea red)</w>
disabl ing,</w>
dis solvable</w>
dis sol
dis satisfied</w>
dis proportionally</w>
dis position,</w>
dis posi
dis missed.</w>
dis mal</w>
dis location,</w>
dis integrins,</w>
dis integrating</w>
dis inhibitory</w>
dis inhibition.</w>
dis h,</w>
dis counting</w>
dis counted</w>
dis closing</w>
dis closed.</w>
dis clo
disclo ses</w>
dis ast
disast rous</w>
dis aggregation</w>
dis abilities,</w>
direct- current</w>
direc ts</w>
direc t"</w>
dipyridamole/ aspirin</w>
dipyridamole- associated</w>
dipyridamole- RNV</w>
dipyridamole- 201Tl</w>
dipyridamol e;</w>
dipyridamol e)</w>
dipren orphine</w>
diplo myelia</w>
dipivox il.</w>
diphther ia-pertussis-tetanus</w>
diphenyl methoxytropane</w>
diphenyl hydantoin
diphenyl -2-
diphenyl-2- picrylhydrazyl</w>
diphenyl -1,
diphenyl-1, 3,5-
diphenyl-1,3,5- hexatriene</w>
diphenyl -
diphenyl- imidazol
diphenhydram ine-induced</w>
diph antoin</w>
dip sia</w>
dip per</w>
dip per
dioxo- 5,5-
dioxo-5,5- diphenyl-imidazol
diop ters</w>
dinitro phenyl</w>
dinitro benzene</w>
dinit rate-</w>
dinit rate,</w>
din ol</w>
dimin ishes,</w>
dimethylbenz imidazol
dimethylamino phenyl)
dimethylamino adamant
dimethyl-4- phenylpiperaz
dimethyl-1-propargyl xanthine</w>
dimethyl-1-propargyl xanthine)</w>
dimethyl sulfoxide</w>
dimethyl sulfoxide,</w>
dimethyl propranolol),</w>
dimethyl barbituric</w>
dimethoxy- 6-(2-
dimeth isterone-ethinyl</w>
dimenhydrin ate.</w>
dimenhydrin ate,</w>
dimen sion.</w>
dilu tional</w>
dilu ents</w>
dilu ents.</w>
diltiazem 's</w>
dilev alol.</w>
dilev alol,</w>
dilemm as</w>
dilat ations</w>
dilat ations.</w>
dil ut
dil antin</w>
dil ant
diisopropyl fluoro
dihydroxy- alpha-
dihydroxy-alpha- truxillic</w>
dihydroxy icosa(5E-9,11,13Z)tetraenoic</w>
dihydroxy but
dihydroxybut anedi
dihydroxybutanedi oate</w>
dihydroxy benzoate</w>
dihydropyridine- type</w>
dihydrobenzofuran-7- carboxamide</w>
dihydro-beta-erythro idine</w>
dihydro-2,3-quinoxaline dione)</w>
dihydro- 7,8-
dihydro- 6-
dihydro uracil</w>
dihydro streptomycin</w>
dihydro rhodamine123</w>
dihydro quinidine,</w>
dihydro progesterone</w>
dihydro ergotamine.</w>
dihydro ergot
dihydro epiandrosterone</w>
dihydro codeine</w>
dihydro chloride.</w>
dihydro benz
dihydro -10-
dihydro -1-
digoxigen in</w>
digox ine</w>
digox in/
digox in-treated</w>
digox in-related</w>
digiti zing</w>
digitalis -,</w>
digit i</w>
digit alization</w>
difluoro methyl</w>
diflun isal,</w>
differenti als</w>
difference= 0.01).</w>
difference );</w>
differenc es?</w>
differen t).</w>
diff usion.</w>
diff using</w>
diff ici
diff er,</w>
diethylnor spermine</w>
diethylenetri amine</w>
diethylcarbamo yl)piperidino]-p-xylene</w>
diethylcarbam azine.</w>
diethylamino ethyl)</w>
diethylamino ethoxy
diethyl- ether.</w>
diethyl- 4,4'-
diethyl-4,4'- stilbene
diethyl dithiocarbamate</w>
diethyl amino)
diethylamino) ethyl</w>
diet :</w>
diet .(ABSTRACT</w>
diet -controlled</w>
diet -</w>
diet +/-
diet+/- AZT,</w>
dien es,</w>
diel drin
dideoxyinos ine,</w>
dideoxy nucleoside-induced</w>
didanos ine:</w>
didanos ine-related</w>
diclofenac/ misoprostol</w>
diclofenac/ misoprostol-treated</w>
diclofenac -treated</w>
diclofenac -dependent</w>
diclofenac )</w>
dichlorophenyl) -1-piperazinyl]
dichlorophenyl)-1-piperazinyl] but
dichlorophenyl)-1-piperazinyl]but yloxy)-
dichlorohexafluorocyclobut ane,</w>
dichlorodiammine platinum(II)</w>
dichloro- 2,2,2-trifluoroethane</w>
dichloro phenazine</w>
dichloro meth
dichloro acetic</w>
dichloro -1,</w>
dichlor v
dich otomy</w>
dich otomous</w>
dich loropyridyloxy)]benzene</w>
dicarboxyl ate,</w>
dic tated</w>
dic tate</w>
dic loxacill
dic ,</w>
dibutyr yl-
dibutyl nitrosamine</w>
dibuc aine-
dibucaine- resistant</w>
dibenzo[ b,
dibenzo[b, f]thiepin-10-yl)oxy]-
diazepam -like</w>
diazepam -evoked</w>
diazepam --
diazep inium</w>
diazemul s</w>
diazemul s,</w>
diathe sis,</w>
diastol ic/systolic</w>
diastol ic.</w>
diastemat omyeli
diarrhe a).</w>
diarrhe a),</w>
diar y-based</w>
diar y,</w>
diaphrag m-like</w>
diaphore tic,</w>
diant um</w>
diameter- diastole,</w>
diameter /
diameter )</w>
diam orphine.</w>
diam mine</w>
diam idine</w>
dialys ates</w>
dialys ate.</w>
dialys ate-
dialysate- side</w>
dialy sis:</w>
diagnos tically</w>
diagnos tic,</w>
diagno sed;</w>
diagno se.</w>
diagno se,</w>
diag ram</w>
diacetyl morphine,</w>
diabet ogenicity</w>
diabet es:</w>
diabe tic.</w>
diabe tic-
di- o-tolylguanidine</w>
di(2-ethylhex yl)</w>
di(2-ethylhex yl)-phthalate</w>
di zed</w>
di vision.</w>
di valproate</w>
di tioned</w>
di sialogangliosides</w>
di re</w>
di r</w>
di propionate.</w>
di polar</w>
di pepti
di palmitoyl</w>
di ocyte</w>
di meric</w>
di hydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benz
di fication</w>
di febarbamate.</w>
di estrous</w>
di enogest</w>
di ene</w>
di ed)</w>
di dn't</w>
di de
di butanoylmorphine</w>
di anhydro
dianhydro galactitol</w>
di an-American</w>
di aminopter
diaminopter idine-6-(N-
di aling</w>
di al-
dial- urethane</w>
di al
dial ing.</w>
di (n-
di(n- but
di(n-but yl)phthalate</w>
df= 3;</w>
dextromor amide</w>
dextro- isomer</w>
dextro se-
dextro rotatory</w>
dextro amphetamine-induced</w>
dexter ity.</w>
dexrazox ane,</w>
dexmedetom idine-associated</w>
dexamethasone- suppressible</w>
dexamethasone- free</w>
dexamethas one;</w>
dexamethas one/
dexamethas one
dex trans</w>
dex fenfluramine)</w>
dex etimide</w>
dex chlorpheniramine,</w>
dex ar
dexar az
dex amp
dexamp etamine</w>
dex amisole</w>
dex a-treated</w>
dex .</w>
dex -H
dex-H T.</w>
devic es,</w>
devi ations.</w>
develop ed:</w>
develop ed),</w>
detri mental.</w>
detox ification,</w>
determin ation,</w>
deterior ates</w>
deterior ates.</w>
deterior ated.</w>
deter rent</w>
deter gent</w>
deter g
detect ed;</w>
detect .</w>
detail s,</w>
detach ed</w>
detach able</w>
det orubicin</w>
destruc tive/disruptive</w>
destruc tion,</w>
dest ine</w>
desquam ative</w>
desper ately</w>
desor ption/ionization</w>
desogestrel .</w>
desogestrel ,</w>
desogestrel )</w>
desmopress in,</w>
desmethyl imipramine,</w>
desmethyl diazepam</w>
desmethyl clomipramine</w>
desmethyl astemizole.</w>
desmethyl astemizole,</w>
design s,</w>
design er</w>
desi red.</w>
desi rab
dese thyl
descript ors</w>
descri ption,</w>
descri p
des-Arg 10
des-Arg10 HOE</w>
des-Arg (10
des-Arg(10 )-
des-Arg(10)- HOE</w>
des loratadine,</w>
des feroxamine</w>
des artan</w>
des acetyl</w>
dermatomyosi tis,</w>
dermato ses</w>
dermat omal</w>
dermat ological,</w>
dermat ologic.</w>
dermat ologic,</w>
derm ally</w>
derivati zed</w>
deriv ate</w>
deri ved:</w>
deri ved.</w>
derang ement.</w>
der ma.</w>
der m-Nitro</w>
der )</w>
depriv ation;</w>
depressi ve-like</w>
depress or,</w>
depress ant-like</w>
depress ant,</w>
depres sive.</w>
depres sions.</w>
depres sion-
depres sed)</w>
depot -type</w>
depot -
depolymer ized</w>
depolymer ization.</w>
depolar ized</w>
depolar izations.</w>
depolar izations,</w>
deple tion;</w>
deple tion/
deple tion)</w>
deple ter</w>
depersonal ization,</w>
depend ents</w>
depend ences</w>
depend ences,</w>
depend ence/abuse</w>
depend ence
depend ,</w>
depart mental</w>
dep ths</w>
dep opulation</w>
deoxynucleoti d
deoxycorticosterone- NaCl</w>
deoxychol ate.</w>
deoxy- Delta
deoxy-Delta 12,
deoxy-Delta12, 14-
deoxy uridine.</w>
deoxy thymidine;</w>
deoxy nojirimycin</w>
deoxy cor
dentistr y</w>
dentistr y,</w>
densit ometry)</w>
dens ity-
dens a.</w>
denop amine,</w>
dendrit e.</w>
dend rin,</w>
den ying</w>
den oting</w>
den ied.</w>
den ham</w>
den at
denat ured</w>
demyelin ative</w>
demonstr ations</w>
demonstr able,</w>
demedull ated</w>
demarc ated,</w>
deman ds,</w>
deman ded</w>
delta- sleep-inducing</w>
delta- delta</w>
delta- amino-n-
delta-amino-n- valeric</w>
delta- HCH</w>
delta- AVA</w>
delta- ALA-
delta FosB</w>
delta (1)-</w>
deliri um)</w>
deline ation</w>
deline ates</w>
deli ber
deli a</w>
dele tion.</w>
dele teri
dele ted.</w>
dele ted,</w>
delay ;</w>
dela y-interposed</w>
delT961 Cn</w>
del ic</w>
del a</w>
dehydrat ed,</w>
dehydrat ase,</w>
defl ection,</w>
deficit s)</w>
deficit )</w>
deficit ),</w>
defibrill ated</w>
defer ox
defensi veness</w>
defect s),</w>
defect ).</w>
defec ate,</w>
def end</w>
deep- tendon</w>
deep ening</w>
decreas ing,</w>
decre mental</w>
decre ment.</w>
decont amin
decontamin ation,</w>
decongest ants</w>
decline d;</w>
decid u
decibel s)</w>
deci sively</w>
deci sions,</w>
dechall enge</w>
dechall enge,</w>
decel eration</w>
deced ents</w>
deced ent</w>
decarboxyl ase.</w>
decapit ate</w>
decade ;</w>
deca hydro
dec ubitus</w>
dec o
dec lines.</w>
dec ilit
dec erebr
dec eptively</w>
dec ay.</w>
dec ameth
debri s</w>
debri s.</w>
debil itation</w>
debat able.</w>
deb ate,</w>
death s)</w>
death s),</w>
death -
deafferen tiation</w>
deafferen tation.</w>
deaf ening.</w>
deaf ening,</w>
deacetyl ases</w>
de-de- pointes</w>
de- escalated</w>
de toxic
de synchronized,</w>
de stin
de sensitisation</w>
de regulation</w>
de potentiation</w>
de posit</w>
de phenylhydantoin</w>
de parting</w>
de odar
de mise</w>
de iodin
de grade</w>
de glutition</w>
de differentiated</w>
de amino-8-D-arginine</w>
de amination</w>
de amin
de activation,</w>
de activ
deactiv ations,</w>
de ).</w>
dd l</w>
dd I
dd C-
ddC- neuropathy</w>
days/ week)</w>
days/ week),</w>
days )].</w>
day- time</w>
day- old)</w>
day- night</w>
day time,</w>
day s.
day s-
day -to-
day-to- day</w>
day -1.</w>
daunorubic in/ebselen-treated</w>
daunorubic in-treated</w>
daun omycin.</w>
daun omyc
daugh ters,</w>
datas et,</w>
datab as
datab an
dat a;</w>
dark- light</w>
dark ness</w>
dark ened</w>
darbe poietin-
dar one</w>
dar ifen
dapson e,</w>
dantrol ene,</w>
danger ousness</w>
danaparo id,</w>
dan sylated</w>
dampen ing</w>
dam ping</w>
dam pen</w>
dam ages.</w>
dam .</w>
daidze in,</w>
dact y
dacarb azine-induced</w>
da zole-induced</w>
da zole,</w>
da iry</w>
da d</w>
dPI/ dt</w>
dP/dtej c)</w>
dP/dt ]</w>
dP/dt ),</w>
d4 T.</w>
d/ wk</w>
d/ mo</w>
d/ mo)</w>
d/ metastatic</w>
d-amphetamine- disrupted</w>
d-B inet</w>
d- week</w>
d- tubocurarine.</w>
d- tubocurarine-induced</w>
d- stage</w>
d- ribose</w>
d- propranolol,</w>
d- jugular</w>
d- isomer</w>
d- glucuronidase,</w>
d- galactosamine</w>
d- dimer</w>
d- carnit
d- bucindolol</w>
d- amphetamine-</w>
d- amphet
d- Tc</w>
d- N-acetylglucosaminidase,</w>
d- AMPH
d-AMPH -treated</w>
d,l- sotal
d, 6
d,6 h),</w>
d(CH2)5D AVP,</w>
d(CH2)5 Tyr
d(CH2)5Tyr (Me
d(CH2)5Tyr(Me )
d(CH2)5Tyr(Me) AVP</w>
d y</w>
d s'</w>
d s
d nig-Hoffmann</w>
d l</w>
d iterpenoids</w>
d ing-
d ine:</w>
d ine-related</w>
d ine's</w>
d ate).</w>
d ance</w>
d actin
d V
d TXB2</w>
d T
dT c,</w>
d SP)</w>
d SP
d Ro
dRo R</w>
d R</w>
d R)</w>
d R
dR /dtmax</w>
d G)</w>
d :
d 8)</w>
d .).</w>
d -related</w>
d (LVP
d(LVP )/
d ';</w>
cytotoxic ,</w>
cytostatic s,</w>
cytos ol.</w>
cytos ine.</w>
cytos ine)</w>
cytoplas ms</w>
cytoplas matic</w>
cytopen ic,</w>
cytoly tic)</w>
cytokine- inducible</w>
cytoarchitect onic</w>
cyto segres
cyto reduction</w>
cyto protectant</w>
cyto proliferative</w>
cyto pathy?</w>
cyto pathic</w>
cyto genetics</w>
cyto differentiating</w>
cyto architecture</w>
cytarab ine:</w>
cyt. c</w>
cyt ology,</w>
cyt ological</w>
cyt ochemistry</w>
cyt ochemistry,</w>
cystometro graphy</w>
cystometro gram</w>
cysti tis-induced</w>
cysti tis)</w>
cysteinyl dopa</w>
cyste inyl</w>
cyste amine.</w>
cyste amine,</w>
cyst ou
cyst oscop
cyst ography</w>
cyst ectomy.</w>
cyst atin</w>
cyst adenomas</w>
cyprohept adine-induced</w>
cynom ologus</w>
cyl inder</w>
cyclosporine- prednisone</w>
cyclosporine- prednisone-treated</w>
cyclospor ine-related</w>
cyclophosphamide/ m2</w>
cyclophosphamide/ etoposide
cyclophosphamide -pretreated</w>
cyclophosphamide -containing</w>
cyclopentyl adenosine,</w>
cyclopent yl</w>
cyclopent amethyl
cyclooxygen ase.</w>
cyclooxygen ase,</w>
cyclohexyl amine</w>
cyclohexyl amine).</w>
cyclohexyl -1-nitrosourea</w>
cyclohexim ide-induced</w>
cyclohexen onic</w>
cyclohex ane</w>
cyclohepten- 5-
cyclohepten-5- ylidene)-1-
cyclohept an-
cycloheptan- 5,10-imine</w>
cyclo thymic</w>
cyclo thymia</w>
cyclo tetrasiloxane</w>
cyclo serine,</w>
cyclo propyl
cyclo oxygenation</w>
cyclo oxygenase-1</w>
cyclo oxygenase-
cyclo oxgenase</w>
cyclo hydrolase</w>
cycli zine.</w>
cycli zine,</w>
cyclase- cyclic</w>
cycl in</w>
cycl idine</w>
cycl ically</w>
cycl es);</w>
cycl an
cyanopindo lol</w>
cyano- 7-nitro
cyan amide</w>
cy tisine,</w>
cy tidine,</w>
cy tidine's</w>
cy te-macrophage</w>
cy st,</w>
cutoff s</w>
cut s</w>
custom ized</w>
custom -made</w>
cus hi
current- voltage</w>
curett age.</w>
cure d,</w>
cur ve(inf)</w>
cur v
cur se,</w>
cur red</w>
cur ious</w>
cur are</w>
cur able</w>
cune atum</w>
cune ate,</w>
cumul atively</w>
cumber some</w>
cultur ist</w>
cult uring</w>
culmin ate</w>
cuff ing</w>
cuff ed</w>
cue- reactivity</w>
cue- exposure</w>
cu. mm.</w>
cu e.</w>
cu bo
cs f</w>
crystall in</w>
cryst al-induced</w>
cryptococ cemia.</w>
cryos urgical</w>
cryos ections</w>
cryoglobul ins</w>
cryo therapy,</w>
cryo preserved</w>
cry oprecipitate,</w>
cry ogenic</w>
cruci ate</w>
cruci al.</w>
cruc ially</w>
crouch ing</w>
cross-tal k</w>
cross-fo ster
cross- titration</w>
cross- sex</w>
cross- sec
cross- reactivity,</w>
cross- reactivities</w>
cross- reactive</w>
cross- reactions</w>
cross- perfused</w>
cross- link</w>
cromoglyc ate,</w>
cromakalim ,</w>
cro ft</w>
critic ized</w>
critic al.</w>
criter ia;</w>
crist ae,</w>
cri spa</w>
cri sis:</w>
cri ed</w>
crest -derived</w>
creatinine "</w>
creatin ines</w>
creatin ine).</w>
creatin in-
cream s.</w>
cre pit
cre eping</w>
cre atin</w>
cre ams</w>
crav ings.</w>
crav ing-related</w>
cranios ynostosis,</w>
crani otom
crani al,</w>
crack -associated</w>
crack ")</w>
cp m/mg</w>
coxib s,</w>
cox a</w>
cox -2</w>
cow s;</w>
covari ance.</w>
cour se:</w>
cour se).</w>
cour aging</w>
coupl ing,</w>
counterpart s,</w>
counter shock</w>
counter s</w>
counsel ing,</w>
coun selling</w>
coumar an-3-yl)
cough s</w>
cough )</w>
cotrimox azole-induced</w>
cot inine,</w>
cost- savings</w>
cost- saving</w>
cost- offset</w>
cost- effective,</w>
cost );</w>
cosol vent
cortis ol-exposed</w>
cortis ol-compared</w>
corticosteroid s:</w>
corticosteroid -
corticoster one-supplemented</w>
corticoster one-induced</w>
corticom edullary</w>
cortico- pontine-cerebellar</w>
cortico id.</w>
cortico id-pretreated</w>
cortical- basal</w>
cortic otropic</w>
cortic opapillary</w>
cortex /
corro sive</w>
correl ational</w>
correl ate.</w>
correc tly.</w>
correc tions</w>
correc tion).</w>
correc table</w>
correc t,</w>
corpor ation</w>
corpor a,</w>
coron aries</w>
coron a
corona virus</w>
corne ally</w>
corne a.</w>
corn u.</w>
corn ification</w>
cord ing.</w>
cord ectomy</w>
cord antly</w>
cor t
cor responds,</w>
cor ded</w>
cor d-
copies/ ml.</w>
copies/ ml,</w>
copies/ mL.</w>
copies/ mL)</w>
cop rimary</w>
cop ious</w>
coordin ative</w>
coordin ate</w>
cooper ative.</w>
convulsion s:</w>
convuls ant-
convul sive,</w>
conver sion;</w>
conver sely</w>
conver ging</w>
conver gent</w>
conver ge</w>
conveni ent,</w>
conven tional,</w>
conve ys</w>
conve ying</w>
controll able.</w>
controll ability</w>
control s.
control .(ABSTRACT</w>
control );</w>
contribut e.</w>
contribu tion.</w>
contralater ally</w>
contralater al)</w>
contradictor y.</w>
contradic tion</w>
contradic t</w>
contract ures.</w>
contrac tion:</w>
contrac tion-associated</w>
contrac tion)</w>
contra indications.</w>
contra indicated,</w>
continu um.</w>
continu ously,</w>
continu ous
continu ations</w>
contin ous</w>
contin ental</w>
contex ts</w>
contex ts,</w>
contempor aneously,</w>
contempor aneous</w>
contamin ating</w>
contamin ants</w>
cont our</w>
cont ain
cont ag
contag ios
cont acts.</w>
cont acting</w>
cont '
consump tion)</w>
consul tations</w>
construc ting</w>
constric tions.</w>
constric t</w>
constitu ents.</w>
constipati on"</w>
consti pating</w>
const ants,</w>
const ant
constant ;</w>
consol idate</w>
consist ently,</w>
consider ably,</w>
consider able.</w>
conside red;</w>
connex in-
connec tivity</w>
connec tivity.</w>
connec tions.</w>
connec tion,</w>
conjug ates.</w>
coni ine-treated</w>
coni ine-induced</w>
congenit a</w>
congenit a.</w>
cong estants,</w>
confusion /
confu sion;</w>
confu sion)</w>
confron t</w>
conflic ting.</w>
conflic ted</w>
conflic t/anxiety</w>
configur ation,</w>
conf used.</w>
condylo ma</w>
conduct ances.</w>
conditioned- cued</w>
condition -
condition- by-time</w>
condition ).</w>
concurren t,</w>
concomit ants</w>
conclu sions:</w>
concer ning.</w>
concept uses.</w>
concept al</w>
concep tion.</w>
concep tion).</w>
concentration/ time</w>
concentration- side</w>
concentration- controlled</w>
concentration- blood</w>
concentration s).</w>
concentration -</w>
conceiv ably</w>
conce al
conceal ment</w>
conc ana
concana valin</w>
con verse</w>
con vection-enhanced</w>
con strain
con son
con sensu
con ing.</w>
con forms</w>
con formation.</w>
con formation,</w>
con form</w>
con e-mediated</w>
con cordantly</w>
con coc
con 2</w>
con 2,</w>
computer- aided</w>
compromi ses</w>
comprehen sively</w>
compound -related</w>
compound 's</w>
compoun ded</w>
compoun d-induced</w>
compoun d-
component s;</w>
complication s--
complication s).</w>
complic ation?</w>
complic ated,</w>
complex es),</w>
complex ;</w>
complex -
complex- partial</w>
complex )</w>
complex ).</w>
comple ters</w>
comple ments</w>
comple ment-fixing</w>
comple ment-dependent</w>
complain ant</w>
competi tive,</w>
compart ment,</w>
comparison s:</w>
compar ator-
comparator- controlled</w>
compan y.</w>
compan y's</w>
compa re,</w>
comp ly</w>
comp any</w>
comorbidi ties;</w>
community- dwelling</w>
common place</w>
common ly.</w>
commissu re-
commis sion</w>
commence ment.</w>
comm ence</w>
combin atorial</w>
combin ations:</w>
combin ations,</w>
comb ustion</w>
comb retastatin</w>
comb at
combat -induced</w>
com ycin.</w>
com pressing</w>
com prehend</w>
com positions</w>
com mitting</w>
com as</w>
com a
coma ',</w>
colum n,</w>
colpos copy</w>
color ata</w>
coloni es.</w>
colocysto plasty,</w>
collo id-osmotic</w>
collicul i</w>
collicul i.</w>
colli sion</w>
collateral- dependent</w>
collateral- CA1</w>
collater als,</w>
collater alized</w>
collap sibility</w>
collap sed.</w>
collagen s.</w>
coll ec
colchic ines.</w>
col laboration</w>
col laborating</w>
col ingual</w>
coincident al.</w>
coincident al,</w>
coincid entally</w>
cognition- improving</w>
cognition- enhancing</w>
cogni tion,</w>
coffe e.</w>
coer uleus.</w>
cod ons</w>
cocult ured</w>
coccidioidomy cosis.</w>
cocaine/ atropine</w>
cocaine/ alcohol</w>
cocaine- withdrawn</w>
cocaine- unrelated</w>
cocaine- seeking.</w>
cocaine- panic</w>
cocaine- mediated</w>
cocaine- kindling</w>
cocaine- experienced</w>
cocaine- diazepam</w>
cocaine- dependent,</w>
cocaine- cue</w>
cocaine- conditioned</w>
cocaine- abuse</w>
coca ine?</w>
coca ine).</w>
coc cygeal</w>
coc a</w>
cobal tous</w>
coal escing</w>
coagul ation:</w>
coagul ation-
coagulation- fibrinolysis</w>
coagul ating</w>
coagul ase</w>
coagul ase-
coagulase- negative</w>
co-ordin ation,</w>
co-morbidi ties</w>
co- treatment.</w>
co- suppression</w>
co- primary</w>
co- prescription</w>
co- operative</w>
co- operation</w>
co- occurrence</w>
co- morbidity.</w>
co- localization</w>
co- injection</w>
co- injected</w>
co- infection:</w>
co- deleted</w>
co- agonist</w>
co- Dobut
co-Dobut amin
co very</w>
co vert</w>
co variance</w>
co res</w>
co receptors.</w>
co re.</w>
co re)</w>
co propor
co localizes</w>
co loboma</w>
co ingestion.</w>
co ingestants</w>
co infusion</w>
co infection</w>
co infection.</w>
co factors,</w>
co exists</w>
co exist</w>
co enzymes</w>
co bra</w>
co at-
coat- core</w>
co assemble</w>
cnemi us</w>
cm2/ min</w>
cm/ sec</w>
cm/ sec,</w>
cm H2O,</w>
cm 2,</w>
cm .
cm (-1))</w>
cm (-
cluster s.</w>
cluster ing,</w>
clump ing,</w>
clum sy</w>
clozap ine:</w>
clozap ine)</w>
cloxacill in:</w>
cloti azepam,</w>
closed- port</w>
closed- loop</w>
clonid ine:</w>
clonid ine-like</w>
clonid ine)-mediated</w>
clonid ine),</w>
clon us.</w>
clon us)</w>
clon ed,</w>
clomi pr
clomi phene-induced</w>
clomi phene,</w>
clofib rate-dependent</w>
clofib rate)</w>
clofazim ine.</w>
clobut inol,</w>
clo voxamine</w>
clo ud
clo ts.</w>
clo ts,</w>
clo th
clo t-
clo t
clo sely,</w>
clo metac
clo bet
clobet asole</w>
clit oris.</w>
clit oral</w>
clinico- therapeutic</w>
clinici an.</w>
clinici an,</w>
clinical/ ethical</w>
clinical- pathologic</w>
clinic ally-
clinic al.</w>
clinic :</w>
clindam ycin-associated</w>
clin ofibrate</w>
clin ofibrate,</w>
climb ing.</w>
clentiaz em,</w>
clemast ine</w>
cleav age-
cleavage- enhancing</w>
clear ly.</w>
cle b
claw ing</w>
clav icle</w>
claudic ation,</w>
clau strum,</w>
clau stroph
classi fications</w>
classi fic
classi c,</w>
classes :</w>
class -specific</w>
clar ified</w>
clamp ,</w>
claim .</w>
cl one.</w>
cl inging</w>
cl en
cl ay</w>
cl an
clan destine</w>
citronell al</w>
citalopram :</w>
cit rate:</w>
cit ing</w>
cisplatin- paclitaxel</w>
cisplatin- ,</w>
cisplatin um-navelbine</w>
cisplat in-treated</w>
cisplat in-resistant</w>
cisplat in-related</w>
cisplat in),</w>
cisapri de-associated</w>
cisapri de-
cisapri de)</w>
cisDDP-then-pct x).</w>
cis- dichlorodiammineplatinum(II)</w>
cis- N-
cis-N- [2-(3,4-dichlorophenyl)ethyl]-
cis-N-[2-(3,4-dichlorophenyl)ethyl]- 2-
cis-N-[2-(3,4-dichlorophenyl)ethyl]-2- (1-pyrrolidinyl)
cis-N-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl) cyclohexylamine).</w>
cis- (+)-
cis-(+)- 5-methoxy
cis-(+)-5-methoxy -1-
cis-(+)-5-methoxy-1- methyl-2-
cis atracurium-induced</w>
cis atracurium,</w>
cirrho sis;</w>
cirrho sis:</w>
cirrho sis).</w>
circumst ance</w>
circumferen ce.</w>
circumferen ce,</w>
circumferen ce
circum ventricular</w>
circum vented</w>
circum oral</w>
circuit ,</w>
circl es,</w>
ciproxif an</w>
cinnar izine,</w>
cing ulated</w>
cinacalce t,</w>
cin chon
cin anserin</w>
cin anserin.</w>
cimetid ine:</w>
cimetid ine-related</w>
cimetid ine)</w>
cim er</w>
cilnidip ine,</w>
cilex etil,</w>
cilex eti
cil 's</w>
cigaret tes,</w>
cidofovir ,</w>
ciclo prolol,</w>
cic atric
cicatric ial</w>
ci tic</w>
ci sional</w>
ci gu
chronotrop ic,</w>
chronic- phase</w>
chronic- onset</w>
chron ological</w>
chron o-</w>
chron ically.</w>
chron ic.</w>
chron ic).</w>
chron ic),</w>
chromos omes.</w>
chromos ome-
chromatography/ time-of-flight</w>
chromatography/ electrochemical</w>
chromatography- tandem</w>
chromat ograms</w>
chrom olytic</w>
chos en,</w>
chori ocarcin
chori ocapillaris</w>
chondro itinase</w>
cholinomime tics,</w>
choling eric</w>
cholinergically- mediated</w>
cholinerg ics)</w>
choline- deficient</w>
cholin oceptive</w>
cholin ';</w>
cholesterol/ HDL</w>
cholesterol ;</w>
cholesterol -like</w>
cholesterol )</w>
cholester ogenesis</w>
cholester ogenesis.</w>
cholestasi s;</w>
cholest atic.</w>
cholecystokin in
cholangi ocellular</w>
cholang iti
chol yl
chol ine-containing</w>
chol angiography.</w>
chol angiogram</w>
chocer ca</w>
chlorpromaz ine-associated</w>
chlorpromaz ine).</w>
chlorothiaz ide-induced</w>
chloroqu ine/hydroxychloroquine</w>
chloroqu ine-</w>
chloroform -
chlorofluoro carbons.</w>
chloroethyl nitrosourea</w>
chlorobut anol</w>
chlorobut anol,</w>
chloro-7- iodo-8-hydroxyquinoline)</w>
chloro- phenyl)-piperazin-1-yl]-propyl}-pyrrolidin-2-one</w>
chloro- APB</w>
chloro- 2,2,2-trifluoroethane</w>
chloro dibenzo[b,f]thiepin-10-yl)oxy]-
chloro benztropine</w>
chloro benzoic</w>
chloro acetaldehyde</w>
chloro -1,
chloro-1, 2,2,2-
chloro-1,2,2,2- tetrafluoroethane</w>
chlorisondam ine,</w>
chlordiazep oxide.</w>
chloramphenic ol,</w>
chlor phentermine</w>
chlor phentermine.</w>
chlor methi
chlor ine</w>
chlor imipramine)</w>
chlor ide;</w>
chlor hydrate</w>
chlor hexidine-digluconate</w>
chlo as
chloas ma.</w>
chim panze
chim ney</w>
chim eric</w>
childhood :</w>
child birth.</w>
child -
child- completed</w>
chicken s.</w>
chicken pox</w>
chicken pox,</w>
chick s,</w>
chias m.</w>
chi ro
chi -squ
chemotherapy- treated</w>
chemotherapy- responsive</w>
chemotherapy- -a</w>
chemotherap y/radiotherapy</w>
chemotherap y)</w>
chemotherap ies.</w>
chemot axis</w>
chemoconvuls ant</w>
chemoconvuls ant-induced</w>
chemo sis,</w>
chemo reflex-induced</w>
chemo prophylaxis,</w>
chemo kine,</w>
chemo genic</w>
chemo embolization</w>
chemo embolization.</w>
chemilumin escence.</w>
chemic al.</w>
chemic al
chem o</w>
chem istry.</w>
chem e</w>
chelat ors.</w>
chelat ors,</w>
chelat es</w>
chel eryth
check list</w>
chec ked.</w>
che ese</w>
che ap
charybdotox in,</w>
charge- density</w>
charge -dependent</w>
characteris ing</w>
character s</w>
character ,</w>
char ts.</w>
char fman</w>
chaper one</w>
channel- blockers</w>
channel s)</w>
channe lopathy</w>
chang es)</w>
chang es),</w>
challenge -
challeng es,</w>
chalaz ion</w>
chain s.</w>
ch rysotherapy</w>
ch op
ch ment</w>
ch ,</w>
ceti rizine-induced</w>
cess ation:</w>
cess (R)</w>
cervix ;</w>
cervix :</w>
cervic al-
certain ly,</w>
certa inty.</w>
cerivastat in-gemfibrozil</w>
cerivastat in,</w>
cerebri ;</w>
cerebello thalamocortical</w>
cerebello medullary</w>
cerebell i</w>
cer oid-lipofuscin
cer amide,</w>
cephapir in,</w>
cephaloth in-induced</w>
cephal y,</w>
ceph azol
centur ies</w>
centur ies,</w>
centro acinar</w>
centrally- injected</w>
centr al/
central/ spinal</w>
cent rifug
cent er-
cent but
cent ;</w>
cembran oid</w>
cellular ity.</w>
cells/micro l;</w>
cells/micro L.</w>
cells/ mm3.</w>
cells/ mm3).</w>
cells/ L</w>
cells/ 3</w>
cell/ mm(3),</w>
cell- rich</w>
cell- reduced</w>
cell- line</w>
cell- deficient</w>
cell- death</w>
cell- cycle</w>
cell ular,</w>
cell s-1</w>
cell ing</w>
cell -like</w>
cell -induced</w>
cell -cell</w>
cell )</w>
cel and</w>
cefuroxi me,</w>
ceftazidime -treated</w>
cefotet an-treated</w>
cefotet an
cefotaxime .</w>
cefosel is-induced</w>
cefoperaz one.</w>
cefoperaz one-induced</w>
cefazed one.</w>
cefazed one)-treated</w>
cef epime-induced</w>
cef epi
cef al
cefal ospor
cef ad
cefad rox
ce t's</w>
ce sium</w>
ce sium.</w>
ce ful</w>
ce ase</w>
ce an</w>
ce -like</w>
ce )</w>
cavit y;</w>
cavernos a</w>
caveol ins</w>
caveol in-
cave olar</w>
cav a,</w>
cauti ously.</w>
cause -specific</w>
cause ".</w>
caus al.</w>
caudat us-
caud ate.</w>
caud alis</w>
caud al-
caud al,</w>
cau ses:</w>
catheter izations,</w>
catheter ization).</w>
catheter ism.</w>
catheter ;</w>
catheter -related</w>
catheter -based</w>
catheter )</w>
cath inone</w>
cath inone,</w>
categor y,</w>
categor ised</w>
catecholamine- halothane-induced</w>
catecholamine- containing</w>
catechol s</w>
catechol aminergic,</w>
catech ol,</w>
cataton ia/
catastroph e</w>
cataract ogenic</w>
catar rh
catar ia)</w>
catar acts;</w>
catar act.</w>
catalyst s.</w>
cataly zing</w>
cataly tic)</w>
cataly tic'</w>
cataly st</w>
catalepsy- enhancing</w>
catalepsy ;</w>
catalepsy )</w>
catalepsy ).</w>
catalepsy ),</w>
catalepsy '</w>
catabol ized</w>
cat chment</w>
castr ation-
castration- resistant</w>
cast rates.</w>
cast or</w>
caspase- 9</w>
caspase- 1</w>
casopit ant,</w>
cases/ person-years</w>
cases/ 1000</w>
case- reports</w>
case- note</w>
case- -
case in)</w>
case i</w>
casca des</w>
cas ual
cas pases</w>
cas h</w>
cas es--
cas enote</w>
carumon am</w>
cartilagin ous.</w>
carri er.</w>
carri age</w>
carrageenan/ kaolin</w>
carrageen an.</w>
carrageen an,</w>
caroti d-jugular</w>
caroten oid</w>
carnit ine;</w>
carnit ine-depleted</w>
carmust ine-
carmofur ,</w>
caregi ver</w>
care r</w>
care -associated</w>
cardioverter/defibrill ator.</w>
cardioverter-defibrill ators</w>
cardioverter-defibrill ator.</w>
cardiover ted</w>
cardiotoxic ity;</w>
cardiotoxic .</w>
cardiotoxic ,</w>
cardiomyopath y--
cardiomyocyt es:</w>
cardiomyo plasty,</w>
cardiomy ocyte-specific</w>
cardio- toxicity</w>
cardio- pulmonary</w>
cardio regulatory</w>
cardio protector</w>
cardio protectant</w>
cardio protect
cardio pathy.</w>
cardio pathy,</w>
cardio inhibition</w>
cardio graphy.</w>
cardio graphy,</w>
cardio acceleration</w>
cardic .</w>
cardi otrophin-1</w>
cardi otoc
cardi ology.</w>
cardi ologists;</w>
cardi c</w>
carcinom as)</w>
carcinom a).</w>
carcin ostatics</w>
carcin omatosis.</w>
carcin oembryonic</w>
carcas s</w>
carcas s.</w>
carboxypiperazin-4- yl)-propyl-1-phosphonic</w>
carboxyp eptidase-G2</w>
carboxymethylcell ulose.</w>
carboxylester ase</w>
carboxylester ase.</w>
carboxyl ate,</w>
carboxycyclo propyl)glycine</w>
carboxy-3-hydroxy phenylglycine</w>
carboxy- ly
carboxy octyl]-L-alan
carboxy methyl</w>
carbox amide)</w>
carboplatin- containing</w>
carboplatin ),</w>
carboplat in)</w>
carbonyl s</w>
carbon )</w>
carbim ide-ethanol</w>
carbim azole-dependent</w>
carbidopa -
carbidopa- levodopa</w>
carbap enem,</w>
carbamyl choline</w>
carbamyl cholin';</w>
carbamo yloxy
carbamazepine -10,</w>
carbamazep ine;</w>
carbamazep ine:</w>
carbaceph em</w>
carb oline-3-carboxylate</w>
car vac
car tograph
car sinom)</w>
car is.</w>
car ious</w>
car ds.</w>
car bodi
carbodi imide</w>
car acemide</w>
captopri l),</w>
capsul e)</w>
capsaicin- untreated,</w>
capsaicin- mediated</w>
capsaicin- injected</w>
capsaicin- containing</w>
capsaicin- based</w>
capsaicin- ,</w>
capsaic inoides</w>
capsaic in:</w>
capsaic in/
capsaic in),</w>
capre omycin.</w>
capecitab ine-docetaxel</w>
capac ities,</w>
cap no
cap itis</w>
cannab imi
candidat es.</w>
candidat es,</w>
candesart an.</w>
candesart an-induced</w>
candesart an)</w>
cancer -associated</w>
cancer --
cancell ed</w>
canalicul us</w>
canalicul i,</w>
canal s</w>
canal .</w>
canal ,</w>
can ned</w>
can .</w>
campt ocormia</w>
campa ign</w>
camera- derived</w>
cam sy
cam era.</w>
calmodul in-dependent</w>
callo sum.</w>
calibr e</w>
caldi amide</w>
calcul ations,</w>
calcul able
calculable ).</w>
calcium/ calmodulin</w>
calcium- sensing</w>
calcium- phosphorus</w>
calcium- entry</w>
calcium- antagonist</w>
calcium- and</w>
calcium- alkali</w>
calcitri ol-mediated</w>
calcit onin.</w>
calcit onin-
calcin osis.</w>
calcific ations,</w>
calci uria,</w>
calci um-</w>
calci um)</w>
calci um's</w>
calbindin- D
calbindin-D 9
calbindin-D9 k</w>
cal pastatin</w>
cal m</w>
cain ide-induced</w>
caffeine- administration</w>
caffe ine-containing</w>
cadher in,</w>
cac hex
cab ergoline.</w>
cab ergoline-induced</w>
ca zole,</w>
ca vities</w>
ca therization</w>
ca thecolamine-induced</w>
ca strat
ca sting</w>
ca siragu
ca re-
ca ine)</w>
ca esarian</w>
ca ecal</w>
ca diocyte</w>
cTn I.</w>
cGMP- dependent</w>
cAMP- regulated</w>
cAMP- PDIE</w>
c/ s;</w>
c/ LDL-c</w>
c-fos -positive</w>
c-fos -
c- positive</w>
c- myc</w>
c- family</w>
c- fa(cp)</w>
c- a</w>
c- Fos-like</w>
c ure.</w>
c ure,</w>
c repancies</w>
c remophor,</w>
c remaster</w>
c ramp</w>
c r</w>
c oxibs</w>
c otrans
c ochemical</w>
c ity.</w>
c f)</w>
c ess</w>
c esare
c er</w>
c ensus</w>
c ensorship</w>
c ecum</w>
c c,</w>
c ane</w>
c ance
c all.</w>
c ages,</w>
c ]-
c RA,</w>
c NOS</w>
c Min
c GVHD.</w>
c GVHD,</w>
c G
c FSGS</w>
c FSGS.</w>
c DNA.</w>
c Clure</w>
c AR
c AMP.</w>
c AMP,</w>
c AMP)</w>
c 2,</w>
c "</w>
bypass :</w>
bypas ses.</w>
bw ).</w>
bw ),</w>
butyryl cholinesterases</w>
butyl- isonitrile</w>
butyl sparteine</w>
buttoc ks.</w>
buttoc k.</w>
butr amine-induced</w>
butaz ones</w>
butaclam ol</w>
but ter</w>
but oxide,</w>
but orphanol.</w>
but aprost</w>
but anol</w>
busulfan/ cyclophosphamide</w>
buspir one:</w>
bus y</w>
burst/ 100</w>
burst s.</w>
burn ing/pruritus</w>
bur ying),</w>
bur n-injured</w>
bur gh,</w>
bupropi on:</w>
bupropi on-associated</w>
buprenorph ine-induced</w>
bupivacaine/ epinephrine/
bupivacaine- ,</w>
bupivaca ine-treated</w>
bund les,</w>
bumin aemic</w>
bulo meter.</w>
bull ae,</w>
bulim ic.</w>
bulb ectomized</w>
bul lo
bul ized</w>
bul ging</w>
bul b.</w>
bul ,</w>
build -up</w>
buff ers</w>
buff ering,</w>
buff er-tip</w>
buff er)</w>
bud ral
bucindo lol.</w>
bucindo lol,</w>
buc kling</w>
buc colingual</w>
buc co-
buc cal
bub ble</w>
bu tramine</w>
bu thionine-
bu se
bu propri
bu procaine</w>
bu pranolol</w>
bu ild</w>
bt O(2)</w>
brucello sis,</w>
bru ising,</w>
bru ise</w>
brother s</w>
bronchospas m)</w>
broncho- pulmonary</w>
broncho- dilating</w>
broncho- alveolar</w>
bronchi olitis</w>
bronchi ectasis</w>
bronch orrhoea,</w>
bronch itis,</w>
bronch io-alveolar</w>
bromocript ine:</w>
bromocript ine)</w>
bromo- 2,5-di
bromo-2,5-di methoxyphenethylamine</w>
bromo fosfamide</w>
bromo -1-
bromo-1- chloro-2,2,2-trifluoroethane</w>
brom peridol.</w>
brom osul
brom ocyclic</w>
brom oc
broaden ing</w>
broad- complex</w>
broad band</w>
broad ,</w>
bro minated</w>
bro iler</w>
briefl y,</w>
bridge -to-
breath- holding</w>
breath s</w>
breath s.</w>
breath lessness</w>
breath ed</w>
breast- conservation</w>
breast feeding.</w>
breast /
breakthrough ,</w>
break s),</w>
break down,</w>
break age</w>
bre vis</w>
bre taz
bre eding</w>
bre ed,</w>
branch es.</w>
bran ded,</w>
brainstem- cerebellum</w>
brainst em
brain- dissociated</w>
brain- death</w>
brain- blood</w>
brain- behavior</w>
braf ish</w>
bradykine tic.</w>
bradykin in-mediated</w>
bradycardia- tachycardia</w>
bradycardia /
bradycardia -induced</w>
bradycardia ).</w>
brady- arrhythmia</w>
brady arrhythmias;</w>
brady arrhythmia.</w>
brady arrhythmia,</w>
bracket ed</w>
bra sili
bra h
bra e</w>
br ush,</w>
br o</w>
br inging</w>
bp m),</w>
box es</w>
boun ds</w>
botul ism.</w>
both ;</w>
both ),</w>
bot tles</w>
bot t</w>
bortezomib- dexamethasone</w>
bortezomib -treated</w>
border line,</w>
bor ns</w>
bor ate</w>
boo ster
bon ding</w>
bolus- dosed</w>
bol uses.</w>
bol us+
bol ster</w>
bol ene</w>
body- building</w>
body builders</w>
bodi es).</w>
bo y)</w>
bo ost</w>
bo ok
blun ted.</w>
blue- albumin</w>
blu e).</w>
blood- pressure.</w>
blood- perilymph</w>
blood- forming</w>
blood- based</w>
blood- aqueous</w>
blood- CNS</w>
blocker s).</w>
blockade :</w>
block s;</w>
block s)</w>
block ing.</w>
block ed,</w>
block age.</w>
block a
blocka des</w>
blo ts</w>
blo ts,</w>
blinde d.</w>
blinde d)</w>
bli ster</w>
bleph ar
blephar itis,</w>
bleph a
blepha rophimosis,</w>
bleed ings</w>
bleed ing;</w>
bleed ing)</w>
bleb s,</w>
ble omycin-induced</w>
ble d,</w>
blast s.</w>
blast ine</w>
blan k</w>
bladder- pelvic</w>
bladder :</w>
bladder -derived</w>
black enings</w>
bl yopia.</w>
bl amed</w>
bizar re,</w>
bismu th,</w>
bis- (2-chloroethyl)-1-nitrosoure
bis-(2-chloroethyl)-1-nitrosoure a),</w>
bis(1-methylethyl) phosphorofluoridate</w>
bis(1- adamant
bis(1-adamant ylcarbamoyl)-1,2-methano[60]fullerene</w>
bis piperazinedione</w>
bis phosphate</w>
bis cus</w>
bis benzyl
bisbenzyl isoquinoline</w>
bis [3-
bis[3- (N,N-
bis[3-(N,N- diethylcarbamoyl)piperidino]-p-xylene</w>
bis [2-
bis[2- (3,5-
bis[2-(3,5- dichloropyridyloxy)]benzene</w>
bis (4'-fluorophenyl)
bis(4'-fluorophenyl) amine</w>
birth weight.</w>
birth s.</w>
bir ds'</w>
bipolar ity,</w>
bipolar ,</w>
biphasi c
biotin ylation</w>
biot in-conjugated</w>
biosyn thesi
biopsy- proven,</w>
biopsy ;</w>
biopsy )</w>
biopsy ).</w>
biopsi es:</w>
biopsi es)</w>
biopsi es).</w>
biopsi es").</w>
biomark ers.</w>
biom icroscopy.</w>
biolog ic,</w>
biochemist ries</w>
bioavail abilities</w>
bio flavonoid,</w>
bio feedback,</w>
bio electrical</w>
bio activation.</w>
binge- eating</w>
binge- abstinence</w>
binge ing</w>
bing es</w>
bind ers</w>
bind ers.</w>
bin omial</w>
bin o-
bin der</w>
bimod ally</w>
bim ato
bim an
biman ual</w>
billion/ mL</w>
bilirub in
bili ver
bile- drained</w>
bilater al),</w>
bil inear</w>
bil ay
bigemin y.</w>
big- ET-1</w>
bifur cations</w>
bifid a:</w>
bif unctional</w>
bif id</w>
bicyclo [2.
bicyclo[2. 2.
bicyclo -
bicyclo- orthobenzoate)</w>
bicucull ine-
bicucul ine</w>
bicarbon ate-treated</w>
bicarbon ate-
bicarbon ate)</w>
bicalutamide- tamoxifen</w>
bicalutamide- anastrozole</w>
bicalut amide.</w>
bicalut amide,</w>
bic eps.</w>
bic eps,</w>
bi- directional</w>
bi- SPEC
bi-SPEC T/
bi-SPECT/ dobutamine</w>
bi sexual</w>
bi pyridine</w>
bi phenyl-4-
bi os
bi le/perfusate</w>
bi le
bi gg
bi ennial</w>
bi dimensional</w>
bi an</w>
bezafib rate.</w>
bezafib rate-induced</w>
bey ond.</w>
bever ages.</w>
between- status</w>
between- product</w>
betwe en
betax olol,</w>
betam imetics</w>
betagam ma-subunits.</w>
betacy totoxic</w>
betacy tot
betablock er.</w>
beta= -
beta4- subunits</w>
beta4- containing</w>
beta2-leukocyte-integrins +</w>
beta2- agonists</w>
beta2- adrenoceptors</w>
beta2- adrenoceptors,</w>
beta1- ,</w>
beta-methyl choline</w>
beta-hydroxy -17</w>
beta-hydroxy -17-
beta-funaltrex amine</w>
beta-carboline-3- carboxamide</w>
beta-carbol ine-induced</w>
beta-OH SD,</w>
beta-HSD 2)</w>
beta-H SD)</w>
beta-D-arabinofuranos ylcytosine</w>
beta-CC E.</w>
beta-(4- dimethylaminophenyl)
beta- stimulatory</w>
beta- rhamnosyl</w>
beta- receptor-blocking</w>
beta- ratio</w>
beta- pregnan</w>
beta- phenylethylamine</w>
beta- oxidation.</w>
beta- ol</w>
beta- naltrexol</w>
beta- muricholic</w>
beta- mimetics</w>
beta- mimetics.</w>
beta- methasone</w>
beta- mediated</w>
beta- hydroxylase-like</w>
beta- cyclopentamethyl
beta- blockage</w>
beta- antagonists.</w>
beta- amyrin,</w>
beta- agonist,</w>
beta- adrenolytic</w>
beta- adrenoceptor-blocking</w>
beta- adrenoceptor-
beta- adren
beta- SR.</w>
beta- GALF</w>
beta- Estradiol</w>
beta- End
beta- Blockade</w>
beta- 2'
beta- (4-chlorophenyl)-1-
beta-(4-chlorophenyl)-1- methylpiperidine-3alpha-
beta- (2'-
beta-(2'- phenyl-2'-cyclopentyl-2'-hydroxy-ethoxy)tropane</w>
beta(2)- agonists</w>
beta(2)- adrenoceptor-mediated</w>
beta(2)- AR</w>
beta(1)- adrenoceptor-selective</w>
beta ]-
beta H</w>
beta H)</w>
beta 3-
beta -1,</w>
beta )-
bet an
bet al
best- assessed</w>
bes ylate</w>
bes udotox</w>
berb erine,</w>
ber ries</w>
benzylthio uracil.</w>
benzylpenicillo yl-poly-L-lysine</w>
benzylpenicillo ate,</w>
benzyloxy resorufin</w>
benzyliden epempidine</w>
benzyliden e-4-phenyl-1,3-diselenole</w>
benzyl pempidine</w>
benzyl glutarim
benzoylecgon ine.</w>
benzodiazepine/ GABAA</w>
benzodiazepine-3- carboxylate)</w>
benzodiazepine- receptor</w>
benzodiazepine- GABAA</w>
benzodiazepine- GABA-
benzodiazepine-GABA- chloride</w>
benzodiazep ine;</w>
benzodi oxane</w>
benzo[ b]
benzo[b] furan-2-ylsulfonyl)
benzo yl-4-chloro-N-methyl-N</w>
benzo yl-
benzo yl)-
benzo ate,</w>
benzo (F
benzene /
benzene/ adrenaline</w>
benz yloxy-4-methoxymethyl-
benz ylate</w>
benz yl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methylaminobenzamide</w>
benz yl)
benz oxaz
benz opyrone</w>
benz ol
benz ocaine</w>
benz iso
benz hex
benz ene-
benz arone</w>
benz aldehyde,</w>
benflu orex.</w>
benefit/ risk</w>
benefit ?</w>
benef its,</w>
bendroflu methiazide</w>
bendroflu methiaz
bench side</w>
bench -to-
bench-to- bedside</w>
benazep ri
ben fotiamine</w>
ben dazole,</w>
bemegri de</w>
below- knee</w>
below- average</w>
bell ifer
bell -shaped</w>
belie ve,</w>
behavior )</w>
begun ;</w>
begun ,</w>
before hand)</w>
before ;</w>
bed- ridden</w>
bed ding</w>
beclo meth
bec ause,</w>
beats/ minute.</w>
beats/ minute,</w>
beats/ hour/patient</w>
beats. min-1</w>
beats. min(-1).</w>
beat .
beat ),</w>
bead ing"</w>
be x</w>
be verage</w>
be st,</w>
be low)</w>
be lia</w>
be lat
be er,</w>
be dridden</w>
be d;</w>
be c</w>
be am
bcl -
bax /
bati mastat</w>
bati ma
bath ,</w>
basel ines</w>
basel ine;</w>
base/ kg,</w>
bas ed.</w>
bas eball</w>
bas ally</w>
bas alis</w>
bas al-to-apical</w>
barri er/density</w>
baroreflex- sympathoneural</w>
baro reflex.</w>
baro reflex,</w>
baro receptors,</w>
bari um-treated</w>
barbit al,</w>
bar /
bar/ podium/grid'</w>
band ed</w>
ban ning</w>
ban k</w>
bambuter ol.</w>
balloon s'</w>
ballo on.</w>
bal salazide</w>
bal ances</w>
baical ein,</w>
bag ,</w>
baculo viral</w>
bacteremia/ sepsis/meningitis</w>
backcros sing,</w>
back- efflux</w>
back wards,</w>
back leak</w>
back crosses,</w>
babo ons.</w>
babo on.</w>
bab esiosis</w>
bF GF,</w>
b.w. /day</w>
b. p.
b- hexahydro
b w/
b w,</w>
b row
b ones,</w>
b l</w>
b ital</w>
b isopro
b id;</w>
b ay
bay esian</w>
b ],</w>
b S)-
b J</w>
b :</w>
b /kg</w>
b )-
b ))</w>
aztreon am.</w>
azithrom ycin-induced,</w>
azimil ide</w>
azido- 2',3'-
azido-2',3'- deoxythymidine;</w>
azetidin ylmethoxy)-2-chloropyridine)</w>
azetid in-2-ones</w>
azepam -induced</w>
azepam )</w>
azep ine]</w>
azep in</w>
azep ex
azathiopr ine:</w>
azathiopr ine-treated</w>
azathiopr ine-related</w>
azaspirodec ane
azaspirodecane dione</w>
az locillin</w>
az ine-
az e</w>
az e)</w>
az ard</w>
az acyclo
azacyclo alk
azacycloalk an-2-
azacycloalkan-2- one</w>
az a-
ay ama</w>
ay ag
ayag ida's</w>
axoplas m</w>
axon opathy"</w>
axo- ax
axo-ax onic</w>
ax oplasmic</w>
ax on.</w>
ax ella</w>
ax )</w>
awaken ed.</w>
awak ening,</w>
awak e.</w>
awa y,</w>
awa king</w>
awa ited.</w>
aw oke</w>
aw kward</w>
aw ian</w>
aw ful);</w>
avoid ,</w>
avocad os</w>
avir/ fosamprenavir</w>
avir -induced</w>
avid in</w>
avi um</w>
avi um-intracellul
avi er</w>
aver ting</w>
aver ted.</w>
aver sions.</w>
aver sion.</w>
aver age)</w>
avail able;</w>
avail ability,</w>
av itript
av a</w>
autotrans plantation</w>
autotrans plant
autos omic</w>
autophag osome</w>
autop sy-proven</w>
autop sies.</w>
autonom ically</w>
autom atic,</w>
autoimmun ity),</w>
auto regulation,</w>
auto receptors.</w>
auto receptors,</w>
auto immune,</w>
auto antigen</w>
auto antibody
autis m:</w>
author ized</w>
author 's</w>
aut um
aut osomal-dominant</w>
aut operfused</w>
aut ogenic</w>
auscult ation</w>
aus sian</w>
aure us.</w>
auranof in.</w>
aur idines</w>
aun ois</w>
aun a)</w>
aul ts</w>
aul inoa</w>
augment in)</w>
augment ed.</w>
audio gram.</w>
audi ovestibular</w>
aud anosine</w>
auc her</w>
au x</w>
au to</w>
au kesha,</w>
au hinia</w>
au d</w>
atyp icals,</w>
atyp ical,</w>
atyp ia,</w>
attribut ing</w>
attribut e,</w>
attri tion,</w>
attri bution</w>
attri bu
attention- demanding</w>
attend ance</w>
atten tiveness</w>
atten tion/
atten ded.</w>
atten ded,</w>
attempt s/
attack s/year)</w>
attac h</w>
atroph ied</w>
atrop ine-treated</w>
atrop ine-
atro gin-1</w>
atrizo ate</w>
atria- His</w>
atri sts</w>
atri o
atri m</w>
atri a;</w>
atri a:</w>
atre sia.</w>
atran orin</w>
atracurium- associated</w>
atracuri um-related</w>
atovaquone/ proguanil</w>
atorvastat in-treated</w>
atomoxet ine,</w>
atmosph eres</w>
atism ,</w>
atipamezol e)</w>
ation/ Western</w>
ation- competent</w>
ation ]</w>
ation .
ation -dose</w>
ation 's</w>
ating- therapy</w>
atid ine.</w>
ati ve)</w>
ati ve"</w>
athle te.</w>
athi on</w>
athero thrombosis</w>
athero thrombosis.</w>
ather o-
athe rectomy</w>
atenolo l-verapamil</w>
atenolo l)</w>
aten olol-induced</w>
aten ess</w>
ate-Lip uro</w>
ate- pretreatment</w>
ate- mefloquine</w>
